Induction NN B-NP
of IN B-PP
NF-KB NN B-NP
during IN B-PP
monocyte NN B-NP
differentiation NN I-NP
by IN B-PP
HIV NN B-NP
type NN I-NP
1 CD I-NP
infection NN I-NP
. . O

The DT B-NP
production NN I-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HIV-1 NN B-NP
) ) O
progeny NN B-NP
was VBD B-VP
followed VBN I-VP
in IN B-PP
the DT B-NP
U937 NN I-NP
promonocytic JJ I-NP
cell NN I-NP
line NN I-NP
after IN B-PP
stimulation NN B-NP
either CC B-PP
with IN I-PP
retinoic JJ B-NP
acid NN I-NP
or CC O
PMA NN B-NP
COMMA COMMA O
and CC O
in IN B-PP
purified VBN B-NP
human JJ I-NP
monocytes NNS B-NP
and CC O
macrophages NNS B-NP
. . O

Electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
and CC O
Southwestern NN B-NP
blotting NN I-NP
experiments NNS I-NP
were VBD B-VP
used VBN I-VP
to TO B-VP
detect VB I-VP
the DT B-NP
binding NN I-NP
of IN B-PP
cellular JJ B-NP
transactivation NN I-NP
factor NN I-NP
NF-KB NN I-NP
to TO B-PP
the DT B-NP
double JJ I-NP
repeat-KB JJ I-NP
enhancer NN I-NP
sequence NN I-NP
located JJ B-ADJP
in IN B-PP
the DT B-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
. . O

PMA NN B-NP
treatment NN I-NP
COMMA COMMA O
and CC B-CONJP
not RB I-CONJP
retinoic JJ B-NP
acid NN I-NP
treatment NN I-NP
of IN B-PP
the DT B-NP
U937 NN I-NP
cells NNS I-NP
acts VBZ B-VP
in IN B-PP
inducing VBG B-VP
NF-KB NN B-NP
expression NN I-NP
in IN B-PP
the DT B-NP
nuclei NNS I-NP
. . O

In IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
from IN B-PP
monocytes NNS B-NP
or CC O
macrophages NNS B-NP
COMMA COMMA O
induction NN B-NP
of IN B-PP
NF-KB NN B-NP
occurred VBD B-VP
only RB B-SBAR
if IN I-SBAR
the DT B-NP
cells NNS I-NP
were VBD B-VP
previously RB I-VP
infected VBN I-VP
with IN B-PP
HIV-1 NN B-NP
. . O

When WRB B-ADVP
U937 NN B-NP
cells NNS I-NP
were VBD B-VP
infected VBN I-VP
with IN B-PP
HIV-1 NN B-NP
COMMA COMMA O
no DT B-NP
induction NN I-NP
of IN B-PP
NF-KB NN B-NP
factor NN I-NP
was VBD B-VP
detected VBN I-VP
COMMA COMMA O
whereas IN O
high JJ B-NP
level NN I-NP
of IN B-PP
progeny NN B-NP
virions NNS I-NP
was VBD B-VP
produced VBN I-VP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
this DT B-NP
factor NN I-NP
was VBD B-VP
not RB I-VP
required VBN I-VP
for IN B-PP
viral JJ B-NP
replication NN I-NP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
in IN B-PP
monocytic JJ B-NP
cell NN I-NP
lineage NN I-NP
COMMA COMMA O
HIV-1 NN B-NP
could MD B-VP
mimic VB I-VP
some DT O
differentiation\/activation JJ B-NP
stimuli NNS B-NP
allowing VBG B-VP
nuclear JJ B-NP
NF-KB NN I-NP
expression NN I-NP
. . O

Positive JJ B-NP
and CC I-NP
negative JJ I-NP
regulation NN I-NP
of IN B-PP
immunoglobulin NN B-NP
gene NN I-NP
expression NN I-NP
by IN B-PP
a DT B-NP
novel JJ I-NP
B-cell-specific JJ I-NP
enhancer NN I-NP
element NN I-NP
. . O

A DT B-NP
new JJ I-NP
B-cell-specific JJ I-NP
enhancer NN I-NP
element NN I-NP
has VBZ B-VP
been VBN I-VP
identified VBN I-VP
3' JJ B-NP
of IN B-PP
E4 NN B-NP
and CC O
the DT B-NP
octamerlike JJ I-NP
motifs NNS I-NP
in IN B-PP
the DT B-NP
human JJ I-NP
immunoglobulin NN I-NP
heavy-chain NN I-NP
gene NN I-NP
enhancer NN I-NP
. . O

Tandem JJ B-NP
copies NNS I-NP
of IN B-PP
this DT B-NP
67-bp JJ I-NP
MnlI-AluI NN I-NP
fragment NN I-NP
COMMA COMMA O
when WRB B-ADVP
fused VBN B-VP
to TO B-PP
the DT B-NP
chloramphenicol JJ I-NP
acetyltransferase NN I-NP
gene NN I-NP
driven VBN B-VP
by IN B-PP
the DT B-NP
conalbumin JJ I-NP
promoter NN I-NP
COMMA COMMA O
stimulated VBD B-VP
transcription NN B-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
but CC B-PP
not RB B-PP
in IN I-PP
Jurkat NN B-NP
T NN I-NP
cells NNS I-NP
or CC O
HeLa NN B-NP
cells NNS I-NP
. . O

Footprinting NN B-NP
analysis NN I-NP
revealed VBD B-VP
that IN B-SBAR
the DT B-NP
identical JJ I-NP
sequence NN I-NP
CCGAAACTGAAAAGG NN I-NP
COMMA COMMA O
designated VBN B-VP
E6 NN B-NP
COMMA COMMA O
was VBD B-VP
protected VBN I-VP
by IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
from IN B-PP
B NN B-NP
cells NNS I-NP
COMMA COMMA O
T NN B-NP
cells NNS I-NP
COMMA COMMA O
or CC O
HeLa NN B-NP
cells NNS I-NP
. . O

Gel NN B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
using VBG B-VP
a DT B-NP
synthetic JJ I-NP
E6 NN I-NP
motif NN I-NP
detected VBD B-VP
a DT B-NP
B-cell-specific JJ I-NP
complex NN I-NP
in IN B-PP
addition NN I-PP
to TO I-PP
a DT B-NP
ubiquitous JJ I-NP
band NN I-NP
found VBN B-VP
also RB B-PP
in IN I-PP
T NN B-NP
cells NNS I-NP
and CC O
HeLa NN B-NP
cells NNS I-NP
. . O

In IN B-PP
agreement NN I-PP
with IN I-PP
the DT B-NP
results NNS I-NP
of IN B-PP
gel NN B-NP
retardation NN I-NP
assays NNS I-NP
COMMA COMMA O
tandem JJ B-NP
copies NNS I-NP
of IN B-PP
the DT B-NP
E6 NN I-NP
motif NN I-NP
stimulated VBD B-VP
transcription NN B-NP
in IN B-PP
ARH77 NN B-NP
and CC O
Raji NN B-NP
cells NNS B-NP
but CC B-PP
not RB B-PP
in IN I-PP
Jurkat NN B-NP
or CC O
HeLa NN B-NP
cells NNS B-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
a DT B-NP
mutant JJ I-NP
E6 NN I-NP
motif NN I-NP
lost VBD B-VP
both CC O
in FW B-NP
vitro FW I-NP
binding NN I-NP
activity NN I-NP
and CC B-PP
in FW B-NP
vivo FW I-NP
enhancer NN I-NP
activity NN I-NP
. . O

In IN B-PP
striking JJ B-NP
contrast NN I-NP
to TO B-PP
the DT B-NP
mouse NN I-NP
Ig NN I-NP
heavy-chain JJ I-NP
enhancer NN I-NP
COMMA COMMA O
in IN B-PP
which WDT B-NP
the DT B-NP
octamer NN I-NP
motif NN I-NP
acts VBZ B-VP
as IN B-PP
a DT B-NP
B-cell-specific JJ I-NP
enhancer NN I-NP
element NN I-NP
COMMA COMMA O
the DT B-NP
human JJ I-NP
enhancer NN I-NP
contains VBZ B-VP
an DT B-NP
octamerlike JJ I-NP
sequence NN I-NP
with IN B-PP
one CD B-NP
base NN I-NP
substitution NN I-NP
which WDT B-NP
bound VBD B-VP
octamer-binding JJ B-NP
proteins NNS I-NP
with IN B-PP
only RB B-NP
very RB I-NP
low JJ I-NP
affinity NN I-NP
and CC O
showed VBD B-VP
no DT B-NP
enhancer NN I-NP
activity NN I-NP
of IN B-PP
its PRP$ B-NP
own JJ I-NP
. . O

Interestingly RB B-ADVP
COMMA COMMA O
the DT B-NP
MnlI-AluI NN I-NP
fragment NN I-NP
could MD B-VP
suppress VB I-VP
the DT B-NP
basal-level JJ I-NP
activity NN I-NP
of IN B-PP
the DT B-NP
conalbumin JJ I-NP
promoter NN I-NP
in IN B-PP
both CC O
Jurkat NN B-NP
and CC O
HeLa NN B-NP
cells NNS B-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
simian JJ B-NP
virus NN I-NP
40 CD I-NP
enhancer NN I-NP
activity NN I-NP
was VBD B-VP
blocked VBN I-VP
by IN B-PP
the DT B-NP
MnlI-AluI NN I-NP
fragment NN I-NP
in IN B-PP
HeLa NN B-NP
cells NNS I-NP
but CC B-PP
not RB B-PP
in IN I-PP
B NN B-NP
cells NNS I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
the DT B-NP
novel JJ I-NP
enhancer NN I-NP
element NN I-NP
identified VBN B-VP
in IN B-PP
this DT B-NP
study NN I-NP
is VBZ B-VP
probably RB B-ADVP
a DT B-NP
target NN I-NP
site NN I-NP
for IN B-PP
both CC B-NP
positive JJ I-NP
and CC I-NP
negative JJ I-NP
factors NNS I-NP
. . O

The DT B-NP
NF NN I-NP
kappa NN I-NP
B NN I-NP
independent JJ I-NP
cis-acting JJ I-NP
sequences NNS I-NP
in IN B-PP
HIV-1 NN B-NP
LTR NN I-NP
responsive NN B-ADJP
to TO B-PP
T-cell NN B-NP
activation NN I-NP
. . O

The DT B-NP
rate NN I-NP
of IN B-PP
transcription NN B-NP
initiation NN I-NP
directed VBN B-VP
by IN B-PP
the DT B-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
( ( O
LTR NN B-NP
) ) O
of IN B-PP
HIV-1 NN B-NP
increases VBZ B-VP
in IN B-PP
response NN I-PP
to TO I-PP
mitogenic JJ B-NP
stimuli NNS I-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
. . O

Here RB B-ADVP
we PRP B-NP
show VBP B-VP
that IN B-SBAR
the DT B-NP
response NN I-NP
of IN B-PP
the DT B-NP
HIV-1 NN I-NP
LTR NN I-NP
may MD B-VP
be VB I-VP
governed VBN I-VP
by IN B-PP
two CD B-NP
independent JJ I-NP
sequences NNS I-NP
located JJ B-ADJP
5' JJ B-NP
to TO B-PP
the DT B-NP
site NN I-NP
of IN B-PP
transcription NN B-NP
initiation NN I-NP
sequences NNS I-NP
that WDT B-NP
bind VBP B-VP
either CC O
NFAT-1 NN B-NP
or CC O
NF NN B-NP
kappa NN I-NP
B NN I-NP
. . O

The DT B-NP
rate NN I-NP
of IN B-PP
LTR-directed JJ B-NP
gene NN I-NP
expression NN I-NP
increased VBD B-VP
in IN B-PP
response NN I-PP
to TO I-PP
treatment NN B-NP
with IN B-PP
either CC O
a DT B-NP
phorbol NN I-NP
ester NN I-NP
or CC O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
if IN B-SBAR
either CC O
the DT O
NFAT-1 NN B-NP
or CC O
NF NN B-NP
kappa NN I-NP
B NN I-NP
binding NN B-NP
sites NNS I-NP
were VBD B-VP
deleted VBN I-VP
COMMA COMMA O
but CC O
failed VBD B-VP
to TO I-VP
respond VB I-VP
to TO B-PP
these DT B-NP
mitogenic JJ I-NP
stimuli NNS I-NP
if IN B-SBAR
both DT B-NP
sequences NNS I-NP
were VBD B-VP
absent JJ B-ADJP
. . O

The DT B-NP
HIV-1 NN I-NP
mutant JJ I-NP
virus NN I-NP
containing VBG B-VP
both CC O
NF NN B-NP
kappa NN I-NP
B NN I-NP
and CC O
NFAT-1 NN B-NP
deletion NN B-NP
was VBD B-VP
able JJ B-ADJP
to TO B-VP
replicate VB I-VP
although IN B-SBAR
at IN B-PP
a DT B-NP
much JJ I-NP
decreased VBN I-NP
growth NN I-NP
rate NN I-NP
COMMA COMMA O
while IN B-SBAR
the DT B-NP
deletion NN I-NP
of IN B-PP
NFAT-1 NN B-NP
alone RB B-ADVP
increased VBD B-VP
the DT B-NP
viral JJ I-NP
growth NN I-NP
rate NN I-NP
in IN B-PP
Jurkat NN B-NP
cells NNS I-NP
. . O

Neither CC O
deletion NN B-NP
of IN B-PP
NF NN B-NP
kappa NN I-NP
B NN I-NP
nor CC O
deletion NN B-NP
of IN B-PP
NFAT-1 NN B-NP
decreased VBD B-VP
activation NN B-NP
of IN B-PP
viral JJ B-NP
replication NN I-NP
by IN B-PP
phorbol NN B-NP
ester NN I-NP
. . O

Specific JJ B-NP
depletion NN I-NP
of IN B-PP
the DT B-NP
B-cell NN I-NP
population NN I-NP
induced VBN B-VP
by IN B-PP
aberrant JJ B-NP
expression NN I-NP
of IN B-PP
human JJ B-NP
interferon NN I-NP
regulatory JJ I-NP
factor NN I-NP
1 CD I-NP
gene NN I-NP
in IN B-PP
transgenic JJ B-NP
mice NNS I-NP
. . O

Interferons NNS B-NP
( ( O
IFNs NNS B-NP
) ) O
are VBP B-VP
well RB I-VP
known VBN I-VP
both CC O
as IN B-PP
antiviral JJ B-NP
proteins NNS I-NP
and CC B-PP
as IN B-PP
potent JJ B-NP
regulators NNS I-NP
of IN B-PP
cell NN B-NP
growth NN B-NP
and CC O
differentiation NN B-NP
. . O

In IN B-PP
fact NN B-NP
COMMA COMMA O
IFNs NNS B-NP
inhibit VBP B-VP
growth NN B-NP
of IN B-PP
various JJ B-NP
normal JJ I-NP
and CC I-NP
transformed VBN I-NP
cell NN I-NP
types NNS I-NP
. . O

Previously RB B-ADVP
COMMA COMMA O
a DT B-NP
nuclear JJ I-NP
factor NN I-NP
COMMA COMMA O
IRF-1 NN B-NP
( ( O
interferon NN B-NP
regulatory JJ I-NP
factor NN I-NP
1 CD I-NP
) ) O
COMMA COMMA O
which WDT B-NP
binds VBZ B-VP
to TO B-PP
type NN B-NP
I CD I-NP
IFN NN I-NP
and CC O
some DT B-NP
IFN-inducible JJ I-NP
gene NN I-NP
promoters NNS I-NP
COMMA COMMA O
was VBD B-VP
identified VBN I-VP
and CC O
cloned VBN B-VP
. . O

Since IN B-SBAR
the DT B-NP
IRF-1 NN I-NP
gene NN I-NP
is VBZ B-VP
both CC O
virus NN B-NP
and CC O
IFN NN B-NP
inducible JJ B-ADJP
COMMA COMMA O
an DT B-NP
intriguing JJ I-NP
issue NN I-NP
is VBZ B-VP
raised VBN I-VP
as IN B-PP
to TO I-PP
whether IN B-SBAR
the DT B-NP
IRF-1 NN I-NP
gene NN I-NP
is VBZ B-VP
functioning VBG I-VP
in IN B-PP
IFN-mediated JJ B-NP
regulation NN I-NP
of IN B-PP
cell NN B-NP
growth NN B-NP
and CC O
differentiation NN B-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
we PRP B-NP
generated VBD B-VP
transgenic JJ B-NP
mice NNS I-NP
carrying VBG B-VP
the DT B-NP
human JJ I-NP
IRF-1 NN I-NP
gene NN I-NP
linked VBN B-VP
to TO B-PP
the DT B-NP
human JJ I-NP
immunoglobulin NN I-NP
heavy-chain JJ I-NP
enhancer NN I-NP
. . O

In IN B-PP
the DT B-NP
transgenic JJ I-NP
mice NNS I-NP
COMMA COMMA O
all PDT B-NP
the DT I-NP
lymphoid JJ I-NP
tissues NNS I-NP
examined VBN B-VP
showed VBD B-VP
a DT B-NP
dramatic JJ I-NP
reduction NN I-NP
in IN B-PP
the DT B-NP
number NN I-NP
of IN B-PP
B NN B-NP
lymphocytes NNS I-NP
( ( O
B NN B-NP
cells NNS I-NP
) ) O
. . O

Preparation NN B-NP
and CC O
analysis NN B-NP
of IN B-PP
bone NN B-NP
marrow NN I-NP
cells NNS I-NP
from IN B-PP
the DT B-NP
chimeric JJ I-NP
mice NNS I-NP
indicated VBD B-VP
that IN B-SBAR
the DT B-NP
bone NN I-NP
marrow NN I-NP
is VBZ B-VP
the DT B-NP
effective JJ I-NP
site NN I-NP
for IN B-PP
specific JJ B-NP
depletion NN I-NP
of IN B-PP
the DT B-NP
B-cell NN I-NP
population NN I-NP
. . O

In IN B-PP
fact NN B-NP
COMMA COMMA O
transgenic JJ B-NP
bone NN I-NP
marrow NN I-NP
cells NNS I-NP
cocultured VBN B-VP
with IN B-PP
a DT B-NP
bone NN I-NP
marrow-derived JJ I-NP
stromal JJ I-NP
cell NN I-NP
line NN I-NP
revealed VBD B-VP
an DT B-NP
altered JJ I-NP
B-cell NN I-NP
maturation NN I-NP
pattern NN I-NP
. . O

Identification NN B-NP
and CC O
cloning NN B-NP
of IN B-PP
TCF-1 NN B-NP
COMMA COMMA O
a DT B-NP
T NN I-NP
lymphocyte-specific JJ I-NP
transcription NN I-NP
factor NN I-NP
containing VBG B-VP
a DT B-NP
sequence-specific JJ I-NP
HMG NN I-NP
box NN I-NP
. . O

CD3-epsilon NN B-NP
expression NN I-NP
is VBZ B-VP
controlled VBN I-VP
by IN B-PP
a DT B-NP
downstream JJ I-NP
T NN I-NP
lymphocyte-specific JJ I-NP
enhancer NN I-NP
element NN I-NP
. . O

We PRP B-NP
report VBP B-VP
the DT B-NP
identification NN I-NP
of IN B-PP
a DT B-NP
T NN I-NP
cell-specific JJ I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
TCF-1 NN B-NP
COMMA COMMA O
binding VBG B-VP
to TO B-PP
this DT B-NP
element NN I-NP
. . O

The DT B-NP
multimerized JJ I-NP
recognition NN I-NP
motif NN I-NP
of IN B-PP
TCF-1 NN B-NP
constituted VBD B-VP
a DT B-NP
T NN I-NP
cell-specific JJ I-NP
enhancer NN I-NP
. . O

Subsequent JJ B-NP
cloning NN I-NP
of IN B-PP
TCF-1 NN B-NP
identified VBD B-VP
three CD B-NP
splice NN I-NP
alternatives NNS I-NP
. . O

TCF-1 NN B-NP
contained VBD B-VP
a DT B-NP
single JJ I-NP
DNA-binding JJ I-NP
HMG NN I-NP
box NN I-NP
most RBS B-ADJP
closely RB I-ADJP
related JJ I-ADJP
to TO B-PP
similar JJ B-NP
boxes NNS I-NP
in IN B-PP
the DT B-NP
putative JJ I-NP
mammalian JJ I-NP
sex-determining JJ I-NP
gene NN I-NP
SRY NN I-NP
and CC B-PP
in IN B-PP
the DT B-NP
Schizosaccharomyces FW I-NP
pombe FW I-NP
Mc NN I-NP
mating NN I-NP
type NN I-NP
gene NN I-NP
. . O

TCF-1 NN B-ADVP
mRNA NN I-ADVP
was VBD B-VP
expressed VBN I-VP
uniquely RB B-ADVP
in IN B-PP
T NN B-NP
lymphocytes NNS I-NP
. . O

Upon IN B-PP
cotransfection NN B-NP
into IN B-PP
non-T JJ B-NP
cells NNS I-NP
COMMA COMMA O
TCF-1 NN B-NP
could MD B-VP
transactivate VB I-VP
through IN B-PP
its PRP$ B-NP
cognate JJ I-NP
motif NN I-NP
. . O

These DT B-NP
results NNS I-NP
identify VBP B-VP
TCF-1 NN B-NP
as IN B-PP
a DT B-NP
T NN I-NP
cell-specific JJ I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
which WDT B-NP
might MD B-VP
play VB I-VP
a DT B-NP
role NN I-NP
in IN B-PP
the DT B-NP
establishment NN I-NP
of IN B-PP
the DT B-NP
mature JJ I-NP
T NN I-NP
cell NN I-NP
phenotype NN I-NP
. . O

Nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
activates VBZ B-VP
proenkephalin NN B-NP
transcription NN I-NP
in IN B-PP
T NN B-NP
lymphocytes NNS I-NP
. . O

Upon IN B-PP
activation NN B-NP
COMMA COMMA O
T NN B-NP
lymphocytes NNS I-NP
accumulate VBP B-VP
high JJ B-NP
levels NNS I-NP
of IN B-PP
the DT B-NP
neuropeptide NN I-NP
enkephalin NN I-NP
which WDT B-NP
correlate VBP B-VP
with IN B-PP
high JJ B-NP
levels NNS I-NP
of IN B-PP
proenkephalin NN B-NP
mRNA NN I-NP
in IN B-PP
the DT B-NP
cells NNS I-NP
. . O

Here RB B-ADVP
we PRP B-NP
investigated VBD B-VP
the DT B-NP
transcriptional JJ I-NP
basis NN I-NP
for IN B-PP
these DT B-NP
changes NNS I-NP
. . O

The DT B-NP
proenkephalin NN I-NP
promoter NN I-NP
contains VBZ B-VP
a DT B-NP
sequence NN I-NP
GGGGACGTCCCC NN I-NP
COMMA COMMA O
named VBN B-VP
B2 NN B-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
similar JJ B-ADJP
to TO B-PP
the DT B-NP
kappa NN I-NP
B NN I-NP
sequence NN I-NP
GGGGACTTTCC NN I-NP
COMMA COMMA O
the DT B-NP
binding VBG I-NP
site NN I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
nuclear JJ B-NP
factor NN I-NP
( ( O
NF NN B-NP
) ) O
-kappa NN B-NP
B NN I-NP
. . O

Activation NN B-NP
of IN B-PP
T NN B-NP
lymphocytes NNS I-NP
induces VBZ B-VP
an DT B-NP
NF-kappa NN I-NP
B-like JJ I-NP
binding NN I-NP
activity NN I-NP
to TO B-PP
the DT B-NP
B2 NN I-NP
site NN I-NP
COMMA COMMA O
concomitant JJ B-ADJP
with IN B-PP
activation NN B-NP
of IN B-PP
the DT B-NP
proenkephalin NN I-NP
promoter NN I-NP
. . O

Mutations NNS B-NP
at IN B-PP
the DT B-NP
B2 NN I-NP
site NN I-NP
abolish VBP B-VP
this DT B-NP
transcriptional JJ I-NP
activation NN I-NP
. . O

The DT B-NP
purified VBN I-NP
homodimer NN I-NP
( ( O
two CD B-NP
p50s NNS I-NP
) ) O
of IN B-PP
the DT B-NP
DNA-binding JJ I-NP
subunit NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
binds VBZ B-VP
the DT B-NP
B2 NN I-NP
site NN I-NP
of IN B-PP
proenkephalin NN B-NP
relatively RB B-ADVP
better JJR I-ADVP
than IN B-SBAR
does VBZ O
the DT O
heterotetramer NN B-NP
( ( O
two CD B-NP
p65s NNS I-NP
plus CC O
two CD B-NP
p50s NNS I-NP
) ) O
form NN B-NP
of IN B-PP
the DT B-NP
factor NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
it PRP B-NP
appears VBZ B-VP
that IN B-SBAR
the DT B-NP
T-cell-specific JJ I-NP
activation NN I-NP
of IN B-PP
the DT B-NP
proenkephalin NN I-NP
promoter NN I-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
NF-kappa NN B-NP
B NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
as IN B-SBAR
NF-kappa NN B-NP
B NN I-NP
is VBZ B-VP
ubiquitous JJ B-ADJP
and CC O
the DT B-NP
transcriptional JJ I-NP
activation NN I-NP
through IN B-PP
the DT B-NP
B2 NN I-NP
site NN I-NP
is VBZ B-VP
T NN B-NP
cell NN I-NP
specific JJ B-ADJP
COMMA COMMA O
yet RB B-NP
another DT I-NP
T-cell-specific JJ I-NP
factor NN I-NP
which WDT B-NP
synergizes VBZ B-VP
with IN B-PP
NF-kappa NN B-NP
B NN I-NP
should MD B-VP
be VB I-VP
considered VBN I-VP
. . O

Expression NN B-NP
of IN B-PP
c-jun NN B-NP
COMMA COMMA O
jun NN B-NP
B NN I-NP
and CC O
jun NN B-NP
D NN I-NP
proto-oncogenes NNS B-NP
in IN B-PP
human JJ B-NP
peripheral-blood JJ I-NP
granulocytes NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
found VBN I-VP
that IN B-SBAR
purified VBN B-NP
human JJ I-NP
peripheral-blood JJ I-NP
granulocytes NNS I-NP
express VBP B-VP
constitutively RB B-NP
significant JJ I-NP
levels NNS I-NP
of IN B-PP
proto-oncogenes NNS B-NP
c-jun NN B-NP
COMMA COMMA O
jun NN B-NP
B NN I-NP
and CC O
jun NN B-NP
D NN I-NP
mRNA NN B-NP
. . O

Upon IN B-PP
functional JJ B-NP
activation NN I-NP
of IN B-PP
granulocytes NNS B-NP
by IN B-PP
4 CD B-NP
beta-phorbol NN I-NP
12-myristate NN I-NP
13-acetate NN I-NP
( ( O
PMA NN B-NP
) ) O
COMMA COMMA O
the DT B-NP
levels NNS I-NP
of IN B-PP
c-jun NN B-NP
COMMA COMMA O
jun NN B-NP
B NN I-NP
and CC O
jun NN B-NP
D NN I-NP
transcripts NNS B-NP
were VBD B-VP
increased VBN I-VP
. . O

The DT B-NP
three CD I-NP
jun NN I-NP
genes NNS I-NP
showed VBD B-VP
a DT B-NP
similar JJ I-NP
time NN I-NP
course NN I-NP
in IN B-PP
their PRP$ B-NP
induction NN I-NP
by IN B-PP
PMA NN B-NP
COMMA COMMA O
maximal JJ B-NP
mRNA NN I-NP
levels NNS I-NP
being VBG B-VP
reached VBN I-VP
after IN B-PP
60 CD B-NP
min NN I-NP
of IN B-PP
induction NN B-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
expression NN B-NP
of IN B-PP
c-jun NN B-NP
COMMA COMMA O
jun NN B-NP
B NN I-NP
and CC O
jun NN B-NP
D NN I-NP
genes NNS B-NP
might MD B-VP
be VB I-VP
involved VBN I-VP
in IN B-PP
terminal JJ B-NP
granulocyte NN I-NP
differentiation NN I-NP
or CC B-PP
in IN B-PP
regulating VBG B-VP
granulocyte NN B-NP
functionality NN I-NP
. . O

Platelet-activating JJ B-NP
factor NN I-NP
induces VBZ B-VP
phospholipid JJ B-NP
turnover NN I-NP
COMMA COMMA O
calcium NN B-NP
flux NN I-NP
COMMA COMMA O
arachidonic JJ B-NP
acid NN I-NP
liberation NN I-NP
COMMA COMMA O
eicosanoid NN B-NP
generation NN I-NP
COMMA COMMA O
and CC O
oncogene JJ B-NP
expression NN I-NP
in IN B-PP
a DT B-NP
human JJ I-NP
B NN I-NP
cell NN I-NP
line NN I-NP
. . O

Platelet-activating JJ B-NP
factor NN I-NP
is VBZ B-VP
a DT B-NP
potent JJ I-NP
mediator NN I-NP
of IN B-PP
the DT B-NP
inflammatory JJ I-NP
response NN I-NP
. . O

Studies NNS B-NP
of IN B-PP
the DT B-NP
actions NNS I-NP
of IN B-PP
platelet-activating JJ B-NP
factor NN I-NP
have VBP B-VP
centered VBN I-VP
mainly RB B-PP
around IN I-PP
neutrophils NNS B-NP
COMMA COMMA O
monocytes NNS B-NP
COMMA COMMA O
and CC O
platelets NNS B-NP
. . O

In IN B-PP
this DT B-NP
report NN I-NP
we PRP B-NP
begin VBP B-VP
to TO I-VP
uncover VB I-VP
the DT B-NP
influence NN I-NP
of IN B-PP
platelet-activating NN B-NP
factor NN I-NP
on IN B-PP
B NN B-NP
lymphocytes NNS I-NP
. . O

Employing VBG B-VP
the DT B-NP
EBV-transformed JJ I-NP
human JJ I-NP
B NN I-NP
cell NN I-NP
line NN I-NP
SKW6.4 NN I-NP
COMMA COMMA O
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
platelet-activating JJ B-NP
factor NN I-NP
significantly RB B-ADVP
alters VBZ B-VP
membrane NN B-NP
phospholipid JJ I-NP
metabolism NN I-NP
indicated VBN B-VP
by IN B-PP
the DT B-NP
incorporation NN I-NP
of IN B-PP
32P NN B-NP
into IN B-PP
phosphatidylcholine NN B-NP
COMMA COMMA O
phosphatidylinositol NN B-NP
COMMA COMMA O
and CC O
phosphatidic JJ B-NP
acid NN I-NP
but CC B-PP
not RB B-ADVP
significantly RB I-ADVP
into IN B-PP
phosphatidylethanolamine NN B-NP
at IN B-PP
concentrations NNS B-NP
ranging VBG B-VP
from IN B-PP
10(-9) CD B-NP
to TO B-PP
10(-6) CD B-NP
M NN B-NP
. . O

The DT B-NP
inactive JJ I-NP
precursor NN I-NP
COMMA COMMA O
lyso-platelet-activating JJ B-NP
factor NN I-NP
COMMA COMMA O
at IN B-PP
a DT B-NP
concentration NN I-NP
as RB B-ADJP
high JJ I-ADJP
as IN B-PP
10(-7) CD B-NP
M NN I-NP
had VBD B-VP
no DT B-NP
effect NN I-NP
on IN B-PP
any DT B-NP
of IN B-PP
the DT B-NP
membrane NN I-NP
phospholipids NNS I-NP
. . O

We PRP B-NP
also RB B-ADVP
show VBP B-VP
that IN B-SBAR
platelet-activating JJ B-NP
factor NN I-NP
from IN B-PP
10(-12) CD B-NP
to TO I-NP
10(-6) CD I-NP
M NN I-NP
induced VBD B-VP
rapid JJ B-NP
and CC I-NP
significant JJ I-NP
elevation NN I-NP
in IN B-PP
intracellular JJ B-NP
calcium NN I-NP
levels NNS I-NP
COMMA COMMA O
whereas IN O
lyso-platelet-activating JJ B-NP
factor NN I-NP
was VBD B-VP
again RB B-ADVP
ineffective JJ B-ADJP
. . O

We PRP B-NP
further RB B-ADVP
demonstrate VBP B-VP
the DT B-NP
impact NN I-NP
of IN B-PP
platelet-activating JJ B-NP
factor NN I-NP
binding VBG B-VP
to TO B-PP
B NN B-NP
cells NNS I-NP
by IN B-PP
measuring VBG B-VP
platelet-activating JJ B-NP
factor NN I-NP
induced JJ B-NP
arachidonic JJ I-NP
acid NN I-NP
release NN I-NP
and CC O
5-hydroxyeicosatetraenoic JJ B-NP
acid NN I-NP
production NN I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
platelet-activating JJ B-NP
factor NN I-NP
was VBD B-VP
capable JJ B-ADJP
of IN B-PP
inducing VBG B-VP
transcription NN B-NP
of IN B-PP
the DT B-NP
nuclear JJ I-NP
proto-oncogenes NNS I-NP
c-fos NN B-NP
and CC O
c-jun NN B-NP
. . O

Finally RB B-ADVP
we PRP B-NP
explored VBD B-VP
the DT B-NP
possible JJ I-NP
role NN I-NP
of IN B-PP
5-hydroxyeicosatetraenoic JJ B-NP
acid NN I-NP
as IN B-PP
a DT B-NP
regulator NN I-NP
of IN B-PP
arachidonic JJ B-NP
acid NN I-NP
liberation NN I-NP
demonstrating VBG B-VP
that IN B-SBAR
endogenous JJ B-NP
5-lipoxygenase NN I-NP
activity NN I-NP
modulates VBZ B-VP
platelet-activating JJ B-NP
factor NN I-NP
induced JJ B-NP
arachidonic JJ I-NP
acid NN I-NP
release NN I-NP
perhaps RB B-ADVP
acting VBG B-VP
at IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
phospholipase NN B-NP
A2 NN I-NP
. . O

In IN B-PP
summary NN B-NP
COMMA COMMA O
platelet-activating JJ B-NP
factor NN I-NP
is VBZ B-VP
shown VBN I-VP
here RB I-VP
to TO I-VP
have VB I-VP
a DT B-NP
direct JJ I-NP
and CC I-NP
profound JJ I-NP
effect NN I-NP
on IN B-PP
a DT B-NP
pure JJ I-NP
B NN I-NP
cell NN I-NP
line NN I-NP
. . O

A DT B-NP
novel JJ I-NP
HIV-1 NN I-NP
isolate JJ I-NP
containing VBG B-VP
alterations NNS B-NP
affecting VBG B-VP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
element NN I-NP
. . O

Three CD B-NP
molecular JJ I-NP
clones NNS I-NP
of IN B-PP
HIV-1 NN B-NP
COMMA COMMA O
derived VBN B-VP
from IN B-PP
a DT B-NP
single JJ I-NP
isolate NN I-NP
( ( O
AL1 NN B-NP
) ) O
COMMA COMMA O
exhibited VBD B-VP
distinct JJ B-NP
replicative JJ I-NP
and CC I-NP
cytopathic JJ I-NP
properties NNS I-NP
during IN B-PP
propagation NN B-NP
in IN B-PP
a DT B-NP
human JJ I-NP
T NN I-NP
cell NN I-NP
line NN I-NP
. . O

The DT B-NP
phenotypic JJ I-NP
differences NNS I-NP
observed VBN B-VP
were VBD B-VP
attributable JJ B-ADJP
COMMA COMMA O
in IN B-PP
large JJ B-NP
part NN I-NP
COMMA COMMA O
to TO B-PP
changes NNS B-NP
affecting VBG B-VP
the DT B-NP
viral JJ I-NP
LTR NN I-NP
. . O

Nucleotide NN B-NP
sequence NN I-NP
and CC O
PCR NN B-NP
analyses NNS I-NP
demonstrated VBD B-VP
the DT B-NP
presence NN I-NP
of IN B-PP
novel JJ B-NP
duplications NNS B-NP
or CC O
deletions NNS B-NP
involving VBG B-VP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
motif NN I-NP
. . O

These DT B-NP
changes NNS I-NP
in IN B-PP
the DT B-NP
enhancer NN I-NP
element NN I-NP
were VBD B-VP
identified VBN I-VP
in IN B-PP
the DT B-NP
original JJ I-NP
AL1 NN I-NP
virus NN I-NP
stock NN I-NP
. . O

Subcloning NN B-NP
of IN B-PP
the DT B-NP
variant JJ I-NP
NF-kappa NN I-NP
B NN I-NP
segments NNS I-NP
into IN B-PP
LTR-driven JJ B-NP
CAT NN I-NP
expression NN I-NP
vectors NNS I-NP
confirmed VBD B-VP
a DT B-NP
correlation NN I-NP
between IN B-PP
promoter JJ B-NP
activity NN I-NP
and CC O
replicative\/cytopathic JJ B-NP
capacity NN I-NP
. . O

1COMMA25-Dihydroxyvitamin NN B-NP
D3 NN I-NP
receptor NN I-NP
RNA NN I-NP
: : O
expression NN B-NP
in IN B-PP
hematopoietic JJ B-NP
cells NNS I-NP
. . O

1COMMA25-Dihydroxyvitamin NN B-NP
D3 NN I-NP
{ ( O
1COMMA25(OH)2D3 NN B-NP
} ) O
induces VBZ B-VP
differentiation NN B-NP
and CC O
inhibits VBZ B-VP
proliferation NN B-NP
of IN B-PP
myeloid JJ B-NP
leukemic JJ I-NP
cells NNS I-NP
from IN B-PP
various JJ B-NP
lines NNS B-NP
and CC O
patients NNS B-NP
; : O
these DT B-NP
effects NNS I-NP
are VBP B-VP
probably RB I-VP
mediated VBN I-VP
through IN B-PP
the DT B-NP
1COMMA25(OH)2D3 NN I-NP
receptor NN I-NP
. . O

Little JJ B-NP
is VBZ B-VP
known VBN I-VP
of IN B-PP
expression NN B-NP
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
receptor NN I-NP
RNA NN I-NP
in IN B-PP
hematopoietic JJ B-NP
cells NNS I-NP
. . O

We PRP B-NP
examined VBD B-VP
the DT B-NP
expression NN B-NP
and CC O
modulation NN B-NP
of IN B-PP
expression NN B-NP
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
receptor NN I-NP
RNA NN I-NP
in IN B-PP
various JJ B-NP
proliferating VBG I-NP
and CC I-NP
nonproliferating JJ I-NP
hematopoietic JJ I-NP
cells NNS I-NP
. . O

Constitutive JJ B-NP
expression NN I-NP
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
receptor NN I-NP
RNA NN I-NP
was VBD B-VP
detected VBN I-VP
in IN B-PP
various JJ B-NP
kinds NNS I-NP
of IN B-PP
hematopoietic JJ B-NP
cells NNS I-NP
COMMA COMMA O
including VBG B-PP
macrophages NNS B-NP
and CC O
activated VBN B-NP
T NN I-NP
lymphocytes NNS I-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
in IN B-PP
cell NN B-NP
lines NNS I-NP
KG-1 NN B-NP
( ( O
myeloblasts NNS B-NP
) ) O
COMMA COMMA O
HL-60 NN B-NP
( ( O
promyelocytes NNS B-NP
) ) O
COMMA COMMA O
ML-3 NN B-NP
( ( O
myelomonoblasts NNS B-NP
) ) O
COMMA COMMA O
U937 NN B-NP
COMMA COMMA O
THP-1 NN B-NP
( ( O
monoblasts NNS B-NP
) ) O
COMMA COMMA O
K562 NN B-NP
( ( O
erythroblasts NNS B-NP
) ) O
COMMA COMMA O
and CC O
S-LB1 NN B-NP
( ( O
HTLV-1-transfected JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
) ) O
. . O

Receptor NN B-NP
transcripts NNS I-NP
were VBD B-VP
4.6 CD B-NP
kilobases NNS B-NP
( ( O
kb NN B-NP
) ) O
COMMA COMMA O
and CC O
no DT B-NP
variant JJ I-NP
sizes NNS I-NP
were VBD B-VP
observed VBN I-VP
. . O

All DT B-NP
cell NN I-NP
lines NNS I-NP
examined VBN B-VP
in IN B-PP
this DT B-NP
group NN I-NP
also RB B-ADVP
expressed VBD B-VP
1COMMA25(OH)2D3 NN B-NP
receptors NNS I-NP
. . O

Most JJS B-NP
B NN I-NP
lymphocyte NN I-NP
lines NNS I-NP
expressed VBD B-VP
negligible JJ B-NP
levels NNS I-NP
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
receptor NN I-NP
RNA NN I-NP
and CC I-NP
protein NN I-NP
; : O
however RB O
; : O
analysis NN B-NP
of IN B-PP
a DT B-NP
lymphoid\/myeloid JJ I-NP
somatic JJ I-NP
hybrid NN I-NP
suggested VBD B-VP
that IN B-SBAR
suppression NN B-NP
of IN B-PP
expression NN B-NP
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
receptor NN I-NP
RNA NN I-NP
in IN B-PP
B NN B-NP
lymphocytes NNS I-NP
may MD B-VP
be VB I-VP
a DT B-NP
dominant JJ I-NP
characteristic NN I-NP
. . O

HL-60 NN B-NP
cells NNS I-NP
were VBD B-VP
cultured VBN I-VP
with IN B-PP
10(-7) CD B-NP
mol\/L NN I-NP
1COMMA25(OH)2D3 NN B-NP
for IN B-PP
24 CD B-NP
to TO I-NP
72 CD I-NP
hours NNS I-NP
COMMA COMMA O
and CC O
levels NNS B-NP
of IN B-PP
expression NN B-NP
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
receptor NN I-NP
and CC O
its PRP$ B-NP
RNA NN I-NP
were VBD B-VP
examined VBN I-VP
. . O

Levels NNS B-NP
of IN B-PP
RNA NN B-NP
coding NN B-VP
for IN B-PP
the DT B-NP
receptor NN I-NP
were VBD B-VP
not RB I-VP
modulated VBN I-VP
by IN B-PP
exposure NN B-NP
to TO B-PP
high JJ B-NP
levels NNS I-NP
of IN B-PP
ligand NN B-NP
. . O

Levels NNS B-NP
of IN B-PP
occupied VBN B-NP
1COMMA25(OH)2D3 NN I-NP
receptor NN I-NP
protein NN I-NP
increased VBD B-VP
in IN B-PP
these DT B-NP
HL-60 NN I-NP
cells NNS I-NP
; : O
but CC O
the DT B-NP
total JJ I-NP
number NN I-NP
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
receptors NNS I-NP
decreased VBD B-VP
about RB B-NP
50 CD I-NP
% NN I-NP
at IN B-PP
24 CD B-NP
hours NNS I-NP
and CC O
returned VBD B-VP
toward IN B-PP
normal JJ B-NP
at IN B-PP
72 CD B-NP
hours NNS I-NP
. . O

Steady-state JJ B-NP
levels NNS I-NP
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
receptor NN I-NP
RNA NN I-NP
were VBD B-VP
not RB I-VP
affected VBN I-VP
by IN B-PP
terminal JJ B-NP
differentiation NN I-NP
of IN B-PP
HL-60 NN B-NP
toward IN B-PP
either CC O
granulocytes NNS B-NP
or CC O
macrophages NNS B-NP
. . O

Nondividing JJ B-NP
macrophages NNS I-NP
from IN B-PP
normal JJ B-NP
individuals NNS I-NP
also RB B-ADVP
expressed VBD B-VP
1COMMA25(OH)2D3 NN B-NP
receptor NN I-NP
RNA NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
nondividing JJ B-NP
peripheral JJ I-NP
blood NN I-NP
lymphocytes NNS I-NP
from IN B-PP
normal JJ B-NP
individuals NNS I-NP
did VBD B-VP
not RB I-VP
express VB I-VP
1COMMA25(OH)2D3 NN B-NP
receptor NN I-NP
RNA NN I-NP
; : O
with IN B-PP
stimulation NN B-NP
of IN B-PP
proliferation NN B-NP
of IN B-PP
these DT B-NP
cells NNS I-NP
COMMA COMMA O
accumulation NN B-NP
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
receptor NN I-NP
RNA NN I-NP
increased VBD B-VP
markedly RB B-ADVP
. . O

Half-life NN B-NP
( ( O
t1\/2 NN B-NP
) ) O
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
receptor NN I-NP
RNA NN I-NP
in IN B-PP
T NN B-NP
lymphocytes NNS I-NP
was VBD B-VP
short JJ B-ADJP
( ( O
1 CD B-NP
hour NN I-NP
) ) O
as IN B-SBAR
determined VBN B-VP
by IN B-PP
measuring VBG B-VP
decay NN B-NP
of IN B-PP
the DT B-NP
message NN I-NP
after IN B-PP
addition NN B-NP
of IN B-PP
actinomycin NN B-NP
D NN I-NP
. . O

Consistent JJ B-ADJP
with IN B-PP
this DT B-NP
short JJ I-NP
t1\/2 NN I-NP
COMMA COMMA O
accumulation NN B-NP
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
receptor NN I-NP
RNA NN I-NP
increased VBD B-VP
in IN B-PP
cells NNS B-NP
as IN B-SBAR
their PRP$ B-NP
protein NN I-NP
synthesis NN I-NP
was VBD B-VP
inhibited VBN I-VP
. . O

Further JJ B-NP
studies NNS I-NP
are VBP B-VP
required VBN I-VP
to TO B-VP
understand VB I-VP
the DT B-NP
physiologic JJ I-NP
role NN I-NP
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
receptors NNS I-NP
in IN B-PP
myeloid JJ B-NP
cells NNS I-NP
and CC O
proliferating VBG B-NP
T NN I-NP
lymphocytes NNS I-NP
. . O

Kappa NN B-NP
B NN I-NP
binding NN I-NP
proteins NNS I-NP
are VBP B-VP
constitutively RB I-VP
expressed VBN I-VP
in IN B-PP
an DT B-NP
IL-2 NN I-NP
autocrine NN I-NP
human JJ I-NP
T NN I-NP
cell NN I-NP
line NN I-NP
. . O

The DT B-NP
IL-2 NN I-NP
and CC O
the DT B-NP
IL-2-R NN I-NP
alpha NN I-NP
genes NNS B-NP
are VBP B-VP
both DT O
expressed VBN B-VP
transiently RB B-ADVP
in IN B-PP
normal JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
after IN B-PP
Ag NN B-NP
or CC O
mitogen NN B-NP
activation NN B-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
the DT B-NP
human JJ I-NP
T NN I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
IARC NN B-NP
301 CD I-NP
COMMA COMMA O
expresses VBZ B-VP
these DT B-NP
two CD I-NP
genes NNS I-NP
constitutively RB B-ADVP
and CC O
we PRP B-NP
have VBP B-VP
previously RB I-VP
demonstrated VBN I-VP
that IN B-SBAR
its PRP$ B-NP
growth NN I-NP
depends VBZ B-VP
on IN B-PP
the DT B-NP
autocrine JJ I-NP
production NN I-NP
of IN B-PP
this DT B-NP
T NN I-NP
cell NN I-NP
growth NN I-NP
factor NN I-NP
and CC O
high JJ B-NP
affinity NN I-NP
IL-2R NN I-NP
. . O

To TO B-VP
dissect VB I-VP
the DT B-NP
molecular JJ I-NP
basis NN I-NP
for IN B-PP
the DT B-NP
unusual JJ I-NP
persistent JJ I-NP
expression NN I-NP
of IN B-PP
the DT O
IL-2 NN B-NP
and CC O
IL-2-R NN B-NP
alpha NN I-NP
genes NNS B-NP
in IN B-PP
these DT B-NP
IARC NN I-NP
301 CD I-NP
T NN I-NP
cells NNS I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
analyzed VBN I-VP
the DT B-NP
interactions NNS I-NP
of IN B-PP
constitutively RB B-NP
expressed VBN I-NP
nuclear JJ I-NP
proteins NNS I-NP
with IN B-PP
the DT B-NP
5' JJ I-NP
flanking JJ I-NP
regions NNS I-NP
of IN B-PP
the DT O
IL-2 NN B-NP
and CC O
IL-2-R NN B-NP
alpha NN I-NP
genes NNS B-NP
using VBG B-VP
both DT B-NP
DNase NN B-NP
I CD I-NP
footprinting NN I-NP
and CC O
gel NN B-NP
retardation NN I-NP
techniques NNS B-NP
. . O

We PRP B-NP
have VBP B-VP
found VBN I-VP
that IN B-SBAR
a DT B-NP
region NN I-NP
in IN B-PP
both DT B-NP
genes NNS I-NP
( ( O
-276 CD B-NP
to TO O
-250 CD B-NP
for IN B-PP
IL-2-R NN B-NP
alpha NN I-NP
and CC O
-203 CD B-NP
to TO O
-183 CD B-NP
for IN B-PP
IL-2 NN B-NP
) ) O
COMMA COMMA O
which WDT B-NP
corresponds VBZ B-VP
to TO B-PP
a DT B-NP
kappa NN I-NP
B NN I-NP
enhancer NN I-NP
element NN I-NP
COMMA COMMA O
is VBZ B-VP
specifically RB I-VP
protected VBN I-VP
by IN B-PP
nuclear JJ B-NP
proteins NNS I-NP
from IN B-PP
IARC NN B-NP
301 CD I-NP
. . O

In IN B-PP
agreement NN I-PP
with IN I-PP
this DT B-NP
finding NN I-NP
COMMA COMMA O
both CC O
the DT O
IL-2 NN B-NP
and CC O
IL-2-R NN B-NP
alpha NN I-NP
promoters NNS B-NP
are VBP B-VP
active JJ B-ADJP
in IN B-PP
transient JJ B-NP
transfection NN I-NP
assays NNS I-NP
in IN B-PP
IARC NN B-NP
301 CD I-NP
cells NNS I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
mutation NN B-NP
of IN B-PP
the DT B-NP
kappa NN I-NP
B NN I-NP
enhancer NN I-NP
results VBZ B-VP
in IN B-PP
markedly RB B-NP
attenuated VBN I-NP
activities NNS I-NP
of IN B-PP
both DT B-NP
promoters NNS I-NP
. . O

Two CD B-NP
proteins NNS I-NP
binding VBG B-VP
the DT B-NP
kappa NN I-NP
B NN I-NP
sequence NN I-NP
COMMA COMMA O
NF-kappa NN B-NP
B NN I-NP
and CC O
KBF1 NN B-NP
COMMA COMMA O
are VBP B-VP
constitutively RB I-VP
expressed VBN I-VP
in IN B-PP
IARC NN B-NP
301 CD I-NP
nuclei NNS I-NP
and CC O
induced VBN B-VP
by IN B-PP
PMA NN B-NP
and CC O
PHA NN B-NP
in IN B-PP
Jurkat NN B-NP
. . O

They PRP B-NP
bind VBP B-VP
to TO B-PP
the DT B-NP
kappa NN I-NP
B NN I-NP
motifs NNS I-NP
with IN B-PP
different JJ B-NP
relative JJ I-NP
affinities NNS I-NP
that WDT B-NP
may MD B-VP
reflect VB I-VP
their PRP$ B-NP
different JJ I-NP
contribution NN I-NP
in IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
various JJ B-NP
promoters NNS I-NP
. . O

The DT B-NP
functional JJ I-NP
domains NNS I-NP
of IN B-PP
the DT B-NP
murine JJ I-NP
Thy-1 NN I-NP
gene NN I-NP
promoter NN I-NP
. . O

The DT B-NP
Thy-1 NN I-NP
gene NN I-NP
promoter NN I-NP
resembles VBZ B-VP
a DT B-NP
" `` I-NP
housekeeping JJ I-NP
" '' I-NP
promoter NN I-NP
in IN B-PP
that IN B-SBAR
it PRP B-NP
is VBZ B-VP
located JJ B-ADJP
within IN B-PP
a DT B-NP
methylation-free JJ I-NP
island NN I-NP
COMMA COMMA O
lacks VBZ B-VP
a DT B-NP
canonical JJ I-NP
TATA NN I-NP
box NN I-NP
COMMA COMMA O
and CC O
displays VBZ B-VP
heterogeneity NN B-NP
in IN B-PP
the DT B-NP
5'-end JJ I-NP
termini NNS I-NP
of IN B-PP
the DT B-NP
mRNA NN I-NP
. . O

Using VBG B-VP
transgenic JJ B-NP
mice NNS I-NP
COMMA COMMA O
we PRP B-NP
show VBP B-VP
that IN B-SBAR
this DT B-NP
promoter NN I-NP
does VBZ B-VP
not RB I-VP
confer VB I-VP
any DT B-NP
tissue NN I-NP
specificity NN I-NP
and CC O
is VBZ B-VP
active JJ B-ADJP
only RB B-PP
in IN I-PP
a DT B-NP
position-dependent JJ I-NP
manner NN I-NP
. . O

It PRP B-NP
can MD B-VP
only RB I-VP
be VB I-VP
activated VBN I-VP
in IN B-PP
a DT B-NP
tissue-specific JJ I-NP
manner NN I-NP
by IN B-PP
elements NNS B-NP
that WDT B-NP
lie VBP B-VP
downstream RB B-ADJP
of IN B-PP
the DT B-NP
initiation NN I-NP
site NN I-NP
. . O

We PRP B-NP
have VBP B-VP
analyzed VBN I-VP
the DT B-NP
functional JJ I-NP
domains NNS I-NP
of IN B-PP
the DT B-NP
minimal JJ I-NP
Thy-1 NN I-NP
promoter NN I-NP
and CC O
show VB B-VP
that IN B-SBAR
the DT B-NP
dominant JJ I-NP
promoter NN I-NP
elements NNS I-NP
consist VBP B-VP
of IN B-PP
multiple JJ B-NP
binding VBG I-NP
sites NNS I-NP
for IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
Sp1 NN I-NP
COMMA COMMA O
an DT B-NP
inverted JJ I-NP
CCAAT NN I-NP
box NN I-NP
COMMA COMMA O
and CC O
sequences VBZ B-NP
proximal JJ B-ADJP
to TO B-PP
the DT B-NP
transcription NN I-NP
start NN I-NP
site NN I-NP
. . O

DNase NN B-NP
I CD I-NP
and CC I-NP
gel NN I-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
show VBP B-VP
the DT B-NP
binding NN I-NP
of IN B-PP
a DT B-NP
number NN I-NP
of IN B-PP
nuclear JJ B-NP
factors NNS I-NP
to TO B-PP
these DT B-NP
elements NNS I-NP
COMMA COMMA O
including VBG B-PP
Sp1 NN B-NP
and CC O
CP1 NN B-NP
. . O

Our PRP$ B-NP
results NNS I-NP
show VBP B-VP
that IN B-SBAR
the DT B-NP
structure NN I-NP
of IN B-PP
this DT B-NP
promoter NN I-NP
only RB B-ADVP
permits VBZ B-VP
productive JJ B-NP
interactions NNS I-NP
of IN B-PP
the DT B-NP
two CD I-NP
transcription NN I-NP
factors NNS I-NP
Sp1 NN B-NP
and CC O
CP1 NN B-NP
with IN B-PP
the DT B-NP
basal JJ I-NP
transcription NN I-NP
machinery NN I-NP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
enhancer NN B-NP
sequences NNS I-NP
. . O

Comparison NN B-NP
of IN B-PP
constitutive JJ B-NP
and CC I-NP
inducible JJ I-NP
transcriptional JJ I-NP
enhancement NN I-NP
mediated VBN B-VP
by IN B-PP
kappa NN B-NP
B-related JJ I-NP
sequences NNS I-NP
: : O
modulation NN B-NP
of IN B-PP
activity NN B-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
by IN B-PP
human JJ B-NP
T-cell NN I-NP
leukemia NN I-NP
virus NN I-NP
type NN I-NP
I CD I-NP
tax NN I-NP
gene NN I-NP
. . O

The DT B-NP
kappa NN I-NP
B NN I-NP
sequence NN I-NP
( ( O
GGGACTTTCC NN B-NP
) ) O
binds VBZ B-VP
a DT B-NP
factor NN I-NP
COMMA COMMA O
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
that WDT B-NP
is VBZ B-VP
constitutively RB I-VP
found VBN I-VP
in IN B-PP
its PRP$ B-NP
functional JJ I-NP
COMMA COMMA I-NP
DNA NN I-NP
binding NN I-NP
form NN I-NP
only RB B-PP
in IN I-PP
B NN B-NP
lymphocytes NNS I-NP
. . O

A DT B-NP
factor NN I-NP
with IN B-PP
apparently RB B-NP
indistinguishable JJ I-NP
sequence NN I-NP
specificity NN I-NP
can MD B-VP
be VB I-VP
induced VBN I-VP
in IN B-PP
many JJ B-NP
other JJ I-NP
cell NN I-NP
types NNS I-NP
COMMA COMMA O
where WRB B-ADVP
it PRP B-NP
is VBZ B-VP
used VBN I-VP
to TO B-VP
regulate VB I-VP
inducible JJ B-NP
gene NN I-NP
expression NN I-NP
. . O

For IN B-PP
example NN B-NP
COMMA COMMA O
kappa NN B-NP
B-related JJ I-NP
sequences NNS I-NP
have VBP B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
important JJ B-ADJP
for IN B-PP
the DT B-NP
transcription NN I-NP
of IN B-PP
a DT B-NP
few JJ I-NP
inducible JJ I-NP
genes NNS I-NP
COMMA COMMA O
such JJ B-PP
as IN I-PP
the DT B-NP
interleukin NN I-NP
2 CD I-NP
receptor NN I-NP
alpha-chain NN I-NP
gene NN I-NP
and CC O
the DT B-NP
beta-interferon NN I-NP
gene NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
these DT B-NP
genes NNS I-NP
are VBP B-VP
not RB O
constitutively RB B-ADJP
active JJ I-ADJP
in IN B-PP
B NN B-NP
lymphocytes NNS I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
other JJ B-NP
regulatory JJ I-NP
mechanisms NNS I-NP
must MD B-VP
play VB I-VP
a DT B-NP
role NN I-NP
in IN B-PP
determining VBG B-VP
the DT B-NP
patterns NNS I-NP
of IN B-PP
expression NN B-NP
. . O

We PRP B-NP
have VBP B-VP
investigated VBN I-VP
the DT B-NP
constitutive JJ I-NP
and CC I-NP
inducible JJ I-NP
transcriptional JJ I-NP
activity NN I-NP
mediated VBN B-VP
by IN B-PP
five CD B-NP
kappa NN I-NP
B-related JJ I-NP
sequence NN I-NP
elements NNS I-NP
in IN B-PP
two CD B-NP
different JJ I-NP
cell NN I-NP
types NNS I-NP
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
in IN B-PP
S194 NN B-NP
plasma NN I-NP
cells NNS I-NP
the DT B-NP
activity NN I-NP
of IN B-PP
each DT B-NP
element NN I-NP
correlates VBZ B-VP
well RB B-ADVP
with IN B-PP
the DT B-NP
relative JJ I-NP
affinity NN I-NP
of IN B-PP
B-cell-derived JJ B-NP
NF-kappa NN I-NP
B NN I-NP
for IN B-PP
that DT B-NP
element NN I-NP
. . O

This DT B-NP
leads VBZ B-VP
to TO B-PP
significantly RB B-NP
lower RBR I-NP
transcription NN I-NP
enhancement NN I-NP
by IN B-PP
sites NNS B-NP
derived VBN B-VP
from IN B-PP
the DT O
interleukin NN B-NP
2 CD I-NP
receptor NN I-NP
or CC O
T-cell NN B-NP
receptor NN I-NP
genes NNS B-NP
in IN B-PP
S194 NN B-NP
cells NNS B-NP
. . O

However RB B-ADVP
COMMA COMMA O
in IN B-PP
either CC O
EL-4 NN B-NP
( ( I-NP
T NN I-NP
) ) I-NP
cells NNS I-NP
or CC O
S194 NN B-NP
cells NNS I-NP
COMMA COMMA O
both DT B-NP
lower-affinity JJ I-NP
sites NNS I-NP
can MD B-VP
be VB I-VP
significantly RB I-VP
induced VBN I-VP
by IN B-PP
the DT B-NP
tax NN I-NP
gene NN I-NP
product NN I-NP
of IN B-PP
human JJ B-NP
T-cell NN I-NP
leukemia NN I-NP
virus NN I-NP
type NN I-NP
I CD I-NP
COMMA COMMA O
showing VBG B-VP
that IN B-SBAR
NF-kappa NN B-NP
B NN I-NP
activity NN I-NP
can MD B-VP
be VB I-VP
modulated VBN I-VP
even RB B-PP
in IN I-PP
a DT B-NP
B-cell NN I-NP
line NN I-NP
that WDT B-NP
constitutively RB B-ADVP
expresses VBZ B-VP
this DT B-NP
factor NN I-NP
. . O

Isolation NN B-NP
of IN B-PP
a DT B-NP
rel-related JJ I-NP
human JJ I-NP
cDNA NN I-NP
that WDT B-NP
potentially RB B-ADVP
encodes VBZ B-VP
the DT B-NP
65-kD JJ I-NP
subunit NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
{ ( O
published VBN B-NP
erratum NN I-NP
appears VBZ B-VP
in IN B-PP
Science NNP B-NP
1991 CD I-NP
Oct NNP I-NP
4 CD I-NP
; : I-NP
254 CD I-NP
( ( I-NP
5028 CD I-NP
) ) I-NP
: : I-NP
11 CD I-NP
} ) O

A DT B-NP
DNA NN I-NP
probe NN I-NP
that WDT B-NP
spanned VBD B-VP
a DT B-NP
domain NN I-NP
conserved VBN B-VP
among IN B-PP
the DT B-NP
proto-oncogene NN I-NP
c-rel NN I-NP
COMMA COMMA O
the DT B-NP
Drosophila NN I-NP
morphogen NN I-NP
dorsal NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
p50 NN I-NP
DNA NN I-NP
binding NN I-NP
subunit NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
was VBD B-VP
generated VBN I-VP
from IN B-PP
Jurkat NN B-NP
T NN I-NP
cell NN I-NP
complementary JJ I-NP
DNA NN I-NP
with IN B-PP
the DT B-NP
polymerase NN I-NP
chain NN I-NP
reaction NN I-NP
( ( O
PCR NN B-NP
) ) O
and CC O
degenerate JJ B-NP
oligonucleotides NNS I-NP
. . O

This DT B-NP
probe NN I-NP
was VBD B-VP
used VBN I-VP
to TO B-VP
identify VB I-VP
a DT B-NP
rel-related JJ I-NP
complementary JJ I-NP
DNA NN I-NP
that WDT B-NP
hybridized VBD B-VP
to TO B-PP
a DT B-NP
2.6-kilobase JJ I-NP
messenger NN I-NP
RNA NN I-NP
present JJ B-ADJP
in IN B-PP
human JJ O
T NN B-NP
and CC O
B NN B-NP
lymphocytes NNS B-NP
. . O

In FW B-NP
vitro FW I-NP
transcription NN B-NP
and CC O
translation NN B-NP
of IN B-PP
the DT B-NP
complementary JJ I-NP
DNA NN I-NP
resulted VBD B-VP
in IN B-PP
the DT B-NP
synthesis NN I-NP
of IN B-PP
a DT B-NP
protein NN I-NP
with IN B-PP
an DT B-NP
apparent JJ I-NP
molecular JJ I-NP
size NN I-NP
of IN B-PP
65 CD B-NP
kilodaltons NNS B-NP
( ( O
kD NN B-NP
) ) O
. . O

The DT B-NP
translated VBN I-NP
protein NN I-NP
showed VBD B-VP
weak JJ B-NP
DNA NN I-NP
binding NN I-NP
with IN B-PP
a DT B-NP
specificity NN I-NP
for IN B-PP
the DT B-NP
kappa NN I-NP
B NN I-NP
binding VBG I-NP
motif NN I-NP
. . O

This DT B-NP
protein-DNA JJ I-NP
complex JJ I-NP
comigrated VBN B-VP
with IN B-PP
the DT B-NP
complex NN I-NP
obtained VBN B-VP
with IN B-PP
the DT B-NP
purified VBN I-NP
human JJ I-NP
p65 NN I-NP
NF-kappa NN I-NP
B NN I-NP
subunit NN I-NP
and CC O
binding NN B-NP
was VBD B-VP
inhibited VBN I-VP
by IN B-PP
I NN B-NP
kappa NN I-NP
B-alpha NN I-NP
and CC O
-beta NN B-NP
proteins NNS B-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
the DT B-NP
65-kD JJ I-NP
protein NN I-NP
associated VBN B-VP
with IN B-PP
the DT B-NP
p50 NN I-NP
subunit NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
and CC O
the DT B-NP
kappa NN I-NP
B NN I-NP
probe NN I-NP
to TO B-VP
form VB I-VP
a DT B-NP
complex NN I-NP
with IN B-PP
the DT B-NP
same JJ I-NP
electrophoretic JJ I-NP
mobility NN I-NP
as IN B-PP
the DT B-NP
NF-kappa NN I-NP
B-DNA JJ I-NP
complex NN I-NP
. . O

Therefore RB B-ADVP
the DT B-NP
rel-related JJ I-NP
65-kD JJ I-NP
protein NN I-NP
may MD B-VP
represent VB I-VP
the DT B-NP
p65 NN I-NP
subunit NN I-NP
of IN B-PP
the DT B-NP
active JJ I-NP
NF-kappa NN I-NP
B NN I-NP
transcription NN I-NP
factor NN I-NP
complex NN I-NP
. . O

Lymphocyte NN B-NP
glucocorticoid NN I-NP
receptor NN I-NP
number NN I-NP
in IN B-PP
posttraumatic JJ B-NP
stress NN I-NP
disorder NN I-NP
. . O

OBJECTIVE NN B-NP
: : O
The DT B-NP
authors NNS I-NP
' POS B-NP
objective NN I-NP
was VBD B-VP
to TO B-VP
investigate VB I-VP
the DT B-NP
possibility NN I-NP
that IN B-SBAR
glucocorticoid NN B-NP
receptor NN I-NP
changes NNS I-NP
may MD B-VP
be VB I-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
dysregulation NN I-NP
of IN B-PP
the DT O
hypothalamic-pituitary-adrenal JJ O
( ( O
HPA JJ B-ADJP
) ) O
axis NN B-NP
in IN B-PP
posttraumatic JJ B-NP
stress NN I-NP
disorder NN I-NP
( ( O
PTSD NN B-NP
) ) O
. . O

METHOD NN B-NP
: : O
They PRP B-NP
measured VBD B-VP
the DT B-NP
number NN I-NP
of IN B-PP
lymphocyte NN B-NP
cytosolic JJ I-NP
glucocorticoid NN I-NP
receptors NNS I-NP
and CC O
plasma NN B-NP
cortisol NN I-NP
concentrations NNS I-NP
in IN O
15 CD B-NP
consecutively RB I-NP
admitted VBN I-NP
male JJ I-NP
combat NN I-NP
Vietnam NN I-NP
veterans NNS I-NP
with IN B-PP
PTSD NN B-NP
and CC B-PP
in IN B-PP
a DT B-NP
normal JJ I-NP
comparison NN I-NP
group NN I-NP
of IN B-PP
11 CD B-NP
subjects NNS I-NP
. . O

RESULTS NNS B-NP
: : O
Both CC O
the DT B-NP
patients NNS I-NP
and CC O
the DT B-NP
normal JJ I-NP
comparison NN I-NP
subjects NNS I-NP
showed VBD B-VP
a DT B-NP
morning-to-afternoon JJ I-NP
decline NN I-NP
in IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
concentrations NNS I-NP
COMMA COMMA O
paralleling VBG B-VP
the DT B-NP
normal JJ I-NP
diurnal JJ I-NP
decline NN I-NP
in IN B-PP
cortisol NN B-NP
levels NNS I-NP
. . O

The DT B-NP
number NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
was VBD B-VP
63 CD B-NP
% NN I-NP
greater JJR B-ADJP
in IN B-PP
the DT B-NP
morning NN I-NP
and CC O
26 CD B-NP
% NN I-NP
greater JJR B-ADJP
in IN B-PP
the DT B-NP
afternoon NN I-NP
in IN B-PP
the DT B-NP
patients NNS I-NP
with IN B-PP
PTSD NN B-NP
than IN B-PP
in IN B-PP
the DT B-NP
normal JJ I-NP
subjects NNS I-NP
. . O

No DT B-NP
group NN I-NP
differences NNS I-NP
in IN B-PP
cortisol NN B-NP
levels NNS I-NP
were VBD B-VP
observed VBN I-VP
COMMA COMMA O
nor CC O
were VBD O
glucocorticoid NN B-NP
receptor NN I-NP
number NN I-NP
and CC O
cortisol NN B-NP
levels NNS I-NP
correlated VBD B-ADJP
. . O

The DT B-NP
number NN I-NP
of IN B-PP
morning NN B-NP
glucocorticoid NN I-NP
receptors NNS I-NP
was VBD B-VP
positively RB B-ADJP
correlated VBN I-ADJP
with IN B-PP
symptoms NNS B-NP
of IN B-PP
PTSD NN B-NP
and CC O
anxiety NN B-NP
. . O

CONCLUSIONS NNS B-NP
: : O
These DT B-NP
results NNS I-NP
provide VBP B-VP
further JJ B-NP
evidence NN I-NP
for IN B-PP
a DT B-NP
dysregulation NN I-NP
of IN B-PP
the DT B-NP
HPA JJ I-NP
axis NN I-NP
in IN B-PP
PTSD NN B-NP
. . O

The DT B-NP
finding NN I-NP
that IN B-SBAR
patients NNS B-NP
with IN B-PP
PTSD NN B-NP
had VBD B-VP
a DT B-NP
substantially RB I-NP
greater JJR I-NP
number NN I-NP
of IN B-PP
lymphocyte NN B-NP
glucocorticoid NN I-NP
receptors NNS I-NP
than IN B-PP
normal JJ B-NP
comparison NN I-NP
subjects NNS I-NP
is VBZ B-VP
consistent JJ B-ADJP
with IN B-PP
the DT B-NP
authors NNS I-NP
' POS B-NP
previous JJ I-NP
observations NNS I-NP
of IN B-PP
low JJ B-NP
24-hour JJ I-NP
urinary JJ I-NP
cortisol NN I-NP
excretion NN I-NP
in IN B-PP
subjects NNS B-NP
with IN B-PP
PTSD NN B-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
the DT B-NP
receptor NN I-NP
changes NNS I-NP
observed VBN B-VP
are VBP B-VP
opposite JJ B-ADJP
of IN B-PP
those DT B-NP
reported VBN B-VP
in IN B-PP
major JJ B-NP
depressive JJ I-NP
disorder NN I-NP
. . O

The DT B-NP
present JJ I-NP
data NNS I-NP
COMMA COMMA O
along IN B-PP
with IN I-PP
other JJ B-NP
findings NNS I-NP
of IN B-PP
HPA JJ B-NP
abnormalities NNS I-NP
in IN B-PP
PTSD NN B-NP
COMMA COMMA O
support VBP B-VP
the DT B-NP
possibility NN I-NP
of IN B-PP
a DT B-NP
greater JJR I-NP
negative JJ I-NP
feedback NN I-NP
sensitivity NN I-NP
at IN B-PP
one CD B-NP
or CC I-NP
more JJR I-NP
levels NNS I-NP
of IN B-PP
the DT B-NP
HPA JJ I-NP
axis NN I-NP
. . O

A DT B-NP
thymus-specific JJ I-NP
member NN I-NP
of IN B-PP
the DT B-NP
HMG NN I-NP
protein NN I-NP
family NN I-NP
regulates VBZ B-VP
the DT B-NP
human JJ I-NP
T NN I-NP
cell NN I-NP
receptor NN I-NP
C NN I-NP
alpha NN I-NP
enhancer NN I-NP
. . O

The DT B-NP
human JJ I-NP
T NN I-NP
cell-specific JJ I-NP
transcription NN I-NP
factor NN I-NP
TCF-1 NN B-NP
alpha NN I-NP
plays VBZ B-VP
a DT B-NP
key JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
tissue-specific JJ I-NP
activation NN I-NP
of IN B-PP
the DT B-NP
T NN I-NP
cell NN I-NP
receptor NN I-NP
( ( I-NP
TCR NN I-NP
) ) I-NP
C NN I-NP
alpha NN I-NP
enhancer NN I-NP
and CC O
binds VBZ B-VP
to TO B-PP
pyrimidine-rich JJ B-NP
elements NNS I-NP
( ( O
5'-PyCTTTG-3' NN B-NP
) ) O
present JJ B-ADJP
in IN B-PP
a DT B-NP
variety NN I-NP
of IN B-PP
other JJ B-NP
T NN I-NP
cell-specific JJ I-NP
control NN I-NP
regions NNS I-NP
. . O

Using VBG B-VP
amino NN B-NP
acid NN I-NP
sequence NN I-NP
information NN I-NP
derived VBN B-VP
from IN B-PP
the DT B-NP
DNA NN I-NP
affinity-purified JJ I-NP
protein NN I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
now RB I-VP
isolated VBN I-VP
cDNA NN B-NP
clones NNS I-NP
encoding VBG B-VP
TCF-1 NN B-NP
alpha NN I-NP
. . O

The DT B-NP
TCF-1 NN I-NP
alpha NN I-NP
cDNA NN I-NP
contains VBZ B-VP
a DT B-NP
single JJ I-NP
68-amino-acid JJ I-NP
domain NN I-NP
that WDT B-NP
is VBZ B-VP
homologous JJ B-ADJP
to TO B-PP
a DT B-NP
region NN I-NP
conserved VBN B-VP
among IN B-PP
high-mobility JJ B-NP
group NN I-NP
( ( O
HMG NN B-NP
) ) O
and CC O
nonhistone JJ B-NP
chromosomal JJ I-NP
proteins NNS I-NP
. . O

Expression NN B-NP
of IN B-PP
full-length JJ B-NP
and CC I-NP
mutant JJ I-NP
cDNA NN I-NP
clones NNS I-NP
in IN B-PP
bacteria NNS B-NP
reveal VBP B-VP
that IN B-SBAR
the DT B-NP
single JJ I-NP
HMG NN I-NP
motif NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
predicted VBN I-VP
to TO I-VP
contain VB I-VP
two CD B-NP
extended VBN I-NP
alpha-helical JJ I-NP
segments NNS I-NP
COMMA COMMA O
is VBZ B-VP
sufficient JJ B-ADJP
to TO B-VP
direct VB I-VP
the DT B-NP
sequence-specific JJ I-NP
binding NN I-NP
of IN B-PP
TCF-1 NN B-NP
alpha NN I-NP
to TO B-PP
DNA NN B-NP
. . O

Northern NN B-NP
blot NN I-NP
experiments NNS I-NP
demonstrate VBP B-VP
further RBR B-ADVP
that IN B-SBAR
TCF-1 NN B-NP
alpha NN I-NP
mRNA NN I-NP
is VBZ B-VP
highly RB B-ADJP
tissue NN I-ADJP
specific JJ I-ADJP
COMMA COMMA O
found VBN B-VP
primarily RB B-ADVP
in IN B-PP
the DT B-NP
thymus NN B-NP
or CC O
T NN B-NP
cell NN I-NP
lines NNS I-NP
. . O

The DT B-NP
immature JJ I-NP
CEM NN I-NP
T NN I-NP
cell NN I-NP
line NN I-NP
expresses VBZ B-VP
relatively RB B-NP
low JJ I-NP
levels NNS I-NP
of IN B-PP
TCF-1 NN B-NP
alpha NN I-NP
mRNA NN I-NP
COMMA COMMA O
which WDT B-NP
are VBP B-VP
increased VBN I-VP
upon IN B-PP
activation NN B-NP
of IN B-PP
these DT B-NP
cells NNS I-NP
by IN B-PP
phorbol NN B-NP
esters NNS I-NP
. . O

Interestingly RB B-ADVP
COMMA COMMA O
the DT B-NP
cloned VBN I-NP
TCF-1 NN I-NP
alpha NN I-NP
protein NN I-NP
is VBZ B-VP
a DT B-NP
potent JJ I-NP
transcriptional JJ I-NP
activator NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
TCR NN I-NP
alpha NN I-NP
enhancer NN I-NP
in IN B-PP
nonlymphoid JJ B-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
whereas IN O
the DT B-NP
activity NN I-NP
of IN B-PP
the DT B-NP
endogenous JJ I-NP
protein NN I-NP
in IN B-PP
T NN B-NP
cell NN I-NP
lines NNS I-NP
is VBZ B-VP
strongly RB B-ADJP
dependent JJ I-ADJP
on IN B-PP
an DT B-NP
additional JJ I-NP
T NN I-NP
cell-specific JJ I-NP
protein NN I-NP
that WDT B-NP
interacts VBZ B-VP
with IN B-PP
the DT B-NP
core NN I-NP
enhancer NN I-NP
. . O

TCF-1 NN B-NP
alpha NN I-NP
is VBZ B-VP
currently RB B-ADJP
unique JJ I-ADJP
among IN B-PP
the DT B-NP
newly RB I-NP
emerging VBG I-NP
family NN I-NP
of IN B-PP
DNA-binding JJ B-NP
regulatory JJ I-NP
proteins NNS I-NP
that WDT B-NP
share VBP B-VP
the DT B-NP
HMG NN I-NP
motif NN I-NP
in IN B-PP
that IN B-NP
it PRP B-NP
is VBZ B-VP
a DT B-NP
highly RB I-NP
tissue-specific JJ I-NP
RNA NN I-NP
polymerase NN I-NP
II CD I-NP
transcription NN I-NP
factor NN I-NP
. . O

Immune JJ B-NP
response NN I-NP
of IN B-PP
peripheral JJ B-NP
blood NN I-NP
mononuclear JJ I-NP
cells NNS I-NP
to TO B-PP
HBx-antigen NN B-NP
of IN B-PP
hepatitis NN B-NP
B NN I-NP
virus NN I-NP
. . O

The DT B-NP
hepatitis NN I-NP
B NN I-NP
virus NN I-NP
genome NN I-NP
encodes VBZ B-VP
a DT B-NP
transcriptional JJ I-NP
transactivator NN I-NP
protein NN I-NP
designated VBN B-VP
HBxAg NN B-NP
. . O

We PRP B-NP
have VBP B-VP
investigated VBN I-VP
whether IN B-SBAR
this DT B-NP
antigen NN I-NP
is VBZ B-VP
a DT B-NP
target NN I-NP
structure NN I-NP
for IN B-PP
human JJ B-NP
T-lymphocytes NNS I-NP
. . O

Using VBG B-VP
recombinant JJ B-NP
HBxAg NN I-NP
protein NN I-NP
COMMA COMMA O
we PRP B-NP
found VBD B-VP
HBxAg-specific JJ B-NP
stimulation NN I-NP
of IN B-PP
peripheral JJ B-NP
blood NN I-NP
mononuclear JJ I-NP
cells NNS I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
acute JJ B-NP
hepatitis NN I-NP
B NN I-NP
virus NN I-NP
infection NN I-NP
( ( O
6 CD B-NP
of IN B-PP
6 CD B-NP
) ) O
and CC O
chronic JJ B-NP
hepatitis NN I-NP
B NN I-NP
virus NN I-NP
infection NN I-NP
( ( O
6 CD B-NP
of IN B-PP
17 CD B-NP
) ) O
but CC B-PP
not RB B-PP
in IN I-PP
healthy JJ B-NP
individuals NNS I-NP
. . O

With IN B-PP
HBxAg-specific JJ B-NP
synthetic JJ I-NP
polypeptides NNS I-NP
COMMA COMMA O
several JJ B-NP
T-cell NN I-NP
epitopes NNS I-NP
were VBD B-VP
identified VBN I-VP
. . O

Most JJS B-NP
were VBD B-VP
located JJ I-VP
in IN B-PP
the DT B-NP
carboxyterminal JJ I-NP
half NN I-NP
of IN B-PP
the DT B-NP
HBxAg NN I-NP
protein NN I-NP
. . O

Five CD B-NP
T-cell NN I-NP
clones NNS I-NP
specific JJ B-ADJP
for IN B-PP
a DT B-NP
T-cell NN I-NP
epitope NN I-NP
located JJ B-ADJP
at IN B-PP
the DT B-NP
carboxyterminal JJ I-NP
region NN I-NP
of IN B-PP
HBxAg NN B-NP
were VBD B-VP
established VBN I-VP
and CC O
found VBN B-VP
to TO I-VP
belong VB I-VP
to TO B-PP
the DT B-NP
CD2\/CD4-positive JJ I-NP
COMMA COMMA I-NP
CD8-negative JJ I-NP
subtype NN I-NP
. . O

These DT B-NP
data NNS I-NP
establish VBP B-VP
for IN B-PP
the DT B-NP
first JJ I-NP
time NN I-NP
HBxAg NN B-NP
as IN B-PP
an DT B-NP
antigen NN I-NP
in IN B-PP
the DT B-NP
cellular JJ I-NP
immune JJ I-NP
response NN I-NP
. . O

A DT B-NP
study NN I-NP
on IN B-PP
the DT B-NP
circadian JJ I-NP
rhythm NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
. . O

Circadian JJ B-NP
rhythm NN I-NP
in IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
( ( O
GR NN B-NP
) ) O
was VBD B-VP
studied VBN I-VP
in IN B-PP
the DT O
rat NN B-NP
liver NN I-NP
and CC O
human JJ B-ADJP
peripheral JJ I-ADJP
leukocytes NNS B-NP
. . O

For IN B-PP
rats NNS B-NP
exposed VBN B-VP
to TO B-PP
a DT B-NP
natural JJ I-NP
environmental JJ I-NP
photic JJ I-NP
cycle NN I-NP
or CC O
a DT B-NP
12L NN I-NP
: : I-NP
12D NN I-NP
artificial JJ I-NP
light NN I-NP
regime NN I-NP
COMMA COMMA O
peak JJ B-NP
values NNS I-NP
of IN B-PP
hepatic JJ B-NP
GR NN I-NP
were VBD B-VP
detected VBN I-VP
between IN B-PP
23:00 CD B-NP
and CC I-NP
02:00 CD I-NP
h NN I-NP
. . O

Except IN B-PP
for IN I-PP
a DT B-NP
4-hour JJ I-NP
advancement NN I-NP
of IN B-PP
the DT B-NP
peak NN I-NP
COMMA COMMA O
a DT B-NP
similar JJ I-NP
circadian JJ I-NP
rhythm NN I-NP
of IN B-PP
hepatic JJ B-NP
GR NN I-NP
was VBD B-VP
detected VBN I-VP
in IN B-PP
rats NNS B-NP
reared VBN B-VP
under IN B-PP
a DT B-NP
reversed VBN I-NP
lighting NN I-NP
regimen NNS I-NP
( ( O
12D NN B-NP
: : I-NP
12L NN I-NP
; : O
lights NNS B-NP
on IN B-ADVP
between IN B-PP
18:30 CD B-NP
and CC I-NP
06:30 CD I-NP
h NN I-NP
) ) O
. . O

In IN B-PP
human JJ B-NP
leukocytes NNS I-NP
COMMA COMMA O
the DT B-NP
peak JJ I-NP
value NN I-NP
of IN B-PP
GR NN B-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
parallel VB I-VP
that DT B-NP
of IN B-PP
plasma NN B-NP
cortisol NN I-NP
with IN B-PP
high JJ B-NP
and CC I-NP
low JJ I-NP
values NNS I-NP
detected VBN B-VP
at IN B-PP
04:00-08:00 CD B-NP
h NN I-NP
and CC O
23:00-24:00 CD B-NP
h NN I-NP
COMMA COMMA O
respectively RB B-ADVP
. . O

In IN B-PP
patients NNS B-NP
suffering VBG B-VP
from IN B-PP
Cushing NN B-NP
's POS B-NP
syndrome NN I-NP
COMMA COMMA O
the DT B-NP
circadian JJ I-NP
rhythm NN I-NP
of IN B-PP
plasma NN B-NP
cortisol NN I-NP
either CC O
disappeared VBD B-VP
or CC O
was VBD B-VP
inverted VBN I-VP
while IN B-SBAR
that DT B-NP
of IN B-PP
GR NN B-NP
did VBD B-VP
not RB I-VP
significantly RB I-VP
deviate VB I-VP
from IN B-PP
the DT B-NP
normal JJ I-NP
subjects NNS I-NP
. . O

For IN B-PP
apoplexic JJ B-NP
patients NNS I-NP
with IN B-PP
lesions NNS B-NP
localized JJ B-VP
to TO B-PP
the DT B-NP
base NN I-NP
of IN B-PP
the DT B-NP
brain NN I-NP
as IN B-SBAR
indicated VBN B-VP
by IN B-PP
computerized VBN B-NP
tomography NN I-NP
COMMA COMMA O
the DT B-NP
diurnal JJ I-NP
variation NN I-NP
of IN B-PP
GR NN B-NP
was VBD B-VP
abolished VBN I-VP
. . O

Conversely RB B-ADVP
COMMA COMMA O
diurnal JJ B-NP
rhythmicity NN I-NP
persisted VBD B-VP
in IN B-PP
apoplexy NN B-NP
patients NNS I-NP
whose WP$ B-NP
lesions NNS I-NP
were VBD B-VP
in IN B-PP
the DT B-NP
cerebral JJ I-NP
cortex NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
we PRP B-NP
postulated VBD B-VP
that IN B-SBAR
the DT B-NP
circadian JJ I-NP
modification NN I-NP
of IN B-PP
GR NN B-NP
was VBD B-VP
independent JJ B-ADJP
of IN B-PP
the DT B-NP
diurnal JJ I-NP
fluctuations NNS I-NP
in IN B-PP
plasma NN B-NP
cortisol NN I-NP
level NN I-NP
or CC O
the DT B-NP
circadian JJ I-NP
variations NNS I-NP
in IN B-PP
environmental JJ B-NP
lighting NN I-NP
and CC O
that IN B-SBAR
the DT B-NP
rhythmicity NN I-NP
might MD B-VP
be VB I-VP
regulated VBN I-VP
by IN B-PP
the DT B-NP
' `` I-NP
circadian JJ I-NP
pacemaker NN I-NP
' '' O
located JJ B-ADJP
in IN B-PP
the DT B-NP
human JJ I-NP
basal JJ I-NP
brain NN I-NP
. . O

These DT B-NP
diurnal JJ I-NP
variations NNS I-NP
in IN B-PP
GR NN B-NP
might MD B-VP
serve VB I-VP
to TO I-VP
coordinate VB I-VP
the DT B-NP
reactivity NN I-NP
of IN B-PP
the DT B-NP
target NN I-NP
cells NNS I-NP
to TO B-PP
cortisol NN B-NP
because IN B-SBAR
the DT B-NP
diurnal JJ I-NP
rhythms NNS I-NP
of IN B-PP
a DT B-NP
GR-mediated JJ I-NP
response NN I-NP
COMMA COMMA O
the DT B-NP
fractional JJ I-NP
inhibition NN I-NP
of IN B-PP
chemotactic JJ B-NP
migration NN I-NP
rate NN I-NP
of IN B-PP
polymorphonuclear JJ B-NP
leukocytes NNS I-NP
by IN B-PP
cortisol NN B-NP
COMMA COMMA O
were VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
synchronous JJ B-ADJP
with IN B-PP
those DT B-NP
of IN B-PP
GR NN B-NP
. . O

Multiple JJ B-NP
Oct2 NN I-NP
isoforms NNS I-NP
are VBP B-VP
generated VBN I-VP
by IN B-PP
alternative JJ B-NP
splicing NN I-NP
. . O

The DT B-NP
interaction NN I-NP
of IN B-PP
the DT B-NP
Oct2 NN I-NP
transcription NN I-NP
factor NN I-NP
with IN B-PP
the DT B-NP
cognate JJ I-NP
octamer NN I-NP
motif NN I-NP
ATGCAAAT NN I-NP
is VBZ B-VP
a DT B-NP
critical JJ I-NP
determinant NN I-NP
of IN B-PP
the DT B-NP
lymphoid-specific JJ I-NP
expression NN I-NP
of IN B-PP
immunoglobulin NN B-NP
genes NNS I-NP
. . O

Ectopic JJ B-NP
expression NN I-NP
of IN B-PP
cloned VBN B-NP
Oct2 NN I-NP
cDNA NN I-NP
was VBD B-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
sufficient JJ B-ADJP
to TO B-VP
reconstitute VB I-VP
at IN B-NP
least JJS I-NP
some DT I-NP
aspects NNS I-NP
of IN B-PP
this DT B-NP
regulation NN I-NP
in IN B-PP
non-lymphoid JJ B-NP
cells NNS I-NP
. . O

We PRP B-NP
describe VBP B-VP
the DT B-NP
isolation NN B-NP
and CC O
characterization NN B-NP
of IN B-PP
multiple JJ B-NP
cDNAs NNS I-NP
encoding VBG B-VP
mouse NN B-NP
Oct2 NN I-NP
from IN B-PP
a DT B-NP
mature JJ I-NP
B-cell NN I-NP
line NN I-NP
and CC O
we PRP B-NP
show VBP B-VP
that IN B-SBAR
a DT B-NP
variety NN I-NP
of IN B-PP
isoforms NNS B-NP
of IN B-PP
this DT B-NP
transcription NN I-NP
factor NN I-NP
is VBZ B-VP
generated VBN I-VP
from IN B-PP
a DT B-NP
single JJ I-NP
gene NN I-NP
by IN B-PP
an DT B-NP
alternative JJ I-NP
splicing NN I-NP
mechanism NN I-NP
. . O

All PDT B-NP
the DT I-NP
isoforms NNS I-NP
retain VBP B-VP
the DT B-NP
previously RB I-NP
characterized VBN I-NP
POU-domain NN I-NP
and CC O
are VBP B-VP
therefore RB B-ADVP
able JJ B-ADJP
to TO B-VP
bind VB I-VP
to TO B-PP
the DT B-NP
octamer NN I-NP
motif NN I-NP
. . O

Different JJ B-NP
amounts NNS I-NP
of IN B-PP
the DT B-NP
various JJ I-NP
isoforms NNS I-NP
are VBP B-VP
present JJ B-ADJP
within IN B-PP
the DT B-NP
same JJ I-NP
B-cell NN I-NP
regardless RB B-ADVP
of IN B-PP
the DT B-NP
developmental JJ I-NP
stage NN I-NP
of IN B-PP
B-cell NN B-NP
differentiation NN I-NP
and CC O
at IN B-ADVP
least JJS I-ADVP
some DT B-NP
of IN B-PP
the DT B-NP
isoforms NNS I-NP
are VBP B-VP
conserved VBN I-VP
between IN B-PP
mouse NN B-NP
and CC O
humans NNS B-NP
. . O

In IN B-PP
cotransfection NN B-NP
experiments NNS I-NP
we PRP B-NP
show VBP B-VP
that IN B-SBAR
all PDT B-NP
the DT I-NP
isoforms NNS I-NP
are VBP B-VP
able JJ B-ADJP
to TO B-VP
activate VB I-VP
an DT B-NP
octamer NN I-NP
containing VBG B-VP
promoter NN B-NP
element NN I-NP
in IN B-PP
fibroblasts NNS B-NP
revealing VBG B-VP
an DT B-NP
unexpected JJ I-NP
functional JJ I-NP
redundancy NN I-NP
. . O

Finally RB B-ADVP
COMMA COMMA O
we PRP B-NP
show VBP B-VP
that IN B-SBAR
one CD B-NP
of IN B-PP
the DT B-NP
isoforms NNS I-NP
encodes VBZ B-VP
the DT B-NP
previously RB I-NP
described VBN I-NP
lymphoid-specific JJ I-NP
Oct2B NN I-NP
protein NN I-NP
which WDT B-NP
has VBZ B-VP
been VBN I-VP
suggested VBN I-VP
to TO I-VP
be VB I-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
function NN I-NP
of IN B-PP
the DT B-NP
octamer NN I-NP
motif NN I-NP
in IN B-PP
the DT I-PP
context NN I-PP
of IN I-PP
the DT O
immunoglobulin NN B-NP
heavy-chain NN I-NP
( ( O
IgH NN B-NP
) ) O
enhancer NN B-NP
. . O

Murine JJ B-NP
and CC I-NP
human JJ I-NP
T-lymphocyte NN I-NP
GATA-3 NN I-NP
factors NNS I-NP
mediate VBP B-VP
transcription NN B-NP
through IN B-PP
a DT B-NP
cis-regulatory JJ I-NP
element NN I-NP
within IN B-PP
the DT B-NP
human JJ I-NP
T-cell NN I-NP
receptor NN I-NP
delta NN I-NP
gene NN I-NP
enhancer NN I-NP
. . O

A DT B-NP
family NN I-NP
of IN B-PP
transcriptional JJ B-NP
activators NNS I-NP
has VBZ B-VP
recently RB I-VP
been VBN I-VP
identified VBN I-VP
in IN B-PP
chickens NNS B-NP
; : O
these DT B-NP
transcriptional JJ I-NP
activators NNS I-NP
recognize VBP B-VP
a DT B-NP
common JJ I-NP
consensus NN I-NP
motif NN I-NP
( ( O
WGATAR NN B-NP
) ) O
through IN B-PP
a DT B-NP
conserved VBN I-NP
C4 NN I-NP
zinc NN I-NP
finger NN I-NP
DNA-binding JJ I-NP
domain NN I-NP
. . O

One CD B-NP
of IN B-PP
the DT B-NP
members NNS I-NP
of IN B-PP
this DT B-NP
multigene JJ I-NP
family NN I-NP
COMMA COMMA O
cGATA-3 NN B-NP
COMMA COMMA O
is VBZ B-VP
most RBS I-VP
abundantly RB I-VP
expressed VBN I-VP
in IN B-PP
the DT B-NP
T-lymphocyte NN I-NP
cell NN I-NP
lineage NN I-NP
. . O

Analysis NN B-NP
of IN B-PP
human JJ B-NP
and CC I-NP
murine JJ I-NP
GATA-3 NN I-NP
factors NNS I-NP
shows VBZ B-VP
a DT B-NP
striking JJ I-NP
degree NN I-NP
of IN B-PP
amino NN B-NP
acid NN I-NP
sequence NN I-NP
identity NN I-NP
and CC O
similar JJ B-NP
patterns NNS I-NP
of IN B-PP
tissue NN B-NP
specificity NN I-NP
of IN B-PP
expression NN B-NP
in IN B-PP
these DT B-NP
three CD I-NP
organisms NNS I-NP
. . O

The DT B-NP
murine JJ I-NP
and CC I-NP
human JJ I-NP
factors NNS I-NP
are VBP B-VP
abundantly RB I-VP
expressed VBN I-VP
in IN B-PP
a DT B-NP
variety NN I-NP
of IN B-PP
human JJ B-NP
and CC I-NP
murine JJ I-NP
T-cell NN I-NP
lines NNS I-NP
and CC O
can MD B-VP
activate VB I-VP
transcription NN B-NP
through IN B-PP
a DT B-NP
tissue-specific JJ I-NP
GATA-binding JJ I-NP
site NN I-NP
identified VBN B-VP
within IN B-PP
the DT B-NP
human JJ I-NP
T-cell NN I-NP
receptor NN I-NP
delta NN I-NP
gene NN I-NP
enhancer NN I-NP
. . O

We PRP B-NP
infer VBP B-VP
that IN B-SBAR
the DT O
murine JJ B-NP
and CC O
human JJ B-ADJP
GATA-3 NN B-NP
proteins NNS I-NP
play VBP B-VP
a DT B-NP
central JJ I-NP
and CC I-NP
highly RB I-NP
conserved VBN I-NP
role NN I-NP
in IN B-PP
vertebrate NN B-NP
T-cell-specific JJ I-NP
transcriptional JJ I-NP
regulation NN I-NP
. . O

Processing NN B-NP
of IN B-PP
the DT B-NP
precursor NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
by IN B-PP
the DT B-NP
HIV-1 NN I-NP
protease NN I-NP
during IN B-PP
acute JJ B-NP
infection NN I-NP
. . O

Transcription NN B-NP
of IN B-PP
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
type-1 NN I-NP
( ( O
HIV-1 NN B-NP
) ) O
genome NN B-NP
is VBZ B-VP
regulated VBN I-VP
in IN B-PP
part NN B-NP
by IN B-PP
cellular JJ B-NP
factors NNS I-NP
and CC O
is VBZ B-VP
stimulated VBN I-VP
by IN B-PP
activation NN B-NP
of IN B-PP
latently RB B-NP
infected JJ I-NP
T NN I-NP
cells NNS I-NP
. . O

T-cell NN B-NP
activation NN I-NP
also RB B-ADVP
correlates VBZ B-VP
with IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
the DT B-NP
factor NN I-NP
NF-kappa NN I-NP
B NN I-NP
which WDT B-NP
binds VBZ B-VP
to TO B-PP
two CD B-NP
adjacent JJ I-NP
sites NNS I-NP
in IN B-PP
the DT B-NP
HIV-1 NN I-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
. . O

This DT B-NP
factor NN I-NP
consists VBZ B-VP
of IN B-PP
two CD B-NP
DNA-binding JJ I-NP
subunits NNS I-NP
of IN B-PP
relative JJ B-NP
molecular JJ I-NP
mass NN I-NP
50COMMA000 CD B-NP
( ( O
50K CD B-NP
) ) O
associated VBN B-VP
with IN B-PP
two CD B-NP
65K CD I-NP
subunits NNS I-NP
. . O

It PRP B-NP
is VBZ B-VP
located JJ B-ADJP
in IN B-PP
the DT B-NP
nucleus NN I-NP
in IN B-PP
mature JJ B-NP
B NN I-NP
cells NNS I-NP
COMMA COMMA O
but CC O
is VBZ B-VP
present JJ B-ADJP
in IN B-PP
other JJ B-NP
cell NN I-NP
types NNS I-NP
as IN B-PP
an DT B-NP
inactive JJ I-NP
cytoplasmic JJ I-NP
complex NN I-NP
. . O

External JJ B-NP
stimuli NNS I-NP
COMMA COMMA O
including VBG B-PP
those DT B-NP
that WDT B-NP
activate VBP B-VP
T NN B-NP
cells NNS I-NP
COMMA COMMA O
result VBP B-VP
in IN B-PP
nuclear JJ B-NP
translocation NN I-NP
of IN B-PP
active JJ B-NP
NF-kappa NN I-NP
B NN I-NP
. . O

The DT B-NP
cloning NN I-NP
of IN B-PP
the DT B-NP
complementary JJ I-NP
DNA NN I-NP
for IN B-PP
the DT B-NP
50K CD I-NP
subunit NN I-NP
helped VBD B-VP
to TO I-VP
identify VB I-VP
an DT B-NP
exclusively RB I-NP
cytoplasmic JJ I-NP
105K CD I-NP
precursor NN I-NP
( ( O
p105 NN B-NP
) ) O
( ( O
V.B. NNP B-NP
COMMA COMMA O
P.K. NNP B-NP
and CC O
A.I. NNP B-NP
COMMA COMMA O
manuscript NN B-NP
submitted VBN B-VP
) ) O
. . O

The DT B-NP
expression NN I-NP
of IN B-PP
active JJ B-NP
NF-kappa NN I-NP
B NN I-NP
might MD B-VP
therefore RB I-VP
also RB I-VP
be VB I-VP
regulated VBN I-VP
by IN B-PP
the DT B-NP
extent NN I-NP
of IN B-PP
processing NN B-NP
of IN B-PP
p105 NN B-NP
. . O

Because IN B-SBAR
HIV-1 NN B-NP
requires VBZ B-VP
active JJ B-NP
NF-kappa NN I-NP
B NN I-NP
for IN B-PP
efficient JJ B-NP
transcription NN I-NP
COMMA COMMA O
we PRP B-NP
tested VBD B-VP
the DT B-NP
effect NN I-NP
of IN B-PP
HIV-1 NN B-NP
infection NN I-NP
on IN B-PP
the DT B-NP
processing NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
105K CD I-NP
precursor NN I-NP
. . O

We PRP B-NP
show VBP B-VP
here RB B-ADVP
that IN B-SBAR
the DT B-NP
HIV-1 NN I-NP
protease NN I-NP
can MD B-VP
process VB I-VP
p105 NN B-NP
and CC O
increases VBZ B-VP
levels NNS B-NP
of IN B-PP
active JJ B-NP
nuclear JJ I-NP
NF-kappa NN I-NP
B NN I-NP
complex NN I-NP
. . O

Vitamin NN B-NP
D NN I-NP
receptor NN I-NP
expression NN I-NP
in IN B-PP
human JJ B-NP
lymphocytes NNS I-NP
. . O

Signal NN B-NP
requirements NNS I-NP
and CC O
characterization NN B-NP
by IN B-PP
western NN B-NP
blots NNS I-NP
and CC O
DNA NN B-NP
sequencing NN I-NP
. . O

The DT B-NP
signals NNS I-NP
controlling VBG B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
receptor NN I-NP
protein NN I-NP
for IN B-PP
1 CD B-NP
alphaCOMMA25-dihydroxyvitamin NN I-NP
D3 NN I-NP
in IN B-PP
normal JJ B-NP
human JJ I-NP
lymphocytes NNS I-NP
and CC O
the DT B-NP
relationship NN I-NP
of IN B-PP
this DT B-NP
protein NN I-NP
to TO B-PP
the DT B-NP
classical JJ I-NP
vitamin NN I-NP
D NN I-NP
receptor NN I-NP
were VBD B-VP
examined VBN I-VP
. . O

Lymphocytes NNS B-NP
activated VBN B-VP
with IN B-PP
the DT B-NP
OKT3 NN I-NP
antibody NN I-NP
to TO B-PP
the DT B-NP
T-cell NN I-NP
antigen NN I-NP
receptor NN I-NP
expressed VBD B-VP
fewer JJR B-NP
binding VBG I-NP
sites NNS I-NP
as IN B-SBAR
compared VBN B-VP
to TO B-PP
lymphocytes NNS B-NP
that WDT B-NP
were VBD B-VP
activated VBN I-VP
by IN B-PP
the DT B-NP
polyclonal JJ I-NP
activator NN I-NP
phytohemagglutinin NN I-NP
( ( O
PHA NN B-NP
) ) O
. . O

However RB B-ADVP
COMMA COMMA O
combination NN B-NP
of IN B-PP
OKT3 NN B-NP
and CC O
phorbol NN B-NP
myristate NN I-NP
acetate NN I-NP
produced VBD B-VP
a DT B-NP
concentration NN I-NP
of IN B-PP
binding VBG B-NP
sites NNS I-NP
similar JJ B-ADJP
to TO B-PP
the DT B-NP
PHA-activated JJ I-NP
cells NNS I-NP
. . O

The DT B-NP
receptor NN I-NP
from IN B-PP
OKT3 NN B-NP
and CC O
OKT3 NN B-ADJP
+ CC I-ADJP
phorbol NN I-ADJP
myristate NN I-ADJP
acetate-activated JJ I-ADJP
lymphocytes NNS B-NP
exhibited VBD B-VP
decreased VBN B-NP
binding NN I-NP
to TO B-PP
DNA-cellulose NN B-NP
compared VBN B-VP
to TO B-PP
PHA-activated JJ B-NP
lymphocytes NNS I-NP
. . O

In IN B-PP
lymphocytes NNS B-NP
activated VBN B-VP
either CC B-PP
by IN I-PP
PHA NN B-NP
or CC O
OKT3 NN B-NP
( ( B-PP
but CC I-PP
not RB B-PP
in IN I-PP
resting VBG B-NP
cells NNS I-NP
) ) O
COMMA COMMA O
a DT B-NP
50-kDa JJ I-NP
species NNS I-NP
cross-reacting VBG B-VP
with IN B-PP
a DT B-NP
monoclonal JJ I-NP
antibody NN I-NP
against IN B-PP
the DT B-NP
intestinal JJ I-NP
vitamin NN I-NP
D NN I-NP
receptor NN I-NP
was VBD B-VP
detected VBN I-VP
. . O

Finally RB B-ADVP
COMMA COMMA O
RNA NN B-NP
from IN B-PP
activated VBN B-NP
lymphocytes NNS I-NP
was VBD B-VP
amplified VBN I-VP
by IN B-PP
polymerase NN B-NP
chain NN I-NP
reaction NN I-NP
using VBG B-VP
oligonucleotide NN B-NP
primers NNS I-NP
flanking VBG B-VP
the DT B-NP
196 CD I-NP
base NN I-NP
pair NN I-NP
long JJ I-NP
region NN I-NP
encoding VBG B-VP
the DT B-NP
DNA-binding JJ I-NP
domain NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
intestinal JJ I-NP
receptor NN I-NP
. . O

The DT B-NP
amplified VBN I-NP
product NN I-NP
showed VBD B-VP
an DT B-NP
identical JJ I-NP
nucleotide NN I-NP
sequence NN I-NP
to TO B-PP
the DT B-NP
DNA-binding JJ I-NP
domain NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
intestinal JJ I-NP
receptor NN I-NP
. . O

These DT B-NP
findings NNS I-NP
suggest VBP B-VP
that IN B-SBAR
expression NN B-NP
of IN B-PP
the DT B-NP
1COMMA25-(OH)2D3 NN I-NP
receptor NN I-NP
in IN B-PP
lymphocytes NNS B-NP
is VBZ B-VP
triggered VBN I-VP
by IN B-PP
distinct JJ B-NP
and CC I-NP
contingent JJ I-NP
signals NNS I-NP
COMMA COMMA O
and CC O
that IN B-SBAR
the DT B-NP
protein NN I-NP
and CC O
the DT B-NP
mRNA NN I-NP
encoding VBG B-VP
it PRP B-NP
are VBP B-VP
identical JJ B-ADJP
to TO B-PP
the DT B-NP
classical JJ I-NP
vitamin NN I-NP
D NN I-NP
receptor NN I-NP
. . O

Cloning NN B-NP
of IN B-PP
murine JJ B-NP
TCF-1 NN I-NP
COMMA COMMA O
a DT B-NP
T NN I-NP
cell-specific JJ I-NP
transcription NN I-NP
factor NN I-NP
interacting VBG B-VP
with IN B-PP
functional JJ B-NP
motifs NNS I-NP
in IN B-PP
the DT B-NP
CD3-epsilon NN I-NP
and CC I-NP
T NN I-NP
cell NN I-NP
receptor NN I-NP
alpha NN I-NP
enhancers NNS I-NP
. . O

CD3-epsilon NN B-NP
gene NN I-NP
expression NN I-NP
is VBZ B-VP
confined VBN I-VP
to TO B-PP
the DT B-NP
T NN I-NP
cell NN I-NP
lineage NN I-NP
. . O

We PRP B-NP
have VBP B-VP
recently RB I-VP
identified VBN I-VP
and CC O
cloned VBN B-VP
a DT B-NP
human JJ I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
TCF-1 NN B-NP
COMMA COMMA O
that WDT B-NP
binds VBZ B-VP
to TO B-PP
a DT B-NP
functional JJ I-NP
element NN I-NP
in IN B-PP
the DT B-NP
T NN I-NP
lymphocyte-specific JJ I-NP
enhancer NN I-NP
of IN B-PP
CD3-epsilon NN B-NP
. . O

In IN B-PP
a DT B-NP
panel NN I-NP
of IN B-PP
human JJ B-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
TCF-1 NN B-NP
expression NN I-NP
was VBD B-VP
restricted JJ B-ADJP
to TO B-PP
T NN B-NP
lineage NN I-NP
cells NNS I-NP
. . O

TCF-1 NN B-NP
belonged VBD B-VP
to TO B-PP
a DT B-NP
novel JJ I-NP
family NN I-NP
of IN B-PP
genes NNS B-NP
that WDT B-NP
contain VBP B-VP
the DT B-NP
so-called JJ I-NP
high JJ I-NP
mobility NN I-NP
group NN I-NP
1 CD I-NP
( ( I-NP
HMG NN I-NP
) ) I-NP
box NN I-NP
. . O

Here RB B-ADVP
we PRP B-NP
report VBP B-VP
the DT B-NP
cloning NN I-NP
of IN B-PP
murine JJ B-NP
TCF-1 NN I-NP
. . O

Two CD B-NP
splice NN I-NP
alternatives NNS I-NP
were VBD B-VP
identified VBN I-VP
that WDT B-NP
were VBD B-VP
not RB I-VP
previously RB I-VP
observed VBN I-VP
in IN B-PP
human JJ B-NP
TCF-1 NN I-NP
. . O

Murine JJ B-NP
and CC I-NP
human JJ I-NP
TCF-1 NN I-NP
displayed VBD B-VP
a DT B-NP
95.5 CD I-NP
% NN I-NP
overall JJ I-NP
amino NN I-NP
acid NN I-NP
homology NN I-NP
. . O

Recombinant JJ B-NP
murine JJ I-NP
and CC I-NP
human JJ I-NP
TCF-1 NN I-NP
recognized VBD B-VP
the DT B-NP
same JJ I-NP
sequence NN I-NP
motif NN I-NP
in IN B-PP
the DT B-NP
CD3-epsilon NN I-NP
enhancer NN I-NP
as IN B-SBAR
judged VBN B-VP
by IN B-PP
gel NN B-NP
retardation NN I-NP
and CC O
methylation NN B-NP
interference NN I-NP
assays NNS B-NP
. . O

With IN B-PP
the DT B-NP
murine JJ I-NP
cDNA NN I-NP
clones NNS I-NP
several JJ B-NP
aspects NNS I-NP
of IN B-PP
TCF-1 NN B-NP
were VBD B-VP
analyzed VBN I-VP
. . O

First RB B-ADVP
COMMA COMMA O
deletion NN B-NP
analysis NN I-NP
revealed VBD B-VP
that IN B-SBAR
a DT B-NP
region NN I-NP
of IN B-PP
TCF-1 NN B-NP
containing VBG B-VP
the DT B-NP
HMG NN I-NP
box NN I-NP
was VBD B-VP
sufficient JJ B-ADJP
for IN B-PP
sequence-specific JJ B-NP
binding NN I-NP
. . O

Second RB B-ADVP
COMMA COMMA O
by IN B-PP
high JJ B-NP
stringency NN I-NP
Northern NN I-NP
blotting NN I-NP
and CC O
in FW B-NP
situ FW I-NP
hybridization NN I-NP
COMMA COMMA O
TCF-1 NN B-NP
expression NN I-NP
was VBD B-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
confined VBN I-VP
to TO B-PP
the DT B-NP
thymus NN I-NP
and CC B-PP
to TO B-PP
the DT B-NP
T NN I-NP
cell NN I-NP
areas NNS I-NP
of IN B-PP
the DT B-NP
spleen NN I-NP
. . O

Third RB B-ADVP
COMMA COMMA O
TCF-1 NN B-NP
bound VBD B-VP
specifically RB B-ADVP
to TO B-PP
a DT B-NP
functional JJ I-NP
T NN I-NP
cell-specific JJ I-NP
element NN I-NP
in IN B-PP
the DT O
T NN B-NP
cell NN I-NP
receptor NN I-NP
alpha NN I-NP
( ( O
TCR-alpha NN B-NP
) ) O
enhancer NN B-NP
. . O

The DT B-NP
T NN I-NP
lineage-specific JJ I-NP
expression NN I-NP
and CC O
the DT B-NP
affinity NN I-NP
for IN B-PP
functional JJ B-NP
motifs NNS I-NP
in IN B-PP
the DT O
TCR-alpha NN B-NP
and CC O
CD3-epsilon NN B-NP
enhancers NNS B-NP
imply VBP B-VP
an DT B-NP
important JJ I-NP
role NN I-NP
for IN B-PP
TCF-1 NN B-NP
in IN B-PP
the DT B-NP
establishment NN I-NP
of IN B-PP
the DT B-NP
mature JJ I-NP
T NN I-NP
cell NN I-NP
phenotype NN I-NP
. . O

HIV NN B-NP
enhancer NN I-NP
activity NN I-NP
perpetuated VBN B-VP
by IN B-PP
NF-kappa NN B-NP
B NN I-NP
induction NN I-NP
on IN B-PP
infection NN B-NP
of IN B-PP
monocytes NNS B-NP
{ ( O
see VB B-VP
comments NNS B-NP
} ) O

Permissiveness NN B-NP
to TO B-PP
replication NN B-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV NN B-NP
) ) O
differs VBZ B-VP
in IN B-PP
T NN B-NP
lymphocytes NNS I-NP
and CC O
macrophages NNS B-NP
. . O

In IN B-PP
T NN B-NP
cells NNS I-NP
COMMA COMMA O
HIV NN B-NP
transcription NN I-NP
is VBZ B-VP
poorly RB I-VP
detected VBN I-VP
in FW B-ADVP
vivo FW I-ADVP
. . O

Cloned VBN B-NP
COMMA COMMA I-NP
normal JJ I-NP
T NN I-NP
lymphocytes NNS I-NP
show VBP B-VP
very RB O
little JJ O
COMMA COMMA O
if IN B-SBAR
any DT O
COMMA COMMA O
basal JJ B-NP
activity NN I-NP
of IN B-PP
the DT B-NP
HIV NN I-NP
enhancer NN I-NP
and CC O
low JJ B-NP
nuclear JJ I-NP
expression NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
a DT B-NP
potent JJ I-NP
transcriptional JJ I-NP
activator NN I-NP
of IN B-PP
the DT B-NP
HIV NN I-NP
enhancer NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
fixed JJ B-NP
tissue NN I-NP
macrophages NNS I-NP
express VBP B-VP
detectable JJ B-NP
HIV NN I-NP
proteins NNS I-NP
COMMA COMMA O
indicating VBG B-VP
permanent JJ B-NP
virus NN I-NP
transcription NN I-NP
. . O

One CD B-NP
explanation NN I-NP
for IN B-PP
the DT B-NP
perpetuation NN I-NP
of IN B-PP
virus NN B-NP
infection NN I-NP
in IN B-PP
macrophages NNS B-NP
could MD B-VP
be VB I-VP
sustained JJ B-NP
nuclear JJ I-NP
NF-kappa NN I-NP
B NN I-NP
expression NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
U937 NN I-NP
monocytic JJ I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
fully RB B-ADJP
permissive JJ I-ADJP
to TO B-PP
HIV NN B-NP
replication NN I-NP
COMMA COMMA O
is VBZ B-VP
known VBN I-VP
to TO I-VP
express VB I-VP
only RB B-NP
low JJ I-NP
levels NNS I-NP
of IN B-PP
nuclear JJ B-NP
NF-kappa NN I-NP
B NN I-NP
. . O

We PRP B-NP
show VBP B-VP
here RB B-ADVP
that IN B-SBAR
chronic JJ B-NP
HIV VBP I-NP
infection NN I-NP
results VBZ B-VP
in IN B-PP
both CC O
induction NN B-NP
of IN B-PP
a DT B-NP
nuclear JJ I-NP
factor NN I-NP
with IN B-PP
antigenic JJ B-NP
properties NNS I-NP
indistinguishable JJ B-ADJP
from IN B-PP
those DT B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
and CC O
permanently RB B-NP
increased VBN I-NP
HIV NN I-NP
enhancer NN I-NP
activity NN I-NP
. . O

This DT B-NP
phenomenon NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
independent JJ B-ADJP
of IN B-PP
tumour NN B-NP
necrosis NN I-NP
factor NN I-NP
COMMA COMMA O
is VBZ B-VP
associated VBN I-VP
with IN B-PP
HIV NN B-NP
replication NN I-NP
COMMA COMMA O
and CC O
is VBZ B-VP
thus RB O
likely JJ B-ADJP
to TO B-VP
explain VB I-VP
at IN B-ADVP
least JJS I-ADVP
in IN B-PP
part NN B-NP
the DT B-NP
perpetuation NN I-NP
of IN B-PP
HIV NN B-NP
infection NN I-NP
in IN B-PP
monocytes NNS B-NP
. . O

Role NN B-NP
for IN B-PP
the DT B-NP
Epstein-Barr JJ I-NP
virus NN I-NP
nuclear JJ I-NP
antigen NN I-NP
2 CD I-NP
in IN B-PP
viral JJ B-NP
promoter NN I-NP
switching VBG I-NP
during IN B-PP
initial JJ B-NP
stages NNS I-NP
of IN B-PP
infection NN B-NP
. . O

During IN B-PP
latent JJ O
Epstein-Barr JJ B-NP
virus NN I-NP
( ( O
EBV NN B-NP
) ) O
infection NN B-NP
of IN B-PP
human JJ B-NP
B NN I-NP
lymphocytes NNS I-NP
COMMA COMMA O
six CD B-NP
viral JJ I-NP
nuclear JJ I-NP
antigen NN I-NP
( ( O
EBNAs NNS B-NP
) ) O
are VBP B-VP
expressed VBN I-VP
from IN B-PP
long JJ B-NP
primary JJ I-NP
transcripts NNS I-NP
by IN B-PP
means NNS I-PP
of IN I-PP
alternative JJ B-NP
splicing NN I-NP
and CC O
alternative JJ B-NP
polyadenylylation NN I-NP
sites NNS I-NP
. . O

These DT B-NP
transcripts NNS I-NP
initiate VBP B-VP
from IN B-PP
one CD B-NP
of IN B-PP
two CD B-NP
promoters NNS I-NP
COMMA COMMA O
Cp NN B-NP
or CC O
Wp NN B-NP
COMMA COMMA O
that WDT B-NP
function VBP B-VP
in IN B-PP
a DT B-NP
mutually RB I-NP
exclusive JJ I-NP
fashion NN I-NP
. . O

Wp NN B-NP
is VBZ B-VP
exclusively RB I-VP
utilized VBN I-VP
during IN B-PP
the DT B-NP
initial JJ I-NP
stages NNS I-NP
of IN B-PP
infection NN B-NP
of IN B-PP
primary JJ B-NP
B NN I-NP
lymphocytes NNS I-NP
COMMA COMMA O
followed VBN B-VP
by IN B-PP
a DT B-NP
switch NN I-NP
to TO B-PP
Cp NN B-NP
usage NN I-NP
. . O

These DT B-NP
studies NNS I-NP
have VBP B-VP
been VBN I-VP
extended VBN I-VP
to TO I-VP
show VB I-VP
that IN B-SBAR
( ( B-LST
i LS I-LST
) ) O
a DT B-NP
mutant JJ I-NP
EBV NN I-NP
strain NN I-NP
lacking VBG B-VP
the DT B-NP
gene NN I-NP
encoding VBG B-VP
EBNA NN B-NP
2 CD I-NP
fails VBZ B-VP
to TO I-VP
switch VB I-VP
from IN B-PP
Wp NN B-NP
to TO B-PP
Cp NN B-NP
usage NN B-NP
in IN B-PP
primary JJ B-NP
B NN I-NP
lymphocytes NNS I-NP
COMMA COMMA O
although IN B-SBAR
the DT B-NP
virus NN I-NP
contains VBZ B-VP
a DT B-NP
functional JJ I-NP
Cp NN I-NP
; : O
( ( B-LST
ii LS I-LST
) ) O
a DT B-NP
region NN I-NP
from IN B-NP
-429 CD I-NP
to TO I-NP
-245 CD I-NP
base NN I-NP
pairs NNS I-NP
upstream JJ B-ADJP
of IN B-PP
Cp NN B-NP
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
Cp NN B-NP
activity NN I-NP
in IN B-PP
B NN B-NP
lymphocytes NNS I-NP
COMMA COMMA O
but CC O
only RB B-PP
in IN I-PP
the DT B-NP
context NN I-NP
of IN B-PP
upstream JJ B-NP
and CC I-NP
downstream JJ I-NP
sequences NNS I-NP
; : O
( ( B-LST
iii LS I-LST
) ) O
this DT B-NP
region NN I-NP
contains VBZ B-VP
an DT B-NP
EBNA NN I-NP
2-dependent JJ I-NP
enhancer NN I-NP
; : O
and CC O
( ( B-LST
iv LS I-LST
) ) O
DNase NN B-NP
I CD I-NP
protection NN I-NP
employing VBG B-VP
nuclear JJ B-NP
extracts NNS I-NP
from IN B-PP
B NN B-NP
and CC O
T NN B-NP
lymphocytes NNS B-NP
revealed VBD B-VP
a DT B-NP
B-cell-specific JJ I-NP
footprint NN I-NP
in IN B-PP
the DT B-NP
region NN I-NP
of IN B-PP
the DT B-NP
EBNA NN I-NP
2-dependent JJ I-NP
enhancer NN I-NP
. . O

These DT B-NP
results NNS I-NP
support VBP B-VP
a DT B-NP
model NN I-NP
for IN B-PP
viral JJ B-NP
promoter NN I-NP
switching NN I-NP
during IN B-PP
the DT B-NP
initial JJ I-NP
stages NNS I-NP
of IN B-PP
infection NN B-NP
in IN B-PP
which WDT B-NP
Wp NN B-NP
activity NN I-NP
leads VBZ B-VP
to TO B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
EBNA NN B-NP
2 CD I-NP
COMMA COMMA O
followed VBN B-VP
by IN B-PP
activation NN B-NP
of IN B-PP
Cp NN B-NP
through IN B-PP
the DT B-NP
EBNA NN I-NP
2-dependent JJ I-NP
enhancer NN I-NP
. . O

Glucocorticoid NN B-NP
receptor NN I-NP
characteristics NNS I-NP
in IN B-PP
monocytes NNS B-NP
of IN B-PP
patients NNS B-NP
with IN B-PP
corticosteroid-resistant JJ B-NP
bronchial JJ I-NP
asthma NN I-NP
. . O

The DT B-NP
mechanism NN I-NP
of IN B-PP
corticosteroid NN B-NP
resistance NN I-NP
in IN B-PP
bronchial JJ B-NP
asthma NN I-NP
has VBZ B-VP
been VBN I-VP
studied VBN I-VP
by IN B-PP
determining VBG B-VP
the DT B-NP
rank NN I-NP
order NN I-NP
of IN B-PP
potency NN B-NP
for IN B-PP
different JJ B-NP
corticosteroids NNS I-NP
in IN B-PP
inhibiting VBG B-VP
the DT B-NP
generation NN I-NP
of IN B-PP
a DT B-NP
3 CD I-NP
kD NN I-NP
molecule NN I-NP
from IN B-PP
peripheral JJ B-NP
blood NN I-NP
monocytes NNS I-NP
isolated VBN B-VP
from IN B-PP
corticosteroid-sensitive JJ O
( ( O
CS JJ B-ADJP
) ) O
and CC O
corticosteroid-resistant JJ O
( ( O
CR JJ B-ADJP
) ) O
asthmatic JJ B-NP
subjects NNS I-NP
COMMA COMMA O
which WDT B-NP
augments VBZ B-VP
leukotriene NN B-NP
B4 NN I-NP
( ( O
LTB4 NN B-NP
) ) O
generation NN B-NP
by IN B-PP
human JJ B-NP
neutrophils NNS I-NP
( ( O
PMN NN B-NP
) ) O
stimulated VBN B-VP
by IN B-PP
calcium NN B-NP
ionophore NN I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
binding VBG B-NP
studies NNS I-NP
with IN B-PP
( ( B-NP
3H NN I-NP
) ) I-NP
dexamethasone NN I-NP
have VBP B-VP
been VBN I-VP
performed VBN I-VP
to TO B-VP
determine VB I-VP
the DT B-NP
dissociation NN I-NP
constant NN I-NP
( ( O
Kd NN B-NP
) ) O
and CC O
receptor NN B-NP
numbers NNS I-NP
( ( O
Ro NN B-NP
) ) O
in IN B-PP
the DT B-NP
monocytes NNS I-NP
of IN B-PP
these DT B-NP
two CD I-NP
groups NNS I-NP
of IN B-PP
subjects NNS B-NP
. . O

The DT B-NP
concentration NN I-NP
of IN B-PP
corticosteroid NN B-NP
producing VBG B-VP
50 CD B-NP
% NN I-NP
inhibition NN I-NP
( ( O
IC50 NN B-NP
) ) O
was VBD B-VP
600 CD B-NP
nM NN I-NP
COMMA COMMA O
70 CD B-NP
nM NN I-NP
COMMA COMMA O
and CC O
0.5 CD B-NP
nM NN I-NP
for IN B-PP
hydrocortisone NN B-NP
COMMA COMMA O
methylprednisolone NN B-NP
COMMA COMMA O
and CC O
dexamethasone NN B-NP
COMMA COMMA O
respectively RB B-ADVP
COMMA COMMA O
in IN B-PP
monocytes NNS B-NP
from IN B-PP
CS JJ B-NP
individuals NNS I-NP
. . O

There EX B-NP
was VBD B-VP
only RB B-NP
weak JJ I-NP
inhibition NN I-NP
of IN B-PP
the DT B-NP
generation NN I-NP
of IN B-PP
enhancing NN B-NP
activity NN I-NP
by IN B-PP
the DT B-NP
corticosteroids NNS I-NP
in IN B-PP
the DT B-NP
CR JJ I-NP
asthmatic JJ I-NP
individuals NNS I-NP
. . O

The DT B-NP
dexamethasone NN I-NP
Kd NN I-NP
was VBD B-VP
2.45 CD B-NP
+\/- CC I-NP
0.58 CD I-NP
nM NN I-NP
( ( O
mean NN B-NP
+\/- CC O
SEM NN B-NP
COMMA COMMA O
n NN B-NP
= JJ B-VP
6 CD B-NP
) ) O
in IN B-PP
the DT O
CS JJ B-NP
group NN B-NP
and CC O
1.6 CD B-NP
+\/- CC I-NP
0.35 CD I-NP
nM NN I-NP
( ( O
mean NN B-NP
+\/- CC O
SEM NN B-NP
COMMA COMMA O
n NN B-NP
= JJ B-VP
6 CD B-NP
) ) O
in IN B-PP
the DT O
CR JJ B-NP
group NN B-NP
of IN B-PP
patients NNS B-NP
( ( O
p NN B-NP
= JJ B-VP
0.14 CD B-NP
) ) O
. . O

The DT B-NP
Ro NN I-NP
in IN B-PP
the DT B-NP
CS JJ I-NP
group NN I-NP
was VBD B-VP
3COMMA605 CD B-NP
+\/- CC I-NP
984 CD I-NP
binding VBG I-NP
sites NNS I-NP
per IN B-PP
nucleus NN B-NP
( ( O
mean NN B-NP
+\/- CC O
SEM NN B-NP
COMMA COMMA O
n NN B-NP
= JJ B-VP
6 CD B-NP
) ) O
and CC O
4COMMA757 CD B-NP
+\/- CC I-NP
692 CD I-NP
binding VBG I-NP
sites NNS I-NP
per IN B-PP
nucleus NN B-NP
( ( O
mean NN B-NP
+\/- CC O
SEM NN B-NP
COMMA COMMA O
n NN B-NP
= JJ B-VP
6 CD B-NP
) ) O
in IN B-PP
the DT B-NP
CR JJ I-NP
group NN I-NP
( ( O
p NN B-NP
= JJ B-VP
0.23 CD B-NP
) ) O
. . O

These DT B-NP
findings NNS I-NP
indicate VBP B-VP
that IN B-SBAR
corticosteroid NN B-NP
resistance NN I-NP
in IN B-PP
bronchial JJ B-NP
asthma NN I-NP
can MD B-VP
not RB I-VP
be VB I-VP
explained VBN I-VP
by IN B-PP
abnormalities NNS B-NP
in IN B-PP
corticosteroid NN B-NP
receptor NN I-NP
characteristics NNS B-NP
. . O

Tissue-specific JJ B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
platelet NN I-NP
GPIIb NN I-NP
gene NN I-NP
. . O

One CD B-NP
of IN B-PP
the DT B-NP
major JJ I-NP
objectives NNS I-NP
in IN B-PP
the DT B-NP
study NN I-NP
of IN B-PP
thrombogenesis NN B-NP
is VBZ B-VP
to TO B-VP
determine VB I-VP
the DT B-NP
mechanisms NNS I-NP
by IN B-PP
which WDT B-NP
a DT B-NP
hematopoietic JJ I-NP
progenitor NN I-NP
is VBZ B-VP
activated VBN I-VP
and CC O
committed VBN B-VP
to TO B-PP
the DT B-NP
megakaryocytic JJ I-NP
lineage NN I-NP
. . O

Recent JJ B-NP
development NN I-NP
of IN B-PP
primary JJ B-NP
cultures NNS I-NP
of IN B-PP
human JJ B-NP
megakaryocytes NNS I-NP
and CC O
the DT B-NP
molecular JJ I-NP
cloning NN I-NP
of IN B-PP
genes NNS B-NP
that WDT B-NP
are VBP B-VP
specific JJ B-ADJP
to TO B-PP
this DT B-NP
lineage NN I-NP
offer VBP B-VP
the DT B-NP
possibility NN I-NP
of IN B-PP
getting VBG B-VP
some DT B-NP
insights NNS I-NP
into IN B-PP
the DT B-NP
genetic JJ I-NP
mechanisms NNS I-NP
that WDT B-NP
control VBP B-VP
megakaryocytopoiesis NNS B-NP
. . O

One CD B-NP
gene NN I-NP
of IN B-PP
interest NN B-NP
is VBZ B-VP
the DT O
glycoprotein NN B-NP
IIb NN I-NP
( ( O
GPIIb NN B-NP
) ) O
gene NN B-NP
; : O
GPIIb NN B-NP
COMMA COMMA O
the DT B-NP
alpha NN I-NP
subunit NN I-NP
of IN B-PP
the DT B-NP
platelet NN I-NP
cytoadhesin NN I-NP
GPIIb-IIIa NN I-NP
COMMA COMMA O
is VBZ B-VP
produced VBN I-VP
in IN B-PP
megakaryocytes NNS B-NP
at IN B-PP
an DT B-NP
early JJ I-NP
stage NN I-NP
of IN B-PP
the DT B-NP
differentiation NN I-NP
COMMA COMMA O
whereas IN O
the DT B-NP
other JJ I-NP
subunit NN I-NP
of IN B-PP
this DT B-NP
complex NN I-NP
COMMA COMMA O
GPIIIa NN B-NP
COMMA COMMA O
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
other JJ B-NP
cells NNS I-NP
. . O

For IN B-PP
these DT B-NP
reasons NNS I-NP
COMMA COMMA O
the DT B-NP
5'-flanking JJ I-NP
region NN I-NP
of IN B-PP
the DT B-NP
GPIIb NN I-NP
gene NN I-NP
was VBD B-VP
used VBN I-VP
to TO B-VP
identify VB I-VP
the DT B-NP
regions NNS I-NP
that WDT B-NP
interact VBP B-VP
with IN B-PP
DNA-binding JJ B-NP
nuclear JJ I-NP
factors NNS I-NP
. . O

A DT B-NP
fragment NN I-NP
extending VBG B-VP
from IN B-PP
-643 CD B-NP
to TO B-PP
+33 CD B-NP
is VBZ B-VP
capable JJ B-ADJP
of IN B-PP
controlling VBG B-VP
the DT B-NP
tissue-specific JJ I-NP
expression NN I-NP
of IN B-PP
the DT B-NP
CAT NN I-NP
gene NN I-NP
in IN B-PP
transfection NN B-NP
experiments NNS I-NP
. . O

Within IN B-PP
this DT B-NP
region NN I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
identified VBN I-VP
several JJ B-NP
sequences NNS I-NP
that WDT B-NP
are VBP B-VP
implicated VBN I-VP
in IN B-PP
DNA NN B-NP
protein NN I-NP
interactions NNS I-NP
as IN B-SBAR
shown VBN B-VP
in IN B-PP
DNAse NN B-NP
I NN I-NP
footprints NNS I-NP
and CC O
gel NN B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
. . O

One CD B-NP
region NN I-NP
COMMA COMMA O
centered VBN B-ADJP
at IN B-PP
-54 CD B-NP
COMMA COMMA O
is VBZ B-VP
similar JJ B-ADJP
to TO B-PP
a DT B-NP
nuclear JJ I-NP
factor NN I-NP
E1-binding JJ I-NP
site NN I-NP
COMMA COMMA O
and CC O
a DT B-NP
region NN I-NP
located JJ B-ADJP
at IN B-PP
position NN B-NP
-233 CD I-NP
contains VBZ B-VP
a DT B-NP
CCAAT NN I-NP
motif NN I-NP
. . O

Two CD B-NP
domains NNS I-NP
centered VBN O
at IN B-PP
positions NNS B-NP
-345 CD B-NP
and CC O
-540 CD B-NP
COMMA COMMA B-ADJP
respectively RB I-ADJP
COMMA COMMA O
bind VBP B-VP
proteins NNS B-NP
that WDT B-NP
are VBP B-VP
present JJ B-ADJP
in IN B-PP
megakaryocytic JJ B-NP
cells NNS I-NP
and CC O
nonrelated JJ B-NP
cells NNS I-NP
as RB B-PP
well RB B-ADVP
. . O

Finally RB B-ADVP
COMMA COMMA O
two CD B-NP
other JJ I-NP
domains NNS I-NP
COMMA COMMA O
located JJ B-ADJP
at IN B-PP
positions NNS B-NP
-460 CD B-NP
and CC O
-510 CD B-NP
COMMA COMMA O
interact VBP B-VP
with IN B-PP
proteins NNS B-NP
that WDT B-NP
are VBP B-VP
only RB B-ADJP
present JJ I-ADJP
in IN B-PP
megakaryocytic JJ B-NP
cells NNS I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
deletion NN B-NP
of IN B-PP
the DT B-NP
region NN I-NP
containing VBG B-VP
these DT B-NP
two CD I-NP
domains NNS I-NP
results VBZ B-VP
in IN B-PP
a DT B-NP
significant JJ I-NP
decrease NN I-NP
of IN B-PP
the DT B-NP
promoter NN I-NP
activity NN I-NP
. . O

It PRP B-NP
is VBZ B-VP
very RB B-ADJP
likely JJ I-ADJP
that IN B-SBAR
these DT B-NP
domains NNS I-NP
bind VBP B-VP
megakaryocyte-specific JJ B-NP
nuclear JJ I-NP
proteins NNS I-NP
acting VBG B-VP
as IN B-PP
positive JJ B-NP
transcription NN I-NP
factors NNS I-NP
. . O

Inhibition NN B-NP
of IN B-PP
protein NN B-NP
phosphatases NNS I-NP
by IN B-PP
okadaic JJ B-NP
acid NN I-NP
induces VBZ B-VP
AP1 NN B-NP
in IN B-PP
human JJ B-NP
T NN I-NP
cells NNS I-NP
. . O

To TO B-VP
examine VB I-VP
the DT B-NP
role NN I-NP
of IN B-PP
protein NN B-NP
phosphatases NNS I-NP
in IN B-PP
T NN B-NP
cell NN I-NP
activation NN I-NP
COMMA COMMA O
Jurkat NN B-NP
cells NNS I-NP
were VBD B-VP
treated VBN I-VP
with IN B-PP
okadaic JJ B-NP
acid NN I-NP
COMMA COMMA O
an DT B-NP
inhibitor NN I-NP
of IN B-PP
type NN B-NP
1 CD I-NP
and CC I-NP
2A NN I-NP
phosphatases NNS I-NP
COMMA COMMA O
and CC O
nuclear JJ B-NP
extracts NNS I-NP
were VBD B-VP
examined VBN I-VP
for IN B-PP
the DT B-NP
presence NN I-NP
of IN B-PP
AP1 NN B-NP
as IN B-PP
a DT B-NP
measure NN I-NP
of IN B-PP
early JJ B-NP
T NN I-NP
cell NN I-NP
activation NN I-NP
. . O

Okadaic JJ B-NP
acid NN I-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
a DT B-NP
potent JJ I-NP
inducer NN I-NP
of IN B-PP
AP1 NN B-NP
. . O

In IN B-PP
contrast NN I-PP
to TO I-PP
phorbol NN B-NP
esters NNS I-NP
such JJ B-PP
as IN I-PP
phorbol NN B-NP
myristate NN I-NP
acetate NN I-NP
( ( O
PMA NN B-NP
) ) O
COMMA COMMA O
the DT B-NP
induction NN I-NP
of IN B-PP
AP1 NN B-NP
by IN B-PP
okadaic JJ B-NP
acid NN I-NP
occurs VBZ B-VP
predominantly RB B-PP
by IN I-PP
transcriptional JJ B-NP
activation NN I-NP
of IN B-PP
the DT O
jun NN B-NP
and CC O
fos NN B-NP
family NN B-NP
of IN B-PP
proto-oncogenes NNS B-NP
. . O

Surprisingly RB B-ADVP
COMMA COMMA O
while IN B-SBAR
the DT B-NP
addition NN I-NP
of IN B-PP
phytohemagglutinin NN B-NP
further RB B-ADVP
enhanced VBD B-VP
the DT B-NP
induction NN I-NP
of IN B-PP
AP1 NN B-NP
COMMA COMMA O
the DT B-NP
addition NN I-NP
of IN B-PP
PMA NN B-NP
inhibited VBD B-VP
it PRP B-NP
. . O

Okadaic JJ B-NP
acid NN I-NP
treatment NN I-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
dramatically RB I-VP
increase VB I-VP
mRNA NN B-NP
transcripts NNS I-NP
of IN B-PP
the DT B-NP
jun NN I-NP
family NN I-NP
of IN B-PP
proto-oncogenes NNS B-NP
including VBG B-PP
c-jun NN B-NP
COMMA COMMA O
junD NN B-NP
COMMA COMMA O
and CC O
junB NN B-NP
and CC O
to TO B-PP
a DT B-NP
lesser JJR I-NP
extent NN I-NP
the DT B-NP
fos NN I-NP
family NN I-NP
including VBG B-PP
c-fos NN B-NP
and CC O
fra-1 NN B-NP
. . O

By IN B-PP
comparison NN B-NP
COMMA COMMA O
PMA NN B-NP
is VBZ B-VP
a DT B-NP
very RB I-NP
inefficient JJ I-NP
inducer NN I-NP
of IN B-PP
the DT B-NP
jun NN I-NP
gene NN I-NP
family NN I-NP
in IN B-PP
Jurkat NN B-NP
cells NNS I-NP
. . O

Similar JJ B-ADJP
to TO B-PP
its PRP$ B-NP
effect NN I-NP
on IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
AP1 NN B-NP
by IN B-PP
okadaic JJ B-NP
acid NN I-NP
COMMA COMMA O
PMA NN B-NP
inhibits VBZ B-VP
the DT B-NP
induction NN I-NP
of IN B-PP
c-jun NN B-NP
mRNA NN I-NP
by IN B-PP
okadaic JJ B-NP
acid NN I-NP
. . O

Transfection NN B-NP
of IN B-PP
c-jun NN B-NP
promoter NN I-NP
constructs NNS I-NP
confirmed VBD B-VP
the DT B-NP
marked JJ I-NP
difference NN I-NP
between IN B-PP
PMA NN B-NP
and CC O
okadaic JJ B-NP
acid NN I-NP
in IN B-PP
inducing VBG B-VP
c-jun NN B-NP
transcription NN I-NP
. . O

The DT B-NP
induction NN I-NP
of IN B-PP
AP1 NN B-NP
by IN B-PP
okadaic JJ B-NP
acid NN I-NP
suggests VBZ B-VP
that IN B-SBAR
protein NN B-NP
phosphatases NNS I-NP
1 CD B-NP
and CC O
2A NN B-NP
( ( O
PP1 NN B-NP
and CC O
PP2A NN B-NP
) ) O
may MD B-VP
be VB I-VP
involved VBN I-VP
in IN B-PP
T NN B-NP
cell NN I-NP
activation NN I-NP
as IN B-PP
important JJ B-NP
negative JJ I-NP
regulators NNS I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
AP1 NN I-NP
. . O

Demonstration NN B-NP
of IN B-PP
estrogen NN B-NP
and CC O
progesterone NN B-NP
receptors NNS B-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
Ki-67 NN B-NP
and CC O
p-145 NN B-NP
antigens NNS B-NP
in IN B-PP
single JJ B-NP
tumor NN I-NP
cells NNS I-NP
from IN B-PP
blood NN B-NP
and CC O
pleural JJ B-ADJP
effusions NNS B-NP
using VBG B-VP
a DT B-NP
slide NN I-NP
assay NN I-NP
. . O

We PRP B-NP
describe VBP B-VP
a DT B-NP
slide NN I-NP
assay NN I-NP
that WDT B-NP
allows VBZ B-VP
the DT B-NP
demonstration NN I-NP
of IN B-PP
antigens NNS B-NP
localized JJ B-ADJP
in IN B-PP
the DT B-NP
nucleus NN I-NP
from IN B-PP
isolated VBN B-NP
white JJ I-NP
blood NN I-NP
cells NNS I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
from IN B-PP
single JJ B-NP
tumor NN I-NP
cells NNS I-NP
derived VBN B-VP
from IN B-PP
malignant JJ B-NP
effusions NNS I-NP
. . O

With IN B-PP
the DT B-NP
antibodies NNS I-NP
Ki-67 NN B-NP
and CC O
anti-p-145 NN B-NP
an DT B-NP
increased VBN I-NP
rate NN I-NP
of IN B-PP
nuclear JJ B-NP
and CC I-NP
nucleolar JJ I-NP
staining NN I-NP
resulted VBD B-VP
in IN B-PP
cells NNS B-NP
from IN B-PP
highly RB B-NP
malignant JJ I-NP
lymphomas NNS I-NP
. . O

An DT B-NP
almost RB I-NP
identical JJ I-NP
reaction NN I-NP
was VBD B-VP
obtained VBN I-VP
when WRB B-ADVP
tumor NN B-NP
cells NNS I-NP
from IN B-PP
malignant JJ B-NP
effusions NNS I-NP
were VBD B-VP
tested VBN I-VP
. . O

Cells NNS B-NP
isolated VBN B-VP
from IN B-PP
the DT B-NP
blood NN I-NP
of IN B-PP
patients NNS B-NP
with IN B-PP
leukemic JJ B-NP
spread NN I-NP
of IN B-PP
lymphomas NNS B-NP
of IN B-PP
low JJ B-NP
malignancy NN I-NP
yielded VBD B-VP
a DT B-NP
weak JJ I-NP
staining NN I-NP
comparable JJ B-ADJP
to TO B-PP
that DT B-NP
of IN B-PP
normal JJ B-NP
mesothelial JJ I-NP
cells NNS I-NP
from IN B-PP
non-tumorous JJ B-NP
cavity NN I-NP
fluids NNS I-NP
. . O

The DT B-NP
detection NN I-NP
of IN B-PP
estrogen NN B-NP
and CC O
progesterone NN B-NP
receptors NNS B-NP
( ( O
ER NN B-NP
and CC O
PR NN B-NP
) ) O
localized JJ B-ADJP
in IN B-PP
the DT B-NP
cell NN I-NP
nucleus NN I-NP
can MD B-VP
be VB I-VP
achieved VBN I-VP
by IN B-PP
the DT B-NP
same JJ I-NP
assay NN I-NP
. . O

The DT B-NP
reaction NN I-NP
is VBZ B-VP
enhanced VBN I-VP
by IN B-PP
incubation NN B-NP
of IN B-PP
the DT B-NP
tumor NN I-NP
cells NNS I-NP
for IN B-PP
30 CD B-NP
min NN I-NP
at IN B-PP
37 CD B-NP
degrees NNS I-NP
C NN I-NP
prior RB B-PP
to TO I-PP
fixation NN B-NP
. . O

Pleural JJ B-NP
effusions NNS I-NP
from IN B-PP
20 CD B-NP
patients NNS I-NP
with IN B-PP
breast NN B-NP
cancer NN I-NP
were VBD B-VP
tested VBN I-VP
. . O

ER NN B-NP
was VBD B-VP
positive JJ B-ADJP
in IN B-PP
13 CD B-NP
and CC O
PR NN B-NP
was VBD B-VP
positive JJ B-ADJP
in IN B-PP
12 CD B-NP
of IN B-PP
the DT B-NP
20 CD I-NP
samples NNS I-NP
. . O

In IN B-PP
5 CD B-NP
cases NNS I-NP
there EX B-NP
was VBD B-VP
a DT B-NP
divergent JJ I-NP
reaction NN I-NP
with IN B-PP
ER NN B-NP
and CC O
PR NN B-NP
antibody NN B-NP
. . O

The DT B-NP
hormone NN I-NP
receptors NNS I-NP
of IN B-PP
the DT B-NP
primary JJ I-NP
tumor NN I-NP
were VBD B-VP
known VBN I-VP
in IN B-PP
15 CD B-NP
( ( O
ER NN B-NP
) ) O
and CC O
14 CD B-NP
( ( O
PR NN B-NP
) ) O
patients NNS B-NP
COMMA COMMA O
respectively RB B-ADVP
. . O

In IN B-PP
each DT B-NP
cohort NN I-NP
there EX B-NP
was VBD B-VP
only RB B-NP
one CD I-NP
case NN I-NP
with IN B-PP
a DT B-NP
negative JJ I-NP
reaction NN I-NP
of IN B-PP
the DT B-NP
primary JJ I-NP
tumor NN I-NP
and CC O
a DT B-NP
positive JJ I-NP
reaction NN I-NP
with IN B-PP
the DT B-NP
isolated VBN I-NP
tumor NN I-NP
cells NNS I-NP
from IN B-PP
the DT B-NP
pleural JJ I-NP
effusions NNS I-NP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
the DT B-NP
demonstration NN I-NP
of IN B-PP
hormone NN B-NP
receptor NN I-NP
proteins NNS I-NP
in IN B-PP
cells NNS B-NP
from IN B-PP
malignant JJ B-NP
effusions NNS I-NP
is VBZ B-VP
possible JJ B-ADJP
and CC O
that IN B-SBAR
there EX B-NP
is VBZ B-VP
a DT B-NP
correlation NN I-NP
with IN B-PP
the DT B-NP
status NN I-NP
of IN B-PP
the DT B-NP
primary JJ I-NP
site NN I-NP
of IN B-PP
cancer NN B-NP
. . O

Transforming VBG B-NP
growth NN I-NP
factor-beta NN I-NP
suppresses VBZ B-VP
human JJ B-NP
B NN I-NP
lymphocyte NN I-NP
Ig NN I-NP
production NN I-NP
by IN B-PP
inhibiting VBG B-VP
synthesis NN B-NP
and CC O
the DT B-NP
switch NN I-NP
from IN B-PP
the DT B-NP
membrane NN I-NP
form NN I-NP
to TO B-PP
the DT B-NP
secreted JJ I-NP
form NN I-NP
of IN B-PP
Ig NN O
mRNA NN O
. . O

Transforming VBG B-NP
growth NN I-NP
factor-beta NN I-NP
( ( O
TGF-beta NN B-NP
) ) O
inhibits VBZ B-VP
B NN B-NP
cell NN I-NP
Ig NN I-NP
secretion NN I-NP
and CC O
reduces VBZ B-VP
B NN B-NP
cell NN I-NP
membrane NN I-NP
Ig NN I-NP
expression NN I-NP
. . O

The DT B-NP
addition NN I-NP
of IN B-PP
TGF-beta NN B-NP
to TO B-PP
human JJ B-NP
B NN I-NP
lymphocyte NN I-NP
cultures NNS I-NP
stimulated VBN B-VP
with IN B-PP
Staphylococcus FW B-NP
aureus FW I-NP
Cowan NN I-NP
strain NN I-NP
I NN I-NP
and CC O
IL-2 NN B-NP
completely RB B-ADVP
inhibited VBD B-VP
B NN B-NP
cell NN I-NP
Ig NN I-NP
secretion NN I-NP
( ( O
greater JJR B-ADVP
than IN B-PP
90 CD B-NP
% NN I-NP
) ) O
and CC O
decreased VBD B-VP
B NN O
cell NN O
surface NN O
IgM NN B-NP
COMMA COMMA O
IgD NN B-NP
COMMA COMMA O
kappa NN B-NP
L NN I-NP
chain NN I-NP
COMMA COMMA O
and CC O
lambda NN B-NP
L NN I-NP
chain NN I-NP
expression NN B-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
TGF-beta NN B-NP
had VBD B-VP
only RB B-NP
minimal JJ I-NP
effects NNS I-NP
on IN B-PP
two CD B-NP
other JJ I-NP
B NN I-NP
cell NN I-NP
membrane NN I-NP
proteins NNS I-NP
COMMA COMMA O
HLA-DR NN B-NP
and CC O
CD20 NN B-NP
. . O

Internal JJ B-NP
labeling NN I-NP
with IN B-PP
{35S}methionine NN B-NP
and CC O
immunoprecipitation NN B-NP
with IN B-PP
anti-IgM JJ B-NP
COMMA COMMA I-NP
anti-kappa JJ I-NP
COMMA COMMA I-NP
and CC I-NP
anti-lambda JJ I-NP
antibodies NNS I-NP
revealed VBD B-VP
a DT B-NP
striking JJ I-NP
reduction NN I-NP
in IN B-PP
kappa NN B-NP
L NN I-NP
chain NN I-NP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
TGF-beta NN B-NP
. . O

A DT B-NP
less RBR I-NP
pronounced JJ I-NP
reduction NN I-NP
in IN B-PP
lambda NN B-NP
L NN I-NP
chain NN I-NP
and CC O
microH NN B-NP
chain NN I-NP
was VBD B-VP
also RB I-VP
noted VBN I-VP
. . O

Northern NN B-NP
blot NN I-NP
analysis NN I-NP
of IN B-PP
RNA NN B-NP
purified VBN B-VP
from IN B-PP
B NN B-NP
cells NNS I-NP
treated VBN B-VP
with IN B-PP
TGF-beta NN B-NP
for IN B-PP
varying VBG B-NP
time NN I-NP
intervals NNS I-NP
revealed VBD B-VP
a DT B-NP
significant JJ I-NP
decrease NN I-NP
in IN B-PP
steady JJ B-NP
state NN I-NP
kappa NN I-NP
and CC I-NP
lambda NN I-NP
L NN I-NP
chain NN I-NP
mRNA NN I-NP
levels NNS I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
a DT B-NP
significant JJ I-NP
decrease NN I-NP
in IN B-PP
the DT B-NP
switch NN I-NP
from IN B-PP
the DT B-NP
membrane NN I-NP
forms NNS I-NP
of IN B-PP
mu NN B-NP
and CC O
gamma NN B-NP
to TO B-PP
their PRP$ B-NP
respective JJ I-NP
secreted JJ I-NP
forms NNS I-NP
was VBD B-VP
noted VBN I-VP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
TGF-beta NN B-NP
. . O

Nuclear JJ B-NP
run-on JJ I-NP
experiments NNS I-NP
demonstrated VBD B-VP
decreased VBN B-NP
transcription NN I-NP
of IN B-PP
kappa NN B-NP
L NN I-NP
chain NN I-NP
. . O

The DT B-NP
effects NNS I-NP
of IN B-PP
TGF-beta NN B-NP
on IN B-PP
two CD B-NP
transcriptional JJ I-NP
regulatory JJ I-NP
factors NNS I-NP
COMMA COMMA O
Oct-2 NN B-NP
and CC O
nuclear JJ B-NP
factor NN I-NP
( ( O
NF NN B-NP
) ) O
kappa NN B-NP
B NN I-NP
COMMA COMMA O
known VBN B-VP
to TO I-VP
be VB I-VP
important JJ B-ADJP
in IN B-PP
Ig NN B-NP
gene NN I-NP
transcription NN I-NP
were VBD B-VP
examined VBN I-VP
. . O

Oct-2 NN B-NP
mRNA NN I-NP
levels NNS I-NP
and CC O
both DT B-NP
Oct-2 NN B-NP
and CC O
NF-kappa NN B-NP
B NN I-NP
proteins NNS B-NP
in IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
were VBD B-VP
not RB I-VP
altered VBN I-VP
by IN B-PP
treatment NN B-NP
with IN B-PP
TGF-beta NN B-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
levels NNS B-NP
of IN B-PP
the DT B-NP
transcriptional JJ I-NP
factor NN I-NP
AP-1 NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
not RB I-VP
known VBN I-VP
to TO I-VP
be VB I-VP
important JJ B-ADJP
in IN B-PP
B NN B-NP
cell NN I-NP
Ig NN I-NP
production NN I-NP
COMMA COMMA O
were VBD B-VP
reduced VBN I-VP
by IN B-PP
TGF-beta NN B-NP
. . O

These DT B-NP
findings NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
TGF-beta NN B-NP
decreases VBZ B-VP
B NN B-NP
lymphocyte NN I-NP
Ig NN I-NP
secretion NN I-NP
by IN B-PP
inhibiting VBG B-VP
the DT B-NP
synthesis NN I-NP
of IN B-PP
Ig NN B-NP
mRNA NN I-NP
and CC O
inhibiting VBG B-VP
the DT B-NP
switch NN I-NP
from IN B-PP
the DT B-NP
membrane NN I-NP
form NN I-NP
to TO B-PP
the DT B-NP
secreted JJ I-NP
forms NNS I-NP
of IN B-PP
mu NN B-NP
and CC O
gamma NN B-NP
mRNA NN B-NP
. . O

The DT B-NP
mechanism NN I-NP
by IN B-PP
which WDT B-NP
TGF-beta NN B-NP
inhibits VBZ B-VP
Ig NN B-NP
chain NN I-NP
synthesis NN I-NP
is VBZ B-VP
unclear JJ B-ADJP
although IN B-SBAR
it PRP B-NP
does VBZ B-VP
not RB I-VP
involve VB I-VP
inhibition NN B-NP
of IN B-PP
the DT B-NP
binding NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
or CC O
Oct-2 NN B-NP
to TO B-PP
their PRP$ B-NP
respective JJ I-NP
target NN I-NP
sequences NNS I-NP
. . O

Differentiation-associated JJ B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
Epstein-Barr JJ I-NP
virus NN I-NP
BZLF1 NN I-NP
transactivator NN I-NP
protein NN I-NP
in IN B-PP
oral JJ B-NP
hairy JJ I-NP
leukoplakia NN I-NP
. . O

The DT B-NP
BZLF1 NN I-NP
protein NN I-NP
of IN B-PP
Epstein-Barr JJ B-NP
virus NN I-NP
( ( O
EBV NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
key JJ I-NP
immediate-early JJ I-NP
protein NN I-NP
which WDT B-NP
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
disrupt VB I-VP
virus NN B-NP
latency NN I-NP
in IN B-PP
EBV-infected JJ B-NP
B NN I-NP
cells NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
generated VBN I-VP
a DT B-NP
monoclonal JJ I-NP
antibody NN I-NP
COMMA COMMA O
BZ1 NN B-NP
COMMA COMMA O
to TO B-PP
BZLF1 NN B-NP
which WDT B-NP
reacts VBZ B-VP
in IN B-PP
immunohistology NN B-NP
COMMA COMMA O
immunoblotting NN B-NP
COMMA COMMA O
and CC O
immunoprecipitation NN B-NP
and CC O
which WDT B-NP
recognizes VBZ B-VP
both CC O
the DT B-NP
active JJ I-NP
COMMA COMMA I-NP
dimeric JJ I-NP
form NN I-NP
and CC O
the DT B-NP
inactive JJ I-NP
COMMA COMMA I-NP
monomeric JJ I-NP
form NN I-NP
of IN B-PP
the DT B-NP
protein NN I-NP
. . O

Biopsies NNS B-NP
of IN B-PP
oral JJ B-NP
hairy JJ I-NP
leukoplakia NN I-NP
COMMA COMMA O
an DT B-NP
AIDS-associated JJ I-NP
lesion NN I-NP
characterized VBN B-VP
by IN B-PP
high-level JJ B-NP
EBV NN I-NP
replication NN I-NP
COMMA COMMA O
were VBD B-VP
examined VBN I-VP
by IN B-PP
immunohistochemistry NN B-NP
using VBG B-VP
the DT B-NP
BZ1 NN I-NP
monoclonal JJ I-NP
antibody NN I-NP
. . O

A DT B-NP
differentiation-associated JJ I-NP
pattern NN I-NP
of IN B-PP
BZLF1 NN B-NP
expression NN I-NP
was VBD B-VP
observed VBN I-VP
COMMA COMMA O
BZ1 NN B-NP
reacting VBG B-VP
with IN B-PP
nuclei NNS B-NP
of IN B-PP
the DT B-NP
upper JJ I-NP
spinous JJ I-NP
layer NN I-NP
of IN B-PP
the DT B-NP
lesion NN I-NP
. . O

This DT B-NP
finding NN I-NP
suggests VBZ B-VP
that IN B-SBAR
the DT B-NP
BZLF1 NN I-NP
promoter NN I-NP
may MD B-VP
be VB I-VP
regulated VBN I-VP
by IN B-PP
the DT B-NP
degree NN I-NP
of IN B-PP
squamous JJ B-NP
differentiation NN I-NP
. . O

A DT B-NP
comparison NN I-NP
of IN B-PP
in FW B-NP
situ FW I-NP
hybridization NN I-NP
to TO B-PP
EBV NN B-NP
DNA NN I-NP
and CC O
viral JJ B-NP
capsid NN I-NP
antigen NN I-NP
staining VBG I-NP
with IN B-PP
BZ1 NN B-NP
reactivity NN I-NP
suggested VBD B-VP
that IN B-SBAR
BZLF1 NN B-NP
expression NN I-NP
precedes VBZ B-VP
rampant JJ B-NP
virus NN I-NP
replication NN I-NP
. . O

The DT B-NP
inability NN I-NP
to TO B-VP
detect VB I-VP
EBV NN B-NP
in IN B-PP
the DT B-NP
lower RBR I-NP
epithelial JJ I-NP
layers NNS I-NP
of IN B-PP
oral JJ B-NP
hairy JJ I-NP
leukoplakia NN I-NP
raises VBZ B-VP
questions NNS B-NP
concerning VBG B-PP
the DT B-NP
nature NN I-NP
of IN B-PP
EBV NN B-NP
latency NN B-NP
and CC O
persistence NN B-NP
in IN B-PP
stratified JJ B-NP
squamous JJ I-NP
epithelium NN I-NP
. . O

Transactivation NN B-NP
of IN B-PP
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
promoter NN I-NP
by IN B-PP
human JJ B-NP
herpesvirus NN I-NP
6 CD I-NP
( ( O
HHV-6 NN B-NP
) ) O
strains VBZ B-NP
GS NN B-NP
and CC O
Z-29 NN B-NP
in IN B-PP
primary JJ B-NP
human JJ I-NP
T NN I-NP
lymphocytes NNS I-NP
and CC O
identification NN B-NP
of IN B-PP
transactivating VBG B-NP
HHV-6 NN I-NP
( ( I-NP
GS NN I-NP
) ) I-NP
gene NN I-NP
fragments NNS I-NP
. . O

Human JJ B-NP
herpesvirus NN I-NP
6 CD I-NP
( ( O
HHV-6 NN B-NP
) ) O
can MD B-VP
activate VB I-VP
the DT O
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV NN B-NP
) ) O
promoter NN B-NP
and CC O
accelerate VB B-VP
cytopathic JJ B-NP
effects NNS I-NP
in IN B-PP
HIV-infected JJ B-NP
human JJ I-NP
T NN I-NP
cells NNS I-NP
. . O

This DT B-NP
study NN I-NP
examines VBZ B-VP
the DT B-NP
regions NNS I-NP
of IN B-PP
the DT B-NP
HIV NN I-NP
promoter NN I-NP
required VBN B-VP
for IN B-PP
HHV-6 NN B-NP
transactivation NN I-NP
in IN B-PP
a DT B-NP
heterogeneous JJ I-NP
population NN I-NP
of IN B-PP
primary JJ B-NP
human JJ I-NP
T NN I-NP
lymphocytes NNS I-NP
with IN B-PP
or CC B-PP
without IN B-PP
antigenic JJ B-NP
stimulation NN I-NP
. . O

Two CD B-NP
different JJ I-NP
strains NNS I-NP
of IN B-PP
HHV-6 NN B-NP
COMMA COMMA O
GS NN B-NP
and CC O
Z29 NN B-NP
COMMA COMMA O
transactivated VBD B-VP
the DT B-NP
HIV NN I-NP
promoter NN I-NP
. . O

The DT B-NP
GS NN I-NP
strain NN I-NP
transactivated VBD B-VP
the DT B-NP
promoter NN I-NP
in IN B-PP
both CC B-NP
stimulated VBN I-NP
and CC I-NP
resting VBG I-NP
T NN I-NP
cells NNS I-NP
COMMA COMMA O
while IN B-SBAR
the DT B-NP
Z29 NN I-NP
strain NN I-NP
increased VBD B-VP
HIV NN B-NP
promoter NN I-NP
activity NN I-NP
only RB B-PP
in IN I-PP
stimulated VBN B-NP
T NN I-NP
cells NNS I-NP
. . O

Three CD B-NP
DNA NN I-NP
clones NNS I-NP
containing VBG B-VP
HHV-6 NN B-NP
( ( I-NP
GS NN I-NP
) ) I-NP
genomic JJ I-NP
fragments NNS I-NP
transactivated VBD B-VP
the DT B-NP
HIV NN I-NP
promoter NN I-NP
in IN B-PP
cotransfected VBN B-NP
T NN I-NP
cells NNS I-NP
. . O

A DT B-NP
21.4-kb JJ I-NP
DNA NN I-NP
clone NN I-NP
COMMA COMMA O
pZVB70 NN B-NP
COMMA COMMA O
showed VBD B-VP
the DT B-NP
highest JJS I-NP
transactivating NN I-NP
ability NN I-NP
COMMA COMMA O
while IN B-SBAR
two CD B-NP
other JJ I-NP
DNA NN I-NP
fragments NNS I-NP
COMMA COMMA O
pZVB10 NN B-NP
( ( O
6.2 CD B-NP
kb NN I-NP
) ) O
and CC O
pZVH14 NN B-NP
( ( O
8.7 CD B-NP
kb NN I-NP
) ) O
COMMA COMMA O
showed VBD B-VP
lower JJR B-NP
activity NN I-NP
. . O

One CD B-NP
of IN B-PP
these DT B-NP
clones NNS I-NP
COMMA COMMA O
pZVH14 NN B-NP
COMMA COMMA O
activated VBD B-VP
the DT B-NP
HIV NN I-NP
promoter NN I-NP
construct NN I-NP
containing VBG B-VP
a DT B-NP
mutation NN I-NP
in IN B-PP
the DT B-NP
NF NN I-NP
kappa NN I-NP
B NN I-NP
site NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
this DT B-NP
mutated VBN I-NP
NF NN I-NP
kappa NN I-NP
B NN I-NP
promoter NN I-NP
was VBD B-VP
not RB I-VP
transactivated VBN I-VP
during IN B-PP
HHV-6 NN B-NP
( ( I-NP
GS NN I-NP
) ) I-NP
infection NN I-NP
or CC B-PP
after IN B-PP
cotransfection NN B-NP
with IN B-PP
pZVB70 NN B-NP
or CC O
pZVB10 NN B-NP
. . O

These DT B-NP
data NNS I-NP
indicate VBP B-VP
that IN B-SBAR
the DT B-NP
NF NN I-NP
kappa NN I-NP
B NN I-NP
sites NNS I-NP
of IN B-PP
the DT B-NP
HIV NN I-NP
promoter NN I-NP
are VBP B-VP
essential JJ B-ADJP
for IN B-PP
its PRP$ B-NP
transactivation NN I-NP
during IN B-PP
HHV-6 NN B-NP
( ( I-NP
GS NN I-NP
) ) I-NP
infection NN I-NP
. . O

By IN B-PP
increasing VBG B-VP
HIV NN B-NP
promoter NN I-NP
activity NN I-NP
in IN B-PP
primary JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
COMMA COMMA O
HHV-6 NN B-NP
may MD B-VP
consequently RB I-VP
increase VB I-VP
HIV NN B-NP
replication NN I-NP
COMMA COMMA O
leading VBG B-VP
to TO B-PP
an DT B-NP
increase NN I-NP
in IN B-PP
the DT B-NP
cytopathic JJ I-NP
effect NN I-NP
on IN B-PP
coinfected VBN B-NP
human JJ I-NP
T NN I-NP
cells NNS I-NP
. . O

The DT B-NP
rhombotin NN I-NP
family NN I-NP
of IN B-PP
cysteine-rich JJ B-NP
LIM-domain JJ I-NP
oncogenes NNS I-NP
: : O
distinct JJ B-NP
members NNS I-NP
are VBP B-VP
involved VBN I-VP
in IN B-PP
T-cell NN B-NP
translocations NNS I-NP
to TO B-PP
human JJ B-NP
chromosomes NNS I-NP
11p15 NN B-NP
and CC O
11p13 NN B-NP
. . O

A DT B-NP
chromosomal NN I-NP
translocation NN I-NP
in IN B-PP
a DT B-NP
T-cell NN I-NP
leukemia NN I-NP
involving VBG B-VP
the DT B-NP
short JJ I-NP
arm NN I-NP
of IN B-PP
human JJ B-NP
chromosome NN I-NP
11 CD I-NP
at IN B-PP
band NN B-NP
11p15 NN I-NP
disrupts VBZ B-VP
the DT B-NP
rhombotin NN I-NP
gene NN I-NP
. . O

This DT B-NP
gene NN I-NP
encodes VBZ B-VP
a DT B-NP
protein NN I-NP
with IN B-PP
duplicated JJ B-NP
cysteine-rich JJ I-NP
regions NNS I-NP
called VBN B-VP
LIM NN B-NP
domains NNS I-NP
COMMA COMMA O
which WDT B-NP
show VBP B-VP
homology NN B-NP
to TO B-PP
zinc-binding JJ B-NP
proteins NNS I-NP
and CC B-PP
to TO B-PP
iron-sulfur JJ B-NP
centers NNS I-NP
of IN B-PP
ferredoxins NNS B-NP
. . O

Two CD B-NP
homologues NNS I-NP
of IN B-PP
the DT B-NP
rhombotin NN I-NP
gene NN I-NP
have VBP B-VP
now RB I-VP
been VBN I-VP
isolated VBN I-VP
. . O

One CD B-NP
of IN B-PP
these DT B-NP
COMMA COMMA O
designated VBN B-VP
Rhom-2 NN B-NP
COMMA COMMA O
is VBZ B-VP
located JJ B-ADJP
on IN B-PP
human JJ B-NP
chromosome NN I-NP
11 CD I-NP
at IN B-PP
band NN B-NP
11p13 NN I-NP
COMMA COMMA O
where WRB B-ADVP
a DT B-NP
cluster NN I-NP
of IN B-PP
T-cell NN B-NP
leukemia-specific JJ I-NP
translocations NNS I-NP
occur VBP B-VP
; : O
all DT B-NP
translocation NN I-NP
breakpoints NNS I-NP
at IN B-PP
11p13 NN B-NP
are VBP B-VP
upstream JJ B-ADJP
of IN B-PP
the DT B-NP
Rhom-2 NN I-NP
gene NN I-NP
. . O

Human JJ O
and CC O
mouse NN B-NP
Rhom-2 NN B-NP
are VBP B-VP
highly RB I-VP
conserved VBN I-VP
and CC O
COMMA COMMA O
like IN B-PP
rhombotin NN B-NP
COMMA COMMA O
encode VBP B-VP
two CD B-NP
tandem JJ I-NP
cysteine-rich JJ I-NP
LIM NN I-NP
domains NNS I-NP
. . O

Rhom-2 NN B-NP
mRNA NN I-NP
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
early JJ B-NP
mouse NN I-NP
development NN I-NP
in IN B-PP
central JJ B-NP
nervous JJ I-NP
system NN I-NP
COMMA COMMA O
lung NN B-NP
COMMA COMMA O
kidney NN B-NP
COMMA COMMA O
liver NN B-NP
COMMA COMMA O
and CC O
spleen NN B-NP
but CC O
only RB B-NP
very RB I-NP
low JJ I-NP
levels NNS I-NP
occur VBP B-VP
in IN B-PP
thymus NN B-NP
. . O

The DT B-NP
other JJ I-NP
gene NN I-NP
COMMA COMMA O
designated VBN B-VP
Rhom-3 NN B-NP
COMMA COMMA O
is VBZ B-VP
not RB O
on IN B-PP
chromosome NN B-NP
11 CD I-NP
but CC B-CONJP
also RB I-CONJP
retains VBZ B-VP
homology NN B-NP
to TO B-PP
the DT B-NP
LIM NN I-NP
domain NN I-NP
of IN B-PP
rhombotin NN B-NP
. . O

Since IN B-SBAR
the DT B-NP
Rhom-2 NN I-NP
gene NN I-NP
is VBZ B-VP
such JJ B-NP
a DT I-NP
common JJ I-NP
site NN I-NP
of IN B-PP
chromosomal JJ B-NP
damage NN I-NP
in IN B-PP
T-cell NN B-NP
tumors NNS I-NP
COMMA COMMA O
the DT B-NP
consistency NN I-NP
of IN B-PP
translocations NNS B-NP
near IN B-PP
the DT B-NP
rhombotin NN I-NP
gene NN I-NP
was VBD B-VP
further RB I-VP
examined VBN I-VP
. . O

A DT B-NP
second JJ I-NP
translocation NN I-NP
adjacent JJ B-ADJP
to TO B-PP
rhombotin NN B-NP
was VBD B-VP
found VBN B-VP
and CC O
at IN B-PP
the DT B-NP
same JJ I-NP
position NN I-NP
as IN B-PP
in IN B-PP
the DT B-NP
previous JJ I-NP
example NN I-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
chromosome NN B-NP
bands NNS I-NP
11p15 NN B-NP
( ( O
rhombotin NN B-NP
) ) O
and CC O
11p13 NN B-NP
( ( O
Rhom-2 NN B-NP
) ) O
are VBP B-VP
consistent JJ B-NP
sites NNS I-NP
of IN B-PP
chromosome NN B-NP
translocation NN I-NP
in IN B-PP
T-cell NN B-NP
leukemia NN I-NP
COMMA COMMA O
with IN B-SBAR
the DT B-NP
11p15 NN I-NP
target NN I-NP
more RBR B-VP
rarely RB I-VP
involved VBN I-VP
. . O

The DT B-NP
results NNS I-NP
define VBP B-VP
the DT B-NP
rhombotin NN I-NP
gene NN I-NP
family NN I-NP
as IN B-PP
a DT B-NP
class NN I-NP
of IN B-PP
T-cell NN B-NP
oncogenes NNS I-NP
with IN B-PP
duplicated JJ B-NP
cysteine-rich JJ I-NP
LIM NN I-NP
domains NNS I-NP
. . O

The DT B-NP
human JJ I-NP
myelomonocytic JJ I-NP
cell NN I-NP
line NN I-NP
U-937 NN I-NP
as IN B-PP
a DT B-NP
model NN I-NP
for IN B-PP
studying VBG B-VP
alterations NNS B-NP
in IN B-PP
steroid-induced JJ B-NP
monokine NN I-NP
gene NN I-NP
expression NN I-NP
: : O
marked JJ B-NP
enhancement NN I-NP
of IN B-PP
lipopolysaccharide-stimulated JJ B-NP
interleukin-1 NN I-NP
beta NN I-NP
messenger NN I-NP
RNA NN I-NP
levels NNS I-NP
by IN B-PP
1COMMA25-dihydroxyvitamin NN B-NP
D3 NN I-NP
. . O

The DT B-NP
active JJ I-NP
metabolite NN I-NP
of IN B-PP
vitamin NN B-NP
D NN I-NP
COMMA COMMA O
1COMMA25-dihydroxyvitamin NN B-NP
D3 NN I-NP
{ ( O
1COMMA25-(OH)2D3 NN B-NP
} ) O
COMMA COMMA O
is VBZ B-VP
a DT B-NP
potent JJ I-NP
regulator NN I-NP
of IN B-PP
human JJ B-NP
monocyte\/macrophage JJ I-NP
function NN I-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

To TO B-VP
establish VB I-VP
a DT B-NP
model NN I-NP
for IN B-PP
1COMMA25-(OH)2D3 NN B-NP
regulation NN I-NP
of IN B-PP
human JJ B-NP
monocyte NN I-NP
monokine NN I-NP
synthesis NN I-NP
COMMA COMMA O
three CD B-NP
human JJ I-NP
cell NN I-NP
lines NNS I-NP
( ( O
U-937 NN B-NP
COMMA COMMA O
THP-1 NN B-NP
COMMA COMMA O
and CC O
HL-60 NN B-NP
) ) O
were VBD B-VP
examined VBN I-VP
for IN B-PP
: : O
1 LS B-LST
) ) O
the DT B-NP
presence NN I-NP
of IN B-PP
functional JJ B-NP
1COMMA25-(OH)2D3 NN I-NP
receptors NNS I-NP
; : O
2 LS B-LST
) ) O
the DT B-NP
accumulation NN I-NP
of IN B-PP
interleukin-1 NN B-NP
beta NN I-NP
( ( O
IL-1 NN B-NP
beta NN I-NP
) ) O
mRNA NN B-NP
and CC O
IL-1 NN B-NP
beta NN I-NP
protein NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
lipopolysaccharide NN B-NP
( ( O
LPS NN B-NP
) ) O
; : O
and CC O
3 LS B-LST
) ) O
the DT B-NP
regulation NN I-NP
of IN B-PP
this DT B-NP
response NN I-NP
by IN B-PP
1COMMA25-(OH)2D3 NN B-NP
. . O

All DT B-NP
three CD I-NP
cell NN I-NP
lines NNS I-NP
expressed VBD B-VP
vitamin NN B-NP
D NN I-NP
receptor NN I-NP
and CC O
had VBD B-VP
increased VBN I-VP
levels NNS B-NP
of IN B-PP
IL-1 NN B-NP
beta NN I-NP
mRNA NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
LPS NN B-NP
. . O

Preincubation NN B-NP
of IN B-PP
cells NNS B-NP
with IN B-PP
1COMMA25-(OH)2D3 NN B-NP
augmented VBD B-VP
IL-1 NN B-NP
beta NN I-NP
mRNA NN I-NP
levels NNS I-NP
only RB B-PP
in IN I-PP
U-937 NN B-NP
and CC O
HL-60 NN B-NP
cells NNS B-NP
. . O

From IN B-PP
these DT B-NP
data NNS I-NP
COMMA COMMA O
and CC O
taking VBG B-VP
into IN B-PP
consideration NN B-NP
their PRP$ B-NP
state NN B-NP
of IN B-PP
differentiation NN B-NP
and CC O
relative JJ B-NP
ease NN I-NP
of IN B-PP
culture NN B-NP
COMMA COMMA O
U-937 NN B-NP
was VBD B-VP
chosen VBN I-VP
over IN B-PP
HL-60 NN B-NP
and CC O
THP-1 NN B-NP
as IN B-PP
the DT B-NP
cell NN I-NP
line NN I-NP
we PRP B-NP
further RB B-ADVP
characterized VBD B-VP
. . O

In IN B-PP
U-937 NN B-NP
cells NNS I-NP
COMMA COMMA O
optimum JJ B-NP
time NN B-NP
and CC O
dose NN B-NP
of IN B-PP
pretreatment NN B-NP
with IN B-PP
1COMMA25-(OH)2D3 NN B-NP
were VBD B-VP
determined VBN I-VP
to TO I-VP
be VB I-VP
12-24 CD B-NP
h NN I-NP
at IN B-PP
a DT B-NP
receptor NN I-NP
saturating JJ I-NP
concentration NN I-NP
of IN B-PP
1COMMA25-(OH)2D3 NN B-NP
( ( O
10 CD B-NP
nM NN I-NP
) ) O
. . O

Preincubation NN B-NP
of IN B-PP
cells NNS B-NP
with IN B-PP
1COMMA25-(OH)2D3 NN B-NP
had VBD B-VP
no DT B-NP
effect NN I-NP
on IN B-PP
the DT B-NP
time NN I-NP
course NN I-NP
of IN B-PP
IL-1 NN B-NP
beta NN I-NP
mRNA NN I-NP
appearance NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
LPS NN B-NP
. . O

However RB B-ADVP
COMMA COMMA O
exposure NN B-NP
of IN B-PP
U-937 NN B-NP
cells NNS I-NP
to TO B-PP
1COMMA25-(OH)2D3 NN B-NP
increased VBD B-VP
by IN B-PP
200 CD B-NP
% NN I-NP
the DT B-NP
level NN I-NP
of IN B-PP
IL-1 NN B-NP
beta NN I-NP
mRNA NN I-NP
detected VBD B-VP
and CC O
decreased VBD B-VP
by IN B-PP
three CD B-NP
orders NNS I-NP
of IN B-PP
magnitude NN B-NP
the DT B-NP
concentration NN I-NP
of IN B-PP
LPS NN B-NP
required VBN B-VP
to TO I-VP
achieve VB I-VP
steady JJ B-NP
state NN I-NP
mRNA NN I-NP
levels NNS I-NP
equivalent JJ B-ADJP
to TO B-PP
those DT B-NP
observed VBN B-VP
in IN B-PP
U-937 NN B-NP
cells NNS I-NP
not RB B-VP
preincubated VBN I-VP
with IN B-PP
the DT B-NP
hormone.2+o NN I-NP

Cortivazol NN B-NP
mediated VBD I-NP
induction NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
messenger NN I-NP
ribonucleic JJ I-NP
acid NN I-NP
in IN B-PP
wild-type JJ B-NP
and CC I-NP
dexamethasone-resistant JJ I-NP
human JJ I-NP
leukemic NN I-NP
( ( I-NP
CEM NN I-NP
) ) I-NP
cells NNS I-NP
. . O

Cortivazol NN B-NP
is VBZ B-VP
a DT B-NP
phenylpyrazolo JJ I-NP
glucocorticoid NN I-NP
of IN B-PP
high JJ B-NP
potency NN I-NP
and CC O
unusual JJ B-NP
structure NN I-NP
. . O

In IN B-PP
both CC O
wild-type JJ O
and CC O
highly RB O
dexamethasone NN B-NP
( ( O
dex NN B-NP
) ) O
-resistant JJ B-NP
clones NNS I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
leukemic JJ I-NP
cell NN I-NP
line NN I-NP
CEM NN I-NP
COMMA COMMA O
exposure NN B-NP
to TO B-PP
cortivazol NN B-NP
leads VBZ B-VP
to TO B-PP
cell NN B-NP
death NN I-NP
. . O

It PRP B-NP
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
recently RB B-ADVP
that IN B-SBAR
in IN B-PP
wild-type JJ B-NP
CEM NN I-NP
cells NNS I-NP
but CC B-PP
not RB B-PP
in IN I-PP
a DT B-NP
dex-resistant JJ I-NP
COMMA COMMA I-NP
glucocorticoid NN I-NP
receptor NN I-NP
( ( I-NP
GR NN I-NP
) ) I-NP
-defective JJ I-NP
clone NN I-NP
ICR-27 NN I-NP
TK-3 NN I-NP
COMMA COMMA O
dex NN B-NP
induces VBZ B-VP
GR NN B-NP
mRNA NN I-NP
. . O

To TO B-VP
test VB I-VP
the DT B-NP
hypothesis NN I-NP
that IN B-SBAR
cortivazol NN B-NP
acts VBZ B-VP
in IN B-PP
dex-resistant JJ B-NP
cells NNS I-NP
by IN B-PP
making VBG B-VP
use NN B-NP
of IN B-PP
the DT B-NP
residual JJ I-NP
GR NN I-NP
found VBN B-VP
there RB B-ADVP
COMMA COMMA O
wild-type JJ B-NP
and CC I-NP
dex-resistant JJ I-NP
clones NNS I-NP
were VBD B-VP
treated VBN I-VP
with IN B-PP
various JJ B-NP
concentrations NNS I-NP
of IN B-PP
cortivazol NN B-NP
and CC O
induction NN B-NP
of IN B-PP
GR NN B-NP
mRNA NN I-NP
was VBD B-VP
studied VBN I-VP
. . O

Cortivazol NN B-NP
significantly RB B-ADVP
induced VBD B-VP
GR NN B-NP
mRNA NN I-NP
in IN B-PP
the DT B-NP
normal JJ I-NP
CEM-C7 NN I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
in IN B-PP
two CD B-NP
classes NNS I-NP
of IN B-PP
dex-resistant JJ B-NP
clones NNS I-NP
COMMA COMMA O
although IN B-SBAR
the DT B-NP
dex-resistant JJ I-NP
clones NNS I-NP
needed VBD B-VP
at IN B-NP
least JJS I-NP
10 CD I-NP
times NNS I-NP
more JJR I-NP
cortivazol NN I-NP
than IN B-PP
the DT B-NP
normal JJ I-NP
cells NNS I-NP
for IN B-PP
significant JJ B-NP
GR NN I-NP
mRNA NN I-NP
induction NN I-NP
. . O

Increased VBN B-NP
levels NNS I-NP
of IN B-PP
GR NN B-NP
mRNA NN I-NP
were VBD B-VP
noticed VBN I-VP
as RB B-ADVP
early RB I-ADVP
as IN B-PP
3 CD B-NP
h NN I-NP
after IN B-PP
treatment NN B-NP
. . O

A DT B-NP
general JJ I-NP
correlation NN I-NP
between IN B-PP
induction NN B-NP
of IN B-PP
GR NN B-NP
mRNA NN I-NP
and CC O
lysis NN B-NP
of IN B-PP
the DT B-NP
normal JJ I-NP
and CC I-NP
dex-resistant JJ I-NP
cells NNS I-NP
was VBD B-VP
found VBN I-VP
. . O

Positive JJ B-NP
induction NN I-NP
of IN B-PP
GR NN B-NP
mRNA NN I-NP
might MD B-VP
be VB I-VP
one CD B-NP
of IN B-PP
the DT B-NP
earliest JJS I-NP
crucial JJ I-NP
steps NNS I-NP
in IN B-PP
the DT B-NP
lysis NN I-NP
of IN B-PP
normal JJ B-NP
and CC I-NP
dex-resistant JJ I-NP
CEM NN I-NP
cells NNS I-NP
COMMA COMMA O
or CC O
might MD B-VP
serve VB I-VP
as IN B-PP
a DT B-NP
marker NN I-NP
for IN B-PP
the DT B-NP
process NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
lysis NN I-NP
pathway NN I-NP
in IN B-PP
the DT B-NP
dex-resistant JJ I-NP
cells NNS I-NP
is VBZ B-VP
defective JJ B-ADJP
in IN B-PP
that IN B-SBAR
dex-resistant JJ B-NP
clones NNS I-NP
needed VBD B-VP
significantly RB B-NP
more JJR I-NP
cortivazol NN I-NP
than IN B-PP
the DT B-NP
normal JJ I-NP
cells NNS I-NP
for IN B-PP
lysis NN B-NP
of IN B-PP
the DT B-NP
cells NNS I-NP
. . O

Expression NN B-NP
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
receptors NNS I-NP
on IN B-PP
alveolar JJ B-NP
lymphocytes NNS I-NP
from IN B-PP
patients NNS B-NP
with IN B-PP
pulmonary JJ B-NP
granulomatous JJ I-NP
diseases NNS I-NP
. . O

1COMMA25(OH)2D3 NN B-NP
is VBZ B-VP
known VBN I-VP
to TO I-VP
be VB I-VP
produced VBN I-VP
at IN B-PP
sites NNS B-NP
of IN B-PP
granulomatous JJ B-NP
reactions NNS I-NP
. . O

In IN B-SBAR
order NN O
to TO O
characterize VB B-VP
the DT B-NP
cell NN I-NP
types NNS I-NP
that WDT B-NP
are VBP B-VP
targets NNS B-NP
for IN B-PP
this DT B-NP
immunoregulatory JJ I-NP
hormone NN I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
evaluated VBN I-VP
the DT B-NP
expression NN I-NP
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
receptors NNS I-NP
on IN B-PP
peripheral JJ B-NP
blood NN I-NP
T-lymphocytes NNS I-NP
and CC O
those DT B-NP
recovered VBN B-VP
from IN B-PP
the DT B-NP
lung NN I-NP
by IN B-PP
bronchoalveolar JJ B-NP
lavage NN I-NP
from IN B-PP
patients NNS B-NP
with IN B-PP
pulmonary JJ B-NP
granulomatous JJ I-NP
diseases NNS I-NP
( ( O
tuberculosis NN B-NP
and CC O
sarcoidosis NN B-NP
) ) O
and CC B-PP
from IN B-PP
normal JJ B-NP
control NN I-NP
subjects NNS I-NP
using VBG B-VP
combined JJ B-NP
autoradiographic JJ I-NP
and CC I-NP
immunohistochemical JJ I-NP
techniques NNS I-NP
. . O

Lavage NN B-NP
T-lymphocytes NNS I-NP
from IN B-PP
patients NNS B-NP
with IN B-PP
tuberculosis NN B-NP
or CC B-PP
with IN B-PP
sarcoidosis NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
those DT B-NP
from IN B-PP
normal JJ B-NP
control NN I-NP
subjects NNS I-NP
COMMA COMMA O
expressed VBD B-VP
1COMMA25(OH)2D3 NN B-NP
receptors NNS I-NP
as IN B-SBAR
demonstrated VBN B-VP
by IN B-PP
binding NN B-NP
of IN B-PP
{3H}1COMMA25(OH)2D3 NN B-NP
COMMA COMMA O
which WDT B-NP
was VBD B-VP
inhibited VBN I-VP
by IN B-PP
the DT B-NP
presence NN I-NP
of IN B-PP
excess JJ B-NP
unlabeled JJ I-NP
1COMMA25(OH)2D3 NN I-NP
COMMA COMMA B-PP
but CC I-PP
not RB B-PP
by IN I-PP
the DT B-NP
presence NN I-NP
of IN B-PP
unlabeled JJ B-NP
25(OH)D3 NN I-NP
( ( O
receptor-positive JJ B-NP
lymphocytes NNS I-NP
: : O
sarcoidosis NN B-NP
COMMA COMMA O
20 CD B-NP
+\/- CC I-NP
12 CD I-NP
% NN I-NP
; : O
tuberculosis NN B-NP
COMMA COMMA O
31 CD B-NP
+\/- CC I-NP
17 CD I-NP
% NN I-NP
) ) O
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
blood NN B-NP
lymphocytes NNS I-NP
from IN B-PP
patients NNS B-NP
with IN B-PP
granulomatous JJ B-NP
diseases NNS I-NP
did VBD B-VP
not RB I-VP
express VB I-VP
detectable JJ B-NP
1COMMA25(OH)2D3 NN I-NP
receptors NNS I-NP
. . O

The DT B-NP
percentage NN I-NP
of IN B-PP
lavage NN B-NP
T-lymphocytes NNS I-NP
expressing VBG B-VP
1COMMA25(OH)2D3 NN B-NP
receptors NNS I-NP
was VBD B-VP
significantly RB B-ADJP
greater JJR I-ADJP
for IN B-PP
patients NNS B-NP
with IN B-PP
tuberculosis NN B-NP
presenting VBG B-VP
with IN B-PP
isolated VBN B-NP
hilar JJ I-NP
adenopathy JJ I-NP
than IN B-PP
for IN B-PP
patients NNS B-NP
with IN B-PP
pulmonary JJ B-NP
infiltrates NNS B-NP
and\/or CC O
cavities NNS B-NP
. . O

1COMMA25(OH)2D3 NN B-NP
receptors NNS I-NP
were VBD B-VP
expressed VBN I-VP
to TO B-PP
a DT B-NP
greater JJR I-NP
extent NN I-NP
on IN B-PP
CD8+ JJ B-NP
T-lymphocytes NNS I-NP
than IN B-PP
on IN B-PP
CD4+ JJ B-NP
T-lymphocytes NNS I-NP
in IN B-PP
sarcoidosis NN B-NP
COMMA COMMA O
whereas IN O
a DT B-NP
greater JJR I-NP
proportion NN I-NP
of IN B-PP
CD4+ JJ B-NP
than IN B-PP
of IN B-PP
CD8+ JJ B-NP
T-lymphocytes NNS B-NP
from IN B-PP
patients NNS B-NP
with IN B-PP
tuberculosis NN B-NP
were VBD B-VP
receptor-positive JJ B-ADJP
. . O

These DT B-NP
findings NNS I-NP
support VBP B-VP
the DT B-NP
conclusion NN I-NP
that IN B-SBAR
the DT B-NP
interaction NN I-NP
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
with IN B-PP
its PRP$ B-NP
receptor NN I-NP
on IN B-PP
T-lymphocytes NNS B-NP
may MD B-VP
play VB I-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
granulomatous JJ B-NP
reactions NNS I-NP
COMMA COMMA O
but CC O
because IN B-SBAR
these DT B-NP
receptors NNS I-NP
are VBP B-VP
expressed VBN I-VP
on IN B-PP
different JJ B-NP
lymphocyte NN I-NP
populations NNS I-NP
COMMA COMMA O
the DT B-NP
net JJ I-NP
effect NN I-NP
of IN B-PP
this DT B-NP
potent JJ I-NP
immunoregulatory JJ I-NP
molecule NN I-NP
is VBZ B-VP
likely RB B-ADJP
different JJ I-ADJP
in IN B-PP
sarcoidosis NN B-NP
and CC O
tuberculosis NN B-NP
. . O

Inhibition NN B-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
belonging VBG B-VP
to TO B-PP
the DT B-NP
rel\/NF-kappa NN I-NP
B NN I-NP
family NN I-NP
by IN B-PP
a DT B-NP
transdominant JJ I-NP
negative JJ I-NP
mutant NN I-NP
. . O

The DT B-NP
KBF1 NN I-NP
factor NN I-NP
COMMA COMMA O
which WDT B-NP
binds VBZ B-VP
to TO B-PP
the DT B-NP
enhancer NN I-NP
A NN I-NP
located JJ B-VP
in IN B-PP
the DT B-NP
promoter NN I-NP
of IN B-PP
the DT B-NP
mouse NN I-NP
MHC NN I-NP
class NN I-NP
I CD I-NP
gene NN I-NP
H-2Kb NN I-NP
COMMA COMMA O
is VBZ B-VP
indistinguishable JJ B-ADJP
from IN B-PP
the DT B-NP
p50 NN I-NP
DNA NN I-NP
binding NN I-NP
subunit NN I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
NF-kappa NN I-NP
B NN I-NP
COMMA COMMA O
which WDT B-NP
regulates VBZ B-VP
a DT B-NP
series NN I-NP
of IN B-PP
genes NNS B-NP
involved VBN B-VP
in IN B-PP
immune JJ B-NP
and CC I-NP
inflammatory JJ I-NP
responses NNS I-NP
. . O

The DT B-NP
KBF1\/p50 NN I-NP
factor NN I-NP
binds VBZ B-VP
as IN B-PP
a DT B-NP
homodimer NN I-NP
but CC O
can MD B-VP
also RB I-VP
form VB I-VP
heterodimers NNS B-NP
with IN B-PP
the DT B-NP
products NNS I-NP
of IN B-PP
other JJ B-NP
members NNS I-NP
of IN B-PP
the DT B-NP
same JJ I-NP
family NN I-NP
COMMA COMMA O
like IN B-PP
the DT O
c-rel NN B-NP
and CC O
v-rel NN B-NP
( ( B-NP
proto NN I-NP
) ) I-NP
oncogenes NNS I-NP
. . O

The DT B-NP
dimerization NN I-NP
domain NN I-NP
of IN B-PP
KBF1\/p50 NN B-NP
is VBZ B-VP
contained VBN I-VP
between IN B-PP
amino NN B-NP
acids NNS I-NP
201 CD B-NP
and CC O
367 CD B-NP
. . O

A DT B-NP
mutant NN I-NP
of IN B-PP
KBF1\/p50 NN B-NP
( ( I-NP
delta NN I-NP
SP NN I-NP
) ) O
COMMA COMMA O
unable JJ B-ADJP
to TO B-VP
bind VB I-VP
to TO B-PP
DNA NN B-NP
but CC O
able JJ B-ADJP
to TO B-VP
form VB I-VP
homo- JJ B-NP
or CC O
heterodimers NNS B-NP
COMMA COMMA O
has VBZ B-VP
been VBN I-VP
constructed VBN I-VP
. . O

This DT B-NP
protein NN I-NP
reduces VBZ B-VP
or CC O
abolishes VBZ B-VP
in FW B-ADVP
vitro FW I-ADVP
the DT B-NP
DNA NN I-NP
binding NN I-NP
activity NN I-NP
of IN B-PP
wild-type JJ B-NP
proteins NNS I-NP
of IN B-PP
the DT B-NP
same JJ I-NP
family NN I-NP
( ( O
KBF1\/p50 NN B-NP
COMMA COMMA O
c- NN B-NP
and CC O
v-rel NN B-NP
) ) O
. . O

This DT B-NP
mutant JJ I-NP
also RB B-ADVP
functions NNS B-VP
in FW B-ADVP
vivo FW I-ADVP
as IN B-PP
a DT B-NP
trans-acting JJ I-NP
dominant JJ I-NP
negative JJ I-NP
regulator NN I-NP
: : O
the DT B-NP
transcriptional JJ I-NP
inducibility NN I-NP
of IN B-PP
the DT B-NP
HIV NN I-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
( ( O
which WDT B-NP
contains VBZ B-VP
two CD B-NP
potential JJ I-NP
NF-kappa NN I-NP
B NN I-NP
binding NN I-NP
sites NNS I-NP
) ) O
by IN B-PP
phorbol NN B-NP
ester NN I-NP
( ( O
PMA NN B-NP
) ) O
is VBZ B-VP
inhibited VBN I-VP
when WRB B-ADVP
it PRP B-NP
is VBZ B-VP
co-transfected VBN I-VP
into IN B-PP
CD4+ JJ B-NP
T NN I-NP
cells NNS I-NP
with IN B-PP
the DT B-NP
delta NN I-NP
SP NN I-NP
mutant NN I-NP
. . O

Similarly RB B-ADVP
the DT O
basal JJ O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
TNF NN B-NP
or CC O
IL1-induced JJ B-ADJP
activity NN B-NP
of IN B-PP
the DT B-NP
MHC NN I-NP
class NN I-NP
I CD I-NP
H-2Kb NN I-NP
promoter NN I-NP
can MD B-VP
be VB I-VP
inhibited VBN I-VP
by IN B-PP
this DT B-NP
mutant NN I-NP
in IN B-PP
two CD B-NP
different JJ I-NP
cell NN I-NP
lines NNS I-NP
. . O

These DT B-NP
results NNS I-NP
constitute VBP B-VP
the DT B-NP
first JJ I-NP
formal JJ I-NP
demonstration NN I-NP
that IN B-SBAR
these DT B-NP
genes NNS I-NP
are VBP B-VP
regulated VBN I-VP
by IN B-PP
members NNS B-NP
of IN B-PP
the DT B-NP
rel\/NF-kappa NN I-NP
B NN I-NP
family NN I-NP
. . O

Human JJ B-NP
erythroid JJ I-NP
5-aminolevulinate NN I-NP
synthase NN I-NP
: : O
promoter NN B-NP
analysis NN I-NP
and CC O
identification NN B-NP
of IN B-PP
an DT B-NP
iron-responsive JJ I-NP
element NN I-NP
in IN B-PP
the DT B-NP
mRNA NN I-NP
. . O

5-Aminolevulinate NN B-NP
synthase NN I-NP
( ( O
ALAS NN B-NP
) ) O
catalyzes VBZ B-VP
the DT B-NP
first JJ I-NP
step NN I-NP
of IN B-PP
the DT B-NP
heme NN I-NP
biosynthetic JJ I-NP
pathway NN I-NP
. . O

cDNA NN B-NP
clones NNS I-NP
for IN B-PP
the DT B-NP
human JJ I-NP
erythroid JJ I-NP
ALAS NN I-NP
isozyme NN I-NP
were VBD B-VP
isolated VBN I-VP
from IN B-PP
a DT B-NP
fetal JJ I-NP
liver NN I-NP
library NN I-NP
. . O

It PRP B-NP
can MD B-VP
be VB I-VP
deduced VBN I-VP
that IN B-SBAR
the DT B-NP
erythroid JJ I-NP
ALAS NN I-NP
precursor NN I-NP
protein NN I-NP
has VBZ B-VP
a DT B-NP
molecular JJ I-NP
weight NN I-NP
of IN B-PP
64.6 CD B-NP
kd NN I-NP
COMMA COMMA O
and CC O
is VBZ B-VP
similar JJ B-ADJP
in IN B-PP
size NN B-NP
to TO B-PP
the DT B-NP
previously RB I-NP
isolated VBN I-NP
human JJ I-NP
housekeeping JJ I-NP
ALAS NN I-NP
precursor NN I-NP
of IN B-PP
molecular JJ B-NP
weight NN I-NP
70.6 CD I-NP
kd NN I-NP
. . O

The DT B-NP
mature JJ I-NP
mitochondrial JJ I-NP
forms NNS I-NP
of IN B-PP
the DT O
erythroid JJ O
and CC O
housekeeping JJ B-NP
ALAS NN B-NP
isozymes NNS I-NP
are VBP B-VP
predicted VBN I-VP
to TO I-VP
have VB I-VP
molecular JJ B-NP
weights NNS I-NP
of IN B-PP
59.5 CD B-NP
kd NN I-NP
and CC O
64.6 CD B-NP
kd NN I-NP
COMMA COMMA O
respectively RB B-ADVP
. . O

The DT B-NP
two CD I-NP
isozymes NNS I-NP
show VBP B-VP
little JJ B-NP
amino NN I-NP
acid NN I-NP
identity NN I-NP
in IN B-PP
their PRP$ B-NP
N-terminal JJ I-NP
signal NN I-NP
sequences NNS I-NP
but CC O
have VBP B-VP
considerable JJ B-NP
sequence NN I-NP
identity NN I-NP
in IN B-PP
the DT B-NP
C-terminal JJ I-NP
two-thirds CD I-NP
of IN B-PP
their PRP$ B-NP
proteins NNS I-NP
. . O

An DT B-NP
analysis NN I-NP
of IN B-PP
the DT B-NP
immediate JJ I-NP
promoter NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
erythroid JJ I-NP
ALAS NN I-NP
gene NN I-NP
revealed VBD B-VP
several JJ B-NP
putative JJ I-NP
erythroid-specific JJ I-NP
cis-acting JJ I-NP
elements NNS I-NP
including VBG B-PP
both PDT O
a DT B-NP
GATA-1 NN I-NP
and CC O
an DT B-NP
NF-E2 NN I-NP
binding NN B-NP
site NN I-NP
. . O

An DT O
iron-responsive JJ B-NP
element NN I-NP
( ( O
IRE NN B-NP
) ) O
motif NN B-NP
has VBZ B-VP
been VBN I-VP
identified VBN I-VP
in IN B-PP
the DT B-NP
5'-untranslated JJ I-NP
region NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
erythroid JJ I-NP
ALAS NN I-NP
mRNA NN I-NP
COMMA COMMA O
but CC O
is VBZ B-VP
not RB O
present JJ B-ADJP
in IN B-PP
the DT B-NP
housekeeping JJ I-NP
ALAS NN I-NP
mRNA NN I-NP
. . O

Gel NN B-NP
retardation NN I-NP
experiments NNS I-NP
established VBD B-VP
that IN B-SBAR
this DT B-NP
IRE NN I-NP
motif NN I-NP
formed VBD B-VP
a DT O
protein-RNA JJ B-NP
complex NN B-NP
with IN B-PP
cytosolic JJ B-NP
extracts NNS I-NP
from IN B-PP
human JJ B-NP
K562 NN I-NP
cells NNS I-NP
and CC O
this DT B-NP
binding NN I-NP
was VBD B-VP
strongly RB I-VP
competed VBN I-VP
with IN B-PP
IRE NN B-NP
transcripts NNS I-NP
from IN B-PP
ferritin NN B-NP
or CC O
transferrin NN B-NP
receptor NN B-NP
mRNAs NNS B-NP
. . O

A DT B-NP
transcript NN I-NP
of IN B-PP
the DT B-NP
ALAS NN I-NP
IRE NN I-NP
COMMA COMMA O
mutated VBN B-VP
in IN B-PP
the DT B-NP
conserved VBN I-NP
loop NN I-NP
of IN B-PP
the DT B-NP
IRE NN I-NP
COMMA COMMA O
did VBD B-VP
not RB I-VP
readily RB I-VP
form VB I-VP
this DT O
protein-RNA JJ B-NP
complex NN B-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
IRE NN I-NP
motif NN I-NP
in IN B-PP
the DT B-NP
ALAS NN I-NP
mRNA NN I-NP
is VBZ B-VP
functional JJ B-ADJP
and CC O
imply VBP B-VP
that IN B-SBAR
translation NN B-NP
of IN B-PP
the DT B-NP
mRNA NN I-NP
is VBZ B-VP
controlled VBN I-VP
by IN B-PP
cellular JJ B-NP
iron NN I-NP
availability NN I-NP
during IN B-PP
erythropoiesis NN B-NP
. . O

Human JJ B-NP
tumor NN I-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
gene NN I-NP
regulation NN I-NP
in IN B-PP
phorbol NN B-NP
ester NN I-NP
stimulated VBD I-NP
T NN I-NP
and CC I-NP
B NN I-NP
cell NN I-NP
lines NNS I-NP
. . O

The DT B-NP
minimal JJ I-NP
region NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
tumor NN I-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
( ( I-NP
TNF-alpha NN I-NP
) ) I-NP
gene NN I-NP
promoter NN I-NP
necessary JJ B-ADJP
for IN B-PP
its PRP$ B-NP
transcriptional JJ I-NP
induction NN I-NP
by IN B-PP
phorbol NN B-NP
esters NNS I-NP
( ( O
PMA NN B-NP
) ) O
in IN B-PP
human JJ B-NP
T NN I-NP
and CC I-NP
B NN I-NP
lymphocyte NN I-NP
cell NN I-NP
lines NNS I-NP
has VBZ B-VP
been VBN I-VP
localized JJ I-VP
between IN B-PP
-52 CD B-NP
and CC O
+89 CD B-NP
nucleotides NNS B-NP
( ( O
nt NN B-NP
) ) O
relative JJ B-ADVP
to TO B-PP
the DT B-NP
gene NN I-NP
's POS B-NP
transcriptional JJ I-NP
start NN I-NP
site NN I-NP
. . O

Comparison NN B-NP
of IN B-PP
these DT B-NP
sequences NNS I-NP
to TO B-PP
those DT B-NP
required VBN B-VP
to TO B-VP
mediate VB I-VP
virus NN B-NP
or CC O
lipopolysaccharide NN B-NP
( ( O
LPS NN B-NP
) ) O
induction NN B-NP
of IN B-PP
the DT B-NP
gene NN I-NP
reveal VB B-VP
significant JJ B-NP
differences NNS I-NP
COMMA COMMA O
and CC O
thus RB O
COMMA COMMA O
the DT B-NP
sequence NN I-NP
requirements NNS I-NP
for IN B-PP
PMA NN B-NP
induction NN I-NP
are VBP B-VP
distinct JJ B-ADJP
from IN B-PP
those DT B-NP
that WDT B-NP
mediate VBP B-VP
induction NN B-NP
by IN B-PP
virus NN B-NP
or CC O
LPS NN B-NP
. . O

Although IN B-SBAR
three CD B-NP
sites NNS I-NP
in IN B-PP
the DT B-NP
TNF-alpha NN I-NP
promoter NN I-NP
( ( O
kappa NN B-NP
1 CD I-NP
COMMA COMMA O
kappa NN B-NP
2 CD I-NP
COMMA COMMA O
and CC O
kappa NN B-NP
3 CD I-NP
) ) O
specifically RB B-ADVP
bind VBP B-VP
the DT B-NP
transcription NN I-NP
factor NN I-NP
NF-kappa NN I-NP
B NN I-NP
in IN B-PP
lymphoid JJ B-NP
nuclear JJ I-NP
extracts NNS I-NP
COMMA COMMA O
TNF-alpha NN B-NP
mRNA NN I-NP
induction NN I-NP
by IN B-PP
PMA NN B-NP
does VBZ B-VP
not RB I-VP
correlate VB I-VP
with IN B-PP
NF-kappa NN B-NP
B NN I-NP
binding NN I-NP
activities NNS I-NP
displayed VBN B-VP
by IN B-PP
different JJ B-NP
T NN I-NP
and CC I-NP
B NN I-NP
cell NN I-NP
lines NNS I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
kappa NN B-NP
1 CD I-NP
- : O
kappa NN B-NP
3 CD I-NP
can MD B-VP
each DT O
be VB B-VP
deleted VBN I-VP
from IN B-PP
the DT B-NP
TNF-alpha NN I-NP
promoter NN I-NP
with IN B-PP
little JJ B-NP
effect NN I-NP
on IN B-PP
the DT B-NP
gene NN I-NP
's POS B-NP
inducibility NN I-NP
by IN B-PP
PMA NN B-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
TNF-alpha NN B-NP
mRNA NN I-NP
induction NN I-NP
by IN B-PP
PMA NN B-NP
COMMA COMMA O
like IN B-PP
its PRP$ B-NP
induction NN I-NP
by IN B-PP
virus NN B-NP
and CC O
LPS NN B-NP
COMMA COMMA O
is VBZ B-VP
not RB I-VP
primarily RB I-VP
mediated VBN I-VP
by IN B-PP
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
but CC B-CONJP
rather RB I-CONJP
is VBZ B-VP
mediated VBN I-VP
through IN B-PP
other JJ B-NP
sequences NNS B-NP
and CC O
protein NN B-NP
factors NNS I-NP
. . O

Surprisingly RB B-ADVP
COMMA COMMA O
multimers NNS B-NP
of IN B-PP
kappa NN B-NP
1 CD I-NP
- : O
kappa NN B-NP
3 CD I-NP
can MD B-VP
confer VB I-VP
PMA NN B-NP
inducibility NN I-NP
on IN B-PP
a DT B-NP
heterologous JJ I-NP
promoter NN I-NP
in IN B-PP
a DT B-NP
B NN B-NP
( ( O
Raji NN B-NP
) ) O
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
a DT B-NP
T NN B-NP
( ( O
HUT78 NN B-NP
) ) O
cell NN B-NP
line NN I-NP
. . O

However WRB O
they PRP B-NP
are VBP B-VP
not RB O
functional JJ B-ADJP
on IN B-PP
a DT B-NP
truncated VBN I-NP
TNF-alpha NN I-NP
promoter NN I-NP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
promoter NN B-NP
context NN I-NP
and CC O
cell NN B-NP
type NN I-NP
specificity NN I-NP
influence VBP B-VP
the DT B-NP
PMA NN I-NP
inducible JJ I-NP
function NN I-NP
of IN B-PP
these DT B-NP
NF-kappa NN I-NP
B NN I-NP
binding NN I-NP
sites NNS I-NP
. . O

Towards IN B-PP
a DT B-NP
molecular JJ I-NP
understanding NN I-NP
of IN B-PP
T-cell NN B-NP
differentiation NN I-NP

Lymphoid JJ B-NP
differentiation NN I-NP
is VBZ B-VP
one CD B-NP
of IN B-PP
the DT B-NP
best RBS I-NP
studied VBN I-NP
examples NNS I-NP
of IN B-PP
mammalian JJ B-NP
development NN I-NP
. . O

Here RB B-ADVP
Hans NNP B-NP
Clevers NNP I-NP
and CC O
Michael NNP B-NP
Owen NNP I-NP
describe VBP B-VP
how WRB B-ADVP
the DT B-NP
cloning NN I-NP
of IN B-PP
the DT B-NP
genes NNS I-NP
that WDT B-NP
encode VBP B-VP
T-cell-specific JJ I-VP
membrane NN I-VP
proteins NNS I-VP
allows VBZ B-VP
the DT B-NP
identification NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
that WDT B-NP
control VBP B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
these DT B-NP
T-cell NN I-NP
genes NNS I-NP
. . O

Such JJ B-NP
transcription NN I-NP
factors NNS I-NP
play VBP B-VP
a DT B-NP
key JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
development NN I-NP
of IN B-PP
the DT B-NP
mature JJ I-NP
T-cell NN I-NP
phenotype NN I-NP
by IN B-PP
functioning VBG B-VP
as IN B-PP
' `` O
master JJ B-NP
regulators NNS I-NP
of IN B-PP
T-cell NN B-NP
differentiation NN I-NP
' '' O
. . O

Regulation NN B-NP
of IN B-PP
jun NN B-NP
and CC I-NP
fos NN I-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
by IN B-PP
the DT B-NP
macrophage NN I-NP
colony-stimulating JJ I-NP
factor NN I-NP
. . O

The DT B-NP
macrophage NN B-NP
colony-stimulating JJ I-NP
factor NN I-NP
( ( O
M-CSF NN B-NP
) ) O
is VBZ B-VP
required VBN I-VP
for IN B-PP
the DT B-NP
growth NN B-NP
and CC O
differentiation NN B-NP
of IN B-PP
mononuclear JJ B-NP
phagocytes NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
signaling NN I-NP
events NNS I-NP
responsible JJ B-ADJP
for IN B-PP
these DT B-NP
effects NNS I-NP
remain VBP B-VP
unclear JJ B-ADJP
. . O

The DT B-NP
present JJ I-NP
studies NNS I-NP
have VBP B-VP
examined VBN I-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
M-CSF NN B-NP
on IN B-PP
potential JJ B-NP
signaling NN I-NP
pathways NNS I-NP
involving VBG B-VP
expression NN B-NP
of IN B-PP
the DT O
jun NN B-NP
and CC O
fos NN B-NP
early JJ B-NP
response NN I-NP
genes NNS I-NP
. . O

Low JJ B-NP
levels NNS I-NP
of IN B-PP
c-jun NN B-NP
transcripts NNS I-NP
were VBD B-VP
detectable JJ B-ADJP
in IN B-PP
resting VBG B-NP
human JJ I-NP
peripheral JJ I-NP
blood NN I-NP
monocytes NNS I-NP
. . O

Treatment NN B-NP
of IN B-PP
these DT B-NP
cells NNS I-NP
with IN B-PP
10(3) CD B-NP
units\/ml NNS I-NP
human JJ I-NP
recombinant JJ I-NP
M-CSF NN I-NP
was VBD B-VP
associated VBN I-VP
with IN B-PP
rapid JJ B-NP
and CC I-NP
transient JJ I-NP
increases NNS I-NP
in IN B-PP
c-jun NN B-NP
mRNA NN I-NP
levels NNS I-NP
. . O

Nuclear JJ B-NP
run-on JJ I-NP
assays NNS I-NP
and CC O
mRNA NN B-NP
stability NN I-NP
studies NNS I-NP
demonstrated VBD B-VP
that IN B-SBAR
M-CSF NN B-NP
regulates VBZ B-VP
c-jun NN B-NP
expression NN I-NP
by IN B-PP
both CC O
an DT B-NP
increase NN I-NP
in IN B-PP
transcription NN B-NP
rate NN I-NP
and CC O
a DT B-NP
prolongation NN I-NP
in IN B-PP
the DT B-NP
half-life NN I-NP
of IN B-PP
c-jun NN B-NP
transcripts NNS I-NP
. . O

M-CSF NN B-NP
treatment NN I-NP
was VBD B-VP
also RB I-VP
associated VBN I-VP
with IN B-PP
a DT B-NP
rapid JJ I-NP
induction NN I-NP
of IN B-PP
the DT B-NP
jun-B NN I-NP
gene NN I-NP
COMMA COMMA O
although IN B-SBAR
expression NN B-NP
of IN B-PP
this DT B-NP
gene NN I-NP
was VBD B-VP
prolonged JJ I-VP
compared VBN B-VP
to TO B-PP
that DT B-NP
of IN B-PP
c-jun NN B-NP
. . O

We PRP B-NP
further RB B-ADVP
demonstrate VBP B-VP
that IN B-SBAR
M-CSF NN B-NP
increases VBZ B-VP
c-fos NN B-NP
mRNA NN I-NP
levels NNS I-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
through IN B-PP
control NN B-NP
at IN B-PP
both CC B-NP
the DT I-NP
transcriptional JJ I-NP
and CC I-NP
posttranscriptional JJ I-NP
levels NNS I-NP
. . O

Maximal JJ B-NP
induction NN I-NP
of IN B-PP
the DT B-NP
c-fos NN I-NP
gene NN I-NP
was VBD B-VP
followed VBN I-VP
by IN B-PP
that DT B-NP
for IN B-PP
the DT B-NP
fos-B NN I-NP
gene NN I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
M-CSF-induced JJ B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
fos-related JJ I-NP
gene NN I-NP
COMMA COMMA O
fra-1 NN B-NP
COMMA COMMA O
was VBD B-VP
delayed VBN I-VP
compared VBN B-VP
to TO B-PP
that DT B-NP
for IN B-PP
both DT B-NP
c-fos NN B-NP
and CC O
fos-B NN B-NP
. . O

Taken VBN B-VP
together RB B-ADVP
COMMA COMMA O
the DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
M-CSF NN B-NP
treatment NN I-NP
is VBZ B-VP
associated VBN I-VP
with IN B-PP
differential JJ B-NP
activation NN I-NP
of IN B-PP
multiple JJ B-NP
members NNS I-NP
of IN B-PP
the DT B-NP
jun\/fos NN I-NP
family NN I-NP
and CC O
that IN B-SBAR
expression NN B-NP
of IN B-PP
these DT B-NP
genes NNS I-NP
could MD B-VP
contribute VB I-VP
to TO B-PP
nuclear JJ B-NP
signaling NN I-NP
mechanisms NNS I-NP
that WDT B-NP
regulate VBP B-VP
a DT B-NP
specific JJ I-NP
program NN I-NP
of IN B-PP
monocyte NN B-NP
differentiation NN I-NP
. . O

Cloning NN B-NP
of IN B-PP
a DT B-NP
human JJ I-NP
homeobox NN I-NP
gene NN I-NP
that WDT B-NP
resembles VBZ B-VP
a DT B-NP
diverged JJ I-NP
Drosophila NN I-NP
homeobox NN I-NP
gene NN I-NP
and CC O
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
activated VBN B-NP
lymphocytes NNS I-NP
. . O

A DT B-NP
new JJ I-NP
homeobox NN I-NP
gene NN I-NP
COMMA COMMA O
HB24 NN B-NP
COMMA COMMA O
has VBZ B-VP
been VBN I-VP
isolated VBN I-VP
from IN B-PP
a DT B-NP
human JJ I-NP
B-lymphocyte NN I-NP
cDNA NN I-NP
library NN I-NP
. . O

Northern JJ B-NP
blot NN I-NP
analysis NN I-NP
of IN B-PP
polyadenylated JJ B-NP
RNA NN I-NP
purified VBN B-VP
from IN B-PP
activated VBN B-NP
human JJ I-NP
B NN I-NP
cells NNS I-NP
revealed VBD B-VP
a DT B-NP
single JJ I-NP
mRNA NN I-NP
transcript NN I-NP
of IN B-PP
approximately RB B-NP
2.3 CD I-NP
kb NN I-NP
. . O

Two CD B-NP
cDNA NN I-NP
clones NNS I-NP
were VBD B-VP
sequenced VBN I-VP
and CC O
provided VBN B-VP
2COMMA250 CD B-NP
nucleotides NNS B-NP
( ( O
nt NN B-NP
) ) O
of IN B-PP
DNA NN B-NP
sequence NN I-NP
information NN I-NP
. . O

There EX B-NP
is VBZ B-VP
a DT B-NP
single JJ I-NP
methionine NN I-NP
codon-initiated JJ I-NP
open JJ I-NP
reading NN I-NP
frame NN I-NP
of IN B-PP
1COMMA458 CD B-NP
nt NN I-NP
in IN B-PP
frame NN B-NP
with IN B-PP
a DT B-NP
homeobox NN I-NP
and CC O
a DT B-NP
CAX NN I-NP
repeat NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
open JJ I-NP
reading NN I-NP
frame NN I-NP
is VBZ B-VP
predicted VBN I-VP
to TO I-VP
encode VB I-VP
a DT B-NP
protein NN I-NP
of IN B-PP
51COMMA659 CD B-NP
daltons NNS I-NP
. . O

When WRB B-ADVP
the DT B-NP
homeodomain NN I-NP
from IN B-PP
HB24 NN B-NP
was VBD B-VP
compared VBN I-VP
to TO B-PP
known JJ O
mammalian JJ O
and CC O
Drosophila NN B-NP
homeodomains NNS B-NP
it PRP B-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
only RB B-ADJP
moderately RB I-ADJP
conserved VBN I-ADJP
COMMA COMMA O
but CC O
when WRB B-ADVP
it PRP B-NP
was VBD B-VP
compared VBN I-VP
to TO B-PP
a DT B-NP
highly RB I-NP
diverged JJ I-NP
Drosophila FW I-NP
homeodomain NN I-NP
COMMA COMMA O
H2.0 NN B-NP
COMMA COMMA O
it PRP B-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
80 CD B-NP
% NN I-NP
identical JJ B-ADJP
. . O

The DT B-NP
HB24 NN I-NP
mRNA NN I-NP
was VBD B-VP
absent JJ B-ADJP
or CC O
present JJ B-ADJP
at IN B-PP
low JJ B-NP
levels NNS I-NP
in IN B-PP
normal JJ B-NP
B NN B-NP
and CC O
T NN B-NP
lymphocytes NNS B-NP
; : O
however RB B-ADVP
COMMA COMMA O
with IN B-PP
the DT B-NP
appropriate JJ I-NP
activation NN I-NP
signal NN I-NP
HB24 NN B-NP
mRNA NN I-NP
was VBD B-VP
induced VBN I-VP
within IN B-PP
several JJ B-NP
hours NNS I-NP
even RB B-PP
in IN I-PP
the DT I-PP
presence NN I-PP
of IN I-PP
cycloheximide NN B-NP
. . O

Characterization NN B-NP
of IN B-PP
HB24 NN B-NP
expression NN I-NP
in IN B-PP
lymphoid JJ B-NP
and CC O
select JJ B-NP
developing VBG I-NP
tissues NNS I-NP
was VBD B-VP
performed VBN I-VP
by IN B-PP
in FW B-NP
situ FW I-NP
hybridization NN I-NP
. . O

Positive JJ B-NP
hybridization NN I-NP
was VBD B-VP
found VBN I-VP
in IN B-PP
thymus NN B-NP
COMMA COMMA O
tonsil NN B-NP
COMMA COMMA O
bone NN B-NP
marrow NN I-NP
COMMA COMMA O
developing VBG B-NP
vessels NNS I-NP
COMMA COMMA B-PP
and CC I-PP
in IN B-PP
fetal JJ B-NP
brain NN I-NP
. . O

HB24 NN B-NP
is VBZ B-VP
likely JJ B-ADJP
to TO B-VP
have VB I-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
lymphocytes NNS B-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
in IN B-PP
certain JJ B-NP
developing VBG I-NP
tissues NNS I-NP
. . O

Severe JJ B-NP
5-fluorouracil NN I-NP
toxicity NN I-NP
secondary JJ B-ADJP
to TO B-PP
dihydropyrimidine NN B-NP
dehydrogenase NN I-NP
deficiency NN I-NP
. . O

A DT B-NP
potentially RB I-NP
more RBR I-NP
common JJ I-NP
pharmacogenetic JJ I-NP
syndrome NN I-NP
. . O

This DT B-NP
study NN I-NP
describes VBZ B-VP
the DT B-NP
inheritance NN I-NP
of IN B-PP
a DT B-NP
defect NN I-NP
in IN B-PP
pyrimidine NN B-NP
catabolism NN I-NP
and CC O
its PRP$ B-NP
association NN I-NP
with IN B-PP
drug-induced JJ B-NP
toxicity NN I-NP
in IN B-PP
a DT B-NP
patient NN I-NP
receiving VBG B-VP
5-fluorouracil NN B-NP
( ( O
FUra NN B-NP
) ) O
as IN B-PP
adjuvant JJ B-NP
chemotherapy NN I-NP
for IN B-PP
breast NN B-NP
carcinoma NN I-NP
. . O

The DT B-NP
study NN I-NP
population NN I-NP
included VBD B-VP
the DT B-NP
affected VBN I-NP
patient NN I-NP
( ( O
proband NN B-NP
) ) O
COMMA COMMA O
nine CD B-NP
of IN B-PP
her PRP$ B-NP
blood NN I-NP
relatives NNS I-NP
COMMA COMMA O
and CC O
seven CD B-NP
healthy JJ I-NP
volunteers NNS I-NP
. . O

The DT B-NP
activity NN I-NP
of IN B-PP
dihydropyrimidine NN B-NP
dehydrogenase NN I-NP
( ( O
DPD NN B-NP
) ) O
COMMA COMMA O
the DT B-NP
initial JJ I-NP
enzyme NN I-NP
of IN B-PP
pyrimidine NN B-NP
( ( O
and CC O
FUra NN B-NP
) ) O
catabolism NN B-NP
COMMA COMMA O
in IN B-PP
peripheral JJ B-NP
blood NN I-NP
mononuclear JJ I-NP
cells NNS I-NP
was VBD B-VP
measured VBN I-VP
in IN B-PP
each DT B-NP
subject NN I-NP
by IN B-PP
a DT B-NP
specific JJ I-NP
radiometric JJ I-NP
assay NN I-NP
using VBG B-VP
FUra NN B-NP
as IN B-PP
the DT B-NP
substrate NN I-NP
. . O

The DT B-NP
proband NN I-NP
had VBD B-VP
no DT B-NP
detectable JJ I-NP
DPD NN I-NP
activity NN I-NP
. . O

When WRB B-ADVP
enzyme NN B-NP
levels NNS I-NP
in IN B-PP
the DT B-NP
proband NN B-NP
and CC O
relatives NNS B-NP
were VBD B-VP
compared VBN I-VP
with IN B-PP
that DT B-NP
in IN B-PP
controls NNS B-NP
COMMA COMMA O
an DT B-NP
autosomal JJ I-NP
recessive JJ I-NP
pattern NN I-NP
of IN B-PP
inheritance NN B-NP
was VBD B-VP
demonstrated VBN I-VP
. . O

This DT B-NP
is VBZ B-VP
the DT B-NP
third JJ I-NP
patient NN I-NP
with IN B-PP
severe JJ B-NP
FUra NN I-NP
toxicity NN I-NP
secondary JJ B-ADJP
to TO B-PP
an DT B-NP
alteration NN I-NP
in IN B-PP
pyrimidine NN B-NP
catabolism NN I-NP
and CC O
the DT B-NP
second NN I-NP
from IN B-PP
our PRP$ B-NP
clinic NN I-NP
population NN I-NP
suggesting VBG B-VP
that IN B-SBAR
the DT B-NP
frequency NN I-NP
of IN B-PP
this DT B-NP
genetic JJ I-NP
defect NN I-NP
may MD B-VP
be VB I-VP
greater JJR B-ADJP
than IN B-SBAR
previously RB B-ADVP
thought VBN B-VP
. . O

Monitoring VBG B-VP
DPD NN B-NP
activity NN I-NP
may MD B-VP
be VB I-VP
important JJ B-ADJP
in IN B-PP
the DT B-NP
management NN I-NP
of IN B-PP
patients NNS B-NP
experiencing VBG B-VP
severe JJ B-NP
toxicity NN I-NP
secondary JJ B-ADJP
to TO B-PP
FUra NN B-NP
chemotherapy NN I-NP
. . O

Characterization NN B-NP
of IN B-PP
an DT B-NP
immediate-early JJ I-NP
gene NN I-NP
induced VBN B-VP
in IN B-PP
adherent JJ B-NP
monocytes NNS I-NP
that WDT B-NP
encodes VBZ B-VP
I NN B-NP
kappa NN I-NP
B-like JJ I-NP
activity NN I-NP
. . O

We PRP B-NP
have VBP B-VP
cloned VBN I-VP
a DT B-NP
group NN I-NP
of IN B-PP
cDNAs NNS B-NP
representing VBG B-VP
mRNAs NNS B-NP
that WDT B-NP
are VBP B-VP
rapidly RB I-VP
induced VBN I-VP
following VBG B-PP
adherence NN B-NP
of IN B-PP
human JJ B-NP
monocytes NNS I-NP
. . O

One CD B-NP
of IN B-PP
the DT B-NP
induced VBN I-NP
transcripts NNS I-NP
( ( O
MAD-3 NN B-NP
) ) O
encodes VBZ B-VP
a DT B-NP
protein NN I-NP
of IN B-PP
317 CD B-NP
amino NN I-NP
acids NNS I-NP
with IN B-PP
one CD B-NP
domain NN I-NP
containing VBG B-VP
five CD B-NP
tandem JJ I-NP
repeats NNS I-NP
of IN B-PP
the DT B-NP
cdc10\/ankyrin JJ I-NP
motif NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
60 CD B-NP
% NN I-NP
similar JJ B-ADJP
( ( O
46 CD B-NP
% NN I-NP
identical JJ B-ADJP
) ) O
to TO B-PP
the DT B-NP
ankyrin NN I-NP
repeat NN I-NP
region NN I-NP
of IN B-PP
the DT B-NP
precursor NN I-NP
of IN B-PP
NF-kappa NN B-NP
B\/KBF1 NN I-NP
p50 NN I-NP
. . O

The DT B-NP
C-terminus NN I-NP
has VBZ B-VP
a DT B-NP
putative JJ I-NP
protein NN I-NP
kinase NN I-NP
C NN I-NP
phosphorylation NN I-NP
site NN I-NP
. . O

In FW B-ADVP
vitro FW I-ADVP
translated VBN B-NP
MAD-3 NN I-NP
protein NN I-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
specifically RB I-VP
inhibit VB I-VP
the DT B-NP
DNA-binding JJ I-NP
activity NN I-NP
of IN B-PP
the DT B-NP
p50\/p65 NN I-NP
NF-kappa NN I-NP
B NN I-NP
complex NN I-NP
but CC B-CONJP
not RB I-CONJP
that DT B-NP
of IN B-PP
the DT B-NP
p50\/p50 NN I-NP
KBF1 NN I-NP
factor NN I-NP
or CC B-PP
of IN B-PP
other JJ B-NP
DNA-binding JJ I-NP
proteins NNS I-NP
. . O

The DT B-NP
MAD-3 NN I-NP
cDNA NN I-NP
encodes VBZ B-VP
an DT B-NP
I NN I-NP
kappa NN I-NP
B-like JJ I-NP
protein NN I-NP
that WDT B-NP
is VBZ B-VP
likely JJ B-ADJP
to TO B-VP
be VB I-VP
involved VBN I-VP
in IN B-PP
regulation NN B-NP
of IN B-PP
transcriptional JJ B-NP
responses NNS I-NP
to TO B-PP
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
including VBG B-PP
adhesion-dependent JJ B-NP
pathways NNS I-NP
of IN B-PP
monocyte NN B-NP
activation NN I-NP
. . O

Reactive JJ B-NP
oxygen NN I-NP
intermediates NNS I-NP
as IN B-PP
apparently RB B-ADJP
widely RB I-ADJP
used VBN I-ADJP
messengers NNS O
in IN B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
NF-kappa NN B-NP
B NN I-NP
transcription NN I-NP
factor NN I-NP
and CC O
HIV-1 NN B-NP
. . O

Hydrogen NN B-NP
peroxide NN I-NP
and CC O
oxygen NN B-NP
radicals NNS B-NP
are VBP B-VP
agents NNS B-NP
commonly RB B-VP
produced VBN I-VP
during IN B-PP
inflammatory JJ B-NP
processes NNS I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
we PRP B-NP
show VBP B-VP
that IN B-SBAR
micromolar JJ B-NP
concentrations NNS I-NP
of IN B-PP
H2O2 NN B-NP
can MD B-VP
induce VB I-VP
the DT B-NP
expression NN B-NP
and CC O
replication NN B-NP
of IN B-PP
HIV-1 NN B-NP
in IN B-PP
a DT B-NP
human JJ I-NP
T NN I-NP
cell NN I-NP
line NN I-NP
. . O

The DT B-NP
effect NN I-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
transcription NN I-NP
factor NN I-NP
which WDT B-NP
is VBZ O
potently RB B-ADVP
and CC O
rapidly RB B-ADVP
activated VBN B-VP
by IN O
an DT B-NP
H2O2 NN I-NP
treatment NN I-NP
of IN B-PP
cells NNS B-NP
from IN B-PP
its PRP$ B-NP
inactive JJ I-NP
cytoplasmic JJ I-NP
form NN I-NP
. . O

N-acetyl-L-cysteine NN B-NP
( ( O
NP NN B-NP
) ) O
COMMA COMMA O
a DT B-NP
well RB I-NP
characterized VBN I-NP
antioxidant NN I-NP
which WDT B-NP
counteracts VBZ B-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
reactive JJ B-NP
oxygen NN I-NP
intermediates NNS I-NP
( ( O
ROI NN B-NP
) ) O
in IN B-PP
living VBG B-NP
cells NNS I-NP
COMMA COMMA O
prevented VBD B-VP
the DT B-NP
activation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
by IN B-PP
H2O2 NN B-NP
. . O

NP NN B-NP
and CC O
other JJ B-NP
thiol JJ I-NP
compounds NNS I-NP
also RB B-ADVP
blocked VBD B-VP
the DT B-NP
activation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
by IN B-PP
cycloheximide NN B-NP
COMMA COMMA O
double-stranded JJ B-NP
RNA NN I-NP
COMMA COMMA O
calcium NN B-NP
ionophore NN I-NP
COMMA COMMA O
TNF-alpha NN B-NP
COMMA COMMA O
active JJ B-NP
phorbol NN I-NP
ester NN I-NP
COMMA COMMA O
interleukin-1 NN B-NP
COMMA COMMA O
lipopolysaccharide NN B-NP
and CC O
lectin NN B-NP
. . O

This DT B-NP
suggests VBZ B-VP
that IN B-SBAR
diverse JJ B-NP
agents NNS I-NP
thought VBN B-VP
to TO I-VP
activate VB I-VP
NF-kappa NN B-NP
B NN I-NP
by IN B-PP
distinct JJ B-NP
intracellular JJ I-NP
pathways NNS I-NP
might MD B-VP
all RB I-VP
act VB I-VP
through IN B-PP
a DT B-NP
common JJ I-NP
mechanism NN I-NP
involving VBG B-VP
the DT B-NP
synthesis NN I-NP
of IN B-PP
ROI NN B-NP
. . O

ROI NN B-NP
appear VBP B-VP
to TO I-VP
serve VB I-VP
as IN B-PP
messengers NNS B-NP
mediating VBG B-VP
directly RB B-ADVP
or CC B-ADVP
indirectly RB B-ADVP
the DT B-NP
release NN I-NP
of IN B-PP
the DT B-NP
inhibitory JJ I-NP
subunit NN I-NP
I NN I-NP
kappa NN I-NP
B NN I-NP
from IN B-PP
NF-kappa NN B-NP
B NN I-NP
. . O

HTLV-1 NN B-NP
Tax NN I-NP
induces VBZ B-VP
expression NN B-NP
of IN B-PP
various JJ B-NP
immediate JJ I-NP
early JJ I-NP
serum NN I-NP
responsive JJ I-NP
genes NNS I-NP
. . O

Human JJ B-NP
T-cell NN I-NP
leukemia NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HTLV-1 NN B-NP
) ) O
is VBZ B-VP
an DT B-NP
etiological JJ I-NP
agent NN I-NP
of IN B-PP
adult JJ B-NP
T-cell NN I-NP
leukemia NN I-NP
( ( O
ATL NN B-NP
) ) O
. . O

We PRP B-NP
showed VBD B-VP
here RB B-ADVP
by IN B-PP
mobility-shift NN B-NP
assay NN I-NP
that IN B-SBAR
T-cell NN B-NP
lines NNS I-NP
transformed VBN B-VP
with IN B-PP
the DT B-NP
virus NN I-NP
contained VBD B-VP
high JJ B-NP
levels NNS I-NP
of IN B-PP
AP-1 NN B-NP
activities NNS I-NP
. . O

Consistent JJ B-ADJP
with IN B-PP
this DT B-NP
result NN I-NP
COMMA COMMA O
these DT B-NP
cell NN I-NP
lines NNS I-NP
expressed VBD B-VP
increased VBN B-NP
levels NNS I-NP
of IN B-PP
mRNAs NNS B-NP
encoding VBG B-VP
the DT B-NP
AP-1 NN I-NP
proteins NNS I-NP
COMMA COMMA O
c-Fos NN B-NP
COMMA COMMA O
Fra-1 NN B-NP
COMMA COMMA O
c-Jun NN B-NP
COMMA COMMA O
JunB NN B-NP
COMMA COMMA O
and CC O
JunD NN B-NP
. . O

Previously RB B-ADVP
COMMA COMMA O
transcription NN B-NP
of IN B-PP
the DT B-NP
c-fos NN I-NP
gene NN I-NP
has VBZ B-VP
been VBN I-VP
reported VBN I-VP
to TO I-VP
be VB I-VP
transactivated VBN I-VP
by IN B-PP
the DT B-NP
viral JJ I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
Tax1 NN B-NP
. . O

By IN B-PP
using VBG B-VP
the DT B-NP
human JJ I-NP
T-cell NN I-NP
line NN I-NP
( ( O
JPX-9 NN B-NP
) ) O
COMMA COMMA O
in IN B-PP
which WDT B-NP
expression NN B-NP
of IN B-PP
the DT B-NP
Tax1 NN I-NP
is VBZ B-VP
inducible JJ B-ADJP
COMMA COMMA O
we PRP B-NP
showed VBD B-VP
that IN B-SBAR
expression NN B-NP
of IN B-PP
mRNAs NNS B-NP
for IN B-PP
Fra-1 NN B-NP
COMMA COMMA O
c-Jun NN B-NP
COMMA COMMA O
and CC O
JunD NN B-NP
was VBD B-VP
also RB I-VP
transactivated VBN I-VP
by IN B-PP
Tax1 NN B-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
Tax1 NN B-NP
activated VBD B-VP
expression NN B-NP
of IN B-PP
two CD B-NP
other JJ I-NP
transcription NN I-NP
factors NNS I-NP
having VBG B-VP
zinc NN B-NP
finger NN I-NP
motifs NNS I-NP
COMMA COMMA O
Egr-1 NN B-NP
and CC O
Egr-2 NN B-NP
COMMA COMMA O
in IN B-PP
the DT B-NP
same JJ I-NP
cells NNS I-NP
. . O

The DT B-NP
Tax1-inducible JJ I-NP
transcription NN I-NP
factors NNS I-NP
identified VBN B-VP
here RB B-ADVP
are VBP B-VP
encoded VBN I-VP
by IN B-PP
the DT B-NP
members NNS I-NP
of IN B-PP
immediate JJ B-NP
early JJ I-NP
genes NNS I-NP
under IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
growth NN B-NP
signals NNS I-NP
. . O

Thus RB O
COMMA COMMA O
Tax1 NN B-NP
was VBD B-VP
suggested VBN I-VP
to TO I-VP
replace VB I-VP
growth NN B-NP
signals NNS I-NP
COMMA COMMA O
at IN B-ADVP
least JJS I-ADVP
in IN B-PP
part NN B-NP
COMMA COMMA O
by IN B-PP
this DT B-NP
mechanism NN I-NP
. . O

Contribution NN B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
and CC O
Sp1 NN B-NP
binding NN B-NP
motifs NNS I-NP
to TO B-PP
the DT B-NP
replicative JJ I-NP
capacity NN I-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
: : O
distinct JJ B-NP
patterns NNS I-NP
of IN B-PP
viral JJ B-NP
growth NN I-NP
are VBP B-VP
determined VBN I-VP
by IN B-PP
T-cell NN B-NP
types NNS I-NP
. . O

Starting VBG B-VP
with IN B-PP
a DT B-NP
replication-incompetent JJ I-NP
molecular JJ I-NP
clone NN I-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
COMMA COMMA O
lacking VBG B-VP
all PDT O
the DT O
NF-kappa NN B-NP
B NN I-NP
and CC O
Sp1 NN B-NP
binding NN B-NP
sites NNS I-NP
present JJ B-ADJP
in IN B-PP
the DT B-NP
native JJ I-NP
long JJ B-NP
terminal JJ I-NP
repeat NN I-NP
( ( O
LTR NN B-NP
) ) O
COMMA COMMA O
proviruses NNS B-NP
containing VBG B-VP
reconstructed VBN B-NP
LTRs NNS I-NP
with IN B-PP
individual JJ B-NP
or CC O
combinations NNS B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
and CC O
Sp1 NN B-NP
elements NNS B-NP
were VBD B-VP
generated VBN I-VP
and CC O
evaluated VBN B-VP
for IN B-PP
their PRP$ B-NP
capacity NN I-NP
to TO B-VP
produce VB I-VP
virus NN B-NP
progeny NN I-NP
following VBG B-PP
transfection-cocultivation NN B-NP
. . O

Virus NN B-NP
stocks NNS I-NP
obtained VBN B-VP
from IN B-PP
these DT B-NP
experiments NNS I-NP
exhibited VBD B-VP
a DT B-NP
continuum NN I-NP
of IN B-PP
replicative JJ B-NP
capacities NNS I-NP
in IN B-PP
different JJ B-NP
human JJ I-NP
T-cell NN I-NP
types NNS I-NP
depending VBG B-PP
on IN B-PP
which WDT B-NP
element NN I-NP
( ( I-NP
s NNS I-NP
) ) O
was VBD B-VP
present JJ B-ADJP
in IN B-PP
the DT B-NP
LTR NN I-NP
. . O

For IN B-PP
example NN B-NP
COMMA COMMA O
in IN B-PP
experiments NNS B-NP
involving VBG B-VP
proviral JJ B-NP
clones NNS I-NP
with IN B-PP
LTRs NNS B-NP
containing VBG B-VP
one CD B-NP
or CC I-NP
two CD I-NP
NF-kappa NN I-NP
B NN I-NP
elements NNS I-NP
( ( O
and CC O
no DT B-NP
Sp1 NN I-NP
binding NN I-NP
sites NNS I-NP
) ) O
COMMA COMMA O
a DT B-NP
hierarchy NN I-NP
of IN B-PP
cellular JJ B-NP
permissivity NN I-NP
to TO B-PP
virus NN B-NP
replication NN I-NP
( ( O
peripheral JJ B-NP
blood NN I-NP
lymphocytes NNS I-NP
= JJ B-VP
MT4 NN B-NP
greater JJR B-ADJP
than IN B-PP
H9 NN B-NP
greater JJR B-ADJP
than IN B-PP
CEM NN B-NP
greater JJR B-ADJP
than IN B-PP
Jurkat NN B-NP
) ) O
was VBD B-VP
observed VBN I-VP
. . O

Of IN B-PP
note NN B-NP
was VBD B-VP
the DT B-NP
associated VBN I-NP
emergence NN I-NP
of IN B-PP
second-site JJ B-NP
LTR NN I-NP
revertants NNS I-NP
which WDT B-NP
involved VBD B-VP
an DT B-NP
alteration NN I-NP
of IN B-PP
the DT B-NP
TATA NN I-NP
box NN I-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
LTR NN I-NP
possesses VBZ B-VP
functional JJ B-NP
redundancy NN I-NP
which WDT B-NP
ensures VBZ B-VP
virus NN B-NP
replication NN I-NP
in IN B-PP
different JJ B-NP
T-cell NN I-NP
types NNS I-NP
and CC O
is VBZ B-VP
capable JJ B-ADJP
of IN B-PP
changing VBG B-VP
depending VBG B-PP
on IN B-PP
the DT B-NP
particular JJ I-NP
combination NN I-NP
of IN B-PP
transcriptional JJ B-NP
factors NNS I-NP
present JJ B-ADJP
. . O

Enhancement NN B-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
1 CD I-NP
replication NN I-NP
in IN B-PP
monocytes NNS B-NP
by IN B-PP
1COMMA25-dihydroxycholecalciferol NN B-NP
. . O

Human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV NN B-NP
) ) O
expression NN B-NP
and CC O
replication NN B-NP
are VBP B-VP
under IN B-PP
tight JJ B-NP
regulatory JJ I-NP
control NN I-NP
. . O

We PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
1COMMA25-dihydroxycholecalciferol NN B-NP
{ ( O
1COMMA25-(OH)2D3 NN B-NP
} ) O
enhances VBZ B-VP
the DT B-NP
replication NN I-NP
of IN B-PP
monocyte- NN B-NP
and CC O
lymphocyte-tropic JJ B-ADJP
strains NNS B-NP
of IN B-PP
HIV-1 NN B-NP
up IN B-PP
to TO I-PP
10COMMA000-fold RB B-ADVP
in IN B-PP
monocyte NN B-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
peripheral JJ B-NP
blood NN I-NP
monocytes NNS I-NP
COMMA COMMA O
and CC O
unfractionated JJ B-NP
peripheral JJ I-NP
blood NN I-NP
mononuclear JJ I-NP
cells NNS I-NP
. . O

1COMMA25(OH)2D3 NN B-NP
is VBZ B-VP
therefore RB B-ADVP
one CD B-NP
of IN B-PP
the DT B-NP
most RBS I-NP
potent JJ I-NP
regulators NNS I-NP
of IN B-PP
HIV-1 NN B-NP
replication NN I-NP
described VBN B-VP
to TO B-PP
date NN B-NP
. . O

Precursors NNS B-NP
of IN B-PP
1COMMA25(OH)2D3 NN B-NP
enhance VBP B-VP
HIV-1 NN B-NP
replication NN I-NP
in IN B-PP
proportion NN I-PP
to TO I-PP
their PRP$ B-NP
affinity NN I-NP
for IN B-PP
the DT B-NP
1COMMA25(OH)2D3 NN I-NP
intracellular JJ I-NP
receptor NN I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
1COMMA25(OH)2D3 NN B-NP
influences VBZ B-VP
HIV-1 NN B-NP
replication NN I-NP
by IN B-PP
mechanisms NNS B-NP
involving VBG B-VP
this DT B-NP
receptor NN I-NP
. . O

These DT B-NP
studies NNS I-NP
may MD B-VP
have VB I-VP
important JJ B-NP
implications NNS I-NP
for IN B-PP
the DT B-NP
design NN I-NP
of IN B-PP
effective JJ B-NP
therapy NN I-NP
of IN B-PP
HIV-1 NN B-NP
infection NN I-NP
. . O

Inhibition NN B-NP
of IN B-PP
HIV-1 NN B-NP
replication NN I-NP
and CC O
NF-kappa NN B-NP
B NN I-NP
activity NN I-NP
by IN B-PP
cysteine NN B-NP
and CC O
cysteine NN B-NP
derivatives NNS I-NP
. . O

HIV-1 NN B-NP
proviral JJ I-NP
DNA NN I-NP
contains VBZ B-VP
two CD B-NP
binding VBG I-NP
sites NNS I-NP
for IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
NF-kappa NN I-NP
B NN I-NP
. . O

HIV-1-infected JJ B-NP
individuals NNS I-NP
have VBP B-VP
COMMA COMMA O
on IN B-PP
average NN B-NP
COMMA COMMA O
abnormally RB B-NP
high JJ I-NP
levels NNS I-NP
of IN B-PP
tumour NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
( ( O
TNF NN B-NP
alpha NN I-NP
) ) O
and CC O
abnormally RB B-NP
low JJ I-NP
plasma NN I-NP
cysteine NN I-NP
levels NNS I-NP
. . O

We PRP B-NP
therefore RB B-ADVP
investigated VBD B-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
cysteine NN B-NP
and CC O
related JJ B-NP
thiols NNS I-NP
on IN B-PP
HIV-1 NN B-NP
replication NN I-NP
and CC O
NF-kappa NN B-NP
B NN I-NP
expression NN I-NP
. . O

The DT B-NP
experiments NNS I-NP
in IN B-PP
this DT B-NP
report NN I-NP
show VBP B-VP
that IN B-SBAR
cysteine NN B-NP
or CC O
N-acetylcysteine NN B-NP
( ( O
NP NN B-NP
) ) O
raise VBP B-VP
the DT B-NP
intracellular JJ I-NP
glutathione NN I-NP
( ( I-NP
GSH NN I-NP
) ) I-NP
level NN I-NP
and CC O
inhibit VBP B-VP
HIV-1 NN B-NP
replication NN I-NP
in IN B-PP
persistently RB O
infected JJ O
Molt-4 NN B-NP
and CC O
U937 NN B-NP
cells NNS B-NP
. . O

However RB B-ADVP
COMMA COMMA O
inhibition NN B-NP
of IN B-PP
HIV-1 NN B-NP
replication NN I-NP
appears VBZ B-VP
not RB I-VP
to TO I-VP
be VB I-VP
directly RB I-VP
correlated VBN I-VP
with IN B-PP
GSH NN B-NP
levels NNS I-NP
. . O

Cysteine NN B-NP
and CC O
NP NN B-NP
also RB B-ADVP
inhibit VBP B-VP
NF-kappa NN B-NP
B NN I-NP
activity NN I-NP
as IN B-SBAR
determined VBN B-VP
by IN B-PP
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
and CC O
chloramphenicol NN B-NP
acetyl-transferase NN I-NP
( ( O
CAT NN B-NP
) ) O
gene NN B-NP
expression NN I-NP
under IN B-PP
control NN B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
binding NN I-NP
sites NNS I-NP
in IN B-PP
uninfected JJ B-NP
cells NNS I-NP
. . O

This DT B-NP
suggests VBZ B-VP
that IN B-SBAR
the DT B-NP
cysteine NN I-NP
deficiency NN I-NP
in IN B-PP
HIV-1-infected JJ B-NP
individuals NNS I-NP
may MD B-VP
cause VB I-VP
an DT B-NP
over-expression NN I-NP
of IN B-PP
NF-kappa NN B-NP
B-dependent JJ I-NP
genes NNS I-NP
and CC O
enhance VB B-VP
HIV-1 NN B-NP
replication NN I-NP
. . O

NP NN B-NP
may MD B-VP
be VB I-VP
considered VBN I-VP
for IN B-PP
the DT B-NP
treatment NN I-NP
of IN B-PP
HIV-1-infected JJ B-NP
individuals NNS I-NP
. . O

Glucocorticoid NN B-NP
receptors NNS I-NP
in IN B-PP
systemic JJ B-NP
lupus NN I-NP
erythematosus NN I-NP
. . O

Glucocorticosteroids NNS B-NP
remain VBP B-VP
the DT B-NP
major JJ I-NP
treatment NN I-NP
modality NN I-NP
for IN B-PP
systemic JJ B-NP
lupus NN I-NP
erythematosus NN I-NP
( ( O
SLE NN B-NP
) ) O
COMMA COMMA O
but CC O
their PRP$ B-NP
mechanism NN I-NP
of IN B-PP
action NN B-NP
is VBZ B-VP
unclear JJ B-ADJP
. . O

Over IN B-PP
the DT B-NP
past JJ I-NP
decade NN I-NP
it PRP B-NP
has VBZ B-VP
become VBN I-VP
clear JJ B-ADJP
that IN B-SBAR
glucocorticosteroid NN B-NP
receptors NNS I-NP
play VBP B-VP
a DT B-NP
significant JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
mechanism NN I-NP
of IN B-PP
glucocorticosteroid NN B-NP
action NN I-NP
. . O

We PRP B-NP
studied VBD B-VP
glucocorticosteroid NN B-NP
receptor NN I-NP
density NN B-NP
and CC O
affinity NN B-NP
on IN B-PP
peripheral JJ B-NP
blood NN I-NP
mononuclear JJ I-NP
cells NNS I-NP
by IN B-PP
the DT B-NP
glucocorticosteroid NN I-NP
binding NN I-NP
assay NN I-NP
in IN B-PP
33 CD B-NP
patients NNS I-NP
with IN B-PP
SLE NN B-NP
who WP B-NP
had VBD B-VP
taken VBN I-VP
no DT B-NP
glucocorticosteroid NN I-NP
for IN B-PP
the DT B-NP
previous JJ I-NP
6 CD I-NP
months NNS I-NP
and CC B-PP
in IN B-PP
32 CD B-NP
healthy JJ I-NP
controls NNS I-NP
. . O

Patients NNS B-NP
' POS B-NP
disease NN I-NP
activity NN I-NP
was VBD B-VP
measured VBN I-VP
by IN B-PP
the DT B-NP
SLE NN I-NP
Disease NN I-NP
Activity NN I-NP
Index NN I-NP
( ( O
SLEDAI NN B-NP
) ) O
. . O

Glucocorticosteroid NN B-NP
receptors NNS I-NP
on IN B-PP
leukocytes NNS B-NP
of IN B-PP
patients NNS B-NP
with IN B-PP
SLE NN O
were VBD B-VP
significantly RB B-ADJP
higher JJR I-ADJP
than IN B-PP
in IN B-PP
healthy JJ B-NP
controls NNS I-NP
( ( O
4419 CD B-NP
+\/- CC I-NP
306 CD I-NP
vs CC O
3369 CD B-NP
+\/- CC I-NP
196 CD I-NP
COMMA COMMA O
p NN B-NP
less JJR B-ADJP
than IN B-PP
0.005 CD B-NP
) ) O
. . O

The DT B-NP
binding NN I-NP
affinity NN I-NP
was VBD B-VP
not RB O
different JJ B-ADJP
between IN B-PP
patients NNS B-NP
and CC O
controls NNS B-NP
. . O

There EX B-NP
was VBD B-VP
no DT B-NP
correlation NN I-NP
between IN B-PP
glucocorticosteroid NN B-NP
receptor NN I-NP
number NN I-NP
and CC O
SLE NN B-NP
disease NN I-NP
activity NN I-NP
. . O

{ ( O
Changes NNS B-NP
in IN B-PP
leucocytic JJ B-NP
estrogen NN I-NP
receptor NN I-NP
levels NNS I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
gynecomastia NN B-NP
} ) O

The DT B-NP
number NN I-NP
of IN B-PP
estrogen NN B-NP
receptor NN I-NP
( ( O
ER NN B-NP
) ) O
in IN B-PP
human JJ B-NP
peripheral JJ I-NP
leucocytes NNS I-NP
in IN B-PP
13 CD B-NP
men NNS I-NP
with IN B-PP
gynecomastia NNS B-NP
were VBD B-VP
measured VBN I-VP
by IN B-PP
radioligand NN B-NP
binding NN I-NP
method NN I-NP
. . O

The DT B-NP
results NNS I-NP
were VBD B-VP
compared VBN I-VP
with IN B-PP
those DT B-NP
of IN B-PP
13 CD B-NP
sex- NN I-NP
and CC I-NP
age-matched JJ I-NP
healthy JJ I-NP
subjects NNS I-NP
. . O

It PRP B-NP
was VBD B-VP
found VBN I-VP
that IN B-SBAR
the DT B-NP
number NN I-NP
of IN B-PP
ER NN B-NP
in IN B-PP
leucocytes NNS B-NP
was VBD B-VP
significantly RB I-VP
increased VBN I-VP
in IN B-PP
gynecomastia NN B-NP
( ( O
Rs NN B-NP
of IN B-PP
leucocytes NNS B-NP
were VBD B-VP
1054 CD B-NP
+\/- CC I-NP
254 CD I-NP
sites\/cell NN I-NP
) ) O
. . O

It PRP B-NP
suggested VBD B-VP
that IN B-SBAR
increase NN B-NP
of IN B-PP
ER NN B-NP
levels NNS I-NP
play VBP B-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
pathogenesis NN I-NP
of IN B-PP
gynecomastia NN B-NP
. . O

{ ( O
Changes NNS B-NP
in IN B-PP
levels NNS B-NP
of IN B-PP
leucocytic JJ B-NP
estrogen NN I-NP
receptor NN I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
menopausal JJ B-NP
type NN I-NP
II CD I-NP
diabetes NNS I-NP
and CC O
its PRP$ B-NP
significance NN I-NP
} ) O

The DT B-NP
number NN I-NP
of IN B-PP
estrogen NN B-NP
receptors NNS I-NP
( ( O
ER NN B-NP
) ) O
in IN B-PP
human JJ B-NP
peripheral JJ I-NP
leucocytes NNS I-NP
in IN B-PP
12 CD B-NP
women NNS I-NP
with IN B-PP
menopausal JJ B-NP
type NN I-NP
II CD I-NP
diabetes NNS I-NP
was VBD B-VP
measured VBN I-VP
with IN B-PP
radio-ligand JJ B-NP
binding NN I-NP
method NN I-NP
. . O

The DT B-NP
results NNS I-NP
were VBD B-VP
compared VBN I-VP
with IN B-PP
those DT B-NP
of IN B-PP
12 CD B-NP
menopausal JJ I-NP
women NNS I-NP
without IN B-PP
diabetes NNS B-NP
and CC O
12 CD B-NP
normal JJ I-NP
women NNS I-NP
of IN B-PP
childbearing JJ B-NP
age NN I-NP
. . O

It PRP B-NP
was VBD B-VP
found VBN I-VP
that IN B-SBAR
the DT B-NP
number NN I-NP
of IN B-PP
ER NN B-NP
in IN B-PP
the DT B-NP
patients NNS I-NP
was VBD B-VP
significantly RB I-VP
decreased VBN I-VP
. . O

Our PRP$ B-NP
data NNS I-NP
indicate VBP B-VP
that IN B-SBAR
decrease NN B-NP
of IN B-PP
ER NN B-NP
level NN I-NP
in IN B-PP
leukocytes NNS B-NP
may MD B-VP
be VB I-VP
related JJ B-ADJP
to TO B-PP
the DT B-NP
pathogenesis NN I-NP
of IN B-PP
type NN B-NP
II CD I-NP
diabetes NNS I-NP
in IN B-PP
menopausal JJ B-NP
period NN I-NP
. . O

Lymphocyte NN B-NP
glucocorticoid NN I-NP
receptor NN I-NP
binding NN I-NP
during IN B-PP
depression NN B-NP
and CC B-PP
after IN B-PP
clinical JJ B-NP
recovery NN I-NP
. . O

Lymphocyte NN B-NP
glucocorticoid NN I-NP
receptor NN I-NP
binding NN I-NP
parameters NNS I-NP
were VBD B-VP
studied VBN I-VP
in IN B-PP
15 CD B-NP
severely RB I-NP
depressed JJ I-NP
patients NNS I-NP
during IN B-PP
depression NN B-NP
and CC B-PP
after IN B-PP
clinical JJ B-NP
recovery NN I-NP
COMMA COMMA O
and CC O
in IN B-PP
15 CD B-NP
healthy JJ I-NP
controls NNS I-NP
. . O

There EX B-NP
was VBD B-VP
no DT B-NP
difference NN I-NP
in IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
number NN B-NP
or CC O
affinity NN B-NP
between IN B-PP
depressed JJ B-NP
patients NNS I-NP
and CC O
recovered JJ B-NP
or CC I-NP
control NN I-NP
subjects NNS I-NP
. . O

Afternoon NN O
ACTH NN B-NP
and CC O
cortisol NN B-NP
concentrations NNS B-NP
did VBD B-VP
not RB I-VP
differ VB I-VP
significantly RB B-ADVP
between IN B-PP
the DT B-NP
three CD I-NP
groups NNS I-NP
. . O

No DT B-NP
relationship NN I-NP
could MD B-VP
be VB I-VP
established VBN I-VP
between IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
binding NN I-NP
and CC O
antidepressant JJ B-NP
medication NN I-NP
. . O

These DT B-NP
data NNS I-NP
support VBP B-VP
the DT B-NP
view NN I-NP
of IN B-PP
an DT B-NP
impaired JJ I-NP
ligand-induced JJ I-NP
plasticity NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
regulation NN I-NP
rather RB B-CONJP
than IN I-CONJP
the DT B-NP
hypothesis NN I-NP
of IN B-PP
decreased VBN B-NP
glucocorticoid NN I-NP
receptor NN I-NP
numbers NNS I-NP
during IN B-PP
depression NN B-NP
. . O

Nuclear JJ B-NP
association NN I-NP
of IN B-PP
a DT B-NP
T-cell NN I-NP
transcription NN I-NP
factor NN I-NP
blocked VBN B-VP
by IN B-PP
FK-506 NN B-NP
and CC O
cyclosporin NN B-NP
A NN I-NP
{ ( O
see VB B-VP
comments NNS B-NP
} ) O

Cyclosporin NN B-NP
A NN I-NP
and CC O
FK506 NN B-NP
inhibit VBP B-VP
T- NN O
and CC O
B-cell NN B-ADJP
activation NN B-NP
and CC O
other JJ B-NP
processes NNS I-NP
essential JJ B-ADJP
to TO B-PP
an DT B-NP
effective JJ I-NP
immune JJ I-NP
response NN I-NP
. . O

In IN B-PP
T NN B-NP
lymphocytes NNS I-NP
these DT B-NP
drugs NNS I-NP
disrupt VBP B-VP
an DT B-NP
unknown JJ I-NP
step NN I-NP
in IN B-PP
the DT B-NP
transmission NN I-NP
of IN B-PP
signals NNS B-NP
from IN B-PP
the DT B-NP
T-cell NN I-NP
antigen NN I-NP
receptor NN I-NP
to TO B-PP
cytokine NN B-NP
genes NNS I-NP
that WDT B-NP
coordinate VBP B-VP
the DT B-NP
immune JJ I-NP
response NN I-NP
. . O

The DT B-NP
putative JJ I-NP
intracellular JJ I-NP
receptors NNS I-NP
for IN B-PP
FK506 NN B-NP
and CC O
cyclosporin NN B-NP
are VBP B-VP
cis-trans JJ B-NP
prolyl JJ I-NP
isomerases NNS I-NP
. . O

Binding NN B-NP
of IN B-PP
the DT B-NP
drug NN I-NP
inhibits VBZ B-VP
isomerase NN B-NP
activity NN I-NP
COMMA COMMA O
but CC O
studies NNS B-NP
with IN B-PP
other JJ B-NP
prolyl JJ I-NP
isomerase NN I-NP
inhibitors NNS I-NP
and CC O
analysis NN B-NP
of IN B-PP
cyclosporin-resistant JJ B-NP
mutants NNS I-NP
in IN B-PP
yeast NN B-NP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
effects NNS I-NP
of IN B-PP
the DT B-NP
drug NN I-NP
result VBP B-VP
from IN B-PP
the DT B-NP
formation NN I-NP
of IN B-PP
an DT B-NP
inhibitory JJ I-NP
complex NN I-NP
between IN B-PP
the DT B-NP
drug NN I-NP
and CC O
isomerase NN B-NP
COMMA COMMA B-PP
and CC I-PP
not RB B-PP
from IN I-PP
inhibition NN B-NP
of IN B-PP
isomerase NN B-NP
activity NN I-NP
. . O

A DT B-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
NF-AT NN B-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
early JJ B-NP
T-cell NN I-NP
gene NN I-NP
activation NN I-NP
COMMA COMMA O
seems VBZ B-VP
to TO I-VP
be VB I-VP
a DT B-NP
specific JJ I-NP
target NN I-NP
of IN B-PP
cyclosporin NN B-NP
A NN I-NP
and CC O
FK506 NN B-NP
action NN B-NP
because IN B-SBAR
transcription NN B-NP
directed VBN B-VP
by IN B-PP
this DT B-NP
protein NN I-NP
is VBZ B-VP
blocked VBN I-VP
in IN B-PP
T NN B-NP
cells NNS I-NP
treated VBN B-VP
with IN B-PP
these DT B-NP
drugs NNS I-NP
COMMA COMMA O
with IN B-PP
little JJ B-NP
or CC I-NP
no DT I-NP
effect NN I-NP
on IN B-PP
other JJ B-NP
transcription NN I-NP
factors NNS I-NP
such JJ B-PP
as IN I-PP
AP-1 NN B-NP
and CC O
NF-kappa NN B-NP
B NN I-NP
. . O

Here RB B-ADVP
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
NF-AT NN B-NP
is VBZ B-VP
formed VBN I-VP
when WRB B-ADVP
a DT B-NP
signal NN I-NP
from IN B-PP
the DT B-NP
antigen NN I-NP
receptor NN I-NP
induces VBZ B-VP
a DT B-NP
pre-existing JJ I-NP
cytoplasmic JJ I-NP
subunit NN I-NP
to TO B-VP
translocate VB I-VP
to TO B-PP
the DT B-NP
nucleus NN I-NP
and CC O
combine VB B-VP
with IN B-PP
a DT B-NP
newly RB I-NP
synthesized VBN I-NP
nuclear JJ I-NP
subunit NN I-NP
of IN B-PP
NF-AT NN B-NP
. . O

FK506 NN B-NP
and CC O
cyclosporin NN B-NP
A NN I-NP
block VBP B-VP
translocation NN B-NP
of IN B-PP
the DT B-NP
cytoplasmic JJ I-NP
component NN I-NP
without IN B-PP
affecting VBG B-VP
synthesis NN B-NP
of IN B-PP
the DT B-NP
nuclear JJ I-NP
subunit NN I-NP
. . O

Regulation NN B-NP
of IN B-PP
M-CSF NN B-NP
expression NN I-NP
by IN B-PP
M-CSF NN B-NP
: : O
role NN B-NP
of IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
and CC O
transcription NN B-NP
factor NN I-NP
NF NN I-NP
kappa NN I-NP
B NN I-NP
. . O

Macrophage-colony-stimulating JJ B-NP
factor NN I-NP
( ( O
M-CSF NN B-NP
) ) O
COMMA COMMA O
also RB B-VP
referred VBN I-VP
to TO B-PP
as IN B-PP
CSF-1 NN B-NP
COMMA COMMA O
regulates VBZ B-VP
the DT B-NP
survival NN B-NP
COMMA COMMA O
growth NN B-NP
COMMA COMMA O
differentiation NN B-NP
and CC O
functional JJ B-NP
activity NN I-NP
of IN B-PP
monocytes NNS B-NP
by IN B-PP
binding VBG B-VP
to TO B-PP
a DT B-NP
single JJ I-NP
class NN I-NP
of IN B-PP
high-affinity JJ B-NP
cell NN I-NP
surface NN I-NP
receptors NNS I-NP
COMMA COMMA O
known VBN B-VP
to TO I-VP
be VB I-VP
the DT B-NP
product NN I-NP
of IN B-PP
the DT B-NP
c-fms NN I-NP
protooncogene NN I-NP
. . O

The DT B-NP
detection NN I-NP
of IN B-PP
both CC O
M-CSF NN B-NP
and CC O
c-fms NN B-NP
expression NN B-NP
by IN B-PP
cells NNS B-NP
of IN B-PP
the DT B-NP
monocyte NN I-NP
lineage NN I-NP
has VBZ B-VP
suggested VBN I-VP
that IN B-SBAR
M-CSF NN B-NP
may MD B-VP
act VB I-VP
by IN B-PP
an DT B-NP
autocrine JJ I-NP
mechanism NN I-NP
. . O

Interestingly RB B-ADVP
COMMA COMMA O
it PRP B-NP
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
that IN B-SBAR
M-CSF NN B-NP
can MD B-VP
induce VB I-VP
the DT B-NP
expression NN I-NP
of IN B-PP
its PRP$ B-NP
own JJ I-NP
gene NN I-NP
. . O

Although IN B-SBAR
sensitivity NN B-NP
to TO B-PP
M-CSF NN B-NP
can MD B-VP
be VB I-VP
modulated VBN I-VP
by IN B-PP
regulation NN B-NP
of IN B-PP
receptor NN B-NP
expression NN B-NP
and CC O
function NN B-NP
COMMA COMMA O
M-CSF NN B-NP
responsiveness NN I-NP
is VBZ B-VP
largely RB I-VP
determined VBN I-VP
at IN B-PP
a DT B-NP
postreceptor NN I-NP
level NN I-NP
. . O

To TO B-PP
date NN B-NP
COMMA COMMA O
little JJ B-NP
is VBZ B-VP
known VBN I-VP
about IN B-PP
the DT B-NP
intracellular JJ I-NP
pathway NN I-NP
of IN B-PP
M-CSF NN B-NP
signal NN I-NP
transduction NN I-NP
. . O

We PRP B-NP
have VBP B-VP
therefore RB I-VP
investigated VBN I-VP
the DT B-NP
changes NNS I-NP
in IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( O
PKC NN B-NP
) ) O
activity NN B-NP
upon IN B-PP
exposure NN B-NP
of IN B-PP
monocytes NNS B-NP
to TO B-PP
M-CSF NN B-NP
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
M-CSF NN B-NP
activates VBZ B-VP
and CC O
translocates VBZ B-VP
PKC NN B-NP
. . O

Inhibition NN B-NP
of IN B-PP
PKC NN B-NP
by IN B-PP
the DT B-NP
isoquinoline NN I-NP
derivative JJ I-NP
H7 NN I-NP
abolishes VBZ B-VP
induction NN B-NP
of IN B-PP
M-CSF NN B-NP
by IN B-PP
M-CSF NN B-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
activation NN B-NP
of IN B-PP
PKC NN B-NP
was VBD B-VP
pertussis-toxin-sensitive JJ B-ADJP
and CC O
was VBD B-VP
associated VBN I-VP
with IN B-PP
the DT B-NP
detection NN I-NP
of IN B-PP
an DT B-NP
NF NN I-NP
kappa NN I-NP
B NN I-NP
protein NN I-NP
in IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
of IN B-PP
M-CSF-induced JJ B-NP
blood NN I-NP
monocytes NNS I-NP
but CC B-PP
not RB B-PP
in IN I-PP
monocytes NNS B-NP
exposed VBN B-VP
to TO B-PP
medium NN B-NP
treatment NN I-NP
only RB B-ADVP
. . O

The DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
M-CSF NN B-NP
induction NN I-NP
of IN B-PP
M-CSF NN B-NP
involves VBZ B-VP
G NN B-NP
proteins NNS I-NP
COMMA COMMA O
PKC NN B-NP
and CC O
NF NN B-NP
kappa NN I-NP
B NN I-NP
. . O

NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
by IN B-PP
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
in IN B-PP
the DT B-NP
Jurkat NN I-NP
T NN I-NP
cell NN I-NP
line NN I-NP
is VBZ B-VP
independent JJ B-ADJP
of IN B-PP
protein NN B-NP
kinase NN I-NP
A NN I-NP
COMMA COMMA O
protein NN B-NP
kinase NN I-NP
C NN I-NP
COMMA COMMA O
and CC O
Ca(2+)-regulated JJ B-NP
kinases NNS I-NP
. . O

NF-kappa NN B-NP
B NN I-NP
is VBZ B-VP
a DT B-NP
DNA-binding JJ I-NP
regulatory JJ I-NP
factor NN I-NP
able JJ B-ADJP
to TO B-VP
control VB I-VP
transcription NN B-NP
of IN B-PP
a DT B-NP
number NN I-NP
of IN B-PP
genes NNS B-NP
COMMA COMMA O
including VBG B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV NN B-NP
) ) O
genes NNS B-NP
. . O

In IN B-PP
T NN B-NP
cells NNS I-NP
COMMA COMMA O
NF-kappa NN B-NP
B NN I-NP
is VBZ B-VP
activated VBN I-VP
upon IN B-PP
cellular JJ B-NP
treatment NN I-NP
by IN B-PP
phorbol NN B-NP
esters NNS I-NP
and CC O
the DT B-NP
cytokine NN I-NP
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
( ( O
TNF NN B-NP
alpha NN I-NP
) ) O
. . O

In IN B-PP
the DT B-NP
present JJ I-NP
work NN I-NP
COMMA COMMA O
we PRP B-NP
investigated VBD B-VP
the DT B-NP
molecular JJ I-NP
events NNS I-NP
leading VBG B-VP
to TO B-PP
NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
by IN B-PP
TNF NN B-NP
alpha NN I-NP
in IN B-PP
a DT B-NP
human JJ I-NP
T NN I-NP
cell NN I-NP
line NN I-NP
( ( O
Jurkat NN B-NP
) ) O
and CC O
its PRP$ B-NP
subclone JJ I-NP
JCT6 NN I-NP
COMMA COMMA O
which WDT B-NP
presents VBZ B-VP
a DT B-NP
deficiency NN I-NP
in IN B-PP
the DT B-NP
PKA NN I-NP
transduction NN I-NP
pathway NN I-NP
. . O

We PRP B-NP
found VBD B-VP
that IN B-SBAR
in IN B-PP
both DT B-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
both CC O
phorbol NN B-NP
ester NN I-NP
and CC O
TNF NN B-NP
alpha NN I-NP
were VBD B-VP
able JJ B-ADJP
to TO B-VP
activate VB I-VP
NF-kappa NN B-NP
B NN I-NP
. . O

Phorbol NN B-NP
activation NN I-NP
was VBD B-VP
positively RB I-VP
modulated VBN I-VP
by IN B-PP
Ca2+ NN B-NP
influx NN I-NP
while IN B-SBAR
TNF NN B-NP
alpha NN I-NP
activation NN I-NP
was VBD B-VP
not RB O
. . O

Furthermore RB B-ADVP
COMMA COMMA O
while IN B-SBAR
PMA NN B-NP
activation NN I-NP
was VBD B-VP
inhibited VBN I-VP
by IN B-PP
the DT B-NP
PKC NN I-NP
inhibitor NN I-NP
staurosporin NN I-NP
COMMA COMMA O
the DT B-NP
TNF NN I-NP
alpha NN I-NP
effect NN I-NP
was VBD B-VP
unchanged JJ B-ADJP
. . O

TNF NN B-NP
alpha NN I-NP
did VBD B-VP
not RB I-VP
activate VB I-VP
cAMP NN B-NP
production NN I-NP
and CC O
its PRP$ B-NP
signal NN I-NP
was VBD B-VP
not RB I-VP
modulated VBN I-VP
by IN B-PP
cAMP NN B-NP
activators NNS I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
cAMP NN B-NP
activators NNS I-NP
did VBD B-VP
not RB I-VP
activate VB I-VP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
Jurkat NN B-NP
cells NNS I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
TNF NN B-NP
alpha-induced JJ I-NP
NF-kappa NN I-NP
B NN I-NP
activation NN I-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
mediated VBN I-VP
by IN B-PP
none NN B-NP
of IN B-PP
the DT B-NP
major JJ I-NP
signal-mediating JJ I-NP
kinases NNS I-NP
such JJ B-PP
as IN I-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( O
PKC NN B-NP
) ) O
COMMA COMMA O
protein NN B-NP
kinase NN I-NP
A NN I-NP
COMMA COMMA O
or CC O
Ca(2+)-regulated JJ B-NP
kinases NNS I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
we PRP B-NP
found VBD B-VP
that IN B-SBAR
cytoplasmic JJ B-NP
acidification NN I-NP
facilitated VBD B-VP
NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
by IN B-PP
both CC O
TNF NN B-NP
alpha NN I-NP
and CC O
PKC NN B-NP
COMMA COMMA O
by IN B-PP
a DT B-NP
mechanism NN I-NP
that WDT B-NP
increases VBZ B-VP
NF-kappa NN B-NP
B\/I NN I-NP
kappa NN I-NP
B NN I-NP
dissociation NN I-NP
without IN B-PP
affecting VBG B-VP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
translocation NN I-NP
step NN I-NP
. . O

NF-kappa NN B-NP
B NN I-NP
activity NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
stably RB B-VP
expressing VBG I-VP
the DT B-NP
Tax NN I-NP
protein NN I-NP
of IN B-PP
human JJ B-NP
T NN I-NP
cell NN I-NP
lymphotropic JJ I-NP
virus NN I-NP
type NN I-NP
I CD I-NP
. . O

The DT B-NP
effect NN I-NP
of IN B-PP
constitutive JJ B-NP
Tax NN I-NP
expression NN I-NP
on IN B-PP
the DT B-NP
interaction NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
with IN B-PP
its PRP$ B-NP
recognition NN I-NP
sequence NN I-NP
and CC B-PP
on IN B-PP
NF-kappa NN B-NP
B-dependent JJ I-NP
gene NN I-NP
expression NN I-NP
was VBD B-VP
examined VBN I-VP
in IN B-PP
T NN B-NP
lymphoid JJ I-NP
Jurkat NN I-NP
cell NN I-NP
lines NNS I-NP
( ( O
19D NN B-NP
and CC O
9J NN B-NP
) ) O
stably RB B-VP
transformed VBN I-VP
with IN B-PP
a DT B-NP
Tax NN I-NP
expression NN I-NP
vector NN I-NP
. . O

Tax NN B-NP
expressing NN I-NP
T NN I-NP
cell NN I-NP
lines NNS I-NP
contained VBD B-VP
a DT B-NP
constitutive JJ I-NP
level NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
binding NN I-NP
activity NN I-NP
COMMA COMMA O
detectable JJ B-ADJP
by IN B-PP
mobility NN B-NP
shift NN I-NP
assay NN I-NP
and CC O
uv NN B-NP
cross-linking NN I-NP
using VBG B-VP
a DT B-NP
palindromic JJ I-NP
NF-kappa NN I-NP
B NN I-NP
probe NN I-NP
homologous JJ B-ADJP
to TO B-PP
the DT B-NP
interferon NN I-NP
beta NN I-NP
PRDII NN I-NP
site NN I-NP
. . O

In IN B-PP
Jurkat NN B-NP
and CC O
NC2.10 NN B-NP
induction NN B-NP
with IN B-PP
phorbol NN B-NP
esters NNS I-NP
resulted VBD B-VP
in IN B-PP
the DT B-NP
appearance NN I-NP
of IN B-PP
new JJ B-NP
DNA NN I-NP
binding NN I-NP
proteins NNS I-NP
of IN B-PP
85 CD B-NP
COMMA COMMA I-NP
75 CD I-NP
COMMA COMMA I-NP
and CC I-NP
54 CD I-NP
kDa NN I-NP
COMMA COMMA O
whereas IN O
in IN B-PP
Tax NN B-NP
expressing NN I-NP
cells NNS I-NP
the DT B-NP
85-kDa JJ I-NP
protein NN I-NP
and CC O
a DT B-NP
92-kDa JJ I-NP
DNA NN I-NP
binding NN I-NP
protein NN I-NP
were VBD B-VP
constitutively RB I-VP
induced VBN I-VP
. . O

Expression NN B-NP
of IN B-PP
Tax NN B-NP
protein NN I-NP
in IN B-PP
19D NN B-NP
and CC O
9J NN B-NP
resulted VBD B-VP
in IN B-PP
transcription NN B-NP
of IN B-PP
the DT B-NP
endogenous JJ I-NP
NF-kappa NN I-NP
B-dependent JJ I-NP
granulocyte-macrophage JJ I-NP
colony NN I-NP
stimulating NN I-NP
factor NN I-NP
gene NN I-NP
and CC O
increased VBD B-NP
basal JJ I-NP
level NN I-NP
expression NN I-NP
of IN B-PP
transfected VBN B-NP
NF-kappa NN I-NP
B-regulated JJ I-NP
promoters NNS I-NP
. . O

Nonetheless RB B-ADVP
transcription NN B-NP
of IN B-PP
both CC O
the DT B-NP
endogenous JJ I-NP
and CC O
the DT B-NP
transfected VBN I-NP
gene NN B-NP
was VBD B-VP
inducible JJ B-ADJP
by IN B-PP
PMA NN B-NP
treatment NN I-NP
. . O

Tax NN B-NP
expression NN I-NP
in IN B-PP
Jurkat NN B-NP
T NN I-NP
cells NNS I-NP
may MD B-VP
alter VB I-VP
the DT B-NP
stoichiometry NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
DNA NN I-NP
binding NN I-NP
proteins NNS I-NP
and CC O
thus RB O
change VB B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
NF-kappa NN B-NP
B-regulated JJ I-NP
promoters NNS I-NP
. . O

Regulation NN B-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
in IN B-PP
human JJ B-NP
mononuclear JJ I-NP
cells NNS I-NP
: : O
effects NNS B-NP
of IN B-PP
glucocorticoid NN B-NP
treatment NN I-NP
COMMA COMMA O
Cushing NN B-NP
's POS B-NP
disease NN I-NP
and CC O
ketoconazole NN B-NP
. . O

Glucocorticoid NN B-NP
receptors NNS I-NP
( ( O
GcR NN B-NP
) ) O
were VBD B-VP
determined VBN I-VP
by IN B-PP
a DT B-NP
whole JJ I-NP
cell NN I-NP
assay NN I-NP
in IN B-PP
human JJ B-NP
mononulear JJ I-NP
leukocytes NNS I-NP
( ( O
hMNL NN B-NP
) ) O
from IN B-PP
control NN B-NP
subjects NNS I-NP
COMMA COMMA O
patients NNS B-NP
receiving VBG B-VP
glucocorticoid NN B-NP
therapy NN I-NP
for IN B-PP
systemic JJ B-NP
diseases NNS I-NP
and CC O
Cushing NN B-NP
's POS B-NP
disease NN I-NP
patients NNS B-NP
with IN B-PP
or CC B-PP
without IN B-PP
ketoconazole NN B-NP
therapy NN I-NP
. . O

Prolonged JJ B-NP
corticosteroid NN I-NP
treatment NN I-NP
resulted VBD B-VP
in IN B-PP
down-regulation NN B-NP
of IN B-PP
GcR NN B-NP
COMMA COMMA O
while IN B-SBAR
the DT B-NP
mean NN I-NP
level NN I-NP
of IN B-PP
GcR NN B-NP
in IN B-PP
Cushing NN B-NP
's POS B-NP
disease NN I-NP
was VBD B-VP
normal JJ B-ADJP
. . O

In IN B-PP
this DT B-NP
group NN I-NP
COMMA COMMA O
however RB B-ADVP
COMMA COMMA O
receptor NN B-NP
levels NNS I-NP
and CC O
morning NN B-NP
plasma NN I-NP
cortisol NN I-NP
values NNS I-NP
showed VBD B-VP
a DT B-NP
negative JJ I-NP
correlation NN I-NP
COMMA COMMA O
indicating VBG B-VP
a DT B-NP
subtle JJ I-NP
down-regulatory JJ I-NP
effect NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
GcR NN B-NP
were VBD B-VP
unaltered JJ B-ADJP
after IN B-SBAR
these DT B-NP
patients NNS I-NP
received VBD B-VP
ketoconazole NN B-NP
COMMA COMMA O
in IN B-PP
spite NN I-PP
of IN I-PP
a DT B-NP
marked JJ I-NP
reduction NN I-NP
in IN B-PP
morning NN B-NP
plasma NN I-NP
cortisol NN I-NP
and CC O
urinary JJ B-NP
free JJ I-NP
cortisol NN I-NP
. . O

We PRP B-NP
also RB B-ADVP
observed VBD B-VP
that IN B-SBAR
ketoconazole NN B-NP
was VBD B-VP
a DT B-NP
weak JJ I-NP
competitor NN I-NP
of IN B-PP
GcR NN B-NP
in IN B-PP
intact JJ B-NP
cells NNS I-NP
COMMA COMMA O
although IN B-SBAR
it PRP B-NP
significantly RB B-ADVP
inhibited VBD B-VP
{3H} NN B-NP
dexamethasone NN I-NP
binding NN I-NP
in IN B-PP
cytosolic JJ B-NP
preparations NNS I-NP
from IN B-PP
rat NN B-NP
tissues NNS I-NP
. . O

The DT B-NP
results NNS I-NP
suggested VBD B-VP
that IN B-SBAR
GcR NN B-NP
in IN B-PP
hMNL NN B-NP
are VBP B-VP
down-regulated VBN I-VP
by IN B-PP
synthetic JJ B-NP
steroids NNS I-NP
given VBN B-VP
in FW B-ADVP
vivo FW I-ADVP
COMMA COMMA O
but CC O
they PRP B-NP
showed VBD B-VP
very RB B-NP
mild JJ I-NP
down-regulation NN I-NP
in IN B-PP
hypercortisolemic JJ B-NP
patients NNS I-NP
suffering VBG B-VP
from IN B-PP
Cushing NN B-NP
's POS B-NP
disease NN I-NP
. . O

Finally RB B-ADVP
COMMA COMMA O
we PRP B-NP
did VBD B-VP
not RB I-VP
observed VBN I-VP
either CC O
up-regulation NN B-NP
or CC O
antagonism NN B-NP
of IN B-PP
GcR NN B-NP
by IN B-PP
ketoconazole NN B-NP
treatment NN I-NP
COMMA COMMA O
at IN B-PP
the DT B-NP
time NN I-NP
that IN B-ADVP
cortisol NN B-NP
levels NNS I-NP
of IN B-PP
patients NNS B-NP
with IN B-PP
Cushing NN B-NP
's POS B-NP
disease NN I-NP
were VBD B-VP
reduced VBN I-VP
. . O

This DT B-NP
indicates VBZ B-VP
that IN B-SBAR
the DT B-NP
beneficial JJ I-NP
effects NNS I-NP
of IN B-PP
ketoconazole NN B-NP
in IN B-PP
Cushing NN B-NP
's POS B-NP
disease NN I-NP
are VBP B-VP
due JJ B-PP
to TO B-PP
adrenal JJ B-NP
cortisol NN I-NP
suppression NN I-NP
and CC B-PP
not RB B-PP
to TO I-PP
interaction NN B-NP
with IN B-PP
GcR NN B-NP
of IN B-PP
target NN B-NP
cells NNS I-NP
COMMA COMMA O
and CC O
that IN B-SBAR
the DT B-NP
process NN I-NP
of IN B-PP
GcR NN B-NP
regulation NN I-NP
in IN B-PP
hMNL NN B-NP
is VBZ B-VP
a DT B-NP
complex JJ I-NP
phenomenon NN I-NP
awaiting VBG B-VP
further RBR B-NP
elucidation NN I-NP
. . O

Glucocorticoid NN B-NP
receptors NNS I-NP
in IN B-PP
lymphocytes NNS B-NP
in IN B-PP
anorexia NN B-NP
nervosa NN I-NP
. . O

OBJECTIVE NN B-NP
: : O
The DT B-NP
aim NN I-NP
was VBD B-VP
to TO B-VP
explore VB I-VP
the DT B-NP
down-regulation NN I-NP
of IN B-PP
the DT B-NP
glucocorticoid NN I-NP
receptors NNS I-NP
during IN B-PP
hypercortisolaemia NN B-NP
in IN B-PP
anorexia NN B-NP
nervosa NN I-NP
. . O

DESIGN NN B-NP
: : O
Urine NN B-NP
and CC O
plasma NN B-NP
samples NNS B-NP
were VBD B-VP
obtained VBN I-VP
for IN B-PP
cortisol NN B-NP
determination NN I-NP
and CC O
blood NN B-NP
lymphocytes NNS I-NP
were VBD B-VP
isolated VBN I-VP
for IN B-PP
receptor NN B-NP
binding NN I-NP
studies NNS I-NP
. . O

PATIENTS NNS B-NP
: : O
Sixteen CD B-NP
anorexic JJ I-NP
patients NNS I-NP
COMMA COMMA O
aged JJ B-ADJP
16-27 CD B-NP
years NNS I-NP
COMMA COMMA O
with IN B-PP
a DT B-NP
mean NN I-NP
+\/- CC I-NP
SEM NN I-NP
body NN I-NP
mass NN I-NP
index NN I-NP
of IN B-PP
14.2 CD B-NP
+\/- CC I-NP
2.0 CD I-NP
( ( O
ranging VBG B-VP
from IN B-PP
11.1 CD B-NP
to TO B-PP
17.4 CD B-NP
) ) O
COMMA COMMA O
and CC O
15 CD B-NP
normal JJ I-NP
women NNS I-NP
were VBD B-VP
studied VBN I-VP
. . O

Six CD B-NP
patients NNS I-NP
were VBD B-VP
reinvestigated VBN I-VP
after IN B-PP
a DT B-NP
significant JJ I-NP
weight NN I-NP
gain NN I-NP
. . O

MEASUREMENTS NNS B-NP
: : O
The DT B-NP
binding NN B-NP
capacity NN B-NP
and CC O
affinity NN B-NP
of IN B-PP
the DT B-NP
glucocorticoid NN I-NP
receptors NNS I-NP
were VBD B-VP
measured VBN I-VP
with IN B-PP
dexamethasone NN B-NP
as IN B-PP
ligand NN B-NP
on IN B-PP
lymphocytes NNS B-NP
. . O

RESULTS NNS B-NP
: : O
In IN B-PP
patients NNS B-NP
COMMA COMMA O
both DT B-NP
total JJ I-NP
and CC I-NP
free JJ I-NP
plasma NN I-NP
cortisol NN I-NP
concentrations NNS I-NP
were VBD B-VP
higher JJR B-ADJP
than IN B-PP
in IN B-PP
the DT B-NP
normal JJ I-NP
women NNS I-NP
COMMA COMMA O
as IN B-SBAR
was VBD O
their PRP$ B-NP
urinary JJ I-NP
free JJ I-NP
cortisol NN I-NP
; : O
the DT B-NP
number NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
per IN B-PP
cell NN B-NP
( ( O
Ro NN B-NP
) ) O
and CC O
the DT B-NP
binding NN I-NP
affinity NN I-NP
( ( O
Kd NN B-NP
) ) O
for IN B-PP
dexamethasone NN B-NP
were VBD B-VP
COMMA COMMA O
however RB B-ADVP
COMMA COMMA O
not RB B-ADJP
significantly RB I-ADJP
different JJ I-ADJP
( ( O
Ro NN B-NP
: : O
7687 CD B-NP
+\/- CC I-NP
1750 CD I-NP
vs CC I-NP
7347 CD I-NP
+\/- CC I-NP
1285 CD I-NP
sites\/cell NN I-NP
; : O
Kd NN B-NP
: : O
7.7 CD B-NP
+\/- CC I-NP
2.4 CD I-NP
vs CC I-NP
7.4 CD I-NP
+\/- CC I-NP
1.7 CD I-NP
nM NN I-NP
at IN B-PP
24 CD B-NP
degrees NNS I-NP
C NN I-NP
) ) O
. . O

After IN B-PP
weight NN B-NP
gain NN I-NP
( ( O
14 CD B-NP
+\/- CC I-NP
2 CD I-NP
to TO I-NP
16 CD I-NP
+\/- CC I-NP
2 CD I-NP
kg\/m2 NN I-NP
) ) O
COMMA COMMA O
receptor NN B-NP
numbers NNS I-NP
were VBD B-VP
8421 CD B-NP
+\/- CC I-NP
2126 CD I-NP
( ( O
pre JJ O
) ) O
and CC O
9011 CD B-NP
+\/- CC I-NP
500 CD I-NP
( ( O
post JJ O
) ) O
sites\/cell NN B-NP
COMMA COMMA O
which WDT B-NP
are VBP B-VP
not RB O
significantly RB B-ADJP
different JJ I-ADJP
( ( O
P NN B-NP
greater JJR B-ADJP
than IN B-PP
0.2 CD B-NP
) ) O
; : O
the DT B-NP
Kd NN I-NP
was VBD B-VP
unchanged JJ B-ADJP
( ( O
9.3 CD B-NP
+\/- CC I-NP
2.6 CD I-NP
vs CC I-NP
9.2 CD I-NP
+\/- CC I-NP
2.4 CD I-NP
nM NN I-NP
) ) O
. . O

CONCLUSIONS NNS B-NP
Hypercortisolaemia NN B-NP
does VBZ B-VP
not RB I-VP
down-regulate VB I-VP
the DT B-NP
lymphocyte NN I-NP
glucocorticoid NN I-NP
receptors NNS I-NP
in IN B-PP
anorexia NN B-NP
nervosa NN I-NP
and CC O
a DT B-NP
post-receptor JJ I-NP
defect NN I-NP
might MD B-VP
be VB I-VP
involved VBN I-VP
in IN B-PP
peripheral JJ B-NP
tissue NN I-NP
resistance NN I-NP
to TO B-PP
the DT B-NP
effects NNS I-NP
of IN B-PP
glucocorticoid NN B-NP
hormones NNS I-NP
in IN B-PP
undernutrition NN B-NP
. . O

Tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
mRNA NN I-NP
accumulation NN I-NP
in IN B-PP
human JJ B-NP
myelomonocytic JJ I-NP
cell NN I-NP
lines NNS I-NP
. . O

Role NN B-NP
of IN B-PP
transcriptional JJ B-NP
regulation NN I-NP
by IN B-PP
DNA NN B-NP
sequence NN I-NP
motifs NNS I-NP
and CC O
mRNA NN B-NP
stabilization NN I-NP
. . O

The DT B-NP
cytokine NN I-NP
TNF NN I-NP
mediates VBZ B-VP
many JJ B-NP
of IN B-PP
the DT B-NP
pathologic JJ I-NP
signs NNS I-NP
of IN B-PP
cachexia NN B-NP
COMMA COMMA O
inflammation NN B-NP
COMMA COMMA O
and CC O
sepsis NN B-NP
. . O

The DT B-NP
current JJ I-NP
work NN I-NP
describes VBZ B-VP
the DT B-NP
regulation NN I-NP
of IN B-PP
TNF NN B-NP
in IN B-PP
human JJ B-NP
myelomonocytic JJ I-NP
cell NN I-NP
lines NNS I-NP
after IN B-PP
PMA NN B-NP
stimulation NN I-NP
. . O

The DT B-NP
cell NN I-NP
lines NNS I-NP
exhibit VBP B-VP
a DT B-NP
low JJ I-NP
level NN I-NP
of IN B-PP
constitutive JJ B-NP
TNF NN I-NP
mRNA NN I-NP
expression NN I-NP
. . O

Within IN B-PP
2 CD B-NP
to TO I-NP
4 CD I-NP
h NN I-NP
of IN B-PP
PMA NN B-NP
exposure NN I-NP
COMMA COMMA O
steady JJ B-NP
state NN I-NP
levels NNS I-NP
of IN B-PP
TNF NN B-NP
mRNA NN I-NP
are VBP B-VP
markedly RB I-VP
elevated JJ I-VP
in IN B-PP
all DT B-NP
myelomonocytic JJ I-NP
cell NN I-NP
lines NNS I-NP
studied VBN B-VP
. . O

This DT B-NP
rise NN I-NP
is VBZ B-VP
due JJ B-PP
to TO B-PP
increased VBN B-NP
mRNA NN I-NP
stability NN I-NP
COMMA COMMA O
which WDT B-NP
increased VBD B-VP
by IN B-PP
almost RB B-NP
twofold RB I-NP
COMMA COMMA B-PP
and CC I-PP
to TO B-PP
an DT B-NP
overall JJ I-NP
increase NN I-NP
in IN B-PP
transcription NN B-NP
COMMA COMMA O
which WDT B-NP
rises VBZ B-VP
by IN B-PP
more JJR B-NP
than IN I-NP
sixfold RB I-NP
. . O

At IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
the DT B-NP
genomic JJ I-NP
TNF NN I-NP
gene NN I-NP
COMMA COMMA O
a DT B-NP
DNase NN I-NP
I CD I-NP
hypersensitive JJ I-NP
site NN I-NP
is VBZ B-VP
detected VBN I-VP
within IN B-PP
the DT B-NP
TNF NN I-NP
promoter NN I-NP
between IN B-PP
-200 CD B-NP
to TO I-NP
-100 CD I-NP
bp NN I-NP
relative JJ B-PP
to TO I-PP
the DT B-NP
transcription NN I-NP
initiation NN I-NP
site NN I-NP
. . O

Although IN B-SBAR
absent JJ B-ADJP
in IN B-PP
nonexpressing VBG B-NP
erythroleukemia NN I-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
the DT B-NP
DNase NN I-NP
I CD I-NP
site NN I-NP
is VBZ B-VP
present JJ B-ADJP
in IN B-PP
uninduced JJ B-NP
myelomonocytic JJ I-NP
cell NN I-NP
lines NNS I-NP
and CC O
is VBZ B-VP
not RB I-VP
changed VBN I-VP
after IN B-PP
PMA NN B-NP
induction NN I-NP
. . O

The DT B-NP
PMA NN I-NP
induction NN I-NP
of IN B-PP
c-fos NN B-NP
mRNA NN I-NP
correlated VBD B-VP
well RB B-ADVP
with IN B-PP
TNF NN B-NP
gene NN I-NP
induction NN I-NP
; : O
expression NN B-NP
of IN B-PP
genes NNS B-NP
encoding VBG B-VP
other JJ B-NP
proteins NNS I-NP
in IN B-PP
the DT B-NP
AP-1 NN I-NP
complex NN I-NP
( ( O
junB NN B-NP
and CC O
junD NN B-NP
) ) O
were VBD B-VP
also RB I-VP
induced VBN I-VP
by IN B-PP
PMA NN B-NP
. . O

The DT B-NP
nuclear JJ I-NP
extracts NNS I-NP
from IN B-PP
resting VBG B-NP
and CC I-NP
induced VBN I-NP
ML-1 NN I-NP
cells NNS I-NP
contain VBP B-VP
proteins NNS B-NP
binding VBG B-VP
specifically RB B-ADVP
to TO B-PP
the DT B-NP
AP-1 NN B-NP
COMMA COMMA O
AP-2 NN B-NP
COMMA COMMA O
and CC O
NF NN B-NP
kappa NN I-NP
B NN I-NP
sequence NN I-NP
located JJ B-ADJP
within IN B-PP
the DT B-NP
TNF NN I-NP
promoter NN I-NP
. . O

PMA NN B-NP
induction NN I-NP
increases VBZ B-VP
the DT B-NP
level NN I-NP
of IN B-PP
a DT B-NP
number NN I-NP
of IN B-PP
specific JJ B-NP
binding VBG I-NP
complexes NNS I-NP
relative JJ B-PP
to TO I-PP
the DT B-NP
resting VBG I-NP
cells NNS I-NP
. . O

The DT B-NP
regulatory JJ I-NP
mechanisms NNS I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
and CC I-NP
murine JJ I-NP
TNF NN I-NP
genes NNS I-NP
are VBP B-VP
discussed VBN I-VP
. . O

USF-related JJ B-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
HIV-TF1 NN B-NP
COMMA COMMA O
stimulates VBZ B-VP
transcription NN B-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus-1 NN I-NP
. . O

The DT B-NP
transcription NN I-NP
factor NN I-NP
HIV-TF1 NN I-NP
COMMA COMMA O
which WDT B-NP
binds VBZ B-VP
to TO B-PP
a DT B-NP
region NN I-NP
about IN B-NP
60 CD I-NP
bp NN I-NP
upstream JJ B-ADJP
from IN B-PP
the DT B-NP
enhancer NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus-1 NN I-NP
( ( O
HIV-1 NN B-NP
) ) O
COMMA COMMA O
was VBD B-VP
purified VBN I-VP
from IN B-PP
human JJ B-NP
B NN I-NP
cells NNS I-NP
. . O

HIV-TF1 NN B-NP
had VBD B-VP
a DT B-NP
molecular JJ I-NP
weight NN I-NP
of IN B-PP
39COMMA000 CD B-NP
. . O

Binding NN B-NP
of IN B-PP
HIV-TF1 NN B-NP
to TO B-PP
the DT B-NP
HIV NN I-NP
long JJ B-NP
terminal JJ I-NP
repeat NN I-NP
( ( O
LTR NN B-NP
) ) O
activated VBD B-VP
transcription NN B-NP
from IN B-PP
the DT B-NP
HIV NN I-NP
promoter NN I-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

The DT B-NP
HIV-TF1-binding JJ I-NP
site NN I-NP
in IN B-PP
HIV NN B-NP
LTR NN I-NP
was VBD B-VP
similar JJ B-ADJP
to TO B-PP
the DT B-NP
site NN I-NP
recognized VBN B-VP
by IN B-PP
upstream JJ B-NP
stimulatory JJ I-NP
factor NN I-NP
( ( O
USF NN B-NP
) ) O
in IN B-PP
the DT B-NP
adenovirus NN I-NP
major JJ I-NP
late JJ I-NP
promoter NN I-NP
. . O

DNA-binding JJ B-NP
properties NNS I-NP
of IN B-PP
HIV-TF1 NN B-NP
suggested VBD B-VP
that IN B-SBAR
HIV-TF1 NN B-NP
might MD B-VP
be VB I-VP
identical JJ B-ADJP
or CC O
related JJ B-ADJP
to TO B-PP
USF NN B-NP
. . O

Interestingly RB B-ADVP
COMMA COMMA O
treatment NN B-NP
of IN B-PP
purified VBN B-NP
HIV-TF1 NN I-NP
by IN B-PP
phosphatase NN B-NP
greatly RB B-ADVP
reduced VBD B-VP
its PRP$ B-NP
DNA-binding JJ I-NP
activity NN I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
phosphorylation NN B-NP
of IN B-PP
HIV-TF1 NN B-NP
was VBD B-VP
essential JJ B-ADJP
for IN B-PP
DNA NN B-NP
binding NN I-NP
. . O

The DT B-NP
disruption NN I-NP
of IN B-PP
HIV-TF1-binding JJ B-NP
site NN I-NP
induced VBD B-VP
a DT B-NP
60 CD B-NP
% NN I-NP
decrease NN B-NP
in IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
transcription NN B-NP
from IN B-PP
the DT B-NP
HIV NN I-NP
promoter NN I-NP
in FW B-ADVP
vivo FW I-ADVP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
HIV-TF1 NN B-NP
is VBZ B-VP
involved VBN I-VP
in IN B-PP
transcriptional JJ B-NP
regulation NN I-NP
of IN B-PP
HIV-1 NN B-NP
. . O

The DT B-NP
effect NN I-NP
of IN B-PP
toremifene NN B-NP
therapy NN I-NP
on IN B-PP
serum NN B-NP
immunoglobulin NN I-NP
levels NNS I-NP
in IN B-PP
breast NN B-NP
cancer NN I-NP
. . O

Estrogens NNS B-NP
and CC O
anti-estrogens NNS B-NP
enhance VBP B-VP
the DT B-NP
number NN I-NP
of IN B-PP
immunoglobulin NN B-NP
( ( I-NP
Ig NN I-NP
) ) I-NP
-secreting NN I-NP
cells NNS I-NP
in IN B-PP
pokeweed NN B-NP
mitogen NN I-NP
( ( I-NP
PWM NN I-NP
) ) I-NP
-stimulated JJ I-NP
lymphocyte NN I-NP
cultures NNS I-NP
. . O

Lymphocytes NNS B-NP
from IN B-PP
patients NNS B-NP
who WP B-NP
have VBP B-VP
received VBN I-VP
anti-estrogen NN B-NP
therapy NN I-NP
show VBP B-VP
similar JJ B-NP
enhancement NN I-NP
of IN B-PP
Ig-secreting JJ B-NP
cells NNS I-NP
after IN B-PP
PWM NN B-NP
stimulation NN I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
the DT B-NP
effect NN I-NP
of IN B-PP
anti-estrogen NN B-NP
( ( I-NP
toremifene NN I-NP
) ) I-NP
therapy NN I-NP
on IN B-PP
serum NN B-NP
immunoglobulin NN I-NP
( ( O
IgA NN B-NP
COMMA COMMA O
IgM NN B-NP
COMMA COMMA O
IgG NN B-NP
) ) O
levels NNS B-NP
in IN B-PP
breast NN B-NP
cancer NN I-NP
patients NNS I-NP
was VBD B-VP
investigated VBN I-VP
. . O

Serum NN B-NP
Ig NN I-NP
levels NNS I-NP
were VBD B-VP
followed VBN I-VP
up RB B-NP
to TO I-NP
two CD I-NP
years NNS I-NP
after IN B-PP
or CC B-PP
during IN B-PP
the DT B-NP
therapy NN I-NP
. . O

An DT B-NP
unexpected JJ I-NP
finding NN I-NP
was VBD B-VP
that IN B-SBAR
the DT B-NP
Ig NN I-NP
levels NNS I-NP
decreased VBD B-VP
during IN B-PP
the DT B-NP
follow-up JJ I-NP
period NN I-NP
. . O

This DT B-NP
decrease NN I-NP
was VBD B-VP
seen VBN I-VP
in IN B-PP
patients NNS B-NP
who WP B-NP
responded VBD B-VP
to TO B-PP
the DT B-NP
therapy NN I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
in IN B-PP
those DT B-NP
who WP B-NP
did VBD B-VP
not RB O
. . O

HIV1 NN B-NP
infection NN I-NP
of IN B-PP
human JJ B-NP
monocytes NNS B-NP
and CC O
macrophages NNS B-NP
promotes VBZ B-VP
induction NN B-NP
or CC O
translocation NN B-NP
of IN B-PP
NF-KB-related JJ B-NP
factors NNS I-NP
. . O

In IN B-PP
1991 CD B-NP
COMMA COMMA O
we PRP B-NP
demonstrated VBD B-VP
COMMA COMMA O
using VBG B-VP
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
COMMA COMMA O
that IN B-SBAR
3 CD B-NP
different JJ I-NP
factors NNS I-NP
( ( O
termed VBN B-VP
B1 NN B-NP
COMMA COMMA O
B2 NN B-NP
and CC O
B3 NN B-NP
) ) O
with IN B-PP
affinity NN B-NP
for IN B-PP
the DT B-NP
KB-enhancer JJ I-NP
target NN I-NP
sequence NN I-NP
were VBD B-VP
specifically RB I-VP
detected VBN I-VP
in IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
from IN B-PP
HIV1-infected JJ B-NP
monocytes NNS B-NP
and CC O
macrophages NNS B-NP
. . O

The DT B-NP
B2 NN I-NP
factor NN I-NP
was VBD B-VP
induced VBN I-VP
in IN B-PP
the DT B-NP
nuclei NNS I-NP
of IN B-PP
these DT B-NP
cells NNS I-NP
only RB B-PP
upon IN I-PP
HIV1 NN B-NP
infection NN I-NP
. . O

The DT B-NP
B3 NN I-NP
factor NN I-NP
was VBD B-VP
only RB B-ADJP
slightly RB I-ADJP
evident JJ I-ADJP
in IN B-PP
nuclei NNS B-NP
of IN B-PP
uninfected JJ B-NP
cells NNS I-NP
but CC O
was VBD B-VP
readily RB B-ADJP
detectable JJ I-ADJP
in IN B-PP
nuclei NNS B-NP
of IN B-PP
infected JJ B-NP
monocytes NNS I-NP
. . O

Its PRP$ B-NP
expression NN I-NP
remained VBD B-VP
very RB B-ADJP
low JJ I-ADJP
in IN B-PP
nuclei NNS B-NP
of IN B-PP
HIV1-infected JJ B-NP
macrophages NNS I-NP
. . O

In IN B-PP
this DT B-NP
paper NN I-NP
COMMA COMMA O
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
the DT B-NP
B2 NN I-NP
factor NN I-NP
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
the DT B-NP
cytosol NN I-NP
of IN B-PP
monocytes NNS B-NP
and CC O
macrophages NNS B-NP
as IN B-PP
a DT B-NP
DNA-binding JJ I-NP
protein NN I-NP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
it PRP B-NP
is VBZ B-VP
not RB I-VP
associated VBN I-VP
with IN B-PP
an DT B-NP
inhibitor NN I-NP
( ( O
IKB NN B-NP
) ) O
. . O

This DT B-NP
factor NN I-NP
remained VBD B-VP
clustered VBN B-ADJP
in IN B-PP
the DT B-NP
cytosol NN I-NP
and CC O
was VBD B-VP
translocated VBN I-VP
to TO B-PP
the DT B-NP
nuclei NNS I-NP
only RB B-PP
after IN I-PP
HIV1 NN B-NP
infection NN I-NP
. . O

The DT B-NP
B3 NN I-NP
factor NN I-NP
is VBZ B-VP
detected VBN I-VP
in IN B-PP
the DT B-NP
cytosol NN I-NP
only RB O
when WRB B-ADVP
cells NNS B-NP
are VBP B-VP
HIV1-infected JJ B-ADJP
. . O

The DT B-NP
role NN I-NP
of IN B-PP
HIV1 NN B-NP
infection NN I-NP
in IN B-PP
the DT B-NP
expression NN I-NP
and CC O
the DT B-NP
translocation NN I-NP
of IN B-PP
these DT B-NP
factors NNS I-NP
is VBZ B-VP
discussed VBN I-VP
. . O

Induction NN B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
during IN B-PP
monocyte NN B-NP
differentiation NN I-NP
is VBZ B-VP
associated VBN I-VP
with IN B-PP
activation NN B-NP
of IN B-PP
HIV-gene JJ B-NP
expression NN I-NP
. . O

Cells NNS B-NP
of IN B-PP
the DT B-NP
monocyte-macrophage JJ I-NP
lineage NN I-NP
are VBP B-VP
important JJ B-NP
targets NNS I-NP
of IN B-PP
HIV NN B-NP
infection NN I-NP
. . O

We PRP B-NP
report VBP B-VP
here RB B-ADVP
that IN B-SBAR
the DT B-NP
phenotypic JJ I-NP
differentiation NN I-NP
of IN B-PP
monocyte NN B-NP
cell NN I-NP
lines NNS I-NP
induced VBN B-VP
by IN B-PP
phorbol NN B-NP
esters NNS I-NP
or CC O
tumour NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
( ( O
TNF NN B-NP
alpha NN I-NP
) ) O
is VBZ B-VP
associated VBN I-VP
with IN B-PP
expression NN B-NP
of IN B-PP
nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
( ( O
NF-kappa NN B-NP
B NN I-NP
) ) O
. . O

In IN B-PP
parallel NN I-PP
with IN I-PP
such JJ B-NP
differentiation NN I-NP
COMMA COMMA O
HIV NN B-NP
transcription NN I-NP
COMMA COMMA O
monitored VBN B-VP
using VBG B-VP
an DT B-NP
HIV NN I-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
reporter NN I-NP
gene NN I-NP
construct NN I-NP
COMMA COMMA O
is VBZ B-VP
activated VBN I-VP
in IN B-PP
such JJ B-NP
cells NNS I-NP
under IN B-PP
the DT B-NP
influence NN I-NP
of IN B-PP
enhanced VBN B-NP
NF-kappa NN I-NP
B NN I-NP
expression NN I-NP
. . O

Also RB B-ADVP
COMMA COMMA O
in IN B-PP
a DT B-NP
promonocyte JJ I-NP
cell NN I-NP
line NN I-NP
chronically RB B-ADJP
infected VBN I-ADJP
with IN B-PP
HIV NN B-NP
COMMA COMMA O
NF-kappa NN B-NP
B NN I-NP
expression NN I-NP
and CC O
HIV NN B-NP
transcription NN I-NP
were VBD B-VP
enhanced VBN I-VP
on IN B-PP
stimulation NN B-NP
with IN B-PP
phorbol NN B-NP
ester NN I-NP
or CC O
TNF NN B-NP
alpha NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
stimulation NN B-NP
of IN B-PP
monocyte NN B-NP
cell NN I-NP
lines NNS I-NP
by IN B-PP
phorbol NN B-NP
esters NNS I-NP
or CC O
TNF NN B-NP
alpha NN I-NP
induces VBZ B-VP
cell NN B-NP
differentiation NN I-NP
and CC O
activates VBZ B-VP
HIV NN B-NP
transcription NN I-NP
. . O

Such PDT B-NP
a DT I-NP
process NN I-NP
may MD B-VP
have VB I-VP
fundamental JJ B-NP
implications NNS I-NP
in IN B-PP
AIDS NN B-NP
pathogenesis NN I-NP
in FW B-ADVP
vivo FW I-ADVP
and CC O
may MD B-VP
be VB I-VP
important JJ B-ADJP
in IN B-PP
disease NN B-NP
progression NN I-NP
induced VBN B-VP
by IN B-PP
opportunistic JJ B-NP
infections NNS I-NP
directly RB B-ADVP
or CC O
indirectly RB B-ADVP
involving VBG B-VP
macrophages NNS B-NP
. . O

A DT B-NP
nuclear JJ I-NP
factor NN I-NP
NF-GM2 NN I-NP
that WDT B-NP
interacts VBZ B-VP
with IN B-PP
a DT B-NP
regulatory JJ I-NP
region NN I-NP
of IN B-PP
the DT B-NP
GM-CSF NN I-NP
gene NN I-NP
essential JJ B-ADJP
for IN B-PP
its PRP$ B-NP
induction NN I-NP
in IN B-PP
responses NNS I-PP
to TO I-PP
T-cell NN B-NP
activation NN I-NP
: : O
purification NN B-NP
from IN B-PP
human JJ B-NP
T-cell NN I-NP
leukemia NN I-NP
line NN I-NP
Jurkat NN I-NP
cells NNS I-NP
and CC O
similarity NN B-NP
to TO B-PP
NF-kappa NN B-NP
B NN I-NP
. . O

Activation NN B-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
by IN B-PP
antigen NN B-NP
COMMA COMMA O
lectin NN B-NP
COMMA COMMA O
or CC O
a DT B-NP
combination NN I-NP
of IN B-PP
phorbol-12-myristate NN B-NP
acetate NN I-NP
( ( O
PMA NN B-NP
) ) O
and CC O
calcium NN B-NP
ionophore NN I-NP
( ( O
A23187 NN B-NP
) ) O
leads VBZ B-VP
to TO B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
genes NNS B-NP
for IN B-PP
a DT B-NP
set NN I-NP
of IN B-PP
lymphokines NNS B-NP
COMMA COMMA O
including VBG B-PP
granulocyte-macrophage JJ B-NP
colony-stimulating JJ I-NP
factor NN I-NP
( ( O
GM-CSF NN B-NP
) ) O
. . O

We PRP B-NP
demonstrated VBD B-VP
in IN B-PP
earlier JJR B-NP
studies NNS I-NP
that IN B-SBAR
the DT B-NP
upstream JJ I-NP
region NN I-NP
of IN B-PP
the DT B-NP
mouse NN I-NP
GM-CSF NN I-NP
promoter NN I-NP
at IN B-PP
positions NNS B-NP
between IN B-PP
-95 CD B-NP
and CC O
-73 CD B-NP
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
transcriptional JJ B-NP
activation NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
PMA\/A23187 NN B-NP
. . O

This DT B-NP
region NN I-NP
contains VBZ B-VP
two CD B-NP
DNA-binding JJ I-NP
motifs NNS I-NP
COMMA COMMA O
GM2 NN B-NP
and CC O
GC-box NN B-NP
. . O

The DT B-NP
GM2 NN I-NP
sequence NN I-NP
( ( O
GGTAGTTCCC NN B-NP
) ) O
is VBZ B-VP
recognized VBN I-VP
by IN B-PP
an DT B-NP
inducible JJ I-NP
factor NN I-NP
NF-GM2 NN I-NP
; : O
the DT B-NP
other JJ I-NP
( ( O
CCGCCC NN B-NP
) ) O
by IN B-PP
constitutive JJ B-NP
factors NNS I-NP
A1 NN B-NP
COMMA COMMA O
A2 NN B-NP
COMMA COMMA O
and CC O
B NN B-NP
. . O

To TO B-VP
elucidate VB I-VP
the DT B-NP
mechanism NN I-NP
of IN B-PP
GM-CSF NN B-NP
gene NN I-NP
activation NN I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
purified VBN I-VP
the DT B-NP
inducible JJ I-NP
factor NN I-NP
NF-GM2 NN I-NP
from IN B-PP
the DT B-NP
nuclear JJ I-NP
extract NN I-NP
of IN B-PP
stimulated VBN B-NP
Jurkat NN I-NP
cells NNS I-NP
on IN B-PP
the DT I-PP
basis NN I-PP
of IN I-PP
specific JJ B-NP
DNA-binding JJ I-NP
activity NN I-NP
. . O

The DT B-NP
purified VBN I-NP
NF-GM2 NN I-NP
consists VBZ B-VP
of IN B-PP
50 CD B-NP
( ( O
p50 NN B-NP
) ) O
and CC O
65 CD B-NP
kDa NN B-NP
( ( O
p65 NN B-NP
) ) O
polypeptides NNS B-NP
and CC O
has VBZ B-VP
a DT B-NP
binding NN I-NP
activity NN I-NP
specific JJ B-ADJP
for IN B-PP
both CC O
the DT O
GM-CSF NN B-NP
and CC O
immunoglobulin NN B-NP
kappa NN I-NP
( ( O
GGAAAGTCCC NN B-NP
) ) O
enhancers NNS B-NP
. . O

Electrophoretically RB B-NP
purified VBN I-NP
p50 NN I-NP
alone RB B-ADVP
can MD B-VP
form VB I-VP
a DT B-NP
protein-DNA JJ I-NP
complex NN I-NP
COMMA COMMA O
but CC O
in IN B-PP
the DT B-NP
mixture NN I-NP
COMMA COMMA O
p50 NN B-NP
associates VBZ B-VP
preferentially RB B-ADVP
with IN B-PP
p65 NN B-NP
to TO B-VP
form VB I-VP
the DT B-NP
NF-GM2 NN I-NP
complex NN I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
p65 NN B-NP
gave VBD B-VP
per FW B-ADVP
se FW I-ADVP
COMMA COMMA O
with IN B-PP
low JJ B-NP
affinity NN I-NP
COMMA COMMA O
a DT B-NP
protein-DNA JJ I-NP
complex NN I-NP
that WDT B-NP
migrated VBD B-VP
more RBR B-ADVP
slowly RB I-ADVP
than IN B-PP
native JJ B-NP
NF-GM2 NN I-NP
complex NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
an DT B-NP
antiserum NN I-NP
against IN B-PP
KBF1 NN B-NP
( ( O
identical JJ B-ADJP
to TO B-PP
50 CD B-NP
kDa NN I-NP
NF-kappa NN I-NP
B NN I-NP
protein NN I-NP
) ) O
reacted VBD B-VP
with IN B-PP
the DT B-NP
p50 NN I-NP
of IN B-PP
NF-GM2 NN B-NP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
the DT B-NP
NF-GM2 NN I-NP
polypeptide NN I-NP
can MD B-VP
not RB I-VP
be VB I-VP
immunologically RB I-VP
differentiated VBN I-VP
from IN B-PP
the DT B-NP
50 CD I-NP
kDa NN I-NP
subunit NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
. . O

The DT B-NP
purified VBN I-NP
NF-GM2 NN I-NP
activated VBD B-VP
in FW B-NP
vitro FW I-NP
transcription NN I-NP
from IN B-PP
the DT B-NP
kappa NN I-NP
B NN I-NP
enhancer NN I-NP
COMMA COMMA O
while IN B-SBAR
it PRP B-NP
failed VBD B-VP
to TO I-VP
stimulate VB I-VP
transcription NN B-NP
from IN B-PP
the DT B-NP
GM-CSF NN I-NP
promoter NN I-NP
harboring VBG B-VP
the DT B-NP
GM2 NN I-NP
sequence NN I-NP
. . O

This DT B-NP
suggests VBZ B-VP
that IN B-SBAR
the DT B-NP
activation NN I-NP
mechanism NN I-NP
of IN B-PP
the DT B-NP
GM-CSF NN I-NP
gene NN I-NP
through IN B-PP
the DT B-NP
GM2\/GC-box JJ I-NP
sequence NN I-NP
is VBZ B-VP
different JJ B-ADJP
from IN B-PP
that DT B-NP
of IN B-PP
genes NNS B-NP
carrying VBG B-VP
the DT B-NP
kappa NN I-NP
B NN I-NP
enhancer NN I-NP
alone RB B-ADVP
. . O

Glucocorticoid NN B-NP
receptors NNS I-NP
in IN B-PP
normal JJ B-NP
leukocytes NNS I-NP
: : O
effects NNS B-NP
of IN B-PP
age NN B-NP
COMMA COMMA O
gender NN B-NP
COMMA COMMA O
season NN B-NP
COMMA COMMA O
and CC O
plasma NN B-NP
cortisol NN I-NP
concentrations NNS I-NP
. . O

We PRP B-NP
measured VBD B-VP
glucocorticoid NN B-NP
receptors NNS I-NP
( ( O
GR NN B-NP
) ) O
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
( ( O
MNL NN B-NP
) ) O
isolated VBN B-VP
from IN B-PP
peripheral JJ B-NP
blood NN I-NP
of IN B-PP
145 CD B-NP
apparently RB I-NP
healthy JJ I-NP
volunteers NNS I-NP
( ( O
86 CD B-NP
men NNS I-NP
and CC O
59 CD B-NP
women NNS I-NP
) ) O
. . O

An DT B-NP
age-related JJ I-NP
decrease NN I-NP
in IN B-PP
the DT B-NP
number NN I-NP
of IN B-PP
GR NN B-NP
was VBD B-VP
suggested VBN I-VP
between IN B-PP
subjects NNS B-NP
younger JJR B-ADJP
than IN B-PP
20 CD B-NP
years NNS I-NP
and CC O
elderly JJ B-NP
subjects NNS I-NP
; : O
there EX B-NP
was VBD B-VP
no DT B-NP
apparent JJ I-NP
seasonal JJ I-NP
variation NN I-NP
in IN B-PP
GR NN B-NP
. . O

Gender NN B-NP
difference NN I-NP
in IN B-PP
the DT B-NP
number NN I-NP
of IN B-PP
GR NN B-NP
was VBD B-VP
not RB O
significant JJ B-ADJP
COMMA COMMA O
although IN B-SBAR
women NNS B-NP
showed VBD B-VP
slightly RB B-NP
fewer JJR I-NP
GR NN I-NP
. . O

Eight CD B-NP
patients NNS I-NP
with IN B-PP
dermatomyositis\/polymyositis NN B-NP
were VBD B-VP
examined VBN I-VP
to TO B-VP
determine VB I-VP
whether IN B-SBAR
the DT B-NP
number NN I-NP
of IN B-PP
GR NN B-NP
in IN B-PP
MNL NN B-NP
could MD B-VP
be VB I-VP
down-regulated VBN I-VP
by IN B-PP
their PRP$ B-NP
cognate JJ I-NP
ligands NNS I-NP
. . O

The DT B-NP
number NN I-NP
of IN B-PP
GR NN B-NP
in IN B-PP
MNL NN B-NP
from IN B-PP
these DT B-NP
patients NNS I-NP
was VBD B-VP
significantly RB I-VP
decreased VBN I-VP
one CD B-NP
month NN I-NP
after IN B-PP
the DT B-NP
initiation NN I-NP
of IN B-PP
prednisolone NN B-NP
therapy NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
in IN B-PP
normal JJ B-NP
subjects NNS I-NP
COMMA COMMA O
the DT B-NP
GR NN I-NP
in IN B-PP
MNL NN B-NP
did VBD B-VP
not RB I-VP
demonstrate VB I-VP
circadian JJ B-NP
variation NN I-NP
COMMA COMMA O
in IN B-PP
contrast NN I-PP
to TO I-PP
concentrations NNS B-NP
of IN B-PP
plasma NN B-NP
cortisol NN I-NP
. . O

Anti-CD2 JJ B-NP
receptor NN I-NP
antibodies NNS I-NP
activate VBP B-VP
the DT B-NP
HIV NN I-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
in IN B-PP
T NN B-NP
lymphocytes NNS I-NP
. . O

The DT B-NP
CD2 NN I-NP
T NN I-NP
lymphocyte NN I-NP
glycoprotein NN I-NP
surface NN I-NP
molecule NN I-NP
mediates VBZ B-VP
both CC O
cell NN B-NP
to TO I-NP
cell NN I-NP
adhesion NN I-NP
and CC O
T NN B-NP
cell NN I-NP
activation NN I-NP
COMMA COMMA O
two CD B-NP
processes NNS I-NP
that WDT B-NP
are VBP B-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
spread NN I-NP
of IN B-PP
HIV NN B-NP
infection NN I-NP
. . O

Treatment NN B-NP
of IN B-PP
chronically RB B-NP
HIV-infected JJ I-NP
PBMC NN I-NP
with IN B-PP
anti-CD2 JJ B-NP
mAb NN I-NP
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
induce VB I-VP
the DT B-NP
expression NN I-NP
of IN B-PP
infectious JJ B-NP
virus NN I-NP
from IN B-PP
these DT B-NP
cultures NNS I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
we PRP B-NP
investigated VBD B-VP
the DT B-NP
mechanisms NNS I-NP
whereby WRB B-ADVP
anti-CD2 JJ B-NP
antibodies NNS I-NP
stimulate VBP B-VP
viral JJ B-NP
production NN I-NP
. . O

We PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
treatment NN B-NP
of IN B-PP
transiently RB B-NP
transfected VBN I-NP
T NN I-NP
lymphocytes NNS I-NP
with IN B-PP
anti-CD2 JJ B-NP
antibodies NNS I-NP
results VBZ B-VP
in IN B-PP
activation NN B-NP
of IN B-PP
the DT B-NP
HIV NN I-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
CAT NN B-NP
assays NNS I-NP
using VBG B-VP
mutated VBN B-NP
HIV NN I-NP
long JJ I-NP
terminal JJ I-NP
repeat-CAT NN I-NP
constructs NNS I-NP
and CC O
gel NN B-NP
shift NN I-NP
assays NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
this DT B-NP
activation NN I-NP
is VBZ B-VP
dependent JJ B-ADJP
on IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
enhancer NN I-NP
. . O

These DT B-NP
studies NNS I-NP
suggest VBP B-VP
that IN B-SBAR
interaction NN B-NP
of IN B-PP
CD2 NN B-NP
with IN B-PP
its PRP$ B-NP
natural JJ I-NP
ligand NN I-NP
COMMA COMMA O
LFA-3 NN B-NP
COMMA COMMA O
may MD B-VP
play VB I-VP
a DT B-NP
role NN I-NP
in IN B-PP
regulation NN B-NP
of IN B-PP
HIV NN B-NP
expression NN I-NP
. . O

Nuclear JJ B-NP
transcription NN I-NP
factors NNS I-NP
that WDT B-NP
bind VBP B-VP
to TO B-PP
elements NNS B-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
. . O

Induction NN B-NP
requirements NNS I-NP
in IN B-PP
primary JJ B-NP
human JJ I-NP
T NN I-NP
cells NNS I-NP
. . O

Prior JJ B-NP
studies NNS I-NP
have VBP B-VP
identified VBN I-VP
several JJ B-NP
elements NNS I-NP
that WDT B-NP
contribute VBP B-VP
to TO B-PP
the DT B-NP
activity NN I-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
in IN B-PP
the DT B-NP
stimulated VBN I-NP
T NN I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
Jurkat NN B-NP
. . O

The DT B-NP
sites NNS I-NP
and CC O
their PRP$ B-NP
corresponding JJ I-NP
nuclear JJ I-NP
binding VBG I-NP
factors NNS I-NP
include VBP B-VP
: : O
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
AP-1 NN B-NP
COMMA COMMA O
AP-3 NN B-NP
COMMA COMMA O
OCT-1 NN B-NP
COMMA COMMA O
and CC O
NF-AT NN B-NP
. . O

The DT B-NP
latter JJ I-NP
" `` O
nuclear JJ B-NP
factor NN I-NP
for IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
" '' O
likely RB B-ADVP
contributes VBZ B-VP
to TO B-PP
the DT B-NP
tissue NN I-NP
specificity NN I-NP
of IN B-PP
IL-2 NN B-NP
gene NN I-NP
expression NN I-NP
. . O

Using VBG B-VP
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
studied VBN I-VP
these DT B-NP
transcription NN B-NP
factors NNS I-NP
in IN B-PP
primary JJ B-NP
T NN I-NP
cells NNS I-NP
from IN B-PP
human JJ B-NP
blood NN I-NP
to TO B-VP
verify VB I-VP
their PRP$ B-NP
presence NN I-NP
in IN B-PP
a DT B-NP
physiologic JJ I-NP
setting NN I-NP
and CC O
to TO B-VP
identify VB I-VP
the DT B-NP
signals NNS I-NP
that WDT B-NP
stimulate VBP B-VP
factor NN B-NP
activity NN I-NP
. . O

All DT B-NP
factors NNS I-NP
are VBP B-VP
induced VBN I-VP
in IN B-PP
the DT B-NP
nuclei NNS I-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
upon IN B-PP
activation NN B-NP
with IN B-PP
mitogens NNS B-NP
but CC B-PP
not RB B-PP
with IN I-PP
exogenous JJ B-NP
IL-2 NN I-NP
growth NN I-NP
factor NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
signaling NN I-NP
requirements NNS I-NP
and CC O
sensitivity NN B-NP
to TO B-PP
protein NN B-NP
synthesis NN I-NP
inhibitors NNS I-NP
differ VBP B-VP
considerably RB B-ADVP
. . O

Only RB B-NP
the DT I-NP
activities NNS I-NP
for IN B-PP
NF-AT NN B-NP
and CC O
AP-1 NN B-NP
sites NNS B-NP
require VBP B-VP
two CD B-NP
signals NNS I-NP
for IN B-PP
optimal JJ B-NP
induction NN I-NP
COMMA COMMA O
i.e. FW B-PP
COMMA COMMA O
PMA NN B-NP
plus CC O
either CC O
lectin NN B-NP
or CC O
antibody NN B-NP
to TO B-PP
the DT O
CD3 NN B-NP
or CC O
CD28 NN B-NP
surface NN B-NP
molecules NNS I-NP
. . O

Other JJ B-NP
factors NNS I-NP
are VBP B-VP
induced VBN I-VP
by IN B-PP
lectin NN B-NP
COMMA COMMA O
antibody NN B-NP
COMMA COMMA O
and\/or CC O
PMA NN B-NP
alone RB B-ADVP
. . O

After IN B-PP
appropriate JJ B-NP
stimulation NN I-NP
COMMA COMMA O
both CC O
NF-AT NN B-NP
and CC O
AP-1 NN B-NP
are VBP B-VP
peculiarly RB B-ADJP
sensitive JJ I-ADJP
to TO B-PP
the DT B-NP
protein NN I-NP
synthesis NN I-NP
inhibitor NN I-NP
anisomycin NN I-NP
. . O

Our PRP$ B-NP
data NNS I-NP
correlate VBP B-VP
the DT B-NP
activity NN I-NP
of IN B-PP
NF-AT NN B-NP
and CC O
AP-1 NN B-NP
in IN B-PP
gel NN B-NP
shift NN I-NP
assays NNS I-NP
with IN B-PP
the DT B-NP
two CD I-NP
signals NNS I-NP
requirements NNS I-NP
for IN B-PP
IL-2 NN B-NP
gene NN I-NP
expression NN I-NP
. . O

An DT B-NP
erythroid JJ I-NP
specific JJ I-NP
enhancer NN I-NP
upstream JJ B-ADJP
to TO B-PP
the DT B-NP
gene NN I-NP
encoding VBG B-VP
the DT B-NP
cell-type JJ I-NP
specific JJ I-NP
transcription NN I-NP
factor NN I-NP
GATA-1 NN I-NP
. . O

The DT B-NP
transcription NN I-NP
factor NN I-NP
GATA-1 NN I-NP
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
a DT B-NP
subset NN I-NP
of IN B-PP
hemopoietic JJ B-NP
cells NNS I-NP
COMMA COMMA O
where WRB B-ADVP
it PRP B-NP
mediates VBZ B-VP
the DT B-NP
cell-type JJ I-NP
specific JJ I-NP
expression NN I-NP
of IN B-PP
several JJ B-NP
genes NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
cloned VBN I-VP
the DT O
mouse NN B-NP
and CC O
human JJ B-NP
GATA-1 NN B-NP
genes NNS I-NP
. . O

A DT B-NP
region NN I-NP
upstream JJ B-ADJP
to TO B-PP
the DT B-NP
first JJ I-NP
exon NN I-NP
COMMA COMMA O
and CC O
highly RB B-VP
conserved VBN I-VP
between IN B-PP
mouse NN B-NP
and CC O
man NN B-NP
COMMA COMMA O
acts VBZ B-VP
as IN B-PP
an DT B-NP
erythroid JJ I-NP
specific JJ I-NP
enhancer NN I-NP
in IN B-PP
transient JJ B-NP
assays NNS I-NP
COMMA COMMA O
if IN B-SBAR
linked VBN B-VP
to TO B-PP
the DT B-NP
GATA-1 NN I-NP
or CC B-PP
to TO B-PP
the DT B-NP
SV40 NN I-NP
promoter NN B-NP
. . O

The DT B-NP
activity NN I-NP
of IN B-PP
the DT B-NP
enhancer NN I-NP
is VBZ B-VP
almost RB B-ADJP
completely RB I-ADJP
dependent JJ I-ADJP
on IN B-PP
the DT B-NP
integrity NN I-NP
of IN B-PP
a DT B-NP
dimeric JJ I-NP
GATA-1 NN I-NP
binding NN I-NP
site NN I-NP
. . O

Demonstration NN B-NP
of IN B-PP
a DT B-NP
1COMMA25-dihydroxyvitamin NN I-NP
D3-responsive JJ I-NP
protein NN I-NP
in IN B-PP
human JJ B-NP
lymphocytes NNS I-NP
: : O
immunologic JJ B-NP
crossreactivity NN I-NP
and CC O
inverse JJ B-NP
regulation NN I-NP
with IN B-PP
the DT B-NP
vitamin NN I-NP
D NN I-NP
receptor NN I-NP
. . O

Using VBG B-VP
Western NN B-NP
blot NN I-NP
analysis NN I-NP
with IN B-PP
a DT B-NP
monoclonal JJ I-NP
antibody NN I-NP
recognizing VBG B-VP
a DT B-NP
17-amino NN I-NP
acid NN I-NP
epitope NN I-NP
of IN B-PP
the DT O
1COMMA25-dihydroxyvitamin NN B-NP
D3 NN I-NP
{ ( O
1COMMA25(OH)2D3 NN B-NP
} ) O
receptor NN B-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
detected VBN I-VP
two CD B-NP
crossreacting VBG I-NP
proteins NNS I-NP
in IN B-PP
activated VBN B-NP
normal JJ I-NP
human JJ I-NP
lymphocytes NNS I-NP
. . O

The DT B-NP
smaller JJR I-NP
of IN B-PP
the DT B-NP
two CD I-NP
proteins NNS I-NP
( ( O
50 CD B-NP
kDa NN I-NP
) ) O
was VBD B-VP
indistinguishable JJ B-ADJP
from IN B-PP
the DT B-NP
classical JJ I-NP
1COMMA25(OH)2D3 NN I-NP
receptor NN I-NP
and CC O
COMMA COMMA O
similar JJ B-ADJP
to TO B-PP
the DT B-NP
classical JJ I-NP
1COMMA25(OH)2D3 NN I-NP
receptor NN I-NP
COMMA COMMA O
was VBD B-VP
upregulated VBN B-VP
in IN B-PP
a DT B-NP
dose-dependent JJ I-NP
fashion NN I-NP
by IN B-PP
1COMMA25(OH)2D3 NN B-NP
. . O

The DT B-NP
larger JJR I-NP
crossreacting VBG I-NP
protein NN I-NP
exhibited VBD B-VP
an DT B-NP
electrophoretic JJ I-NP
mobility NN I-NP
of IN B-PP
80 CD B-NP
kDa NN I-NP
COMMA COMMA O
was VBD B-VP
localized JJ I-VP
in IN B-PP
the DT B-NP
cell NN I-NP
cytosol NN I-NP
COMMA COMMA O
and CC O
appeared VBD B-VP
to TO I-VP
be VB I-VP
specific JJ B-ADJP
for IN B-PP
activated VBN B-NP
lymphocytes NNS I-NP
since IN B-SBAR
it PRP B-NP
was VBD B-VP
not RB I-VP
detected VBN I-VP
in IN B-PP
several JJ B-NP
other JJ I-NP
human JJ I-NP
cells NNS I-NP
including VBG B-PP
monocytes NNS B-NP
. . O

More RBR B-ADVP
strikingly RB I-ADVP
COMMA COMMA O
the DT B-NP
80-kDa JJ I-NP
protein NN I-NP
was VBD B-VP
downregulated VBN I-VP
in IN B-PP
a DT B-NP
dose-dependent JJ I-NP
fashion NN I-NP
by IN B-PP
1COMMA25(OH)2D3 NN B-NP
; : O
this DT B-NP
effect NN I-NP
was VBD B-VP
independent JJ B-ADJP
of IN B-PP
the DT B-NP
mode NN I-NP
of IN B-PP
lymphocyte NN B-NP
activation NN I-NP
and CC O
specific JJ B-ADJP
for IN B-PP
the DT B-NP
1COMMA25(OH)2D3 NN I-NP
metabolite NN I-NP
of IN B-PP
vitamin NN B-NP
D3 NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
two CD B-NP
potent JJ I-NP
immunosuppressive JJ I-NP
agents NNS I-NP
COMMA COMMA O
glucocorticoids NNS B-NP
and CC O
cyclosporin NN B-NP
A DT I-NP
COMMA COMMA O
also RB B-ADVP
inhibited VBD B-VP
the DT B-NP
80-kDa JJ I-NP
protein NN I-NP
. . O

T-helper-cell JJ B-NP
determinants NNS I-NP
in IN B-PP
protein NN B-NP
antigens NNS I-NP
are VBP B-VP
preferentially RB B-ADVP
located JJ I-ADVP
in IN B-PP
cysteine-rich JJ B-NP
antigen NN I-NP
segments NNS I-NP
resistant JJ B-ADJP
to TO B-PP
proteolytic JJ B-NP
cleavage NN I-NP
by IN B-PP
cathepsin NN B-NP
B NN B-NP
COMMA COMMA O
L NN B-NP
COMMA COMMA O
and CC O
D NN B-NP
. . O

We PRP B-NP
report VBP B-VP
on IN B-PP
a DT B-NP
computer NN I-NP
algorithm NN I-NP
capable JJ B-ADJP
of IN B-PP
predicting VBG B-VP
the DT B-NP
location NN I-NP
of IN B-PP
T-helper-cell NN B-NP
epitopes NNS I-NP
in IN B-PP
protein NN B-NP
antigen NN B-NP
( ( O
Ag NN B-NP
) ) O
by IN B-PP
analysing VBG B-VP
the DT B-NP
Ag NN I-NP
amino NN I-NP
acid NN I-NP
sequence NN I-NP
. . O

The DT B-NP
algorithm NN I-NP
was VBD B-VP
constructed VBN I-VP
with IN B-PP
the DT B-NP
aim NN I-NP
of IN B-PP
identifying VBG B-VP
segments NNS B-NP
in IN B-PP
Ag NN B-NP
which WDT B-NP
are VBP B-VP
resistant JJ B-ADJP
to TO B-PP
proteolytic JJ B-NP
degradation NN I-NP
by IN B-PP
the DT B-NP
enzymes NNS I-NP
cathepsin NN I-NP
B NN B-NP
COMMA COMMA O
L NN B-NP
COMMA COMMA O
and CC O
D NN B-NP
. . O

These DT B-NP
are VBP B-VP
prominent JJ B-NP
enzymes NNS I-NP
in IN B-PP
the DT B-NP
endocytic JJ I-NP
pathway NN I-NP
through IN B-PP
which WDT B-NP
soluble JJ B-NP
protein NN I-NP
Ag NN I-NP
enter VBP B-VP
APC NN B-NP
COMMA COMMA O
and CC O
resistant JJ B-NP
segments NNS I-NP
in IN B-PP
Ag NN B-NP
may MD B-VP
COMMA COMMA O
therefore RB B-ADVP
COMMA COMMA O
be VB B-VP
expected VBN I-VP
to TO I-VP
contain VB I-VP
more JJR B-NP
T-cell NN I-NP
determinants NNS I-NP
than IN B-PP
susceptible JJ B-NP
segments NNS I-NP
. . O

From IN B-PP
information NN B-NP
available JJ B-ADJP
in IN B-PP
the DT B-NP
literature NN I-NP
on IN B-PP
the DT B-NP
substrate JJ I-NP
specificity NN I-NP
of IN B-PP
the DT B-NP
three CD I-NP
enzymes NNS I-NP
COMMA COMMA O
it PRP B-NP
is VBZ B-VP
clear JJ B-ADJP
that IN B-SBAR
a DT B-NP
cysteine NN I-NP
is VBZ B-VP
not RB I-VP
accepted VBN I-VP
in IN B-PP
any DT B-NP
of IN B-PP
the DT O
S2 NN B-NP
COMMA COMMA O
S1 NN B-NP
COMMA COMMA O
S1' NN B-NP
COMMA COMMA O
and CC O
S2' NN B-NP
subsites NNS B-NP
of IN B-PP
cathepsin NN B-NP
B NN B-NP
and CC O
L NN B-NP
COMMA COMMA B-PP
and CC I-PP
not RB B-PP
in IN I-PP
the DT O
S1 NN B-NP
and CC O
S1' NN B-NP
subsites NNS B-NP
of IN B-PP
cathepsin NN B-NP
D NN I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
noticed VBN I-VP
that IN B-SBAR
cysteine-containing JJ B-NP
T-cell NN I-NP
determinants NNS I-NP
in IN B-PP
a DT B-NP
number NN I-NP
of IN B-PP
protein NN B-NP
Ag NN I-NP
are VBP B-VP
particularly RB B-ADJP
rich JJ I-ADJP
in IN B-PP
the DT B-NP
amino NN I-NP
acids NNS I-NP
alanine NN B-NP
COMMA COMMA O
glycine NN B-NP
COMMA COMMA O
lysine NN B-NP
COMMA COMMA O
leucine NN B-NP
COMMA COMMA O
serine NN B-NP
COMMA COMMA O
threonine NN B-NP
COMMA COMMA O
and CC O
valine NN B-NP
. . O

By IN B-PP
searching VBG B-VP
protein NN B-NP
Ag NN I-NP
for IN B-PP
clusters NNS B-NP
of IN B-PP
amino NN B-NP
acids NNS I-NP
containing VBG B-VP
cysteine NN B-NP
and CC O
two CD B-NP
of IN B-PP
the DT B-NP
other JJ I-NP
amino NN I-NP
acids NNS I-NP
we PRP B-NP
were VBD B-VP
able JJ B-ADJP
to TO B-VP
predict VB I-VP
17 CD B-NP
out IN I-NP
of IN I-NP
23 CD I-NP
empirically RB I-NP
known VBN I-NP
T-cell NN I-NP
determinants NNS I-NP
in IN B-PP
the DT B-NP
Ag NN I-NP
with IN B-PP
a DT B-NP
relatively RB I-NP
low JJ I-NP
number NN I-NP
of IN B-PP
false JJ O
( ( O
positive JJ B-ADJP
) ) O
predictions NNS B-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
we PRP B-NP
present VBP B-VP
a DT B-NP
new JJ I-NP
principle NN I-NP
for IN B-PP
searching VBG B-VP
Ag NN B-NP
for IN B-PP
potential JJ B-NP
amphipatic JJ I-NP
alpha-helical JJ I-NP
protein NN I-NP
segments NNS I-NP
. . O

Such JJ B-NP
segments NNS I-NP
accord VBP B-VP
well RB B-ADVP
with IN B-PP
empirically RB B-NP
known JJ I-NP
T-cell NN I-NP
determinants NNS I-NP
and CC O
our PRP$ B-NP
algorithm NN I-NP
produces VBZ B-VP
a DT B-NP
lower JJR I-NP
number NN I-NP
of IN B-PP
false JJ B-NP
positive JJ I-NP
predictions NNS I-NP
than IN B-PP
the DT B-NP
principle NN I-NP
based VBN B-PP
on IN B-PP
discrete JJ B-NP
Fourier NN I-NP
transformations NNS I-NP
previously RB B-VP
described VBN I-VP
. . O

A DT B-NP
human JJ I-NP
putative JJ I-NP
lymphocyte NN I-NP
G0\/G1 NN I-NP
switch NN I-NP
gene NN I-NP
containing VBG B-VP
a DT B-NP
CpG-rich JJ I-NP
island NN I-NP
encodes VBZ B-VP
a DT B-NP
small JJ I-NP
basic JJ I-NP
protein NN I-NP
with IN B-PP
the DT B-NP
potential NN I-NP
to TO B-VP
be VB I-VP
phosphorylated VBN I-VP
. . O

Genes NNS B-NP
actively RB B-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
G0\/G1 NN I-NP
switch NN I-NP
( ( O
G0S NN B-NP
genes NNS I-NP
) ) O
may MD B-VP
be VB I-VP
differentially RB I-VP
expressed VBN I-VP
during IN B-PP
the DT B-NP
lectin-induced JJ I-NP
switch NN I-NP
of IN B-PP
lymphocytes NNS B-NP
from IN B-PP
the DT B-NP
G0 NN I-NP
to TO B-PP
the DT B-NP
G1 NN I-NP
phases NNS I-NP
of IN B-PP
the DT B-NP
cell NN I-NP
cycle NN I-NP
. . O

This DT B-NP
paper NN I-NP
presents VBZ B-VP
studies NNS B-NP
of IN B-PP
G0S2 NN B-NP
COMMA COMMA O
a DT B-NP
member NN I-NP
of IN B-PP
a DT B-NP
set NN I-NP
of IN B-PP
putative JJ B-NP
G0S NN I-NP
genes NNS I-NP
COMMA COMMA O
for IN B-PP
which WDT B-NP
cDNAs NNS B-NP
were VBD B-VP
cloned VBN I-VP
and CC O
selected VBN B-VP
on IN B-PP
the DT I-PP
basis NN I-PP
of IN I-PP
differential JJ B-NP
cDNA NN I-NP
hybridization NN I-NP
. . O

G0S2 NN B-NP
mRNA NN I-NP
increases VBZ B-VP
transiently RB B-ADVP
within IN B-PP
1-2 CD B-NP
hr NN I-NP
of IN B-PP
the DT B-NP
addition NN I-NP
of IN B-PP
lectin NN B-NP
or CC O
cycloheximide NN B-NP
to TO B-PP
cultured VBN B-NP
blood NN I-NP
mononuclear JJ I-NP
cells NNS I-NP
. . O

Comparison NN B-NP
of IN B-PP
a DT B-NP
nearly RB I-NP
full-length JJ I-NP
cDNA NN I-NP
sequence NN I-NP
with IN B-PP
the DT B-NP
corresponding JJ I-NP
genomic JJ I-NP
sequence NN I-NP
reveals VBZ B-VP
one CD B-NP
small JJ I-NP
intron NN I-NP
and CC O
an DT B-NP
open JJ I-NP
reading NN I-NP
frame NN I-NP
in IN B-PP
the DT B-NP
second JJ I-NP
exon NN I-NP
. . O

The DT B-NP
derived VBN I-NP
103-amino-acid JJ I-NP
basic JJ I-NP
protein NN I-NP
has VBZ B-VP
two CD B-NP
potential JJ I-NP
alpha-helical JJ I-NP
domains NNS I-NP
separated VBN B-VP
by IN B-PP
a DT B-NP
hydrophobic JJ I-NP
region NN I-NP
with IN B-PP
the DT B-NP
potential NN I-NP
to TO B-VP
generate VB I-VP
turns NNS B-NP
and CC O
assume VB B-VP
a DT B-NP
beta-sheet JJ I-NP
conformation NN I-NP
. . O

Consistent JJ B-ADJP
with IN B-PP
involvement NN B-NP
in IN B-PP
the DT B-NP
G0\/G1 NN I-NP
switch NN I-NP
COMMA COMMA O
the DT B-NP
protein NN I-NP
contains VBZ B-VP
potential JJ B-NP
sites NNS I-NP
for IN B-PP
phosphorylation NN B-NP
by IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
and CC O
casein NN B-NP
kinase NN I-NP
II CD I-NP
. . O

The DT B-NP
gene NN I-NP
contains VBZ B-VP
a DT B-NP
CpG-rich JJ I-NP
island NN I-NP
suggesting VBG B-VP
expression NN B-NP
in IN B-PP
the DT B-NP
germ NN I-NP
line NN I-NP
. . O

An DT B-NP
upstream JJ I-NP
segment NN I-NP
contains VBZ B-VP
tandem JJ B-NP
dinucleotide NN I-NP
repeats NNS I-NP
(CT)19\/(CA)16 NN I-NP
. . O

There EX B-NP
is VBZ B-VP
a DT B-NP
suitably RB I-NP
located JJ I-NP
TATA NN I-NP
box NN I-NP
COMMA COMMA O
but CC O
potential JJ B-NP
sites NNS I-NP
for IN B-PP
CCAAT-box NN B-NP
binding NN I-NP
factors NNS I-NP
are VBP B-VP
far RB B-ADJP
upstream JJ I-ADJP
COMMA COMMA O
embedded JJ B-ADJP
in IN B-PP
a DT B-NP
42-nucleotide JJ I-NP
repeat NN I-NP
element NN I-NP
. . O

Potential JJ B-NP
sites NNS I-NP
for IN B-PP
transcription NN B-NP
factors NNS I-NP
AP1 NN B-NP
COMMA COMMA O
AP2 NN B-NP
COMMA COMMA O
and CC O
AP3 NN B-NP
are VBP B-VP
consistent JJ B-ADJP
with IN B-PP
rapid JJ B-NP
transcriptional JJ I-NP
activation NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
inducing VBG B-NP
agents NNS I-NP
. . O

Synergism NN B-NP
between IN B-PP
two CD B-NP
distinct JJ I-NP
elements NNS I-NP
of IN B-PP
the DT B-NP
HTLV-I NN I-NP
enhancer NN I-NP
during IN B-PP
activation NN B-NP
by IN B-PP
the DT B-NP
trans-activator NN I-NP
of IN B-PP
HTLV-I NN B-NP
. . O

We PRP B-NP
have VBP B-VP
conducted VBN I-VP
functional JJ B-NP
studies NNS I-NP
of IN B-PP
the DT B-NP
enhancer NN I-NP
elements NNS I-NP
of IN B-PP
human JJ B-NP
T-cell NN I-NP
leukemia NN I-NP
virus NN I-NP
type NN I-NP
I CD I-NP
( ( O
HTLV-I NN B-NP
) ) O
using VBG B-VP
the DT B-NP
human JJ I-NP
T-cell NN I-NP
lines NNS I-NP
Jurkat NN B-NP
and CC O
MOLT NN B-NP
4 CD I-NP
COMMA COMMA O
which WDT B-NP
are VBP B-VP
negative JJ B-ADJP
for IN B-PP
HTLV-I NN B-NP
COMMA COMMA O
and CC O
MT-2 NN B-NP
and CC O
TL-Mor NN B-NP
COMMA COMMA O
which WDT B-NP
carry VBP B-VP
the DT B-NP
proviral JJ I-NP
genome NN I-NP
of IN B-PP
HTLV-I NN B-NP
. . O

Two CD B-NP
distinct JJ I-NP
elements NNS I-NP
have VBP B-VP
been VBN I-VP
implicated VBN I-VP
in IN B-PP
function NN B-NP
of IN B-PP
the DT B-NP
HTLV-I NN I-NP
enhancer NN I-NP
. . O

One CD B-NP
is VBZ B-VP
the DT O
21-base-pair JJ O
( ( O
bp NN B-NP
) ) O
core NN B-NP
element NN I-NP
that WDT B-NP
is VBZ B-VP
responsible JJ B-ADJP
for IN B-PP
trans-activation NN B-NP
by IN B-PP
the DT B-NP
HTLV-I NN I-NP
trans-activator NN I-NP
p40tax NN I-NP
and CC O
that WDT B-NP
has VBZ B-VP
the DT B-NP
ability NN I-NP
to TO B-VP
bind VB I-VP
to TO B-PP
cyclic-AMP NN B-NP
responsive JJ I-NP
element NN I-NP
binding NN I-NP
factor NN I-NP
( ( I-NP
CREB NN I-NP
) ) I-NP
-like JJ I-NP
factor NN I-NP
( ( I-NP
s NNS I-NP
) ) O
. . O

The DT B-NP
other JJ I-NP
is VBZ B-VP
a DT B-NP
region NN I-NP
interposed VBN B-ADJP
between IN B-PP
the DT B-NP
21-bp JJ I-NP
elements NNS I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
a DT B-NP
subfragment NN I-NP
( ( O
C26 NN B-NP
) ) O
in IN B-PP
the DT B-NP
region NN I-NP
between IN B-PP
the DT B-NP
21-bp JJ I-NP
elements NNS I-NP
is VBZ B-VP
involved VBN I-VP
in IN B-PP
trans-activation NN B-NP
by IN B-PP
p40tax NN B-NP
COMMA COMMA O
possibly RB B-PP
through IN I-PP
binding NN B-NP
to TO B-PP
an DT B-NP
NF-kappa NN I-NP
B-like JJ I-NP
nuclear JJ I-NP
factor NN B-NP
or CC O
factors NNS B-NP
. . O

Formation NN B-NP
of IN B-PP
the DT B-NP
protein-DNA JJ I-NP
complex NN I-NP
with IN B-PP
the DT B-NP
C26 NN I-NP
subfragment NN I-NP
was VBD B-VP
positively RB I-VP
affected VBN I-VP
by IN B-PP
p40tax NN B-NP
. . O

The DT B-NP
C26 NN I-NP
element NN I-NP
conferred VBD B-VP
partial JJ B-NP
responsiveness NN I-NP
to TO B-PP
p40tax NN B-NP
when WRB B-ADVP
linked VBN B-VP
to TO B-PP
one CD B-NP
copy NN I-NP
of IN B-PP
the DT B-NP
21-bp JJ I-NP
element NN I-NP
that WDT B-NP
COMMA COMMA O
by IN B-PP
itself PRP B-NP
COMMA COMMA O
showed VBD B-VP
little JJ B-NP
activation NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
p40tax NN B-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
C26 NN I-NP
element NN I-NP
alone RB B-ADVP
COMMA COMMA O
even RB B-ADVP
when WRB I-ADVP
repeated VBN B-VP
COMMA COMMA O
could MD B-VP
not RB I-VP
be VB I-VP
activated VBN I-VP
by IN B-PP
p40tax NN B-NP
COMMA COMMA O
unlike IN B-PP
other JJ B-NP
NF-kappa NN I-NP
B-binding JJ I-NP
elements NNS I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
the DT B-NP
C26 NN I-NP
element NN I-NP
itself PRP B-NP
was VBD B-VP
profoundly RB I-VP
activated VBN I-VP
upon IN B-PP
stimulation NN B-NP
with IN B-PP
12-O-tetradecanoylphorbol-13-acetate NN B-NP
. . O

These DT B-NP
findings NNS I-NP
therefore RB B-ADVP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
HTLV-I NN I-NP
enhancer NN I-NP
contains VBZ B-VP
multiple JJ B-NP
functional JJ I-NP
elements NNS I-NP
COMMA COMMA O
including VBG B-PP
binding VBG B-NP
sites NNS I-NP
for IN B-PP
at IN B-NP
least JJS I-NP
CREB- NN I-NP
and CC I-NP
NF-kappa NN I-NP
B-like JJ I-NP
factors NNS I-NP
COMMA COMMA O
which WDT B-NP
synergistically RB B-ADVP
cooperate VBP B-VP
in IN B-PP
activation NN B-NP
of IN B-PP
the DT B-NP
HTLV-I NN I-NP
enhancer NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
p40tax NN B-NP
. . O

Our PRP$ B-NP
results NNS I-NP
also RB B-ADVP
demonstrate VBP B-VP
that IN B-SBAR
TPA-dependent JJ B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
HTLV-I NN I-NP
enhancer NN I-NP
may MD B-VP
be VB I-VP
mediated VBN I-VP
through IN B-PP
the DT B-NP
C26 NN I-NP
element NN I-NP
. . O

v-erbA NN B-NP
overexpression NN I-NP
is VBZ B-VP
required VBN I-VP
to TO I-VP
extinguish VB I-VP
c-erbA NN B-NP
function NN I-NP
in IN B-PP
erythroid JJ B-NP
cell NN I-NP
differentiation NN I-NP
and CC O
regulation NN B-NP
of IN B-PP
the DT B-NP
erbA NN I-NP
target NN I-NP
gene NN I-NP
CAII NN I-NP
. . O

The DT B-NP
v-erbA NN I-NP
oncoprotein NN I-NP
represents VBZ B-VP
a DT B-NP
retrovirus-transduced JJ I-NP
oncogenic JJ I-NP
version NN I-NP
of IN B-PP
the DT B-NP
thyroid NN I-NP
hormone NN I-NP
( ( I-NP
T3\/T4 NN I-NP
) ) I-NP
receptor NN I-NP
c-erbA NN I-NP
( ( I-NP
type NN I-NP
alpha NN I-NP
) ) O
. . O

It PRP B-NP
contributes VBZ B-VP
to TO B-PP
virus-induced JJ B-NP
erythroleukemia NN I-NP
by IN B-PP
efficiently RB B-ADVP
arresting VBG B-VP
differentiation NN B-NP
of IN B-PP
red JJ B-NP
cell NN I-NP
progenitors NNS I-NP
and CC B-PP
by IN B-PP
suppressing VBG B-VP
transcription NN B-NP
of IN B-PP
erythrocyte-specific JJ B-NP
genes NNS I-NP
. . O

Here RB B-ADVP
COMMA COMMA O
we PRP B-NP
show VBP B-VP
that IN B-SBAR
v-erbA NN B-NP
and CC O
c-erbA NN B-NP
bind VBP B-VP
directly RB B-ADVP
to TO B-PP
sequences NNS B-NP
within IN B-PP
the DT B-NP
promoter NN I-NP
of IN B-PP
the DT B-NP
erythrocyte-specific JJ I-NP
carbonic JJ B-NP
anhydrase NN I-NP
II CD I-NP
( ( O
CAII NN B-NP
) ) O
COMMA COMMA O
a DT B-NP
gene NN I-NP
whose WP$ B-NP
transcription NN I-NP
is VBZ B-VP
efficiently RB I-VP
suppressed VBN I-VP
by IN B-PP
v-erbA NN B-NP
. . O

This DT B-NP
erbA-binding JJ I-NP
site NN I-NP
confers VBZ B-VP
thyroid NN B-NP
hormone NN I-NP
responsiveness NN I-NP
to TO B-PP
a DT B-NP
heterologous JJ I-NP
promoter NN I-NP
in IN B-PP
transient JJ B-NP
expression NN I-NP
experiments NNS I-NP
and CC O
is VBZ B-VP
a DT B-NP
target NN I-NP
for IN B-PP
efficient JJ B-NP
down-regulation NN I-NP
of IN B-PP
CAII NN B-NP
transcription NN I-NP
by IN B-PP
the DT B-NP
v-erbA NN I-NP
oncoprotein NN I-NP
. . O

In IN B-PP
stably RB B-NP
transformed VBN I-NP
erythroblasts NNS I-NP
coexpressing VBG B-VP
the DT B-NP
v-erbA NN I-NP
oncoprotein NN I-NP
and CC O
the DT B-NP
c-erbA\/T3 NN I-NP
receptor NN I-NP
at IN B-PP
an DT B-NP
approximately RB I-NP
equimolar JJ I-NP
ratio NN I-NP
COMMA COMMA O
c-erbA NN B-NP
activity NN I-NP
is VBZ B-VP
dominant JJ B-ADJP
over IN B-PP
v-erbA NN B-NP
. . O

T3 NN B-NP
efficiently RB B-ADVP
induced VBD B-VP
erythroid JJ B-NP
differentiation NN I-NP
in IN B-PP
these DT B-NP
cells NNS I-NP
COMMA COMMA O
thus RB O
overcoming VBG B-VP
the DT B-NP
v-erbA-mediated JJ I-NP
differentiation NN I-NP
arrest NN I-NP
. . O

Likewise RB B-ADVP
COMMA COMMA O
T3 NN B-NP
activated VBD B-VP
CAII NN B-NP
transcription NN I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
transient JJ B-NP
expression NN I-NP
of IN B-PP
a DT B-NP
T3-responsive JJ I-NP
reporter NN I-NP
gene NN I-NP
containing VBG B-VP
the DT B-NP
CAII-specific JJ I-NP
erbA-binding JJ I-NP
site NN I-NP
. . O

The DT B-NP
c-erbA-dependent JJ I-NP
activation NN I-NP
of IN B-PP
this DT B-NP
CAII NN I-NP
reporter NN I-NP
construct NN I-NP
could MD B-VP
only RB I-VP
be VB I-VP
suppressed VBN I-VP
by IN B-PP
very RB B-NP
high JJ I-NP
amounts NNS I-NP
of IN B-PP
v-erbA NN B-NP
. . O

Our PRP$ B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
overexpression NN B-NP
of IN B-PP
v-erbA NN B-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
its PRP$ B-NP
function NN I-NP
as IN B-PP
an DT B-NP
oncoprotein NN I-NP
. . O

Inhibition NN B-NP
of IN B-PP
phorbol NN B-NP
ester-induced JJ I-NP
monocytic JJ I-NP
differentiation NN I-NP
by IN B-PP
dexamethasone NN B-NP
is VBZ B-VP
associated VBN I-VP
with IN B-PP
down-regulation NN B-NP
of IN B-PP
c-fos NN B-NP
and CC O
c-jun NN B-NP
( ( O
AP-1 NN B-NP
) ) O
. . O

Previous JJ B-NP
studies NNS I-NP
have VBP B-VP
shown VBN I-VP
that IN B-SBAR
treatment NN B-NP
of IN B-PP
human JJ B-NP
myeloid JJ I-NP
leukemia NN I-NP
cells NNS I-NP
with IN B-PP
12-O-tetradecanoylphorbol-13-acetate NN B-NP
( ( O
TPA NN B-NP
) ) O
is VBZ B-VP
associated VBN I-VP
with IN B-PP
induction NN B-NP
of IN B-PP
monocytic JJ B-NP
differentiation NN B-NP
and CC O
expression NN B-NP
of IN B-PP
the DT O
c-jun NN B-NP
and CC O
c-fos NN B-NP
early JJ B-NP
response NN I-NP
genes NNS I-NP
. . O

The DT B-NP
present JJ I-NP
work NN I-NP
demonstrates VBZ B-VP
that IN B-SBAR
the DT B-NP
glucocorticoid NN I-NP
dexamethasone NN I-NP
inhibits VBZ B-VP
TPA-induced JJ B-NP
increases NNS I-NP
in IN B-PP
c-jun NN B-NP
and CC O
c-fos NN B-NP
mRNA NN B-NP
levels NNS I-NP
in IN B-PP
U-937 NN B-NP
leukemia NN I-NP
cells NNS I-NP
. . O

These DT B-NP
findings NNS I-NP
were VBD B-VP
associated VBN I-VP
with IN B-PP
a DT B-NP
block NN I-NP
in IN B-PP
appearance NN B-NP
of IN B-PP
the DT B-NP
monocytic JJ I-NP
phenotype NN I-NP
COMMA COMMA O
including VBG B-PP
inhibition NN B-NP
of IN B-PP
TPA-induced JJ B-NP
increases NNS I-NP
in IN B-PP
lamin NN B-NP
A NN I-NP
COMMA COMMA O
lamin NN B-NP
C NN I-NP
COMMA COMMA O
and CC O
vimentin NN B-NP
transcripts NNS I-NP
. . O

Other JJ B-NP
studies NNS I-NP
have VBP B-VP
demonstrated VBN I-VP
that IN B-SBAR
TPA-induced JJ B-NP
monocytic JJ I-NP
differentiation NN B-NP
and CC O
expression NN B-NP
of IN B-PP
the DT O
c-jun NN B-NP
and CC O
c-fos NN B-NP
genes NNS B-NP
in IN B-PP
myeloid JJ B-NP
leukemia NN I-NP
cells NNS I-NP
are VBP B-VP
regulated VBN I-VP
by IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( O
PKC NN B-NP
) ) O
. . O

The DT B-NP
finding NN I-NP
that IN B-SBAR
dexamethasone NN B-NP
has VBZ B-VP
no DT B-NP
effect NN I-NP
on IN B-PP
TPA-induced JJ B-NP
activation NN I-NP
of IN B-PP
PKC NN B-NP
suggests VBZ B-VP
that IN B-SBAR
this DT B-NP
glucocorticoid NN I-NP
inhibits VBZ B-VP
signals NNS B-NP
downstream JJ B-ADJP
or CC O
parallel JJ B-ADJP
to TO B-PP
this DT B-NP
enzyme NN I-NP
. . O

Nuclear JJ B-NP
run-on JJ I-NP
assays NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
: : O
( ( B-LST
1 LS I-LST
) ) O
induction NN B-NP
of IN B-PP
c-jun NN B-NP
and CC O
c-fos NN B-NP
expression NN B-NP
by IN B-PP
TPA NN B-NP
is VBZ B-VP
regulated VBN I-VP
by IN B-PP
transcriptional JJ B-NP
mechanisms NNS I-NP
COMMA COMMA O
( ( B-LST
2 LS I-LST
) ) O
TPA-induced JJ B-NP
expression NN I-NP
of IN B-PP
c-jun NN B-NP
and CC O
c-fos NN B-NP
does VBZ B-VP
not RB I-VP
require VB I-VP
protein NN B-NP
synthesis NN I-NP
COMMA COMMA O
and CC O
( ( B-LST
3 LS I-LST
) ) O
TPA-induced JJ B-NP
expression NN I-NP
of IN B-PP
both DT B-NP
genes NNS I-NP
is VBZ B-VP
inhibited VBN I-VP
at IN B-PP
the DT B-NP
transcriptional JJ I-NP
level NN I-NP
by IN B-PP
dexamethasone NN B-NP
. . O

To TO B-VP
further RB I-VP
define VB I-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
dexamethasone NN B-NP
at IN B-PP
the DT B-NP
molecular JJ I-NP
level NN I-NP
COMMA COMMA O
we PRP B-NP
prepared VBD B-VP
a DT B-NP
series NN I-NP
of IN B-PP
deleted VBN B-NP
c-jun NN I-NP
promoter NN I-NP
fragments NNS I-NP
linked VBN B-VP
to TO B-PP
the DT O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
( ( O
CAT NN B-NP
) ) O
gene NN B-NP
. . O

Increases NNS B-NP
in IN B-PP
CAT NN B-NP
activity NN I-NP
during IN B-PP
transient JJ B-NP
expression NN I-NP
of IN B-PP
these DT B-NP
constructs NNS I-NP
in IN B-PP
TPA-treated JJ B-NP
U-937 NN I-NP
cells NNS I-NP
could MD B-VP
be VB I-VP
assigned VBN I-VP
to TO B-PP
the DT B-NP
region NN I-NP
( ( O
-97 CD B-NP
to TO O
-20 CD B-NP
) ) O
of IN B-PP
the DT B-NP
promoter NN I-NP
that WDT B-NP
contains VBZ B-VP
the DT B-NP
AP-1 NN I-NP
binding NN I-NP
site NN I-NP
. . O

This DT B-NP
induction NN I-NP
of IN B-PP
CAT NN B-NP
activity NN I-NP
was VBD B-VP
sensitive JJ B-ADJP
to TO B-PP
dexamethasone NN B-NP
. . O

These DT B-NP
findings NNS I-NP
suggest VBP B-VP
that IN B-SBAR
dexamethasone NN B-NP
down-regulates VBZ B-VP
TPA-induced JJ B-NP
transcription NN I-NP
of IN B-PP
the DT B-NP
c-jun NN I-NP
gene NN I-NP
during IN B-PP
monocytic JJ B-NP
differentiation NN I-NP
by IN B-PP
inhibiting VBG B-VP
activation NN B-NP
of IN B-PP
the DT B-NP
AP-1 NN I-NP
site NN I-NP
. . O

Charybdotoxin-sensitive JJ B-NP
COMMA COMMA I-NP
Ca(2+)-dependent JJ I-NP
membrane NN I-NP
potential JJ I-NP
changes NNS I-NP
are VBP B-VP
not RB I-VP
involved VBN I-VP
in IN B-PP
human JJ B-NP
T NN I-NP
or CC I-NP
B NN I-NP
cell NN I-NP
activation NN B-NP
and CC O
proliferation NN B-NP
. . O

The DT B-NP
involvement NN I-NP
of IN B-PP
ion NN B-NP
channels NNS I-NP
in IN B-PP
B NN B-NP
and CC I-NP
T NN I-NP
lymphocyte NN I-NP
activation NN I-NP
is VBZ B-VP
supported VBN I-VP
by IN B-PP
many JJ B-NP
reports NNS I-NP
of IN B-PP
changes NNS B-NP
in IN B-PP
ion NN B-NP
fluxes NNS I-NP
and CC O
membrane NN B-NP
potential NN I-NP
after IN B-PP
mitogen NN B-NP
binding NN I-NP
. . O

Human JJ B-NP
T NN I-NP
and CC I-NP
B NN I-NP
lymphocytes NNS I-NP
demonstrate VBP B-VP
an DT B-NP
early JJ I-NP
and CC I-NP
transient JJ I-NP
hyperpolarization NN I-NP
after IN B-PP
ligand JJ B-NP
binding NN I-NP
. . O

Inasmuch RB B-SBAR
as IN I-SBAR
the DT B-NP
change NN I-NP
in IN B-PP
membrane NN B-NP
potential NN I-NP
is VBZ B-VP
dependent JJ B-ADJP
on IN B-PP
elevation NN B-NP
of IN B-PP
free JJ B-NP
cytosolic JJ I-NP
calcium NN I-NP
COMMA COMMA O
the DT B-NP
hyperpolarization NN I-NP
is VBZ B-VP
presumably RB B-ADVP
through IN B-PP
opening NN B-NP
of IN B-PP
Ca(2+)-stimulated JJ B-NP
K+ NN I-NP
channels NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
used VBN I-VP
charybdotoxin NN B-NP
COMMA COMMA O
a DT B-NP
known JJ I-NP
inhibitor NN I-NP
of IN B-PP
Ca(2+)-dependent JJ B-NP
K+ NN I-NP
channels NNS I-NP
COMMA COMMA O
to TO B-VP
study VB I-VP
the DT B-NP
role NN I-NP
of IN B-PP
these DT B-NP
channels NNS I-NP
in IN B-PP
lymphocyte NN B-NP
activation NN B-NP
and CC O
mitogenesis NN B-NP
. . O

We PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
charybdotoxin NN B-NP
inhibits VBZ B-VP
the DT B-NP
ligand-induced JJ I-NP
transient JJ I-NP
membrane NN I-NP
hyperpolarization NN I-NP
in IN B-PP
B NN B-NP
and CC O
T NN B-NP
cells NNS B-NP
in IN B-PP
a DT B-NP
dose-dependent JJ I-NP
fashion NN I-NP
COMMA COMMA O
without IN B-PP
affecting VBG B-VP
changes NNS B-NP
in IN B-PP
cytosolic JJ B-NP
Ca2+ NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
blockade NN B-NP
of IN B-PP
the DT B-NP
Ca(2+)-activated JJ I-NP
K+ NN I-NP
channel NN I-NP
is VBZ B-VP
not RB I-VP
associated VBN I-VP
with IN B-PP
changes NNS B-NP
in IN B-PP
cell-cycle JJ B-NP
gene NN I-NP
activation NN I-NP
COMMA COMMA O
IL-2 NN B-NP
production NN I-NP
COMMA COMMA O
IL-2R NN B-NP
expression NN I-NP
or CC O
B NN B-NP
and CC O
T NN B-NP
cell NN B-NP
mitogenesis NN I-NP
. . O

These DT B-NP
results NNS I-NP
imply VBP B-VP
that IN B-SBAR
membrane NN B-NP
potential JJ I-NP
changes NNS I-NP
secondary JJ B-ADJP
to TO B-PP
the DT B-NP
ligand-dependent JJ I-NP
opening NN I-NP
of IN B-PP
Ca(2+)-activated JJ B-NP
K+ NN I-NP
channels NNS I-NP
are VBP B-VP
not RB I-VP
involved VBN I-VP
in IN B-PP
B NN B-NP
and CC O
T NN B-NP
lymphocyte NN B-NP
activation NN B-NP
and CC O
mitogenesis NN B-NP
. . O

Evaluation NN B-NP
of IN B-PP
the DT B-NP
role NN I-NP
of IN B-PP
ligand NN B-NP
and CC O
thermal JJ B-NP
activation NN I-NP
of IN B-PP
specific JJ B-NP
DNA NN I-NP
binding NN I-NP
by IN B-PP
in FW B-ADVP
vitro FW I-ADVP
synthesized VBN B-NP
human JJ I-NP
glucocorticoid NN I-NP
receptor NN I-NP
. . O

We PRP B-NP
have VBP B-VP
used VBN I-VP
a DT B-NP
DNA-binding\/immunoprecipitation JJ I-NP
assay NN I-NP
to TO B-VP
analyze VB I-VP
the DT B-NP
capacity NN I-NP
of IN B-PP
human JJ B-NP
glucocorticoid NN I-NP
receptor NN I-NP
( ( O
hGR NN B-NP
) ) O
COMMA COMMA O
generated VBN B-VP
in IN B-PP
rabbit NN B-NP
reticulocyte NN I-NP
lysates NNS I-NP
COMMA COMMA O
to TO B-VP
bind VB I-VP
DNA NN B-NP
. . O

In FW B-ADVP
vitro FW I-ADVP
translated VBN B-NP
hGR NN I-NP
was VBD B-VP
indistinguishable JJ B-ADJP
from IN B-PP
native JJ B-NP
hGR NN I-NP
COMMA COMMA O
as IN B-SBAR
determined VBN B-VP
by IN B-PP
migration NN B-NP
on IN B-PP
sodium NN B-NP
dodecyl NN I-NP
sulfate-polyacrylamide JJ I-NP
gels NNS I-NP
COMMA COMMA O
sedimentation NN B-NP
on IN B-PP
sucrose NN B-NP
density NN I-NP
gradients NNS I-NP
COMMA COMMA O
and CC O
reactivity NN B-NP
with IN B-PP
antipeptide JJ B-NP
antibodies NNS I-NP
generated VBN B-VP
against IN B-PP
hGR NN B-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
cell-free JJ B-NP
synthesized VBN I-NP
hGR NN I-NP
was VBD B-VP
capable JJ B-ADJP
of IN B-PP
specific JJ B-NP
binding NN I-NP
to TO B-PP
glucocorticoid NN B-NP
response NN I-NP
element NN I-NP
( ( I-NP
GRE NN I-NP
) ) I-NP
-containing JJ I-NP
DNA NN I-NP
fragments NNS I-NP
. . O

Using VBG B-VP
this DT B-NP
assay NN I-NP
system NN I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
evaluated VBN I-VP
the DT B-NP
contributions NNS I-NP
of IN B-PP
ligand NN B-NP
binding NN I-NP
and CC O
heat NN B-NP
activation NN I-NP
to TO B-PP
DNA NN B-NP
binding NN I-NP
by IN B-PP
these DT B-NP
glucocorticoid NN I-NP
receptors NNS I-NP
. . O

In FW B-ADVP
vitro FW I-ADVP
translated VBN B-NP
hGR NN I-NP
was VBD B-VP
capable JJ B-ADJP
of IN B-PP
selective JJ B-NP
DNA NN I-NP
binding NN I-NP
even RB B-PP
in IN I-PP
the DT I-PP
absence NN I-PP
of IN I-PP
glucocorticoid NN B-NP
. . O

Treatment NN B-NP
with IN B-PP
dexamethasone NN B-NP
or CC O
the DT B-NP
antiglucocorticoid JJ I-NP
RU486 NN I-NP
had VBD B-VP
no DT B-NP
additional JJ I-NP
effect NN I-NP
on IN B-PP
the DT B-NP
DNA-binding JJ I-NP
capacity NN I-NP
when WRB B-ADVP
receptor NN B-NP
preparations NNS I-NP
were VBD B-VP
maintained VBN I-VP
at IN B-PP
0 CD B-NP
C NN I-NP
( ( O
no DT B-NP
activation NN I-NP
) ) O
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
addition NN B-NP
of IN B-PP
either CC O
ligand NN B-NP
or CC O
antagonist NN B-NP
in IN B-PP
combination NN B-NP
with IN B-PP
a DT B-NP
heat NN I-NP
activation NN I-NP
step NN I-NP
promoted VBD B-VP
DNA NN B-NP
binding NN I-NP
by IN B-PP
approximately RB B-NP
3-fold RB I-NP
over IN B-PP
that DT B-NP
of IN B-PP
heat-activated JJ B-NP
unliganded JJ I-NP
receptors NNS I-NP
. . O

Agonist NN B-NP
( ( O
dexamethasone NN B-NP
) ) O
was VBD B-VP
slightly RB B-ADJP
more JJR I-ADJP
effective JJ I-ADJP
in IN B-PP
supporting VBG B-VP
specific JJ B-NP
DNA NN I-NP
binding NN I-NP
than IN B-PP
antagonist NN B-NP
( ( O
RU486 NN B-NP
) ) O
. . O

DNA NN B-NP
binding NN I-NP
by IN B-PP
in FW B-ADVP
vitro FW I-ADVP
synthesized VBN B-NP
GR NN I-NP
was VBD B-VP
blocked VBN I-VP
by IN B-PP
the DT B-NP
addition NN I-NP
of IN B-PP
sodium NN B-NP
molybdate NN I-NP
to TO B-PP
the DT B-NP
receptor NN I-NP
preparations NNS I-NP
before IN B-PP
steroid NN B-NP
addition NN I-NP
and CC O
thermal JJ B-NP
activation NN I-NP
. . O

Addition NN B-NP
of IN B-PP
KCl NN B-NP
resulted VBD B-VP
in IN B-PP
less RBR B-NP
DNA NN I-NP
binding NN I-NP
either CC B-PP
due JJ I-PP
to TO I-PP
blockage NN B-NP
of IN B-PP
DNA-receptor JJ B-NP
complex NN I-NP
formation NN I-NP
or CC O
disruption NN B-NP
of IN B-PP
the DT B-NP
complexes NNS I-NP
. . O

The DT B-NP
specificity NN I-NP
of IN B-PP
DNA NN B-NP
binding NN I-NP
by IN B-PP
cell-free JJ B-NP
synthesized VBN I-NP
hGR NN I-NP
was VBD B-VP
analyzed VBN I-VP
further RB B-ADVP
by IN B-PP
examining VBG B-VP
the DT B-NP
abilities NNS I-NP
of IN B-PP
various JJ B-NP
DNAs NNS I-NP
to TO B-VP
compete VB I-VP
for IN B-PP
binding VBG B-VP
to TO B-PP
a DT B-NP
naturally RB I-NP
occurring VBG I-NP
GRE NN I-NP
found VBD B-VP
in IN B-PP
the DT B-NP
mouse NN I-NP
mammary JJ I-NP
tumor NN I-NP
virus-long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
. . O

Oligonucleotides NNS B-NP
containing VBG B-VP
the DT B-NP
consensus NN I-NP
GRE NN I-NP
were VBD B-VP
the DT B-NP
most RBS I-NP
efficient JJ I-NP
competitors NNS I-NP
COMMA COMMA O
and CC O
fragments NNS B-NP
containing VBG B-VP
regulatory JJ B-NP
sequences NNS I-NP
from IN B-PP
glucocorticoid-repressible JJ B-NP
genes NNS I-NP
were VBD B-VP
somewhat RB B-ADJP
competitive JJ I-ADJP
COMMA COMMA O
whereas IN O
single JJ B-NP
stranded JJ I-NP
oligonucleotides NNS I-NP
were VBD B-VP
unable JJ B-ADJP
to TO B-VP
compete VB I-VP
for IN B-PP
mouse NN B-NP
mammary JJ I-NP
tumor NN I-NP
virus-long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
DNA NN I-NP
binding NN I-NP
COMMA COMMA O
except IN B-PP
when WRB B-ADVP
competitor NN B-NP
was VBD B-VP
present JJ B-ADJP
at IN B-PP
extremely RB B-NP
high JJ I-NP
concentrations NNS I-NP
. . O

Together RB B-ADVP
these DT B-NP
studies NNS I-NP
indicate VBP B-VP
that IN B-SBAR
hGR NN B-NP
synthesized VBN B-VP
in IN B-PP
rabbit NN B-NP
reticulocyte NN I-NP
lysates NNS I-NP
displays VBZ B-VP
many JJ B-NP
of IN B-PP
the DT B-NP
same JJ I-NP
properties NNS I-NP
COMMA COMMA O
including VBG B-PP
GRE-specific JJ B-NP
DNA NN I-NP
binding NN I-NP
COMMA COMMA O
observed VBN B-VP
for IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
present JJ B-ADJP
in IN B-PP
cytosolic JJ B-NP
extracts NNS I-NP
of IN B-PP
mammalian JJ B-NP
cells NNS B-NP
and CC O
tissues NNS B-NP
. . O

Similarities NNS B-NP
between IN B-PP
the DT B-NP
effects NNS I-NP
of IN B-PP
dexamethasone NN B-NP
and CC O
RU486 NN B-NP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
antiglucocorticoid JJ I-NP
properties NNS I-NP
of IN B-PP
RU486 NN B-NP
do VBP B-VP
not RB I-VP
occur VB I-VP
at IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
specific JJ B-NP
DNA NN I-NP
binding NN I-NP
. . O

One CD B-NP
base NN I-NP
pair NN I-NP
change NN I-NP
abolishes VBZ B-VP
the DT B-NP
T NN I-NP
cell-restricted JJ I-NP
activity NN I-NP
of IN B-PP
a DT B-NP
kB-like JJ I-NP
proto-enhancer NN I-NP
element NN I-NP
from IN B-PP
the DT B-NP
interleukin NN I-NP
2 CD I-NP
promoter NN I-NP
. . O

The DT B-NP
inducible JJ I-NP
COMMA COMMA I-NP
T NN I-NP
cell-specific JJ I-NP
enhancers NNS I-NP
of IN B-PP
murine JJ O
and CC O
human JJ O
Interleukin NN B-NP
2 CD I-NP
( ( O
Il-2 NN B-NP
) ) O
genes NNS B-NP
contain VBP B-VP
the DT B-NP
kB-like JJ I-NP
sequence NN I-NP
GGGATTTCACC NN I-NP
as IN B-PP
an DT B-NP
essential JJ I-NP
cis-acting JJ I-NP
enhancer NN I-NP
motif NN I-NP
. . O

When WRB B-ADVP
cloned VBN B-VP
in IN B-PP
multiple JJ B-NP
copies NNS I-NP
this DT B-NP
so-called JJ I-NP
TCEd NN B-NP
( ( O
distal JJ B-NP
T NN I-NP
cell NN I-NP
element NN I-NP
) ) O
acts VBZ B-VP
as IN B-PP
an DT B-NP
inducible JJ I-NP
proto-enhancer NN I-NP
element NN I-NP
in IN B-PP
E14 NN B-NP
T NN I-NP
lymphoma NN I-NP
cells NNS I-NP
COMMA COMMA B-PP
but CC I-PP
not RB B-PP
in IN I-PP
HeLa NN B-NP
cells NNS I-NP
. . O

In IN B-PP
extracts NNS B-NP
of IN B-PP
induced VBN B-NP
COMMA COMMA I-NP
Il-2 NN I-NP
secreting NN I-NP
El4 NN I-NP
cells NNS I-NP
three CD B-NP
individual JJ I-NP
protein NN I-NP
factors NNS I-NP
bind VBP B-VP
to TO B-PP
TCEd NN B-NP
DNA NN I-NP
. . O

The DT B-NP
binding NN I-NP
of IN B-PP
the DT B-NP
most RBS I-NP
prominent JJ I-NP
factor NN I-NP
COMMA COMMA O
named VBN B-VP
TCF-1 NN B-NP
( ( O
T NN B-NP
cell NN I-NP
factor NN I-NP
1 CD I-NP
) ) O
COMMA COMMA O
is VBZ B-VP
correlated VBN I-VP
with IN B-PP
the DT B-NP
proto-enhancer NN I-NP
activity NN I-NP
of IN B-PP
TCEd NN B-NP
. . O

TCF-1 NN B-NP
consists VBZ B-VP
of IN B-PP
two CD B-NP
polypeptides NNS I-NP
of IN B-PP
about RB B-ADVP
50 CD B-NP
kD NN I-NP
and CC O
105 CD B-NP
kD NN I-NP
; : O
the DT B-NP
former JJ I-NP
seems VBZ B-VP
to TO I-VP
be VB I-VP
related JJ B-ADJP
to TO B-PP
the DT B-NP
50 CD B-NP
kD NN I-NP
polypeptide NN B-NP
of IN B-PP
NF-kB NN B-NP
. . O

Purified VBN B-NP
NF-kB NN I-NP
is VBZ B-VP
also RB B-ADJP
able JJ I-ADJP
to TO B-VP
bind VB I-VP
to TO B-PP
the DT B-NP
TCEd NN I-NP
COMMA COMMA O
but CC O
TCF-1 NN B-NP
binds VBZ B-VP
stronger JJR B-ADVP
than IN B-PP
NF-kB NN B-NP
to TO B-PP
TCEd NN B-NP
DNA NN I-NP
. . O

The DT B-NP
conversion NN I-NP
of IN B-PP
the DT B-NP
TCEd NN I-NP
to TO B-PP
a DT B-NP
' `` I-NP
perfect JJ I-NP
' '' I-NP
NF-kB NN I-NP
binding NN I-NP
site NN I-NP
leads VBZ B-VP
to TO B-PP
a DT B-NP
tighter JJR I-NP
binding NN I-NP
of IN B-PP
NF-kB NN B-NP
to TO B-PP
TCEd NN B-NP
DNA NN I-NP
and CC O
COMMA COMMA O
as IN B-PP
a DT B-NP
functional JJ I-NP
consequence NN I-NP
COMMA COMMA O
to TO B-PP
the DT B-NP
activity NN I-NP
of IN B-PP
the DT B-NP
' `` I-NP
converted VBN I-NP
' '' I-NP
TCEd NN I-NP
motifs NNS I-NP
in IN B-PP
HeLa NN B-NP
cells NNS I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
the DT B-NP
substitution NN I-NP
of IN B-PP
the DT B-NP
underlined VBN I-NP
A NN I-NP
residue NN I-NP
to TO B-PP
a DT B-NP
C NN I-NP
within IN B-PP
the DT B-NP
GGGATTTCACC NN I-NP
motif NN I-NP
abolishes VBZ B-VP
its PRP$ B-NP
T NN I-NP
cell-restricted JJ I-NP
activity NN I-NP
and CC O
leads VBZ B-VP
to TO B-PP
its PRP$ B-NP
functioning VBG B-VP
in IN B-PP
both CC O
El4 NN B-NP
cells NNS I-NP
and CC O
HeLa NN B-NP
cells NNS I-NP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
lymphocyte-specific JJ B-NP
factors NNS I-NP
binding VBG B-VP
to TO B-PP
the DT B-NP
TCEd NN I-NP
are VBP B-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
T NN B-NP
cell NN I-NP
specific-transcription NN I-NP
of IN B-PP
the DT B-NP
Il-2 NN I-NP
gene NN I-NP
. . O

Negative JJ B-NP
regulation NN I-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
expression NN I-NP
in IN B-PP
monocytes NNS B-NP
: : O
role NN B-NP
of IN B-PP
the DT B-NP
65-kDa JJ I-NP
plus CC I-NP
50-kDa JJ I-NP
NF-kappa NN I-NP
B NN I-NP
dimer NN I-NP
. . O

Although IN B-SBAR
monocytic JJ B-NP
cells NNS I-NP
can MD B-VP
provide VB I-VP
a DT B-NP
reservoir NN I-NP
for IN B-PP
viral JJ B-NP
production NN I-NP
in FW B-ADVP
vivo FW I-ADVP
COMMA COMMA O
their PRP$ B-NP
regulation NN I-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HIV-1 NN B-NP
) ) O
transcription NN B-NP
can MD B-VP
be VB I-VP
either CC O
latent JJ B-ADJP
COMMA COMMA O
restricted JJ B-ADJP
COMMA COMMA O
or CC O
productive JJ B-ADJP
. . O

These DT B-NP
differences NNS I-NP
in IN B-PP
gene NN B-NP
expression NN I-NP
have VBP B-VP
not RB I-VP
been VBN I-VP
molecularly RB B-ADJP
defined VBN I-ADJP
. . O

In IN B-PP
THP-1 NN B-NP
cells NNS I-NP
with IN B-PP
restricted JJ B-NP
HIV NN I-NP
expression NN I-NP
COMMA COMMA O
there EX B-NP
is VBZ B-VP
an DT B-NP
absence NN I-NP
of IN B-PP
DNA-protein JJ B-NP
binding NN I-NP
complex NN I-NP
formation NN I-NP
with IN B-PP
the DT B-NP
HIV-1 NN I-NP
promoter-enhancer NN I-NP
associated VBN B-VP
with IN B-PP
markedly RB B-ADVP
less JJR I-ADVP
viral JJ B-NP
RNA NN I-NP
production NN I-NP
. . O

This DT B-NP
absence NN I-NP
of IN B-PP
binding NN B-NP
was VBD B-VP
localized JJ B-ADJP
to TO B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
region NN I-NP
of IN B-PP
the DT B-NP
HIV-1 NN I-NP
enhancer NN I-NP
; : O
the DT B-NP
65-kDa JJ I-NP
plus CC I-NP
50-kDa JJ I-NP
NF-kappa NN I-NP
B NN I-NP
heterodimer NN I-NP
was VBD B-VP
preferentially RB B-ADJP
lost VBN I-ADJP
. . O

Adding VBG B-VP
purified VBN B-NP
NF-kappa NN I-NP
B NN I-NP
protein NN I-NP
to TO B-PP
nuclear JJ B-NP
extracts NNS I-NP
from IN B-PP
cells NNS B-NP
with IN B-PP
restricted JJ B-NP
expression NN I-NP
overcomes VBZ B-VP
this DT B-NP
lack NN I-NP
of IN B-PP
binding NN B-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
treatment NN B-NP
of IN B-PP
these DT B-NP
nuclear JJ I-NP
extracts NNS I-NP
with IN B-PP
sodium NN B-NP
deoxycholate NN I-NP
restored VBD B-VP
their PRP$ B-NP
ability NN I-NP
to TO B-VP
form VB I-VP
the DT B-NP
heterodimer NN I-NP
COMMA COMMA O
suggesting VBG B-VP
the DT B-NP
presence NN I-NP
of IN B-PP
an DT B-NP
inhibitor NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
activity NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
treatment NN B-NP
of IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
from IN B-PP
these DT B-NP
cells NNS I-NP
that WDT B-NP
had VBD B-VP
restricted JJ B-NP
expression NN I-NP
with IN B-PP
lipopolysaccharide NN B-NP
increased VBD B-VP
viral JJ B-NP
production NN I-NP
and CC O
NF-kappa NN B-NP
B NN I-NP
activity NN I-NP
. . O

Antiserum NN B-NP
specific JJ B-ADJP
for IN B-PP
NF-kappa NN B-NP
B NN I-NP
binding NN I-NP
proteins NNS I-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
c-rel-specific JJ B-NP
antiserum NN I-NP
COMMA COMMA O
disrupted VBD B-VP
heterodimer NN B-NP
complex NN I-NP
formation NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
both DT B-NP
NF-kappa NN I-NP
B-binding JJ I-NP
complexes NNS I-NP
are VBP B-VP
needed VBN I-VP
for IN B-PP
optimal JJ B-NP
viral JJ I-NP
transcription NN I-NP
. . O

Binding NN B-NP
of IN B-PP
the DT B-NP
65-kDa JJ I-NP
plus CC I-NP
50-kDa JJ I-NP
heterodimer NN I-NP
to TO B-PP
the DT B-NP
HIV-1 NN I-NP
enhancer NN I-NP
can MD B-VP
be VB I-VP
negatively RB I-VP
regulated VBN I-VP
in IN B-PP
monocytes NNS B-NP
COMMA COMMA O
providing VBG B-VP
one CD B-NP
mechanism NN I-NP
restricting VBG B-VP
HIV-1 NN B-NP
gene NN I-NP
expression NN I-NP
. . O

Isolation NN B-NP
of IN B-PP
a DT B-NP
candidate NN I-NP
repressor\/activator NN B-NP
COMMA COMMA O
NF-E1 NN B-NP
( ( O
YY-1 NN B-NP
COMMA COMMA I-NP
delta NN I-NP
) ) O
COMMA COMMA O
that WDT B-NP
binds VBZ B-VP
to TO B-PP
the DT B-NP
immunoglobulin NN I-NP
kappa NN I-NP
3' JJ I-NP
enhancer NN I-NP
and CC O
the DT B-NP
immunoglobulin NN I-NP
heavy-chain NN I-NP
mu NN I-NP
E1 NN I-NP
site NN I-NP
. . O

We PRP B-NP
have VBP B-VP
determined VBN I-VP
that IN B-SBAR
the DT B-NP
developmental JJ I-NP
control NN I-NP
of IN B-PP
immunoglobulin NN B-NP
kappa NN I-NP
3' JJ I-NP
enhancer NN I-NP
( ( I-NP
kappa NN I-NP
E3' NN I-NP
) ) I-NP
activity NN I-NP
is VBZ B-VP
the DT B-NP
result NN I-NP
of IN B-PP
the DT B-NP
combined JJ I-NP
influence NN I-NP
of IN B-PP
positive- JJ B-NP
and CC I-NP
negative-acting JJ I-NP
elements NNS I-NP
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
a DT B-NP
central JJ I-NP
core NN I-NP
in IN B-PP
the DT B-NP
kappa NN I-NP
E3' NN I-NP
enhancer NN I-NP
is VBZ B-VP
active JJ B-ADJP
at IN B-PP
the DT B-NP
pre-B-cell JJ I-NP
stage NN I-NP
but CC O
is VBZ B-VP
repressed VBN I-VP
by IN B-PP
flanking VBG B-NP
negative-acting JJ I-NP
elements NNS I-NP
. . O

The DT B-NP
negative-acting JJ I-NP
sequences NNS I-NP
repress VBP B-VP
enhancer NN B-NP
activity NN I-NP
in IN B-PP
a DT O
position- NN B-NP
and CC O
orientation-independent JJ B-ADJP
manner NN B-NP
at IN B-PP
the DT B-NP
pre-B-cell JJ I-NP
stage NN I-NP
. . O

We PRP B-NP
have VBP B-VP
isolated VBN I-VP
a DT B-NP
human JJ I-NP
cDNA NN I-NP
clone NN I-NP
encoding VBG B-VP
a DT B-NP
zinc NN I-NP
finger NN I-NP
protein NN I-NP
( ( O
NF-E1 NN B-NP
) ) O
that WDT B-NP
binds VBZ B-VP
to TO B-PP
the DT B-NP
negative-acting JJ I-NP
segment NN I-NP
of IN B-PP
the DT B-NP
kappa NN I-NP
E3' NN I-NP
enhancer NN I-NP
. . O

This DT B-NP
protein NN I-NP
also RB B-ADVP
binds VBZ B-VP
to TO B-PP
the DT B-NP
immunoglobulin NN I-NP
heavy-chain NN I-NP
enhancer NN I-NP
mu NN I-NP
E1 NN I-NP
site NN I-NP
. . O

NF-E1 NN B-NP
is VBZ B-VP
encoded VBN I-VP
by IN B-PP
the DT B-NP
same JJ I-NP
gene NN I-NP
as IN B-PP
the DT B-NP
YY-1 NN I-NP
protein NN I-NP
COMMA COMMA O
which WDT B-NP
binds VBZ B-VP
to TO B-PP
the DT B-NP
adeno-associated JJ I-NP
virus NN I-NP
P5 NN I-NP
promoter NN I-NP
. . O

NF-E1 NN B-NP
is VBZ B-VP
also RB B-ADVP
the DT B-NP
human JJ I-NP
homologue NN I-NP
of IN B-PP
the DT B-NP
mouse NN I-NP
delta NN I-NP
protein NN I-NP
COMMA COMMA O
which WDT B-NP
binds VBZ B-VP
to TO B-PP
ribosomal JJ B-NP
protein NN I-NP
gene NN I-NP
promoters NNS I-NP
. . O

The DT B-NP
predicted VBN I-NP
amino NN I-NP
acid NN I-NP
sequence NN I-NP
of IN B-PP
this DT B-NP
protein NN I-NP
contains VBZ B-VP
features NNS B-NP
characteristic JJ B-ADJP
of IN B-PP
transcriptional JJ B-NP
activators NNS I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
transcriptional JJ B-NP
repressors NNS I-NP
. . O

Cotransfection NN B-NP
studies NNS I-NP
with IN B-PP
this DT B-NP
cDNA NN I-NP
indicate VBP B-VP
that IN B-SBAR
it PRP B-NP
can MD B-VP
repress VB I-VP
basal JJ B-NP
promoter NN I-NP
activity NN I-NP
. . O

The DT B-NP
apparent JJ I-NP
dual JJ I-NP
function NN I-NP
of IN B-PP
this DT B-NP
protein NN I-NP
is VBZ B-VP
discussed VBN I-VP
. . O

Clone NN B-NP
pAT NN I-NP
133 CD I-NP
identifies VBZ B-VP
a DT B-NP
gene NN I-NP
that WDT B-NP
encodes VBZ B-VP
another DT B-NP
human JJ I-NP
member NN I-NP
of IN B-PP
a DT B-NP
class NN I-NP
of IN B-PP
growth NN B-NP
factor-induced JJ I-NP
genes NNS I-NP
with IN B-PP
almost RB B-NP
identical JJ I-NP
zinc-finger NN I-NP
domains NNS I-NP
. . O

We PRP B-NP
report VBP B-VP
the DT B-NP
structure NN B-NP
and CC O
regulation NN B-NP
of IN B-PP
a DT B-NP
gene NN I-NP
represented VBN B-VP
by IN B-PP
clone NN B-NP
pAT NN I-NP
133 CD I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
induced VBN I-VP
upon IN B-PP
transition NN B-NP
from IN B-PP
a DT B-NP
resting JJ I-NP
state NN I-NP
( ( O
G0 NN B-NP
) ) O
through IN B-PP
the DT B-NP
early JJ I-NP
phase NN I-NP
of IN B-PP
the DT B-NP
cell NN I-NP
cycle NN I-NP
( ( O
G1 NN B-NP
) ) O
. . O

The DT B-NP
pAT NN I-NP
133 CD I-NP
gene NN I-NP
is VBZ B-VP
immediately RB I-VP
induced VBN I-VP
COMMA COMMA O
with IN B-PP
FOS-like JJ B-NP
kinetics NNS I-NP
COMMA COMMA O
in IN B-PP
human JJ B-NP
T NN I-NP
cells NNS I-NP
and CC B-PP
in IN B-PP
fibroblasts NNS B-NP
. . O

Primary JJ B-NP
structure NN I-NP
analysis NN I-NP
showed VBD B-VP
that IN B-SBAR
the DT B-NP
encoded VBN I-NP
protein NN I-NP
contains VBZ B-VP
three CD B-NP
tandem JJ I-NP
zinc-finger NN I-NP
sequences NNS I-NP
of IN B-PP
the DT B-NP
type NN I-NP
Cys2-Xaa12-His2 NN I-NP
. . O

This DT B-NP
zinc-finger NN I-NP
region NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
thought VBN I-VP
to TO I-VP
bind VB I-VP
DNA NN B-NP
in IN B-PP
a DT B-NP
sequence-specific JJ I-NP
manner NN I-NP
COMMA COMMA O
is VBZ B-VP
similar JJ B-ADJP
( ( O
greater JJR B-NP
than IN I-NP
80 CD I-NP
% NN I-NP
on IN B-PP
the DT B-NP
amino NN I-NP
acid NN I-NP
level NN I-NP
) ) O
to TO B-PP
two CD B-NP
previously RB I-NP
described VBN I-NP
transcription NN I-NP
factors NNS I-NP
pAT NN B-NP
225\/EGR1 NN I-NP
and CC O
pAT NN B-NP
591\/EGR2 NN I-NP
. . O

Except IN B-PP
for IN I-PP
the DT B-NP
conserved VBN I-NP
zinc-finger NN I-NP
domains NNS I-NP
COMMA COMMA O
the DT B-NP
amino NN I-NP
acid NN I-NP
sequences NNS I-NP
of IN B-PP
the DT B-NP
three CD I-NP
proteins NNS I-NP
are VBP B-VP
distinct JJ B-ADJP
. . O

This DT B-NP
structural JJ I-NP
similarity NN I-NP
suggests VBZ B-VP
that IN B-SBAR
the DT B-NP
pAT NN I-NP
133 CD I-NP
gene NN I-NP
encodes VBZ B-VP
a DT B-NP
transcription NN I-NP
factor NN I-NP
with IN B-PP
a DT B-NP
specific JJ I-NP
biological JJ I-NP
function NN I-NP
. . O

Comparing VBG B-VP
the DT B-NP
regulation NN I-NP
of IN B-PP
these DT B-NP
related JJ I-NP
zinc-finger-encoding JJ I-NP
genes NNS I-NP
showed VBD B-VP
coordinate JJ B-NP
induction NN I-NP
upon IN B-PP
mitogenic JJ B-NP
stimulation NN I-NP
of IN B-PP
resting VBG B-NP
T NN I-NP
lymphocytes NNS I-NP
and CC B-PP
of IN B-PP
resting VBG B-NP
fibroblasts NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
upon IN B-PP
transition NN B-NP
from IN B-PP
a DT B-NP
proliferating JJ I-NP
( ( O
G1 NN B-NP
) ) O
to TO B-PP
a DT B-NP
resting JJ I-NP
state NN B-NP
of IN B-PP
the DT B-NP
cell NN I-NP
cycle NN I-NP
the DT B-NP
three CD I-NP
genes NNS I-NP
were VBD B-VP
differently RB I-VP
regulated VBN I-VP
. . O

In IN B-PP
human JJ B-NP
histiocytic JJ I-NP
U937 NN I-NP
cells NNS I-NP
mRNA NN B-NP
of IN B-PP
clone NN B-NP
pAT NN I-NP
133 CD I-NP
was VBD B-VP
constitutively RB I-VP
expressed VBN I-VP
COMMA COMMA O
whereas IN O
mRNA NN B-NP
of IN B-PP
pAT NN B-NP
225\/EGR1 NN I-NP
was VBD B-VP
induced VBN I-VP
upon IN B-PP
induction NN B-NP
of IN B-PP
terminal JJ B-NP
differentiation NN I-NP
. . O

In IN B-PP
contrast NN B-NP
mRNA NN B-NP
representing VBG B-VP
pAT NN B-NP
591\/EGR2 NN I-NP
was VBD B-VP
not RB I-VP
expressed VBN I-VP
in IN B-PP
these DT B-NP
cells NNS I-NP
. . O

This DT B-NP
difference NN I-NP
in IN B-PP
gene NN B-NP
regulation NN I-NP
suggests VBZ B-VP
distinct JJ B-NP
biological JJ I-NP
roles NNS I-NP
in IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
cell NN B-NP
proliferation NN I-NP
for IN B-PP
the DT B-NP
respective JJ I-NP
proteins NNS I-NP
. . O

cAMP-dependent JJ B-NP
regulation NN I-NP
of IN B-PP
proenkephalin NN B-NP
by IN B-PP
JunD NN B-NP
and CC O
JunB NN B-NP
: : O
positive JJ B-NP
and CC I-NP
negative JJ I-NP
effects NNS I-NP
of IN B-PP
AP-1 NN B-NP
proteins NNS I-NP
. . O

We PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
JunD NN B-NP
COMMA COMMA O
a DT B-NP
component NN I-NP
of IN B-PP
the DT B-NP
AP-1 NN I-NP
transcription NN I-NP
factor NN I-NP
complex NN I-NP
COMMA COMMA O
activates VBZ B-VP
transcription NN B-NP
of IN B-PP
the DT B-NP
human JJ I-NP
proenkephalin NN I-NP
gene NN I-NP
in IN B-PP
a DT B-NP
fashion NN I-NP
that WDT B-NP
is VBZ B-VP
completely RB B-ADJP
dependent JJ I-ADJP
upon IN B-PP
the DT B-NP
cAMP-dependent JJ I-NP
protein NN I-NP
kinase NN I-NP
COMMA COMMA O
protein NN B-NP
kinase NN I-NP
A NN I-NP
. . O

Activation NN B-NP
of IN B-PP
proenkephalin NN B-NP
transcription NN I-NP
by IN B-PP
JunD NN B-NP
is VBZ B-VP
dependent JJ B-ADJP
upon IN B-PP
a DT O
previously RB O
characterized VBN O
cAMP- NN B-NP
COMMA COMMA O
phorbol NN B-NP
ester- NN I-NP
COMMA COMMA O
and CC O
Ca(2+)-inducible JJ B-ADJP
enhancer NN B-NP
COMMA COMMA O
and CC O
JunD NN B-NP
is VBZ B-VP
shown VBN I-VP
to TO I-VP
bind VB I-VP
the DT B-NP
enhancer NN I-NP
as IN B-PP
a DT B-NP
homodimer NN I-NP
. . O

Another DT B-NP
component NN I-NP
of IN B-PP
the DT B-NP
AP-1 NN I-NP
transcription NN I-NP
complex NN I-NP
COMMA COMMA O
JunB NN B-NP
COMMA COMMA O
is VBZ B-VP
shown VBN I-VP
to TO I-VP
inhibit VB I-VP
activation NN B-NP
mediated VBN B-VP
by IN B-PP
JunD NN B-NP
. . O

As IN B-PP
a DT B-NP
homodimer NN I-NP
JunB NN B-NP
is VBZ B-VP
unable JJ B-ADJP
to TO B-VP
bind VB I-VP
the DT B-NP
enhancer NN I-NP
; : O
however RB O
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
c-Fos NN B-NP
COMMA COMMA O
high-affinity JJ B-NP
binding NN I-NP
is VBZ B-VP
observed VBN I-VP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
JunD NN B-NP
is VBZ B-VP
shown VBN I-VP
to TO I-VP
activate VB I-VP
transcription NN B-NP
of IN B-PP
genes NNS B-NP
linked VBN B-VP
to TO B-PP
both CC O
cAMP NN B-NP
and CC O
phorbol NN B-NP
ester NN I-NP
response NN B-NP
elements NNS I-NP
in IN B-PP
a DT B-NP
protein NN I-NP
kinase NN I-NP
A-dependent JJ I-NP
fashion NN I-NP
COMMA COMMA O
further RB B-ADVP
blurring VBG B-VP
the DT B-NP
distinction NN I-NP
between IN B-PP
these DT B-NP
response NN I-NP
elements NNS I-NP
. . O

These DT B-NP
results NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
the DT B-NP
transcriptional JJ I-NP
activity NN I-NP
of IN B-PP
an DT B-NP
AP-1-related JJ I-NP
protein NN I-NP
is VBZ B-VP
regulated VBN I-VP
by IN B-PP
the DT B-NP
cAMP-dependent JJ I-NP
second-messenger NN I-NP
pathway NN I-NP
and CC O
suggest VBP B-VP
that IN B-SBAR
JunD NN B-NP
and CC O
other JJ B-NP
AP-1-related JJ I-NP
proteins NNS I-NP
may MD B-VP
play VB I-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
gene NN B-NP
expression NN I-NP
by IN B-PP
cAMP-dependent JJ B-NP
intracellular JJ I-NP
signaling NN I-NP
pathways NNS I-NP
. . O

Glucocorticoid NN B-NP
resistance NN I-NP
in IN B-PP
chronic JJ B-NP
asthma NN I-NP
. . O

Glucocorticoid NN B-NP
pharmacokinetics NNS I-NP
COMMA COMMA O
glucocorticoid NN B-NP
receptor NN I-NP
characteristics NNS I-NP
COMMA COMMA O
and CC O
inhibition NN B-NP
of IN B-PP
peripheral JJ B-NP
blood NN I-NP
T NN I-NP
cell NN I-NP
proliferation NN I-NP
by IN B-PP
glucocorticoids NNS B-NP
in FW B-ADJP
vitro FW I-ADJP
. . O

A DT B-NP
total NN I-NP
of IN B-PP
37 CD B-NP
chronic JJ I-NP
COMMA COMMA I-NP
severe JJ I-NP
COMMA COMMA I-NP
nonsmoking JJ I-NP
asthmatic JJ I-NP
patients NNS I-NP
with IN B-PP
documented JJ B-NP
reversible JJ I-NP
airways NNS I-NP
obstruction NN I-NP
were VBD B-VP
classified VBN I-VP
as IN B-PP
glucocorticoid-sensitive JJ B-ADJP
or CC O
-resistant JJ B-ADJP
on IN B-PP
the DT I-PP
basis NN I-PP
of IN I-PP
changes NNS B-NP
in IN B-PP
FEV1 NN B-NP
COMMA COMMA O
FVC NN B-NP
COMMA COMMA O
and CC O
peak JJ B-NP
expiratory NN I-NP
flow NN I-NP
( ( O
PEF NN B-NP
) ) O
after IN B-PP
oral JJ B-NP
prednisolone NN I-NP
. . O

The DT B-NP
resistant JJ I-NP
patients NNS I-NP
showed VBD B-VP
no DT B-NP
significant JJ I-NP
improvements NNS I-NP
in IN B-PP
airflow NN B-NP
limitation NN I-NP
. . O

Phytohemagglutinin NN B-NP
( ( I-NP
PHA NN I-NP
) ) I-NP
-induced JJ I-NP
proliferation NN I-NP
of IN B-PP
peripheral JJ B-NP
blood NN I-NP
T NN I-NP
lymphocytes NNS I-NP
from IN B-PP
the DT B-NP
sensitive JJ I-NP
but CC B-CONJP
not RB I-CONJP
the DT B-NP
resistant JJ I-NP
asthmatic JJ B-NP
patients NNS I-NP
was VBD O
significantly RB O
( ( O
p NN B-NP
less JJR B-ADJP
than IN B-PP
0.01 CD B-NP
) ) O
inhibited VBN B-VP
by IN B-PP
dexamethasone NN B-NP
( ( O
10(-7) CD B-NP
mol\/L NN I-NP
) ) O
COMMA COMMA O
reflecting VBG B-VP
a DT B-NP
shift NN I-NP
of IN B-PP
the DT B-NP
dose-response JJ I-NP
curve NN I-NP
. . O

When WRB B-ADVP
all PDT B-NP
the DT I-NP
asthmatic JJ I-NP
patients NNS I-NP
were VBD B-VP
analyzed VBN I-VP
together RB B-ADVP
COMMA COMMA O
there EX B-NP
was VBD B-VP
a DT B-NP
significant JJ I-NP
correlation NN I-NP
between IN B-PP
the DT B-NP
degree NN I-NP
of IN B-PP
sensitivity NN B-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
to TO B-PP
dexamethasone NN B-NP
and CC O
the DT B-NP
clinical JJ I-NP
responsiveness NN I-NP
to TO B-PP
prednisolone JJ B-NP
( ( O
p NN B-NP
less RBR B-ADJP
than IN B-PP
0.01 CD B-NP
) ) O
. . O

No DT B-NP
differences NNS I-NP
were VBD B-VP
observed VBN I-VP
between IN B-PP
six CD B-NP
of IN B-PP
the DT B-NP
sensitive JJ I-NP
and CC I-NP
resistant JJ I-NP
patients NNS I-NP
in IN B-PP
the DT B-NP
clearance NN I-NP
of IN B-PP
plasma NN B-NP
prednisolone JJ I-NP
derived VBN B-VP
from IN B-PP
orally RB B-NP
administered VBN I-NP
prednisone NN I-NP
. . O

Peripheral JJ B-NP
blood NN I-NP
mononuclear JJ I-NP
cell NN I-NP
glucocorticoid NN I-NP
receptors NNS I-NP
were VBD B-VP
also RB I-VP
characterized VBN I-VP
in IN B-PP
five CD B-NP
sensitive JJ I-NP
and CC O
seven CD B-NP
resistant JJ I-NP
patients NNS B-NP
. . O

The DT B-NP
numbers NNS B-NP
and CC O
binding NN B-NP
affinities NNS I-NP
of IN B-PP
these DT B-NP
receptors NNS I-NP
could MD B-VP
not RB I-VP
account VB I-VP
for IN B-PP
the DT B-NP
observed VBN I-NP
difference NN I-NP
in IN B-PP
the DT B-NP
susceptibility NN I-NP
of IN B-PP
these DT B-NP
cells NNS I-NP
to TO B-PP
functional JJ B-NP
inhibition NN I-NP
by IN B-PP
dexamethasone NN B-NP
in FW B-ADJP
vitro FW I-ADJP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
clinical JJ B-NP
glucocorticoid NN I-NP
resistance NN I-NP
in IN B-PP
chronic JJ B-NP
asthma NN I-NP
does VBZ B-VP
not RB I-VP
reflect VB I-VP
abnormal JJ B-NP
glucocorticoid NN I-NP
clearance NN I-NP
but CC O
may MD B-VP
be VB I-VP
due JJ O
at IN B-ADVP
least JJS I-ADVP
partly RB B-ADVP
to TO B-PP
a DT B-NP
relative JJ I-NP
insensitivity NN I-NP
of IN B-PP
T NN B-NP
lymphocytes NNS I-NP
to TO B-PP
glucocorticoids NNS B-NP
. . O

This DT B-NP
lack NN I-NP
of IN B-PP
sensitivity NN B-NP
is VBZ B-VP
unexplained JJ B-ADJP
but CC O
is VBZ B-VP
not RB O
attributable JJ B-ADJP
to TO B-PP
abnormalities NNS B-NP
of IN B-PP
cellular JJ B-NP
glucocorticoid NN I-NP
receptors NNS I-NP
. . O

Regulation NN B-NP
of IN B-PP
interleukin-1 NN B-NP
beta NN I-NP
production NN I-NP
by IN B-PP
glucocorticoids NNS B-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
: : O
the DT B-NP
mechanism NN I-NP
of IN B-PP
action NN B-NP
depends VBZ B-VP
on IN B-PP
the DT B-NP
activation NN I-NP
signal NN I-NP
. . O

Glucocorticoids NNS B-NP
are VBP B-VP
known VBN I-VP
to TO I-VP
downregulate VB I-VP
interleukin-1 NN B-NP
beta NN I-NP
production NN I-NP
in IN B-PP
monocytic JJ B-NP
cells NNS I-NP
by IN B-PP
two CD B-NP
different JJ I-NP
mechanims NNS I-NP
: : O
direct JJ B-NP
inhibition NN I-NP
of IN B-PP
the DT B-NP
gene NN I-NP
transcription NN I-NP
and CC O
destabilization NN B-NP
of IN B-PP
the DT B-NP
preformed JJ I-NP
interleukin-1 NN I-NP
beta NN I-NP
mRNA NN I-NP
. . O

Now RB B-ADVP
we PRP B-NP
have VBP B-VP
examined VBN I-VP
the DT B-NP
effect NN I-NP
of IN B-PP
the DT B-NP
nature NN I-NP
of IN B-PP
the DT B-NP
monocyte NN I-NP
activating NN I-NP
signal NN I-NP
on IN B-PP
these DT B-NP
two CD I-NP
inhibitory JJ I-NP
mechanims NNS I-NP
. . O

When WRB B-ADVP
human JJ B-NP
monocytes NNS I-NP
were VBD B-VP
preincubated VBN I-VP
with IN B-PP
dexamethasone NN B-NP
for IN B-PP
1 CD B-NP
hour NN I-NP
and CC O
then RB O
stimulated VBN B-VP
either CC B-PP
with IN I-PP
bacterial JJ B-NP
lipopolysaccharide NN I-NP
or CC O
phorbol NN B-NP
myristate NN I-NP
COMMA COMMA O
it PRP B-NP
was VBD B-VP
found VBN I-VP
that IN B-SBAR
dexamethasone NN B-NP
inhibited VBD B-VP
the DT B-NP
lipopolysaccharide-induced JJ I-NP
interleukin-1 NN I-NP
beta NN I-NP
protein NN I-NP
production NN I-NP
COMMA COMMA O
but CC O
the DT B-NP
phorbol NN I-NP
myristate-induced JJ I-NP
production NN I-NP
was VBD B-VP
increased VBN I-VP
3-10 CD B-NP
fold RB I-NP
. . O

This DT B-NP
difference NN I-NP
was VBD B-VP
also RB I-VP
seen VBN I-VP
at IN B-PP
the DT B-NP
mRNA NN I-NP
level NN I-NP
. . O

When WRB B-ADVP
dexamethasone NN B-NP
was VBD B-VP
added VBN I-VP
to TO B-PP
the DT B-NP
cultures NNS I-NP
3 CD B-NP
hours NNS I-NP
after IN B-PP
the DT B-NP
stimulators NNS I-NP
COMMA COMMA O
it PRP B-NP
clearly RB B-ADVP
decreased VBD B-VP
the DT B-NP
interleukin-1 NN I-NP
beta NN I-NP
mRNA NN I-NP
levels NNS I-NP
regardless RB B-ADVP
of IN B-PP
the DT B-NP
stimulator NN I-NP
used VBN B-VP
( ( O
although IN B-SBAR
the DT B-NP
effect NN I-NP
was VBD B-VP
clearly RB B-ADJP
weaker JJR I-ADJP
on IN B-PP
the DT B-NP
PMA-induced JJ I-NP
mRNA NN I-NP
) ) O
. . O

Thus RB B-ADVP
these DT B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
phorbol NN I-NP
myristate-induced JJ I-NP
signal NN I-NP
( ( O
prolonged JJ B-NP
protein NN I-NP
kinase NN I-NP
C NN I-NP
activation NN I-NP
? . O
) ) O
can MD B-VP
not RB I-VP
be VB I-VP
inhibited VBN I-VP
by IN B-PP
prior JJ B-NP
incubation NN I-NP
with IN B-PP
dexamethasone NN B-NP
and CC O
it PRP B-NP
also RB B-ADVP
protects VBZ B-VP
the DT B-NP
induced VBN I-NP
mRNA NN I-NP
for IN B-PP
the DT B-NP
degradative JJ I-NP
action NN I-NP
of IN B-PP
dexamethasone NN B-NP
. . O

Identification NN B-NP
of IN B-PP
transcriptional JJ B-NP
suppressor NN I-NP
proteins NNS I-NP
that WDT B-NP
bind VBP B-VP
to TO B-PP
the DT B-NP
negative JJ I-NP
regulatory JJ I-NP
element NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
. . O

Two CD B-NP
different JJ I-NP
proteins NNS I-NP
which WDT B-NP
independently RB B-ADVP
bound VBD B-VP
to TO B-PP
neighboring VBG B-NP
sequences NNS I-NP
within IN B-PP
the DT B-NP
negative JJ I-NP
regulatory JJ I-NP
element NN I-NP
( ( O
NRE NN B-NP
) ) O
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HIV-1 NN B-NP
) ) O
were VBD B-VP
detected VBN I-VP
in IN B-PP
the DT B-NP
nuclear JJ I-NP
extract NN I-NP
of IN B-PP
a DT B-NP
virus-infected JJ I-NP
human JJ I-NP
T NN I-NP
cell NN I-NP
line NN I-NP
. . O

One CD B-NP
of IN B-PP
the DT B-NP
factors NNS I-NP
bound VBD B-VP
to TO B-PP
a DT B-NP
novel JJ I-NP
dyad NN I-NP
symmetrical JJ I-NP
sequence NN I-NP
. . O

This DT B-NP
sequence NN I-NP
is VBZ B-VP
well RB I-VP
conserved VBN I-VP
in IN B-PP
various JJ B-NP
HIV-1 NN I-NP
isolates NNS I-NP
and CC O
partial JJ B-NP
homology NN I-NP
was VBD B-VP
found VBN I-VP
with IN B-PP
the DT B-NP
promoter JJ I-NP
region NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
retinoblastoma NN I-NP
gene NN I-NP
. . O

Similar JJ B-NP
DNA NN I-NP
binding NN I-NP
activity NN I-NP
was VBD B-VP
detected VBN I-VP
in IN B-PP
a DT B-NP
variety NN I-NP
of IN B-PP
virus-uninfected JJ B-NP
human JJ I-NP
T NN B-NP
cell NN I-NP
lines NNS I-NP
and CC O
HeLa NN B-NP
cells NNS I-NP
by IN B-PP
means NNS I-PP
of IN I-PP
a DT B-NP
gel NN I-NP
mobility NN I-NP
shift NN I-NP
assay NN I-NP
. . O

The DT B-NP
other JJ I-NP
factor NN I-NP
bound VBN B-VP
to TO B-PP
a DT B-NP
putative JJ I-NP
AP-1 NN I-NP
recognition NN I-NP
sequence NN I-NP
predicted VBD B-VP
for IN B-PP
the DT B-NP
HIV-1 NN I-NP
NRE NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
this DT B-NP
factor NN I-NP
did VBD B-VP
not RB I-VP
bind VB I-VP
to TO B-PP
a DT B-NP
typical JJ I-NP
AP-1 NN I-NP
site NN I-NP
. . O

The DT B-NP
insertion NN I-NP
of IN B-PP
multiple JJ B-NP
copies NNS I-NP
of IN B-PP
the DT B-NP
binding VBG I-NP
site NN I-NP
for IN B-PP
the DT B-NP
former JJ I-NP
or CC I-NP
latter JJ I-NP
factor NN I-NP
into IN B-PP
a DT B-NP
heterologous JJ I-NP
promoter NN I-NP
reduced VBD B-VP
the DT B-NP
promoter NN I-NP
activity NN I-NP
to TO B-PP
one-tenth CD B-NP
or CC O
one-third CD B-NP
COMMA COMMA O
respectively RB B-ADVP
. . O

Thus RB B-ADVP
COMMA COMMA O
each DT B-NP
factor NN I-NP
may MD B-VP
function VB I-VP
as IN B-PP
a DT B-NP
novel JJ I-NP
negative JJ I-NP
regulator NN I-NP
of IN B-PP
transcription NN B-NP
. . O

Constitutive JJ B-NP
activation NN I-NP
of IN B-PP
NF-kB NN B-NP
in IN B-PP
human JJ B-NP
thymocytes NNS I-NP
. . O

NF-kB NN B-NP
is VBZ B-VP
a DT B-NP
eukaryotic JJ I-NP
transcription NN I-NP
regulatory JJ I-NP
factor NN I-NP
. . O

In IN B-PP
T NN B-NP
cells NNS I-NP
and CC O
T NN B-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
NF-kB NN B-NP
is VBZ B-VP
bound VBN I-VP
to TO B-PP
a DT B-NP
cytoplasmic JJ I-NP
proteic JJ I-NP
inhibitor NN I-NP
COMMA COMMA O
the DT B-NP
IkB NN I-NP
. . O

Treatment NN B-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
with IN B-PP
mitogens NNS B-NP
( ( O
phorbol NN B-NP
esters NNS I-NP
) ) O
or CC O
cytokines NNS B-NP
( ( O
TNF NN B-NP
alpha NN I-NP
) ) O
induces VBZ B-VP
NF-kB NN B-NP
nuclear JJ I-NP
translocation NN I-NP
and CC O
the DT B-NP
subsequent JJ I-NP
expression NN I-NP
of IN B-PP
NF-kB NN B-NP
dependent JJ I-NP
T NN I-NP
cell NN I-NP
genes NNS I-NP
. . O

Here RB B-ADVP
we PRP B-NP
examined VBD B-VP
the DT B-NP
activation NN I-NP
of IN B-PP
NF-kB NN B-NP
in IN B-PP
human JJ B-NP
T NN I-NP
cell NN I-NP
thymic JJ I-NP
progenitors NNS I-NP
. . O

We PRP B-NP
report VBP B-VP
differences NNS B-NP
in IN B-PP
(Ca2+)i NN B-NP
requirement NN I-NP
for IN B-NP
NF-kB NN B-NP
activation NN I-NP
in IN B-PP
thymocytes NNS B-NP
as IN B-SBAR
compared VBN B-VP
to TO B-PP
mature JJ B-NP
T NN I-NP
cells NNS I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
our PRP$ B-NP
results NNS I-NP
indicated VBD B-VP
that IN B-SBAR
thymocytes NNS B-NP
have VBP B-VP
a DT B-NP
constitutively RB I-NP
active JJ I-NP
form NN I-NP
of IN B-PP
NF-kB NN B-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
they PRP B-NP
are VBP B-VP
activated VBN I-VP
in FW B-ADVP
vivo FW I-ADVP
. . O

The DT B-NP
role NN I-NP
of IN B-PP
jun NN B-NP
and CC I-NP
fos NN I-NP
gene NN I-NP
family NN I-NP
members NNS I-NP
in IN B-PP
12-O-tetradecanoylphorbol-13-acetate NN B-NP
induced VBD I-NP
hemopoietic JJ I-NP
differentiation NN I-NP
. . O

Terminal JJ B-NP
differentiation NN I-NP
of IN B-PP
the DT B-NP
leukemic JJ I-NP
cell NN I-NP
lines NNS I-NP
U-937 NN B-NP
and CC O
HL-60 NN B-NP
by IN B-PP
12-O-tetradecanoylphorbol-13-acetate NN B-NP
is VBZ B-VP
accompanied VBN I-VP
by IN B-PP
marked JJ B-NP
changes NNS I-NP
in IN B-PP
gene NN B-NP
expression NN I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
the DT B-NP
expression NN I-NP
of IN B-PP
jun NN B-NP
and CC I-NP
fos NN I-NP
gene NN I-NP
family NN I-NP
members NNS I-NP
is VBZ B-VP
induced VBN I-VP
with IN B-PP
variable JJ B-NP
kinetics NNS I-NP
during IN B-PP
12-O-tetradecanoylphorbol-13-acetate NN B-NP
induced VBD I-NP
differentiation NN I-NP
COMMA COMMA O
with IN B-PP
c-jun NN B-NP
expression NN I-NP
best RB B-ADVP
paralleling JJ B-VP
differentiation NN B-NP
. . O

The DT B-NP
generation NN I-NP
of IN B-PP
AP-1 NN B-NP
complexes NNS I-NP
COMMA COMMA O
as IN B-SBAR
measured VBN B-VP
by IN B-PP
DNA NN B-NP
binding NN I-NP
activity NN I-NP
COMMA COMMA O
closely RB B-ADVP
parallels VBZ B-VP
morphological JJ B-NP
differentiation NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
the DT B-NP
ability NN I-NP
of IN B-PP
these DT B-NP
complexes NNS I-NP
to TO B-VP
regulate VB I-VP
gene NN B-NP
expression NN I-NP
is VBZ B-VP
demonstrated VBN I-VP
by IN B-PP
increased VBN B-NP
transcription NN I-NP
from IN B-PP
an DT B-NP
AP-1 NN I-NP
driven VBN I-NP
reporter NN I-NP
construct NN I-NP
and CC O
marked JJ B-NP
increases NNS I-NP
in IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
endogenous JJ B-NP
AP-1 NN I-NP
regulated JJ I-NP
genes NNS I-NP
. . O

Differentiation NN B-NP
assays NNS I-NP
using VBG B-VP
water NN B-NP
soluble JJ I-NP
phorbol NN I-NP
esters NNS I-NP
reveal VBP B-VP
that IN B-SBAR
differentiation NN B-NP
becomes VBZ B-VP
irreversible JJ B-ADJP
soon RB B-ADVP
after IN B-SBAR
AP-1 NN B-NP
appears VBZ B-VP
. . O

This DT B-NP
tight JJ I-NP
correlation NN I-NP
between IN B-PP
c-jun NN B-NP
expression NN I-NP
COMMA COMMA O
the DT B-NP
generation NN I-NP
of IN B-PP
AP-1 NN B-NP
activity NN I-NP
COMMA COMMA O
and CC O
differentiation NN B-NP
suggests VBZ B-VP
a DT B-NP
critical JJ I-NP
role NN I-NP
for IN B-PP
this DT O
gene NN B-NP
and CC O
transcriptional JJ B-ADJP
complex NN B-NP
during IN B-PP
this DT B-NP
process NN I-NP
. . O

TCF-1 NN B-NP
COMMA COMMA O
a DT B-NP
T NN I-NP
cell-specific JJ I-NP
transcription NN I-NP
factor NN I-NP
of IN B-PP
the DT B-NP
HMG NN I-NP
box NN I-NP
family NN I-NP
COMMA COMMA O
interacts VBZ B-VP
with IN B-PP
sequence NN B-NP
motifs NNS I-NP
in IN B-PP
the DT O
TCR NN B-NP
beta NN I-NP
and CC O
TCR NN B-NP
delta NN I-NP
enhancers NNS B-NP
. . O

We PRP B-NP
have VBP B-VP
recently RB I-VP
identified VBN I-VP
and CC O
cloned VBN B-VP
TCF-1 NN B-NP
COMMA COMMA O
a DT B-NP
T NN I-NP
cell-specific JJ I-NP
transcription NN I-NP
factor NN I-NP
with IN B-PP
specificity NN B-NP
for IN B-PP
the DT B-NP
AACAAAG NN I-NP
motif NN I-NP
in IN B-PP
the DT B-NP
CD3 NN I-NP
epsilon NN I-NP
enhancer NN I-NP
and CC B-PP
for IN B-PP
the DT B-NP
TTCAAAG NN I-NP
motif NN I-NP
in IN B-PP
the DT B-NP
TCR NN I-NP
alpha NN I-NP
enhancer NN I-NP
. . O

TCF-1 NN B-NP
belongs VBZ B-VP
to TO B-PP
the DT B-NP
family NN I-NP
of IN B-PP
transcription-regulating JJ B-NP
proteins NNS I-NP
which WDT B-NP
share VBP B-VP
a DT B-NP
region NN I-NP
of IN B-PP
homology NN B-NP
termed VBN B-VP
the DT B-NP
HMG-box NN I-NP
. . O

Here RB B-ADVP
COMMA COMMA O
we PRP B-NP
show VBP B-VP
by IN B-PP
gel NN B-NP
retardation NN I-NP
analysis NN I-NP
that IN B-SBAR
TCF-1 NN B-NP
specifically RB B-ADVP
recognizes VBZ B-VP
the DT B-NP
T NN I-NP
beta NN I-NP
5 CD I-NP
element NN I-NP
of IN B-PP
the DT B-NP
TCR NN I-NP
beta NN I-NP
enhancer NN I-NP
and CC O
the DT B-NP
T NN I-NP
delta NN I-NP
7 CD I-NP
element NN I-NP
of IN B-PP
the DT B-NP
TCR NN I-NP
delta NN I-NP
enhancer NN I-NP
. . O

Comparison NN B-NP
of IN B-PP
the DT B-NP
sequences NNS I-NP
of IN B-PP
all DT B-NP
elements NNS I-NP
recognized VBN B-VP
by IN B-PP
TCF-1 NN B-NP
defines VBZ B-VP
a DT B-NP
consensus NN I-NP
motif NN I-NP
A\/T NN I-NP
A\/T NN I-NP
C NN I-NP
A NN I-NP
A\/G NN I-NP
A NN I-NP
G NN I-NP
. . O

These DT B-NP
observations NNS I-NP
imply VBP B-VP
that IN B-SBAR
TCF-1 NN B-NP
is VBZ B-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
several JJ B-NP
T NN I-NP
cell-specific JJ I-NP
genes NNS I-NP
and CC O
might MD B-VP
thus RB I-VP
play VB I-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
establishment NN B-NP
and CC O
maintenance NN B-NP
of IN B-PP
the DT B-NP
mature JJ I-NP
T NN I-NP
cell NN I-NP
phenotype NN I-NP
. . O

The DT B-NP
cellular JJ I-NP
oncogene NN I-NP
c-myb NN I-NP
can MD B-VP
interact VB I-VP
synergistically RB B-ADVP
with IN B-PP
the DT B-NP
Epstein-Barr JJ I-NP
virus NN I-NP
BZLF1 NN I-NP
transactivator NN I-NP
in IN B-PP
lymphoid JJ B-NP
cells NNS I-NP
. . O

Regulation NN B-NP
of IN B-PP
replicative JJ B-NP
functions NNS I-NP
in IN B-PP
the DT O
Epstein-Barr JJ B-NP
virus NN I-NP
( ( O
EBV NN B-NP
) ) O
genome NN B-NP
is VBZ B-VP
mediated VBN I-VP
through IN B-PP
activation NN B-NP
of IN B-PP
a DT B-NP
virally RB I-NP
encoded VBN I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
Z NN B-NP
( ( O
BZLF1 NN B-NP
) ) O
. . O

We PRP B-NP
have VBP B-VP
shown VBN I-VP
that IN B-SBAR
the DT B-NP
Z NN I-NP
gene NN I-NP
product NN I-NP
COMMA COMMA O
which WDT B-NP
binds VBZ B-VP
to TO B-PP
AP-1 NN B-NP
sites NNS I-NP
as IN B-PP
a DT B-NP
homodimer NN I-NP
and CC O
has VBZ B-VP
sequence NN B-NP
similarity NN I-NP
to TO B-PP
c-Fos NN B-NP
COMMA COMMA O
can MD B-VP
efficiently RB I-VP
activate VB I-VP
the DT B-NP
EBV NN I-NP
early JJ I-NP
promoter NN I-NP
COMMA COMMA O
BMRF1 NN B-NP
COMMA COMMA O
in IN B-PP
certain JJ B-NP
cell NN I-NP
types NNS I-NP
( ( O
i.e. FW B-NP
COMMA COMMA O
HeLa NN B-NP
cells NNS I-NP
) ) O
but CC B-CONJP
not RB I-CONJP
others NNS B-NP
( ( O
i.e. FW B-NP
COMMA COMMA O
Jurkat NN B-NP
cells NNS I-NP
) ) O
. . O

Here RB B-ADVP
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
the DT B-NP
c-myb NN I-NP
proto-oncogene NN I-NP
product NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
itself PRP B-NP
a DT B-NP
DNA-binding JJ I-NP
protein NN I-NP
and CC O
transcriptional JJ B-NP
transactivator NN I-NP
COMMA COMMA O
can MD B-VP
interact VB I-VP
synergistically RB B-ADVP
with IN B-PP
Z NN B-NP
in IN B-PP
activating VBG B-VP
the DT B-NP
BMRF1 NN I-NP
promoter NN I-NP
in IN B-PP
Jurkat NN B-NP
cells NNS I-NP
( ( O
a DT B-NP
T-cell NN I-NP
line NN I-NP
) ) O
or CC O
Raji NN B-NP
cells NNS I-NP
( ( O
an DT B-NP
EBV-positive JJ I-NP
B-cell NN I-NP
) ) O
COMMA COMMA O
whereas IN O
the DT B-NP
c-myb NN I-NP
gene NN I-NP
product NN I-NP
by IN B-PP
itself PRP B-NP
has VBZ B-VP
little JJ B-NP
effect NN I-NP
. . O

The DT B-NP
simian JJ I-NP
virus NN I-NP
40 CD I-NP
early JJ I-NP
promoter NN I-NP
is VBZ B-VP
also RB I-VP
synergistically RB I-VP
activated VBN I-VP
by IN B-PP
the DT B-NP
Z\/c-myb NN I-NP
combination NN I-NP
. . O

Synergistic JJ B-NP
transactivation NN I-NP
of IN B-PP
the DT B-NP
BMRF1 NN I-NP
promoter NN I-NP
by IN B-PP
the DT B-NP
Z\/c-myb NN I-NP
combination NN I-NP
appears VBZ B-VP
to TO I-VP
involve VB I-VP
direct JJ B-NP
binding NN I-NP
by IN B-PP
the DT B-NP
Z NN I-NP
protein NN I-NP
but CC B-CONJP
not RB I-CONJP
the DT B-NP
c-myb NN I-NP
protein NN I-NP
. . O

A DT B-NP
30-bp JJ I-NP
sequence NN I-NP
in IN B-PP
the DT B-NP
BMRF1 NN I-NP
promoter NN I-NP
which WDT B-NP
contains VBZ B-VP
a DT B-NP
Z NN I-NP
binding NN I-NP
site NN I-NP
( ( O
a DT B-NP
consensus NN I-NP
AP-1 NN I-NP
site NN I-NP
) ) O
is VBZ B-VP
sufficient JJ B-ADJP
to TO B-VP
transfer VB I-VP
high-level JJ B-NP
lymphoid-specific JJ I-NP
responsiveness NN I-NP
to TO B-PP
the DT B-NP
Z\/c-myb NN I-NP
combination NN I-NP
to TO B-PP
a DT B-NP
heterologous JJ I-NP
promoter NN I-NP
. . O

That IN B-SBAR
the DT B-NP
c-myb NN I-NP
oncogene NN I-NP
product NN I-NP
can MD B-VP
interact VB I-VP
synergistically RB B-ADVP
with IN B-PP
an DT B-NP
EBV-encoded JJ I-NP
member NN I-NP
of IN B-PP
the DT B-NP
leucine NN I-NP
zipper NN I-NP
protein NN I-NP
family NN I-NP
suggests VBZ B-VP
c-myb NN B-NP
is VBZ B-VP
likely JJ B-ADJP
to TO B-VP
engage VB I-VP
in IN B-PP
similar JJ B-NP
interactions NNS I-NP
with IN B-PP
cellularly RB B-NP
encoded VBN I-NP
transcription NN I-NP
factors NNS I-NP
. . O

The DT B-NP
29-kDa JJ I-NP
proteins NNS I-NP
phosphorylated VBN B-VP
in IN B-PP
thrombin-activated JJ B-NP
human JJ I-NP
platelets NNS I-NP
are VBP B-VP
forms NNS B-NP
of IN B-PP
the DT B-NP
estrogen NN I-NP
receptor-related JJ I-NP
27-kDa JJ I-NP
heat NN I-NP
shock NN I-NP
protein NN I-NP
. . O

Thrombin NN B-NP
plays VBZ B-VP
a DT B-NP
critical JJ I-NP
role NN I-NP
in IN B-PP
platelet NN B-NP
activation NN I-NP
COMMA COMMA O
hemostasis NN B-NP
COMMA COMMA O
and CC O
thrombosis NN B-NP
. . O

Cellular JJ B-NP
activation NN I-NP
by IN B-PP
thrombin NN B-NP
leads VBZ B-VP
to TO B-PP
the DT B-NP
phosphorylation NN I-NP
of IN B-PP
multiple JJ B-NP
proteins NNS I-NP
COMMA COMMA O
most JJS B-NP
of IN B-PP
which WDT B-NP
are VBP B-VP
unidentified JJ B-ADJP
. . O

We PRP B-NP
have VBP B-VP
characterized VBN I-VP
several JJ B-NP
29-kDa JJ I-NP
proteins NNS I-NP
that WDT B-NP
are VBP B-VP
rapidly RB I-VP
phosphorylated VBN I-VP
following VBG B-PP
exposure NN B-NP
of IN B-PP
intact JJ B-NP
human JJ I-NP
platelets NNS I-NP
to TO B-PP
thrombin NN B-NP
. . O

A DT B-NP
murine JJ I-NP
monoclonal JJ I-NP
antibody NN I-NP
raised VBN B-VP
to TO B-PP
an DT B-NP
unidentified JJ I-NP
estrogen NN I-NP
receptor-related JJ I-NP
29-kDa JJ I-NP
protein NN I-NP
selectively RB B-ADVP
recognized VBD B-VP
these DT B-NP
proteins NNS I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
a DT B-NP
more RBR I-NP
basic JJ I-NP
COMMA COMMA I-NP
unphosphorylated JJ I-NP
27-kDa JJ I-NP
protein NN I-NP
. . O

Cellular JJ B-NP
activation NN I-NP
by IN B-PP
thrombin NN B-NP
led VBN B-VP
to TO B-PP
a DT B-NP
marked JJ I-NP
shift NN I-NP
in IN B-PP
the DT B-NP
proportion NN I-NP
of IN B-PP
protein NN B-NP
from IN B-PP
the DT B-NP
27-kDa JJ I-NP
unphosphorylated JJ I-NP
form NN I-NP
to TO B-PP
the DT B-NP
29-kDa JJ I-NP
phosphoprotein NN I-NP
species NNS I-NP
. . O

Using VBG B-VP
this DT B-NP
antibody NN I-NP
COMMA COMMA O
we PRP B-NP
isolated VBD B-VP
and CC O
sequenced VBD B-VP
a DT B-NP
human JJ I-NP
cDNA NN I-NP
clone NN I-NP
encoding VBG B-VP
a DT B-NP
protein NN I-NP
that WDT B-NP
was VBD B-VP
identical JJ B-ADJP
to TO B-PP
the DT B-NP
mammalian JJ I-NP
27-kDa JJ I-NP
heat NN I-NP
shock NN I-NP
protein NN I-NP
( ( O
HSP27 NN B-NP
) ) O
COMMA COMMA O
a DT B-NP
protein NN I-NP
of IN B-PP
uncertain JJ B-NP
function NN I-NP
that WDT B-NP
is VBZ B-VP
known VBN I-VP
to TO B-VP
be VB I-VP
phosphorylated VBN I-VP
to TO B-PP
several JJ B-NP
forms NNS I-NP
and CC O
to TO B-VP
be VB I-VP
transcriptionally RB I-VP
induced VBN I-VP
by IN B-PP
estrogen NN B-NP
. . O

The DT B-NP
29-kDa JJ I-NP
proteins NNS I-NP
were VBD B-VP
confirmed VBN I-VP
to TO I-VP
be VB I-VP
phosphorylated VBN B-NP
forms NNS I-NP
of IN B-PP
HSP27 NN B-NP
by IN B-PP
immunoprecipitation NN B-NP
studies NNS I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
the DT B-NP
" `` I-NP
estrogen NN I-NP
receptor-related JJ I-NP
protein NN I-NP
" '' O
is VBZ B-VP
HSP27 NN B-NP
COMMA COMMA O
and CC O
the DT B-NP
three CD I-NP
major JJ I-NP
29-kDa JJ I-NP
proteins NNS I-NP
phosphorylated VBN B-VP
in IN B-PP
thrombin-activated JJ B-NP
platelets NNS I-NP
are VBP B-VP
forms NNS B-NP
of IN B-PP
HSP27 NN B-NP
. . O

These DT B-NP
data NNS I-NP
suggest VBP B-VP
a DT B-NP
role NN I-NP
for IN B-PP
HSP27 NN B-NP
in IN B-PP
the DT B-NP
signal NN I-NP
transduction NN I-NP
events NNS I-NP
of IN B-PP
platelet NN B-NP
activation NN I-NP
. . O

Characterization NN B-NP
of IN B-PP
a DT B-NP
cofactor NN I-NP
that WDT B-NP
regulates VBZ B-VP
dimerization NN B-NP
of IN B-PP
a DT B-NP
mammalian JJ I-NP
homeodomain NN I-NP
protein NN I-NP
. . O

Dimerization NN B-NP
among IN B-PP
transcription NN B-NP
factors NNS I-NP
has VBZ B-VP
become VBN I-VP
a DT B-NP
recurrent JJ I-NP
theme NN I-NP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
eukaryotic JJ B-NP
gene NN I-NP
expression NN I-NP
. . O

Hepatocyte NN B-NP
nuclear JJ I-NP
factor-1 NN I-NP
alpha NN I-NP
( ( O
HNF-1 NN B-NP
alpha NN I-NP
) ) O
is VBZ B-VP
a DT B-NP
homeodomain-containing JJ I-NP
protein NN I-NP
that WDT B-NP
functions VBZ B-VP
as IN B-PP
a DT B-NP
dimer NN I-NP
. . O

A DT B-NP
dimerization NN I-NP
cofactor NN I-NP
of IN B-PP
HNF-1 NN B-NP
alpha NN I-NP
( ( O
DCoH NN B-NP
) ) O
was VBD B-VP
identified VBN I-VP
that WDT B-NP
displayed VBD B-VP
a DT B-NP
restricted JJ I-NP
tissue NN I-NP
distribution NN I-NP
and CC O
did VBD B-VP
not RB I-VP
bind VB I-VP
to TO B-PP
DNA NN B-NP
COMMA COMMA O
but CC B-CONJP
COMMA COMMA I-CONJP
rather RB I-CONJP
COMMA COMMA O
selectively RB B-VP
stabilized VBD I-VP
HNF-1 NN B-NP
alpha NN I-NP
dimers NNS I-NP
. . O

The DT B-NP
formation NN I-NP
of IN B-PP
a DT B-NP
stable JJ I-NP
tetrameric JJ I-NP
DCoH-HNF-1 NN I-NP
alpha NN I-NP
complex NN I-NP
COMMA COMMA O
which WDT B-NP
required VBD B-VP
the DT B-NP
dimerization NN I-NP
domain NN I-NP
of IN B-PP
HNF-1 NN B-NP
alpha NN I-NP
COMMA COMMA O
did VBD B-VP
not RB I-VP
change VB I-VP
the DT B-NP
DNA NN I-NP
binding NN I-NP
characteristics NNS I-NP
of IN B-PP
HNF-1 NN B-NP
alpha NN I-NP
COMMA COMMA O
but CC O
enhanced VBD B-VP
its PRP$ B-NP
transcriptional JJ I-NP
activity NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
DCoH NN B-NP
did VBD B-VP
not RB I-VP
confer VB I-VP
transcriptional JJ B-NP
activation NN I-NP
to TO B-PP
the DT B-NP
GAL4 NN I-NP
DNA NN I-NP
binding NN I-NP
domain NN I-NP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
DCoH NN B-NP
regulates VBZ B-VP
formation NN B-NP
of IN B-PP
transcriptionally RB B-NP
active JJ I-NP
tetrameric JJ I-NP
complexes NNS I-NP
and CC O
may MD B-VP
contribute VB I-VP
to TO B-PP
the DT B-NP
developmental JJ I-NP
specificity NN I-NP
of IN B-PP
the DT B-NP
complex NN I-NP
. . O

High JJ B-NP
affinity NN I-NP
aldosterone NN I-NP
binding VBG B-VP
to TO B-PP
plasma NN B-NP
membrane NN I-NP
rich JJ I-NP
fractions NNS I-NP
from IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
: : O
is VBZ O
there EX B-NP
a DT B-NP
membrane NN I-NP
receptor NN I-NP
for IN B-PP
mineralocorticoids NNS B-NP
? . O

In FW B-NP
vitro FW I-NP
effects NNS I-NP
of IN B-PP
aldosterone NN B-NP
on IN B-PP
the DT B-NP
intracellular JJ I-NP
concentrations NNS I-NP
of IN B-PP
sodium NN B-NP
COMMA COMMA O
potassium NN B-NP
and CC O
calcium NN B-NP
COMMA COMMA O
cell NN B-NP
volume NN I-NP
and CC O
the DT B-NP
sodium-proton-antiport NN I-NP
have VBP B-VP
been VBN I-VP
described VBN I-VP
in IN B-PP
intact JJ B-NP
human JJ B-NP
mononuclear JJ I-NP
leukocytes NNS I-NP
( ( O
HML NN B-NP
) ) O
. . O

In IN B-PP
the DT B-NP
present JJ I-NP
paper NN I-NP
COMMA COMMA O
the DT B-NP
binding NN I-NP
of IN B-PP
a DT B-NP
{125I}-labeled JJ I-NP
aldosterone NN I-NP
derivative JJ I-NP
to TO B-PP
plasma NN B-NP
membrane NN I-NP
rich JJ B-NP
fractions NNS I-NP
of IN B-PP
HML NN B-NP
was VBD B-VP
studied VBN I-VP
. . O

High JJ B-NP
affinity NN I-NP
binding NN I-NP
of IN B-PP
the DT B-NP
radioligand NN I-NP
with IN B-PP
an DT B-NP
apparent JJ I-NP
Kd NN I-NP
of IN B-PP
approximately RB B-NP
0.1 CD I-NP
nM NN I-NP
was VBD B-VP
found VBN I-VP
. . O

Aldosterone NN B-NP
displaced VBD B-VP
the DT B-NP
tracer NN I-NP
at IN B-PP
a DT B-NP
similar JJ I-NP
Kd NN I-NP
. . O

Both CC O
canrenone NN B-NP
and CC O
cortisol NN B-NP
were VBD B-VP
inactive JJ B-ADJP
as IN B-PP
ligands NNS B-NP
up RB B-PP
to TO I-PP
concentrations NNS B-NP
of IN B-PP
0.1 CD B-NP
microM NN I-NP
. . O

The DT B-NP
findings NNS I-NP
are VBP B-VP
the DT B-NP
first JJ I-NP
to TO B-VP
demonstrate VB I-VP
membrane NN B-NP
binding NN I-NP
sites NNS I-NP
with IN B-PP
a DT B-NP
high JJ I-NP
affinity NN I-NP
for IN B-PP
aldosterone NN B-NP
COMMA COMMA B-PP
but CC I-PP
not RB B-PP
for IN I-PP
cortisol NN B-NP
. . O

These DT B-NP
data NNS I-NP
are VBP B-VP
perfectly RB B-ADJP
compatible JJ I-ADJP
with IN B-PP
major JJ B-NP
properties NNS I-NP
of IN B-PP
steroidal JJ B-NP
effects NNS I-NP
on IN B-PP
the DT B-NP
sodium-proton-antiport NN I-NP
in IN B-PP
HML NN B-NP
and CC O
thus RB O
very RB B-VP
likely RB I-VP
represent VBP I-VP
membrane NN B-NP
receptors NNS I-NP
for IN B-PP
aldosterone NN B-NP
. . O

Transcription NN B-NP
factor NN I-NP
requirements NNS I-NP
for IN B-PP
U2 NN B-NP
snRNA-encoding JJ I-NP
gene NN I-NP
activation NN I-NP
in IN B-PP
B NN B-NP
lymphoid JJ I-NP
cells NNS I-NP
. . O

Transcription NN B-NP
of IN B-PP
a DT B-NP
human JJ I-NP
U2 NN I-NP
small JJ I-NP
nuclear JJ I-NP
RNA NN I-NP
( ( I-NP
snRNA NN I-NP
) ) I-NP
-encoding JJ I-NP
gene NN I-NP
in IN B-PP
HeLa NN B-NP
cells NNS I-NP
requires VBZ B-VP
a DT B-NP
distal JJ I-NP
enhancer NN I-NP
element NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
composed VBN I-VP
of IN B-PP
one CD B-NP
octamer NN B-NP
motif NN I-NP
( ( O
Oct NN B-NP
) ) O
and CC O
three CD B-NP
Sp NN I-NP
1-binding JJ I-NP
sites NNS I-NP
. . O

To TO B-VP
study VB I-VP
the DT B-NP
transcription NN I-NP
factor NN I-NP
requirement NN I-NP
in IN B-PP
B-cells NNS B-NP
COMMA COMMA O
different JJ B-NP
U2 NN I-NP
enhancer NN I-NP
constructions NNS I-NP
were VBD B-VP
transfected VBN I-VP
into IN B-PP
the DT B-NP
lymphoid JJ I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
BJA-B NN B-NP
. . O

The DT B-NP
results NNS I-NP
showed VBD B-VP
that IN B-SBAR
the DT B-NP
activation NN I-NP
of IN B-PP
U2 NN B-NP
snRNA NN I-NP
transcription NN I-NP
in IN B-PP
B-cells NNS B-NP
also RB B-ADVP
requires VBZ B-VP
an DT B-NP
enhancer NN I-NP
comprising VBG B-VP
both CC O
the DT B-NP
Oct NN I-NP
and CC O
at IN B-NP
least JJS I-NP
one CD I-NP
Sp NN I-NP
1-binding JJ I-NP
site NN I-NP
. . O

Deletion NN B-NP
of IN B-PP
all PDT B-NP
the DT I-NP
Sp NN I-NP
1-binding JJ I-NP
sites NNS I-NP
from IN B-PP
the DT B-NP
enhancer NN I-NP
reduces VBZ B-VP
transcription NN B-NP
by IN B-PP
80-90 CD B-NP
% NN I-NP
in IN B-PP
HeLa NN B-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
in IN B-PP
BJA-B NN B-NP
cells NNS B-NP
COMMA COMMA O
whereas IN O
the DT B-NP
removal NN I-NP
of IN B-PP
the DT B-NP
octamer-binding JJ I-NP
site NN I-NP
reduces VBZ B-VP
transcription NN B-NP
to TO B-PP
levels NNS B-NP
below IN B-PP
detection NN B-NP
in IN B-PP
both DT B-NP
cell NN I-NP
types NNS I-NP
. . O

Enhancers NNS B-NP
containing VBG B-VP
a DT B-NP
single JJ I-NP
Oct NN I-NP
have VBP B-VP
COMMA COMMA O
nevertheless RB B-ADVP
COMMA COMMA O
the DT B-NP
capacity NN I-NP
to TO B-VP
partially RB I-VP
activate VB I-VP
U2 NN B-NP
snRNA NN I-NP
transcription NN I-NP
in IN B-PP
both DT B-NP
HeLa NN I-NP
cells NNS I-NP
COMMA COMMA O
in IN B-PP
which WDT B-NP
only RB B-NP
OTF-1 NN I-NP
is VBZ B-VP
expressed VBN I-VP
COMMA COMMA B-PP
and CC I-PP
in IN B-PP
BJA-B NN B-NP
cells NNS I-NP
in IN B-PP
which WDT B-NP
OTF-2 NN B-NP
is VBZ B-VP
the DT B-NP
predominantly RB I-NP
expressed VBN I-NP
octamer-binding JJ I-NP
factor NN I-NP
. . O

The DT B-NP
most RBS I-NP
likely JJ I-NP
interpretation NN I-NP
of IN B-PP
our PRP$ B-NP
results NNS I-NP
is VBZ B-VP
that IN B-SBAR
both CC O
the DT B-NP
ubiquitous JJ I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
OTF-1 NN B-NP
COMMA COMMA O
and CC O
the DT B-NP
B-cell-specific JJ I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
OTF-2 NN B-NP
COMMA COMMA O
can MD B-VP
activate VB I-VP
U2 NN B-NP
snRNA NN I-NP
transcription NN I-NP
. . O

The DT B-NP
results NNS I-NP
also RB B-ADVP
revealed VBD B-VP
a DT B-NP
similar JJ I-NP
functional JJ I-NP
cooperation NN I-NP
between IN B-PP
the DT B-NP
transcription NN I-NP
factors NNS I-NP
which WDT B-NP
bind VBP B-VP
to TO B-PP
the DT B-NP
Oct NN I-NP
and CC O
the DT B-NP
adjacent JJ I-NP
Sp NN I-NP
1-binding JJ I-NP
site NN B-NP
in IN B-PP
BJA-B NN B-NP
cells NNS I-NP
COMMA COMMA O
as IN B-SBAR
has VBZ B-VP
been VBN I-VP
observed VBN I-VP
in IN B-PP
HeLa NN B-NP
cells NNS I-NP
COMMA COMMA O
since IN B-SBAR
a DT B-NP
template NN I-NP
which WDT B-NP
contains VBZ B-VP
a DT B-NP
weak JJ I-NP
binding VBG I-NP
site NN I-NP
for IN B-PP
OTFs NNS B-NP
expresses VBZ B-VP
wild-type JJ B-NP
levels NNS I-NP
of IN B-PP
U2 NN B-NP
snRNA NN I-NP
in IN B-PP
both DT B-NP
cell NN I-NP
types NNS I-NP
when WRB B-ADVP
the DT B-NP
weak JJ I-NP
octamer-binding JJ I-NP
site NN I-NP
is VBZ B-VP
combined VBN I-VP
with IN B-PP
a DT B-NP
Sp NN I-NP
1-binding JJ I-NP
site NN I-NP
. . O

Cortisol NN B-NP
receptor NN I-NP
resistance NN I-NP
: : O
the DT B-NP
variability NN I-NP
of IN B-PP
its PRP$ B-NP
clinical JJ B-NP
presentation NN I-NP
and CC O
response NN B-NP
to TO B-PP
treatment NN B-NP
. . O

Primary JJ B-NP
( ( I-NP
partial JJ I-NP
) ) I-NP
cortisol NN I-NP
receptor NN I-NP
resistance NN I-NP
was VBD B-VP
previously RB I-VP
reported VBN I-VP
in IN B-PP
a DT B-NP
total NN I-NP
of IN B-PP
7 CD B-NP
patients NNS I-NP
and CC O
14 CD B-NP
asymptomatic JJ I-NP
family NN I-NP
members NNS I-NP
. . O

Its PRP$ B-NP
occurrence NN I-NP
is VBZ B-VP
considered VBN I-VP
to TO I-VP
be VB I-VP
extremely RB B-ADJP
rare JJ I-ADJP
. . O

In IN B-PP
the DT B-NP
present JJ I-NP
study NN I-NP
we PRP B-NP
report VBP B-VP
on IN B-PP
6 CD B-NP
patients NNS I-NP
( ( O
2 CD B-NP
males NNS I-NP
and CC O
4 CD B-NP
females NNS I-NP
) ) O
with IN B-PP
the DT B-NP
syndrome NN I-NP
. . O

The DT B-NP
first JJ I-NP
male JJ I-NP
patient NN I-NP
presented VBD B-VP
with IN B-PP
mild JJ B-NP
hypertension NN I-NP
. . O

Hydrochlorothiazide NN B-NP
therapy NN I-NP
resulted VBD B-VP
in IN B-PP
life-threatening JJ B-NP
hypokalemia NN I-NP
. . O

The DT B-NP
second JJ I-NP
male JJ I-NP
patient NN I-NP
had VBD B-VP
slight JJ B-NP
hypertension NN I-NP
without IN B-PP
hypokalemia NN B-NP
. . O

All DT B-NP
four CD I-NP
female JJ I-NP
patients NNS I-NP
presented VBD B-VP
between IN B-PP
the DT B-NP
age NN I-NP
of IN B-PP
20-30 CD B-NP
yr NN I-NP
with IN B-PP
acne NN B-NP
COMMA COMMA O
hirsutism NN B-NP
COMMA COMMA O
and CC O
irregular JJ B-NP
menstruations NNS I-NP
. . O

Low JJ B-NP
dose NN I-NP
dexamethasone NN I-NP
therapy NN I-NP
( ( O
1-1.5 CD B-NP
mg\/day NN I-NP
) ) O
was VBD B-VP
of IN B-PP
clinical JJ B-NP
benefit NN I-NP
in IN B-PP
these DT B-NP
patients NNS I-NP
. . O

All DT B-NP
patients NNS I-NP
showed VBD B-VP
insufficient JJ B-NP
suppression NN I-NP
of IN B-PP
serum NN B-NP
cortisol NN I-NP
concentrations NNS I-NP
in IN B-PP
the DT B-NP
overnight JJ I-NP
1-mg JJ I-NP
dexamethasone NN I-NP
test NN I-NP
. . O

The DT B-NP
diurnal JJ I-NP
rhythm NN I-NP
of IN B-PP
ACTH NN B-NP
and CC O
cortisol NN B-NP
was VBD B-VP
intact JJ B-ADJP
COMMA COMMA O
albeit IN B-PP
at IN B-PP
an DT B-NP
elevated JJ I-NP
level NN I-NP
. . O

There EX B-NP
was VBD B-VP
a DT B-NP
normal JJ I-NP
increase NN I-NP
in IN B-PP
ACTH NN B-NP
COMMA COMMA O
cortisol NN B-NP
COMMA COMMA O
and CC O
GH NN B-NP
( ( O
except IN B-PP
in IN B-PP
one CD B-NP
obese JJ I-NP
patient NN I-NP
) ) O
in IN B-PP
response NN I-PP
to TO I-PP
insulin-induced JJ B-NP
hypoglycemia NN I-NP
COMMA COMMA O
while IN B-SBAR
cortisol NN B-NP
production NN I-NP
was VBD B-VP
elevated JJ I-VP
in IN B-PP
three CD B-NP
patients NNS I-NP
. . O

Circulating VBG B-NP
adrenal JJ I-NP
androgen NN I-NP
levels NNS I-NP
were VBD B-VP
increased VBN I-VP
in IN B-PP
all DT B-NP
patients NNS I-NP
. . O

Glucocorticoid NN B-NP
receptors NNS I-NP
were VBD B-VP
investigated VBN I-VP
in IN B-PP
a DT B-NP
whole JJ I-NP
cell NN I-NP
dexamethasone NN I-NP
binding NN I-NP
assay NN I-NP
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
. . O

In IN B-PP
the DT B-NP
first JJ I-NP
male JJ I-NP
patient NN I-NP
COMMA COMMA O
the DT B-NP
number NN I-NP
of IN B-PP
receptors NNS B-NP
was VBD B-VP
very RB B-ADJP
low JJ I-ADJP
COMMA COMMA O
while IN B-SBAR
the DT B-NP
affinity NN I-NP
was VBD B-VP
lower JJR B-ADJP
than IN B-PP
that DT B-NP
in IN B-PP
controls NNS B-NP
. . O

A DT B-NP
lowered JJ I-NP
affinity NN I-NP
to TO B-PP
dexamethasone NN B-NP
was VBD B-VP
found VBN I-VP
in IN B-PP
one CD B-NP
female JJ I-NP
patient NN I-NP
COMMA COMMA O
while IN B-SBAR
a DT B-NP
lowered JJ I-NP
number NN I-NP
of IN B-PP
receptors NNS B-NP
was VBD B-VP
found VBN I-VP
in IN B-PP
three CD B-NP
patients NNS I-NP
. . O

In IN B-PP
the DT B-NP
second JJ I-NP
male JJ I-NP
patient NN I-NP
COMMA COMMA O
no DT B-NP
abnormalities NNS I-NP
were VBD B-VP
found VBN I-VP
. . O

As IN B-PP
a DT B-NP
bioassay NN I-NP
for IN B-PP
glucocorticoid NN B-NP
action NN I-NP
we PRP B-NP
also RB B-ADVP
measured VBD B-VP
dexamethasone NN B-NP
suppressibility NN I-NP
of IN B-PP
mitogen-stimulated JJ B-NP
incorporation NN I-NP
of IN B-PP
{3H}thymidine NN B-NP
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
. . O

In IN B-PP
the DT B-NP
male JJ I-NP
patient NN I-NP
with IN B-PP
normal JJ B-NP
receptor NN I-NP
status NN I-NP
COMMA COMMA O
dexamethasone NN B-NP
suppressibility NN I-NP
of IN B-PP
{3H}thymidine NN B-NP
incorporation NN I-NP
was VBD B-VP
significantly RB B-ADJP
lower JJR I-ADJP
than IN B-PP
that DT B-NP
in IN B-PP
healthy JJ B-NP
controls NNS I-NP
with IN B-PP
respect NN I-PP
to TO I-PP
both CC O
maximal JJ B-NP
suppression NN I-NP
and CC O
IC50 NN B-NP
. . O

Partial JJ B-NP
cortisol NN I-NP
receptor NN I-NP
resistance NN I-NP
might MD B-VP
be VB I-VP
less RBR B-ADJP
rare JJ I-ADJP
than IN B-SBAR
previously RB B-VP
thought VBN I-VP
. . O

In IN B-PP
the DT B-NP
six CD I-NP
patients NNS I-NP
presented VBN B-VP
COMMA COMMA O
at IN B-NP
least JJS I-NP
three CD I-NP
different JJ I-NP
forms NNS I-NP
can MD B-VP
be VB I-VP
recognized VBN I-VP
. . O

Therapy NN B-NP
with IN B-PP
dexamethasone NN B-NP
was VBD B-VP
successful JJ B-ADJP
in IN B-PP
female JJ B-NP
patients NNS I-NP
with IN B-PP
acne NN B-NP
and CC O
hirsutism NN B-NP
COMMA COMMA O
as IN B-SBAR
the DT B-NP
secondary JJ I-NP
increase NN I-NP
in IN B-PP
the DT B-NP
production NN I-NP
of IN B-PP
adrenal JJ B-NP
androgens NNS I-NP
was VBD B-VP
effectively RB I-VP
controlled VBN I-VP
. . O

Kappa NN B-NP
B-specific JJ I-NP
DNA NN I-NP
binding NN I-NP
proteins NNS I-NP
are VBP B-VP
differentially RB I-VP
inhibited VBN I-VP
by IN B-PP
enhancer NN B-NP
mutations NNS I-NP
and CC O
biological JJ B-NP
oxidation NN I-NP
. . O

Kappa NN B-NP
B NN I-NP
( ( O
kappa NN B-NP
B NN I-NP
) ) O
enhancer NN B-NP
binding NN I-NP
proteins NNS I-NP
isolated VBN B-VP
from IN B-PP
the DT B-NP
nuclei NNS I-NP
of IN B-PP
activated VBN B-NP
human JJ I-NP
T NN I-NP
cells NNS I-NP
produce VBP B-VP
two CD B-NP
distinct JJ I-NP
nucleoprotein NN I-NP
complexes NNS I-NP
when WRB B-ADVP
incubated VBN B-VP
with IN B-PP
the DT B-NP
kappa NN I-NP
B NN I-NP
element NN I-NP
from IN B-PP
the DT O
interleukin-2 NN B-NP
receptor-alpha NN I-NP
( ( O
IL-2R NN B-NP
alpha NN I-NP
) ) O
gene NN B-NP
. . O

These DT B-NP
two CD I-NP
DNA-protein JJ I-NP
complexes NNS I-NP
are VBP B-VP
composed VBN I-VP
of IN B-PP
at IN B-NP
least JJS I-NP
four CD I-NP
host NN I-NP
proteins NNS I-NP
( ( O
p50 NN B-NP
COMMA COMMA O
p55 NN B-NP
COMMA COMMA O
p75 NN B-NP
COMMA COMMA O
p85 NN B-NP
) ) O
COMMA COMMA O
each DT B-NP
of IN B-PP
which WDT B-NP
shares VBZ B-VP
structural JJ B-NP
similarity NN I-NP
with IN B-PP
the DT B-NP
v-rel NN I-NP
oncogene NN I-NP
product NN I-NP
. . O

Nuclear JJ B-NP
expression NN I-NP
of IN B-PP
these DT B-NP
proteins NNS I-NP
is VBZ B-VP
induced VBN I-VP
with IN B-PP
distinctly RB B-NP
biphasic JJ I-NP
kinetics NNS I-NP
following VBG B-PP
phorbol NN B-NP
ester NN I-NP
activation NN I-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
( ( O
p55\/p75 NN B-NP
early JJ I-NP
and CC O
p50\/p85 NN B-NP
late JJ I-NP
) ) O
. . O

DNA-protein JJ B-NP
crosslinking NN I-NP
studies NNS I-NP
have VBP B-VP
revealed VBN I-VP
that IN B-SBAR
the DT O
more RBR B-ADVP
rapidly RB I-ADVP
migrating VBG B-NP
B2 NN I-NP
complex NN I-NP
contains VBZ B-VP
both CC O
p50 NN B-NP
and CC O
p55 NN B-NP
while IN B-SBAR
the DT O
more RBR B-ADVP
slowly RB I-ADVP
migrating VBG B-NP
B1 NN I-NP
complex NN I-NP
is VBZ B-VP
composed VBN I-VP
of IN B-PP
p50 NN B-NP
COMMA COMMA O
p55 NN B-NP
COMMA COMMA O
p75 NN B-NP
COMMA COMMA O
and CC O
p85 NN B-NP
. . O

Site-directed JJ B-NP
mutagenesis NN I-NP
of IN B-PP
the DT B-NP
wild-type JJ I-NP
IL-2R NN I-NP
alpha NN I-NP
kappa NN I-NP
B NN I-NP
enhancer NN I-NP
( ( O
GGGGAATCTCCC NN B-NP
) ) O
has VBZ B-VP
revealed VBN I-VP
that IN B-SBAR
the DT B-NP
binding NN I-NP
of IN B-PP
p50 NN B-NP
and CC O
p55 NN B-NP
( ( O
B2 NN B-NP
complex NN I-NP
) ) O
is VBZ B-VP
particularly RB B-ADJP
sensitive JJ I-ADJP
to TO B-PP
alteration NN B-NP
of IN B-PP
the DT B-NP
5' JJ I-NP
triplet NN I-NP
of IN B-PP
deoxyguanosine NN B-NP
residues NNS I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
formation NN B-NP
of IN B-PP
the DT B-NP
B1 NN I-NP
complex NN I-NP
COMMA COMMA O
reflecting VBG B-VP
the DT B-NP
binding NN I-NP
of IN B-PP
p75 NN B-NP
and CC O
p85 NN B-NP
COMMA COMMA O
critically RB B-ADVP
depends VBZ B-VP
upon IN B-PP
the DT B-NP
more RBR I-NP
3' JJ I-NP
sequences NNS I-NP
of IN B-PP
this DT B-NP
enhancer NN I-NP
element NN I-NP
. . O

DNA NN B-NP
binding NN I-NP
by IN B-PP
all DT B-NP
four CD I-NP
of IN B-PP
these DT B-NP
Rel-related JJ I-NP
factors NNS I-NP
is VBZ B-VP
blocked VBN I-VP
by IN B-PP
selective JJ B-NP
chemical JJ I-NP
modification NN I-NP
of IN B-PP
lysine NN B-NP
and CC O
arginine NN B-NP
residues NNS B-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
both DT B-NP
of IN B-PP
these DT B-NP
basic JJ I-NP
amino NN I-NP
acids NNS I-NP
are VBP B-VP
required VBN I-VP
for IN B-PP
binding VBG B-VP
to TO B-PP
the DT B-NP
kappa NN I-NP
B NN I-NP
element NN I-NP
. . O

Similarly RB B-ADVP
COMMA COMMA O
covalent JJ B-NP
modification NN I-NP
of IN B-PP
free JJ B-NP
sulfhydryl NN I-NP
groups NNS I-NP
with IN B-PP
diamide NN B-NP
( ( O
reversible JJ B-ADJP
) ) O
or CC O
N-ethylmaleimide NN B-NP
( ( O
irreversible JJ B-ADJP
) ) O
results VBZ B-VP
in IN B-PP
a DT B-NP
complete JJ I-NP
loss NN I-NP
of IN B-PP
DNA NN B-NP
binding NN I-NP
activity NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
mild JJ B-NP
oxidation NN I-NP
with IN B-PP
glucose NN B-NP
oxidase NN I-NP
selectively RB B-ADVP
inhibits VBZ B-VP
p75 NN B-NP
and CC O
p85 NN B-NP
binding NN B-NP
while IN B-SBAR
not RB B-VP
blocking VBG I-VP
p50 NN B-NP
and CC O
p55 NN B-NP
interactions NNS B-NP
. . O

These DT B-NP
findings NNS I-NP
suggest VBP B-VP
that IN B-SBAR
reduced VBN B-NP
cysteine NN I-NP
thiols NNS I-NP
play VBP B-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
DNA NN I-NP
binding NN I-NP
activity NN I-NP
of IN B-PP
this DT B-NP
family NN I-NP
of IN B-PP
Rel-related JJ B-NP
transcription NN I-NP
factors NNS I-NP
. . O

A DT B-NP
novel JJ I-NP
mitogen-inducible JJ I-NP
gene NN I-NP
product NN I-NP
related JJ B-ADJP
to TO B-PP
p50\/p105-NF-kappa NN B-NP
B NN I-NP
participates VBZ B-VP
in IN B-PP
transactivation NN B-NP
through IN B-PP
a DT B-NP
kappa NN I-NP
B NN I-NP
site NN I-NP
. . O

A DT B-NP
Rel-related JJ I-NP
COMMA COMMA I-NP
mitogen-inducible JJ I-NP
COMMA COMMA I-NP
kappa NN I-NP
B-binding JJ I-NP
protein NN I-NP
has VBZ B-VP
been VBN I-VP
cloned VBN I-VP
as IN B-PP
an DT B-NP
immediate-early JJ I-NP
activation NN I-NP
gene NN I-NP
of IN B-PP
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
T NN I-NP
cells NNS I-NP
. . O

The DT B-NP
cDNA NN I-NP
has VBZ B-VP
an DT B-NP
open JJ I-NP
reading NN I-NP
frame NN I-NP
of IN B-PP
900 CD B-NP
amino NN I-NP
acids NNS I-NP
capable JJ B-ADJP
of IN B-PP
encoding VBG B-VP
a DT B-NP
97-kDa JJ I-NP
protein NN I-NP
. . O

This DT B-NP
protein NN I-NP
is VBZ B-VP
most RBS B-ADJP
similar JJ I-ADJP
to TO B-PP
the DT B-NP
105-kDa JJ I-NP
precursor NN I-NP
polypeptide NN I-NP
of IN B-PP
p50-NF-kappa NN B-NP
B NN I-NP
. . O

Like IN B-PP
the DT B-NP
105-kDa JJ I-NP
precursor NN I-NP
COMMA COMMA O
it PRP B-NP
contains VBZ B-VP
an DT B-NP
amino-terminal JJ I-NP
Rel-related JJ I-NP
domain NN I-NP
of IN B-PP
about IN B-NP
300 CD I-NP
amino NN I-NP
acids NNS I-NP
and CC O
a DT B-NP
carboxy-terminal JJ I-NP
domain NN I-NP
containing VBG B-VP
six CD O
full JJ B-NP
cell NN I-NP
cycle NN I-NP
or CC O
ankyrin NN B-NP
repeats NNS B-NP
. . O

In FW B-NP
vitro-translated JJ I-NP
proteins NNS I-NP
COMMA COMMA O
truncated VBN B-VP
downstream RB B-ADVP
of IN B-PP
the DT B-NP
Rel NN I-NP
domain NN I-NP
and CC O
excluding VBG B-VP
the DT B-NP
repeats NNS I-NP
COMMA COMMA O
bind VBP B-VP
kappa NN B-NP
B NN I-NP
sites NNS I-NP
. . O

We PRP B-NP
refer VBP B-VP
to TO B-PP
the DT B-NP
kappa NN I-NP
B-binding JJ I-NP
COMMA COMMA O
truncated VBN B-NP
protein NN I-NP
as IN B-PP
p50B NN B-NP
by IN B-PP
analogy NN B-NP
with IN B-PP
p50-NF-kappa NN B-NP
B NN I-NP
and CC B-PP
to TO B-PP
the DT B-NP
full-length JJ I-NP
protein NN I-NP
as IN B-PP
p97 NN B-NP
. . O

p50B NN B-NP
is VBZ B-VP
able JJ B-ADJP
to TO B-VP
form VB I-VP
heteromeric JJ B-NP
kappa NN I-NP
B-binding JJ I-NP
complexes NNS I-NP
with IN B-PP
RelB NN B-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
with IN B-PP
p65 NN B-NP
and CC O
p50 NN B-NP
COMMA COMMA O
the DT B-NP
two CD I-NP
subunits NNS I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
. . O

Transient-transfection NN B-NP
experiments NNS I-NP
in IN B-PP
embryonal JJ B-NP
carcinoma NN I-NP
cells NNS I-NP
demonstrate VBP B-VP
a DT B-NP
functional JJ I-NP
cooperation NN I-NP
between IN B-PP
p50B NN B-NP
and CC O
RelB NN B-NP
or CC O
p65 NN B-NP
in IN B-PP
transactivation NN B-NP
of IN B-PP
a DT B-NP
reporter NN I-NP
plasmid NN I-NP
dependent JJ B-ADJP
on IN B-PP
a DT B-NP
kappa NN I-NP
B NN I-NP
site NN I-NP
. . O

The DT B-NP
data NNS I-NP
imply VBP B-VP
the DT B-NP
existence NN I-NP
of IN B-PP
a DT B-NP
complex JJ I-NP
family NN I-NP
of IN B-PP
NF-kappa NN B-NP
B-like JJ I-NP
transcription NN I-NP
factors NNS I-NP
. . O

{ ( O
Changes NNS B-NP
in IN B-PP
leucocytic JJ B-NP
estrogen NN I-NP
receptor NN I-NP
levels NNS I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
climacteric JJ B-NP
syndrome NN I-NP
and CC O
therapeutic JJ B-NP
effect NN I-NP
of IN B-PP
liuwei FW B-NP
dihuang FW I-NP
pills NNS I-NP
} ) O

The DT B-NP
numbers NNS I-NP
of IN B-PP
estrogen NN B-NP
receptor NN I-NP
( ( O
ER NN B-NP
) ) O
in IN B-PP
human JJ B-NP
peripheral JJ I-NP
leucocytes NNS I-NP
in IN B-PP
22 CD B-NP
women NNS I-NP
with IN B-PP
climacteric JJ B-NP
syndrome NN I-NP
were VBD B-VP
measured VBN I-VP
by IN B-PP
radioligand NN B-NP
method NN I-NP
. . O

The DT B-NP
results NNS I-NP
were VBD B-VP
compared VBN I-VP
with IN B-PP
those DT B-NP
of IN B-PP
12 CD B-NP
normal JJ I-NP
child-bearing-age JJ I-NP
women NNS I-NP
. . O

It PRP B-NP
wat VBD B-VP
found VBN I-VP
that IN B-SBAR
the DT B-NP
contents NNS I-NP
of IN B-PP
leucocytic JJ B-NP
ER NN I-NP
in IN B-PP
climacteric JJ B-NP
syndrome NN I-NP
patients NNS I-NP
were VBD B-VP
significantly RB B-ADJP
lower JJR I-ADJP
than IN B-PP
normal JJ B-NP
child-bearing-age JJ I-NP
women NNS I-NP
. . O

The DT B-NP
authors NNS I-NP
used VBD B-VP
a DT B-NP
Chinese JJ I-NP
prescription NN I-NP
-- : O
Liuwei FW B-NP
Dihuang FW I-NP
Pills NNS I-NP
( ( O
LDP NN B-NP
) ) O
to TO B-VP
treat VB I-VP
the DT B-NP
patients NNS I-NP
for IN B-PP
2 CD B-NP
months NNS I-NP
. . O

The DT B-NP
numbers NNS I-NP
of IN B-PP
leucocytic JJ B-NP
ER NN I-NP
were VBD B-VP
significantly RB I-VP
increased VBN I-VP
after IN B-PP
treatment NN B-NP
. . O

The DT B-NP
data NNS I-NP
indicate VBP B-VP
that IN B-SBAR
decrease NN B-NP
of IN B-PP
ER NN B-NP
levels NNS I-NP
in IN B-PP
cell NN B-NP
may MD B-VP
involve VB I-VP
in IN B-PP
the DT B-NP
pathogenesis NN I-NP
of IN B-PP
climacteric JJ B-NP
syndrome NN I-NP
. . O

LDP NN B-NP
not RB B-CONJP
only RB I-CONJP
increases VBZ B-VP
plasma NN B-NP
estradiol NN I-NP
levels NNS I-NP
COMMA COMMA O
but CC B-CONJP
also RB I-CONJP
increases VBZ B-VP
the DT B-NP
leucocytic JJ I-NP
ER NN I-NP
levels NNS I-NP
. . O

This DT B-NP
may MD B-VP
be VB I-VP
the DT B-NP
basis NN I-NP
of IN B-PP
the DT B-NP
therapeutic JJ I-NP
effect NN I-NP
on IN B-PP
the DT B-NP
disease NN I-NP
. . O

A DT B-NP
novel JJ I-NP
primer NN I-NP
extension NN I-NP
method NN I-NP
to TO B-VP
detect VB I-VP
the DT B-NP
number NN I-NP
of IN B-PP
CAG NN B-NP
repeats NNS I-NP
in IN B-PP
the DT B-NP
androgen NN I-NP
receptor NN I-NP
gene NN I-NP
in IN B-PP
families NNS B-NP
with IN B-PP
X-linked JJ B-NP
spinal JJ I-NP
and CC I-NP
bulbar JJ I-NP
muscular JJ I-NP
atrophy NN I-NP
. . O

X-linked JJ B-NP
spinal JJ I-NP
and CC I-NP
bulbar JJ I-NP
muscular JJ I-NP
atrophy NN I-NP
( ( O
SBMA NN B-NP
) ) O
COMMA COMMA O
an DT B-NP
adult-onset JJ I-NP
form NN I-NP
of IN B-PP
motor NN B-NP
neuron NN I-NP
disease NN I-NP
COMMA COMMA O
was VBD B-VP
recently RB I-VP
reported VBN I-VP
to TO I-VP
be VB I-VP
caused VBN I-VP
by IN B-PP
amplification NN B-NP
of IN B-PP
the DT B-NP
CAG NN I-NP
repeats NNS I-NP
in IN B-PP
the DT B-NP
androgen NN I-NP
receptor NN I-NP
gene NN I-NP
. . O

We PRP B-NP
report VBP B-VP
here RB B-ADVP
a DT B-NP
simple JJ I-NP
and CC I-NP
rapid JJ I-NP
strategy NN I-NP
to TO B-VP
detect VB I-VP
the DT B-NP
precise JJ I-NP
number NN I-NP
of IN B-PP
the DT B-NP
CAGs NNS I-NP
. . O

After IN B-SBAR
the DT B-NP
DNA NN I-NP
fragment NN I-NP
containing VBG B-VP
the DT B-NP
CAG NN I-NP
repeats NNS I-NP
is VBZ B-VP
amplified VBN I-VP
by IN B-PP
the DT B-NP
polymerase NN I-NP
chain NN I-NP
reaction NN I-NP
COMMA COMMA O
a DT B-NP
primer NN I-NP
extension NN I-NP
is VBZ B-VP
carried VBN I-VP
out RP B-PRT
; : O
the DT B-NP
extension NN I-NP
of IN B-PP
the DT B-NP
end-labelled JJ I-NP
reverse JJ I-NP
primer NN I-NP
adjacent JJ B-ADJP
to TO B-PP
3' JJ B-NP
end NN I-NP
of IN B-PP
CAG NN B-NP
repeats NNS I-NP
stops VBZ B-VP
at IN B-PP
the DT B-NP
first JJ I-NP
T NN I-NP
after IN B-PP
CAG NN B-NP
repeats NNS I-NP
with IN B-PP
the DT B-NP
incorporation NN I-NP
of IN B-PP
dideoxy JJ B-NP
ATP NN I-NP
in IN B-PP
the DT B-NP
reaction NN I-NP
mixture NN I-NP
. . O

The DT B-NP
resultant JJ I-NP
primer NN I-NP
products NNS I-NP
are VBP B-VP
analysed VBN I-VP
by IN B-PP
denaturing VBG B-VP
polyacrylamide NN B-NP
gel NN I-NP
electrophoresis NN I-NP
and CC O
autoradiography NN B-NP
. . O

This DT B-NP
method NN I-NP
could MD B-VP
be VB I-VP
quite RB B-ADJP
useful JJ I-ADJP
to TO B-VP
detect VB I-VP
not RB B-CONJP
only RB I-CONJP
CAG NN B-NP
repeats NNS I-NP
in IN B-PP
SBMA NN B-NP
but CC B-CONJP
also RB I-CONJP
other JJ O
polymorphic JJ O
dinucleotide JJ B-NP
and CC O
trinucleotide JJ B-NP
repeats NNS B-NP
. . O

Activity NN B-NP
of IN B-PP
the DT B-NP
kappa NN I-NP
B NN I-NP
enhancer NN I-NP
of IN B-PP
the DT B-NP
interleukin-2 NN I-NP
receptor NN I-NP
alpha NN I-NP
chain NN I-NP
in IN B-PP
somatic JJ B-NP
cell NN I-NP
hybrids NNS I-NP
is VBZ B-VP
accompanied VBN I-VP
by IN B-PP
the DT B-NP
nuclear JJ I-NP
localization NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
. . O

The DT B-NP
two CD I-NP
nuclear JJ I-NP
proteins NNS I-NP
NF-kappa NN I-NP
B NN I-NP
( ( O
consisting VBG B-VP
of IN B-PP
subunits NNS B-NP
p50 NN B-NP
and CC O
p65 NN B-NP
) ) O
and CC O
the DT B-NP
DNA-binding JJ I-NP
subunit NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
( ( O
p50 NN B-NP
) ) O
by IN B-PP
itself PRP B-NP
COMMA COMMA O
also RB B-VP
called VBN I-VP
KBF1 NN B-NP
COMMA COMMA O
are VBP B-VP
constitutively RB I-VP
expressed VBN I-VP
and CC O
localized JJ B-VP
in IN B-PP
the DT B-NP
nucleus NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
T-cell NN I-NP
line NN I-NP
IARC NN I-NP
301.5 CD I-NP
. . O

In IN B-SBAR
order NN O
to TO O
define VB B-VP
the DT B-NP
roles NNS I-NP
of IN B-PP
these DT B-NP
two CD I-NP
factors NNS I-NP
COMMA COMMA O
which WDT B-NP
bind VBP B-VP
to TO B-PP
the DT B-NP
same JJ I-NP
kappa NN I-NP
B NN I-NP
enhancers NNS I-NP
COMMA COMMA O
in IN B-PP
transcription NN B-NP
activation NN I-NP
we PRP B-NP
have VBP B-VP
prepared VBN I-VP
somatic JJ B-NP
cell NN I-NP
hybrids NNS I-NP
between IN B-PP
IARC NN B-NP
301.5 CD I-NP
and CC O
a DT B-NP
murine JJ I-NP
myeloma NN I-NP
. . O

Most JJS B-NP
hybrids NNS I-NP
express VBP B-VP
both CC O
KBF1 NN B-NP
and CC O
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
their PRP$ B-NP
nuclei NNS I-NP
COMMA COMMA O
but CC O
one CD B-NP
hybrid NN I-NP
expresses VBZ B-VP
only RB B-NP
KBF1 NN I-NP
. . O

The DT B-NP
kappa NN I-NP
B NN I-NP
enhancer NN I-NP
of IN B-PP
the DT B-NP
gene NN I-NP
encoding VBG B-VP
the DT O
interleukin-2 NN B-NP
( ( O
IL-2 NN B-NP
) ) O
receptor NN B-NP
alpha NN I-NP
chain NN I-NP
( ( O
IL-2R NN B-NP
alpha NN I-NP
) ) O
is VBZ B-VP
functional JJ B-ADJP
only RB B-PP
in IN I-PP
the DT B-NP
hybrids NNS I-NP
expressing VBG B-VP
nuclear JJ B-NP
NF-kappa NN I-NP
B NN I-NP
. . O

These DT B-NP
findings NNS I-NP
show VBP B-VP
that IN B-SBAR
nuclear JJ B-NP
NF-kappa NN I-NP
B NN I-NP
is VBZ B-VP
necessary JJ B-ADJP
to TO B-VP
activate VB I-VP
the DT B-NP
kappa NN I-NP
B NN I-NP
enhancer NN I-NP
COMMA COMMA O
while IN B-SBAR
KBF1 NN B-NP
by IN B-PP
itself PRP B-NP
is VBZ B-VP
not RB O
sufficient JJ B-ADJP
. . O

We PRP B-NP
propose VBP B-VP
that IN B-SBAR
KBF1 NN B-NP
is VBZ B-VP
a DT B-NP
competitive JJ I-NP
inhibitor NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
and CC O
discuss VB B-VP
how WRB B-ADVP
these DT B-NP
factors NNS I-NP
may MD B-VP
be VB I-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
transient JJ I-NP
expression NN I-NP
of IN B-PP
IL-2 NN B-NP
and CC O
IL-2 NN B-NP
alpha NN I-NP
genes NNS B-NP
during IN B-PP
the DT B-NP
immune JJ I-NP
response NN I-NP
. . O

Influence NN B-NP
of IN B-PP
estradiol NN B-NP
and CC O
tamoxifen NN B-NP
on IN B-PP
susceptibility NN B-NP
of IN B-PP
human JJ B-NP
breast NN I-NP
cancer NN I-NP
cell NN I-NP
lines NNS I-NP
to TO B-PP
lysis NN B-NP
by IN B-PP
lymphokine-activated JJ B-NP
killer NN I-NP
cells NNS I-NP
. . O

The DT B-NP
design NN I-NP
of IN B-PP
combination NN B-NP
hormonal JJ I-NP
and CC I-NP
immunotherapeutic JJ I-NP
protocols NNS I-NP
for IN B-PP
breast NN B-NP
cancer NN I-NP
patients NNS I-NP
may MD B-VP
be VB I-VP
facilitated VBN I-VP
by IN B-PP
analysis NN B-NP
of IN B-PP
preclinical JJ B-NP
in FW I-NP
vitro FW I-NP
model JJ I-NP
systems NNS I-NP
. . O

Estrogen NN O
receptor NN O
positive JJ O
( ( O
ER+ JJ B-ADJP
: : O
MCF-7 NN B-NP
) ) O
and CC O
negative JJ O
( ( O
ER- JJ B-ADJP
: : O
MDA-MB-231 NN B-NP
) ) O
human JJ B-NP
breast NN I-NP
cancer NN I-NP
cell NN I-NP
lines NNS I-NP
were VBD B-VP
utilized VBN I-VP
to TO B-VP
evaluate VB I-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
tamoxifen NN B-NP
( ( O
TAM NN B-NP
) ) O
and CC O
estradiol NN B-NP
( ( O
E2 NN B-NP
) ) O
on IN B-PP
modulation NN B-NP
of IN B-PP
breast NN B-NP
cancer NN I-NP
target NN I-NP
susceptibility NN I-NP
to TO B-PP
lysis NN B-NP
by IN B-PP
lymphokine-activated JJ B-NP
killer NN I-NP
( ( O
LAK NN B-NP
) ) O
cells NNS B-NP
. . O

E2-stimulated JJ B-NP
ER+ JJ I-NP
cells NNS I-NP
were VBD B-VP
more RBR B-ADJP
susceptible JJ I-ADJP
to TO B-PP
lysis NN B-NP
by IN B-PP
LAK NN B-NP
cells NNS I-NP
than IN B-PP
corresponding VBG O
TAM-treated JJ O
or CC O
control NN B-NP
cells NNS B-NP
COMMA COMMA O
while IN B-SBAR
treatment NN B-NP
of IN B-PP
ER- JJ B-NP
cells NNS I-NP
with IN B-PP
either CC O
E2 NN B-NP
or CC O
TAM NN B-NP
alone RB B-ADVP
did VBD B-VP
not RB I-VP
alter VB I-VP
from IN B-PP
control NN B-NP
their PRP$ B-NP
susceptibility NN I-NP
to TO B-PP
this DT B-NP
immune-mediated JJ I-NP
lysis NN I-NP
. . O

All DT B-NP
ER+ JJ I-NP
and CC I-NP
ER- JJ I-NP
cells NNS I-NP
tested VBN B-VP
remained VBD B-VP
sensitive JJ B-ADJP
after IN B-PP
treatment NN B-NP
with IN B-PP
TAM NN B-NP
to TO B-PP
lysis NN B-NP
by IN B-PP
LAK NN B-NP
cells NNS I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
an DT O
adenocarcinoma NN B-NP
reactive JJ O
human-mouse JJ B-ADJP
chimeric JJ I-ADJP
monoclonal JJ B-NP
antibody NN I-NP
( ( O
ING-1 NN B-NP
) ) O
was VBD B-VP
able JJ B-ADJP
to TO B-VP
significantly RB I-VP
boost VB I-VP
in FW B-ADVP
vivo FW I-ADVP
generated VBN B-NP
LAK NN I-NP
cell-mediated JJ I-NP
lysis NN I-NP
of IN B-PP
control NN B-NP
COMMA COMMA O
E2-treated JJ B-ADJP
COMMA COMMA O
and CC O
TAM-treated JJ B-ADJP
ER+ JJ B-ADJP
and CC O
ER- JJ B-ADJP
cells NNS B-NP
. . O

These DT B-NP
in FW I-NP
vitro FW I-NP
results NNS I-NP
provide VBP B-VP
a DT B-NP
preclinical JJ I-NP
rationale NN I-NP
for IN B-PP
in FW B-NP
vivo FW I-NP
testing NN I-NP
of IN B-PP
TAM NN B-NP
COMMA COMMA O
interleukin-2 NN B-NP
( ( O
IL-2 NN B-NP
) ) O
COMMA COMMA O
and CC O
breast NN B-NP
cancer NN I-NP
reactive JJ I-NP
antibody-dependent JJ I-NP
cellular JJ I-NP
cytotoxicity NN I-NP
facilitating VBG B-VP
antibody NN B-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
refractory JJ O
or CC O
high JJ B-NP
risk NN I-NP
breast NN B-NP
cancer NN I-NP
. . O

Glucocorticoid NN B-NP
receptor NN I-NP
and CC O
inhibition NN B-NP
of IN B-PP
3-O-methyl-D-glucose NN B-NP
uptake NN I-NP
by IN B-PP
glucocorticoids NNS B-NP
in IN B-PP
peripheral JJ B-NP
blood NN I-NP
leukocytes NNS I-NP
from IN B-PP
normal JJ B-NP
humans NNS I-NP
: : O
correlation NN B-NP
between IN B-PP
receptor NN B-NP
level NN I-NP
and CC O
hormone NN B-NP
effect NN I-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

We PRP B-NP
have VBP B-VP
measured VBN I-VP
the DT B-NP
glucocorticoid NN I-NP
receptor NN I-NP
concentration NN I-NP
in IN B-PP
mononuclear JJ B-NP
and CC I-NP
polymorphonuclear JJ I-NP
leukocytes NNS I-NP
COMMA COMMA O
both DT B-NP
of IN B-PP
which WDT B-NP
were VBD B-VP
isolated VBN I-VP
from IN B-PP
peripheral JJ B-NP
blood NN I-NP
from IN B-PP
ten CD B-NP
healthy JJ I-NP
male JJ I-NP
volunteers NNS I-NP
. . O

In IN B-PP
parallel NN B-NP
COMMA COMMA O
the DT B-NP
inhibitory JJ I-NP
effect NN I-NP
of IN B-PP
dexamethasone NN B-NP
on IN B-PP
3-O-methyl-D-glucose NN B-NP
uptake NN I-NP
was VBD B-VP
assayed VBN I-VP
in IN B-PP
the DT B-NP
corresponding JJ I-NP
mononuclear JJ I-NP
leukocytes NNS I-NP
. . O

The DT B-NP
glucocorticoid NN I-NP
receptor NN I-NP
levels NNS I-NP
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
correlated VBD B-VP
with IN B-PP
those DT B-NP
in IN B-PP
polymorphonuclear JJ B-NP
leukocytes NNS I-NP
COMMA COMMA O
and CC O
there EX B-NP
was VBD B-VP
a DT B-NP
linear JJ I-NP
relationship NN I-NP
between IN B-PP
the DT B-NP
cellular JJ I-NP
glucocorticoid NN I-NP
receptor NN I-NP
levels NNS I-NP
and CC O
glucocorticoid-mediated JJ B-NP
inhibition NN I-NP
of IN B-PP
the DT B-NP
uptake NN I-NP
of IN B-PP
3-O-methyl-D-glucose NN B-NP
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
. . O

When WRB B-ADVP
mononuclear JJ B-NP
leukocytes NNS I-NP
were VBD B-VP
incubated VBN I-VP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
8-bromo-cAMP NN B-NP
COMMA COMMA O
cellular JJ B-NP
glucocorticoid NN I-NP
receptor NN I-NP
levels NNS I-NP
increased VBD B-VP
and CC O
a DT B-NP
more RBR I-NP
pronounced JJ I-NP
inhibitory JJ I-NP
effect NN I-NP
of IN B-PP
dexamethasone NN B-NP
was VBD B-VP
observed VBN I-VP
on IN B-PP
the DT B-NP
transport NN I-NP
of IN B-PP
3-O-methyl-D-glucose NN B-NP
. . O

We PRP B-NP
conclude VBP B-VP
that IN B-SBAR
the DT B-NP
cellular JJ I-NP
glucocorticoid NN I-NP
receptor NN I-NP
levels NNS I-NP
in IN B-PP
peripheral JJ B-NP
blood NN I-NP
leukocytes NNS I-NP
reflect VBP B-VP
in FW B-NP
vitro FW I-NP
responsiveness NN I-NP
to TO B-PP
glucocorticoids NNS B-NP
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
from IN B-PP
healthy JJ B-NP
males NNS I-NP
COMMA COMMA O
and CC O
that IN B-SBAR
the DT B-NP
individual JJ I-NP
responsiveness NN I-NP
may MD B-VP
alter VB I-VP
upon IN B-PP
changes NNS B-NP
in IN B-PP
the DT B-NP
cellular JJ I-NP
levels NNS I-NP
of IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
. . O

Stimulation NN B-NP
of IN B-PP
interferon NN B-NP
beta NN I-NP
gene NN I-NP
transcription NN I-NP
in FW B-ADVP
vitro FW I-ADVP
by IN B-PP
purified VBN B-NP
NF-kappa NN I-NP
B NN I-NP
and CC O
a DT B-NP
novel JJ I-NP
TH NN I-NP
protein NN I-NP
. . O

The DT O
human JJ O
interferon NN B-NP
beta NN I-NP
( ( O
IFN-beta NN B-NP
) ) O
regulatory JJ B-NP
element NN I-NP
consists VBZ B-VP
of IN B-PP
multiple JJ B-NP
enhanson NN I-NP
domains NNS I-NP
which WDT B-NP
are VBP B-VP
targets NNS B-NP
for IN B-PP
transcription NN B-NP
factors NNS I-NP
involved VBN B-VP
in IN B-PP
inducible JJ B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
promoter NN I-NP
. . O

To TO B-VP
further RB I-VP
characterize VB I-VP
the DT B-NP
protein-DNA JJ I-NP
interactions NNS I-NP
mediating VBG B-VP
IFN-beta NN B-NP
induction NN I-NP
COMMA COMMA O
positive JJ B-NP
regulatory JJ I-NP
domain NN I-NP
( ( O
PRD NN B-NP
) ) O
II CD B-NP
binding NN I-NP
proteins NNS I-NP
were VBD B-VP
purified VBN I-VP
from IN B-PP
phorbol NN B-NP
ester NN I-NP
induced JJ B-NP
Jurkat NN I-NP
T-cells NNS I-NP
and CC B-PP
from IN B-PP
IFN NN B-NP
primed VBN B-ADJP
COMMA COMMA O
cycloheximide\/polyinosinic-polycytidylic JJ B-NP
acid NN I-NP
treated VBN B-ADJP
HeLa NN O
S3 NN O
cells NNS O
. . O

From IN B-PP
HeLa NN B-NP
cells NNS I-NP
COMMA COMMA O
two CD B-NP
major JJ I-NP
proteins NNS I-NP
of IN B-PP
52 CD B-NP
and CC O
45 CD B-NP
kilodaltons NNS B-NP
( ( O
kD NN B-NP
) ) O
copurified VBD B-VP
with IN B-PP
DNA NN B-NP
binding NN I-NP
activity NN I-NP
COMMA COMMA O
whereas IN O
from IN B-PP
T-cells NNS B-NP
COMMA COMMA O
four CD B-NP
proteins NNS I-NP
-- : O
a DT B-NP
major JJ I-NP
protein NN I-NP
of IN B-PP
52 CD B-NP
kD NN I-NP
and CC O
three CD B-NP
minor JJ I-NP
proteins NNS I-NP
of IN B-PP
82 CD B-NP
COMMA COMMA I-NP
67 CD I-NP
COMMA COMMA I-NP
and CC I-NP
43-47 CD I-NP
kD NN I-NP
-- : O
were VBD B-VP
purified VBN I-VP
. . O

Also RB B-ADVP
COMMA COMMA O
an DT O
induction NN B-NP
specific JJ B-NP
DNA NN I-NP
binding NN I-NP
protein NN I-NP
was VBD B-VP
purified VBN I-VP
from IN B-PP
HeLa NN B-NP
cells NNS I-NP
that WDT B-NP
interacted VBD B-VP
with IN B-PP
the DT B-NP
( ( I-NP
AAGTGA NN I-NP
) ) I-NP
4 CD I-NP
tetrahexamer NN I-NP
sequence NN I-NP
and CC O
the DT B-NP
PRDI NN I-NP
domain NN I-NP
. . O

This DT B-NP
protein NN I-NP
is VBZ B-VP
immunologically RB B-ADJP
distinct JJ I-ADJP
from IN B-PP
IRF-1\/ISGF2 NN B-NP
. . O

Uninduced JJ O
or CC O
Sendai NN B-NP
virus NN I-NP
induced JJ B-NP
HeLa NN I-NP
extracts NNS I-NP
were VBD B-VP
used VBN I-VP
to TO B-VP
examine VB I-VP
transcription NN B-NP
in FW B-ADVP
vitro FW I-ADVP
using VBG B-VP
a DT B-NP
series NN I-NP
of IN B-PP
IFN NN B-NP
beta NN I-NP
promoter NN I-NP
deletions NNS I-NP
. . O

Deletions NNS B-NP
upstream JJ B-ADJP
of IN B-PP
the DT B-NP
PRDII NN I-NP
element NN I-NP
increased VBD B-VP
transcription NN B-NP
in IN B-PP
the DT B-NP
uninduced JJ I-NP
extract NN I-NP
COMMA COMMA O
indicating VBG B-VP
predominantly RB B-NP
negative JJ I-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
promoter NN I-NP
. . O

A DT B-NP
2-4-fold JJ I-NP
increase NN I-NP
in IN B-PP
IFN-beta NN B-NP
promoter NN I-NP
transcription NN I-NP
was VBD B-VP
observed VBN I-VP
in IN B-PP
Sendai NN B-NP
virus NN I-NP
induced JJ B-NP
extracts NNS I-NP
COMMA COMMA O
and CC O
deletion NN B-NP
of IN B-PP
PRDI NN B-NP
and CC O
PRDII NN B-NP
elements NNS B-NP
decreased VBD B-VP
this DT B-NP
induced VBN I-NP
level NN I-NP
of IN B-PP
transcription NN B-NP
. . O

When WRB B-ADVP
purified VBN B-NP
PRDII NN I-NP
and CC O
tetrahexamer NN B-NP
binding NN I-NP
proteins NNS I-NP
were VBD B-VP
added VBN I-VP
to TO B-PP
the DT B-NP
induced VBN I-NP
extract NN I-NP
COMMA COMMA O
a DT B-NP
4-fold JJ I-NP
increase NN I-NP
in IN B-PP
transcription NN B-NP
was VBD B-VP
observed VBN I-VP
. . O

These DT B-NP
experiments NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
it PRP B-NP
is VBZ B-VP
possible JJ B-ADJP
to TO B-VP
modulate VB I-VP
IFN-beta NN B-NP
transcription NN I-NP
in FW B-ADVP
vitro FW I-ADVP
but CC O
indicate VBP B-VP
that IN B-SBAR
additional JJ B-NP
proteins NNS I-NP
may MD B-VP
be VB I-VP
required VBN I-VP
to TO I-VP
fully RB I-VP
activate VB I-VP
IFN-beta NN B-NP
transcription NN I-NP
. . O

Structure NN B-NP
function NN I-NP
analysis NN I-NP
of IN B-PP
vitamin NN B-NP
D NN I-NP
analogs NNS I-NP
with IN B-PP
C-ring NN B-NP
modifications NNS I-NP
. . O

Analogs NNS B-NP
of IN B-PP
1 CD B-NP
alphaCOMMA25-dihydroxyvitamin NN I-NP
D3 NN I-NP
( ( O
1 CD B-NP
alphaCOMMA25-(OH) NN I-NP
2D3 NN I-NP
) ) O
with IN B-PP
substitutions NNS B-NP
on IN B-PP
C-11 NN B-NP
were VBD B-VP
synthesized VBN I-VP
. . O

Small JJ B-NP
apolar JJ I-NP
substitutions NNS I-NP
( ( O
11 CD B-NP
alpha-methyl NN I-NP
COMMA COMMA O
11 CD B-NP
alpha-fluoromethyl NN I-NP
) ) O
did VBD B-VP
not RB I-VP
markedly RB I-VP
decrease VB I-VP
the DT B-NP
affinity NN I-NP
for IN B-PP
the DT B-NP
vitamin NN I-NP
D NN I-NP
receptor NN I-NP
COMMA COMMA O
but CC O
larger JJR O
( ( O
11 CD B-NP
alpha-chloromethyl NN I-NP
or CC O
11 CD B-NP
alpha- NN I-NP
or CC B-NP
11 CD I-NP
beta-phenyl NN I-NP
) ) O
or CC B-NP
more RBR I-NP
polar JJ I-NP
substitutions NNS I-NP
( ( O
11 CD B-NP
alpha-hydroxymethyl NN I-NP
COMMA COMMA O
11 CD B-NP
alpha-(2-hydroxyethyl NN I-NP
} ) O
decreased VBD B-VP
the DT B-NP
affinity NN I-NP
to TO B-PP
less JJR B-NP
than IN I-NP
5 CD I-NP
% NN I-NP
of IN B-PP
that DT B-NP
of IN B-PP
1 CD B-NP
alphaCOMMA25-OH)2D3 NN I-NP
. . O

Their PRP$ B-NP
affinity NN I-NP
for IN B-PP
the DT B-NP
vitamin NN I-NP
D-binding JJ I-NP
protein NN I-NP
COMMA COMMA O
however RB B-ADVP
COMMA COMMA O
increased VBD B-VP
up RB B-ADVP
to TO I-ADVP
4-fold RB I-ADVP
. . O

The DT B-NP
biological JJ I-NP
activity NN I-NP
of IN B-PP
11 CD B-NP
alpha-methyl-1 NN I-NP
alphaCOMMA25-(OH)2D3 NN I-NP
closely RB B-ADVP
resembled VBD B-VP
that DT B-NP
of IN B-PP
the DT B-NP
natural JJ I-NP
hormone NN I-NP
on IN B-PP
normal JJ B-NP
and CC I-NP
leukemic JJ I-NP
cell NN B-NP
proliferation NN I-NP
and CC O
bone NN B-NP
resorption NN I-NP
COMMA COMMA O
whereas IN O
its PRP$ B-NP
in FW I-NP
vivo FW I-NP
effect NN I-NP
on IN B-PP
calcium NN B-NP
metabolism NN I-NP
of IN B-PP
the DT B-NP
rachitic JJ I-NP
chick NN I-NP
was VBD B-VP
about IN B-NP
50 CD I-NP
% NN I-NP
of IN B-PP
that DT B-NP
of IN B-PP
1 CD B-NP
alphaCOMMA25-(OH)2D3 NN I-NP
. . O

The DT B-NP
11 CD I-NP
beta-methyl NN I-NP
analog NN I-NP
had VBD B-VP
a DT O
greater JJR B-ADVP
than IN I-ADVP
10-fold RB I-ADVP
lower JJR B-NP
activity NN I-NP
. . O

The DT B-NP
differentiating JJ I-NP
effects NNS I-NP
of IN B-PP
the DT B-NP
other JJ I-NP
C-11 NN I-NP
analogs NNS I-NP
on IN B-PP
human JJ B-NP
promyeloid JJ I-NP
leukemia NN I-NP
cells NNS I-NP
( ( O
HL-60 NN B-NP
) ) O
agreed VBD B-VP
well RB B-ADVP
with IN B-PP
their PRP$ B-NP
bone-resorbing JJ B-NP
activity NN I-NP
and CC O
receptor NN B-NP
affinity NN I-NP
COMMA COMMA O
but CC O
they PRP B-NP
demonstrated VBD B-VP
lower JJR B-NP
calcemic JJ I-NP
effects NNS I-NP
in FW B-ADVP
vivo FW I-ADVP
. . O

Large JJ B-NP
or CC I-NP
polar JJ I-NP
substitutions NNS I-NP
on IN B-PP
C-11 NN B-NP
of IN B-PP
1 CD B-NP
alphaCOMMA25-(OH)2D3 NN I-NP
thus RB B-ADVP
impair VBP B-VP
the DT B-NP
binding NN I-NP
of IN B-PP
the DT B-NP
vitamin NN I-NP
D NN I-NP
receptor NN I-NP
but CC O
increase VBP B-VP
the DT B-NP
affinity NN I-NP
to TO B-PP
vitamin NN B-NP
D-binding JJ I-NP
protein NN I-NP
. . O

The DT B-NP
effects NNS I-NP
of IN B-PP
many JJ B-NP
C-11-substituted JJ I-NP
1 CD I-NP
alphaCOMMA25-(OH)2D3 NN I-NP
analogs NNS I-NP
on IN B-PP
HL-60 NN B-NP
cell NN I-NP
differentiation NN I-NP
exceeded VBD B-VP
their PRP$ B-NP
activity NN I-NP
on IN B-PP
calcium NN B-NP
metabolism NN I-NP
. . O

Transcriptional JJ B-NP
regulation NN I-NP
during IN B-PP
T-cell NN B-NP
development NN I-NP
: : O
the DT B-NP
alpha NN I-NP
TCR NN I-NP
gene NN I-NP
as IN B-PP
a DT B-NP
molecular JJ I-NP
model NN I-NP
. . O

The DT B-NP
regulation NN I-NP
of IN B-PP
gene NN B-NP
expression NN I-NP
during IN B-PP
lymphocyte NN B-NP
differentiation NN I-NP
is VBZ B-VP
a DT B-NP
complex JJ I-NP
process NN I-NP
involving VBG B-VP
interactions NNS B-NP
between IN B-PP
multiple JJ B-NP
positive JJ I-NP
and CC I-NP
negative JJ I-NP
transcriptional JJ I-NP
regulatory JJ I-NP
elements NNS I-NP
. . O

In IN B-PP
this DT B-NP
article NN I-NP
COMMA COMMA O
transcriptional JJ B-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
archetypal JJ I-NP
T-cell-specific JJ I-NP
gene NN I-NP
COMMA COMMA O
alpha NN B-NP
TCR NN I-NP
COMMA COMMA O
is VBZ B-VP
discussed VBN I-VP
. . O

Major JJ B-NP
recent JJ I-NP
developments NNS I-NP
COMMA COMMA O
including VBG B-PP
the DT B-NP
identification NN I-NP
of IN B-PP
novel JJ B-NP
families NNS I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
that WDT B-NP
regulate VBP B-VP
multiple JJ B-NP
T-cell NN I-NP
genes NNS I-NP
during IN B-PP
thymocyte NN B-NP
ontogeny NN I-NP
and CC O
T-cell NN B-NP
activation NN I-NP
COMMA COMMA O
are VBP B-VP
described VBN I-VP
. . O

Cortisol NN B-NP
resistance NN I-NP
in IN B-PP
acquired VBN B-NP
immunodeficiency NN I-NP
syndrome NN I-NP
. . O

This DT B-NP
study NN I-NP
concerns VBZ B-VP
9 CD B-NP
iv NN I-NP
drug NN I-NP
abusers NNS I-NP
with IN B-PP
acquired VBN B-NP
immunodeficiency NN I-NP
syndrome NN I-NP
( ( O
AIDS NN B-NP
) ) O
who WP B-NP
developed VBD B-VP
hypercortisolism NN B-NP
without IN B-PP
the DT B-NP
clinical JJ B-NP
signs NNS I-NP
or CC O
metabolic JJ B-NP
consequences NNS I-NP
of IN B-PP
hypercortisolism NN B-NP
. . O

All DT B-NP
patients NNS I-NP
were VBD B-VP
characterized VBN I-VP
by IN B-PP
an DT B-NP
Addisonian JJ I-NP
picture NN I-NP
( ( O
weakness NN B-NP
COMMA COMMA O
weight NN B-NP
loss NN I-NP
COMMA COMMA O
hypotension NN B-NP
COMMA COMMA O
hyponatremia NN B-NP
COMMA COMMA O
and CC O
intense JJ B-NP
mucocutaneous JJ I-NP
melanosis NN I-NP
) ) O
. . O

An DT B-NP
acquired JJ I-NP
form NN I-NP
of IN B-PP
peripheral JJ B-NP
resistance NN I-NP
to TO B-PP
glucocorticoids NNS B-NP
was VBD B-VP
suspected VBN I-VP
. . O

We PRP B-NP
COMMA COMMA O
therefore RB B-ADVP
COMMA COMMA O
examined VBD B-VP
glucocorticoid NN B-NP
receptor NN I-NP
characteristics NNS I-NP
on IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
by IN B-PP
measuring VBG B-VP
{3H}dexamethasone NN B-NP
binding NN I-NP
and CC O
the DT B-NP
effect NN I-NP
of IN B-PP
dexamethasone NN B-NP
on IN B-PP
{3H}thymidine NN B-NP
incorporation NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
one CD B-NP
of IN B-PP
the DT B-NP
effects NNS I-NP
of IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
activation NN I-NP
. . O

Glucocorticoid NN B-NP
receptor NN I-NP
density NN I-NP
was VBD B-VP
increased VBN I-VP
in IN B-PP
AIDS NN B-NP
patients NNS I-NP
with IN B-PP
an DT B-NP
Addisonian JJ I-NP
picture NN I-NP
( ( O
group NN B-NP
1 CD I-NP
; : O
16.2 CD B-NP
+\/- CC I-NP
9.4 CD I-NP
fmol\/million NN I-NP
cells NNS I-NP
) ) O
compared VBN B-VP
to TO B-PP
values NNS B-NP
in IN B-PP
12 CD B-NP
AIDS NN I-NP
patients NNS I-NP
without IN B-PP
an DT B-NP
Addisonian JJ I-NP
picture NN I-NP
( ( O
group NN B-NP
2 CD I-NP
; : O
6.05 CD B-NP
+\/- CC I-NP
2.6 CD I-NP
fmol\/million NN I-NP
cells NNS I-NP
; : O
P NN B-NP
less JJR B-NP
than IN I-NP
0.01 CD I-NP
) ) O
and CC O
sex- NN B-NP
and CC O
age-matched JJ B-ADJP
controls NNS B-NP
( ( O
3.15 CD B-NP
+\/- CC I-NP
2.3 CD I-NP
fmol\/million NN I-NP
cells NNS I-NP
; : O
P NN B-NP
less JJR B-NP
than IN I-NP
0.01 CD I-NP
) ) O
. . O

The DT B-NP
affinity NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
( ( O
Kd NN B-NP
) ) O
was VBD B-VP
strikingly RB I-VP
decreased VBN I-VP
( ( O
9.36 CD B-NP
+\/- CC I-NP
3.44 CD I-NP
nM NN I-NP
in IN B-PP
group NN B-NP
1 CD I-NP
; : O
3.2 CD B-NP
+\/- CC I-NP
1.5 CD I-NP
nM NN I-NP
in IN B-PP
group NN B-NP
2 CD I-NP
; : O
2.0 CD B-NP
+\/- CC I-NP
0.8 CD I-NP
nM NN I-NP
in IN B-PP
controls NNS B-NP
; : O
P NN B-NP
less JJR B-NP
than IN I-NP
0.01 CD I-NP
) ) O
. . O

{3H}Thymidine NN B-NP
incorporation NN I-NP
was VBD B-VP
decreased VBN I-VP
dose-dependently RB B-ADVP
by IN B-PP
dexamethasone NN B-NP
in IN B-PP
controls NNS B-NP
and CC O
patients NNS B-NP
; : O
the DT B-NP
effect NN I-NP
was VBD B-VP
significantly RB I-VP
blunted VBN I-VP
( ( O
P NN B-NP
less JJR B-NP
than IN I-NP
0.05 CD I-NP
) ) O
in IN B-PP
group NN B-NP
1 CD I-NP
patients NNS I-NP
COMMA COMMA O
which WDT B-NP
suggests VBZ B-VP
that IN B-SBAR
activation NN B-NP
of IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
is VBZ B-VP
impaired JJ B-ADJP
as IN B-PP
a DT B-NP
result NN I-NP
of IN B-PP
the DT B-NP
glucocorticoid NN I-NP
receptor NN I-NP
abnormality NN I-NP
. . O

In IN B-PP
conclusion NN B-NP
COMMA COMMA O
AIDS NN B-NP
patients NNS I-NP
with IN B-PP
hypercortisolism NN B-NP
and CC O
clinical JJ B-NP
features NNS I-NP
of IN B-PP
peripheral JJ B-NP
resistance NN I-NP
to TO B-PP
glucocorticoids NNS B-NP
are VBP B-VP
characterized VBN I-VP
by IN B-PP
abnormal JJ B-NP
glucocorticoid NN I-NP
receptors NNS I-NP
on IN B-PP
lymphocytes NNS B-NP
. . O

Resistance NN B-NP
to TO B-PP
glucocorticoids NNS B-NP
implies VBZ B-VP
a DT B-NP
complex JJ I-NP
change NN I-NP
in IN B-PP
immune-endocrine JJ B-NP
function NN I-NP
COMMA COMMA O
which WDT B-NP
may MD B-VP
be VB I-VP
important JJ B-ADJP
in IN B-PP
the DT B-NP
course NN I-NP
of IN B-PP
immunodeficiency NN B-NP
syndrome NN I-NP
. . O

Induction NN B-NP
of IN B-PP
monocytic JJ B-NP
differentiation NN I-NP
and CC O
NF-kappa NN B-NP
B-like JJ I-NP
activities NNS I-NP
by IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
1 CD I-NP
infection NN I-NP
of IN B-PP
myelomonoblastic JJ B-NP
cells NNS I-NP
. . O

The DT B-NP
effects NNS I-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
1 CD I-NP
( ( O
HIV-1 NN B-NP
) ) O
infection NN B-NP
on IN B-PP
cellular JJ B-NP
differentiation NN I-NP
and CC O
NF-kappa NN B-NP
B NN I-NP
DNA NN I-NP
binding NN I-NP
activity NN I-NP
have VBP B-VP
been VBN I-VP
investigated VBN I-VP
in IN B-PP
a DT B-NP
new JJ I-NP
model NN I-NP
of IN B-PP
myeloid JJ B-NP
differentiation NN I-NP
. . O

PLB-985 NN B-NP
cells NNS I-NP
represent VBP B-VP
a DT B-NP
bipotential JJ I-NP
myelomonoblastic JJ I-NP
cell NN I-NP
population NN I-NP
capable JJ B-ADJP
of IN B-PP
either CC B-NP
granulocytic JJ I-NP
or CC I-NP
monocytic JJ I-NP
differentiation NN I-NP
after IN B-PP
induction NN B-NP
with IN B-PP
appropriate JJ B-NP
inducers NNS I-NP
. . O

By IN B-PP
virtue NN I-PP
of IN I-PP
the DT B-NP
presence NN I-NP
of IN B-PP
CD4 NN B-NP
on IN B-PP
the DT B-NP
cell NN I-NP
surface NN I-NP
COMMA COMMA O
PLB-985 NN B-NP
cells NNS I-NP
were VBD B-VP
chronically RB I-VP
infected VBN I-VP
with IN B-PP
HIV-1 NN B-NP
strain NN I-NP
IIIB NN I-NP
. . O

PLB-IIIB NN B-NP
cells NNS I-NP
clearly RB B-ADVP
possessed VBD B-VP
a DT B-NP
more RBR I-NP
monocytic JJ I-NP
phenotype NN I-NP
than IN B-PP
the DT B-NP
parental JJ I-NP
myeloblasts NNS I-NP
COMMA COMMA O
as IN B-SBAR
determined VBN B-VP
by IN B-PP
differential JJ B-NP
staining NN I-NP
COMMA COMMA O
increased VBN B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
myeloid-specific JJ I-NP
surface NN I-NP
markers NNS I-NP
COMMA COMMA O
and CC O
transcription NN B-NP
of IN B-PP
the DT B-NP
c-fms NN I-NP
proto-oncogene NN I-NP
. . O

NF-kappa NN B-NP
B NN I-NP
binding NN I-NP
activity NN I-NP
was VBD B-VP
inducible JJ B-ADJP
by IN B-PP
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
and CC O
phorbol NN B-NP
myristate NN I-NP
acetate NN I-NP
in IN B-PP
PLB-985 NN B-NP
. . O

However RB B-ADVP
COMMA COMMA O
in IN B-PP
PLB-IIIB NN B-NP
cells NNS I-NP
COMMA COMMA O
constitutive JJ B-NP
expression NN I-NP
of IN B-PP
a DT B-NP
novel JJ I-NP
NF-kappa NN I-NP
B NN I-NP
complex NN I-NP
was VBD B-VP
detected VBN I-VP
COMMA COMMA O
composed VBN B-VP
of IN B-PP
proteins NNS B-NP
ranging VBG B-VP
between IN B-PP
70 CD B-NP
and CC I-NP
110 CD I-NP
kD NN I-NP
. . O

These DT B-NP
proteins NNS I-NP
interacted VBD B-VP
specifically RB B-PP
with IN I-PP
the DT B-NP
symmetric JJ I-NP
NF-kappa NN I-NP
B NN I-NP
site NN I-NP
from IN B-PP
the DT O
interferon NN B-NP
beta NN I-NP
( ( O
IFN-beta NN B-NP
) ) O
promoter NN B-NP
. . O

Mutations NNS B-NP
affecting VBG B-VP
the DT B-NP
5' JJ I-NP
guanine JJ I-NP
residues NNS I-NP
of IN B-PP
the DT B-NP
kappa NN I-NP
B NN I-NP
site NN I-NP
were VBD B-VP
unable JJ B-ADJP
to TO B-VP
compete VB I-VP
for IN B-PP
these DT B-NP
NF-kappa NN I-NP
B-related JJ I-NP
proteins NNS I-NP
. . O

Inducibility NN B-NP
of IN B-PP
endogenous JJ O
IFN-beta NN B-NP
and CC O
IFN-alpha NN B-NP
RNA NN B-NP
was VBD B-VP
also RB I-VP
increased VBN I-VP
in IN B-PP
PLB-IIIB NN B-NP
cells NNS I-NP
. . O

These DT B-NP
studies NNS I-NP
indicate VBP B-VP
that IN B-SBAR
HIV-1 NN B-NP
infection NN I-NP
of IN B-PP
myelomonoblastic JJ B-NP
cells NNS I-NP
may MD B-VP
select VB I-VP
for IN B-PP
a DT B-NP
more RBR I-NP
mature JJ I-NP
monocytic JJ I-NP
phenotype NN I-NP
and CC O
that IN B-SBAR
unique JJ B-NP
subunit NN I-NP
associations NNS I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
DNA NN I-NP
binding NN I-NP
proteins NNS I-NP
may MD B-VP
contribute VB I-VP
to TO B-PP
differential JJ B-NP
NF-kappa NN I-NP
B-mediated JJ I-NP
gene NN I-NP
expression NN I-NP
. . O

The DT B-NP
AP-1 NN I-NP
site NN I-NP
at IN B-PP
-150 CD B-NP
bp NN I-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
site NN I-NP
COMMA COMMA O
is VBZ B-VP
likely JJ B-ADJP
to TO B-VP
represent VB I-VP
the DT B-NP
major JJ I-NP
target NN I-NP
of IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
in IN B-PP
the DT B-NP
interleukin NN I-NP
2 CD I-NP
promoter NN I-NP
. . O

Stimulation NN B-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
with IN B-PP
antigen NN B-NP
results VBZ B-VP
in IN B-PP
activation NN B-NP
of IN B-PP
several JJ B-NP
kinases NNS I-NP
COMMA COMMA O
including VBG B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( O
PKC NN B-NP
) ) O
COMMA COMMA O
that WDT B-NP
may MD B-VP
mediate VB I-VP
the DT B-NP
later JJ I-NP
induction NN I-NP
of IN B-PP
activation-related JJ B-NP
genes NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
examined VBN I-VP
the DT B-NP
potential JJ I-NP
role NN I-NP
of IN B-PP
PKC NN B-NP
in IN B-PP
induction NN B-NP
of IN B-PP
the DT O
interleukin NN B-NP
2 CD I-NP
( ( O
IL-2 NN B-NP
) ) O
gene NN B-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
stimulated VBN B-VP
through IN B-PP
the DT B-NP
T NN I-NP
cell NN I-NP
receptor\/CD3 NN I-NP
complex NN I-NP
. . O

We PRP B-NP
have VBP B-VP
previously RB I-VP
shown VBN I-VP
that IN B-SBAR
prolonged JJ B-NP
treatment NN I-NP
of IN B-PP
the DT B-NP
untransformed JJ I-NP
T NN I-NP
cell NN I-NP
clone NN I-NP
Ar-5 NN I-NP
with IN B-PP
phorbol NN B-NP
esters NNS I-NP
results VBZ B-VP
in IN B-PP
downmodulation NN B-NP
of IN B-PP
the DT O
alpha NN B-NP
and CC O
beta NN B-NP
isozymes NNS B-NP
of IN B-PP
PKC NN B-NP
COMMA COMMA O
and CC O
abrogates VBZ B-VP
induction NN B-NP
of IN B-PP
IL-2 NN B-NP
mRNA NN I-NP
and CC O
protein NN B-NP
. . O

Here RB B-ADVP
we PRP B-NP
show VBP B-VP
that IN B-SBAR
phorbol NN B-NP
ester NN I-NP
treatment NN I-NP
also RB B-ADVP
abolishes VBZ B-VP
induction NN B-NP
of IN B-PP
chloramphenicol JJ B-NP
acetyltransferase NN I-NP
activity NN I-NP
in IN B-PP
Ar-5 NN B-NP
cells NNS I-NP
transfected VBN B-VP
with IN B-PP
a DT B-NP
plasmid NN I-NP
containing VBG B-VP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
linked VBN B-VP
to TO B-PP
this DT B-NP
reporter NN I-NP
gene NN I-NP
. . O

The DT B-NP
IL-2 NN I-NP
promoter NN I-NP
contains VBZ B-VP
binding VBG B-NP
sites NNS I-NP
for IN B-PP
nuclear JJ B-NP
factors NNS I-NP
including VBG B-PP
NFAT-1 NN B-NP
COMMA COMMA O
Oct NN B-NP
COMMA COMMA O
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
and CC O
AP-1 NN B-NP
COMMA COMMA O
which WDT B-NP
are VBP B-VP
all DT B-ADJP
potentially RB I-ADJP
sensitive JJ I-ADJP
to TO B-PP
activation NN B-NP
of IN B-PP
PKC NN B-NP
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
induction NN B-NP
of IN B-PP
a DT B-NP
trimer NN I-NP
of IN B-PP
the DT O
NFAT NN B-NP
and CC O
Oct NN B-NP
sites NNS B-NP
is VBZ B-VP
not RB O
sensitive JJ B-ADJP
to TO B-PP
phorbol NN B-NP
ester NN I-NP
treatment NN I-NP
COMMA COMMA O
and CC O
that IN B-SBAR
mutations NNS B-NP
in IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
site NN I-NP
have VBP B-VP
no DT B-NP
effect NN I-NP
on IN B-PP
inducibility NN B-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
mutations NNS B-NP
in IN B-PP
the DT B-NP
AP-1 NN I-NP
site NN I-NP
located JJ B-ADJP
at IN B-PP
-150 CD B-NP
bp NN I-NP
almost RB B-ADVP
completely RB I-ADVP
abrogate VBP B-VP
induction NN B-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
COMMA COMMA O
and CC O
appearance NN B-NP
of IN B-PP
an DT B-NP
inducible JJ I-NP
nuclear JJ I-NP
factor NN I-NP
binding VBG B-VP
to TO B-PP
this DT B-NP
site NN I-NP
is VBZ B-VP
sensitive JJ B-ADJP
to TO B-PP
PKC NN B-NP
depletion NN I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
cotransfections NNS B-NP
with IN B-PP
c-fos NN B-NP
and CC O
c-jun NN B-NP
expression NN B-NP
plasmids NNS I-NP
markedly RB B-ADVP
enhance VBP B-VP
induction NN B-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
in IN B-PP
minimally RB B-NP
stimulated VBN I-NP
T NN I-NP
cells NNS I-NP
. . O

Our PRP$ B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
the DT B-NP
AP-1 NN I-NP
site NN I-NP
at IN B-PP
-150 CD B-NP
bp NN I-NP
represents VBZ B-VP
a DT B-NP
major JJ I-NP
COMMA COMMA O
if IN B-SBAR
not RB O
the DT B-NP
only JJ I-NP
COMMA COMMA O
site NN B-NP
of IN B-PP
PKC NN B-NP
responsiveness NN I-NP
in IN B-PP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
. . O

Interleukin NN B-NP
6-induced JJ I-NP
differentiation NN I-NP
of IN B-PP
a DT B-NP
human JJ I-NP
B NN I-NP
cell NN I-NP
line NN I-NP
into IN B-PP
IgM-secreting JJ B-NP
plasma NN I-NP
cells NNS I-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
c-fos NN B-NP
. . O

The DT B-NP
role NN I-NP
of IN B-PP
the DT B-NP
protooncogene NN I-NP
c-fos NN I-NP
in IN B-PP
interleukin NN B-NP
( ( I-NP
IL NN I-NP
) ) I-NP
6-induced JJ I-NP
B NN I-NP
cell NN I-NP
differentiation NN I-NP
was VBD B-VP
assessed VBN I-VP
. . O

Treatment NN B-NP
of IN B-PP
SKW NN B-NP
6.4 CD I-NP
cells NNS I-NP
with IN B-PP
IL NN B-NP
6 CD I-NP
induced VBD B-VP
a DT B-NP
transient JJ I-NP
and CC I-NP
early JJ I-NP
stimulation NN I-NP
of IN B-PP
c-fos NN B-NP
sense NN I-NP
mRNA NN I-NP
expression NN I-NP
. . O

The DT B-NP
effect NN I-NP
appeared VBD B-VP
within IN B-PP
30 CD B-NP
min NN I-NP
and CC O
returned VBD B-VP
to TO B-PP
basal JJ B-NP
levels NNS I-NP
after IN B-PP
2 CD B-NP
h NN I-NP
. . O

The DT B-NP
addition NN I-NP
of IN B-PP
antisense JJ B-NP
oligonucleotides NNS I-NP
to TO B-PP
c-fos NN B-NP
significantly RB B-ADVP
inhibited VBD B-VP
IL NN B-NP
6-induced JJ I-NP
IgM NN I-NP
production NN I-NP
by IN B-PP
SKW NN B-NP
6.4 CD I-NP
cells NNS I-NP
( ( O
p NN B-NP
less JJR B-NP
than IN I-NP
0.001 CD I-NP
) ) O
COMMA COMMA O
whereas IN O
control NN B-NP
oligonucleotides NNS I-NP
had VBD B-VP
no DT B-NP
inhibitory JJ I-NP
effect NN I-NP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
activation NN B-NP
of IN B-PP
c-fos NN B-NP
is VBZ B-VP
involved VBN I-VP
in IN B-PP
IL NN B-NP
6-induced JJ I-NP
differentiation NN I-NP
of IN B-PP
SKW NN B-NP
6.4 CD I-NP
cells NNS I-NP
into IN B-PP
IgM-secreting JJ B-NP
cells NNS I-NP
. . O

Binding NN B-NP
of IN B-PP
erythroid JJ B-NP
and CC I-NP
non-erythroid JJ I-NP
nuclear JJ I-NP
proteins NNS I-NP
to TO B-PP
the DT B-NP
silencer NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
epsilon-globin-encoding JJ I-NP
gene NN I-NP
. . O

To TO B-VP
clarify VB I-VP
the DT B-NP
molecular JJ I-NP
mechanisms NNS I-NP
involved VBN B-VP
in IN B-PP
the DT B-NP
developmental JJ I-NP
control NN I-NP
of IN B-PP
hemoglobin-encoding JJ B-NP
genes NNS I-NP
we PRP B-NP
have VBP B-VP
been VBN I-VP
studying VBG I-VP
the DT B-NP
expression NN I-NP
of IN B-PP
these DT B-NP
genes NNS I-NP
in IN B-PP
human JJ B-NP
cells NNS I-NP
in IN B-PP
continuous JJ B-NP
culture NN I-NP
. . O

We PRP B-NP
have VBP B-VP
previously RB I-VP
reported VBN I-VP
the DT B-NP
presence NN I-NP
of IN B-PP
a DT B-NP
transcriptional JJ I-NP
control NN I-NP
element NN I-NP
with IN B-PP
the DT B-NP
properties NNS I-NP
of IN B-PP
a DT B-NP
silencer NN I-NP
extending VBG B-VP
from IN B-PP
-392 CD B-NP
to TO B-PP
-177 CD B-NP
bp NN B-NP
relative JJ B-PP
to TO I-PP
the DT B-NP
cap NN I-NP
site NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
epsilon-globin-encoding JJ I-NP
gene NN I-NP
{ ( O
Cao NNP B-NP
et FW B-NP
al. FW B-NP
COMMA COMMA O
Proc.Natl.Acad.Sci.USA NNP B-NP
86 CD I-NP
( ( I-NP
1989 CD I-NP
) ) I-NP
5306-5309 CD I-NP
} ) O
. . O

We PRP B-NP
also RB B-ADVP
showed VBD B-VP
that IN B-SBAR
this DT B-NP
silencer NN I-NP
has VBZ B-VP
stronger JJR B-NP
inhibitory JJ I-NP
activity NN I-NP
in IN B-PP
HeLa NN B-NP
cells NNS I-NP
COMMA COMMA O
as IN B-SBAR
compared VBN B-VP
to TO B-PP
K562 NN B-NP
human JJ I-NP
erythroleukemia NN I-NP
cells NNS I-NP
. . O

Using VBG B-VP
deletion NN B-NP
mutants NNS I-NP
and CC O
cis-cloned JJ B-NP
synthetic JJ I-NP
oligodeoxyribonucleotides NNS I-NP
in IN B-PP
transient JJ B-NP
expression NN I-NP
assays NNS I-NP
COMMA COMMA O
nucleotide NN B-NP
sequences NNS I-NP
responsible JJ B-ADJP
for IN B-PP
this DT B-NP
effect NN I-NP
have VBP B-VP
now RB I-VP
been VBN I-VP
further RBR I-VP
delimited VBN I-VP
to TO B-PP
44 CD B-NP
bp NN I-NP
located JJ B-ADJP
from IN B-PP
-294 CD B-NP
to TO B-PP
-251 CD B-NP
bp NN B-NP
. . O

Gel NN B-NP
electrophoresis NN I-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
and CC O
DNaseI NN B-NP
footprinting NN I-NP
assays NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
these DT B-NP
negative JJ I-NP
regulatory JJ I-NP
sequences NNS I-NP
are VBP B-VP
recognized VBN I-VP
differently RB B-ADVP
by IN B-PP
proteins NNS B-NP
present JJ B-ADJP
in IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
obtained VBN B-VP
from IN B-PP
HeLa NN B-NP
and CC O
K562 NN B-NP
cells NNS B-NP
. . O

Two CD B-NP
binding VBG I-NP
proteins NNS I-NP
are VBP B-VP
detected VBN I-VP
in IN B-PP
K562 NN B-NP
nuclear JJ I-NP
extracts NNS I-NP
COMMA COMMA O
while IN B-SBAR
only RB B-NP
one CD I-NP
is VBZ B-VP
found VBN I-VP
in IN B-PP
extracts NNS B-NP
from IN B-PP
HeLa NN B-NP
cells NNS I-NP
. . O

Possible JJ B-NP
mechanisms NNS I-NP
by IN B-PP
which WDT B-NP
these DT B-NP
proteins NNS I-NP
may MD B-VP
regulate VB I-VP
transcription NN B-NP
of IN B-PP
the DT B-NP
epsilon-globin-encoding JJ I-NP
gene NN I-NP
in IN B-PP
erythroid JJ B-NP
and CC I-NP
non-erythroid JJ I-NP
cells NNS I-NP
are VBP B-VP
discussed VBN I-VP
. . O

Gangliosides NN B-NP
suppress VBP B-VP
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
production NN I-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
. . O

Both CC B-NP
normal JJ I-NP
and CC I-NP
malignant JJ I-NP
cells NNS I-NP
contain VBP B-VP
gangliosides NNS B-NP
as IN B-PP
important JJ B-NP
cell NN I-NP
membrane NN I-NP
constituents NNS I-NP
that WDT B-NP
COMMA COMMA O
after IN B-PP
being VBG B-VP
shed VBN I-VP
COMMA COMMA O
may MD B-VP
influence VB I-VP
cells NNS B-NP
of IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
. . O

We PRP B-NP
have VBP B-VP
studied VBN I-VP
the DT B-NP
impact NN I-NP
of IN B-PP
gangliosides NNS B-NP
on IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
TNF NN B-NP
in IN B-PP
blood NN B-NP
monocytes NNS I-NP
and CC B-PP
in IN B-PP
the DT B-NP
monocytic JJ I-NP
cell NN I-NP
line NN I-NP
Mono NN I-NP
Mac NN I-NP
6 CD I-NP
. . O

Although IN B-SBAR
under IN B-PP
standard JJ B-NP
culture NN I-NP
conditions NNS I-NP
COMMA COMMA O
bovine JJ B-NP
brain NN I-NP
gangliosides NNS I-NP
( ( O
100 CD B-NP
micrograms\/ml NNS I-NP
) ) O
suppressed VBD B-VP
LPS-stimulated JJ B-NP
TNF NN I-NP
production NN I-NP
5-fold RB B-ADVP
in IN B-PP
PBMC NN B-NP
and CC O
10-fold RB B-ADVP
in IN B-PP
Mono NN B-NP
Mac NN I-NP
6 CD I-NP
cells NNS I-NP
COMMA COMMA O
suppression NN B-NP
was VBD B-VP
more RBR B-ADJP
efficient JJ I-ADJP
under IN B-PP
serum-free JJ B-NP
conditions NNS I-NP
. . O

Looking VBG B-VP
at IN B-PP
highly RB B-NP
purified VBN I-NP
gangliosides NNS I-NP
COMMA COMMA O
GD3 NN B-NP
COMMA COMMA O
GD1a NN B-NP
COMMA COMMA O
GM3 NN B-NP
COMMA COMMA O
GM2 NN B-NP
COMMA COMMA O
and CC O
GM1 NN B-NP
were VBD B-VP
all DT B-ADJP
effective JJ I-ADJP
in IN B-PP
reducing VBG B-VP
TNF NN B-NP
production NN I-NP
in IN B-PP
PBMC NN B-NP
COMMA COMMA B-PP
and CC I-PP
in IN B-PP
Mono NN B-NP
Mac NN I-NP
6 CD I-NP
by IN B-PP
factor NN B-NP
10 CD B-NP
to TO O
50 CD B-NP
. . O

The DT B-NP
suppressive JJ I-NP
activity NN I-NP
was VBD B-VP
lost VBN I-VP
in IN B-PP
molecules NNS B-NP
COMMA COMMA O
lacking VBG B-VP
the DT B-NP
sugar NN I-NP
moiety NN I-NP
or CC O
the DT B-NP
lipid NN I-NP
moiety NN I-NP
. . O

Gangliosides NNS B-NP
appear VBP B-VP
to TO I-VP
act VB I-VP
at IN B-PP
an DT B-NP
early JJ I-NP
step NN I-NP
of IN B-PP
activation NN B-NP
in IN B-PP
that IN B-NP
TNF NN B-NP
transcripts NNS I-NP
were VBD B-VP
reduced VBN I-VP
and CC O
the DT B-NP
mobilization NN I-NP
of IN B-PP
the DT B-NP
nuclear JJ I-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
was VBD B-VP
blocked VBN I-VP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
in IN B-PP
time NN B-NP
kinetics NNS I-NP
COMMA COMMA O
gangliosides NNS B-NP
were VBD B-VP
effective JJ B-ADJP
for IN B-PP
up RB B-NP
to TO I-NP
30 CD I-NP
min NN I-NP
after IN B-PP
addition NN B-NP
of IN B-PP
LPS NN B-NP
COMMA COMMA O
but CC O
not RB B-ADVP
thereafter RB I-ADVP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
CD14 NN I-NP
Ag NN I-NP
COMMA COMMA O
a DT B-NP
receptor NN I-NP
molecule NN I-NP
for IN B-PP
LPS-LPS NN B-NP
binding NN I-NP
protein NN I-NP
complexes NNS I-NP
COMMA COMMA O
was VBD B-VP
unaffected JJ I-VP
by IN B-PP
gangliosides NNS B-NP
. . O

Finally RB B-ADVP
COMMA COMMA O
when WRB B-ADVP
using VBG B-VP
Staphylococcus FW B-NP
aureus FW I-NP
or CC O
platelet NN B-NP
activating NN I-NP
factor NN I-NP
as IN B-PP
a DT B-NP
stimulus NN I-NP
COMMA COMMA O
gangliosides NNS B-NP
were VBD B-VP
able JJ B-ADJP
to TO B-VP
suppress VB I-VP
TNF NN B-NP
production NN I-NP
in IN B-PP
Mono NN B-NP
Mac NN I-NP
6 CD I-NP
cells NNS I-NP
by IN B-PP
factor NN B-NP
5 CD B-NP
to TO O
10 CD B-NP
COMMA COMMA O
as RB B-PP
well RB B-ADVP
. . O

On IN B-PP
the DT B-NP
other JJ I-NP
hand NN I-NP
COMMA COMMA O
phorbol NN B-NP
ester-induced JJ I-NP
production NN I-NP
of IN B-PP
O2- NN B-NP
was VBD B-VP
similar JJ B-ADJP
in IN B-PP
cells NNS B-NP
treated VBN B-VP
with IN B-PP
and CC B-PP
without IN B-PP
gangliosides NNS B-NP
. . O

Taken VBN B-VP
together RB B-ADVP
COMMA COMMA O
our PRP$ B-NP
data NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
TNF NN B-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
monocytes NNS B-NP
induced VBN B-VP
by IN B-PP
different JJ B-NP
types NNS I-NP
of IN B-PP
stimuli NNS B-NP
can MD B-VP
be VB I-VP
blocked VBN I-VP
by IN B-PP
gangliosides NNS B-NP
at IN B-PP
an DT B-NP
early JJ I-NP
step NN I-NP
of IN B-PP
signal JJ B-NP
transduction NN I-NP
. . O

T NN B-NP
cell-specific JJ I-NP
negative JJ I-NP
regulation NN I-NP
of IN B-PP
transcription NN B-NP
of IN B-PP
the DT B-NP
human JJ I-NP
cytokine NN I-NP
IL-4 NN I-NP
. . O

IL-4 NN B-NP
secreted VBN B-VP
by IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
is VBZ B-VP
a DT B-NP
pleiotropic JJ I-NP
cytokine NN I-NP
affecting VBG B-VP
growth NN B-NP
and CC O
differentiation NN B-NP
of IN B-PP
diverse JJ B-NP
cell NN I-NP
types NNS I-NP
such JJ B-PP
as IN I-PP
T NN B-NP
cells NNS I-NP
COMMA COMMA O
B NN B-NP
cells NNS I-NP
COMMA COMMA O
and CC O
mast NN B-NP
cells NNS I-NP
. . O

We PRP B-NP
investigated VBD B-VP
the DT B-NP
upstream JJ I-NP
regulatory JJ I-NP
elements NNS I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
IL-4 NN I-NP
promoter NN I-NP
. . O

A DT B-NP
novel JJ I-NP
T NN I-NP
cell-specific JJ I-NP
negative JJ I-NP
regulatory JJ I-NP
element NN I-NP
( ( O
NRE NN B-NP
) ) O
composed VBN B-VP
of IN B-PP
two CD B-NP
protein-binding JJ I-NP
sites NNS I-NP
were VBD B-VP
mapped VBN I-VP
in IN B-PP
the DT B-NP
5' JJ I-NP
flanking JJ I-NP
region NN I-NP
of IN B-PP
the DT B-NP
IL-4 NN I-NP
gene NN I-NP
: : O
-311CTCCCTTCT-303 NN B-NP
( ( O
NRE-I NN B-NP
) ) O
and CC O
-288CTTTTTGCTT-TGC-300 NN B-NP
( ( O
NRE-II NN B-NP
) ) O
. . O

A DT B-NP
T NN I-NP
cell-specific JJ I-NP
protein NN I-NP
Neg-1 NN I-NP
and CC O
a DT B-NP
ubiquitous JJ I-NP
protein NN I-NP
Neg-2 NN I-NP
binding VBG B-VP
to TO B-PP
NRE-I NN B-NP
and CC O
NRE-II NN B-NP
COMMA COMMA O
respectively RB B-ADVP
COMMA COMMA O
were VBD B-VP
identified VBN I-VP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
a DT B-NP
positive JJ I-NP
regulatory JJ I-NP
element NN I-NP
was VBD B-VP
found VBN I-VP
45 CD B-NP
bp NN I-NP
downstream RB B-ADVP
of IN B-PP
the DT B-NP
NRE NN I-NP
. . O

The DT B-NP
enhancer NN I-NP
activity NN I-NP
of IN B-PP
the DT B-NP
PRE NN I-NP
was VBD B-VP
completely RB I-VP
suppressed VBN I-VP
when WRB B-ADVP
the DT B-NP
NRE NN I-NP
was VBD B-VP
present JJ B-ADJP
. . O

These DT B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
IL-4 NN B-NP
promoter NN I-NP
activity NN I-NP
is VBZ B-VP
normally RB I-VP
down-regulated VBN I-VP
by IN B-PP
an DT B-NP
NRE NN I-NP
via IN B-PP
repression NN B-NP
of IN B-PP
the DT B-NP
enhancer NN I-NP
positive JJ I-NP
regulatory JJ I-NP
element NN I-NP
. . O

These DT B-NP
data NNS I-NP
may MD B-VP
have VB I-VP
implications NNS B-NP
for IN B-PP
the DT B-NP
stringent JJ I-NP
control NN I-NP
of IN B-PP
IL-4 NN B-NP
expression NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
. . O

{ ( O
Regulatory JJ B-NP
effect NN I-NP
of IN B-PP
insulin NN B-NP
on IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
in IN B-PP
human JJ B-NP
peripheral JJ I-NP
leukocytes NNS I-NP
} ) O

The DT B-NP
regulatory JJ I-NP
effect NN I-NP
of IN B-PP
insulin NN B-NP
on IN B-PP
the DT B-NP
specific JJ I-NP
binding VBG I-NP
power NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
( ( O
GR NN B-NP
) ) O
of IN B-PP
human JJ B-NP
leukocytes NNS I-NP
was VBD B-VP
assessed VBN I-VP
by IN B-PP
the DT B-NP
unoccupied JJ I-NP
receptor NN I-NP
sites NNS I-NP
capable JJ B-ADJP
of IN B-PP
combining VBG B-VP
with IN B-PP
{3H} NN B-NP
labelled JJ I-NP
dexamethasone NN I-NP
measured VBN B-VP
at IN B-PP
3 CD B-NP
and CC I-NP
24 CD I-NP
h NN I-NP
after IN B-PP
incubation NN B-NP
with IN B-PP
various JJ B-NP
concentrations NNS I-NP
of IN B-PP
insulin NN B-NP
added VBN B-VP
to TO B-PP
the DT B-NP
medium NN I-NP
. . O

After IN B-PP
3 CD B-NP
h NN I-NP
incubation NN I-NP
the DT B-NP
specific JJ I-NP
binding VBG I-NP
power NN I-NP
with IN B-PP
{3H} NN B-NP
Dex NN I-NP
was VBD B-VP
decreased VBN I-VP
by IN B-PP
23.3 CD B-NP
+\/- CC I-NP
10.0 CD I-NP
COMMA COMMA O
32.2 CD B-NP
+\/- CC I-NP
13.2 CD I-NP
and CC O
54.3 CD B-NP
+\/- CC I-NP
9.2 CD I-NP
% NN B-NP
( ( O
P NN B-NP
greater JJR B-ADJP
than IN B-PP
0.05 CD B-NP
COMMA COMMA O
P NN B-NP
greater JJR B-ADJP
than IN B-PP
0.05 CD B-NP
and CC O
P NN B-NP
less JJR B-ADJP
than IN B-PP
0.01 CD B-NP
as IN B-SBAR
compared VBN B-VP
with IN B-PP
the DT B-NP
control NN I-NP
value NN I-NP
of IN B-PP
100 CD B-NP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
insulin NN B-NP
) ) O
respectively RB B-ADVP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
20 CD B-NP
mU\/L NN I-NP
( ( O
physiological JJ B-NP
testing NN I-NP
concentration NN I-NP
) ) O
COMMA COMMA O
200 CD B-NP
mU\/L NN I-NP
( ( O
physiological JJ B-NP
upper JJ I-NP
limit NN I-NP
) ) O
and CC O
2COMMA000 CD B-NP
mU\/L NN I-NP
( ( O
pharmacological JJ B-NP
concentration NN I-NP
) ) O
insulin NN B-NP
in IN B-PP
the DT B-NP
incubation NN I-NP
medium NN I-NP
. . O

After IN B-PP
24 CD B-NP
h NN I-NP
incubation NN I-NP
the DT B-NP
decrease NN I-NP
of IN B-PP
these DT B-NP
values NNS I-NP
increased VBD B-VP
respectively RB B-ADVP
to TO B-PP
43.5 CD B-NP
+\/- CC I-NP
19.0 CD I-NP
COMMA COMMA O
56.1 CD B-NP
+\/- CC I-NP
20.7 CD I-NP
and CC O
80.2 CD B-NP
+\/- CC I-NP
15.5 CD I-NP
( ( O
P NN B-NP
less JJR B-ADJP
than IN B-PP
0.05 CD B-NP
COMMA COMMA O
P NN B-NP
less JJR B-ADJP
than IN B-PP
0.01 CD B-NP
and CC O
P NN B-NP
less JJR B-ADJP
than IN B-PP
0.01 CD B-NP
compared VBN B-VP
with IN B-PP
control NN B-NP
) ) O
. . O

Thus RB B-ADVP
the DT B-NP
inhibitory JJ I-NP
effect NN I-NP
of IN B-PP
insulin NN B-NP
on IN B-PP
the DT B-NP
GR NN I-NP
binding NN I-NP
power NN I-NP
is VBZ B-VP
both CC O
dose- NN B-NP
and CC O
time-dependent JJ B-ADJP
COMMA COMMA O
which WDT B-NP
strongly RB B-ADVP
suggests VBZ B-VP
that IN B-SBAR
GR NN B-NP
is VBZ B-VP
tonically RB I-VP
controlled VBN I-VP
by IN B-PP
insulin NN B-NP
concentration NN I-NP
change NN I-NP
under IN B-PP
physiological JJ B-NP
conditions NNS I-NP
. . O

Human JJ B-NP
T NN I-NP
cell NN I-NP
activation NN I-NP
through IN B-PP
the DT B-NP
activation-inducer JJ I-NP
molecule\/CD69 NN I-NP
enhances VBZ B-VP
the DT B-NP
activity NN I-NP
of IN B-PP
transcription NN B-NP
factor NN I-NP
AP-1 NN I-NP
. . O

The DT B-NP
induction NN I-NP
of IN B-PP
the DT B-NP
AP-1 NN I-NP
transcription NN I-NP
factor NN I-NP
has VBZ B-VP
been VBN I-VP
ascribed VBN I-VP
to TO B-PP
the DT B-NP
early JJ I-NP
events NNS I-NP
leading VBG B-VP
to TO B-PP
T NN B-NP
cell NN I-NP
differentiation NN B-NP
and CC O
activation NN B-NP
. . O

We PRP B-NP
have VBP B-VP
studied VBN I-VP
the DT B-NP
regulation NN I-NP
of IN B-PP
AP-1 NN B-NP
activity NN I-NP
in IN B-PP
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
T NN I-NP
lymphocytes NNS I-NP
stimulated VBN B-VP
through IN B-PP
the DT B-NP
activation NN I-NP
inducer NN I-NP
molecule NN I-NP
( ( I-NP
AIM NN I-NP
) ) I-NP
\/CD69 NN I-NP
activation NN I-NP
pathway NN I-NP
. . O

Phorbol NN B-NP
esters NNS I-NP
are VBP B-VP
required VBN I-VP
to TO B-VP
induce VB I-VP
AIM\/CD69 NN B-NP
cell-surface JJ I-NP
expression NN I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
for IN B-PP
triggering VBG B-VP
the DT B-NP
proliferation NN I-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
in IN B-PP
conjunction NN I-PP
with IN I-PP
anti-AIM JJ B-NP
mAb NN I-NP
. . O

Mobility NN B-NP
shift NN I-NP
assays NNS I-NP
showed VBD B-VP
that IN B-SBAR
addition NN B-NP
of IN B-PP
anti-AIM JJ B-NP
mAb NN I-NP
to TO B-PP
PMA-treated JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
markedly RB B-ADVP
enhanced VBD B-VP
the DT B-NP
binding NN I-NP
activity NN I-NP
of IN B-PP
AP-1 NN B-NP
to TO B-PP
its PRP$ B-NP
cognate JJ I-NP
sequence NN I-NP
COMMA COMMA O
the DT B-NP
phorbol NN I-NP
ester NN I-NP
response NN I-NP
element NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
anti-AIM NN B-NP
mAb NN I-NP
did VBD B-VP
not RB I-VP
induce VB I-VP
any DT B-NP
change NN I-NP
in IN B-PP
the DT B-NP
binding NN I-NP
activity NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
a DT B-NP
transcription NN I-NP
factor NN I-NP
whose WP$ B-NP
activity NN I-NP
is VBZ B-VP
also RB I-VP
regulated VBN I-VP
by IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
. . O

The DT B-NP
increase NN I-NP
in IN B-PP
AP-1-binding JJ B-NP
activity NN I-NP
was VBD B-VP
accompanied VBN I-VP
by IN B-PP
the DT B-NP
marked JJ I-NP
stimulation NN I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
of IN B-PP
c-fos NN B-NP
but CC B-CONJP
not RB I-CONJP
that DT B-NP
of IN B-PP
c-jun NN B-NP
. . O

Blockade NN B-NP
of IN B-PP
the DT B-NP
DNA-binding JJ I-NP
complexes NNS I-NP
with IN B-PP
an DT B-NP
anti-Fos JJ I-NP
mAb NN I-NP
demonstrated VBD B-VP
a DT B-NP
direct JJ I-NP
participation NN I-NP
of IN B-PP
c-Fos NN B-NP
in IN B-PP
the DT B-NP
AP-1 NN I-NP
complexes NNS I-NP
induced VBN B-VP
by IN B-PP
anti-AIM NN B-NP
mAb NN I-NP
. . O

Most JJS B-NP
of IN B-PP
the DT B-NP
AP-1 NN I-NP
activity NN I-NP
could MD B-VP
be VB I-VP
eliminated VBN I-VP
when WRB B-ADVP
the DT B-NP
anti-AIM NN I-NP
mAb NN I-NP
was VBD B-VP
added VBN I-VP
to TO B-PP
the DT B-NP
culture NN I-NP
medium NN I-NP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
cycloheximide NN B-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
de FW B-NP
novo FW I-NP
protein NN I-NP
synthesis NN I-NP
is VBZ B-VP
crucial JJ B-ADJP
for IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
AP-1-binding JJ B-NP
activity NN I-NP
. . O

These DT B-NP
data NNS I-NP
provide VBP B-VP
the DT B-NP
evidence NN I-NP
that IN B-SBAR
activation NN B-NP
of IN B-PP
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
T NN I-NP
cells NNS I-NP
through IN B-PP
the DT B-NP
AIM NN I-NP
activation NN I-NP
pathway NN I-NP
regulate VBP B-VP
the DT B-NP
activity NN I-NP
of IN B-PP
AP-1 NN B-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
this DT B-NP
pathway NN I-NP
appears VBZ B-VP
as IN B-PP
a DT B-NP
crucial JJ I-NP
step NN I-NP
in IN B-PP
the DT B-NP
initiation NN I-NP
of IN B-PP
early JJ B-NP
T NN I-NP
cell NN I-NP
activation NN I-NP
events NNS I-NP
. . O

cis-acting JJ B-NP
sequences NNS I-NP
required VBN B-VP
for IN B-PP
inducible JJ B-NP
interleukin-2 NN I-NP
enhancer NN I-NP
function NN I-NP
bind VBP B-VP
a DT B-NP
novel JJ I-NP
Ets-related JJ I-NP
protein NN I-NP
COMMA COMMA O
Elf-1 NN B-NP
. . O

The DT B-NP
recent JJ I-NP
definition NN I-NP
of IN B-PP
a DT B-NP
consensus NN I-NP
DNA NN I-NP
binding NN I-NP
sequence NN I-NP
for IN B-PP
the DT B-NP
Ets NN I-NP
family NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
has VBZ B-VP
allowed VBN I-VP
the DT B-NP
identification NN I-NP
of IN B-PP
potential JJ B-NP
Ets NN I-NP
binding NN I-NP
sites NNS I-NP
in IN B-PP
the DT B-NP
promoters NNS B-NP
and CC O
enhancers NNS B-NP
of IN B-PP
many JJ B-NP
inducible JJ I-NP
T-cell NN I-NP
genes NNS I-NP
. . O

In IN B-PP
the DT B-NP
studies NNS I-NP
described VBN B-VP
in IN B-PP
this DT B-NP
report NN I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
identified VBN I-VP
two CD B-NP
potential JJ I-NP
Ets NNS I-NP
binding NN I-NP
sites NNS I-NP
COMMA COMMA O
EBS1 NN B-NP
and CC O
EBS2 NN B-NP
COMMA COMMA O
which WDT B-NP
are VBP B-VP
conserved VBN I-VP
in IN B-PP
both CC B-NP
the DT I-NP
human JJ I-NP
and CC I-NP
murine JJ I-NP
interleukin-2 NN I-NP
enhancers NNS I-NP
. . O

Within IN B-PP
the DT B-NP
human JJ I-NP
enhancer NN I-NP
COMMA COMMA O
these DT B-NP
two CD I-NP
sites NNS I-NP
are VBP B-VP
located JJ O
within IN B-PP
the DT B-NP
previously RB I-NP
defined VBN I-NP
DNase NN I-NP
I CD I-NP
footprints NNS I-NP
COMMA COMMA O
NFAT-1 NN B-NP
and CC O
NFIL-2B NN B-NP
COMMA COMMA O
respectively RB B-ADJP
. . O

Electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
and CC O
methylation NN B-NP
interference NN I-NP
analyses NNS B-NP
demonstrated VBD B-VP
that IN B-SBAR
EBS1 NN B-NP
and CC O
EBS2 NN B-NP
are VBP B-VP
essential JJ B-ADJP
for IN B-PP
the DT B-NP
formation NN I-NP
of IN B-PP
the DT O
NFAT-1 NN B-NP
and CC O
NFIL-2B NN B-NP
nuclear JJ B-NP
protein NN I-NP
complexes NNS I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
in FW B-NP
vitro FW I-NP
mutagenesis NN I-NP
experiments NNS I-NP
demonstrated VBD B-VP
that IN B-SBAR
inducible JJ B-NP
interleukin-2 NN I-NP
enhancer NN I-NP
function NN I-NP
requires VBZ B-VP
the DT B-NP
presence NN I-NP
of IN B-PP
either CC O
EBS1 NN B-NP
or CC O
EBS2 NN B-NP
. . O

Two CD B-NP
well-characterized JJ I-NP
Ets NN I-NP
family NN I-NP
members NNS I-NP
COMMA COMMA O
Ets-1 NN B-NP
and CC O
Ets-2 NN B-NP
COMMA COMMA O
are VBP B-VP
reciprocally RB I-VP
expressed VBN I-VP
during IN B-PP
T-cell NN B-NP
activation NN I-NP
. . O

Surprisingly RB B-ADVP
COMMA COMMA O
however RB B-ADVP
COMMA COMMA O
neither DT B-NP
of IN B-PP
these DT B-NP
proteins NNS I-NP
bound VBD B-VP
in FW B-ADVP
vitro FW I-ADVP
to TO B-PP
EBS1 NN B-NP
or CC O
EBS2 NN B-NP
. . O

We PRP B-NP
therefore RB B-ADVP
screened VBD B-VP
a DT B-NP
T-cell NN I-NP
cDNA NN I-NP
library NN I-NP
under IN B-PP
low-stringency NN B-NP
conditions NNS I-NP
with IN B-PP
a DT B-NP
probe NN I-NP
from IN B-PP
the DT B-NP
DNA NN I-NP
binding NN I-NP
domain NN I-NP
of IN B-PP
Ets-1 NN B-NP
and CC O
isolated VBD B-VP
a DT B-NP
novel JJ I-NP
Ets NN I-NP
family NN I-NP
member NN I-NP
COMMA COMMA O
Elf-1 NN B-NP
. . O

Elf-1 NN B-NP
contains VBZ B-VP
a DT B-NP
DNA NN I-NP
binding NN I-NP
domain NN I-NP
that WDT B-NP
is VBZ B-VP
nearly RB B-ADJP
identical JJ I-ADJP
to TO B-PP
that DT B-NP
of IN B-PP
E74 NN B-NP
COMMA COMMA O
the DT B-NP
ecdysone-inducible JJ I-NP
Drosophila NN I-NP
transcription NN I-NP
factor NN I-NP
required VBN B-VP
for IN B-PP
metamorphosis NN B-NP
( ( O
hence RB B-ADVP
the DT B-NP
name NN I-NP
Elf-1 NN I-NP
COMMA COMMA O
for IN B-PP
E74-like JJ B-NP
factor NN I-NP
1 CD I-NP
) ) O
. . O

Elf-1 NN B-NP
bound VBD B-VP
specifically RB B-PP
to TO I-PP
both CC O
EBS1 NN B-NP
and CC O
EBS2 NN B-NP
in IN B-PP
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
. . O

It PRP B-NP
also RB B-ADVP
bound VBD B-VP
to TO B-PP
the DT B-NP
purine-rich JJ I-NP
CD3R NN I-NP
element NN I-NP
from IN B-PP
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
2 CD I-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
inducible JJ B-NP
virus NN I-NP
expression NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
signalling NN B-NP
through IN B-PP
the DT B-NP
T-cell NN I-NP
receptor NN I-NP
. . O

Taken VBN B-VP
together RB B-ADVP
COMMA COMMA O
these DT B-NP
results NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
multiple JJ B-NP
Ets NN I-NP
family NN I-NP
members NNS I-NP
with IN B-PP
apparently RB B-NP
distinct JJ I-NP
DNA NN I-NP
binding NN I-NP
specificities NNS I-NP
regulate VBP B-VP
differential JJ B-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
resting VBG B-NP
and CC I-NP
activated VBN I-NP
T NN I-NP
cells NNS I-NP
. . O

Mineralocorticoids NNPS B-NP
and CC O
mineralocorticoid NN B-NP
receptors NNS I-NP
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
pregnancy-induced JJ B-NP
hypertension NN I-NP
. . O

To TO B-VP
examine VB I-VP
the DT B-NP
role NN I-NP
of IN B-PP
mineralocorticoids NNS B-NP
in IN B-PP
the DT B-NP
pathophysiology NN I-NP
of IN B-PP
pregnancy-induced JJ B-NP
hypertension NN I-NP
( ( O
PIH NN B-NP
) ) O
COMMA COMMA O
we PRP B-NP
studied VBD B-VP
plasma NN B-NP
aldosterone NN I-NP
and CC O
18-hydroxycorticosterone NN B-NP
levels NNS B-NP
in IN B-PP
25 CD B-NP
women NNS I-NP
with IN B-PP
PIH NN B-NP
and CC O
25 CD B-NP
normal JJ I-NP
pregnant JJ I-NP
women NNS I-NP
COMMA COMMA O
as IN B-PP
controls NNS B-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
we PRP B-NP
evaluated VBD B-VP
the DT O
mineralocorticoid NN B-NP
receptor NN I-NP
( ( O
MR NN B-NP
) ) O
status NN B-NP
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
in IN B-PP
the DT B-NP
2 CD I-NP
groups NNS I-NP
. . O

MR NN B-NP
count NN I-NP
was VBD B-VP
significantly RB B-ADVP
( ( O
P NN B-NP
less JJR B-NP
than IN I-NP
0.0005 CD I-NP
) ) O
decreased VBN B-VP
in IN B-PP
the DT B-NP
PIH NN I-NP
group NN I-NP
( ( O
148 CD B-NP
+\/- CC I-NP
9 CD I-NP
binding VBG I-NP
sites\/cell NNS I-NP
) ) O
compared VBN B-PP
with IN B-PP
the DT B-NP
control NN I-NP
group NN I-NP
( ( O
300 CD B-NP
+\/- CC I-NP
17 CD I-NP
binding VBG I-NP
sites\/cell NNS I-NP
; : O
mean NN B-NP
+\/- CC I-NP
SEM NN I-NP
) ) O
. . O

Plasma NN B-NP
aldosterone NN I-NP
in IN B-PP
women NNS B-NP
with IN B-PP
PIH NN B-NP
was VBD B-VP
281 CD B-NP
+\/- CC I-NP
61 CD I-NP
pmol\/L NN I-NP
; : O
in IN B-PP
normal JJ B-NP
pregnant JJ I-NP
women NNS I-NP
it PRP B-NP
was VBD B-VP
697 CD B-NP
+\/- CC I-NP
172 CD I-NP
pmol\/L NN I-NP
( ( O
P NN B-NP
less JJR B-NP
than IN I-NP
0.025 CD I-NP
) ) O
. . O

Plasma NN B-NP
18-hydroxycorticosterone NN I-NP
was VBD B-VP
also RB B-ADVP
significantly RB O
( ( O
P NN B-NP
less JJR B-NP
than IN I-NP
0.025 CD I-NP
) ) O
lower JJR B-ADJP
( ( O
PIH NN B-NP
COMMA COMMA O
1071 CD B-NP
+\/- CC I-NP
149 CD I-NP
pmol\/L NN I-NP
; : O
controls NNS B-NP
COMMA COMMA O
1907 CD B-NP
+\/- CC I-NP
318 CD I-NP
pmol\/L NN I-NP
) ) O
. . O

These DT B-NP
values NNS I-NP
were VBD B-VP
determined VBN I-VP
at IN B-PP
the DT B-NP
onset NN I-NP
of IN B-PP
clinical JJ B-NP
symptoms NNS I-NP
of IN B-PP
PIH NN B-NP
. . O

These DT B-NP
results NNS I-NP
can MD B-VP
not RB I-VP
be VB I-VP
explained VBN I-VP
by IN B-PP
receptor NN B-NP
down-regulation NN I-NP
due JJ B-PP
to TO I-PP
higher JJR B-NP
levels NNS I-NP
of IN B-PP
mineralocorticoids NNS B-NP
in IN B-PP
PIH NN B-NP
; : O
a DT B-NP
hitherto RB I-NP
unknown JJ I-NP
mineralocorticoid NN I-NP
may MD B-VP
COMMA COMMA O
thus RB B-ADVP
COMMA COMMA O
be VB B-VP
responsible JJ B-ADJP
for IN B-PP
the DT O
hypertension NN B-NP
and CC O
altered JJ B-NP
MR NN I-NP
status NN B-NP
. . O

Mineralocorticoid NN B-NP
effector NN I-NP
mechanism NN I-NP
in IN B-PP
preeclampsia NN B-NP
. . O

Mineralocorticoid NN B-NP
effector NN I-NP
mechanisms NNS I-NP
were VBD B-VP
evaluated VBN I-VP
in IN B-PP
29 CD B-NP
patients NNS I-NP
with IN B-PP
preeclampsia NN B-NP
and CC B-PP
in IN B-PP
25 CD B-NP
uncomplicated JJ I-NP
pregnancies NNS I-NP
by IN B-PP
measurement NN B-NP
of IN B-PP
plasma NN B-NP
aldosterone NN I-NP
COMMA COMMA O
levels NNS B-NP
of IN B-PP
mineralocorticoid NN B-NP
receptor NN I-NP
( ( O
MR NN B-NP
) ) O
in IN B-PP
mononuclear JJ B-NP
leucocytes NNS I-NP
COMMA COMMA O
and CC O
subtraction NN B-NP
potential NN I-NP
difference NN I-NP
( ( O
SPD NN B-NP
; : O
rectal JJ B-NP
minus CC I-NP
oral JJ I-NP
values NNS I-NP
) ) O
. . O

Mean NN B-NP
values NNS I-NP
for IN B-PP
plasma NN B-NP
aldosterone NN I-NP
were VBD B-VP
not RB O
different JJ B-ADJP
between IN B-PP
the DT B-NP
two CD I-NP
groups NNS I-NP
COMMA COMMA O
but CC O
significant JJ B-NP
differences NNS I-NP
were VBD B-VP
observed VBN I-VP
for IN B-PP
MR NN B-NP
( ( O
preeclampsia NN B-NP
COMMA COMMA O
81 CD B-NP
+\/- CC I-NP
44 CD I-NP
receptors\/cell NNS I-NP
; : O
controls NNS B-NP
COMMA COMMA O
306 CD B-NP
+\/- CC I-NP
168 CD I-NP
) ) O
and CC O
SPD NN B-NP
( ( O
preeclampsia NN B-NP
COMMA COMMA O
65 CD B-NP
+\/- CC I-NP
7 CD I-NP
mV NN I-NP
; : O
controls NNS B-NP
COMMA COMMA O
12 CD B-NP
+\/- CC I-NP
5 CD I-NP
mV NN I-NP
) ) O
. . O

In IN B-PP
six CD B-NP
cases NNS I-NP
we PRP B-NP
determined VBD B-VP
MR NN B-NP
COMMA COMMA O
plasma NN B-NP
aldosterone NN I-NP
COMMA COMMA O
and CC O
SPD NN B-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
preeclampsia NN B-NP
before IN B-PP
and CC B-PP
3 CD B-NP
months NNS I-NP
after IN B-PP
delivery NN B-NP
. . O

MR NNS B-NP
were VBD B-VP
reduced VBN I-VP
before IN B-PP
delivery NN B-NP
( ( O
96 CD B-NP
+\/- CC I-NP
27 CD I-NP
receptors\/cell NNS I-NP
) ) O
COMMA COMMA O
and CC O
SPD NN B-NP
increased VBD B-VP
( ( O
64 CD B-NP
+\/- CC I-NP
8 CD I-NP
mV NN I-NP
) ) O
COMMA COMMA O
with IN B-PP
both DT B-NP
parameters NNS I-NP
normalizing VBG B-VP
after IN B-PP
delivery NN B-NP
( ( O
MR NN B-NP
COMMA COMMA O
242 CD B-NP
+\/- CC I-NP
79 CD I-NP
; : O
SPD NN B-NP
COMMA COMMA O
14.0 CD B-NP
+\/- CC I-NP
4 CD I-NP
mV NN I-NP
) ) O
. . O

Aldosterone NN B-NP
levels NNS I-NP
returned VBD B-VP
to TO B-PP
normal JJ B-NP
nonpregnant JJ I-NP
values NNS I-NP
after IN B-PP
delivery NN B-NP
. . O

These DT B-NP
data NNS I-NP
suggest VBP B-VP
an DT B-NP
important JJ I-NP
role NN I-NP
for IN B-PP
abnormalities NNS B-NP
in IN B-PP
mineralocorticoid NN B-NP
effector NN I-NP
mechanisms NNS I-NP
in IN B-PP
the DT B-NP
etiology NN I-NP
of IN B-PP
preeclampsia NN B-NP
and CC O
could MD B-VP
be VB I-VP
an DT B-NP
useful JJ I-NP
marker NN I-NP
for IN B-PP
diagnosis NN B-NP
. . O

A DT B-NP
lymphoid JJ I-NP
cell-specific JJ I-NP
nuclear JJ I-NP
factor NN I-NP
containing VBG B-VP
c-Rel-like JJ B-NP
proteins NNS I-NP
preferentially RB B-ADVP
interacts VBZ B-VP
with IN B-PP
interleukin-6 NN B-NP
kappa NN I-NP
B-related JJ I-NP
motifs NNS I-NP
whose WP$ B-NP
activities NNS I-NP
are VBP B-VP
repressed VBN I-VP
in IN B-PP
lymphoid JJ B-NP
cells NNS I-NP
. . O

The DT B-NP
proto-oncoprotein NN I-NP
c-Rel NN I-NP
is VBZ B-VP
a DT B-NP
member NN I-NP
of IN B-PP
the DT B-NP
nuclear JJ I-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
transcription NN I-NP
factor NN I-NP
family NN I-NP
COMMA COMMA O
which WDT B-NP
includes VBZ B-VP
the DT O
p50 NN B-NP
and CC O
p65 NN B-NP
subunits NNS B-NP
of IN B-PP
nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
. . O

We PRP B-NP
show VBP B-VP
here RB B-ADVP
that IN B-SBAR
c-Rel NN B-NP
binds VBZ B-VP
to TO B-PP
kappa NN B-NP
B NN I-NP
sites NNS I-NP
as IN B-PP
homodimers NNS B-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
heterodimers NNS B-NP
with IN B-PP
p50 NN B-NP
. . O

These DT B-NP
homodimers NNS B-NP
and CC O
heterodimers NNS B-NP
show VBP B-VP
distinct JJ B-NP
DNA-binding JJ I-NP
specificities NNS I-NP
and CC O
affinities NNS B-NP
for IN B-PP
various JJ B-NP
kappa NN I-NP
B NN I-NP
motifs NNS I-NP
. . O

In IN B-PP
particular JJ B-NP
COMMA COMMA O
the DT B-NP
c-Rel NN I-NP
homodimer NN I-NP
has VBZ B-VP
a DT B-NP
high JJ I-NP
affinity NN I-NP
for IN B-PP
interleukin-6 NN B-NP
( ( O
IL-6 NN B-NP
) ) O
and CC O
beta NN B-NP
interferon NN I-NP
kappa NN I-NP
B NN I-NP
sites NNS B-NP
. . O

In IN B-PP
spite NN I-PP
of IN I-PP
its PRP$ B-NP
association NN I-NP
with IN B-PP
p50 NN B-NP
in FW B-ADVP
vitro FW I-ADVP
COMMA COMMA O
however RB B-ADVP
COMMA COMMA O
we PRP B-NP
found VBD B-VP
a DT B-NP
lymphoid JJ I-NP
cell-specific JJ I-NP
nuclear JJ I-NP
factor NN I-NP
in FW B-ADVP
vivo FW I-ADVP
that WDT B-NP
contains VBZ B-VP
c-Rel NN B-NP
but CC B-CONJP
not RB I-CONJP
p50 NN B-NP
epitopes NNS B-NP
; : O
this DT B-NP
factor NN I-NP
COMMA COMMA O
termed VBN B-VP
IL-6 NN B-NP
kappa NN I-NP
B NN I-NP
binding NN I-NP
factor NN I-NP
II CD I-NP
COMMA COMMA O
appears VBZ B-VP
to TO I-VP
contain VB I-VP
the DT B-NP
c-Rel NN I-NP
homodimer NN I-NP
and CC O
preferentially RB B-VP
recognizes VBZ I-VP
several JJ B-NP
IL-6 NN I-NP
kappa NN I-NP
B-related JJ I-NP
kappa NN I-NP
B NN I-NP
motifs NNS I-NP
. . O

Although IN B-SBAR
it PRP B-NP
has VBZ B-VP
been VBN I-VP
previously RB I-VP
shown VBN I-VP
that IN B-SBAR
the DT B-NP
IL-6 NN I-NP
kappa NN I-NP
B NN I-NP
motif NN I-NP
functions VBZ B-VP
as IN B-PP
a DT B-NP
potent JJ I-NP
IL-1\/tumor NN I-NP
necrosis NN I-NP
factor-responsive JJ I-NP
element NN I-NP
in IN B-PP
nonlymphoid JJ B-NP
cells NNS I-NP
COMMA COMMA O
its PRP$ B-NP
activity NN I-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
repressed VBN I-VP
in IN B-PP
lymphoid JJ B-NP
cells NNS I-NP
such JJ B-PP
as IN I-PP
a DT B-NP
Jurkat NN I-NP
T-cell NN I-NP
line NN I-NP
. . O

We PRP B-NP
also RB B-ADVP
present VBP B-VP
evidence NN B-NP
that IN B-SBAR
IL-6 NN B-NP
kappa NN I-NP
B NN I-NP
binding NN I-NP
factor NN I-NP
II CD I-NP
functions VBZ B-VP
as IN B-PP
a DT B-NP
repressor NN I-NP
specific JJ B-ADJP
for IN B-PP
IL-6 NN B-NP
kappa NN I-NP
B-related JJ I-NP
kappa NN I-NP
B NN I-NP
motifs NNS I-NP
in IN B-PP
lymphoid JJ B-NP
cells NNS I-NP
. . O

Modulation NN B-NP
of IN B-PP
normal JJ B-NP
erythroid JJ I-NP
differentiation NN I-NP
by IN B-PP
the DT O
endogenous JJ B-NP
thyroid NN I-NP
hormone NN I-NP
and CC O
retinoic JJ B-NP
acid NN I-NP
receptors NNS B-NP
: : O
a DT B-NP
possible JJ I-NP
target NN I-NP
for IN B-PP
v-erbA NN B-NP
oncogene NN I-NP
action NN I-NP
. . O

The DT B-NP
v-erbA NN I-NP
oncogene NN I-NP
COMMA COMMA O
a DT B-NP
mutated VBN I-NP
version NN I-NP
of IN B-PP
the DT B-NP
thyroid NN I-NP
hormone NN I-NP
receptor NN I-NP
alpha NN I-NP
( ( O
c-erbA\/TR-alpha NN B-NP
) ) O
COMMA COMMA O
inhibits VBZ B-VP
erythroid JJ B-NP
differentiation NN I-NP
and CC O
constitutively RB B-VP
represses VBZ I-VP
transcription NN B-NP
of IN B-PP
certain JJ B-NP
erythrocyte NN I-NP
genes NNS I-NP
COMMA COMMA O
suggesting VBG B-VP
a DT B-NP
normal JJ I-NP
function NN I-NP
of IN B-PP
the DT B-NP
proto-oncogene NN I-NP
c-erbA NN I-NP
in IN B-PP
erythropoiesis NN B-NP
. . O

Here RB B-ADVP
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
the DT B-NP
endogenous JJ I-NP
thyroid NN I-NP
hormone NN I-NP
receptor NN I-NP
alpha NN I-NP
( ( O
c-erbA\/TR-alpha NN B-NP
) ) O
and CC O
the DT B-NP
closely RB I-NP
related JJ I-NP
retinoic JJ B-NP
acid NN I-NP
receptor NN I-NP
alpha NN I-NP
( ( O
RAR-alpha NN B-NP
) ) O
play VBP B-VP
a DT B-NP
role NN I-NP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
normal JJ B-NP
erythroid JJ I-NP
differentiation NN I-NP
. . O

Retinoic JJ B-NP
acid NN I-NP
( ( O
RA NN B-NP
) ) O
distinctly RB B-ADVP
modulated VBD B-VP
the DT B-NP
erythroid JJ I-NP
differentiation NN I-NP
program NN I-NP
of IN B-PP
normal JJ B-NP
erythroid JJ I-NP
progenitors NNS I-NP
and CC O
erythroblasts NNS B-NP
reversibly RB B-VP
transformed VBN I-VP
by IN B-PP
a DT B-NP
conditional JJ I-NP
tyrosine NN I-NP
kinase NN I-NP
oncogene NN I-NP
. . O

When WRB B-ADVP
added VBN B-VP
pulsewise RB B-ADVP
to TO B-PP
immature JJ B-NP
cells NNS I-NP
COMMA COMMA O
differentiation NN B-NP
was VBD B-VP
accelerated VBN I-VP
while IN B-SBAR
more RBR B-NP
mature JJ I-NP
cells NNS I-NP
underwent VBD B-VP
premature JJ B-NP
cell NN I-NP
death NN I-NP
. . O

Thyroid NN B-NP
hormone NN I-NP
( ( O
T3 NN B-NP
) ) O
alone RB B-ADVP
caused VBD B-VP
similar JJ B-NP
but CC I-NP
weaker JJR I-NP
effects NNS I-NP
. . O

Interestingly RB B-ADVP
COMMA COMMA O
T3 NN B-NP
strongly RB B-ADVP
enhanced VBD B-VP
the DT B-NP
action NN I-NP
of IN B-PP
RA NN B-NP
COMMA COMMA O
suggesting VBG B-VP
cooperative JJ B-NP
action NN I-NP
of IN B-PP
the DT B-NP
two CD I-NP
receptors NNS I-NP
in IN B-PP
modulating VBG B-VP
erythroid JJ B-NP
differentiation NN I-NP
. . O

Expression NN B-NP
of IN B-PP
the DT B-NP
human JJ I-NP
RAR-alpha NN I-NP
in IN B-PP
receptor-negative JJ B-NP
erythroblasts NNS I-NP
conferred VBD B-VP
RA-induced JJ B-NP
regulation NN I-NP
of IN B-PP
differentiation NN B-NP
to TO B-PP
the DT B-NP
otherwise RB I-NP
unresponsive JJ I-NP
cells NNS I-NP
COMMA COMMA O
thus RB O
showing VBG B-VP
that IN B-SBAR
the DT B-NP
RAR-alpha NN I-NP
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
the DT B-NP
RA NN I-NP
effect NN I-NP
. . O

Likewise RB B-ADVP
COMMA COMMA O
enhanced VBN B-NP
expression NN I-NP
of IN B-PP
exogenous JJ B-NP
c-erbA\/TR-alpha NN I-NP
in IN B-PP
erythroblasts NNS B-NP
rendered VBD B-VP
them PRP B-NP
susceptible JJ B-ADJP
to TO B-PP
modulation NN B-NP
of IN B-PP
differentiation NN B-NP
by IN B-PP
T3 NN B-NP
COMMA COMMA O
suggesting VBG B-VP
a DT B-NP
similar JJ I-NP
function NN I-NP
of IN B-PP
both DT B-NP
receptors NNS I-NP
. . O

Leukotriene NN B-NP
B4 NN I-NP
stimulates VBZ B-VP
c-fos NN B-NP
and CC O
c-jun NN B-NP
gene NN B-NP
transcription NN I-NP
and CC O
AP-1 NN B-NP
binding NN I-NP
activity NN I-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
examined VBN I-VP
the DT B-NP
effect NN I-NP
of IN B-PP
leukotriene NN B-NP
B4 NN I-NP
( ( O
LTB4 NN B-NP
) ) O
COMMA COMMA O
a DT B-NP
potent JJ I-NP
lipid NN I-NP
proinflammatory JJ I-NP
mediator NN I-NP
COMMA COMMA O
on IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
proto-oncogenes NNS I-NP
c-jun NN B-NP
and CC O
c-fos NN B-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
we PRP B-NP
looked VBD B-VP
at IN B-PP
the DT B-NP
modulation NN I-NP
of IN B-PP
nuclear JJ B-NP
factors NNS I-NP
binding VBG B-VP
specifically RB B-PP
to TO I-PP
the DT B-NP
AP-1 NN I-NP
element NN I-NP
after IN B-PP
LTB4 NN B-NP
stimulation NN I-NP
. . O

LTB4 NN B-NP
increased VBD B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
c-fos NN I-NP
gene NN I-NP
in IN B-PP
a DT O
time- NN B-NP
and CC O
concentration-dependent JJ B-ADJP
manner NN B-NP
. . O

The DT B-NP
c-jun NN I-NP
mRNA NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
constitutively RB I-VP
expressed VBN I-VP
in IN B-PP
human JJ B-NP
peripheral-blood NN I-NP
monocytes NNS I-NP
at IN B-PP
relatively RB B-NP
high JJ I-NP
levels NNS I-NP
COMMA COMMA O
was VBD B-VP
also RB I-VP
slightly RB I-VP
augmented JJ I-VP
by IN B-PP
LTB4 NN B-NP
COMMA COMMA O
although IN B-SBAR
to TO B-PP
a DT B-NP
much RB I-NP
lower JJR I-NP
extent NN I-NP
than IN B-PP
c-fos NN B-NP
. . O

The DT B-NP
kinetics NNS I-NP
of IN B-PP
expression NN B-NP
of IN B-PP
the DT B-NP
two CD I-NP
genes NNS I-NP
were VBD B-VP
also RB B-ADJP
slightly RB I-ADJP
different JJ I-ADJP
COMMA COMMA O
with IN B-PP
c-fos NN B-NP
mRNA NN I-NP
reaching VBG B-VP
a DT B-NP
peak NN I-NP
at IN B-PP
15 CD B-NP
min NN I-NP
after IN B-PP
stimulation NN B-NP
and CC O
c-jun NN B-NP
at IN B-PP
30 CD B-NP
min NN I-NP
. . O

Both DT B-NP
messages NNS I-NP
rapidly RB B-ADVP
declined VBD B-VP
thereafter RB B-ADVP
. . O

Stability NN B-NP
of IN B-PP
the DT O
c-fos NN B-NP
and CC O
c-jun NN B-NP
mRNA NN B-NP
was VBD B-VP
not RB I-VP
affected VBN I-VP
by IN B-PP
LTB4 NN B-NP
COMMA COMMA O
as IN B-SBAR
assessed VBN B-VP
after IN B-PP
actinomycin NN B-NP
D NN I-NP
treatment NN I-NP
. . O

Nuclear JJ B-NP
transcription NN I-NP
studies NNS I-NP
in FW B-ADVP
vitro FW I-ADVP
showed VBD B-VP
that IN B-SBAR
LTB4 NN B-NP
increased VBD B-VP
the DT B-NP
transcription NN I-NP
of IN B-PP
the DT B-NP
c-fos NN I-NP
gene NN I-NP
7-fold RB B-ADVP
and CC O
the DT B-NP
c-jun NN I-NP
gene NN I-NP
1.4-fold RB B-ADVP
. . O

Resting VBG B-NP
monocytes NNS I-NP
contained VBD B-VP
nuclear JJ B-NP
factors NNS I-NP
binding VBG B-VP
to TO B-PP
the DT B-NP
AP-1 NN I-NP
element NN I-NP
COMMA COMMA O
but CC O
stimulation NN B-NP
of IN B-PP
monocytes NNS B-NP
with IN B-PP
LTB4 NN B-NP
induced VBD B-VP
greater JJR B-NP
AP-1-binding JJ I-NP
activity NN I-NP
of IN B-PP
nuclear JJ B-NP
proteins NNS I-NP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
LTB4 NN B-NP
may MD B-VP
regulate VB I-VP
the DT B-NP
production NN I-NP
of IN B-PP
different JJ B-NP
cytokines NNS I-NP
by IN B-PP
modulating VBG B-VP
the DT B-NP
yield NN I-NP
and\/or CC O
the DT B-NP
function NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
such JJ B-PP
as IN I-PP
AP-1-binding JJ B-NP
proto-oncogene NN I-NP
products NNS I-NP
. . O

An DT B-NP
11-base-pair JJ I-NP
DNA NN I-NP
sequence NN I-NP
motif NN I-NP
apparently RB B-ADJP
unique JJ I-ADJP
to TO B-PP
the DT B-NP
human JJ I-NP
interleukin NN I-NP
4 CD I-NP
gene NN I-NP
confers VBZ B-VP
responsiveness NN B-NP
to TO B-PP
T-cell NN B-NP
activation NN I-NP
signals NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
identified VBN I-VP
a DT B-NP
DNA NN I-NP
segment NN I-NP
that WDT B-NP
confers VBZ B-VP
responsiveness NN B-NP
to TO B-PP
antigen NN B-NP
stimulation NN I-NP
signals NNS I-NP
on IN B-PP
the DT O
human JJ O
interleukin NN B-NP
( ( O
IL NN B-NP
) ) O
4 CD B-NP
gene NN I-NP
in IN B-PP
Jurkat NN B-NP
cells NNS I-NP
. . O

The DT B-NP
human JJ I-NP
IL-4 NN I-NP
gene NN I-NP
COMMA COMMA O
of IN B-PP
10 CD B-NP
kilobases NNS I-NP
COMMA COMMA O
is VBZ B-VP
composed VBN I-VP
of IN B-PP
four CD B-NP
exons NNS I-NP
and CC O
three CD B-NP
introns NNS I-NP
. . O

A DT B-NP
cis-acting JJ I-NP
element NN I-NP
( ( O
P NN B-NP
sequence NN I-NP
) ) O
resides VBZ B-VP
in IN B-PP
the DT O
5' JJ B-NP
upstream JJ B-NP
region NN I-NP
; : O
no DT B-NP
additional JJ I-NP
DNA NN I-NP
segments NNS I-NP
with IN B-PP
enhancer NN B-NP
activity NN I-NP
were VBD B-VP
identified VBN I-VP
in IN B-PP
the DT B-NP
human JJ I-NP
IL-4 NN I-NP
gene NN I-NP
. . O

For IN B-PP
further JJ B-NP
mapping NN I-NP
purposes NNS I-NP
COMMA COMMA O
a DT B-NP
fusion NN I-NP
promoter NN I-NP
was VBD B-VP
constructed VBN I-VP
with IN B-PP
the DT B-NP
granulocyte\/macrophage JJ I-NP
colony-stimulating JJ I-NP
factor NN I-NP
basic JJ I-NP
promoter NN I-NP
containing VBG B-VP
60 CD B-NP
base NN I-NP
pairs NNS I-NP
of IN B-PP
sequence NN B-NP
upstream JJ B-ADJP
from IN B-PP
the DT B-NP
cap NN I-NP
site NN I-NP
of IN B-PP
the DT B-NP
mouse NN I-NP
granulocyte\/macrophage JJ I-NP
colony-stimulating JJ I-NP
factor NN I-NP
gene NN I-NP
and CC O
various JJ B-NP
lengths NNS I-NP
of IN B-PP
the DT O
5' JJ B-NP
upstream JJ B-NP
sequence NN I-NP
of IN B-PP
the DT B-NP
IL-4 NN I-NP
gene NN I-NP
. . O

The DT B-NP
P NN I-NP
sequence NN I-NP
was VBD B-VP
located JJ B-ADJP
between IN B-PP
positions NNS B-NP
-79 CD B-NP
and CC O
-69 CD B-NP
relative JJ B-PP
to TO I-PP
the DT B-NP
transcription NN I-NP
start NN I-NP
site NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
IL-4 NN I-NP
gene NN I-NP
COMMA COMMA O
and CC O
this DT B-NP
location NN I-NP
was VBD B-VP
confirmed VBN I-VP
by IN B-PP
base-substitution NN B-NP
mutations NNS I-NP
. . O

The DT B-NP
plasmids NNS I-NP
carrying VBG B-VP
multiple JJ B-NP
copies NNS I-NP
of IN B-PP
the DT B-NP
P NN I-NP
sequence NN I-NP
showed VBD B-VP
higher JJR B-NP
responsiveness NN I-NP
to TO B-PP
the DT B-NP
stimulation NN I-NP
. . O

The DT B-NP
binding VBG I-NP
protein NN I-NP
( ( I-NP
s NNS I-NP
) ) O
that WDT B-NP
recognize VBP B-VP
the DT B-NP
P NN I-NP
sequence NN I-NP
of IN B-PP
the DT B-NP
IL-4 NN I-NP
gene NN I-NP
were VBD B-VP
identified VBN I-VP
by IN B-PP
DNA-mobility-shift JJ B-NP
assays NNS I-NP
. . O

The DT B-NP
binding NN I-NP
of IN B-PP
NF(P) NN B-NP
( ( O
a DT B-NP
DNA NN I-NP
binding NN I-NP
protein NN I-NP
that WDT B-NP
specifically RB B-ADVP
recognizes VBZ B-VP
the DT B-NP
P NN I-NP
sequence NN I-NP
) ) O
to TO B-PP
the DT B-NP
P NN I-NP
sequence NN I-NP
was VBD B-VP
abolished VBN I-VP
when WRB B-ADVP
oligonucleotides NNS B-NP
carrying VBG B-VP
base NN B-NP
substitutions NNS I-NP
were VBD B-VP
used VBN I-VP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
the DT B-NP
NF(P) NN I-NP
interaction NN I-NP
is VBZ B-VP
sequence-specific JJ B-ADJP
and CC O
that IN B-SBAR
binding NN B-NP
specificity NN I-NP
of IN B-PP
the DT B-NP
protein NN I-NP
paralleled VBD B-VP
the DT B-NP
sequence NN I-NP
requirements NNS I-NP
for IN B-PP
IL-4 NN B-NP
expression NN I-NP
in FW B-ADVP
vivo FW I-ADVP
. . O

The DT B-NP
P NN I-NP
sequence NN I-NP
does VBZ B-VP
not RB I-VP
share VB I-VP
homology NN B-NP
with IN B-PP
the DT O
5' JJ B-NP
upstream JJ B-NP
sequence NN I-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
gene NN I-NP
COMMA COMMA O
even RB B-SBAR
though IN I-SBAR
surrounding VBG B-NP
sequences NNS I-NP
of IN B-PP
the DT B-NP
IL-4 NN I-NP
gene NN I-NP
share NN B-VP
high JJ B-NP
homology NN I-NP
with IN B-PP
the DT B-NP
IL-2 NN I-NP
gene NN I-NP
. . O

We PRP B-NP
conclude VBP B-VP
that IN B-SBAR
a DT B-NP
different JJ I-NP
set NN I-NP
of IN B-PP
proteins NNS B-NP
recognize VBP B-VP
IL-2 NN B-NP
and CC O
IL-4 NN B-NP
genes NNS B-NP
. . O

Glucocorticoid NN B-NP
receptor NN I-NP
binding NN I-NP
in IN B-PP
three CD B-NP
different JJ I-NP
cell NN I-NP
types NNS I-NP
in IN B-PP
major JJ B-NP
depressive JJ I-NP
disorder NN I-NP
: : O
lack NN B-NP
of IN B-PP
evidence NN B-NP
of IN B-PP
receptor NN B-NP
binding NN I-NP
defect NN I-NP
. . O

1 LS B-LST
. . O
In IN B-SBAR
order NN O
to TO O
further RB B-ADVP
understand VB B-VP
the DT B-NP
apparent JJ I-NP
glucocorticoid NN I-NP
resistance NN I-NP
in IN B-PP
major JJ B-NP
depressive JJ I-NP
disorder NN I-NP
COMMA COMMA O
circadian JJ B-NP
variation NN I-NP
in IN B-PP
cortisol NN B-NP
concentration NN I-NP
COMMA COMMA O
dexamethasone NN B-NP
suppression NN I-NP
and CC O
glucocorticoid NN B-NP
receptor NN I-NP
binding NN I-NP
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
COMMA COMMA O
polymorphonuclear JJ B-NP
leukocytes NNS I-NP
and CC O
cultured VBN B-NP
skin NN I-NP
fibroblasts NNS I-NP
were VBD B-VP
measured VBN I-VP
in IN B-PP
rigidly RB B-NP
defined VBN I-NP
major JJ I-NP
depressive JJ I-NP
disorder NN I-NP
patients NNS I-NP
and CC O
non-depressed JJ B-NP
psychiatric JJ I-NP
controls NNS I-NP
. . O

2 LS B-LST
. . O
Mononuclear JJ B-NP
leukocytes NNS I-NP
binding VBG B-VP
to TO B-PP
glucocorticoid NN B-NP
correlated VBD B-VP
significantly RB B-ADVP
with IN B-PP
polymorphonuclear JJ B-NP
leukocytes NNS I-NP
binding VBG B-VP
to TO B-PP
glucocorticoid NN B-NP
COMMA COMMA O
but CC O
both DT B-NP
determinations NNS I-NP
failed VBD B-VP
to TO I-VP
differentiate VB I-VP
major JJ B-NP
depressive JJ I-NP
disorder NN I-NP
and CC O
control NN B-NP
subjects NNS I-NP
. . O

3 LS B-LST
. . O
Initial JJ B-NP
and CC I-NP
post-dexamethasone JJ I-NP
in FW I-NP
vitro FW I-NP
fibroblast NN I-NP
binding VBG B-VP
to TO B-PP
glucocorticoid NN B-NP
was VBD B-VP
not RB O
different JJ B-ADJP
between IN B-PP
major JJ B-NP
depressive JJ I-NP
disorder NN I-NP
and CC O
non-depressed JJ B-NP
control NN I-NP
subjects NNS I-NP
. . O

4 LS B-LST
. . O
The DT B-NP
phenomenon NN I-NP
of IN B-PP
glucocorticoid NN B-NP
resistance NN I-NP
in IN B-PP
major JJ B-NP
depressive JJ I-NP
disorder NN I-NP
remains VBZ B-VP
unexplained JJ B-ADJP
. . O

Kinetics NNS B-NP
of IN B-PP
nuclear JJ B-NP
translocation NN I-NP
and CC O
turnover NN B-NP
of IN B-PP
the DT B-NP
vitamin NN I-NP
D NN I-NP
receptor NN I-NP
in IN B-PP
human JJ B-NP
HL60 NN I-NP
leukemia NN I-NP
cells NNS I-NP
and CC O
peripheral JJ B-NP
blood NN I-NP
lymphocytes NNS I-NP
-- : O
coincident JJ B-NP
rise NN I-NP
of IN B-PP
DNA-relaxing JJ B-NP
activity NN I-NP
in IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
. . O

High JJ B-NP
affinity NN I-NP
receptors NNS I-NP
( ( O
VDR NN B-NP
) ) O
for IN B-PP
1COMMA25-dihydroxycholecalciferol NN B-NP
( ( O
calcitriol NN B-NP
) ) O
are VBP B-VP
expressed VBN I-VP
in IN B-PP
HL60 NN B-NP
human JJ I-NP
leukemia NN I-NP
cells NNS I-NP
and CC B-PP
in IN B-PP
low JJ B-NP
numbers NNS I-NP
in IN B-PP
peripheral JJ B-NP
blood NN I-NP
lymphocytes NNS I-NP
( ( O
PBL NN B-NP
) ) O
. . O

HL60 NN B-NP
cells NNS I-NP
COMMA COMMA O
expressing VBG B-VP
some DT B-NP
characteristics NNS I-NP
of IN B-PP
promyelocytes NNS B-NP
COMMA COMMA O
can MD B-VP
be VB I-VP
induced VBN I-VP
to TO B-PP
monocytoid NN B-NP
differentiation NN I-NP
by IN B-PP
calcitriol NN B-NP
. . O

Specific JJ B-NP
nuclear JJ I-NP
translocation NN I-NP
of IN B-PP
{3H}calcitriol\/VDR NN B-NP
was VBD B-VP
examined VBN I-VP
after IN B-PP
exposure NN B-NP
of IN B-PP
whole JJ B-NP
cells NNS I-NP
to TO B-PP
10(-9) CD B-NP
M\/l NN I-NP
calcitriol NN I-NP
in IN B-PP
the DT B-NP
presence NN B-NP
and CC O
absence NN B-NP
of IN B-PP
a DT B-NP
500-fold JJ I-NP
excess NN I-NP
of IN B-PP
unlabeled JJ B-NP
ligand NN I-NP
and CC O
subsequent JJ B-NP
isolation NN I-NP
of IN B-PP
nuclei NNS B-NP
. . O

Specific JJ B-NP
nuclear JJ I-NP
translocation NN I-NP
of IN B-PP
{3H}calcitriol\/VDR NN B-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
time NN B-ADJP
dependent JJ I-ADJP
reaching VBG B-VP
a DT B-NP
maximum NN I-NP
of IN B-PP
approximately RB B-NP
2100 CD I-NP
binding VBG I-NP
sites\/nucleus NNS I-NP
after IN B-PP
3 CD B-NP
h NN I-NP
of IN B-PP
incubation NN B-NP
in IN B-PP
HL60 NN B-NP
cells NNS I-NP
COMMA COMMA O
whereas IN O
a DT B-NP
maximum NN I-NP
of IN B-PP
approximately RB B-NP
310 CD I-NP
binding VBG I-NP
sites\/nucleus NNS I-NP
was VBD B-VP
found VBN I-VP
after IN B-PP
3 CD B-NP
h NN I-NP
in IN B-PP
PBL NN B-NP
. . O

Pulse NN B-NP
exposure NN I-NP
of IN B-PP
HL60 NN B-NP
to TO B-PP
radiolabeled VBN B-NP
hormone NN I-NP
for IN B-PP
3 CD B-NP
h NN I-NP
followed VBN B-VP
by IN B-PP
culture NN B-NP
in IN B-PP
medium NN B-NP
without IN B-PP
serum NN B-NP
and CC O
calcitriol NN B-NP
lead VBD B-VP
to TO B-PP
nuclear JJ B-NP
retention NN I-NP
of IN B-PP
approximately RB B-NP
1600 CD I-NP
radiolabeled VBN I-NP
VDR NN I-NP
by IN B-PP
8 CD B-NP
h NN I-NP
and CC O
approximately RB B-NP
1000 CD I-NP
VDR NN I-NP
by IN B-PP
24 CD B-NP
h NN I-NP
. . O

Radiolabeled VBN B-NP
VDR NN I-NP
disappeared VBD B-VP
from IN B-PP
the DT B-NP
nuclear JJ I-NP
compartment NN I-NP
with IN B-PP
a DT B-NP
halflife NN I-NP
of IN B-PP
approximately RB B-NP
30 CD I-NP
min NN I-NP
if IN B-SBAR
cells NNS B-NP
were VBD B-VP
cultured VBN I-VP
with IN B-PP
identical JJ B-NP
concentrations NNS I-NP
of IN B-PP
unlabeled JJ B-NP
hormone NN I-NP
after IN B-PP
the DT B-NP
pulse NN I-NP
( ( O
pulse\/chase-experiments NNS B-NP
) ) O
. . O

No DT B-NP
difference NN I-NP
of IN B-PP
VDR NN B-NP
retention NN I-NP
in IN B-PP
pulse NN B-NP
and CC O
pulse\/chase-experiments NNS B-NP
was VBD B-VP
seen VBN I-VP
in IN B-PP
PBL NN B-NP
COMMA COMMA O
where WRB B-ADVP
VDR NN B-NP
halflife NN I-NP
was VBD B-VP
approximately RB B-NP
30 CD I-NP
min NN I-NP
. . O

No DT B-NP
specific JJ I-NP
translocation NN I-NP
into IN B-PP
the DT B-NP
nuclear JJ I-NP
compartment NN I-NP
was VBD B-VP
seen VBN I-VP
when WRB B-ADVP
isolated VBN B-NP
nuclei NNS I-NP
were VBD B-VP
incubated VBN I-VP
in IN B-PP
{3H}calcitriol NN B-NP
. . O

Radiolabeled VBN B-NP
hormone\/receptor NN I-NP
complexes NNS I-NP
of IN B-PP
nuclei NNS B-NP
isolated VBN B-VP
from IN B-PP
cells NNS B-NP
exposed VBN B-VP
for IN B-PP
3 CD B-NP
h NN I-NP
to TO B-PP
radiolabeled VBN B-NP
hormone NN I-NP
-- : O
in IN B-PP
contrast NN I-PP
to TO I-PP
identical JJ B-NP
experiments NNS I-NP
with IN B-PP
intact JJ B-NP
cells NNS I-NP
-- : O
did VBD B-VP
not RB I-VP
disappear VB I-VP
from IN B-PP
the DT B-NP
nuclear JJ I-NP
compartment NN I-NP
upon IN B-PP
incubation NN B-NP
of IN B-PP
nuclei NNS B-NP
with IN B-PP
identical JJ B-NP
concentrations NNS I-NP
of IN B-PP
the DT B-NP
unlabeled JJ I-NP
compound NN I-NP
. . O

The DT B-NP
activity NN I-NP
of IN B-PP
DNA NN B-NP
relaxing NN I-NP
enzymes NNS I-NP
( ( O
e.g. FW B-ADVP
topoisomerases NNS B-NP
I CD B-NP
and CC O
II CD B-NP
) ) O
in IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
was VBD B-VP
measured VBN I-VP
using VBG B-VP
a DT B-NP
PBR NN I-NP
322-relaxation-assay NN I-NP
. . O

Enhanced VBN B-NP
overall JJ I-NP
enzyme NN I-NP
activity NN I-NP
was VBD B-VP
found VBN I-VP
in IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
by IN B-PP
1 CD B-NP
h NN I-NP
after IN B-PP
incubation NN B-NP
with IN B-PP
calcitriol NN B-NP
( ( O
final JJ B-NP
ethanol NN I-NP
concentration NN I-NP
0.0001 CD B-NP
% NN I-NP
v\/v NN I-NP
) ) O
in IN B-PP
HL60 NN B-NP
and CC O
PBL NN B-NP
. . O

The DT B-NP
enhanced VBN I-NP
activity NN I-NP
disappeared VBD B-VP
after IN B-PP
2 CD B-NP
h NN I-NP
in IN B-PP
PBL NN B-NP
COMMA COMMA O
whereas IN O
it PRP B-NP
was VBD B-VP
still RB I-VP
enhanced VBN I-VP
by IN B-PP
4 CD B-NP
h NN I-NP
in IN B-PP
HL60 NN B-NP
. . O

No DT B-NP
effect NN I-NP
was VBD B-VP
seen VBN I-VP
in IN B-PP
ethanol NN B-NP
treated JJ I-NP
controls NNS I-NP
. . O

We PRP B-NP
conclude VBP B-VP
that IN B-SBAR
a DT B-NP
specific JJ I-NP
nuclear JJ I-NP
translocation NN I-NP
mechanism NN I-NP
exists VBZ B-VP
for IN B-PP
calcitriol NN B-NP
in IN B-PP
both DT B-NP
cell NN I-NP
types NNS I-NP
examined VBN B-VP
COMMA COMMA O
most RBS B-ADVP
likely RB I-ADVP
due IN B-PP
to TO I-PP
translocation NN B-NP
of IN B-PP
receptor NN B-NP
proteins NNS I-NP
after IN B-PP
hormone NN B-NP
binding NN I-NP
. . O

Translocated VBN B-NP
hormone\/receptor NN I-NP
complexes NNS I-NP
compete VBP B-VP
for IN B-PP
a DT B-NP
limited JJ I-NP
number NN I-NP
of IN B-PP
specific JJ B-NP
nuclear JJ I-NP
binding VBG I-NP
sites NNS I-NP
. . O

Enhanced VBN B-NP
activity NN I-NP
of IN B-PP
topoisomerases NNS B-NP
in IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
upon IN B-PP
translocation NN B-NP
of IN B-PP
VDR NN B-NP
might MD B-VP
reflect VB I-VP
interaction NN B-NP
of IN B-PP
both DT B-NP
within IN B-PP
the DT B-NP
nuclear JJ I-NP
compartment NN I-NP
COMMA COMMA O
thus RB B-ADVP
initiating VBG B-VP
DNA-unwinding NN B-NP
COMMA COMMA O
a DT B-NP
prerequisite NN I-NP
of IN B-PP
transcription NN B-NP
initiation NN I-NP
. . O

The DT B-NP
B NN I-NP
cell-specific JJ I-NP
nuclear JJ I-NP
factor NN I-NP
OTF-2 NN I-NP
positively RB B-ADVP
regulates VBZ B-VP
transcription NN B-NP
of IN B-PP
the DT B-NP
human JJ I-NP
class NN I-NP
II CD I-NP
transplantation NN I-NP
gene NN I-NP
COMMA COMMA O
DRA NN B-NP
. . O

The DT B-NP
promoter NN I-NP
of IN B-PP
the DT B-NP
major JJ I-NP
histocompatibility NN I-NP
class NN I-NP
II CD I-NP
gene NN I-NP
DRA NN I-NP
contains VBZ B-VP
an DT B-NP
octamer NN I-NP
element NN I-NP
( ( O
ATTTGCAT NN B-NP
) ) O
that WDT B-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
efficient JJ B-NP
DRA NN I-NP
expression NN I-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
. . O

Several JJ B-NP
DNA-binding JJ I-NP
proteins NNS I-NP
are VBP B-VP
known VBN I-VP
to TO I-VP
bind VB I-VP
this DT B-NP
sequence NN I-NP
. . O

The DT B-ADJP
best RBS I-ADJP
characterized VBN I-ADJP
are VBP B-VP
the DT B-NP
B NN I-NP
cell-specific JJ I-NP
OTF-2 NN I-NP
and CC O
the DT B-NP
ubiquitous JJ I-NP
OTF-1 NN I-NP
. . O

This DT B-NP
report NN I-NP
directly RB B-ADVP
demonstrates VBZ B-VP
that IN B-SBAR
OTF-2 NN B-NP
but CC B-CONJP
not RB I-CONJP
OTF-1 NN B-NP
regulates VBZ B-VP
the DT B-NP
DRA NN I-NP
gene NN I-NP
. . O

In FW B-NP
vitro FW I-NP
transcription NN I-NP
analysis NN I-NP
using VBG B-VP
protein NN B-NP
fractions NNS I-NP
enriched VBN B-ADJP
for IN B-PP
the DT B-NP
octamer-binding JJ I-NP
protein NN I-NP
OTF-2 NN I-NP
demonstrate VBP B-VP
a DT B-NP
positive JJ I-NP
functional JJ I-NP
role NN I-NP
for IN B-PP
OTF-2 NN B-NP
in IN B-PP
DRA NN B-NP
gene NN I-NP
transcription NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
OTF-1-enriched JJ B-NP
protein NN I-NP
fractions NNS I-NP
did VBD B-VP
not RB I-VP
affect VB I-VP
DRA NN B-NP
gene NN I-NP
transcription NN I-NP
although IN B-SBAR
it PRP B-NP
functionally RB B-ADVP
enhanced VBD B-VP
the DT B-NP
transcription NN I-NP
of IN B-PP
another DT B-NP
gene NN I-NP
. . O

Recombinant JJ B-NP
OTF-2 NN I-NP
protein NN I-NP
produced VBN B-VP
by IN B-PP
in FW B-NP
vitro FW I-NP
transcription\/translation NN I-NP
could MD B-VP
also RB I-VP
enhance VB I-VP
DRA NN B-NP
gene NN I-NP
transcription NN I-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

In FW B-NP
vivo FW I-NP
transient JJ I-NP
transfection NN I-NP
studies NNS I-NP
utilizing VBG B-VP
an DT B-NP
OTF-2 NN I-NP
expression NN I-NP
vector NN I-NP
resulted VBD B-VP
in IN B-PP
similar JJ B-NP
findings NNS I-NP
: : O
that IN B-SBAR
OTF-2 NN B-NP
protein NN I-NP
enhanced VBD B-VP
DRA NN B-NP
gene NN I-NP
transcription NN I-NP
COMMA COMMA O
and CC O
that IN B-SBAR
this DT B-NP
effect NN I-NP
requires VBZ B-VP
an DT B-NP
intact JJ I-NP
octamer NN I-NP
element NN I-NP
. . O

Together RB B-ADVP
these DT B-NP
results NNS I-NP
constitute VBP B-VP
the DT B-NP
first JJ I-NP
direct JJ I-NP
evidence NN I-NP
of IN B-PP
a DT B-NP
positive JJ I-NP
role NN I-NP
for IN B-PP
the DT B-NP
lymphoid-specific JJ I-NP
octamer-binding JJ I-NP
factor NN I-NP
in IN B-PP
DRA NN B-NP
gene NN I-NP
transcription NN I-NP
. . O

{ ( O
Regulation NN B-NP
of IN B-PP
intracellular JJ B-NP
cholesterol NN I-NP
synthesis NN I-NP
in IN B-PP
hypercholesterolemia NN B-NP
by IN B-PP
glucocorticoids NNS B-NP
} ) O

The DT B-NP
rate NN I-NP
of IN B-PP
endogenous JJ B-NP
cholesterol NN I-NP
synthesis NN I-NP
in IN B-PP
blood NN B-NP
lymphocytes NNS I-NP
and CC O
skin NN B-NP
fibroblasts NNS I-NP
from IN B-PP
patients NNS B-NP
with IN B-PP
type NN B-NP
IIa NN I-NP
hyperlipidemia NN I-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
increased VBN I-VP
in IN B-PP
comparison NN I-PP
with IN I-PP
healthy JJ B-NP
donors NNS I-NP
. . O

The DT B-NP
cells NNS I-NP
of IN B-PP
hyperlipidemic JJ B-NP
patients NNS I-NP
had VBD B-VP
lowered JJ B-NP
levels NNS I-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
concomitantly RB B-PP
with IN I-PP
a DT B-NP
partial JJ I-NP
loss NN I-NP
of IN B-PP
their PRP$ B-NP
sensitivity NN I-NP
to TO B-PP
glucocorticoids NNS B-NP
. . O

In IN B-PP
fibroblasts NNS B-NP
from IN B-PP
patients NNS B-NP
with IN B-PP
hereditary JJ B-NP
hypercholesteremia NN I-NP
of IN B-PP
homozygous JJ B-NP
type NN I-NP
the DT B-NP
number NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
did VBD B-VP
not RB I-VP
exceed VB I-VP
10 CD B-NP
% NN I-NP
of IN B-PP
their PRP$ B-NP
content NN I-NP
in IN B-PP
normal JJ B-NP
cells NNS I-NP
. . O

The DT B-NP
decrease NN I-NP
of IN B-PP
the DT B-NP
number NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
type NN B-NP
IIa NN I-NP
hyperlipidemia NN I-NP
seems VBZ B-VP
to TO I-VP
be VB I-VP
a DT B-NP
compensatory JJ I-NP
response NN I-NP
of IN B-PP
cells NNS B-NP
culminating VBG B-VP
in IN B-PP
activation NN B-NP
of IN B-PP
endogenous JJ B-NP
cholesterol NN I-NP
synthesis NN I-NP
. . O

Transcription NN B-NP
factor NN I-NP
activation NN I-NP
and CC O
functional JJ B-NP
stimulation NN I-NP
of IN B-PP
human JJ B-NP
monocytes NNS I-NP
. . O

Activation NN B-NP
of IN B-PP
expression NN B-NP
of IN B-PP
genes NNS B-NP
encoding VBG B-VP
transcription NN B-NP
factors NNS I-NP
: : O
c-fos NN B-NP
and CC O
c-jun NN B-NP
and CC O
formation NN B-NP
of IN B-PP
AP1 NN B-NP
transcriptional JJ I-NP
complex NN I-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
was VBD B-VP
investigated VBN I-VP
. . O

It PRP B-NP
was VBD B-VP
found VBN I-VP
that IN B-SBAR
lipopolysaccharide NN B-NP
induced VBD B-VP
strongly RB B-ADVP
both CC O
c-fos NN B-NP
and CC O
c-jun NN B-NP
expression NN B-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
AP1 NN B-NP
formation NN I-NP
. . O

Interferon NN B-NP
gamma NN I-NP
activated VBD B-VP
strongly RB B-ADVP
c-fos NN B-NP
and CC O
weakly RB B-ADVP
c-jun NN B-NP
and CC O
AP1 NN B-NP
. . O

Tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
induced VBD B-VP
slightly RB B-ADVP
c-fos NN B-NP
and CC O
had VBD B-VP
almost RB B-NP
no DT I-NP
effect NN I-NP
on IN B-PP
c-jun NN B-NP
and CC O
AP1 NN B-NP
. . O

The DT B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
differences NNS B-NP
in IN B-PP
functional JJ B-NP
responses NNS I-NP
elicited VBN B-VP
in IN B-PP
monocytes NNS B-NP
by IN B-PP
all DT B-NP
three CD I-NP
factors NNS I-NP
may MD B-VP
be VB I-VP
dependent JJ B-ADJP
on IN B-PP
different JJ B-NP
routes NNS I-NP
on IN B-PP
nuclear JJ B-NP
signalling NN I-NP
employed VBN B-VP
by IN B-PP
the DT B-NP
factors NNS I-NP
. . O

Corticosteroid NN B-NP
receptors NNS I-NP
and CC O
lymphocyte NN B-NP
subsets NNS I-NP
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
in IN B-PP
aging NN B-NP
. . O

Plasma NN B-NP
cortisol NN I-NP
and CC O
aldosterone NN B-NP
levels NNS B-NP
and CC O
number NN B-NP
of IN B-PP
related JJ B-NP
receptors NNS I-NP
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
were VBD B-VP
measured VBN I-VP
in IN B-PP
49 CD B-NP
healthy JJ I-NP
aged JJ I-NP
subjects NNS I-NP
( ( O
62-97 CD B-NP
yr NN I-NP
) ) O
and CC B-PP
in IN B-PP
21 CD B-NP
adult JJ I-NP
controls NNS I-NP
( ( O
21-50 CD B-NP
yr NN I-NP
) ) O
. . O

In IN B-PP
all DT B-NP
subjects NNS I-NP
COMMA COMMA O
in IN B-PP
addition NN B-NP
COMMA COMMA O
lymphocyte NN B-NP
subsets NNS I-NP
were VBD B-VP
determined VBN I-VP
as IN B-PP
an DT B-NP
index NN I-NP
of IN B-PP
corticosteroid NN B-NP
action NN I-NP
. . O

The DT B-NP
mean NN I-NP
number NN I-NP
of IN B-PP
type NN B-NP
I CD I-NP
and CC O
type NN B-NP
II CD I-NP
receptors NNS B-NP
was VBD B-VP
significantly RB B-ADJP
lower JJR I-ADJP
in IN B-PP
aged JJ B-NP
subjects NNS I-NP
than IN B-PP
in IN B-PP
controls NNS B-NP
( ( O
respectively RB B-ADVP
COMMA COMMA O
198 CD B-NP
+\/- CC I-NP
96 CD I-NP
and CC I-NP
272 CD I-NP
+\/- CC I-NP
97 CD I-NP
receptors\/cell NNS I-NP
for IN B-PP
type NN B-NP
I CD I-NP
COMMA COMMA O
and CC O
1COMMA794 CD B-NP
+\/- CC I-NP
803 CD I-NP
and CC I-NP
3COMMA339 CD I-NP
+\/- CC I-NP
918 CD I-NP
for IN B-PP
type NN B-NP
II CD I-NP
receptors NNS B-NP
) ) O
. . O

Plasma NN B-NP
aldosterone NN B-NP
and CC O
cortisol NN B-NP
and CC O
lymphocyte NN B-NP
subsets NNS I-NP
were VBD B-VP
not RB O
different JJ B-ADJP
in IN B-PP
the DT B-NP
two CD I-NP
groups NNS I-NP
. . O

All DT B-NP
of IN B-PP
the DT B-NP
parameters NNS I-NP
were VBD B-VP
also RB I-VP
tested VBN I-VP
for IN B-PP
correlation NN B-NP
COMMA COMMA O
and CC O
a DT B-NP
significant JJ I-NP
inverse JJ I-NP
correlation NN I-NP
was VBD B-VP
found VBN I-VP
between IN B-PP
age NN B-NP
and CC O
type NN B-NP
I CD I-NP
and CC O
type NN B-NP
II CD I-NP
receptors NNS B-NP
when WRB B-ADVP
all DT B-NP
subjects NNS I-NP
were VBD B-VP
plotted VBN I-VP
and CC O
between IN B-PP
aged JJ B-NP
and CC I-NP
CD4 NN I-NP
and CC I-NP
age NN I-NP
and CC I-NP
CD4\/CD8 NN I-NP
in IN B-PP
the DT B-NP
aged JJ I-NP
group NN I-NP
. . O

These DT B-NP
data NNS I-NP
show VBP B-VP
that IN B-SBAR
aged JJ B-NP
subjects NNS I-NP
have VBP B-VP
reductions NNS B-NP
of IN B-PP
corticosteroid NN B-NP
receptors NNS I-NP
that WDT B-NP
are VBP B-VP
not RB I-VP
associated VBN I-VP
with IN B-PP
increase NN B-NP
of IN B-PP
related JJ B-NP
steroids NNS I-NP
and CC O
that IN B-SBAR
this DT B-NP
situation NN I-NP
probably RB B-ADVP
represents VBZ B-VP
a DT B-NP
concomitant NN I-NP
of IN B-PP
the DT B-NP
normal JJ I-NP
aging NN I-NP
process NN I-NP
. . O

Stable JJ B-NP
expression NN I-NP
of IN B-PP
HB24 NN B-NP
COMMA COMMA O
a DT B-NP
diverged JJ I-NP
human JJ I-NP
homeobox NN I-NP
gene NN I-NP
COMMA COMMA O
in IN B-PP
T NN B-NP
lymphocytes NNS I-NP
induces VBZ B-VP
genes NNS B-NP
involved VBN B-VP
in IN B-PP
T NN B-NP
cell NN I-NP
activation NN B-NP
and CC O
growth NN B-NP
. . O

A DT B-NP
diverged JJ I-NP
homeobox NN I-NP
gene NN I-NP
COMMA COMMA O
HB24 NN B-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
known VBN I-VP
to TO I-VP
be VB I-VP
induced VBN I-VP
following VBG B-PP
lymphocyte NN B-NP
activation NN I-NP
COMMA COMMA O
was VBD B-VP
introduced VBN I-VP
into IN B-PP
Jurkat NN B-NP
T NN I-NP
cells NNS I-NP
under IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
a DT B-NP
constitutive JJ I-NP
promoter NN I-NP
. . O

Stable JJ B-NP
transfectants NNS I-NP
of IN B-PP
HB24 NN B-NP
were VBD B-VP
established VBN I-VP
that WDT B-NP
expressed VBD B-VP
high JJ B-NP
levels NNS I-NP
of IN B-PP
HB24 NN B-NP
mRNA NN I-NP
and CC O
possessed VBD B-VP
an DT B-NP
altered JJ I-NP
phenotype NN I-NP
suggestive JJ B-ADJP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
. . O

A DT B-NP
number NN I-NP
of IN B-PP
genes NNS B-NP
known VBN B-VP
to TO I-VP
be VB I-VP
induced VBN I-VP
following VBG B-PP
T NN B-NP
cell NN I-NP
activation NN I-NP
and CC O
associated VBN B-VP
with IN B-PP
cell NN B-NP
growth NN I-NP
were VBD B-VP
increased VBN I-VP
in IN B-PP
the DT B-NP
transfectants NNS I-NP
COMMA COMMA O
including VBG B-PP
c-fos NN B-NP
COMMA COMMA O
c-myc NN B-NP
COMMA COMMA O
c-myb NN B-NP
COMMA COMMA O
HLA-DR NN B-NP
COMMA COMMA O
lck NN B-NP
COMMA COMMA O
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
interleukin-2 NN B-NP
and CC O
interleukin-2 NN B-NP
receptor NN I-NP
alpha NN I-NP
( ( O
IL-2R NN B-NP
alpha NN I-NP
) ) O
. . O

Analysis NN B-NP
of IN B-PP
IL-2R NN B-NP
alpha NN I-NP
expression NN I-NP
by IN B-PP
transient JJ B-NP
transfection NN I-NP
of IN B-PP
IL-2R NN B-NP
alpha NN I-NP
promoter NN I-NP
constructs NNS I-NP
into IN B-PP
the DT B-NP
HB24 NN I-NP
transfectants NNS I-NP
revealed VBD B-VP
constitutive JJ B-NP
expression NN I-NP
( ( O
about RB B-NP
60 CD I-NP
% NN I-NP
of IN B-PP
phytohemagglutinin- NN B-NP
and CC O
phorbol NN B-ADJP
ester-activated JJ I-ADJP
Jurkat NN B-NP
cells NNS I-NP
) ) O
that WDT B-NP
was VBD B-VP
dependent JJ B-ADJP
on IN B-PP
the DT B-NP
kappa NN I-NP
B NN I-NP
site NN I-NP
in IN B-PP
the DT B-NP
IL-2R NN I-NP
alpha NN I-NP
promoter NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
as IN B-PP
a DT B-NP
consequence NN I-NP
of IN B-PP
the DT B-NP
increased VBN I-NP
HB24 NN I-NP
mRNA NN I-NP
levels NNS I-NP
COMMA COMMA O
the DT B-NP
Jurkat NN I-NP
HB24 NN I-NP
transfectants NNS I-NP
proliferated VBD B-VP
more RBR B-ADVP
rapidly RB I-ADVP
than IN B-PP
control NN B-NP
cell NN I-NP
lines NNS I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
stable JJ B-NP
expression NN I-NP
of IN B-PP
HB24 NN B-NP
confers VBZ B-VP
an DT B-NP
activation NN I-NP
phenotype NN I-NP
on IN B-PP
a DT B-NP
human JJ I-NP
T NN I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
implicating VBG B-VP
this DT B-NP
gene NN I-NP
as IN B-PP
an DT B-NP
important JJ I-NP
transcriptional JJ I-NP
factor NN I-NP
during IN B-PP
T NN B-NP
cell NN I-NP
activation NN B-NP
and CC O
growth NN B-NP
. . O

Studies NNS B-NP
on IN B-PP
the DT B-NP
biological JJ I-NP
activity NN I-NP
of IN B-PP
triiodothyronine NN B-NP
sulfate NN I-NP
. . O

Hepatic JJ B-NP
microsomes NNS I-NP
and CC O
isolated VBN B-NP
hepatocytes NNS I-NP
in IN B-PP
short JJ B-NP
term NN I-NP
culture NN I-NP
desulfate VBP B-VP
T3 NN B-NP
sulfate NN I-NP
( ( O
T3SO4 NN B-NP
) ) O
. . O

We PRP B-NP
COMMA COMMA O
therefore RB B-ADVP
COMMA COMMA O
wished VBD B-VP
to TO I-VP
determine VB I-VP
whether IN B-SBAR
T3SO4 NN B-NP
could MD B-VP
mimic VB I-VP
the DT B-NP
action NN I-NP
of IN B-PP
thyroid NN B-NP
hormone NN I-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

T3SO4 NN B-NP
had VBD B-VP
no DT B-NP
thyromimetic JJ I-NP
effect NN I-NP
on IN B-PP
the DT B-NP
activity NN I-NP
of IN B-PP
Ca(2+)-ATPase NN B-NP
in IN B-PP
human JJ B-NP
erythrocyte NN I-NP
membranes NNS I-NP
at IN B-PP
doses NNS B-NP
up RB B-NP
to TO I-NP
10COMMA000 CD I-NP
times NNS I-NP
the DT I-NP
maximally RB I-NP
effective JJ I-NP
dose NN I-NP
of IN B-PP
T3 NN B-NP
( ( O
10\/(-10) CD B-NP
mol\/L NN I-NP
) ) O
. . O

In IN B-PP
GH4C1 NN B-NP
pituitary JJ I-NP
cells NNS I-NP
COMMA COMMA O
T3SO4 NN B-NP
failed VBD B-VP
to TO I-VP
displace VB I-VP
{125I}T3 NN B-NP
from IN B-PP
nuclear JJ B-NP
receptors NNS I-NP
in IN B-PP
intact JJ B-NP
cells NNS I-NP
or CC O
soluble JJ B-NP
preparations NNS I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
T3SO4 NN B-NP
was VBD B-VP
not RB O
directly RB B-ADVP
thyromimetic JJ B-ADJP
in IN B-PP
either CC O
an DT B-NP
isolated VBN I-NP
human JJ I-NP
membrane NN I-NP
system NN I-NP
or CC O
a DT B-NP
pituitary JJ I-NP
cell NN I-NP
system NN I-NP
in IN B-PP
which WDT B-NP
nuclear JJ B-NP
receptor NN I-NP
occupancy NN I-NP
correlates VBZ B-VP
with IN B-PP
GH NN B-NP
synthesis NN I-NP
. . O

Thyroid NN B-NP
hormones NNS I-NP
inhibit VBP B-VP
{3H}glycosaminoglycan NN B-NP
synthesis NN I-NP
by IN B-PP
cultured VBN B-NP
human JJ I-NP
dermal JJ I-NP
fibroblasts NNS I-NP
COMMA COMMA O
and CC O
T3SO4 NN B-NP
displayed VBN B-VP
about IN B-NP
0.5 CD I-NP
% NN I-NP
the DT B-NP
activity NN I-NP
of IN B-PP
T3 NN B-NP
at IN B-PP
72 CD B-NP
h NN I-NP
. . O

Human JJ B-NP
fibroblasts NNS I-NP
contained VBD B-VP
roughly RB B-ADVP
the DT B-NP
same JJ I-NP
level NN I-NP
of IN B-PP
microsomal JJ B-NP
p-nitrophenyl NN I-NP
sulfatase NN I-NP
activity NN I-NP
as IN B-PP
that DT B-NP
previously RB B-VP
observed VBN I-VP
in IN B-PP
hepatic JJ B-NP
microsomes NNS I-NP
. . O

Propylthiouracil NN B-NP
( ( O
50 CD B-NP
mumol\/L NN I-NP
) ) O
did VBD B-VP
not RB I-VP
affect VB I-VP
the DT B-NP
action NN I-NP
of IN B-PP
T3SO4 NN B-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
deiodination NN B-NP
was VBD B-VP
not RB O
important JJ B-ADJP
for IN B-PP
this DT B-NP
activity NN I-NP
of IN B-PP
T3SO4 NN B-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
it PRP B-NP
appears VBZ B-VP
T3SO4 NN B-NP
has VBZ B-VP
no DT B-NP
intrinsic JJ I-NP
biological JJ I-NP
activity NN I-NP
COMMA COMMA O
but CC O
COMMA COMMA O
under IN B-PP
certain JJ B-NP
circumstances NNS I-NP
COMMA COMMA O
may MD B-VP
be VB I-VP
reactivated VBN I-VP
by IN B-PP
desulfation NN B-NP
. . O

Nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
contains VBZ B-VP
Fos NN B-NP
and CC O
Jun NN B-NP
. . O

The DT B-NP
nuclear JJ I-NP
factor NN I-NP
NF-AT NN I-NP
( ( O
ref. NN B-NP
1 CD I-NP
) ) O
is VBZ B-VP
induced VBN I-VP
in IN B-PP
T NN B-NP
cells NNS I-NP
stimulated VBN B-VP
through IN B-PP
the DT B-NP
T-cell NN I-NP
receptor\/CD3 NN I-NP
complex NN I-NP
COMMA COMMA O
and CC O
is VBZ B-VP
required VBN I-VP
for IN B-PP
interleukin-2 NN B-NP
( ( O
IL-2 NN B-NP
) ) O
gene NN B-NP
induction NN I-NP
. . O

Although IN B-SBAR
NF-AT NN B-NP
has VBZ B-VP
not RB I-VP
been VBN I-VP
cloned VBN I-VP
or CC O
purified VBN B-VP
COMMA COMMA O
there EX B-NP
is VBZ B-VP
evidence NN B-NP
that IN B-SBAR
it PRP B-NP
is VBZ B-VP
a DT B-NP
major JJ I-NP
target NN I-NP
for IN B-PP
immunosuppression NN B-NP
by IN B-PP
cyclosporin NN B-NP
A NN I-NP
( ( O
CsA NN B-NP
) ) O
and CC O
FK506 NN B-NP
( ( O
refs NNS B-NP
2-7 CD B-NP
) ) O
. . O

NF-AT NN B-NP
induction NN I-NP
may MD B-VP
require VB I-VP
two CD B-NP
activation-dependent JJ I-NP
events NNS I-NP
: : O
the DT B-NP
CsA-sensitive JJ I-NP
translocation NN I-NP
of IN B-PP
a DT B-NP
pre-existing JJ I-NP
component NN I-NP
and CC O
the DT B-NP
CsA-resistant JJ I-NP
synthesis NN I-NP
of IN B-PP
a DT B-NP
nuclear JJ I-NP
component NN I-NP
. . O

Here RB B-ADVP
we PRP B-NP
report VBP B-VP
that IN B-SBAR
the DT B-NP
newly RB I-NP
synthesized VBN I-NP
nuclear JJ I-NP
component NN I-NP
of IN B-PP
NF-AT NN B-NP
is VBZ B-VP
the DT B-NP
transcription NN I-NP
factor NN I-NP
AP-1 NN I-NP
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
the DT B-NP
inducible JJ I-NP
nuclear JJ I-NP
form NN I-NP
of IN B-PP
NF-AT NN B-NP
contains VBZ B-VP
Fos NN B-NP
and CC O
Jun NN B-NP
proteins NNS B-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
we PRP B-NP
identify VBP B-VP
a DT B-NP
pre-existing JJ I-NP
NF-AT-binding JJ I-NP
factor NN I-NP
that WDT B-NP
is VBZ B-VP
present JJ B-ADJP
in IN B-PP
hypotonic JJ B-NP
extracts NNS I-NP
of IN B-PP
unstimulated JJ B-NP
T NN I-NP
cells NNS I-NP
. . O

On IN B-PP
the DT I-PP
basis NN I-PP
of IN I-PP
binding NN B-NP
COMMA COMMA O
reconstitution NN B-NP
and CC O
cotransfection NN B-NP
experiments NNS B-NP
COMMA COMMA O
we PRP B-NP
propose VBP B-VP
that IN B-SBAR
activation NN B-NP
of IN B-PP
NF-AT NN B-NP
occurs VBZ B-VP
in IN B-PP
at IN B-NP
least JJS I-NP
two CD I-NP
stages NNS I-NP
: : O
a DT B-NP
CsA-sensitive JJ I-NP
stage NN I-NP
involving VBG B-VP
modification NN B-NP
and\/or CC O
translocation NN B-NP
of IN B-PP
the DT B-NP
pre-existing JJ I-NP
NF-AT NN I-NP
complex NN I-NP
COMMA COMMA O
and CC O
a DT B-NP
CsA-insensitive JJ I-NP
stage NN I-NP
involving VBG B-VP
the DT B-NP
addition NN I-NP
of IN B-PP
newly RB O
synthesized VBN O
Fos NN B-NP
or CC O
Fos\/Jun NN B-NP
proteins NNS B-NP
to TO B-PP
the DT B-NP
pre-existing JJ I-NP
complex NN I-NP
. . O

Interferon-gamma NN B-NP
potentiates VBZ B-VP
the DT B-NP
antiviral JJ I-NP
activity NN I-NP
and CC O
the DT B-NP
expression NN I-NP
of IN B-PP
interferon-stimulated JJ B-NP
genes NNS I-NP
induced VBN B-VP
by IN B-PP
interferon-alpha NN B-NP
in IN B-PP
U937 NN B-NP
cells NNS I-NP
. . O

Binding NN B-NP
of IN B-PP
type NN B-NP
I CD I-NP
interferon NN I-NP
( ( O
IFN-alpha\/beta NN B-NP
) ) O
to TO B-PP
specific JJ B-NP
receptors NNS I-NP
results VBZ B-VP
in IN B-PP
the DT B-NP
rapid JJ I-NP
transcriptional JJ I-NP
activation NN I-NP
COMMA COMMA O
independent JJ B-ADJP
of IN B-PP
protein NN B-NP
synthesis NN I-NP
COMMA COMMA O
of IN B-PP
IFN-alpha-stimulated JJ B-NP
genes NNS I-NP
( ( O
ISGs NNS B-NP
) ) O
in IN B-PP
human JJ B-NP
fibroblasts NNS I-NP
and CC O
HeLa NN B-NP
and CC O
Daudi NN B-NP
cell NN B-NP
lines NNS I-NP
. . O

The DT B-NP
binding NN I-NP
of IN B-PP
ISGF3 NN B-NP
( ( O
IFN-stimulated JJ B-NP
gene NN I-NP
factor NN I-NP
3 CD I-NP
) ) O
to TO B-PP
the DT B-NP
conserved VBN I-NP
IFN-stimulated JJ B-NP
response NN I-NP
element NN I-NP
( ( O
ISRE NN B-NP
) ) O
results VBZ B-VP
in IN B-PP
transcriptional JJ B-NP
activation NN I-NP
. . O

This DT B-NP
factor NN I-NP
is VBZ B-VP
composed VBN I-VP
of IN B-PP
a DT B-NP
DNA-binding JJ I-NP
protein NN I-NP
( ( O
ISGF3 NN B-NP
gamma NN I-NP
) ) O
COMMA COMMA O
which WDT B-NP
normally RB B-ADVP
is VBZ B-VP
present JJ B-ADJP
in IN B-PP
the DT B-NP
cytoplasm NN I-NP
COMMA COMMA O
and CC O
other JJ B-NP
IFN-alpha-activated JJ I-NP
proteins NNS I-NP
which WDT B-NP
preexist VBP B-VP
as IN B-PP
latent JJ B-NP
cytoplasmic JJ I-NP
precursors NNS I-NP
( ( O
ISGF3 NN B-NP
alpha NN I-NP
) ) O
. . O

We PRP B-NP
have VBP B-VP
found VBN I-VP
that IN B-SBAR
ISG NN B-NP
expression NN I-NP
in IN B-PP
the DT B-NP
monocytic JJ I-NP
U937 NN I-NP
cell NN I-NP
line NN I-NP
differs VBZ B-VP
from IN B-PP
most JJS B-NP
cell NN I-NP
lines NNS I-NP
previously RB B-VP
examined VBN I-VP
. . O

U937 NN B-NP
cells NNS I-NP
express VBP B-VP
both CC O
type NN B-NP
I CD I-NP
and CC O
type NN B-NP
II CD I-NP
IFN NN B-NP
receptors NNS I-NP
COMMA COMMA O
but CC O
only RB B-NP
IFN-alpha NN I-NP
is VBZ B-VP
capable JJ B-ADJP
of IN B-PP
inducing VBG B-VP
antiviral JJ B-NP
protection NN I-NP
in IN B-PP
these DT B-NP
cells NNS I-NP
. . O

Pretreatment NN B-NP
with IN B-PP
IFN-gamma NN B-NP
potentiates VBZ B-VP
the DT B-NP
IFN-alpha-induced JJ I-NP
protection NN I-NP
COMMA COMMA O
but CC O
IFN-gamma NN B-NP
alone RB B-ADVP
does VBZ B-VP
not RB I-VP
have VB I-VP
any DT B-NP
antiviral JJ I-NP
activity NN I-NP
. . O

ISG15 NN B-NP
mRNA NN I-NP
accumulation NN I-NP
in IN B-PP
U937 NN B-NP
cells NNS I-NP
is VBZ B-VP
not RB O
detectable JJ B-ADJP
before IN B-PP
6 CD B-NP
h NN I-NP
of IN B-PP
IFN-alpha NN B-NP
treatment NN I-NP
COMMA COMMA O
peaks VBZ B-VP
at IN B-PP
24 CD B-NP
h NN I-NP
COMMA COMMA O
and CC O
requires VBZ B-VP
protein NN B-NP
synthesis NN I-NP
. . O

Although IN B-SBAR
IFN-gamma NN B-NP
alone RB B-ADVP
does VBZ B-VP
not RB I-VP
induce VB I-VP
ISG NN B-NP
expression NN I-NP
COMMA COMMA O
IFN-gamma NN B-NP
pretreatment NN I-NP
markedly RB B-ADVP
increases VBZ B-VP
and CC O
hastens VBZ B-VP
ISG NN B-NP
expression NN I-NP
and CC O
transcriptional JJ B-NP
induction NN I-NP
. . O

Nuclear JJ B-NP
extracts NNS I-NP
assayed VBN B-VP
for IN B-PP
the DT B-NP
presence NN I-NP
of IN B-PP
ISRE NN B-NP
binding NN I-NP
factors NNS I-NP
by IN B-PP
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
show VBP B-VP
that IN B-SBAR
ISGF3 NN B-NP
is VBZ B-VP
induced VBN I-VP
by IN B-PP
IFN-alpha NN B-NP
within IN B-PP
6 CD B-NP
h NN I-NP
from IN B-PP
undetectable JJ B-NP
basal JJ I-NP
levels NNS I-NP
in IN B-PP
untreated JJ B-NP
U937 NN I-NP
cells NNS I-NP
. . O

Activation NN B-NP
of IN B-PP
ISGF3 NN B-NP
alpha NN I-NP
COMMA COMMA O
the DT B-NP
latent JJ I-NP
component NN I-NP
of IN B-PP
ISGF3 NN B-NP
COMMA COMMA O
occurs VBZ B-VP
rapidly RB B-ADVP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
increase NN I-NP
in IN B-PP
ISGF3 NN B-NP
activity NN I-NP
ultimately RB B-ADVP
correlates VBZ B-VP
with IN B-PP
the DT B-NP
accumulation NN I-NP
of IN B-PP
ISGF3 NN B-NP
gamma NN I-NP
induced VBN B-VP
by IN B-PP
IFN-alpha NN B-NP
or CC O
IFN-gamma NN B-NP
. . O

( ( O
ABSTRACT NN B-NP
TRUNCATED VBN B-VP
AT IN B-PP
250 CD B-NP
WORDS NNS I-NP
) ) O

The DT B-NP
mechanism NN I-NP
of IN B-PP
action NN B-NP
of IN B-PP
cyclosporin NN B-NP
A NN I-NP
and CC O
FK506 NN B-NP
. . O

CsA NN B-NP
and CC O
FK506 NN B-NP
are VBP B-VP
powerful JJ B-NP
suppressors NNS I-NP
of IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
COMMA COMMA O
most RBS B-ADVP
notably RB I-ADVP
of IN B-PP
T NN B-NP
cells NNS I-NP
. . O

They PRP B-NP
act VBP B-VP
at IN B-PP
a DT B-NP
point NN I-NP
in IN B-PP
activation NN B-NP
that WDT B-NP
lies VBZ B-VP
between IN B-PP
receptor NN B-NP
ligation NN I-NP
and CC O
the DT B-NP
transcription NN I-NP
of IN B-PP
early JJ B-NP
genes NNS I-NP
. . O

Here RB B-ADVP
COMMA COMMA O
Stuart NNP B-NP
Schreiber NNP I-NP
and CC O
Gerald NNP B-NP
Crabtree NNP I-NP
review VBP B-VP
recent JJ B-NP
findings NNS I-NP
that WDT B-NP
indicate VBP O
CsA NN B-NP
and CC O
FK506 NN B-NP
operate VBP B-VP
as IN B-PP
prodrugs NNS B-NP
: : O
they PRP B-NP
bind VBP B-VP
endogenous JJ B-NP
intracellular JJ I-NP
receptors NNS I-NP
COMMA COMMA O
the DT B-NP
immunophilins NNS I-NP
COMMA COMMA O
and CC O
the DT B-NP
resulting VBG I-NP
complex NN I-NP
targets VBZ B-VP
the DT B-NP
protein NN I-NP
phosphatase NN I-NP
COMMA COMMA O
calcineurin NN B-NP
COMMA COMMA O
to TO B-VP
exert VB I-VP
the DT B-NP
immunosuppressive JJ I-NP
effect NN I-NP
. . O

{ ( O
Plasma NN B-NP
cortisol NN I-NP
concentration NN I-NP
and CC O
blood NN B-NP
leukocyte NN I-NP
content NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
deficiency-cold JJ B-NP
vs CC I-NP
deficiency-heat JJ I-NP
syndromes NNS I-NP
} ) O

Plasma NN B-NP
cortisol NN I-NP
concentration NN I-NP
and CC O
blood NN B-NP
leukocyte NN I-NP
content NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
( ( O
GCR NN B-NP
) ) O
were VBD B-VP
assayed VBN I-VP
in IN B-PP
20 CD B-NP
patients NNS I-NP
with IN B-PP
deficiency NN B-NP
syndromes NNS I-NP
COMMA COMMA O
10 CD B-NP
cold JJ B-ADJP
in IN B-PP
property NN B-NP
( ( O
deficiency-cold JJ B-ADJP
) ) O
COMMA COMMA O
the DT B-NP
other JJ I-NP
10 CD B-NP
hot JJ B-ADJP
in IN B-PP
property NN B-NP
( ( O
deficiency-heat JJ B-ADJP
) ) O
COMMA COMMA O
and CC O
also RB O
in IN B-PP
10 CD B-NP
healthy JJ I-NP
individuals NNS I-NP
as IN B-PP
normal JJ B-NP
control NN I-NP
for IN B-PP
the DT B-NP
purpose NN I-NP
of IN B-PP
investigating VBG B-VP
the DT B-NP
nature NN I-NP
of IN B-PP
cold NN O
and CC O
heat NN B-NP
syndromes NNS B-NP
. . O

As IN B-PP
a DT B-NP
result NN I-NP
COMMA COMMA O
the DT B-NP
cases NNS I-NP
of IN B-PP
deficiency-cold JJ B-NP
syndrome NN I-NP
( ( O
DCS NN B-NP
) ) O
had VBD B-VP
a DT B-NP
normal JJ I-NP
concentration NN I-NP
of IN B-PP
plasma NN B-NP
cortisol NN I-NP
but CC O
a DT B-NP
lowered JJ I-NP
content NN I-NP
of IN B-PP
GCR NN B-NP
in IN B-PP
leukocytes NNS B-NP
when WRB B-ADVP
compared VBN B-VP
with IN B-PP
the DT B-NP
normal JJ I-NP
control NN I-NP
( ( O
P NN B-NP
less JJR B-NP
than IN I-NP
0.05 CD I-NP
) ) O
; : O
the DT B-NP
cases NNS I-NP
of IN B-PP
deficiency-heat JJ B-NP
syndrome NN I-NP
( ( O
DHS NN B-NP
) ) O
had VBD B-VP
a DT B-NP
higher JJR I-NP
concentration NN I-NP
of IN B-PP
plasma NN B-NP
cortisol NN I-NP
than IN B-PP
the DT B-NP
normal JJ I-NP
control NN I-NP
( ( O
P NN B-NP
less JJR B-NP
than IN I-NP
0.05 CD I-NP
) ) O
and CC O
a DT B-NP
slightly RB I-NP
higher JJR I-NP
content NN I-NP
of IN B-PP
GCR NN B-NP
in IN B-PP
leukocytes NNS B-NP
. . O

It PRP B-NP
was VBD B-VP
concluded VBN I-VP
that IN B-SBAR
the DT B-NP
DCS NN I-NP
is VBZ B-VP
characterized VBN I-VP
by IN B-PP
diminished VBN B-NP
biological JJ I-NP
effects NNS I-NP
of IN B-PP
adrenocortical JJ B-NP
activity NN I-NP
COMMA COMMA O
while IN O
the DT B-NP
DHS NN I-NP
COMMA COMMA O
by IN B-PP
augmented JJ B-NP
biological JJ I-NP
effects NNS I-NP
of IN B-PP
adrenocortical JJ B-NP
activity NN I-NP
. . O

Specific JJ B-NP
NF-kappa NN I-NP
B NN I-NP
subunits NNS I-NP
act VBP B-VP
in IN B-PP
concert NN I-PP
with IN I-PP
Tat NN B-NP
to TO B-VP
stimulate VB I-VP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
transcription NN I-NP
. . O

NF-kappa NN B-NP
B NN I-NP
is VBZ B-VP
a DT B-NP
protein NN I-NP
complex NN I-NP
which WDT B-NP
functions VBZ B-VP
in IN B-PP
concert NN I-PP
with IN I-PP
the DT B-NP
tat-I NN I-NP
gene NN I-NP
product NN I-NP
to TO B-VP
stimulate VB I-VP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV NN B-NP
) ) O
transcription NN B-NP
. . O

To TO B-VP
determine VB I-VP
whether IN B-SBAR
specific JJ B-NP
members NNS I-NP
of IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
family NN I-NP
contribute VBP B-VP
to TO B-PP
this DT B-NP
effect NN I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
examined VBN I-VP
the DT B-NP
abilities NNS I-NP
of IN B-PP
different JJ B-NP
NF-kappa NN I-NP
B NN I-NP
subunits NNS I-NP
to TO B-VP
act VB I-VP
with IN B-PP
Tat-I NN B-NP
to TO B-VP
stimulate VB I-VP
transcription NN B-NP
of IN B-PP
HIV NN B-NP
in IN B-PP
Jurkat NN B-NP
T-leukemia NN I-NP
cells NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
found VBN I-VP
that IN B-SBAR
the DT B-NP
p49 NN I-NP
( ( I-NP
100 CD I-NP
) ) I-NP
DNA NN I-NP
binding NN I-NP
subunit NN I-NP
COMMA COMMA O
together RB B-PP
with IN I-PP
p65 NN B-NP
COMMA COMMA O
can MD B-VP
act VB I-VP
in IN B-PP
concert NN I-PP
with IN I-PP
Tat-I NN B-NP
to TO B-VP
stimulate VB I-VP
the DT B-NP
expression NN I-NP
of IN B-PP
HIV-CAT NN B-NP
plasmid NN I-NP
. . O

Little JJ B-NP
effect NN I-NP
was VBD B-VP
observed VBN I-VP
with IN B-PP
50-kDa JJ B-NP
forms NNS I-NP
of IN B-PP
p105 NN B-NP
NF-kappa NN I-NP
B NN I-NP
or CC O
rel NN B-NP
COMMA COMMA O
in IN B-PP
combination NN B-NP
with IN B-PP
p65 NN B-NP
or CC O
full-length JJ B-NP
c-rel NN I-NP
COMMA COMMA O
which WDT B-NP
do VBP B-VP
not RB I-VP
stimulate VB I-VP
the DT B-NP
HIV NN I-NP
enhancer NN I-NP
in IN B-PP
these DT B-NP
cells NNS I-NP
. . O

These DT B-NP
findings NNS I-NP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
combination NN I-NP
of IN B-PP
p49 NN B-NP
( ( I-NP
100 CD I-NP
) ) O
and CC O
p65 NN B-NP
NF-kappa NN I-NP
B NN I-NP
can MD B-VP
act VB I-VP
in IN B-PP
concert NN I-PP
with IN I-PP
the DT B-NP
tat-I NN I-NP
gene NN I-NP
product NN I-NP
to TO B-VP
stimulate VB I-VP
the DT B-NP
synthesis NN I-NP
of IN B-PP
HIV NN B-NP
RNA NN I-NP
. . O

Activation NN B-NP
of IN B-PP
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
enhancer NN I-NP
is VBZ B-VP
not RB O
dependent JJ B-ADJP
on IN B-PP
NFAT-1 NN B-NP
. . O

The DT B-NP
function NN I-NP
of IN B-PP
a DT B-NP
putative JJ I-NP
NFAT-1 NN I-NP
site NN I-NP
in IN B-PP
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
enhancer NN I-NP
has VBZ B-VP
been VBN I-VP
analyzed VBN I-VP
. . O

Activation NN B-NP
by IN B-PP
the DT B-NP
T-cell NN I-NP
antigen NN I-NP
receptor NN I-NP
is VBZ B-VP
minimal JJ B-ADJP
in IN B-PP
Jurkat NN B-NP
cells NNS I-NP
and CC O
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
the DT B-NP
kappa NN I-NP
B NN I-NP
sites NNS I-NP
. . O

The DT B-NP
putative JJ I-NP
NFAT-1 NN I-NP
region NN I-NP
is VBZ B-VP
not RB I-VP
required VBN I-VP
for IN B-PP
the DT B-NP
response NN I-NP
to TO B-PP
anti-CD3 NN B-NP
or CC B-PP
to TO B-PP
mitogens NNS B-NP
in IN B-PP
T-cell NN B-NP
COMMA COMMA O
B-cell NN B-NP
COMMA COMMA O
or CC O
monocyte\/macrophage NN B-NP
leukemia NN I-NP
lines NNS B-NP
COMMA COMMA O
nor CC O
is VBZ B-VP
it PRP B-NP
a DT B-NP
cis-acting JJ I-NP
negative JJ I-NP
regulatory JJ I-NP
element NN I-NP
. . O

Protein NN B-NP
kinase NN I-NP
C NN I-NP
activation NN I-NP
and CC O
protooncogene NN B-NP
expression NN I-NP
in IN B-PP
differentiation\/retrodifferentiation NN B-NP
of IN B-PP
human JJ B-NP
U-937 NN I-NP
leukemia NN I-NP
cells NNS I-NP
. . O

Human JJ B-NP
U-937 NN I-NP
leukemia NN I-NP
cells NNS I-NP
differentiate VBP B-VP
along IN B-PP
the DT B-NP
monocytic JJ I-NP
lineage NN I-NP
following VBG B-PP
3-day JJ B-NP
exposures NNS I-NP
to TO B-PP
12-O-tetradecanoylphorbol-13-acetate NN B-NP
( ( O
TPA NN B-NP
) ) O
. . O

This DT B-NP
induction NN I-NP
of IN B-PP
differentiation NN B-NP
is VBZ B-VP
accompanied VBN I-VP
by IN B-PP
adherence NN B-NP
and CC O
loss NN B-NP
of IN B-PP
proliferation NN B-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
expression\/repression NN B-NP
of IN B-PP
differentiation-associated JJ B-NP
genes NNS I-NP
. . O

Long JJ B-NP
term NN I-NP
culture NN I-NP
of IN B-PP
TPA-differentiated JJ B-NP
U-937 NN I-NP
cells NNS I-NP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
phorbol NN B-NP
ester NN I-NP
for IN B-PP
32-36 CD B-NP
days NNS I-NP
resulted VBD B-VP
in IN B-PP
a DT B-NP
process NN I-NP
of IN B-PP
retrodifferentiation NN B-NP
. . O

The DT B-NP
retrodifferentiated VBN I-NP
cells NNS I-NP
detached VBD B-VP
from IN B-PP
the DT B-NP
substrate NN I-NP
and CC O
reinitiated VBD B-VP
proliferation NN B-NP
. . O

Other JJ B-NP
cellular JJ I-NP
parameters NNS I-NP
COMMA COMMA O
such JJ B-PP
as IN I-PP
glycosidase NN B-NP
activities NNS I-NP
COMMA COMMA O
cytokine NN B-NP
release NN I-NP
COMMA COMMA O
and CC O
filament NN B-NP
expression NN I-NP
COMMA COMMA O
returned VBD B-VP
to TO B-PP
levels NNS B-NP
similar JJ B-ADJP
to TO B-PP
that DT B-NP
observed VBN B-VP
in IN B-PP
uninduced JJ B-NP
cells NNS I-NP
. . O

Treatment NN B-NP
of IN B-PP
U-937 NN B-NP
cells NNS I-NP
with IN B-PP
TPA NN B-NP
resulted VBD B-VP
in IN B-PP
a DT B-NP
rapid JJ I-NP
translocation NN I-NP
of IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( O
PKC NN B-NP
) ) O
from IN B-PP
the DT B-NP
cytosol NN I-NP
to TO B-PP
cell NN B-NP
membrane NN I-NP
fractions NNS I-NP
within IN B-PP
2-8 CD B-NP
min NN I-NP
. . O

Increased VBN B-NP
levels NNS I-NP
of IN B-PP
membrane-associated JJ B-NP
PKC NN I-NP
activity NN I-NP
persisted VBD B-VP
until IN B-PP
17-29 CD B-NP
days NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
longer JJR B-NP
periods NNS I-NP
of IN B-PP
incubation NN B-NP
were VBD B-VP
associated VBN I-VP
with IN B-PP
a DT B-NP
return NN I-NP
to TO B-PP
the DT B-NP
distribution NN I-NP
of IN B-PP
PKC NN B-NP
in IN B-PP
control NN B-NP
cells NNS I-NP
. . O

Activation NN B-NP
of IN B-PP
PKC NN B-NP
has VBZ B-VP
been VBN I-VP
implicated VBN I-VP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
certain JJ B-NP
immediate JJ I-NP
early JJ I-NP
response NN I-NP
genes NNS I-NP
COMMA COMMA O
and CC O
in IN B-PP
the DT B-NP
present JJ I-NP
studies NNS I-NP
COMMA COMMA O
TPA NN B-NP
rapidly RB B-ADVP
induced VBD B-VP
c-fos NN B-NP
and CC O
c-jun NN B-NP
gene NN B-NP
expression NN I-NP
. . O

Levels NNS B-NP
of IN B-PP
c-fos NN B-NP
and CC O
c-jun NN B-NP
transcripts NNS B-NP
remained VBD B-VP
elevated JJ B-ADJP
during IN B-PP
periods NNS B-NP
of IN B-PP
PKC NN B-NP
activation NN I-NP
and CC O
also RB O
returned VBD B-VP
to TO B-PP
levels NNS B-NP
observed VBN B-VP
in IN B-PP
control NN B-NP
cells NNS I-NP
by IN B-PP
30-36 CD B-NP
days NNS I-NP
COMMA COMMA O
when WRB B-ADVP
the DT B-NP
cells NNS I-NP
entered VBD B-VP
retrodifferentiation NN B-NP
. . O

Staurosporine NN B-NP
COMMA COMMA O
a DT B-NP
nonspecific JJ I-NP
inhibitor NN I-NP
of IN B-PP
PKC NN B-NP
COMMA COMMA O
partially RB B-VP
blocked VBD I-VP
TPA-induced JJ B-NP
adherence NN I-NP
and CC O
growth NN B-NP
inhibition NN I-NP
and CC O
concomitantly RB B-VP
prevented VBD I-VP
TPA-induced JJ O
c-fos NN B-NP
and CC O
c-jun NN B-NP
gene NN B-NP
expression NN I-NP
. . O

( ( O
ABSTRACT NN B-NP
TRUNCATED VBN B-VP
AT IN B-PP
250 CD B-NP
WORDS NNS I-NP
) ) O

The DT B-NP
promoter NN I-NP
of IN B-PP
the DT B-NP
CD19 NN I-NP
gene NN I-NP
is VBZ B-VP
a DT B-NP
target NN I-NP
for IN B-PP
the DT B-NP
B-cell-specific JJ I-NP
transcription NN I-NP
factor NN I-NP
BSAP NN I-NP
. . O

The DT B-NP
CD19 NN I-NP
protein NN I-NP
is VBZ B-VP
expressed VBN I-VP
on IN B-PP
the DT B-NP
surface NN I-NP
of IN B-PP
all DT B-NP
B-lymphoid JJ I-NP
cells NNS I-NP
with IN B-PP
the DT B-NP
exception NN I-NP
of IN B-PP
terminally RB B-NP
differentiated VBN I-NP
plasma NN I-NP
cells NNS I-NP
and CC O
has VBZ B-VP
been VBN I-VP
implicated VBN I-VP
as IN B-PP
a DT B-NP
signal-transducing JJ I-NP
receptor NN I-NP
in IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
proliferation NN B-NP
and CC O
differentiation NN B-NP
. . O

Here RB B-ADVP
we PRP B-NP
demonstrate VBP B-VP
complete JJ B-NP
correlation NN I-NP
between IN B-PP
the DT B-NP
expression NN I-NP
pattern NN I-NP
of IN B-PP
the DT B-NP
CD19 NN I-NP
gene NN I-NP
and CC O
the DT B-NP
B-cell-specific JJ I-NP
transcription NN I-NP
factor NN I-NP
BSAP NN I-NP
in IN B-PP
a DT B-NP
large JJ I-NP
panel NN I-NP
of IN B-PP
B-lymphoid JJ B-NP
cell NN I-NP
lines NNS I-NP
. . O

The DT B-NP
human JJ I-NP
CD19 NN I-NP
gene NN I-NP
has VBZ B-VP
been VBN I-VP
cloned VBN I-VP
COMMA COMMA O
and CC O
several JJ B-NP
BSAP-binding JJ I-NP
sites NNS I-NP
have VBP B-VP
been VBN I-VP
mapped VBN I-VP
by IN B-PP
in FW B-NP
vitro FW I-NP
protein-DNA JJ I-NP
binding NN I-NP
studies NNS I-NP
. . O

In IN B-PP
particular JJ B-NP
COMMA COMMA O
a DT B-NP
high-affinity JJ I-NP
BSAP-binding JJ I-NP
site NN I-NP
instead RB B-CONJP
of IN I-CONJP
a DT B-NP
TATA NN I-NP
sequence NN I-NP
is VBZ B-VP
located JJ B-ADJP
in IN B-PP
the DT B-NP
-30 CD I-NP
promoter NN I-NP
region NN I-NP
upstream JJ B-ADJP
of IN B-PP
a DT B-NP
cluster NN I-NP
of IN B-PP
heterogeneous JJ B-NP
transcription NN I-NP
start NN I-NP
sites NNS I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
this DT B-NP
site NN I-NP
is VBZ B-VP
occupied VBN I-VP
by IN B-PP
BSAP NN B-NP
in FW B-ADVP
vivo FW I-ADVP
in IN B-PP
a DT B-NP
CD19-expressing JJ I-NP
B-cell NN I-NP
line NN I-NP
but CC B-PP
not RB B-PP
in IN I-PP
plasma NN B-NP
or CC O
HeLa NN B-NP
cells NNS B-NP
. . O

This DT B-NP
high-affinity JJ I-NP
site NN I-NP
has VBZ B-VP
been VBN I-VP
conserved VBN I-VP
in IN B-PP
the DT B-NP
promoters NNS I-NP
of IN B-PP
both CC O
human JJ O
and CC O
mouse NN B-NP
CD19 NN B-NP
genes NNS I-NP
and CC O
was VBD B-VP
furthermore RB I-VP
shown VBN I-VP
to TO I-VP
confer VB I-VP
B-cell NN B-NP
specificity NN I-NP
to TO B-PP
a DT B-NP
beta-globin NN I-NP
reporter NN I-NP
gene NN I-NP
in IN B-PP
transient JJ B-NP
transfection NN I-NP
experiments NNS I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
BSAP NN B-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
the DT B-NP
only RB I-NP
abundant JJ I-NP
DNA-binding JJ I-NP
activity NN I-NP
of IN B-PP
B-cell NN B-NP
nuclear JJ I-NP
extracts NNS I-NP
that WDT B-NP
interacts VBZ B-VP
with IN B-PP
the DT B-NP
CD19 NN I-NP
promoter NN I-NP
. . O

Together RB B-ADVP
COMMA COMMA O
this DT B-NP
evidence NN I-NP
strongly RB B-ADVP
implicates VBZ B-VP
BSAP NN B-NP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
CD19 NN I-NP
gene NN I-NP
. . O

Reduced VBN B-NP
susceptibility NN I-NP
to TO B-PP
HIV-1 NN B-NP
infection NN I-NP
of IN B-PP
ethyl-methanesulfonate-treated JJ B-NP
CEM NN I-NP
subclones NNS I-NP
correlates VBZ B-VP
with IN B-PP
a DT B-NP
blockade NN I-NP
in IN B-PP
their PRP$ B-NP
protein NN I-NP
kinase NN I-NP
C NN I-NP
signaling NN I-NP
pathway NN I-NP
. . O

We PRP B-NP
have VBP B-VP
described VBN I-VP
the DT B-NP
isolation NN I-NP
of IN B-PP
chemically RB B-NP
induced VBN I-NP
CEM NN I-NP
subclones NNS I-NP
that WDT B-NP
express VBP B-VP
CD4 NN B-NP
receptors NNS I-NP
and CC O
bind VBP B-VP
soluble JJ B-NP
gp120 NN I-NP
COMMA COMMA O
yet RB O
show VBP B-VP
a DT B-NP
markedly RB I-NP
reduced VBN I-NP
susceptibility NN I-NP
to TO B-PP
infection NN B-NP
with IN B-PP
HIV-1 NN B-NP
. . O

Two CD B-NP
subclones NNS I-NP
were VBD B-VP
found VBN I-VP
to TO I-VP
have VB I-VP
an DT B-NP
abnormal JJ I-NP
response NN I-NP
to TO B-PP
the DT O
protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( O
PKC NN B-NP
) ) O
activator NN B-NP
PMA NN I-NP
. . O

PMA NN B-NP
treatment NN I-NP
induced VBD B-VP
CD3 NN B-NP
and CC O
CD25 NN B-NP
( ( O
IL-2R NN B-NP
) ) O
receptors NNS B-NP
on IN B-PP
the DT B-NP
parental JJ I-NP
line NN I-NP
and CC O
on IN B-PP
other JJ B-NP
ethyl-methanesulfonate-derived JJ I-NP
subclones NNS I-NP
COMMA COMMA B-PP
but CC I-PP
not RB B-PP
on IN I-PP
these DT B-NP
two CD I-NP
mutants NNS I-NP
. . O

Direct JJ B-NP
assays NNS I-NP
of IN B-PP
PKC NN B-NP
activity NN I-NP
were VBD B-VP
conducted VBN I-VP
. . O

Total JJ B-NP
cellular JJ I-NP
PKC NN I-NP
enzymatic JJ I-NP
activity NN I-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
normal JJ B-ADJP
in IN B-PP
these DT B-NP
subclones NNS I-NP
. . O

PMA-induced JJ B-NP
CD4 NN I-NP
down-modulation NN I-NP
occurred VBD B-VP
normally RB B-ADVP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
activation NN B-NP
of IN B-PP
c-raf NN B-NP
kinase NN I-NP
was VBD B-VP
normal JJ B-ADJP
. . O

Since IN B-SBAR
HIV-1 NN B-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
contains VBZ B-VP
two CD O
functional JJ O
nuclear JJ B-NP
factor NN I-NP
kB NN I-NP
( ( O
NF-kB NN B-NP
) ) O
regulatory JJ B-NP
elements NNS I-NP
COMMA COMMA O
we PRP B-NP
studied VBD B-VP
the DT B-NP
ability NN I-NP
of IN B-PP
PMA NN B-NP
to TO B-VP
induce VB I-VP
NF-kB NN B-NP
binding NN I-NP
activity NN I-NP
by IN B-PP
different JJ B-NP
assays NNS I-NP
. . O

Chloramphenicol NN B-NP
acetyl NN I-NP
transferase NN I-NP
( ( O
CAT NN B-NP
) ) O
assays NNS B-NP
using VBG B-VP
the DT B-NP
HIV-1 NN I-NP
( ( I-NP
-139 CD I-NP
) ) I-NP
long JJ I-NP
terminal JJ I-NP
repeat-CAT JJ I-NP
construct NN I-NP
showed VBD B-VP
no DT B-NP
PMA NN I-NP
induction NN I-NP
of IN B-PP
CAT NN B-NP
activity NN I-NP
in IN B-PP
these DT B-NP
subclones NNS I-NP
( ( O
unlike IN B-PP
the DT B-NP
parental JJ I-NP
line NN I-NP
and CC O
other JJ B-NP
subclones NNS I-NP
) ) O
. . O

Okadaic JJ B-NP
acid NN I-NP
COMMA COMMA O
an DT B-NP
inhibitor NN I-NP
of IN B-PP
phosphatases NNS B-NP
1 CD B-NP
and CC O
2A NN B-NP
COMMA COMMA O
did VBD B-VP
not RB I-VP
overcome VB I-VP
the DT B-NP
defect NN I-NP
in IN B-PP
these DT B-NP
subclones NNS I-NP
. . O

Gel NN B-NP
retardation NN I-NP
assays NNS I-NP
COMMA COMMA O
using VBG B-VP
a DT B-NP
32P-probe NN I-NP
containing VBG B-VP
the DT B-NP
HIV-1 NN I-NP
NF-kB NN I-NP
probe NN I-NP
and CC O
nuclear JJ B-NP
extracts NNS I-NP
from IN B-PP
PMA-treated JJ B-NP
cells NNS I-NP
COMMA COMMA O
showed VBD B-VP
significantly RB B-NP
reduced VBN I-NP
induction NN I-NP
of IN B-PP
nuclear JJ B-NP
NF-kB NN I-NP
binding NN I-NP
proteins NNS I-NP
in IN B-PP
these DT B-NP
two CD I-NP
subclones NNS I-NP
compared VBN B-PP
with IN B-PP
wild JJ B-NP
type NN I-NP
CEM NN I-NP
and CC O
a DT B-NP
control NN I-NP
subclone NN I-NP
. . O

Deoxycholate JJ B-NP
treatment NN I-NP
of IN B-PP
cytoplasmic JJ B-NP
extracts NNS I-NP
from IN B-PP
these DT B-NP
subclones NNS I-NP
released VBD B-VP
much JJ B-NP
reduced VBN I-NP
NF-kB NN I-NP
binding NN I-NP
proteins NNS I-NP
from IN B-PP
their PRP$ B-NP
cytoplasmic JJ I-NP
pools NNS I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
reduced JJ B-NP
levels NNS I-NP
of IN B-PP
PKC-induced JJ B-NP
nuclear JJ I-NP
NF-kB NN I-NP
activity NN I-NP
in IN B-PP
two CD B-NP
T NN I-NP
cell NN I-NP
subclones NNS I-NP
did VBD B-VP
not RB I-VP
affect VB I-VP
their PRP$ B-NP
normal JJ I-NP
cell NN I-NP
growth NN I-NP
COMMA COMMA O
but CC O
correlated VBD B-VP
with IN B-PP
a DT B-NP
pronounced JJ I-NP
reduction NN I-NP
in IN B-PP
their PRP$ B-NP
susceptibility NN I-NP
to TO B-PP
HIV-1 NN B-NP
infection NN I-NP
. . O

Eicosanoids NNS B-NP
in IN B-PP
breast NN B-NP
cancer NN I-NP
patients NNS I-NP
before IN B-PP
and CC B-PP
after IN B-PP
mastectomy NN B-NP
. . O

In IN B-PP
19 CD B-NP
patients NNS I-NP
with IN B-PP
a DT B-NP
malignant JJ I-NP
breast NN I-NP
tumor NN I-NP
COMMA COMMA O
tumor NN B-NP
tissue NN I-NP
and CC O
blood NN B-NP
were VBD B-VP
taken VBN I-VP
to TO B-VP
determine VB I-VP
the DT B-NP
eicosanoid NN B-NP
profile NN I-NP
and CC O
platelet NN B-NP
aggregation NN I-NP
. . O

Values NNS B-NP
were VBD B-VP
compared VBN I-VP
with IN B-PP
those DT B-NP
of IN B-PP
patients NNS B-NP
with IN B-PP
benign JJ B-NP
tumors NNS I-NP
( ( O
n NN B-NP
= JJ B-VP
4 CD B-NP
) ) O
COMMA COMMA O
or CC O
undergoing VBG B-VP
a DT B-NP
mammary JJ I-NP
reduction NN I-NP
( ( O
n NN B-NP
= JJ B-VP
7 CD B-NP
) ) O
. . O

Postoperatively RB B-ADVP
COMMA COMMA O
blood NN B-NP
was VBD B-VP
taken VBN I-VP
as RB B-PP
well RB B-ADVP
in IN B-SBAR
order NN O
to TO O
compare VB B-VP
pre- JJ B-NP
and CC I-NP
postoperative JJ I-NP
values NNS I-NP
. . O

Eicosanoids NNS B-NP
were VBD B-VP
measured VBN I-VP
in IN B-PP
peripheral JJ B-NP
blood NN I-NP
monocytes NNS I-NP
and CC O
mammary JJ B-NP
tissue NN I-NP
by IN B-PP
means NNS I-PP
of IN I-PP
HPLC NN B-NP
; : O
furthermore RBR B-ADVP
COMMA COMMA O
TXA2 NN B-NP
COMMA COMMA O
6-keto-PGF1 NN B-NP
alpha NN I-NP
COMMA COMMA O
and CC O
PGE2 NN B-NP
were VBD B-VP
determined VBN I-VP
by IN B-PP
RIA NN B-NP
. . O

Differences NNS B-NP
in IN B-PP
pre- JJ B-NP
and CC I-NP
postoperative JJ I-NP
values NNS I-NP
of IN B-PP
cancer NN B-NP
patients NNS I-NP
were VBD B-VP
seen VBN I-VP
in IN B-PP
plasma NN B-NP
RIA NN I-NP
values NNS I-NP
: : O
PGE2 NN B-NP
and CC O
6-k-PGF1 NN B-NP
alpha NN I-NP
were VBD B-VP
significantly RB B-ADJP
higher JJR I-ADJP
preoperatively RB B-ADVP
when WRB B-ADVP
compared VBN B-VP
with IN B-PP
postoperatively RB B-ADVP
COMMA COMMA O
however RB O
COMMA COMMA O
such JJ B-NP
differences NNS I-NP
were VBD B-VP
seen VBN I-VP
in IN B-PP
the DT B-NP
control NN I-NP
groups NNS I-NP
as RB B-PP
well RB B-ADVP
. . O

Compared VBN B-PP
to TO B-PP
benign JJ B-NP
tumor NN I-NP
or CC O
mammary JJ B-NP
reduction NN I-NP
test NN B-NP
material NN I-NP
the DT B-NP
eicosanoid NN I-NP
profile NN I-NP
of IN B-PP
tissue NN B-NP
obtained VBN B-VP
from IN B-PP
malignant JJ B-NP
mammary JJ I-NP
tumors NNS I-NP
showed VBD B-VP
important JJ B-NP
differences NNS I-NP
. . O

Except IN B-PP
for IN I-PP
PGF2 NN B-NP
alpha NN I-NP
COMMA COMMA O
HHT NN B-NP
and CC O
15-HETE NN B-NP
no DT B-NP
detectable JJ I-NP
quantities NNS I-NP
of IN B-PP
eicosanoids NNS B-NP
were VBD B-VP
found VBN I-VP
in IN B-PP
the DT B-NP
non-tumor JJ I-NP
material NN I-NP
COMMA COMMA O
whereas IN O
in IN B-PP
the DT B-NP
malignant JJ I-NP
tumor NN I-NP
material NN I-NP
substantial JJ B-NP
quantities NNS I-NP
of IN B-PP
a DT B-NP
number NN I-NP
of IN B-PP
eicosanoid NN B-NP
metabolites NNS I-NP
were VBD B-VP
present JJ B-ADJP
. . O

Statistically RB B-NP
significant JJ I-NP
correlations NNS I-NP
could MD B-VP
be VB I-VP
established VBN I-VP
between IN B-PP
patient\/histopathology NN B-NP
data NNS I-NP
and CC O
the DT B-NP
results NNS I-NP
of IN B-PP
the DT B-NP
platelet NN I-NP
aggregation NN I-NP
assays NNS I-NP
COMMA COMMA B-PP
e.g. FW I-PP
between IN B-PP
menopausal JJ B-NP
status NN I-NP
and CC O
ADP NN B-NP
aggregation NN I-NP
; : O
oestrogen NN B-NP
receptor NN I-NP
( ( O
+\/- JJ B-NP
) ) O
and CC O
collagen NN B-NP
and CC O
arachidonic JJ B-NP
acid NN I-NP
aggregation NN I-NP
COMMA COMMA O
inflammatory JJ B-NP
cell NN I-NP
infiltration NN I-NP
score NN I-NP
and CC O
arachidonic JJ B-NP
acid NN I-NP
aggregation NN I-NP
and CC O
fibrosis NN B-NP
score NN I-NP
and CC O
ADP NN B-NP
aggregation NN I-NP
. . O

The DT B-NP
results NNS I-NP
show VBP B-VP
that IN B-SBAR
eicosanoid NN B-NP
synthesis NN I-NP
in IN B-PP
material NN B-NP
from IN B-PP
mammary JJ B-NP
cancer NN I-NP
patients NNS I-NP
is VBZ B-VP
different JJ B-ADJP
from IN B-PP
that DT B-NP
in IN B-PP
benign JJ B-NP
mammary JJ I-NP
tissue NN I-NP
. . O

The DT B-NP
implications NNS I-NP
COMMA COMMA O
in IN B-PP
particular JJ B-NP
COMMA COMMA B-PP
in IN I-PP
relation NN I-PP
to TO I-PP
future JJ B-NP
prognosis NN I-NP
of IN B-PP
the DT B-NP
patient NN I-NP
COMMA COMMA O
remain VBP B-VP
obscure JJ B-ADJP
. . O

c-myc NN B-NP
mRNA NN I-NP
expression NN I-NP
in IN B-PP
minor JJ B-NP
salivary JJ I-NP
glands NNS I-NP
of IN B-PP
patients NNS B-NP
with IN B-PP
Sjogren NN B-NP
's POS B-NP
syndrome NN I-NP
. . O

c-myc NN B-NP
protooncogene NN I-NP
is VBZ B-VP
implicated VBN I-VP
in IN B-PP
the DT B-NP
pathogenesis NN I-NP
of IN B-PP
B NN B-NP
cell NN I-NP
lymphoid JJ I-NP
malignancies NNS I-NP
and CC O
high JJ B-NP
levels NNS I-NP
of IN B-PP
c-myc NN B-NP
mRNA NN I-NP
expression NN I-NP
are VBP B-VP
observed VBN I-VP
in IN B-PP
activated VBN B-NP
blood NN I-NP
mononuclear JJ I-NP
cells NNS I-NP
. . O

Sjogren NN B-NP
's POS B-NP
syndrome NN I-NP
( ( O
SS NN B-NP
) ) O
is VBZ B-VP
characterized VBN I-VP
by IN B-PP
lymphocytic JJ B-NP
infiltrates NNS I-NP
of IN B-PP
exocrine JJ B-NP
glands NNS I-NP
COMMA COMMA O
remarkable JJ B-NP
B NN I-NP
cell NN I-NP
hyperreactivity NN I-NP
and CC O
a DT B-NP
strong JJ I-NP
predisposition NN I-NP
to TO B-PP
B NN B-NP
cell NN I-NP
neoplasia NN I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
c-myc NN B-NP
protooncogene NN I-NP
mRNA NN I-NP
expression NN I-NP
in IN B-PP
29 CD B-NP
labial JJ I-NP
minor JJ I-NP
salivary JJ I-NP
gland NN I-NP
biopsies NNS I-NP
from IN B-PP
patients NNS B-NP
with IN B-PP
primary JJ B-NP
SS NNS I-NP
and CC O
15 CD B-NP
controls NNS I-NP
was VBD B-VP
examined VBN I-VP
using VBG B-VP
in FW B-NP
situ FW I-NP
hybridization NN I-NP
histochemistry NN I-NP
. . O

Two CD B-NP
40mer JJ I-NP
oligonucleotides NNS I-NP
from IN B-PP
the DT B-NP
1st JJ I-NP
and CC O
the DT B-NP
2nd JJ I-NP
exon NN B-NP
of IN B-PP
the DT B-NP
c-myc NN I-NP
gene NN I-NP
COMMA COMMA O
labeled VBN B-VP
with IN B-PP
35S NN B-NP
COMMA COMMA O
were VBD B-VP
used VBN I-VP
as IN B-PP
probes NNS B-NP
. . O

To TO B-VP
detect VB I-VP
the DT B-NP
origin NN I-NP
of IN B-PP
the DT B-NP
cell NN I-NP
hybridized VBN B-VP
with IN B-PP
a DT B-NP
c-myc NN I-NP
probe NN I-NP
COMMA COMMA O
a DT B-NP
combined JJ I-NP
immunochemistry NN I-NP
in FW I-NP
situ FW I-NP
hybridization NN I-NP
histochemistry NN I-NP
technique NN I-NP
was VBD B-VP
used VBN I-VP
. . O

High JJ B-NP
c-myc NN I-NP
mRNA NN I-NP
expression NN I-NP
was VBD B-VP
detected VBN I-VP
on IN B-PP
acinar JJ B-NP
epithelial JJ I-NP
cells NNS I-NP
. . O

c-myc NN B-NP
did VBD B-VP
not RB I-VP
correlate VB I-VP
with IN B-PP
c-fos NN B-NP
and CC O
c-jun NN B-NP
protein NN B-NP
expression NN I-NP
. . O

Stronger JJR B-NP
c-myc NN I-NP
mRNA NN I-NP
expression NN I-NP
was VBD B-VP
detected VBN I-VP
in IN B-PP
labial JJ B-NP
salivary JJ I-NP
glands NNS I-NP
of IN B-PP
patients NNS B-NP
with IN B-PP
longer JJR B-NP
disease NN I-NP
duration NN I-NP
( ( O
p NN B-NP
less JJR B-NP
than IN I-NP
or CC I-NP
equal JJ I-NP
to TO I-NP
0.002 CD I-NP
) ) O
and CC O
more RBR B-NP
intense JJ I-NP
T NN I-NP
lymphocyte NN I-NP
infiltrates NNS I-NP
( ( O
p NN B-NP
less JJR B-NP
than IN I-NP
0.05 CD I-NP
) ) O
although IN B-SBAR
these DT B-NP
patients NNS I-NP
revealed VBD B-VP
no DT B-NP
hypergammaglobulinemia NN I-NP
. . O

No DT B-NP
correlation NN I-NP
was VBD B-VP
observed VBN I-VP
between IN B-PP
c-myc NN B-NP
mRNA NN I-NP
and CC O
B NN B-NP
lymphocyte NN I-NP
monoclonicity NN B-NP
or CC O
lymphoma NN B-NP
. . O

In IN B-PP
conclusion NN B-NP
COMMA COMMA O
strong JJ B-NP
c-myc NN I-NP
mRNA NN I-NP
expression NN I-NP
was VBD B-VP
observed VBN I-VP
on IN B-PP
epithelial JJ B-NP
cells NNS I-NP
of IN B-PP
labial JJ B-NP
salivary JJ I-NP
glands NNS I-NP
from IN B-PP
patients NNS B-NP
with IN B-PP
primary JJ B-NP
SS NN I-NP
. . O

Our PRP$ B-NP
findings NNS I-NP
may MD B-VP
indicate VB I-VP
the DT B-NP
presence NN I-NP
of IN B-PP
a DT B-NP
reactivated VBN I-NP
virus NN I-NP
hosted VBN B-VP
in IN B-PP
these DT B-NP
cells NNS I-NP
. . O

Cytoplasmic JJ B-NP
domain NN I-NP
heterogeneity NN I-NP
and CC O
functions NNS B-NP
of IN B-PP
IgG NN B-NP
Fc NN I-NP
receptors NNS I-NP
in IN B-PP
B NN B-NP
lymphocytes NNS I-NP
. . O

B NN B-NP
lymphocytes NNS I-NP
and CC O
macrophages NNS B-NP
express VBP B-VP
closely RB B-NP
related JJ I-NP
immunoglobulin NN B-NP
G NN I-NP
( ( O
IgG NN B-NP
) ) O
Fc NN B-NP
receptors NNS I-NP
( ( O
Fc NN O
gamma NN O
RII NN O
) ) O
that WDT B-NP
differ VBP B-VP
only RB B-ADVP
in IN I-ADVP
the DT B-NP
structures NNS I-NP
of IN B-PP
their PRP$ B-NP
cytoplasmic JJ I-NP
domains NNS I-NP
. . O

Because IN B-PP
of IN I-PP
cell NN B-NP
type-specific JJ I-NP
alternative JJ I-NP
messenger NN I-NP
RNA NN I-NP
splicing NN I-NP
COMMA COMMA O
B-cell NN B-NP
Fc NN I-NP
gamma NN I-NP
RII NN I-NP
contains VBZ B-VP
an DT B-NP
insertion NN I-NP
of IN B-PP
47 CD B-NP
amino NN I-NP
acids NNS I-NP
that WDT B-NP
participates VBZ B-VP
in IN B-PP
determining VBG B-VP
receptor NN B-NP
function NN I-NP
in IN B-PP
these DT B-NP
cells NNS I-NP
. . O

Transfection NN B-NP
of IN B-PP
an DT B-NP
Fc NN I-NP
gamma NN I-NP
RII-negative JJ I-NP
B-cell NN I-NP
line NN I-NP
with IN B-PP
complementary JJ B-NP
DNA NN I-NP
's POS B-NP
encoding VBG B-VP
the DT B-NP
two CD I-NP
splice NN I-NP
products NNS I-NP
and CC O
various JJ B-NP
receptor NN I-NP
mutants NNS I-NP
indicated VBD B-VP
that IN B-SBAR
the DT B-NP
insertion NN I-NP
was VBD B-VP
responsible JJ B-ADJP
for IN B-PP
preventing VBG B-VP
both CC O
Fc NN B-NP
gamma NN I-NP
RII-mediated JJ I-NP
endocytosis NN I-NP
and CC O
Fc NN B-NP
gamma NN I-NP
RII-mediated JJ I-NP
antigen NN I-NP
presentation NN I-NP
. . O

The DT B-NP
insertion NN I-NP
was VBD B-VP
not RB I-VP
required VBN I-VP
for IN B-PP
Fc NN B-NP
gamma NN I-NP
RII NN I-NP
to TO B-VP
modulate VB I-VP
surface NN B-NP
immunoglobulin-triggered JJ I-NP
B-cell NN I-NP
activation NN I-NP
. . O

Instead RB B-ADVP
COMMA COMMA O
regulation NN B-NP
of IN B-PP
activation NN B-NP
involved VBD B-VP
a DT B-NP
region NN I-NP
of IN B-PP
the DT B-NP
cytoplasmic JJ I-NP
domain NN I-NP
common JJ B-ADJP
to TO B-PP
both CC O
the DT O
lymphocyte NN B-NP
and CC O
macrophage NN B-NP
receptor NN B-NP
isoforms NNS I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
the DT B-NP
insertion NN I-NP
did VBD B-VP
contribute VB I-VP
to TO B-PP
the DT B-NP
formation NN I-NP
of IN B-PP
caps NNS B-NP
in IN B-PP
response NN I-PP
to TO I-PP
receptor NN B-NP
cross-linking NN I-NP
COMMA COMMA O
consistent JJ B-ADJP
with IN B-PP
suggestions NNS B-NP
that IN B-SBAR
the DT O
lymphocyte NN B-NP
but CC B-CONJP
not RB I-CONJP
macrophage NN B-NP
form NN B-NP
of IN B-PP
the DT B-NP
receptor NN I-NP
can MD B-VP
associate VB I-VP
with IN B-PP
the DT B-NP
detergent-insoluble JJ I-NP
cytoskeleton NN I-NP
. . O

Every DT B-NP
enhancer NN I-NP
works VBZ B-VP
with IN B-PP
every DT B-NP
promoter NN I-NP
for IN B-PP
all PDT B-NP
the DT I-NP
combinations NNS I-NP
tested VBN B-VP
: : O
could MD O
new JJ B-NP
regulatory JJ I-NP
pathways NNS I-NP
evolve VBP B-VP
by IN B-PP
enhancer NN B-NP
shuffling NN I-NP
? . O

The DT B-NP
promoters NNS B-NP
and CC O
enhancers NNS B-NP
of IN B-PP
cell NN B-NP
type-specific JJ I-NP
genes NNS I-NP
are VBP B-VP
often RB I-VP
conserved VBN I-VP
in IN B-PP
evolution NN B-NP
COMMA COMMA O
and CC O
hence RB O
one NN B-NP
might MD B-VP
expect VB I-VP
that IN B-SBAR
a DT B-NP
given JJ I-NP
enhancer NN I-NP
has VBZ B-VP
evolved VBN I-VP
to TO I-VP
work VB I-VP
best RBS B-ADVP
with IN B-PP
its PRP$ B-NP
own JJ I-NP
promoter NN I-NP
. . O

While IN B-SBAR
this DT B-NP
expectation NN I-NP
may MD B-VP
be VB I-VP
realized VBN I-VP
in IN B-PP
some DT B-NP
cases NNS I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
not RB I-VP
found VBN I-VP
evidence NN B-NP
for IN B-PP
it PRP B-NP
. . O

A DT B-NP
total NN I-NP
of IN B-PP
27 CD B-NP
combinations NNS I-NP
of IN B-PP
different JJ B-NP
promoters NNS B-NP
and CC O
enhancers NNS B-NP
were VBD B-VP
tested VBN I-VP
by IN B-PP
transfection NN B-NP
into IN B-PP
cultured VBN B-NP
cells NNS I-NP
. . O

We PRP B-NP
found VBD B-VP
that IN B-SBAR
the DT B-NP
relative JJ I-NP
efficiency NN I-NP
of IN B-PP
the DT B-NP
enhancers NNS I-NP
is VBZ B-VP
approximately RB B-ADVP
the DT B-NP
same JJ I-NP
COMMA COMMA O
irrespective JJ B-ADJP
of IN B-PP
the DT B-NP
type NN I-NP
of IN B-PP
promoter NN B-NP
used VBN B-VP
COMMA COMMA O
i.e. FW O
COMMA COMMA O
there EX B-NP
was VBD B-VP
no DT B-NP
strong JJ I-NP
preference NN I-NP
for IN B-PP
any DT B-NP
given JJ I-NP
enhancer\/promoter JJ I-NP
combination NN I-NP
. . O

Notably RB B-ADVP
COMMA COMMA O
we PRP B-NP
do VBP B-VP
not RB I-VP
see VB I-VP
particularly RB B-NP
strong JJ I-NP
transcription NN I-NP
when WRB B-ADVP
the DT B-NP
immunoglobulin NN I-NP
kappa NN I-NP
enhancer NN I-NP
( ( O
or CC O
the DT B-NP
immunoglobulin NN I-NP
heavy JJ I-NP
chain NN I-NP
enhancer NN I-NP
) ) O
is VBZ B-VP
used VBN I-VP
to TO B-VP
activate VB I-VP
a DT B-NP
kappa NN I-NP
gene NN I-NP
promoter NN I-NP
. . O

We PRP B-NP
propose VBP B-VP
that IN B-SBAR
a DT B-NP
generally RB I-NP
permissive JJ I-NP
enhancer\/promoter JJ I-NP
interaction NN I-NP
is VBZ B-VP
of IN B-PP
evolutionary JJ B-NP
benefit NN I-NP
for IN B-PP
higher JJR B-NP
eukaryotes NNS I-NP
: : O
by IN B-PP
enhancer NN B-NP
shuffling NN I-NP
COMMA COMMA O
genes NNS B-NP
could MD B-VP
be VB I-VP
easily RB I-VP
brought VBN I-VP
under IN B-PP
a DT B-NP
new JJ I-NP
type NN I-NP
of IN B-PP
inducibility\/cell NN B-NP
type NN I-NP
specificity NN I-NP
. . O

Heterodimerization NN B-NP
and CC O
transcriptional JJ B-NP
activation NN I-NP
in FW B-ADVP
vitro FW I-ADVP
by IN B-PP
NF-kappa NN B-NP
B NN I-NP
proteins NNS I-NP
. . O

The DT B-NP
NF-kappa NN I-NP
B NN I-NP
family NN I-NP
of IN B-PP
transcription NN B-NP
proteins NNS I-NP
represents VBZ B-VP
multiple JJ B-NP
DNA NN I-NP
binding NN I-NP
COMMA COMMA O
rel NN B-NP
related JJ B-NP
polypeptides NNS I-NP
that WDT B-NP
contribute VBP B-VP
to TO B-PP
regulation NN B-NP
of IN B-PP
genes NNS B-NP
involved VBN B-VP
in IN B-PP
immune JJ B-NP
responsiveness NN I-NP
and CC O
inflammation NN B-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
activation NN B-NP
of IN B-PP
the DT B-NP
HIV NN I-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
multiple JJ O
NF-kappa NN B-NP
B NN I-NP
related JJ B-NP
polypeptides NNS I-NP
ranging VBG B-VP
from IN B-PP
85 CD I-PP
to TO I-PP
45 CD O
kDa NN O
were VBD B-VP
examined VBN I-VP
for IN B-PP
their PRP$ B-NP
capacity NN I-NP
to TO B-VP
interact VB I-VP
with IN B-PP
the DT B-NP
PRDII NN I-NP
regulatory JJ I-NP
element NN I-NP
of IN B-PP
interferon NN B-NP
beta NN I-NP
and CC O
were VBD B-VP
shown VBN I-VP
to TO I-VP
possess VB I-VP
distinct JJ B-NP
intrinsic JJ I-NP
DNA NN I-NP
binding NN I-NP
affinities NNS I-NP
for IN B-PP
this DT B-NP
NF-kappa NN I-NP
B NN I-NP
site NN I-NP
and CC O
form VB B-VP
multiple JJ B-NP
DNA NN I-NP
binding NN I-NP
homo- JJ I-NP
and CC I-NP
heterodimer NN I-NP
complexes NNS I-NP
in IN B-PP
co-renaturation NN B-NP
experiments NNS I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
using VBG B-VP
DNA NN B-NP
templates NNS I-NP
containing VBG B-VP
two CD B-NP
copies NNS I-NP
of IN B-PP
the DT B-NP
PRDII NN I-NP
domain NN I-NP
linked VBN B-VP
to TO B-PP
the DT B-NP
rabbit NN I-NP
beta NN I-NP
globin NN I-NP
gene NN I-NP
COMMA COMMA O
the DT B-NP
purified VBN I-NP
polypeptides NNS I-NP
specifically RB B-ADVP
stimulated VBD B-VP
NF-kappa NN B-NP
B NN I-NP
dependent JJ B-NP
transcription NN I-NP
in IN B-PP
an DT B-NP
in FW I-NP
vitro FW I-NP
reconstitution NN I-NP
assay NN I-NP
as IN B-PP
heterodimers NNS B-NP
but CC B-PP
not RB B-PP
as IN I-PP
p50 NN B-NP
homodimers NNS I-NP
. . O

These DT B-NP
experiments NNS I-NP
emphasize VBP B-VP
the DT B-NP
role NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
dimerization NN I-NP
as IN B-PP
a DT B-NP
distinct JJ I-NP
level NN I-NP
of IN B-PP
transcriptional JJ B-NP
control NN I-NP
that WDT B-NP
may MD B-VP
permit VB I-VP
functional JJ B-NP
diversification NN I-NP
of IN B-PP
a DT B-NP
limited JJ I-NP
number NN I-NP
of IN B-PP
regulatory JJ B-NP
proteins NNS I-NP
. . O

Oct2 NN B-NP
transactivation NN I-NP
from IN B-PP
a DT B-NP
remote JJ I-NP
enhancer NN I-NP
position NN I-NP
requires VBZ B-VP
a DT B-NP
B-cell-restricted JJ I-NP
activity NN I-NP
. . O

Previous JJ B-NP
cotransfection NN I-NP
experiments NNS I-NP
had VBD B-VP
demonstrated VBN I-VP
that IN B-SBAR
ectopic JJ B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
lymphocyte-specific JJ I-NP
transcription NN I-NP
factor NN I-NP
Oct2 NN I-NP
could MD B-VP
efficiently RB I-VP
activate VB I-VP
a DT B-NP
promoter NN I-NP
containing VBG B-VP
an DT B-NP
octamer NN I-NP
motif NN I-NP
. . O

Oct2 NN B-NP
expression NN I-NP
was VBD B-VP
unable JJ B-ADJP
to TO B-VP
stimulate VB I-VP
a DT B-NP
multimerized JJ I-NP
octamer NN I-NP
enhancer NN I-NP
element NN I-NP
in IN B-PP
HeLa NN B-NP
cells NNS I-NP
COMMA COMMA O
however RB B-ADVP
. . O

We PRP B-NP
have VBP B-VP
tested VBN I-VP
a DT B-NP
variety NN I-NP
of IN B-PP
Oct2 NN B-NP
isoforms VBZ I-NP
generated VBN B-VP
by IN B-PP
alternative JJ B-NP
splicing NN I-NP
for IN B-PP
the DT B-NP
capability NN I-NP
to TO B-VP
activate VB I-VP
an DT B-NP
octamer NN I-NP
enhancer NN I-NP
in IN B-PP
nonlymphoid JJ B-NP
cells NNS I-NP
and CC O
a DT B-NP
B-cell NN I-NP
line NN I-NP
. . O

Our PRP$ B-NP
analyses NNS I-NP
show VBP B-VP
that IN B-SBAR
several JJ B-NP
Oct2 NN I-NP
isoforms NNS I-NP
can MD B-VP
stimulate VB I-VP
from IN B-PP
a DT B-NP
remote JJ I-NP
position NN I-NP
but CC O
that IN B-SBAR
this DT B-NP
stimulation NN I-NP
is VBZ B-VP
restricted JJ I-VP
to TO B-PP
B NN B-NP
cells NNS I-NP
. . O

This DT B-NP
result NN I-NP
indicates VBZ B-VP
the DT B-NP
involvement NN I-NP
of IN B-PP
either CC O
a DT B-NP
B-cell-specific JJ I-NP
cofactor NN I-NP
or CC O
a DT B-NP
specific JJ I-NP
modification NN I-NP
of IN B-PP
a DT B-NP
cofactor NN I-NP
or CC O
the DT B-NP
Oct2 NN I-NP
protein NN I-NP
in IN B-PP
Oct2-mediated JJ B-NP
enhancer NN I-NP
activation NN I-NP
. . O

Mutational JJ B-NP
analyses NNS I-NP
indicate VBP B-VP
that IN B-SBAR
the DT B-NP
carboxy-terminal JJ I-NP
domain NN I-NP
of IN B-PP
Oct2 NN B-NP
is VBZ B-VP
critical JJ B-ADJP
for IN B-PP
enhancer NN B-NP
activation NN I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
this DT B-NP
domain NN I-NP
conferred VBD B-VP
enhancing NN B-NP
activity NN I-NP
when WRB O
fused VBN B-VP
to TO B-PP
the DT B-NP
Oct1 NN I-NP
protein NN I-NP
COMMA COMMA O
which WDT B-NP
by IN B-PP
itself PRP B-NP
was VBD B-VP
unable JJ B-ADJP
to TO B-VP
stimulate VB I-VP
from IN B-PP
a DT B-NP
remote JJ I-NP
position NN I-NP
. . O

The DT B-NP
glutamine-rich JJ I-NP
activation NN I-NP
domain NN I-NP
present JJ B-ADJP
in IN B-PP
the DT B-NP
amino-terminal JJ I-NP
portion NN I-NP
of IN B-PP
Oct2 NN B-NP
and CC O
the DT B-NP
POU NN I-NP
domain NN I-NP
contribute VBP B-VP
only RB B-ADVP
marginally RB I-ADVP
to TO B-PP
the DT B-NP
transactivation NN I-NP
function NN I-NP
from IN B-PP
a DT B-NP
distal JJ I-NP
position NN I-NP
. . O

Induction NN B-NP
of IN B-PP
the DT B-NP
POU NN I-NP
domain NN I-NP
transcription NN I-NP
factor NN I-NP
Oct-2 NN I-NP
during IN B-PP
T-cell NN B-NP
activation NN I-NP
by IN B-PP
cognate JJ B-NP
antigen NN I-NP
. . O

Oct-2 NN B-NP
is VBZ B-VP
a DT B-NP
transcription NN I-NP
factor NN I-NP
that WDT B-NP
binds VBZ B-VP
specifically RB B-PP
to TO I-PP
octamer NN B-NP
DNA NN I-NP
motifs NNS I-NP
in IN B-PP
the DT B-NP
promoters NNS I-NP
of IN B-PP
immunoglobulin NN B-NP
and CC O
interleukin-2 NN B-NP
genes NNS B-NP
. . O

All DT B-NP
tumor NN I-NP
cell NN I-NP
lines NNS I-NP
from IN B-PP
the DT B-NP
B-cell NN I-NP
lineage NN I-NP
and CC O
a DT B-NP
few JJ I-NP
from IN B-PP
the DT B-NP
T-cell NN I-NP
lineage NN I-NP
express VBP B-VP
Oct-2 NN B-NP
. . O

To TO B-VP
address VB I-VP
the DT B-NP
role NN I-NP
of IN B-PP
Oct-2 NN B-NP
in IN B-PP
the DT B-NP
T-cell NN I-NP
lineage NN I-NP
COMMA COMMA O
we PRP B-NP
studied VBD B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
Oct-2 NN B-NP
mRNA NN I-NP
and CC O
protein NN B-NP
in IN B-PP
nontransformed JJ O
human JJ O
and CC O
mouse NN B-NP
T NN B-NP
cells NNS I-NP
. . O

Oct-2 NN B-NP
was VBD B-VP
found VBN I-VP
in IN B-PP
CD4+ JJ B-NP
and CC I-NP
CD8+ JJ I-NP
T NN I-NP
cells NNS I-NP
prepared VBN B-VP
from IN B-PP
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
and CC B-PP
in IN B-PP
mouse NN B-NP
lymph NN I-NP
node NN I-NP
T NN I-NP
cells NNS I-NP
. . O

In IN B-PP
a DT B-NP
T-cell NN I-NP
clone NN I-NP
specific JJ B-ADJP
for IN B-PP
pigeon NN B-NP
cytochrome NN I-NP
c NN I-NP
in IN B-PP
the DT I-PP
context NN I-PP
of IN I-PP
I-Ek NN B-NP
COMMA COMMA O
Oct-2 NN B-NP
was VBD B-VP
induced VBN I-VP
by IN B-PP
antigen NN B-NP
stimulation NN I-NP
COMMA COMMA O
with IN B-SBAR
the DT B-NP
increase NN I-NP
in IN B-PP
Oct-2 NN B-NP
protein NN I-NP
seen VBN B-VP
first RB B-ADVP
at IN B-PP
3 CD B-NP
h NN I-NP
after IN B-PP
activation NN B-NP
and CC O
continuing VBG B-VP
for IN B-PP
at IN B-NP
least JJS I-NP
24 CD I-NP
h NN I-NP
. . O

Oct-2 NN B-NP
mRNA NN I-NP
induction NN I-NP
during IN B-PP
antigen-driven JJ B-NP
T-cell NN I-NP
activation NN I-NP
was VBD B-VP
blocked VBN I-VP
by IN B-PP
cyclosporin NN B-NP
A NN I-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
by IN B-PP
protein NN B-NP
synthesis NN I-NP
inhibitors NNS I-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
Oct-2 NN B-NP
participates VBZ B-VP
in IN B-PP
transcriptional JJ B-NP
regulation NN I-NP
during IN B-PP
T-cell NN B-NP
activation NN I-NP
. . O
The DT B-NP
relatively RB I-NP
delayed VBN I-NP
kinetics NNS I-NP
of IN B-PP
Oct-2 NN B-NP
induction NN I-NP
suggests VBZ B-VP
that IN B-SBAR
Oct-2 NN B-NP
mediates VBZ B-VP
the DT B-NP
changes NNS I-NP
in IN B-PP
gene NN B-NP
expression NN I-NP
which WDT B-NP
occur VBP B-VP
many JJ B-NP
hours NNS B-NP
or CC O
days NNS B-NP
following VBG B-PP
antigen NN B-NP
stimulation NN I-NP
of IN B-PP
T NN B-NP
lymphocytes NNS I-NP
. . O

{ ( O
Changes NNS B-NP
in IN B-PP
plasma NN B-NP
interleukin-1 NN I-NP
and CC O
their PRP$ B-NP
possible JJ I-NP
relationship NN I-NP
with IN B-PP
the DT B-NP
changes NNS I-NP
in IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
in IN B-PP
aged JJ B-NP
long-distance JJ I-NP
runner NN I-NP
} ) O

For IN B-PP
the DT B-NP
study NN I-NP
of IN B-PP
the DT B-NP
changes NNS I-NP
in IN B-PP
plasma NN B-NP
interleukin-1 NN B-NP
( ( O
IL-1 NN B-NP
) ) O
and CC O
their PRP$ B-NP
possible JJ I-NP
relationship NN I-NP
with IN B-PP
the DT B-NP
changes NNS I-NP
in IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
( ( O
GR NN B-NP
) ) O
COMMA COMMA O
plasma NN B-NP
IL-1 NN I-NP
and CC O
GR NN B-NP
in IN B-PP
peripheral JJ B-NP
blood NN I-NP
leukocytes NNS I-NP
in IN B-PP
aged JJ B-NP
long-distance JJ I-NP
runner NN I-NP
were VBD B-VP
measured VBN I-VP
simultaneously RB B-ADVP
. . O

The DT B-NP
activity NN I-NP
of IN B-PP
IL-1 NN B-NP
was VBD B-VP
expressed VBN I-VP
as IN B-PP
its PRP$ B-NP
ability NN I-NP
to TO B-VP
stimulate VB I-VP
3H-TdR NN B-NP
incorporation NN I-NP
in IN B-PP
the DT B-NP
thymocytes NNS I-NP
of IN B-PP
C57 NN B-NP
mice NNS I-NP
. . O

GR NN B-NP
was VBD B-VP
determined VBN I-VP
by IN B-PP
whole JJ B-NP
cell NN I-NP
assay NN I-NP
with IN B-PP
3H-Dex NN B-NP
. . O

The DT B-NP
results NNS I-NP
showed VBD B-VP
that IN B-SBAR
the DT B-NP
activity NN I-NP
of IN B-PP
plasma NN B-NP
IL-1 NN I-NP
in IN B-PP
aged JJ B-NP
long-distance JJ I-NP
runner NN I-NP
was VBD B-VP
209 CD B-NP
% NN I-NP
COMMA COMMA O
223 CD B-NP
% NN I-NP
and CC O
145 CD B-NP
% NN I-NP
of IN B-PP
the DT B-NP
control NN I-NP
at IN B-PP
14.7-18.7 CD B-NP
COMMA COMMA I-NP
3.8-7.0 CD I-NP
and CC I-NP
1.5-2.6 CD I-NP
KD NN I-NP
fractions NNS B-NP
. . O

The DT B-NP
GR NN I-NP
in IN B-PP
peripheral JJ B-NP
blood NN I-NP
leukocytes NNS I-NP
in IN B-PP
aged JJ B-NP
runner NN I-NP
was VBD B-VP
65 CD B-NP
% NN I-NP
of IN B-PP
the DT B-NP
control NN I-NP
. . O

Possible JJ B-NP
relationship NN I-NP
between IN B-PP
the DT B-NP
changes NNS I-NP
in IN B-PP
IL-1 NN B-NP
and CC O
GR NN B-NP
in IN B-PP
aged JJ B-NP
long-distance JJ I-NP
runner NN I-NP
and CC O
its PRP$ B-NP
physiological JJ I-NP
significance NN I-NP
are VBP B-VP
discussed VBN I-VP
. . O

Transcription NN B-NP
factor NN I-NP
AP-2 NN I-NP
activates VBZ B-VP
gene NN B-NP
expression NN I-NP
of IN B-PP
HTLV-I NN B-NP
. . O

The DT B-NP
HTLV-I NN I-NP
LTR NN I-NP
contains VBZ B-VP
three CD B-NP
conserved VBN I-NP
regulatory JJ I-NP
elements NNS I-NP
known VBN B-VP
as IN B-PP
21 CD B-NP
base NN I-NP
pair NN I-NP
repeats NNS I-NP
which WDT B-NP
are VBP B-VP
required VBN I-VP
for IN B-PP
stimulation NN B-NP
of IN B-PP
gene NN B-NP
expression NN I-NP
by IN B-PP
the DT B-NP
transactivator NN I-NP
protein NN I-NP
tax NN I-NP
. . O

Mutagenesis NN B-NP
indicates VBZ B-VP
that IN B-SBAR
the DT B-NP
21 CD I-NP
bp NN I-NP
repeats NNS I-NP
can MD B-VP
be VB I-VP
subdivided VBN I-VP
into IN B-PP
three CD B-NP
motifs NNS I-NP
COMMA COMMA O
A NN B-NP
COMMA COMMA O
B NN B-NP
and CC O
C NN B-NP
COMMA COMMA O
each DT B-NP
of IN B-PP
which WDT B-NP
influences VBZ B-VP
the DT B-NP
level NN I-NP
of IN B-PP
tax NN B-NP
activation NN I-NP
. . O

The DT B-NP
A NN I-NP
site NN I-NP
in IN B-PP
the DT B-NP
21 CD I-NP
bp NN I-NP
repeat NN I-NP
has VBZ B-VP
strong JJ B-NP
homology NN I-NP
with IN B-PP
previously RB B-NP
described VBN I-NP
binding VBG I-NP
sites NNS I-NP
for IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
AP-2 NN I-NP
. . O

We PRP B-NP
demonstrated VBD B-VP
that IN B-SBAR
AP-2 NN B-NP
mRNA NN I-NP
was VBD B-VP
present JJ B-ADJP
in IN B-PP
T-lymphocytes NNS B-NP
and CC O
that IN B-SBAR
cellular JJ B-NP
factors NNS I-NP
from IN B-PP
both CC B-NP
non-transformed JJ I-NP
and CC I-NP
transformed VBN I-NP
T-lymphocytes NNS I-NP
specifically RB B-ADVP
bound VBD B-VP
to TO B-PP
the DT B-NP
consensus NN I-NP
motif NN I-NP
for IN B-PP
AP-2 NN B-NP
in IN B-PP
each DT B-NP
21 CD I-NP
bp NN I-NP
. . O

To TO B-VP
determine VB I-VP
the DT B-NP
role NN I-NP
of IN B-PP
AP-2 NN B-NP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
HTLV-I NN I-NP
LTR NN I-NP
gene NN I-NP
expression NN I-NP
COMMA COMMA O
we PRP B-NP
used VBD B-VP
an DT B-NP
AP-2 NN I-NP
cDNA NN I-NP
in IN B-PP
DNA NN B-NP
binding NN I-NP
and CC O
transient JJ B-NP
expression NN I-NP
assays NNS B-NP
. . O

Gel NN B-NP
retardation NN I-NP
and CC O
methylation NN B-NP
interference NN I-NP
studies NNS B-NP
revealed VBD B-VP
that IN B-SBAR
bacterially RB B-NP
produced VBN I-NP
AP-2 NN I-NP
bound VBD B-VP
specifically RB B-ADVP
and CC O
with IN B-PP
high JJ B-NP
affinity NN I-NP
to TO B-PP
all DT B-NP
three CD I-NP
21 CD I-NP
bp NN I-NP
repeats NNS I-NP
COMMA COMMA O
and CC O
that IN B-SBAR
it PRP B-NP
required VBD B-VP
the DT B-NP
core NN I-NP
sequence NN I-NP
AGGC NN I-NP
for IN B-PP
specific JJ B-NP
binding NN I-NP
. . O

Binding NN B-NP
of IN B-PP
AP-2 NN B-NP
prevented VBD B-VP
the DT B-NP
subsequent JJ I-NP
binding NN I-NP
of IN B-PP
members NNS B-NP
of IN B-PP
the DT B-NP
CREB\/ATF NN I-NP
family NN I-NP
to TO B-PP
an DT B-NP
adjacent JJ I-NP
regulatory JJ I-NP
motif NN I-NP
in IN B-PP
the DT B-NP
21 CD I-NP
bp NN I-NP
repeat NN I-NP
. . O

Transfection NN B-NP
of IN B-PP
an DT B-NP
AP-2 NN I-NP
expression NN I-NP
construct NN I-NP
into IN B-PP
T-lymphocytes NNS B-NP
activated VBD B-VP
gene NN B-NP
expression NN I-NP
from IN B-PP
the DT B-NP
HTLV-I NN I-NP
LTR NN I-NP
. . O

At IN B-NP
least JJS I-NP
two CD I-NP
21 CD I-NP
bp NN I-NP
repeats NNS I-NP
were VBD B-VP
required VBN I-VP
for IN B-PP
high JJ B-NP
levels NNS I-NP
of IN B-PP
AP-2 NN B-NP
activation NN I-NP
and CC O
mutagenesis NN B-NP
of IN B-PP
the DT B-NP
AP-2 NN I-NP
consensus NN I-NP
binding NN I-NP
sequences NNS I-NP
in IN B-PP
the DT B-NP
21 CD I-NP
bp NN I-NP
repeats NNS I-NP
eliminate VBP B-VP
this DT B-NP
activation NN I-NP
. . O

( ( O
ABSTRACT NN B-NP
TRUNCATED VBN B-VP
AT IN B-PP
250 CD B-NP
WORDS NNS I-NP
) ) O

Cell NN B-NP
cycle-dependent JJ I-NP
initiation NN I-NP
and CC O
lineage-dependent JJ B-NP
abrogation NN I-NP
of IN B-PP
GATA-1 NN B-NP
expression NN I-NP
in IN B-PP
pure JJ B-NP
differentiating VBG I-NP
hematopoietic JJ I-NP
progenitors NNS I-NP
. . O

The DT B-NP
programmed VBN I-NP
activation\/repression NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
in IN B-PP
early JJ B-NP
hematopoietic JJ I-NP
differentiation NN I-NP
has VBZ B-VP
not RB I-VP
yet RB I-VP
been VBN I-VP
explored VBN I-VP
. . O

The DT B-NP
DNA-binding JJ I-NP
protein NN I-NP
GATA-1 NN I-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
normal JJ B-NP
erythroid JJ I-NP
development NN I-NP
and CC O
regulates VBZ B-VP
erythroid-expressed JJ B-NP
genes NNS I-NP
in IN B-PP
maturing VBG B-NP
erythroblasts NNS I-NP
. . O

We PRP B-NP
analyzed VBD B-VP
GATA-1 NN B-NP
expression NN I-NP
in IN B-PP
early JJ B-NP
human JJ I-NP
adult JJ I-NP
hematopoiesis NN I-NP
by IN B-PP
using VBG B-VP
an DT B-NP
in FW I-NP
vitro FW I-NP
system NN I-NP
in IN B-PP
which WDT B-NP
" `` B-NP
pure JJ I-NP
" '' I-NP
early JJ I-NP
hematopoietic JJ I-NP
progenitors NNS I-NP
are VBP B-VP
induced VBN I-VP
to TO B-PP
gradual JJ B-NP
and CC I-NP
synchronized VBD I-NP
differentiation NN I-NP
selectively RB B-ADVP
along IN B-PP
the DT B-NP
erythroid JJ I-NP
or CC I-NP
granulocyte-macrophage JJ I-NP
pathway NN I-NP
by IN B-PP
differential JJ B-NP
treatment NN I-NP
with IN B-PP
hematopoietic JJ B-NP
growth NN I-NP
factors NNS I-NP
. . O

The DT B-NP
GATA-1 NN I-NP
gene NN I-NP
COMMA COMMA O
though IN B-SBAR
virtually RB B-ADJP
silent JJ I-ADJP
in IN B-PP
quiescent JJ B-NP
progenitors NNS I-NP
COMMA COMMA O
is VBZ B-VP
activated VBN I-VP
after IN B-PP
entrance NN B-NP
into IN B-PP
the DT B-NP
cell NN I-NP
cycle NN I-NP
upon IN B-PP
stimulation NN B-NP
with IN B-PP
hematopoietic JJ B-NP
growth NN I-NP
factors NNS I-NP
. . O

Subsequently RB B-ADVP
COMMA COMMA O
increasing VBG B-NP
expression NN I-NP
along IN B-PP
the DT B-NP
erythroid JJ I-NP
pathway NN I-NP
contrasts VBZ B-VP
with IN B-PP
an DT B-NP
abrupt JJ I-NP
downregulation NN I-NP
in IN B-PP
the DT B-NP
granulocyte-macrophage JJ I-NP
lineage NN I-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
a DT B-NP
microenvironment-directed JJ I-NP
COMMA COMMA I-NP
two-step JJ I-NP
model NN I-NP
for IN B-PP
GATA-1 NN B-NP
expression NN I-NP
in IN B-PP
differentiating VBG B-NP
hematopoietic JJ I-NP
progenitors NNS I-NP
that WDT B-NP
involves VBZ B-VP
( ( B-LST
i LS I-LST
) ) O
cycle-dependent JJ B-NP
initiation NN I-NP
and CC O
( ( B-LST
ii LS I-LST
) ) O
lineage-dependent JJ B-NP
maintenance NN B-NP
or CC O
suppression NN B-NP
. . O

Hypothetically RB B-ADVP
COMMA COMMA O
on\/off JJ B-NP
switches NNS I-NP
of IN B-PP
lineage-restricted JJ B-NP
transactivators NNS I-NP
may MD B-VP
underlie VB I-VP
the DT B-NP
binary JJ I-NP
fate NN I-NP
decisions NNS I-NP
of IN B-PP
hematopoietic JJ B-NP
progenitors NNS I-NP
. . O

{ ( O
Age-related JJ B-NP
changes NNS I-NP
in IN B-PP
glucocorticoid NN B-NP
and CC O
mineralocorticoid NN B-NP
receptors NNS B-NP
in IN B-PP
lymphocytes NNS B-NP
of IN B-PP
healthy JJ B-NP
persons NNS I-NP
and CC O
patients NNS B-NP
with IN B-PP
hypertension NN B-NP
} ) O

It PRP B-NP
has VBZ B-VP
been VBN I-VP
found VBN I-VP
that IN B-SBAR
the DT B-NP
number NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
in IN B-PP
lymphocytes NNS B-NP
of IN B-PP
the DT B-NP
peripheral JJ I-NP
blood NN I-NP
of IN B-PP
healthy JJ B-NP
elderly JJ I-NP
subjects NNS I-NP
increases VBZ B-VP
COMMA COMMA O
while IN B-SBAR
the DT B-NP
number NN I-NP
of IN B-PP
mineralocorticoid NN B-NP
receptors NNS I-NP
decreases VBZ B-VP
. . O

The DT B-NP
mechanisms NNS I-NP
of IN B-PP
hormone-receptor NN B-NP
interactions NNS I-NP
in IN B-PP
hypertension NN B-NP
are VBP B-VP
activated VBN I-VP
: : O
the DT B-NP
number NN I-NP
of IN B-PP
glucocorticoid NN B-NP
and CC O
mineralocorticoid NN B-NP
binding NN B-NP
sites NNS I-NP
grows VBZ B-VP
in IN B-PP
hypertensive JJ B-NP
patients NNS I-NP
. . O

Still RB B-ADVP
a DT B-NP
more RBR I-NP
essential JJ I-NP
rise NN I-NP
in IN B-PP
the DT B-NP
number NN I-NP
of IN B-PP
receptors NNS B-NP
is VBZ B-VP
observed VBN I-VP
in IN B-PP
mid-age JJ B-NP
hypertensive NN I-NP
patients NNS I-NP
than IN B-PP
in IN B-PP
elderly JJ B-NP
ones NNS I-NP
. . O

In FW B-NP
vivo FW I-NP
footprint NN I-NP
analysis NN I-NP
of IN B-PP
the DT B-NP
HLA-DRA NN I-NP
gene NN I-NP
promoter NN I-NP
: : O
cell-specific JJ B-NP
interaction NN I-NP
at IN B-PP
the DT B-NP
octamer NN I-NP
site NN I-NP
and CC O
up-regulation NN B-NP
of IN B-PP
X NN B-NP
box NN I-NP
binding NN I-NP
by IN B-PP
interferon NN B-NP
gamma NN I-NP
. . O

Analysis NN B-NP
of IN B-PP
the DT B-NP
major JJ I-NP
histocompatibility NN I-NP
complex NN I-NP
class NN I-NP
II CD I-NP
gene NN I-NP
promoter NN I-NP
DRA NN I-NP
has VBZ B-VP
previously RB I-VP
identified VBN I-VP
at IN B-NP
least JJS I-NP
five CD I-NP
cis-acting JJ I-NP
regions NNS I-NP
required VBN B-VP
for IN B-PP
maximal JJ B-NP
expression NN I-NP
. . O

We PRP B-NP
have VBP B-VP
examined VBN I-VP
the DT B-NP
DRA NN I-NP
promoter NN I-NP
for IN B-PP
protein-DNA JJ B-NP
interactions NNS I-NP
in IN B-PP
the DT B-NP
intact JJ I-NP
cell NN I-NP
COMMA COMMA O
which WDT B-NP
may MD B-VP
mediate VB I-VP
transcriptional JJ B-NP
activation NN I-NP
. . O

Using VBG B-VP
in FW B-NP
vivo FW I-NP
genomic JJ I-NP
footprinting NN I-NP
we PRP B-NP
identified VBD B-VP
interactions NNS B-NP
in IN B-PP
B-cell NN B-NP
lines NNS I-NP
at IN B-PP
the DT B-NP
octamer NN I-NP
site NN I-NP
and CC O
the DT O
Y NN B-NP
COMMA COMMA O
X1 NN B-NP
COMMA COMMA O
and CC O
X2 NN B-NP
boxes NNS B-NP
. . O

Class NN B-NP
II CD I-NP
antigen NN I-NP
expressing VBG I-NP
T-cell NN I-NP
lines NNS I-NP
maintained VBD B-VP
contacts NNS B-NP
identical JJ B-ADJP
to TO B-PP
B-cell NN B-NP
lines NNS I-NP
COMMA COMMA O
while IN B-SBAR
class NN B-NP
II-negative JJ I-NP
T-cell NN I-NP
lines NNS I-NP
exhibited VBD B-VP
no DT B-NP
interactions NNS I-NP
. . O

In IN B-PP
lymphoid JJ B-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
the DT B-NP
octamer NN I-NP
site NN I-NP
is VBZ B-VP
occupied VBN I-VP
and CC O
required VBN B-VP
for IN B-PP
maximal JJ B-NP
expression NN I-NP
. . O

This DT B-NP
is VBZ B-VP
most RBS B-ADVP
likely RB I-ADVP
due JJ B-PP
to TO I-PP
the DT B-NP
presence NN I-NP
of IN B-PP
the DT B-NP
lymphoid-specific JJ I-NP
OTF-2 NN I-NP
factor NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
the DT B-NP
class NN I-NP
II-positive JJ I-NP
nonlymphoid JJ I-NP
glioblastoma NN I-NP
cell NN I-NP
line NN I-NP
does VBZ B-VP
not RB I-VP
exhibit VB I-VP
interactions NNS B-NP
at IN B-PP
the DT B-NP
octamer NN I-NP
site NN I-NP
despite IN B-PP
the DT B-NP
presence NN I-NP
of IN B-PP
the DT B-NP
ubiquitous JJ I-NP
OTF-1 NN I-NP
factor NN I-NP
and CC O
an DT B-NP
open JJ I-NP
binding VBG I-NP
site NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
the DT B-NP
DRA NN I-NP
promoter NN I-NP
discriminates VBZ B-VP
against IN B-PP
OTF-1 NN B-NP
activation NN I-NP
at IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
DNA NN B-NP
binding NN I-NP
in IN B-PP
the DT B-NP
glioblastoma NN I-NP
line NN I-NP
. . O

Interferon NN B-NP
gamma NN I-NP
induces VBZ B-VP
class NN B-NP
II CD I-NP
expression NN I-NP
in IN B-PP
this DT B-NP
glioblastoma NN I-NP
cell NN I-NP
line NN I-NP
and CC O
COMMA COMMA O
in IN B-PP
parallel NN B-NP
COMMA COMMA B-VP
up-regulates VBZ I-VP
X1 NN B-NP
and CC O
X2 NN B-NP
box NN B-NP
protein-DNA JJ I-NP
interactions NNS I-NP
COMMA COMMA O
while IN B-SBAR
all DT B-NP
other JJ I-NP
interactions NNS I-NP
remain VBP B-VP
unchanged JJ B-ADJP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
interferon NN B-NP
gamma NN I-NP
functions VBZ B-VP
on IN B-PP
a DT B-NP
poised VBN I-NP
promoter NN I-NP
by IN B-PP
altering VBG B-VP
weak JJ B-NP
COMMA COMMA I-NP
nonproductive JJ I-NP
interactions NNS I-NP
at IN B-PP
the DT B-NP
X NN I-NP
boxes NNS I-NP
to TO B-PP
strong JJ B-NP
interactions NNS I-NP
. . O

These DT B-NP
findings NNS I-NP
provide VBP B-VP
direct JJ B-NP
in FW I-NP
vivo FW I-NP
evidence NN I-NP
to TO B-VP
strongly RB I-VP
suggest VB I-VP
that IN B-SBAR
the DT B-NP
modulation NN I-NP
of IN B-PP
X1 NN B-NP
and CC O
X2 NN B-NP
interactions NNS B-NP
is VBZ B-VP
an DT B-NP
important JJ I-NP
constituent NN I-NP
of IN B-PP
the DT B-NP
interferon NN I-NP
gamma NN I-NP
induction NN I-NP
pathway NN I-NP
. . O

Simple JJ B-NP
derivation NN I-NP
of IN B-PP
TFIID-dependent JJ B-NP
RNA NN I-NP
polymerase NN I-NP
II CD I-NP
transcription NN I-NP
systems NNS I-NP
from IN B-PP
Schizosaccharomyces FW B-NP
pombe FW I-NP
and CC O
other JJ B-NP
organisms NNS I-NP
COMMA COMMA O
and CC O
factors NNS B-NP
required VBN B-VP
for IN B-PP
transcriptional JJ B-NP
activation NN I-NP
. . O

Resolution NN B-NP
of IN B-PP
whole JJ B-NP
cell NN I-NP
extract NN I-NP
through IN B-PP
two CD B-NP
chromatographic JJ I-NP
steps NNS I-NP
yields VBZ B-VP
a DT B-NP
single JJ I-NP
protein NN I-NP
fraction NN I-NP
requiring VBG B-VP
only RB B-NP
the DT I-NP
addition NN I-NP
of IN B-PP
TFIID NN B-NP
for IN B-PP
the DT B-NP
initiation NN I-NP
of IN B-PP
transcription NN B-NP
at IN B-PP
RNA NN B-NP
polymerase NN I-NP
II CD I-NP
promoters NNS I-NP
. . O

This DT B-NP
approach NN I-NP
allows VBZ B-VP
the DT B-NP
convenient JJ I-NP
generation NN I-NP
of IN B-PP
RNA NN B-NP
polymerase NN I-NP
II CD I-NP
transcription NN I-NP
systems NNS I-NP
from IN B-PP
Saccharomyces FW B-NP
cerevisiae FW I-NP
COMMA COMMA O
human JJ B-NP
lymphocytes NNS I-NP
COMMA COMMA O
and CC O
Schizosaccharomyces FW B-NP
pombe FW I-NP
. . O

TFIIDs NNS B-NP
from IN B-PP
all DT B-NP
three CD I-NP
organisms NNS I-NP
are VBP B-VP
interchangeable JJ B-ADJP
among IN B-PP
all DT B-NP
three CD I-NP
systems NNS I-NP
. . O

The DT O
S. FW B-NP
cerevisiae FW I-NP
and CC O
Sch. FW B-NP
pombe FW I-NP
systems NNS B-NP
support VBP B-VP
effects NNS B-NP
of IN B-PP
acidic JJ B-NP
activator NN I-NP
proteins NNS I-NP
COMMA COMMA O
provided VBN B-PP
a DT B-NP
further JJ I-NP
protein NN I-NP
fraction NN I-NP
from IN B-PP
S. FW B-NP
cerevisiae FW I-NP
is VBZ B-VP
supplied VBN I-VP
. . O

This DT B-NP
further JJ I-NP
fraction NN I-NP
is VBZ B-VP
distinct JJ B-ADJP
from IN B-PP
the DT B-NP
mediator NN I-NP
of IN B-PP
transcriptional JJ B-NP
activation NN I-NP
described VBN B-VP
previously RB B-ADVP
and CC O
represents VBZ B-VP
a DT B-NP
second JJ I-NP
component NN I-NP
in IN B-PP
addition NN I-PP
to TO I-PP
general JJ B-NP
initiation NN I-NP
factors NNS I-NP
that WDT B-NP
may MD B-VP
facilitate VB I-VP
a DT B-NP
response NN I-NP
to TO B-PP
acidic JJ B-NP
activators NNS I-NP
. . O

NF-kappa NN B-NP
B-dependent JJ I-NP
induction NN I-NP
of IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
p50 NN I-NP
subunit NN I-NP
gene NN I-NP
promoter NN I-NP
underlies VBZ B-VP
self-perpetuation NN B-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
transcription NN I-NP
in IN B-PP
monocytic JJ B-NP
cells NNS I-NP
. . O

The DT B-NP
molecular JJ I-NP
mechanisms NNS I-NP
underlying VBG B-VP
the DT B-NP
sustained JJ I-NP
nuclear JJ I-NP
translocation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
observed VBN B-VP
in IN B-PP
U937 NN B-NP
monocytic JJ I-NP
cells NNS I-NP
chronically RB B-VP
infected VBN I-VP
with IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV NN B-NP
) ) O
were VBD B-VP
studied VBN I-VP
. . O

The DT B-NP
activity NN I-NP
of IN B-PP
the DT B-NP
promoter NN I-NP
regulating VBG B-VP
the DT B-NP
synthesis NN I-NP
of IN B-PP
the DT B-NP
p105 NN I-NP
precursor NN I-NP
of IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
p50 NN I-NP
subunit NN I-NP
was VBD B-VP
enhanced VBN I-VP
in IN B-PP
these DT B-NP
cells NNS I-NP
. . O

Deletions NNS B-NP
in IN B-PP
this DT B-NP
promoter NN I-NP
indicated VBD B-VP
that IN B-SBAR
this DT B-NP
upregulation NN I-NP
was VBD B-VP
mediated VBN I-VP
through IN B-PP
the DT B-NP
NF-kappa NN B-NP
B- NN I-NP
but CC B-CONJP
not RB I-CONJP
the DT B-NP
AP-1-binding JJ I-NP
motif NN B-NP
COMMA COMMA O
by IN B-PP
bona FW B-NP
fide FW I-NP
p50\/p65 NN I-NP
heterodimers NNS I-NP
. . O

Analysis NN B-NP
of IN B-PP
cytosolic JJ B-NP
extracts NNS I-NP
indicated VBD B-VP
that IN B-SBAR
NF-kappa NN B-NP
B NN I-NP
levels NNS I-NP
were VBD B-VP
increased VBN I-VP
in IN B-PP
HIV-infected JJ B-NP
cells NNS I-NP
. . O

In IN B-PP
contrast NN I-PP
to TO I-PP
the DT B-NP
transient JJ I-NP
NF-kappa NN I-NP
B NN I-NP
activation NN I-NP
induced VBN B-VP
by IN B-PP
phorbol NN B-NP
ester NN I-NP
COMMA COMMA O
the DT B-NP
permanent JJ I-NP
NF-kappa NN I-NP
B NN I-NP
translocation NN I-NP
induced VBN B-VP
by IN B-PP
HIV NN B-NP
infection NN I-NP
was VBD B-VP
not RB O
dependent JJ B-ADJP
on IN B-PP
PKC NN B-NP
isoenzymes NNS I-NP
alpha NN B-NP
and CC O
beta NN B-NP
as IN B-SBAR
shown VBN B-VP
by IN B-PP
the DT B-NP
use NN I-NP
of IN B-PP
a DT B-NP
specific JJ I-NP
inhibitor NN I-NP
( ( O
GF NN B-NP
109203X NN I-NP
) ) O
. . O

These DT B-NP
observations NNS I-NP
indicate VBP B-VP
that IN B-SBAR
during IN B-PP
chronic JJ B-NP
HIV NN I-NP
infection NN I-NP
of IN B-PP
U937 NN B-NP
cells NNS I-NP
COMMA COMMA O
continuous JJ O
NF-kappa NN O
B NN O
( ( O
p50\/p65 NN B-NP
) ) O
translocation NN B-NP
results VBZ B-VP
in IN B-PP
p105 NN B-NP
promoter NN I-NP
upregulation NN I-NP
with IN B-PP
subsequent JJ B-NP
cytosolic JJ I-NP
NF-kappa NN I-NP
B NN I-NP
accumulation NN I-NP
COMMA COMMA O
ready JJ B-ADJP
for IN B-PP
further JJ B-NP
translocation NN I-NP
. . O

This DT B-NP
HIV-mediated JJ I-NP
mechanism NN I-NP
results VBZ B-VP
in IN B-PP
a DT B-NP
self-perpetuating JJ I-NP
loop NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
production NN I-NP
. . O

The DT B-NP
development NN I-NP
of IN B-PP
functionally RB B-NP
responsive JJ I-NP
T NN I-NP
cells NNS I-NP
. . O

The DT B-NP
work NN I-NP
reviewed VBN B-VP
in IN B-PP
this DT B-NP
article NN I-NP
separates VBZ B-VP
T NN B-NP
cell NN I-NP
development NN I-NP
into IN B-PP
four CD B-NP
phases NNS I-NP
. . O

First JJ B-ADJP
is VBZ B-VP
an DT B-NP
expansion NN I-NP
phase NN I-NP
prior RB B-PP
to TO I-PP
TCR NN B-NP
rearrangement NN I-NP
COMMA COMMA O
which WDT B-NP
appears VBZ B-VP
to TO I-VP
be VB I-VP
correlated VBN I-VP
with IN B-PP
programming NN B-NP
of IN B-PP
at IN B-NP
least JJS I-NP
some DT I-NP
response NN I-NP
genes NNS I-NP
for IN B-PP
inducibility NN B-NP
. . O

This DT B-NP
phase NN I-NP
can MD B-VP
occur VB I-VP
to TO B-PP
some DT B-NP
extent NN I-NP
outside IN B-ADVP
of IN B-PP
the DT B-NP
thymus NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
profound JJ I-NP
T NN I-NP
cell NN I-NP
deficit NN I-NP
of IN B-PP
nude JJ B-NP
mice NNS I-NP
indicates VBZ B-VP
that IN B-SBAR
the DT B-NP
thymus NN I-NP
is VBZ B-VP
by IN B-PP
far RB B-ADVP
the DT B-NP
most RBS I-NP
potent JJ I-NP
site NN I-NP
for IN B-PP
inducing VBG B-VP
the DT B-NP
expansion NN I-NP
per FW B-ADVP
se FW I-ADVP
COMMA COMMA O
even RB B-SBAR
if IN I-SBAR
other JJ B-NP
sites NNS I-NP
can MD B-VP
induce VB I-VP
some DT B-NP
response NN I-NP
acquisition NN I-NP
. . O

Second JJ B-ADJP
is VBZ B-VP
a DT B-NP
controlled JJ I-NP
phase NN I-NP
of IN B-PP
TCR NN B-NP
gene NN I-NP
rearrangement NN I-NP
. . O

The DT B-NP
details NNS I-NP
of IN B-PP
the DT B-NP
regulatory JJ I-NP
mechanism NN I-NP
that WDT B-NP
selects VBZ B-VP
particular JJ B-NP
loci NNS I-NP
for IN B-PP
rearrangement NN B-NP
are VBP B-VP
still RB I-VP
not RB I-VP
known VBN I-VP
. . O

It PRP B-NP
seems VBZ B-VP
that IN B-SBAR
the DT B-NP
rearrangement NN I-NP
of IN B-PP
the DT B-NP
TCR NN I-NP
gamma NN I-NP
loci NNS I-NP
in IN B-PP
the DT B-NP
gamma NN I-NP
delta NN I-NP
lineage NN I-NP
may MD B-VP
not RB I-VP
always RB I-VP
take VB I-VP
place NN B-NP
at IN B-PP
a DT B-NP
developmental JJ I-NP
stage NN I-NP
strictly RB B-ADJP
equivalent JJ I-ADJP
to TO B-PP
the DT B-NP
rearrangement NN I-NP
of IN B-PP
TCR NN B-NP
beta NN I-NP
in IN B-PP
the DT B-NP
alpha NN I-NP
beta NN I-NP
lineage NN I-NP
COMMA COMMA O
and CC O
it PRP B-NP
is VBZ B-VP
not RB O
clear JJ B-ADJP
just RB B-ADVP
how WRB I-ADVP
early RB I-ADVP
the DT B-NP
two CD I-NP
lineages NNS I-NP
diverge VBP B-VP
. . O

In IN B-PP
the DT B-NP
TCR NN I-NP
alpha NN I-NP
beta NN I-NP
lineage NN I-NP
COMMA COMMA O
however RB B-ADVP
COMMA COMMA O
the DT B-NP
final JJ I-NP
gene NN I-NP
rearrangement NN I-NP
events NNS I-NP
are VBP B-VP
accompanied VBN I-VP
by IN B-PP
rapid JJ B-NP
proliferation NN I-NP
and CC O
an DT B-NP
interruption NN I-NP
in IN B-PP
cellular JJ B-NP
response NN I-NP
gene NN I-NP
inducibility NN I-NP
. . O

The DT B-NP
loss NN I-NP
of IN B-PP
conventional JJ B-NP
responsiveness NN I-NP
is VBZ B-VP
probably RB I-VP
caused VBN I-VP
by IN B-PP
alterations NNS B-NP
at IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
signaling NN B-NP
COMMA COMMA O
and CC O
may MD B-VP
be VB I-VP
a DT B-NP
manifestation NN I-NP
of IN B-PP
the DT B-NP
physiological JJ I-NP
state NN I-NP
that WDT B-NP
is VBZ B-VP
a DT B-NP
precondition NN I-NP
for IN B-PP
selection NN B-NP
. . O

Third JJ B-ADJP
is VBZ B-VP
the DT B-NP
complex JJ I-NP
process NN I-NP
of IN B-PP
selection NN B-NP
. . O

Whereas IN B-SBAR
peripheral JJ B-NP
T NN I-NP
cells NNS I-NP
can MD B-VP
undergo VB I-VP
forms NNS B-NP
of IN B-PP
positive JJ B-NP
selection NN I-NP
( ( O
by IN B-PP
antigen-driven JJ B-NP
clonal JJ I-NP
expansion NN I-NP
) ) O
and CC O
negative JJ B-NP
selection NN I-NP
( ( O
by IN B-PP
abortive JJ B-NP
stimulation NN I-NP
leading VBG B-VP
to TO B-PP
anergy NN B-NP
or CC O
death NN B-NP
) ) O
COMMA COMMA O
neither DT B-NP
is VBZ B-VP
exactly RB B-NP
the DT I-NP
same JJ I-NP
phenomenon NN I-NP
that WDT B-NP
occurs VBZ B-VP
in IN B-PP
the DT B-NP
thymic JJ I-NP
cortex NN I-NP
. . O

Negative JJ B-NP
selection NN I-NP
in IN B-PP
the DT B-NP
cortex NN I-NP
appears VBZ B-VP
to TO I-VP
be VB I-VP
a DT B-NP
suicidal JJ I-NP
inversion NN I-NP
of IN B-PP
antigen NN B-NP
responsiveness NN I-NP
: : O
instead RB B-PP
of IN I-PP
turning VBG B-VP
on IN B-PRT
IL-2 NN B-NP
expression NN I-NP
COMMA COMMA O
the DT B-NP
activated VBN I-NP
cell NN I-NP
destroys VBZ B-VP
its PRP$ B-NP
own JJ I-NP
chromatin NN I-NP
. . O

The DT B-NP
genes NNS I-NP
that WDT B-NP
need VBP B-VP
to TO I-VP
be VB I-VP
induced VBN I-VP
for IN B-PP
this DT B-NP
response NN I-NP
are VBP B-VP
not RB I-VP
yet RB I-VP
identified VBN I-VP
COMMA COMMA O
but CC O
it PRP B-NP
is VBZ B-VP
unquestionably RB B-ADVP
a DT B-NP
form NN I-NP
of IN B-PP
activation NN B-NP
. . O

It PRP B-NP
is VBZ B-VP
interesting JJ B-ADJP
that IN B-SBAR
in IN B-PP
humans NNS B-NP
and CC O
rats NNS B-NP
COMMA COMMA O
cortical JJ B-NP
thymocytes NNS I-NP
undergoing VBG B-VP
negative JJ B-NP
selection NN I-NP
can MD B-VP
still RB I-VP
induce VB I-VP
IL-2R NN B-NP
alpha NN I-NP
expression NN I-NP
and CC O
even RB B-VP
be VB I-VP
rescued VBN I-VP
in FW B-ADVP
vitro FW I-ADVP
COMMA COMMA O
if IN B-SBAR
exogenous JJ B-NP
IL-2 NN I-NP
is VBZ B-VP
provided VBN I-VP
. . O

Perhaps RB B-ADVP
murine JJ B-NP
thymocytes NNS I-NP
are VBP B-VP
denied VBN I-VP
this DT B-NP
form NN I-NP
of IN B-PP
rescue NN B-NP
because IN B-SBAR
they PRP B-NP
shut VBD B-VP
off RP B-PRT
IL-2R NN B-NP
beta NN I-NP
chain NN I-NP
expression NN I-NP
at IN B-PP
an DT B-NP
earlier JJR I-NP
stage NN I-NP
or CC O
because IN B-SBAR
they PRP B-NP
may MD B-VP
be VB I-VP
uncommonly RB O
Bcl-2 NN B-NP
deficient JJ B-ADJP
( ( O
cf. VBP B-VP
Sentman NNP B-NP
et FW I-NP
al. FW I-NP
COMMA COMMA I-NP
1991 CD I-NP
; : O
Strasser NNP B-NP
et FW I-NP
al. FW I-NP
COMMA COMMA I-NP
1991 CD I-NP
) ) O
. . O

Even RB B-ADVP
so RB I-ADVP
COMMA COMMA O
medullary JJ B-NP
thymocytes NNS I-NP
remain VBP B-VP
at IN B-ADJP
least JJS I-ADJP
partially RB I-ADJP
susceptible JJ I-ADJP
to TO B-PP
negative JJ B-NP
selection NN I-NP
even RB B-SBAR
as IN I-SBAR
they PRP B-NP
continue VBP B-VP
to TO I-VP
mature VB I-VP
. . O

SRC-related JJ B-NP
proto-oncogenes NNS I-NP
and CC O
transcription NN B-NP
factors NNS I-NP
in IN B-PP
primary JJ B-NP
human JJ I-NP
T NN I-NP
cells NNS I-NP
: : O
modulation NN B-NP
by IN B-PP
cyclosporin NN B-NP
A NN I-NP
and CC O
FK506 NN B-NP
. . O

Activation NN B-NP
of IN B-PP
T NN B-NP
lymphocytes NNS I-NP
induces VBZ B-VP
transcription NN B-NP
of IN B-PP
genes NNS B-NP
encoding VBG B-VP
for IN B-PP
lymphokines NNS B-NP
. . O

Interleukin-2 NN B-NP
( ( O
IL-2 NN B-NP
) ) O
gene NN B-NP
expression NN I-NP
is VBZ B-VP
controlled VBN I-VP
transcriptionally RB B-ADVP
by IN B-PP
the DT B-NP
cooperative JJ I-NP
activity NN I-NP
of IN B-PP
specific JJ B-NP
trans-activating JJ I-NP
factors NNS I-NP
that WDT B-NP
bind VBP B-VP
to TO B-PP
the DT B-NP
IL-2 NN I-NP
enhancer NN I-NP
. . O

Cyclosporin NN B-NP
A NN I-NP
( ( O
CsA NN B-NP
) ) O
and CC O
FK506 NN B-NP
inhibit VBP B-VP
the DT B-NP
production NN I-NP
of IN B-PP
IL-2 NN B-NP
in IN B-PP
T NN B-NP
lymphocytes NNS I-NP
at IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
gene NN B-NP
transcription NN I-NP
. . O

A DT B-NP
member NN I-NP
of IN B-PP
the DT B-NP
src NN I-NP
gene NN I-NP
family NN I-NP
COMMA COMMA O
the DT B-NP
lymphocyte-specific JJ I-NP
protein NN I-NP
tyrosine NN I-NP
kinase NN I-NP
COMMA COMMA O
p56lck NN B-NP
COMMA COMMA O
has VBZ B-VP
been VBN I-VP
implicated VBN I-VP
in IN B-PP
IL-2 NN B-NP
production NN I-NP
. . O

CsA NN B-NP
was VBD B-VP
found VBN I-VP
not RB I-VP
to TO I-VP
inhibit VB I-VP
lck NN B-NP
gene NN I-NP
expression NN I-NP
COMMA COMMA O
nor CC O
the DT B-NP
activity NN I-NP
of IN B-PP
the DT B-NP
lck NN I-NP
gene NN I-NP
product NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
CsA NN B-NP
and CC O
FK506 NN B-NP
inhibit VBP B-VP
the DT B-NP
appearance NN I-NP
of IN B-PP
DNA NN B-NP
binding NN I-NP
activity NN I-NP
of IN B-PP
factors NNS B-NP
that WDT B-NP
bind VBP B-VP
to TO B-PP
the DT O
NF-AT NN B-NP
and CC O
AP-1 NN B-NP
sites NNS B-NP
in IN B-PP
the DT B-NP
IL-2 NN I-NP
enhancer NN I-NP
. . O

Since IN B-SBAR
the DT B-NP
induction NN I-NP
of IN B-PP
NF-AT NN B-NP
and CC O
AP-1 NN B-NP
is VBZ B-VP
induced VBN I-VP
by IN B-PP
the DT B-NP
same JJ I-NP
stimuli NNS I-NP
that WDT B-NP
stimulate VBP B-VP
IL-2 NN B-NP
production NN I-NP
COMMA COMMA O
these DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
the DT B-NP
immunosuppressant JJ I-NP
action NN I-NP
of IN B-PP
CsA NN B-NP
and CC O
FK506 NN B-NP
is VBZ B-VP
exerted VBN I-VP
at IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
these DT B-NP
trans-activating JJ I-NP
factors NNS I-NP
. . O

TAR-independent JJ B-NP
transactivation NN I-NP
by IN B-PP
Tat NN B-NP
in IN B-PP
cells NNS B-NP
derived VBN B-VP
from IN B-PP
the DT B-NP
CNS NN I-NP
: : O
a DT B-NP
novel JJ I-NP
mechanism NN I-NP
of IN B-PP
HIV-1 NN B-NP
gene NN I-NP
regulation NN I-NP
. . O

The DT B-NP
Tat NN I-NP
protein NN I-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HIV-1 NN B-NP
) ) O
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
productive JJ B-NP
infection NN I-NP
and CC O
is VBZ B-VP
a DT B-NP
potential JJ I-NP
target NN I-NP
for IN B-PP
antiviral JJ B-NP
therapy NN I-NP
. . O

Tat NN B-NP
COMMA COMMA O
a DT B-NP
potent JJ I-NP
activator NN I-NP
of IN B-PP
HIV-1 NN B-NP
gene NN I-NP
expression NN I-NP
COMMA COMMA O
serves VBZ B-VP
to TO I-VP
greatly RB I-VP
increase VB I-VP
the DT B-NP
rate NN I-NP
of IN B-PP
transcription NN B-NP
directed VBN B-VP
by IN B-PP
the DT B-NP
viral JJ I-NP
promoter NN I-NP
. . O

This DT B-NP
induction NN I-NP
COMMA COMMA O
which WDT B-NP
seems VBZ B-VP
to TO I-VP
be VB I-VP
an DT B-NP
important JJ I-NP
component NN I-NP
in IN B-PP
the DT B-NP
progression NN I-NP
of IN B-PP
acquired VBN B-NP
immune JJ I-NP
deficiency NN I-NP
syndrome NN I-NP
( ( O
AIDS NN B-NP
) ) O
COMMA COMMA O
may MD B-VP
be VB I-VP
due JJ B-PP
to TO I-PP
increased VBN B-NP
transcriptional JJ I-NP
initiation NN I-NP
COMMA COMMA O
increased VBN B-NP
transcriptional JJ I-NP
elongation NN I-NP
COMMA COMMA O
or CC O
a DT B-NP
combination NN I-NP
of IN B-PP
these DT B-NP
processes NNS I-NP
. . O

Much JJ B-NP
attention NN I-NP
has VBZ B-VP
been VBN I-VP
focused VBN I-VP
on IN B-PP
the DT B-NP
interaction NN I-NP
of IN B-PP
Tat NN B-NP
with IN B-PP
a DT B-NP
specific JJ I-NP
RNA NN I-NP
target NN I-NP
termed VBN B-VP
TAR NN B-NP
( ( O
transactivation NN B-NP
responsive NN I-NP
) ) O
which WDT B-NP
is VBZ B-VP
present JJ B-ADJP
in IN B-PP
the DT B-NP
leader NN I-NP
sequence NN I-NP
of IN B-PP
all DT B-NP
HIV-1 NN I-NP
mRNAs NNS I-NP
. . O

This DT B-NP
interaction NN I-NP
is VBZ B-VP
believed VBN I-VP
to TO I-VP
be VB I-VP
an DT B-NP
important JJ I-NP
component NN I-NP
of IN B-PP
the DT B-NP
mechanism NN I-NP
of IN B-PP
transactivation NN B-NP
. . O

In IN B-PP
this DT B-NP
report NN I-NP
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
in IN B-PP
certain JJ B-NP
CNS-derived JJ I-NP
cells NNS I-NP
Tat NN B-NP
is VBZ B-VP
capable JJ B-ADJP
of IN B-PP
activating VBG B-VP
HIV-1 NN B-NP
through IN B-PP
a DT B-NP
TAR-independent JJ I-NP
pathway NN I-NP
. . O

A DT B-NP
Tat-responsive JJ I-NP
element NN I-NP
is VBZ B-VP
found VBN I-VP
upstream RB B-ADVP
within IN B-PP
the DT B-NP
viral JJ I-NP
promoter NN I-NP
that WDT B-NP
in IN B-PP
glial-derived JJ B-NP
cell NN I-NP
lines NNS I-NP
allows VBZ B-VP
transactivation NN B-NP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
TAR NN B-NP
. . O

Deletion NN B-NP
mapping NN I-NP
and CC O
hybrid NN B-NP
promoter NN I-NP
constructs NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
the DT B-NP
newly RB I-NP
identified VBN I-NP
Tat-responsive JJ I-NP
element NN I-NP
corresponds VBZ B-VP
to TO B-PP
a DT B-NP
sequence NN I-NP
within IN B-PP
the DT B-NP
viral JJ I-NP
long JJ B-NP
terminal JJ I-NP
repeat NN I-NP
( ( O
LTR NN B-NP
) ) O
previously RB B-VP
identified VBN I-VP
as IN B-PP
the DT B-NP
HIV-1 NN I-NP
enhancer NN I-NP
COMMA COMMA O
or CC O
NF-kappa NN B-NP
B NN I-NP
domain NN I-NP
. . O

DNA NN B-NP
band-shift JJ I-NP
analysis NN I-NP
reveals VBZ B-VP
NF-kappa NN B-NP
B NN I-NP
binding NN I-NP
activity NN I-NP
in IN B-PP
glial JJ B-NP
cells NNS I-NP
that WDT B-NP
differs VBZ B-VP
from IN B-PP
that DT B-NP
present JJ B-ADJP
in IN B-PP
T NN B-NP
lymphoid JJ I-NP
cells NNS I-NP
. . O

Further RB B-ADVP
COMMA COMMA O
we PRP B-NP
observe VBP B-VP
that IN B-SBAR
TAR-deleted JJ B-NP
mutants NNS I-NP
of IN B-PP
HIV-1 NN B-NP
demonstrate VBP B-VP
normal JJ B-NP
late JJ I-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
glial JJ B-NP
cells NNS I-NP
as IN B-SBAR
evidenced VBN B-VP
by IN B-PP
syncytia NN B-NP
formation NN B-NP
and CC O
production NN B-NP
of IN B-PP
viral JJ B-NP
p24 NN I-NP
antigen NN I-NP
. . O

( ( O
ABSTRACT NN B-NP
TRUNCATED VBN B-VP
AT IN B-PP
250 CD B-NP
WORDS NNS I-NP
) ) O

Bcl-2 NN B-NP
: : O
a DT B-NP
repressor NN I-NP
of IN B-PP
lymphocyte NN B-NP
death NN I-NP
. . O

The DT B-NP
genes NNS B-NP
and CC O
mechanisms NNS B-NP
that WDT B-NP
control VBP B-VP
programmed VBN B-NP
cell NN I-NP
death NN I-NP
are VBP B-VP
currently RB B-ADVP
the DT B-NP
subject NN I-NP
of IN B-PP
intense JJ B-NP
study NN I-NP
. . O

The DT B-NP
bcl-2 NN I-NP
gene NN I-NP
COMMA COMMA O
a DT B-NP
repressor NN I-NP
of IN B-PP
lymphocyte NN B-NP
death NN I-NP
COMMA COMMA O
is VBZ B-VP
perhaps RB B-ADVP
the DT B-NP
best JJS I-NP
understood VBN I-NP
of IN B-PP
the DT O
programmed VBN B-NP
cell NN I-NP
death NN I-NP
associated JJ B-NP
genes NNS I-NP
. . O

Here RB B-ADVP
COMMA COMMA O
Stanley NNP B-NP
Korsmeyer NNP I-NP
provides VBZ B-VP
a DT B-NP
brief JJ I-NP
overview NN I-NP
of IN B-PP
bcl-2 NN B-NP
COMMA COMMA O
concentrating VBG B-VP
on IN B-PP
its PRP$ B-NP
roles NNS I-NP
in IN B-PP
B- NN B-NP
and CC O
T-cell NN B-NP
development NN B-NP
and CC B-PP
in IN B-PP
oncogenesis NN B-NP
. . O

Mitogen NN B-NP
stimulation NN I-NP
of IN B-PP
T-cells NNS B-NP
increases VBZ B-VP
c-Fos NN B-NP
and CC O
c-Jun NN B-NP
protein NN B-NP
levels NNS I-NP
COMMA COMMA O
AP-1 NN B-NP
binding NN I-NP
and CC O
AP-1 NN B-NP
transcriptional JJ I-NP
activity NN I-NP
. . O

We PRP B-NP
have VBP B-VP
analysed VBN I-VP
the DT B-NP
effect NN I-NP
of IN B-PP
mitogenic JJ B-NP
lectins NNS I-NP
on IN B-PP
c-Fos NN B-NP
and CC O
c-Jun NN B-NP
protein NN B-NP
levels NNS I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
on IN B-PP
activator NN B-NP
protein-1 NN I-NP
( ( O
AP-1 NN B-NP
) ) O
binding NN B-NP
and CC O
enhancer NN B-NP
activity NN I-NP
in IN B-PP
Jurkat NN B-NP
T-cells NNS I-NP
. . O

Both CC O
c-Fos NN B-NP
and CC O
c-Jun NN B-NP
protein NN B-NP
levels NNS I-NP
were VBD B-VP
increased VBN I-VP
after IN B-PP
Con NN B-NP
A NN I-NP
and CC O
PHA NN B-NP
stimulation NN B-NP
. . O

Since IN B-SBAR
T-cell NN B-NP
stimulation NN I-NP
increases VBZ B-VP
both CC O
intracellular JJ O
Ca2+ NN B-NP
and CC O
cAMP NN B-NP
levels NNS B-NP
and CC O
activates VBZ B-VP
protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( O
PKC NN B-NP
) ) O
COMMA COMMA O
the DT B-NP
possible JJ I-NP
involvement NN I-NP
of IN B-PP
these DT B-NP
intracellular JJ I-NP
messengers NNS I-NP
in IN B-PP
c-Fos NN B-NP
and CC O
c-Jun NN B-NP
induction NN B-NP
was VBD B-VP
tested VBN I-VP
. . O

PMA NN B-NP
COMMA COMMA O
which WDT B-NP
directly RB B-ADVP
activates VBZ B-VP
PKC NN B-NP
COMMA COMMA O
mimicked VBD B-VP
the DT B-NP
effect NN I-NP
of IN B-PP
the DT B-NP
lectins NNS I-NP
on IN B-PP
c-Fos NN B-NP
and CC O
c-Jun NN B-NP
COMMA COMMA O
but CC O
elevation NN B-NP
of IN B-PP
either CC O
intracellular JJ O
Ca2+ NN B-NP
or CC O
cAMP NN B-NP
levels NNS B-NP
had VBD B-VP
little JJ B-NP
or CC I-NP
no DT I-NP
effect NN I-NP
. . O

The DT B-NP
mitogen-induced JJ I-NP
increase NN I-NP
of IN B-PP
c-Fos NN B-NP
and CC O
c-Jun NN B-NP
immunoreactivity NN B-NP
was VBD B-VP
inhibited VBN I-VP
by IN B-PP
H-7 NN B-NP
COMMA COMMA O
a DT B-NP
kinase NN I-NP
inhibitor NN I-NP
with IN B-PP
relatively RB B-NP
high JJ I-NP
specificity NN I-NP
for IN B-PP
PKC NN B-NP
COMMA COMMA O
and CC O
less RBR B-ADVP
efficiently RB I-ADVP
by IN B-PP
H-8 NN B-NP
COMMA COMMA O
a DT B-NP
structurally RB I-NP
related JJ I-NP
kinase NN I-NP
inhibitor NN I-NP
less RBR B-ADJP
active JJ I-ADJP
on IN B-PP
PKC NN B-NP
COMMA COMMA O
but CC O
more RBR B-ADJP
active JJ I-ADJP
on IN B-PP
cyclic JJ B-NP
nucleotide-dependent JJ I-NP
kinases NNS I-NP
. . O

Con NN B-NP
A NN I-NP
stimulation NN I-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
increase VB I-VP
both CC O
binding NN B-NP
of IN B-PP
AP-1 NN B-NP
to TO B-PP
the DT B-NP
AP-1 NN I-NP
consensus NN I-NP
sequence NN I-NP
COMMA COMMA O
TRE NN B-NP
COMMA COMMA O
and CC O
AP-1 NN B-NP
enhancer NN I-NP
activity NN I-NP
COMMA COMMA O
in IN B-PP
Jurkat NN B-NP
cells NNS I-NP
. . O

PMA NN B-NP
was VBD B-VP
also RB I-VP
found VBN I-VP
to TO I-VP
increase VB I-VP
the DT B-NP
AP-1 NN I-NP
enhancer NN I-NP
activity NN I-NP
COMMA COMMA O
whereas IN O
elevation NN B-NP
of IN B-PP
Ca2+ NN B-NP
or CC O
cAMP NN B-NP
had VBD B-VP
only RB B-NP
minor JJ I-NP
effects NNS I-NP
. . O

We PRP B-NP
conclude VBP B-VP
that IN B-SBAR
stimulation NN B-NP
with IN B-PP
mitogenic JJ B-NP
lectins NNS I-NP
is VBZ B-VP
sufficient JJ B-ADJP
to TO B-VP
increase VB I-VP
both CC O
c-Fos NN B-NP
and CC O
c-Jun NN B-NP
protein NN B-NP
levels NNS I-NP
COMMA COMMA O
AP-1 NN B-NP
binding NN I-NP
and CC O
AP-1 NN B-NP
enhancer NN I-NP
activity NN I-NP
in IN B-PP
Jurkat NN B-NP
cells NNS I-NP
and CC O
that IN B-SBAR
they PRP B-NP
act VBP B-VP
via IN B-PP
mechanisms NNS B-NP
that WDT B-NP
could MD B-VP
involve VB I-VP
the DT B-NP
activation NN I-NP
of IN B-PP
PKC NN B-NP
. . O

Functional JJ B-NP
interaction NN I-NP
between IN B-PP
the DT B-NP
two CD I-NP
zinc NN I-NP
finger NN I-NP
domains NNS I-NP
of IN B-PP
the DT B-NP
v-erb NN I-NP
A NN I-NP
oncoprotein NN I-NP
. . O

The DT B-NP
v-erb NN I-NP
A NN I-NP
oncogene NN I-NP
of IN B-PP
avian JJ B-NP
erythroblastosis NN I-NP
virus NN I-NP
is VBZ B-VP
a DT B-NP
mutated VBN I-NP
and CC I-NP
virally RB I-NP
transduced VBN I-NP
copy NN I-NP
of IN B-PP
a DT B-NP
host NN I-NP
cell NN I-NP
gene NN I-NP
encoding VBG B-VP
a DT B-NP
thyroid NN I-NP
hormone NN I-NP
receptor NN I-NP
. . O

The DT B-NP
protein NN I-NP
expressed VBN B-VP
by IN B-PP
the DT B-NP
v-erb NN I-NP
A NN I-NP
oncogene NN I-NP
binds VBZ B-VP
to TO B-PP
DNA NN B-NP
and CC O
acts VBZ B-VP
as IN B-PP
a DT B-NP
dominant JJ I-NP
negative JJ I-NP
inhibitor NN I-NP
of IN B-PP
both CC O
the DT B-NP
thyroid NN I-NP
hormone NN I-NP
receptor NN I-NP
and CC O
the DT B-NP
closely RB I-NP
related JJ I-NP
retinoic JJ I-NP
acid NN I-NP
receptor NN I-NP
. . O

The DT B-NP
v-erb NN I-NP
A NN I-NP
protein NN I-NP
has VBZ B-VP
sustained VBN I-VP
two CD B-NP
amino NN I-NP
acid NN I-NP
alterations NNS I-NP
within IN B-PP
its PRP$ B-NP
DNA-binding JJ I-NP
domain NN I-NP
relative JJ B-PP
to TO I-PP
that DT B-NP
of IN B-PP
c-erb NN B-NP
A NN I-NP
COMMA COMMA O
one CD B-NP
of IN B-PP
which WDT B-NP
COMMA COMMA O
at IN B-PP
serine NN B-NP
61 CD I-NP
COMMA COMMA O
is VBZ B-VP
known VBN I-VP
to TO I-VP
be VB I-VP
important JJ B-ADJP
for IN B-PP
v-erb NN B-NP
A NN I-NP
function NN I-NP
in IN B-PP
the DT B-NP
neoplastic JJ I-NP
cell NN I-NP
. . O

We PRP B-NP
report VBP B-VP
here RB B-ADVP
that IN B-SBAR
the DT B-NP
second JJ I-NP
alteration NN I-NP
COMMA COMMA O
at IN B-PP
threonine NN B-NP
78 CD I-NP
COMMA COMMA O
also RB B-ADVP
plays VBZ B-VP
an DT B-NP
important JJ I-NP
COMMA COMMA I-NP
although IN I-NP
more RBR I-NP
indirect JJ I-NP
COMMA COMMA I-NP
role NN I-NP
: : O
alteration NN B-NP
of IN B-PP
the DT B-NP
sequence NN I-NP
at IN B-PP
threonine NN B-NP
78 CD I-NP
such JJ B-SBAR
that IN I-SBAR
it PRP B-NP
resembles VBZ B-VP
that DT B-NP
of IN B-PP
c-erb NN B-NP
A NN I-NP
can MD B-VP
act VB I-VP
as IN B-PP
an DT B-NP
intragenic JJ I-NP
suppressor NN I-NP
and CC O
can MD B-VP
partially RB I-VP
restore VB I-VP
function NN B-NP
to TO B-PP
a DT B-NP
v-erb NN I-NP
A NN I-NP
protein NN I-NP
rendered VBN B-VP
defective JJ B-ADJP
due JJ B-PP
to TO I-PP
a DT B-NP
mutation NN I-NP
at IN B-PP
position NN B-NP
61 CD I-NP
. . O

Threonine NN B-NP
78 CD I-NP
lies VBZ B-VP
within IN B-PP
the DT B-NP
D-box NN I-NP
of IN B-PP
the DT B-NP
v-erb NN I-NP
A NN I-NP
protein NN I-NP
COMMA COMMA O
a DT B-NP
region NN I-NP
thought VBN B-VP
to TO I-VP
mediate VB I-VP
receptor-receptor JJ B-NP
dimerizations NNS I-NP
COMMA COMMA O
and CC O
is VBZ B-VP
not RB O
in IN B-PP
physical JJ B-NP
proximity NN I-NP
to TO B-PP
the DT B-NP
serine NN I-NP
at IN B-PP
position NN B-NP
61 CD I-NP
. . O

It PRP B-NP
therefore RB B-ADVP
appears VBZ B-VP
that IN B-SBAR
an DT B-NP
indirect JJ I-NP
interaction NN I-NP
occurs VBZ B-VP
between IN B-PP
these DT B-NP
two CD I-NP
sites NNS I-NP
and CC O
that IN B-SBAR
this DT B-NP
interaction NN I-NP
is VBZ B-VP
crucial JJ B-ADJP
for IN B-PP
v-erb NN B-NP
A NN I-NP
function NN I-NP
. . O

Pax-5 NN B-NP
encodes VBZ B-VP
the DT B-NP
transcription NN I-NP
factor NN I-NP
BSAP NN I-NP
and CC O
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
B NN B-NP
lymphocytes NNS I-NP
COMMA COMMA O
the DT B-NP
developing VBG I-NP
CNS NNS I-NP
COMMA COMMA O
and CC O
adult JJ B-NP
testis NN I-NP
. . O

BSAP NN B-NP
has VBZ B-VP
been VBN I-VP
identified VBN I-VP
previously RB B-ADVP
as IN B-PP
a DT B-NP
transcription NN I-NP
factor NN I-NP
that WDT B-NP
is VBZ B-VP
expressed VBN I-VP
at IN B-PP
early JJ B-NP
COMMA COMMA I-NP
but CC I-NP
not RB I-NP
late JJ I-NP
COMMA COMMA I-NP
stages NNS I-NP
of IN B-PP
B-cell NN B-NP
differentiation NN I-NP
. . O

Biochemical JJ B-NP
purification NN I-NP
and CC O
cDNA NN B-NP
cloning NN I-NP
has VBZ B-VP
now RB I-VP
revealed VBN I-VP
that IN B-SBAR
BSAP NN B-NP
belongs VBZ B-VP
to TO B-PP
the DT B-NP
family NN I-NP
of IN B-PP
paired JJ B-NP
domain NN I-NP
proteins NNS I-NP
. . O

BSAP NN B-NP
is VBZ B-VP
encoded VBN I-VP
by IN B-PP
the DT B-NP
Pax-5 NN I-NP
gene NN I-NP
and CC O
has VBZ B-VP
been VBN I-VP
highly RB I-VP
conserved VBN I-VP
between IN B-PP
human JJ B-NP
and CC O
mouse NN B-NP
. . O

An DT B-NP
intact JJ I-NP
paired JJ I-NP
domain NN I-NP
was VBD B-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
both CC O
necessary JJ B-ADJP
and CC O
sufficient JJ B-ADJP
for IN B-PP
DNA NN B-NP
binding NN I-NP
of IN B-PP
BSAP NN B-NP
. . O

Binding VBG B-NP
studies NNS I-NP
with IN B-PP
several JJ B-NP
BSAP NN I-NP
recognition NN I-NP
sequences NNS I-NP
demonstrated VBD B-VP
that IN B-SBAR
the DT B-NP
sequence NN I-NP
specificity NN I-NP
of IN B-PP
BSAP NN B-NP
differs VBZ B-VP
from IN B-PP
that DT B-NP
of IN B-PP
the DT B-NP
distantly RB I-NP
related JJ I-NP
paired JJ I-NP
domain NN I-NP
protein NN I-NP
Pax-1 NN I-NP
. . O

During IN B-PP
embryogenesis NN B-NP
COMMA COMMA O
the DT B-NP
BSAP NN I-NP
gene NN I-NP
is VBZ B-VP
transiently RB I-VP
expressed VBN I-VP
in IN B-PP
the DT B-NP
mesencephalon NN B-NP
and CC O
spinal JJ B-NP
cord NN I-NP
with IN B-PP
a DT B-NP
spatial JJ I-NP
and CC I-NP
temporal JJ I-NP
expression NN I-NP
pattern NN I-NP
that WDT B-NP
is VBZ B-VP
distinct JJ B-ADJP
from IN B-PP
that DT B-NP
of IN B-PP
other JJ B-NP
Pax NN I-NP
genes NNS I-NP
in IN B-PP
the DT B-NP
developing VBG I-NP
central JJ B-NP
nervous JJ I-NP
system NN I-NP
( ( O
CNS NN B-NP
) ) O
. . O

Later RB B-ADVP
COMMA COMMA O
the DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
BSAP NN I-NP
gene NN I-NP
shifts VBZ B-VP
to TO B-PP
the DT B-NP
fetal JJ I-NP
liver NN I-NP
where WRB B-ADVP
it PRP B-NP
correlates VBZ B-VP
with IN B-PP
the DT B-NP
onset NN I-NP
of IN B-PP
B NN B-NP
lymphopoiesis NN I-NP
. . O

BSAP NN B-NP
expression NN I-NP
persists VBZ B-VP
in IN B-PP
B NN B-NP
lymphocytes NNS I-NP
and CC O
is VBZ B-VP
also RB I-VP
seen VBN I-VP
in IN B-PP
the DT B-NP
testis NN I-NP
of IN B-PP
the DT B-NP
adult JJ I-NP
mouse NN I-NP
. . O

All DT B-NP
of IN B-PP
this DT B-NP
evidence NN I-NP
indicates VBZ B-VP
that IN B-SBAR
the DT B-NP
transcription NN I-NP
factor NN I-NP
BSAP NN I-NP
may MD B-VP
not RB B-CONJP
only RB I-CONJP
play VB B-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
B-cell NN B-NP
differentiation NN I-NP
but CC B-CONJP
also RB I-CONJP
in IN B-PP
neural JJ B-NP
development NN I-NP
and CC O
spermatogenesis NN B-NP
. . O

Okadaic JJ B-NP
acid NN I-NP
is VBZ B-VP
a DT B-NP
potent JJ I-NP
inducer NN I-NP
of IN B-PP
AP-1 NN B-NP
COMMA COMMA O
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
and CC O
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
in IN B-PP
human JJ B-NP
B NN I-NP
lymphocytes NNS I-NP
. . O

Treatment NN B-NP
of IN B-PP
human JJ B-NP
B NN I-NP
lymphocytes NNS I-NP
with IN B-PP
an DT B-NP
optimal JJ I-NP
concentration NN I-NP
of IN B-PP
okadaic JJ B-NP
acid NN I-NP
COMMA COMMA O
an DT B-NP
inhibitor NN I-NP
of IN B-PP
phosphatases NNS B-NP
1 CD B-NP
and CC O
2A NN B-NP
COMMA COMMA O
resulted VBD B-VP
in IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
AP-1 NN B-NP
and CC O
a DT B-NP
marked JJ I-NP
increase NN I-NP
in IN B-PP
NF-kappa NN B-NP
B NN I-NP
levels NNS I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
no DT B-NP
effect NN I-NP
on IN B-PP
the DT B-NP
levels NNS I-NP
of IN B-PP
the DT B-NP
octamer NN I-NP
binding NN I-NP
proteins NNS I-NP
COMMA COMMA O
Oct-1 NN B-NP
or CC O
Oct-2 NN B-NP
COMMA COMMA O
were VBD B-VP
found VBN I-VP
. . O

Since IN B-SBAR
both CC O
AP-1 NN B-NP
and CC O
NF-kappa NN B-NP
B NN I-NP
have VBP B-VP
been VBN I-VP
reported VBN I-VP
to TO I-VP
be VB I-VP
important JJ B-ADJP
in IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
the DT O
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
( ( O
TNF-alpha NN B-NP
) ) O
gene NN B-NP
we PRP B-NP
examined VBD B-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
okadaic JJ B-NP
acid NN I-NP
on IN B-PP
TNF-alpha NN B-NP
mRNA NN I-NP
levels NNS I-NP
. . O

Treatment NN B-NP
with IN B-PP
okadaic JJ B-NP
acid NN I-NP
resulted VBD B-VP
in IN B-PP
a DT B-NP
striking JJ I-NP
increase NN I-NP
in IN B-PP
TNF-alpha NN B-NP
mRNA NN I-NP
transcripts NNS I-NP
within IN B-PP
1 CD B-NP
h NN I-NP
of IN B-PP
stimulation NN B-NP
and CC O
large JJ B-NP
amounts NNS I-NP
of IN B-PP
TNF-alpha NN B-NP
were VBD B-VP
released VBN I-VP
into IN B-PP
the DT B-NP
culture NN I-NP
media NNS I-NP
. . O

Although IN B-SBAR
okadaic JJ B-NP
acid NN I-NP
provides VBZ B-VP
a DT B-NP
potent JJ I-NP
inductive JJ I-NP
signal NN I-NP
for IN B-PP
AP-1 NN B-NP
and CC O
NF-kappa NN B-NP
B NN I-NP
it PRP B-NP
did VBD B-VP
not RB I-VP
induce VB I-VP
either CC O
B NN B-NP
cell NN I-NP
proliferation NN I-NP
or CC O
immunoglobulin NN B-NP
secretion NN I-NP
. . O

A DT B-NP
novel JJ I-NP
Ets-related JJ I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
Elf-1 NN B-NP
COMMA COMMA O
binds VBZ B-VP
to TO B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
2 CD I-NP
regulatory JJ I-NP
elements NNS I-NP
that WDT B-NP
are VBP B-VP
required VBN I-VP
for IN B-PP
inducible JJ B-NP
trans JJ I-NP
activation NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
. . O

Human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HIV-1 NN B-NP
) ) O
and CC O
HIV-2 NN B-NP
are VBP B-VP
structurally RB B-NP
related JJ I-NP
retroviruses NNS I-NP
which WDT B-NP
both DT O
cause VBP B-VP
AIDS NN B-NP
in IN B-PP
humans NNS B-NP
. . O

Although IN B-SBAR
both DT B-NP
viruses NNS I-NP
establish VBP B-VP
latency NN B-NP
in IN B-PP
quiescent JJ B-NP
human-peripheral-blood JJ I-NP
T NN I-NP
cells NNS I-NP
COMMA COMMA O
the DT B-NP
asymptomatic JJ I-NP
phase NN I-NP
of IN B-PP
HIV-2 NN B-NP
infection NN I-NP
may MD B-VP
be VB I-VP
more JJR B-ADJP
prolonged JJ I-ADJP
than IN B-PP
that DT B-NP
of IN B-PP
HIV-1 NN B-NP
. . O

The DT B-NP
latent JJ I-NP
phases NNS I-NP
of IN B-PP
both CC O
HIV-1 NN B-NP
and CC O
HIV-2 NN B-NP
infection NN B-NP
have VBP B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
disrupted VBN I-VP
by IN B-PP
T-cell NN B-NP
activation NN I-NP
COMMA COMMA O
a DT B-NP
process NN I-NP
that WDT B-NP
requires VBZ B-VP
host NN B-NP
cell NN I-NP
transcription NN I-NP
factors NNS I-NP
. . O

In IN B-PP
the DT B-NP
case NN I-NP
of IN B-PP
HIV-1 NN B-NP
COMMA COMMA O
the DT B-NP
transcription NN I-NP
factor NN I-NP
NF-kappa NN I-NP
B NN I-NP
is VBZ B-VP
sufficient JJ B-ADJP
for IN B-PP
inducible JJ B-NP
transcriptional JJ I-NP
activation NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
factors NNS B-NP
in IN B-PP
addition NN I-PP
to TO I-PP
NF-kappa NN B-NP
B NN I-NP
are VBP B-VP
required VBN I-VP
to TO I-VP
activate VB I-VP
HIV-2 NN B-NP
transcription NN I-NP
in IN B-PP
infected JJ B-NP
T NN I-NP
cells NNS I-NP
. . O

In IN B-PP
this DT B-NP
report NN I-NP
COMMA COMMA O
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
a DT B-NP
novel JJ I-NP
Ets-related JJ I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
Elf-1 NN B-NP
COMMA COMMA O
binds VBZ B-VP
specifically RB B-ADVP
to TO B-PP
two CD B-NP
purine-rich JJ I-NP
motifs NNS I-NP
in IN B-PP
the DT B-NP
HIV-2 NN I-NP
enhancer NN I-NP
. . O

Mutagenesis NN B-NP
experiments NNS I-NP
demonstrated VBD B-VP
that IN B-SBAR
these DT B-NP
Elf-1 NN I-NP
binding NN I-NP
sites NNS I-NP
are VBP B-VP
required VBN I-VP
for IN B-PP
induction NN B-NP
of IN B-PP
HIV-2 NN B-NP
transcription NN I-NP
following VBG B-PP
T-cell-receptor-mediated JJ B-NP
T-cell NN I-NP
activation NN I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
Elf-1 NN B-NP
is VBZ B-VP
the DT B-NP
only JJ I-NP
factor NN I-NP
present JJ B-ADJP
in IN B-PP
activated VBN B-NP
T-cell NN I-NP
nuclear JJ I-NP
extracts NNS I-NP
that WDT B-NP
binds VBZ B-VP
to TO B-PP
these DT B-NP
sites NNS I-NP
in IN B-PP
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
Elf-1 NN B-NP
is VBZ B-VP
a DT B-NP
novel JJ I-NP
transcription NN I-NP
factor NN I-NP
that WDT B-NP
appears VBZ B-VP
to TO I-VP
be VB I-VP
required VBN I-VP
for IN B-PP
the DT B-NP
T-cell-receptor-mediated JJ I-NP
trans JJ I-NP
activation NN I-NP
of IN B-PP
HIV-2 NN B-NP
gene NN I-NP
expression NN I-NP
. . O

These DT B-NP
results NNS I-NP
may MD B-VP
explain VB I-VP
differences NNS B-NP
in IN B-PP
the DT B-NP
clinical JJ I-NP
spectra NNS I-NP
of IN B-PP
diseases NNS B-NP
caused VBN B-VP
by IN B-PP
HIV-1 NN B-NP
and CC O
HIV-2 NN B-NP
and CC O
may MD B-VP
also RB I-VP
have VB I-VP
implications NNS B-NP
for IN B-PP
the DT B-NP
design NN I-NP
of IN B-PP
therapeutic JJ B-NP
approaches NNS I-NP
to TO B-PP
HIV-2 NN B-NP
infection NN I-NP
. . O

Human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
Nef NN I-NP
protein NN I-NP
inhibits VBZ B-VP
NF-kappa NN B-NP
B NN I-NP
induction NN I-NP
in IN B-PP
human JJ B-NP
T NN I-NP
cells NNS I-NP
. . O

Human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HIV-1 NN B-NP
) ) O
can MD B-VP
establish VB I-VP
a DT B-NP
persistent JJ I-NP
and CC I-NP
latent JJ I-NP
infection NN I-NP
in IN B-PP
CD4+ JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
( ( O
W.C.Greene NNP B-NP
COMMA COMMA O
N.Engl.J. NNP B-NP
Med.324 NNP I-NP
: : I-NP
308-317 CD I-NP
COMMA COMMA O
1991 CD B-NP
; : O
S.M.Schnittman NNP B-NP
COMMA COMMA O
M.C.Psallidopoulos NNP B-NP
COMMA COMMA O
H.C. NNP B-NP
Lane NNP I-NP
COMMA COMMA O
L.Thompson NNP B-NP
COMMA COMMA O
M.Baseler NNP B-NP
COMMA COMMA O
F.Massari NNP B-NP
COMMA COMMA O
C.H.Fox NNP B-NP
COMMA COMMA O
N.P.Salzman NNP B-NP
COMMA COMMA O
and CC O
A.S.Fauci NNP B-NP
COMMA COMMA O
Science NNP B-NP
245 CD I-NP
: : I-NP
305-308 CD I-NP
COMMA COMMA O
1989 CD B-NP
) ) O
. . O

Production NN B-NP
of IN B-PP
HIV-1 NN B-NP
from IN B-PP
latently RB B-NP
infected JJ I-NP
cells NNS I-NP
requires VBZ B-VP
host NN B-NP
cell NN I-NP
activation NN I-NP
by IN B-PP
T-cell NN B-NP
mitogens NNS I-NP
( ( O
T.Folks NNP B-NP
COMMA COMMA O
D.M.Powell NNP B-NP
COMMA COMMA O
M.M.Lightfoote NNP B-NP
COMMA COMMA O
S.Benn NNP B-NP
COMMA COMMA O
M.A. NNP B-NP
Martin NNP I-NP
COMMA COMMA O
and CC O
A.S.Fauci NNP B-NP
COMMA COMMA O
Science NNP B-NP
231 CD I-NP
: : I-NP
600-602 CD I-NP
COMMA COMMA O
1986 CD B-NP
; : O
D.Zagury NNP B-NP
COMMA COMMA O
J. NNP B-NP
Bernard NNP I-NP
COMMA COMMA O
R.Leonard NNP B-NP
COMMA COMMA O
R.Cheynier NNP B-NP
COMMA COMMA O
M.Feldman NNP B-NP
COMMA COMMA O
P.S.Sarin NNP B-NP
COMMA COMMA O
and CC O
R.C. NNP B-NP
Gallo NNP I-NP
COMMA COMMA O
Science NNP B-NP
231 CD I-NP
: : I-NP
850-853 CD I-NP
COMMA COMMA O
1986 CD B-NP
) ) O
. . O

This DT B-NP
activation NN I-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
the DT B-NP
host NN I-NP
transcription NN I-NP
factor NN I-NP
NF-kappa NN I-NP
B NN I-NP
{ ( O
G.Nabel NNP B-NP
and CC O
D.Baltimore NNP B-NP
COMMA COMMA O
Nature NNP B-NP
( ( I-NP
London NNP I-NP
) ) I-NP
326 CD I-NP
: : I-NP
711-717 CD I-NP
COMMA COMMA O
1987 CD B-NP
} ) O
. . O

We PRP B-NP
report VBP B-VP
here RB B-ADVP
that IN B-SBAR
the DT B-NP
HIV-1-encoded JJ I-NP
Nef NN I-NP
protein NN I-NP
inhibits VBZ B-VP
the DT B-NP
induction NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
DNA-binding JJ I-NP
activity NN I-NP
by IN B-PP
T-cell NN B-NP
mitogens NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
Nef NN B-NP
does VBZ B-VP
not RB I-VP
affect VB I-VP
the DT B-NP
DNA-binding JJ I-NP
activity NN I-NP
of IN B-PP
other JJ B-NP
transcription NN I-NP
factors NNS I-NP
implicated VBN B-VP
in IN B-PP
HIV-1 NN B-NP
regulation NN I-NP
COMMA COMMA O
including VBG B-PP
SP-1 NN B-NP
COMMA COMMA O
USF NN B-NP
COMMA COMMA O
URS NN B-NP
COMMA COMMA O
and CC O
NF-AT NN B-NP
. . O

Additionally RB B-ADVP
COMMA COMMA O
Nef NN B-NP
inhibits VBZ B-VP
the DT B-NP
induction NN I-NP
of IN B-PP
HIV-1- NN B-NP
and CC O
interleukin NN B-ADJP
2-directed JJ I-ADJP
gene NN B-NP
expression NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
effect NN I-NP
on IN B-PP
HIV-1 NN B-NP
transcription NN I-NP
depends VBZ B-VP
on IN B-PP
an DT B-NP
intact JJ I-NP
NF-kappa NN I-NP
B-binding JJ I-NP
site NN I-NP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
defective JJ B-NP
recruitment NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
may MD B-VP
underlie VB I-VP
Nef NN B-NP
's POS B-NP
negative JJ I-NP
transcriptional JJ I-NP
effects NNS I-NP
on IN B-PP
the DT O
HIV-1 NN B-NP
and CC O
interleukin NN B-NP
2 CD I-NP
promoters NNS B-NP
. . O

Further JJ B-NP
evidence NN I-NP
suggests VBZ B-VP
that IN B-SBAR
Nef NN B-NP
inhibits VBZ B-VP
NF-kappa NN B-NP
B NN I-NP
induction NN I-NP
by IN B-PP
interfering VBG B-VP
with IN B-PP
a DT B-NP
signal NN I-NP
derived VBN B-VP
from IN B-PP
the DT B-NP
T-cell NN I-NP
receptor NN I-NP
complex NN I-NP
. . O

{ ( O
Effect NN B-NP
of IN B-PP
antihypertensive JJ B-NP
therapy NN I-NP
with IN B-PP
captopril NN B-NP
on IN B-PP
gluco- JJ B-NP
and CC O
mineralocorticoid NN B-NP
receptors NNS B-NP
of IN B-PP
peripheral JJ B-NP
blood NN I-NP
lymphocytes NNS I-NP
in IN B-PP
hypertensive JJ B-NP
patients NNS I-NP
of IN B-PP
various JJ B-NP
age NN I-NP
} ) O

Binding NN B-NP
of IN B-PP
3H-dexamethasone NN B-NP
and CC O
3H-aldosterone NN B-NP
by IN B-PP
peripheral JJ B-NP
lymphocyte NN I-NP
receptors NNS I-NP
was VBD B-VP
investigated VBN I-VP
in IN B-PP
healthy JJ B-NP
persons NNS I-NP
and CC O
hypertensive JJ B-NP
patients NNS I-NP
before IN B-PP
and CC B-PP
after IN B-PP
2-week JJ B-NP
captopril NN I-NP
treatment NN I-NP
. . O

The DT B-NP
number NN I-NP
of IN B-PP
glucocorticoid NN B-NP
and CC O
mineralocorticoid NN B-NP
binding NN B-NP
sites NNS I-NP
was VBD B-VP
increased VBN I-VP
in IN B-PP
hypertensives NNS B-NP
vs CC O
normotensives NNS B-NP
. . O

The DT B-NP
treatment NN I-NP
with IN B-PP
the DT B-NP
ACE NN I-NP
inhibitor NN I-NP
captopril NN I-NP
led VBD B-VP
to TO B-PP
activation NN B-NP
of IN B-PP
hormone-receptor NN B-NP
interactions NNS I-NP
. . O

There EX B-NP
was VBD B-VP
a DT B-NP
more RBR I-NP
marked JJ I-NP
rise NN I-NP
of IN B-PP
the DT B-NP
number NN I-NP
of IN B-PP
receptors NNS B-NP
in IN B-PP
middle-aged JJ O
( ( O
44-55 CD B-NP
years NNS I-NP
) ) O
hypertensives NNS B-NP
vs CC O
elderly JJ O
( ( O
61-80 CD B-NP
years NNS I-NP
) ) O
subjects NNS B-NP
after IN B-PP
captopril NN B-NP
treatment NN I-NP
. . O

Leukotriene NN B-NP
B4 NN I-NP
transcriptionally RB B-ADVP
activates VBZ B-VP
interleukin-6 NN B-NP
expression NN I-NP
involving VBG B-VP
NK-chi NN B-NP
B NN I-NP
and CC O
NF-IL6 NN B-NP
. . O

Leukotriene NN B-NP
B4 NN I-NP
( ( O
LTB4 NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
notable JJ I-NP
participant NN I-NP
in IN B-PP
inflammation NN B-NP
and CC O
chemotaxis NN B-NP
. . O

It PRP B-NP
is VBZ B-VP
COMMA COMMA O
however RB B-ADVP
COMMA COMMA O
still RB B-ADJP
unclear JJ I-ADJP
whether IN B-SBAR
LTB4 NN B-NP
acts VBZ B-VP
in IN B-PP
this DT B-NP
regard NN I-NP
directly RB B-ADVP
or CC B-ADVP
indirectly RB B-ADVP
by IN B-PP
stimulating VBG B-VP
the DT B-NP
release NN I-NP
of IN B-PP
chemotactic JJ B-NP
and CC I-NP
inflammatory JJ I-NP
cytokines NNS I-NP
. . O

Here RB B-ADVP
we PRP B-NP
report VBP B-VP
that IN B-SBAR
LTB4 NN B-NP
induces VBZ B-VP
synthesis NN B-NP
of IN B-PP
interleukin NN B-NP
( ( O
IL NN B-NP
) ) O
-6 CD B-NP
by IN B-PP
human JJ B-NP
blood NN I-NP
monocytes NNS I-NP
through IN B-PP
transcriptional JJ B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
IL-6 NN I-NP
gene NN I-NP
. . O

We PRP B-NP
furthermore RB B-ADVP
demonstrate VBP B-VP
that IN B-SBAR
this DT B-NP
process NN I-NP
involves VBZ B-VP
activation NN B-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
NF-chi NN I-NP
B NN I-NP
and CC O
COMMA COMMA O
to TO B-PP
a DT B-NP
lesser JJR I-NP
extent NN I-NP
COMMA COMMA O
of IN B-PP
NF-IL6 NN B-NP
COMMA COMMA O
while IN B-SBAR
the DT B-NP
activity NN I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
AP-1 NN I-NP
COMMA COMMA O
shown VBN B-VP
to TO I-VP
otherwise RB I-VP
confer VB I-VP
IL-6 NN B-NP
inducibility NN I-NP
COMMA COMMA O
appeared VBD B-VP
to TO I-VP
be VB I-VP
unaffected JJ I-VP
by IN B-PP
LTB4 NN B-NP
. . O

Involvement NN B-NP
of IN B-PP
NF-chi NN B-NP
B NN I-NP
and CC O
NF-IL6 NN B-NP
in IN B-PP
induction NN B-NP
of IN B-PP
IL-6 NN B-NP
transcription NN I-NP
by IN B-PP
monocytes NNS B-NP
was VBD B-VP
demonstrated VBN I-VP
using VBG B-VP
deleted JJ B-NP
forms NNS I-NP
of IN B-PP
the DT B-NP
IL-6 NN I-NP
promoter NN I-NP
. . O

Activation NN B-NP
of IN B-PP
the DT B-NP
IL-6 NN I-NP
promoter NN I-NP
by IN B-PP
LTB4 NN B-NP
was VBD B-VP
not RB B-CONJP
only RB I-CONJP
associated VBN B-VP
with IN B-PP
accumulation NN B-NP
of IN B-PP
the DT B-NP
respective JJ I-NP
transcripts NNS I-NP
but CC O
resulted VBD B-VP
in IN B-PP
synthesis NN B-NP
of IN B-PP
functional JJ B-NP
IL-6 NN I-NP
protein NN I-NP
as RB B-PP
well RB B-ADVP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
LTB4 NN B-NP
mediated VBD B-VP
transactivation NN B-NP
of IN B-PP
a DT B-NP
heterologous JJ I-NP
promoter NN I-NP
construct NN I-NP
containing VBG B-VP
the DT B-NP
NF-chi NN I-NP
B NN I-NP
or CC O
the DT B-NP
NF-IL6 NN I-NP
enhancer NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
the DT B-NP
AP-1 NN I-NP
enhancer NN I-NP
. . O

The DT B-NP
signaling NN I-NP
events NNS I-NP
mediating VBG B-VP
this DT B-NP
effect NN I-NP
appeared VBD B-VP
to TO I-VP
involve VB I-VP
the DT B-NP
release NN I-NP
of IN B-PP
H2O2 NN B-NP
COMMA COMMA O
since IN B-SBAR
LTB4 NN B-NP
failed VBD B-VP
to TO I-VP
induce VB I-VP
NF-chi NN B-NP
B NN I-NP
or CC O
NF-IL6 NN B-NP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
the DT B-NP
scavenger NN I-NP
of IN B-PP
H2O2 NN B-NP
COMMA COMMA O
N-acetyl-L-cysteine NN B-NP
. . O

Estrogen NN B-NP
binding NN I-NP
sites NNS I-NP
in IN B-PP
peripheral JJ B-NP
blood NN I-NP
monocytes NNS I-NP
and CC O
effects NNS B-NP
of IN B-PP
danazol NN B-NP
on IN B-PP
their PRP$ B-NP
sites NNS I-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

1 LS B-LST
. . O
This DT B-NP
study NN I-NP
was VBD B-VP
designed VBN I-VP
to TO B-VP
investigate VB I-VP
the DT B-NP
presence NN I-NP
of IN B-PP
estrogen NN O
type NN B-NP
I CD I-NP
( ( O
high JJ B-NP
affinity NN I-NP
COMMA COMMA O
low JJ B-NP
capacity NN I-NP
) ) O
and CC O
type NN B-NP
II CD I-NP
( ( O
low JJ B-NP
affinity NN I-NP
COMMA COMMA O
high JJ B-NP
capacity NN I-NP
) ) O
binding NN B-NP
sites NNS I-NP
in IN B-PP
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
monocytes NNS I-NP
and CC O
the DT B-NP
effects NNS I-NP
of IN B-PP
danazol NN B-NP
on IN B-PP
these DT B-NP
sites NNS I-NP
. . O

2 LS B-LST
. . O
These DT B-NP
two CD I-NP
types NNS I-NP
of IN B-PP
estrogen NN B-NP
binding NN I-NP
sites NNS I-NP
existed VBD B-VP
in IN B-PP
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
monocytes NNS I-NP
. . O

3 LS B-LST
. . O
Danazol NN B-NP
bound VBD B-VP
to TO B-PP
these DT B-NP
sites NNS I-NP
in IN B-PP
high JJ B-NP
concentration NN I-NP
( ( O
10(-6) CD B-NP
M NN I-NP
COMMA COMMA O
clinical JJ B-ADJP
serum NN B-NP
concentration NN I-NP
during IN B-PP
danazol NN B-NP
therapy NN I-NP
) ) O
and CC O
decreased VBD B-VP
the DT B-NP
number NN I-NP
of IN B-PP
both DT B-NP
sites NNS I-NP
. . O

4 LS B-LST
. . O
It PRP B-NP
is VBZ B-VP
suggested VBN I-VP
that IN B-SBAR
danazol NN B-NP
has VBZ B-VP
an DT B-NP
anti-estrogenic JJ I-NP
action NN I-NP
to TO B-PP
the DT B-NP
monocytes NNS I-NP
through IN B-PP
the DT B-NP
competition NN B-NP
and CC O
suppression NN B-NP
of IN B-PP
estrogen NN B-NP
binding NN I-NP
sites NNS I-NP
as IN B-SBAR
seen VBN B-VP
in IN B-PP
the DT B-NP
estrogen NN I-NP
target NN I-NP
organ NN I-NP
. . O

{ ( O
Mechanism NN B-NP
of IN B-PP
action NN B-NP
of IN B-PP
steroid NN B-NP
hormones NNS I-NP
. . I-NP
I LS I-NP
. . I-NP
Estrogens NNS I-NP
} ) O

The DT B-NP
steroid NN I-NP
hormone NN I-NP
are VBP B-VP
very RB B-NP
versatile JJ I-NP
molecules NNS I-NP
: : O
although IN B-SBAR
they PRP B-NP
are VBP B-VP
related JJ B-ADJP
among IN B-PP
them PRP B-NP
by IN B-PP
their PRP$ B-NP
chemical JJ I-NP
structure NN I-NP
COMMA COMMA O
they PRP B-NP
have VBP B-VP
very RB B-NP
diverse JJ I-NP
functions NNS I-NP
and CC O
including VBG B-PP
antagonic JJ B-NP
. . O

Their PRP$ B-NP
action NN I-NP
mechanism NN I-NP
is VBZ B-VP
not RB I-VP
completely RB I-VP
cleared VBN I-VP
. . O

The DT B-NP
estrogens NNS I-NP
participate VBP B-VP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
practically RB B-NP
all PDT I-NP
the DT I-NP
reproductive JJ I-NP
and CC I-NP
sexual JJ I-NP
events NNS I-NP
of IN B-PP
the DT B-NP
female NN I-NP
COMMA COMMA O
although IN B-SBAR
the DT B-NP
intracellular JJ I-NP
actions NNS I-NP
by IN B-PP
which WDT B-NP
they PRP B-NP
take VBP B-VP
place NN B-NP
are VBP B-VP
not RB I-VP
well RB I-VP
known VBN I-VP
and CC O
the DT B-NP
proposed JJ I-NP
models NNS I-NP
do VBP B-VP
not RB I-VP
adequately RB I-VP
satisfy VB I-VP
the DT B-NP
questions NNS I-NP
. . O

Currently RB B-ADVP
it PRP B-NP
is VBZ B-VP
accepted VBN I-VP
the DT B-NP
existence NN I-NP
of IN B-PP
a DT B-NP
cytoplasmic JJ I-NP
and\/or CC I-NP
nuclear JJ I-NP
receptor NN I-NP
COMMA COMMA O
without IN B-PP
explaining VBG B-VP
satisfactorily RB B-ADVP
how WRB B-ADVP
the DT B-NP
hormones NNS I-NP
come VBN B-VP
to TO B-PP
the DT B-NP
nucleus NN I-NP
. . O

The DT B-NP
endocrine JJ I-NP
events NNS I-NP
that WDT B-NP
are VBP O
rapidly RB B-ADVP
expressed VBN B-VP
( ( O
seconds NNS B-NP
) ) O
are VBP B-VP
due JJ B-PP
to TO I-PP
a DT B-NP
possible JJ I-NP
interaction NN I-NP
with IN B-PP
cellular JJ B-NP
membrane NN I-NP
. . O

The DT B-NP
purpose NN I-NP
of IN B-PP
this DT B-NP
review NN I-NP
is VBZ B-VP
to TO B-VP
analyze VB I-VP
and CC O
concilliate VB B-VP
the DT B-NP
reported VBN I-NP
data NNS I-NP
on IN B-PP
the DT B-NP
mechanism NN I-NP
of IN B-PP
action NN B-NP
of IN B-PP
estrogens NNS B-NP
. . O

Stable JJ B-NP
expression NN I-NP
of IN B-PP
transdominant JJ B-NP
Rev NN I-NP
protein NN I-NP
in IN B-PP
human JJ B-NP
T NN I-NP
cells NNS I-NP
inhibits VBZ B-VP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
replication NN I-NP
. . O

The DT O
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV NN B-NP
) ) O
Rev NN B-NP
protein NN I-NP
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
viral JJ B-NP
structural JJ I-NP
protein NN I-NP
expression NN I-NP
( ( O
Gag NN B-NP
COMMA COMMA O
Pol NN B-NP
COMMA COMMA O
and CC O
Env NN B-NP
) ) O
and CC B-PP
COMMA COMMA I-PP
hence RB I-PP
COMMA COMMA O
for IN B-PP
viral JJ B-NP
replication NN I-NP
. . O

In IN B-PP
transient JJ B-NP
transfection NN I-NP
assays NNS I-NP
COMMA COMMA O
mutant JJ B-NP
forms NNS I-NP
of IN B-PP
Rev NN B-NP
have VBP B-VP
been VBN I-VP
identified VBN I-VP
that WDT B-NP
inhibit VBP B-VP
wild-type JJ B-NP
Rev NN I-NP
activity NN I-NP
and CC O
therefore RB O
suppress VBP B-VP
viral JJ B-NP
replication NN I-NP
. . O

To TO B-VP
determine VB I-VP
whether IN B-SBAR
such JJ B-NP
transdominant JJ I-NP
Rev NN I-NP
proteins NNS I-NP
could MD B-VP
provide VB I-VP
long-term JJ B-NP
protection NN I-NP
against IN B-PP
HIV NN B-NP
infection NN I-NP
without IN B-PP
affecting VBG B-VP
T NN B-NP
cell NN I-NP
function NN I-NP
COMMA COMMA O
T NN B-NP
leukemia NN I-NP
cell NN I-NP
lines NNS I-NP
were VBD B-VP
stably RB I-VP
transduced VBN I-VP
with IN B-PP
a DT B-NP
retroviral JJ I-NP
vector NN I-NP
encoding VBG B-VP
a DT B-NP
transdominant JJ I-NP
mutant NN I-NP
of IN B-PP
the DT B-NP
Rev NN I-NP
protein NN I-NP
COMMA COMMA O
M10 NN B-NP
. . O

While IN B-SBAR
all PDT B-NP
the DT I-NP
M10-expressing JJ I-NP
cell NN I-NP
lines NNS I-NP
remained VBD B-VP
infectable JJ B-ADJP
by IN B-PP
HIV-1 NN B-NP
COMMA COMMA O
these DT B-NP
same JJ I-NP
cells NNS I-NP
failed VBD B-VP
to TO I-VP
support VB I-VP
a DT B-NP
productive JJ I-NP
replication NN I-NP
cycle NN I-NP
when WRB B-ADVP
infected VBN B-VP
with IN B-PP
a DT B-NP
cloned VBN I-NP
isolate NN I-NP
of IN B-PP
HIV-1 NN B-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
two CD B-NP
out IN I-NP
of IN I-NP
three CD I-NP
M10-expressing JJ I-NP
CEM NN I-NP
clones NNS I-NP
were VBD B-VP
also RB B-ADJP
resistant JJ I-ADJP
to TO B-PP
highly RB B-NP
productive JJ I-NP
infection NN I-NP
by IN B-PP
a DT B-NP
heterogeneous JJ I-NP
HIV-1 NN I-NP
pool NN I-NP
. . O

Expression NN B-NP
of IN B-PP
M10 NN B-NP
did VBD B-VP
not RB I-VP
affect VB I-VP
induction NN B-NP
of IN B-PP
HIV NN B-NP
transcription NN I-NP
mediated VBN B-VP
by IN B-PP
the DT B-NP
kappa NN I-NP
B NN I-NP
regulatory JJ I-NP
element NN I-NP
or CC O
Tat NN B-NP
. . O

Importantly RB B-ADVP
COMMA COMMA O
constitutive JJ B-NP
expression NN I-NP
of IN B-PP
Rev NN B-NP
M10 NN I-NP
did VBD B-VP
not RB I-VP
alter VB I-VP
the DT B-NP
secretion NN I-NP
of IN B-PP
interleukin NN B-NP
2 CD I-NP
in IN B-PP
response NN I-PP
to TO I-PP
mitogen NN B-NP
stimulation NN I-NP
of IN B-PP
EL-4 NN B-NP
and CC O
Jurkat NN B-NP
cells NNS B-NP
. . O

The DT B-NP
inhibition NN I-NP
of IN B-PP
HIV NN B-NP
infection NN I-NP
in IN B-PP
cells NNS B-NP
stably RB B-VP
expressing VBG I-VP
a DT B-NP
transdominant JJ I-NP
Rev NN I-NP
protein NN I-NP
COMMA COMMA O
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
any DT B-NP
deleterious JJ I-NP
effect NN I-NP
on IN B-PP
T NN B-NP
cell NN I-NP
function NN I-NP
COMMA COMMA O
suggests VBZ B-VP
that IN B-SBAR
such PDT B-NP
a DT I-NP
strategy NN I-NP
could MD B-VP
provide VB I-VP
a DT B-NP
therapeutic JJ I-NP
effect NN I-NP
in IN B-PP
the DT B-NP
T NN I-NP
lymphocytes NNS I-NP
of IN B-PP
acquired VBN B-NP
immunodeficiency NN I-NP
syndrome NN I-NP
patients NNS I-NP
. . O

Glucocorticoid NN B-NP
receptor NN I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
lupus NN B-NP
nephritis NN I-NP
: : O
relationship NN B-NP
between IN B-PP
receptor NN B-NP
levels NNS I-NP
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
and CC O
effect NN B-NP
of IN B-PP
glucocorticoid NN B-NP
therapy NN I-NP
. . O

We PRP B-NP
investigated VBD B-VP
the DT B-NP
clinical JJ I-NP
significance NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
determination NN I-NP
in IN B-PP
20 CD B-NP
patients NNS I-NP
with IN B-PP
systemic JJ B-NP
lupus NN I-NP
erythematosus NN I-NP
( ( O
SLE NN B-NP
) ) O
who WP B-NP
afterwards RB B-ADVP
developed VBD B-VP
nephrotic JJ B-NP
syndrome NN I-NP
. . O

Glucocorticoid NN B-NP
receptor NN I-NP
concentrations NNS I-NP
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
( ( O
MNL NNS B-NP
) ) O
in IN B-PP
these DT B-NP
patients NNS I-NP
were VBD B-VP
comparable JJ B-ADJP
with IN B-PP
those DT B-NP
in IN B-PP
both CC O
other JJ B-NP
patients NNS I-NP
with IN B-PP
SLE NN B-NP
and CC O
healthy JJ B-NP
persons NNS I-NP
. . O

Improvement NN B-NP
in IN B-PP
urinary JJ B-NP
protein NN I-NP
excretion NN I-NP
and CC B-PP
in IN B-PP
disease NN B-NP
activity NN I-NP
COMMA COMMA O
which WDT B-NP
was VBD B-VP
scored VBN I-VP
according VBG B-PP
to TO B-PP
the DT B-NP
SLE NNP I-NP
Disease NNP I-NP
Activity NNP I-NP
Index NNP I-NP
system NN I-NP
of IN B-PP
the DT B-NP
University NNP I-NP
of IN B-PP
Toronto NNP B-NP
COMMA COMMA O
closely RB B-ADVP
related JJ B-VP
to TO B-PP
the DT B-NP
glucocorticoid NN I-NP
receptor NN I-NP
concentrations NNS I-NP
in IN B-PP
MNL NN B-NP
isolated VBN B-VP
from IN B-PP
the DT B-NP
corresponding JJ I-NP
patients NNS I-NP
. . O

In IN B-PP
summary NN B-NP
COMMA COMMA O
glucocorticoid NN B-NP
receptor NN I-NP
determination NN I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
lupus NN B-NP
nephritis NN I-NP
may MD B-VP
be VB I-VP
a DT B-NP
predictive JJ I-NP
clue NN I-NP
for IN B-PP
assessing VBG B-VP
responsiveness NN B-NP
to TO B-PP
glucocorticoid NN B-NP
therapy NN I-NP
. . O

Selection NN B-NP
of IN B-PP
optimal JJ B-NP
kappa NN I-NP
B\/Rel NN I-NP
DNA-binding JJ I-NP
motifs NNS I-NP
: : O
interaction NN B-NP
of IN B-PP
both DT B-NP
subunits NNS I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
with IN B-PP
DNA NN B-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
transcriptional JJ B-NP
activation NN I-NP
. . O

Analysis NN B-NP
of IN B-PP
the DT O
p50 NN B-NP
and CC O
p65 NN B-NP
subunits NNS B-NP
of IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
transcription NN I-NP
factor NN I-NP
complex NN I-NP
has VBZ B-VP
revealed VBN I-VP
that IN B-SBAR
both DT B-NP
proteins NNS I-NP
can MD B-VP
interact VB I-VP
with IN B-PP
related JJ B-NP
DNA NN I-NP
sequences NNS I-NP
through IN B-PP
either CC O
homo- JJ B-NP
or CC O
heterodimer NN B-NP
formation NN B-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
the DT B-NP
product NN I-NP
of IN B-PP
the DT B-NP
proto-oncogene NN I-NP
c-rel NN I-NP
can MD B-VP
bind VB I-VP
to TO B-PP
similar JJ B-NP
DNA NN I-NP
motifs NNS I-NP
by IN B-PP
itself PRP B-NP
or CC B-PP
as IN B-PP
a DT B-NP
heterodimer NN I-NP
with IN B-PP
p50 NN B-NP
or CC O
p65 NN B-NP
. . O

However RB B-ADVP
COMMA COMMA O
these DT B-NP
studies NNS I-NP
have VBP B-VP
used VBN I-VP
a DT B-NP
limited JJ I-NP
number NN I-NP
of IN B-PP
known JJ B-NP
kappa NN I-NP
B NN I-NP
DNA NN I-NP
motifs NNS I-NP
COMMA COMMA O
and CC O
the DT B-NP
question NN I-NP
of IN B-PP
the DT B-NP
optimal JJ I-NP
DNA NN I-NP
sequences NNS I-NP
preferred VBN B-VP
by IN B-PP
each DT B-NP
homodimer NN I-NP
has VBZ B-VP
not RB I-VP
been VBN I-VP
addressed VBN I-VP
. . O

Using VBG B-VP
purified VBN O
recombinant JJ O
p50 NN B-NP
COMMA COMMA O
p65 NN B-NP
COMMA COMMA O
and CC O
c-Rel NN B-NP
proteins NNS B-NP
COMMA COMMA O
optimal JJ B-NP
DNA-binding JJ I-NP
motifs NNS I-NP
were VBD B-VP
selected VBN I-VP
from IN B-PP
a DT B-NP
pool NN I-NP
of IN B-PP
random JJ B-NP
oligonucleotides NNS I-NP
. . O

Alignment NN B-NP
of IN B-PP
the DT B-NP
selected VBN I-NP
sequences NNS I-NP
allowed VBD B-VP
us PRP B-NP
to TO B-VP
predict VB I-VP
a DT B-NP
consensus NN I-NP
sequence NN I-NP
for IN B-PP
binding NN B-NP
of IN B-PP
the DT B-NP
individual JJ I-NP
homodimeric JJ I-NP
Rel-related JJ I-NP
proteins NNS I-NP
COMMA COMMA O
and CC O
DNA-protein NN B-NP
binding NN I-NP
analysis NN I-NP
of IN B-PP
the DT B-NP
selected VBN I-NP
DNA NN I-NP
sequences VBZ I-NP
revealed VBD B-VP
sequence NN B-NP
specificity NN I-NP
of IN B-PP
the DT B-NP
proteins NNS I-NP
. . O

Contrary JJ B-PP
to TO I-PP
previous JJ B-NP
assumptions NNS I-NP
COMMA COMMA O
we PRP B-NP
observed VBD B-VP
that IN B-SBAR
p65 NN B-NP
homodimers NNS I-NP
can MD B-VP
interact VB I-VP
with IN B-PP
a DT B-NP
subset NN I-NP
of IN B-PP
DNA NN B-NP
sequences VBZ I-NP
not RB B-VP
recognized VBN I-VP
by IN B-PP
p50 NN B-NP
homodimers NNS I-NP
. . O

Differential JJ B-NP
binding NN I-NP
affinities NNS I-NP
were VBD B-VP
also RB I-VP
obtained VBN I-VP
with IN B-PP
p50- NN B-NP
and CC O
c-Rel-selected JJ B-ADJP
sequences NNS B-NP
. . O

Using VBG B-VP
either CC O
a DT O
p50- NN B-NP
or CC O
p65-selected JJ B-ADJP
kappa NN B-NP
B NN I-NP
motif NN I-NP
COMMA COMMA O
which WDT B-NP
displayed VBD B-VP
differential JJ B-NP
binding NN I-NP
with IN B-PP
respect NN I-PP
to TO I-PP
the DT B-NP
other JJ I-NP
protein NN I-NP
COMMA COMMA O
little JJ B-NP
to TO I-NP
no DT I-NP
binding NN I-NP
was VBD B-VP
observed VBN I-VP
with IN B-PP
the DT B-NP
heterodimeric JJ I-NP
NF-kappa NN I-NP
B NN I-NP
complex NN I-NP
. . O

Similarly RB B-ADVP
COMMA COMMA O
in IN B-PP
transfection NN B-NP
experiments NNS I-NP
in IN B-PP
which WDT B-NP
the DT B-NP
selective JJ I-NP
kappa NN I-NP
B NN I-NP
binding NN I-NP
sites NNS I-NP
were VBD B-VP
used VBN I-VP
to TO B-VP
drive VB I-VP
the DT B-NP
expression NN I-NP
of IN B-PP
a DT B-NP
chloramphenicol NN I-NP
acetyltransferase NN I-NP
reporter NN I-NP
construct NN I-NP
COMMA COMMA O
the DT O
p65- NN B-NP
and CC O
p50-selected JJ B-ADJP
motifs NNS B-NP
were VBD B-VP
activated VBN I-VP
only RB B-PP
in IN I-PP
the DT I-PP
presence NN I-PP
of IN I-PP
p65 NN B-NP
and CC O
p50\/65 NN B-NP
( ( O
a DT B-NP
chimeric JJ I-NP
protein NN I-NP
with IN B-PP
the DT B-NP
p50 NN B-NP
DNA NN I-NP
binding NN I-NP
domain NN I-NP
and CC O
p65 NN B-NP
activation NN I-NP
domain NN I-NP
) ) O
expression NN B-NP
vectors NNS I-NP
COMMA COMMA O
respectively RB B-ADVP
COMMA COMMA O
and CC O
neither DT B-NP
demonstrated VBD B-VP
a DT B-NP
significant JJ I-NP
response NN I-NP
to TO B-PP
stimuli NNS B-NP
that WDT B-NP
induce VBP B-VP
NF-kappa NN B-NP
B NN I-NP
activity NN I-NP
. . O

These DT B-NP
findings NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
interaction NN B-NP
of IN B-PP
both DT B-NP
subunits NNS I-NP
of IN B-PP
the DT B-NP
heterodimeric JJ I-NP
NF-kappa NN I-NP
B NN I-NP
complex NN I-NP
with IN B-PP
DNA NN B-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
DNA NN B-NP
binding NN I-NP
and CC O
transcriptional JJ B-NP
activation NN I-NP
and CC O
suggest VBP B-VP
that IN B-SBAR
transcriptional JJ B-NP
activation NN I-NP
mediated VBN B-VP
by IN B-PP
the DT B-NP
individual JJ I-NP
rel-related JJ I-NP
proteins NNS I-NP
will MD B-VP
differ VB I-VP
dramatically RB B-ADVP
COMMA COMMA O
depending VBG B-PP
on IN B-PP
the DT B-NP
specific JJ I-NP
kappa NN I-NP
B NN I-NP
motifs NNS I-NP
present JJ B-ADJP
. . O

Characterization NN B-NP
of IN B-PP
a DT B-NP
new JJ I-NP
tissue-specific JJ I-NP
transcription NN I-NP
factor NN I-NP
binding VBG B-VP
to TO B-PP
the DT B-NP
simian JJ I-NP
virus NN I-NP
40 CD I-NP
enhancer NN I-NP
TC-II NN I-NP
( ( I-NP
NF-kappa NN I-NP
B NN I-NP
) ) I-NP
element NN I-NP
. . O

We PRP B-NP
have VBP O
biochemically RB B-ADVP
and CC O
functionally RB B-ADVP
characterized VBN B-VP
a DT B-NP
new JJ I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
NP-TCII NN B-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
present JJ B-ADJP
in IN B-PP
nuclei NNS B-NP
from IN B-PP
unstimulated JJ O
T NN B-NP
and CC O
B NN B-NP
lymphocytes NNS B-NP
but CC O
is VBZ B-VP
not RB I-VP
found VBN I-VP
in IN B-PP
nonhematopoietic JJ B-NP
cells NNS I-NP
. . O

This DT B-NP
factor NN I-NP
has VBZ B-VP
a DT B-NP
DNA-binding JJ I-NP
specificity NN I-NP
similar JJ B-ADJP
to TO B-PP
that DT B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
but CC O
is VBZ B-VP
unrelated JJ B-ADJP
to TO B-PP
this DT B-NP
or CC I-NP
other JJ I-NP
Rel NN I-NP
proteins NNS I-NP
by IN B-PP
functional JJ B-NP
and CC I-NP
biochemical JJ I-NP
criteria NNS I-NP
. . O

It PRP B-NP
can MD B-VP
also RB I-VP
be VB I-VP
distinguished VBN I-VP
from IN B-PP
other JJ B-NP
previously RB I-NP
described VBN I-NP
lymphocyte-specific JJ I-NP
DNA-binding JJ I-NP
proteins NNS I-NP
. . O

The DT B-NP
candidate NN I-NP
oncoprotein NN I-NP
Bcl-3 NN I-NP
is VBZ B-VP
an DT B-NP
antagonist NN I-NP
of IN B-PP
p50\/NF-kappa NN B-NP
B-mediated JJ I-NP
inhibition NN I-NP
. . O

The DT B-NP
candidate NN I-NP
oncogene NN I-NP
bcl-3 NN I-NP
was VBD B-VP
discovered VBN I-VP
as IN B-PP
a DT B-NP
translocation NN I-NP
into IN B-PP
the DT B-NP
immunoglobulin NN I-NP
alpha-locus NN I-NP
in IN B-PP
some DT B-NP
cases NNS I-NP
of IN B-PP
B-cell NN B-NP
chronic JJ I-NP
lymphocytic JJ I-NP
leukaemias NNS I-NP
. . O

The DT B-NP
protein NN I-NP
Bcl-3 NN I-NP
contains VBZ B-VP
seven CD B-NP
so-called JJ I-NP
ankyrin NN I-NP
repeats NNS I-NP
. . O

Similar JJ B-NP
repeat NN I-NP
motifs NNS I-NP
are VBP B-VP
found VBN I-VP
in IN B-PP
a DT B-NP
number NN I-NP
of IN B-PP
diverse JJ B-NP
regulatory JJ I-NP
proteins NNS I-NP
but CC O
the DT B-NP
motifs NNS I-NP
of IN B-PP
Bcl-3 NN B-NP
are VBP B-VP
most RBS B-ADJP
closely RB I-ADJP
related JJ I-ADJP
to TO B-PP
those DT B-NP
found VBN B-VP
in IN B-PP
I NN B-NP
kappa NN I-NP
B NN I-NP
proteins NNS I-NP
in IN B-PP
which WDT B-NP
the DT B-NP
ankyrin NN I-NP
repeat NN I-NP
domain NN I-NP
is VBZ B-VP
thought VBN I-VP
to TO I-VP
be VB I-VP
directly RB I-VP
involved VBN I-VP
in IN B-PP
inhibition NN B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
activity NN I-NP
. . O

No DT B-NP
biological JJ I-NP
function NN I-NP
has VBZ B-VP
yet RB I-VP
been VBN I-VP
described VBN I-VP
for IN B-PP
Bcl-3 NN B-NP
COMMA COMMA O
but CC O
it PRP B-NP
was VBD B-VP
noted VBN I-VP
recently RB B-ADVP
that IN B-SBAR
Bcl-3 NN B-NP
interferes VBZ B-VP
with IN B-PP
DNA-binding NN B-NP
of IN B-PP
the DT B-NP
p50 NN I-NP
subunit NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

Here RB B-ADVP
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
Bcl-3 NN B-NP
can MD B-VP
aid VB I-VP
kappa NN B-NP
B NN I-NP
site-dependent JJ I-NP
transcription NN I-NP
in FW B-ADVP
vivo FW I-ADVP
by IN B-PP
counteracting VBG B-VP
the DT B-NP
inhibitory JJ I-NP
effects NNS I-NP
of IN B-PP
p50\/NF-kappa NN B-NP
B NN I-NP
homodimers NNS I-NP
. . O

Bcl-3 NN B-NP
may MD B-VP
therefore RB I-VP
aid VB I-VP
activation NN B-NP
of IN B-PP
select JJ B-NP
NF-kappa NN I-NP
B-regulated JJ I-NP
genes NNS I-NP
COMMA COMMA O
including VBG B-PP
those DT B-NP
of IN B-PP
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
. . O

A DT B-NP
microtitre NN I-NP
assay NN I-NP
system NN I-NP
for IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
: : O
decreased VBN B-NP
receptor NN I-NP
concentration NN I-NP
in IN B-PP
myocardial JJ B-NP
infarction NN I-NP
. . O

A DT B-NP
major JJ I-NP
difficulty NN I-NP
in IN B-PP
determination NN B-NP
of IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
sites NNS I-NP
is VBZ B-VP
the DT B-NP
very RB I-NP
complicated JJ I-NP
assay NN I-NP
procedure NN I-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
we PRP B-NP
describe VBP B-VP
a DT B-NP
microtitre NN I-NP
assay NN I-NP
system NN I-NP
for IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
which WDT B-NP
is VBZ B-VP
a DT B-NP
whole-cell JJ I-NP
competitive JJ I-NP
binding NN I-NP
radioassay NN I-NP
using VBG B-VP
{3H}-dexamethasone NN B-NP
as IN B-PP
radioligand NN B-NP
. . O

This DT B-NP
modification NN I-NP
of IN B-PP
a DT B-NP
previously RB I-NP
described VBN I-NP
protocol NN I-NP
simplifies VBZ B-VP
and CC O
reduces VBZ B-VP
laboratory NN B-NP
work NN I-NP
and CC O
allows VBZ B-VP
assay NN B-NP
reproducibility NN I-NP
to TO B-VP
be VB I-VP
controlled VBN I-VP
more RBR B-ADVP
reliably RB I-ADVP
. . O

Thus RB B-VP
enabled VBN I-VP
to TO I-VP
perform VB I-VP
the DT B-NP
test NN I-NP
on IN B-PP
multiple JJ B-NP
blood NN I-NP
samples NNS I-NP
in IN B-PP
parallel NN B-NP
COMMA COMMA O
we PRP B-NP
investigated VBD B-VP
cardiac JJ B-NP
infarction NN I-NP
patients NNS I-NP
over IN B-PP
a DT B-NP
12-day JJ I-NP
period NN I-NP
to TO B-VP
test VB I-VP
if IN B-SBAR
glucocorticoid NN B-NP
receptor NN I-NP
binding NN I-NP
is VBZ B-VP
altered VBN I-VP
in IN B-PP
this DT B-NP
' `` I-NP
stressful JJ I-NP
' '' I-NP
disease NN I-NP
. . O

On IN B-PP
the DT B-NP
first JJ I-NP
day NN I-NP
of IN B-PP
the DT B-NP
disease NN I-NP
COMMA COMMA O
glucocorticoid NN B-NP
receptor NN I-NP
capacity NN I-NP
was VBD B-VP
significantly RB I-VP
decreased VBN I-VP
without IN B-PP
alteration NN B-NP
of IN B-PP
the DT B-NP
receptor-ligand JJ I-NP
affinity NN I-NP
COMMA COMMA O
whereas IN O
on IN B-PP
days NNS B-NP
4 CD B-NP
and CC O
12 CD B-NP
the DT B-NP
number NN I-NP
of IN B-PP
receptor NN B-NP
sites NNS I-NP
was VBD B-VP
normal JJ B-ADJP
again RB B-ADVP
. . O

This DT B-NP
result NN I-NP
fits VBZ B-VP
well RB B-ADVP
into IN B-PP
the DT B-NP
general JJ I-NP
observation NN I-NP
of IN B-PP
stress-induced JJ B-NP
down-regulation NN I-NP
of IN B-PP
immune JJ B-NP
responses NNS I-NP
. . O

Regulation NN B-NP
of IN B-PP
c-jun NN B-NP
expression NN I-NP
during IN B-PP
induction NN B-NP
of IN B-PP
monocytic JJ B-NP
differentiation NN I-NP
by IN B-PP
okadaic JJ B-NP
acid NN I-NP
. . O

The DT B-NP
present JJ I-NP
work NN I-NP
has VBZ B-VP
examined VBN I-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
okadaic JJ B-NP
acid NN I-NP
COMMA COMMA O
an DT B-NP
inhibitor NN I-NP
of IN B-PP
type NN O
1 CD B-NP
and CC O
2A NN B-NP
protein NN B-NP
phosphatases NNS I-NP
COMMA COMMA O
on IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
c-jun NN B-NP
expression NN I-NP
during IN B-PP
monocytic JJ B-NP
differentiation NN I-NP
of IN B-PP
U-937 NN B-NP
leukemia NN I-NP
cells NNS I-NP
. . O

The DT B-NP
results NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
okadaic JJ B-NP
acid NN I-NP
treatment NN I-NP
is VBZ B-VP
associated VBN I-VP
with IN B-PP
induction NN B-NP
of IN B-PP
a DT B-NP
differentiated VBN I-NP
monocyte NN I-NP
phenotype NN I-NP
characterized VBN B-VP
by IN B-PP
: : O
( ( B-LST
a LS I-LST
) ) O
growth NN B-NP
arrest NN I-NP
; : O
( ( B-LST
b LS I-LST
) ) O
increases NNS B-NP
in IN B-PP
Mac-1 NN B-NP
cell NN I-NP
surface NN I-NP
antigen NN I-NP
expression NN I-NP
; : O
( ( B-LST
c LS I-LST
) ) O
down-regulation NN B-NP
of IN B-PP
c-myc NN B-NP
transcripts NNS I-NP
; : O
and CC O
( ( B-LST
d LS I-LST
) ) O
induction NN B-NP
of IN B-PP
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
gene NN I-NP
expression NN I-NP
. . O

This DT B-NP
induction NN I-NP
of IN B-PP
monocytic JJ B-NP
differentiation NN I-NP
was VBD B-VP
associated VBN I-VP
with IN B-PP
transient JJ B-NP
increases NNS I-NP
in IN B-PP
c-jun NN B-NP
mRNA NN I-NP
levels NNS I-NP
COMMA COMMA O
which WDT B-NP
were VBD B-VP
maximal JJ B-ADJP
at IN B-PP
6 CD B-NP
h NN I-NP
. . O

Similar JJ B-NP
effects NNS I-NP
were VBD B-VP
obtained VBN I-VP
for IN B-PP
the DT B-NP
c-fos NN I-NP
gene NN I-NP
. . O

Run-on JJ B-NP
analysis NN I-NP
demonstrated VBD B-VP
detectable JJ B-NP
levels NNS I-NP
of IN B-PP
c-jun NN B-NP
transcription NN I-NP
in IN B-PP
U-937 NN B-NP
cells NNS I-NP
and CC O
that IN B-SBAR
this DT B-NP
rate NN I-NP
is VBZ B-VP
increased VBN I-VP
approximately RB B-ADVP
40-fold RB I-ADVP
following VBG B-PP
okadaic JJ B-NP
acid NN I-NP
exposure NN I-NP
. . O

c-jun NN B-NP
mRNA NN I-NP
levels NNS I-NP
were VBD B-VP
superinduced VBN I-VP
in IN B-PP
cells NNS B-NP
treated VBN B-VP
with IN B-PP
both CC O
okadaic JJ B-NP
acid NN I-NP
and CC O
cycloheximide NN B-NP
COMMA COMMA O
whereas IN O
inhibition NN B-NP
of IN B-PP
protein NN B-NP
synthesis NN I-NP
had VBD B-VP
little JJ O
COMMA COMMA O
if IN B-SBAR
any DT B-ADJP
COMMA COMMA O
effect NN B-NP
on IN B-PP
okadaic JJ B-NP
acid-induced JJ I-NP
c-jun NN I-NP
transcription NN I-NP
. . O

The DT B-NP
half-life NN I-NP
of IN B-PP
c-jun NN B-NP
mRNA NN I-NP
was VBD B-VP
similar JJ B-ADJP
( ( O
45-50 CD B-NP
min NN I-NP
) ) O
in IN B-PP
both CC B-NP
untreated JJ I-NP
and CC I-NP
okadaic JJ I-NP
acid-induced JJ I-NP
cells NNS I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
treatment NN B-NP
with IN B-PP
both DT B-NP
okadaic JJ B-NP
acid NN I-NP
and CC O
cycloheximide NN B-NP
was VBD B-VP
associated VBN I-VP
with IN B-PP
stabilization NN B-NP
( ( O
t NN B-NP
1\/2 CD I-NP
= JJ B-VP
90 CD B-NP
min NN I-NP
) ) O
of IN B-PP
c-jun NN B-NP
transcripts NNS I-NP
. . O

Taken VBN B-VP
together RB B-ADVP
COMMA COMMA O
these DT B-NP
findings NNS I-NP
indicate VBP B-VP
that IN B-SBAR
the DT B-NP
induction NN I-NP
of IN B-PP
c-jun NN B-NP
transcription NN I-NP
by IN B-PP
okadaic JJ B-NP
acid NN I-NP
is VBZ B-VP
controlled VBN I-VP
primarily RB B-ADVP
by IN B-PP
a DT B-NP
transcriptional JJ I-NP
mechanism NN I-NP
. . O

Since IN B-SBAR
previous JJ B-NP
studies NNS I-NP
have VBP B-VP
demonstrated VBN I-VP
that IN B-SBAR
the DT B-NP
c-jun NN I-NP
gene NN I-NP
is VBZ B-VP
autoinduced VBN I-VP
by IN B-PP
Jun\/AP-1 NN B-NP
COMMA COMMA O
we PRP B-NP
also RB B-ADVP
studied VBD B-VP
transcription NN B-NP
of IN B-PP
c-jun NN O
promoter NN O
( ( O
positions NNS B-NP
-132\/+170 CD B-NP
) ) O
-reporter JJ B-NP
gene NN I-NP
constructs NNS I-NP
with IN B-PP
and CC B-PP
without IN B-PP
a DT B-NP
mutated VBN I-NP
AP-1 NN I-NP
element NN I-NP
. . O

( ( O
ABSTRACT NN B-NP
TRUNCATED VBN B-VP
AT IN B-PP
250 CD B-NP
WORDS NNS I-NP
) ) O

Activation NN B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
by IN B-PP
interleukin NN B-NP
2 CD I-NP
in IN B-PP
human JJ B-NP
blood NN I-NP
monocytes NNS I-NP
. . O

We PRP B-NP
report VBP B-VP
here RB B-ADVP
that IN B-SBAR
interleukin NN B-NP
2 CD I-NP
( ( O
IL-2 NN B-NP
) ) O
acts VBZ B-VP
on IN B-PP
human JJ B-NP
blood NN I-NP
monocytes NNS I-NP
by IN B-PP
enhancing VBG B-VP
binding NN B-NP
activity NN I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
NF-kappa NN I-NP
B NN I-NP
to TO B-PP
its PRP$ B-NP
consensus NN I-NP
sequence NN I-NP
in IN B-PP
the DT B-NP
5' JJ I-NP
regulatory JJ I-NP
enhancer NN I-NP
region NN I-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
receptor NN I-NP
alpha NN I-NP
chain NN I-NP
( ( O
p55 NN B-NP
) ) O
. . O

Similarly RB B-ADVP
COMMA COMMA O
IL-2 NN B-NP
activates VBZ B-VP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
the DT B-NP
human JJ I-NP
monocytic JJ I-NP
cell NN I-NP
line NN I-NP
U NN I-NP
937 CD I-NP
COMMA COMMA B-PP
but CC I-PP
not RB B-PP
in IN I-PP
resting VBG B-NP
human JJ I-NP
T-cells NNS I-NP
. . O

This DT B-NP
effect NN I-NP
is VBZ B-VP
detectable JJ B-ADJP
within IN B-PP
15 CD B-NP
min NN I-NP
and CC O
peaks VBZ B-VP
1 CD B-NP
h NN I-NP
after IN B-PP
exposure NN B-NP
to TO B-PP
IL-2 NN B-NP
. . O

Enhanced VBN B-NP
NF-kappa NN I-NP
B NN I-NP
binding NN I-NP
activity NN I-NP
is VBZ B-VP
followed VBN I-VP
by IN B-PP
functional JJ B-NP
activation NN I-NP
in IN B-PP
that IN B-NP
inducibility NN B-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
receptor NN I-NP
alpha NN I-NP
chain NN I-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
enhanced VBN B-NP
NF-kappa NN I-NP
B NN I-NP
binding NN I-NP
and CC O
that IN B-NP
a DT B-NP
heterologous JJ I-NP
promoter NN I-NP
containing VBG B-VP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
consensus NN I-NP
sequence NN I-NP
( ( O
-291 CD B-NP
to TO O
-245 CD B-NP
) ) O
of IN B-PP
the DT B-NP
IL-2 NN I-NP
receptor NN I-NP
alpha NN I-NP
chain NN I-NP
gene NN I-NP
is VBZ B-VP
activated VBN I-VP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
IL-2 NN B-NP
is VBZ B-VP
capable JJ B-ADJP
of IN B-PP
increasing VBG B-VP
transcript NN B-NP
levels NNS I-NP
of IN B-PP
the DT B-NP
p50 NN I-NP
gene NN I-NP
coding VBG B-VP
for IN B-PP
the DT B-NP
p50 NN I-NP
subunit NN I-NP
of IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
whereas IN O
mRNA NN B-NP
levels NNS I-NP
of IN B-PP
the DT B-NP
p65 NN I-NP
NF-kappa NN I-NP
B NN I-NP
gene NN I-NP
remained VBD B-VP
unchanged JJ B-ADJP
. . O

Single JJ B-NP
point NN I-NP
estimation NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
in IN B-PP
lymphocytes NNS B-NP
of IN B-PP
normal JJ B-NP
subjects NNS I-NP
and CC B-PP
of IN B-PP
children NNS B-NP
under IN B-PP
long JJ B-NP
term NN I-NP
glucocorticoid NN I-NP
treatment NN I-NP
. . O

A DT B-NP
single JJ I-NP
point NN I-NP
assay NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
( ( O
GR NN B-NP
) ) O
in IN B-PP
human JJ B-NP
lymphocytes NNS I-NP
based VBN B-PP
on IN B-PP
the DT B-NP
measurement NN I-NP
of IN B-PP
specific JJ B-NP
dexamethasone NN I-NP
binding NN I-NP
has VBZ B-VP
been VBN I-VP
developed VBN I-VP
and CC O
compared VBN B-VP
with IN B-PP
a DT B-NP
common JJ I-NP
multi-point JJ I-NP
Scatchard NN I-NP
analysis NN I-NP
. . O

The DT B-NP
assay NN I-NP
conditions NN I-NP
- : O
concentration NN B-NP
of IN B-PP
the DT B-NP
ligand NN I-NP
20 CD B-NP
nmol\/l NN I-NP
COMMA COMMA O
incubation NN B-NP
time NN I-NP
2 CD I-NP
h NN I-NP
and CC O
the DT B-NP
cell NN I-NP
count NN I-NP
2-6 CD I-NP
mil. CD I-NP
cells\/tube NNS I-NP
in IN B-PP
the DT B-NP
assay NN I-NP
volume NN I-NP
0.25 CD I-NP
ml NN I-NP
were VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
optimal JJ B-ADJP
. . O

An DT B-NP
attempt NN I-NP
was VBD B-VP
also RB I-VP
undertaken VBN I-VP
to TO B-VP
use VB I-VP
a DT B-NP
cell NN I-NP
harvester NN I-NP
for IN B-PP
the DT B-NP
separation NN I-NP
of IN B-PP
cells NNS B-NP
from IN B-PP
unbound JJ B-NP
ligand NN I-NP
. . O

Though IN B-SBAR
specifically RB B-NP
bound VBN I-NP
dexamethasone NN I-NP
measured VBN B-VP
by IN B-PP
whole-cell JJ B-NP
assay NN I-NP
and CC O
that DT B-NP
using VBG B-VP
cell NN B-NP
harvester NN I-NP
correlated VBD B-VP
well RB B-ADVP
COMMA COMMA O
almost RB B-PP
by IN I-PP
one CD B-NP
order NN I-NP
lower JJR B-NP
values NNS I-NP
obtained VBN B-VP
with IN B-PP
the DT B-NP
latter JJ I-NP
method NN I-NP
render VBP B-VP
it PRP B-NP
non-applicable JJ B-ADJP
for IN B-PP
receptor NN B-NP
quantitation NN I-NP
. . O

The DT B-NP
results NNS I-NP
from IN B-PP
9 CD B-NP
healthy JJ I-NP
volunteers NNS I-NP
( ( O
average JJ B-NP
GR NN I-NP
concentration NN I-NP
7131 CD B-NP
+\/- CC I-NP
1256 CD I-NP
sites\/cell NNS I-NP
) ) O
correlated VBD B-VP
excellently RB B-ADVP
with IN B-PP
those DT B-NP
obtained VBN B-VP
by IN B-PP
the DT B-NP
Scatchard NN I-NP
analysis NN I-NP
. . O

The DT B-NP
single JJ I-NP
point NN I-NP
assay NN I-NP
has VBZ B-VP
been VBN I-VP
also RB I-VP
applied VBN I-VP
for IN B-PP
determination NN B-NP
of IN B-PP
GH NN B-NP
in IN B-PP
10 CD B-NP
children NNS I-NP
treated VBN B-VP
with IN B-PP
large JJ B-NP
doses NNS I-NP
of IN B-PP
prednisone NN B-NP
. . O

The DT B-NP
average JJ I-NP
values NNS I-NP
from IN B-PP
healthy JJ B-NP
volunteers NNS I-NP
did VBD B-VP
not RB I-VP
differ VB I-VP
significantly RB B-ADVP
from IN B-PP
those DT B-NP
found VBN B-VP
in IN B-PP
these DT B-NP
children NNS I-NP
COMMA COMMA O
though RB O
much RB B-NP
broader JJR I-NP
range NN I-NP
was VBD B-VP
found VBN I-VP
in IN B-PP
patients NNS B-NP
. . O

A DT B-NP
novel JJ I-NP
B NN I-NP
cell-derived JJ I-NP
coactivator NN I-NP
potentiates VBZ B-VP
the DT B-NP
activation NN I-NP
of IN B-PP
immunoglobulin NN B-NP
promoters NNS I-NP
by IN B-PP
octamer-binding JJ B-NP
transcription NN I-NP
factors NNS I-NP
. . O

A DT B-NP
novel JJ I-NP
B NN I-NP
cell-restricted JJ I-NP
activity NN I-NP
COMMA COMMA O
required VBN B-VP
for IN B-PP
high JJ B-NP
levels NNS I-NP
of IN B-PP
octamer\/Oct-dependent JJ B-NP
transcription NN I-NP
from IN B-PP
an DT O
immunoglobulin NN B-NP
heavy JJ I-NP
chain NN I-NP
( ( O
IgH NN B-NP
) ) O
promoter NN B-NP
COMMA COMMA O
was VBD B-VP
detected VBN I-VP
in IN B-PP
an DT B-NP
in FW I-NP
vitro FW I-NP
system NN I-NP
consisting VBG B-VP
of IN B-PP
HeLa NN B-NP
cell-derived JJ I-NP
extracts NNS I-NP
complemented VBN B-VP
with IN B-PP
fractionated VBN B-NP
B NN I-NP
cell NN I-NP
nuclear JJ I-NP
proteins NNS I-NP
. . O

The DT B-NP
factor NN I-NP
responsible JJ B-ADJP
for IN B-PP
this DT B-NP
activity NN I-NP
was VBD B-VP
designated VBN I-VP
Oct NN B-NP
coactivator NN I-NP
from IN B-PP
B NN B-NP
cells NNS I-NP
( ( O
OCA-B NN B-NP
) ) O
. . O

OCA-B NN B-NP
stimulates VBZ B-VP
the DT B-NP
transcription NN I-NP
from IN B-PP
an DT B-NP
IgH NN I-NP
promoter NN I-NP
in IN B-PP
conjunction NN I-PP
with IN I-PP
either CC O
Oct-1 NN B-NP
or CC O
Oct-2 NN B-NP
but CC O
shows VBZ B-VP
no DT B-NP
significant JJ I-NP
effect NN I-NP
on IN B-PP
the DT B-NP
octamer\/Oct-dependent JJ I-NP
transcription NN I-NP
of IN B-PP
the DT B-NP
ubiquitously RB I-NP
expressed VBN I-NP
histone NN I-NP
H2B NN I-NP
promoter NN I-NP
and CC O
the DT B-NP
transcription NN I-NP
of IN B-PP
USF- NN B-NP
and CC O
Sp1-regulated JJ B-ADJP
promoters NNS B-NP
. . O

Taken VBN B-VP
together RB B-ADVP
COMMA COMMA O
our PRP$ B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
OCA-B NN B-NP
is VBZ B-VP
a DT O
tissue- NN B-NP
COMMA COMMA O
promoter- NN B-NP
COMMA COMMA O
and CC O
factor-specific JJ B-ADJP
coactivator NN B-NP
and CC O
that IN B-SBAR
OCA-B NN B-NP
may MD B-VP
be VB I-VP
a DT B-NP
major JJ I-NP
determinant NN I-NP
for IN B-PP
B NN B-NP
cell-specific JJ I-NP
activation NN I-NP
of IN B-PP
immunoglobulin NN B-NP
promoters NNS I-NP
. . O

In IN B-PP
light NN I-PP
of IN I-PP
the DT B-NP
evidence NN I-NP
showing VBG B-VP
physical JJ B-NP
and CC I-NP
functional JJ I-NP
interactions NNS I-NP
between IN B-PP
Oct NN B-NP
factors NNS I-NP
and CC O
OCA-B NN B-NP
COMMA COMMA O
we PRP B-NP
propose VBP B-VP
a DT B-NP
mechanism NN I-NP
of IN B-PP
action NN B-NP
for IN B-PP
OCA-B NN B-NP
and CC O
discuss VBP B-VP
the DT B-NP
implications NNS I-NP
of IN B-PP
OCA-B NN B-NP
for IN B-PP
the DT B-NP
transcriptional JJ I-NP
regulation NN I-NP
of IN B-PP
other JJ B-NP
tissue-specific JJ I-NP
promoters NNS I-NP
. . O

The DT B-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
tumor NN I-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
promoter NN I-NP
region NN I-NP
in IN B-PP
macrophage NN B-NP
COMMA COMMA O
T NN B-NP
cell NN I-NP
COMMA COMMA O
and CC O
B NN B-NP
cell NN I-NP
lines NNS B-NP
. . O

The DT B-NP
1311-base JJ I-NP
pair NN I-NP
human JJ I-NP
tumor NN I-NP
necrosis NN I-NP
factor NN I-NP
( ( I-NP
TNF NN I-NP
) ) I-NP
alpha NN I-NP
promoter NN I-NP
region NN I-NP
was VBD B-VP
fused VBN I-VP
to TO B-PP
the DT O
luciferase NN B-NP
( ( O
Luc NN B-NP
) ) O
reporter NN B-NP
gene NN I-NP
and CC O
studied VBN B-VP
in IN B-PP
a DT B-NP
transient JJ I-NP
transfection NN I-NP
system NN I-NP
in IN B-PP
three CD B-NP
TNF NN I-NP
producing NN I-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
the DT B-NP
U937 NN I-NP
macrophage NN I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
the DT B-NP
MLA NN I-NP
144 CD I-NP
T NN I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
729-6 CD I-NP
B NN I-NP
cell NN I-NP
line NN I-NP
. . O

This DT B-NP
full JJ I-NP
length NN I-NP
promoter NN I-NP
construct NN I-NP
can MD B-VP
be VB I-VP
induced VBN I-VP
by IN B-PP
phorbol NN B-NP
13-myristate NN I-NP
acetate NN I-NP
( ( O
PMA NN B-NP
) ) O
in IN B-PP
each DT B-NP
of IN B-PP
these DT B-NP
cell NN I-NP
types NNS I-NP
. . O

Analysis NN B-NP
of IN B-PP
a DT B-NP
series NN I-NP
of IN B-PP
5'-truncations NNS B-NP
showed VBD B-VP
several JJ B-NP
peaks NNS I-NP
of IN B-PP
basal JJ B-NP
and CC I-NP
PMA NN I-NP
induced JJ I-NP
activity NN I-NP
suggesting VBG B-VP
the DT B-NP
presence NN I-NP
of IN B-PP
several JJ B-NP
positive JJ I-NP
and CC I-NP
negative JJ I-NP
regulatory JJ I-NP
elements NNS I-NP
. . O

A DT B-NP
PMA NN I-NP
responsive JJ I-NP
element NN I-NP
was VBD B-VP
localized JJ I-VP
to TO B-PP
a DT B-NP
region NN I-NP
between IN B-PP
-95 CD B-NP
and CC O
-36 CD B-NP
bp NN B-NP
relative JJ B-ADJP
to TO B-PP
the DT B-NP
transcription NN I-NP
start NN I-NP
site NN I-NP
. . O

Within IN B-PP
this DT B-NP
region NN I-NP
COMMA COMMA O
single JJ B-NP
AP-2- NN I-NP
and CC I-NP
AP-1-like JJ I-NP
consensus NN I-NP
sequences NNS I-NP
were VBD B-VP
noted VBN I-VP
. . O

These DT O
AP-2 NN B-NP
and CC O
AP-1 NN B-NP
sites NNS B-NP
were VBD B-VP
each DT O
modified VBN B-VP
with IN B-PP
a DT B-NP
double JJ I-NP
point NN I-NP
mutation NN I-NP
. . O

A DT O
modest JJ O
( ( O
20-50 CD B-NP
% NN I-NP
) ) O
reduction NN B-NP
in IN B-PP
TNF NN B-NP
promoter NN I-NP
activity NN I-NP
was VBD B-VP
observed VBN I-VP
with IN B-PP
the DT B-NP
AP-2 NN I-NP
site NN I-NP
mutation NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
mutation NN B-NP
of IN B-PP
the DT B-NP
AP-1 NN I-NP
site NN I-NP
markedly RB B-ADVP
diminished VBD B-VP
both CC B-NP
the DT I-NP
basal JJ I-NP
and CC I-NP
PMA-activated JJ I-NP
promoter NN I-NP
activity NN I-NP
. . O

Also RB B-ADVP
co-transfections NNS B-NP
of IN B-PP
the DT B-NP
wild-type JJ I-NP
promoter NN I-NP
construct NN I-NP
with IN B-PP
an DT B-NP
AP-1\/c-jun NN I-NP
expression NN I-NP
vector NN I-NP
resulted VBD B-VP
in IN B-PP
augmented JJ B-NP
basal JJ I-NP
and CC I-NP
PMA-induced JJ I-NP
promoter NN I-NP
activity NN I-NP
. . O

Redox NN B-NP
status NN I-NP
of IN B-PP
cells NNS B-NP
influences VBZ B-VP
constitutive JJ B-NP
or CC I-NP
induced VBN I-NP
NF-kappa NN I-NP
B NN I-NP
translocation NN I-NP
and CC O
HIV NN B-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
activity NN I-NP
in IN B-PP
human JJ O
T NN B-NP
and CC O
monocytic JJ B-ADJP
cell NN B-NP
lines NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
tested VBN I-VP
the DT B-NP
hypothesis NN I-NP
that IN B-SBAR
cellular JJ B-NP
activation NN I-NP
events NNS I-NP
occurring VBG B-VP
in IN B-PP
T NN B-NP
lymphocytes NNS I-NP
and CC O
monocytes NNS B-NP
and CC O
mediated VBN B-VP
through IN B-PP
translocation NN B-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
NF-kappa NN I-NP
B NN I-NP
are VBP B-VP
dependent JJ B-ADJP
upon IN B-PP
the DT B-NP
constitutive JJ I-NP
redox NN I-NP
status NN I-NP
of IN B-PP
these DT B-NP
cells NNS I-NP
. . O

We PRP B-NP
used VBD B-VP
phenolic JJ B-NP
COMMA COMMA I-NP
lipid-soluble JJ I-NP
COMMA COMMA I-NP
chain-breaking JJ I-NP
antioxidants NNS I-NP
( ( O
butylated VBN B-NP
hydroxyanisole NN I-NP
( ( O
BHA NN B-NP
) ) O
COMMA COMMA O
nordihydroquairetic JJ B-NP
acid NN I-NP
COMMA COMMA O
or CC O
alpha-tocopherol NN B-NP
( ( O
vitamin NN B-NP
E NN I-NP
) ) O
to TO B-VP
show VB I-VP
that IN B-SBAR
peroxyl JJ B-NP
radical JJ I-NP
scavenging NN I-NP
in IN B-PP
unstimulated JJ O
and CC O
PMA- NN B-NP
or CC O
TNF-stimulated JJ B-ADJP
cells NNS B-NP
blocks VBZ B-VP
the DT B-NP
functions NNS I-NP
depending VBG B-PP
on IN B-PP
NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
. . O

BHA NN B-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
suppress VB I-VP
not RB B-CONJP
only RB I-CONJP
PMA- NN B-NP
or CC O
TNF-induced JJ B-ADJP
COMMA COMMA O
but CC B-CONJP
also RB I-CONJP
constitutive JJ B-ADJP
COMMA COMMA B-NP
HIV-enhancer JJ I-NP
activity NN I-NP
concomitant JJ B-ADJP
to TO B-PP
an DT B-NP
inhibition NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
binding NN I-NP
activity NN I-NP
in IN B-PP
both CC O
lymphoblastoid JJ O
T NN O
( ( O
J.Jhan NN B-NP
) ) O
and CC O
monocytic JJ O
( ( O
U937 NN B-NP
) ) O
cell NN B-NP
lines NNS I-NP
. . O

This DT B-NP
was VBD B-VP
also RB B-ADVP
true JJ B-ADJP
for IN B-PP
KBF NN B-NP
( ( O
p50 NN B-NP
homodimer NN I-NP
) ) O
binding NN B-NP
activity NN I-NP
in IN B-PP
U937 NN B-NP
cells NNS I-NP
. . O

Secretion NN B-NP
of IN B-PP
TNF NN B-NP
COMMA COMMA O
the DT B-NP
product NN I-NP
of IN B-PP
another DT B-NP
NF-kappa NN I-NP
B-dependent JJ I-NP
gene NN I-NP
COMMA COMMA O
was VBD B-VP
abolished VBN I-VP
by IN B-PP
BHA NN B-NP
in IN B-PP
PMA-stimulated JJ B-NP
U937 NN I-NP
cells NNS I-NP
. . O

The DT B-NP
anti-oxidative JJ I-NP
effect NN I-NP
of IN B-PP
BHA NN B-NP
was VBD B-VP
accompanied VBN I-VP
by IN B-PP
an DT B-NP
increase NN I-NP
in IN B-PP
thiol NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
glutathione NN B-NP
COMMA COMMA O
content NN B-NP
in IN B-PP
stimulated VBN B-NP
and CC I-NP
unstimulated JJ I-NP
T NN I-NP
cell NN I-NP
COMMA COMMA O
whereas IN O
TNF NN B-NP
stimulation NN I-NP
itself PRP B-NP
barely RB B-ADVP
modified VBD B-VP
the DT B-NP
cellular JJ I-NP
thiol NN I-NP
level NN I-NP
. . O

Oxidative JJ B-NP
stress NN I-NP
obtained VBN B-VP
by IN B-PP
the DT B-NP
addition NN I-NP
of IN B-PP
H2O2 NN B-NP
to TO B-PP
the DT B-NP
culture NN I-NP
medium NN I-NP
of IN B-PP
J.Jhan NN B-NP
or CC O
U937 NN B-NP
cells NNS B-NP
could MD B-VP
not RB O
by IN B-PP
itself PRP B-NP
induce VB B-VP
NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
. . O

These DT B-NP
observations NNS I-NP
suggest VBP B-VP
that IN B-SBAR
TNF NN B-NP
and CC O
PMA NN B-NP
do VBP B-VP
not RB I-VP
lead VB I-VP
to TO B-PP
NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
through IN B-PP
induction NN B-NP
of IN B-PP
changes NNS B-NP
in IN B-PP
the DT B-NP
cell NN I-NP
redox NN I-NP
status NN I-NP
. . O

Rather RB B-ADVP
COMMA COMMA O
TNF NN B-NP
and CC O
PMA NN B-NP
can MD B-VP
exert VB I-VP
their PRP$ B-NP
effect NN I-NP
only RB B-SBAR
if IN I-SBAR
cells NNS B-NP
are VBP B-VP
in IN B-PP
an DT B-NP
appropriate JJ I-NP
redox NN I-NP
status NN I-NP
COMMA COMMA O
because IN B-SBAR
prior JJ B-NP
modification NN I-NP
toward IN B-PP
reduction NN B-NP
with IN B-PP
BHA NN B-NP
treatment NN I-NP
prevents VBZ B-VP
this DT I-VP
activation NN I-VP
. . O

It PRP B-NP
appears VBZ B-VP
that IN B-SBAR
a DT B-NP
basal JJ I-NP
redox NN I-NP
equilibrium NN I-NP
tending VBG B-VP
toward IN B-PP
oxidation NN B-NP
is VBZ B-VP
a DT B-NP
prerequisite NN I-NP
for IN B-PP
full JJ B-NP
activation NN I-NP
of IN B-PP
transduction NN B-NP
pathways NNS I-NP
regulating VBG B-VP
the DT B-NP
activity NN I-NP
of IN B-PP
NF-kappa NN B-NP
B-dependent JJ I-NP
genes NNS I-NP
. . O

Expression NN B-NP
of IN B-PP
c-fos NN B-NP
COMMA COMMA O
c-jun NN B-NP
and CC O
jun NN B-NP
B NN I-NP
in IN B-PP
peripheral JJ B-NP
blood NN I-NP
lymphocytes NNS I-NP
from IN B-PP
young JJ B-NP
and CC I-NP
elderly JJ I-NP
adults NNS I-NP
. . O

The DT B-NP
expression NN I-NP
of IN B-PP
c-fos NN B-NP
COMMA COMMA O
c-jun NN B-NP
and CC O
jun NN B-NP
B NN I-NP
proto-oncogenes NNS B-NP
was VBD B-VP
studied VBN I-VP
in IN B-PP
phytohemagglutinin NN B-NP
( ( O
PHA NN B-NP
) ) O
activated VBN B-NP
peripheral JJ B-NP
blood NN I-NP
lymphocytes NNS I-NP
( ( O
PBL NN B-NP
) ) O
from IN B-PP
young JJ B-NP
and CC I-NP
aged JJ I-NP
humans NNS I-NP
. . O

Specific JJ B-NP
mRNAs NNS I-NP
for IN B-PP
c-fos NN B-NP
and CC O
c-jun NN B-NP
were VBD B-VP
detectable JJ B-ADJP
within IN B-PP
30 CD B-NP
min NN I-NP
after IN B-PP
cell NN B-NP
activation NN I-NP
and CC O
reached VBD B-VP
maximal JJ B-NP
levels NNS I-NP
within IN B-PP
2 CD B-NP
h NN I-NP
. . O

Both CC O
c-fos NN B-NP
and CC O
jun NN B-NP
B NN I-NP
mRNAs NNS B-NP
decreased VBD B-VP
to TO B-PP
pre-activation NN B-NP
levels NNS I-NP
within IN B-PP
6 CD B-NP
h NN I-NP
COMMA COMMA O
while IN B-SBAR
c-jun NN B-NP
mRNA NN I-NP
remained VBD B-VP
elevated JJ B-ADJP
. . O

In IN B-PP
PHA-activated JJ B-NP
PBL NN I-NP
COMMA COMMA O
no DT B-NP
age-related JJ I-NP
differences NNS I-NP
were VBD B-VP
observed VBN I-VP
in IN B-PP
c-fos NN B-NP
or CC O
jun NN B-NP
B NN I-NP
mRNA NN B-NP
expression NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
c-jun NN B-NP
mRNA NN I-NP
levels NNS I-NP
decreased VBD B-VP
significantly RB B-ADVP
( ( O
1.73 CD B-NP
+\/- CC I-NP
0.08 CD I-NP
vs. CC O
1.16 CD B-NP
+\/- CC I-NP
0.09 CD I-NP
arbitrary JJ B-NP
units NNS I-NP
COMMA COMMA O
P NN B-NP
&lt; VBG B-VP
0.01 CD B-NP
COMMA COMMA O
young JJ B-ADJP
vs. CC O
old JJ B-ADJP
) ) O
in IN B-PP
PBL NN B-NP
from IN B-PP
elderly JJ B-NP
individuals NNS I-NP
activated VBN B-VP
with IN B-PP
PHA NN B-NP
. . O

Because IN B-SBAR
previous JJ B-NP
work NN I-NP
has VBZ B-VP
demonstrated VBN I-VP
that IN B-SBAR
T NN B-NP
cells NNS I-NP
from IN B-PP
elderly JJ B-NP
individuals NNS I-NP
may MD B-VP
display VB I-VP
normal JJ B-NP
proliferative JJ I-NP
responses NNS I-NP
when WRB B-ADVP
activated VBN B-VP
via IN B-PP
the DT B-NP
anti-CD2 JJ I-NP
pathway NN I-NP
COMMA COMMA O
c-jun NN B-NP
and CC O
jun NN B-NP
B NN I-NP
mRNA NN B-NP
expression NN I-NP
was VBD B-VP
also RB I-VP
studied VBN I-VP
in IN B-PP
anti-CD2-activated JJ B-NP
purified VBN I-NP
T NN I-NP
cells NNS I-NP
. . O

No DT B-NP
age-related JJ I-NP
differences NNS I-NP
were VBD B-VP
found VBN I-VP
in IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
either DT B-NP
of IN B-PP
these DT B-NP
two CD I-NP
proto-oncogenes NNS I-NP
by IN B-PP
anti-CD2 NN B-NP
activated JJ I-NP
T NN I-NP
cells NNS I-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
decreased VBN I-NP
IL-2 NN I-NP
production NN I-NP
and CC O
proliferative JJ B-NP
response NN I-NP
displayed VBN B-VP
by IN B-PP
PHA-activated JJ B-NP
PBL NN I-NP
from IN B-PP
elderly JJ B-NP
adults NNS I-NP
may MD B-VP
be VB I-VP
related JJ B-ADJP
to TO B-PP
age-related JJ B-NP
changes NNS I-NP
in IN B-PP
c-jun NN B-NP
mRNA NN I-NP
expression NN I-NP
and CC B-PP
in IN B-PP
the DT B-NP
ratio NN I-NP
of IN B-PP
c-fos NN B-NP
to TO B-PP
c-jun NN B-NP
mRNA NN B-NP
. . O

Characterization NN B-NP
of IN B-PP
a DT B-NP
novel JJ I-NP
T NN I-NP
lymphocyte NN I-NP
protein NN I-NP
which WDT B-NP
binds VBZ B-VP
to TO B-PP
a DT B-NP
site NN I-NP
related JJ B-ADJP
to TO B-PP
steroid\/thyroid JJ B-NP
hormone NN B-NP
receptor NN I-NP
response NN I-NP
elements NNS I-NP
in IN B-PP
the DT B-NP
negative JJ I-NP
regulatory JJ I-NP
sequence NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
. . O

We PRP B-NP
have VBP B-VP
previously RB I-VP
identified VBN I-VP
a DT B-NP
T NN I-NP
lymphocyte NN I-NP
protein NN I-NP
which WDT B-NP
binds VBZ B-VP
to TO B-PP
a DT B-NP
site NN I-NP
within IN B-PP
the DT B-NP
LTR NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HIV-1 NN B-NP
) ) O
and CC O
exerts VBZ B-VP
an DT B-NP
inhibitory JJ I-NP
effect NN I-NP
on IN B-PP
virus NN B-NP
gene NN I-NP
expression NN I-NP
. . O

The DT B-NP
palindromic JJ I-NP
site NN I-NP
( ( O
site NN B-NP
B NN I-NP
) ) O
recognized VBN B-VP
by IN B-PP
this DT B-NP
protein NN I-NP
is VBZ B-VP
related JJ B-ADJP
to TO B-PP
the DT B-NP
palindromic JJ I-NP
binding VBG I-NP
sites NNS I-NP
of IN B-PP
members NNS B-NP
of IN B-PP
the DT O
steroid\/thyroid JJ B-NP
hormone NN B-NP
receptor NN I-NP
family NN I-NP
. . O

Here RB B-ADVP
we PRP B-NP
characterize VBP B-VP
the DT B-NP
T NN I-NP
cell NN I-NP
protein NN I-NP
binding VBG B-VP
to TO B-PP
this DT B-NP
site NN I-NP
as IN B-PP
a DT B-NP
100 CD I-NP
kD NN I-NP
protein NN I-NP
which WDT B-NP
is VBZ B-VP
most RBS B-ADJP
abundant JJ I-ADJP
in IN B-PP
T NN B-NP
cells NNS I-NP
and CC O
which WDT B-NP
binds VBZ B-VP
to TO B-PP
site NN B-NP
B NN I-NP
as IN B-PP
a DT B-NP
200 CD I-NP
kD NN I-NP
complex NN I-NP
. . O

This DT B-NP
protein NN I-NP
is VBZ B-VP
distinct JJ B-ADJP
from IN B-PP
other JJ B-NP
members NNS I-NP
of IN B-PP
the DT O
steroid\/thyroid JJ B-NP
hormone NN B-NP
receptor NN I-NP
family NN I-NP
including VBG B-PP
the DT B-NP
COUP NN I-NP
protein NN I-NP
which WDT B-NP
has VBZ B-VP
a DT B-NP
closely RB I-NP
related JJ I-NP
DNA NN I-NP
binding NN I-NP
specificity NN I-NP
. . O

A DT B-NP
mechanism NN I-NP
for IN B-PP
the DT B-NP
antiinflammatory JJ I-NP
effects NNS I-NP
of IN B-PP
corticosteroids NNS B-NP
: : O
the DT B-NP
glucocorticoid NN I-NP
receptor NN I-NP
regulates VBZ B-VP
leukocyte NN B-NP
adhesion NN I-NP
to TO B-PP
endothelial JJ B-NP
cells NNS I-NP
and CC O
expression NN B-NP
of IN B-PP
endothelial-leukocyte JJ B-NP
adhesion NN I-NP
molecule NN I-NP
1 CD I-NP
and CC O
intercellular JJ B-NP
adhesion NN I-NP
molecule NN I-NP
1 CD I-NP
. . O

Corticosteroids NNS B-NP
are VBP B-VP
the DT B-NP
preeminent JJ I-NP
antiinflammatory JJ I-NP
agents NNS I-NP
although IN B-SBAR
the DT B-NP
molecular JJ I-NP
mechanisms NNS I-NP
that WDT B-NP
impart VBP B-VP
their PRP$ B-NP
efficacy NN I-NP
have VBP B-VP
not RB I-VP
been VBN I-VP
defined VBN I-VP
. . O

The DT B-NP
endothelium NN I-NP
plays VBZ B-VP
a DT B-NP
critical JJ I-NP
role NN I-NP
in IN B-PP
inflammation NN B-NP
by IN B-PP
directing VBG B-VP
circulating VBG B-NP
leukocytes NNS I-NP
into IN B-PP
extravascular JJ B-NP
tissues NNS I-NP
by IN B-PP
expressing VBG B-VP
adhesive JJ B-NP
molecules NNS I-NP
for IN B-PP
leukocytes NNS B-NP
{ ( O
e.g. FW B-PP
COMMA COMMA O
endothelial-leukocyte JJ B-NP
adhesion NN I-NP
molecule NN I-NP
1 CD I-NP
( ( O
ELAM-1 NN B-NP
) ) O
and CC O
intercellular JJ B-NP
adhesion NN I-NP
molecule NN I-NP
1 CD I-NP
( ( O
ICAM-1 NN B-NP
) ) O
} ) O
. . O

We PRP B-NP
therefore RB B-ADVP
determined VBD B-VP
whether IN B-SBAR
corticosteroids NNS B-NP
suppress VBP B-VP
inflammation NN B-NP
by IN B-PP
inhibiting VBG B-VP
endothelial JJ B-NP
expression NN I-NP
of IN B-PP
adhesion NN B-NP
molecules NNS I-NP
for IN B-PP
neutrophils NNS B-NP
( ( O
polymorphonuclear JJ B-NP
leukocytes NNS I-NP
) ) O
. . O

Preincubation NN B-NP
of IN B-PP
endothelial JJ B-NP
cells NNS I-NP
with IN B-PP
endotoxin NN B-NP
{ ( O
lipopolysaccharide NN B-NP
( ( O
LPS NN B-NP
) ) O
COMMA COMMA O
1 CD B-NP
microgram\/ml NN I-NP
} ) O
led VBD B-VP
to TO B-PP
a DT B-NP
4-fold JJ I-NP
increase NN I-NP
in IN B-PP
subsequent JJ B-NP
adherence NN I-NP
of IN B-PP
polymorphonuclear JJ B-NP
leukocytes NNS I-NP
( ( O
P NN B-NP
&lt; VBG B-VP
0.0001 CD B-NP
COMMA COMMA O
n NN B-NP
= JJ B-VP
10 CD B-NP
) ) O
to TO B-PP
endothelial JJ B-NP
cells NNS I-NP
COMMA COMMA O
an DT B-NP
increase NN I-NP
that WDT B-NP
was VBD B-VP
markedly RB I-VP
attenuated VBN I-VP
when WRB B-ADVP
endothelial JJ B-NP
cells NNS I-NP
were VBD B-VP
treated VBN I-VP
with IN B-PP
dexamethasone NN B-NP
( ( O
IC50 NN B-NP
&lt; VBG B-VP
1 CD B-NP
nM NN I-NP
COMMA COMMA O
P NN B-NP
&lt; VBG B-VP
0.0001 CD B-NP
COMMA COMMA O
n NN B-NP
= VBG B-VP
6 CD B-NP
or CC O
7 CD B-NP
) ) O
during IN B-PP
preincubation NN B-NP
with IN B-PP
LPS NN B-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
the DT B-NP
steroid NN I-NP
receptor NN I-NP
agonist NN I-NP
cortisol NN I-NP
( ( O
10 CD B-NP
microM NN I-NP
) ) O
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
its PRP$ B-NP
inactive JJ I-NP
metabolite NN I-NP
tetrahydrocortisol NN I-NP
( ( O
10 CD B-NP
microM NN I-NP
) ) O
COMMA COMMA O
diminished VBD B-VP
LPS-induced JJ B-NP
endothelial JJ I-NP
cell NN I-NP
adhesiveness NN I-NP
. . O

Further JJ B-NP
evidence NN I-NP
that IN B-SBAR
the DT B-NP
action NN I-NP
of IN B-PP
dexamethasone NN B-NP
was VBD B-VP
mediated VBN I-VP
through IN B-PP
ligation NN B-NP
of IN B-PP
corticosteroid NN B-NP
receptors NNS I-NP
{ ( O
human JJ B-NP
glucocorticoid NN I-NP
receptors NNS I-NP
( ( O
hGRs NNS B-NP
) ) O
} ) O
was VBD B-VP
provided VBN I-VP
by IN B-PP
experiments NNS B-NP
utilizing VBG B-VP
the DT B-NP
steroid NN I-NP
antagonist NN I-NP
RU-486 NN I-NP
. . O

RU-486 NN B-NP
( ( O
10 CD B-NP
microM NN I-NP
) ) O
COMMA COMMA O
which WDT B-NP
prevents VBZ B-VP
translocation NN B-NP
of IN B-PP
ligated VBN B-NP
hGR NN I-NP
to TO B-PP
the DT B-NP
nucleus NN I-NP
by IN B-PP
inhibiting VBG B-VP
dissociation NN B-NP
of IN B-PP
hGR NN B-NP
from IN B-PP
heat NN B-NP
shock NN I-NP
protein NN I-NP
90 CD I-NP
COMMA COMMA O
completely RB B-ADVP
aborted VBD B-VP
the DT B-NP
effect NN I-NP
of IN B-PP
dexamethasone NN B-NP
on IN B-PP
adhesiveness NN B-NP
of IN B-PP
endothelial JJ B-NP
cells NNS I-NP
( ( O
P NN B-NP
&lt; VBG B-VP
0.0005 CD B-NP
COMMA COMMA O
n NN B-NP
= JJ B-VP
3 CD B-NP
) ) O
. . O

Treatment NN B-NP
of IN B-PP
endothelial JJ B-NP
cells NNS I-NP
with IN B-PP
LPS NN B-NP
( ( O
1 CD B-NP
microgram\/ml NN I-NP
) ) O
stimulated VBD B-VP
transcription NN B-NP
of IN B-PP
ELAM-1 NN B-NP
COMMA COMMA O
as IN B-SBAR
shown VBN B-VP
by IN B-PP
Northern NN B-NP
blot NN I-NP
analysis NN I-NP
COMMA COMMA O
and CC O
expression NN B-NP
of IN B-PP
membrane-associated JJ B-NP
ELAM-1 NN B-NP
and CC O
ICAM-1 NN B-NP
COMMA COMMA O
as IN B-SBAR
shown VBN B-VP
by IN B-PP
quantitative JJ B-NP
immunofluorescence NN I-NP
( ( O
both DT B-NP
P NN I-NP
&lt; VBG B-VP
0.001 CD B-NP
COMMA COMMA O
n NN B-NP
= VBG B-VP
9 CD B-NP
) ) O
. . O

Dexamethasone NN B-NP
markedly RB B-ADVP
inhibited VBD B-VP
LPS-stimulated JJ B-NP
accumulation NN I-NP
of IN B-PP
mRNA NN B-NP
for IN B-PP
ELAM-1 NN B-NP
and CC O
expression NN B-NP
of IN B-PP
ELAM-1 NN B-NP
and CC O
ICAM-1 NN B-NP
( ( O
IC50 NN B-NP
&lt; VBG B-VP
10 CD B-NP
nM NN I-NP
COMMA COMMA O
both DT B-NP
P NN I-NP
&lt; VBG B-VP
0.001 CD B-NP
COMMA COMMA O
n NN B-NP
= VBG B-VP
4-9 CD B-NP
) ) O
; : O
inhibition NN B-NP
of IN B-PP
expression NN B-NP
by IN B-PP
dexamethasone NN B-NP
was VBD B-VP
reversed VBN I-VP
by IN B-PP
RU-486 NN B-NP
( ( O
both DT B-NP
P NN I-NP
&lt; VBG B-VP
0.005 CD B-NP
COMMA COMMA O
n NN B-NP
= VBG B-VP
4-6 CD B-NP
) ) O
. . O

As IN B-SBAR
in IN B-PP
the DT B-NP
adhesion NN I-NP
studies NNS I-NP
COMMA COMMA O
cortisol NN B-NP
but CC B-CONJP
not RB I-CONJP
tetrahydrocortisol NN B-NP
inhibited VBD B-VP
expression NN B-NP
of IN B-PP
ELAM-1 NN B-NP
and CC O
ICAM-1 NN B-NP
( ( O
both DT B-NP
P NN I-NP
&lt; VBG B-VP
0.005 CD B-NP
COMMA COMMA O
n NN B-NP
= JJ B-VP
3 CD B-NP
or CC O
4 CD B-NP
) ) O
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
sodium NN B-NP
salicylate NN I-NP
( ( O
1 CD B-NP
mM NN I-NP
) ) O
inhibited VBD B-VP
neither CC O
adhesion NN B-NP
nor CC O
expression NN B-NP
of IN B-PP
these DT B-NP
adhesion NN I-NP
molecules NNS I-NP
. . O

These DT B-NP
studies NNS I-NP
suggest VBP B-VP
that IN B-SBAR
antagonism NN B-NP
by IN B-PP
dexamethasone NN B-NP
of IN B-PP
endotoxin-induced JJ B-NP
inflammation NN I-NP
is VBZ B-VP
a DT B-NP
specific JJ I-NP
instance NN I-NP
of IN B-PP
the DT B-NP
general JJ I-NP
biological JJ I-NP
principle NN I-NP
that IN B-SBAR
the DT B-NP
glucocorticoid NN I-NP
receptor NN I-NP
is VBZ B-VP
a DT B-NP
hormone-dependent JJ I-NP
regulator NN I-NP
of IN B-PP
transcription NN B-NP
. . O

Membrane NN B-NP
receptors NNS I-NP
for IN B-PP
aldosterone NN B-NP
: : O
a DT B-NP
novel JJ I-NP
pathway NN I-NP
for IN B-PP
mineralocorticoid NN B-NP
action NN I-NP
. . O

Rapid JJ B-NP
nongenomic JJ I-NP
in FW I-NP
vitro FW I-NP
effects NNS I-NP
of IN B-PP
aldosterone NN B-NP
on IN B-PP
intracellular JJ B-NP
electrolytes NNS I-NP
COMMA COMMA O
cell NN B-NP
volume NN I-NP
COMMA COMMA O
and CC O
Na(+)-H+ JJ B-NP
antiport NN I-NP
have VBP B-VP
been VBN I-VP
found VBN I-VP
in IN B-PP
human JJ B-NP
mononuclear JJ I-NP
leukocytes NNS I-NP
( ( O
HML NN B-NP
) ) O
. . O

Binding NN B-NP
of IN B-PP
125I-labeled JJ B-NP
aldosterone NN I-NP
to TO B-PP
plasma NN B-NP
membranes NNS I-NP
of IN B-PP
HML NN B-NP
shares VBZ B-VP
important JJ B-NP
features NNS I-NP
with IN B-PP
these DT B-NP
functional JJ I-NP
data NNS I-NP
. . O

This DT B-NP
includes VBZ B-VP
a DT B-NP
very RB I-NP
low JJ I-NP
apparent JJ I-NP
dissociation NN B-NP
constant NN I-NP
( ( O
Kd NN B-NP
) ) O
of IN B-PP
0.1 CD B-NP
nM NN I-NP
for IN B-PP
both CC O
aldosterone NN B-NP
and CC O
the DT B-NP
effect NN I-NP
on IN B-PP
the DT B-NP
Na(+)-H(+)-antiport NN I-NP
COMMA COMMA O
a DT B-NP
high JJ I-NP
turnover NN I-NP
rate NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
almost RB I-NP
exclusive JJ I-NP
binding NN I-NP
selectivity NN I-NP
for IN B-PP
aldosterone NN B-NP
. . O

Dexamethasone NN B-NP
COMMA COMMA O
RU NN B-NP
26988 CD I-NP
COMMA COMMA O
corticosterone NN B-NP
COMMA COMMA O
ouabain NN B-NP
COMMA COMMA O
amiloride NN B-NP
COMMA COMMA O
and CC O
18-hydroxyprogesterone NN B-NP
were VBD B-VP
inactive JJ B-ADJP
as IN B-PP
ligands NNS B-NP
. . O

Deoxycorticosterone NN B-NP
acetate NN I-NP
had VBD B-VP
an DT B-NP
intermediate JJ I-NP
activity NN I-NP
with IN B-PP
an DT B-NP
apparent JJ I-NP
Kd NN I-NP
of IN B-PP
100 CD B-NP
nM NN I-NP
. . O

These DT B-NP
findings NNS I-NP
are VBP B-VP
the DT B-NP
first JJ I-NP
to TO B-VP
demonstrate VB I-VP
membrane NN B-NP
binding NN I-NP
of IN B-PP
aldosterone NN B-NP
being VBG B-VP
compatible JJ B-ADJP
with IN B-PP
major JJ B-NP
aspects NNS I-NP
of IN B-PP
its PRP$ B-NP
nongenomic JJ I-NP
effects NNS I-NP
. . O

Reticuloendotheliosis NN B-NP
virus NN I-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
elements NNS I-NP
are VBP B-VP
efficient JJ B-NP
promoters NNS I-NP
in IN B-PP
cells NNS B-NP
of IN B-PP
various JJ B-NP
species NNS B-NP
and CC O
tissue NN B-NP
origin NN B-NP
COMMA COMMA O
including VBG B-PP
human JJ B-NP
lymphoid JJ I-NP
cells NNS I-NP
. . O

Promiscuous JJ B-NP
transcriptional JJ I-NP
activity NN I-NP
of IN B-PP
the DT B-NP
reticuloendotheliosis NN I-NP
virus NN I-NP
( ( O
REV NN B-NP
) ) O
long JJ B-NP
terminal JJ I-NP
repeat NN I-NP
( ( O
LTR NN B-NP
) ) O
was VBD B-VP
detected VBN I-VP
in IN B-PP
transient JJ B-NP
expression NN I-NP
assays NNS I-NP
using VBG B-VP
LTR-chloramphenicol NN B-NP
acetyltransferase-encoding JJ I-NP
gene NN I-NP
chimeras NNS I-NP
COMMA COMMA O
and CC O
cells NNS B-NP
of IN B-PP
diverse JJ B-NP
species NNS B-NP
and CC O
tissue NN B-NP
type NN B-NP
; : O
levels NNS B-NP
of IN B-PP
expression NN B-NP
from IN B-PP
two CD B-NP
different JJ I-NP
REV NN I-NP
LTRs NNS I-NP
correlate VBP B-VP
with IN B-PP
reports NNS B-NP
of IN B-PP
pathogenicity NN B-NP
of IN B-PP
the DT B-NP
respective JJ I-NP
viruses NNS I-NP
in FW B-ADVP
vivo FW I-ADVP
. . O

REVs NNS B-NP
do VBP B-VP
not RB I-VP
encode VB I-VP
a DT B-NP
transactivator NN I-NP
targeted VBN B-VP
to TO B-PP
the DT B-NP
viral JJ I-NP
LTR NN I-NP
COMMA COMMA O
and CC O
cells NNS B-NP
infected VBN B-VP
with IN B-PP
Marek NN B-NP
's POS B-NP
disease NN I-NP
virus NN I-NP
COMMA COMMA O
a DT B-NP
herpesvirus NN I-NP
with IN B-PP
an DT B-NP
overlapping VBG I-NP
host NN I-NP
range NN I-NP
COMMA COMMA O
do VBP B-VP
not RB I-VP
express VB I-VP
factors NNS B-NP
that WDT B-NP
preferentially RB B-ADVP
enhance VBP B-VP
expression NN B-NP
from IN B-PP
REV NN B-NP
or CC O
avian JJ B-NP
sarcoma\/leukemia NN I-NP
virus NN I-NP
LTRs NNS I-NP
. . O

REV NN B-NP
LTRs NNS I-NP
work VBP B-VP
efficiently RB B-ADVP
in IN B-PP
human JJ B-NP
lymphoid JJ I-NP
cells NNS I-NP
COMMA COMMA O
and CC O
are VBP B-VP
viable JJ B-NP
alternatives NNS I-NP
to TO B-PP
promoters NNS B-NP
commonly RB B-VP
used VBN I-VP
for IN B-PP
expression NN B-NP
of IN B-PP
cloned VBN B-NP
genes NNS I-NP
. . O

They PRP B-NP
may MD B-VP
also RB I-VP
prove VB I-VP
useful JJ B-ADJP
in IN B-PP
the DT B-NP
identification NN I-NP
of IN B-PP
new JJ B-NP
COMMA COMMA I-NP
ubiquitous JJ I-NP
cellular JJ I-NP
transcription NN I-NP
factors NNS I-NP
. . O

Natural JJ B-NP
variants NNS I-NP
of IN B-PP
the DT B-NP
HIV-1 NN I-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
: : O
analysis NN B-NP
of IN B-PP
promoters NNS B-NP
with IN B-PP
duplicated JJ B-NP
DNA NN I-NP
regulatory JJ I-NP
motifs NNS I-NP
. . O

Sequence NN B-NP
variation NN I-NP
in IN B-PP
the DT O
long JJ B-NP
terminal JJ I-NP
repeat NN I-NP
( ( O
LTR NN B-NP
) ) O
region NN B-NP
of IN B-PP
HIV-1 NN B-NP
was VBD B-VP
analyzed VBN I-VP
in IN B-PP
viral JJ B-NP
isolates NNS I-NP
of IN B-PP
17 CD B-NP
infected JJ I-NP
individuals NNS I-NP
. . O

Two CD B-NP
classes NNS I-NP
of IN B-PP
LTR NN B-NP
size NN I-NP
variants NNS I-NP
were VBD B-VP
found VBN I-VP
. . O

One CD B-NP
HIV-1 NN I-NP
variant NN I-NP
was VBD B-VP
detected VBN I-VP
containing VBG B-VP
an DT B-NP
additional JJ I-NP
binding VBG I-NP
site NN I-NP
for IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
Sp1 NN I-NP
. . O

Another DT B-NP
LTR NN I-NP
size NN I-NP
variation NN I-NP
was VBD B-VP
observed VBN I-VP
in IN B-PP
four CD B-NP
patients NNS I-NP
in IN B-PP
a DT B-NP
region NN I-NP
just RB B-ADJP
upstream JJ I-ADJP
of IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
enhancer NN I-NP
. . O

This DT B-NP
variation NN I-NP
was VBD B-VP
the DT B-NP
result NN I-NP
of IN B-PP
a DT B-NP
duplication NN I-NP
of IN B-PP
a DT B-NP
short JJ I-NP
DNA NN I-NP
sequence NN I-NP
( ( O
CTG-motif NN B-NP
) ) O
. . O

Cell NN B-NP
culture NN I-NP
experiments NNS I-NP
demonstrated VBD B-VP
that IN B-SBAR
the DT B-NP
natural JJ I-NP
variant NN I-NP
with IN B-PP
four CD B-NP
Sp1 NN I-NP
sites NNS I-NP
had VBD B-VP
a DT B-NP
slightly RB I-NP
higher JJR I-NP
promoter NN B-NP
activity NN I-NP
and CC O
viral JJ B-NP
replication NN I-NP
rate NN I-NP
than IN B-PP
the DT B-NP
isogenic JJ I-NP
control NN I-NP
LTR NN I-NP
with IN B-PP
three CD B-NP
Sp1 NN I-NP
sites NNS I-NP
. . O

No DT B-NP
positive JJ I-NP
effect NN I-NP
of IN B-PP
the DT B-NP
duplicated JJ I-NP
CTG-motif NN I-NP
could MD B-VP
be VB I-VP
detected VBN I-VP
. . O

In IN B-SBAR
order NN O
to TO O
measure VB B-VP
small JJ B-NP
differences NNS I-NP
in IN B-PP
virus NN B-NP
production NN I-NP
more RBR B-ADVP
accurately RB I-ADVP
COMMA COMMA O
equal JJ B-NP
amounts NNS I-NP
of IN B-PP
a DT B-NP
size NN I-NP
variant NN I-NP
and CC O
the DT B-NP
wild-type JJ I-NP
plasmid NN I-NP
were VBD B-VP
cotransfected VBN I-VP
into IN B-PP
T-cells NNS B-NP
. . O

The DT B-NP
virus NN I-NP
with IN B-PP
four CD B-NP
Sp1 NN I-NP
sites NNS I-NP
did VBD B-VP
outgrow VB I-VP
the DT B-NP
three CD I-NP
Sp1 NN I-NP
virus NN I-NP
in IN B-PP
35 CD B-NP
days NNS I-NP
of IN B-PP
culture NN B-NP
and CC O
CTG-monomer NN B-NP
virus NN I-NP
outcompeted VBD B-VP
the DT B-NP
CTG-dimer NN I-NP
virus NN I-NP
in IN B-PP
42 CD B-NP
days NNS I-NP
. . O

Based VBN B-PP
on IN B-PP
these DT B-NP
results NNS I-NP
we PRP B-NP
estimate VBP B-VP
a DT B-NP
5-10 CD I-NP
% NN I-NP
difference NN I-NP
in IN B-PP
virus NN B-NP
production NN I-NP
of IN B-PP
the DT B-NP
LTR NN I-NP
variants NNS I-NP
when WRB B-ADVP
compared VBN B-VP
to TO B-PP
that DT B-NP
of IN B-PP
wild-type NN B-NP
. . O

SCL NN B-NP
and CC O
related JJ B-NP
hemopoietic JJ I-NP
helix-loop-helix JJ I-NP
transcription NN I-NP
factors NNS I-NP
. . O

The DT O
helix-loop-helix JJ O
( ( O
HLH JJ B-ADJP
) ) O
proteins NNS B-NP
are VBP B-VP
a DT B-NP
family NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
that WDT B-NP
include VBP B-VP
proteins NNS B-NP
critical JJ B-ADJP
to TO B-PP
differentiation NN B-NP
and CC O
development NN B-NP
in IN B-PP
species NNS B-NP
ranging VBG B-VP
from IN B-PP
plants NNS B-NP
to TO B-PP
mammals NNS B-NP
. . O

Five CD B-NP
members NNS I-NP
of IN B-PP
this DT B-NP
family NN I-NP
( ( O
MYC NN B-NP
COMMA COMMA O
SCL NN B-NP
COMMA COMMA O
TAL-2 NN B-NP
COMMA COMMA O
LYL-1 NN B-NP
and CC O
E2A NN B-NP
) ) O
are VBP B-VP
implicated VBN I-VP
in IN B-PP
oncogenic JJ B-NP
events NNS I-NP
in IN B-PP
human JJ B-NP
lymphoid JJ I-NP
tumors NNS I-NP
because IN B-PP
of IN I-PP
their PRP$ B-NP
consistent JJ I-NP
involvement NN I-NP
in IN B-PP
chromosomal JJ B-NP
translocations NNS I-NP
. . O

Although IN B-SBAR
activated VBN B-VP
in IN B-PP
T NN B-NP
cell NN I-NP
leukemias NNS I-NP
COMMA COMMA O
expression NN B-NP
of IN B-PP
SCL NN B-NP
and CC O
LYL-1 NN B-NP
is VBZ B-VP
low JJ B-ADJP
or CC O
undetectable JJ B-ADJP
in IN B-PP
normal JJ B-NP
T NN I-NP
cell NN I-NP
populations NNS I-NP
. . O

SCL NN B-NP
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
erythroid JJ O
COMMA COMMA O
megakaryocyte NN B-NP
and CC O
mast NN B-NP
cell NN I-NP
populations NNS B-NP
( ( O
the DT B-NP
same JJ I-NP
cell NN I-NP
lineages NNS I-NP
as IN B-PP
GATA-1 NN B-NP
COMMA COMMA O
a DT B-NP
zinc-finger NN I-NP
transcription NN I-NP
factor NN I-NP
) ) O
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
both CC O
SCL NN B-NP
and CC O
GATA-1 NN B-NP
undergo VBP B-VP
coordinate JJ B-NP
modulation NN I-NP
during IN B-PP
chemically RB B-NP
induced VBN I-NP
erythroid JJ I-NP
differentiation NN I-NP
of IN B-PP
mouse NN B-NP
erythroleukemia NN I-NP
cells NNS I-NP
and CC O
are VBP B-VP
down-modulated VBN I-VP
during IN B-PP
myeloid JJ B-NP
differentiation NN I-NP
of IN B-PP
human JJ B-NP
K562 NN I-NP
cells NNS I-NP
COMMA COMMA O
thus RB B-ADVP
implying VBG B-VP
a DT B-NP
role NN I-NP
for IN B-PP
SCL NN B-NP
in IN B-PP
erythroid JJ B-NP
differentiation NN I-NP
events NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
in IN B-PP
contrast NN I-PP
to TO I-PP
GATA-1 NN B-NP
COMMA COMMA O
SCL NN B-NP
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
the DT B-NP
developing VBG I-NP
brain NN I-NP
. . O

Studies NNS B-NP
of IN B-PP
the DT B-NP
function NN I-NP
of IN B-PP
SCL NN B-NP
suggest VBP B-VP
it PRP B-NP
is VBZ B-VP
also RB B-ADJP
important JJ I-ADJP
in IN B-PP
proliferation NN B-NP
and CC O
self-renewal JJ B-ADJP
events NNS B-NP
in IN B-PP
erythroid JJ B-NP
cells NNS I-NP
. . O

Transcription NN B-NP
of IN B-PP
the DT B-NP
hypersensitive JJ I-NP
site NN I-NP
HS2 NN I-NP
enhancer NN I-NP
in IN B-PP
erythroid JJ B-NP
cells NNS I-NP
. . O

In IN B-PP
the DT B-NP
human JJ I-NP
genome NN I-NP
COMMA COMMA O
the DT B-NP
erythroid-specific JJ I-NP
hypersensitive JJ I-NP
site NN I-NP
HS2 NN I-NP
enhancer NN I-NP
regulates VBZ B-VP
the DT B-NP
transcription NN I-NP
of IN B-PP
the DT B-NP
downstream JJ I-NP
beta-like JJ I-NP
globin NN I-NP
genes NNS I-NP
10-50 CD B-NP
kilobases NNS I-NP
away RB B-ADVP
. . O

The DT B-NP
mechanism NN I-NP
of IN B-PP
HS2 NN B-NP
enhancer NN I-NP
function NN I-NP
is VBZ B-VP
not RB I-VP
known VBN I-VP
. . O

The DT B-NP
present JJ I-NP
study NN I-NP
employs VBZ B-VP
RNA NN B-NP
protection NN I-NP
assays NNS I-NP
to TO B-VP
analyze VB I-VP
the DT B-NP
transcriptional JJ I-NP
status NN I-NP
of IN B-PP
the DT B-NP
HS2 NN I-NP
enhancer NN I-NP
in IN B-PP
transfected VBN O
recombinant JJ O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
( ( O
CAT NN B-NP
) ) O
plasmids NNS B-NP
. . O

In IN B-PP
erythroid JJ B-NP
K562 NN I-NP
cells NNS I-NP
in IN B-PP
which WDT B-NP
the DT B-NP
HS2 NN I-NP
enhancer NN I-NP
is VBZ B-VP
active JJ B-ADJP
COMMA COMMA O
the DT B-NP
HS2 NN I-NP
sequence NN I-NP
directs VBZ B-VP
the DT B-NP
synthesis NN I-NP
of IN B-PP
long JJ B-NP
enhancer NN I-NP
transcripts NNS I-NP
that WDT B-NP
are VBP B-VP
initiated VBN I-VP
apparently RB B-ADVP
from IN B-PP
within IN B-PP
the DT B-NP
enhancer NN I-NP
and CC O
elongated VBN B-VP
through IN B-PP
the DT B-NP
intervening VBG I-NP
DNA NN I-NP
into IN B-PP
the DT B-NP
cis-linked JJ I-NP
CAT NN I-NP
gene NN I-NP
. . O

In IN B-PP
nonerythroid JJ B-NP
HL-60 NN I-NP
cells NNS I-NP
in IN B-PP
which WDT B-NP
the DT B-NP
HS2 NN I-NP
enhancer NN I-NP
is VBZ B-VP
inactive JJ B-ADJP
COMMA COMMA O
long JJ B-NP
enhancer NN I-NP
transcripts NNS I-NP
are VBP B-VP
not RB O
detectable JJ B-ADJP
. . O

Splitting VBG B-VP
the DT B-NP
HS2 NN I-NP
enhancer NN I-NP
between IN B-PP
two CD B-NP
tandem JJ I-NP
Ap1 NN I-NP
sites NNS I-NP
abolishes VBZ B-VP
the DT B-NP
synthesis NN I-NP
of IN B-PP
a DT B-NP
group NN I-NP
of IN B-PP
long JJ B-NP
enhancer NN I-NP
transcripts NNS I-NP
and CC O
results VBZ B-VP
in IN B-PP
loss NN B-NP
of IN B-PP
enhancer NN B-NP
function NN I-NP
and CC O
transcriptional JJ B-NP
silencing NN I-NP
of IN B-PP
the DT B-NP
cis-linked JJ I-NP
CAT NN I-NP
gene NN I-NP
. . O

In IN B-PP
directing VBG B-VP
the DT B-NP
synthesis NN I-NP
of IN B-PP
RNA NN B-NP
through IN B-PP
the DT B-NP
intervening VBG I-NP
DNA NN I-NP
and CC O
the DT B-NP
gene NN I-NP
by IN B-PP
a DT O
tracking NN B-NP
and CC O
transcription NN B-NP
mechanism NN B-NP
COMMA COMMA O
the DT B-NP
HS2 NN I-NP
enhancer NN I-NP
may MD O
( ( B-LST
i LS I-LST
) ) O
open VB B-VP
up RP B-PRT
the DT B-NP
chromatin NN I-NP
structure NN I-NP
of IN B-PP
a DT B-NP
gene NN I-NP
domain NN I-NP
and CC O
( ( B-LST
ii LS I-LST
) ) O
deliver VB B-VP
enhancer NN B-NP
binding NN I-NP
proteins NNS I-NP
to TO B-PP
the DT B-NP
promoter NN I-NP
sequence NN I-NP
where WRB B-ADVP
they PRP B-NP
may MD B-VP
stimulate VB I-VP
the DT B-NP
transcription NN I-NP
of IN B-PP
the DT B-NP
gene NN I-NP
at IN B-PP
the DT B-NP
cap NN I-NP
site NN I-NP
. . O

Phorbol NN B-NP
ester NN I-NP
reduces VBZ B-VP
constitutive JJ B-NP
nuclear JJ I-NP
NF NN I-NP
kappa NN I-NP
B NN I-NP
and CC O
inhibits VBZ B-VP
HIV-1 NN B-NP
production NN I-NP
in IN B-PP
mature JJ B-NP
human JJ I-NP
monocytic JJ I-NP
cells NNS I-NP
. . O

NF NN B-NP
kappa NN I-NP
B NN I-NP
is VBZ B-VP
a DT B-NP
potent JJ I-NP
mediator NN I-NP
of IN B-PP
specific JJ B-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
and CC O
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
play VB I-VP
a DT B-NP
role NN I-NP
in IN B-PP
transcription NN B-NP
of IN B-PP
the DT B-NP
HIV-1 NN I-NP
genome NN I-NP
in IN B-PP
promonocytic JJ B-NP
leukemias NNS I-NP
. . O

There EX B-NP
is VBZ B-VP
little JJ B-NP
information NN I-NP
available JJ B-ADJP
on IN B-PP
the DT B-NP
response NN I-NP
of IN B-PP
NF NN B-NP
kappa NN I-NP
B NN I-NP
to TO B-PP
cytokines NNS B-NP
in IN B-PP
normal JJ B-NP
human JJ I-NP
monocytes NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
used VBN I-VP
a DT B-NP
32P-labeled JJ I-NP
oligonucleotide NN I-NP
derived VBN B-VP
from IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV-1 NN B-NP
) ) O
long JJ B-NP
terminal JJ I-NP
repeat NN I-NP
COMMA COMMA O
which WDT B-NP
contains VBZ B-VP
a DT B-NP
tandem JJ I-NP
repeat NN I-NP
of IN B-PP
the DT B-NP
NF NN I-NP
kappa NN I-NP
B NN I-NP
binding NN I-NP
sequence NN I-NP
COMMA COMMA O
as IN B-PP
a DT B-NP
probe NN I-NP
in IN B-PP
a DT B-NP
gel NN I-NP
retardation NN I-NP
assay NN I-NP
to TO B-VP
study VB I-VP
this DT B-NP
transcription NN I-NP
factor NN I-NP
. . O

Using VBG B-VP
this DT B-NP
assay NN I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
detected VBN I-VP
NF NN B-NP
kappa NN I-NP
B NN I-NP
in IN B-PP
extracts NNS B-NP
of IN B-PP
nuclei NNS B-NP
from IN B-PP
normal JJ B-NP
human JJ I-NP
monocytes NNS I-NP
. . O

Treatment NN B-NP
of IN B-PP
normal JJ B-NP
monocytes NNS I-NP
with IN B-PP
12-0-tetradecanoyl JJ B-NP
phorbol-13-acetate NN I-NP
( ( O
TPA NN B-NP
) ) O
for IN B-PP
4-24 CD B-NP
h NN I-NP
caused VBD B-VP
the DT B-NP
complete JJ I-NP
disappearance NN I-NP
of IN B-PP
NF NN B-NP
kappa NN I-NP
B NN I-NP
from IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
of IN B-PP
monocytes NNS B-NP
. . O

A DT B-NP
similar JJ I-NP
result NN I-NP
was VBD B-VP
obtained VBN I-VP
with IN B-PP
the DT B-NP
mature JJ I-NP
monocytic JJ I-NP
leukemia NN I-NP
cell NN I-NP
line NN I-NP
THP-1 NN I-NP
. . O

The DT B-NP
constitutive JJ I-NP
transcription NN I-NP
factor NN I-NP
SP1 NN I-NP
was VBD B-VP
unaffected JJ I-VP
by IN B-PP
addition NN B-NP
of IN B-PP
TPA NN B-NP
. . O

The DT B-NP
disappearance NN I-NP
of IN B-PP
NF NN B-NP
kappa NN I-NP
B NN I-NP
from IN B-PP
the DT B-NP
nucleus NN I-NP
was VBD B-VP
concentration NN B-NP
dependent JJ B-ADJP
between IN B-PP
10 CD B-NP
and CC I-NP
50 CD I-NP
ng\/ml NN I-NP
of IN B-PP
phorbol NN B-NP
ester NN I-NP
. . O

In IN B-PP
THP-1 NN B-NP
cells NNS I-NP
COMMA COMMA O
TPA NN B-NP
also RB B-ADVP
induced VBD B-VP
a DT B-NP
new JJ I-NP
COMMA COMMA I-NP
faster-migrating JJ I-NP
NF NN I-NP
kappa NN I-NP
B NN I-NP
species NNS I-NP
not RB B-VP
induced VBN I-VP
in IN B-PP
monocytes NNS B-NP
. . O

Protein NN B-NP
kinase NN I-NP
C NN I-NP
inhibitor NN I-NP
staurosporine NN I-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
cyclic JJ B-NP
nucleotide-dependent JJ I-NP
protein NN I-NP
kinase NN I-NP
inhibitor NN I-NP
HA-1004 NN I-NP
COMMA COMMA O
also RB B-ADVP
dramatically RB B-ADVP
reduced VBD B-VP
constitutive JJ B-NP
levels NNS I-NP
of IN B-PP
nuclear JJ B-NP
NF NN I-NP
kappa NN I-NP
B NN I-NP
. . O

Finally RB B-ADVP
COMMA COMMA O
TPA NN B-NP
addition NN I-NP
to TO B-PP
monocytes NNS B-NP
infected VBN B-VP
with IN B-PP
HIV-1 NN B-NP
inhibited VBD B-VP
HIV-1 NN B-NP
replication NN I-NP
COMMA COMMA O
as IN B-SBAR
determined VBN B-VP
by IN B-PP
reverse JJ B-NP
transcriptase NN I-NP
assays NNS I-NP
COMMA COMMA O
in IN B-PP
a DT B-NP
concentration-dependent JJ I-NP
manner NN I-NP
. . O

These DT B-NP
results NNS I-NP
are VBP B-VP
in IN B-PP
striking JJ B-NP
contrast NN I-NP
to TO B-PP
the DT B-NP
increase NN I-NP
in IN B-PP
nuclear JJ B-NP
NF NN I-NP
kappa NN I-NP
B NN I-NP
and CC O
HIV-1 NN B-NP
replication NN I-NP
induced VBN B-VP
by IN B-PP
phorbol NN B-NP
esters NNS I-NP
in IN B-PP
promonocytic JJ B-NP
leukemia NN I-NP
cells NNS I-NP
U937 NN B-NP
and CC O
HL-60 NN B-NP
COMMA COMMA O
and CC O
emphasize VBP B-VP
the DT B-NP
importance NN I-NP
of IN B-PP
studying VBG B-VP
cytokine NN B-NP
regulation NN I-NP
of IN B-PP
HIV-1 NN B-NP
in IN B-PP
normal JJ B-NP
monocytes NNS I-NP
. . O

Ablation NN B-NP
of IN B-PP
transplanted VBN B-NP
HTLV-I NN I-NP
Tax-transformed JJ I-NP
tumors NNS I-NP
in IN B-PP
mice NNS B-NP
by IN B-PP
antisense JJ B-NP
inhibition NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
{ ( O
published VBN B-NP
erratum NN I-NP
appears VBZ B-VP
in IN B-PP
Science NNP B-NP
1993 CD I-NP
Mar NNP I-NP
12 CD I-NP
; : I-NP
259 CD I-NP
( ( I-NP
5101 CD I-NP
) ) I-NP
: : I-NP
1523 CD I-NP
} ) O

Mice NNS B-NP
transgenic JJ B-ADJP
for IN B-PP
the DT O
human JJ B-NP
T NN I-NP
cell NN I-NP
leukemia NN I-NP
virus NN I-NP
( ( O
HTLV-I NN B-NP
) ) O
Tax NN B-NP
gene NN I-NP
develop VBP B-VP
fibroblastic JJ B-NP
tumors NNS I-NP
that WDT B-NP
express VBP B-VP
NF-kappa NN B-NP
B-inducible JJ I-NP
early JJ I-NP
genes NNS I-NP
. . O

In FW B-NP
vitro FW I-NP
inhibition NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
expression NN I-NP
by IN B-PP
antisense JJ B-NP
oligodeoxynucleotides NNS B-NP
( ( O
ODNs NNS B-NP
) ) O
inhibited VBD B-VP
growth NN B-NP
of IN B-PP
these DT B-NP
culture-adapted JJ I-NP
Tax-transformed JJ I-NP
fibroblasts NNS I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
an DT B-NP
HTLV-I-transformed JJ I-NP
human JJ I-NP
lymphocyte NN I-NP
line NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
antisense JJ B-NP
inhibition NN I-NP
of IN B-PP
Tax NN B-NP
itself PRP B-NP
had VBD B-VP
no DT B-NP
apparent JJ I-NP
effect NN I-NP
on IN B-PP
cell NN B-NP
growth NN I-NP
. . O

Mice NNS B-NP
treated VBN B-VP
with IN B-PP
antisense NN B-NP
to TO B-PP
NF-kappa NN B-NP
B NN I-NP
ODNs NNS I-NP
showed VBD B-VP
rapid JJ B-NP
regression NN I-NP
of IN B-PP
transplanted VBN B-NP
fibrosarcomas NNS I-NP
. . O

This DT B-NP
suggests VBZ B-VP
that IN B-SBAR
NF-kappa NN B-NP
B NN I-NP
expression NN I-NP
may MD B-VP
be VB I-VP
necessary JJ B-ADJP
for IN B-PP
the DT B-NP
maintenance NN I-NP
of IN B-PP
the DT B-NP
malignant JJ I-NP
phenotype NN I-NP
and CC O
provides VBZ B-VP
a DT B-NP
therapeutic JJ I-NP
approach NN I-NP
for IN B-PP
HTLV-I-associated JJ B-NP
disease NN I-NP
. . O

Inhibition NN B-NP
of IN B-PP
anti-CD3 JJ B-NP
monoclonal JJ I-NP
antibody-induced JJ I-NP
T-cell NN I-NP
proliferation NN I-NP
by IN B-PP
dexamethasone NN B-NP
COMMA COMMA O
isoproterenol NN B-NP
COMMA COMMA O
or CC O
prostaglandin NN B-NP
E2 NN I-NP
either CC O
alone RB B-ADVP
or CC O
in IN B-PP
combination NN B-NP
. . O

1 LS B-LST
. . O
The DT B-NP
purpose NN I-NP
of IN B-PP
these DT B-NP
studies NNS I-NP
was VBD B-VP
to TO B-VP
investigate VB I-VP
the DT B-NP
modulation NN I-NP
of IN B-PP
the DT B-NP
proliferation NN I-NP
of IN B-PP
human JJ B-NP
T NN I-NP
cells NNS I-NP
obtained VBN B-VP
from IN B-PP
peripheral JJ B-NP
blood NN I-NP
by IN B-PP
dexamethasone NN B-NP
( ( O
DEX NN B-NP
) ) O
COMMA COMMA O
isoproterenol NN B-NP
( ( O
ISO NN B-NP
) ) O
COMMA COMMA O
and CC O
prostaglandin NN B-NP
E2 NN I-NP
( ( O
PGE2 NN B-NP
) ) O
. . O

The DT B-NP
former JJ I-NP
two CD I-NP
substances NNS I-NP
interact VBP B-VP
with IN B-PP
T NN B-NP
cells NNS I-NP
via IN B-PP
the DT O
glucocorticoid NN B-NP
and CC O
beta-adrenergic JJ B-ADJP
receptors NNS B-NP
respectively RB B-ADVP
. . O

When WRB B-ADVP
occupied VBN B-VP
by IN B-PP
their PRP$ B-NP
natural JJ I-NP
ligands NNS I-NP
COMMA COMMA O
glucocorticosteroids NNS B-NP
and CC O
catecholamines NNS B-NP
COMMA COMMA O
these DT B-NP
receptors NNS I-NP
have VBP B-VP
a DT B-NP
role NN I-NP
in IN B-PP
modulating VBG B-VP
T-cell NN B-NP
function NN I-NP
during IN B-PP
stress NN B-NP
. . O

During IN B-PP
the DT B-NP
inflammatory JJ I-NP
response NN I-NP
increased VBN B-NP
levels NNS I-NP
of IN B-PP
PGE2 NN B-NP
bind VBP B-VP
to TO B-PP
their PRP$ B-NP
receptors NNS I-NP
on IN B-PP
T NN B-NP
cells NNS I-NP
and CC O
thus RB O
alter VBP B-VP
responsiveness NN B-NP
. . O

Proliferation NN B-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
was VBD B-VP
induced VBN I-VP
by IN B-PP
immobilized VBN B-NP
anti-CD3 JJ I-NP
monoclonal JJ B-NP
antibody NN I-NP
( ( O
mAb NN B-NP
) ) O
in IN B-PP
the DT B-NP
presence NN B-NP
or CC O
absence NN B-NP
of IN B-PP
an DT B-NP
additional JJ I-NP
costimulatory JJ I-NP
signal NN I-NP
delivered VBN B-VP
by IN B-PP
anti-CD28 JJ B-NP
mAb NN I-NP
. . O

2 LS B-LST
. . O
Various JJ B-NP
physiologic JJ I-NP
concentrations NNS I-NP
of IN B-PP
DEX NN B-NP
COMMA COMMA O
ISO NN B-NP
COMMA COMMA O
or CC O
PGE2 NN B-NP
were VBD B-VP
added VBN I-VP
at IN B-PP
the DT B-NP
time NN I-NP
of IN B-PP
initiation NN B-NP
of IN B-PP
the DT B-NP
cultures NNS I-NP
and CC O
subsequent JJ B-NP
proliferation NN I-NP
of IN B-PP
the DT B-NP
unstimulated JJ I-NP
T NN I-NP
cells NNS I-NP
was VBD B-VP
determined VBN I-VP
. . O

The DT B-NP
results NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
physiologic JJ B-NP
concentrations NNS I-NP
of IN B-PP
all DT B-NP
three CD I-NP
of IN B-PP
these DT B-NP
agents NNS I-NP
inhibit VBP B-VP
the DT B-NP
anti-CD3 JJ I-NP
mAb-induced JJ I-NP
proliferation NN I-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
. . O

3 LS B-LST
. . O
Although IN B-SBAR
DEX NN B-NP
and CC O
PGE2 NN B-NP
were VBD B-VP
equipotent JJ B-ADJP
in IN B-PP
suppressing JJ B-VP
T-cell NN B-NP
proliferation NN I-NP
COMMA COMMA O
ISO NN B-NP
was VBD B-VP
much RB B-ADJP
less RBR I-ADJP
effective JJ I-ADJP
. . O

4 LS B-LST
. . O
Because IN B-SBAR
concomitant JJ B-NP
elevations NNS I-NP
in IN B-PP
the DT B-NP
peripheral JJ I-NP
levels NNS I-NP
of IN B-PP
these DT B-NP
substances NNS I-NP
may MD B-VP
occur VB I-VP
COMMA COMMA O
experiments NNS B-NP
were VBD B-VP
performed VBN I-VP
to TO B-VP
determine VB I-VP
the DT B-NP
T-cell NN I-NP
inhibitory JJ I-NP
effects NNS I-NP
of IN B-PP
DEX NN B-NP
together RB B-PP
with IN I-PP
either CC O
PGE2 NN B-NP
or CC O
ISO NN B-NP
. . O

Synergistic JJ B-NP
suppression NN I-NP
of IN B-PP
T-cell NN B-NP
proliferation NN I-NP
was VBD B-VP
observed VBN I-VP
when WRB B-ADVP
various JJ B-NP
concentrations NNS I-NP
of IN B-PP
DEX NN B-NP
and CC O
PGE2 NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
DEX NN B-NP
and CC O
ISO NN B-NP
COMMA COMMA O
were VBD B-VP
added VBN I-VP
to TO B-PP
cultures NNS B-NP
. . O

This DT B-NP
synergistic JJ I-NP
suppression NN I-NP
could MD B-VP
not RB I-VP
be VB I-VP
explained VBN I-VP
by IN B-PP
an DT B-NP
increase NN I-NP
in IN B-PP
cAMP NN B-NP
accumulation NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
stimulated VBN B-VP
with IN B-PP
DEX NN B-NP
and CC O
PGE2 NN B-NP
. . O

5 LS B-LST
. . O
Finally RB B-ADVP
COMMA COMMA O
the DT B-NP
addition NN I-NP
of IN B-PP
anti-CD28 JJ B-NP
mAb NN I-NP
to TO B-PP
anti-CD3 JJ B-NP
mAb-stimulated JJ I-NP
T NN I-NP
cells NNS I-NP
overcame VBD B-VP
much JJ B-NP
of IN B-PP
the DT B-NP
suppression NN I-NP
of IN B-PP
proliferation NN B-NP
induced VBN B-VP
by IN B-PP
PGE2 NN B-NP
or CC O
ISO NN B-NP
but CC O
less RBR B-ADVP
so RB I-ADVP
than IN B-PP
that DT B-NP
induced VBN B-VP
by IN B-PP
DEX NN B-NP
. . O

Targeted VBN B-NP
degradation NN I-NP
of IN B-PP
c-Fos NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
v-Fos NN B-NP
COMMA COMMA O
by IN B-PP
a DT B-NP
phosphorylation-dependent JJ I-NP
signal NN I-NP
on IN B-PP
c-Jun NN B-NP
. . O

The DT B-NP
proto-oncogene NN I-NP
products NNS I-NP
c-Fos NN B-NP
and CC O
c-Jun NN B-NP
heterodimerize VBP B-VP
through IN B-PP
their PRP$ B-NP
leucine NN I-NP
zippers NNS I-NP
to TO B-VP
form VB I-VP
the DT B-NP
AP-1 NN I-NP
transcription NN I-NP
factor NN I-NP
. . O

The DT B-NP
transcriptional JJ I-NP
activity NN I-NP
of IN B-PP
the DT B-NP
heterodimer NN I-NP
is VBZ B-VP
regulated VBN I-VP
by IN B-PP
signal-dependent JJ O
phosphorylation NN B-NP
and CC O
dephosphorylation NN B-NP
events NNS B-NP
. . O

The DT B-NP
stability NN I-NP
of IN B-PP
c-Fos NN B-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
also RB I-VP
be VB I-VP
controlled VBN I-VP
by IN B-PP
intracellular JJ B-NP
signal NN I-NP
transduction NN I-NP
. . O

In IN B-PP
transient JJ B-NP
expression NN I-NP
and CC O
in FW B-NP
vitro FW I-NP
degradation NN I-NP
experiments NNS B-NP
COMMA COMMA O
the DT B-NP
stability NN I-NP
of IN B-PP
c-Fos NN B-NP
was VBD B-VP
decreased VBN I-VP
when WRB B-ADVP
the DT B-NP
protein NN I-NP
was VBD B-VP
dimerized JJ I-VP
with IN B-PP
phosphorylated VBN B-NP
c-Jun NN I-NP
. . O

c-Jun NN B-NP
protein NN I-NP
isolated VBN B-VP
from IN B-PP
phorbol NN B-NP
ester-induced JJ I-NP
cells NNS I-NP
did VBD B-VP
not RB I-VP
target VB I-VP
c-Fos NN B-NP
for IN B-PP
degradation NN B-NP
COMMA COMMA O
which WDT B-NP
suggests VBZ B-VP
that IN B-SBAR
c-Fos NN B-NP
is VBZ B-VP
transiently RB I-VP
stabilized VBN I-VP
after IN B-PP
stimulation NN B-NP
of IN B-PP
cell NN B-NP
growth NN I-NP
. . O

v-Fos NN B-NP
protein NN I-NP
COMMA COMMA O
the DT B-NP
retroviral JJ I-NP
counterpart NN I-NP
of IN B-PP
c-Fos NN B-NP
COMMA COMMA O
was VBD B-VP
not RB O
susceptible JJ B-ADJP
to TO B-PP
degradation NN B-NP
targeted VBN B-VP
by IN B-PP
c-Jun NN B-NP
. . O

Mutations NNS B-NP
in IN B-PP
the DT B-NP
Pit-1 NN I-NP
gene NN I-NP
in IN B-PP
children NNS B-NP
with IN B-PP
combined JJ B-NP
pituitary JJ I-NP
hormone NN I-NP
deficiency NN I-NP
. . O

Pit-1 NN B-NP
is VBZ B-VP
a DT B-NP
pituitary-specific JJ I-NP
transcription NN I-NP
factor NN I-NP
that WDT B-NP
binds VBZ B-VP
to TO B-PP
and CC O
transactivates VBZ B-VP
promoters NNS B-NP
of IN B-PP
growth NN B-NP
hormone NN I-NP
and CC O
prolactin NN B-NP
genes NNS I-NP
. . O

In IN B-PP
three CD B-NP
unrelated JJ I-NP
Japanese JJ I-NP
children NNS I-NP
with IN B-PP
combined JJ B-NP
pituitary JJ I-NP
hormone NN I-NP
deficiency NN I-NP
COMMA COMMA O
we PRP B-NP
identified VBD B-VP
three CD B-NP
point NN I-NP
mutations NNS I-NP
in IN B-PP
the DT B-NP
Pit-1 NN I-NP
gene NN I-NP
COMMA COMMA O
Pro24Leu NN B-NP
COMMA COMMA O
Arg143Gln NN B-NP
COMMA COMMA O
and CC O
Arg271Trp NN B-NP
COMMA COMMA O
located JJ O
on IN B-PP
the DT B-NP
major JJ I-NP
transactivation NN I-NP
region NN I-NP
COMMA COMMA O
POU-specific JJ B-NP
domain NN I-NP
COMMA COMMA O
and CC O
POU-homeodomain NN B-NP
COMMA COMMA O
respectively RB B-ADJP
. . O

Calcitriol NN B-NP
: : O
a DT B-NP
hematolymphopoietrope NN I-NP
? . O
{ ( O
editorial NN B-NP
} ) O

A DT B-NP
MEDLINE NN I-NP
search NN I-NP
of IN B-PP
the DT B-NP
English-language JJ I-NP
literature NN I-NP
was VBD B-VP
conducted VBN I-VP
using VBG B-VP
the DT B-NP
indexing NN I-NP
terms NNS I-NP
' `` O
immunology NN B-NP
COMMA COMMA O
calcitriol NN B-NP
and CC O
vitamin NN B-NP
D NN I-NP
' '' O
to TO B-VP
identify VB I-VP
studies NNS B-NP
indicating VBG B-VP
a DT B-NP
role NN I-NP
for IN B-PP
calcitriol NN B-NP
as IN B-PP
a DT B-NP
primary JJ I-NP
immunomodulator NN I-NP
. . O

Sixty-six CD B-NP
papers NNS I-NP
published VBN B-VP
between IN B-PP
January NNP B-NP
1956 CD I-NP
and CC O
June NNP B-NP
1991 CD I-NP
were VBD B-VP
identified VBN I-VP
. . O

Forty-five CD B-NP
of IN B-PP
these DT B-NP
reports NNS I-NP
are VBP B-VP
cited VBN I-VP
in IN B-PP
this DT B-NP
review NN I-NP
. . O

The DT B-NP
data NNS I-NP
strongly RB B-ADVP
suggest VBP B-VP
an DT B-NP
endocrine NN I-NP
COMMA COMMA I-NP
autocrine NN I-NP
and\/or CC I-NP
paracrine NN I-NP
role NN I-NP
for IN B-PP
calcitriol NN B-NP
in IN B-PP
immune JJ B-NP
regulation NN I-NP
. . O

No DT B-NP
unifying JJ I-NP
hypothesis NN I-NP
has VBZ B-VP
yet RB I-VP
emerged VBN I-VP
explaining VBG I-VP
this DT B-NP
collection NN I-NP
of IN B-PP
data NNS B-NP
. . O

This DT B-NP
paper NN I-NP
provides VBZ B-VP
a DT B-NP
brief JJ I-NP
review NN I-NP
of IN B-PP
immune JJ B-NP
properties NNS I-NP
currently RB B-VP
attributed VBN I-VP
to TO B-PP
calcitriol NN B-NP
. . O

Activation NN B-NP
of IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
and CC O
elevation NN B-NP
of IN B-PP
cAMP NN B-NP
interact VBP B-VP
synergistically RB I-VP
to TO I-VP
raise VB I-VP
c-Fos NN B-NP
and CC O
AP-1 NN B-NP
activity NN B-NP
in IN B-PP
Jurkat NN B-NP
cells NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
earlier RBR I-VP
found VBN I-VP
that IN B-SBAR
in IN B-PP
Jurkat NN B-NP
cells NNS I-NP
activation NN B-NP
of IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( O
PKC NN B-NP
) ) O
enhances VBZ B-VP
the DT O
cyclic JJ B-NP
adenosine NN I-NP
monophosphate NN I-NP
( ( O
cAMP NN B-NP
) ) O
accumulation NN B-NP
induced VBN B-VP
by IN B-PP
adenosine NN B-NP
receptor NN I-NP
stimulation NN I-NP
or CC O
activation NN B-NP
of IN B-PP
Gs NN B-NP
. . O

Here RB B-ADVP
we PRP B-NP
have VBP B-VP
therefore RB I-VP
examined VBN I-VP
the DT B-NP
effect NN I-NP
of IN B-PP
the DT B-NP
phorbol NN I-NP
ester NN I-NP
PMA NN B-NP
( ( O
phorbol NN B-NP
12-myristate NN I-NP
13-acetate NN I-NP
) ) O
which WDT B-NP
stimulates VBZ B-VP
PKC NN B-NP
and CC O
a DT B-NP
combination NN I-NP
of IN B-PP
the DT B-NP
adenosine NN I-NP
receptor NN I-NP
agonist NN I-NP
NECA NN B-NP
( ( O
5'-(N-ethyl)-carboxamido JJ B-NP
adenosine NN I-NP
) ) O
and CC O
forskolin NN B-NP
to TO B-VP
raise VB I-VP
cAMP NN B-NP
COMMA COMMA O
on IN B-PP
the DT B-NP
levels NNS I-NP
of IN B-PP
c-Fos NN B-NP
and CC O
Jun NN B-NP
and CC B-PP
on IN B-PP
the DT B-NP
binding VBG B-NP
and CC O
transcriptional JJ B-NP
activity NN I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
activator NN B-NP
protein-1 NN I-NP
( ( O
AP-1 NN B-NP
) ) O
. . O

PMA NN B-NP
treatment NN I-NP
caused VBD B-VP
a DT O
concentration- NN B-NP
and CC O
time-dependent JJ B-ADJP
increase NN B-NP
in IN B-PP
both CC O
c-Fos NN B-NP
and CC O
Jun NN B-NP
immunoreactivity NN B-NP
in IN B-PP
contrast NN I-PP
to TO I-PP
cAMP NN B-NP
elevation NN I-NP
that WDT B-NP
had VBD B-VP
only RB B-NP
a DT I-NP
slight JJ I-NP
effect NN I-NP
. . O

Both CC O
PMA NN B-NP
and CC O
the DT B-NP
combination NN I-NP
of IN B-PP
NECA NN B-NP
and CC O
forskolin NN B-NP
acted VBD B-VP
together RB B-ADVP
either CC O
to TO B-VP
increase VB I-VP
( ( O
c-Fos NN B-NP
) ) O
or CC O
decrease VB B-VP
( ( O
Jun NN B-NP
) ) O
protein NN B-NP
levels NNS I-NP
as RB B-PP
well RB I-PP
as IN I-PP
increasing VBG B-VP
AP-1 NN B-NP
binding NN I-NP
COMMA COMMA O
as IN B-SBAR
judged VBN B-VP
by IN B-PP
gel-shift NN B-NP
assay NN I-NP
COMMA COMMA O
and CC O
AP-1 NN B-NP
transcriptional JJ I-NP
activity NN I-NP
. . O

Furthermore RB B-ADVP
there EX B-NP
was VBD B-VP
a DT B-NP
clear-cut JJ I-NP
synergy NN I-NP
between IN B-PP
the DT B-NP
PKC NN I-NP
stimulator NN I-NP
and CC O
the DT B-NP
cAMP NN I-NP
elevating NN I-NP
agents NNS I-NP
. . O

The DT B-NP
results NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
the DT B-NP
simultaneous JJ I-NP
activation NN B-NP
of IN B-PP
PKC NN B-NP
and CC O
elevation NN B-NP
of IN B-PP
cAMP NN B-NP
leads VBZ B-VP
to TO B-PP
an DT B-NP
enhanced VBN I-NP
AP-1 NN I-NP
transcriptional JJ I-NP
activity NN I-NP
in IN B-PP
a DT B-NP
T-leukemia NN I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
the DT B-NP
previously RB I-NP
observed VBN I-NP
interaction NN I-NP
between IN B-PP
the DT B-NP
parallel JJ I-NP
signal NN I-NP
transduction NN I-NP
pathways NNS I-NP
may MD B-VP
have VB I-VP
functional JJ B-NP
consequences NNS I-NP
at IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
gene NN B-NP
transcription NN I-NP
. . O

The DT B-NP
use NN I-NP
of IN B-PP
interferon-gamma-treated JJ B-NP
U937 NN I-NP
cells NNS I-NP
in IN B-PP
chemiluminescence NN B-NP
assays NNS I-NP
to TO B-VP
detect VB I-VP
red JJ B-NP
cell NN I-NP
COMMA COMMA O
platelet NN B-NP
and CC O
granulocyte NN B-NP
antibodies NNS I-NP
of IN B-PP
potential JJ B-NP
clinical JJ I-NP
significance NN I-NP
. . O

The DT O
chemiluminescent JJ O
( ( O
CL JJ B-ADJP
) ) O
response NN B-NP
of IN B-PP
interferon-gamma-treated JJ B-NP
U937 NN I-NP
( ( O
IFN-U937 NN B-NP
) ) O
cells NNS B-NP
to TO B-PP
sensitized VBN B-NP
target NN I-NP
cells NNS I-NP
has VBZ B-VP
been VBN I-VP
used VBN I-VP
to TO B-VP
detect VB I-VP
red JJ B-NP
cell NN I-NP
COMMA COMMA O
platelet NN B-NP
and CC O
granulocyte NN B-NP
antibodies NNS I-NP
. . O

A DT B-NP
clone NN I-NP
of IN B-PP
U937 NN B-NP
cells NNS I-NP
was VBD B-VP
selected VBN I-VP
which WDT B-NP
expressed VBD B-VP
Fc NN B-NP
receptor NN I-NP
I NN I-NP
( ( O
Fc NN B-NP
gamma NN I-NP
RI NN I-NP
) ) O
and CC O
which WDT B-NP
COMMA COMMA O
after IN B-PP
incubation NN B-NP
with IN B-PP
IFN-gamma NN B-NP
for IN B-PP
72 CD B-NP
h NN I-NP
COMMA COMMA O
was VBD B-VP
capable JJ B-ADJP
of IN B-PP
generating VBG B-VP
high JJ B-NP
levels NNS I-NP
of IN B-PP
lucigenin-enhanced JJ B-NP
CL NN I-NP
. . O

The DT B-NP
CL NN I-NP
responses NNS I-NP
of IN B-PP
IFN-U937 NN B-NP
cells NNS I-NP
and CC O
peripheral JJ B-NP
blood NN I-NP
human JJ I-NP
monocytes NNS I-NP
to TO B-PP
sensitized VBN B-NP
red JJ B-NP
cells NNS I-NP
COMMA COMMA O
platelets NNS B-NP
or CC O
granulocytes NNS B-NP
were VBD B-VP
then RB I-VP
compared VBN I-VP
. . O

Assays NNS B-NP
using VBG B-VP
monocytes NNS B-NP
or CC O
IFN-U937 NN B-NP
cells NNS I-NP
were VBD B-VP
of IN B-PP
comparable JJ B-NP
sensitivity NN I-NP
for IN B-PP
detection NN B-NP
of IN B-PP
antibodies NNS B-NP
against IN B-PP
all DT B-NP
three CD I-NP
types NNS I-NP
of IN B-PP
target NN B-NP
cell NN I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
the DT B-NP
use NN I-NP
of IN B-PP
IFN-U937 NN B-NP
cells NNS I-NP
reduced VBD B-VP
interassay JJ B-NP
variation NN I-NP
and CC O
simplified VBD B-VP
assay NN B-NP
performance NN I-NP
. . O

The DT B-NP
potential JJ I-NP
clinical JJ I-NP
usefulness NN I-NP
of IN B-PP
these DT B-NP
CL NN I-NP
assays NNS I-NP
was VBD B-VP
suggested VBN I-VP
by IN B-PP
the DT B-NP
ability NN I-NP
of IN B-PP
both CC O
monocytes NNS B-NP
and CC O
IFN-U937 NN B-NP
cells NNS I-NP
to TO B-VP
respond VB I-VP
to TO B-PP
red JJ B-NP
cells NNS I-NP
COMMA COMMA O
platelets NNS B-NP
or CC O
granulocytes NNS B-NP
sensitized VBN B-VP
with IN B-PP
sera NN B-NP
from IN B-PP
pregnant JJ B-NP
women NNS I-NP
whose WP$ B-NP
babies NNS I-NP
had VBD B-VP
either CC O
haemolytic JJ B-NP
disease NN I-NP
of IN I-NP
the DT I-NP
newborn JJ I-NP
( ( O
HDN NN B-NP
) ) O
COMMA COMMA O
alloimmune JJ B-NP
thrombocytopenia NN I-NP
or CC O
alloimmune JJ B-NP
neutropenia NN I-NP
respectively RB B-ADVP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
monocytes NNS B-NP
and CC O
IFN-U937 NN B-NP
cells NNS I-NP
both DT B-NP
responded VBD B-VP
to TO B-PP
red JJ B-NP
cells NNS I-NP
sensitized VBN B-VP
with IN B-PP
antibodies NNS B-NP
against IN B-PP
a DT B-NP
variety NN I-NP
of IN B-PP
specificities NNS B-NP
of IN B-PP
assumed VBN B-NP
( ( I-NP
although IN I-NP
not RB I-NP
documented VBN I-NP
) ) I-NP
clinical JJ I-NP
significance NN I-NP
for IN B-PP
blood NN B-NP
transfusion NN I-NP
recipients NNS I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
monocytes NNS B-NP
and CC O
IFN-U937 NN B-NP
cells NNS I-NP
responded VBD B-VP
only RB B-ADVP
weakly RB I-ADVP
to TO B-PP
red JJ B-NP
cells NNS I-NP
sensitized VBN B-VP
with IN B-PP
either CC I-PP
anti-D JJ B-NP
in IN B-PP
sera NN B-NP
from IN B-PP
mothers NNS B-NP
of IN B-PP
babies NNS B-NP
unaffected JJ B-VP
by IN B-PP
HDN NN B-NP
COMMA COMMA B-PP
or CC I-PP
with IN B-PP
antisera NNS B-NP
containing VBG B-VP
high JJ B-NP
titre NN I-NP
antibodies NNS I-NP
with IN B-PP
specificities NNS B-NP
not RB B-VP
normally RB I-VP
associated VBN I-VP
with IN B-PP
significantly RB B-NP
reduced VBN I-NP
red JJ I-NP
cell NN I-NP
survival NN I-NP
. . O

Photoaffinity NN B-NP
labeling NN I-NP
of IN B-PP
plasma NN B-NP
membrane NN I-NP
receptors NNS I-NP
for IN B-PP
aldosterone NN B-NP
from IN B-PP
human JJ B-NP
mononuclear JJ I-NP
leukocytes NNS I-NP
. . O

Non-genomic JJ B-NP
effects NNS I-NP
of IN B-PP
aldosterone NN B-NP
on IN B-PP
the DT B-NP
sodium-proton-antiport NN I-NP
have VBP B-VP
been VBN I-VP
shown VBN I-VP
in IN B-PP
human JJ B-NP
mononuclear JJ I-NP
leukocytes NNS I-NP
which WDT B-NP
could MD B-VP
be VB I-VP
related JJ B-ADJP
to TO B-PP
a DT B-NP
new JJ I-NP
aldosterone NN I-NP
membrane NN I-NP
receptor NN I-NP
. . O

In IN B-PP
the DT B-NP
present JJ I-NP
paper NN I-NP
plasma NN B-NP
membranes NNS I-NP
from IN B-PP
human JJ B-NP
mononuclear JJ I-NP
leukocytes NNS I-NP
were VBD B-VP
covalently RB I-VP
photolabeled VBN I-VP
with IN B-PP
a DT B-NP
{125I}-aldosterone NN I-NP
derivative NN I-NP
. . O

Sodium NN B-NP
dodecyl NN I-NP
sulfate-polyacrylamide JJ I-NP
gel NN I-NP
electrophoresis NN I-NP
showed VBD B-VP
significant JJ B-NP
aldosterone NN I-NP
binding NN I-NP
at IN B-PP
a DT B-NP
molecular JJ I-NP
weight NN I-NP
of IN B-PP
approximately RB B-NP
50000 CD I-NP
Dalton NN I-NP
which WDT B-NP
was VBD B-VP
absent JJ B-ADJP
with IN B-PP
1 CD B-NP
microM NN I-NP
cold JJ B-NP
aldosterone NN I-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
cortisol NN B-NP
in IN B-PP
the DT B-NP
binding VBG I-NP
media NNS I-NP
. . O

The DT B-NP
presence NN I-NP
of IN B-PP
the DT B-NP
sulfhydryl NN I-NP
agent NN I-NP
dithiothreitol NN I-NP
did VBD B-VP
not RB I-VP
affect VB I-VP
results NNS B-NP
suggesting VBG B-VP
the DT B-NP
absence NN I-NP
of IN B-PP
disulfide NN B-NP
bridges NNS I-NP
in IN B-PP
the DT B-NP
steroid NN I-NP
binding NN I-NP
domain NN I-NP
of IN B-PP
the DT B-NP
receptor NN I-NP
. . O

These DT B-NP
data NNS I-NP
are VBP B-VP
the DT B-NP
first JJ I-NP
to TO B-VP
define VB I-VP
the DT B-NP
molecular JJ I-NP
weight NN I-NP
of IN B-PP
the DT B-NP
membrane NN I-NP
receptor NN I-NP
for IN B-PP
aldosterone NN B-NP
. . O

Alpha-lipoic JJ B-NP
acid NN I-NP
is VBZ B-VP
a DT B-NP
potent JJ I-NP
inhibitor NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
in IN B-PP
human JJ B-NP
T NN I-NP
cells NNS I-NP
. . O

Acquired VBN B-NP
immunodeficiency NN I-NP
syndrome NN I-NP
( ( O
AIDS NN B-NP
) ) O
results VBZ B-VP
from IN B-PP
infection NN B-NP
with IN B-PP
a DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV NN B-NP
) ) O
. . O

The DT O
long JJ B-NP
terminal JJ I-NP
repeat NN I-NP
( ( O
LTR NN B-NP
) ) O
region NN B-NP
of IN B-PP
HIV NN B-NP
proviral JJ I-NP
DNA NN I-NP
contains VBZ B-VP
binding VBG B-NP
sites NNS I-NP
for IN B-PP
nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
( ( O
NF-kappa NN B-NP
B NN I-NP
) ) O
COMMA COMMA O
and CC O
this DT B-NP
transcriptional JJ I-NP
activator NN I-NP
appears VBZ B-VP
to TO I-VP
regulate VB I-VP
HIV NN B-NP
activation NN I-NP
. . O

Recent JJ B-NP
findings NNS I-NP
suggest VBP B-VP
an DT B-NP
involvement NN I-NP
of IN B-PP
reactive JJ B-NP
oxygen NN I-NP
species NNS I-NP
( ( O
ROS NN B-NP
) ) O
in IN B-PP
signal NN B-NP
transduction NN I-NP
pathways NNS I-NP
leading VBG B-VP
to TO B-PP
NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
. . O

The DT B-NP
present JJ I-NP
study NN I-NP
was VBD B-VP
based VBN I-VP
on IN B-PP
reports NNS B-NP
that IN B-SBAR
antioxidants NNS B-NP
which WDT B-NP
eliminate VBP B-VP
ROS NN B-NP
should MD B-VP
block VB I-VP
the DT B-NP
activation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
and CC O
subsequently RB B-ADVP
HIV NN B-NP
transcription NN I-NP
COMMA COMMA O
and CC O
thus RB O
antioxidants NNS B-NP
can MD B-VP
be VB I-VP
used VBN I-VP
as IN B-PP
therapeutic JJ B-NP
agents NNS I-NP
for IN B-PP
AIDS NN B-NP
. . O

Incubation NN B-NP
of IN B-PP
Jurkat NN B-NP
T NN I-NP
cells NNS I-NP
( ( O
1 CD B-NP
x CC I-NP
10(6) CD I-NP
cells\/ml NNS I-NP
) ) O
with IN B-PP
a DT B-NP
natural JJ I-NP
thiol NN I-NP
antioxidant NN I-NP
COMMA COMMA I-NP
alpha-lipoic JJ I-NP
acid NN I-NP
COMMA COMMA O
prior JJ B-PP
to TO I-PP
the DT B-NP
stimulation NN I-NP
of IN B-PP
cells NNS B-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
inhibit VB I-VP
NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
induced VBN B-VP
by IN B-PP
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
( ( O
25 CD B-NP
ng\/ml NN I-NP
) ) O
or CC B-PP
by IN B-PP
phorbol NN B-NP
12-myristate NN I-NP
13-acetate NN I-NP
( ( O
50 CD B-NP
ng\/ml NN I-NP
) ) O
. . O

The DT B-NP
inhibitory JJ I-NP
action NN I-NP
of IN B-PP
alpha-lipoic JJ B-NP
acid NN I-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
very RB B-ADJP
potent JJ I-ADJP
as IN B-SBAR
only RB B-NP
4 CD I-NP
mM NN I-NP
was VBD B-VP
needed VBN I-VP
for IN B-PP
a DT B-NP
complete JJ I-NP
inhibition NN I-NP
COMMA COMMA O
whereas IN O
20 CD B-NP
mM NN I-NP
was VBD B-VP
required VBN I-VP
for IN B-PP
N-acetylcysteine NN B-NP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
alpha-lipoic JJ B-NP
acid NN I-NP
may MD B-VP
be VB I-VP
effective JJ B-ADJP
in IN B-PP
AIDS NN B-NP
therapeutics NNS I-NP
. . O

Activation NN B-NP
of IN B-PP
lymphokine NN B-NP
genes NNS I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
: : O
role NN B-NP
of IN B-PP
cis-acting JJ B-NP
DNA NN I-NP
elements NNS I-NP
that WDT B-NP
respond VBP B-VP
to TO B-PP
T NN B-NP
cell NN I-NP
activation NN I-NP
signals NNS I-NP
. . O

Activation NN B-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
is VBZ B-VP
initiated VBN I-VP
by IN B-PP
the DT B-NP
recognition NN I-NP
of IN B-PP
antigen NN B-NP
on IN B-PP
antigen NN B-NP
presenting NN I-NP
cells NNS I-NP
to TO B-VP
exert VB I-VP
the DT B-NP
effector NN I-NP
functions NNS I-NP
in IN B-PP
immune JJ B-NP
and CC I-NP
inflammatory JJ I-NP
responses NNS I-NP
. . O

Two CD B-NP
types NNS I-NP
of IN B-PP
helper NN B-NP
T NN I-NP
cell NN I-NP
( ( O
Th NN B-NP
) ) O
clones NNS B-NP
( ( O
Th1 NN B-NP
and CC O
Th2 NN B-NP
) ) O
are VBP B-VP
defined VBN I-VP
on IN B-PP
the DT I-PP
basis NN I-PP
of IN I-PP
different JJ B-NP
patterns NNS I-NP
of IN B-PP
cytokine NN B-NP
( ( O
lymphokine NN B-NP
) ) O
secretion NN B-NP
. . O

They PRP B-NP
determine VBP B-VP
the DT B-NP
outcome NN I-NP
of IN B-PP
an DT B-NP
antigenic JJ I-NP
response NN I-NP
toward IN B-PP
humoral JJ B-NP
or CC I-NP
cell-mediated JJ I-NP
immunity NN I-NP
. . O

Although IN B-SBAR
lymphokine NN B-NP
genes NNS I-NP
are VBP B-VP
coordinately RB I-VP
regulated VBN I-VP
upon IN B-PP
antigen NN B-NP
stimulation NN I-NP
COMMA COMMA O
they PRP B-NP
are VBP B-VP
regulated VBN I-VP
by IN B-PP
the DT B-NP
mechanisms NNS I-NP
common JJ B-ADJP
to TO B-PP
all DT B-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
those DT B-NP
which WDT B-NP
are VBP B-VP
unique JJ B-ADJP
to TO B-PP
each DT B-NP
gene NN I-NP
. . O

For IN B-PP
most JJS B-NP
lymphokine NN I-NP
genes NNS I-NP
COMMA COMMA O
a DT B-NP
combination NN I-NP
of IN B-PP
phorbol NN B-NP
esters NNS I-NP
( ( O
phorbol NN B-NP
12-myristate NN I-NP
13 CD I-NP
acetate NN I-NP
COMMA COMMA O
PMA NN B-NP
) ) O
and CC O
calcium NN B-NP
ionophores NNS I-NP
( ( O
A23187 NN B-NP
) ) O
is VBZ B-VP
required VBN I-VP
for IN B-PP
their PRP$ B-NP
maximal JJ I-NP
induction NN I-NP
. . O

Yet RB O
phorbol NN B-NP
ester NN I-NP
alone RB B-ADVP
or CC O
calcium NN B-NP
ionophore NN I-NP
alone RB B-ADVP
produce VBP B-VP
several JJ B-NP
lymphokines NNS I-NP
. . O

The DT B-NP
production NN I-NP
of IN B-PP
the DT B-NP
granulocyte-macrophage JJ I-NP
colony NN I-NP
stimulating NN I-NP
factor NN I-NP
( ( O
GM-CSF NN B-NP
) ) O
is VBZ B-VP
completely RB B-ADJP
dependent JJ I-ADJP
on IN B-PP
the DT B-NP
two CD I-NP
signals NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
previously RB I-VP
found VBN I-VP
a DT B-NP
cis-acting JJ I-NP
region NN I-NP
spanning VBG B-VP
the DT B-NP
GM-CSF NN I-NP
promoter NN I-NP
region NN I-NP
( ( O
positions NNS B-NP
-95 CD B-NP
to TO O
+27 CD B-NP
) ) O
that WDT B-NP
confers VBZ B-VP
inducibility NN B-NP
to TO B-PP
reporter NN B-NP
genes NNS I-NP
in IN B-PP
transient JJ B-NP
transfection NN I-NP
assays NNS I-NP
. . O

Further JJ B-NP
analysis NN I-NP
identified VBD B-VP
three CD B-NP
elements NNS I-NP
required VBN B-VP
for IN B-PP
efficient JJ B-NP
induction NN I-NP
COMMA COMMA O
referred VBN B-VP
to TO B-PP
as IN B-PP
GM2 NN B-NP
COMMA COMMA O
GC-box NN B-NP
and CC O
conserved VBN B-NP
lymphokine NN I-NP
element NN I-NP
( ( O
CLE0 NN B-NP
) ) O
. . O

GM2 NN B-NP
defines VBZ B-VP
a DT B-NP
binding VBG I-NP
site NN I-NP
for IN B-PP
protein NN B-NP
( ( I-NP
s NNS I-NP
) ) O
whose WP$ B-NP
binding NN I-NP
is VBZ B-VP
inducible JJ B-ADJP
by IN B-PP
PMA NN B-NP
. . O

One CD B-NP
protein NN I-NP
COMMA COMMA O
NF-GM2 NN B-NP
is VBZ B-VP
similar JJ B-ADJP
to TO B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
NF-kB NN I-NP
. . O

GC-box NN B-NP
is VBZ B-VP
a DT B-NP
binding VBG I-NP
site NN I-NP
for IN B-PP
constitutively RB B-NP
bound VBN I-NP
proteins NNS I-NP
. . O

CLEO NN B-NP
defines VBZ B-VP
a DT B-NP
binding VBG I-NP
site NN I-NP
for IN B-PP
protein NN B-NP
( ( I-NP
s NNS I-NP
) ) O
whose WP$ B-NP
optimum NN I-NP
binding NN I-NP
is VBZ B-VP
stimulated VBN I-VP
by IN B-PP
PMA NN B-NP
and CC O
A23187 NN B-NP
. . O

Viral JJ B-NP
trans-activators NNS I-NP
such JJ B-PP
as IN I-PP
Tax NN B-NP
( ( O
human JJ B-NP
T NN I-NP
cell NN I-NP
leukemia NN I-NP
virus-1 NN I-NP
COMMA COMMA O
HTLV-1 NN B-NP
) ) O
and CC O
E2 NN B-NP
( ( O
bovine JJ B-NP
papilloma NN I-NP
virus NN I-NP
COMMA COMMA O
BPV NN B-NP
) ) O
proteins NNS B-NP
are VBP B-VP
other JJ B-NP
agents NNS I-NP
which WDT B-NP
activate VBP B-VP
lymphokine NN B-NP
gene NN I-NP
expression NN I-NP
by IN B-PP
bypassing VBG B-VP
T NN B-NP
cell NN I-NP
receptor NN I-NP
( ( O
TCR NN B-NP
) ) O
mediated JJ B-NP
signaling NN I-NP
. . O

The DT B-NP
trans-activation NN I-NP
domain NN I-NP
of IN B-PP
E2 NN B-NP
and CC O
Tax NN B-NP
is VBZ B-VP
interchangeable JJ B-ADJP
although IN B-SBAR
they PRP B-NP
have VBP B-VP
no DT B-NP
obvious JJ I-NP
sequence NN I-NP
homology NN I-NP
between IN B-PP
them PRP B-NP
. . O

The DT B-NP
viral JJ I-NP
trans-activators NNS I-NP
appear VBP B-VP
to TO I-VP
target VB I-VP
specific JJ B-NP
DNA NN I-NP
binding NN I-NP
protein NN I-NP
such JJ B-PP
as IN I-PP
NF-kB NN B-NP
and CC O
Sp1 NN B-NP
to TO B-PP
cis-acting JJ B-NP
DNA NN I-NP
site NN I-NP
and CC O
promote VB B-VP
lymphokine NN B-NP
gene NN I-NP
expression NN I-NP
without IN B-PP
TCR-mediated JJ B-NP
stimulation NN I-NP
. . O

I NN B-NP
kappa NN I-NP
B\/MAD-3 NN I-NP
masks VBZ B-VP
the DT B-NP
nuclear JJ I-NP
localization NN I-NP
signal NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
p65 NN I-NP
and CC O
requires VBZ B-VP
the DT B-NP
transactivation NN I-NP
domain NN I-NP
to TO B-VP
inhibit VB I-VP
NF-kappa NN B-NP
B NN I-NP
p65 NN I-NP
DNA NN I-NP
binding NN I-NP
. . O

The DT B-NP
active JJ I-NP
nuclear JJ I-NP
form NN I-NP
of IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
transcription NN I-NP
factor NN I-NP
complex NN I-NP
is VBZ B-VP
composed VBN I-VP
of IN B-PP
two CD B-NP
DNA NN I-NP
binding NN I-NP
subunits NNS I-NP
COMMA COMMA O
NF-kappa NN B-NP
B NN I-NP
p65 NN I-NP
and CC O
NF-kappa NN B-NP
B NN I-NP
p50 NN I-NP
COMMA COMMA O
both DT B-NP
of IN B-PP
which WDT B-NP
share VBP B-VP
extensive JJ B-NP
N-terminal JJ I-NP
sequence NN I-NP
homology NN I-NP
with IN B-PP
the DT B-NP
v-rel NN I-NP
oncogene NN I-NP
product NN I-NP
. . O

The DT B-NP
NF-kappa NN I-NP
B NN I-NP
p65 NN I-NP
subunit NN I-NP
provides VBZ B-VP
the DT B-NP
transactivation NN I-NP
activity NN I-NP
in IN B-PP
this DT B-NP
complex JJ I-NP
and CC O
serves VBZ B-VP
as IN B-PP
an DT B-NP
intracellular JJ I-NP
receptor NN I-NP
for IN B-PP
a DT B-NP
cytoplasmic JJ I-NP
inhibitor NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
termed VBN B-VP
I NN B-NP
kappa NN I-NP
B NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
NF-kappa NN B-NP
B NN I-NP
p50 NN I-NP
alone RB B-ADVP
fails VBZ B-VP
to TO I-VP
stimulate VB I-VP
kappa NN B-NP
B-directed JJ I-NP
transcription NN I-NP
COMMA COMMA O
and CC O
based VBN B-PP
on IN B-PP
prior JJ B-NP
in FW I-NP
vitro FW I-NP
studies NNS I-NP
COMMA COMMA O
is VBZ B-VP
not RB I-VP
directly RB I-VP
regulated VBN I-VP
by IN B-PP
I NN B-NP
kappa NN I-NP
B NN I-NP
. . O

To TO B-VP
investigate VB I-VP
the DT B-NP
molecular JJ I-NP
basis NN I-NP
for IN B-PP
the DT B-NP
critical JJ I-NP
regulatory JJ I-NP
interaction NN I-NP
between IN B-PP
NF-kappa NN B-NP
B NN I-NP
and CC O
I NN B-NP
kappa NN I-NP
B\/MAD-3 NN I-NP
COMMA COMMA O
a DT B-NP
series NN I-NP
of IN B-PP
human JJ B-NP
NF-kappa NN I-NP
B NN I-NP
p65 NN I-NP
mutants NNS I-NP
was VBD B-VP
identified VBN I-VP
that WDT B-NP
functionally RB B-ADVP
segregated VBD B-VP
DNA NN B-NP
binding NN I-NP
COMMA COMMA O
I NN B-NP
kappa NN I-NP
B-mediated JJ I-NP
inhibition NN I-NP
COMMA COMMA O
and CC O
I NN B-NP
kappa NN I-NP
B-induced JJ I-NP
nuclear JJ I-NP
exclusion NN I-NP
of IN B-PP
this DT B-NP
transcription NN I-NP
factor NN I-NP
. . O

Results NNS B-NP
from IN B-PP
in FW B-NP
vivo FW I-NP
expression NN I-NP
studies NNS I-NP
performed VBN B-VP
with IN B-PP
these DT B-NP
NF-kappa NN I-NP
B NN I-NP
p65 NN I-NP
mutants NNS I-NP
revealed VBD B-VP
the DT B-NP
following NN I-NP
: : O
1 LS B-LST
) ) O
I NN B-NP
kappa NN I-NP
B\/MAD-3 NN I-NP
completely RB B-ADVP
inhibits VBZ B-VP
NF-kappa NN B-NP
B NN I-NP
p65-dependent JJ I-NP
transcriptional JJ I-NP
activation NN I-NP
mediated VBN B-VP
through IN B-PP
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
kappa NN I-NP
B NN I-NP
enhancer NN I-NP
in IN B-PP
human JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
COMMA COMMA O
2 LS B-LST
) ) O
the DT B-NP
binding NN I-NP
of IN B-PP
I NN B-NP
kappa NN I-NP
B\/MAD-3 NN I-NP
to TO B-PP
NF-kappa NN B-NP
B NN I-NP
p65 NN I-NP
is VBZ B-VP
sufficient JJ B-ADJP
to TO B-VP
retarget VB I-VP
NF-kappa NN B-NP
B NN I-NP
p65 NN I-NP
from IN B-PP
the DT B-NP
nucleus NN I-NP
to TO B-PP
the DT B-NP
cytoplasm NN I-NP
COMMA COMMA O
3 LS B-LST
) ) O
selective JJ B-NP
deletion NN I-NP
of IN B-PP
the DT B-NP
functional JJ I-NP
nuclear JJ I-NP
localization NN I-NP
signal NN I-NP
present JJ B-ADJP
in IN B-PP
the DT B-NP
Rel NN I-NP
homology NN I-NP
domain NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
p65 NN I-NP
disrupts VBZ B-VP
its PRP$ B-NP
ability NN I-NP
to TO B-VP
engage VB I-VP
I NN B-NP
kappa NN I-NP
B\/MAD-3 NN I-NP
COMMA COMMA O
and CC O
4 LS B-LST
) ) O
the DT B-NP
unique JJ I-NP
C-terminus NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
p65 NN I-NP
attenuates VBZ B-VP
its PRP$ B-NP
own JJ I-NP
nuclear JJ I-NP
localization NN I-NP
and CC O
contains VBZ B-VP
sequences NNS B-NP
that WDT B-NP
are VBP B-VP
required VBN I-VP
for IN B-PP
I NN B-NP
kappa NN I-NP
B-mediated JJ I-NP
inhibition NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
p65 NN I-NP
DNA NN I-NP
binding NN I-NP
activity NN I-NP
. . O

Together RB B-ADVP
COMMA COMMA O
these DT B-NP
findings NNS I-NP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
nuclear JJ B-NP
localization NN I-NP
signal NN I-NP
and CC O
transactivation NN B-NP
domain NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
p65 NN I-NP
constitute VBP B-VP
a DT B-NP
bipartite JJ I-NP
system NN I-NP
that WDT B-NP
is VBZ B-VP
critically RB I-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
inhibitory JJ I-NP
function NN I-NP
of IN B-PP
I NN B-NP
kappa NN I-NP
B\/MAD-3 NN I-NP
. . O

Unexpectedly RB B-ADVP
COMMA COMMA O
our PRP$ B-NP
in FW I-NP
vivo FW I-NP
studies NNS I-NP
also RB B-ADVP
demonstrate VBP B-VP
that IN B-SBAR
I NN B-NP
kappa NN I-NP
B\/MAD-3 NN I-NP
binds VBZ B-VP
directly RB B-ADVP
to TO B-PP
NF-kappa NN B-NP
B NN I-NP
p50 NN I-NP
. . O

This DT B-NP
interaction NN I-NP
is VBZ B-VP
functional JJ B-ADJP
as IN B-SBAR
it PRP B-NP
leads VBZ B-VP
to TO B-PP
retargeting NN B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
p50 NN I-NP
from IN B-PP
the DT B-NP
nucleus NN I-NP
to TO B-PP
the DT B-NP
cytoplasm NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
no DT B-NP
loss NN I-NP
of IN B-PP
DNA NN B-NP
binding NN I-NP
activity NN I-NP
is VBZ B-VP
observed VBN I-VP
COMMA COMMA O
presumably RB B-ADVP
reflecting VBG B-VP
the DT B-NP
unique JJ I-NP
C-terminal JJ I-NP
domain NN I-NP
that WDT B-NP
is VBZ B-VP
distinct JJ B-ADJP
from IN B-PP
that DT B-NP
present JJ B-ADJP
in IN B-PP
NF-kappa NN B-NP
B NN I-NP
p65 NN I-NP
. . O

Surrogate NN B-NP
thyroglobulin NN I-NP
receptors NNS I-NP
and CC O
T NN B-NP
cell NN I-NP
proliferation NN I-NP
in IN B-PP
Hashimoto NN B-NP
's POS B-NP
thyroiditis NN I-NP
. . O

Immunoglobulin NN B-NP
molecules NNS I-NP
on IN B-PP
the DT B-NP
surface NN I-NP
of IN B-PP
a DT B-NP
B NN I-NP
lymphocyte NN I-NP
are VBP B-VP
the DT B-NP
endogenous JJ I-NP
" `` I-NP
receptors NNS I-NP
" '' O
to TO B-PP
which WDT B-NP
specific JJ B-NP
antigens NNS I-NP
bind VBP B-VP
. . O

Studies NNS B-NP
in IN B-PP
mice NNS B-NP
have VBP B-VP
shown VBN I-VP
that IN B-SBAR
a DT B-NP
monoclonal JJ I-NP
antibody NN I-NP
COMMA COMMA O
conjugated VBN B-VP
with IN B-PP
palmitate NN B-NP
to TO B-VP
provide VB I-VP
a DT B-NP
lipid NN I-NP
tail NN I-NP
COMMA COMMA O
can MD B-VP
be VB I-VP
inserted VBN I-VP
into IN B-PP
the DT B-NP
cell NN I-NP
membrane NN I-NP
to TO B-VP
provide VB I-VP
a DT B-NP
" `` I-NP
surrogate JJ I-NP
" '' I-NP
antigen NN I-NP
receptor NN I-NP
. . O

We PRP B-NP
have VBP B-VP
investigated VBN I-VP
whether IN B-SBAR
a DT B-NP
palmitate JJ I-NP
conjugate NN I-NP
of IN B-PP
a DT B-NP
human JJ I-NP
monoclonal JJ I-NP
antibody NN I-NP
specific JJ B-ADJP
for IN B-PP
thyroglobulin NN B-NP
( ( O
TG NN B-NP
) ) O
could MD B-VP
function VB I-VP
as IN B-PP
a DT B-NP
surrogate JJ I-NP
TG NN I-NP
receptor NN I-NP
on IN B-PP
blood NN B-NP
mononuclear JJ I-NP
cells NNS I-NP
separated VBN B-VP
into IN B-PP
fractions NNS B-NP
enriched VBN B-VP
for IN B-PP
T NN B-NP
cells NNS I-NP
or CC O
depleted VBN B-VP
of IN B-PP
T NN B-NP
cells NNS I-NP
( ( O
non-T JJ B-NP
cells NNS I-NP
) ) O
. . O

Using VBG B-VP
flow NN B-NP
cytometry NN I-NP
COMMA COMMA O
we PRP B-NP
detected VBD B-VP
surrogate JJ B-NP
TG NN I-NP
receptors NNS I-NP
on IN B-PP
non-T JJ B-NP
( ( B-PP
but CC I-PP
not RB B-PP
on IN I-PP
T NN B-NP
) ) O
cells NNS B-NP
from IN B-PP
11 CD B-NP
of IN I-NP
11 CD I-NP
individuals NNS I-NP
studied VBN B-VP
( ( O
5 CD B-NP
Hashimoto NN I-NP
patients NNS I-NP
and CC O
6 CD B-NP
control NN I-NP
donors NNS I-NP
) ) O
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
endogenous JJ B-NP
TG NN I-NP
receptors NNS I-NP
could MD B-VP
only RB I-VP
be VB I-VP
detected VBN I-VP
on IN B-PP
non-T JJ B-NP
cells NNS I-NP
from IN B-PP
1 CD B-NP
of IN I-NP
3 CD I-NP
Hashimoto NN I-NP
patients NNS I-NP
and CC B-PP
from IN B-PP
0 CD B-NP
of IN I-NP
4 CD I-NP
control NN I-NP
donors NNS I-NP
. . O

Because IN B-PP
of IN I-PP
the DT B-NP
efficient JJ I-NP
binding NN I-NP
of IN B-PP
TG NN B-NP
by IN B-PP
surrogate JJ B-NP
receptors NNS I-NP
on IN B-PP
non-T JJ B-NP
cells NNS I-NP
COMMA COMMA O
we PRP B-NP
assessed VBD B-VP
the DT B-NP
ability NN I-NP
of IN B-PP
such JJ B-NP
cells NNS I-NP
to TO B-VP
present VB I-VP
TG NN B-NP
to TO B-PP
T NN B-NP
cells NNS I-NP
. . O

Proliferation NN B-NP
in IN B-PP
response NN I-PP
to TO I-PP
TG NN B-NP
was VBD B-VP
observed VBN I-VP
in IN B-PP
T NN B-NP
cells NNS I-NP
from IN B-PP
only RB B-NP
1 CD I-NP
of IN I-NP
5 CD I-NP
Hashimoto NN I-NP
patients NNS I-NP
. . O

This DT B-NP
low JJ I-NP
frequency NN I-NP
of IN B-PP
response NN B-NP
was VBD B-VP
no RB B-ADJP
different JJ I-ADJP
from IN B-PP
that DT B-NP
previously RB B-VP
detected VBN I-VP
using VBG B-VP
cultures NNS B-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
and CC O
autologous JJ B-NP
dendritic JJ I-NP
cells NNS I-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
the DT B-NP
successful JJ I-NP
generation NN I-NP
of IN B-PP
surrogate JJ B-NP
receptors NNS I-NP
on IN B-PP
non-T JJ B-NP
cells NNS I-NP
is VBZ B-VP
not RB I-VP
associated VBN I-VP
with IN B-PP
more RBR B-NP
efficient JJ I-NP
TG NN I-NP
presentation NN I-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
the DT B-NP
significance NN I-NP
of IN B-PP
the DT B-NP
present JJ I-NP
study NN I-NP
is VBZ B-VP
that IN B-SBAR
the DT B-NP
T NN I-NP
cells NNS I-NP
COMMA COMMA B-NP
not RB I-NP
the DT B-NP
antigen-presenting JJ I-NP
cells NNS I-NP
COMMA COMMA O
are VBP B-VP
likely JJ B-ADJP
to TO B-VP
be VB I-VP
the DT B-NP
limiting VBG I-NP
element NN I-NP
in IN B-PP
the DT B-NP
T NN I-NP
cell NN I-NP
proliferative JJ I-NP
response NN I-NP
to TO B-PP
TG NN B-NP
and CC O
other JJ B-NP
thyroid NN I-NP
autoantigens NNS I-NP
. . O

Aldosterone-specific JJ B-NP
membrane NN I-NP
receptors NNS I-NP
and CC O
rapid JJ B-NP
non-genomic JJ I-NP
actions NNS I-NP
of IN B-PP
mineralocorticoids NNS B-NP
. . O

Functional JJ B-NP
studies NNS I-NP
in IN B-PP
extrarenal JJ B-NP
COMMA COMMA I-NP
non-epithelial JJ I-NP
cells NNS I-NP
such JJ B-PP
as IN I-PP
smooth JJ B-NP
muscle NN I-NP
cells NNS I-NP
and CC O
more RBR B-ADVP
recently RB I-ADVP
circulating VBG B-NP
human JJ I-NP
lymphocytes NNS I-NP
have VBP B-VP
provided VBN I-VP
increasing VBG B-NP
evidence NN I-NP
that IN B-SBAR
aldosterone NN B-NP
produces VBZ B-VP
not RB B-CONJP
only RB I-CONJP
classical JJ B-NP
genomic JJ I-NP
effects NNS I-NP
COMMA COMMA O
but CC B-CONJP
also RB I-CONJP
rapid JJ B-NP
COMMA COMMA I-NP
non-genomic JJ I-NP
effects NNS I-NP
on IN B-PP
transmembrane NN B-NP
electrolyte NN I-NP
movements NNS I-NP
. . O

These DT B-NP
involve VBP B-VP
activation NN B-NP
of IN B-PP
the DT B-NP
sodium\/proton NN I-NP
exchanger NN I-NP
of IN B-PP
the DT B-NP
cell NN I-NP
membrane NN I-NP
at IN B-PP
very RB B-NP
low JJ I-NP
COMMA COMMA I-NP
physiological JJ I-NP
concentrations NNS I-NP
of IN B-PP
aldosterone NN B-NP
with IN B-PP
an DT B-NP
acute JJ I-NP
onset NN I-NP
within IN B-PP
1-2 CD B-NP
min NN I-NP
. . O

A DT B-NP
second JJ I-NP
messenger NN I-NP
cascade NN I-NP
involved VBN B-VP
is VBZ B-VP
the DT B-NP
inositol NN I-NP
1COMMA4COMMA5-trisphosphate\/calcium NN I-NP
pathway NN I-NP
which WDT B-NP
responds VBZ B-VP
over IN B-PP
the DT B-NP
same JJ I-NP
rapid JJ I-NP
time NN I-NP
course NN I-NP
. . O

Such JJ B-NP
changes NNS I-NP
clearly RB B-ADVP
can MD B-VP
not RB I-VP
be VB I-VP
explained VBN I-VP
by IN B-PP
genomic JJ B-NP
mechanisms NNS I-NP
COMMA COMMA O
which WDT B-NP
are VBP B-VP
responsible JJ B-ADJP
for IN B-PP
later JJ B-NP
effects NNS I-NP
than IN B-PP
the DT O
membrane NN B-NP
related JJ B-NP
rapid JJ I-NP
responses NNS I-NP
. . O

The DT B-NP
mechanisms NNS I-NP
underlying VBG B-VP
these DT B-NP
rapid JJ I-NP
effects NNS I-NP
of IN B-PP
aldosterone NN B-NP
on IN B-PP
electrolytes NNS B-NP
have VBP B-VP
been VBN I-VP
extensively RB I-VP
studied VBN I-VP
in IN B-PP
human JJ B-NP
lymphocytes NNS I-NP
COMMA COMMA O
which WDT B-NP
thus RB B-ADVP
may MD B-VP
represent VB I-VP
valuable JJ B-NP
tools NNS I-NP
in IN B-PP
the DT B-NP
delineation NN I-NP
of IN B-PP
the DT B-NP
receptor-effector JJ I-NP
mechanisms NNS I-NP
involved VBN B-VP
. . O

The DT B-NP
unique JJ I-NP
characteristics NNS I-NP
of IN B-PP
this DT B-NP
new JJ I-NP
pathway NN I-NP
for IN B-PP
steroid NN B-NP
action NN I-NP
include VBP B-VP
its PRP$ B-NP
rapid JJ I-NP
time NN I-NP
course NN I-NP
COMMA COMMA O
10COMMA000-fold JJ B-NP
selectivity NN I-NP
for IN B-PP
aldosterone NN B-NP
over IN B-PP
cortisol NN B-NP
and CC O
the DT B-NP
ineffectiveness NN I-NP
of IN B-PP
spironolactones NNS B-NP
COMMA COMMA O
classical JJ B-NP
mineralocorticoid NN I-NP
antagonists NNS I-NP
COMMA COMMA O
as IN B-PP
antagonists NNS B-NP
of IN B-PP
the DT B-NP
response NN I-NP
. . O

Cellular JJ O
immune JJ O
and CC O
cytokine NN B-NP
pathways NNS B-NP
resulting VBG B-VP
in IN B-PP
tissue NN B-NP
factor NN I-NP
expression NN I-NP
and CC O
relevance NN B-NP
to TO B-PP
septic JJ B-NP
shock NN I-NP
. . O

Cells NNS B-NP
of IN B-PP
monocyte NN B-NP
lineage NN I-NP
serve VBP B-VP
as IN B-PP
effector NN B-NP
cells NNS I-NP
in IN B-PP
the DT B-NP
cellular JJ I-NP
immune JJ I-NP
response NN I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
they PRP B-NP
respond VBP B-VP
to TO B-PP
LPS NN B-NP
and CC O
cytokines NNS B-NP
with IN B-PP
activation NN B-NP
and CC O
expression NN B-NP
of IN B-PP
inflammatory JJ B-NP
effector NN I-NP
gene NN I-NP
products NNS I-NP
similar JJ B-ADJP
to TO B-PP
those DT B-NP
elicited VBN B-VP
by IN B-PP
the DT O
antigen NN B-NP
driven JJ B-NP
response NN I-NP
. . O

The DT B-NP
response NN I-NP
to TO B-PP
antigen NN B-NP
proceeds VBZ B-VP
at IN B-PP
the DT B-NP
T NN I-NP
helper NN I-NP
cell NN I-NP
level NN I-NP
through IN B-PP
two CD B-NP
independent JJ I-NP
forms NNS I-NP
of IN B-PP
cellular JJ B-NP
collaboration NN I-NP
COMMA COMMA O
contact NN B-NP
and CC O
lymphokine NN B-NP
. . O

We PRP B-NP
review VBP B-VP
the DT B-NP
control NN I-NP
of IN B-PP
expression NN B-NP
of IN B-PP
the DT O
Tissue NN B-NP
Factor NN I-NP
( ( O
TF NN B-NP
) ) O
gene NN B-NP
and CC O
the DT B-NP
function NN I-NP
of IN B-PP
the DT B-NP
TF NN I-NP
protein NN I-NP
. . O

The DT B-NP
enhanced VBN I-NP
initiation NN I-NP
of IN B-PP
transcription NN B-NP
of IN B-PP
the DT B-NP
TF NN I-NP
gene NN I-NP
appears VBZ B-VP
to TO I-VP
require VB I-VP
engagement NN B-NP
of IN B-PP
a DT B-NP
56 CD I-NP
bp NN I-NP
LPS NN I-NP
Response NN I-NP
Element NN I-NP
COMMA COMMA O
an DT B-NP
enhancer NN I-NP
that WDT B-NP
is VBZ B-VP
engaged VBN I-VP
by IN B-PP
both DT B-NP
AP-1 NN B-NP
type NN I-NP
heterodimeric JJ I-NP
complexes NNS I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
NF NN B-NP
kappa NN I-NP
B NN I-NP
like IN B-NP
heterodimeric JJ I-NP
complexes NNS I-NP
. . O

Dissociation NN B-NP
of IN B-PP
NF NN B-NP
kappa NN I-NP
B NN I-NP
from IN B-PP
Ig NN B-NP
kappa NN I-NP
B NN I-NP
by IN B-PP
cytokine NN B-NP
and CC O
LPS NN B-NP
stimulation NN B-NP
COMMA COMMA O
and CC O
possibly RB B-ADVP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
COMMA COMMA O
may MD B-VP
represent VB I-VP
a DT B-NP
common JJ I-NP
pathway NN I-NP
to TO B-PP
induction NN B-NP
of IN B-PP
the DT B-NP
TF NN B-NP
and CC O
other JJ B-NP
inflammatory JJ I-NP
genes NNS B-NP
. . O

Enhancement NN B-NP
of IN B-PP
expression NN B-NP
of IN B-PP
TF NN B-NP
is VBZ B-VP
observed VBN I-VP
upon IN B-PP
adhesion NN B-NP
of IN B-PP
Mo NN B-NP
to TO B-PP
endothelial JJ B-NP
cells NNS I-NP
and CC O
extracellular JJ B-NP
matrix JJ I-NP
proteins NNS I-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
upon IN B-PP
engagement NN B-NP
of IN B-PP
leukocyte NN B-NP
integrins NNS I-NP
. . O

The DT B-NP
biological JJ I-NP
effects NNS I-NP
that WDT B-NP
follow VBP B-VP
from IN B-PP
expression NN B-NP
of IN B-PP
TF NN B-NP
by IN B-PP
vascular JJ B-NP
cells NNS I-NP
have VBP B-VP
been VBN I-VP
resolved VBN I-VP
by IN B-PP
analysis NN B-NP
of IN B-PP
function NN B-NP
aided VBN B-VP
by IN B-PP
the DT B-NP
use NN I-NP
of IN B-PP
recombinant JJ B-NP
full JJ I-NP
length NN I-NP
TF NN I-NP
and CC O
truncated VBN B-NP
surface NN I-NP
domain NN I-NP
of IN B-PP
TF NN B-NP
. . O

The DT B-NP
rules NNS I-NP
of IN B-PP
assembly NN B-NP
of IN B-PP
the DT B-NP
cognate JJ I-NP
ligands NNS I-NP
of IN B-PP
TF NN B-NP
COMMA COMMA B-NP
namely RB I-NP
the DT B-NP
zymogen NN I-NP
plasma NN I-NP
factors NNS I-NP
VII NN I-NP
and CC O
the DT B-NP
serine NN I-NP
protease NN I-NP
factor NN I-NP
VIIa NN I-NP
COMMA COMMA O
with IN B-PP
the DT B-NP
soluble JJ I-NP
surface NN I-NP
domain NN I-NP
of IN B-PP
TF NN B-NP
in IN B-PP
free JJ B-NP
solution NN I-NP
COMMA COMMA O
in IN B-PP
the DT B-NP
presence NN I-NP
of IN B-PP
phospholipid JJ B-NP
surfaces NNS I-NP
and CC O
cell NN B-NP
surface NN I-NP
and CC B-PP
of IN B-PP
the DT B-NP
anchored VBN I-NP
TF NN I-NP
molecule NN I-NP
have VBP B-VP
been VBN I-VP
described VBN I-VP
. . O

It PRP B-NP
is VBZ B-VP
evident JJ B-ADJP
that IN B-SBAR
assembly NN B-NP
of IN B-PP
the DT B-NP
surface NN I-NP
domain NN I-NP
of IN B-PP
TF NN B-NP
with IN B-PP
VIIa NN B-NP
to TO B-VP
form VB I-VP
the DT B-NP
binary JJ I-NP
TF.VIIa NN I-NP
complex NN I-NP
induces VBZ B-VP
a DT B-NP
significant JJ I-NP
increase NN I-NP
in IN B-PP
the DT B-NP
Kcat NN I-NP
of IN B-PP
the DT B-NP
catalytic JJ I-NP
domain NN I-NP
of IN B-PP
VIIa NN B-NP
for IN B-PP
small JJ B-NP
peptidyl JJ I-NP
substrates NNS I-NP
and CC B-PP
more JJR B-ADVP
profoundly RB I-ADVP
for IN B-PP
protein NN B-NP
substrate NN I-NP
. . O

This DT B-NP
provides VBZ B-VP
substantial JJ B-NP
evidence NN I-NP
for IN B-PP
an DT B-NP
allosteric JJ I-NP
effect NN I-NP
on IN B-PP
the DT B-NP
catalytic JJ I-NP
cleft NN I-NP
of IN B-PP
VIIa NN B-NP
that WDT B-NP
is VBZ B-VP
imparted VBN I-VP
by IN B-PP
binding VBG B-VP
to TO B-PP
TF NN B-NP
COMMA COMMA O
its PRP$ B-NP
cognate JJ I-NP
catalytic JJ I-NP
cofactor NN I-NP
. . O

It PRP B-NP
is VBZ B-VP
also RB B-ADJP
evident JJ I-ADJP
that IN B-SBAR
the DT B-NP
TF.VIIa NN I-NP
complex NN I-NP
is VBZ B-VP
proteolytically RB B-ADJP
active JJ I-ADJP
and CC O
can MD B-VP
activate VB I-VP
the DT B-NP
zymogen NN I-NP
plasma NN I-NP
factor NN I-NP
X NN I-NP
to TO B-PP
the DT B-NP
serine NN I-NP
protease NN I-NP
Xa NN I-NP
in IN B-PP
free JJ B-NP
solution NN I-NP
COMMA COMMA O
inferring VBG B-VP
that IN B-SBAR
extended VBN B-NP
substrate NN I-NP
recognition NN I-NP
by IN B-PP
induced VBN B-NP
structural JJ I-NP
loci NNS I-NP
of IN B-PP
the DT B-NP
TF.VIIa NN I-NP
complex NN I-NP
are VBP B-VP
created VBN I-VP
from IN B-PP
either DT B-NP
or CC O
both DT B-NP
proteins NNS B-NP
to TO B-VP
constitute VB I-VP
a DT B-NP
new JJ I-NP
recognition NN I-NP
structure NN I-NP
. . O

It PRP B-NP
is VBZ B-VP
also RB B-ADJP
evident JJ I-ADJP
that IN B-SBAR
association NN B-NP
of IN B-PP
X NN B-NP
with IN B-PP
charged JJ B-NP
phospholipid JJ I-NP
surfaces NNS I-NP
enhances VBZ B-VP
the DT B-NP
proteolytic JJ I-NP
activation NN I-NP
of IN B-PP
this DT B-NP
zymogen NN I-NP
by IN B-PP
increasing VBG B-VP
recognition NN B-NP
and CC O
susceptibility NN B-NP
of IN B-PP
the DT B-NP
sessile NN I-NP
peptide NN I-NP
bond NN I-NP
deduced VBN B-VP
from IN B-PP
the DT B-NP
markedly RB B-ADVP
decreased VBN B-NP
Km NN I-NP
and CC O
increased VBN B-NP
Kcat NN I-NP
. . O

Involvement NN B-NP
of IN B-PP
Alu NN B-NP
sequences NNS I-NP
in IN B-PP
the DT B-NP
cell-specific JJ I-NP
regulation NN I-NP
of IN B-PP
transcription NN B-NP
of IN B-PP
the DT B-NP
gamma NN I-NP
chain NN I-NP
of IN B-PP
Fc NN B-NP
and CC O
T NN B-NP
cell NN I-NP
receptors NNS B-NP
. . O

The DT B-NP
Fc NN I-NP
epsilon NN I-NP
RI-gamma NN I-NP
chains NNS I-NP
are VBP B-VP
expressed VBN I-VP
in IN B-PP
a DT B-NP
variety NN I-NP
of IN B-PP
hematopoietic JJ B-NP
cells NNS I-NP
where WRB B-ADVP
they PRP B-NP
play VBP B-VP
a DT B-NP
critical JJ I-NP
role NN I-NP
in IN B-PP
signal NN B-NP
transduction NN I-NP
. . O

They PRP B-NP
are VBP B-VP
part NN B-NP
of IN B-PP
the DT B-NP
high JJ I-NP
affinity NN I-NP
IgE NN I-NP
receptor NN I-NP
in IN B-PP
mast NN B-NP
cells NNS I-NP
COMMA COMMA O
basophils NNS B-NP
COMMA COMMA O
Langerhans NN B-NP
cells NNS I-NP
COMMA COMMA O
and CC O
possibly RB B-NP
other JJ I-NP
cells NNS I-NP
; : O
a DT B-NP
component NN I-NP
of IN B-PP
the DT B-NP
low JJ I-NP
affinity NN I-NP
receptor NN I-NP
for IN B-PP
IgG NN B-NP
( ( O
Fc NN B-NP
gamma NN I-NP
RIIIA NN I-NP
or CC O
CD16 NN B-NP
) ) O
in IN B-PP
natural JJ B-NP
killer NN I-NP
cells NNS I-NP
and CC O
macrophages NNS B-NP
; : O
and CC O
part NN B-NP
of IN B-PP
the DT B-NP
T NN I-NP
cell NN I-NP
antigen NN I-NP
receptor NN I-NP
in IN B-PP
subsets NNS B-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
. . O

Here RB B-ADVP
we PRP B-NP
have VBP B-VP
investigated VBN I-VP
the DT B-NP
transcriptional JJ I-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
gamma NN I-NP
chain NN I-NP
gene NN I-NP
by IN B-PP
analyzing VBG B-VP
the DT B-NP
2.5-kilobase JJ I-NP
sequence NN I-NP
upstream JJ B-ADVP
of IN B-PP
the DT B-NP
transcription NN I-NP
start NN I-NP
site NN I-NP
. . O

This DT B-NP
sequence NN I-NP
contains VBZ B-VP
a DT B-NP
promoter NN I-NP
specific JJ B-ADJP
to TO B-PP
cells NNS B-NP
of IN B-PP
hematopoietic JJ B-NP
lineage NN I-NP
. . O

We PRP B-NP
have VBP B-VP
identified VBN I-VP
two CD B-NP
adjacent JJ I-NP
cis-acting JJ I-NP
regulatory JJ I-NP
elements NNS I-NP
COMMA COMMA O
both DT B-NP
of IN B-PP
which WDT B-NP
are VBP B-VP
part NN B-NP
of IN B-PP
an DT B-NP
Alu NN I-NP
repeat NN I-NP
. . O

The DT B-NP
first JJ I-NP
( ( O
-445\/-366 CD B-NP
) ) O
is VBZ B-VP
a DT B-NP
positive JJ I-NP
element NN I-NP
active JJ B-ADJP
in IN B-PP
both CC O
basophils NNS B-NP
and CC O
T NN B-NP
cells NNS I-NP
. . O

The DT B-NP
second JJ I-NP
( ( O
-365\/-264 CD B-NP
) ) O
binds VBZ B-VP
to TO B-PP
nuclear JJ B-NP
factors NNS I-NP
COMMA COMMA O
which WDT B-NP
appear VBP B-VP
to TO I-VP
be VB I-VP
different JJ B-ADJP
in IN B-PP
basophils NNS B-NP
and CC O
T NN B-NP
cells NNS I-NP
COMMA COMMA O
and CC O
acts VBZ B-VP
as IN B-PP
a DT B-NP
negative JJ I-NP
element NN I-NP
in IN B-PP
basophils NNS B-NP
and CC O
as IN B-PP
a DT B-NP
positive JJ I-NP
one NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
this DT B-NP
Alu NN I-NP
repeat NN I-NP
( ( O
90 CD B-NP
% NN B-ADJP
identical JJ B-PP
to TO B-NP
Alu NN I-NP
consensus NN I-NP
sequences NNS B-NP
) ) O
has VBZ B-VP
evolved VBN I-VP
to TO I-VP
become VB B-NP
both CC I-NP
a DT I-NP
positive JJ I-NP
and CC I-NP
negative JJ I-NP
regulator NN O

Human JJ B-NP
immunodeficiency NN I-NP
viruses NNS I-NP
containing VBG B-VP
heterologous JJ B-NP
enhancer\/promoters NNS I-NP
are VBP B-VP
replication NN B-ADJP
competent JJ I-ADJP
and CC O
exhibit VBP B-VP
different JJ B-NP
lymphocyte NN I-NP
tropisms NNS I-NP
. . O

The DT O
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV NN B-NP
) ) O
type NN B-NP
1 CD I-NP
long JJ B-NP
terminal JJ I-NP
repeat NN I-NP
( ( O
LTR NN B-NP
) ) O
contains VBZ B-VP
binding VBG B-NP
sites NNS I-NP
for IN B-PP
nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
( ( O
NF-kappa NN B-NP
B NN I-NP
) ) O
and CC O
the DT B-NP
constitutively RB I-NP
expressed VBN I-NP
transcription NN I-NP
factor NN I-NP
Sp1 NN I-NP
COMMA COMMA O
both DT B-NP
of IN B-PP
which WDT B-NP
are VBP B-VP
highly RB I-VP
conserved VBN I-VP
in IN B-PP
HIV NN B-NP
and CC O
simian JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
isolates NNS B-NP
. . O

To TO B-VP
delineate VB I-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
these DT B-NP
motifs NNS I-NP
on IN B-PP
the DT B-NP
replicative JJ I-NP
capacity NN I-NP
of IN B-PP
HIV NN B-NP
and CC O
to TO B-VP
explore VB I-VP
the DT B-NP
possibility NN I-NP
of IN B-PP
extending VBG B-VP
the DT B-NP
virus NN I-NP
host NN I-NP
range NN I-NP
COMMA COMMA O
known VBN B-NP
heterologous JJ I-NP
enhancer\/promoters NNS I-NP
were VBD B-VP
inserted VBN I-VP
into IN B-PP
the DT B-NP
HIV-1 NN I-NP
LTR NN I-NP
in IN B-PP
place NN I-PP
of IN I-PP
the DT O
NF-kappa NN B-NP
B NN I-NP
and CC O
Sp1 NN B-NP
binding NN B-NP
sites NNS I-NP
. . O

The DT B-NP
effects NNS I-NP
of IN B-PP
these DT B-NP
substitutions NNS I-NP
on IN B-PP
viral JJ B-NP
replication NN I-NP
in IN B-PP
transfected VBN B-NP
HeLa NN I-NP
cells NNS I-NP
and CC B-PP
on IN B-PP
HIV NN B-NP
infection NN I-NP
of IN B-PP
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
lymphocytes NNS I-NP
or CC O
continuous JJ B-NP
T-leukemia NN I-NP
cell NN I-NP
lines NNS I-NP
were VBD B-VP
evaluated VBN I-VP
. . O

HIVs NN B-NP
in IN B-PP
which WDT B-NP
the DT B-NP
NF- NN I-NP
kappa NN I-NP
B\/Sp1 NN I-NP
enhancer NN I-NP
plus CC O
the DT B-NP
downstream JJ I-NP
TATA NN I-NP
element NN I-NP
were VBD B-VP
replaced VBN I-VP
with IN B-PP
heterologous JJ B-NP
enhancer\/promoters NNS I-NP
were VBD B-VP
also RB I-VP
constructed VBN I-VP
. . O

Viruses NNS B-NP
containing VBG B-VP
the DT B-NP
human JJ I-NP
cytomegalovirus NN I-NP
immediate-early JJ I-NP
enhancer NN I-NP
exhibited VBD B-VP
infectious JJ B-NP
kinetics NNS I-NP
similar JJ B-ADJP
to TO B-PP
that DT B-NP
of IN B-PP
wild-type JJ B-NP
HIV NN I-NP
in IN B-PP
activated VBN B-NP
human JJ I-NP
peripheral JJ I-NP
blood NN I-NP
lymphocytes NNS I-NP
and CC O
AA2 NN B-NP
cells NNS I-NP
but CC O
replicated VBD B-VP
less RBR B-ADVP
efficiently RB I-ADVP
in IN B-PP
H9 NN B-NP
and CC O
CEM NN B-NP
cells NNS B-NP
. . O

These DT B-NP
studies NNS I-NP
indicate VBP B-VP
that IN B-SBAR
heterologous JJ B-NP
enhancer NN I-NP
elements NNS I-NP
are VBP B-VP
capable JJ B-ADJP
of IN B-PP
restoring VBG B-VP
Tat NN B-NP
responsiveness NN I-NP
to TO B-PP
the DT B-NP
HIV NN I-NP
LTR NN I-NP
in IN B-PP
the DT I-PP
context NN I-PP
of IN I-PP
directing VBG B-VP
reporter NN B-NP
gene NN I-NP
expression NN I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
in IN B-PP
the DT B-NP
production NN I-NP
of IN B-PP
infectious JJ B-NP
progeny NN I-NP
virions NNS I-NP
. . O

Tyrosine NN B-NP
phosphorylation NN I-NP
is VBZ B-VP
a DT B-NP
mandatory JJ I-NP
proximal JJ I-NP
step NN I-NP
in IN B-PP
radiation-induced JJ B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
protein NN I-NP
kinase NN I-NP
C NN I-NP
signaling NN I-NP
pathway NN I-NP
in IN B-PP
human JJ B-NP
B- NN I-NP
lymphocyte NN I-NP
precursors NNS I-NP
{ ( O
published VBN B-NP
erratum NN I-NP
appears VBZ B-VP
in IN B-PP
Proc NNP B-NP
Natl NNP I-NP
Acad NNP I-NP
Sci NNP I-NP
U NNP I-NP
S NNP I-NP
A NNP I-NP
1993 CD B-NP
Apr NNP I-NP
15 CD I-NP
; : O
90 CD B-NP
( ( I-NP
8 CD I-NP
) ) I-NP
: : I-NP
3775 CD I-NP
} ) O

Ionizing VBG B-NP
radiation NN I-NP
triggers VBZ B-VP
a DT B-NP
signal NN I-NP
in IN B-PP
human JJ B-NP
B-lymphocyte NN I-NP
precursors NNS I-NP
that WDT B-NP
is VBZ B-VP
intimately RB I-VP
linked VBN I-VP
to TO B-PP
an DT B-NP
active JJ I-NP
protein-tyrosine NN I-NP
kinase NN I-NP
regulatory JJ I-NP
pathway NN I-NP
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
in IN B-PP
B-lymphocyte NN B-NP
precursors NNS I-NP
COMMA COMMA O
irradiation NN B-NP
with IN B-PP
gamma-rays NNS B-NP
leads VBZ B-VP
to TO B-PP
( ( B-LST
i LS I-LST
) ) O
stimulation NN B-NP
of IN B-PP
phosphatidylinositol NN B-NP
turnover NN I-NP
; : O
( ( B-LST
ii LS I-LST
) ) O
downstream JJ B-NP
activation NN I-NP
by IN B-PP
covalent JJ B-NP
modification NN I-NP
of IN B-PP
multiple JJ B-NP
serine-specific JJ I-NP
protein NN I-NP
kinases NNS I-NP
COMMA COMMA O
including VBG B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
; : O
and CC O
( ( B-LST
iii LS I-LST
) ) O
activation NN B-NP
of IN B-PP
nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
. . O

All DT B-NP
of IN B-PP
the DT B-NP
radiation-induced JJ I-NP
signals NNS I-NP
were VBD B-VP
effectively RB I-VP
prevented VBN I-VP
by IN B-PP
the DT B-NP
protein-tyrosine NN I-NP
kinase NN I-NP
inhibitors NNS I-NP
genistein NN B-NP
and CC O
herbimycin NN B-NP
A NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
tyrosine NN B-NP
phosphorylation NN I-NP
is VBZ B-VP
an DT O
important JJ O
and CC O
perhaps RB B-ADVP
mandatory JJ B-NP
proximal JJ I-NP
step NN I-NP
in IN B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
protein NN I-NP
kinase NN I-NP
C NN I-NP
signaling NN I-NP
cascade NN I-NP
in IN B-PP
human JJ B-NP
B-lymphocyte NN I-NP
precursors NNS I-NP
. . O

Our PRP$ B-NP
report VBP I-NP
expands NNS B-VP
current JJ B-NP
knowledge NN I-NP
of IN B-PP
the DT B-NP
radiation-induced JJ I-NP
signaling NN I-NP
cascade NN I-NP
by IN B-PP
clarifying VBG B-VP
the DT B-NP
chronological JJ I-NP
sequence NN I-NP
of IN B-PP
biochemical JJ B-NP
events NNS I-NP
that WDT B-NP
follow VBP B-VP
irradiation NN B-NP
. . O

A DT B-NP
human JJ I-NP
putative JJ I-NP
lymphocyte NN I-NP
G0\/G1 NN I-NP
switch VBP I-NP
gene NN I-NP
homologous JJ B-ADJP
to TO B-PP
a DT B-NP
rodent JJ I-NP
gene NN I-NP
encoding VBG B-VP
a DT B-NP
zinc-binding JJ I-NP
potential JJ I-NP
transcription NN I-NP
factor NN I-NP
. . O

G0S24 NN B-NP
is VBZ B-VP
a DT B-NP
member NN I-NP
of IN B-PP
a DT B-NP
set NN I-NP
of IN B-PP
genes NNS B-NP
( ( O
putative JJ B-NP
G0\/G1 NN I-NP
switch NN I-NP
regulatory JJ I-NP
genes NNS I-NP
) ) O
that WDT B-NP
are VBP B-VP
expressed VBN I-VP
transiently RB B-ADVP
within IN B-PP
1-2 CD B-NP
hr NN I-NP
of IN B-PP
the DT B-NP
addition NN I-NP
of IN B-PP
lectin NN B-NP
or CC O
cycloheximide NN B-NP
to TO B-PP
human JJ B-NP
blood NN I-NP
mononuclear JJ I-NP
cells NNS I-NP
. . O

Comparison NN B-NP
of IN B-PP
a DT B-NP
full-length JJ I-NP
cDNA NN I-NP
sequence NN I-NP
with IN B-PP
the DT B-NP
corresponding JJ I-NP
genomic JJ I-NP
sequence NN I-NP
reveals VBZ B-VP
an DT B-NP
open JJ I-NP
reading NN I-NP
frame NN I-NP
of IN B-PP
326 CD B-NP
amino NN I-NP
acids NNS I-NP
COMMA COMMA O
distributed VBN B-VP
across IN B-PP
two CD B-NP
exons NNS I-NP
. . O

Potential JJ B-NP
phosphorylation NN I-NP
sites NNS I-NP
include VBP B-VP
the DT B-NP
sequence NN I-NP
PSPTSPT NN I-NP
COMMA COMMA O
which WDT B-NP
resembles VBZ B-VP
an DT B-NP
RNA NN I-NP
polymerase NN I-NP
II CD I-NP
repeat NN I-NP
reported VBN B-VP
to TO I-VP
be VB I-VP
a DT B-NP
target NN I-NP
of IN B-PP
the DT B-NP
cell NN I-NP
cycle NN I-NP
control NN I-NP
kinase NN I-NP
cdc2 NN I-NP
. . O

Comparison NN B-NP
of IN B-PP
the DT B-NP
derived VBN I-NP
protein NN I-NP
sequence NN I-NP
with IN B-PP
those DT B-NP
of IN B-PP
rodent JJ B-NP
homologs NNS I-NP
allows VBZ B-VP
classification NN B-NP
into IN B-PP
three CD B-NP
groups NNS I-NP
. . O

Group NN B-NP
1 CD I-NP
contains VBZ B-VP
G0S24 NN B-NP
and CC O
the DT O
rat NN B-NP
and CC O
mouse NN B-NP
TIS11 NN B-NP
genes NNS I-NP
( ( O
also RB B-VP
known VBN I-VP
as IN B-PP
TTP NN B-NP
COMMA COMMA O
Nup475 NN B-NP
COMMA COMMA O
and CC O
Zfp36 NN B-NP
) ) O
. . O

Members NNS B-NP
of IN B-PP
this DT B-NP
group NN I-NP
have VBP B-VP
three CD B-NP
tetraproline JJ I-NP
repeats NNS I-NP
. . O

Groups NNS B-NP
1 CD B-NP
and CC O
2 CD B-NP
have VBP B-VP
a DT B-NP
serine-rich JJ I-NP
region NN I-NP
and CC O
an DT B-NP
" `` I-NP
arginine NN I-NP
element NN I-NP
" '' O
( ( O
RRLPIF NN B-NP
) ) O
at IN B-PP
the DT B-NP
carboxyl NN I-NP
terminus NN I-NP
. . O

All DT B-NP
groups NNS I-NP
contain VBP B-VP
cysteine- NN B-NP
and CC O
histidine-rich JJ B-ADJP
putative JJ B-NP
zinc NN I-NP
finger NN I-NP
domains NNS I-NP
and CC O
a DT B-NP
serine-phenylalanine JJ I-NP
" `` I-NP
SFS NNS I-NP
" '' I-NP
domain NN I-NP
similar JJ B-ADJP
to TO B-PP
part NN B-NP
of IN B-PP
the DT B-NP
large JJ I-NP
subunit NN I-NP
of IN B-PP
eukaryotic JJ B-NP
RNA NN I-NP
polymerase NN I-NP
II CD I-NP
. . O

Comparison NN B-NP
of IN B-PP
group NN O
1 CD O
human JJ O
and CC O
mouse NN B-NP
genomic JJ B-NP
sequences NNS I-NP
shows VBZ B-VP
high JJ B-NP
conservation NN I-NP
in IN B-PP
the DT B-NP
5' JJ I-NP
flank NN I-NP
and CC O
exons NNS B-NP
. . O

A DT B-NP
CpG NN I-NP
island NN I-NP
suggests VBZ B-VP
expression NN B-NP
in IN B-PP
the DT B-NP
germ NN I-NP
line NN I-NP
. . O

G0S24 NN B-NP
has VBZ B-VP
potential JJ B-NP
sites NNS I-NP
for IN B-PP
transcription NN B-NP
factors NNS I-NP
in IN B-PP
the DT B-NP
5' JJ I-NP
flank NN I-NP
and CC O
intron NN B-NP
; : O
these DT B-NP
include VBP B-VP
a DT B-NP
serum NN I-NP
response NN I-NP
element NN I-NP
. . O

Protein NN B-NP
and CC O
genomic JJ B-ADJP
sequences NNS B-NP
show VBP B-VP
similarities NNS B-NP
with IN B-PP
those DT B-NP
of IN B-PP
a DT B-NP
variety NN I-NP
of IN B-PP
proteins NNS B-NP
involved VBN B-VP
in IN B-PP
transcription NN B-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
the DT B-NP
G0S24 NN I-NP
product NN I-NP
has VBZ B-VP
a DT B-NP
similar JJ I-NP
role NN I-NP
. . O

Interleukin-4 NN B-NP
inhibits VBZ B-VP
the DT B-NP
lipopolysaccharide-induced JJ B-NP
expression NN I-NP
of IN B-PP
c-jun NN B-NP
and CC O
c-fos NN B-NP
messenger NN B-NP
RNA NN I-NP
and CC O
activator NN B-NP
protein-1 NN I-NP
binding NN I-NP
activity NN I-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
. . O

We PRP B-NP
studied VBD B-VP
the DT B-NP
effect NN I-NP
of IN B-PP
interleukin-4 NN B-NP
( ( O
IL-4 NN B-NP
) ) O
on IN B-PP
the DT O
lipopolysaccharide NN B-NP
( ( O
LPS NN B-NP
) ) O
induction NN B-NP
of IN B-PP
two CD B-NP
immediate JJ I-NP
early JJ I-NP
genes NNS I-NP
c-fos NN B-NP
and CC O
c-jun NN B-NP
. . O

These DT B-NP
genes NNS I-NP
encode VBP B-VP
proteins NNS B-NP
that WDT B-NP
form VBP B-VP
the DT B-NP
dimeric JJ I-NP
complex NN I-NP
activator NN I-NP
protein-1 NN I-NP
( ( O
AP-1 NN B-NP
) ) O
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
active JJ B-ADJP
as IN B-PP
a DT B-NP
transcriptional JJ I-NP
factor NN I-NP
. . O

Maximal JJ B-NP
accumulation NN I-NP
of IN B-PP
either CC O
c-fos NN B-NP
and CC O
c-jun NN B-NP
messenger NN B-NP
RNA NN I-NP
( ( O
mRNA NN B-NP
) ) O
occurred VBD B-VP
30 CD B-NP
minutes NNS I-NP
after IN B-PP
LPS NN B-NP
addition NN I-NP
. . O

When WRB B-ADVP
cells NNS B-NP
were VBD B-VP
treated VBN I-VP
with IN B-PP
IL-4 NN B-NP
for IN B-PP
5 CD B-NP
hours NNS I-NP
before IN B-PP
LPS NN B-NP
activation NN I-NP
COMMA COMMA O
both CC O
the DT B-NP
c-fos NN I-NP
and CC O
the DT B-NP
c-jun NN I-NP
mRNA NN B-NP
expression NN I-NP
was VBD B-VP
decreased VBN I-VP
. . O

The DT B-NP
inhibition NN I-NP
of IN B-PP
c-fos NN B-NP
and CC O
c-jun NN B-NP
expression NN B-NP
by IN B-PP
IL-4 NN B-NP
in IN B-PP
LPS-treated JJ B-NP
cells NNS I-NP
was VBD B-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
due JJ B-PP
to TO I-PP
a DT B-NP
lower JJR I-NP
transcription NN I-NP
rate NN I-NP
of IN B-PP
the DT O
c-fos NN B-NP
and CC O
c-jun NN B-NP
genes NNS B-NP
. . O

IL-4 NN B-NP
did VBD B-VP
not RB I-VP
affect VB I-VP
the DT B-NP
stability NN I-NP
of IN B-PP
the DT O
c-fos NN B-NP
and CC O
c-jun NN B-NP
transcripts NNS B-NP
. . O

Finally RB B-ADVP
COMMA COMMA O
using VBG B-VP
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
COMMA COMMA O
evidence NN B-NP
was VBD B-VP
obtained VBN I-VP
that IN B-SBAR
IL-4 NN B-NP
inhibits VBZ B-VP
LPS-induced JJ B-NP
expression NN I-NP
of IN B-PP
AP-1 NN B-NP
protein NN I-NP
. . O

These DT B-NP
data NNS I-NP
indicate VBP B-VP
that IN B-SBAR
IL-4 NN B-NP
suppresses VBZ B-VP
the DT B-NP
induction NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
in IN B-PP
human JJ B-NP
activated VBN I-NP
monocytes NNS I-NP
. . O

Ras NN B-NP
oncogene NN I-NP
transformation NN I-NP
of IN B-PP
human JJ B-NP
B NN I-NP
lymphoblasts NNS I-NP
is VBZ B-VP
associated VBN I-VP
with IN B-PP
lymphocyte NN B-NP
activation NN I-NP
and CC B-PP
with IN B-PP
a DT B-NP
block NN I-NP
of IN B-PP
differentiation NN B-NP
. . O

The DT B-NP
p21ras NN I-NP
small JJ I-NP
GTP NN I-NP
binding NN I-NP
proteins NNS I-NP
participate VBP B-VP
in IN B-PP
signal JJ B-NP
transduction NN I-NP
from IN B-PP
cell NN B-NP
surface NN I-NP
receptors NNS I-NP
and CC O
affect VB B-VP
neoplastic JJ B-NP
transformation NN B-NP
and CC O
development NN B-NP
in IN B-PP
many JJ B-NP
different JJ I-NP
cell NN I-NP
types NNS I-NP
. . O

In IN B-PP
the DT B-NP
present JJ I-NP
study NN I-NP
COMMA COMMA O
we PRP B-NP
examined VBD B-VP
the DT B-NP
relationship NN I-NP
between IN B-PP
ras NN B-NP
transformation NN B-NP
and CC O
differentiation NN B-NP
of IN B-PP
human JJ B-NP
B NN I-NP
lymphocytes NNS I-NP
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
the DT B-NP
constitutive JJ I-NP
expression NN I-NP
of IN B-PP
the DT B-NP
T24 NN I-NP
Ha-ras NN I-NP
oncogene NN I-NP
in IN B-PP
EBV-immortalized JJ B-NP
B NN I-NP
lymphoblasts NNS I-NP
was VBD B-VP
associated VBN I-VP
with IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
the DT B-NP
interleukin NN I-NP
2 CD I-NP
receptor NN I-NP
alpha NN I-NP
subunit NN I-NP
COMMA COMMA O
with IN B-PP
an DT B-NP
impaired JJ I-NP
immunoglobulin NN I-NP
gene NN I-NP
expression NN I-NP
COMMA COMMA O
altered JJ B-NP
adhesion NN I-NP
properties NNS I-NP
and CC O
increased VBN B-NP
survival NN I-NP
in IN B-PP
serum-free JJ B-NP
medium NN I-NP
. . O

Since IN B-SBAR
induction NN B-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
receptor NN I-NP
alpha NN I-NP
subunit NN I-NP
is VBZ B-VP
a DT B-NP
hallmark NN I-NP
of IN B-PP
lymphocyte NN B-NP
activation NN I-NP
COMMA COMMA O
we PRP B-NP
suggest VBP B-VP
that IN B-SBAR
p21ras NN B-NP
naturally RB B-ADVP
triggers VBZ B-VP
B NN B-NP
cell NN I-NP
activation NN I-NP
. . O

The DT B-NP
ras-transformed JJ I-NP
lymphocytes NNS I-NP
displayed VBD B-VP
a DT B-NP
fully RB I-NP
functional JJ I-NP
IL-2r NN I-NP
COMMA COMMA O
as IN B-SBAR
assessed VBN B-VP
by IN B-PP
c-fos NN B-NP
induction NN I-NP
following VBG B-PP
treatment NN B-NP
with IN B-PP
IL-2 NN B-NP
; : O
nevertheless RB B-ADVP
COMMA COMMA O
they PRP B-NP
were VBD B-VP
not RB O
growth NN B-NP
stimulated VBN B-VP
by IN B-PP
this DT B-NP
lymphokine NN I-NP
. . O

The DT B-NP
decreased VBN I-NP
expression NN I-NP
of IN B-PP
immunoglobulin NN B-NP
genes NNS I-NP
indicates VBZ B-VP
that IN B-SBAR
the DT B-NP
ras NN I-NP
oncogene NN I-NP
blocks VBZ B-VP
terminal JJ B-NP
differentiation NN I-NP
to TO B-PP
plasma NN B-NP
cells NNS I-NP
COMMA COMMA O
possibly RB B-ADVP
by IN B-PP
inhibiting VBG B-VP
the DT B-NP
activity NN I-NP
of IN B-PP
lymphocyte-specific JJ B-NP
transcription NN I-NP
factors NNS I-NP
. . O

Somewhat RB B-ADVP
unexpectedly RB I-ADVP
COMMA COMMA O
the DT B-NP
constitutive JJ I-NP
p21ras NN I-NP
activity NN I-NP
did VBD B-VP
not RB I-VP
cause VB I-VP
an DT B-NP
increased VBN I-NP
DNA NN I-NP
binding NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
PEA1 NN B-NP
( ( O
AP1 NN B-NP
) ) O
COMMA COMMA O
PEA3 NN B-NP
COMMA COMMA O
Oct-2 NN B-NP
or CC O
NF-kB NN B-NP
. . O

Transcription NN B-NP
factor NN I-NP
GATA-1 NN I-NP
and CC O
erythroid JJ B-NP
development NN I-NP
. . O

In IN B-PP
summary NN B-NP
COMMA COMMA O
we PRP B-NP
derived VBD B-VP
an DT B-NP
experimental JJ I-NP
system NN I-NP
that WDT B-NP
allows VBZ B-VP
us PRP B-NP
to TO B-VP
dissect VB I-VP
the DT B-NP
function NN I-NP
of IN B-PP
GATA-1 NN B-NP
in IN B-PP
red JJ B-NP
cell NN I-NP
development NN I-NP
at IN B-PP
a DT B-NP
genetic JJ I-NP
level NN I-NP
. . O

We PRP B-NP
have VBP B-VP
established VBN I-VP
the DT B-NP
essential JJ I-NP
nature NN I-NP
of IN B-PP
GATA-1 NN B-NP
during IN B-PP
both CC B-NP
primitive JJ I-NP
and CC I-NP
definitive JJ I-NP
erythropoiesis NN I-NP
. . O

By IN B-PP
ablating VBG B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
endogenous JJ I-NP
GATA-1 NN I-NP
gene NN I-NP
COMMA COMMA O
we PRP B-NP
are VBP B-VP
in IN B-PP
a DT B-NP
position NN I-NP
to TO B-VP
introduce VB I-VP
a DT B-NP
variety NN I-NP
of IN B-PP
constructs NNS B-NP
that WDT B-NP
harbor VBP B-VP
subtle JJ B-NP
modifications NNS I-NP
in IN B-PP
flanking JJ B-NP
or CC I-NP
protein-coding JJ I-NP
sequences NNS I-NP
. . O

We PRP B-NP
can MD B-VP
now RB I-VP
study VB I-VP
regulatory JJ B-NP
regions NNS I-NP
and CC O
functional JJ B-NP
domains NNS I-NP
of IN B-PP
the DT B-NP
protein NN I-NP
in IN B-PP
the DT B-NP
context NN I-NP
of IN B-PP
a DT B-NP
true JJ I-NP
erythroid JJ I-NP
environment NN I-NP
COMMA COMMA O
experiments NNS B-NP
that WDT B-NP
have VBP B-VP
not RB I-VP
been VBN I-VP
possible JJ B-ADJP
heretofore RB B-ADVP
. . O

Although IN B-SBAR
the DT B-NP
assay NN I-NP
involves VBZ B-VP
the DT B-NP
dramatic JJ I-NP
loss NN I-NP
of IN B-PP
red JJ B-NP
cell NN I-NP
production NN I-NP
COMMA COMMA O
it PRP B-NP
should MD B-VP
be VB I-VP
possible JJ B-ADJP
to TO B-VP
define VB I-VP
important JJ B-NP
regulatory JJ I-NP
domains NNS I-NP
that WDT B-NP
can MD B-VP
then RB I-VP
be VB I-VP
assayed VBN I-VP
using VBG B-VP
less RBR B-NP
stringent JJ I-NP
systems NNS I-NP
COMMA COMMA O
such JJ B-PP
as IN I-PP
cell-free JJ B-NP
extracts NNS I-NP
for IN B-PP
in FW B-NP
vitro FW I-NP
transcription NN I-NP
. . O

The DT B-NP
ideal JJ I-NP
situation NN I-NP
would MD B-VP
be VB I-VP
analyses NNS B-NP
conducted VBN B-VP
in IN B-PP
GATA-1- JJ B-NP
erythroid NN I-NP
cells NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
these DT B-NP
cells NNS I-NP
have VBP B-VP
been VBN I-VP
impossible JJ B-ADJP
to TO B-VP
generate VB I-VP
given VBN B-PP
the DT B-NP
requirement NN I-NP
of IN B-PP
GATA-1 NN B-NP
for IN B-PP
Epo NN B-NP
receptor NN I-NP
expression NN I-NP
and CC O
red JJ B-NP
cell NN I-NP
viability NN I-NP
( ( O
C. NNP B-NP
Simon NNP I-NP
and CC O
S. NNP B-NP
Orkin NNP I-NP
COMMA COMMA O
unpublished JJ B-NP
observations NNS I-NP
) ) O
. . O

It PRP B-NP
may MD B-VP
be VB I-VP
possible JJ B-ADJP
to TO B-VP
produce VB I-VP
such JJ B-NP
cells NNS I-NP
by IN B-PP
first RB B-VP
expressing VBG I-VP
the DT B-NP
Epo NN I-NP
receptor NN I-NP
under IN B-PP
the DT B-NP
influence NN I-NP
of IN B-PP
a DT B-NP
constitutive JJ I-NP
promoter NN I-NP
and CC O
then RB B-VP
targeting VBG I-VP
the DT B-NP
GATA-1 NN I-NP
gene NN I-NP
. . O

If IN B-SBAR
GATA-1- JJ B-NP
-red JJ I-NP
cells NNS I-NP
were VBD B-VP
available JJ B-ADJP
COMMA COMMA O
the DT B-NP
analyses NNS I-NP
would MD B-VP
involve VB I-VP
the DT B-NP
actual JJ B-NP
transcription NN I-NP
of IN B-PP
or CC O
chromatin NN B-NP
structure NN I-NP
surrounding VBG B-VP
the DT B-NP
globin NN I-NP
genes NNS I-NP
. . O

Structure-function JJ B-NP
studies NNS I-NP
of IN B-PP
the DT B-NP
GATA-1 NN I-NP
protein NN I-NP
could MD B-VP
be VB I-VP
greatly RB I-VP
simplified VBN I-VP
and CC O
a DT B-NP
larger JJR I-NP
number NN I-NP
of IN B-PP
mutants NNS B-NP
studied VBN B-VP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
ES NN I-NP
cell NN I-NP
system NN I-NP
can MD B-VP
be VB I-VP
used VBN I-VP
as IN B-PP
an DT B-NP
alternative NN I-NP
until IN B-SBAR
targeted VBN B-NP
erythroleukemia NN I-NP
cells NNS I-NP
become VBP B-VP
available JJ B-ADJP
. . O

Other JJ B-NP
applications NNS I-NP
involve VBP B-VP
the DT B-NP
introduction NN I-NP
of IN B-PP
other JJ B-NP
GATA-binding JJ I-NP
protein NN I-NP
family NN I-NP
members NNS I-NP
to TO B-VP
determine VB I-VP
whether IN B-SBAR
they PRP B-NP
rescue VBP B-VP
the DT B-NP
mutation NN I-NP
. . O

If IN B-SBAR
they PRP B-NP
can MD B-VP
not RB O
COMMA COMMA O
chimeric JJ B-NP
proteins NNS I-NP
can MD B-VP
be VB I-VP
tested VBN I-VP
to TO B-VP
identify VB I-VP
which WDT B-NP
amino NN I-NP
acids NNS I-NP
distinguish VBP B-VP
the DT B-NP
different JJ I-NP
family NN I-NP
members NNS I-NP
. . O

We PRP B-NP
feel VBP B-VP
that IN B-SBAR
these DT B-NP
experiments NNS I-NP
are VBP B-VP
vital JJ B-ADJP
to TO B-PP
understanding VBG B-VP
the DT B-NP
function NN I-NP
of IN B-PP
GATA-1 NN B-NP
during IN B-PP
erythroid JJ B-NP
ontogeny NN I-NP
. . O

How WRB B-ADVP
does VBZ O
GATA-1 NN B-NP
regulate VB B-VP
red JJ B-NP
cell NN I-NP
genes NNS I-NP
like IN B-PP
globin NN B-NP
or CC O
the DT B-NP
Epo NN I-NP
receptor NN I-NP
? . O

Once IN B-SBAR
we PRP B-NP
identify VB B-VP
the DT B-NP
functional JJ I-NP
domains NNS I-NP
of IN B-PP
the DT B-NP
GATA-binding JJ I-NP
proteins NNS I-NP
COMMA COMMA O
we PRP B-NP
hope VBP B-VP
to TO I-VP
learn VB I-VP
what WP B-NP
proteins NNS I-NP
GATA-1 NN B-NP
binds VBZ B-VP
to TO B-PP
in IN B-PP
the DT B-NP
basic JJ I-NP
transcription NN I-NP
machinery NN I-NP
or CC B-PP
in IN B-PP
chromatin NN B-NP
. . O

Is VBZ O
GATA-1 NN B-NP
necessary JJ B-ADJP
for IN B-PP
globin NN B-NP
gene NN I-NP
switching NN I-NP
? . O

GATA-1 NN B-NP
may MD B-VP
be VB I-VP
modified VBN I-VP
differently RB B-ADVP
during IN B-PP
development NN B-NP
so IN B-SBAR
that IN I-SBAR
the DT B-NP
locus NN I-NP
control NN I-NP
region NN I-NP
can MD B-VP
interact VB I-VP
with IN B-PP
different JJ B-NP
globin NN I-NP
promoters NNS I-NP
. . O

We PRP B-NP
may MD B-VP
find VB I-VP
that IN B-SBAR
one CD B-NP
region NN I-NP
of IN B-PP
the DT B-NP
protein NN I-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
embryonic JJ B-NP
expression NN I-NP
and CC O
another DT B-NP
for IN B-PP
adult JJ B-NP
globin NN I-NP
gene NN I-NP
expression NN I-NP
. . O

The DT B-NP
zinc NN I-NP
finger NN I-NP
transcription NN I-NP
factor NN I-NP
Egr-1 NN I-NP
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
and CC O
restricts VBZ B-VP
differentiation NN B-NP
along IN B-PP
the DT B-NP
macrophage NN I-NP
lineage NN I-NP
. . O

We PRP B-NP
have VBP B-VP
isolated VBN I-VP
cDNA NN B-NP
clones NNS I-NP
of IN B-PP
myeloid JJ B-NP
differentiation NN I-NP
primary JJ I-NP
response NN I-NP
( ( O
MyD NN B-NP
) ) O
genes NNS B-NP
COMMA COMMA O
activated VBN B-VP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
de FW B-NP
novo FW I-NP
protein NN I-NP
synthesis NN I-NP
following VBG B-PP
induction NN B-NP
for IN B-PP
differentiation NN B-NP
along IN B-PP
either CC O
the DT O
macrophage NN B-NP
or CC O
granulocyte NN B-NP
lineage NN B-NP
in IN B-PP
human JJ B-NP
myeloblastic JJ I-NP
leukemia NN I-NP
HL-60 NN I-NP
cells NNS I-NP
. . O

One CD B-NP
cDNA NN I-NP
clone NN I-NP
of IN B-PP
a DT B-NP
primary JJ I-NP
response NN I-NP
gene NN I-NP
COMMA COMMA O
expressed VBN B-VP
upon IN B-PP
macrophage NN B-NP
differentiation NN I-NP
COMMA COMMA O
encoded VBD B-VP
for IN B-PP
Egr-1 NN B-NP
COMMA COMMA O
a DT B-NP
zinc NN I-NP
finger NN I-NP
transcription NN I-NP
factor NN I-NP
. . O

The DT B-NP
Egr-1 NN I-NP
gene NN I-NP
was VBD B-VP
observed VBN I-VP
to TO I-VP
be VB I-VP
transcriptionally RB B-ADVP
silent JJ B-ADJP
in IN B-PP
HL-60 NN B-NP
cells NNS I-NP
COMMA COMMA O
but CC O
active JJ B-ADJP
in IN B-PP
U-937 NN B-NP
and CC O
M1 NN B-NP
cells NNS B-NP
COMMA COMMA O
the DT B-NP
latter JJ I-NP
two CD I-NP
being VBG B-VP
predetermined VBN B-ADJP
for IN B-PP
macrophage NN B-NP
differentiation NN I-NP
. . O

Egr-1 NN B-NP
antisense JJ I-NP
oligomers NNS I-NP
in IN B-PP
the DT B-NP
culture NN I-NP
media NNS I-NP
blocked VBD B-VP
macrophage NN B-NP
differentiation NN I-NP
in IN B-PP
both DT B-NP
myeloid JJ B-NP
leukemia NN I-NP
cell NN I-NP
lines NNS I-NP
and CC O
normal JJ B-NP
myeloblasts NNS I-NP
. . O

HL-60 NN B-NP
cells NNS I-NP
constitutively RB B-VP
expressing VBG I-VP
an DT B-NP
Egr-1 NN I-NP
transgene NN I-NP
( ( O
HL-60Egr-1 NN B-NP
) ) O
could MD B-VP
be VB I-VP
induced VBN I-VP
for IN B-PP
macrophage NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
granulocyte NN B-NP
COMMA COMMA O
differentiation NN B-NP
. . O

These DT B-NP
observations NNS I-NP
indicate VBP B-VP
that IN B-SBAR
expression NN B-NP
of IN B-PP
Egr-1 NN B-NP
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
and CC O
restricts VBZ B-VP
differentiation NN B-NP
of IN B-PP
myeloblasts NNS B-NP
along IN B-PP
the DT B-NP
macrophage NN I-NP
lineage NN I-NP
. . O

Expression NN B-NP
of IN B-PP
tal-1 NN B-NP
and CC O
GATA-binding JJ B-ADJP
proteins NNS B-NP
during IN B-PP
human JJ B-NP
hematopoiesis NN I-NP
. . O

Tal-1 NN B-NP
rearrangements NNS I-NP
are VBP B-VP
associated VBN I-VP
with IN B-PP
nearly RB B-NP
30 CD I-NP
% NN I-NP
of IN B-PP
human JJ B-NP
T NN I-NP
acute JJ I-NP
lymphoblastic JJ I-NP
leukemia NN I-NP
. . O

Tal-1 NN B-NP
gene NN I-NP
encodes VBZ B-VP
a DT B-NP
putative JJ I-NP
transcription NN I-NP
factor NN I-NP
with IN B-PP
a DT B-NP
basic JJ I-NP
helix-loop-helix JJ I-NP
domain NN I-NP
and CC O
is VBZ B-VP
known VBN I-VP
to TO I-VP
be VB I-VP
predominantly RB I-VP
expressed VBN I-VP
in IN B-PP
hematopoietic JJ B-NP
cells NNS I-NP
. . O

We PRP B-NP
investigated VBD B-VP
the DT B-NP
pattern NN I-NP
of IN B-PP
tal-1 NN B-NP
expression NN I-NP
in IN B-PP
purified VBN B-NP
human JJ I-NP
hematopoietic JJ I-NP
cells NNS I-NP
by IN B-PP
in FW B-NP
situ FW I-NP
hybridization NN I-NP
and CC O
reverse JJ B-NP
transcriptase NN I-NP
polymerase NN I-NP
chain NN I-NP
reaction NN I-NP
analysis NN I-NP
. . O

Both DT B-NP
methods NNS I-NP
demonstrated VBD B-VP
that IN B-SBAR
the DT B-NP
tal-1 NN I-NP
gene NN I-NP
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
megakaryocytes NNS B-NP
and CC O
erythroblasts NNS B-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
in IN B-PP
basophilic JJ B-NP
granulocytes NNS I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
our PRP$ B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
the DT B-NP
tal-1 NN I-NP
1A NN I-NP
promoter NN I-NP
COMMA COMMA O
which WDT B-NP
contains VBZ B-VP
two CD B-NP
consensus NN I-NP
GATA-binding JJ I-NP
sites NNS I-NP
COMMA COMMA O
is VBZ B-VP
active JJ B-ADJP
mainly RB B-PP
in IN I-PP
these DT B-NP
lineages NNS I-NP
. . O

Because IN B-SBAR
the DT B-NP
GATA-1 NN I-NP
gene NN I-NP
is VBZ B-VP
known VBN I-VP
to TO I-VP
transactivate VB I-VP
several JJ B-NP
genes NNS I-NP
specific JJ B-ADJP
for IN B-PP
the DT B-NP
erythroid JJ I-NP
COMMA COMMA I-NP
megakaryocytic JJ I-NP
COMMA COMMA I-NP
and CC I-NP
mastocytic\/basophilic JJ I-NP
lineages NNS I-NP
COMMA COMMA O
we PRP B-NP
studied VBD B-VP
GATA-1 NN B-NP
expression NN I-NP
in IN B-PP
these DT B-NP
purified VBN I-NP
hematopoietic JJ I-NP
cells NNS I-NP
. . O

We PRP B-NP
found VBD B-VP
that IN B-SBAR
GATA-1 NN B-NP
and CC O
tal-1 NN B-NP
genes NNS B-NP
are VBP B-VP
coexpressed VBN I-VP
in IN B-PP
these DT B-NP
three CD I-NP
lineages NNS I-NP
. . O

Remarkably RB B-ADVP
COMMA COMMA O
the DT B-NP
expression NN I-NP
of IN B-PP
both DT B-NP
genes NNS I-NP
is VBZ B-VP
downmodulated VBN I-VP
during IN B-PP
erythroid JJ B-NP
and CC I-NP
megakaryocytic JJ I-NP
terminal JJ I-NP
maturation NN I-NP
. . O

In IN B-PP
immature JJ B-NP
hematopoietic JJ I-NP
cells NNS I-NP
COMMA COMMA O
tal-1 NN B-NP
and CC O
GATA-1 NN B-NP
genes NNS B-NP
are VBP B-VP
coexpressed VBN I-VP
in IN B-PP
committed VBN B-NP
progenitors NNS I-NP
cells NNS I-NP
( ( O
CD34+\/CD38(2+) JJ B-NP
) ) O
COMMA COMMA O
whereas IN B-SBAR
they PRP B-NP
are VBP B-VP
not RB O
detectable JJ B-ADJP
in IN B-PP
the DT B-NP
most RBS I-NP
primitive JJ I-NP
cells NNS I-NP
( ( O
CD34(2+)\/CD38- JJ B-NP
) ) O
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
GATA-2 NN B-NP
is VBZ B-VP
strongly RB I-VP
expressed VBN I-VP
in IN B-PP
both CC O
most RBS B-NP
primitive JJ I-NP
and CC O
committed VBN B-NP
progenitors NNS I-NP
cells NNS B-NP
COMMA COMMA O
whereas IN O
GATA-3 NN B-NP
is VBZ B-VP
mostly RB I-VP
detected VBN I-VP
in IN B-PP
most RBS B-NP
primitive JJ I-NP
ones NNS I-NP
. . O

Altogether RB B-ADVP
our PRP$ B-NP
results NNS I-NP
strongly RB B-ADVP
suggest VBP B-VP
that IN B-SBAR
GATA-1 NN B-NP
modulates VBZ B-VP
the DT B-NP
transcription NN I-NP
of IN B-PP
tal-1 NN B-NP
during IN B-PP
the DT B-NP
differentiation NN I-NP
of IN B-PP
the DT B-NP
erythroid JJ I-NP
COMMA COMMA I-NP
megakaryocytic JJ I-NP
COMMA COMMA I-NP
and CC I-NP
basosophilic JJ I-NP
lineages NNS I-NP
. . O

Cell-type-specific JJ B-NP
transactivation NN I-NP
of IN B-PP
the DT B-NP
parathyroid JJ I-NP
hormone-related JJ I-NP
protein NN I-NP
gene NN I-NP
promoter NN I-NP
by IN B-PP
the DT O
human JJ B-NP
T-cell NN I-NP
leukemia NN I-NP
virus NN I-NP
type NN I-NP
I CD I-NP
( ( O
HTLV-I NN B-NP
) ) O
tax NN B-NP
and CC O
HTLV-II NN B-NP
tax NN I-NP
proteins NNS B-NP
. . O

The DT O
human JJ B-NP
T-cell NN I-NP
leukemia NN I-NP
virus NN I-NP
type NN I-NP
I CD I-NP
( ( O
HTLV-I NN B-NP
) ) O
and CC O
HTLV-II NN B-NP
Tax NN B-NP
proteins NNS I-NP
are VBP B-VP
potent JJ B-NP
transactivators NNS I-NP
of IN B-PP
viral JJ B-NP
and CC I-NP
cellular JJ I-NP
gene NN I-NP
expression NN I-NP
. . O

Using VBG B-VP
deletion NN B-NP
mutants NNS I-NP
COMMA COMMA O
the DT O
downstream JJ O
parathyroid JJ B-NP
hormone-related JJ I-NP
protein NN I-NP
( ( O
PTHrP NN B-NP
) ) O
promoter NN B-NP
is VBZ B-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
responsive JJ B-ADJP
to TO B-PP
both CC O
HTLV-I NN B-NP
and CC O
HTLV-II NN B-NP
Tax NN B-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
the DT B-NP
AP1\/c-jun NN I-NP
proto-oncogene NN I-NP
. . O

Transactivation NN B-NP
of IN B-PP
PTHrP NN B-NP
by IN B-PP
Tax NN B-NP
was VBD B-VP
seen VBN I-VP
in IN B-PP
T NN B-NP
cells NNS I-NP
but CC B-PP
not RB B-PP
in IN I-PP
B-cell NN B-NP
lines NNS I-NP
or CC O
fibroblasts NNS B-NP
. . O

A DT B-NP
carboxy NN I-NP
terminal JJ I-NP
Tax NN I-NP
deletion NN I-NP
mutant NN I-NP
was VBD B-VP
deficient JJ B-ADJP
in IN B-PP
transactivation NN B-NP
of IN B-PP
both CC O
the DT O
PTHrP NN B-NP
and CC O
IL2R NN B-NP
alpha NN I-NP
promoters NNS B-NP
but CC B-CONJP
not RB I-CONJP
the DT B-NP
HTLV-I NN I-NP
long JJ B-NP
terminal JJ I-NP
repeat NN I-NP
( ( O
LTR NN B-NP
) ) O
. . O

Exogenous JJ B-NP
provision NN I-NP
of IN B-PP
NFkB NN B-NP
rescued VBD B-VP
IL2R NN B-NP
alpha NN I-NP
expression NN I-NP
but CC B-CONJP
not RB I-CONJP
the DT B-NP
PTHrP NN I-NP
promoter NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
HTLV-I NN B-NP
Tax NN I-NP
COMMA COMMA O
HTLV-II NN B-NP
Tax NN I-NP
COMMA COMMA O
and CC O
c-jun NN B-NP
transactivate VBP B-VP
PTHrP NN B-NP
and CC O
may MD B-VP
contribute VB I-VP
to TO B-PP
the DT B-NP
pathogenesis NN I-NP
of IN B-PP
hypercalcemia NN B-NP
in IN B-PP
adult JJ B-NP
T-cell NN I-NP
leukemia NN I-NP
. . O

Interleukin-3 NN B-NP
expression NN I-NP
by IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
involves VBZ B-VP
an DT B-NP
inducible JJ I-NP
COMMA COMMA I-NP
T-cell-specific JJ I-NP
factor NN I-NP
and CC O
an DT B-NP
octamer NN I-NP
binding NN I-NP
protein NN I-NP
. . O

Interleukin-3 NN B-NP
( ( O
IL-3 NN B-NP
) ) O
is VBZ B-VP
exclusively RB I-VP
expressed VBN I-VP
by IN B-PP
activated VBN B-NP
T NN I-NP
and CC O
natural JJ B-NP
killer NN I-NP
cells NNS B-NP
COMMA COMMA O
a DT B-NP
function NN I-NP
that WDT B-NP
is VBZ B-VP
tightly RB I-VP
controlled VBN I-VP
both CC O
in IN B-PP
a DT B-NP
lineage-specific JJ I-NP
and CC B-PP
in IN B-PP
a DT B-NP
stimulation-dependent JJ I-NP
manner NN B-NP
. . O

We PRP B-NP
have VBP B-VP
investigated VBN I-VP
the DT B-NP
protein NN B-NP
binding NN I-NP
characteristics NNS I-NP
and CC O
functional JJ B-NP
importance NN I-NP
of IN B-PP
the DT B-NP
ACT-1-activating JJ I-NP
region NN I-NP
of IN B-PP
the DT B-NP
IL-3 NN I-NP
promoter NN I-NP
. . O

This DT B-NP
region NN I-NP
binds VBZ B-VP
an DT B-NP
inducible JJ I-NP
COMMA COMMA I-NP
T-cell-specific JJ I-NP
factor NN I-NP
over IN B-PP
its PRP$ B-NP
5' JJ I-NP
end NN I-NP
COMMA COMMA O
a DT B-NP
site NN I-NP
that WDT B-NP
is VBZ B-VP
necessary JJ B-ADJP
for IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
IL-3 NN B-NP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
other JJ B-NP
upstream JJ I-NP
elements NNS I-NP
. . O

Over IN B-PP
its PRP$ B-NP
3' JJ I-NP
end NN I-NP
COMMA COMMA O
it PRP B-NP
binds VBZ B-VP
a DT B-NP
factor NN I-NP
that WDT B-NP
is VBZ O
ubiquitously RB B-ADVP
and CC O
constitutively RB B-ADVP
expressed VBN B-VP
. . O

This DT B-NP
factor NN I-NP
is VBZ B-VP
Oct-1 NN B-NP
or CC O
an DT B-NP
immunologically RB I-NP
related JJ I-NP
octamer-binding JJ I-NP
protein NN I-NP
COMMA COMMA O
and CC O
it PRP B-NP
plays VBZ B-VP
a DT B-NP
role NN I-NP
in IN B-PP
coordinating VBG B-VP
the DT B-NP
activity NN I-NP
of IN B-PP
several JJ B-NP
regulatory JJ I-NP
elements NNS I-NP
. . O

These DT B-NP
characteristics NNS I-NP
make VBP B-VP
the DT B-NP
ACT-1 NN I-NP
site NN I-NP
analogous JJ B-ADJP
to TO B-PP
the DT B-NP
activating VBG I-NP
ARRE-1 NN I-NP
site NN I-NP
in IN B-PP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
and CC O
despite IN B-PP
a DT B-NP
lack NN I-NP
of IN B-PP
sequence NN B-NP
homology NN I-NP
COMMA COMMA O
the DT B-NP
promoters NNS I-NP
of IN B-PP
IL-3 NN B-NP
and CC O
IL-2 NN B-NP
share VBP B-VP
an DT B-NP
organizational JJ I-NP
pattern NN I-NP
of IN B-PP
regulatory JJ B-NP
elements NNS I-NP
that WDT B-NP
is VBZ B-VP
likely JJ B-ADJP
to TO B-VP
be VB I-VP
important JJ B-ADJP
for IN B-PP
the DT B-NP
T-cell-specific JJ I-NP
expression NN I-NP
of IN B-PP
these DT B-NP
genes NNS I-NP
. . O

The DT B-NP
Epstein-Barr JJ I-NP
virus NN I-NP
nuclear JJ I-NP
antigen NN I-NP
2 CD I-NP
interacts VBZ B-VP
with IN B-PP
an DT B-NP
EBNA2 NN I-NP
responsive JJ I-NP
cis-element NN I-NP
of IN B-PP
the DT B-NP
terminal JJ I-NP
protein NN I-NP
1 CD I-NP
gene NN I-NP
promoter NN I-NP
. . O

The DT B-NP
Epstein-Barr JJ I-NP
virus NN I-NP
protein NN I-NP
EBNA2 NN I-NP
acts VBZ B-VP
as IN B-PP
a DT B-NP
transcriptional JJ I-NP
activator NN I-NP
of IN B-PP
cellular JJ B-NP
and CC I-NP
viral JJ I-NP
genes NNS I-NP
and CC O
plays VBZ B-VP
a DT B-NP
crucial JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
immortalization NN I-NP
of IN B-PP
human JJ B-NP
primary JJ I-NP
B-cells NNS I-NP
by IN B-PP
EBV NN B-NP
. . O

We PRP B-NP
have VBP B-VP
shown VBN I-VP
previously RB B-ADVP
that IN B-SBAR
EBNA2 NN B-NP
transactivates VBZ B-VP
the DT B-NP
promoters NNS I-NP
of IN B-PP
the DT B-NP
latent JJ I-NP
membrane NN I-NP
antigens NNS I-NP
LMP NN B-NP
COMMA COMMA O
TP1 NN B-NP
and CC O
TP2 NN B-NP
. . O

The DT B-NP
promoter NN I-NP
of IN B-PP
the DT B-NP
TP1 NN I-NP
gene NN I-NP
was VBD B-VP
chosen VBN I-VP
as IN B-PP
a DT B-NP
model JJ I-NP
system NN I-NP
to TO B-VP
study VB I-VP
the DT B-NP
molecular JJ I-NP
mechanism NN I-NP
of IN B-PP
EBNA2 NN B-NP
mediated JJ I-NP
transactivation NN I-NP
. . O

To TO B-VP
identify VB I-VP
an DT B-NP
EBNA2 NN I-NP
dependent JJ I-NP
cis-acting JJ I-NP
element NN I-NP
COMMA COMMA O
various JJ B-NP
TP1 NN I-NP
promoter-reporter NN I-NP
gene NN I-NP
constructs NNS I-NP
were VBD B-VP
transfected VBN I-VP
in IN B-PP
the DT B-NP
absence NN B-NP
and CC O
presence NN B-NP
of IN B-PP
an DT B-NP
EBNA2 NN I-NP
expression NN I-NP
vector NN I-NP
into IN B-PP
the DT B-NP
established JJ I-NP
B-cell NN I-NP
line NN I-NP
BL41-P3HR1 NN I-NP
. . O

We PRP B-NP
were VBD B-VP
able JJ B-ADJP
to TO B-VP
delineate VB I-VP
an DT B-NP
81 CD I-NP
bp NN I-NP
EBNA2 NN I-NP
responsive JJ I-NP
region NN I-NP
between IN B-PP
-258 CD B-NP
and CC O
-177 CD B-NP
relative JJ B-PP
to TO I-PP
the DT B-NP
TP1 NN I-NP
RNA NN I-NP
start NN I-NP
site NN I-NP
. . O

The DT B-NP
element NN I-NP
worked VBD B-VP
in IN B-PP
either DT B-NP
orientation NN I-NP
and CC O
could MD B-VP
mediate VB I-VP
EBNA2 NN B-NP
dependent JJ I-NP
transactivation NN I-NP
on IN B-PP
a DT B-NP
heterologous JJ I-NP
promoter NN I-NP
. . O

Electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
revealed VBD B-VP
three CD B-NP
specific JJ I-NP
protein-DNA NN I-NP
complexes NNS I-NP
formed VBN B-VP
with IN B-PP
sequences NNS B-NP
of IN B-PP
the DT B-NP
EBNA2 NN I-NP
responsive JJ I-NP
element NN I-NP
. . O

Two CD B-NP
of IN B-PP
these DT B-NP
were VBD B-VP
not RB O
cell NN B-NP
type NN I-NP
specific JJ B-ADJP
COMMA COMMA O
but CC O
the DT B-NP
third JJ I-NP
was VBD B-VP
detected VBN I-VP
only RB B-PP
in IN I-PP
EBNA2 NN B-NP
positive JJ I-NP
cell NN I-NP
extracts NNS I-NP
. . O

Gel-shift JJ B-NP
analysis NN I-NP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
EBNA2 NN B-NP
specific JJ I-NP
monoclonal JJ I-NP
antibodies NNS I-NP
revealed VBD B-VP
that IN B-SBAR
EBNA2 NN B-NP
is VBZ B-VP
a DT B-NP
component NN I-NP
of IN B-PP
the DT B-NP
third JJ I-NP
complex NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
these DT B-NP
experiments NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
EBNA2 NN B-NP
interacts VBZ B-VP
with IN B-PP
an DT B-NP
EBNA2 NN I-NP
responsive JJ I-NP
cis-element NN I-NP
of IN B-PP
the DT B-NP
TP1 NN I-NP
promoter NN I-NP
. . O

ras NN B-NP
protein NN I-NP
activity NN I-NP
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
T-cell NN B-NP
antigen NN I-NP
receptor NN I-NP
signal NN I-NP
transduction NN I-NP
. . O

In IN B-PP
a DT B-NP
Jurkat NN I-NP
cell NN I-NP
model NN I-NP
of IN B-PP
T-cell NN B-NP
activation NN I-NP
an DT B-NP
interleukin-2 NN I-NP
promoter\/reporter NN I-NP
gene NN I-NP
construct NN I-NP
was VBD B-VP
activated VBN I-VP
by IN B-PP
antigen NN B-NP
receptor NN I-NP
agonism NN I-NP
in IN B-PP
combination NN B-NP
with IN B-PP
the DT B-NP
lymphokine NN I-NP
interleukin-1 NN I-NP
. . O

Antigen NN B-NP
receptor NN I-NP
signals NNS I-NP
could MD B-VP
be VB I-VP
mimicked VBN I-VP
by IN B-PP
suboptimal JJ B-NP
activation NN I-NP
of IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( O
PKC NN B-NP
) ) O
with IN B-PP
phorbol NN B-NP
esters NNS I-NP
in IN B-PP
combination NN B-NP
with IN B-PP
calcium NN B-NP
mobilization NN I-NP
by IN B-PP
an DT B-NP
ionophore NN I-NP
. . O

In IN B-PP
cotransfection NN B-NP
experiments NNS I-NP
COMMA COMMA O
oncogenic JJ B-NP
rats NNS I-NP
obviated VBD B-VP
the DT B-NP
need NN I-NP
for IN B-PP
PKC NN B-NP
stimulation NN I-NP
but CC O
did VBD B-VP
not RB I-VP
replace VB I-VP
either CC O
the DT B-NP
calcium NN I-NP
signal NN I-NP
or CC O
interleukin-1 NN B-NP
. . O

Activated VBN B-NP
ras NN I-NP
expression NN I-NP
also RB B-ADVP
replaced VBD B-VP
the DT B-NP
requirement NN I-NP
for IN B-PP
PKC NN B-NP
stimulation NN I-NP
in IN B-PP
activation NN B-NP
of IN B-PP
the DT B-NP
T-cell NN I-NP
transcription NN I-NP
factor NN I-NP
NF-AT NN I-NP
. . O

A DT B-NP
dominant JJ I-NP
inhibitory JJ I-NP
ras NN I-NP
mutant NN I-NP
specifically RB B-ADVP
blocked VBD B-VP
antigen NN B-NP
receptor NN I-NP
agonism NN I-NP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
ras NN B-NP
activity NN I-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
antigen NN B-NP
receptor NN I-NP
signaling NN I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
an DT B-NP
inhibitor NN I-NP
of IN B-PP
PKC NN B-NP
blocked VBD B-VP
both CC O
activated VBD B-NP
ras NN I-NP
and CC O
phorbol NN B-NP
ester NN I-NP
stimulation NN I-NP
COMMA COMMA O
suggesting VBG B-VP
a DT B-NP
role NN I-NP
for IN B-PP
ras NN B-NP
upstream JJ B-ADVP
of IN B-PP
PKC NN B-NP
. . O

Characterization NN B-NP
of IN B-PP
the DT B-NP
nuclear JJ I-NP
and CC I-NP
cytoplasmic JJ I-NP
components NNS I-NP
of IN B-PP
the DT O
lymphoid-specific JJ O
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
( ( O
NF-AT NN B-NP
) ) O
complex NN B-NP
. . O

The DT B-NP
lymphoid-specific JJ I-NP
transcription NN I-NP
complex NN I-NP
COMMA COMMA O
NF-AT NN B-NP
COMMA COMMA O
is VBZ B-VP
involved VBN I-VP
in IN B-PP
early JJ B-NP
gene NN I-NP
activation NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
and CC O
is VBZ B-VP
assembled VBN I-VP
from IN B-PP
a DT O
pre-existing JJ O
COMMA COMMA O
T NN B-NP
cell NN I-NP
restricted JJ B-NP
cytoplasmic JJ I-NP
factor NN I-NP
and CC O
an DT B-NP
inducible JJ I-NP
ubiquitous JJ I-NP
nuclear JJ I-NP
component NN I-NP
within IN B-NP
30 CD I-NP
min NN I-NP
after IN B-PP
activation NN B-NP
through IN B-PP
the DT B-NP
antigen NN I-NP
receptor NN I-NP
. . O

Recent JJ B-NP
studies NNS I-NP
have VBP B-VP
implicated VBN I-VP
the DT B-NP
family NN I-NP
of IN B-PP
AP1 NN B-NP
factors NNS I-NP
as IN B-PP
components NNS B-NP
of IN B-PP
the DT B-NP
murine JJ I-NP
NF-AT NN I-NP
complex NN I-NP
. . O

Evidence NN B-NP
is VBZ B-VP
provided VBN I-VP
here RB B-ADVP
that IN B-SBAR
the DT B-NP
nuclear JJ I-NP
component NN I-NP
of IN B-PP
human JJ B-NP
NF-AT NN I-NP
contains VBZ B-VP
the DT B-NP
phorbol NN I-NP
ester-inducible JJ I-NP
transcription NN I-NP
factor NN I-NP
AP1 NN I-NP
( ( O
Jun\/Fos NN B-NP
) ) O
. . O

We PRP B-NP
further RB B-ADVP
characterize VBP B-VP
which WDT B-NP
AP1 NN I-NP
family NN I-NP
members NNS I-NP
can MD B-VP
assume VB I-VP
this DT B-NP
role NN I-NP
. . O

Antisera NN B-NP
to TO B-PP
Fos NN B-NP
inhibits VBZ B-VP
NF-AT NN B-NP
DNA NN I-NP
binding NN I-NP
as IN B-SBAR
does VBZ O
an DT B-NP
oligonucleotide NN I-NP
containing VBG B-VP
a DT B-NP
binding VBG I-NP
site NN I-NP
for IN B-PP
AP1 NN B-NP
. . O

Constitutive JJ B-NP
expression NN I-NP
in FW B-ADVP
vivo FW I-ADVP
of IN B-PP
Fos NN B-NP
COMMA COMMA O
and CC O
to TO B-PP
a DT B-NP
lesser JJR I-NP
extent NN I-NP
Fra-1 NN B-NP
COMMA COMMA O
eliminates VBZ B-VP
the DT B-NP
requirement NN I-NP
for IN B-PP
phorbol NN B-NP
12-myristate NN I-NP
13-acetate NN I-NP
( ( O
PMA NN B-NP
) ) O
stimulation NN B-NP
COMMA COMMA O
leaving VBG B-VP
NF-AT-directed JJ B-NP
transcription NN I-NP
responsive JJ B-ADJP
to TO B-PP
calcium NN B-NP
ionophore NN I-NP
alone RB B-ADVP
. . O

Overexpression NN B-NP
of IN B-PP
cJun NN B-NP
or CC O
JunD NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
JunB NN B-NP
COMMA COMMA O
also RB B-ADVP
eliminates VBZ B-VP
the DT B-NP
requirement NN I-NP
for IN B-PP
PMA NN B-NP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
many JJ O
but CC O
not RB O
all DT O
Jun- NN B-NP
and CC O
Fos-related JJ B-ADJP
proteins NNS B-NP
functionally RB B-ADVP
activate VBP B-VP
NF-AT-dependent JJ B-NP
transcription NN I-NP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
the DT B-NP
cytoplasmic JJ I-NP
component NN I-NP
. . O

NF-AT NN B-NP
DNA NN I-NP
binding NN I-NP
can MD B-VP
be VB I-VP
reconstituted VBN I-VP
in FW B-ADVP
vitro FW I-ADVP
using VBG B-VP
semi-purified JJ B-NP
AP1 NN I-NP
proteins NNS I-NP
mixed VBN B-VP
with IN B-PP
cytosol NN B-NP
from IN B-PP
T NN B-NP
lymphocytes NNS I-NP
. . O

Fos NN B-NP
proteins NNS I-NP
are VBP B-VP
not RB I-VP
needed VBN I-VP
for IN B-PP
this DT B-NP
reconstitution NN I-NP
COMMA COMMA O
and CC O
although IN B-SBAR
JunB NN B-NP
is VBZ B-VP
not RB O
functional JJ B-ADJP
COMMA COMMA O
it PRP B-NP
can MD B-VP
participate VB I-VP
in IN B-PP
the DT B-NP
NF-AT NN I-NP
DNA NN I-NP
binding NN I-NP
complex NN I-NP
. . O

Finally RB B-ADVP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
partially RB I-VP
purified VBN I-VP
the DT B-NP
cytoplasmic JJ I-NP
component NN I-NP
of IN B-PP
NF-AT NN B-NP
and CC O
show VBP B-VP
by IN B-PP
elution NN B-NP
and CC O
renaturation NN B-NP
from IN B-PP
SDS-polyacrylamide NN B-NP
gel NN I-NP
electrophoresis NN I-NP
gels NNS I-NP
that IN B-SBAR
it PRP B-NP
has VBZ B-VP
a DT B-NP
molecular JJ I-NP
mass NN I-NP
between IN B-NP
94 CD I-NP
and CC I-NP
116 CD I-NP
kDa NN I-NP
and CC O
may MD B-VP
have VB I-VP
multiple JJ B-NP
differentially RB I-NP
modified JJ I-NP
forms NNS I-NP
. . O

The DT B-NP
c-rel NN I-NP
protooncogene NN I-NP
product NN I-NP
represses VBZ B-VP
NF-kappa NN B-NP
B NN I-NP
p65-mediated JJ I-NP
transcriptional JJ I-NP
activation NN I-NP
of IN B-PP
the DT B-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
of IN B-PP
type NN B-NP
1 CD I-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
. . O

The DT B-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
( ( O
LTR NN B-NP
) ) O
of IN B-PP
the DT B-NP
type NN I-NP
1 CD I-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV-1 NN B-NP
) ) O
and CC O
the DT B-NP
5' JJ I-NP
regulatory JJ I-NP
region NN I-NP
of IN B-PP
the DT B-NP
gene NN I-NP
encoding VBG B-VP
the DT B-NP
interleukin NN I-NP
2 CD I-NP
receptor NN I-NP
alpha NN I-NP
subunit NN I-NP
( ( O
IL-2R NN B-NP
alpha NN I-NP
) ) O
share NN B-VP
functional JJ B-NP
kappa NN I-NP
B NN I-NP
enhancer NN I-NP
elements NNS I-NP
involved VBN B-VP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
these DT B-NP
inducible JJ I-NP
transcription NN I-NP
units NNS I-NP
during IN B-PP
T-cell NN B-NP
activation NN I-NP
. . O

These DT B-NP
kappa NN I-NP
B NN I-NP
enhancer NN I-NP
elements NNS I-NP
are VBP B-VP
recognized VBN I-VP
by IN B-PP
a DT B-NP
structurally RB I-NP
related JJ I-NP
family NN I-NP
of IN B-PP
interactive JJ B-NP
proteins NNS I-NP
that WDT B-NP
includes VBZ B-VP
p50 NN B-NP
COMMA COMMA O
p65 NN B-NP
COMMA COMMA O
and CC O
the DT B-NP
product NN I-NP
of IN B-PP
the DT B-NP
c-rel NN I-NP
protooncogene NN I-NP
( ( O
c-Rel NN B-NP
) ) O
. . O

Recent JJ B-NP
biochemical JJ I-NP
studies NNS I-NP
have VBP B-VP
shown VBN I-VP
that IN B-SBAR
p65 NN B-NP
and CC O
p50 NN B-NP
form VBP B-VP
the DT B-NP
prototypical JJ I-NP
NF-kappa NN I-NP
B NN I-NP
complex NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
rapidly RB I-VP
translocated VBN I-VP
from IN B-PP
the DT B-NP
cytoplasm NN I-NP
to TO B-PP
the DT B-NP
nucleus NN I-NP
during IN B-PP
T-cell NN B-NP
activation NN I-NP
. . O

This DT B-NP
intracellular JJ I-NP
signaling NN I-NP
complex NN I-NP
potently RB B-ADVP
stimulates VBZ B-VP
kappa NN B-NP
B-directed JJ I-NP
transcription NN I-NP
from IN B-PP
either CC O
the DT B-NP
HIV-1 NN I-NP
LTR NN I-NP
or CC O
the DT B-NP
IL-2R NN I-NP
alpha NN I-NP
promoter NN I-NP
via IN B-PP
the DT B-NP
strong JJ I-NP
transactivation NN I-NP
domain NN I-NP
present JJ B-ADJP
in IN B-PP
p65 NN B-NP
. . O

We PRP B-NP
now RB B-ADVP
demonstrate VBP B-VP
that IN B-SBAR
nuclear JJ B-NP
expression NN I-NP
of IN B-PP
human JJ B-NP
c-Rel NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
induced VBN I-VP
by IN B-PP
either DT B-NP
phorbol NN B-NP
ester NN I-NP
or CC O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
with IN B-PP
delayed VBN B-NP
kinetics NNS I-NP
relative JJ B-ADJP
to TO B-PP
p65 NN B-NP
COMMA COMMA O
markedly RB B-ADVP
represses VBZ B-VP
p65-mediated JJ B-NP
activation NN I-NP
of IN B-PP
these DT B-NP
transcription NN I-NP
units NNS I-NP
. . O

These DT B-NP
inhibitory JJ I-NP
effects NNS I-NP
of IN B-PP
c-Rel NN B-NP
correlate VBP B-VP
with IN B-PP
its PRP$ B-NP
DNA-binding JJ I-NP
activity NN I-NP
but CC B-PP
not RB B-PP
with IN I-PP
its PRP$ B-NP
ability NN I-NP
to TO B-VP
heterodimerize VB I-VP
with IN B-PP
p50 NN B-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
c-Rel NN B-NP
inhibition NN I-NP
involves VBZ B-VP
competition NN B-NP
with IN B-PP
p50\/p65 NN B-NP
for IN B-PP
occupancy NN B-NP
of IN B-PP
the DT B-NP
kappa NN I-NP
B NN I-NP
enhancer NN I-NP
element NN I-NP
. . O

Together RB B-ADVP
COMMA COMMA O
these DT B-NP
findings NNS I-NP
suggest VBP B-VP
that IN B-SBAR
one CD B-NP
function NN I-NP
of IN B-PP
c-Rel NN B-NP
is VBZ B-VP
as IN B-PP
a DT B-NP
physiologic JJ I-NP
repressor NN I-NP
of IN B-PP
the DT O
HIV-1 NN B-NP
LTR NN I-NP
and CC O
IL-2R NN B-NP
alpha NN I-NP
promoters NNS B-NP
COMMA COMMA O
serving VBG B-VP
to TO I-VP
efficiently RB I-VP
counter VB I-VP
the DT B-NP
strong JJ I-NP
transcriptional JJ I-NP
activating JJ I-NP
effects NNS I-NP
of IN B-PP
p65 NN B-NP
. . O

Protease NN B-NP
treatment NN I-NP
of IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
distinguishes VBZ B-VP
between IN B-PP
class NN B-NP
II CD I-NP
MHC NN I-NP
X1 NN I-NP
box NN I-NP
DNA-binding JJ I-NP
proteins NNS I-NP
in IN B-PP
wild-type JJ B-NP
and CC I-NP
class NN I-NP
II-deficient JJ I-NP
B NN I-NP
cells NNS I-NP
. . O

The DT B-NP
X NN I-NP
box NN I-NP
region NN I-NP
is VBZ B-VP
critical JJ B-ADJP
for IN B-PP
directing VBG B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
class NN B-NP
II CD I-NP
major JJ I-NP
histocompatibility NN I-NP
complex NN I-NP
genes NNS I-NP
in IN B-PP
B NN B-NP
lymphocytes NNS I-NP
. . O

Although IN B-SBAR
several JJ B-NP
class NN I-NP
II CD I-NP
promoter-specific JJ I-NP
DNA NN I-NP
binding NN I-NP
factors NNS I-NP
have VBP B-VP
been VBN I-VP
described VBN I-VP
COMMA COMMA O
only RB B-NP
the DT I-NP
X NN I-NP
box NN I-NP
region NN I-NP
factor NN I-NP
COMMA COMMA O
RFX NN B-NP
COMMA COMMA O
shows VBZ B-VP
a DT B-NP
genetic JJ I-NP
correlation NN I-NP
with IN B-PP
class NN B-NP
II CD I-NP
expression NN I-NP
COMMA COMMA O
being VBG B-VP
deficient JJ B-ADJP
in IN B-PP
some DT B-NP
B NN I-NP
cell NN I-NP
lines NNS I-NP
derived VBN B-VP
from IN B-PP
patients NNS B-NP
with IN B-PP
class NN B-NP
II-deficient JJ I-NP
congenital JJ I-NP
immunodeficiency NN I-NP
. . O

To TO B-VP
further RB I-VP
evaluate VB I-VP
the DT B-NP
role NN I-NP
of IN B-PP
X NN B-NP
box NN I-NP
DNA-binding JJ I-NP
proteins NNS I-NP
in IN B-PP
class NN B-NP
II CD I-NP
gene NN I-NP
expression NN I-NP
COMMA COMMA O
the DT B-NP
role NN I-NP
of IN B-PP
the DT B-NP
X NN I-NP
box NN I-NP
region NN I-NP
was VBD B-VP
examined VBN I-VP
in IN B-PP
both DT B-NP
class NN I-NP
II-positive JJ I-NP
and CC I-NP
-negative JJ I-NP
lymphoid JJ I-NP
cells NNS I-NP
. . O

In IN B-PP
addition NN I-PP
to TO I-PP
the DT B-NP
wild-type JJ I-NP
B NN I-NP
cell NN I-NP
line NN I-NP
Raji NN I-NP
COMMA COMMA O
two CD B-NP
class NN I-NP
II CD I-NP
transcriptional JJ I-NP
mutant JJ I-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
SJO NN B-NP
and CC O
RJ2.2.5 NN B-NP
COMMA COMMA O
and CC O
Jurkat NN B-NP
COMMA COMMA O
a DT B-NP
class NN I-NP
II CD I-NP
negative JJ I-NP
T NN I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
were VBD B-VP
examined VBN I-VP
. . O

In IN B-PP
contrast NN I-PP
to TO I-PP
wild-type JJ B-NP
B NN I-NP
cells NNS I-NP
COMMA COMMA O
neither DT B-NP
of IN B-PP
the DT B-NP
class NN I-NP
II CD I-NP
mutant JJ I-NP
cell NN I-NP
lines NNS I-NP
could MD B-VP
use VB I-VP
the DT B-NP
X NN I-NP
box NN I-NP
region NN I-NP
to TO B-VP
direct VB I-VP
the DT B-NP
expression NN I-NP
of IN B-PP
a DT B-NP
transiently RB I-NP
transfected VBN I-NP
reporter NN I-NP
gene NN I-NP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
the DT B-NP
X NN I-NP
box-dependent JJ I-NP
transcriptional JJ I-NP
pathway NN I-NP
is VBZ B-VP
defective JJ B-ADJP
in IN B-PP
these DT B-NP
cells NNS I-NP
. . O

The DT B-NP
binding NN I-NP
activity NN I-NP
of IN B-PP
the DT B-NP
X1 NN I-NP
box NN I-NP
DNA-binding JJ I-NP
protein NN I-NP
RFX NN I-NP
was VBD B-VP
examined VBN I-VP
and CC O
found VBN B-VP
to TO I-VP
be VB I-VP
present JJ B-ADJP
in IN B-PP
wild-type JJ B-NP
B NN I-NP
cells NNS I-NP
and CC O
the DT B-NP
mutant JJ I-NP
RJ2.2.5 NN I-NP
but CC O
was VBD B-VP
absent JJ B-ADJP
in IN B-PP
SJO NN B-NP
and CC O
Jurkat NN B-NP
. . O

However RB B-ADVP
COMMA COMMA O
other JJ B-NP
X1 NN I-NP
box-specific JJ I-NP
activities NNS I-NP
were VBD B-VP
detected VBN I-VP
in IN B-PP
all DT B-NP
these DT I-NP
cell NN I-NP
lines NNS I-NP
. . O

To TO B-VP
determine VB I-VP
whether IN B-SBAR
these DT B-NP
different JJ I-NP
X1 NN I-NP
box NN I-NP
activities NNS I-NP
represented VBD B-VP
distinct JJ B-NP
DNA NN I-NP
binding NN I-NP
proteins NNS I-NP
or CC O
multimeric JJ B-NP
forms NNS I-NP
of IN B-PP
the DT B-NP
same JJ I-NP
factor NN I-NP
( ( I-NP
s NNS I-NP
) ) O
COMMA COMMA O
protease NN B-NP
treatment NN I-NP
of IN B-PP
the DT B-NP
crude JJ I-NP
nuclear JJ I-NP
extracts NNS I-NP
followed VBN B-VP
by IN B-PP
DNA-binding JJ B-NP
assays NNS I-NP
were VBD B-VP
carried VBN I-VP
out RP B-PRT
and CC O
demonstrated VBD B-VP
that IN B-SBAR
B NN B-NP
cell NN I-NP
extracts NNS I-NP
contain VBP B-VP
at IN B-NP
least JJS I-NP
two CD I-NP
X1-specific JJ I-NP
factors NNS I-NP
. . O

One CD B-NP
of IN B-PP
these DT B-NP
cleaved VBN I-NP
products NNS I-NP
( ( O
band NN B-NP
1 CD I-NP
pk NN I-NP
) ) O
correlates VBZ B-VP
with IN B-PP
RFX NN B-NP
activity NN I-NP
. . O

A DT B-NP
similar JJ I-NP
comparison NN I-NP
with IN B-PP
protease-treated JJ B-NP
extracts NNS I-NP
prepared VBN B-VP
from IN B-PP
Jurkat NN B-NP
cells NNS I-NP
demonstrated VBD B-VP
the DT B-NP
presence NN I-NP
of IN B-PP
the DT B-NP
band NN I-NP
1pk NN I-NP
activity NN I-NP
despite IN B-PP
an DT B-NP
absence NN I-NP
of IN B-PP
the DT B-NP
native JJ I-NP
RFX NN I-NP
activity NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
protease NN B-NP
treatment NN B-NP
and CC O
analysis NN B-NP
of IN B-PP
SJO NN B-NP
extracts NNS I-NP
showed VBD B-VP
no DT B-NP
detectable JJ I-NP
levels NNS I-NP
of IN B-PP
the DT B-NP
band NN I-NP
1pk NN I-NP
activity NN I-NP
. . O

These DT B-NP
results NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
multiple JJ B-NP
X1 NN I-NP
box-specific JJ I-NP
DNA-binding JJ I-NP
activities NNS I-NP
exist VBP B-VP
in IN B-PP
all DT B-NP
lymphoid JJ I-NP
cells NNS I-NP
COMMA COMMA O
but CC O
the DT B-NP
presence NN I-NP
of IN B-PP
an DT B-NP
actively RB I-NP
binding NN I-NP
RFX NN I-NP
species NNS I-NP
correlates VBZ B-VP
with IN B-PP
class NN B-NP
II CD I-NP
transcription NN I-NP
. . O

Replication NN B-NP
of IN B-PP
type NN B-NP
1 CD I-NP
human JJ I-NP
immunodeficiency NN I-NP
viruses NNS I-NP
containing VBG B-VP
linker NN B-NP
substitution NN I-NP
mutations NNS I-NP
in IN B-PP
the DT B-NP
-201 CD B-NP
to TO O
-130 CD B-NP
region NN B-NP
of IN B-PP
the DT B-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
. . O

In IN B-PP
previous JJ B-NP
transfection NN I-NP
analyses NNS I-NP
using VBG B-VP
the DT B-NP
chloramphenicol JJ I-NP
acetyltransferase NN I-NP
reporter NN I-NP
gene NN I-NP
system NN I-NP
COMMA COMMA O
we PRP B-NP
determined VBD B-VP
that IN B-SBAR
linker NN B-NP
substitution NN I-NP
( ( O
LS NN B-NP
) ) O
mutations NNS B-NP
between IN B-PP
-201 CD B-NP
and CC O
-130 CD B-NP
( ( O
relative JJ B-ADJP
to TO B-PP
the DT B-NP
transcription NN I-NP
start NN I-NP
site NN I-NP
) ) O
of IN B-PP
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
long JJ B-NP
terminal JJ I-NP
repeat NN I-NP
( ( O
LTR NN B-NP
) ) O
caused VBD B-VP
moderate JJ B-NP
decreases NNS I-NP
in IN B-PP
LTR NN B-NP
transcriptional JJ I-NP
activity NN I-NP
in IN B-PP
a DT B-NP
T-cell NN I-NP
line NN I-NP
( ( O
S.L.Zeichner NNP B-NP
COMMA COMMA O
J.Y.H. NNP B-NP
Kim NNP I-NP
COMMA COMMA O
and CC O
J.C.Alwine NNP B-NP
COMMA COMMA O
J.Virol.65 NNP B-NP
: : O
2436-2444 CD B-NP
COMMA COMMA O
1991 CD B-NP
) ) O
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
two CD B-NP
mutations NNS I-NP
between IN B-PP
-93 CD B-NP
and CC O
-76 CD B-NP
and CC B-PP
between IN B-PP
-75 CD B-NP
and CC O
-58 CD B-NP
were VBD B-VP
utilized VBN I-VP
COMMA COMMA O
since IN B-SBAR
they PRP B-NP
affect VBP B-VP
the DT O
nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
( ( O
NF-kappa NN B-NP
B NN I-NP
) ) O
- : O
and CC O
Sp1-binding JJ B-ADJP
sites NNS B-NP
and CC O
were VBD B-VP
expected VBN I-VP
to TO I-VP
diminish VB I-VP
viral JJ B-NP
replication NN I-NP
. . O

Our PRP$ B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
while IN B-SBAR
transfection NN B-NP
analyses NNS I-NP
offer VBP B-VP
an DT B-NP
adequate JJ I-NP
approximation NN I-NP
of IN B-PP
the DT B-NP
effects NNS I-NP
of IN B-PP
the DT B-NP
LS NN I-NP
mutations NNS I-NP
COMMA COMMA O
the DT B-NP
analysis NN I-NP
of IN B-PP
viral JJ B-NP
replication NN I-NP
using VBG B-VP
a DT B-NP
mutant JJ I-NP
viral JJ I-NP
stock NN I-NP
presents VBZ B-VP
a DT B-NP
more RBR I-NP
accurate JJ I-NP
picture NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
sometimes RB B-ADVP
at IN B-PP
variance NN I-PP
with IN I-PP
the DT B-NP
transfection NN I-NP
results NNS I-NP
. . O

Three CD B-NP
mutants NNS I-NP
( ( O
-201\/-184 CD B-NP
NXS NN I-NP
COMMA COMMA O
-165\/-148 CD B-NP
NXS NN I-NP
COMMA COMMA O
and CC O
-147\/-130 CD B-NP
NXS NN I-NP
) ) O
had VBD B-VP
effects NNS B-NP
on IN B-PP
viral JJ B-NP
replication NN I-NP
that WDT B-NP
were VBD B-VP
much RB B-ADJP
more RBR I-ADJP
severe JJ I-ADJP
than IN B-PP
the DT B-NP
effects NNS I-NP
predicted VBN B-VP
from IN B-PP
their PRP$ B-NP
performance NN I-NP
in IN B-PP
transfection NN B-NP
analyses NNS I-NP
COMMA COMMA O
and CC O
the DT B-NP
effects NNS I-NP
of IN B-PP
two CD B-NP
LS NN I-NP
mutations NNS I-NP
( ( O
-201\/-184 CD B-NP
NXS NN I-NP
and CC O
-183\/-166 CD B-NP
NXS NN I-NP
) ) O
were VBD B-VP
not RB I-VP
predicted VBN I-VP
by IN B-PP
their PRP$ B-NP
effects NNS I-NP
in IN B-PP
transfection NN B-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
we PRP B-NP
observed VBD B-VP
cell NN B-NP
type-specific JJ I-NP
permissiveness NN I-NP
to TO B-PP
replication NN B-NP
of IN B-PP
some DT B-NP
mutant JJ I-NP
viruses NNS I-NP
. . O

In IN B-PP
the DT B-NP
cell NN I-NP
types NNS I-NP
tested VBN B-VP
COMMA COMMA O
the DT B-NP
LS NN I-NP
mutations NNS I-NP
indicated VBD B-VP
an DT B-NP
apparent JJ I-NP
requirement NN I-NP
not RB B-CONJP
only RB I-CONJP
for IN B-PP
the DT O
intact JJ O
NF-kappa NN B-NP
B NN I-NP
and CC O
SP1-binding JJ B-ADJP
sites NNS B-NP
but CC B-CONJP
also RB I-CONJP
for IN B-PP
several JJ B-NP
regions NNS I-NP
between IN B-PP
-201 CD B-NP
and CC O
-130 CD B-NP
not RB B-VP
previously RB I-VP
associated VBN I-VP
with IN B-PP
viral JJ B-NP
infectivity NN I-NP
. . O

Dimerization NN B-NP
of IN B-PP
NF-KB2 NN B-NP
with IN B-PP
RelA(p65) NN B-NP
regulates VBZ B-VP
DNA NN B-NP
binding NN I-NP
COMMA COMMA O
transcriptional JJ B-NP
activation NN I-NP
COMMA COMMA O
and CC O
inhibition NN B-NP
by IN B-PP
an DT B-NP
I NN I-NP
kappa NN I-NP
B-alpha NN I-NP
( ( O
MAD-3 NN B-NP
) ) O
. . O

Inducible JJ B-NP
expression NN I-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV NN B-NP
) ) O
is VBZ B-VP
regulated VBN I-VP
by IN B-PP
a DT B-NP
cellular JJ I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
( ( O
NF-kappa NN B-NP
B NN I-NP
) ) O
. . O

NF-kappa NN B-NP
B NN I-NP
is VBZ B-VP
composed VBN I-VP
of IN B-PP
distinct JJ B-NP
subunits NNS I-NP
; : O
five CD B-NP
independent JJ I-NP
genes NNS I-NP
COMMA COMMA O
NFKB1(p105) NN B-NP
COMMA COMMA O
NFKB2(p100) NN B-NP
COMMA COMMA O
RelA(p65) NN B-NP
COMMA COMMA O
c-rel NN B-NP
and CC O
relB NN B-NP
COMMA COMMA O
that WDT B-NP
encode VBP B-VP
related JJ B-NP
proteins NNS I-NP
that WDT B-NP
bind VBP B-VP
to TO B-PP
kappa NN B-NP
B NN I-NP
DNA NN I-NP
elements NNS I-NP
have VBP B-VP
been VBN I-VP
isolated VBN I-VP
. . O

We PRP B-NP
have VBP B-VP
previously RB I-VP
found VBN I-VP
that IN B-SBAR
NFKB2(p49\/p52) NN B-NP
acts VBZ B-VP
in IN B-PP
concert NN I-PP
with IN I-PP
RelA(p65) NN B-NP
to TO B-VP
stimulate VB I-VP
the DT B-NP
HIV NN I-NP
enhancer NN I-NP
in IN B-PP
Jurkat NN B-NP
T-leukemia NN I-NP
cells NNS I-NP
. . O

Here RB B-ADVP
we PRP B-NP
examine VBP B-VP
the DT B-NP
biochemical JJ I-NP
basis NN I-NP
for IN B-PP
the DT B-NP
transcriptional JJ I-NP
regulation NN I-NP
of IN B-PP
HIV NN B-NP
by IN B-PP
NFKB2 NN B-NP
. . O

Using VBG B-VP
Scatchard NN B-NP
analysis NN I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
determined VBN I-VP
the DT B-NP
dissociation NN I-NP
constants NNS I-NP
of IN B-PP
homodimeric JJ B-NP
p49 NN I-NP
and CC O
heterodimeric JJ B-NP
p49\/p65 NN I-NP
for IN B-PP
binding NN B-VP
to TO B-PP
the DT B-NP
HIV NN I-NP
kappa NN I-NP
B NN I-NP
site NN I-NP
. . O

p49 NN B-NP
has VBZ B-VP
a DT B-NP
approximately RB I-NP
18-fold-lower JJ I-NP
affinity NN I-NP
for IN B-PP
the DT B-NP
HIV NN I-NP
kappa NN I-NP
B NN I-NP
site NN I-NP
( ( O
KD NN B-NP
= JJ B-VP
69.1 CD B-NP
pM NN I-NP
) ) O
than IN B-SBAR
does VBZ O
the DT B-NP
approximately RB I-NP
50-kDa JJ I-NP
protein NN I-NP
NFKB1(p50) NN B-NP
derived VBN B-VP
from IN B-PP
p105 NN B-NP
( ( O
KD NN B-NP
= JJ B-VP
3.9 CD B-NP
pM NN I-NP
) ) O
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
the DT B-NP
affinity NN I-NP
of IN B-PP
heterodimeric JJ B-NP
NFKB2(p49)\/RelA(p65) NN I-NP
for IN B-PP
this DT B-NP
site NN I-NP
is VBZ B-VP
approximately RB B-ADJP
6-fold RB I-ADJP
higher JJR I-ADJP
( ( O
KD NN B-NP
= JJ B-VP
11.8 CD B-NP
pM NN I-NP
) ) O
than IN B-PP
that DT B-NP
of IN B-PP
p49 NN B-NP
alone RB B-ADVP
. . O

Consistent JJ B-ADJP
with IN B-PP
these DT B-NP
findings NNS I-NP
COMMA COMMA O
in FW B-NP
vitro FW I-NP
transcription NN I-NP
was VBD B-VP
stimulated VBN I-VP
18-fold RB B-ADVP
by IN B-PP
the DT B-NP
addition NN I-NP
of IN B-PP
preformed JJ B-NP
COMMA COMMA I-NP
heterodimeric JJ I-NP
NFKB2(p49)\/RelA(p65) NN I-NP
protein NN I-NP
. . O

Transcriptional JJ B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
HIV NN I-NP
enhancer NN I-NP
was VBD B-VP
also RB B-ADVP
subject JJ B-ADJP
to TO B-PP
regulation NN B-NP
by IN B-PP
recently RB B-NP
cloned VBN I-NP
I NN B-NP
kappa NN I-NP
B-alpha NN I-NP
( ( O
MAD-3 NN B-NP
) ) O
. . O

Recombinant JJ B-NP
I NN B-NP
kappa NN I-NP
B-alpha NN I-NP
( ( O
MAD-3 NN B-NP
) ) O
inhibited VBD B-VP
the DT B-NP
DNA NN I-NP
binding NN I-NP
activity NN I-NP
of IN B-PP
p65 NN B-NP
COMMA COMMA O
p49\/p65 NN B-NP
COMMA COMMA O
and CC O
p50\/p65 NN B-NP
but CC O
stimulated VBD B-VP
the DT B-NP
binding NN I-NP
of IN B-PP
NFKB2(p49) NN B-NP
or CC O
NFKB1(p50) NN B-NP
. . O

Functional JJ B-NP
activation NN I-NP
of IN B-PP
an DT B-NP
HIV NN I-NP
reporter NN I-NP
plasmid NN I-NP
by IN B-PP
p49\/p65 NN B-NP
in IN B-PP
transiently RB B-NP
transfected VBN I-NP
Jurkat NN I-NP
T-leukemia JJ I-NP
cells NNS I-NP
was VBD B-VP
also RB I-VP
inhibited VBN I-VP
by IN B-PP
coexpression NN B-NP
of IN B-PP
MAD-3 NN B-NP
. . O

( ( O
ABSTRACT NN B-NP
TRUNCATED VBN B-VP
AT IN B-PP
250 CD B-NP
WORDS NNS I-NP
) ) O

The DT B-NP
human JJ I-NP
prointerleukin NN I-NP
1 CD I-NP
beta NN I-NP
gene NN I-NP
requires VBZ B-VP
DNA NN B-NP
sequences NNS I-NP
both CC O
proximal JJ B-ADJP
and CC O
distal JJ B-ADJP
to TO B-PP
the DT B-NP
transcription NN I-NP
start NN I-NP
site NN I-NP
for IN B-PP
tissue-specific JJ B-NP
induction NN I-NP
. . O

In IN B-PP
these DT B-NP
studies NNS I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
identified VBN I-VP
DNA NN B-NP
sequences NNS I-NP
and CC O
specific JJ B-NP
protein NN I-NP
interactions NNS I-NP
necessary JJ B-ADJP
for IN B-PP
transcriptional JJ B-NP
regulation NN I-NP
of IN B-PP
the DT O
human JJ O
prointerleukin NN B-NP
1 CD I-NP
beta NN I-NP
( ( O
proIL-1 NN B-NP
beta NN I-NP
) ) O
gene NN B-NP
. . O

A DT B-NP
cell-type-independent JJ I-NP
lipopolysaccharide NN I-NP
( ( I-NP
LPS NN I-NP
) ) I-NP
-responsive JJ I-NP
enhancer NN I-NP
element NN I-NP
located JJ O
between IN B-PP
-3757 CD B-NP
and CC O
-2729 CD B-NP
bp NN B-NP
upstream RB B-ADJP
from IN B-PP
the DT B-NP
transcription NN I-NP
start NN I-NP
site NN I-NP
( ( O
cap NN B-NP
site NN I-NP
) ) O
consisted VBD B-VP
of IN B-PP
at IN B-NP
least JJS I-NP
six CD I-NP
discrete JJ I-NP
subregions NNS I-NP
which WDT B-NP
were VBD B-VP
essential JJ B-ADJP
to TO B-PP
the DT B-NP
maximal JJ I-NP
induction NN I-NP
by IN B-PP
LPS NN B-NP
in IN B-PP
transfected VBN B-NP
monocytes NNS I-NP
. . O

The DT B-NP
enhancer NN I-NP
also RB B-ADVP
appeared VBD B-VP
to TO I-VP
mediate VB I-VP
phorbol NN B-NP
myristate NN I-NP
acetate NN I-NP
induction NN I-NP
in IN B-PP
monocytes NNS B-NP
and CC O
IL-1 NN B-NP
responsiveness NN I-NP
in IN B-PP
fibroblasts NNS B-NP
. . O

Deletion NN B-NP
and CC O
base NN B-NP
substitution NN I-NP
mutations NNS I-NP
along IN B-CONJP
with IN I-CONJP
DNA NN B-NP
binding NN I-NP
studies NNS I-NP
demonstrated VBD B-VP
that IN B-SBAR
the DT B-NP
enhancer NN I-NP
contained VBD B-VP
a DT B-NP
minimum NN I-NP
of IN B-PP
three CD B-NP
functional JJ I-NP
protein NN I-NP
binding NN I-NP
sequences NNS I-NP
COMMA COMMA O
two CD B-NP
of IN B-PP
which WDT B-NP
appeared VBD B-VP
to TO I-VP
be VB I-VP
important JJ B-ADJP
for IN B-PP
gene NN B-NP
induction NN I-NP
. . O

One CD B-NP
of IN B-PP
the DT B-NP
essential JJ I-NP
proteins NNS I-NP
which WDT B-NP
bound VBD B-VP
to TO B-PP
the DT B-NP
enhancer NN I-NP
was VBD B-VP
similar JJ B-ADJP
or CC O
identical JJ B-ADJP
to TO B-PP
members NNS B-NP
of IN B-PP
the DT B-NP
C\/EBP NN I-NP
family NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
required VBN B-VP
for IN B-PP
both CC O
IL-1- NN B-NP
and CC O
LPS-specific JJ B-ADJP
induction NN B-NP
of IN B-PP
the DT B-NP
IL-6 NN I-NP
gene NN I-NP
( ( O
i.e. FW B-ADVP
COMMA COMMA B-NP
the DT I-NP
NF-IL6 NN I-NP
proteins NNS I-NP
) ) O
. . O

When WRB B-ADVP
ligated VBN B-VP
to TO B-PP
the DT B-NP
proIL-1 NN I-NP
beta NN I-NP
cap NN I-NP
site-proximal JJ I-NP
region NN I-NP
( ( O
located JJ B-ADJP
between IN B-PP
-131 CD B-NP
to TO O
+12 CD B-NP
) ) O
COMMA COMMA O
both CC O
the DT B-NP
proIL-1 NN I-NP
beta NN I-NP
and CC O
the DT B-NP
simian JJ I-NP
virus NN I-NP
40 CD I-NP
enhancer NN I-NP
elements NNS I-NP
functioned VBD B-VP
more RBR B-ADVP
efficiently RB I-ADVP
in IN B-PP
monocytes NNS B-NP
than IN B-PP
in IN B-PP
HeLa NN B-NP
cells NNS I-NP
COMMA COMMA O
which WDT B-NP
are VBP B-VP
not RB O
normally RB B-ADVP
competent JJ B-ADJP
for IN B-PP
IL-1 NN B-NP
beta NN I-NP
expression NN I-NP
. . O

When WRB B-ADVP
ligated VBN B-VP
to TO B-PP
the DT B-NP
murine JJ I-NP
c-fos NN I-NP
promoter NN I-NP
COMMA COMMA O
however RB B-ADVP
COMMA COMMA O
the DT B-NP
proIL-1 NN I-NP
beta NN I-NP
enhancer NN I-NP
was VBD B-VP
inducible JJ B-ADJP
in IN B-PP
phorbol NN B-NP
myristate NN I-NP
acetate-stimulated JJ I-NP
HeLa NN I-NP
cells NNS I-NP
COMMA COMMA O
suggesting VBG B-VP
the DT B-NP
existence NN I-NP
of IN B-PP
a DT B-NP
proIL-1 NN I-NP
beta NN I-NP
promoter-proximal JJ I-NP
requirement NN I-NP
for IN B-PP
tissue NN B-NP
specificity NN I-NP
. . O

Expression NN B-NP
of IN B-PP
PILOT NN B-NP
COMMA COMMA O
a DT B-NP
putative JJ I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
requires VBZ B-VP
two CD B-NP
signals NNS I-NP
and CC O
is VBZ B-VP
cyclosporin NN B-NP
A NN I-NP
sensitive JJ B-ADJP
in IN B-PP
T NN B-NP
cells NNS I-NP
. . O

Few JJ B-NP
known JJ I-NP
genes NNS I-NP
( ( O
IL-2 NN B-NP
COMMA COMMA O
members NNS B-NP
of IN B-PP
the DT B-NP
IL-8 NN I-NP
family NN I-NP
COMMA COMMA O
interferon-gamma NN B-NP
) ) O
are VBP B-VP
induced VBN I-VP
in IN B-PP
T NN B-NP
cells NNS I-NP
only RB B-PP
through IN I-PP
the DT B-NP
combined JJ I-NP
effect NN I-NP
of IN B-PP
phorbol NN B-NP
myristic JJ I-NP
acetate NN I-NP
( ( O
PMA NN B-NP
) ) O
and CC O
a DT B-NP
Ca(2+)-ionophore NN I-NP
COMMA COMMA O
and CC O
expression NN B-NP
of IN B-PP
only RB B-NP
these DT I-NP
genes NNS I-NP
can MD B-VP
be VB I-VP
fully RB I-VP
suppressed VBN I-VP
by IN B-PP
Cyclosporin NN B-NP
A NN I-NP
( ( O
CyA NN B-NP
) ) O
. . O

We PRP B-NP
have VBP B-VP
identified VBN I-VP
a DT B-NP
putative JJ I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
designated VBN B-VP
PILOT NN B-NP
COMMA COMMA O
with IN B-PP
an DT B-NP
identical JJ I-NP
dual JJ I-NP
signal NN I-NP
requirement NN I-NP
for IN B-PP
expression NN B-NP
. . O

Induction NN B-NP
of IN B-PP
the DT B-NP
PILOT NN I-NP
gene NN I-NP
is VBZ B-VP
detectable JJ B-ADJP
in IN B-PP
human JJ B-NP
T NN I-NP
cells NNS I-NP
20 CD B-NP
min NN I-NP
following VBG B-PP
activation NN B-NP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
cycloheximide NN B-NP
and CC O
is VBZ B-VP
fully RB I-VP
suppressed VBN I-VP
by IN B-PP
CyA NN B-NP
. . O

The DT B-NP
PILOT NN I-NP
protein NN I-NP
has VBZ B-VP
a DT B-NP
calculated VBN I-NP
M(r) NN I-NP
of IN B-PP
42.6 CD B-NP
kDa NN I-NP
and CC O
contains VBZ B-VP
three CD B-NP
zinc NN I-NP
fingers NNS I-NP
of IN B-PP
the DT B-NP
C2H2-type NN I-NP
at IN B-PP
the DT B-NP
carboxyl-terminus NN I-NP
which WDT B-NP
are VBP B-VP
highly RB B-ADJP
homologous JJ I-ADJP
to TO B-PP
the DT B-NP
zinc NN I-NP
finger NN I-NP
regions NNS I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factors NNS I-NP
EGR1 NNS B-NP
COMMA COMMA O
EGR2 NNS B-NP
COMMA COMMA O
and CC O
pAT NN B-NP
133 CD I-NP
. . O

In IN B-PP
contrast NN I-PP
to TO I-PP
T NN B-NP
cells NNS I-NP
COMMA COMMA O
in IN B-PP
fibroblasts NNS B-NP
PILOT NN B-NP
gene NN I-NP
expression NN I-NP
requires VBZ B-VP
only RB B-NP
one CD I-NP
signal NN I-NP
( ( O
PMA NN B-NP
) ) O
and CC O
is VBZ B-VP
not RB I-VP
affected VBN I-VP
by IN B-PP
CyA NN B-NP
. . O

This DT B-NP
observation NN I-NP
directly RB B-ADVP
demonstrates VBZ B-VP
the DT B-NP
existence NN I-NP
of IN B-PP
a DT B-NP
Ca2+ NN I-NP
signal-dependent JJ I-NP
regulatory JJ I-NP
element NN I-NP
obligatory JJ B-ADJP
for IN B-PP
expression NN B-NP
of IN B-PP
some DT B-NP
genes NNS I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
but CC B-PP
not RB B-PP
in IN I-PP
fibroblasts NNS B-NP
. . O

This DT B-NP
differential JJ I-NP
expression NN I-NP
model NN I-NP
will MD B-VP
be VB I-VP
valuable JJ B-ADJP
in IN B-PP
the DT B-NP
dissection NN I-NP
of IN B-PP
the DT B-NP
dual JJ I-NP
signal NN I-NP
pathway NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
and CC O
the DT B-NP
effects NNS I-NP
of IN B-PP
CyA NN B-NP
upon IN B-PP
it PRP B-NP
. . O

Human JJ B-NP
CD4 NN I-NP
lymphocytes NNS I-NP
specifically RB B-ADVP
recognize VBP B-VP
a DT B-NP
peptide NN I-NP
representing VBG B-VP
the DT B-NP
fusion NN I-NP
region NN I-NP
of IN B-PP
the DT B-NP
hybrid NN I-NP
protein NN I-NP
pml\/RAR NN I-NP
alpha NN I-NP
present JJ B-ADJP
in IN B-PP
acute JJ B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
cells NNS I-NP
. . O

Fusion NN B-NP
proteins NNS I-NP
present JJ B-ADJP
in IN B-PP
leukemic JJ B-NP
cells NNS I-NP
frequently RB B-ADVP
contain VBP B-VP
a DT B-NP
new JJ I-NP
amino NN I-NP
acid NN I-NP
at IN B-PP
the DT B-NP
fusion NN I-NP
point NN I-NP
. . O

We PRP B-NP
tested VBD B-VP
whether IN B-SBAR
a DT B-NP
peptide NN I-NP
( ( O
BCR1\/25 NN B-NP
) ) O
encompassing VBG B-VP
the DT B-NP
fusion NN I-NP
region NN I-NP
of IN B-PP
the DT B-NP
hybrid NN I-NP
molecule NN I-NP
pml\/RAR NN I-NP
alpha NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
selectively RB I-VP
expressed VBN I-VP
by IN B-PP
acute JJ B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
( ( O
APL NN B-NP
) ) O
cells NNS B-NP
COMMA COMMA O
can MD B-VP
be VB I-VP
recognized VBN I-VP
by IN B-PP
human JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

CD4+ JJ B-NP
lymphocytes NNS I-NP
COMMA COMMA O
at IN B-PP
both CC B-NP
polyclonal JJ I-NP
and CC I-NP
clonal JJ I-NP
level NN I-NP
COMMA COMMA O
recognized VBD B-VP
peptide NN B-NP
BCR1\/25 NN I-NP
in IN B-PP
an DT B-NP
HLA-DR--restricted JJ I-NP
fashion NN I-NP
on IN B-PP
presentation NN B-NP
by IN B-PP
autologous JJ B-NP
antigen-presenting JJ B-NP
cell NN I-NP
( ( O
APC NN B-NP
) ) O
or CC B-PP
by IN B-PP
APC NN B-NP
expressing VBG B-VP
the DT B-NP
HLA-DR11 NN I-NP
restricting NN I-NP
molecule NN I-NP
. . O

Control NN B-NP
peptides NNS I-NP
corresponding VBG B-VP
to TO B-PP
the DT O
normal JJ B-NP
pml NN I-NP
and CC O
RAR NN B-NP
alpha NN I-NP
proteins NNS B-NP
were VBD B-VP
not RB I-VP
recognized VBN I-VP
. . O

One CD B-NP
clone NN I-NP
( ( O
DEG5 NN B-NP
) ) O
also RB B-ADVP
exerted VBD B-VP
a DT B-NP
high JJ I-NP
and CC I-NP
specific JJ I-NP
cytotoxicity NN I-NP
against IN B-PP
autologous JJ B-NP
cells NNS I-NP
pulsed VBN B-VP
with IN B-PP
BCR1\/25 NN B-NP
. . O

The DT B-NP
autologous JJ I-NP
DE NN I-NP
LCL NN I-NP
containing VBG B-VP
a DT B-NP
transduced VBN I-NP
pml\/RAR NN I-NP
alpha NN I-NP
fusion NN I-NP
gene NN I-NP
and CC O
expressing VBG B-VP
a DT B-NP
bcr1 NN I-NP
type NN I-NP
of IN B-PP
the DT B-NP
pml\/RAR NN I-NP
alpha NN I-NP
hybrid NN I-NP
protein NN I-NP
induced VBD B-VP
the DT B-NP
proliferation NN I-NP
of IN B-PP
DE NN B-NP
anti-BCR1\/25 CD I-NP
T NN I-NP
cell NN I-NP
clones NNS I-NP
. . O

It PRP B-NP
is VBZ B-VP
concluded VBN I-VP
that IN B-SBAR
the DT B-NP
bcr1 NN I-NP
type-pml\/RAR NN I-NP
alpha NN I-NP
fusion NN I-NP
protein NN I-NP
of IN B-PP
APL NN B-NP
contains VBZ B-VP
an DT B-NP
antigenic JJ I-NP
site NN I-NP
COMMA COMMA O
absent JJ B-ADJP
from IN B-PP
the DT B-NP
normal JJ I-NP
parent NN I-NP
molecules NNS I-NP
and CC O
recognized VBN B-VP
by IN B-PP
human JJ B-NP
CD4+ JJ I-NP
lymphocytes NNS I-NP
. . O

A DT B-NP
serum NN I-NP
response NN I-NP
element NN I-NP
and CC O
a DT B-NP
binding VBG I-NP
site NN I-NP
for IN B-PP
NF-Y NN B-NP
mediate VB B-VP
the DT B-NP
serum NN I-NP
response NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
thrombospondin NN I-NP
1 CD I-NP
gene NN I-NP
. . O

The DT B-NP
expression NN I-NP
of IN B-PP
thrombospondin NN B-NP
1 CD I-NP
( ( O
TSP NN B-NP
1 CD I-NP
) ) O
COMMA COMMA O
a DT B-NP
member NN I-NP
of IN B-PP
the DT B-NP
TSP NN I-NP
gene NN I-NP
family NN I-NP
COMMA COMMA O
is VBZ B-VP
rapidly RB I-VP
induced VBN I-VP
by IN B-PP
growth NN B-NP
factors NNS I-NP
. . O

We PRP B-NP
tested VBD B-VP
the DT B-NP
ability NN I-NP
of IN B-PP
human JJ B-NP
TSP NN I-NP
1-chloramphenicol JJ I-NP
acetyltransferase NN I-NP
constructs NNS I-NP
to TO B-VP
respond VB I-VP
to TO B-PP
serum NN B-NP
in IN B-PP
stably RB B-NP
transfected VBN I-NP
NIH-3T3 NN I-NP
cells NNS I-NP
. . O

Two CD B-NP
transcriptional JJ I-NP
elements NNS I-NP
in IN B-PP
the DT B-NP
TSP NN I-NP
1 CD I-NP
promoter NN I-NP
COMMA COMMA O
a DT B-NP
distal JJ I-NP
element NN I-NP
at IN B-PP
-1280 CD B-NP
and CC O
a DT B-NP
proximal JJ I-NP
element NN I-NP
at IN B-PP
-65 CD B-NP
COMMA COMMA O
were VBD B-VP
required VBN I-VP
for IN B-PP
the DT B-NP
response NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
TSP NN I-NP
1 CD I-NP
gene NN I-NP
to TO B-PP
serum NN B-NP
. . O

Deletions NNS B-NP
or CC O
mutations NNS B-NP
in IN B-PP
this DT B-NP
element NN I-NP
reduced VBD B-VP
the DT B-NP
serum NN I-NP
response NN I-NP
of IN B-PP
the DT B-NP
TSP NN I-NP
1 CD I-NP
gene NN I-NP
by IN B-PP
80-90 CD B-NP
% NN I-NP
. . O

In IN B-PP
gel-shift JJ B-NP
assays NNS I-NP
COMMA COMMA O
the DT B-NP
-1280 CD I-NP
element NN I-NP
and CC O
the DT B-NP
c-fos NN I-NP
SRE NN I-NP
cross-competed VBD B-VP
COMMA COMMA O
whereas IN O
their PRP$ B-NP
functional JJ I-NP
and CC I-NP
binding VBG I-NP
mutants NNS I-NP
did VBD B-VP
not RB O
. . O

The DT B-NP
proximal JJ I-NP
element NN I-NP
contains VBZ B-VP
the DT B-NP
sequence NN I-NP
5'-GGCCAATGGG-3' NN I-NP
COMMA COMMA O
which WDT B-NP
closely RB B-VP
resembles VBZ I-VP
the DT B-NP
consensus NN I-NP
binding NN I-NP
motif NN I-NP
for IN B-PP
the DT B-NP
CCAAT-binding JJ I-NP
factor NN I-NP
NF-Y NN I-NP
( ( O
CBF NN B-NP
COMMA COMMA O
CP1 NN B-NP
COMMA COMMA O
alpha NN B-NP
CP1 NN I-NP
) ) O
. . O

Deletions NNS B-NP
or CC O
mutations NNS B-NP
in IN B-PP
this DT B-NP
element NN I-NP
also RB B-ADVP
reduced VBD B-VP
the DT B-NP
serum NN I-NP
response NN I-NP
by IN B-PP
80-90 CD B-NP
% NN I-NP
. . O

Methylation NN B-NP
interference NN I-NP
analysis NN I-NP
of IN B-PP
the DT B-NP
-65 CD I-NP
region NN I-NP
identified VBD B-VP
a DT B-NP
pattern NN I-NP
of IN B-PP
contacts NNS B-NP
with IN B-PP
nuclear JJ B-NP
factors NNS I-NP
resembling VBG B-VP
that DT B-NP
for IN B-PP
NF-Y NN B-NP
COMMA COMMA O
and CC O
an DT B-NP
NF-Y-binding JJ I-NP
site NN I-NP
and CC O
the DT B-NP
proximal JJ I-NP
TSP NN I-NP
1 CD I-NP
element NN I-NP
cross-competed VBD B-VP
in IN B-PP
gel-shift JJ B-NP
assays NNS I-NP
COMMA COMMA O
whereas IN O
their PRP$ B-NP
binding VBG I-NP
mutants NNS I-NP
did VBD B-VP
not RB O
. . O

Finally RB B-ADVP
COMMA COMMA O
an DT B-NP
abbreviated VBN I-NP
TSP NN I-NP
1 CD I-NP
promoter\/5'-flank NN I-NP
COMMA COMMA O
containing VBG B-VP
the DT O
SRE- NN B-NP
and CC O
NF-Y-binding JJ B-ADJP
sites NNS B-NP
COMMA COMMA O
mediated VBD B-VP
a DT B-NP
serum NN I-NP
response NN I-NP
that WDT B-NP
was VBD B-VP
close JJ B-ADJP
in IN B-PP
magnitude NN B-NP
to TO B-PP
that DT B-NP
of IN B-PP
the DT B-NP
parent NN I-NP
promoter NN I-NP
. . O

We PRP B-NP
conclude VBP B-VP
that IN B-SBAR
the DT B-NP
serum NN I-NP
response NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
TSP NN I-NP
1 CD I-NP
gene NN I-NP
requires VBZ B-VP
the DT B-NP
coordinated VBN I-NP
function NN I-NP
of IN B-PP
an DT O
SRE- NN B-NP
and CC O
NF-Y-binding JJ B-ADJP
site NN B-NP
. . O

Suppression NN B-NP
of IN B-PP
a DT B-NP
cellular JJ I-NP
differentiation NN I-NP
program NN I-NP
by IN B-PP
phorbol NN B-NP
esters NNS I-NP
coincides VBZ B-VP
with IN B-PP
inhibition NN B-NP
of IN B-PP
binding NN B-NP
of IN B-PP
a DT B-NP
cell-specific JJ I-NP
transcription NN I-NP
factor NN I-NP
( ( O
NF-E2 NN B-NP
) ) O
to TO B-PP
an DT B-NP
enhancer NN I-NP
element NN I-NP
required VBN B-VP
for IN B-PP
expression NN B-NP
of IN B-PP
an DT B-NP
erythroid-specific JJ I-NP
gene NN I-NP
. . O

Induction NN B-NP
by IN B-PP
hemin NN B-NP
increases VBZ B-VP
COMMA COMMA O
while IN B-SBAR
induction NN B-NP
with IN B-PP
12-O-tetradecanoylphorbol-13-acetate NN B-NP
( ( O
TPA NN B-NP
) ) O
represses VBZ B-VP
COMMA COMMA O
erythroid-specific JJ B-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
the DT B-NP
human JJ I-NP
cell NN I-NP
line NN I-NP
K562 NN I-NP
. . O

We PRP B-NP
analyzed VBD B-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
hemin NN B-NP
or CC O
TPA NN B-NP
induction NN B-NP
on IN B-PP
the DT B-NP
binding NN B-NP
and CC O
activity NN B-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
at IN B-PP
a DT B-NP
regulatory JJ I-NP
element NN I-NP
found VBN B-VP
within IN B-PP
the DT B-NP
transcriptional JJ I-NP
regulatory JJ I-NP
sequences NNS I-NP
of IN B-PP
many JJ B-NP
erythroid-specific JJ I-NP
genes NNS I-NP
. . O

TPA NN B-NP
induction NN I-NP
increases VBZ B-VP
the DT B-NP
binding NN I-NP
of IN B-PP
ubiquitous JJ B-NP
AP-1 NN I-NP
factors NNS I-NP
to TO B-PP
this DT B-NP
element NN I-NP
. . O

TPA NN B-NP
induction NN I-NP
inhibits VBZ B-VP
the DT B-NP
binding NN I-NP
of IN B-PP
the DT B-NP
lineage NN I-NP
limited JJ I-NP
transcription NN I-NP
factor NN I-NP
NF-E2 NN I-NP
to TO B-PP
this DT B-NP
transcriptional JJ I-NP
control NN I-NP
element NN I-NP
. . O

Hemin NN B-NP
induction NN I-NP
of IN B-PP
K562 NN B-NP
cells NNS I-NP
does VBZ B-VP
not RB I-VP
facilitate VB I-VP
the DT B-NP
binding NN I-NP
of IN B-PP
NF-E2 NN B-NP
to TO B-PP
its PRP$ B-NP
recognition NN I-NP
site NN I-NP
. . O

Hemin NN B-NP
induction NN I-NP
appears VBZ B-VP
to TO I-VP
nonspecifically RB I-VP
increase VB I-VP
the DT B-NP
expression NN I-NP
of IN B-PP
transiently RB B-NP
transfected VBN I-NP
genes NNS I-NP
in IN B-PP
K562 NN B-NP
cells NNS I-NP
. . O

Beyond IN B-PP
this DT B-NP
nonspecific JJ I-NP
increase NN I-NP
in IN B-PP
gene NN B-NP
expression NN I-NP
COMMA COMMA O
hemin NN B-NP
induction NN I-NP
acts VBZ B-VP
to TO I-VP
increase VB I-VP
the DT B-NP
activity NN I-NP
of IN B-PP
the DT B-NP
lineage NN I-NP
limited JJ I-NP
transcription NN I-NP
factor NN I-NP
NF-E2 NN I-NP
. . O

The DT B-NP
divergent JJ I-NP
effects NNS I-NP
of IN B-PP
hemin NN B-NP
and CC O
TPA NN B-NP
on IN B-PP
gene NN B-NP
expression NN I-NP
in IN B-PP
K562 NN B-NP
cells NNS I-NP
are VBP B-VP
mediated VBN I-VP
COMMA COMMA O
in IN B-PP
part NN B-NP
COMMA COMMA B-PP
by IN I-PP
their PRP$ B-NP
contrasting JJ I-NP
effects NNS I-NP
on IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
NF-E2 NN I-NP
. . O

The DT B-NP
interleukin NN I-NP
2 CD I-NP
CD28-responsive JJ I-NP
complex NN I-NP
contains VBZ B-VP
at IN B-NP
least JJS I-NP
three CD I-NP
members NNS I-NP
of IN B-PP
the DT B-NP
NF NN I-NP
kappa NN I-NP
B NN I-NP
family NN I-NP
: : O
c-Rel NN B-NP
COMMA COMMA O
p50 NN B-NP
COMMA COMMA O
and CC O
p65 NN B-NP
. . O

Optimal JJ B-NP
activation NN I-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
requires VBZ B-VP
at IN B-NP
least JJS I-NP
two CD I-NP
signals NNS I-NP
. . O

One CD B-NP
signal NN I-NP
can MD B-VP
be VB I-VP
delivered VBN I-VP
by IN B-PP
the DT B-NP
antigen-specific JJ I-NP
T-cell NN I-NP
receptor NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
second JJ I-NP
signal NN I-NP
is VBZ B-VP
provided VBN I-VP
by IN B-PP
the DT B-NP
costimulatory JJ I-NP
molecule NN I-NP
( ( I-NP
s NNS I-NP
) ) O
delivered VBN B-VP
by IN B-PP
the DT B-NP
antigen-presenting JJ I-NP
cell NN I-NP
. . O

CD28 NN B-NP
is VBZ B-VP
a DT B-NP
T-cell NN I-NP
surface NN I-NP
molecule NN I-NP
and CC O
stimulation NN B-NP
through IN B-PP
this DT B-NP
protein NN I-NP
plays VBZ B-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
delivering VBG B-VP
the DT B-NP
second JJ I-NP
activation NN I-NP
signal NN I-NP
. . O

In IN B-PP
this DT B-NP
report NN I-NP
COMMA COMMA O
we PRP B-NP
show VBP B-VP
that IN B-SBAR
in IN B-PP
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
T NN I-NP
cells NNS I-NP
COMMA COMMA O
CD28-mediated JJ B-NP
signal NN I-NP
transduction NN I-NP
involves VBZ B-VP
the DT B-NP
rel NN I-NP
family NN I-NP
proteins NNS I-NP
-- : O
c-Rel NN B-NP
COMMA COMMA O
p50 NN B-NP
COMMA COMMA O
and CC O
p65 NN B-NP
. . O

Treatment NN B-NP
of IN B-PP
peripheral JJ B-NP
blood NN I-NP
T NN I-NP
cells NNS I-NP
with IN B-PP
phorbol NN B-NP
12-myristate NN I-NP
13-acetate NN I-NP
( ( O
PMA NN B-NP
) ) O
and CC O
anti-CD28 JJ B-NP
monoclonal JJ I-NP
antibody NN I-NP
( ( O
mAb NN B-NP
) ) O
results VBZ B-VP
in IN B-PP
augmentation NN B-NP
of IN B-PP
nuclear JJ B-NP
c-Rel NN B-NP
COMMA COMMA O
p50 NN B-NP
COMMA COMMA O
and CC O
p65 NN B-NP
COMMA COMMA O
and CC O
this DT B-NP
augmentation NN I-NP
can MD B-VP
occur VB I-VP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
the DT B-NP
immunosuppressant JJ I-NP
cyclosporin NN I-NP
A NN I-NP
. . O

It PRP B-NP
is VBZ B-VP
also RB I-VP
shown VBN I-VP
in IN B-PP
this DT B-NP
report NN I-NP
that IN B-SBAR
COMMA COMMA O
in IN B-PP
response NN I-PP
to TO I-PP
PMA\/anti-CD28 JJ B-NP
mAb NN I-NP
or CC O
anti-CD3\/anti-CD28 JJ B-NP
mAb NN I-NP
COMMA COMMA O
c-Rel NN B-NP
COMMA COMMA O
p50 NN B-NP
COMMA COMMA O
and CC O
p65 NN B-NP
are VBP B-VP
associated VBN I-VP
with IN B-PP
CD28-responsive JJ B-NP
element NN I-NP
present JJ B-ADJP
in IN B-PP
the DT B-NP
promoter NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
interleukin NN I-NP
2 CD I-NP
gene NN I-NP
. . O

The DT B-NP
functional JJ I-NP
significance NN I-NP
of IN B-PP
c-Rel NN B-NP
involvement NN I-NP
in IN B-PP
the DT B-NP
CD28-responsive JJ I-NP
complex NN I-NP
is VBZ B-VP
demonstrated VBN I-VP
by IN B-PP
transient JJ B-NP
transfection NN I-NP
analysis NN I-NP
COMMA COMMA O
where WRB B-ADVP
cotransfection NN B-NP
of IN B-PP
c-Rel NN B-NP
augments VBZ B-VP
the DT B-NP
level NN I-NP
of IN B-PP
expression NN B-NP
of IN B-PP
a DT B-NP
chloramphenicol JJ I-NP
acetyltransferase NN I-NP
reporter NN I-NP
gene NN I-NP
linked VBN B-VP
to TO B-PP
the DT B-NP
CD28-responsive JJ I-NP
element NN I-NP
. . O

Expression NN B-NP
of IN B-PP
the DT B-NP
Tat NN I-NP
protein NN I-NP
of IN B-PP
HIV1 NN B-NP
in IN B-PP
human JJ B-NP
promonocytic JJ I-NP
U937 NN I-NP
cells NNS I-NP
. . O

Numerous JJ B-NP
studies NNS I-NP
have VBP B-VP
shown VBN I-VP
that IN B-SBAR
COMMA COMMA O
upon IN B-PP
HIV1 NN B-NP
infection NN I-NP
COMMA COMMA O
human JJ B-NP
promonocytic JJ I-NP
U937 NN I-NP
cells NNS I-NP
were VBD B-VP
induced VBN I-VP
to TO I-VP
differentiate VB I-VP
COMMA COMMA O
as IN B-SBAR
indicated VBN B-VP
COMMA COMMA O
for IN B-PP
example NN B-NP
COMMA COMMA O
by IN B-PP
increased VBN B-NP
expression NN I-NP
of IN B-PP
adhesion NN B-NP
molecules NNS I-NP
. . O

One CD B-NP
of IN B-PP
the DT B-NP
viral JJ I-NP
proteins NNS I-NP
involved VBN B-VP
in IN B-PP
this DT B-NP
process NN I-NP
might MD B-VP
be VB I-VP
the DT B-NP
Tat NN I-NP
protein NN I-NP
. . O

Indeed RB B-ADVP
COMMA COMMA O
this DT B-NP
viral JJ I-NP
protein NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
productive JJ B-NP
infection NN I-NP
COMMA COMMA O
has VBZ B-VP
also RB I-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
display VB I-VP
growth-stimulating JJ B-NP
properties NNS I-NP
and CC O
immunomodulatory JJ B-NP
activities NNS I-NP
. . O

In IN B-SBAR
order NN O
to TO O
apprehend VB B-VP
the DT B-NP
role NN I-NP
of IN B-PP
the DT B-NP
HIV1 NN I-NP
tat NN I-NP
gene NN I-NP
in IN B-PP
inducing VBG B-VP
the DT B-NP
differentiation NN I-NP
of IN B-PP
HIV1-infected JJ B-NP
U937 NN I-NP
cells NNS I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
successfully RB I-VP
introduced VBN I-VP
this DT B-NP
gene NN I-NP
into IN B-PP
U937 NN B-NP
cells NNS I-NP
by IN B-PP
infecting VBG B-VP
them PRP B-NP
with IN B-PP
retroviral JJ B-NP
particles NNS I-NP
transducing VBG I-NP
tat NN I-NP
. . O

The DT B-NP
effect NN I-NP
of IN B-PP
the DT B-NP
Tat NN I-NP
protein NN I-NP
constitutively RB B-VP
expressed VBN I-VP
by IN B-PP
these DT B-NP
cells NNS I-NP
upon IN B-PP
their PRP$ B-NP
differentiation NN I-NP
was VBD B-VP
then RB I-VP
evaluated VBN I-VP
by IN B-PP
looking VBG B-VP
for IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
c-fos NN I-NP
and CC B-PP
of IN B-PP
the DT B-NP
c-fms NN I-NP
proto-oncogenes NNS B-NP
which WDT B-NP
are VBP B-VP
linked VBN I-VP
to TO B-PP
the DT B-NP
differentiation NN I-NP
of IN B-PP
myelomonoblastic JJ B-NP
cells NNS I-NP
. . O

Northern NN B-NP
blot NN I-NP
analysis NN I-NP
revealed VBD B-VP
in IN B-PP
these DT B-NP
cells NNS I-NP
COMMA COMMA O
an DT B-NP
increase NN I-NP
in IN B-PP
the DT B-NP
transcription NN I-NP
of IN B-PP
these DT B-NP
two CD I-NP
proto-oncogenes NNS I-NP
COMMA COMMA O
and CC O
this DT B-NP
increase NN I-NP
was VBD B-VP
amplified VBN I-VP
after IN B-PP
treatment NN B-NP
with IN B-PP
phorbol NN B-NP
myristate NN I-NP
acetate NN I-NP
. . O

No DT B-NP
such JJ I-NP
increase NN I-NP
was VBD B-VP
observed VBN I-VP
in IN B-PP
control NN B-NP
U937 NN I-NP
cells NNS I-NP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
COMMA COMMA O
among IN B-PP
HIV1 NN B-NP
gene NN I-NP
products NNS I-NP
COMMA COMMA O
the DT B-NP
Tat NN I-NP
protein NN I-NP
appears VBZ B-VP
to TO I-VP
trigger VB I-VP
monocytic JJ B-NP
differentiation NN I-NP
COMMA COMMA O
and CC O
suggests VBZ B-VP
that IN B-SBAR
this DT B-NP
viral JJ I-NP
protein NN I-NP
directs VBZ B-VP
progenitors NNS B-NP
of IN B-PP
the DT B-NP
monocyte\/macrophage NN I-NP
lineage NN I-NP
towards IN B-PP
a DT B-NP
differentiation NN I-NP
stage NN I-NP
in IN B-PP
which WDT B-NP
production NN B-NP
of IN B-PP
viral JJ B-NP
antigens NNS I-NP
and CC O
virions NNS B-NP
might MD B-VP
be VB I-VP
more RBR B-ADJP
efficient JJ I-ADJP
. . O

Transcriptional JJ B-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
pyruvate NN I-NP
kinase NN I-NP
erythroid-specific JJ I-NP
promoter NN I-NP
. . O

Mammal JJ B-NP
pyruvate NN I-NP
kinases NNS I-NP
are VBP B-VP
encoded VBN I-VP
by IN B-PP
two CD B-NP
genes NNS I-NP
. . O

The DT B-NP
L NN I-NP
gene NN I-NP
produces VBZ B-VP
the DT B-NP
erythroid JJ I-NP
( ( O
R-PK NN B-NP
) ) O
or CC O
the DT B-NP
hepatic JJ I-NP
( ( O
L-PK JJ B-NP
) ) O
isozymes NNS B-NP
by IN B-PP
the DT B-NP
alternative JJ I-NP
use NN I-NP
of IN B-PP
two CD B-NP
promoters NNS I-NP
. . O

We PRP B-NP
report VBP B-VP
the DT B-NP
characterization NN I-NP
of IN B-PP
the DT O
cis- JJ B-NP
and CC O
trans-acting JJ B-ADJP
elements NNS B-NP
involved VBN B-VP
in IN B-PP
the DT B-NP
tissue-specific JJ I-NP
activity NN I-NP
of IN B-PP
the DT B-NP
L NN I-NP
gene NN I-NP
erythroid JJ I-NP
promoter NN I-NP
. . O

A DT B-NP
R-PK NN I-NP
DNA NN I-NP
fragment NN I-NP
extending VBG B-VP
from IN B-PP
-870 CD B-NP
to TO B-PP
+54 CD B-NP
relative JJ B-PP
to TO I-PP
the DT B-NP
cap NN I-NP
site NN I-NP
confers VBZ B-VP
erythroid JJ B-NP
specificity NN I-NP
to TO B-PP
a DT B-NP
reporter NN I-NP
gene NN I-NP
. . O

Within IN B-PP
this DT B-NP
region NN I-NP
COMMA COMMA O
we PRP B-NP
define VBP B-VP
a DT B-NP
minimal JJ I-NP
promoter NN I-NP
( ( O
-62 CD B-NP
to TO O
+54 CD B-NP
) ) O
that WDT B-NP
displays VBZ B-VP
erythroid-specific JJ B-NP
activity NN I-NP
and CC O
contains VBZ B-VP
two CD B-NP
DNA NN I-NP
binding NN I-NP
sites NNS I-NP
. . O

One CD B-NP
COMMA COMMA O
located JJ B-ADJP
at IN B-PP
-50 CD B-NP
COMMA COMMA O
binds VBZ B-VP
members NNS B-NP
of IN B-PP
the DT B-NP
CCACC\/Sp1 NN I-NP
family NN I-NP
and CC O
the DT B-NP
other JJ I-NP
COMMA COMMA O
located JJ B-ADJP
at IN B-PP
-20 CD B-NP
COMMA COMMA O
binds VBZ B-VP
the DT B-NP
erythroid JJ I-NP
factor NN I-NP
GATA-1 NN I-NP
. . O

Although IN B-SBAR
the DT B-NP
-20 CD I-NP
GATA NN I-NP
binding NN I-NP
site NN I-NP
( ( O
AGATAA NN B-NP
) ) O
is VBZ B-VP
also RB B-ADVP
a DT B-NP
potential JJ I-NP
TFIID NN I-NP
binding NN I-NP
site NN I-NP
COMMA COMMA O
it PRP B-NP
does VBZ B-VP
not RB I-VP
bind VB I-VP
TFIID NN B-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
the DT B-NP
substitution NN I-NP
of IN B-PP
this DT B-NP
GATA NN I-NP
binding NN I-NP
site NN I-NP
by IN B-PP
a DT B-NP
canonical JJ I-NP
TFIID NN I-NP
binding NN I-NP
site NN I-NP
suppresses VBZ B-VP
the DT B-NP
promoter NN I-NP
activity NN I-NP
. . O

Mutations NNS B-NP
and CC O
deletions NNS B-NP
of IN B-PP
both DT B-NP
sites NNS I-NP
indicate VBP B-VP
that IN B-SBAR
only RB B-NP
the DT I-NP
association NN I-NP
of IN B-PP
CCACC\/Sp1 NN B-NP
and CC O
GATA NN B-NP
binding NN B-NP
sites NNS I-NP
can MD B-VP
drive VB I-VP
efficient JJ B-NP
and CC I-NP
tissue-specific JJ I-NP
expression NN I-NP
of IN B-PP
this DT B-NP
R-PK NN I-NP
minimal JJ I-NP
promoter NN I-NP
. . O

Finally RB B-ADVP
COMMA COMMA O
by IN B-PP
co-transfection NN B-NP
experiments NNS I-NP
COMMA COMMA O
we PRP B-NP
study VBD B-VP
the DT B-NP
elements NNS I-NP
involved VBN B-VP
in IN B-PP
the DT B-NP
hGATA-1 NN I-NP
transactivation NN I-NP
of IN B-PP
the DT B-NP
R-PK NN I-NP
promoter NN I-NP
in IN B-PP
HeLa NN B-NP
cells NNS I-NP
. . O

Stimulation NN B-NP
of IN B-PP
interleukin-1 NN B-NP
alpha NN I-NP
and CC O
interleukin-1 NN B-NP
beta NN I-NP
production NN B-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
by IN B-PP
protein NN O
phosphatase NN O
1 CD B-NP
and CC O
2A NN B-NP
inhibitors NNS B-NP
. . O

Protein NN B-NP
phosphatases NNS I-NP
1 CD B-NP
and CC O
2A NN B-NP
are VBP B-VP
important JJ B-ADJP
in IN B-PP
regulating VBG B-VP
cellular JJ B-NP
functions NNS I-NP
by IN B-PP
controlling VBG B-VP
the DT B-NP
phosphorylation NN I-NP
state NN I-NP
of IN B-PP
their PRP$ B-NP
substrates NNS I-NP
. . O

In IN B-PP
human JJ B-NP
monocytes NNS I-NP
COMMA COMMA O
the DT B-NP
inhibitors NNS I-NP
of IN B-PP
these DT B-NP
phosphatases NNS I-NP
COMMA COMMA O
okadaic JJ B-NP
acid NN I-NP
and CC O
calyculin NN B-NP
A NN I-NP
COMMA COMMA O
were VBD B-VP
found VBN I-VP
to TO I-VP
increase VB I-VP
the DT B-NP
mRNA NN B-NP
accumulation NN I-NP
and CC O
cytokine NN B-NP
production NN I-NP
of IN B-PP
interleukin-1 NN B-NP
beta NN I-NP
and CC O
interleukin-1 NN B-NP
alpha NN I-NP
. . O

The DT B-NP
increased VBN I-NP
mRNA NN I-NP
accumulation NN I-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
primarily RB B-PP
because IN I-PP
of IN I-PP
the DT B-NP
increase NN I-NP
in IN B-PP
the DT B-NP
transcription NN I-NP
rate NN I-NP
of IN B-PP
the DT B-NP
interleukin-1 NN I-NP
genes NNS I-NP
. . O

Stimulation NN B-NP
of IN B-PP
interleukin-1 NN B-NP
gene NN I-NP
transcription NN I-NP
may MD B-VP
be VB I-VP
caused VBN I-VP
by IN B-PP
the DT B-NP
stimulation NN I-NP
of IN B-PP
transcription NN B-NP
factor NN I-NP
activities NNS I-NP
COMMA COMMA O
including VBG B-PP
those DT B-NP
of IN B-PP
AP-1 NN B-NP
COMMA COMMA O
by IN B-PP
these DT B-NP
protein NN I-NP
phosphatase NN I-NP
inhibitors NNS I-NP
. . O

Okadaic JJ B-NP
acid NN I-NP
increased VBD B-VP
the DT B-NP
synthesis NN I-NP
of IN B-PP
the DT O
interleukin-1 NN O
beta NN O
precursor NN B-NP
and CC O
mature JJ B-ADJP
forms NNS B-NP
and CC O
their PRP$ B-NP
secretion NN I-NP
. . O

This DT B-NP
increased VBD I-NP
processing NN B-NP
and CC O
secretion NN B-NP
correlated VBN B-VP
with IN B-PP
the DT B-NP
stimulation NN I-NP
of IN B-PP
IL-1 NN B-NP
beta NN I-NP
convertase NN I-NP
mRNA NN I-NP
accumulation NN I-NP
. . O

The DT B-NP
stimulation NN I-NP
of IN B-PP
interleukin-1 NN B-NP
alpha NN I-NP
production NN I-NP
by IN B-PP
okadaic JJ B-NP
acid NN I-NP
was VBD B-VP
more RBR B-ADJP
modest JJ I-ADJP
than IN B-PP
that DT B-NP
of IN B-PP
interleukin-1 NN B-NP
beta NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
phosphorylation NN I-NP
of IN B-PP
the DT B-NP
precursor NN I-NP
interleukin-1 NN I-NP
alpha NN I-NP
cytokine NN I-NP
was VBD B-VP
increased VBN I-VP
. . O

These DT B-NP
results NNS I-NP
show VBP B-VP
that IN B-SBAR
protein NN O
phosphatase NN O
1 CD B-NP
and CC O
2A NN B-NP
inhibitors NNS B-NP
exert VBP B-VP
multiple JJ B-NP
effects NNS I-NP
on IN B-PP
cytokine NN B-NP
production NN I-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
and CC O
suggest VBP B-VP
that IN B-SBAR
these DT B-NP
two CD I-NP
phosphatases NNS I-NP
play VBP B-VP
important JJ B-NP
roles NNS I-NP
in IN B-PP
regulating VBG B-VP
interleukin-1 NN B-NP
production NN I-NP
. . O

Cell NN B-NP
type- NN I-NP
and CC O
stage-specific JJ B-ADJP
expression NN B-NP
of IN B-PP
the DT B-NP
CD20\/B1 NN I-NP
antigen NN I-NP
correlates VBZ B-VP
with IN B-PP
the DT B-NP
activity NN I-NP
of IN B-PP
a DT B-NP
diverged JJ I-NP
octamer NN I-NP
DNA NN I-NP
motif NN I-NP
present JJ B-ADJP
in IN B-PP
its PRP$ B-NP
promoter NN I-NP
. . O

The DT B-NP
CD20 NN I-NP
( ( I-NP
B1 NN I-NP
) ) I-NP
gene NN I-NP
encodes VBZ B-VP
a DT B-NP
B NN I-NP
cell-specific JJ I-NP
protein NN I-NP
involved VBN B-VP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
human JJ B-NP
B NN I-NP
cell NN I-NP
proliferation NN B-NP
and CC O
differentiation NN B-NP
. . O

Studies NNS B-NP
with IN B-PP
5' JJ B-NP
deletion NN I-NP
CD20 NN I-NP
promoter-CAT NN I-NP
constructs NNS I-NP
have VBP B-VP
previously RB I-VP
revealed VBN I-VP
two CD B-NP
regions NNS I-NP
of IN B-PP
the DT B-NP
promoter NN I-NP
between IN B-PP
bases NNS B-NP
-186 CD B-NP
and CC O
-280 CD B-NP
and CC B-PP
between IN B-PP
bases NNS B-NP
-280 CD B-NP
and CC O
-454 CD B-NP
which WDT B-NP
contained VBD B-VP
positive JJ B-NP
regulatory JJ I-NP
elements NNS I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
we PRP B-NP
identified VBD B-VP
a DT B-NP
sequence NN I-NP
element NN I-NP
present JJ B-ADJP
in IN B-PP
the DT B-NP
most RBS I-NP
proximal JJ I-NP
region NN I-NP
located JJ B-ADJP
between IN B-PP
bases NNS B-NP
-214 CD B-NP
and CC O
-201 CD B-NP
COMMA COMMA O
TTCTTCTAATTAA NN B-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
important JJ B-ADJP
in IN B-PP
the DT B-NP
high JJ I-NP
constitutive JJ I-NP
expression NN I-NP
of IN B-PP
CD20 NN B-NP
in IN B-PP
mature JJ B-NP
B NN I-NP
cells NNS I-NP
and CC O
the DT B-NP
induction NN I-NP
of IN B-PP
CD20 NN B-NP
in IN B-PP
pre-B JJ B-NP
cells NNS I-NP
. . O

This DT B-NP
sequence NN I-NP
element NN I-NP
was VBD B-VP
referred VBN I-VP
to TO B-PP
as IN B-PP
the DT B-NP
BAT NN I-NP
box NN I-NP
and CC O
its PRP$ B-NP
deletion NN I-NP
significantly RB B-ADVP
reduced VBD B-VP
the DT B-NP
activity NN I-NP
of IN B-PP
a DT B-NP
CD20 NN I-NP
promoter-CAT JJ I-NP
construct NN I-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
. . O

Mobility NN B-NP
shift NN I-NP
assays NNS I-NP
with IN B-PP
various JJ B-NP
mutant JJ I-NP
probes NNS I-NP
and CC O
B NN B-NP
cell NN I-NP
nuclear JJ I-NP
extracts NNS I-NP
demonstrated VBD B-VP
that IN B-SBAR
the DT B-NP
core NN I-NP
sequence NN I-NP
TAAT NN I-NP
was VBD B-VP
essential JJ B-ADJP
for IN B-PP
binding VBG B-VP
to TO B-PP
this DT B-NP
site NN I-NP
. . O

Cross NN B-NP
competition NN I-NP
experiments NNS I-NP
with IN B-PP
an DT B-NP
octamer NN I-NP
sequence NN I-NP
from IN B-PP
the DT B-NP
Ig NN I-NP
heavy JJ I-NP
chain NN I-NP
promoter NN I-NP
COMMA COMMA O
the DT B-NP
BAT NN I-NP
box NN I-NP
COMMA COMMA O
and CC O
a DT B-NP
TA-rich JJ I-NP
sequence NN I-NP
present JJ B-ADJP
in IN B-PP
the DT B-NP
CD21 NN I-NP
promoter NN I-NP
revealed VBD B-VP
that IN B-SBAR
all DT B-NP
three CD I-NP
sequences NNS I-NP
bound VBD B-VP
the DT B-NP
same JJ I-NP
nuclear JJ I-NP
proteins NNS I-NP
suggesting VBG B-VP
that IN B-SBAR
the DT B-NP
BAT NN I-NP
box NN I-NP
binding NN I-NP
proteins NNS I-NP
were VBD B-VP
Oct-1 NN B-NP
and CC O
Oct-2 NN B-NP
. . O

Southwestern NN B-NP
blotting NN I-NP
and CC O
UV NN B-NP
cross-linking NN I-NP
studies NNS I-NP
confirmed VBD B-VP
that IN B-SBAR
the DT B-NP
BAT NN I-NP
box NN I-NP
binding NN I-NP
proteins NNS I-NP
were VBD B-VP
Oct-1 NN B-NP
and CC O
Oct-2 NN B-NP
. . O

The DT B-NP
affinity NN I-NP
of IN B-PP
the DT B-NP
BAT NN I-NP
box NN I-NP
binding NN I-NP
proteins NNS I-NP
for IN B-PP
the DT B-NP
BAT NN I-NP
box NN I-NP
was VBD B-VP
approximately RB B-ADJP
25-fold RB I-ADJP
less JJR I-ADJP
than IN B-PP
for IN B-PP
the DT B-NP
octamer NN I-NP
sequence NN I-NP
and CC O
the DT B-NP
BAT NN I-NP
box NN I-NP
binding NN I-NP
proteins NNS I-NP
dissociated VBD B-VP
from IN B-PP
the DT B-NP
BAT NN I-NP
box NN I-NP
10-fold RB B-ADVP
more RBR I-ADVP
rapidly RB B-ADVP
than IN B-PP
from IN B-PP
the DT B-NP
octamer NN I-NP
sequence NN I-NP
. . O

Despite IN B-PP
this DT B-NP
lower JJR I-NP
affinity NN I-NP
COMMA COMMA O
a DT B-NP
trimer NN I-NP
of IN B-PP
the DT B-NP
BAT NN I-NP
box NN I-NP
sequence NN I-NP
was VBD O
as IN B-ADVP
efficiently RB I-ADVP
transactivated VBN B-VP
by IN B-PP
an DT B-NP
Oct-2 NN I-NP
expression NN I-NP
vector NN I-NP
as IN B-SBAR
was VBD O
a DT B-NP
trimer NN I-NP
of IN B-PP
the DT B-NP
octamer NN I-NP
sequence NN I-NP
in IN B-PP
HeLa NN B-NP
cells NNS I-NP
. . O

The DT B-NP
BAT NN B-NP
box NN I-NP
and CC O
Oct-2 NN B-NP
were VBD B-VP
also RB I-VP
implicated VBN I-VP
in IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
CD20 NN B-NP
in IN B-PP
the DT B-NP
pre-B JJ I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
PB-697 NN B-NP
COMMA COMMA O
via IN B-PP
phorbol NN B-NP
esters NNS I-NP
. . O

The DT B-NP
induction NN I-NP
of IN B-PP
CD20 NN B-NP
mRNA NN I-NP
was VBD B-VP
temporally RB I-VP
associated VBN I-VP
with IN B-PP
induction NN B-NP
of IN B-PP
Oct-2 NN B-NP
mRNA NN I-NP
and CC O
a DT B-NP
BAT NN I-NP
box-deleted JJ I-NP
CD20-CAT NN I-NP
construct NN I-NP
COMMA COMMA O
in IN B-PP
contrast NN I-PP
to TO I-PP
the DT B-NP
wild JJ I-NP
type NN I-NP
COMMA COMMA O
was VBD B-VP
poorly RB I-VP
induced VBN I-VP
by IN B-PP
phorbol NN B-NP
esters NNS I-NP
. . O

Together RB B-ADVP
these DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
BAT NN I-NP
box NN I-NP
binding NN I-NP
proteins NNS I-NP
are VBP B-VP
important JJ B-ADJP
in IN B-PP
the DT O
B NN B-NP
cell NN I-NP
specific JJ B-NP
expression NN I-NP
of IN B-PP
CD20 NN B-NP
and CC O
perhaps RB B-ADVP
CD21 NN B-NP
. . O

Transcription NN B-NP
factor NN I-NP
jun-B NN I-NP
is VBZ B-VP
target NN B-NP
of IN B-PP
autoreactive JJ B-NP
T-cells NNS I-NP
in IN B-PP
IDDM NN B-NP
. . O

Target NN B-NP
antigens NNS I-NP
defined VBN B-VP
by IN B-PP
autoantibodies NNS B-NP
in IN B-PP
IDDM NN B-NP
include VBP B-VP
insulin NN B-NP
COMMA COMMA O
a DT B-NP
putative JJ I-NP
glycolipid NN I-NP
that WDT B-NP
reacts VBZ B-VP
with IN B-PP
islet NN B-NP
cell NN I-NP
antibodies NNS I-NP
COMMA COMMA O
and CC O
a DT B-NP
64COMMA000-M(r) JJ I-NP
protein NN I-NP
recently RB B-VP
identified VBN I-VP
as IN B-PP
glutamic JJ B-NP
acid NN I-NP
decarboxylase NN I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
some DT B-NP
IDDM NN I-NP
sera NN I-NP
that WDT B-NP
contain VBP B-VP
antibodies NNS B-NP
to TO B-PP
glutamic JJ B-NP
acid NN I-NP
decarboxylase NN I-NP
also RB B-ADVP
coprecipitate VBP B-VP
a DT B-NP
38COMMA000-M(r) JJ I-NP
protein NN I-NP
from IN B-PP
islets NNS B-NP
. . O

This DT B-NP
study NN I-NP
used VBD B-VP
a DT B-NP
high JJ I-NP
titer NN I-NP
anti-38COMMA000-M(r) JJ I-NP
serum NN I-NP
to TO B-VP
screen VB I-VP
bacteriophage NN B-NP
lambda NN I-NP
cDNA NN I-NP
expression NN I-NP
libraries NNS I-NP
and CC O
identified VBD B-VP
human JJ B-NP
islet NN I-NP
and CC O
placental JJ B-NP
clones NNS I-NP
encoding VBG B-VP
jun-B NN B-NP
COMMA COMMA O
the DT B-NP
nuclear JJ I-NP
transcription NN I-NP
protein NN I-NP
COMMA COMMA O
of IN B-PP
predicted VBN B-NP
38COMMA000 CD I-NP
M(r) NN I-NP
. . O

Peripheral JJ B-NP
blood NN I-NP
T-cells NNS I-NP
exhibited VBD B-VP
significant JJ B-NP
proliferation NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
a DT B-NP
recombinant JJ I-NP
fragment NN I-NP
of IN B-PP
jun-B NN B-NP
( ( O
amino NN B-NP
acids NNS I-NP
1-180 CD I-NP
) ) O
in IN B-PP
12 CD O
of IN O
17 CD O
( ( O
71 CD B-NP
% NN I-NP
) ) O
recent-onset JJ B-NP
IDDM NN I-NP
subjects NNS I-NP
COMMA COMMA O
8 CD O
of IN O
16 CD O
( ( O
50 CD B-NP
% NN I-NP
) ) O
ICA-positive JJ B-NP
first-degree JJ I-NP
relatives NNS I-NP
of IN B-PP
IDDM NN B-NP
subjects NNS I-NP
who WP B-NP
were VBD B-VP
at IN B-PP
risk NN B-NP
COMMA COMMA O
3 CD O
of IN O
12 CD O
( ( O
25 CD B-NP
% NN I-NP
) ) O
other JJ B-NP
autoimmune JJ I-NP
disease NN I-NP
subjects NNS I-NP
COMMA COMMA O
and CC O
0 CD B-NP
of IN I-NP
10 CD I-NP
healthy JJ I-NP
control NN I-NP
subjects NNS I-NP
. . O

Proliferation NN B-NP
to TO B-PP
tetanus NN B-NP
toxoid NN I-NP
did VBD B-VP
not RB I-VP
differ VB I-VP
significantly RB B-ADVP
between IN B-PP
the DT B-NP
groups NNS I-NP
. . O

Responses NNS B-NP
to TO B-PP
jun-B NN B-NP
were VBD B-VP
not RB O
related JJ B-ADJP
to TO B-PP
age NN B-NP
COMMA COMMA O
sex NN B-NP
COMMA COMMA O
or CC O
human JJ B-NP
leukocyte NN I-NP
antigen NN I-NP
status NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
autoreactive JJ B-NP
T-cells NNS I-NP
identify VBP B-VP
a DT B-NP
novel JJ I-NP
antigen NN I-NP
COMMA COMMA O
p38 NN B-NP
jun-B NN I-NP
COMMA COMMA O
in IN B-PP
IDDM NN B-NP
and CC O
appear VBP B-VP
to TO I-VP
indicate VB I-VP
subjects NNS B-NP
at IN B-PP
risk NN B-NP
for IN B-PP
the DT B-NP
development NN I-NP
of IN B-PP
clinical JJ B-NP
disease NN I-NP
. . O

Transcriptional JJ B-NP
regulation NN I-NP
of IN B-PP
interleukin NN B-NP
3 CD I-NP
( ( O
IL3 NN B-NP
) ) O
in IN B-PP
primary JJ B-NP
human JJ I-NP
T NN I-NP
lymphocytes NNS I-NP
. . O

Role NN B-NP
of IN B-PP
AP-1- NN B-NP
and CC O
octamer-binding JJ B-ADJP
proteins NNS B-NP
in IN B-PP
control NN B-NP
of IN B-PP
IL3 NN B-NP
gene NN I-NP
expression NN I-NP
. . O

We PRP B-NP
have VBP B-VP
investigated VBN I-VP
the DT B-NP
molecular JJ I-NP
and CC I-NP
biochemical JJ I-NP
basis NN I-NP
for IN B-PP
activation NN B-NP
of IN B-PP
interleukin NN B-NP
3 CD I-NP
( ( O
IL3 NN B-NP
) ) O
gene NN B-NP
expression NN I-NP
in IN B-PP
primary JJ B-NP
human JJ I-NP
T NN I-NP
lymphocytes NNS I-NP
following VBG B-PP
CD3 NN B-NP
and CC O
CD2 NN B-NP
receptor NN B-NP
stimulation NN B-NP
or CC O
activation NN B-NP
by IN B-PP
phytohemagglutinin NN B-NP
plus CC O
phorbol NN B-NP
12-myristate NN I-NP
13-acetate NN I-NP
. . O

Using VBG B-VP
transfection NN B-NP
and CC O
reporter NN B-NP
gene NN I-NP
assays NNS B-NP
specifically RB B-VP
designed VBN I-VP
for IN B-PP
primary JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
in IN B-PP
conjunction NN I-PP
with IN I-PP
gel NN B-NP
retardation NN I-NP
assays NNS I-NP
COMMA COMMA O
Western NN B-NP
blot NN I-NP
analyses NNS I-NP
and CC O
UV NN B-NP
cross-linking JJ I-NP
studies NNS I-NP
COMMA COMMA O
we PRP B-NP
found VBD B-VP
that IN B-SBAR
c-Jun NN B-NP
COMMA COMMA O
c-Fos NN B-NP
COMMA COMMA O
and CC O
octamer-binding NN B-ADJP
proteins NNS B-NP
play VBP B-VP
a DT B-NP
major JJ I-NP
role NN I-NP
in IN B-PP
transcriptional JJ B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
IL3 NN I-NP
gene NN I-NP
via IN B-PP
their PRP$ B-NP
interaction NN I-NP
with IN B-PP
two CD B-NP
specific JJ I-NP
regions NNS I-NP
contained VBN B-VP
within IN B-PP
the DT B-NP
IL3 NN I-NP
5'-flanking JJ I-NP
sequence NN I-NP
. . O

Additionally RB B-ADVP
COMMA COMMA O
the DT B-NP
region NN I-NP
between IN B-PP
bases NNS B-NP
-107 CD B-NP
and CC O
-59 CD B-NP
of IN B-PP
the DT B-NP
IL3 NN I-NP
promoter NN I-NP
containing VBG B-VP
putative JJ O
AP-2 NN B-NP
and CC O
Sp1 NN B-NP
binding NN B-NP
motifs NNS I-NP
appears VBZ B-VP
necessary JJ B-ADJP
for IN B-PP
basal JJ B-NP
level NN I-NP
expression NN I-NP
of IN B-PP
the DT B-NP
IL3 NN I-NP
gene NN I-NP
. . O

The DT B-NP
data NNS I-NP
also RB B-ADVP
indicate VBP B-VP
that IN B-SBAR
CD2 NN B-NP
receptor NN I-NP
activation NN I-NP
and CC O
phytohemagglutinin NN B-NP
plus CC O
phorbol NN B-NP
12-myristate NN I-NP
13-acetate NN I-NP
stimulation NN B-NP
augment VBP B-VP
T NN B-NP
cell NN I-NP
IL3 NN I-NP
gene NN I-NP
expression NN I-NP
through IN B-PP
the DT O
same JJ O
cis- JJ B-NP
and CC O
trans-activating JJ B-ADJP
signals NNS B-NP
. . O

These DT B-NP
results NNS I-NP
should MD B-VP
contribute VB I-VP
to TO B-PP
a DT B-NP
better JJR I-NP
understanding NN I-NP
of IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
IL3 NN B-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
human JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
. . O

Transcriptional JJ B-NP
activation NN I-NP
of IN B-PP
human JJ B-NP
zeta NN I-NP
2 CD I-NP
globin NN I-NP
promoter NN I-NP
by IN B-PP
the DT B-NP
alpha NN I-NP
globin NN I-NP
regulatory JJ I-NP
element NN I-NP
( ( O
HS-40 NN B-NP
) ) O
: : O
functional JJ B-NP
role NN I-NP
of IN B-PP
specific JJ B-NP
nuclear JJ I-NP
factor-DNA JJ I-NP
complexes NNS I-NP
. . O

We PRP B-NP
studied VBD B-VP
the DT B-NP
functional JJ I-NP
interaction NN I-NP
between IN B-PP
human JJ B-NP
embryonic JJ I-NP
zeta NN I-NP
2 CD I-NP
globin NN I-NP
promoter NN I-NP
and CC O
the DT B-NP
alpha NN I-NP
globin NN I-NP
regulatory JJ I-NP
element NN I-NP
( ( O
HS-40 NN B-NP
) ) O
located JJ O
40 CD B-NP
kb NN I-NP
upstream RB B-ADJP
of IN B-PP
the DT B-NP
zeta NN I-NP
2 CD I-NP
globin NN I-NP
gene NN I-NP
. . O

It PRP B-NP
was VBD B-VP
shown VBN I-VP
by IN B-PP
transient JJ B-NP
expression NN I-NP
assay NN I-NP
that IN B-SBAR
HS-40 NN B-NP
behaved VBD B-VP
as IN B-PP
an DT B-NP
authentic JJ I-NP
enhancer NN I-NP
for IN B-PP
high-level JJ B-NP
zeta NN I-NP
2 CD I-NP
globin NN I-NP
promoter NN I-NP
activity NN I-NP
in IN B-PP
K562 NN B-NP
cells NNS I-NP
COMMA COMMA O
an DT B-NP
erythroid JJ I-NP
cell NN I-NP
line NN I-NP
of IN B-PP
embryonic JJ B-NP
and\/or CC I-NP
fetal JJ I-NP
origin NN I-NP
. . O

Although IN B-SBAR
sequences NNS B-NP
located JJ B-ADJP
between IN B-PP
-559 CD B-NP
and CC O
-88 CD B-NP
of IN B-PP
the DT B-NP
zeta NN I-NP
2 CD I-NP
globin NN I-NP
gene NN I-NP
were VBD B-VP
dispensable JJ B-ADJP
for IN B-PP
its PRP$ B-NP
expression NN I-NP
on IN B-PP
enhancerless NN B-NP
plasmids NNS I-NP
COMMA COMMA O
they PRP B-NP
were VBD B-VP
required VBN I-VP
for IN B-PP
the DT B-NP
HS-40 NN I-NP
enhancer-mediated JJ I-NP
activity NN I-NP
of IN B-PP
the DT B-NP
zeta NN I-NP
2 CD I-NP
globin NN I-NP
promoter NN I-NP
. . O

Site-directed JJ B-NP
mutagenesis NN I-NP
demonstrated VBD B-VP
that IN B-SBAR
this DT B-NP
HS-40 NN I-NP
enhancer-zeta NN I-NP
2 CD I-NP
globin NN I-NP
promoter NN I-NP
interaction NN I-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
the DT B-NP
two CD I-NP
GATA-1 NN I-NP
factor NN I-NP
binding NN I-NP
motifs NNS I-NP
located JJ B-ADJP
at IN B-PP
-230 CD B-NP
and CC O
-104 CD B-NP
COMMA COMMA O
respectively RB B-ADVP
. . O

The DT B-NP
functional JJ I-NP
domains NNS I-NP
of IN B-PP
HS-40 NN B-NP
were VBD B-VP
also RB I-VP
mapped VBN I-VP
. . O

Bal NN B-NP
31 CD I-NP
deletion NN I-NP
mapping VBG I-NP
data NNS I-NP
suggested VBD B-VP
that IN B-SBAR
one CD B-NP
GATA-1 NN I-NP
motif NN I-NP
COMMA COMMA O
one CD B-NP
GT NN I-NP
motif NN I-NP
COMMA COMMA O
and CC O
two CD B-NP
NF-E2\/AP1 NN I-NP
motifs NNS I-NP
together RB B-ADVP
formed VBD B-VP
the DT B-NP
functional JJ I-NP
core NN I-NP
of IN B-PP
HS-40 NN B-NP
in IN B-PP
the DT B-NP
erythroid-specific JJ I-NP
activation NN I-NP
of IN B-PP
the DT B-NP
zeta NN I-NP
2 CD I-NP
globin NN I-NP
promoter NN I-NP
. . O

Site-directed JJ B-NP
mutagenesis NN I-NP
further RBR B-ADVP
demonstrated VBD B-VP
that IN B-SBAR
the DT B-NP
enhancer NN I-NP
function NN I-NP
of IN B-PP
one CD B-NP
of IN B-PP
the DT B-NP
two CD I-NP
NF-E2\/AP1 NN I-NP
motifs NNS I-NP
of IN B-PP
HS-40 NN B-NP
is VBZ B-VP
mediated VBN I-VP
through IN B-PP
its PRP$ B-NP
binding NN I-NP
to TO B-PP
NF-E2 NN B-NP
but CC B-CONJP
not RB I-CONJP
AP1 NN B-NP
transcription NN I-NP
factor NN I-NP
. . O

Finally RB B-ADVP
COMMA COMMA O
we PRP B-NP
did VBD B-VP
genomic JJ B-NP
footprinting NN I-NP
of IN B-PP
the DT B-NP
HS-40 NN I-NP
enhancer NN I-NP
region NN I-NP
in IN B-PP
K562 NN B-NP
cells NNS I-NP
COMMA COMMA O
adult JJ B-NP
nucleated JJ I-NP
erythroblasts NNS I-NP
COMMA COMMA O
and CC O
different JJ B-NP
nonerythroid JJ I-NP
cells NNS I-NP
. . O

All DT B-NP
sequence NN I-NP
motifs NNS I-NP
within IN B-PP
the DT B-NP
functional JJ I-NP
core NN I-NP
of IN B-PP
HS-40 NN B-NP
COMMA COMMA O
as IN B-SBAR
mapped VBN B-VP
by IN B-PP
transient JJ B-NP
expression NN I-NP
analysis NN I-NP
COMMA COMMA O
appeared VBD B-VP
to TO I-VP
bind VB I-VP
a DT B-NP
nuclear JJ I-NP
factor NN I-NP
( ( I-NP
s NNS I-NP
) ) O
in IN B-PP
living VBG B-NP
K562 NN I-NP
cells NNS I-NP
but CC B-PP
not RB B-PP
in IN I-PP
nonerythroid JJ B-NP
cells NNS I-NP
. . O

On IN B-PP
the DT B-NP
other JJ I-NP
hand NN I-NP
COMMA COMMA O
only RB B-NP
one CD I-NP
of IN B-PP
the DT B-NP
apparently RB I-NP
nonfunctional JJ I-NP
sequence NN I-NP
motifs NNS I-NP
was VBD B-VP
bound VBN I-VP
with IN B-PP
factors NNS B-NP
in FW B-ADVP
vivo FW I-ADVP
. . O

In IN B-PP
comparison NN I-PP
to TO I-PP
K562 NN B-NP
COMMA COMMA O
nucleated JJ B-NP
erythroblasts NNS I-NP
from IN B-PP
adult JJ B-NP
human JJ I-NP
bone NN I-NP
marrow NN I-NP
exhibited VBD B-VP
a DT B-NP
similar JJ I-NP
but CC I-NP
nonidentical JJ I-NP
pattern NN I-NP
of IN B-PP
nuclear JJ B-NP
factor NN I-NP
binding NN I-NP
in FW B-ADVP
vivo FW I-ADVP
at IN B-PP
the DT B-NP
HS-40 NN I-NP
region NN I-NP
. . O

These DT B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
transcriptional JJ B-NP
activation NN I-NP
of IN B-PP
human JJ B-NP
embryonic JJ I-NP
zeta NN I-NP
2 CD I-NP
globin NN I-NP
gene NN I-NP
and CC O
the DT B-NP
fetal\/adult JJ I-NP
alpha NN I-NP
globin NN I-NP
genes NNS I-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
erythroid JJ B-NP
cell-specific JJ I-NP
and CC I-NP
developmental JJ I-NP
stage-specific JJ I-NP
nuclear JJ I-NP
factor-DNA NN I-NP
complexes NNS I-NP
which WDT B-NP
form VBP B-VP
at IN B-PP
the DT B-NP
enhancer NN I-NP
( ( O
HS-40 NN B-NP
) ) O
and CC O
the DT B-NP
globin NN I-NP
promoters NNS I-NP
. . O

Interaction NN B-NP
between IN B-PP
NF-kappa NN B-NP
B- NN I-NP
and CC O
serum NN B-ADJP
response NN I-ADJP
factor-binding JJ I-ADJP
elements NNS B-NP
activates VBZ B-VP
an DT B-NP
interleukin-2 NN I-NP
receptor NN I-NP
alpha-chain JJ I-NP
enhancer NN I-NP
specifically RB B-ADVP
in IN B-PP
T NN B-NP
lymphocytes NNS I-NP
. . O

We PRP B-NP
find VBP B-VP
that IN B-SBAR
a DT B-NP
short JJ I-NP
enhancer NN I-NP
element NN I-NP
containing VBG B-VP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
binding NN I-NP
site NN I-NP
from IN B-PP
the DT B-NP
interleukin-2 NN I-NP
receptor NN I-NP
alpha-chain JJ I-NP
gene NN I-NP
( ( O
IL-2R NN B-NP
alpha NN I-NP
) ) O
is VBZ B-VP
preferentially RB I-VP
activated VBN I-VP
in IN B-PP
T NN B-NP
cells NNS I-NP
. . O

The DT B-NP
IL-2R NN I-NP
alpha NN I-NP
enhancer NN I-NP
binds VBZ B-VP
NF-kappa NN B-NP
B NN I-NP
poorly RB B-ADVP
and CC O
is VBZ B-VP
only RB I-VP
weakly RB I-VP
activated VBN I-VP
by IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
site NN I-NP
alone RB B-ADVP
. . O

Serum NN B-NP
response NN I-NP
factor NN I-NP
( ( O
SRF NN B-NP
) ) O
binds VBZ B-VP
to TO B-PP
a DT B-NP
site NN I-NP
adjacent JJ B-ADJP
to TO B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
site NN I-NP
in IN B-PP
the DT B-NP
IL-2R NN I-NP
enhancer NN I-NP
COMMA COMMA O
and CC O
both DT B-NP
sites NNS I-NP
together RB B-ADVP
have VBP B-VP
strong JJ B-NP
transcriptional JJ I-NP
activity NN I-NP
specifically RB B-ADVP
in IN B-PP
T NN B-NP
cells NNS I-NP
. . O

Surprisingly RB B-ADVP
COMMA COMMA O
the DT B-NP
levels NNS I-NP
of IN B-PP
SRF NN B-NP
constitutively RB B-VP
expressed VBN I-VP
in IN B-PP
T NN B-NP
cells NNS I-NP
are VBP B-VP
consistently RB B-ADVP
higher JJR B-ADJP
than IN B-PP
in IN B-PP
other JJ B-NP
cell NN I-NP
types NNS I-NP
. . O

Overexpression NN B-NP
of IN B-PP
SRF NN B-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
causes VBZ B-VP
the DT B-NP
IL-2R NN I-NP
enhancer NN I-NP
to TO B-VP
function VB I-VP
as RB B-SBAR
well RB I-SBAR
as IN I-SBAR
it PRP B-NP
does VBZ B-VP
in IN B-PP
T NN B-NP
cells NNS I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
the DT B-NP
high JJ I-NP
level NN I-NP
of IN B-PP
SRF NN B-NP
binding NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
is VBZ B-VP
functionally RB B-ADVP
important JJ B-ADJP
. . O

The DT B-NP
transcriptionally RB I-NP
active JJ I-NP
factors NNS I-NP
mediating VBG B-VP
the DT B-NP
effect NN I-NP
of IN B-PP
the DT B-NP
HTLV-I NN I-NP
Tax NN I-NP
transactivator NN I-NP
on IN B-PP
the DT B-NP
IL-2R NN I-NP
alpha NN I-NP
kappa NN I-NP
B NN I-NP
enhancer NN I-NP
include VBP B-VP
the DT B-NP
product NN I-NP
of IN B-PP
the DT B-NP
c-rel NN I-NP
proto-oncogene NN I-NP
. . O

The DT B-NP
transactivator NN I-NP
HTLV-I NN I-NP
Tax NN I-NP
activates VBZ B-VP
the DT B-NP
promoter NN I-NP
of IN B-PP
the DT B-NP
gene NN I-NP
coding VBG B-VP
for IN B-PP
the DT B-NP
interleukin NN I-NP
2 CD I-NP
alpha-chain JJ I-NP
receptor NN I-NP
( ( O
IL-2R NN B-NP
alpha NN I-NP
) ) O
via IN B-PP
a DT B-NP
kappa NN I-NP
B NN I-NP
site NN I-NP
that WDT B-NP
can MD B-VP
bind VB I-VP
several JJ B-NP
protein NN I-NP
species NNS I-NP
of IN B-PP
the DT B-NP
rel NN I-NP
family NN I-NP
. . O

Tax1 NN B-NP
strongly RB B-ADVP
activates VBZ B-VP
the DT B-NP
enhancer NN I-NP
activity NN I-NP
of IN B-PP
this DT B-NP
motif NN I-NP
COMMA COMMA O
in IN B-PP
both CC O
epithelial JJ B-NP
HeLa NN I-NP
and CC O
lymphoid JJ B-NP
Jurkat NN I-NP
cells NNS B-NP
. . O

This DT B-NP
activation NN I-NP
was VBD B-VP
not RB I-VP
observed VBN I-VP
in IN B-PP
undifferentiated JJ B-NP
embryocarcinoma NN I-NP
F9 NN I-NP
cells NNS I-NP
. . O

Overexpression NN B-NP
of IN B-PP
the DT O
p50 NN B-NP
COMMA COMMA O
p65 NN B-NP
and CC O
Rel NN B-NP
proteins NNS B-NP
in IN B-PP
these DT B-NP
cells NNS I-NP
showed VBD B-VP
that IN B-SBAR
significant JJ B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
IL-2R NN I-NP
alpha NN I-NP
kappa NN I-NP
B NN I-NP
site NN I-NP
was VBD B-VP
observed VBN I-VP
only RB B-PP
with IN I-PP
Rel NN B-NP
and CC O
Rel NN B-NP
plus CC O
p65 NN B-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
whereas IN B-SBAR
both CC O
Tax NN B-NP
and CC O
phorbol NN B-NP
12-myristate NN I-NP
13-acetate NN I-NP
( ( O
PMA NN B-NP
) ) O
are VBP B-VP
able JJ B-ADJP
to TO B-VP
efficiently RB I-VP
induce VB I-VP
the DT B-NP
binding NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
to TO B-PP
the DT B-NP
IL-2R NN I-NP
alpha NN I-NP
kappa NN I-NP
B NN I-NP
site NN I-NP
COMMA COMMA O
PMA NN B-NP
is VBZ B-VP
functionally RB B-ADVP
inactive JJ B-ADJP
. . O

Using VBG B-VP
the DT B-NP
DNA NN I-NP
affinity NN I-NP
precipitation NN I-NP
assay NN I-NP
COMMA COMMA O
we PRP B-NP
observed VBD B-VP
that IN B-SBAR
Tax1 NN B-NP
is VBZ B-VP
able JJ B-ADJP
to TO B-VP
efficiently RB I-VP
induce VB I-VP
the DT B-NP
binding NN I-NP
of IN B-PP
Rel NN B-NP
COMMA COMMA O
whereas IN O
PMA NN B-NP
is VBZ B-VP
not RB O
. . O

This DT B-NP
established VBD B-VP
a DT B-NP
clear JJ I-NP
difference NN I-NP
between IN B-PP
both DT B-NP
stimuli NNS I-NP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
Rel NN B-NP
is VBZ B-VP
the DT B-NP
functionally RB I-NP
active JJ I-NP
factor NN I-NP
. . O

We PRP B-NP
conclude VBP B-VP
from IN B-PP
these DT B-NP
results NNS I-NP
that IN B-SBAR
the DT B-NP
functional JJ I-NP
activity NN I-NP
of IN B-PP
members NNS B-NP
of IN B-PP
the DT B-NP
rel NN I-NP
family NN I-NP
is VBZ B-VP
regulated VBN I-VP
by IN B-PP
their PRP$ B-NP
interaction NN I-NP
with IN B-PP
DNA NN B-NP
and CC O
that IN B-SBAR
Rel NN B-NP
can MD B-VP
be VB I-VP
a DT B-NP
potent JJ I-NP
transcriptional JJ I-NP
activator NN I-NP
on IN B-PP
specific JJ B-NP
kappa NN I-NP
B NN I-NP
sites NNS I-NP
. . O

NF-kappa NN B-NP
B NN I-NP
controls VBZ B-VP
expression NN B-NP
of IN B-PP
inhibitor NN B-NP
I NN I-NP
kappa NN I-NP
B NN I-NP
alpha NN I-NP
: : O
evidence NN B-NP
for IN B-PP
an DT B-NP
inducible JJ I-NP
autoregulatory JJ I-NP
pathway NN I-NP
. . O

The DT B-NP
eukaryotic JJ I-NP
transcription NN I-NP
factor NN I-NP
nuclear JJ B-NP
factor-kappa NN I-NP
B NN I-NP
( ( O
NF-kappa NN B-NP
B NN I-NP
) ) O
participates VBZ B-VP
in IN B-PP
many JJ B-NP
parts NNS I-NP
of IN B-PP
the DT B-NP
genetic JJ I-NP
program NN I-NP
mediating VBG B-VP
T NN B-NP
lymphocyte NN I-NP
activation NN B-NP
and CC O
growth NN B-NP
. . O

Nuclear JJ B-NP
expression NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
occurs VBZ B-VP
after IN B-PP
its PRP$ B-NP
induced VBN I-NP
dissociation NN I-NP
from IN B-PP
its PRP$ B-NP
cytoplasmic JJ I-NP
inhibitor NN I-NP
I NN I-NP
kappa NN I-NP
B NN I-NP
alpha NN I-NP
. . O

Phorbol NN B-NP
ester NN I-NP
and CC O
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
induction NN B-NP
of IN B-PP
nuclear JJ B-NP
NF-kappa NN I-NP
B NN I-NP
is VBZ B-VP
associated VBN I-VP
with IN B-PP
both CC O
the DT B-NP
degradation NN I-NP
of IN B-PP
performed VBN B-NP
I NN I-NP
kappa NN I-NP
B NN I-NP
alpha NN I-NP
and CC O
the DT B-NP
activation NN I-NP
of IN B-PP
I NN B-NP
kappa NN I-NP
B NN I-NP
alpha NN I-NP
gene NN I-NP
expression NN I-NP
. . O

Transfection NN B-NP
studies NNS I-NP
indicate VBP B-VP
that IN B-SBAR
the DT B-NP
I NN I-NP
kappa NN I-NP
B NN I-NP
alpha NN I-NP
gene NN I-NP
is VBZ B-VP
specifically RB I-VP
induced VBN I-VP
by IN B-PP
the DT B-NP
65-kilodalton JJ I-NP
transactivating VBG I-NP
subunit NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
. . O

Association NN B-NP
of IN B-PP
the DT B-NP
newly RB I-NP
synthesized VBN I-NP
I NN I-NP
kappa NN I-NP
B NN I-NP
alpha NN I-NP
with IN B-PP
p65 NN B-NP
restores VBZ B-VP
intracellular JJ B-NP
inhibition NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
DNA NN I-NP
binding NN I-NP
activity NN I-NP
and CC O
prolongs VBZ B-VP
the DT B-NP
survival NN I-NP
of IN B-PP
this DT B-NP
labile JJ I-NP
inhibitor NN I-NP
. . O

Together RB B-ADVP
COMMA COMMA O
these DT B-NP
results NNS I-NP
show VBP B-VP
that IN B-SBAR
NF-kappa NN B-NP
B NN I-NP
controls VBZ B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
I NN B-NP
kappa NN I-NP
B NN I-NP
alpha NN I-NP
by IN B-PP
means NNS I-PP
of IN I-PP
an DT B-NP
inducible JJ I-NP
autoregulatory JJ I-NP
pathway NN I-NP
. . O

p105 NN B-NP
and CC O
p98 NN B-NP
precursor NN B-NP
proteins NNS I-NP
play VBP B-VP
an DT B-NP
active JJ I-NP
role NN I-NP
in IN B-PP
NF-kappa NN B-NP
B-mediated JJ I-NP
signal NN I-NP
transduction NN I-NP
. . O

The DT B-NP
Rel\/NF-kappa NN I-NP
B NN I-NP
family NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
is VBZ B-VP
composed VBN I-VP
of IN B-PP
two CD B-NP
distinct JJ I-NP
subgroups NNS I-NP
COMMA COMMA O
proteins NNS B-NP
that WDT B-NP
undergo VBP B-VP
proteolytic JJ B-NP
processing NN I-NP
and CC O
contain VBP B-VP
SWI6\/ankyrin NN B-NP
repeats NNS I-NP
in IN B-PP
their PRP$ B-NP
carboxyl NN I-NP
termini NNS I-NP
( ( O
p105 NN B-NP
COMMA COMMA O
p98 NN B-NP
) ) O
COMMA COMMA O
and CC O
those DT B-NP
without IN B-PP
such JJ B-NP
repeats NNS I-NP
that WDT B-NP
do VBP B-VP
not RB I-VP
require VB I-VP
processing NN B-NP
( ( O
p65 NN B-NP
COMMA COMMA O
c-Rel NN B-NP
COMMA COMMA O
RelB NN B-NP
COMMA COMMA O
and CC O
Dorsal NN B-NP
) ) O
. . O

We PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
the DT O
p105 NN B-NP
and CC O
p98 NN B-NP
precursors NNS B-NP
share VBP B-VP
functional JJ B-NP
properties NNS I-NP
with IN B-PP
the DT B-NP
I NN I-NP
kappa NN I-NP
B NN I-NP
proteins NNS I-NP
COMMA COMMA O
which WDT B-NP
also RB B-ADVP
contain VBP B-VP
SWI6\/ankyrin NN B-NP
repeats NNS I-NP
. . O

Both CC O
p105 NN B-NP
and CC O
p98 NN B-NP
were VBD B-VP
found VBN I-VP
to TO I-VP
form VB I-VP
stable JJ B-NP
complexes NNS I-NP
with IN B-PP
other JJ B-NP
Rel\/NF-kappa NN I-NP
B NN I-NP
family NN I-NP
members NNS I-NP
COMMA COMMA O
including VBG B-PP
p65 NN B-NP
and CC O
c-Rel NN B-NP
. . O

Association NN B-NP
with IN B-PP
the DT B-NP
precursors NNS I-NP
is VBZ B-VP
sufficient JJ B-ADJP
for IN B-PP
cytoplasmic JJ B-NP
retention NN I-NP
of IN B-PP
either CC O
p65 NN B-NP
or CC O
c-Rel NN B-NP
COMMA COMMA O
both DT B-NP
of IN B-PP
which WDT B-NP
are VBP B-VP
otherwise RB B-ADVP
nuclear JJ B-ADJP
. . O

These DT B-NP
complexes NNS I-NP
undergo VBP B-VP
stimulus-responsive JJ B-NP
processing NN I-NP
to TO B-VP
produce VB I-VP
active JJ B-NP
p50\/c-Rel NN I-NP
and CC I-NP
p55\/c-Rel NN I-NP
complexes NNS I-NP
. . O

These DT B-NP
observations NNS I-NP
suggest VBP B-VP
a DT B-NP
second JJ I-NP
pathway NN I-NP
leading VBG B-VP
to TO B-PP
NF-kappa NN B-NP
B NN I-NP
induction NN I-NP
COMMA COMMA O
in IN B-PP
which WDT B-NP
processing NN B-NP
of IN B-PP
the DT B-NP
precursors NNS I-NP
rather RB B-CONJP
than IN I-CONJP
phosphorylation NN B-NP
of IN B-PP
I NN B-NP
kappa NN I-NP
B NN I-NP
plays VBZ B-VP
a DT B-NP
major JJ I-NP
role NN I-NP
. . O

Mutual JJ B-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
transcriptional JJ I-NP
activator NN I-NP
NF-kappa NN I-NP
B NN I-NP
and CC O
its PRP$ B-NP
inhibitor NN I-NP
COMMA COMMA O
I NN B-NP
kappa NN I-NP
B-alpha NN I-NP
. . O

The DT B-NP
NK-kappa NN I-NP
B NN I-NP
transcription NN I-NP
factor NN I-NP
complex NN I-NP
is VBZ B-VP
sequestered VBN I-VP
in IN B-PP
the DT B-NP
cytoplasm NN I-NP
by IN B-PP
the DT B-NP
inhibitory JJ I-NP
protein NN I-NP
I NN B-NP
kappa NN I-NP
B-alpha NN I-NP
( ( O
MAD-3 NN B-NP
) ) O
. . O

Various JJ B-NP
cellular JJ I-NP
stimuli NNS I-NP
relieve VBP B-VP
this DT B-NP
inhibition NN I-NP
by IN B-PP
mechanisms NNS B-NP
largely RB B-ADJP
unknown JJ I-ADJP
COMMA COMMA O
leading VBG B-VP
to TO B-PP
NF-kappa NN B-NP
B NN I-NP
nuclear JJ I-NP
localization NN I-NP
and CC O
transactivation NN B-NP
of IN B-PP
its PRP$ B-NP
target NN I-NP
genes NNS I-NP
. . O

It PRP B-NP
is VBZ B-VP
demonstrated VBN I-VP
here RB B-ADVP
with IN B-PP
human JJ B-NP
T NN B-NP
lymphocytes NNS I-NP
and CC O
monocytes NNS B-NP
that IN B-SBAR
different JJ B-NP
stimuli NNS I-NP
COMMA COMMA O
including VBG B-PP
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
and CC O
phorbol NN B-NP
12-myristate NN I-NP
13-acetate NN I-NP
COMMA COMMA O
cause VB B-VP
rapid JJ B-NP
degradation NN I-NP
of IN B-PP
I NN B-NP
kappa NN I-NP
B-alpha NN I-NP
COMMA COMMA O
with IN B-PP
concomitant JJ B-NP
activation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
followed VBN B-VP
by IN B-PP
a DT B-NP
dramatic JJ I-NP
increase NN I-NP
in IN B-PP
I NN O
kappa NN O
B-alpha NN O
mRNA NN B-NP
and CC O
protein NN B-NP
synthesis NN B-NP
. . O

Transfection NN B-NP
studies NNS I-NP
reveal VBP B-VP
that IN B-SBAR
the DT B-NP
I NN I-NP
kappa NN I-NP
B-alpha NN I-NP
mRNA NN I-NP
and CC O
the DT B-NP
encoded VBN I-NP
protein NN I-NP
are VBP B-VP
potently RB I-VP
induced VBN I-VP
by IN B-PP
NF-kappa NN B-NP
B NN I-NP
and CC B-PP
by IN B-PP
homodimers NNS B-NP
of IN B-PP
p65 NN B-NP
and CC B-PP
of IN B-PP
c-Rel NN B-NP
. . O

We PRP B-NP
propose VBP B-VP
a DT B-NP
model NN I-NP
in IN B-PP
which WDT B-NP
NF-kappa NN B-NP
B NN I-NP
and CC O
I NN B-NP
kappa NN I-NP
B-alpha NN I-NP
mutually RB B-ADVP
regulate VBP B-VP
each DT B-NP
other JJ I-NP
in IN B-PP
a DT B-NP
cycle NN I-NP
: : O
saturating JJ B-NP
amounts NNS I-NP
of IN B-PP
the DT B-NP
inhibitory JJ I-NP
I NN I-NP
kappa NN I-NP
B-alpha NN I-NP
protein NN I-NP
are VBP B-VP
destroyed VBN I-VP
upon IN B-PP
stimulation NN B-NP
COMMA COMMA O
allowing VBG B-VP
rapid JJ B-VP
activation NN I-VP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
. . O

Subsequently RB B-ADVP
COMMA COMMA O
I NN O
kappa NN O
B-alpha NN O
mRNA NN B-NP
and CC O
protein NN B-NP
levels NNS B-NP
are VBP B-VP
quickly RB I-VP
induced VBN I-VP
by IN B-PP
the DT B-NP
activated VBN I-NP
NF-kappa NN I-NP
B NN I-NP
. . O

This DT B-NP
resurgence NN I-NP
of IN B-PP
I NN B-NP
kappa NN I-NP
B-alpha NN I-NP
protein NN I-NP
acts VBZ B-VP
to TO I-VP
restore VB I-VP
an DT B-NP
equilibrium NN I-NP
in IN B-PP
which WDT B-NP
NF-kappa NN B-NP
B NN I-NP
is VBZ B-VP
again RB I-VP
inhibited VBN I-VP
. . O

Induced VBN B-NP
myeloid JJ I-NP
differentiation NN I-NP
of IN B-PP
K562 NN B-NP
cells NNS I-NP
with IN B-PP
downregulation NN B-NP
of IN B-PP
erythroid JJ B-NP
and CC I-NP
megakaryocytic JJ I-NP
transcription NN I-NP
factors NNS I-NP
: : O
a DT B-NP
novel JJ I-NP
experimental JJ I-NP
model NN I-NP
for IN B-PP
hemopoietic JJ B-NP
lineage NN I-NP
restriction NN I-NP
. . O

The DT B-NP
human JJ I-NP
erythroleukemia NN I-NP
cell NN I-NP
line NN I-NP
K562 NN I-NP
can MD B-VP
be VB I-VP
induced VBN I-VP
to TO I-VP
differentiate VB I-VP
along IN B-PP
the DT B-NP
erythroid JJ I-NP
and CC I-NP
megakaryocytic JJ I-NP
lineages NNS I-NP
. . O

Here RB B-ADVP
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
hexamethylene NN B-NP
bisacetamide NN I-NP
( ( O
HMBA NN B-NP
) ) O
induced VBD B-VP
K562 NN B-NP
cells NNS I-NP
to TO B-VP
differentiate VB I-VP
along IN B-PP
a DT B-NP
third JJ I-NP
pathway NN I-NP
. . O

This DT B-NP
was VBD B-VP
accompanied VBN I-VP
by IN B-PP
downregulation NN B-NP
of IN B-PP
two CD B-NP
transcription NN I-NP
factors NNS I-NP
normally RB B-VP
expressed VBN I-VP
in IN B-PP
erythroid JJ B-NP
COMMA COMMA I-NP
mast NN I-NP
and CC I-NP
megakaryocyte NN I-NP
lineages NNS I-NP
. . O

Northern NN B-NP
analysis NN I-NP
demonstrated VBD B-VP
coordinate JJ B-NP
downregulation NN I-NP
of IN B-PP
alpha NN B-NP
globin NN I-NP
and CC O
gamma NN B-NP
globin NN I-NP
in IN B-CONJP
addition NN O
to TO O
the DT B-NP
two CD I-NP
lineage-restricted JJ I-NP
transcription NN I-NP
factors NNS I-NP
COMMA COMMA O
SCL NN B-NP
and CC O
GATA-1 NN B-NP
. . O

Proliferation NN B-NP
of IN B-PP
the DT B-NP
K562 NN I-NP
cells NNS I-NP
was VBD B-VP
also RB I-VP
suppressed VBN I-VP
. . O

Clonal JJ B-NP
assay NN I-NP
showed VBD B-VP
that IN B-SBAR
the DT B-NP
suppression NN I-NP
was VBD B-VP
irreversible JJ B-ADJP
and CC O
appeared VBD B-VP
analogous JJ B-ADJP
to TO B-PP
the DT B-NP
commitment NN I-NP
of IN B-PP
murine JJ B-NP
erythroleukemia NN I-NP
( ( O
MEL NN B-NP
) ) O
cells NNS B-NP
to TO B-PP
terminal JJ B-NP
differentiation NN I-NP
. . O

In IN B-PP
contrast NN I-PP
to TO I-PP
MEL NN B-NP
cells NNS I-NP
COMMA COMMA O
however RB B-ADVP
COMMA COMMA O
K562 NN B-NP
cells NNS I-NP
acquired VBD B-VP
a DT B-NP
macrophage-like JJ I-NP
morphology NN I-NP
and CC O
exhibited VBD B-VP
a DT B-NP
complete JJ I-NP
failure NN I-NP
to TO B-VP
generate VB I-VP
benzidine-positive JJ B-NP
cells NNS I-NP
. . O

Electron NN B-NP
microscopy NN I-NP
revealed VBD B-VP
a DT B-NP
marked JJ I-NP
increase NN I-NP
in IN B-PP
granules NNS B-NP
resembling VBG B-VP
those DT B-NP
specific JJ B-ADJP
for IN B-PP
eosinophils NNS B-NP
. . O

Surface NN B-NP
marker NN I-NP
analysis NN I-NP
showed VBD B-VP
that IN B-SBAR
HMBA-induced JJ B-NP
cells NNS I-NP
expressed VBD B-VP
reduced VBN B-NP
levels NNS I-NP
of IN B-PP
glycophorin NN B-NP
A NN I-NP
COMMA COMMA O
CD5 NN B-NP
COMMA COMMA O
CD7 NN B-NP
and CC O
CD11b NN B-NP
. . O

No DT B-NP
upregulation NN I-NP
of IN B-PP
megakaryocyte NN B-NP
or CC I-NP
lymphoid JJ I-NP
markers NNS I-NP
occurred VBD B-VP
. . O

Thus RB B-ADVP
the DT B-NP
response NN I-NP
of IN B-PP
K562 NN B-NP
cells NNS I-NP
to TO B-PP
HMBA NN B-NP
may MD B-VP
provide VB I-VP
a DT B-NP
useful JJ I-NP
experimental JJ I-NP
system NN I-NP
for IN B-PP
studying VBG B-VP
the DT B-NP
molecular JJ I-NP
mechanisms NNS I-NP
responsible JJ B-ADJP
for IN B-PP
downmodulation NN B-NP
of IN B-PP
lineage-restricted JJ B-NP
transcription NN I-NP
factors NNS I-NP
during IN B-PP
hemopoietic JJ B-NP
lineage NN I-NP
commitment NN I-NP
. . O

The DT B-NP
Sp1 NN I-NP
transcription NN I-NP
factor NN I-NP
binds VBZ B-VP
the DT B-NP
CD11b NN I-NP
promoter NN I-NP
specifically RB B-PP
in IN I-PP
myeloid JJ B-NP
cells NNS I-NP
in FW B-ADVP
vivo FW I-ADVP
and CC O
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
myeloid-specific JJ B-NP
promoter NN I-NP
activity NN I-NP
. . O

The DT B-NP
myeloid JJ I-NP
integrin NN I-NP
CD11b NN I-NP
is VBZ B-VP
expressed VBN I-VP
selectively RB B-ADVP
on IN B-PP
the DT B-NP
surface NN I-NP
of IN B-PP
mature JJ B-NP
macrophages NNS I-NP
COMMA COMMA O
monocytes NNS B-NP
COMMA COMMA O
neutrophils NNS B-NP
COMMA COMMA O
and CC O
natural JJ B-NP
killer NN I-NP
cells NNS I-NP
. . O

Lineage-specific JJ B-NP
expression NN I-NP
is VBZ B-VP
controlled VBN I-VP
at IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
mRNA NN B-NP
transcription NN I-NP
. . O

Recent JJ B-NP
isolation NN I-NP
of IN B-PP
the DT B-NP
CD11b NN I-NP
promoter NN I-NP
shows VBZ B-VP
that IN B-SBAR
92 CD B-NP
base NN B-NP
pairs NNS I-NP
( ( O
bp NN B-NP
) ) O
of IN B-PP
5'-flanking JJ B-NP
DNA NN I-NP
are VBP B-VP
sufficient JJ B-ADJP
to TO B-VP
direct VB I-VP
myeloid-specific JJ B-NP
expression NN I-NP
of IN B-PP
a DT B-NP
reporter NN I-NP
gene NN I-NP
. . O

To TO B-VP
characterize VB I-VP
regulatory JJ B-NP
sequences NNS I-NP
important JJ B-ADJP
for IN B-PP
promoter NN B-NP
activity NN I-NP
COMMA COMMA O
we PRP B-NP
performed VBD B-VP
linker NN B-NP
scanning NN I-NP
analysis NN I-NP
of IN B-PP
the DT B-NP
92-bp JJ I-NP
CD11b NN I-NP
promoter NN I-NP
and CC O
demonstrate VB B-VP
that IN B-SBAR
a DT B-NP
sequence NN I-NP
at IN B-PP
bp NN B-NP
-60 CD I-NP
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
CD11b NN B-NP
promoter NN I-NP
activity NN I-NP
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
this DT B-NP
sequence NN I-NP
binds VBZ B-VP
the DT B-NP
transcription NN I-NP
factor NN I-NP
Sp1 NN I-NP
in FW B-ADVP
vitro FW I-ADVP
and CC B-ADVP
in FW B-ADVP
vivo FW I-ADVP
. . O

In FW B-ADVP
vivo FW I-ADVP
the DT B-NP
Sp1 NN I-NP
site NN I-NP
is VBZ B-VP
bound VBN I-VP
only RB B-PP
in IN I-PP
myeloid JJ O
( ( O
U937 NN B-NP
) ) O
cells NNS B-NP
COMMA COMMA O
not RB B-PP
in IN I-PP
cervical JJ B-NP
carcinoma NN I-NP
( ( O
HeLa NN B-NP
) ) O
cells NNS B-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
the DT B-NP
macrophage NN I-NP
transcription NN I-NP
factor NN I-NP
PU.1 NN I-NP
binds VBZ B-VP
the DT B-NP
CD11b NN I-NP
promoter NN I-NP
in FW B-ADVP
vitro FW I-ADVP
and CC B-ADVP
in FW B-ADVP
vivo FW I-ADVP
close RB B-ADVP
to TO B-PP
the DT B-NP
Sp1 NN I-NP
site NN I-NP
. . O

We PRP B-NP
propose VBP B-VP
a DT B-NP
model NN I-NP
in IN B-PP
which WDT B-NP
binding NN B-NP
of IN B-PP
a DT B-NP
myeloid-specific JJ I-NP
factor NN I-NP
( ( O
PU.1 NN B-NP
) ) O
allows VBZ B-VP
a DT B-NP
general JJ I-NP
factor NN I-NP
( ( O
Sp1 NN B-NP
) ) O
to TO B-VP
bind VB I-VP
in IN B-PP
a DT B-NP
tissue-specific JJ I-NP
fashion NN I-NP
thereby RB B-ADVP
contributing VBG B-VP
to TO B-PP
the DT B-NP
myeloid-specific JJ I-NP
expression NN I-NP
of IN B-PP
CD11b NN B-NP
. . O

Costimulation NN B-NP
of IN B-PP
peripheral JJ B-NP
blood NN I-NP
T NN I-NP
cell NN I-NP
activation NN I-NP
by IN B-PP
human JJ B-NP
endothelial JJ I-NP
cells NNS I-NP
. . O

Enhanced VBD B-NP
IL-2 NN I-NP
transcription NN I-NP
correlates VBZ B-VP
with IN B-PP
increased VBN B-NP
c-fos NN I-NP
synthesis NN I-NP
and CC O
increased VBN B-NP
Fos NN I-NP
content NN I-NP
of IN B-PP
AP-1 NN B-NP
. . O

Endothelial JJ B-NP
cells NNS I-NP
( ( O
EC NN B-NP
) ) O
act VBP B-VP
as IN B-PP
APC NN B-NP
for IN B-PP
resting VBG B-NP
PBL NN I-NP
in FW B-ADVP
vitro FW I-ADVP
COMMA COMMA O
and CC O
may MD B-VP
have VB I-VP
important JJ B-NP
roles NNS I-NP
in FW B-ADVP
vivo FW I-ADVP
in IN B-PP
the DT B-NP
pathogenesis NN I-NP
of IN B-PP
allograft NN B-NP
rejection NN I-NP
and CC O
delayed VBN B-NP
hypersensitivity NN I-NP
. . O

We PRP B-NP
previously RB B-ADVP
reported VBD B-VP
that IN B-SBAR
human JJ B-NP
umbilical JJ I-NP
vein NN I-NP
EC NN I-NP
provide VBP B-VP
costimulatory JJ B-NP
signals NNS I-NP
to TO B-PP
PHA-stimulated JJ B-NP
PBL NN I-NP
via IN B-PP
CD2:lymphocyte NN B-NP
function-associated JJ I-NP
Ag-3 NN I-NP
and CC O
an DT B-NP
unidentified JJ I-NP
ligand NN I-NP
pair NN I-NP
COMMA COMMA O
resulting VBG B-VP
in IN B-PP
a DT B-NP
three- CD I-NP
to TO I-NP
eight-fold JJ I-NP
enhancement NN I-NP
of IN B-PP
IL-2 NN B-NP
production NN I-NP
. . O

The DT B-NP
physiologic JJ I-NP
relevance NN I-NP
of IN B-PP
this DT B-NP
increase NN I-NP
was VBD B-VP
demonstrated VBN I-VP
by IN B-PP
the DT B-NP
proliferative JJ I-NP
advantage NN I-NP
provided VBN B-VP
by IN B-PP
EC NN B-NP
to TO B-PP
PBL NN B-NP
suboptimally RB B-VP
stimulated VBN I-VP
with IN B-PP
mAb NN B-NP
OKT3 NN I-NP
. . O

We PRP B-NP
now RB B-ADVP
report VBP B-VP
that IN B-SBAR
EC NN B-NP
costimulation NN I-NP
causes VBZ B-VP
increased VBN B-NP
levels NNS I-NP
of IN B-PP
IL-2 NN B-NP
mRNA NN I-NP
as IN B-PP
a DT B-NP
result NN I-NP
of IN B-PP
increased VBN B-NP
IL-2 NN I-NP
transcription NN I-NP
in IN B-PP
PBL NN B-NP
. . O

We PRP B-NP
therefore RB B-ADVP
examined VBD B-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
EC NN B-NP
on IN B-PP
T NN B-NP
cell NN I-NP
nuclear JJ I-NP
factors NNS I-NP
known VBN B-VP
to TO I-VP
regulate VB I-VP
IL-2 NN B-NP
transcription NN I-NP
COMMA COMMA O
including VBG B-PP
c-jun NN B-NP
and CC O
c-fos-two NN B-NP
components NNS B-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
AP-1 NN I-NP
COMMA COMMA O
NFAT NN B-NP
COMMA COMMA O
and CC O
others NNS B-NP
. . O

PBL NN B-NP
constitutively RB B-ADVP
express VBP B-VP
c-jun NN B-NP
transcripts NNS I-NP
COMMA COMMA O
and CC O
the DT B-NP
level NN I-NP
of IN B-PP
c-jun NN B-NP
mRNA NN I-NP
is VBZ B-VP
not RB I-VP
altered VBN I-VP
by IN B-PP
PHA NN B-NP
activation NN I-NP
in IN B-PP
the DT B-NP
absence NN B-NP
or CC O
presence NN B-NP
of IN B-PP
EC NN B-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
c-fos NN B-NP
mRNA NN I-NP
is VBZ B-VP
absent JJ B-ADJP
from IN B-PP
resting VBG B-NP
T NN I-NP
cells NNS I-NP
and CC O
is VBZ B-VP
induced VBN I-VP
on IN B-PP
PHA NN B-NP
activation NN I-NP
. . O

EC NN B-NP
alone RB B-ADVP
do VBP B-VP
not RB I-VP
induce VB I-VP
c-fos NN B-NP
mRNA NN I-NP
but CC O
augment VBP B-VP
the DT B-NP
level NN I-NP
of IN B-PP
c-fos NN B-NP
mRNA NN I-NP
in IN B-PP
PHA-activated JJ B-NP
T NN I-NP
cells NNS I-NP
by IN B-PP
3- CD B-NP
to TO I-NP
10-fold RB I-NP
. . O

This DT B-NP
effect NN I-NP
is VBZ B-VP
largely RB B-ADJP
independent JJ I-ADJP
of IN B-PP
the DT B-NP
CD2:lymphocyte NN I-NP
function-associated JJ I-NP
Ag-3 NN I-NP
pathway NN I-NP
. . O

Gel-shift NN B-NP
analysis NN I-NP
reveals VBZ B-VP
the DT B-NP
constitutive JJ I-NP
presence NN I-NP
of IN B-PP
nuclear JJ B-NP
factors NNS I-NP
in IN B-PP
resting VBG B-NP
PBL NN I-NP
that WDT B-NP
bind VBP B-VP
to TO B-PP
the DT B-NP
proximal JJ I-NP
AP-1 NN I-NP
site NN I-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
and CC O
that IN B-NP
contain VBP B-VP
immunoreactive JJ O
c-Jun NN B-NP
but CC B-CONJP
not RB I-CONJP
c-Fos NN B-NP
protein NN B-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
AP-1 NN B-NP
from IN B-PP
PHA-activated JJ B-NP
cells NNS I-NP
contains VBZ B-VP
c-Jun NN B-NP
and CC O
low JJ B-NP
levels NNS I-NP
of IN B-PP
c-Fos NN B-NP
. . O

Strikingly RB B-ADVP
COMMA COMMA O
costimulation NN B-NP
with IN B-PP
EC NN B-NP
results VBZ B-VP
in IN B-PP
a DT B-NP
dramatic JJ I-NP
increase NN I-NP
( ( O
up NN B-NP
to TO I-NP
15-fold JJ I-NP
) ) O
in IN B-PP
the DT B-NP
c-Fos NN I-NP
content NN I-NP
of IN B-PP
AP-1 NN B-NP
. . O

Levels NNS B-NP
of IN B-PP
other JJ B-NP
nuclear JJ I-NP
factors NNS I-NP
involved VBN B-VP
in IN B-PP
IL-2 NN B-NP
regulation NN I-NP
were VBD B-VP
not RB I-VP
altered VBN I-VP
by IN B-PP
EC NN B-NP
COMMA COMMA O
although IN B-SBAR
NFAT-DNA NN B-NP
complexes NNS I-NP
migrated VBD B-VP
at IN B-PP
a DT B-NP
slightly RB I-NP
different JJ I-NP
mobility NN I-NP
. . O

In IN B-PP
summary NN B-NP
COMMA COMMA O
our PRP$ B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
changes NNS B-NP
in IN B-PP
the DT B-NP
composition NN I-NP
of IN B-PP
transcription NN B-NP
factor NN I-NP
AP-1 NN I-NP
is VBZ B-VP
a DT B-NP
key JJ I-NP
molecular JJ I-NP
mechanism NN I-NP
for IN B-PP
increasing VBG B-NP
IL-2 NN I-NP
transcription NN I-NP
and CC O
may MD B-VP
underlie VB I-VP
the DT B-NP
phenomenon NN I-NP
of IN B-PP
costimulation NN B-NP
by IN B-PP
EC NN B-NP
. . O

A DT B-NP
protein NN I-NP
of IN B-PP
the DT B-NP
AP-1 NN I-NP
family NN I-NP
is VBZ B-VP
a DT B-NP
component NN I-NP
of IN B-PP
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
. . O

Nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
( ( O
NF-AT NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
transcriptional JJ I-NP
activator NN I-NP
involved VBN B-VP
in IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
IL-2 NN B-NP
gene NN I-NP
expression NN I-NP
. . O

The DT B-NP
response NN I-NP
element NN I-NP
for IN B-PP
NF-AT NN B-NP
is VBZ B-VP
a DT B-NP
sequence NN I-NP
localized JJ B-VP
between IN B-PP
-285\/-254 CD B-NP
in IN B-PP
the DT B-NP
IL-2 NN I-NP
regulatory JJ I-NP
region NN I-NP
. . O

The DT B-NP
composition NN I-NP
of IN B-PP
NF-AT NN B-NP
protein NN I-NP
is VBZ B-VP
still RB I-VP
not RB I-VP
fully RB I-VP
elucidated VBN I-VP
. . O

We PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
COMMA COMMA O
in IN B-PP
normal JJ B-NP
human JJ I-NP
T NN I-NP
cells NNS I-NP
COMMA COMMA O
an DT B-NP
AP-1 NN I-NP
protein NN I-NP
is VBZ B-VP
a DT B-NP
component NN I-NP
of IN B-PP
the DT B-NP
NF-AT NN I-NP
protein NN I-NP
complex NN I-NP
. . O

This DT B-NP
was VBD B-VP
evidenced VBN I-VP
by IN B-PP
the DT B-NP
ability NN I-NP
of IN B-PP
the DT B-NP
AP-1 NN I-NP
site NN I-NP
to TO B-VP
compete VB I-VP
with IN B-PP
the DT B-NP
NF-AT NN I-NP
site NN I-NP
for IN B-PP
binding NN B-VP
to TO B-PP
NF-AT NN B-NP
and CC B-PP
by IN B-PP
the DT B-NP
capacity NN I-NP
of IN B-PP
immobilized VBN B-NP
anti-Jun JJ I-NP
and CC I-NP
anti-Fos JJ I-NP
antibodies NNS I-NP
to TO B-VP
deplete VB I-VP
NF-AT-binding NN B-NP
activity NN I-NP
from IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
. . O

There EX B-NP
was VBD B-VP
no DT B-NP
detectable JJ I-NP
binding NN I-NP
of IN B-PP
in FW B-ADVP
vitro FW I-ADVP
translated VBN B-NP
Jun\/Fos NN B-NP
heterodimer NN I-NP
( ( O
AP-1 NN B-NP
) ) O
to TO B-PP
the DT B-NP
NF-AT NN I-NP
sequence NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
NF-AT NN I-NP
sequence NN I-NP
was VBD B-VP
unable JJ B-ADJP
to TO B-VP
inhibit VB I-VP
the DT B-NP
binding NN I-NP
of IN B-PP
Jun\/Fos NN B-NP
to TO B-PP
the DT B-NP
AP-1 NN I-NP
sequence NN I-NP
. . O

The DT B-NP
presence NN I-NP
of IN B-PP
an DT B-NP
AP-1 NN I-NP
protein NN I-NP
in IN B-PP
the DT B-NP
NF-AT NN I-NP
protein NN I-NP
complex NN I-NP
may MD B-VP
regulate VB I-VP
NF-AT-binding JJ B-NP
activity NN I-NP
through IN B-PP
protein-protein JJ B-NP
interaction NN I-NP
. . O

Functional JJ B-NP
antagonism NN I-NP
between IN B-PP
vitamin NN B-NP
D3 NN I-NP
and CC O
retinoic JJ B-NP
acid NN I-NP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
CD14 NN B-NP
and CC O
CD23 NN B-NP
expression NN B-NP
during IN B-PP
monocytic JJ B-NP
differentiation NN I-NP
of IN B-PP
U-937 NN B-NP
cells NNS I-NP
. . O

1COMMA25 CD B-NP
alpha-Dihydroxicholecalciferol NN I-NP
( ( O
VitD3 NN B-NP
) ) O
and CC O
retinoic JJ B-NP
acid NN I-NP
( ( O
RA NN B-NP
) ) O
are VBP B-VP
important JJ B-NP
regulators NNS I-NP
of IN B-PP
the DT B-NP
proliferation NN B-NP
and CC O
differentiation NN B-NP
of IN B-PP
several JJ B-NP
cell NN I-NP
types NNS I-NP
. . O

This DT B-NP
paper NN I-NP
describes VBZ B-VP
how WRB B-ADVP
the DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
monocyte-macrophage JJ I-NP
Ag NN I-NP
COMMA COMMA O
CD14 NN B-NP
COMMA COMMA O
and CC O
the DT B-NP
low JJ I-NP
affinity NN I-NP
Fc NN I-NP
receptor NN I-NP
for IN B-PP
IgE NN B-NP
COMMA COMMA O
CD23 NN B-NP
COMMA COMMA O
were VBD B-VP
inversely RB I-VP
regulated VBN I-VP
during IN B-PP
VitD3- NN B-NP
and CC O
RA-induced JJ B-ADJP
monocytic JJ B-NP
differentiation NN I-NP
of IN B-PP
human JJ B-NP
U-937 NN I-NP
monoblasts NNS I-NP
. . O

PMA NN B-NP
induced VBD B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
both CC O
CD14 NN B-NP
and CC O
CD23 NN B-NP
mRNA NN B-NP
and CC O
protein NN B-NP
. . O

Exposure NN B-NP
to TO B-PP
VitD3 NN B-NP
rapidly RB B-ADVP
induced VBD B-VP
the DT B-NP
de FW I-NP
novo FW I-NP
expression NN I-NP
of IN B-PP
CD14 NN B-NP
mRNA NN B-NP
and CC O
protein NN B-NP
. . O

The DT B-NP
addition NN I-NP
of IN B-PP
cycloheximide NN B-NP
completely RB B-ADVP
blocked VBD B-VP
the DT B-NP
VitD3 NN I-NP
induction NN I-NP
of IN B-PP
CD14 NN B-NP
mRNA NN I-NP
expression NN I-NP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
the DT B-NP
induction NN I-NP
was VBD B-VP
dependent JJ B-ADJP
on IN B-PP
ongoing JJ B-NP
protein NN I-NP
synthesis NN I-NP
. . O

While IN B-SBAR
inducing VBG B-VP
CD14 NN B-NP
expression NN I-NP
COMMA COMMA O
VitD3 NN B-NP
concomitantly RB B-ADVP
suppressed VBD B-VP
the DT O
basal JJ O
COMMA COMMA O
PMA- NN B-NP
COMMA COMMA O
and CC O
RA-inducible JJ B-ADJP
CD23 NN B-NP
expression NN I-NP
in IN B-PP
a DT B-NP
dose-dependent JJ I-NP
manner NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
U-937 NN B-NP
cells NNS I-NP
induced VBN B-VP
by IN B-PP
RA NN B-NP
strongly RB B-ADVP
increased VBD B-VP
their PRP$ B-NP
expression NN I-NP
of IN B-PP
CD23 NN B-NP
mRNA NN B-NP
and CC O
protein NN B-NP
COMMA COMMA O
whereas IN O
they PRP B-NP
completely RB B-ADVP
lacked VBD B-VP
detectable JJ O
CD14 NN O
cell NN B-NP
surface NN I-NP
or CC O
mRNA NN B-NP
expression NN B-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
the DT B-NP
VitD3- NN B-NP
and CC O
the DT B-NP
PMA-induced JJ I-NP
CD14 NN B-NP
expression NN I-NP
was VBD B-VP
inhibited VBN I-VP
as IN B-PP
a DT B-NP
temporal JJ I-NP
consequence NN I-NP
of IN B-PP
the DT B-NP
RA-induced JJ I-NP
differentiation NN I-NP
. . O

The DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
there EX B-NP
exists VBZ B-VP
a DT B-NP
functional JJ I-NP
antagonism NN I-NP
between IN B-PP
VitD3 NN B-NP
and CC O
RA NN B-NP
that WDT B-NP
may MD B-VP
have VB I-VP
important JJ B-NP
implications NNS I-NP
for IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
certain JJ B-NP
immune JJ I-NP
and CC I-NP
inflammatory JJ I-NP
responses NNS I-NP
through IN B-PP
their PRP$ B-NP
inverse JJ I-NP
effects NNS I-NP
on IN B-PP
CD14 NN B-NP
and CC O
CD23 NN B-NP
gene NN B-NP
expression NN I-NP
. . O

The DT B-NP
lytic JJ I-NP
transition NN I-NP
of IN B-PP
Epstein-Barr JJ B-NP
virus NN I-NP
is VBZ B-VP
imitated VBN I-VP
by IN B-PP
recombinant JJ B-NP
B-cells NNS I-NP
. . O

Lytic JJ B-NP
transition NN I-NP
of IN B-PP
Epstein-Barr JJ B-NP
virus NN I-NP
( ( O
EBV NN B-NP
) ) O
is VBZ B-VP
initiated VBN I-VP
by IN B-PP
distinct JJ B-NP
immediate JJ I-NP
early JJ I-NP
regulators NNS I-NP
of IN B-PP
the DT B-NP
viral JJ I-NP
cycle NN I-NP
COMMA COMMA O
in IN B-PP
synchronization NN B-NP
to TO B-PP
temporary JJ B-NP
COMMA COMMA I-NP
permissive JJ I-NP
conditions NNS I-NP
during IN B-PP
host NN B-NP
cell NN I-NP
differentiation NN I-NP
. . O

We PRP B-NP
developed VBD B-VP
eukaryotic JJ B-NP
vectors NNS I-NP
suitable JJ B-ADJP
to TO B-VP
imitate VB I-VP
the DT B-NP
processes NNS I-NP
involved VBN B-VP
in IN B-PP
lytic JJ B-NP
transition NN I-NP
in IN B-PP
cell NN B-NP
culture NN I-NP
systems NNS I-NP
. . O

Two CD B-NP
stable JJ I-NP
B NN I-NP
cell NN I-NP
lines NNS I-NP
were VBD B-VP
established VBN I-VP
: : O
R59Z NN B-NP
activator NN I-NP
cells NNS I-NP
were VBD B-VP
used VBN I-VP
to TO B-VP
induce VB I-VP
lytic JJ B-NP
EBV NN I-NP
expression NN I-NP
in IN B-PP
a DT B-NP
constitutive JJ I-NP
manner NN I-NP
by IN B-PP
the DT B-NP
production NN I-NP
of IN B-PP
the DT B-NP
BZLF NN I-NP
1 CD I-NP
trans-activator NN I-NP
( ( O
Zta NN B-NP
) ) O
. . O

R7-57 NN B-NP
reporter NN I-NP
cells NNS I-NP
COMMA COMMA O
on IN B-PP
the DT B-NP
other JJ I-NP
hand NN I-NP
COMMA COMMA O
signaled VBD B-VP
induced VBN B-NP
activity NN I-NP
of IN B-PP
the DT B-NP
lytic JJ I-NP
origin NN I-NP
of IN B-PP
EBV NN B-NP
replication NN I-NP
( ( O
ori NN B-NP
Lyt NN I-NP
) ) O
. . O

Different JJ B-NP
modes NNS I-NP
COMMA COMMA O
like IN B-PP
chemical JJ B-NP
induction NN I-NP
COMMA COMMA O
lytic JJ B-NP
superinfection NN I-NP
with IN B-PP
EBV NN B-NP
and CC O
single JJ B-NP
gene NN I-NP
trans-activation NN I-NP
converted VBD B-VP
the DT B-NP
recombinant JJ I-NP
ori NN I-NP
Lyt NN I-NP
element NN I-NP
in IN B-PP
R7-57 NN B-NP
reporter NN I-NP
cells NNS I-NP
. . O

BZLF NN B-NP
1 CD I-NP
COMMA COMMA O
transiently RB B-VP
expressed VBN I-VP
in IN B-PP
R7-57 NN B-NP
reporter NN I-NP
cells NNS I-NP
COMMA COMMA O
was VBD B-VP
the DT B-NP
only JJ I-NP
EBV NN I-NP
trans-activator NN I-NP
found VBN B-VP
COMMA COMMA O
sufficient JJ B-ADJP
in NN O
inducing VBG B-VP
the DT B-NP
viral JJ I-NP
lytic JJ I-NP
cycle NN I-NP
. . O

Basing VBG B-PP
on IN B-PP
these DT B-NP
experiments NNS I-NP
COMMA COMMA O
trans-cellular JJ B-NP
activation NN I-NP
of IN B-PP
EBV NN B-NP
was VBD B-VP
tested VBN I-VP
by IN B-PP
cocultivation NN B-NP
of IN B-PP
BZLF NN B-NP
1-expressing JJ I-NP
R59Z NN I-NP
activator NN I-NP
cells NNS I-NP
with IN B-PP
the DT B-NP
R7-57 NN I-NP
reporter NN I-NP
line NN I-NP
. . O

No DT B-NP
lytic JJ I-NP
effect NN I-NP
on IN B-PP
the DT B-NP
reporter NN I-NP
cells NNS I-NP
could MD B-VP
be VB I-VP
measured VBN I-VP
COMMA COMMA O
neither CC O
by IN B-PP
cocultivation NN B-NP
of IN B-PP
activator NN B-NP
cells NNS I-NP
nor CC B-PP
by IN B-PP
coincubation NN B-NP
of IN B-PP
BZLF NN B-NP
1-containing JJ I-NP
cell NN I-NP
lysates NNS I-NP
. . O

Latency NN B-NP
breaking NN I-NP
activity NN I-NP
COMMA COMMA O
however RB B-ADVP
COMMA COMMA O
was VBD B-VP
transferred VBN I-VP
from IN B-PP
activator NN B-NP
to TO B-PP
reporter NN B-NP
cells NNS I-NP
when WRB B-ADVP
active JJ B-NP
COMMA COMMA I-NP
exogenous JJ I-NP
virus NN I-NP
was VBD B-VP
added VBN I-VP
. . O

The DT B-NP
cell NN I-NP
system NN I-NP
described VBN B-VP
in IN B-PP
these DT B-NP
experiments NNS I-NP
provides VBZ B-VP
a DT B-NP
tool NN I-NP
for IN B-PP
the DT B-NP
detection NN I-NP
of IN B-PP
EBV NN B-NP
reactivation NN I-NP
and CC O
demonstrates VBZ B-VP
the DT B-NP
potential NN I-NP
of IN B-PP
the DT B-NP
lytic JJ I-NP
regulatory JJ I-NP
gene NN I-NP
BZLF NN I-NP
1 CD I-NP
. . O

Immobilization NN B-NP
and CC O
recovery NN B-NP
of IN B-PP
fusion NN B-NP
proteins NNS I-NP
and CC O
B-lymphocyte NN B-NP
cells NNS I-NP
using VBG B-VP
magnetic JJ B-NP
separation NN I-NP
. . O

A DT B-NP
new JJ I-NP
approach NN I-NP
to TO B-VP
facilitate VB I-VP
immobilization NN B-NP
and CC O
affinity NN B-NP
purification NN I-NP
of IN B-PP
recombinant JJ B-NP
proteins NNS I-NP
and CC O
selected VBN B-NP
human JJ I-NP
B NN I-NP
lymphocytes NNS I-NP
has VBZ B-VP
been VBN I-VP
developed VBN I-VP
. . O

Using VBG B-VP
magnetic JJ B-NP
beads NNS I-NP
with IN B-PP
attached VBN B-NP
DNA NN I-NP
containing VBG B-VP
the DT B-NP
Escherichia FW I-NP
coli FW I-NP
lac NN I-NP
operator NN I-NP
COMMA COMMA O
fusion NN B-NP
proteins NNS I-NP
comprising VBG B-VP
the DT B-NP
DNA-binding JJ I-NP
lac NN I-NP
repressor NN I-NP
could MD B-VP
be VB I-VP
affinity-purified JJ I-VP
and CC O
recovered VBN B-VP
by IN B-PP
gentle JJ B-NP
elution NN I-NP
conditions NNS I-NP
COMMA COMMA O
such JJ B-PP
as IN I-PP
with IN B-PP
a DT B-NP
lactose NN I-NP
analogue NN I-NP
or CC B-PP
by IN B-PP
enzymatic JJ B-NP
means NNS I-NP
using VBG B-VP
either CC O
deoxyribonuclease NN B-NP
( ( O
DNase NN B-NP
) ) O
or CC O
restriction NN B-NP
endonucleases NNS I-NP
. . O

The DT B-NP
results NNS I-NP
show VBP B-VP
for IN B-PP
the DT B-NP
first JJ I-NP
time NN I-NP
that IN B-SBAR
a DT B-NP
DNA-binding JJ I-NP
protein NN I-NP
can MD B-VP
be VB I-VP
used VBN I-VP
for IN B-PP
affinity NN B-NP
purification NN I-NP
of IN B-PP
fusion NN B-NP
proteins NNS I-NP
as IN B-SBAR
exemplified VBN B-VP
by IN B-PP
the DT B-NP
specific JJ I-NP
and CC I-NP
gentle JJ I-NP
recovery NN I-NP
of IN B-PP
beta-galactosidase NN B-NP
and CC O
alkaline NN B-NP
phosphatase NN I-NP
from IN B-PP
bacterial JJ B-NP
lysates NNS I-NP
using VBG B-VP
immunomagnetic JJ B-NP
separation NN I-NP
. . O

The DT B-NP
approach NN I-NP
was VBD B-VP
further RB I-VP
extended VBN I-VP
to TO B-PP
cell NN B-NP
separation NN I-NP
by IN B-PP
the DT B-NP
efficient JJ I-NP
recovery NN B-NP
and CC O
elution NN B-NP
of IN B-PP
human JJ B-NP
CD37 NN I-NP
B NN I-NP
lymphocytes NNS I-NP
from IN B-PP
peripheral JJ B-NP
blood NN I-NP
. . O

Negative JJ B-NP
transcriptional JJ I-NP
regulation NN I-NP
of IN B-PP
human JJ O
interleukin NN B-NP
2 CD I-NP
( ( O
IL-2 NN B-NP
) ) O
gene NN B-NP
by IN B-PP
glucocorticoids NNS B-NP
through IN B-PP
interference NN B-NP
with IN B-PP
nuclear JJ B-NP
transcription NN I-NP
factors NNS I-NP
AP-1 NN B-NP
and CC O
NF-AT NN B-NP
. . O

IL-2 NN B-NP
gene NN I-NP
transcription NN I-NP
is VBZ B-VP
affected VBN I-VP
by IN B-PP
several JJ B-NP
nuclear JJ I-NP
proteins NNS I-NP
. . O

We PRP B-NP
asked VBD B-VP
whether IN B-SBAR
dexamethasone NN B-NP
( ( O
Dex NN B-NP
) ) O
and CC O
cyclosporin NN B-NP
A NN I-NP
( ( O
CsA NN B-NP
) ) O
inhibit VBP B-VP
IL-2 NN B-NP
gene NN I-NP
transcription NN I-NP
by IN B-PP
interfering VBG B-VP
with IN B-PP
the DT B-NP
activity NN I-NP
of IN B-PP
nuclear JJ B-NP
proteins NNS I-NP
that WDT B-NP
bind VBP B-VP
to TO B-PP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
. . O

Nuclear JJ B-NP
extracts NNS I-NP
from IN B-PP
primary JJ B-PP
human JJ I-PP
T NN O
lymphocytes NNS O
were VBD B-VP
analyzed VBN I-VP
by IN B-PP
electrophoretic JJ B-NP
DNA NN I-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
. . O

Both CC O
Dex NN B-NP
and CC O
CsA NN B-NP
inhibited VBD B-VP
the DT B-NP
binding NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
AP-1 NN B-NP
and CC O
NF-AT NN B-NP
COMMA COMMA B-PP
but CC I-PP
not RB B-PP
of IN I-PP
NF-kB NN B-NP
and CC O
OCT-1\/OAF NN B-NP
COMMA COMMA O
to TO B-PP
their PRP$ B-NP
corresponding JJ I-NP
sites NNS I-NP
on IN B-PP
the DT B-NP
IL-2 NN I-NP
gene NN I-NP
promoter NN I-NP
. . O

To TO B-VP
correlate VB I-VP
changes NNS B-NP
in IN B-PP
nuclear JJ B-NP
factor NN I-NP
binding NN I-NP
in FW B-ADVP
vitro FW I-ADVP
with IN B-PP
transcriptional JJ B-NP
activity NN I-NP
in FW B-ADVP
vivo FW I-ADVP
and CC O
define VB B-VP
the DT B-NP
structural JJ I-NP
requirements NNS I-NP
for IN B-PP
IL-2 NN B-NP
promoter NN I-NP
repression NN I-NP
COMMA COMMA O
we PRP B-NP
used VBD B-VP
transient JJ B-NP
DNA NN I-NP
transfections NNS I-NP
. . O

Jurkat NN B-NP
cells NNS I-NP
were VBD B-VP
transfected VBN I-VP
with IN B-PP
plasmids NNS B-NP
containing VBG B-VP
either CC O
the DT B-NP
intact JJ I-NP
IL-2 NN I-NP
promoter NN I-NP
or CC O
its PRP$ O
AP-1 NN B-NP
COMMA COMMA O
NF-AT NN B-NP
COMMA COMMA O
and CC O
NF-kB NN B-NP
motifs NNS B-NP
. . O

Dex NN B-NP
inhibited VBD B-VP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
and CC O
the DT B-NP
AP-1 NN I-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
the DT B-NP
NF-AT NN B-NP
and CC O
NF-kB NN B-NP
plasmids NNS B-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
CsA NN B-NP
inhibited VBD B-VP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
and CC O
the DT B-NP
NF-AT NN I-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
the DT B-NP
AP-1 NN B-NP
and CC O
NF-kB NN B-NP
plasmids NNS B-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
in IN B-PP
human JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
both CC O
Dex NN B-NP
and CC O
CsA NN B-NP
inhibited VBD B-VP
IL-2 NN B-NP
gene NN I-NP
transcription NN I-NP
through IN B-PP
interference NN B-NP
with IN B-PP
transcription NN B-NP
factors NNS I-NP
AP-1 NN B-NP
and CC O
NF-AT NN B-NP
. . O

We PRP B-NP
propose VBP B-VP
that IN B-SBAR
COMMA COMMA O
while IN B-NP
maximum NN I-NP
inhibition NN B-VP
may MD I-VP
involve VB B-NP
interaction NN O
with IN B-NP
both DT I-NP
transcription NN I-NP
factors NNS O
COMMA COMMA O
AP-1 NN B-VP
is VBZ B-NP
the DT I-NP
primary JJ I-NP
target NN O
of IN B-NP
Dex NN O

Lymphocytes NNS B-NP
from IN B-PP
the DT B-NP
site NN I-NP
of IN B-PP
disease NN B-NP
suggest VBP B-VP
adenovirus NN B-NP
is VBZ B-VP
one CD B-NP
cause NN I-NP
of IN B-PP
persistent JJ B-NP
or CC I-NP
recurrent JJ I-NP
inflammatory JJ I-NP
arthritis NN I-NP
. . O

The DT B-NP
assessment NN I-NP
of IN B-PP
synovial JJ B-NP
lymphocyte NN I-NP
reactivity NN I-NP
to TO B-PP
adenovirus NN B-NP
antigen NN I-NP
stimulation NN I-NP
was VBD B-VP
undertaken VBN I-VP
in IN B-PP
patients NNS B-NP
with IN B-PP
persistent JJ B-NP
or CC I-NP
recurrent JJ I-NP
inflammatory JJ I-NP
arthritis NN I-NP
. . O

The DT B-NP
3H-thymidine JJ I-NP
uptake NN I-NP
procedure NN I-NP
was VBD B-VP
employed VBN I-VP
COMMA COMMA O
incorporating VBG B-VP
multiple JJ B-NP
microbiological JJ I-NP
antigens NNS I-NP
. . O

Five CD B-NP
patients NNS I-NP
were VBD B-VP
found VBN I-VP
with IN B-PP
repeated VBN B-NP
maximal JJ I-NP
responses NNS I-NP
to TO B-PP
adenovirus NN B-NP
antigen NN I-NP
; : O
in IN B-PP
one CD B-NP
of IN B-PP
these DT B-NP
adenovirus NN B-NP
nucleotide NN I-NP
sequences NNS I-NP
were VBD B-VP
present JJ B-ADJP
in IN B-PP
a DT B-NP
synovial JJ I-NP
biopsy NN I-NP
specimen NN I-NP
. . O

It PRP B-NP
is VBZ B-VP
concluded VBN I-VP
that IN B-SBAR
adenovirus NN B-NP
may MD B-VP
be VB I-VP
one CD B-NP
cause NN I-NP
of IN B-PP
persistent JJ B-NP
or CC I-NP
recurrent JJ I-NP
inflammatory JJ I-NP
arthritis NN I-NP
. . O

Human JJ B-NP
CD3-CD16+ JJ I-NP
natural JJ I-NP
killer NN I-NP
cells NNS I-NP
express VBP B-VP
the DT B-NP
hGATA-3 NN I-NP
T NN I-NP
cell NN I-NP
transcription NN I-NP
factor NN I-NP
and CC O
an DT B-NP
unrearranged JJ I-NP
2.3-kb JJ I-NP
TcR NN I-NP
delta NN I-NP
transcript NN I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
we PRP B-NP
analyzed VBD B-VP
the DT O
T NN B-NP
cell NN I-NP
receptor NN I-NP
( ( O
TcR NN B-NP
) ) O
delta NN B-NP
transcripts NNS I-NP
expressed VBN B-VP
by IN B-PP
CD3-CD16+ JJ B-NP
cells NNS I-NP
and CC O
we PRP B-NP
investigated VBD B-VP
whether IN B-SBAR
these DT B-NP
cells NNS I-NP
expressed VBD B-VP
the DT B-NP
hGATA-3 NN I-NP
T NN I-NP
cell NN I-NP
transcription NN I-NP
factor NN I-NP
and CC O
the DT B-NP
recombination-activating JJ I-NP
gene NN I-NP
( ( I-NP
RAG NN I-NP
) ) I-NP
-1 CD I-NP
. . O

Multiple JJ B-NP
TcR NN I-NP
delta NN I-NP
transcripts NNS I-NP
deriving VBG B-VP
from IN B-PP
an DT B-NP
unrearranged JJ I-NP
TcR NN I-NP
delta NN I-NP
gene NN I-NP
were VBD B-VP
detected VBN I-VP
in IN B-PP
both CC O
polyclonal JJ O
and CC O
clonal JJ O
CD3-CD16+ JJ O
natural JJ B-NP
killer NN I-NP
( ( O
NK NN B-NP
) ) O
cell NN B-NP
lines NNS I-NP
. . O

Two CD B-NP
unrearranged JJ I-NP
TcR NN I-NP
delta NN I-NP
transcripts NNS I-NP
had VBD B-VP
a DT B-NP
size NN I-NP
similar JJ B-ADJP
to TO B-PP
that DT B-NP
of IN B-PP
the DT B-NP
functional JJ I-NP
TcR NN I-NP
delta NN I-NP
mRNA NN I-NP
( ( O
2.3 CD B-NP
and CC I-NP
1.3 CD I-NP
kb NN I-NP
) ) O
found VBN B-VP
in IN B-PP
TcR NN B-NP
gamma\/delta+ JJ I-NP
T NN I-NP
lymphocytes NNS I-NP
. . O

Sequence NN B-NP
analysis NN I-NP
of IN B-PP
nine CD B-NP
different JJ I-NP
2.3-kb JJ I-NP
cDNA NN I-NP
clones NNS I-NP
obtained VBN B-VP
from IN B-PP
NK-derived JJ B-NP
polyA+ JJ I-NP
RNA NN I-NP
confirmed VBD B-VP
that IN B-SBAR
they PRP B-NP
corresponded VBD B-VP
to TO B-PP
an DT B-NP
unrearranged JJ I-NP
TcR NN I-NP
delta NN I-NP
gene NN I-NP
. . O

These DT B-NP
cDNA NN I-NP
were VBD B-VP
2343 CD B-NP
bp NN I-NP
long JJ B-ADJP
and CC O
their PRP$ B-NP
transcription NN I-NP
initiation NN I-NP
site NN I-NP
was VBD B-VP
located JJ O
814 CD B-NP
bp NN I-NP
upstream RB B-ADJP
from IN B-PP
the DT B-NP
J NN I-NP
delta NN I-NP
1 CD I-NP
segment NN I-NP
. . O

The DT B-NP
sequence NN I-NP
located JJ B-ADJP
upstream RB I-ADJP
of IN B-PP
the DT B-NP
J NN I-NP
delta NN I-NP
1 CD I-NP
segment NN I-NP
corresponded VBD B-VP
to TO B-PP
the DT B-NP
previously RB I-NP
reported VBN I-NP
germ-line JJ I-NP
sequence NN I-NP
. . O

The DT B-NP
J NN I-NP
delta NN I-NP
1 CD I-NP
segment NN I-NP
was VBD B-VP
correctly RB I-VP
spliced VBN I-VP
to TO B-PP
C NN B-NP
delta NN I-NP
; : O
in IN B-PP
addition NN B-NP
the DT B-NP
four CD I-NP
C NN I-NP
delta NN I-NP
exons NNS I-NP
were VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
already RB I-VP
assembled VBN I-VP
. . O

Two CD B-NP
polyadenylation NN I-NP
sites NNS I-NP
were VBD B-VP
present JJ B-ADJP
in IN B-PP
the DT B-NP
fourth JJ I-NP
C NN I-NP
delta NN I-NP
exon NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
only JJ B-NP
that WDT I-NP
located JJ B-ADJP
at IN B-PP
the DT B-NP
3' JJ I-NP
end NN I-NP
appeared VBD B-VP
to TO I-VP
be VB I-VP
utilized VBN I-VP
in IN B-PP
the DT B-NP
2.3-kb JJ I-NP
cDNA NN I-NP
. . O

The DT B-NP
expression NN I-NP
of IN B-PP
hGATA-3 NN B-NP
COMMA COMMA O
a DT B-NP
T NN I-NP
cell-specific JJ I-NP
factor NN I-NP
known VBN B-VP
to TO I-VP
be VB I-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
of IN B-PP
TcR NN B-NP
delta NN I-NP
locus NN I-NP
COMMA COMMA O
was VBD B-VP
analyzed VBN I-VP
by IN B-PP
Northern NN B-NP
blot NN I-NP
COMMA COMMA O
in IN B-PP
cultured VBN B-NP
NK NN I-NP
cell NN B-NP
population NN I-NP
and CC O
clones NNS B-NP
( ( B-PP
but CC I-PP
not RB B-PP
in IN I-PP
freshly RB B-NP
derived VBN I-NP
cell NN I-NP
populations NNS I-NP
) ) O
. . O

All DT B-NP
NK NN I-NP
clones NNS B-NP
and CC O
cell NN B-NP
lines NNS I-NP
studied VBN B-VP
were VBD B-VP
found VBN I-VP
to TO I-VP
express VB I-VP
hGATA-3-specific JJ B-NP
mRNA NN I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
hGATA-3 NN B-NP
may MD B-VP
be VB I-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
unrearranged JJ I-NP
TcR NN I-NP
delta NN I-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
NK NN B-NP
cells NNS I-NP
. . O

Finally RB B-ADVP
COMMA COMMA O
no DT B-NP
transcription NN I-NP
of IN B-PP
the DT B-NP
RAG-1 NN I-NP
gene NN I-NP
could MD B-VP
be VB I-VP
detected VBN I-VP
in IN B-PP
all DT B-NP
NK NN I-NP
cell NN B-NP
lines NNS I-NP
or CC O
clones NNS B-NP
analyzed VBN B-VP
. . O

Cell-specific JJ B-NP
expression NN I-NP
of IN B-PP
helix-loop-helix JJ B-NP
transcription NN I-NP
factors NNS I-NP
encoded VBN B-VP
by IN B-PP
the DT B-NP
E2A NN I-NP
gene NN I-NP
. . O

The DT B-NP
E2A NN I-NP
gene NN I-NP
encodes VBZ B-VP
transcription NN B-NP
factors NNS I-NP
of IN B-PP
the DT B-NP
helix-loop-helix JJ I-NP
family NN I-NP
that WDT B-NP
are VBP B-VP
implicated VBN I-VP
in IN B-PP
cell-specific JJ B-NP
gene NN I-NP
expression NN I-NP
as IN B-PP
part NN B-NP
of IN B-PP
dimeric JJ B-NP
complexes NNS I-NP
that WDT B-NP
interact VBP B-VP
with IN B-PP
E NN B-NP
box NN I-NP
enhancer NN I-NP
elements NNS I-NP
. . O

It PRP B-NP
has VBZ B-VP
previously RB I-VP
been VBN I-VP
shown VBN I-VP
that IN B-SBAR
transcripts NNS B-NP
of IN B-PP
the DT B-NP
E2A NN I-NP
gene NN I-NP
can MD B-VP
be VB I-VP
detected VBN I-VP
in IN B-PP
a DT B-NP
wide JJ I-NP
range NN I-NP
of IN B-PP
cell NN B-NP
types NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
now RB I-VP
examined VBN I-VP
expression NN B-NP
of IN B-PP
the DT B-NP
mouse NN I-NP
E2A NN I-NP
gene NN I-NP
at IN B-PP
the DT B-NP
protein NN I-NP
level NN I-NP
using VBG B-VP
polyclonal JJ B-NP
antisera NNS I-NP
directed VBN B-VP
against IN B-PP
distinct JJ B-NP
portions NNS I-NP
of IN B-PP
the DT B-NP
E2A NN I-NP
protein NN I-NP
to TO B-VP
probe NN I-VP
blots NNS B-NP
of IN B-PP
cellular JJ B-NP
extracts NNS I-NP
. . O

A DT B-NP
73 CD I-NP
kDa NN I-NP
protein NN I-NP
was VBD B-VP
identified VBN I-VP
by IN B-PP
this DT B-NP
analysis NN I-NP
: : O
this DT B-NP
protein NN I-NP
is VBZ B-VP
highly RB B-ADJP
enriched VBN I-ADJP
in IN B-PP
cell NN B-NP
lines NNS I-NP
of IN B-PP
B NN B-NP
lymphoid JJ I-NP
origin NN I-NP
as IN B-SBAR
compared VBN B-VP
to TO B-PP
pancreatic JJ B-NP
beta-cells NNS I-NP
and CC O
fibroblast NN B-NP
cells NNS I-NP
. . O

The DT B-NP
detection NN I-NP
of IN B-PP
this DT B-NP
protein NN I-NP
selectively RB B-PP
in IN I-PP
extracts NNS B-NP
of IN B-PP
lymphoid JJ B-NP
cells NNS I-NP
correlates VBZ B-VP
with IN B-PP
the DT B-NP
presence NN I-NP
of IN B-PP
the DT B-NP
E NN I-NP
box-binding JJ I-NP
activity NN I-NP
LEF1\/BCF1 NN I-NP
in IN B-PP
these DT B-NP
cells NNS I-NP
; : O
this DT B-NP
binding NN I-NP
activity NN I-NP
was VBD B-VP
previously RB I-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
efficiently RB I-VP
recognized VBN I-VP
by IN B-PP
antiserum NN B-NP
directed VBN B-VP
against IN B-PP
E2A NN B-NP
gene NN I-NP
products NNS I-NP
. . O

Transfection NN B-NP
of IN B-PP
cells NNS B-NP
with IN B-PP
full JJ B-NP
length NN I-NP
E2A NN I-NP
cDNA NN I-NP
leads VBZ B-VP
to TO B-PP
appearance NN B-NP
of IN B-PP
protein NN B-NP
co-migrating VBG B-VP
with IN B-PP
the DT B-NP
73 CD I-NP
kDa NN I-NP
protein NN I-NP
on IN B-PP
SDS NN B-NP
gel NN I-NP
electrophoresis NN I-NP
and CC O
co-migrating VBG B-VP
with IN B-PP
LEF1\/BCF1 NN B-NP
on IN B-PP
mobility NN B-NP
shift NN I-NP
analysis NN I-NP
. . O

Our PRP$ B-NP
results NNS I-NP
are VBP B-VP
consistent JJ B-ADJP
with IN B-PP
the DT B-NP
view NN I-NP
that IN B-SBAR
the DT B-NP
DNA-binding JJ I-NP
activity NN I-NP
LEF1\/BCF1 NN I-NP
is VBZ B-VP
a DT B-NP
homodimer NN I-NP
of IN B-PP
E2A NN B-NP
proteins NNS I-NP
; : O
the DT B-NP
selective JJ I-NP
appearance NN I-NP
of IN B-PP
this DT B-NP
putative JJ I-NP
cell-specific JJ I-NP
transcription NN I-NP
factor NN I-NP
in IN B-PP
B NN B-NP
lymphoid JJ I-NP
cells NNS I-NP
seems VBZ B-VP
to TO I-VP
be VB I-VP
attributable JJ B-ADJP
COMMA COMMA O
at IN B-ADVP
least JJS I-ADVP
in IN B-PP
part NN B-NP
COMMA COMMA B-PP
to TO I-PP
the DT B-NP
elevated JJ I-NP
E2A NN I-NP
protein NN I-NP
concentrations NNS I-NP
in IN B-PP
these DT B-NP
cells NNS I-NP
. . O

HIV-1 NN B-NP
Nef NN I-NP
protein NN I-NP
inhibits VBZ B-VP
the DT B-NP
recruitment NN I-NP
of IN B-PP
AP-1 NN B-NP
DNA-binding JJ I-NP
activity NN I-NP
in IN B-PP
human JJ B-NP
T-cells NNS I-NP
. . O

The DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
COMMA COMMA O
HIV-1-LTR NN B-NP
COMMA COMMA O
contains VBZ B-VP
binding VBG B-NP
sites NNS I-NP
for IN B-PP
several JJ B-NP
cellular JJ I-NP
transcription NN I-NP
factors NNS I-NP
which WDT B-NP
contribute VBP B-VP
to TO B-PP
HIV-1 NN B-NP
gene NN I-NP
expression NN I-NP
. . O

Our PRP$ B-NP
previous JJ I-NP
studies NNS I-NP
on IN B-PP
the DT B-NP
function NN I-NP
of IN B-PP
the DT B-NP
HIV-1-encoded JJ I-NP
Nef NN I-NP
protein NN I-NP
suggested VBD B-VP
that IN B-SBAR
Nef NN B-NP
may MD B-VP
be VB I-VP
an DT B-NP
inhibitor NN I-NP
HIV-1 NN I-NP
transcription NN I-NP
. . O

To TO B-VP
determine VB I-VP
whether IN B-SBAR
Nef NN B-NP
affects VBZ B-VP
the DT B-NP
binding NN I-NP
of IN B-PP
cellular JJ B-NP
factors NNS I-NP
implicated VBN B-VP
in IN B-PP
HIV-1 NN B-NP
regulation NN I-NP
COMMA COMMA O
32P-labeled JJ B-NP
oligonucleotides NNS I-NP
corresponding VBG B-VP
to TO B-PP
the DT B-NP
binding VBG I-NP
sites NNS I-NP
were VBD B-VP
incubated VBN I-VP
with IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
prepared VBN B-VP
from IN B-PP
Nef-expressing JJ B-NP
T-cell NN I-NP
lines NNS I-NP
that WDT B-NP
were VBD B-VP
not RB I-VP
stimulated VBN I-VP
or CC O
were VBD B-VP
stimulated VBN I-VP
with IN B-PP
T-cell NN B-NP
mitogens NNS I-NP
. . O

We PRP B-NP
found VBD B-VP
that IN B-SBAR
Nef NN B-NP
inhibited VBD B-VP
the DT B-NP
recruitment NN I-NP
of IN B-PP
AP-1 NN B-NP
DNA-binding JJ I-NP
activity NN I-NP
in IN B-PP
mitogen-stimulated JJ B-NP
human JJ I-NP
T-cells NNS I-NP
. . O

Additionally RB B-ADVP
COMMA COMMA O
Nef NN B-NP
expressing NN I-NP
cells NNS I-NP
were VBD B-VP
transiently RB I-VP
transfected VBN I-VP
with IN B-PP
a DT B-NP
plasmid NN I-NP
in IN B-PP
which WDT B-NP
HIV-1 NN B-NP
AP-1 NN I-NP
DNA NN I-NP
recognition NN I-NP
sequences NNS I-NP
were VBD B-VP
cloned VBN I-VP
downstream RB B-ADVP
of IN B-PP
the DT O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
( ( O
CAT NN B-NP
) ) O
gene NN B-NP
. . O

Mitogen-mediated JJ B-NP
transcriptional JJ I-NP
activation NN I-NP
of IN B-PP
the DT B-NP
CAT NN I-NP
gene NN I-NP
in IN B-PP
this DT B-NP
construct NN I-NP
was VBD B-VP
inhibited VBN I-VP
in IN B-PP
Nef-expressing JJ B-NP
cells NNS I-NP
but CC B-PP
not RB B-PP
in IN I-PP
control NN B-NP
cells NNS I-NP
. . O

These DT B-NP
studies NNS I-NP
suggest VBP B-VP
that IN B-SBAR
COMMA COMMA O
by IN O
inhibiting VBG B-NP
AP-1 NN I-NP
activation NN O
COMMA COMMA O
Nef NN B-VP
may MD I-VP
play VB B-NP
a DT I-NP
role NN O
in IN O
regulating VBG B-NP
HIV-1 NN I-NP
gene NN I-NP
expression NN O
in IN B-NP
infected JJ I-NP
T-cells NNS O

Hypertension NN B-NP
in IN B-PP
pregnancy NN B-NP
. . O

Pregnancy-induced JJ B-NP
hypertension NN I-NP
( ( O
PIH NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
frequent JJ I-NP
cause NN I-NP
of IN B-PP
maternal JJ B-NP
and CC I-NP
neonatal JJ I-NP
morbidity NN B-NP
and CC O
mortality NN B-NP
. . O

In IN B-PP
the DT B-NP
present JJ I-NP
study NN I-NP
we PRP B-NP
focused VBD B-VP
on IN B-PP
the DT B-NP
pathophysiology NN I-NP
of IN B-PP
PIH NN B-NP
COMMA COMMA O
mainly RB B-PP
on IN I-PP
the DT B-NP
role NN I-NP
of IN B-PP
mineralocorticoids NNS B-NP
COMMA COMMA O
reversed VBN B-NP
blood NN I-NP
pressure NN I-NP
patterns NNS I-NP
COMMA COMMA O
and CC O
the DT B-NP
resulting VBG I-NP
necessity NN I-NP
of IN B-PP
continuous JJ B-NP
monitoring NN I-NP
of IN B-PP
the DT B-NP
preeclamptic JJ I-NP
mother NN I-NP
. . O

Problems NNS B-NP
of IN B-PP
antihypertensive JJ B-NP
therapy NN I-NP
are VBP B-VP
discussed VBN I-VP
and CC O
the DT B-NP
first JJ I-NP
results NNS I-NP
of IN B-PP
a DT B-NP
pilot NN I-NP
study NN I-NP
with IN B-PP
Urapidil NN B-NP
are VBP B-VP
presented VBN I-VP
. . O

To TO B-VP
examine VB I-VP
the DT B-NP
role NN I-NP
of IN B-PP
mineralocorticoids NNS B-NP
in IN B-PP
the DT B-NP
pathophysiology NN I-NP
of IN B-PP
PIH NN B-NP
COMMA COMMA O
we PRP B-NP
studied VBD B-VP
plasma NN B-NP
aldosterone NN I-NP
and CC O
18-hydroxy-corticosterone NN B-NP
( ( O
18-OH-B NN B-NP
) ) O
levels NNS B-NP
in IN B-PP
25 CD B-NP
women NNS I-NP
with IN B-PP
PIH NN B-NP
and CC B-PP
in IN B-PP
25 CD B-NP
healthy JJ I-NP
pregnant JJ I-NP
women NNS I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
we PRP B-NP
evaluated VBD B-VP
the DT B-NP
mineralocorticoid NN I-NP
receptor NN I-NP
( ( O
MR NN B-NP
) ) O
count NN B-NP
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
in IN B-PP
the DT B-NP
2 CD I-NP
groups NNS I-NP
. . O

The DT B-NP
MR-count NN I-NP
was VBD B-VP
significantly RB I-VP
decreased VBN I-VP
in IN B-PP
the DT B-NP
PIH-group NN I-NP
. . O

The DT B-NP
values NNS I-NP
of IN B-PP
plasma NN B-NP
aldosterone NN I-NP
and CC O
18-OH-B NN B-NP
were VBD B-VP
also RB B-ADVP
low JJ B-ADJP
. . O

These DT B-NP
results NNS I-NP
can MD B-VP
not RB I-VP
be VB I-VP
explained VBN I-VP
by IN B-PP
receptor NN B-NP
down-regulation NN I-NP
due JJ B-PP
to TO I-PP
higher JJR B-NP
level NN I-NP
of IN B-PP
mineralocorticoids NNS B-NP
of IN B-PP
the DT B-NP
zona NN I-NP
glomerulosa NN I-NP
. . O

Perhaps RB B-ADVP
deoxycorticosterone NN B-NP
or CC O
a DT B-NP
hitherto RB I-NP
unknown JJ I-NP
mineralocorticoid NN I-NP
is VBZ B-VP
responsible JJ B-ADJP
for IN B-PP
the DT B-NP
hypertension NN B-NP
and CC O
altered JJ B-NP
MR-status NN I-NP
. . O

The DT B-NP
first JJ I-NP
results NNS I-NP
of IN B-PP
continuous JJ B-NP
blood NN I-NP
pressure NN I-NP
measurements NNS I-NP
with IN B-PP
a DT B-NP
noninvasive JJ I-NP
COMMA COMMA I-NP
real-time JJ I-NP
blood NN I-NP
pressure NN I-NP
monitor NN I-NP
( ( O
Finapres NN B-NP
) ) O
are VBP B-VP
presented VBN I-VP
. . O

The DT B-NP
comparison NN I-NP
of IN B-PP
the DT B-NP
obtained VBN I-NP
values NNS I-NP
with IN B-PP
intraarterial JJ B-NP
measurements NNS I-NP
demonstrates VBZ B-VP
a DT B-NP
good JJ I-NP
correlation NN I-NP
between IN B-PP
the DT B-NP
two CD I-NP
methods NNS I-NP
. . O

We PRP B-NP
also RB B-ADVP
report VBP B-VP
on IN B-PP
the DT B-NP
first JJ I-NP
experiences NNS I-NP
with IN B-PP
Urapidil NN B-NP
in IN B-PP
the DT B-NP
treatment NN I-NP
of IN B-PP
hypertension NN B-NP
in IN B-PP
severe JJ B-NP
preeclampsia NN I-NP
. . O

The DT B-NP
data NNS I-NP
show VBP B-VP
that IN B-SBAR
hypertension NN B-NP
in IN B-PP
preeclamptic JJ B-NP
women NNS I-NP
can MD B-VP
be VB I-VP
treated VBN I-VP
by IN B-PP
Urapidil NN B-NP
without IN B-PP
side JJ B-NP
effects NNS I-NP
or CC O
reflex-tachycardia NN B-NP
. . O

Further JJ B-NP
studies NNS I-NP
will MD B-VP
have VB I-VP
to TO I-VP
prove VB I-VP
if IN B-SBAR
Urapidil NN B-NP
is VBZ B-VP
suited VBN O
for IN B-PP
prepartal JJ B-NP
treatment NN I-NP
of IN B-PP
PIH NN B-NP
as RB B-ADJP
well RB I-ADJP
. . O

Adenovirus NN B-NP
E1A NN I-NP
inhibits VBZ B-VP
IFN-induced JJ B-NP
resistance NN I-NP
to TO B-PP
cytolysis NN B-NP
by IN B-PP
natural JJ B-NP
killer NN I-NP
cells NNS I-NP
. . O

Infection NN B-NP
of IN B-PP
target NN B-NP
cells NNS I-NP
with IN B-PP
cytopathic JJ B-NP
viruses NNS I-NP
inhibits VBZ B-VP
IFN NN B-NP
induction NN I-NP
of IN B-PP
cytolytic JJ B-NP
resistance NN I-NP
to TO B-PP
NK NN B-NP
cell-mediated JJ I-NP
cytolysis NN I-NP
{ ( O
IFN-mediated JJ B-NP
cytoprotection NN I-NP
( ( O
IFN-MCP NN B-NP
) ) O
} ) O
. . O

It PRP B-NP
has VBZ B-VP
been VBN I-VP
thought VBN I-VP
that IN B-SBAR
the DT B-NP
virally RB I-NP
induced VBN I-NP
inhibition NN I-NP
of IN B-PP
IFN-MCP NN B-NP
is VBZ B-VP
secondary JJ B-ADJP
to TO B-PP
the DT B-NP
shutdown NN I-NP
of IN B-PP
cellular JJ B-NP
macromolecular JJ I-NP
synthesis NN I-NP
that WDT B-NP
accompanies VBZ B-VP
cytopathic JJ B-NP
virus NN I-NP
infections NNS I-NP
. . O

Group NN O
C NN O
COMMA COMMA O
adenovirus NN B-NP
serotype NN I-NP
5 CD I-NP
( ( O
Ad5 NN B-NP
) ) O
infection NN B-NP
inhibits VBZ B-VP
both CC O
IFN-MCP NN B-NP
and CC O
cellular JJ B-NP
protein NN I-NP
synthesis NN I-NP
. . O

This DT B-NP
study NN I-NP
determined VBD B-VP
if IN B-SBAR
the DT B-NP
Ad5-induced JJ I-NP
inhibition NN I-NP
of IN B-PP
IFN-MCP NN B-NP
was VBD B-VP
independent JJ B-ADJP
of IN B-PP
adenovirus NN B-NP
( ( O
Ad NN B-NP
) ) O
infection NN B-NP
and CC O
secondary JJ B-ADJP
only RB B-PP
to TO I-PP
the DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
Ad NN I-NP
early JJ B-NP
region NN I-NP
1A NN I-NP
gene NN I-NP
( ( O
E1A NN B-NP
) ) O
. . O

To TO B-VP
test VB I-VP
this DT B-NP
hypothesis NN I-NP
COMMA COMMA O
4-h JJ B-NP
NK NN I-NP
cytolysis NN I-NP
assays NNS I-NP
were VBD B-VP
performed VBN I-VP
on IN B-PP
IFN-gamma-treated JJ B-NP
human JJ I-NP
cells NNS I-NP
infected VBN B-ADJP
with IN B-PP
an DT B-NP
Ad5 NN I-NP
E1A NN I-NP
deletion NN I-NP
mutant NN I-NP
COMMA COMMA O
dl343 NN B-NP
COMMA COMMA O
or CC O
transfected VBN B-ADJP
with IN B-PP
the DT B-NP
Ad5 NN I-NP
E1A NN I-NP
gene NN I-NP
. . O

IFN-MCP NN B-NP
was VBD B-VP
not RB I-VP
inhibited VBN I-VP
by IN B-PP
infection NN B-NP
with IN B-PP
dl343 NN B-NP
COMMA COMMA O
despite IN B-PP
the DT B-NP
production NN I-NP
of IN B-PP
large JJ B-NP
amounts NNS I-NP
of IN B-PP
both CC O
early JJ B-NP
( ( O
E1B NN B-NP
COMMA COMMA O
p55 NN B-NP
) ) O
and CC O
late JJ B-NP
( ( O
hexon NN B-NP
) ) O
Ad NN B-NP
proteins NNS I-NP
. . O

In IN B-PP
contrast NN I-PP
to TO I-PP
E1A-negative JJ B-NP
COMMA COMMA I-NP
parental JJ I-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
IFN-MCP NN B-NP
was VBD B-VP
blocked VBN I-VP
in IN B-PP
Ad5 NN B-NP
E1A-transfected JJ I-NP
epithelial JJ I-NP
and CC I-NP
fibroblastic JJ I-NP
cell NN I-NP
lines NNS I-NP
. . O

Genetic JJ B-NP
mapping NN I-NP
studies NNS I-NP
within IN B-PP
the DT B-NP
E1A NN I-NP
gene NN I-NP
demonstrated VBD B-VP
that IN B-SBAR
expression NN B-NP
of IN B-PP
only RB B-NP
the DT I-NP
first JJ I-NP
exon NN I-NP
of IN B-PP
E1A NN B-NP
was VBD B-VP
sufficient JJ B-ADJP
to TO B-VP
inhibit VB I-VP
IFN-MCP NN B-NP
. . O

DNA NN B-NP
sequence NN I-NP
homology NN I-NP
of IN B-PP
E1A NN B-NP
genes NNS I-NP
between IN B-PP
different JJ B-NP
Ad NN I-NP
groups NNS I-NP
( ( O
group NN B-NP
A NN I-NP
COMMA COMMA O
Ad12 NN B-NP
; : O
group NN B-NP
C NN I-NP
COMMA COMMA O
Ad5 NN B-NP
) ) O
is VBZ B-VP
limited VBN I-VP
almost RB B-ADVP
entirely RB I-ADVP
to TO B-PP
three CD B-NP
conserved VBN I-NP
regions NNS I-NP
located JJ B-ADJP
within IN B-PP
the DT B-NP
first JJ I-NP
exon NN I-NP
of IN B-PP
E1A NN B-NP
. . O

Because IN B-SBAR
IFN-MCP NN B-NP
was VBD B-VP
also RB I-VP
blocked VBN I-VP
in IN B-PP
Ad12 NN B-NP
E1A-transfected JJ I-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
expression NN B-NP
of IN B-PP
one CD B-NP
or CC I-NP
more JJR I-NP
of IN B-PP
the DT B-NP
E1A-conserved JJ I-NP
regions NNS I-NP
may MD B-VP
be VB I-VP
necessary JJ B-ADJP
to TO B-VP
inhibit VB I-VP
IFN-MCP NN B-NP
. . O

In IN B-PP
summary NN B-NP
COMMA COMMA O
the DT B-NP
expression NN I-NP
of IN B-PP
E1A NN B-NP
gene NN I-NP
products NNS I-NP
inhibited VBD B-VP
IFN-MCP NN B-NP
independently RB B-ADVP
of IN B-PP
virus NN B-NP
infection NN I-NP
. . O

E1A NN B-NP
's POS B-NP
inhibition NN O
of IN B-NP
IFN-MCP NN B-VP
has VBZ B-NP
the DT I-NP
net JJ I-NP
effect NN O
of IN O
promoting VBG B-NP
the DT I-NP
selective JJ I-NP
NK NN I-NP
cell-mediated JJ I-NP
clearance NN O
of IN B-NP
Ad-infected JJ I-NP
or CC I-NP
Ad-transformed JJ I-NP
human JJ I-NP
cells NNS O

A DT B-NP
chimeric JJ I-NP
type NN I-NP
II CD I-NP
\/ : I-NP
type NN I-NP
I CD I-NP
interleukin-1 NN I-NP
receptor NN I-NP
can MD B-VP
mediate VB I-VP
interleukin-1 NN B-NP
induction NN I-NP
of IN B-PP
gene NN B-NP
expression NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
. . O

The DT B-NP
type NN I-NP
I CD I-NP
interleukin-1 NN B-NP
receptor NN I-NP
( ( O
IL-1R NN B-NP
) ) O
is VBZ B-VP
capable JJ B-ADJP
of IN B-PP
transducing VBG B-VP
a DT B-NP
signal NN I-NP
resulting VBG B-VP
in IN B-PP
promoter NN B-NP
activation NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
. . O

This DT B-NP
signal NN I-NP
transduction NN I-NP
is VBZ B-VP
dependent JJ B-ADJP
on IN B-PP
the DT B-NP
cytoplasmic JJ I-NP
domain NN I-NP
COMMA COMMA O
which WDT B-NP
consists VBZ B-VP
of IN B-PP
213 CD B-NP
amino NN I-NP
acids NNS I-NP
. . O

In IN B-PP
contrast NN I-PP
to TO I-PP
the DT B-NP
type NN I-NP
I CD I-NP
receptor NN I-NP
COMMA COMMA O
the DT B-NP
type NN I-NP
II CD I-NP
IL-1R NN I-NP
has VBZ B-VP
a DT B-NP
small JJ I-NP
cytoplasmic JJ I-NP
tail NN I-NP
COMMA COMMA O
and CC O
it PRP B-NP
is VBZ B-VP
not RB O
clear JJ B-ADJP
whether IN B-SBAR
this DT B-NP
receptor NN I-NP
is VBZ B-VP
a DT B-NP
signal-transducing JJ I-NP
or CC O
a DT B-NP
regulatory JJ I-NP
molecule NN B-NP
. . O

Here RB B-ADVP
we PRP B-NP
report VBP B-VP
that IN B-SBAR
the DT B-NP
type NN I-NP
II CD I-NP
IL-1R NN I-NP
does VBZ B-VP
not RB I-VP
mediate VB I-VP
gene NN B-NP
activation NN I-NP
in IN B-PP
Jurkat NN B-NP
cells NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
a DT B-NP
hybrid NN I-NP
receptor NN I-NP
composed VBN B-VP
of IN B-PP
the DT B-NP
extracellular JJ I-NP
and CC I-NP
transmembrane NN I-NP
regions NNS I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
type NN I-NP
II CD I-NP
interleukin-1 NN I-NP
fused VBN B-VP
to TO B-PP
the DT B-NP
cytoplasmic JJ I-NP
domain NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
type NN I-NP
I CD I-NP
IL-1R NN I-NP
was VBD B-VP
capable JJ B-ADJP
of IN B-PP
transducing VBG B-VP
a DT B-NP
signal NN I-NP
across IN B-PP
the DT B-NP
membrane NN I-NP
resulting VBG B-VP
in IN B-PP
a DT B-NP
pattern NN I-NP
of IN B-PP
gene NN B-NP
activation NN I-NP
identical JJ B-ADJP
to TO B-PP
that DT B-NP
mediated VBN B-VP
by IN B-PP
the DT B-NP
type NN I-NP
I CD I-NP
IL-1R NN I-NP
. . O

Our PRP$ B-NP
results NNS I-NP
indicated VBD B-VP
that IN B-SBAR
the DT B-NP
extracellular JJ I-NP
domain NN I-NP
of IN B-PP
the DT B-NP
type NN I-NP
II CD I-NP
IL-1R NN I-NP
was VBD B-VP
capable JJ B-ADJP
of IN B-PP
functionally RB B-VP
interacting VBG I-VP
with IN B-PP
interleukin-1 NN B-NP
and CC O
transmitting VBG B-VP
the DT B-NP
resulting VBG I-NP
signal NN I-NP
to TO B-PP
a DT B-NP
heterologous JJ I-NP
cytoplasmic JJ I-NP
domain NN I-NP
. . O

A DT B-NP
mutation NN I-NP
of IN B-PP
the DT B-NP
glucocorticoid NN I-NP
receptor NN I-NP
in IN B-PP
primary JJ B-NP
cortisol NN I-NP
resistance NN I-NP
. . O

The DT B-NP
precise JJ I-NP
molecular JJ I-NP
abnormalities NNS I-NP
that WDT B-NP
cause VBP B-VP
primary JJ B-NP
cortisol NN I-NP
resistance NN I-NP
have VBP B-VP
not RB I-VP
been VBN I-VP
completely RB I-VP
described VBN I-VP
. . O

In IN B-PP
a DT B-NP
subject NN I-NP
with IN B-PP
primary JJ B-NP
cortisol NN I-NP
resistance NN I-NP
we PRP B-NP
have VBP B-VP
observed VBN I-VP
glucocorticoid NN B-NP
receptors NNS I-NP
( ( O
hGR NN B-NP
) ) O
with IN B-PP
a DT B-NP
decreased VBN I-NP
affinity NN I-NP
for IN B-PP
dexamethasone NN B-NP
. . O

We PRP B-NP
hypothesize VBP B-VP
that IN B-SBAR
a DT B-NP
mutation NN I-NP
of IN B-PP
the DT B-NP
hGR NN I-NP
glucocorticoid-binding JJ I-NP
domain NN I-NP
is VBZ B-VP
the DT B-NP
cause NN I-NP
of IN B-PP
cortisol NN B-NP
resistance NN I-NP
. . O

Total JJ B-NP
RNA NN I-NP
isolated VBN B-VP
from IN B-PP
the DT B-NP
index NN I-NP
subject NN I-NP
's POS B-NP
mononuclear JJ I-NP
leukocytes NNS I-NP
was VBD B-VP
used VBN I-VP
to TO B-VP
produce VB I-VP
first JJ B-NP
strand NN I-NP
hGR NN I-NP
cDNAs NNS I-NP
COMMA COMMA O
and CC O
the DT B-NP
entire JJ I-NP
hGR NN I-NP
cDNA NN I-NP
was VBD B-VP
amplified VBN I-VP
in IN B-PP
segments NNS B-NP
and CC O
sequenced VBN B-VP
. . O

At IN B-PP
nucleotide NN B-NP
2COMMA317 CD I-NP
we PRP B-NP
identified VBD B-VP
a DT B-NP
homozygous JJ I-NP
A NN I-NP
for IN B-PP
G NN B-NP
point NN I-NP
mutation NN I-NP
that WDT B-NP
predicts VBZ B-VP
an DT B-NP
isoleucine NN I-NP
( ( O
ATT NN B-NP
) ) O
for IN B-PP
valine NN B-NP
( ( I-NP
GTT NN I-NP
) ) I-NP
substitution NN I-NP
at IN B-PP
amino NN B-NP
acid NN I-NP
729 CD I-NP
. . O

When WRB B-ADVP
the DT B-NP
wild-type JJ I-NP
hGR NN I-NP
and CC O
hGR-Ile NN B-NP
729 CD I-NP
were VBD B-VP
expressed VBN I-VP
in IN B-PP
COS-1 NN B-NP
cells NNS I-NP
and CC O
assayed VBN B-VP
for IN B-PP
{3H}-Dexamethasone NN B-NP
binding NN I-NP
COMMA COMMA O
the DT B-NP
dissociation NN I-NP
constants NNS I-NP
were VBD B-VP
0.799 CD B-NP
+\/- CC I-NP
0.068 CD I-NP
and CC I-NP
1.54 CD I-NP
+\/- CC I-NP
0.06 CD I-NP
nM NN I-NP
( ( O
mean NN B-NP
+\/- CC O
SEM NN B-NP
) ) O
( ( O
P NN B-NP
&lt; JJR B-NP
0.01 CD I-NP
) ) O
COMMA COMMA O
respectively RB B-ADVP
. . O

When WRB B-ADVP
the DT B-NP
wild-type JJ I-NP
hGR NN I-NP
and CC O
hGR-Ile NN B-NP
729 CD I-NP
were VBD B-VP
expressed VBN I-VP
in IN B-PP
CV-1 NN B-NP
cells NNS I-NP
that WDT B-NP
were VBD B-VP
cotransfected VBN I-VP
with IN B-PP
the DT B-NP
mouse NN I-NP
mammary JJ I-NP
tumor NN I-NP
virus NN I-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
fused VBN B-VP
to TO B-PP
the DT O
chloramphenicol NN B-NP
acetyl NN I-NP
transferase NN I-NP
( ( O
CAT NN B-NP
) ) O
gene NN B-NP
COMMA COMMA O
the DT B-NP
hGR-Ile NN I-NP
729 CD I-NP
conferred VBD B-VP
a DT B-NP
fourfold JJ I-NP
decrease NN I-NP
in IN B-PP
apparent JJ B-NP
potency NN I-NP
on IN B-PP
dexamethasone NN B-NP
stimulation NN I-NP
of IN B-PP
CAT NN B-NP
activity NN I-NP
. . O

The DT B-NP
isoleucine NN I-NP
for IN B-PP
valine NN B-NP
substitution NN I-NP
at IN B-PP
amino NN B-NP
acid NN I-NP
729 CD I-NP
impairs VBZ B-VP
the DT B-NP
function NN I-NP
of IN B-PP
the DT B-NP
hGR NN I-NP
and CC O
is VBZ B-VP
the DT B-NP
likely JJ I-NP
cause NN I-NP
of IN B-PP
primary JJ B-NP
cortisol NN I-NP
resistance NN I-NP
in IN B-PP
this DT B-NP
subject NN I-NP
. . O

Mice NNS B-NP
deficient NN B-ADJP
for IN B-PP
the DT B-NP
55 CD I-NP
kd JJ I-NP
tumor NN I-NP
necrosis NN I-NP
factor NN I-NP
receptor NN I-NP
are VBP B-VP
resistant JJ B-ADJP
to TO B-PP
endotoxic JJ B-NP
shock NN I-NP
COMMA COMMA O
yet RB O
succumb VBP B-VP
to TO B-PP
L. FW B-NP
monocytogenes NNS I-NP
infection NN I-NP
. . O

The DT B-NP
multiple JJ I-NP
biological JJ I-NP
activities NNS I-NP
of IN B-PP
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
( ( O
TNF NN B-NP
) ) O
are VBP B-VP
mediated VBN I-VP
by IN B-PP
two CD B-NP
distinct JJ I-NP
cell NN I-NP
surface NN I-NP
receptors NNS I-NP
of IN B-PP
55 CD B-NP
kd NNS I-NP
( ( O
TNFRp55 NN B-NP
) ) O
and CC O
75 CD B-NP
kd NN I-NP
( ( O
TNFRp75 NN B-NP
) ) O
. . O

Using VBG B-VP
gene NN B-NP
targeting NN I-NP
COMMA COMMA O
we PRP B-NP
generated VBD B-VP
a DT B-NP
TNFRp55-deficient JJ I-NP
mouse NN I-NP
strain NN I-NP
. . O

Cells NNS B-NP
from IN B-PP
TNFRp55-\/-mutant JJ B-NP
mice NNS I-NP
lack VBP B-VP
expression NN B-NP
of IN B-PP
TNFRp55 NN B-NP
but CC O
display VBP B-VP
normal JJ B-NP
numbers NNS I-NP
of IN B-PP
high JJ B-NP
affinity NN I-NP
TNFRp75 NN I-NP
molecules NNS I-NP
. . O

Thymocyte NN B-NP
development NN I-NP
and CC O
lymphocyte NN B-NP
populations NNS I-NP
are VBP B-VP
unaltered JJ B-ADJP
COMMA COMMA O
and CC O
clonal JJ B-NP
deletion NN I-NP
of IN B-PP
potentially RB B-NP
self-reactive JJ I-NP
T NN I-NP
cells NNS I-NP
is VBZ B-VP
not RB O
impaired JJ B-ADJP
. . O

However RB B-ADVP
COMMA COMMA O
TNF NN B-NP
signaling NN I-NP
is VBZ B-VP
largely RB I-VP
abolished VBN I-VP
COMMA COMMA O
as IN B-SBAR
judged VBN B-VP
by IN B-PP
the DT B-NP
failure NN I-NP
of IN B-PP
TNF NN B-NP
to TO B-VP
induce VB I-VP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
T NN B-NP
lymphocytes NNS I-NP
from IN B-PP
TNFRp55-deficient JJ B-NP
mice NNS I-NP
. . O

The DT B-NP
loss NN I-NP
of IN B-PP
TNFRp55 NN B-NP
function NN I-NP
renders VBZ B-VP
mice NNS B-NP
resistant JJ B-ADJP
to TO B-PP
lethal JJ B-NP
dosages NNS I-NP
of IN B-PP
either CC O
lipopolysaccharides NNS B-NP
or CC O
S. FW B-NP
aureus FW I-NP
enterotoxin NN I-NP
B NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
TNFRp55-deficient JJ B-NP
mice NNS I-NP
are VBP B-VP
severely RB B-ADJP
impaired JJ I-ADJP
to TO B-VP
clear VB I-VP
L. FW B-NP
monocytogenes FW I-NP
and CC O
readily RB B-VP
succumb VBP I-VP
to TO B-PP
infection NN B-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
the DT B-NP
55 CD I-NP
kd NN I-NP
TNFR NN I-NP
plays VBZ B-VP
a DT B-NP
decisive JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
host NN I-NP
's POS B-NP
defense NN O
against IN B-NP
microorganisms NNS B-NP
and CC B-NP
their PRP$ I-NP
pathogenic JJ I-NP
factors NNS O

Cloning NN B-NP
and CC O
functional JJ B-NP
characterization NN I-NP
of IN B-PP
early JJ B-NP
B-cell NN I-NP
factor NN I-NP
COMMA COMMA O
a DT B-NP
regulator NN I-NP
of IN B-PP
lymphocyte-specific JJ B-NP
gene NN I-NP
expression NN I-NP
. . O

Early JJ B-NP
B-cell NN I-NP
factor NN I-NP
( ( O
EBF NN B-NP
) ) O
was VBD B-VP
identified VBN I-VP
previously RB B-ADVP
as IN B-PP
a DT B-NP
tissue-specific JJ I-NP
and CC I-NP
differentiation NN I-NP
stage-specific JJ I-NP
DNA-binding JJ I-NP
protein NN I-NP
that WDT B-NP
participates VBZ B-VP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
the DT O
pre-B JJ B-NP
and CC O
B NN B-NP
lymphocyte-specific JJ B-NP
mb-1 NN I-NP
gene NN I-NP
. . O

Partial JJ B-NP
amino NN I-NP
acid NN I-NP
sequences NNS I-NP
obtained VBN B-VP
from IN B-PP
purified VBN B-NP
EBF NN I-NP
were VBD B-VP
used VBN I-VP
to TO B-VP
isolate VB I-VP
cDNA NN B-NP
clones NNS I-NP
COMMA COMMA O
which WDT B-NP
by IN B-PP
multiple JJ B-NP
criteria NNS I-NP
encode VB B-VP
EBF NN B-NP
. . O

The DT B-NP
recombinant JJ I-NP
polypeptide NN I-NP
formed VBD B-VP
sequence-specific JJ B-NP
complexes NNS I-NP
with IN B-PP
the DT B-NP
EBF-binding NN I-NP
site NN I-NP
in IN B-PP
the DT B-NP
mb-1 NN I-NP
promoter NN I-NP
. . O

The DT B-NP
cDNA NN I-NP
hybridized VBD B-VP
to TO B-PP
multiple JJ B-NP
transcripts NNS I-NP
in IN B-PP
pre-B JJ B-NP
and CC O
B-cell NN B-NP
lines NNS B-NP
COMMA COMMA O
but CC O
transcripts NNS B-NP
were VBD B-VP
not RB I-VP
detected VBN I-VP
at IN B-PP
significant JJ B-NP
levels NNS I-NP
in IN B-PP
plasmacytoma NN B-NP
COMMA COMMA O
T-cell NN B-NP
COMMA COMMA O
and CC O
nonlymphoid JJ B-ADJP
cell NN B-NP
lines NNS I-NP
. . O

Expression NN B-NP
of IN B-PP
recombinant JJ B-NP
EBF NN I-NP
in IN B-PP
transfected VBN B-NP
nonlymphoid JJ I-NP
cells NNS I-NP
strongly RB B-ADVP
activated VBD B-VP
transcription NN B-NP
from IN B-PP
reporter NN B-NP
plasmids NNS I-NP
containing VBG B-VP
functional JJ B-NP
EBF-binding JJ I-NP
sites NNS I-NP
. . O

Analysis NN B-NP
of IN B-PP
DNA NN B-NP
binding NN I-NP
by IN B-PP
deletion NN B-NP
mutants NNS I-NP
of IN B-PP
EBF NN B-NP
identified VBD B-VP
an DT B-NP
amino-terminal JJ I-NP
cysteine-rich JJ I-NP
DNA-binding JJ I-NP
domain NN I-NP
lacking VBG B-VP
obvious JJ B-NP
sequence NN I-NP
similarity NN I-NP
to TO B-PP
known JJ B-NP
transcription NN I-NP
factors NNS I-NP
. . O

DNA-binding JJ B-NP
assays NNS I-NP
with IN B-PP
cotranslated VBN B-NP
wild-type JJ I-NP
and CC O
truncated JJ B-NP
forms NNS B-NP
of IN B-PP
EBF NN B-NP
indicated VBD B-VP
that IN B-SBAR
the DT B-NP
protein NN I-NP
interacts VBZ B-VP
with IN B-PP
its PRP$ B-NP
site NN I-NP
as IN B-PP
a DT B-NP
homodimer NN I-NP
. . O

Deletions NNS B-NP
delineated VBD B-VP
a DT B-NP
carboxy-terminal JJ I-NP
dimerization NN I-NP
region NN I-NP
containing VBG B-VP
two CD B-NP
repeats NNS I-NP
of IN B-PP
15 CD B-NP
amino NN I-NP
acids NNS I-NP
that WDT B-NP
show VBP B-VP
similarity NN B-NP
with IN B-PP
the DT B-NP
dimerization NN I-NP
domains NNS I-NP
of IN B-PP
basic-helix-loop-helix JJ B-NP
proteins NNS I-NP
. . O

Together RB B-ADVP
COMMA COMMA O
these DT B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
EBF NN B-NP
represents VBZ B-VP
a DT B-NP
novel JJ I-NP
regulator NN I-NP
of IN B-PP
B NN B-NP
lymphocyte-specific JJ I-NP
gene NN I-NP
expression NN I-NP
. . O

{ ( O
The DT B-NP
trend NN I-NP
of IN B-PP
molecular JJ B-NP
biology NN I-NP
study NN I-NP
on IN B-PP
eosinophils NNS B-NP
} ) O

Recently RB B-ADVP
COMMA COMMA O
many JJ B-NP
investigators NNS I-NP
have VBP B-VP
been VBN I-VP
interested JJ B-ADJP
in IN B-PP
the DT B-NP
study NN I-NP
on IN B-PP
eosinophil NN B-NP
biology NN I-NP
since IN B-SBAR
genes NNS B-NP
association NN I-NP
with IN B-PP
eosinophils NNS B-NP
such JJ B-PP
as IN I-PP
interleukin-5 NN B-NP
or CC O
eosinophil NN B-NP
granule NN I-NP
proteins NNS I-NP
( ( O
EPO NN B-NP
COMMA COMMA O
ECP NN B-NP
COMMA COMMA O
EDN NN B-NP
COMMA COMMA O
MBP NN B-NP
COMMA COMMA O
and CC O
CLC NN B-NP
) ) O
COMMA COMMA O
were VBD B-VP
isolated VBN I-VP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
molecular JJ I-NP
basis NN I-NP
for IN B-PP
the DT B-NP
commitment NN I-NP
of IN B-PP
progenitors NNS B-NP
to TO B-PP
the DT B-NP
eosinophil NN I-NP
lineage NN I-NP
has VBZ B-VP
not RB I-VP
been VBN I-VP
determined VBN I-VP
. . O

The DT B-NP
mechanism NN I-NP
by IN B-PP
which WDT B-NP
eosinophil-specific JJ B-NP
genes NNS I-NP
encoding VBG B-VP
primary JJ B-NP
and CC I-NP
secondary JJ I-NP
granule NN I-NP
proteins NNS I-NP
( ( O
e.g. FW B-ADVP
ECP NN B-NP
COMMA COMMA O
EDN NN B-NP
COMMA COMMA O
EPO NN B-NP
COMMA COMMA O
MBP NN B-NP
COMMA COMMA O
and CC O
CLC NN B-NP
) ) O
are VBP B-VP
expressed VBN I-VP
and CC O
regulated VBN B-VP
during IN B-PP
eosinophilopoiesis NN B-NP
is VBZ B-VP
also RB B-ADVP
unknown JJ B-ADJP
. . O

In IN B-PP
this DT B-NP
paper NN I-NP
COMMA COMMA O
I PRP B-NP
described VBD B-VP
the DT B-NP
characterization NN I-NP
of IN B-PP
genes NNS B-NP
encoding VBG B-VP
eosinophil NN B-NP
granule NN I-NP
proteins NNS I-NP
and CC O
the DT B-NP
mRNA NN I-NP
expression NN I-NP
of IN B-PP
GATA-1 NN B-NP
binding NN I-NP
transcription NN I-NP
factor NN I-NP
during IN B-PP
eosinophil NN B-NP
differentiation NN I-NP
. . O

Regulation NN B-NP
of IN B-PP
the DT B-NP
Ets-related JJ I-NP
transcription NN I-NP
factor NN I-NP
Elf-1 NN I-NP
by IN B-PP
binding VBG B-VP
to TO B-PP
the DT B-NP
retinoblastoma NN I-NP
protein NN I-NP
. . O

The DT B-NP
retinoblastoma NN I-NP
gene NN I-NP
product NN I-NP
( ( O
Rb NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
nuclear JJ I-NP
phosphoprotein NN I-NP
that WDT B-NP
regulates VBZ B-VP
cell NN B-NP
cycle NN I-NP
progression NN I-NP
. . O

Elf-1 NN B-NP
is VBZ B-VP
a DT B-NP
lymphoid-specific JJ I-NP
Ets NN I-NP
transcription NN I-NP
factor NN I-NP
that WDT B-NP
regulates VBZ B-VP
inducible JJ B-NP
gene NN I-NP
expression NN I-NP
during IN B-PP
T NN B-NP
cell NN I-NP
activation NN I-NP
. . O

In IN B-PP
this DT B-NP
report NN I-NP
COMMA COMMA O
it PRP B-NP
is VBZ B-VP
demonstrated VBN I-VP
that IN B-SBAR
Elf-1 NN B-NP
contains VBZ B-VP
a DT B-NP
sequence NN I-NP
motif NN I-NP
that WDT B-NP
is VBZ B-VP
highly RB B-ADJP
related JJ I-ADJP
to TO B-PP
the DT B-NP
Rb NN I-NP
binding NN I-NP
sites NNS I-NP
of IN B-PP
several JJ B-NP
viral JJ I-NP
oncoproteins NNS I-NP
and CC O
binds VBZ B-VP
to TO B-PP
the DT B-NP
pocket NN I-NP
region NN I-NP
of IN B-PP
Rb NN B-NP
both CC O
in FW B-ADVP
vitro FW I-ADVP
and CC B-ADVP
in FW B-ADVP
vivo FW I-ADVP
. . O

Elf-1 NN B-NP
binds VBZ B-VP
exclusively RB B-ADVP
to TO B-PP
the DT B-NP
underphosphorylated JJ I-NP
form NN I-NP
of IN B-PP
Rb NN B-NP
and CC O
fails VBZ B-VP
to TO I-VP
bind VB I-VP
to TO B-PP
Rb NN B-NP
mutants NNS I-NP
derived VBN B-VP
from IN B-PP
patients NNS B-NP
with IN B-PP
retinoblastoma NN B-NP
. . O

Co-immunoprecipitation NN B-NP
experiments NNS I-NP
demonstrated VBD B-VP
an DT B-NP
association NN I-NP
between IN B-PP
Elf-1 NN B-NP
and CC O
Rb NN B-NP
in IN B-PP
resting VBG B-NP
normal JJ I-NP
human JJ I-NP
T NN I-NP
cells NNS I-NP
. . O

After IN B-PP
T NN B-NP
cell NN I-NP
activation NN I-NP
COMMA COMMA O
the DT B-NP
phosphorylation NN I-NP
of IN B-PP
Rb NN B-NP
results VBZ B-VP
in IN B-PP
the DT B-NP
release NN I-NP
of IN B-PP
Elf-1 NN B-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
correlated VBN I-VP
temporally RB B-ADVP
with IN B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
Elf-1-mediated JJ B-NP
transcription NN I-NP
. . O

Overexpression NN B-NP
of IN B-PP
a DT B-NP
phosphorylation-defective JJ I-NP
form NN I-NP
of IN B-PP
Rb NN B-NP
inhibited VBD B-VP
Elf-1-dependent JJ B-NP
transcription NN I-NP
during IN B-PP
T NN B-NP
cell NN I-NP
activation NN I-NP
. . O

These DT B-NP
results NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
Rb NN B-NP
interacts VBZ B-VP
specifically RB B-ADVP
with IN B-PP
a DT B-NP
lineage-restricted JJ I-NP
Ets NN I-NP
transcription NN I-NP
factor NN I-NP
. . O

This DT B-NP
regulated JJ I-NP
interaction NN I-NP
may MD B-VP
be VB I-VP
important JJ B-ADJP
for IN B-PP
the DT B-NP
coordination NN I-NP
of IN B-PP
lineage-specific JJ B-NP
effector NN I-NP
functions NNS I-NP
such JJ B-PP
as IN I-PP
lymphokine NN B-NP
production NN I-NP
with IN B-PP
cell NN B-NP
cycle NN I-NP
progression NN I-NP
in IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
. . O

Activation NN B-NP
of IN B-PP
primary JJ B-NP
human JJ I-NP
T-lymphocytes NNS I-NP
through IN B-PP
CD2 NN B-NP
plus CC O
CD28 NN B-NP
adhesion NN B-NP
molecules NNS I-NP
induces VBZ B-VP
long-term JJ B-NP
nuclear JJ I-NP
expression NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
. . O

Stimulation NN B-NP
of IN B-PP
highly RB B-NP
purified VBN I-NP
human JJ I-NP
T-cells NNS I-NP
via IN B-PP
CD2 NN B-NP
and CC O
CD28 NN B-NP
adhesion NN B-NP
molecules NNS I-NP
induces VBZ B-VP
and CC O
maintains VBZ B-VP
proliferation NN B-NP
for IN B-PP
more JJR B-NP
than IN I-NP
3 CD I-NP
weeks NNS I-NP
. . O

This DT B-NP
potent JJ I-NP
interleukin NN I-NP
2 CD I-NP
( ( I-NP
IL-2 NN I-NP
) ) I-NP
-dependent JJ I-NP
activation NN I-NP
does VBZ B-VP
not RB I-VP
require VB I-VP
monocytes NNS B-NP
or CC O
accessory JJ B-NP
cells NNS I-NP
. . O

Long-lasting JJ B-NP
IL-2 NN I-NP
receptivity NN I-NP
is VBZ B-VP
associated VBN I-VP
with IN B-PP
high-level JJ B-NP
expression NN I-NP
of IN B-PP
the DT O
inducible JJ O
IL-2 NN B-NP
receptor NN I-NP
alpha NN I-NP
chain NN I-NP
( ( O
IL-2R NN B-NP
alpha NN I-NP
) ) O
gene NN B-NP
that WDT B-NP
is VBZ B-VP
regulated VBN I-VP
at IN B-PP
both CC B-NP
transcriptional JJ I-NP
and CC I-NP
posttranscriptional JJ I-NP
levels NNS I-NP
. . O

Increase NN B-NP
of IN B-PP
IL-2R NN B-NP
alpha NN I-NP
gene NN I-NP
transcription NN I-NP
involves VBZ B-VP
the DT B-NP
enhanced VBN I-NP
binding NN I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
NF-kappa NN I-NP
B NN I-NP
to TO B-PP
its PRP$ B-NP
consensus NN I-NP
sequence NN I-NP
in IN B-PP
the DT B-NP
5'-regulatory JJ I-NP
region NN I-NP
of IN B-PP
the DT B-NP
IL-2R NN I-NP
alpha NN I-NP
gene NN I-NP
. . O

To TO B-VP
dissect VB I-VP
the DT B-NP
molecular JJ I-NP
basis NN I-NP
for IN B-PP
the DT B-NP
unusually RB I-NP
persistent JJ I-NP
transcription NN I-NP
of IN B-PP
the DT B-NP
IL-2R NN I-NP
alpha NN I-NP
gene NN I-NP
COMMA COMMA O
we PRP B-NP
analyzed VBD B-VP
nuclear JJ B-NP
NF-kappa NN I-NP
B NN I-NP
binding VBG I-NP
to TO B-PP
a DT B-NP
radiolabeled VBN I-NP
IL-2R NN I-NP
alpha NN I-NP
kappa NN I-NP
B-specific JJ I-NP
oligonucleotide NN I-NP
probe NN I-NP
during IN B-PP
the DT B-NP
time NN I-NP
course NN I-NP
of IN B-PP
CD2 NN B-NP
+ CC O
CD28 NN B-NP
activation NN B-NP
. . O

Resting VBG B-NP
T-cell NN I-NP
nuclear JJ I-NP
extracts NNS I-NP
contained VBD B-VP
KBF1\/p50 NN B-NP
homodimer NN I-NP
. . O

After IN B-PP
stimulation NN B-NP
COMMA COMMA O
two CD B-NP
new JJ I-NP
kappa NN I-NP
B-specific JJ I-NP
complexes NNS I-NP
were VBD B-VP
identified VBN I-VP
as IN B-PP
NF-kappa NN B-NP
B NN I-NP
p50-p65 NN I-NP
heterodimer NN I-NP
and CC O
putative JJ B-NP
c-Rel NN B-NP
homodimer NN I-NP
or CC O
c-Rel-p65 NN B-NP
heterodimer NN I-NP
. . O

Both DT B-NP
inducible JJ I-NP
complexes NNS I-NP
persisted VBD B-VP
for IN B-PP
at IN B-NP
least JJS I-NP
3 CD I-NP
weeks NNS I-NP
. . O

Their PRP$ B-NP
relative JJ I-NP
levels NNS I-NP
were VBD B-VP
very RB B-ADJP
similar JJ I-ADJP
for IN B-PP
the DT B-NP
duration NN I-NP
of IN B-PP
proliferation NN B-NP
. . O

In IN B-PP
parallel NN B-NP
COMMA COMMA O
CD2 NN B-NP
+ CC O
CD28 NN B-NP
activation NN B-NP
triggered VBD B-VP
a DT B-NP
significant JJ I-NP
intracellular JJ I-NP
thiol NN I-NP
decrease NN I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
oxygen NN B-NP
radicals NNS I-NP
are VBP B-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
signaling NN I-NP
pathway NN I-NP
of IN B-PP
adhesion NN B-NP
molecules NNS I-NP
. . O

Finally RB B-ADVP
COMMA COMMA O
micromolar JJ B-NP
amounts NNS I-NP
of IN B-PP
pyrrolidine NN B-NP
dithiocarbamate NN I-NP
COMMA COMMA O
an DT B-NP
oxygen NN I-NP
radical NN I-NP
scavenger NN I-NP
that WDT B-NP
efficiently RB B-ADVP
blocked VBD B-VP
the DT B-NP
nuclear JJ I-NP
appearance NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
T-lymphocytes NNS B-NP
COMMA COMMA O
also RB B-ADVP
inhibited VBD B-VP
IL-2 NN B-NP
secretion NN I-NP
COMMA COMMA O
IL-2R NN B-NP
alpha NN I-NP
cell NN I-NP
surface NN I-NP
expression NN I-NP
COMMA COMMA O
and CC O
T-cell NN B-NP
proliferation NN I-NP
. . O

Together RB B-ADVP
COMMA COMMA O
these DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
NF-kappa NN B-NP
B NN I-NP
plays VBZ B-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
long-term JJ B-NP
activation NN I-NP
of IN B-PP
human JJ B-NP
primary JJ I-NP
T-lymphocytes NNS I-NP
via IN B-PP
CD2 NN B-NP
+ CC O
CD28 NN B-NP
. . O

Oxidoreductive JJ B-NP
regulation NN I-NP
of IN B-PP
nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
. . O

Involvement NN B-NP
of IN B-PP
a DT B-NP
cellular JJ I-NP
reducing NN I-NP
catalyst NN I-NP
thioredoxin NN I-NP
. . O

We PRP B-NP
have VBP O
investigated VBN O
an DT B-NP
oxidoreductive JJ I-NP
regulatory JJ I-NP
pathway NN I-NP
for IN B-PP
the DT B-NP
DNA NN I-NP
binding NN I-NP
activity NN I-NP
of IN B-PP
a DT B-NP
pleiotropic JJ I-NP
cellular JJ I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
( ( O
NF NN B-NP
kappa NN I-NP
B NN I-NP
) ) O
COMMA COMMA O
has VBZ B-VP
been VBN I-VP
investigated VBN I-VP
by IN B-PP
using VBG B-VP
NF NN B-NP
kappa NN I-NP
B NN I-NP
prepared VBN B-VP
from IN B-PP
the DT B-NP
nucleus NN I-NP
and CC O
the DT B-NP
cytosol NN I-NP
of IN B-PP
the DT B-NP
primary JJ I-NP
human JJ I-NP
T NN I-NP
lymphocytes NNS I-NP
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
a DT B-NP
cellular JJ I-NP
reducing NN I-NP
catalyst NN I-NP
thioredoxin NN B-NP
( ( O
Trx NN B-NP
) ) O
plays VBZ B-VP
a DT B-NP
major JJ I-NP
role NN I-NP
in IN B-PP
activation NN B-NP
of IN B-PP
the DT B-NP
DNA NN I-NP
binding NN I-NP
of IN B-PP
NF NN B-NP
kappa NN I-NP
B NN I-NP
in FW B-ADVP
vitro FW I-ADVP
and CC O
stimulation NN B-NP
of IN B-PP
transcription NN B-NP
from IN B-PP
the DT B-NP
NF NN I-NP
kappa NN I-NP
B-dependent JJ I-NP
gene NN I-NP
expression NN I-NP
. . O

We PRP B-NP
demonstrate VBP B-VP
evidence NN B-NP
suggesting VBG B-VP
that IN B-SBAR
redox NN B-NP
regulation NN I-NP
of IN B-PP
NF NN B-NP
kappa NN I-NP
B NN I-NP
by IN B-PP
Trx NN B-NP
might MD B-VP
be VB I-VP
exerted VBN I-VP
at IN B-PP
a DT B-NP
step NN I-NP
after IN B-PP
dissociation NN B-NP
of IN B-PP
the DT B-NP
inhibitory JJ I-NP
molecule NN I-NP
I NN I-NP
kappa NN I-NP
B NN I-NP
COMMA COMMA O
a DT B-NP
cytosolic-anchoring JJ I-NP
protein NN I-NP
for IN B-PP
NF NN B-NP
kappa NN I-NP
B NN I-NP
. . O

To TO B-VP
examine VB I-VP
the DT B-NP
effect NN I-NP
of IN B-PP
Trx NN B-NP
in IN B-PP
intact JJ B-NP
cells NNS I-NP
COMMA COMMA O
we PRP B-NP
performed VBD B-VP
transient JJ B-NP
assay NN I-NP
with IN B-PP
a DT B-NP
chloramphenicol NN I-NP
acetyltransferase-expressing JJ I-NP
plasmid NN I-NP
under IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV NN B-NP
) ) O
long JJ B-NP
terminal JJ I-NP
repeat NN I-NP
and CC O
an DT B-NP
effector NN I-NP
plasmid NN I-NP
expressing VBG B-VP
human JJ B-NP
Trx NN I-NP
. . O

The DT B-NP
promoter NN I-NP
activity NN I-NP
from IN B-PP
HIV NN B-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
was VBD B-VP
greatly RB I-VP
augmented VBN I-VP
by IN B-PP
co-transfecting VBG B-VP
the DT B-NP
Trx-expressing NN I-NP
plasmid NN I-NP
COMMA COMMA O
whose WP$ B-NP
effect NN I-NP
was VBD B-VP
dependent JJ B-ADJP
on IN B-PP
the DT B-NP
NF NN I-NP
kappa NN I-NP
B-binding NN I-NP
sites NNS I-NP
. . O

These DT B-NP
findings NNS I-NP
have VBP B-VP
suggested VBN I-VP
that IN B-SBAR
cysteine NN B-NP
residue NN I-NP
( ( I-NP
s NNS I-NP
) ) O
of IN B-PP
NF NN B-NP
kappa NN I-NP
B NN I-NP
might MD B-VP
be VB I-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
DNA-recognition NN I-NP
by IN B-PP
NF NN B-NP
kappa NN I-NP
B NN I-NP
and CC O
that IN B-SBAR
the DT B-NP
redox NN I-NP
control NN I-NP
mechanism NN I-NP
mediated VBN B-VP
by IN B-PP
Trx NN B-NP
might MD B-VP
have VB I-VP
a DT B-NP
regulatory JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
NF NN I-NP
kappa NN I-NP
B-mediated JJ I-NP
gene NN I-NP
expression NN I-NP
. . O

These DT B-NP
results NNS I-NP
may MD B-VP
also RB I-VP
provide VB I-VP
a DT B-NP
clue NN I-NP
to TO B-PP
understanding NN B-NP
of IN B-PP
the DT B-NP
molecular JJ I-NP
process NN I-NP
of IN B-PP
AIDS NN B-NP
pathogenesis NN I-NP
and CC O
its PRP$ B-NP
possible JJ I-NP
biochemical JJ I-NP
intervention NN I-NP
. . O

Expression NN B-NP
levels NNS I-NP
of IN B-PP
the DT B-NP
thyrotropin NN I-NP
receptor NN I-NP
gene NN I-NP
in IN B-PP
autoimmune JJ B-NP
thyroid NN I-NP
disease NN I-NP
: : O
coregulation NN B-NP
with IN B-PP
parameters NNS B-NP
of IN B-PP
thyroid NN B-NP
function NN I-NP
and CC O
inverse JJ B-NP
relation NN I-NP
to TO B-PP
major JJ B-NP
histocompatibility NN I-NP
complex NN I-NP
classes NNS I-NP
I CD B-NP
and CC O
II CD B-NP
. . O

Using VBG B-VP
a DT O
human JJ O
TSH NN B-NP
receptor NN I-NP
( ( O
TSH-R NN B-NP
) ) O
cDNA NN B-NP
probe NN I-NP
COMMA COMMA O
we PRP B-NP
investigated VBD B-VP
TSH-R NN B-NP
transcript NN I-NP
levels NNS I-NP
in IN B-PP
13 CD B-NP
human JJ I-NP
thyroid NN I-NP
fragments NNS I-NP
by IN B-PP
Northern NN B-NP
blot NN I-NP
analysis NN I-NP
; : O
7 CD O
Graves NN B-NP
' POS B-NP
disease NN I-NP
COMMA COMMA O
2 CD O
Hashimoto NN B-NP
's POS B-NP
disease NN I-NP
COMMA COMMA O
3 CD B-NP
endemic JJ I-NP
goiter NN I-NP
COMMA COMMA O
and CC O
1 CD B-NP
healthy JJ I-NP
thyroid NN I-NP
gland NN I-NP
were VBD B-VP
studied VBN I-VP
. . O

TSH-R NN B-NP
expression NN I-NP
levels NNS I-NP
were VBD B-VP
variable JJ B-ADJP
COMMA COMMA O
but CC O
displayed VBD B-VP
a DT B-NP
close JJ I-NP
correlation NN I-NP
to TO B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
thyroid NN B-NP
peroxidase NN I-NP
( ( O
r NN B-NP
= JJ B-VP
0.703 CD B-NP
; : O
P NN B-NP
&lt; JJR B-NP
0.05 CD I-NP
) ) O
COMMA COMMA O
thyroglobulin NN B-NP
( ( O
r NN B-NP
= JJ B-VP
0.817 CD B-NP
; : O
P NN B-NP
&lt; JJR B-NP
0.01 CD I-NP
) ) O
COMMA COMMA O
and CC O
the DT B-NP
nuclear JJ I-NP
oncogene NN I-NP
c-fos NN I-NP
( ( O
r NN B-NP
= JJ B-VP
0.935 CD B-NP
; : O
P NN B-NP
&lt; JJR B-NP
0.001 CD I-NP
) ) O
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
c-myc NN B-NP
. . O

Overall RB B-ADVP
COMMA COMMA O
TSH-R NN B-NP
transcript NN I-NP
levels NNS I-NP
were VBD B-VP
low JJ B-ADJP
or CC O
absent JJ B-ADJP
in IN B-PP
those DT B-NP
thyroids NNS I-NP
in IN B-PP
which WDT B-NP
expression NN B-NP
of IN B-PP
the DT B-NP
major JJ I-NP
histocompatibility NN I-NP
complex NN I-NP
class NN I-NP
I CD B-NP
or CC O
II CD B-NP
( ( O
MHC NN B-NP
I CD B-NP
or CC O
II CD B-NP
) ) O
was VBD B-VP
high JJ B-ADJP
COMMA COMMA O
thus RB B-ADVP
establishing VBG B-VP
an DT B-NP
inverse JJ I-NP
relation NN I-NP
( ( O
MHC NN O
I NN O
COMMA COMMA O
r NN B-NP
= JJ B-VP
-0.791 CD B-NP
; : O
P NN B-NP
&lt; JJR B-NP
0.01 CD I-NP
; : O
MHC NN O
II CD O
COMMA COMMA O
r NN B-NP
= JJ B-VP
-0.784 NN B-NP
; : O
P NN B-NP
&lt; JJR B-NP
0.01 CD I-NP
) ) O
. . O

In FW B-NP
situ FW I-NP
hybridization NN I-NP
showed VBD B-VP
that IN B-SBAR
apart RB B-PP
from IN I-PP
lymphocytes NNS B-NP
COMMA COMMA O
thyroid NN B-NP
cells NNS I-NP
themselves PRP B-NP
were VBD B-VP
the DT B-NP
source NN I-NP
of IN B-PP
MHC NN B-NP
II CD I-NP
transcripts NNS I-NP
. . O

gamma-Interferon NN B-NP
expression NN I-NP
was VBD B-VP
only RB B-ADJP
detectable JJ I-ADJP
in IN B-PP
1 CD O
Hashimoto NN B-NP
's POS B-NP
goiter NN I-NP
. . O

Our PRP$ B-NP
findings NNS I-NP
suggest VBP B-VP
that IN B-SBAR
next JJ B-ADVP
to TO B-PP
lymphocyte NN B-NP
infiltration NN I-NP
COMMA COMMA O
active JJ B-NP
regulatory JJ I-NP
events NNS I-NP
in IN B-PP
the DT B-NP
thyrocyte NN I-NP
are VBP B-VP
responsible JJ B-ADJP
for IN B-PP
the DT B-NP
inverse JJ I-NP
relation NN I-NP
between IN B-PP
functional JJ B-NP
parameters NNS I-NP
( ( O
TSH-R NN B-NP
COMMA COMMA O
thyroid NN B-NP
peroxidase NN I-NP
COMMA COMMA O
thyroglobulin NN B-NP
COMMA COMMA O
and CC O
c-fos NN B-NP
) ) O
and CC O
immunological JJ B-NP
markers NNS I-NP
( ( O
MHC NN B-NP
I CD B-NP
and CC O
II CD B-NP
) ) O
. . O

Regulation NN B-NP
of IN B-PP
the DT O
interleukin-1 NN B-NP
beta NN I-NP
( ( O
IL-1 NN B-NP
beta NN I-NP
) ) O
gene NN B-NP
by IN B-PP
mycobacterial JJ B-NP
components NNS I-NP
and CC O
lipopolysaccharide NN B-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
two CD B-NP
nuclear JJ I-NP
factor-IL6 JJ I-NP
motifs NNS I-NP
. . O

The DT B-NP
cytokines NNS I-NP
interleukin-1 NN B-NP
beta NN I-NP
( ( O
IL-1 NN B-NP
beta NN I-NP
) ) O
and CC O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
( ( O
TNF-alpha NN B-NP
) ) O
are VBP B-VP
released VBN I-VP
by IN B-PP
mononuclear JJ B-NP
phagocytes NNS I-NP
in FW B-ADVP
vitro FW I-ADVP
after IN B-PP
stimulation NN B-NP
with IN B-PP
mycobacteria NNS B-NP
and CC O
are VBP B-VP
considered VBN I-VP
to TO I-VP
mediate VB I-VP
pathophysiologic JJ B-NP
events NNS I-NP
COMMA COMMA O
including VBG B-PP
granuloma NN B-NP
formation NN I-NP
and CC O
systemic JJ B-NP
symptoms NNS I-NP
. . O

We PRP B-NP
demonstrated VBD B-VP
that IN B-SBAR
the DT B-NP
Mycobacterium NN I-NP
tuberculosis NN I-NP
cell NN I-NP
wall NN I-NP
component NN I-NP
lipoarabinomannan NN B-NP
( ( O
LAM NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
very RB I-NP
potent JJ I-NP
inducer NN I-NP
of IN B-PP
IL-1 NN B-NP
beta NN I-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
and CC O
investigated VBD B-VP
the DT B-NP
mechanism NN I-NP
of IN B-PP
this DT B-NP
effect NN I-NP
. . O

We PRP B-NP
localized VBD B-VP
the DT O
LAM- NN B-NP
COMMA COMMA O
lipopolysaccharide NN B-NP
( ( O
LPS NN B-NP
) ) O
- : O
COMMA COMMA O
and CC O
TNF-alpha-inducible JJ B-ADJP
promoter NN B-NP
activity NN I-NP
to TO B-PP
a DT O
-131\/+15 CD O
( ( O
positions NNS B-NP
-131 CD B-NP
to TO O
+15 CD B-NP
) ) O
DNA NN B-NP
fragment NN I-NP
of IN B-PP
the DT B-NP
IL-1 NN I-NP
beta NN I-NP
gene NN I-NP
by IN B-PP
deletion NN B-NP
analysis NN I-NP
and CC O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
assay NN I-NP
. . O

Within IN B-PP
this DT B-NP
DNA NN I-NP
fragment NN I-NP
COMMA COMMA O
there EX B-NP
were VBD B-VP
two CD B-NP
novel JJ I-NP
9-bp JJ I-NP
motifs NNS I-NP
( ( O
-90\/-82 CD B-NP
and CC O
-40\/-32 CD B-NP
) ) O
with IN B-PP
high JJ B-NP
homology NN I-NP
to TO B-PP
the DT O
nuclear JJ B-NP
factor-IL6 NN I-NP
( ( O
NF-IL6 NN B-NP
) ) O
binding NN B-NP
site NN I-NP
. . O

Site-directed JJ B-NP
mutagenesis NN I-NP
demonstrated VBD B-VP
that IN B-SBAR
the DT B-NP
two CD I-NP
NF-IL-6 NN I-NP
motifs NNS I-NP
could MD B-VP
be VB I-VP
independently RB I-VP
activated VBN I-VP
by IN B-PP
LAM NN B-NP
COMMA COMMA O
LPS NN B-NP
COMMA COMMA O
or CC O
TNF-alpha NN B-NP
and CC O
that IN B-SBAR
they PRP B-NP
acted VBD B-VP
in IN B-PP
an DT B-NP
orientation-independent JJ I-NP
manner NN I-NP
. . O

DNA NN B-NP
mobility NN I-NP
shift NN I-NP
assay NN I-NP
revealed VBD B-VP
specific JJ B-NP
binding NN I-NP
of IN B-PP
nuclear JJ B-NP
protein NN I-NP
( ( I-NP
s NNS I-NP
) ) O
from IN B-PP
LAM- NN B-NP
COMMA COMMA I-NP
LPS- NN I-NP
COMMA COMMA I-NP
or CC I-NP
TNF-alpha- NN I-NP
stimulated JJ I-NP
THP-1 NN I-NP
cells NNS I-NP
to TO B-PP
the DT B-NP
NF-IL6 NN I-NP
motifs NNS I-NP
. . O

We PRP B-NP
conclude VBP B-VP
that IN B-SBAR
the DT B-NP
two CD I-NP
NF-IL6 NN I-NP
sites NNS I-NP
mediate VBP B-VP
induction NN B-NP
of IN B-PP
IL-1 NN B-NP
beta NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
the DT B-NP
stimuli NNS I-NP
LAM NN B-NP
COMMA COMMA O
LPS NN B-NP
COMMA COMMA O
and CC O
TNF-alpha NN B-NP
. . O

Synergism NN B-NP
between IN B-PP
the DT O
CD3 NN B-NP
antigen- NN I-NP
and CC O
CD2 NN B-ADJP
antigen-derived JJ I-ADJP
signals NNS B-NP
. . O

Exploration NN B-NP
at IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
induction NN B-NP
of IN B-PP
DNA-binding JJ B-NP
proteins NNS I-NP
and CC O
characterization NN B-NP
of IN B-PP
the DT B-NP
inhibitory JJ I-NP
activity NN I-NP
of IN B-PP
cyclosporine NN B-NP
. . O

We PRP B-NP
have VBP B-VP
demonstrated VBN I-VP
earlier RBR B-ADVP
that IN B-SBAR
the DT B-NP
crosslinkage NN I-NP
of IN B-PP
the DT B-NP
CD3\/TCR NN I-NP
complex NN I-NP
with IN B-PP
the DT B-NP
CD2 NN I-NP
antigen NN I-NP
results VBZ B-VP
in IN B-PP
the DT B-NP
proliferation NN I-NP
of IN B-PP
normal JJ B-NP
human JJ I-NP
T NN I-NP
cells NNS I-NP
. . O

The DT B-NP
effect NN I-NP
of IN B-PP
this DT B-NP
synergism NN I-NP
was VBD B-VP
perceptible JJ B-ADJP
at IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
induction NN B-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
gene NN I-NP
COMMA COMMA O
a DT B-NP
process NN I-NP
critical JJ B-ADJP
for IN B-PP
T NN B-NP
cell NN I-NP
growth NN I-NP
. . O

To TO B-VP
further RB I-VP
understand VB I-VP
the DT B-NP
molecular JJ I-NP
and CC I-NP
nuclear JJ I-NP
basis NN I-NP
for IN B-PP
this DT B-NP
synergism NN I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
explored VBN I-VP
the DT B-NP
induction NN I-NP
of IN B-PP
DNA-binding JJ B-NP
proteins NNS I-NP
in IN B-PP
highly RB B-NP
purified VBN I-NP
normal JJ I-NP
human JJ I-NP
T NN I-NP
cells NNS I-NP
signaled VBN B-VP
via IN B-PP
the DT O
CD3 NN B-NP
and\/or CC O
CD2 NN B-NP
proteins NNS B-NP
. . O

The DT B-NP
effect NN I-NP
of IN B-PP
transmembrane NN B-NP
signaling NN I-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
with IN B-PP
ionomycin NN B-NP
COMMA COMMA O
and\/or CC O
sn-1COMMA2 NN B-NP
dioctanoyl NN I-NP
glycerol NN I-NP
COMMA COMMA O
was VBD B-VP
also RB I-VP
determined VBN I-VP
. . O

The DT B-NP
emergence NN I-NP
of IN B-PP
nuclear JJ B-NP
binding NN I-NP
proteins NNS I-NP
was VBD B-VP
investigated VBN I-VP
using VBG B-VP
interleukin-2 NN B-NP
sequence NN I-NP
specific JJ I-NP
oligonucleotide NN I-NP
probes NNS I-NP
in IN B-PP
the DT B-NP
electrophoretic JJ I-NP
mobility NN I-NP
shift NN I-NP
assay NN I-NP
. . O

Our PRP$ B-NP
studies NNS I-NP
demonstrate VBP B-VP
for IN B-PP
the DT B-NP
first JJ I-NP
time NN I-NP
that IN B-SBAR
CD3 NN B-NP
antigen-derived JJ I-NP
signals NNS I-NP
and CC O
CD2 NN B-NP
antigen-derived JJ I-NP
signals NNS I-NP
are VBP B-VP
synergistic JJ B-ADJP
in IN B-PP
inducing VBG B-VP
the DT B-NP
emergence NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
that WDT B-NP
bind VBP B-VP
to TO B-PP
the DT O
NF-AT1 NN B-NP
COMMA COMMA O
AP-1 NN B-NP
COMMA COMMA O
and CC O
NF-kB NN B-NP
sites NNS B-NP
located JJ B-ADJP
in IN B-PP
the DT B-NP
promoter\/enhancer NN I-NP
region NN I-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
gene NN I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
cyclosporine NN B-NP
COMMA COMMA O
at IN B-PP
concentrations NNS B-NP
readily RB B-VP
accomplished VBN I-VP
in IN B-PP
clinical JJ B-NP
practice NN I-NP
COMMA COMMA O
was VBD B-VP
found VBN I-VP
to TO I-VP
inhibit VB I-VP
the DT B-NP
emergence NN I-NP
of IN B-PP
these DT B-NP
DNA-binding JJ I-NP
proteins NNS I-NP
in IN B-PP
normal JJ B-NP
human JJ I-NP
T NN I-NP
cells NNS I-NP
signaled VBN B-VP
via IN B-PP
cell NN B-NP
surface NN I-NP
proteins NNS I-NP
implicated VBN B-VP
in IN B-PP
antigen-dependent JJ B-NP
T NN I-NP
cell NN I-NP
activation NN I-NP
and CC B-PP
in IN B-PP
T NN B-NP
cells NNS I-NP
stimulated VBN B-VP
by IN B-PP
mobilization NN B-NP
of IN B-PP
cellular JJ B-NP
calcium NN I-NP
and CC O
activation NN B-NP
of IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
. . O

Calcium NN B-NP
dependent JJ I-NP
activation NN I-NP
of IN B-PP
the DT B-NP
NF-AT NN I-NP
transcription NN I-NP
factor NN I-NP
by IN B-PP
p59fyn NN B-NP
. . O

A DT B-NP
reporter NN I-NP
gene NN I-NP
under IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
a DT B-NP
T-cell NN I-NP
antigen NN I-NP
receptor NN I-NP
element NN I-NP
was VBD B-VP
activated VBN I-VP
in IN B-PP
Jurkat NN B-NP
cells NNS I-NP
by IN B-PP
antigen NN B-NP
receptor NN I-NP
triggering NN I-NP
or CC B-PP
by IN B-PP
a DT B-NP
combination NN I-NP
of IN B-PP
phorbol NN B-NP
myristate NN I-NP
acetate NN I-NP
COMMA COMMA O
which WDT B-NP
activates VBZ B-VP
protein NN B-NP
kinase NN I-NP
C NN I-NP
COMMA COMMA O
and CC O
a DT B-NP
calcium NN I-NP
ionophore NN I-NP
. . O

Both DT B-NP
these DT I-NP
signals NNS I-NP
were VBD B-VP
necessary JJ B-ADJP
for IN B-PP
expression NN B-NP
of IN B-PP
the DT B-NP
reporter NN I-NP
gene NN I-NP
. . O

When WRB B-ADVP
co-transfected VBN B-VP
with IN B-PP
a DT B-NP
construct NN I-NP
capable JJ B-ADJP
of IN B-PP
overexpressing VBG B-VP
the DT B-NP
tyrosine NN I-NP
kinase NN I-NP
p59fyn NN I-NP
COMMA COMMA O
the DT B-NP
reporter NN I-NP
gene NN I-NP
was VBD B-VP
activated VBN I-VP
by IN B-PP
PMA NN B-NP
alone RB B-ADVP
. . O

Thus RB B-ADVP
p59fyn NN B-NP
could MD B-VP
replace VB I-VP
the DT B-NP
calcium NN I-NP
ionophore NN I-NP
but CC B-CONJP
not RB I-CONJP
activation NN B-NP
of IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
. . O

The DT B-NP
activation NN I-NP
by IN B-PP
p59fyn NN B-NP
plus CC O
PMA NN B-NP
was VBD B-VP
blocked VBN I-VP
by IN B-PP
EGTA NN B-NP
and CC B-PP
by IN B-PP
the DT B-NP
immunosuppressant JJ I-NP
drug NN I-NP
cyclosporin NN I-NP
A NN I-NP
. . O

Cell-specific JJ B-NP
bifunctional JJ I-NP
role NN I-NP
of IN B-PP
Jun NN B-NP
oncogene NN I-NP
family NN I-NP
members NNS I-NP
on IN B-PP
glucocorticoid NN B-NP
receptor-dependent JJ I-NP
transcription NN I-NP
. . O

Interaction NN B-NP
between IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( I-NP
PKC NN I-NP
) ) O
- : O
and CC O
glucocorticoid NN B-ADJP
receptor NN I-ADJP
( ( I-ADJP
GR NN I-ADJP
) ) I-ADJP
-mediated JJ I-ADJP
signaling NN B-NP
is VBZ B-VP
suggested VBN I-VP
by IN B-PP
the DT B-NP
ability NN I-NP
of IN B-PP
the DT B-NP
PKC NN I-NP
activating NN I-NP
phorbol NN I-NP
ester NN I-NP
12-O-tetradecanoylphorbol-13-acetate NN B-NP
( ( O
TPA NN B-NP
) ) O
to TO B-VP
inhibit VB I-VP
GR-dependent JJ B-NP
transcription NN I-NP
of IN B-PP
the DT B-NP
mouse NN B-NP
mammary JJ I-NP
tumor NN I-NP
virus NN I-NP
( ( O
MMTV NN B-NP
) ) O
long JJ B-NP
terminal JJ I-NP
repeat NN I-NP
( ( O
LTR NN B-NP
) ) O
. . O

Here RB B-ADVP
we PRP B-NP
report VBP B-VP
that IN B-SBAR
this DT B-NP
interference NN I-NP
is VBZ B-VP
cell NN B-ADJP
specific JJ I-ADJP
COMMA COMMA O
as IN B-SBAR
TPA NN B-NP
augmented VBD B-VP
dexamethasone-induced JJ B-NP
transcriptional JJ I-NP
activation NN I-NP
of IN B-PP
the DT B-NP
MMTV NN I-NP
LTR NN I-NP
in IN B-PP
several JJ B-NP
T NN I-NP
cell NN I-NP
lines NNS I-NP
but CC O
was VBD B-VP
inhibitory JJ B-ADJP
in IN B-PP
NIH-3T3 NN B-NP
fibroblasts NNS I-NP
. . O

TPA-GR NN B-NP
synergism NN I-NP
was VBD B-VP
determined VBN I-VP
to TO I-VP
have VB I-VP
occurred VBN I-VP
at IN B-PP
the DT O
GR-responsive JJ B-NP
element NN I-NP
( ( O
GRE NN B-NP
) ) O
level NN B-NP
by IN B-PP
functional JJ B-NP
analysis NN I-NP
of IN B-PP
deletion NN B-NP
mutants NNS I-NP
or CC O
synthetic JJ B-NP
GRE NN I-NP
oligonucleotides NNS I-NP
driving VBG B-VP
chloramphenicol NN B-NP
acetyl-transferase NN I-NP
expression NN I-NP
. . O

Synergism NN B-NP
required VBD B-VP
an DT B-NP
intact JJ I-NP
GR NN I-NP
DNA-binding JJ I-NP
domain NN I-NP
COMMA COMMA O
whereas IN O
amino- NN B-NP
or CC I-NP
carboxyl-terminal JJ I-NP
domains NNS I-NP
were VBD B-VP
dispensable JJ B-ADJP
. . O

The DT B-NP
effect NN I-NP
was VBD B-VP
abrogated VBN I-VP
by IN B-PP
the DT B-NP
PKC NN I-NP
inhibitor NN I-NP
staurosporine NN I-NP
COMMA COMMA O
suggesting VBG B-VP
a DT B-NP
role NN I-NP
for IN B-PP
PKC NN B-NP
. . O

Increased VBN O
c-jun NN B-NP
COMMA COMMA O
jun-B NN B-NP
COMMA COMMA O
and CC O
jun-D NN B-NP
expression NN B-NP
above IN B-PP
basal JJ B-NP
levels NNS I-NP
and CC O
increased VBN B-NP
transcriptional JJ I-NP
activity NN I-NP
of IN B-PP
AP-1\/TPA NN B-NP
responsive JJ I-NP
elements NNS I-NP
fused VBN B-VP
to TO B-PP
chloramphenicol NN B-NP
acetyl-transferase NN I-NP
vectors NNS I-NP
were VBD B-VP
observed VBN I-VP
in IN B-PP
T NN B-NP
cells NNS I-NP
treated VBN B-VP
with IN B-PP
TPA NN B-NP
alone RB B-ADVP
or CC O
in IN B-PP
combination NN B-NP
with IN B-PP
dexamethasone NN B-NP
. . O

The DT B-NP
ability NN I-NP
of IN B-PP
Jun NN B-NP
proteins NNS I-NP
to TO B-VP
cooperate VB I-VP
with IN B-PP
GR NN B-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
has VBZ B-VP
been VBN I-VP
investigated VBN I-VP
after IN B-PP
transfection NN B-NP
of IN B-PP
c-jun NN B-NP
COMMA COMMA O
jun-B NN B-NP
COMMA COMMA O
or CC O
jun-D NN B-NP
expression NN B-NP
vectors NNS I-NP
COMMA COMMA O
which WDT B-NP
augmented VBD B-VP
GR-dependent JJ B-NP
transcription NN I-NP
from IN B-PP
either CC O
MMTV NN B-NP
LTR NN I-NP
or CC O
GRE NN B-NP
. . O

Conversely RB B-ADVP
COMMA COMMA O
c-jun NN B-NP
and CC O
jun-B NN B-NP
transfection NN B-NP
blunted VBD B-VP
GR-dependent JJ B-NP
transcription NN I-NP
in IN B-PP
HeLa NN B-NP
cells NNS I-NP
. . O

The DT B-NP
presence NN I-NP
of IN B-PP
c-fos NN B-NP
had VBD B-VP
a DT B-NP
negative JJ I-NP
influence NN I-NP
on IN B-PP
GR NN B-NP
function NN I-NP
and CC O
correlated VBD B-VP
with IN B-PP
the DT B-NP
cell-specific JJ I-NP
synergistic JJ I-NP
or CC I-NP
antagonistic JJ I-NP
activity NN I-NP
of IN B-PP
Jun NN B-NP
with IN B-PP
respect NN I-PP
to TO I-PP
GR NN B-NP
; : O
high JJ B-NP
basal JJ I-NP
expression NN I-NP
of IN B-PP
c-fos NN B-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
AP-1 NN B-NP
DNA NN I-NP
binding NN I-NP
and CC O
transcriptional JJ B-NP
activity NN I-NP
were VBD B-VP
observed VBN I-VP
in IN B-PP
HeLa NN B-NP
cells NNS I-NP
COMMA COMMA B-PP
but CC I-PP
not RB B-PP
in IN I-PP
T NN B-NP
cells NNS I-NP
. . O

Furthermore RB B-ADVP
overexpression NN B-NP
of IN B-PP
exogenous JJ B-NP
c-fos NN I-NP
has VBZ B-VP
an DT B-NP
inhibitory JJ I-NP
effect NN I-NP
on IN B-PP
GR-dependent JJ B-NP
transcription NN I-NP
from IN B-PP
GRE NN B-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
. . O

We PRP B-NP
propose VBP B-VP
that IN B-SBAR
Jun NN B-NP
plays VBZ B-VP
a DT B-NP
bifunctional JJ I-NP
role NN I-NP
on IN B-PP
GR-dependent JJ B-NP
transcriptional JJ I-NP
activation NN I-NP
of IN B-PP
GRE NN B-NP
COMMA COMMA O
selecting VBG B-VP
either CC B-NP
synergistic JJ I-NP
or CC I-NP
antagonistic JJ I-NP
activity NN I-NP
depending VBG B-PP
on IN B-PP
the DT B-NP
cell-specific JJ I-NP
microenvironment NN I-NP
. . O

In IN B-PP
this DT B-NP
regard NN I-NP
COMMA COMMA O
intracellular JJ B-NP
levels NNS I-NP
of IN B-PP
c-fos NN B-NP
appear VBP B-VP
to TO I-VP
be VB I-VP
influential JJ B-ADJP
. . O

A DT B-NP
concatenated JJ I-NP
form NN I-NP
of IN B-PP
Epstein-Barr JJ B-NP
viral JJ I-NP
DNA NN I-NP
in IN B-PP
lymphoblastoid JJ B-NP
cell NN I-NP
lines NNS I-NP
induced VBN B-VP
by IN B-PP
transfection NN B-NP
with IN B-PP
BZLF1 NN B-NP
. . O

The DT B-NP
replicative JJ I-NP
form NN I-NP
of IN B-PP
Epstein-Barr JJ B-NP
virus NN I-NP
( ( O
EBV NN B-NP
) ) O
DNA NN B-NP
was VBD B-VP
studied VBN I-VP
using VBG B-VP
two CD B-NP
lymphoblastoid JJ I-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
X50-7 NN B-NP
and CC O
6F11 NN B-NP
COMMA COMMA O
which WDT B-NP
are VBP B-VP
latently RB I-VP
infected VBN I-VP
by IN B-PP
Epstein-Barr JJ B-NP
virus NN I-NP
. . O

The DT B-NP
lytic JJ I-NP
cycle NN I-NP
of IN B-PP
EBV NN B-NP
infection NN I-NP
was VBD B-VP
induced VBN I-VP
by IN B-PP
transfection NN B-NP
of IN B-PP
the DT B-NP
cells NNS I-NP
with IN B-PP
the DT B-NP
BRLF1\/BZLF1 NN I-NP
coding NN I-NP
region NN I-NP
of IN B-PP
the DT B-NP
P3HR-1 NN I-NP
defective JJ I-NP
genome NN I-NP
. . O

We PRP B-NP
combined VBD B-VP
two CD B-NP
techniques NNS I-NP
to TO B-VP
identify VB I-VP
the DT B-NP
productive JJ I-NP
replicative JJ I-NP
form NN I-NP
of IN B-PP
Epstein-Barr JJ B-NP
viral JJ I-NP
DNA NN I-NP
in IN B-PP
the DT B-NP
lytic JJ I-NP
cycle-induced JJ I-NP
cells NNS I-NP
. . O

Restriction NN B-NP
enzyme NN I-NP
analysis NN I-NP
followed VBN B-VP
by IN B-PP
Southern NN B-NP
blot NN I-NP
hybridization NN I-NP
identified VBD B-VP
a DT B-NP
significant JJ I-NP
increase NN I-NP
in IN B-PP
the DT B-NP
fused VBN I-NP
fragment NN I-NP
encompassing VBG B-VP
both DT B-NP
ends NNS I-NP
of IN B-PP
EBV NN B-NP
DNA NN I-NP
. . O

This DT B-NP
indicates VBZ B-VP
an DT B-NP
increase NN I-NP
in IN B-PP
either CC O
episomal JJ B-NP
DNA NN I-NP
or CC O
concatameric JJ B-NP
linear JJ I-NP
DNA NN I-NP
. . O

Southern NN B-NP
blot NN I-NP
analysis NN I-NP
of IN B-PP
in FW B-NP
situ FW I-NP
lysing VBG I-NP
gels NNS I-NP
revealed VBD B-VP
that IN B-SBAR
the DT B-NP
cellular JJ I-NP
content NN I-NP
of IN B-PP
linear JJ B-NP
EBV NN I-NP
DNA NN I-NP
was VBD B-VP
also RB I-VP
increased VBN I-VP
significantly RB B-ADVP
after IN B-PP
the DT B-NP
initiation NN I-NP
of IN B-PP
the DT B-NP
viral JJ I-NP
lytic JJ I-NP
cycle NN I-NP
COMMA COMMA O
while IN B-SBAR
the DT B-NP
amount NN I-NP
of IN B-PP
circular JJ B-NP
DNA NN I-NP
remained VBD B-VP
approximately RB B-ADJP
constant JJ I-ADJP
. . O

We PRP B-NP
propose VBP B-VP
from IN B-PP
these DT B-NP
results NNS I-NP
that IN B-SBAR
the DT B-NP
source NN I-NP
of IN B-PP
the DT B-NP
fused VBN I-NP
fragment NN I-NP
encompassing VBG B-VP
both DT B-NP
ends NNS I-NP
of IN B-PP
EBV NN B-NP
DNA NN I-NP
is VBZ B-VP
a DT B-NP
concatenated VBN I-NP
linear JJ I-NP
EBV NN I-NP
DNA NN I-NP
molecule NN I-NP
COMMA COMMA O
and CC O
that IN B-SBAR
such PDT B-NP
a DT I-NP
concatenated VBN I-NP
molecule NN I-NP
most RBS B-ADVP
likely RB I-ADVP
represents VBZ B-VP
a DT B-NP
replicative JJ I-NP
form NN I-NP
of IN B-PP
EBV NN B-NP
DNA NN I-NP
in IN B-PP
productively RB B-NP
infected JJ I-NP
cells NNS I-NP
. . O

Regulation NN B-NP
of IN B-PP
the DT B-NP
beta-globin NN I-NP
locus NN I-NP
. . O

Transcription NN B-NP
of IN B-PP
the DT B-NP
human JJ I-NP
beta-globin NN I-NP
gene NN I-NP
cluster NN I-NP
depends VBZ B-VP
upon IN B-PP
upstream JJ B-NP
regulatory JJ I-NP
sequences NNS I-NP
COMMA COMMA O
which WDT B-NP
are VBP B-VP
collectively RB I-VP
termed VBN I-VP
the DT B-NP
locus NN I-NP
control NN I-NP
region NN I-NP
. . O

Recent JJ B-NP
studies NNS I-NP
have VBP B-VP
provided VBN I-VP
new JJ B-NP
insights NNS I-NP
into IN B-PP
how WRB B-ADVP
the DT B-NP
individual JJ I-NP
genes NNS I-NP
of IN B-PP
the DT B-NP
cluster NN I-NP
are VBP B-VP
regulated VBN I-VP
through IN B-PP
development NN B-NP
. . O

The DT B-NP
crux NN I-NP
of IN B-PP
transcriptional JJ B-NP
activation NN I-NP
is VBZ B-VP
how WRB B-ADVP
the DT B-NP
locus NN I-NP
control NN I-NP
region NN I-NP
communicates VBZ B-VP
with IN B-PP
the DT B-NP
gene-proximal JJ I-NP
regulatory JJ I-NP
elements NNS I-NP
. . O

Ectopic JJ B-NP
expression NN I-NP
of IN B-PP
a DT B-NP
conditional JJ I-NP
GATA-2\/estrogen NN I-NP
receptor NN I-NP
chimera NN I-NP
arrests VBZ B-VP
erythroid JJ B-NP
differentiation NN I-NP
in IN B-PP
a DT B-NP
hormone-dependent JJ I-NP
manner NN I-NP
. . O

The DT B-NP
GATA NN I-NP
factors NNS I-NP
are VBP B-VP
a DT B-NP
family NN I-NP
of IN B-PP
transcriptional JJ B-NP
regulatory JJ I-NP
proteins NNS I-NP
in IN B-PP
eukaryotes NNS B-NP
that WDT B-NP
share VBP B-VP
extensive JJ B-NP
homology NN I-NP
in IN B-PP
their PRP$ B-NP
DNA-binding JJ I-NP
domains NNS I-NP
. . O

One CD B-NP
enigmatic JJ I-NP
aspect NN I-NP
of IN B-PP
GATA NN B-NP
factor NN I-NP
expression NN I-NP
is VBZ B-VP
that IN B-SBAR
several JJ B-NP
GATA NN I-NP
proteins NNS I-NP
COMMA COMMA O
which WDT B-NP
ostensibly RB B-ADVP
share VBP B-VP
the DT B-NP
same JJ I-NP
DNA-binding JJ I-NP
site NN I-NP
specificity NN I-NP
COMMA COMMA O
are VBP B-VP
coexpressed VBN I-VP
in IN B-PP
erythroid JJ B-NP
cells NNS I-NP
. . O

To TO B-VP
elucidate VB I-VP
the DT B-NP
roles NNS I-NP
of IN B-PP
individual JJ B-NP
GATA NN I-NP
factors NNS I-NP
in IN B-PP
erythropoiesis NN B-NP
COMMA COMMA O
conditional JJ B-NP
alleles NNS I-NP
of IN B-PP
GATA-1 NN B-NP
COMMA COMMA O
GATA-2 NN B-NP
COMMA COMMA O
and CC O
GATA-3 NN B-NP
were VBD B-VP
prepared VBN I-VP
by IN B-PP
fusing VBG B-VP
each DT B-NP
of IN B-PP
the DT B-NP
factors NNS I-NP
to TO B-PP
the DT B-NP
hormone-binding JJ I-NP
domain NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
estrogen NN B-NP
receptor NN I-NP
( ( O
ER NN B-NP
) ) O
. . O

These DT B-NP
GATA\/ER NN I-NP
chimeric JJ I-NP
factors NNS I-NP
were VBD B-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
hormone-inducible JJ B-NP
trans-activating JJ I-NP
proteins NNS I-NP
in IN B-PP
transient JJ B-NP
transfection NN I-NP
assays NNS I-NP
. . O

When WRB B-ADVP
stably RB B-ADVP
introduced VBN B-VP
into IN B-PP
primary JJ B-NP
erythroblasts NNS I-NP
or CC O
conditionally RB B-NP
transformed VBN I-NP
erythroid JJ I-NP
progenitors NNS I-NP
cells NNS I-NP
COMMA COMMA O
exogenous JJ B-NP
GATA-2\/ER NN I-NP
promoted VBD B-VP
proliferation NN B-NP
and CC O
inhibited VBD B-VP
terminal JJ B-NP
differentiation NN I-NP
in IN B-PP
an DT B-NP
estrogen-dependent JJ I-NP
manner NN I-NP
. . O

These DT B-NP
phenotypic JJ I-NP
effects NNS I-NP
are VBP B-VP
specifically RB B-ADVP
attributable JJ B-ADJP
to TO B-PP
the DT B-NP
action NN I-NP
of IN B-PP
ectopically RB B-NP
expressed VBN I-NP
GATA-2\/ER NN I-NP
because IN B-SBAR
erythroblasts NNS B-NP
expressing VBG B-VP
exogenous JJ B-NP
GATA-2 NN I-NP
are VBP B-VP
constitutively RB I-VP
arrested VBN I-VP
in IN B-PP
differentiation NN B-NP
and CC O
because IN B-SBAR
erythroid JJ B-NP
progenitors NNS I-NP
expressing VBG B-VP
either CC O
Gal\/ER NN B-NP
or CC O
GATA-3\/ER NN B-NP
do VBP B-VP
not RB I-VP
display VB I-VP
a DT B-NP
hormone-responsive JJ I-NP
block NN I-NP
in IN B-PP
differentiation NN B-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
the DT B-NP
GATA-2 NN I-NP
transcription NN I-NP
factor NN I-NP
appears VBZ B-VP
to TO I-VP
play VB I-VP
a DT B-NP
role NN I-NP
in IN B-PP
regulating VBG B-VP
the DT B-NP
self-renewal JJ I-NP
capacity NN I-NP
of IN B-PP
early JJ B-NP
erythroid JJ I-NP
progenitor NN I-NP
cells NNS I-NP
. . O

Lipopolysaccharide NN B-NP
induces VBZ B-VP
phosphorylation NN B-NP
of IN B-PP
MAD3 NN B-NP
and CC O
activation NN B-NP
of IN B-PP
c-Rel NN B-NP
and CC O
related JJ B-NP
NF-kappa NN I-NP
B NN I-NP
proteins NNS B-NP
in IN B-PP
human JJ B-NP
monocytic JJ I-NP
THP-1 NN I-NP
cells NNS I-NP
. . O

Many JJ B-NP
effects NNS I-NP
of IN B-PP
lipopolysaccharide NN B-NP
( ( O
LPS NN B-NP
) ) O
on IN B-PP
gene NN B-NP
expression NN I-NP
COMMA COMMA O
including VBG B-PP
that DT B-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV NN B-NP
) ) O
COMMA COMMA O
in IN B-PP
monocytic JJ B-NP
cells NNS I-NP
are VBP B-VP
mediated VBN I-VP
by IN B-PP
activation NN B-NP
of IN B-PP
kappa NN B-NP
B NN I-NP
DNA-binding JJ I-NP
proteins NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
specific JJ I-NP
members NNS I-NP
of IN B-PP
the DT B-NP
NF-kappa NN I-NP
B\/Rel NN I-NP
transcription NN I-NP
factor NN I-NP
family NN I-NP
involved VBN B-VP
in IN B-PP
the DT B-NP
LPS NN I-NP
response NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
mechanisms NNS I-NP
through IN B-PP
which WDT B-NP
LPS-generated JJ B-NP
signals NNS I-NP
are VBP B-VP
transduced VBN I-VP
remain VBP B-VP
unclear JJ B-ADJP
. . O

Here RB B-ADVP
we PRP B-NP
show VBP B-VP
that IN B-SBAR
LPS NN B-NP
induces VBZ B-VP
nuclear JJ B-NP
expression NN I-NP
of IN B-PP
c-Rel\/p50 NN B-NP
heterodimers NNS I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
p50\/p65 NN B-NP
( ( O
NF-kappa NN B-NP
B NN I-NP
) ) O
kappa NN B-NP
B NN I-NP
DNA-binding JJ I-NP
complexes NNS I-NP
in IN B-PP
human JJ B-NP
monocytic JJ I-NP
THP-1 NN I-NP
cells NNS I-NP
. . O

Nuclear JJ B-NP
localization NN I-NP
of IN B-PP
these DT B-NP
proteins NNS I-NP
occurred VBD B-VP
concomitantly RB B-PP
with IN I-PP
a DT B-NP
rapid JJ I-NP
decrease NN I-NP
in IN B-PP
their PRP$ B-NP
cytosolic JJ I-NP
levels NNS I-NP
and CC O
was VBD B-VP
independent JJ B-ADJP
of IN B-PP
phorbol NN B-NP
ester-sensitive JJ I-NP
protein NN I-NP
kinase NN I-NP
C NN I-NP
. . O

Within IN B-PP
24 CD B-NP
h NN I-NP
following VBG B-PP
LPS NN B-NP
stimulation NN I-NP
there EX B-NP
was VBD B-VP
a DT B-NP
striking JJ I-NP
increase NN I-NP
in IN B-PP
the DT B-NP
levels NNS I-NP
of IN B-PP
c-Rel NN B-NP
COMMA COMMA O
p105 NN B-NP
COMMA COMMA O
and CC O
p50 NN B-NP
in IN B-PP
the DT B-NP
cytosol NN I-NP
. . O

The DT B-NP
increased VBN I-NP
levels NNS I-NP
of IN B-PP
these DT B-NP
proteins NNS I-NP
correlated VBD B-VP
with IN B-PP
increases NNS B-NP
in IN B-PP
the DT B-NP
amounts NNS I-NP
of IN B-PP
their PRP$ B-NP
mRNAs NNS I-NP
during IN B-PP
LPS NN B-NP
activation NN I-NP
of IN B-PP
THP-1 NN B-NP
cells NNS I-NP
. . O

LPS NN B-NP
activation NN I-NP
of IN B-PP
THP-1 NN B-NP
cells NNS I-NP
resulted VBD B-VP
in IN B-PP
phosphorylation NN B-NP
of IN B-PP
MAD3 NN B-NP
( ( O
an DT B-NP
I NN I-NP
kappa NN I-NP
B-like JJ I-NP
protein NN I-NP
) ) O
COMMA COMMA O
a DT B-NP
rapid JJ I-NP
increase NN I-NP
in IN B-PP
MAD3 NN B-NP
mRNA NN I-NP
COMMA COMMA O
and CC O
an DT B-NP
increase NN I-NP
in IN B-PP
MAD3 NN B-NP
protein NN I-NP
by IN B-PP
2 CD B-NP
h NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
LPS NN B-NP
activation NN I-NP
of IN B-PP
human JJ B-NP
monocytic JJ I-NP
cells NNS I-NP
results VBZ B-VP
in IN B-PP
nuclear JJ B-NP
expression NN I-NP
of IN B-PP
c-Rel\/p50 NN B-NP
and CC O
p50\/p65 NN B-NP
( ( O
NF-kappa NN B-NP
B NN I-NP
) ) O
and CC O
induces VBZ B-VP
phosphorylation NN B-NP
of IN B-PP
MAD3 NN B-NP
. . O

Induction NN B-NP
of IN B-PP
CD8 NN O
antigen NN B-NP
and CC O
suppressor NN B-NP
activity NN B-NP
by IN B-PP
glucocorticoids NNS B-NP
in IN B-PP
a DT B-NP
CEM NN I-NP
human JJ I-NP
leukemic JJ I-NP
cell NN I-NP
clone NN I-NP
. . O

The DT B-NP
relationship NN I-NP
between IN B-PP
glucocorticoid NN B-NP
effect NN I-NP
and CC O
regulation NN B-NP
of IN B-PP
cell NN B-NP
surface NN I-NP
antigens NNS I-NP
was VBD B-VP
investigated VBN I-VP
in IN B-PP
two CD B-NP
models NNS I-NP
of IN B-PP
leukemic JJ B-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
CEM NN B-NP
C7 NN I-NP
denoted VBN B-VP
( ( O
r+ JJ B-ADJP
COMMA COMMA O
ly+ JJ B-ADJP
) ) O
and CC O
CEM NN B-NP
C1 NN I-NP
( ( O
r+ JJ B-ADJP
COMMA COMMA O
ly- JJ B-ADJP
) ) O
. . O

The DT B-NP
reactivity NN I-NP
of IN B-PP
murine JJ B-NP
monoclonal JJ I-NP
antibodies NNS I-NP
COMMA COMMA O
anti-CD4-FITC NN B-NP
COMMA COMMA O
anti-CD8-FITC NN B-NP
COMMA COMMA O
anti-CD2-FITC NN B-NP
and CC O
anti-calla-FITC NN B-NP
COMMA COMMA O
were VBD B-VP
analyzed VBN I-VP
using VBG B-VP
flow NN B-NP
cytometry NN I-NP
. . O

The DT B-NP
suppressor NN I-NP
function NN I-NP
was VBD B-VP
determined VBN I-VP
using VBG B-VP
{3H}thymidine NN B-NP
incorporation NN I-NP
into IN B-PP
phytohemagglutinin-activated JJ B-NP
peripheral JJ I-NP
blood NN I-NP
lymphocytes NNS I-NP
. . O

Dexamethasone NN B-NP
treatment NN I-NP
of IN B-PP
a DT B-NP
human JJ I-NP
leukemic JJ I-NP
cell NN I-NP
clone NN I-NP
CEM NN I-NP
C7 NN I-NP
caused VBD B-VP
an DT B-NP
increase NN I-NP
in IN B-PP
a DT B-NP
subset NN I-NP
of IN B-PP
cells NNS B-NP
expressing VBG B-VP
the DT B-NP
surface NN I-NP
antigen NN I-NP
CD8 NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
present JJ B-ADJP
on IN B-PP
suppressor NN B-NP
and CC O
cytotoxic JJ B-ADJP
T-lymphocytes NNS B-NP
. . O

By IN B-PP
comparison NN B-NP
COMMA COMMA O
there EX B-NP
was VBD B-VP
no DT B-NP
modification NN I-NP
of IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
CD4 NN B-NP
antigen NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
expressed VBN I-VP
at IN B-PP
high JJ B-NP
levels NNS I-NP
in IN B-PP
these DT B-NP
cells NNS I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
there EX B-NP
was VBD B-VP
no DT B-NP
regulation NN I-NP
by IN B-PP
glucocorticoids NNS B-NP
of IN B-PP
either CC O
the DT O
CD8 NN B-NP
or CC O
CD4 NN B-NP
antigens NNS B-NP
in IN B-PP
the DT B-NP
leukemic JJ I-NP
clone NN I-NP
CEM NN I-NP
C1 NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
no DT B-NP
modification NN I-NP
of IN B-PP
the DT B-NP
suppressor NN I-NP
function NN I-NP
in IN B-PP
CEM NN B-NP
C1 NN I-NP
cells NNS I-NP
by IN B-PP
dexamethasone NN B-NP
was VBD B-VP
observed VBN I-VP
. . O

In IN B-PP
the DT B-NP
human JJ I-NP
leukemic JJ I-NP
cells NNS I-NP
studied VBN B-VP
here RB B-ADVP
COMMA COMMA O
the DT B-NP
ability NN I-NP
to TO B-VP
induce VB I-VP
CD8 NN B-NP
antigen NN I-NP
expression NN I-NP
in IN B-PP
a DT B-NP
CD4+ JJ I-NP
cells NNS I-NP
correlates VBZ B-VP
with IN B-PP
the DT B-NP
ability NN I-NP
to TO B-VP
induce VB I-VP
cell NN B-NP
lysis NN I-NP
in IN B-PP
a DT B-NP
glucocorticoid NN I-NP
receptor NN I-NP
positive JJ I-NP
cell NN I-NP
population NN I-NP
. . O

Molecular JJ B-NP
basis NN I-NP
of IN B-PP
a DT B-NP
multiple JJ I-NP
lymphokine NN I-NP
deficiency NN I-NP
in IN B-PP
a DT B-NP
patient NN I-NP
with IN B-PP
severe JJ B-NP
combined JJ I-NP
immunodeficiency NN I-NP
. . O

We PRP B-NP
have VBP B-VP
previously RB I-VP
reported VBN I-VP
that IN B-SBAR
the DT B-NP
T NN I-NP
lymphocytes NNS I-NP
of IN B-PP
a DT B-NP
child NN I-NP
with IN B-PP
severe JJ B-NP
combined JJ I-NP
immunodeficiency NN I-NP
are VBP B-VP
defective JJ B-ADJP
in IN B-PP
the DT B-NP
transcription NN I-NP
of IN B-PP
several JJ B-NP
lymphokine NN I-NP
genes NNS I-NP
that WDT B-NP
include VBP B-VP
IL2 NN B-NP
COMMA COMMA O
IL3 NN B-NP
COMMA COMMA O
IL4 NN B-NP
COMMA COMMA O
and CC O
IL5 NN B-NP
COMMA COMMA O
which WDT B-NP
encode VBP B-VP
interleukins NNS B-NP
2 CD B-NP
COMMA COMMA O
3 CD B-NP
COMMA COMMA O
4 CD B-NP
COMMA COMMA O
and CC O
5 CD B-NP
( ( O
IL-2 NN B-NP
COMMA COMMA O
-3 CD B-NP
COMMA COMMA O
-4 CD B-NP
COMMA COMMA O
and CC O
-5 CD B-NP
) ) O
. . O

To TO B-VP
determine VB I-VP
whether IN B-SBAR
the DT B-NP
defect NN I-NP
in IN B-PP
the DT B-NP
patient NN I-NP
's POS B-NP
T NN I-NP
lymphocytes NNS I-NP
involved VBD B-VP
a DT B-NP
trans-acting JJ I-NP
factor NN I-NP
common JJ B-ADJP
to TO B-PP
the DT B-NP
affected VBN I-NP
lymphokine NN I-NP
genes NNS I-NP
COMMA COMMA O
we PRP B-NP
examined VBD B-VP
the DT B-NP
ability NN I-NP
of IN B-PP
nuclear JJ B-NP
factors NNS I-NP
from IN B-PP
the DT B-NP
patient NN I-NP
's POS B-NP
T NN I-NP
lymphocytes NNS I-NP
to TO B-VP
bind VB I-VP
response NN B-NP
elements NNS I-NP
present JJ B-ADJP
in IN B-PP
the DT B-NP
regulatory JJ I-NP
region NN I-NP
of IN B-PP
IL2 NN B-NP
. . O

Nuclear JJ B-NP
factor NN I-NP
NF-kB NN I-NP
COMMA COMMA O
activation NN B-NP
protein NN I-NP
1 CD I-NP
( ( O
AP-1 NN B-NP
) ) O
COMMA COMMA O
OCT-1 NN B-NP
COMMA COMMA O
and CC O
NF-IL-2B NN B-NP
binding NN I-NP
activity NN I-NP
were VBD B-VP
normal JJ B-ADJP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
the DT B-NP
binding NN I-NP
of IN B-PP
the DT B-NP
nuclear JJ I-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
( ( O
NF-AT NN B-NP
) ) O
to TO B-PP
its PRP$ B-NP
response NN I-NP
element NN I-NP
in IN B-PP
the DT B-NP
IL2 NN I-NP
enhancer NN I-NP
and CC B-PP
to TO B-PP
an DT B-NP
NF-AT-like JJ I-NP
response NN I-NP
element NN I-NP
present JJ B-ADJP
in IN B-PP
the DT B-NP
IL4 NN I-NP
enhancer NN I-NP
was VBD B-VP
abnormal JJ B-ADJP
. . O

To TO B-VP
ascertain VB I-VP
whether IN B-SBAR
the DT B-NP
abnormal JJ I-NP
NF-AT NN I-NP
binding NN I-NP
activity NN I-NP
was VBD B-VP
related JJ B-ADJP
to TO B-PP
an DT B-NP
impaired JJ I-NP
function NN I-NP
COMMA COMMA O
we PRP B-NP
transfected VBD B-VP
patient NN B-NP
and CC O
control NN B-NP
T NN B-NP
lymphocytes NNS I-NP
with IN B-PP
constructs NNS B-NP
containing VBG B-VP
the DT B-NP
reporter NN I-NP
gene NN I-NP
encoding JJ B-VP
chloramphenicol NN B-NP
acetyl NN I-NP
transferase NN I-NP
( ( O
CAT NN B-NP
) ) O
under IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
the DT B-NP
entire JJ I-NP
IL2 NN I-NP
regulatory JJ I-NP
region NN I-NP
or CC B-PP
of IN B-PP
multimers NNS B-NP
of IN B-PP
individual JJ B-NP
enhancer NN I-NP
sequences NNS I-NP
. . O

CAT NN B-NP
expression NN I-NP
directed VBN B-VP
by IN B-PP
the DT B-NP
IL2 NN I-NP
regulatory JJ I-NP
region NN I-NP
or CC B-PP
by IN B-PP
a DT B-NP
multimer NN I-NP
of IN B-PP
the DT B-NP
NF-AT-binding JJ I-NP
site NN I-NP
was VBD B-VP
markedly RB B-ADJP
lower JJR I-ADJP
in IN B-PP
the DT B-NP
patient NN I-NP
relative JJ B-PP
to TO I-PP
controls NNS B-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
CAT NN B-NP
gene NN I-NP
expression NN I-NP
directed VBN B-VP
by IN B-PP
a DT B-NP
multimer NN I-NP
of IN B-PP
the DT B-NP
OCT-1 NN I-NP
proximal NN I-NP
( ( I-NP
OCT-1p NN I-NP
) ) I-NP
-binding JJ I-NP
site NN I-NP
was VBD B-VP
equivalent JJ B-ADJP
in IN B-PP
patient NN B-NP
and CC O
controls NNS B-NP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
an DT B-NP
abnormality NN I-NP
of IN B-PP
\/ CC O
or CC O
influencing JJ B-NP
NF-AT NN B-VP
may MD I-VP
underlie VB B-NP
the DT I-NP
multiple JJ I-NP
lymphokine NN I-NP
deficiency NN O
in IN B-NP
this DT I-NP
patient NN O

Expression NN B-NP
of IN B-PP
mRNA NN B-NP
for IN B-PP
the DT B-NP
GATA-binding JJ I-NP
proteins NNS I-NP
in IN B-PP
human JJ B-NP
eosinophils NNS B-NP
and CC O
basophils NNS B-NP
: : O
potential JJ B-NP
role NN I-NP
in IN B-PP
gene NN B-NP
transcription NN I-NP
. . O

The DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
hematopoietic JJ I-NP
transcription NN I-NP
factors NNS I-NP
GATA-1 NN B-NP
COMMA COMMA O
GATA-2 NN B-NP
COMMA COMMA O
and CC O
GATA-3 NN B-NP
was VBD B-VP
studied VBN I-VP
in IN B-PP
eosinophils NNS B-NP
and CC O
basophils NNS B-NP
. . O

Eosinophils NNS B-NP
express VBP B-VP
mRNA NN B-NP
for IN B-PP
GATA-1 NN B-NP
COMMA COMMA O
GATA-2 NN B-NP
COMMA COMMA O
and CC O
GATA-3 NN B-NP
. . O

Basophils NNS B-NP
express VBP B-VP
GATA-2 NN B-NP
and CC O
GATA-3 NN B-NP
. . O

Treatment NN B-NP
of IN B-PP
HL-60 NN B-NP
eosinophilic JJ I-NP
sublines NNS I-NP
with IN B-PP
either CC O
interleukin-5 NN B-NP
or CC O
butyric JJ B-NP
acid NN I-NP
increased VBD B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
GATA-1 NN B-NP
mRNA NN I-NP
concomitant JJ B-ADJP
with IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
eosinophil-specific JJ B-NP
genes NNS I-NP
COMMA COMMA O
whereas IN O
levels NNS B-NP
of IN B-PP
GATA-2 NN B-NP
mRNA NN I-NP
remained VBD B-VP
relatively RB B-ADJP
constant JJ I-ADJP
. . O

The DT B-NP
presence NN I-NP
of IN B-PP
mRNA NN B-NP
for IN B-PP
these DT B-NP
proteins NNS I-NP
in IN B-PP
eosinophils NNS B-NP
and CC O
basophils NNS B-NP
suggests VBZ B-VP
that IN B-SBAR
gene NN B-NP
transcription NN I-NP
in IN B-PP
these DT B-NP
lineages NNS I-NP
may MD B-VP
be VB I-VP
regulated VBN I-VP
by IN B-PP
GATA-binding JJ B-NP
proteins NNS I-NP
. . O

Proliferation NN B-NP
index NN I-NP
as IN B-PP
a DT B-NP
prognostic JJ I-NP
marker NN I-NP
in IN B-PP
breast NN B-NP
cancer NN I-NP
. . O

BACKGROUND NN B-NP
. . O

The DT B-NP
proliferative JJ I-NP
activity NN I-NP
of IN B-PP
tumors NNS B-NP
has VBZ B-VP
been VBN I-VP
extensively RB I-VP
investigated VBN I-VP
with IN B-PP
different JJ B-NP
approaches NNS I-NP
COMMA COMMA O
among IN B-PP
which WDT B-NP
the DT B-NP
use NN I-NP
of IN B-PP
the DT B-NP
monoclonal JJ I-NP
antibody NN I-NP
Ki-67 NN I-NP
represents VBZ B-VP
an DT B-NP
easy JJ I-NP
and CC I-NP
reliable JJ I-NP
means NN I-NP
of IN B-PP
assessing VBG B-VP
cell NN B-NP
proliferation NN I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
the DT B-NP
proliferative JJ I-NP
activity NN I-NP
of IN B-PP
129 CD B-NP
primary JJ I-NP
breast NN I-NP
cancers NNS I-NP
was VBD B-VP
investigated VBN I-VP
COMMA COMMA O
and CC O
the DT B-NP
results NNS I-NP
were VBD B-VP
related JJ I-VP
to TO B-PP
prognosis NN B-NP
. . O

METHODS NNS B-NP
. . O

Tumor NN B-NP
samples NNS I-NP
COMMA COMMA O
obtained VBN B-VP
from IN B-PP
129 CD B-NP
patients NNS I-NP
who WP B-NP
underwent VBD B-VP
surgery NN B-NP
between IN B-PP
January NNP B-NP
1987 CD I-NP
and CC O
December NNP B-NP
1988 CD I-NP
COMMA COMMA O
were VBD B-VP
processed VBN I-VP
for IN B-PP
staining VBG B-NP
by IN B-PP
an DT B-NP
immunohistochemical JJ I-NP
procedure NN I-NP
( ( O
avidin-biotin NN B-NP
complex NN I-NP
) ) O
. . O

The DT B-NP
median JJ I-NP
time NN I-NP
of IN B-PP
observation NN B-NP
was VBD B-VP
42 CD B-NP
months NNS I-NP
( ( O
range NN B-NP
COMMA COMMA O
31-55 CD B-NP
months NNS I-NP
) ) O
. . O

Life-table JJ B-NP
analysis NN I-NP
( ( O
Mantel-Cox NN B-NP
) ) O
was VBD B-VP
used VBN I-VP
to TO B-VP
assess VB I-VP
the DT B-NP
probability NN I-NP
of IN B-PP
disease-free JJ B-NP
survival NN I-NP
( ( O
DFS NN B-NP
) ) O
and CC O
overall JJ B-NP
survival NN I-NP
( ( O
OS NN B-NP
) ) O
. . O

RESULTS NNS B-NP
. . O

Tumors NNS B-NP
with IN B-PP
high JJ B-NP
Ki-67 NN I-NP
proliferation NN I-NP
indices NNS I-NP
( ( O
&gt; JJR B-NP
20 CD I-NP
% NN I-NP
) ) O
were VBD B-VP
associated VBN I-VP
with IN B-PP
a DT B-NP
higher JJR I-NP
4-year JJ I-NP
probability NN I-NP
of IN B-PP
relapse NN B-NP
of IN B-PP
disease NN B-NP
( ( O
55.3 CD B-NP
% NN I-NP
versus CC O
79.1 CD B-NP
% NN I-NP
; : O
P NN B-NP
= JJ B-VP
0.003 CD B-NP
) ) O
and CC O
death NN B-NP
( ( O
71 CD B-NP
% NN I-NP
versus CC O
95.6 CD B-NP
% NN I-NP
; : O
P NN B-NP
= JJ B-VP
0.00005 CD B-NP
) ) O
when WRB B-ADVP
compared VBN B-VP
with IN B-PP
tumors NNS B-NP
with IN B-PP
low JJ B-NP
Ki-67 NN I-NP
values NNS I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
this DT B-NP
proliferative JJ I-NP
parameter NN I-NP
maintained VBD B-VP
its PRP$ B-NP
prognostic JJ I-NP
significance NN I-NP
when WRB B-ADVP
the DT B-NP
patients NNS I-NP
were VBD B-VP
stratified VBN I-VP
according VBG B-PP
to TO B-PP
lymph NN B-NP
node NN I-NP
involvement NN I-NP
COMMA COMMA O
menopausal JJ B-NP
status NN I-NP
COMMA COMMA O
and CC O
nuclear JJ B-NP
estrogen NN I-NP
receptor NN I-NP
content NN I-NP
. . O

CONCLUSIONS NNS B-NP
. . O

Tumor NN B-NP
proliferative JJ I-NP
activity NN I-NP
as IN B-SBAR
evaluated VBN B-VP
by IN B-PP
the DT B-NP
monoclonal JJ I-NP
antibody NN I-NP
Ki-67 NN I-NP
seems VBZ B-VP
to TO I-VP
be VB I-VP
an DT B-NP
effective JJ I-NP
indicator NN I-NP
of IN B-PP
prognosis NN B-NP
in IN B-PP
breast NN B-NP
cancer NN I-NP
for IN B-PP
DFS NN B-NP
and CC O
OS NN B-NP
. . O

Defective JJ B-NP
translocation NN I-NP
of IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
in IN B-PP
multidrug-resistant JJ B-NP
HL-60 NN I-NP
cells NNS I-NP
confers VBZ B-VP
a DT B-NP
reversible JJ I-NP
loss NN I-NP
of IN B-PP
phorbol NN B-NP
ester-induced JJ I-NP
monocytic JJ I-NP
differentiation NN I-NP
. . O

Previous JJ B-NP
studies NNS I-NP
have VBP B-VP
demonstrated VBN I-VP
that IN B-SBAR
human JJ B-NP
HL-60 NN I-NP
myeloid JJ I-NP
leukemia NN I-NP
cells NNS I-NP
differentiate VBP B-VP
in IN B-PP
response NN I-PP
to TO I-PP
phorbol NN B-NP
esters NNS I-NP
. . O

This DT B-NP
event NN I-NP
is VBZ B-VP
associated VBN I-VP
with IN B-PP
induction NN B-NP
of IN B-PP
the DT B-NP
c-jun NN I-NP
early JJ I-NP
response NN I-NP
gene NN I-NP
and CC O
appearance NN B-NP
of IN B-PP
a DT B-NP
monocytic JJ I-NP
phenotype NN I-NP
. . O

The DT B-NP
present JJ I-NP
studies NNS I-NP
have VBP B-VP
examined VBN I-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
vincristine-selected JJ B-NP
COMMA COMMA I-NP
multidrug JJ I-NP
resistance NN I-NP
on IN B-PP
12-O-tetradecanoylphorbol-13-acetate NN B-NP
( ( I-NP
TPA NN I-NP
) ) I-NP
-induced JJ I-NP
HL-60 NN I-NP
cell NN I-NP
differentiation NN I-NP
. . O

The DT B-NP
results NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
multidrug-resistant JJ B-NP
HL-60 NN I-NP
cells NNS I-NP
COMMA COMMA O
designated VBN B-VP
HL-60\/vinc NN B-NP
COMMA COMMA O
fail VBP B-VP
to TO I-VP
respond VB I-VP
to TO B-PP
TPA NN B-NP
with IN B-PP
an DT B-NP
increase NN I-NP
in IN B-PP
c-jun NN B-NP
transcripts NNS I-NP
or CC O
other JJ B-NP
phenotypic JJ I-NP
characteristics NNS I-NP
of IN B-PP
monocytic JJ B-NP
differentiation NN I-NP
. . O

By IN B-PP
contrast NN B-NP
COMMA COMMA O
treatment NN B-NP
of IN B-PP
HL-60\/vinc NN B-NP
cells NNS I-NP
with IN B-PP
okadaic JJ B-NP
acid NN I-NP
COMMA COMMA O
an DT B-NP
inhibitor NN I-NP
of IN B-PP
serine\/threonine NN B-NP
protein NN I-NP
phosphatases NNS I-NP
COMMA COMMA O
induces VBZ B-VP
c-jun NN B-NP
transcription NN I-NP
COMMA COMMA O
growth NN B-NP
arrest NN I-NP
COMMA COMMA O
and CC O
expression NN B-NP
of IN B-PP
the DT B-NP
c-fms NN I-NP
gene NN I-NP
. . O

Studies NNS B-NP
were VBD B-VP
also RB I-VP
performed VBN I-VP
with IN B-PP
an DT O
HL-60\/vinc NN O
revertant NN O
( ( O
HL-60\/vinc/R NN B-ADJP
) ) O
line NN B-NP
that WDT B-NP
has VBZ B-VP
regained VBN I-VP
partial JJ B-NP
sensitivity NN I-NP
to TO B-PP
vincristine NN B-NP
. . O

The DT B-NP
finding NN I-NP
that IN B-SBAR
HL-60\/vinc/R NN B-NP
cells NNS I-NP
respond VBP B-VP
to TO B-PP
TPA NN B-NP
with IN B-PP
induction NN B-NP
of IN B-PP
a DT B-NP
monocytic JJ I-NP
phenotype NN I-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
c-jun NN B-NP
expression NN I-NP
COMMA COMMA O
suggests VBZ B-VP
that IN B-SBAR
c-jun NN B-NP
induction NN I-NP
is VBZ B-VP
not RB O
obligatory JJ B-ADJP
for IN B-PP
monocytic JJ B-NP
differentiation NN I-NP
. . O

Other JJ B-NP
studies NNS I-NP
further RB B-ADVP
demonstrate VBP B-VP
that IN B-SBAR
the DT O
jun-B NN B-NP
and CC O
fra-1 NN B-NP
genes NNS B-NP
are VBP B-VP
induced VBN I-VP
by IN B-PP
TPA NN B-NP
in IN B-PP
both CC B-NP
HL-60\/vinc NN I-NP
and CC I-NP
HL-60\/vinc/R NN I-NP
cells NNS I-NP
COMMA COMMA O
whereas IN O
c-fos NN B-NP
expression NN I-NP
is VBZ B-VP
attenuated VBN I-VP
in IN B-PP
the DT B-NP
HL-60\/vinc NN I-NP
line NN I-NP
. . O

Since IN B-SBAR
TPA NN B-NP
activates VBZ B-VP
protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( O
PKC NN B-NP
) ) O
COMMA COMMA O
we PRP B-NP
examined VBD B-VP
translocation NN B-NP
of IN B-PP
PKC NN B-NP
from IN B-PP
the DT B-NP
cytosol NN I-NP
to TO B-PP
the DT B-NP
membrane NN I-NP
fraction NN I-NP
. . O

Although IN B-SBAR
HL-60 NN B-NP
and CC O
HL-60\/vinc/R NN B-ADJP
cells NNS B-NP
demonstrated VBD B-VP
translocation NN B-NP
of IN B-PP
PKC NN B-NP
activity NN I-NP
COMMA COMMA O
this DT B-NP
subcellular JJ I-NP
redistribution NN I-NP
was VBD B-VP
undetectable JJ B-ADJP
in IN B-PP
HL-60\/vinc NN B-NP
cells NNS I-NP
. . O

Activity NN B-NP
of IN B-PP
the DT B-NP
mitogen-activated JJ I-NP
protein NN I-NP
kinase NN I-NP
family NN I-NP
with IN B-PP
associated JJ B-NP
phosphorylation NN I-NP
of IN B-PP
c-Jun NN B-NP
Y-peptide NN I-NP
was VBD B-VP
markedly RB I-VP
diminished VBN I-VP
in IN B-PP
TPA-treated JJ B-NP
HL-60\/vinc NN I-NP
cells NNS I-NP
COMMA COMMA O
but CC O
not RB B-PP
in IN I-PP
response NN I-PP
to TO I-PP
okadaic JJ B-NP
acid NN I-NP
. . O

Taken VBN B-VP
together RB B-ADVP
COMMA COMMA O
these DT B-NP
findings NNS I-NP
suggest VBP B-VP
that IN B-SBAR
vincristine NN B-NP
resistance NN I-NP
confers VBZ B-VP
insensitivity NN B-NP
to TO B-PP
TPA-induced JJ B-NP
differentiation NN I-NP
and CC O
can MD B-VP
include VB I-VP
defects NNS B-NP
in IN B-PP
PKC-mediated JJ B-NP
signaling NN I-NP
events NNS I-NP
and CC O
induction NN B-NP
of IN B-PP
jun\/fos NN B-NP
early JJ I-NP
response NN I-NP
gene NN I-NP
expression NN I-NP
. . O

Differential JJ B-NP
contribution NN I-NP
of IN B-PP
herpes NN B-NP
simplex NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
gene NN B-NP
products NNS I-NP
and CC O
cellular JJ B-NP
factors NNS I-NP
to TO B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
provirus NN I-NP
. . O

We PRP B-NP
have VBP B-VP
previously RB I-VP
reported VBN I-VP
that IN B-SBAR
infection NN B-NP
with IN B-PP
herpes NN B-NP
simplex NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HSV-1 NN B-NP
) ) O
activates VBZ B-VP
expression NN B-NP
of IN B-PP
the DT O
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HIV-1 NN B-NP
) ) O
provirus NN B-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
. . O

Activation NN B-NP
of IN B-PP
the DT B-NP
HIV-1 NN I-NP
provirus NN I-NP
correlated VBD B-VP
with IN B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
binding NN B-NP
of IN B-PP
55- CD B-NP
and CC O
85-kDa JJ B-ADJP
proteins NNS B-NP
to TO B-PP
the DT B-NP
kappa NN I-NP
B NN I-NP
enhancer NN I-NP
and CC O
binding NN B-NP
of IN B-PP
the DT B-NP
50-kDa JJ I-NP
HLP-1 NN I-NP
protein NN I-NP
to TO B-PP
the DT B-NP
LBP-1 NN I-NP
sequences NNS I-NP
of IN B-PP
the DT B-NP
HIV-1 NN I-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
. . O

Further RB B-NP
examination NN I-NP
of IN B-PP
this DT B-NP
system NN I-NP
has VBZ B-VP
shown VBN I-VP
that IN B-SBAR
the DT B-NP
inhibition NN I-NP
of IN B-PP
HSV-1 NN B-NP
replication NN I-NP
by IN B-PP
the DT B-NP
antiviral JJ I-NP
drug NN I-NP
acyclovir NN I-NP
does VBZ B-VP
not RB I-VP
inhibit VB I-VP
HSV-1-mediated JJ B-NP
induction NN I-NP
of IN B-PP
HIV-1 NN B-NP
provirus NN I-NP
. . O

Surprisingly RB B-ADVP
COMMA COMMA O
the DT O
NF-kappa NN B-NP
B NN I-NP
and CC O
HLP-1 NN B-NP
binding NN B-NP
activities NNS I-NP
were VBD B-VP
substantially RB I-VP
inhibited VBN I-VP
in IN B-PP
acyclovir-treated JJ B-NP
cells NNS I-NP
. . O

In IN B-PP
the DT B-NP
transient-transfection JJ I-NP
assay NN I-NP
COMMA COMMA O
ICP0 NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
ICP4 NN B-NP
COMMA COMMA O
activated VBD B-VP
the DT B-NP
HIV-1 NN I-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
promoter NN I-NP
region NN I-NP
and CC O
the DT B-NP
effect NN I-NP
of IN B-PP
ICP0 NN B-NP
was VBD B-VP
greatly RB I-VP
enhanced VBN I-VP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
binding NN I-NP
proteins NNS I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
induction NN B-NP
of IN B-PP
the DT B-NP
HIV-1 NN I-NP
provirus NN I-NP
involves VBZ B-VP
cooperation NN B-NP
between IN B-PP
the DT B-NP
HSV-1-activated JJ I-NP
cellular JJ I-NP
factor NN I-NP
COMMA COMMA O
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
virus-encoded JJ I-NP
transactivator NN I-NP
COMMA COMMA O
ICP0 NN B-NP
. . O

Glucocorticoid NN B-NP
receptors NNS I-NP
in IN B-PP
mononuclear JJ B-NP
cells NNS I-NP
of IN B-PP
patients NNS B-NP
with IN B-PP
sepsis NN B-NP
. . O

Glucocorticoid NN B-NP
receptor NN I-NP
( ( O
GR NN B-NP
) ) O
hormone-binding NN B-NP
activity NN I-NP
was VBD B-VP
studied VBN I-VP
by IN B-PP
a DT B-NP
whole-cell JJ I-NP
method NN I-NP
in IN B-PP
mononuclear JJ B-NP
cells NNS I-NP
( ( O
MNC NN B-NP
) ) O
from IN B-PP
peripheral JJ B-NP
blood NN I-NP
of IN B-PP
7 CD B-NP
patients NNS I-NP
during IN B-PP
the DT B-NP
hemodynamic JJ I-NP
compensatory JJ I-NP
phase NN I-NP
of IN B-PP
sepsis NN B-NP
. . O

4 CD B-NP
patients NNS I-NP
were VBD B-VP
receiving VBG I-VP
dopamine NN B-NP
COMMA COMMA O
which WDT B-NP
did VBD B-VP
not RB I-VP
affect VB I-VP
the DT B-NP
GR NN I-NP
count NN I-NP
. . O

The DT B-NP
patients NNS I-NP
' POS B-NP
plasma NN I-NP
cortisol NN I-NP
concentrations NNS I-NP
were VBD B-VP
normal JJ B-ADJP
or CC O
slightly RB B-ADJP
elevated JJ I-ADJP
. . O

Despite IN B-PP
a DT B-NP
wide JJ I-NP
range NN I-NP
COMMA COMMA O
the DT B-NP
mean NN I-NP
GR NN I-NP
count NN B-NP
and CC O
affinity NN B-NP
in IN B-PP
MNC NN B-NP
from IN B-PP
septic JJ B-NP
patients NNS I-NP
did VBD B-VP
not RB I-VP
differ VB I-VP
from IN B-PP
those DT B-NP
in IN B-PP
normal JJ B-NP
controls NNS I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
glucocorticoids NNS B-NP
could MD B-VP
still RB I-VP
be VB I-VP
effective JJ B-ADJP
in IN B-PP
the DT B-NP
hemodynamic JJ I-NP
compensatory JJ I-NP
phase NN I-NP
of IN B-PP
sepsis NN B-NP
. . O

Dependence NN B-NP
for IN B-PP
the DT B-NP
proliferative JJ I-NP
response NN I-NP
to TO B-PP
erythropoietin NN B-NP
on IN B-PP
an DT B-NP
established JJ I-NP
erythroid JJ I-NP
differentiation NN I-NP
program NN I-NP
in IN B-PP
a DT B-NP
human JJ I-NP
hematopoietic JJ I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
UT-7 NN B-NP
. . O

Erythroid JJ B-NP
differentiation NN I-NP
involves VBZ B-VP
the DT B-NP
activation NN I-NP
of IN B-PP
a DT B-NP
number NN I-NP
of IN B-PP
erythroid-specific JJ B-NP
genes NNS I-NP
COMMA COMMA O
most JJS B-NP
of IN B-PP
which WDT B-NP
COMMA COMMA O
including VBG B-PP
the DT B-NP
globin NN I-NP
genes NNS I-NP
and CC O
the DT B-NP
erythropoietin NN I-NP
receptor NN I-NP
( ( O
Epo-R NN B-NP
) ) O
gene NN B-NP
COMMA COMMA O
are VBP B-VP
COMMA COMMA O
at IN B-ADVP
least JJS I-ADVP
in IN B-PP
part NN B-NP
COMMA COMMA O
regulated VBN B-VP
by IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
GATA-1 NN I-NP
. . O

In IN B-SBAR
order NN O
to TO O
understand VB B-VP
the DT B-NP
relationship NN I-NP
COMMA COMMA O
if IN B-SBAR
any DT B-NP
COMMA COMMA O
between IN B-PP
expression NN B-NP
of IN B-PP
GATA-1 NN B-NP
COMMA COMMA O
response NN B-NP
to TO B-PP
Epo NN B-NP
and CC O
erythroid JJ B-NP
differentiation NN I-NP
COMMA COMMA O
we PRP B-NP
analyzed VBD B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
GATA-1 NN B-NP
COMMA COMMA O
Epo-R NN B-NP
and CC O
globin NN B-NP
genes NNS I-NP
in IN B-PP
an DT B-NP
Epo-dependent JJ I-NP
human JJ I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
UT-7 NN B-NP
Epo NN I-NP
. . O

The DT B-NP
results NNS I-NP
were VBD B-VP
compared VBN I-VP
to TO B-PP
those DT B-NP
obtained VBN B-VP
with IN B-PP
the DT B-NP
parental JJ I-NP
granulocyte-macrophage JJ I-NP
colony-stimulating JJ I-NP
factor NN I-NP
( ( I-NP
GM-CSF NN I-NP
) ) I-NP
-dependent JJ I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
UT-7 NN B-NP
COMMA COMMA O
which WDT B-NP
has VBZ B-VP
a DT B-NP
predominantly RB I-NP
megakaryoblastic JJ I-NP
phenotype NN I-NP
and CC O
is VBZ B-VP
unable JJ B-ADJP
to TO B-VP
proliferate VB I-VP
continuously RB B-ADVP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
Epo NN B-NP
. . O

UT-7 NN B-NP
Epo NN I-NP
and CC O
UT-7 NN B-NP
expressed VBD B-VP
similar JJ B-NP
levels NNS I-NP
of IN B-PP
GATA-1 NN B-NP
mRNA NN I-NP
and CC O
binding NN B-NP
activity NN I-NP
. . O

The DT B-NP
two CD I-NP
lines NNS I-NP
also RB B-ADVP
expressed VBD B-VP
comparable JJ B-NP
levels NNS I-NP
of IN B-PP
Epo-R NN B-NP
mRNA NN I-NP
while IN B-SBAR
the DT B-NP
number NN I-NP
of IN B-PP
Epo-binding JJ B-NP
sites NNS I-NP
on IN B-PP
UT-7 NN B-NP
Epo NN I-NP
cells NNS I-NP
was VBD B-VP
one-sixth CD B-NP
the DT I-NP
number NN I-NP
of IN B-PP
UT-7 NN B-NP
cells NNS I-NP
( ( O
2400 CD B-NP
+\/- CC I-NP
3 CD I-NP
vs. CC O
13COMMA800 CD B-NP
+\/- CC I-NP
300 CD I-NP
) ) O
. . O

This DT B-NP
difference NN I-NP
in IN B-PP
the DT B-NP
number NN I-NP
of IN B-PP
binding VBG B-NP
sites NNS I-NP
could MD B-VP
be VB I-VP
due JJ B-PP
to TO I-PP
differences NNS B-NP
in IN B-PP
cell NN B-NP
surface NN I-NP
( ( O
UT-7 NN B-NP
cells NNS I-NP
are VBP B-VP
20 CD B-NP
% NN I-NP
smaller JJR B-ADJP
than IN B-PP
the DT B-NP
parental JJ I-NP
UT-7 NN I-NP
cells NNS I-NP
) ) O
or CC B-PP
in IN B-PP
receptor NN B-NP
turnover NN I-NP
. . O

By IN B-PP
Northern NN B-NP
analysis NN I-NP
COMMA COMMA O
UT-7 NN B-NP
cells NNS I-NP
expressed VBD B-VP
detectable JJ B-NP
levels NNS I-NP
of IN B-PP
beta- NN B-NP
and CC O
gamma-globin NN B-NP
but CC B-CONJP
not RB I-CONJP
alpha-globin NN B-NP
. . O

In IN B-PP
comparison NN B-NP
COMMA COMMA O
UT-7 NN B-NP
Epo NN I-NP
cells NNS I-NP
expressed VBD B-VP
alpha-globin NN B-NP
and CC O
higher JJR B-NP
levels NNS I-NP
of IN B-PP
gamma-globin NN B-NP
( ( O
5-fold JJ B-ADJP
) ) O
and CC O
beta-globin NN B-NP
( ( O
from IN B-PP
barely RB B-ADVP
to TO B-PP
clearly RB B-ADVP
detectable JJ B-ADJP
) ) O
. . O

Globin NN B-NP
chains NNS I-NP
( ( O
alpha NN B-NP
COMMA COMMA O
beta NN B-NP
and CC O
gamma NN B-NP
) ) O
were VBD B-VP
clearly RB B-ADJP
detectable JJ I-ADJP
by IN B-PP
affinity NN B-NP
chromatography NN I-NP
in IN B-PP
UT-7 NN B-NP
Epo NN I-NP
but CC B-CONJP
not RB I-CONJP
in IN B-PP
UT-7 NN B-NP
cells NNS I-NP
. . O

The DT B-NP
frequency NN I-NP
of IN B-PP
the DT B-NP
cells NNS I-NP
which WDT B-NP
expressed VBD B-VP
beta- NN B-NP
and CC O
gamma-globin NN B-NP
genes NNS I-NP
in IN B-PP
the DT B-NP
two CD I-NP
cell NN I-NP
populations NNS I-NP
was VBD B-VP
measured VBN I-VP
by IN B-PP
immunofluorescence NN B-NP
with IN B-PP
beta- NN B-NP
and CC O
gamma-specific JJ B-ADJP
antibodies NNS B-NP
. . O

The DT B-NP
number NN I-NP
of IN B-PP
gamma-positive JJ B-NP
cells NNS I-NP
and CC O
their PRP$ B-NP
fluorescence NN I-NP
intensity NN I-NP
were VBD B-VP
higher JJR B-ADJP
in IN B-PP
UT-7 NN B-NP
Epo NN I-NP
than IN B-PP
in IN B-PP
UT-7 NN B-NP
cells NNS I-NP
( ( O
0 CD B-NP
to TO I-NP
17 CD I-NP
% NN I-NP
barely RB B-NP
positive JJ I-NP
cells NNS I-NP
and CC O
23 CD B-NP
to TO I-NP
40 CD I-NP
% NN I-NP
clearly RB B-NP
positive JJ I-NP
cells NNS I-NP
COMMA COMMA O
respectively RB B-ADVP
) ) O
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
the DT B-NP
increase NN I-NP
in IN B-PP
globin NN B-NP
mRNA NN I-NP
observed VBN B-VP
in IN B-PP
UT-7 NN B-NP
Epo NN I-NP
is VBZ B-VP
due JJ B-PP
to TO I-PP
both CC O
an DT B-NP
increase NN I-NP
of IN B-PP
gene NN B-NP
expression NN I-NP
per IN B-PP
cell NN B-NP
and CC O
an DT B-NP
increase NN I-NP
in IN B-PP
numbers NNS B-NP
of IN B-PP
cells NNS B-NP
containing VBG B-VP
gamma-globin NN B-NP
. . O

The DT B-NP
levels NNS I-NP
of IN B-PP
GATA-1 NN B-NP
COMMA COMMA O
Epo-R NN B-NP
and CC O
globin NN B-NP
mRNA NN I-NP
expressed VBN B-VP
were VBD B-VP
not RB I-VP
affected VBN I-VP
by IN B-PP
a DT B-NP
24-hour JJ I-NP
incubation NN I-NP
of IN B-PP
either CC B-NP
cell NN I-NP
line NN I-NP
with IN B-PP
Epo NN B-NP
COMMA COMMA O
GM-CSF NN B-NP
or CC O
interleukin-3 NN B-NP
( ( O
IL-3 NN B-NP
) ) O
. . O

( ( O
ABSTRACT NN B-NP
TRUNCATED VBN B-VP
AT IN B-PP
400 CD B-NP
WORDS NNS I-NP
) ) O

Transcriptional JJ B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
macrophage NN I-NP
colony-stimulating JJ I-NP
factor NN I-NP
gene NN I-NP
by IN B-PP
IL-2 NN B-NP
is VBZ B-VP
associated VBN I-VP
with IN B-PP
secretion NN B-NP
of IN B-PP
bioactive JJ B-NP
macrophage NN I-NP
colony-stimulating JJ I-NP
factor NN I-NP
protein NN I-NP
by IN B-PP
monocytes NNS B-NP
and CC O
involves VBZ B-VP
activation NN B-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
NF-kappa NN I-NP
B NN I-NP
. . O

Human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
monocytes NNS B-NP
( ( O
Mo NN B-NP
) ) O
constitutively RB B-ADVP
display VBP B-VP
the DT B-NP
beta-chain NN I-NP
of IN B-PP
the DT B-NP
receptor NN I-NP
for IN B-PP
IL-2 NN B-NP
COMMA COMMA O
whereas IN O
expression NN B-NP
of IN B-PP
the DT B-NP
IL-2R NN I-NP
alpha-chain NN I-NP
is VBZ B-VP
not RB B-ADJP
constitutive JJ B-ADJP
but CC O
inducible JJ B-ADJP
with IN B-PP
IL-2 NN B-NP
. . O

Here RB B-ADVP
we PRP B-NP
report VBP B-VP
that IN B-SBAR
binding NN B-NP
of IN B-PP
human JJ B-NP
IL-2 NN I-NP
to TO B-PP
its PRP$ B-NP
binding VBG I-NP
site NN I-NP
leads VBZ B-VP
to TO B-PP
transcriptional JJ B-NP
activation NN I-NP
of IN B-PP
the DT O
macrophage NN B-NP
CSF NN I-NP
( ( O
M-CSF NN B-NP
) ) O
gene NN B-NP
in IN B-PP
Mo NN B-NP
resulting VBG B-VP
in IN B-PP
accumulation NN B-NP
of IN B-PP
M-CSF NN B-NP
mRNA NN I-NP
and CC O
subsequent JJ B-NP
release NN I-NP
of IN B-PP
bioactive JJ B-NP
M-CSF NN I-NP
protein NN I-NP
as IN B-SBAR
demonstrated VBN B-VP
by IN B-PP
ELISA NN B-NP
and CC O
inhibition NN B-NP
of IN B-PP
IL-2 NN B-NP
induced JJ I-NP
release NN I-NP
of IN B-PP
an DT B-NP
activity-stimulating JJ I-NP
growth NN I-NP
of IN B-PP
monocyte-type JJ B-NP
colonies NNS I-NP
by IN B-PP
a DT B-NP
neutralizing VBG I-NP
anti-M-CSF JJ I-NP
antibody NN I-NP
. . O

Transcriptional JJ B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
M-CSF NN I-NP
gene NN I-NP
by IN B-PP
IL-2 NN B-NP
is VBZ B-VP
preceded VBN I-VP
by IN B-PP
enhanced VBN B-NP
binding NN I-NP
activity NN I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
NF-kappa NN I-NP
B NN I-NP
to TO B-PP
its PRP$ B-NP
recognition NN I-NP
sequence NN I-NP
in IN B-PP
the DT B-NP
5' JJ I-NP
regulatory JJ I-NP
enhancer NN I-NP
region NN I-NP
of IN B-PP
the DT B-NP
M-CSF NN I-NP
gene NN I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
using VBG B-VP
a DT B-NP
heterologous JJ I-NP
promoter NN I-NP
( ( O
herpes NN B-NP
thymidine NN I-NP
kinase NN I-NP
) ) O
construct NN B-NP
containing VBG B-VP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
consensus NN I-NP
sequence NN I-NP
COMMA COMMA O
it PRP B-NP
is VBZ B-VP
shown VBN I-VP
that IN B-SBAR
NF-kappa NN B-NP
B NN I-NP
binding NN I-NP
by IN B-PP
an DT B-NP
IL-2-induced JJ I-NP
monocyte-derived JJ I-NP
nuclear JJ I-NP
protein NN I-NP
confers VBZ B-VP
reporter NN B-NP
gene NN I-NP
( ( O
human JJ B-NP
growth NN I-NP
hormone NN I-NP
) ) O
activity NN B-NP
. . O

Taken VBN B-VP
together RB B-ADVP
COMMA COMMA O
our PRP$ B-NP
findings NNS I-NP
indicate VBP B-VP
that IN B-SBAR
IL-2 NN B-NP
induces VBZ B-VP
gene NN B-NP
expression NN I-NP
of IN B-PP
M-CSF NN B-NP
in IN B-PP
human JJ B-NP
blood-derived JJ I-NP
Mo NN I-NP
and CC O
provide VBP B-VP
evidence NN B-NP
for IN B-PP
involvement NN B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
transcriptional JJ B-NP
regulation NN I-NP
of IN B-PP
this DT B-NP
gene NN I-NP
. . O

Comparative JJ B-NP
analysis NN I-NP
of IN B-PP
NFAT NN B-NP
( ( O
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
) ) O
complex JJ B-NP
in IN B-PP
human JJ O
T NN B-NP
and CC O
B NN B-NP
lymphocytes NNS B-NP
. . O

Nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
( ( O
NFAT NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
transcriptional JJ I-NP
activator NN I-NP
that WDT B-NP
binds VBZ B-VP
to TO B-PP
sequences NNS B-NP
in IN B-PP
the DT O
interleukin-2 NN B-NP
( ( O
IL-2 NN B-NP
) ) O
promoter NN B-NP
and CC O
is VBZ B-VP
thought VBN I-VP
to TO I-VP
be VB I-VP
largely RB B-ADJP
responsible JJ I-ADJP
for IN B-PP
the DT B-NP
T NN I-NP
cell-specific JJ I-NP
inducibility NN I-NP
of IN B-PP
IL-2 NN B-NP
expression NN I-NP
. . O

Electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
( ( O
EMSA NN B-NP
) ) O
showed VBD B-VP
that IN B-SBAR
specific JJ B-NP
NFAT NN I-NP
binding NN I-NP
activity NN I-NP
could MD B-VP
also RB I-VP
be VB I-VP
induced VBN I-VP
in IN B-PP
human JJ B-NP
B NN I-NP
cells NNS I-NP
. . O

The DT B-NP
B NN I-NP
cell NN I-NP
NFAT NN I-NP
complex NN I-NP
COMMA COMMA O
however RB B-ADVP
COMMA COMMA O
was VBD B-VP
not RB O
functional JJ B-ADJP
COMMA COMMA O
since IN B-SBAR
it PRP B-NP
failed VBD B-VP
to TO I-VP
activate VB I-VP
transcription NN B-NP
from IN B-PP
an DT O
NFAT-driven JJ O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
( ( O
CAT NN B-NP
) ) O
construct NN B-NP
. . O

Competition NN B-NP
with IN B-PP
an DT B-NP
AP-1 NN I-NP
motif NN I-NP
or CC B-PP
with IN B-PP
anti-Jun JJ B-NP
and CC I-NP
anti-Fos JJ I-NP
antibodies NNS I-NP
abolished VBD B-VP
binding NN B-NP
to TO B-PP
the DT B-NP
NFAT NN I-NP
motif NN I-NP
in IN B-PP
both CC O
T NN B-NP
and CC O
B NN B-NP
cells NNS B-NP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
Jun NN B-NP
and CC O
Fos NN B-NP
are VBP B-VP
critical JJ B-ADJP
for IN B-PP
NFAT NN B-NP
complex NN I-NP
formation NN I-NP
in IN B-PP
both DT B-NP
cell NN I-NP
types NNS I-NP
. . O

Purified VBN O
recombinant JJ O
Jun NN B-NP
and CC O
Fos NN B-NP
proteins NNS B-NP
failed VBD B-VP
to TO I-VP
bind VB I-VP
directly RB B-ADVP
to TO B-PP
the DT B-NP
NFAT NN I-NP
motif NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
when WRB B-ADVP
combined VBN B-VP
with IN B-PP
unstimulated JJ O
B NN B-NP
or CC O
T NN B-NP
cell NN B-NP
extracts NNS I-NP
COMMA COMMA O
full-length JJ B-NP
COMMA COMMA I-NP
but CC I-NP
not RB I-NP
truncated VBN I-NP
COMMA COMMA I-NP
Jun\/Fos NN I-NP
heterodimers NNS I-NP
were VBD B-VP
able JJ B-ADJP
to TO B-VP
form VB I-VP
an DT B-NP
NFAT NN I-NP
complex NN I-NP
COMMA COMMA O
indicating VBG B-VP
the DT B-NP
presence NN I-NP
of IN B-PP
a DT B-NP
constitutively RB I-NP
expressed VBN I-NP
nuclear JJ I-NP
factor NN I-NP
( ( I-NP
s NNS I-NP
) ) O
in IN B-PP
B NN B-NP
and CC O
T NN B-NP
cells NNS B-NP
necessary JJ B-ADJP
for IN B-PP
the DT B-NP
formation NN I-NP
of IN B-PP
the DT B-NP
NFAT NN I-NP
complex NN I-NP
in IN B-PP
both DT B-NP
cell NN I-NP
types NNS I-NP
. . O

An DT B-NP
NFAT NN I-NP
oligonucleotide NN I-NP
carrying VBG B-VP
mutations NNS B-NP
in IN B-PP
the DT B-NP
5' JJ I-NP
purine-rich JJ I-NP
part NN I-NP
of IN B-PP
the DT B-NP
NFAT NN I-NP
sequence NN I-NP
failed VBD B-VP
to TO I-VP
form VB I-VP
a DT B-NP
complex NN I-NP
and CC O
to TO B-VP
compete VB I-VP
with IN B-PP
the DT B-NP
wild JJ I-NP
type NN I-NP
motif NN I-NP
for IN B-PP
NFAT NN B-NP
complex NN I-NP
formation NN I-NP
in IN B-PP
both CC O
T NN B-NP
and CC O
B NN B-NP
cells NNS B-NP
. . O

We PRP B-NP
therefore RB B-ADVP
propose VBP B-VP
a DT B-NP
model NN I-NP
whereby WRB B-ADVP
a DT B-NP
core NN I-NP
NFAT NN I-NP
complex NN I-NP
consisting VBG B-VP
of IN B-PP
Jun NN B-NP
COMMA COMMA O
Fos NN B-NP
COMMA COMMA O
and CC O
a DT B-NP
constitutive JJ I-NP
nuclear JJ I-NP
factor NN I-NP
is VBZ B-VP
formed VBN I-VP
in IN B-PP
both DT B-NP
T NN B-NP
and CC O
B NN B-NP
cells NNS B-NP
COMMA COMMA O
but CC O
an DT B-NP
additional JJ I-NP
factor NN I-NP
and\/or CC O
post-translational JJ B-NP
modification NN I-NP
of IN B-PP
a DT B-NP
factor NN I-NP
COMMA COMMA O
missing VBG B-ADJP
in IN B-PP
B NN B-NP
cells NNS I-NP
COMMA COMMA O
might MD B-VP
be VB I-VP
required VBN I-VP
for IN B-PP
transactivation NN B-NP
by IN B-PP
NFAT NN B-NP
. . O

1COMMA25-Dihydroxy NN B-NP
vitamin NN I-NP
D3 NN I-NP
and CC O
12-O-tetradecanoyl NN B-NP
phorbol-13-acetate NN I-NP
synergistically RB B-ADVP
induce VBP B-VP
monocytic JJ B-NP
cell NN I-NP
differentiation NN I-NP
: : O
FOS NN B-NP
and CC O
RB NN B-NP
expression NN B-NP
. . O

1COMMA25-dihydroxy NN B-NP
vitamin NN I-NP
D3 NN I-NP
and CC O
12-O-tetradecanoyl NN B-NP
phorbol-13-acetate NN I-NP
( ( O
TPA NN B-NP
) ) O
interact VBP B-VP
synergistically RB I-VP
to TO I-VP
induce VB I-VP
monocytic JJ B-NP
differentiation NN I-NP
of IN B-PP
U937 NN B-NP
histiocytic JJ I-NP
lymphoma NN I-NP
cells NNS I-NP
. . O

Addition NN B-NP
of IN B-PP
TPA NN B-NP
causes VBZ B-VP
an DT B-NP
otherwise JJ I-NP
ineffective JJ I-NP
dose NN I-NP
of IN B-PP
1COMMA25-dihydroxy NN B-NP
vitamin NN I-NP
D3 NN I-NP
to TO B-VP
induce VB I-VP
differentiation NN B-NP
. . O

The DT B-NP
induced VBD I-NP
differentiation NN I-NP
depends VBZ B-VP
on IN B-PP
the DT B-NP
simultaneous JJ I-NP
( ( I-NP
vs. CC I-NP
sequential JJ I-NP
) ) I-NP
presence NN I-NP
of IN B-PP
both DT B-NP
agents NNS I-NP
. . O

The DT B-NP
kinetics NNS I-NP
of IN B-PP
induced JJ B-NP
differentiation NN I-NP
are VBP B-VP
consistent JJ B-ADJP
with IN B-PP
a DT B-NP
G1 NN I-NP
specific JJ I-NP
cellular JJ I-NP
response NN I-NP
to TO B-VP
initiate VB I-VP
the DT B-NP
metabolic JJ I-NP
cascade NN I-NP
culminating VBG B-VP
in IN B-PP
cell NN B-NP
differentiation NN I-NP
. . O

The DT B-NP
induced VBD I-NP
differentiation NN I-NP
occurs VBZ B-VP
with IN B-PP
down-regulation NN B-NP
of IN B-PP
c-fos NN B-NP
protein NN I-NP
and CC O
an DT B-NP
accompanying VBG I-NP
up-regulation NN I-NP
of IN B-PP
RB NN B-NP
protein NN I-NP
expression NN I-NP
COMMA COMMA O
consistent JJ B-ADJP
with IN B-PP
a DT B-NP
possible JJ I-NP
need NN I-NP
for IN B-SBAR
up-regulated JJ B-NP
RB NN I-NP
expression NN I-NP
to TO B-VP
maintain VB I-VP
a DT B-NP
given JJ I-NP
differentiated VBN I-NP
phenotype NN I-NP
and CC O
suppress VB B-VP
transcriptional JJ B-NP
activators NNS I-NP
that WDT B-NP
might MD B-VP
typically RB I-VP
be VB I-VP
associated VBN I-VP
with IN B-PP
proliferation NN B-NP
. . O

Regulation NN B-NP
of IN B-PP
lymphoid-specific JJ B-NP
immunoglobulin NN I-NP
mu NN I-NP
heavy NN I-NP
chain NN I-NP
gene NN I-NP
enhancer NN I-NP
by IN B-PP
ETS-domain JJ B-NP
proteins NNS I-NP
. . O

The DT B-NP
enhancer NN I-NP
for IN B-PP
the DT B-NP
immunoglobulin NN I-NP
mu NN I-NP
heavy NN I-NP
chain NN I-NP
gene NN I-NP
( ( O
IgH NN B-NP
) ) O
activates VBZ B-VP
a DT B-NP
heterologous JJ I-NP
gene NN I-NP
at IN B-PP
the DT B-NP
pre-B JJ I-NP
cell NN I-NP
stage NN I-NP
of IN B-PP
B NN B-NP
lymphocyte NN I-NP
differentiation NN I-NP
. . O

A DT B-NP
lymphoid-specific JJ I-NP
element NN I-NP
COMMA COMMA O
microB NN B-NP
COMMA COMMA O
is VBZ B-VP
necessary JJ B-ADJP
for IN B-PP
enhancer NN B-NP
function NN I-NP
in IN B-PP
pre-B JJ B-NP
cells NNS I-NP
. . O

A DT B-NP
microB NN I-NP
binding NN I-NP
protein NN I-NP
is VBZ B-VP
encoded VBN I-VP
by IN B-PP
the DT B-NP
PU.1\/Spi-1 NN I-NP
proto-oncogene NN I-NP
. . O

Another DT B-NP
sequence NN I-NP
element NN I-NP
COMMA COMMA O
microA NN B-NP
COMMA COMMA O
was VBD B-VP
identified VBN I-VP
in IN B-PP
the DT B-NP
mu NN I-NP
enhancer NN I-NP
that WDT B-NP
binds VBZ B-VP
the DT B-NP
product NN I-NP
of IN B-PP
the DT B-NP
ets-1 NN I-NP
proto-oncogene NN I-NP
. . O

The DT B-NP
microA NN I-NP
motif NN I-NP
was VBD B-VP
required VBN I-VP
for IN B-PP
microB-dependent JJ B-NP
enhancer NN I-NP
activity NN I-NP
COMMA COMMA O
which WDT B-NP
suggests VBZ B-VP
that IN B-SBAR
a DT B-NP
minimal JJ I-NP
B NN I-NP
cell-specific JJ I-NP
enhancer NN I-NP
is VBZ B-VP
composed VBN I-VP
of IN B-PP
both CC O
the DT O
PU.1 NN B-NP
and CC O
Ets-1 NN B-NP
binding NN B-NP
sites NNS I-NP
. . O

Co-expression NN B-NP
of IN B-PP
both CC O
PU.1 NN B-NP
and CC O
Ets-1 NN B-NP
in IN B-PP
nonlymphoid JJ B-NP
cells NNS I-NP
trans-activated JJ B-VP
reporter NN B-NP
plasmids NNS I-NP
that WDT B-NP
contained VBD B-VP
the DT B-NP
minimal JJ I-NP
mu NN I-NP
enhancer NN I-NP
. . O

These DT B-NP
results NNS I-NP
implicate VBP B-VP
two CD B-NP
members NNS I-NP
of IN B-PP
the DT B-NP
Ets NN I-NP
family NN I-NP
in IN B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
IgH NN B-NP
gene NN I-NP
expression NN I-NP
. . O

Differential JJ B-NP
autoregulation NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
expression NN I-NP
in IN B-PP
human JJ O
T- NN B-NP
and CC O
B-cell NN B-NP
lines NNS B-NP
. . O

Regulation NN B-NP
of IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
( ( O
GR NN B-NP
) ) O
expression NN B-NP
by IN B-PP
its PRP$ B-NP
cognate JJ I-NP
ligand NN I-NP
was VBD B-VP
examined VBN I-VP
in IN B-PP
the DT B-NP
glucocorticoid-sensitive JJ I-NP
human JJ I-NP
leukemic JJ I-NP
T-cell NN I-NP
line NN I-NP
6TG1.1 NN I-NP
and CC B-PP
in IN B-PP
the DT B-NP
human JJ I-NP
B-cell NN I-NP
line NN I-NP
IM-9 NN I-NP
. . O

In IN B-PP
contrast NN I-PP
to TO I-PP
the DT B-NP
decrease NN I-NP
in IN B-PP
GR NN B-NP
mRNA NN I-NP
seen VBN B-VP
in IN B-PP
IM-9 NN B-NP
cells NNS I-NP
after IN B-PP
treatment NN B-NP
with IN B-PP
1 CD B-NP
microM NN I-NP
dexamethasone NN I-NP
for IN B-PP
16-18 CD B-NP
h NN I-NP
COMMA COMMA O
treatment NN B-NP
of IN B-PP
6TG1.1 NN B-NP
cells NNS I-NP
resulted VBD B-VP
in IN B-PP
an DT B-NP
8-fold JJ I-NP
increase NN I-NP
in IN B-PP
GR NN B-NP
mRNA NN I-NP
COMMA COMMA O
as IN B-SBAR
determined VBN B-VP
by IN B-PP
Northern NN B-NP
blot NN I-NP
and CC O
RNase NN B-NP
protection NN I-NP
analysis NN B-NP
COMMA COMMA O
with IN B-PP
a DT O
corresponding JJ O
3- CD B-NP
to TO O
4-fold JJ B-ADJP
increase NN B-NP
in IN B-PP
GR NN B-NP
protein NN I-NP
. . O

Half-maximal JJ B-NP
induction NN I-NP
of IN B-PP
GR NN B-NP
mRNA NN B-NP
and CC O
protein NN B-NP
in IN B-PP
6TG1.1 NN B-NP
cells NNS I-NP
was VBD B-VP
observed VBN I-VP
between IN B-PP
10-100 CD B-NP
nM NN I-NP
dexamethasone NN I-NP
COMMA COMMA O
and CC O
inclusion NN B-NP
of IN B-PP
1 CD B-NP
microM NN I-NP
RU NN I-NP
38486 CD I-NP
completely RB B-ADVP
blocked VBD B-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
100 CD B-NP
nM NN I-NP
dexamethasone NN I-NP
COMMA COMMA O
demonstrating VBG B-VP
that IN B-SBAR
positive JJ B-NP
autoregulation NN I-NP
of IN B-PP
GR NN B-NP
expression NN I-NP
in IN B-PP
6TG1.1 NN B-NP
cells NNS I-NP
is VBZ B-VP
a DT B-NP
receptor-mediated JJ I-NP
response NN I-NP
. . O

Positive JJ B-NP
autoregulation NN I-NP
of IN B-PP
GR NN B-NP
expression NN I-NP
was VBD B-VP
also RB I-VP
observed VBN I-VP
in IN B-PP
glucocorticoid-resistant JJ B-NP
CEM-C1 NN I-NP
cells NNS I-NP
COMMA COMMA O
which WDT B-NP
contain VBP B-VP
functional JJ B-NP
GR NN I-NP
COMMA COMMA O
but CC O
whose WP$ B-NP
growth NN I-NP
is VBZ B-VP
unaffected VBN I-VP
by IN B-PP
glucocorticoids NNS B-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
positive JJ B-NP
autoregulation NN I-NP
is VBZ B-VP
neither CC O
a DT B-NP
consequence NN I-NP
nor CC O
the DT B-NP
sole JJ I-NP
cause NN I-NP
of IN B-PP
growth NN B-NP
arrest NN I-NP
. . O

The DT B-NP
degree NN I-NP
of IN B-PP
negative JJ B-NP
autoregulation NN I-NP
in IN B-PP
IM-9 NN B-NP
cells NNS I-NP
and CC O
positive JJ B-NP
autoregulation NN I-NP
in IN B-PP
6TG1.1 NN B-NP
cells NNS I-NP
was VBD B-VP
unaffected VBN I-VP
by IN B-PP
inhibition NN B-NP
of IN B-PP
protein NN B-NP
synthesis NN I-NP
with IN B-PP
cycloheximide NN B-NP
. . O

Measurement NN B-NP
of IN B-PP
GR NN B-NP
mRNA NN I-NP
turnover NN I-NP
in IN B-PP
6TG1.1 NN B-NP
cells NNS I-NP
treated VBN B-VP
with IN B-PP
actinomycin-D NN B-NP
revealed VBD B-VP
a DT B-NP
half-life NN I-NP
of IN B-PP
2.5 CD B-NP
h NN I-NP
COMMA COMMA O
which WDT B-NP
was VBD B-VP
unaffected JJ I-VP
by IN B-PP
dexamethasone NN B-NP
treatment NN I-NP
. . O

A DT B-NP
similar JJ I-NP
half-life NN I-NP
was VBD B-VP
determined VBN I-VP
in IN B-PP
IM-9 NN B-NP
cells NNS I-NP
and CC O
was VBD B-VP
also RB I-VP
unaffected JJ I-VP
by IN B-PP
steroid NN B-NP
treatment NN I-NP
. . O

These DT B-NP
results NNS I-NP
are VBP B-VP
consistent JJ B-ADJP
with IN B-PP
the DT B-NP
interpretation NN I-NP
that IN B-SBAR
glucocorticoid-mediated JJ B-NP
autoregulation NN I-NP
of IN B-PP
GR NN B-NP
expression NN I-NP
is VBZ B-VP
a DT B-NP
tissue-specific JJ I-NP
primary JJ I-NP
transcriptional JJ I-NP
response NN I-NP
. . O

The DT B-NP
p65 NN I-NP
subunit NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
regulates VBZ B-VP
I NN B-NP
kappa NN I-NP
B NN I-NP
by IN B-PP
two CD B-NP
distinct JJ I-NP
mechanisms NNS I-NP
. . O

Transcription NN B-NP
factor NN I-NP
NF-kappa NN I-NP
B NN I-NP
( ( O
p50\/p65 NN B-NP
) ) O
is VBZ B-VP
generally RB I-VP
localized JJ I-VP
to TO B-PP
the DT B-NP
cytoplasm NN I-NP
by IN B-PP
its PRP$ B-NP
inhibitor NN I-NP
I NN I-NP
kappa NN I-NP
B NN I-NP
. . O

Overproduced JJ B-NP
I NN I-NP
kappa NN I-NP
B NN I-NP
COMMA COMMA O
free JJ B-ADJP
from IN B-PP
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
is VBZ B-VP
rapidly RB I-VP
degraded VBN I-VP
. . O

Overexpression NN B-NP
of IN B-PP
p65 NN B-NP
increases VBZ B-VP
endogenous JJ B-NP
I NN I-NP
kappa NN I-NP
B NN I-NP
protein NN I-NP
in IN B-PP
both CC O
carcinoma NN B-NP
and CC O
lymphoid JJ B-NP
cells NNS I-NP
by IN B-PP
two CD B-NP
mechanisms NNS I-NP
: : O
protein NN B-NP
stabilization NN I-NP
and CC O
increased VBN B-NP
transcription NN I-NP
of IN B-PP
I NN B-NP
kappa NN I-NP
B NN I-NP
mRNA NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
p65 NN B-NP
delta NN I-NP
COMMA COMMA O
a DT B-NP
naturally RB I-NP
occurring VBG I-NP
splice NN I-NP
variant NN I-NP
COMMA COMMA O
fails VBZ B-VP
to TO I-VP
markedly RB I-VP
augment VB I-VP
I NN B-NP
kappa NN I-NP
B NN I-NP
protein NN I-NP
levels NNS I-NP
. . O

Both CC O
overexpressed JJ B-NP
p65 NN I-NP
and CC O
coexpressed JJ B-NP
p50 NN I-NP
are VBP B-VP
cytoplasmic JJ B-ADJP
COMMA COMMA O
whereas IN O
p65 NN B-NP
delta NN I-NP
is VBZ B-VP
partly RB B-ADJP
nuclear JJ I-ADJP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
the DT B-NP
I NN I-NP
kappa NN I-NP
B NN I-NP
induced VBN B-VP
by IN B-PP
p65 NN B-NP
can MD B-VP
maintain VB I-VP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
the DT B-NP
cytoplasm NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
p65 NN B-NP
and CC O
I NN B-NP
kappa NN I-NP
B NN I-NP
are VBP B-VP
linked VBN I-VP
in IN B-PP
an DT B-NP
autoregulatory JJ I-NP
loop NN I-NP
COMMA COMMA O
ensuring VBG B-VP
that IN B-SBAR
NF-kappa NN B-NP
B NN I-NP
is VBZ B-VP
held VBN I-VP
in IN B-PP
the DT B-NP
cytoplasm NN I-NP
until IN B-SBAR
cells NNS B-NP
are VBP B-VP
specifically RB I-VP
induced VBN I-VP
to TO I-VP
translocate VB I-VP
it PRP B-NP
to TO B-PP
the DT B-NP
nucleus NN I-NP
. . O

Cell NN B-NP
cycle NN I-NP
analysis NN I-NP
of IN B-PP
E2F NN B-NP
in IN B-PP
primary JJ B-NP
human JJ I-NP
T NN I-NP
cells NNS I-NP
reveals VBZ B-VP
novel JJ B-NP
E2F NN I-NP
complexes NNS I-NP
and CC O
biochemically RB B-NP
distinct JJ I-NP
forms NNS I-NP
of IN B-PP
free JJ B-NP
E2F NN I-NP
. . O

The DT B-NP
transcription NN I-NP
factor NN I-NP
E2F NN I-NP
activates VBZ B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
multiple JJ B-NP
genes NNS I-NP
involved VBN B-VP
in IN B-PP
cell NN B-NP
proliferation NN I-NP
COMMA COMMA O
such JJ B-PP
as IN I-PP
c-myc NN B-NP
and CC O
the DT B-NP
dihydrofolate JJ I-NP
reductase NN I-NP
gene NN I-NP
. . O

Regulation NN B-NP
of IN B-PP
E2F NN B-NP
involves VBZ B-VP
its PRP$ B-NP
interactions NNS I-NP
with IN B-PP
other JJ B-NP
cellular JJ I-NP
proteins NNS I-NP
COMMA COMMA O
including VBG B-PP
the DT B-NP
retinoblastoma NN I-NP
protein NN I-NP
( ( O
Rb NN B-NP
) ) O
COMMA COMMA O
the DT B-NP
Rb-related JJ I-NP
protein NN I-NP
p107 NN I-NP
COMMA COMMA O
cyclin NN B-NP
A NN I-NP
COMMA COMMA O
and CC O
cdk2 NN B-NP
. . O

We PRP B-NP
undertook VBD B-VP
a DT B-NP
detailed JJ I-NP
analysis NN I-NP
of IN B-PP
E2F NN B-NP
DNA-binding JJ I-NP
activities NNS I-NP
and CC O
their PRP$ B-NP
cell NN I-NP
cycle NN I-NP
behavior NN I-NP
in IN B-PP
primary JJ B-NP
human JJ I-NP
T NN I-NP
cells NNS I-NP
. . O

Three CD B-NP
E2F NN I-NP
DNA-binding JJ I-NP
activities NNS I-NP
were VBD B-VP
identified VBN I-VP
in IN B-PP
resting VBG B-NP
( ( I-NP
G0 NN I-NP
) ) I-NP
T NN I-NP
cells NNS I-NP
with IN B-PP
mobilities NNS B-NP
in IN B-PP
gel NN B-NP
shift NN I-NP
assays NNS I-NP
distinct JJ B-ADJP
from IN B-PP
those DT B-NP
of IN B-PP
previously RB B-NP
defined VBN I-NP
E2F NN I-NP
complexes NNS I-NP
. . O

One CD B-NP
of IN B-PP
these DT B-NP
activities NNS I-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
a DT B-NP
novel JJ I-NP
COMMA COMMA I-NP
less RBR I-NP
abundant JJ I-NP
COMMA COMMA I-NP
Rb-E2F NN I-NP
complex NN I-NP
. . O

The DT B-NP
most RBS I-NP
prominent JJ I-NP
E2F NN I-NP
activity NN I-NP
in IN B-PP
resting VBG B-NP
T NN I-NP
cells NNS I-NP
( ( O
termed VBN B-VP
complex JJ B-NP
X NN I-NP
) ) O
was VBD B-VP
abundant JJ B-ADJP
in IN B-PP
both CC O
G0 NN B-NP
and CC O
G1 NN B-NP
but CC O
disappeared VBD B-VP
as IN B-SBAR
cells NNS B-NP
entered VBD B-VP
S NN B-NP
phase NN I-NP
COMMA COMMA O
suggesting VBG B-VP
a DT B-NP
possible JJ I-NP
role NN I-NP
in IN B-PP
negatively RB B-NP
regulating VBG I-NP
E2F NN I-NP
function NN I-NP
. . O

Complex NN B-NP
X NN I-NP
could MD B-VP
be VB I-VP
dissociated VBN I-VP
by IN B-PP
adenovirus NN B-NP
E1A NN I-NP
with IN B-PP
a DT B-NP
requirement NN I-NP
for IN B-PP
an DT B-NP
intact JJ I-NP
E1A NN I-NP
conserved VBN I-NP
region NN I-NP
2 CD I-NP
. . O

However RB B-ADVP
COMMA COMMA O
X NN B-NP
failed VBD B-VP
to TO I-VP
react VB I-VP
with IN B-PP
a DT B-NP
variety NN I-NP
of IN B-PP
antibodies NNS B-NP
against IN B-PP
Rb NN B-NP
or CC O
p107 NN B-NP
COMMA COMMA O
implicating VBG B-VP
the DT B-NP
involvement NN I-NP
of IN B-PP
an DT B-NP
E1A-binding JJ I-NP
protein NN I-NP
other JJ B-PP
than IN I-PP
Rb NN B-NP
or CC O
p107 NN B-NP
. . O

In IN B-PP
addition NN I-PP
to TO I-PP
these DT B-NP
novel JJ I-NP
E2F NN I-NP
complexes NNS I-NP
COMMA COMMA O
three CD B-NP
distinct JJ I-NP
forms NNS I-NP
of IN B-PP
unbound JJ O
( ( O
free JJ B-ADJP
) ) O
E2F NN B-NP
were VBD B-VP
resolved VBN I-VP
in IN B-PP
gel NN B-NP
shift NN I-NP
experiments NNS I-NP
. . O

These DT B-NP
species NNS I-NP
showed VBD B-VP
different JJ B-NP
cell NN I-NP
cycle NN I-NP
kinetics NNS I-NP
. . O

UV NN B-NP
cross-linking JJ I-NP
experiments NNS I-NP
suggested VBD B-VP
that IN B-SBAR
a DT B-NP
distinct JJ I-NP
E2F NN I-NP
DNA-binding JJ I-NP
protein NN I-NP
is VBZ B-VP
uniquely RB I-VP
associated VBN I-VP
with IN B-PP
the DT B-NP
S-phase NN I-NP
p107 NN I-NP
complex NN I-NP
and CC O
is VBZ B-VP
not RB I-VP
associated VBN I-VP
with IN B-PP
Rb NN B-NP
. . O

Together RB B-ADVP
COMMA COMMA O
these DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
E2F NN B-NP
consists VBZ B-VP
of IN B-PP
multiple JJ B-NP
COMMA COMMA I-NP
biochemically RB I-NP
distinct JJ I-NP
DNA-binding JJ I-NP
proteins NNS I-NP
which WDT B-NP
function VBP B-VP
at IN B-PP
different JJ B-NP
points NNS I-NP
in IN B-PP
the DT B-NP
cell NN I-NP
cycle NN I-NP
. . O

Occurrence NN B-NP
of IN B-PP
a DT B-NP
silencer NN I-NP
of IN B-PP
the DT B-NP
interleukin-2 NN I-NP
gene NN I-NP
in IN B-PP
naive JJ B-NP
but CC B-PP
not RB B-PP
in IN I-PP
memory NN B-NP
resting VBG I-NP
T NN B-NP
helper NN I-NP
lymphocytes NNS I-NP
. . O

In IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
the DT B-NP
first JJ I-NP
activation NN I-NP
of IN B-PP
a DT B-NP
naive JJ I-NP
T NN I-NP
cell NN I-NP
by IN B-PP
antigen NN B-NP
is VBZ B-VP
a DT B-NP
key JJ I-NP
step NN I-NP
in IN B-PP
the DT B-NP
shaping NN B-NP
of IN B-PP
the DT B-NP
peripheral JJ I-NP
T NN I-NP
cell NN I-NP
specificity NN I-NP
repertoire NN I-NP
and CC O
maintenance NN B-NP
of IN B-PP
self-tolerance NN B-NP
. . O

In IN B-PP
the DT B-NP
present JJ I-NP
study NN I-NP
COMMA COMMA O
analysis NN B-NP
of IN B-PP
the DT O
interleukin-2 NN B-NP
( ( O
IL-2 NN B-NP
) ) O
gene NN B-NP
activation NN I-NP
shows VBZ B-VP
that IN B-SBAR
naive JJ B-NP
human JJ I-NP
helper NN I-NP
T NN I-NP
cells NNS I-NP
( ( O
cord NN B-NP
blood NN I-NP
CD4+ JJ I-NP
T NN I-NP
cells NNS I-NP
COMMA COMMA O
adult JJ B-NP
CD4+CD45RO- JJ I-NP
T NN I-NP
cells NNS I-NP
) ) O
regulate VBP B-VP
IL-2 NN B-NP
transcription NN I-NP
by IN B-PP
a DT B-NP
mechanism NN I-NP
involving VBG B-VP
both CC O
a DT B-NP
silencer NN I-NP
and CC O
an DT B-NP
activator NN I-NP
acting VBG B-VP
on IN B-PP
the DT B-NP
purine-rich JJ I-NP
IL-2 NN I-NP
promoter NN I-NP
elements NNS I-NP
( ( O
NF-AT NN B-NP
binding NN I-NP
sites NNS I-NP
) ) O
. . O

By IN B-PP
contrast NN B-NP
COMMA COMMA O
memory NN B-NP
cells NNS I-NP
COMMA COMMA O
either CC O
in FW B-ADVP
vitro FW I-ADVP
activated VBN B-NP
helper NN I-NP
T NN I-NP
cells NNS I-NP
reverting VBG B-VP
to TO B-PP
a DT B-NP
resting JJ I-NP
state NN I-NP
COMMA COMMA O
or CC O
CD4+ JJ B-NP
T NN I-NP
( ( I-NP
memory NN I-NP
) ) I-NP
clones NNS I-NP
COMMA COMMA O
or CC O
CD4+CD45RO+ JJ B-NP
T NN I-NP
cells NNS I-NP
isolated VBN B-VP
ex FW B-ADVP
vivo FW I-ADVP
COMMA COMMA O
no RB B-ADVP
longer RB I-ADVP
have VBP B-VP
a DT B-NP
silencer NN I-NP
. . O

Their PRP$ B-NP
IL-2 NN I-NP
transcription NN I-NP
seems VBZ B-VP
to TO I-VP
be VB I-VP
controlled VBN I-VP
solely RB B-PP
by IN I-PP
the DT B-NP
transition NN I-NP
from IN B-PP
inactive JJ B-NP
to TO B-PP
active JJ B-NP
functional JJ B-NP
state NN I-NP
of IN B-PP
a DT B-NP
positive JJ I-NP
transcription NN I-NP
factor NN I-NP
binding VBG B-VP
to TO B-PP
these DT B-NP
promoter NN I-NP
elements NNS I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
its PRP$ B-NP
cytoplasmic JJ I-NP
or CC I-NP
nuclear JJ I-NP
location NN I-NP
: : O
in IN B-PP
resting VBG B-NP
memory NN I-NP
T NN I-NP
cells NNS I-NP
the DT B-NP
activator NN I-NP
is VBZ B-VP
located JJ B-ADJP
in IN B-PP
the DT B-NP
cytoplasm NN I-NP
and CC O
is VBZ B-VP
inactive JJ B-ADJP
COMMA COMMA O
whereas IN O
in IN B-PP
stimulated VBN B-NP
cells NNS I-NP
it PRP B-NP
is VBZ B-VP
functional JJ B-ADJP
in IN B-PP
promoting VBG B-VP
transcription NN B-NP
and CC O
now RB B-VP
resides VBZ I-VP
in IN B-PP
the DT B-NP
nucleus NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
the DT B-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
gene NN I-NP
coding VBG I-NP
for IN B-PP
the DT B-NP
main JJ I-NP
T NN I-NP
cell NN I-NP
growth NN I-NP
factor NN I-NP
changes VBZ B-VP
irreversibly RB B-ADVP
after IN B-PP
the DT B-NP
first JJ I-NP
encounter NN I-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
with IN B-PP
antigen NN B-NP
. . O

It PRP B-NP
is VBZ B-VP
most RBS B-ADJP
likely JJ I-ADJP
that IN B-SBAR
the DT B-NP
presence NN I-NP
of IN B-PP
a DT B-NP
silencer NN I-NP
contributes VBZ B-VP
to TO B-PP
the DT B-NP
more RBR I-NP
stringent JJ I-NP
activation NN I-NP
requirements NNS I-NP
of IN B-PP
naive JJ B-NP
CD4+ JJ I-NP
T NN I-NP
cells NNS I-NP
. . O

Single JJ B-NP
strand NN I-NP
conformation NN I-NP
polymorphism NN I-NP
analysis NN I-NP
of IN B-PP
androgen NN B-NP
receptor NN I-NP
gene NN I-NP
mutations NNS I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
androgen NN B-NP
insensitivity NN I-NP
syndromes NNS I-NP
: : O
application NN B-NP
for IN B-PP
diagnosis NN B-NP
COMMA COMMA O
genetic JJ B-NP
counseling NN I-NP
COMMA COMMA O
and CC O
therapy NN B-NP
. . O

Recent JJ B-NP
studies NNS I-NP
indicate VBP B-VP
that IN B-SBAR
mutations NNS B-NP
in IN B-PP
the DT B-NP
androgen NN I-NP
receptor NN I-NP
gene NN I-NP
are VBP B-VP
associated VBN I-VP
with IN B-PP
androgen NN B-NP
insensitivity NN I-NP
syndromes NNS I-NP
COMMA COMMA O
a DT B-NP
heterogeneous JJ I-NP
group NN I-NP
of IN B-PP
related JJ B-NP
disorders NNS I-NP
involving VBG B-VP
defective JJ B-NP
sexual JJ I-NP
differentiation NN I-NP
in IN B-PP
karyotypic JJ B-NP
males NNS I-NP
. . O

In IN B-PP
this DT B-NP
report NN I-NP
COMMA COMMA O
we PRP B-NP
address VBP B-VP
the DT B-NP
possibility NN I-NP
of IN B-PP
rapid JJ B-NP
mutational JJ I-NP
analysis NN I-NP
of IN B-PP
the DT B-NP
androgen NN I-NP
receptor NN I-NP
gene NN I-NP
for IN B-PP
initial JJ B-NP
diagnosis NN I-NP
COMMA COMMA O
genetic JJ B-NP
counseling NN I-NP
COMMA COMMA O
and CC O
molecular JJ B-NP
subclassification NN I-NP
of IN B-PP
affected VBN B-NP
patients NNS I-NP
and CC O
their PRP$ B-NP
families NNS I-NP
. . O

DNA NN B-NP
from IN B-PP
peripheral JJ B-NP
blood NN I-NP
leukocytes NNS I-NP
of IN B-PP
six CD B-NP
patients NNS I-NP
from IN B-PP
five CD B-NP
families NNS I-NP
with IN B-PP
various JJ B-NP
degrees NNS I-NP
of IN B-PP
androgen NN B-NP
insensitivity NN I-NP
was VBD B-VP
studied VBN I-VP
. . O

Exons NNS B-NP
2 CD B-NP
to TO O
8 CD B-NP
of IN B-PP
the DT B-NP
androgen NN I-NP
receptor NN I-NP
gene NN I-NP
were VBD B-VP
analyzed VBN I-VP
using VBG B-VP
a DT B-NP
combination NN I-NP
of IN B-PP
single JJ B-NP
strand NN I-NP
conformation NN I-NP
polymorphism NN I-NP
analysis NN I-NP
and CC O
direct JJ B-NP
DNA NN I-NP
sequencing NN I-NP
. . O

Female JJ B-NP
family NN I-NP
members NNS I-NP
were VBD B-VP
also RB I-VP
studied VBN I-VP
to TO B-VP
identify VB I-VP
heterozygote NN B-NP
carriers NNS I-NP
. . O

Point NN B-NP
mutations NNS I-NP
in IN B-PP
the DT B-NP
AR NN I-NP
gene NN I-NP
were VBD B-VP
identified VBN I-VP
in IN B-PP
all DT B-NP
six CD I-NP
patients NNS I-NP
COMMA COMMA O
and CC O
all DT B-NP
mutations NNS I-NP
caused VBD B-VP
amino NN B-NP
acid NN I-NP
substitutions NNS I-NP
. . O

One CD B-NP
patient NN I-NP
with IN B-PP
incomplete JJ B-NP
androgen NN I-NP
insensitivity NN I-NP
was VBD B-VP
a DT B-NP
mosaic NN I-NP
for IN B-PP
the DT B-NP
mutation NN I-NP
. . O

Four CD B-NP
of IN B-PP
the DT B-NP
five CD I-NP
mothers NNS I-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
a DT B-NP
young JJ I-NP
sister NN I-NP
of IN B-PP
one CD B-NP
patient NN I-NP
COMMA COMMA O
were VBD B-VP
carriers NNS B-NP
of IN B-PP
the DT B-NP
mutation NN I-NP
present JJ B-ADJP
in IN B-PP
the DT B-NP
affected VBN I-NP
child NN I-NP
. . O

Our PRP$ B-NP
data NNS I-NP
show VBP B-VP
that IN B-SBAR
new JJ B-NP
mutations NNS I-NP
may MD B-VP
occur VB I-VP
in IN B-PP
the DT B-NP
androgen NN I-NP
receptor NN I-NP
gene NN I-NP
leading VBG B-VP
to TO B-PP
sporadic JJ B-NP
androgen NN I-NP
insensitivity NN I-NP
syndrome NN I-NP
. . O

Molecular JJ B-NP
genetic JJ I-NP
characterization NN I-NP
of IN B-PP
the DT B-NP
variant JJ I-NP
allele NN I-NP
can MD B-VP
serve VB I-VP
as IN B-PP
a DT B-NP
primary JJ I-NP
tool NN I-NP
for IN B-PP
diagnosis NN B-NP
and CC O
subsequent JJ B-NP
therapy NN I-NP
COMMA COMMA O
and CC O
can MD B-VP
provide VB I-VP
a DT B-NP
basis NN I-NP
for IN B-PP
distinguishing VBG B-VP
heterozygous JJ B-NP
carriers NNS I-NP
in IN B-PP
familial JJ B-NP
androgen NN I-NP
resistance NN I-NP
. . O

The DT B-NP
identification NN I-NP
of IN B-PP
carriers NNS B-NP
is VBZ B-VP
of IN B-PP
substantial JJ B-NP
clinical JJ I-NP
importance NN I-NP
for IN B-PP
genetic JJ B-NP
counseling NN I-NP
. . O

Minimally RB B-NP
modified VBN I-NP
low JJ I-NP
density NN I-NP
lipoprotein-induced JJ I-NP
inflammatory JJ I-NP
responses NNS I-NP
in IN B-PP
endothelial JJ B-NP
cells NNS I-NP
are VBP B-VP
mediated VBN I-VP
by IN B-PP
cyclic JJ B-NP
adenosine NN I-NP
monophosphate NN I-NP
. . O

We PRP B-NP
have VBP B-VP
previously RB I-VP
shown VBN I-VP
that IN B-SBAR
minimally RB B-NP
oxidized VBN I-NP
LDL NN I-NP
( ( O
MM-LDL NN B-NP
) ) O
activated VBD B-VP
endothelial JJ B-NP
cells NNS I-NP
to TO B-VP
increase VB I-VP
their PRP$ B-NP
interaction NN I-NP
with IN B-PP
monocytes NNS B-NP
but CC B-CONJP
not RB I-CONJP
neutrophils NNS B-NP
COMMA COMMA O
inducing VBG B-VP
monocyte NN B-NP
but CC B-CONJP
not RB I-CONJP
neutrophil NN B-NP
binding NN B-NP
and CC O
synthesis NN B-NP
of IN B-PP
monocyte NN B-NP
chemotactic JJ I-NP
protein-1 NN I-NP
and CC O
monocyte NN B-NP
colony-stimulating JJ I-NP
factor NN I-NP
( ( O
M-CSF NN B-NP
) ) O
. . O

In IN B-PP
the DT B-NP
present JJ I-NP
studies NNS I-NP
we PRP B-NP
have VBP B-VP
examined VBN I-VP
the DT B-NP
signaling NN I-NP
pathways NNS I-NP
by IN B-PP
which WDT B-NP
this DT B-NP
monocyte-specific JJ I-NP
response NN I-NP
is VBZ B-VP
induced VBN I-VP
. . O

Both CC O
induction NN B-NP
of IN B-PP
monocyte NN B-NP
binding NN I-NP
and CC O
mRNA NN B-NP
levels NNS I-NP
for IN B-PP
M-CSF NN B-NP
by IN B-PP
MM-LDL NN B-NP
were VBD B-VP
not RB I-VP
inhibited VBN I-VP
in IN B-PP
protein NN B-NP
kinase NN I-NP
C-depleted JJ I-NP
endothelial JJ I-NP
cells NNS I-NP
. . O

A DT B-NP
number NN I-NP
of IN B-PP
our PRP$ B-NP
studies NNS I-NP
indicate VBP B-VP
that IN B-SBAR
cAMP NN B-NP
is VBZ B-VP
the DT B-NP
second JJ I-NP
messenger NN I-NP
for IN B-PP
the DT B-NP
effects NNS I-NP
of IN B-PP
MM-LDL NN B-NP
cited VBN B-VP
above RB B-ADVP
. . O

Incubation NN B-NP
of IN B-PP
endothelial JJ B-NP
cells NNS I-NP
with IN B-PP
MM-LDL NN B-NP
caused VBD I-NP
a DT O
173 CD B-NP
% NN I-NP
increase NN I-NP
in IN B-PP
intracellular JJ B-NP
cAMP NN I-NP
levels NNS I-NP
. . O

Agents NNS B-NP
which WDT B-NP
increased VBD B-VP
cAMP NN B-NP
levels NNS I-NP
COMMA COMMA O
including VBG B-PP
cholera NN B-NP
toxin NN I-NP
COMMA COMMA O
pertussis NN B-NP
toxin NN I-NP
COMMA COMMA O
dibutyryl NN B-NP
cAMP NN I-NP
COMMA COMMA O
and CC O
isoproterenol NN B-NP
mimicked VBD B-VP
the DT B-NP
actions NNS I-NP
of IN B-PP
MM-LDL NN B-NP
. . O

Agents NNS B-NP
which WDT B-NP
elevated VBD B-VP
cAMP NN B-NP
were VBD B-VP
also RB I-VP
shown VBN I-VP
to TO I-VP
activate VB I-VP
NF NN B-NP
kappa NN I-NP
B NN I-NP
COMMA COMMA O
suggesting VBG B-VP
a DT B-NP
role NN I-NP
for IN B-PP
this DT B-NP
transcription NN I-NP
factor NN I-NP
in IN B-PP
activation NN B-NP
of IN B-PP
monocyte-endothelial JJ B-NP
interactions NNS I-NP
. . O

Although IN B-SBAR
endothelial JJ B-NP
leukocyte NN I-NP
adhesion NN I-NP
molecule NN I-NP
( ( O
ELAM NN B-NP
) ) O
mRNA NN B-NP
synthesis NN I-NP
can MD B-VP
be VB I-VP
regulated VBN I-VP
by IN B-PP
NF NN B-NP
kappa NN I-NP
B NN I-NP
COMMA COMMA O
ELAM NN B-NP
was VBD B-VP
not RB I-VP
expressed VBN I-VP
and CC O
ELAM NN B-NP
mRNA NN I-NP
was VBD B-VP
only RB I-VP
slightly RB I-VP
elevated JJ I-VP
in IN B-PP
response NN I-PP
to TO I-PP
MM-LDL NN B-NP
. . O

We PRP B-NP
present VBP B-VP
evidence NN B-NP
that IN B-SBAR
induction NN B-NP
of IN B-PP
neutrophil NN B-NP
binding NN I-NP
by IN B-PP
LPS NN B-NP
is VBZ B-VP
actually RB I-VP
suppressed VBN I-VP
by IN B-PP
agents NNS B-NP
that WDT B-NP
elevated VBD B-VP
cAMP NN B-NP
levels NNS I-NP
. . O

Antisense JJ B-NP
oligonucleotides NNS I-NP
to TO B-PP
the DT B-NP
p65 NN I-NP
subunit NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
block VBP B-VP
CD11b NN B-NP
expression NN I-NP
and CC O
alter VBP B-VP
adhesion NN B-NP
properties NNS I-NP
of IN B-PP
differentiated VBN B-NP
HL-60 NN I-NP
granulocytes NNS I-NP
. . O

NF-kappa NN B-NP
B NN I-NP
is VBZ B-VP
a DT B-NP
pleiotropic JJ I-NP
regulator NN I-NP
of IN B-PP
a DT B-NP
variety NN I-NP
of IN B-PP
genes NNS B-NP
implicated VBN B-VP
in IN B-PP
the DT B-NP
cellular JJ I-NP
response NN I-NP
to TO B-PP
injury NN B-NP
. . O

This DT B-NP
function NN I-NP
has VBZ B-VP
been VBN I-VP
attributed VBN I-VP
to TO B-PP
the DT B-NP
coordinated VBN I-NP
binding NN I-NP
of IN B-PP
subunits NNS B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
to TO B-PP
distinct JJ B-NP
regions NNS I-NP
of IN B-PP
the DT B-NP
promoter JJ I-NP
elements NNS I-NP
of IN B-PP
numerous JJ B-NP
genes NNS I-NP
COMMA COMMA O
including VBG B-PP
cytokines NNS B-NP
COMMA COMMA O
growth NN B-NP
factor NN I-NP
receptors NNS I-NP
COMMA COMMA O
and CC O
adhesion NN B-NP
molecules NNS I-NP
. . O

Antisense JJ B-NP
phosphorothioate JJ I-NP
oligonucleotides NNS I-NP
to TO B-PP
the DT O
p50 NN B-NP
and CC O
p65 NN B-NP
subunits NNS B-NP
of IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
complex NN I-NP
were VBD B-VP
used VBN I-VP
to TO B-VP
define VB I-VP
the DT B-NP
physiologic JJ I-NP
role NN I-NP
of IN B-PP
this DT B-NP
transcription NN I-NP
factor NN I-NP
in IN B-PP
resting VBG B-NP
and CC I-NP
stimulated VBN I-NP
granulocytes NNS I-NP
. . O

A DT B-NP
reduction NN I-NP
in IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
p65 NN B-NP
was VBD B-VP
produced VBN I-VP
by IN B-PP
treatment NN B-NP
with IN B-PP
the DT B-NP
phosphorothioate JJ I-NP
antisense JJ I-NP
oligodeoxynucleotide NN I-NP
. . O

This DT B-NP
reduction NN I-NP
was VBD B-VP
accompanied VBN I-VP
by IN B-PP
rapid JJ B-NP
changes NNS I-NP
in IN B-PP
the DT B-NP
cellular JJ I-NP
adhesion NN I-NP
of IN B-PP
dimethyl JJ B-NP
sulfoxide-differentiated JJ I-NP
HL-60 NN I-NP
leukemia NN I-NP
cells NNS I-NP
stimulated VBN B-VP
by IN B-PP
12-O-tetradecanoylphorbol NN B-NP
13-acetate NN I-NP
( ( O
TPA NN B-NP
) ) O
. . O

These DT B-NP
effects NNS I-NP
were VBD B-VP
characterized VBN I-VP
by IN B-PP
a DT B-NP
marked JJ I-NP
reduction NN I-NP
in IN B-PP
CD11b NN B-NP
integrin JJ I-NP
expression NN I-NP
on IN B-PP
the DT B-NP
surface NN I-NP
of IN B-PP
treated VBN B-NP
cells NNS I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
the DT B-NP
p65 NN I-NP
antisense JJ I-NP
oligomer NN I-NP
effectively RB B-ADVP
abolished VBD B-VP
an DT B-NP
upregulation NN I-NP
of IN B-PP
CD11b NN B-NP
that WDT B-NP
was VBD B-VP
produced VBN I-VP
by IN B-PP
formyl-met-leu-phe NN B-NP
and CC O
TPA NN B-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
p65 NN I-NP
antisense JJ I-NP
phosphorothioate JJ I-NP
oligodeoxynucleotide NN I-NP
had VBD B-VP
no DT B-NP
significant JJ I-NP
effect NN I-NP
on IN B-PP
the DT B-NP
production NN I-NP
of IN B-PP
reactive JJ B-NP
oxygen NN I-NP
intermediates NNS I-NP
or CC B-PP
on IN B-PP
phagocytosis NNS B-NP
by IN B-PP
these DT B-NP
cells NNS I-NP
. . O

These DT B-NP
findings NNS I-NP
indicate VBP B-VP
that IN B-SBAR
antisense JJ B-NP
oligomers NNS I-NP
to TO B-PP
p65 NN B-NP
can MD B-VP
be VB I-VP
used VBN I-VP
to TO B-VP
define VB I-VP
the DT B-NP
role NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
the DT B-NP
activation NN I-NP
pathways NNS I-NP
of IN B-PP
neutrophils NNS B-NP
. . O

Costimulation NN B-NP
of IN B-PP
cAMP NN B-NP
and CC O
protein NN B-NP
kinase NN I-NP
C NN I-NP
pathways NNS B-NP
inhibits VBZ B-VP
the DT B-NP
CD3-dependent JJ I-NP
T NN I-NP
cell NN I-NP
activation NN I-NP
and CC O
leads VBZ B-VP
to TO B-PP
a DT B-NP
persistent JJ I-NP
expression NN I-NP
of IN B-PP
the DT B-NP
AP-1 NN I-NP
transcription NN I-NP
factor NN I-NP
. . O

The DT B-NP
effects NNS I-NP
mediated VBN B-VP
by IN B-PP
a DT B-NP
combined JJ I-NP
stimulation NN I-NP
of IN B-PP
cAMP- NN B-NP
and CC O
protein NN B-ADJP
kinase NN I-ADJP
C NN I-ADJP
( ( I-ADJP
PKC NN I-ADJP
) ) I-ADJP
-dependent JJ I-ADJP
pathways NNS B-NP
have VBP B-VP
been VBN I-VP
investigated VBN I-VP
in IN B-PP
different JJ B-NP
cellular JJ I-NP
systems NNS I-NP
COMMA COMMA O
and CC O
it PRP B-NP
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
that IN B-SBAR
they PRP B-NP
may MD B-VP
complement VB I-VP
each DT B-NP
other JJ I-NP
in IN B-PP
activating VBG B-VP
cell NN B-NP
proliferation NN B-NP
and CC O
differentiation NN B-NP
. . O

In IN B-PP
this DT B-NP
report NN I-NP
COMMA COMMA O
we PRP B-NP
show VBP B-VP
that IN B-SBAR
upon IN B-PP
the DT B-NP
stimulation NN I-NP
of IN B-PP
both DT B-NP
pathways NNS I-NP
T NN B-NP
lymphocytes NNS I-NP
became VBD B-VP
refractory JJ B-ADJP
to TO B-PP
activation NN B-NP
via IN B-PP
the DT B-NP
CD3\/T NN I-NP
cell NN I-NP
receptor NN I-NP
( ( I-NP
TcR NN I-NP
) ) I-NP
complex NN I-NP
. . O

T NN B-NP
cells NNS I-NP
preincubated VBN B-VP
with IN B-PP
phorbol NN B-NP
12-myristate NN I-NP
13-acetate NN I-NP
( ( O
PMA NN B-NP
) ) O
and CC O
dibutyryl NN B-NP
cAMP NN I-NP
( ( O
Bt2cAMP NN B-NP
) ) O
displayed VBD B-VP
a DT B-NP
deficient JJ I-NP
proliferative JJ I-NP
ability NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
anti-CD3 JJ B-NP
mAb NN I-NP
stimulation NN I-NP
COMMA COMMA O
whereas IN O
lymphocytes NNS B-NP
treated VBN B-VP
individually RB B-ADVP
with IN B-PP
either CC O
Bt2cAMP NN B-NP
or CC O
PMA NN B-NP
responded VBD B-VP
comparably RB B-ADVP
to TO B-PP
untreated JJ B-NP
samples NNS I-NP
. . O

We PRP B-NP
detected VBD B-VP
an DT B-NP
association NN I-NP
between IN B-PP
the DT B-NP
reduced VBN B-NP
mitogenic JJ I-NP
response NN I-NP
and CC O
low JJ B-NP
expression NN I-NP
of IN B-PP
both CC O
interleukin-2 NN B-NP
( ( O
IL-2 NN B-NP
) ) O
and CC O
the DT B-NP
alpha NN I-NP
chain NN I-NP
( ( O
CD25 NN B-NP
) ) O
of IN B-PP
the DT B-NP
IL-2 NN I-NP
receptor NN I-NP
( ( O
IL-2R NN B-NP
) ) O
. . O

Analysis NN B-NP
of IN B-PP
intracellular JJ B-NP
Ca2+ NN I-NP
mobilization NN I-NP
suggested VBD B-VP
that IN B-SBAR
the DT B-NP
CD3\/TcR-dependent JJ I-NP
signal NN I-NP
transduction NN I-NP
was VBD B-VP
impaired JJ I-VP
in IN B-PP
PMA\/Bt2cAMP-treated JJ B-NP
cells NNS I-NP
. . O

Remarkably RB B-ADVP
COMMA COMMA O
we PRP B-NP
observed VBD B-VP
that IN B-SBAR
these DT B-NP
samples NNS I-NP
displayed VBD B-VP
a DT B-NP
persistent JJ I-NP
expression NN I-NP
of IN B-PP
the DT B-NP
c-fos NN I-NP
protooncogene NN I-NP
COMMA COMMA O
associated VBN B-VP
to TO B-PP
an DT B-NP
increased VBN I-NP
AP-1 NN I-NP
DNA-binding JJ I-NP
activity NN I-NP
COMMA COMMA O
whereas IN O
no DT B-NP
variations NNS I-NP
of IN B-PP
CREB NN B-NP
or CC O
NF-kB NN B-NP
were VBD B-VP
detected VBN I-VP
. . O

Neither CC O
Bt2cAMP NN B-NP
nor CC O
PMA NN B-NP
individually RB B-ADVP
mediated VBD B-VP
these DT B-NP
sustained JJ I-NP
effects NNS I-NP
COMMA COMMA O
which WDT B-NP
therefore RB B-ADVP
appear VBP B-VP
as IN B-PP
a DT B-NP
consequence NN I-NP
of IN B-PP
the DT B-NP
interplay NN I-NP
between IN B-PP
both DT B-NP
metabolic JJ I-NP
stimuli NNS I-NP
. . O

Altogether RB B-ADVP
COMMA COMMA O
the DT B-NP
data NNS I-NP
provide VBP B-VP
the DT B-NP
evidence NN I-NP
that IN B-SBAR
both DT B-NP
pathways NNS I-NP
complement VBP B-VP
each DT B-NP
other JJ I-NP
in IN B-PP
regulating VBG B-VP
gene NN B-NP
expression NN I-NP
and CC O
COMMA COMMA O
conversely RB O
COMMA COMMA O
downregulate VBP B-NP
the DT I-NP
TcR NN I-NP
transduction NN I-NP
mechanisms NNS O

Nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
COMMA COMMA O
a DT B-NP
mediator NN I-NP
of IN B-PP
lipopolysaccharide NN B-NP
effects NNS I-NP
. . O

Exposure NN B-NP
of IN B-PP
certain JJ B-NP
cell NN I-NP
types NNS I-NP
to TO B-PP
bacterial JJ B-NP
lipopolysaccharide NN B-NP
( ( O
LPS NN B-NP
) ) O
leads VBZ B-VP
to TO B-PP
activation NN B-NP
of IN B-PP
nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
( ( O
NF-kappa NN B-NP
B NN I-NP
) ) O
COMMA COMMA O
an DT B-NP
inducible JJ I-NP
transcription NN I-NP
factor NN I-NP
. . O

One CD B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
's POS B-NP
unique JJ I-NP
properties NNS I-NP
is VBZ B-VP
its PRP$ B-NP
posttranslational JJ I-NP
activation NN I-NP
via IN B-PP
release NN B-NP
of IN B-PP
an DT B-NP
inhibitory JJ I-NP
subunit NN I-NP
COMMA COMMA O
called VBN B-VP
inhibitor NN B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
( ( O
I NN B-NP
kappa NN I-NP
B NN I-NP
) ) O
COMMA COMMA O
from IN B-PP
a DT B-NP
sequestered JJ I-NP
cytoplasmic JJ I-NP
form NN I-NP
. . O

This DT B-NP
event NN I-NP
is VBZ B-VP
also RB I-VP
triggered VBN I-VP
under IN B-PP
various JJ B-NP
other JJ I-NP
conditions NNS I-NP
of IN B-PP
biomedical JJ B-NP
importance NN I-NP
. . O

Other JJ B-NP
bacterial JJ I-NP
toxins NNS I-NP
COMMA COMMA O
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
( ( O
TNF NN B-NP
) ) O
COMMA COMMA O
interleukin-1 NN B-NP
( ( O
IL-1 NN B-NP
) ) O
COMMA COMMA O
T NN B-NP
cell NN I-NP
mitogens NNS I-NP
COMMA COMMA O
UV NN B-NP
light NN I-NP
COMMA COMMA O
gamma NN B-NP
rays NNS I-NP
and CC O
oxidative JJ B-NP
stress NN I-NP
were VBD B-VP
reported VBN I-VP
to TO I-VP
induce VB I-VP
NF-kappa NN B-NP
B NN I-NP
. . O

The DT B-NP
activated JJ I-NP
form NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
rapidly RB I-VP
taken VBN I-VP
up RP B-PRT
into IN B-PP
nuclei NNS B-NP
COMMA COMMA O
initiates VBZ B-VP
transcription NN B-NP
from IN B-PP
immediate JJ B-NP
early JJ I-NP
genes NNS I-NP
in IN B-PP
a DT B-NP
wide JJ I-NP
variety NN I-NP
of IN B-PP
cell NN B-NP
types NNS I-NP
. . O

Most JJS B-NP
of IN B-PP
the DT B-NP
target NN I-NP
genes NNS I-NP
for IN B-PP
NF-kappa NN B-NP
B NN I-NP
are VBP B-VP
of IN B-PP
relevance NN B-NP
for IN B-PP
the DT B-NP
immune JJ I-NP
response NN I-NP
and CC O
can MD B-VP
be VB I-VP
grouped VBN I-VP
into IN B-PP
those DT B-NP
encoding JJ B-VP
cytokines NNS B-NP
COMMA COMMA O
cell NN B-NP
surface NN I-NP
receptors NNS I-NP
COMMA COMMA O
acute JJ B-NP
phase NN I-NP
proteins NNS I-NP
and CC O
viral JJ B-NP
genomes NNS I-NP
COMMA COMMA O
such JJ B-PP
as IN I-PP
that DT B-NP
of IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HIV-1 NN B-NP
) ) O
. . O

We PRP B-NP
will MD B-VP
discuss VB I-VP
recent JJ B-NP
experimental JJ I-NP
evidences NNS I-NP
suggesting VBG B-VP
that IN B-SBAR
LPS NN B-NP
might MD B-VP
share VB I-VP
a DT B-NP
pathway NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
with IN B-PP
other JJ B-NP
inducers NNS I-NP
of IN B-PP
the DT B-NP
factor NN I-NP
. . O

This DT B-NP
common JJ I-NP
pathway NN I-NP
may MD B-VP
involve VB I-VP
reactive JJ B-NP
oxygen NN I-NP
intermediates NNS I-NP
( ( O
ROI NN B-NP
) ) O
as IN B-PP
messenger NN B-NP
molecules NNS I-NP
. . O

Human JJ B-NP
T NN I-NP
cell NN I-NP
transcription NN I-NP
factor NN I-NP
GATA-3 NN I-NP
stimulates VBZ B-VP
HIV-1 NN B-NP
expression NN I-NP
. . O

A DT B-NP
family NN I-NP
of IN B-PP
transcriptional JJ B-NP
activating VBG I-NP
proteins NNS I-NP
COMMA COMMA O
the DT B-NP
GATA NN I-NP
factors NNS I-NP
COMMA COMMA O
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
bind VB I-VP
to TO B-PP
a DT B-NP
consensus NN I-NP
motif NN I-NP
through IN B-PP
a DT B-NP
highly RB I-NP
conserved VBN I-NP
C4 NN I-NP
zinc NN I-NP
finger NN I-NP
DNA NN I-NP
binding NN I-NP
domain NN I-NP
. . O

One CD B-NP
member NN I-NP
of IN B-PP
this DT B-NP
multigene JJ I-NP
family NN I-NP
COMMA COMMA O
GATA-3 NN B-NP
COMMA COMMA O
is VBZ B-VP
most RBS I-VP
abundantly RB I-VP
expressed VBN I-VP
in IN B-PP
T NN B-NP
lymphocytes NNS I-NP
COMMA COMMA O
a DT B-NP
cellular JJ I-NP
target NN I-NP
for IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HIV-1 NN B-NP
) ) O
infection NN B-NP
and CC O
replication NN B-NP
. . O

In FW B-NP
vitro FW I-NP
DNase NN I-NP
I CD I-NP
footprinting NN I-NP
analysis NN I-NP
revealed VBD B-VP
six CD B-NP
hGATA-3 NN I-NP
binding NN I-NP
sites NNS I-NP
in IN B-PP
the DT B-NP
U3 NN I-NP
region NN I-NP
( ( O
the DT B-NP
transcriptional JJ I-NP
regulatory JJ I-NP
domain NN I-NP
) ) O
of IN B-PP
the DT B-NP
HIV-1 NN I-NP
LTR NN I-NP
. . O

Cotransfection NN B-NP
of IN B-PP
an DT B-NP
hGATA-3 NN I-NP
expression NN I-NP
plasmid NN I-NP
with IN B-PP
a DT B-NP
reporter NN I-NP
plasmid NN I-NP
whose WP$ B-NP
transcription NN I-NP
is VBZ B-VP
directed VBN I-VP
by IN B-PP
the DT B-NP
HIV-1 NN I-NP
LTR NN I-NP
resulted VBD B-VP
in IN B-PP
6- CD B-NP
to TO I-NP
10-fold JJ I-NP
stimulation NN I-NP
of IN B-PP
LTR-mediated JJ B-NP
transcription NN I-NP
COMMA COMMA O
whereas IN O
site NN B-NP
specific JJ I-NP
mutation NN I-NP
of IN B-PP
these DT B-NP
GATA NN I-NP
sites NNS I-NP
resulted VBD B-VP
in IN B-PP
virtual JJ B-NP
abrogation NN I-NP
of IN B-PP
the DT B-NP
activation NN I-NP
by IN B-PP
hGATA-3 NN B-NP
. . O

Further RB B-ADVP
COMMA COMMA O
deletion NN B-NP
of IN B-PP
the DT B-NP
hGATA-3 NN I-NP
transcriptional JJ I-NP
activation NN I-NP
domain NN I-NP
abolished VBD B-VP
GATA-dependent JJ B-NP
HIV-1 NN I-NP
trans-activation NN I-NP
COMMA COMMA O
showing VBG B-VP
that IN B-SBAR
the DT B-NP
stimulation NN I-NP
of IN B-PP
viral JJ B-NP
transcription NN I-NP
observed VBN B-VP
is VBZ B-VP
a DT B-NP
direct JJ I-NP
effect NN I-NP
of IN B-PP
cotransfected VBN B-NP
hGATA-3 NN I-NP
. . O

Introduction NN B-NP
of IN B-PP
the DT B-NP
HIV-1 NN I-NP
plasmids NNS I-NP
in IN B-PP
which WDT B-NP
the DT B-NP
GATA NN I-NP
sites NNS I-NP
have VBP B-VP
been VBN I-VP
mutated VBN I-VP
into IN B-PP
human JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
also RB B-ADVP
caused VBD B-VP
a DT B-NP
significant JJ I-NP
reduction NN I-NP
in IN B-PP
LTR-mediated JJ B-NP
transcription NN I-NP
at IN B-PP
both CC B-NP
the DT I-NP
basal JJ I-NP
level NN I-NP
and CC B-PP
in IN B-PP
( ( O
PHA- NN B-NP
plus CC O
PMA- NN B-NP
) ) B-NP
stimulated JJ I-NP
T NN I-NP
cells NNS I-NP
. . O

These DT B-NP
observations NNS I-NP
suggest VBP B-VP
that IN B-SBAR
in IN B-PP
addition NN I-PP
to TO I-PP
its PRP$ B-NP
normal JJ I-NP
role NN I-NP
in IN B-PP
T NN B-NP
lymphocyte NN I-NP
gene NN I-NP
regulation NN I-NP
COMMA COMMA O
hGATA-3 NN B-NP
may MD B-VP
also RB I-VP
play VB I-VP
a DT B-NP
significant JJ I-NP
role NN I-NP
in IN B-PP
HIV-1 NN B-NP
transcriptional JJ I-NP
activation NN I-NP
. . O

Analysis NN B-NP
of IN B-PP
the DT B-NP
preexisting JJ I-NP
and CC I-NP
nuclear JJ I-NP
forms NNS I-NP
of IN B-PP
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
. . O

The DT B-NP
nuclear JJ I-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
( ( O
NF-AT NN B-NP
) ) O
3 CD B-NP
is VBZ B-VP
an DT B-NP
inducible JJ I-NP
DNA-binding JJ I-NP
protein NN I-NP
that WDT B-NP
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
transcriptional JJ B-NP
induction NN I-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
gene NN I-NP
during IN B-PP
T NN B-NP
cell NN I-NP
activation NN I-NP
. . O

NF-AT NN B-NP
is VBZ B-VP
thought VBN I-VP
to TO I-VP
consist VB I-VP
of IN B-PP
two CD B-NP
components NNS I-NP
: : O
a DT B-NP
ubiquitous JJ I-NP
COMMA COMMA I-NP
inducible JJ I-NP
nuclear JJ I-NP
component NN I-NP
that WDT B-NP
we PRP B-NP
have VBP B-VP
identified VBN I-VP
as IN B-PP
Fos NN B-NP
and CC O
Jun NN B-NP
proteins NNS B-NP
COMMA COMMA O
and CC O
a DT B-NP
preexisting VBG I-NP
COMMA COMMA I-NP
T NN I-NP
cell-specific JJ I-NP
component NN I-NP
( ( O
NF-ATp NN B-NP
) ) O
which WDT B-NP
is VBZ B-VP
the DT B-NP
target NN I-NP
for IN B-PP
the DT B-NP
immunosuppressive JJ I-NP
agents NNS I-NP
cyclosporin NN B-NP
A NN I-NP
( ( O
CsA NN B-NP
) ) O
and CC O
FK506 NN B-NP
. . O

We PRP B-NP
have VBP B-VP
previously RB I-VP
shown VBN I-VP
that IN B-SBAR
nuclear JJ B-NP
extracts NNS I-NP
from IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
form VBP B-VP
two CD B-NP
inducible JJ I-NP
NF-AT NN I-NP
complexes NNS I-NP
with IN B-PP
an DT B-NP
oligonucleotide NN I-NP
corresponding VBG B-VP
to TO B-PP
the DT B-NP
distal JJ I-NP
NF-AT NN I-NP
site NN I-NP
of IN B-PP
the DT B-NP
murine JJ I-NP
IL-2 NN I-NP
promoter NN I-NP
COMMA COMMA O
although IN B-SBAR
hypotonic JJ B-NP
extracts NNS I-NP
of IN B-PP
unstimulated JJ B-NP
T NN I-NP
cells NNS I-NP
form VBP B-VP
a DT B-NP
single JJ I-NP
complex NN I-NP
containing VBG B-VP
NF-ATp NN B-NP
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
the DT B-NP
ability NN I-NP
to TO B-VP
detect VB I-VP
NF-ATp NN B-NP
in IN B-PP
a DT B-NP
gel NN I-NP
shift NN I-NP
assay NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
purification NN B-NP
and CC O
biochemical JJ B-NP
studies NNS I-NP
of IN B-PP
this DT B-NP
protein NN I-NP
COMMA COMMA O
is VBZ B-VP
strikingly RB B-ADJP
dependent JJ I-ADJP
on IN B-PP
the DT B-NP
precise JJ I-NP
sequence NN I-NP
of IN B-PP
the DT B-NP
NF-AT NN I-NP
oligonucleotide NN I-NP
used VBN B-VP
as IN B-PP
the DT B-NP
labeled JJ I-NP
probe NN I-NP
. . O

Moreover RB B-ADVP
we PRP B-NP
present VBP B-VP
evidence NN B-NP
that IN B-SBAR
the DT B-NP
component NN I-NP
that WDT B-NP
forms VBZ B-VP
the DT O
faster-migrating JJ O
( ( O
" `` O
lower JJR B-ADJP
" '' O
) ) O
nuclear JJ B-NP
NF-AT NN I-NP
complex NN I-NP
is VBZ B-VP
derived VBN I-VP
by IN B-PP
a DT B-NP
calcium-dependent JJ I-NP
COMMA COMMA I-NP
cyclosporin-sensitive JJ I-NP
COMMA COMMA I-NP
posttranslational JJ I-NP
modification NN I-NP
of IN B-PP
NF-ATp NN B-NP
COMMA COMMA O
and CC O
that IN B-SBAR
Fos NN B-NP
and CC O
Jun NN B-NP
proteins NNS B-NP
stabilize VBP B-VP
its PRP$ B-NP
interaction NN I-NP
with IN B-PP
DNA NN B-NP
. . O

The DT B-NP
results NNS I-NP
are VBP B-VP
discussed VBN I-VP
in IN B-PP
the DT B-NP
context NN I-NP
of IN B-PP
a DT B-NP
model NN I-NP
relating VBG B-VP
the DT B-NP
two CD I-NP
nuclear JJ I-NP
NF-AT NN I-NP
complexes NNS I-NP
to TO B-PP
NF-ATp NN B-NP
. . O

Enhancing NN B-NP
effect NN I-NP
of IN B-PP
17 CD B-NP
beta-estradiol NN I-NP
on IN B-PP
human JJ B-NP
NK NN I-NP
cell NN I-NP
activity NN I-NP
. . O

The DT B-NP
in FW I-NP
vitro FW I-NP
effect NN I-NP
of IN B-PP
17 CD B-NP
beta-estradiol NN I-NP
on IN B-PP
NK NN B-NP
activity NN I-NP
was VBD B-VP
studied VBN I-VP
. . O

The DT B-NP
proliferation NN B-NP
and CC O
NK NN B-NP
activity NN I-NP
of IN B-PP
YT-N17 NN B-NP
( ( O
a DT B-NP
human JJ I-NP
NK-like JJ I-NP
cell NN I-NP
line NN I-NP
) ) O
were VBD B-VP
enhanced VBN I-VP
by IN B-PP
17 CD B-NP
beta-estradiol NN I-NP
( ( O
E2 NN B-NP
) ) O
COMMA COMMA O
and CC O
the DT B-NP
enhancement NN I-NP
was VBD B-VP
blocked VBN I-VP
by IN B-PP
tamoxifen NN B-NP
( ( O
Tx NN B-NP
) ) O
COMMA COMMA O
an DT B-NP
antagonist NN I-NP
of IN B-PP
E2 NN B-NP
. . O

On IN B-PP
the DT B-NP
contrary NN I-NP
COMMA COMMA O
other JJ B-NP
steroid NN I-NP
hormones NNS I-NP
such JJ B-PP
as IN I-PP
Tx NN B-NP
COMMA COMMA O
progesterone NN B-NP
COMMA COMMA O
and CC O
testosterone NN B-NP
had VBD B-VP
no DT B-NP
effect NN I-NP
. . O

YT-N17 NN B-NP
contained VBD B-VP
11.8 CD B-NP
fmol\/mg NN I-NP
protein NN I-NP
of IN B-PP
estrogen NN B-NP
receptor NN I-NP
( ( O
mean NN B-NP
of IN B-PP
two CD B-NP
independent JJ I-NP
assays NNS I-NP
) ) O
COMMA COMMA O
a DT B-NP
value NN I-NP
which WDT B-NP
was VBD B-VP
5-10-fold RB B-ADJP
higher JJR I-ADJP
than IN B-PP
that DT B-NP
of IN B-PP
other JJ B-NP
hematopoietic JJ I-NP
cell NN I-NP
lines NNS I-NP
. . O

An DT B-NP
enhancement NN I-NP
of IN B-PP
NK NN B-NP
activity NN I-NP
by IN B-PP
E2 NN B-NP
was VBD B-VP
also RB I-VP
seen VBN I-VP
in IN B-PP
large JJ B-NP
granular JJ I-NP
lymphocytes NNS I-NP
obtained VBN B-VP
from IN B-PP
normal JJ B-NP
subjects NNS I-NP
COMMA COMMA O
and CC O
it PRP B-NP
was VBD B-VP
again RB I-VP
suppressed VBN I-VP
by IN B-PP
Tx NN B-NP
. . O

These DT B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
E2 NN B-NP
is VBZ B-VP
one CD B-NP
of IN B-PP
the DT B-NP
activating VBG I-NP
factors NNS I-NP
for IN B-PP
NK\/LGL NN B-NP
cells NNS I-NP
. . O

Cytokine NN B-NP
modulation NN I-NP
of IN B-PP
HIV NN B-NP
expression NN I-NP
. . O

Cytokines NNS B-NP
COMMA COMMA O
the DT B-NP
peptide NN I-NP
hormones NNS I-NP
which WDT B-NP
control VBP B-VP
the DT B-NP
homeostasis NN I-NP
of IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
and CC O
also RB O
play VBP B-VP
a DT B-NP
fundamental JJ I-NP
role NN I-NP
in IN B-PP
inflammatory JJ B-NP
and CC I-NP
immune JJ I-NP
mediated JJ I-NP
reactions NNS I-NP
COMMA COMMA O
have VBP B-VP
been VBN I-VP
involved VBN I-VP
at IN B-PP
multiple JJ B-NP
levels NNS I-NP
in IN B-PP
the DT B-NP
pathogenesis NN I-NP
of IN B-PP
the DT B-NP
acquired VBN I-NP
immune JJ I-NP
deficiency NN I-NP
syndrome NN I-NP
( ( O
AIDS NN B-NP
) ) O
. . O

Infection NN B-NP
with IN B-PP
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV NN B-NP
) ) O
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
induce VB I-VP
production NN B-NP
of IN B-PP
several JJ B-NP
cytokines NNS I-NP
both CC O
in FW B-ADVP
vitro FW I-ADVP
and CC B-ADVP
in FW B-ADVP
vivo FW I-ADVP
. . O

Conversely RB B-ADVP
COMMA COMMA O
several JJ B-NP
cytokines NNS I-NP
modulate VBP B-VP
the DT B-NP
levels NNS I-NP
of IN B-PP
HIV NN B-NP
expression NN I-NP
in IN B-PP
infected JJ B-NP
cells NNS I-NP
of IN B-PP
both CC B-NP
T NN I-NP
lymphocytic JJ I-NP
and CC I-NP
mononuclear JJ I-NP
phagocytic JJ I-NP
lineage NN I-NP
. . O

Activated VBN B-NP
mononuclear JJ I-NP
cells NNS I-NP
COMMA COMMA O
particularly RB B-NP
B NN I-NP
cells NNS I-NP
which WDT B-NP
are VBP B-VP
in IN B-PP
a DT B-NP
state NN I-NP
of IN B-PP
chronic JJ B-NP
activation NN I-NP
in IN B-PP
HIV NN B-NP
infected JJ I-NP
individuals NNS I-NP
COMMA COMMA O
release VBP B-VP
HIV-inductive JJ B-NP
cytokines NNS I-NP
and CC O
thus RB O
play VBP B-VP
a DT B-NP
potentially RB I-NP
important JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
pathogenesis NN I-NP
of IN B-PP
HIV NN B-NP
infection NN I-NP
. . O

Tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
receptor NN I-NP
expression NN I-NP
and CC O
signal NN B-NP
transduction NN I-NP
in IN B-PP
HIV-1-infected JJ B-NP
cells NNS I-NP
. . O

OBJECTIVE NN B-NP
: : O
To TO B-VP
examine VB I-VP
the DT B-NP
inter-relationship NN I-NP
between IN B-PP
HIV-1 NN B-NP
infection NN I-NP
and CC O
the DT B-NP
cell NN I-NP
surface NN I-NP
receptors NNS I-NP
for IN B-PP
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
( ( I-NP
TNF NN I-NP
) ) I-NP
-alpha NN I-NP
COMMA COMMA O
an DT B-NP
immunoregulatory JJ I-NP
cytokine NN I-NP
that WDT B-NP
can MD B-VP
enhance VB I-VP
HIV-1 NN B-NP
replication NN I-NP
. . O

DESIGN NN B-NP
: : O
Infected JJ B-NP
promyelocytic JJ I-NP
and CC I-NP
promonocytic JJ I-NP
cells NNS I-NP
were VBD B-VP
examined VBN I-VP
because IN B-SBAR
they PRP B-NP
normally RB B-ADVP
express VBP B-VP
both DT B-NP
types NNS I-NP
of IN B-PP
TNF NN B-NP
receptors NNS I-NP
. . O

METHODS NNS B-NP
: : O
TNF NN B-NP
receptor NN I-NP
surface NN I-NP
expression NN I-NP
was VBD B-VP
determined VBN I-VP
by IN B-PP
specific JJ B-NP
monoclonal JJ I-NP
antibody NN I-NP
recognition NN I-NP
and CC O
flow NN B-NP
cytometry NN I-NP
COMMA COMMA O
and CC O
signal NN B-NP
transduction NN I-NP
was VBD B-VP
detected VBN I-VP
by IN B-PP
gel NN B-NP
shift NN I-NP
analysis NN I-NP
. . O

HIV-1 NN B-NP
activation NN B-NP
and CC O
expression NN B-NP
was VBD B-VP
quantitated VBN I-VP
by IN B-PP
reverse JJ B-NP
transcriptase NN I-NP
assay NN I-NP
. . O

RESULTS NNS B-NP
: : O
In IN B-PP
the DT B-NP
OM-10.1 NN I-NP
promyelocytic JJ I-NP
model NN I-NP
of IN B-PP
chronic JJ B-NP
infection NN I-NP
COMMA COMMA O
TNF-alpha-induced JJ B-NP
HIV-1 NN I-NP
expression NN I-NP
also RB B-ADVP
resulted VBD B-VP
in IN B-PP
a DT B-NP
substantial JJ I-NP
increase NN I-NP
in IN B-PP
75 CD B-NP
kd NN I-NP
TNF NN I-NP
receptor NN I-NP
( ( O
TR75 NN B-NP
) ) O
expression NN B-NP
although IN B-SBAR
55 CD B-NP
kD NN I-NP
TNF NN I-NP
receptor NN I-NP
( ( O
TR55 NN B-NP
) ) O
levels NNS B-NP
were VBD B-VP
not RB I-VP
dramatically RB I-VP
altered VBN I-VP
. . O

A DT B-NP
series NN I-NP
of IN B-PP
uninfected JJ B-NP
parental JJ I-NP
HL-60 NN I-NP
subclones NNS I-NP
all DT B-ADVP
reduced VBD B-VP
TR75 NN B-NP
surface NN I-NP
expression NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
TNF-alpha NN B-NP
treatment NN I-NP
. . O

Enhanced VBN B-NP
TR75 NN I-NP
expression NN I-NP
on IN B-PP
OM-10.1 NN B-NP
cells NNS I-NP
followed VBD B-VP
the DT B-NP
same JJ I-NP
TNF-alpha-dose NN I-NP
dependency NN I-NP
as IN B-PP
that WDT B-NP
observed VBN B-VP
for IN B-PP
HIV-1 NN B-NP
production NN I-NP
. . O

An DT B-NP
increase NN I-NP
in IN B-PP
TR75 NN B-NP
expression NN I-NP
was VBD B-VP
also RB B-ADVP
evident JJ B-ADJP
during IN B-PP
the DT B-NP
peak NN I-NP
of IN B-PP
an DT B-NP
acute JJ I-NP
HIV-1 NN I-NP
infection NN I-NP
of IN B-PP
HL-60 NN B-NP
promyelocytes NNS I-NP
. . O

Although IN B-SBAR
TR55 NN B-NP
expression NN I-NP
was VBD B-VP
unaltered JJ B-ADJP
during IN B-PP
TNF-alpha-induced JJ B-NP
HIV NN I-NP
activation NN I-NP
COMMA COMMA O
this DT B-NP
receptor NN I-NP
was VBD B-VP
still RB I-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
viral JJ I-NP
activation NN I-NP
process NN I-NP
. . O

Antibody NN B-NP
cross-linking NN I-NP
of IN B-PP
TR55 NN B-NP
COMMA COMMA O
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
exogenous JJ B-NP
TNF-alpha NN I-NP
COMMA COMMA O
induced VBN B-VP
maximal JJ B-NP
HIV-1 NN I-NP
expression NN I-NP
COMMA COMMA O
an DT B-NP
up-modulation NN I-NP
of IN B-PP
surface NN B-NP
TR75 NN I-NP
COMMA COMMA O
and CC O
nuclear JJ B-NP
NF-kappa NN I-NP
B NN I-NP
activity NN I-NP
in IN B-PP
OM-10.1 NN B-NP
cultures NNS I-NP
. . O

Surprisingly RB B-ADVP
COMMA COMMA O
this DT B-NP
was VBD B-VP
the DT B-NP
case NN I-NP
even RB B-ADVP
when WRB I-ADVP
an DT B-NP
antagonistic JJ I-NP
anti-TR55 JJ I-NP
antibody NN I-NP
was VBD B-VP
used VBN I-VP
. . O

Anti-TR55 JJ B-NP
antibody NN I-NP
cross-linking NN I-NP
in IN B-PP
chronically RB B-NP
infected JJ I-NP
U1 NN I-NP
promonocytic JJ I-NP
cultures NNS I-NP
could MD B-VP
only RB I-VP
partially RB I-VP
substitute VB I-VP
for IN B-PP
TNF-alpha-induced JJ B-NP
HIV-1 NN I-NP
expression NN I-NP
. . O

CONCLUSIONS NNS B-NP
: : O
Our PRP$ B-NP
results NNS I-NP
demonstrated VBD B-VP
that IN B-SBAR
HIV-1 NN B-NP
infection NN I-NP
can MD B-VP
selectively RB I-VP
influence VB I-VP
the DT B-NP
surface NN I-NP
expression NN I-NP
of IN B-PP
TNF NN B-NP
receptors NNS I-NP
COMMA COMMA O
potentially RB B-ADVP
influencing VBG B-VP
its PRP$ B-NP
own JJ I-NP
expression NN I-NP
and CC O
altering VBG B-VP
normal JJ B-NP
immunoregulatory JJ I-NP
signal NN I-NP
transduction NN I-NP
. . O

FK506 NN B-NP
and CC O
ciclosporin NN B-NP
: : O
molecular JJ B-NP
probes NNS I-NP
for IN B-PP
studying VBG B-VP
intracellular JJ B-NP
signal NN I-NP
transduction NN I-NP
. . O

The DT B-NP
immunosuppressants NNS I-NP
ciclosporin NN B-NP
and CC O
FK506 NN B-NP
block VBP B-VP
the DT B-NP
Ca(2+)-dependent JJ I-NP
signal-transduction NN I-NP
pathway NN I-NP
emanating VBG B-VP
from IN B-PP
the DT B-NP
T-cell NN I-NP
receptor NN I-NP
COMMA COMMA O
thereby RB B-ADVP
inhibiting VBG B-VP
the DT B-NP
activation NN I-NP
of IN B-PP
helper NN B-NP
T NN I-NP
cells NNS I-NP
. . O

Using VBG B-VP
these DT B-NP
drugs NNS I-NP
as IN B-PP
probes NNS B-NP
COMMA COMMA O
chemists NNS B-NP
and CC O
biologists NNS B-NP
have VBP B-VP
uncovered VBN I-VP
several JJ B-NP
intracellular JJ I-NP
signalling NN I-NP
molecules NNS I-NP
bridging VBG B-VP
the DT B-NP
generation NN I-NP
of IN B-PP
second-messenger NN B-NP
Ca2+ NN I-NP
ions NNS I-NP
and CC O
the DT B-NP
transcriptional JJ I-NP
activation NN I-NP
of IN B-PP
IL-2 NN B-NP
COMMA COMMA O
among IN B-PP
which WDT B-NP
are VBP B-VP
calmodulin NN B-NP
COMMA COMMA O
calcineurin NN B-NP
and CC O
the DT B-NP
nuclear JJ I-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
( ( O
NF-AT NN B-NP
) ) O
. . O

Hence RB B-ADVP
COMMA COMMA O
Ca2+ NN B-NP
binds VBZ B-VP
to TO B-PP
calmodulin NN B-NP
COMMA COMMA O
leading VBG B-VP
to TO B-PP
the DT B-NP
binding NN I-NP
of IN B-PP
calmodulin NN B-NP
to TO B-PP
calcineurin NN B-NP
; : O
the DT B-NP
activated VBN I-NP
calcineurin NN I-NP
COMMA COMMA O
in IN B-PP
turn NN B-NP
COMMA COMMA O
may MD B-VP
dephosphorylate VB I-VP
the DT B-NP
cytoplasmic JJ I-NP
subunit NN I-NP
of IN B-PP
NF-AT NN B-NP
COMMA COMMA O
resulting VBG B-VP
in IN B-PP
its PRP$ B-NP
translocation NN I-NP
from IN B-PP
the DT B-NP
cytoplasm NN I-NP
into IN B-PP
the DT B-NP
nucleus NN I-NP
to TO B-VP
form VB I-VP
a DT B-NP
competent JJ I-NP
transcriptional JJ I-NP
activator NN I-NP
. . O

As IN B-SBAR
described VBN B-VP
by IN B-PP
Jun NNP B-NP
Liu NNP I-NP
COMMA COMMA O
these DT B-NP
drugs NNS I-NP
manifest VBP B-VP
their PRP$ B-NP
effects NNS I-NP
in IN B-PP
an DT B-NP
unprecedented JJ I-NP
fashion NN I-NP
. . O

They PRP B-NP
do VBP B-VP
not RB I-VP
directly RB I-VP
intercept VB I-VP
intracellular JJ B-NP
signalling NN I-NP
molecules NNS I-NP
. . O

Instead RB B-ADVP
COMMA COMMA O
they PRP B-NP
form VBP B-VP
tight JJ B-NP
complexes NNS I-NP
with IN B-PP
two CD B-NP
different JJ I-NP
classes NNS I-NP
of IN B-PP
abundant JJ B-NP
cytosolic JJ I-NP
receptors NNS I-NP
called VBN B-VP
immunophilins NNS B-NP
upon IN B-PP
entering VBG B-VP
the DT B-NP
cell NN I-NP
COMMA COMMA O
and CC O
consequently RB B-VP
inhibit VBP I-VP
their PRP$ B-NP
peptidyl JJ I-NP
prolyl JJ I-NP
cis-trans JJ I-NP
isomerase NN I-NP
activities NNS I-NP
. . O

The DT B-NP
two CD I-NP
structurally RB I-NP
distinct JJ I-NP
immunophilin-drug JJ I-NP
complexes NNS I-NP
bind VBP B-VP
to TO B-PP
COMMA COMMA O
and CC O
inhibit VBP B-VP
COMMA COMMA O
the DT B-NP
phosphatase JJ I-NP
activity NN I-NP
of IN B-PP
calcineurin NN B-NP
. . O

The DT B-NP
impaired JJ I-NP
transcription NN I-NP
factor NN I-NP
AP-1 NN I-NP
DNA NN I-NP
binding NN I-NP
activity NN I-NP
in IN B-PP
lymphocytes NNS B-NP
derived VBN B-VP
from IN B-PP
subjects NNS B-NP
with IN B-PP
some DT B-NP
symptoms NNS I-NP
of IN B-PP
premature JJ B-NP
aging NN I-NP
. . O

The DT B-NP
study NN I-NP
of IN B-PP
human JJ B-NP
disorders NNS I-NP
known VBN B-VP
as IN B-PP
premature JJ B-NP
aging NN I-NP
syndromes NNS I-NP
may MD B-VP
provide VB I-VP
insight NN B-NP
into IN B-PP
the DT B-NP
mechanisms NNS I-NP
of IN B-PP
cellular JJ B-NP
senescence NN I-NP
. . O

The DT B-NP
main JJ I-NP
feature NN I-NP
of IN B-PP
cellular JJ B-NP
senescence NN I-NP
in FW B-ADVP
vitro FW I-ADVP
is VBZ B-VP
cessation NN B-NP
of IN B-PP
cell NN B-NP
proliferation NN I-NP
. . O

Down NN B-NP
syndrome NN I-NP
( ( O
DS NN B-NP
) ) O
and CC O
neuronal JJ B-NP
ceroid-lypofuscinosis NN I-NP
( ( O
NCL NN B-NP
) ) O
are VBP B-VP
clinically RB I-VP
characterized VBN I-VP
by IN B-PP
the DT B-NP
premature JJ I-NP
onset NN I-NP
of IN B-PP
numerous JJ B-NP
features NNS I-NP
normally RB B-VP
associated VBN I-VP
with IN B-PP
human JJ B-NP
aging NN I-NP
. . O

Phytohemagglutinin NN B-NP
stimulated JJ B-NP
lymphocytes NNS I-NP
derived VBN B-VP
from IN B-PP
DS NN B-NP
subjects NNS I-NP
showed VBD B-VP
a DT B-NP
statistically RB I-NP
significant JJ I-NP
diminished VBN I-NP
proliferation NN I-NP
capacity NN I-NP
in IN B-PP
comparison NN I-PP
with IN I-PP
lymphocytes NNS B-NP
derived VBN B-VP
from IN B-PP
NCL NN B-NP
and CC O
healthy JJ B-ADJP
individuals NNS B-NP
. . O

We PRP B-NP
demonstrated VBD B-VP
COMMA COMMA O
by IN B-PP
applying VBG B-VP
the DT B-NP
electrophoretic JJ I-NP
mobility NN I-NP
shift NN I-NP
assay NN I-NP
COMMA COMMA O
slightly RB B-NP
impaired JJ I-NP
AP-1 NN I-NP
DNA NN I-NP
binding NN I-NP
activity NN I-NP
in IN B-PP
NCL NN B-NP
lymphocytes NNS I-NP
and CC O
strong JJ B-NP
in IN B-PP
DS NN B-NP
ones NNS I-NP
. . O

Our PRP$ B-NP
results NNS I-NP
showed VBD B-VP
that IN B-SBAR
the DT B-NP
same JJ I-NP
molecular JJ I-NP
mechanisms NNS I-NP
of IN B-PP
proliferation NN B-NP
cessation NN I-NP
could MD B-VP
exist VB I-VP
in IN B-PP
fibroblasts NNS B-NP
characterized VBN B-VP
by IN B-PP
replicative JJ B-NP
senescence NN I-NP
and CC B-PP
in IN B-PP
lymphocytes NNS B-NP
derived VBN B-VP
from IN B-PP
individuals NNS B-NP
with IN B-PP
premature JJ B-NP
aging NN I-NP
syndromes NNS I-NP
( ( O
Down NN B-NP
) ) O
. . O

Inhibition NN B-NP
of IN B-PP
HIV-1 NN B-NP
latency NN I-NP
reactivation NN I-NP
by IN B-PP
dehydroepiandrosterone NN B-NP
( ( O
DHEA NN B-NP
) ) O
and CC O
an DT B-NP
analog NN I-NP
of IN B-PP
DHEA NN B-NP
. . O

The DT B-NP
initial JJ I-NP
infection NN I-NP
with IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HIV-1 NN B-NP
) ) O
in IN B-PP
most JJS B-NP
individuals NNS I-NP
usually RB B-ADVP
results VBZ B-VP
in IN B-PP
the DT B-NP
establishment NN I-NP
of IN B-PP
a DT B-NP
latent JJ I-NP
or CC I-NP
chronic JJ I-NP
infection NN I-NP
before IN B-PP
eventual JJ B-NP
progression NN I-NP
toward IN B-PP
acquired VBN B-NP
immunodeficiency NN I-NP
syndrome NN I-NP
. . O

HIV-1 NN B-NP
can MD B-VP
also RB I-VP
establish VB I-VP
a DT B-NP
latent JJ I-NP
or CC I-NP
persistent JJ I-NP
infection NN I-NP
in IN B-PP
some DT B-NP
T NN I-NP
cell NN I-NP
lines NNS I-NP
that WDT B-NP
show VBP B-VP
minimal JJ B-NP
constitutive JJ I-NP
virus NN I-NP
expression NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
activation NN B-NP
of IN B-PP
the DT B-NP
T NN I-NP
cell NN I-NP
lines NNS I-NP
leading VBG B-VP
to TO B-PP
enhanced VBN B-NP
HIV-1 NN I-NP
replication NN I-NP
can MD B-VP
be VB I-VP
induced VBN I-VP
by IN B-PP
antigens NNS B-NP
COMMA COMMA O
mitogens NNS B-NP
COMMA COMMA O
and CC O
cytokines NNS B-NP
( ( O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
{ ( O
TNF-alpha NN B-NP
} ) O
COMMA COMMA O
interleukin NN B-NP
1 CD I-NP
COMMA COMMA O
and CC O
interleukin-2 NN B-NP
) ) O
. . O

Various JJ B-NP
gene NN I-NP
products NNS I-NP
from IN B-PP
other JJ B-NP
viruses NNS I-NP
( ( O
HTLV-1 NN B-NP
COMMA COMMA O
HSV NN B-NP
COMMA COMMA O
EBV NN B-NP
COMMA COMMA O
CMV NN B-NP
COMMA COMMA O
HBV NN B-NP
COMMA COMMA O
and CC O
HHV-6 NN B-NP
) ) O
can MD B-VP
also RB I-VP
enhance VB I-VP
HIV-1 NN B-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
( ( I-NP
LTR NN I-NP
) ) I-NP
-driven JJ I-NP
reporter NN I-NP
gene NN I-NP
activity NN I-NP
. . O

On IN B-PP
the DT I-PP
basis NN I-PP
of IN I-PP
these DT B-NP
observations NNS I-NP
COMMA COMMA O
it PRP B-NP
has VBZ B-VP
been VBN I-VP
proposed VBN I-VP
that IN B-SBAR
reactivation NN B-NP
of IN B-PP
latent JJ B-NP
HIV-1 NN I-NP
harbored VBN B-VP
in IN B-PP
chronically RB B-NP
infected JJ I-NP
T NN B-NP
lymphocytes NNS I-NP
COMMA COMMA O
monocytes NNS B-NP
COMMA COMMA O
or CC O
macrophages NNS B-NP
plays VBZ B-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
pathogenesis NN I-NP
of IN B-PP
AIDS NN B-NP
. . O

So RB B-ADVP
far RB I-ADVP
COMMA COMMA O
there EX B-NP
are VBP B-VP
no DT B-NP
drugs NNS B-NP
or CC O
therapy NN B-NP
available JJ B-ADJP
that WDT B-NP
can MD B-VP
provide VB I-VP
protection NN B-NP
against IN B-PP
HIV-1 NN B-NP
latency NN I-NP
reactivation NN I-NP
. . O

ACH-2 NN B-NP
COMMA COMMA O
derived VBN B-VP
from IN B-PP
a DT B-NP
human JJ I-NP
T NN I-NP
cell NN I-NP
line NN I-NP
( ( O
CEM NN B-NP
) ) O
COMMA COMMA O
is VBZ B-VP
chronically RB B-ADJP
infected VBN I-ADJP
with IN B-PP
HIV-1 NN O
COMMA COMMA O
with IN B-PP
low JJ B-NP
levels NNS I-NP
of IN B-PP
constitutive JJ B-NP
virus NN I-NP
expression NN I-NP
. . O

ACH-2 NN B-NP
can MD B-VP
be VB I-VP
converted VBN I-VP
to TO B-PP
productive JJ B-NP
infection NN I-NP
by IN B-PP
stimulation NN B-NP
of IN B-PP
the DT B-NP
cells NNS I-NP
with IN B-PP
12-O-tetradecanoylphorbol-13-acetate NN B-NP
( ( O
TPA NN B-NP
) ) O
COMMA COMMA O
mitogen NN B-NP
or CC O
cytokines NNS B-NP
( ( O
TNF-alpha NN B-NP
) ) O
COMMA COMMA O
or CC O
infection NN B-NP
with IN B-PP
HSV NN B-NP
. . O

Therefore RB B-ADVP
the DT B-NP
ACH-2 NN I-NP
cell NN I-NP
line NN I-NP
is VBZ B-VP
a DT B-NP
good JJ I-NP
candidate NN I-NP
for IN B-PP
studying VBG B-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
drugs NNS B-NP
on IN B-PP
HIV-1 NN B-NP
activation NN I-NP
. . O

Previously RB B-ADVP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
reported VBN I-VP
that IN B-SBAR
DHEA NN B-NP
and CC O
synthetic JJ B-NP
analogs NNS I-NP
of IN B-PP
DHEA NN B-NP
can MD B-VP
be VB I-VP
modest JJ B-NP
inhibitors NNS I-NP
of IN B-PP
HIV-1 NN B-NP
IIIB NN I-NP
replication NN I-NP
in IN B-PP
phytohemagglutinin-stimulated JJ B-NP
peripheral JJ I-NP
blood NN I-NP
lymphocyte NN I-NP
cultures NNS I-NP
. . O

( ( O
ABSTRACT NN B-NP
TRUNCATED VBN B-VP
AT IN B-PP
250 CD B-NP
WORDS NNS I-NP
) ) O

Visualization NN B-NP
of IN B-PP
the DT B-NP
endogenous JJ I-NP
NF-kappa NN I-NP
B NN I-NP
p50 NN I-NP
subunit NN I-NP
in IN B-PP
the DT B-NP
nucleus NN I-NP
of IN B-PP
follicular JJ B-NP
dendritic JJ I-NP
cells NNS I-NP
in IN B-PP
germinal JJ B-NP
centers NNS I-NP
. . O

NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
a DT O
50 CD O
kDa\/65 CD O
kDa NN O
( ( O
p50\/p65 NN B-ADJP
) ) O
heterodimer NN B-NP
COMMA COMMA O
is VBZ B-VP
a DT B-NP
ubiquitous JJ I-NP
transcription NN I-NP
factor NN I-NP
involved VBN B-VP
in IN B-PP
the DT B-NP
positive JJ I-NP
regulation NN I-NP
of IN B-PP
various JJ B-NP
immune JJ I-NP
genes NNS I-NP
. . O

The DT B-NP
aim NN I-NP
of IN B-PP
this DT B-NP
study NN I-NP
was VBD B-VP
to TO B-VP
determine VB I-VP
whether IN B-SBAR
NF-kappa NN B-NP
B NN I-NP
is VBZ B-VP
related JJ B-ADJP
to TO B-PP
a DT B-NP
particular JJ B-NP
cell NN I-NP
type NN I-NP
and\/or CC O
differentiation NN B-NP
step NN I-NP
during IN B-PP
immunopoiesis NN B-NP
. . O

Using VBG B-VP
in FW B-NP
situ FW I-NP
hybridization NN I-NP
on IN B-PP
sections NNS B-NP
from IN B-PP
non JJ B-NP
HIV NN I-NP
hyperplastic JJ I-NP
lymph NN I-NP
nodes NNS I-NP
COMMA COMMA O
we PRP B-NP
found VBD B-VP
that IN B-SBAR
the DT B-NP
gene NN I-NP
of IN B-PP
the DT B-NP
105 CD I-NP
kDa NN I-NP
precursor NN I-NP
of IN B-PP
p50 NN B-NP
was VBD B-VP
overexpressed VBN I-VP
in IN B-PP
the DT B-NP
light JJ I-NP
zone NN I-NP
of IN B-PP
germinal JJ B-NP
centers NNS I-NP
COMMA COMMA O
with IN B-PP
a DT B-NP
network NN I-NP
aspect NN I-NP
COMMA COMMA O
which WDT B-NP
suggested VBD B-VP
the DT B-NP
involvement NN I-NP
of IN B-PP
follicular JJ B-NP
dendritic JJ I-NP
cells NNS I-NP
( ( O
FDC NN B-NP
) ) O
. . O

By IN B-PP
immunohistochemistry NN B-NP
COMMA COMMA O
p50 NN B-NP
protein NN I-NP
was VBD B-VP
detected VBN I-VP
in IN B-PP
the DT B-NP
cytoplasm NN B-NP
and CC O
nucleus NN B-NP
of IN B-PP
FDC NN B-NP
COMMA COMMA O
confirming VBG B-VP
the DT B-NP
involvement NN I-NP
of IN B-PP
FDC NN B-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
p50 NN B-NP
protein NN I-NP
was VBD B-VP
detected VBN I-VP
in IN B-PP
the DT B-NP
cytoplasm NN I-NP
of IN B-PP
all DT B-NP
lymphocytes NNS I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
we PRP B-NP
focused VBD B-VP
our PRP$ B-NP
study NN I-NP
on IN B-PP
isolated VBN B-NP
FDC NN I-NP
clusters NNS I-NP
from IN B-PP
normal JJ B-NP
tonsils NNS I-NP
. . O

As IN B-SBAR
showed VBN B-VP
on IN B-PP
tissue NN B-NP
sections NNS I-NP
COMMA COMMA O
we PRP B-NP
detected VBD B-VP
the DT B-NP
p50 NN I-NP
in IN B-PP
both CC O
cytoplasm NN B-NP
and CC O
nucleus NN B-NP
of IN B-PP
FDC NN B-NP
. . O

Nuclei NNS B-NP
of IN B-PP
lymphocytes NNS B-NP
from IN B-PP
FDC NN B-NP
clusters NNS I-NP
were VBD B-VP
negative JJ B-ADJP
. . O

We PRP B-NP
next RB B-ADVP
studied VBD B-VP
p65 NN B-NP
and CC O
c-Rel NN B-NP
protein NN I-NP
expression NN B-NP
in IN B-PP
FDC NN B-NP
clusters NNS I-NP
. . O

p65 NN B-NP
was VBD B-VP
detected VBN I-VP
in IN B-PP
the DT B-NP
cytoplasm NN I-NP
of IN B-PP
FDC NN B-NP
COMMA COMMA O
whereas IN O
nuclei NNS B-NP
were VBD B-VP
negative JJ B-ADJP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
p65 NN B-NP
was VBD B-VP
detected VBN I-VP
in IN B-PP
the DT B-NP
nuclei NNS I-NP
of IN B-PP
some DT B-NP
lymphocytes NNS I-NP
. . O

c-Rel NN B-NP
protein NN I-NP
was VBD B-VP
detected VBN I-VP
only RB B-PP
in IN I-PP
the DT B-NP
cytoplasm NN I-NP
of IN B-PP
lymphocytes NNS B-NP
and CC B-PP
not RB B-PP
in IN I-PP
the DT B-NP
nucleus NN B-NP
and CC O
cytoplasm NN B-NP
of IN B-PP
FDC NN B-NP
. . O

Our PRP$ B-NP
results NNS I-NP
indicated VBD B-VP
that IN B-SBAR
COMMA COMMA O
in IN B-PP
the DT I-PP
context NN I-PP
of IN I-PP
T NN B-NP
cell-dependent JJ I-NP
B NN I-NP
cell NN I-NP
immunopoiesis NN I-NP
occurring VBG B-VP
in IN B-PP
FDC NN B-NP
clusters NNS I-NP
COMMA COMMA O
p50 NN B-NP
is VBZ B-VP
mainly RB B-ADVP
related JJ B-ADJP
to TO B-PP
FDC NN B-NP
with IN B-PP
a DT B-NP
massive JJ I-NP
overexpression NN I-NP
in IN B-PP
the DT B-NP
nuclei NNS I-NP
COMMA COMMA O
whereas IN O
p65 NN B-NP
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
a DT B-NP
scattered VBN I-NP
manner NN I-NP
in IN B-PP
the DT B-NP
nuclei NNS I-NP
of IN B-PP
lymphocytes NNS B-NP
and CC O
c-Rel NN B-NP
protein NN I-NP
exclusively RB B-ADVP
in IN B-PP
the DT B-NP
cytoplasm NN I-NP
of IN B-PP
lymphocytes NNS B-NP
from IN B-PP
FDC NN B-NP
clusters NNS I-NP
. . O

These DT B-NP
results NNS I-NP
suggested VBD B-VP
that IN B-SBAR
the DT B-NP
two CD I-NP
subunits NNS I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
and CC O
the DT B-NP
c-Rel NN I-NP
protein NN I-NP
have VBP B-VP
different JJ B-NP
roles NNS I-NP
in IN B-PP
different JJ B-NP
cell NN I-NP
types NNS I-NP
during IN B-PP
B NN B-NP
cell NN I-NP
immunopoiesis NN I-NP
. . O

Involvement NN B-NP
of IN B-PP
transcription NN B-NP
factor NN I-NP
YB-1 NN I-NP
in IN B-PP
human JJ B-NP
T-cell NN I-NP
lymphotropic JJ I-NP
virus NN I-NP
type NN I-NP
I CD I-NP
basal JJ I-NP
gene NN I-NP
expression NN I-NP
. . O

Sequences NNS B-NP
which WDT B-NP
control VBP B-VP
basal JJ O
human JJ B-NP
T-cell NN I-NP
lymphotropic NN I-NP
virus NN I-NP
type NN I-NP
I CD I-NP
( ( O
HTLV-I NN B-NP
) ) O
transcription NN B-NP
likely RB B-ADVP
play VB B-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
initiation NN B-NP
and CC O
maintenance NN B-NP
of IN B-PP
virus NN B-NP
replication NN I-NP
. . O

We PRP B-NP
previously RB B-ADVP
identified VBD B-VP
and CC O
analyzed VBD B-VP
a DT B-NP
45-nucleotide JJ I-NP
sequence NN I-NP
( ( O
downstream JJ B-NP
regulatory JJ I-NP
element NN I-NP
1 CD I-NP
{ ( O
DRE NN B-NP
1 CD I-NP
} ) O
) ) O
COMMA COMMA O
+195 CD B-NP
to TO O
+240 CD B-NP
COMMA COMMA O
at IN B-PP
the DT B-NP
boundary NN I-NP
of IN B-PP
the DT B-NP
R\/U5 NN I-NP
region NN I-NP
of IN B-PP
the DT B-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
which WDT B-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
HTLV-I NN B-NP
basal JJ I-NP
transcription NN I-NP
. . O

We PRP B-NP
identified VBD B-VP
a DT B-NP
protein NN I-NP
COMMA COMMA O
p37 NN B-NP
COMMA COMMA O
which WDT B-NP
specifically RB B-ADVP
bound VBD B-VP
to TO B-PP
DRE NN B-NP
1 CD I-NP
. . O

An DT B-NP
affinity NN I-NP
column NN I-NP
fraction NN I-NP
COMMA COMMA O
containing VBG B-VP
p37 NN B-NP
COMMA COMMA O
stimulated VBD B-VP
HTLV-I NN B-NP
transcription NN I-NP
approximately RB B-ADVP
12-fold RB I-ADVP
in FW B-ADVP
vitro FW I-ADVP
. . O

We PRP B-NP
now RB B-ADVP
report VBP B-VP
the DT B-NP
identification NN I-NP
of IN B-PP
a DT B-NP
cDNA NN I-NP
clone NN I-NP
( ( O
15B-7 NN B-NP
) ) O
COMMA COMMA O
from IN B-PP
a DT B-NP
Jurkat NN I-NP
expression NN I-NP
library NN I-NP
COMMA COMMA O
that WDT B-NP
binds VBZ B-VP
specifically RB B-ADVP
to TO B-PP
the DT B-NP
DRE NN I-NP
1 CD I-NP
regulatory JJ I-NP
sequence NN I-NP
. . O

Binding NN B-NP
of IN B-PP
the DT B-NP
cDNA NN I-NP
fusion NN I-NP
protein NN I-NP
COMMA COMMA O
similarly RB B-ADVP
to TO B-PP
the DT B-NP
results NNS I-NP
obtained VBN B-VP
with IN B-PP
purified VBN B-NP
Jurkat NN I-NP
protein NN I-NP
COMMA COMMA O
was VBD B-VP
decreased VBN I-VP
by IN B-PP
introduction NN B-NP
of IN B-PP
site-specific JJ B-NP
mutations NNS I-NP
in IN B-PP
the DT B-NP
DRE NN I-NP
1 CD I-NP
regulatory JJ I-NP
sequence NN I-NP
. . O

In FW B-NP
vitro FW I-NP
transcription NN B-NP
and CC O
translation NN B-NP
of IN B-PP
15B-7 NN B-NP
cDNA NN I-NP
produced VBD B-VP
a DT B-NP
fusion NN I-NP
protein NN I-NP
which WDT B-NP
bound VBD B-VP
specifically RB B-ADVP
to TO B-PP
the DT O
HTLV-I NN O
+195 CD B-NP
to TO O
+240 CD B-NP
oligonucleotide NN B-NP
. . O

The DT B-NP
partial JJ I-NP
cDNA NN I-NP
encodes VBZ B-VP
a DT B-NP
protein NN I-NP
which WDT B-NP
is VBZ B-VP
homologous JJ B-ADJP
to TO B-PP
the DT B-NP
C-terminal JJ I-NP
196 CD I-NP
amino NN I-NP
acids NNS I-NP
of IN B-PP
the DT B-NP
36-kDa JJ I-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
YB-1 NN B-NP
. . O

Cotransfection NN B-NP
of IN B-PP
a DT B-NP
YB-1 NN I-NP
expression NN I-NP
plasmid NN I-NP
increases VBZ B-VP
HTLV-I NN B-NP
basal JJ I-NP
transcription NN I-NP
approximately RB B-ADVP
14-fold RB I-ADVP
in IN B-PP
Jurkat NN B-NP
T NN I-NP
lymphocytes NNS I-NP
. . O

On IN B-PP
the DT I-PP
basis NN I-PP
of IN I-PP
the DT B-NP
molecular JJ I-NP
weight NN I-NP
COMMA COMMA O
DNA-binding JJ B-NP
characteristics NNS I-NP
COMMA COMMA O
and CC O
in FW B-NP
vivo FW I-NP
transactivation NN I-NP
activity NN I-NP
COMMA COMMA O
we PRP B-NP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
previously RB I-NP
identified VBN I-NP
DRE NN I-NP
1-binding JJ I-NP
protein NN I-NP
COMMA COMMA O
p37 NN B-NP
COMMA COMMA O
is VBZ B-VP
YB-1 NN B-NP
. . O

Chlorinated VBN B-NP
dibenzo-p-dioxins NNS B-NP
and CC O
dibenzofurans NNS B-NP
and CC O
the DT B-NP
human JJ I-NP
immune JJ I-NP
system NN I-NP
. . O

1 LS B-LST
. . O
Blood NN B-NP
cell NN I-NP
receptors NNS I-NP
in IN B-PP
volunteers NNS B-NP
with IN B-PP
moderately RB B-NP
increased VBN I-NP
body NN I-NP
burdens NNS I-NP
. . O

Using VBG B-VP
monoclonal JJ B-NP
antibodies NNS I-NP
( ( O
mAbs NNS B-NP
) ) O
and CC O
flow NN B-NP
cytometry NN I-NP
COMMA COMMA O
we PRP B-NP
studied VBD B-VP
a DT B-NP
variety NN I-NP
of IN B-PP
surface NN B-NP
receptors NNS I-NP
on IN B-PP
lymphocyte NN B-NP
subpopulations NNS I-NP
of IN B-PP
workers NNS B-NP
with IN B-PP
moderately RB B-NP
increased VBN I-NP
body NN I-NP
burdens NNS I-NP
of IN B-PP
2COMMA3COMMA7COMMA8-tetrachlorodibenzo-p-dioxin NN B-NP
( ( O
TCDD NN B-NP
) ) O
and CC B-PP
of IN B-PP
other JJ B-NP
polychlorinated VBN B-NP
dibenzo-p-dioxins NNS B-NP
and CC O
dibenzofurans NNS B-NP
( ( O
PCDD\/PCDF NN B-NP
) ) O
COMMA COMMA O
expressed VBN B-VP
here RB B-ADVP
as IN B-PP
International-Toxicity NN B-NP
Equivalencies NN I-NP
( ( O
I-TE NN B-NP
) ) O
. . O

The DT B-NP
hypothesis NN I-NP
to TO B-VP
be VB I-VP
tested VBN I-VP
was VBD B-VP
whether IN B-SBAR
or CC O
not RB O
humans NNS B-NP
exhibit VBP B-VP
a DT B-NP
similar JJ I-NP
susceptibility NN I-NP
to TO B-PP
PCDDs\/PCDFs NNS B-NP
with IN B-PP
respect NN I-PP
to TO I-PP
the DT B-NP
surface NN I-NP
receptors NNS I-NP
found VBN B-VP
previously RB I-VP
to TO I-VP
respond VB I-VP
to TO B-PP
small JJ B-NP
doses NNS I-NP
of IN B-PP
2COMMA3COMMA7COMMA8-tetrachlorodibenzo-p-dioxin NN B-NP
( ( O
TCDD NN B-NP
) ) O
in IN B-PP
Callithrix FW B-NP
jacchus FW I-NP
. . O

These DT B-NP
are VBP B-VP
: : O
helper-inducer JJ B-NP
( ( O
memory NN B-NP
) ) O
T NN B-NP
cells NNS I-NP
( ( O
CD4+CD45R0+CD45RA-CD29highCD11a+ JJ B-NP
) ) O
COMMA COMMA O
CD20+ JJ B-NP
B NN I-NP
cells NNS I-NP
COMMA COMMA O
and CC O
cytotoxic JJ B-NP
T NN I-NP
cells NNS I-NP
( ( O
CD8+CD56+\/CD57+ JJ B-NP
) ) O
. . O

Furthermore RB B-ADVP
COMMA COMMA O
68 CD B-NP
triple-labellings NNS I-NP
with IN B-PP
mAbs NNS B-NP
were VBD B-VP
performed VBN I-VP
on IN B-PP
the DT B-NP
cells NNS I-NP
of IN B-PP
each DT B-NP
volunteer NN I-NP
to TO B-VP
possibly RB I-VP
generate VB I-VP
further JJ B-NP
hypotheses NNS I-NP
. . O

It PRP B-NP
was VBD B-VP
evaluated VBN I-VP
whether IN B-SBAR
any DT B-NP
of IN B-PP
the DT B-NP
variables NNS I-NP
might MD B-VP
be VB I-VP
used VBN I-VP
as IN B-PP
a DT B-NP
biomarker NN I-NP
of IN B-PP
effects NNS B-NP
for IN B-PP
this DT B-NP
class NN I-NP
of IN B-PP
compounds NNS B-NP
. . O

There EX B-NP
were VBD B-VP
two CD B-NP
main JJ I-NP
goals NNS I-NP
: : O
( ( B-LST
1 LS I-LST
) ) O
to TO B-VP
evaluate VB I-VP
whether IN B-SBAR
workers NNS B-NP
with IN B-PP
a DT B-NP
moderately RB I-NP
increased VBN I-NP
PCDD\/PCDF-body NN I-NP
burden NN I-NP
{ ( O
25-140 CD B-NP
ppt NN I-NP
TCDD NN I-NP
or CC O
104-522 CD B-NP
ppt NN I-NP
I-TE NN I-NP
in IN B-PP
blood NN B-NP
fat NN I-NP
} ) O
exhibit VBP B-VP
changes NNS B-NP
in IN B-PP
the DT B-NP
surface NN I-NP
receptors NNS I-NP
of IN B-PP
white JJ B-NP
blood NN I-NP
cells NNS I-NP
COMMA COMMA O
as IN B-SBAR
observed VBN B-VP
in IN B-PP
previous JJ B-NP
studies NNS I-NP
in IN B-PP
non-human JJ B-NP
primates NNS I-NP
COMMA COMMA O
and CC O
( ( B-LST
2 LS I-LST
) ) O
to TO B-VP
clarify VB I-VP
whether IN B-SBAR
persons NNS B-NP
at IN B-PP
the DT B-NP
upper JJ I-NP
range NN I-NP
{ ( O
10-23 CD B-NP
ppt NN I-NP
TCDD NN I-NP
or CC O
30-90 CD B-NP
ppt NN I-NP
I-TE NN I-NP
in IN B-PP
blood NN B-NP
fat NN I-NP
} ) O
of IN B-PP
the DT B-NP
body NN I-NP
burden NN I-NP
reference NN I-NP
values NNS I-NP
of IN B-PP
a DT O
not RB B-ADVP
particularly RB I-ADVP
exposed VBN B-NP
population NN I-NP
show VBP B-VP
detectable JJ B-NP
deviations NNS I-NP
in IN B-PP
these DT B-NP
immunological JJ I-NP
variables NNS I-NP
COMMA COMMA O
when WRB B-ADVP
compared VBN B-VP
with IN B-PP
persons NNS B-NP
at IN B-PP
the DT B-NP
lower JJR I-NP
and CC I-NP
medium NN I-NP
range NN I-NP
{ ( O
1-3 CD B-NP
ppt NN I-NP
TCDD NN I-NP
or CC O
9-29 CD B-NP
ppt NN I-NP
I-TE NN I-NP
} ) O
of IN B-PP
these DT B-NP
body NN I-NP
burden NN I-NP
reference NN I-NP
values NNS I-NP
. . O

Regression NN B-NP
analysis NN I-NP
of IN B-PP
our PRP$ B-NP
data NNS I-NP
revealed VBD B-VP
slight JJ B-NP
trends NNS I-NP
for IN B-PP
some DT B-NP
of IN B-PP
the DT B-NP
biomarkers NNS I-NP
( ( O
e.g. FW B-ADVP
CD45R0+ JJ B-NP
) ) O
. . O

With IN B-PP
one CD B-NP
exception NN I-NP
COMMA COMMA O
these DT B-NP
were VBD B-VP
all DT B-ADVP
increases NNS B-NP
. . O

None NN B-NP
of IN B-PP
the DT B-NP
alterations NNS I-NP
observed VBN B-VP
are VBP B-VP
of IN B-PP
medical JJ B-NP
relevance NN I-NP
. . O

The DT B-NP
slight JJ I-NP
increase NN I-NP
in IN B-PP
the DT B-NP
percentage NN I-NP
of IN B-PP
CD4+CD45R0+ JJ B-NP
cells NNS I-NP
remained VBD B-VP
significant JJ B-ADJP
even RB B-PP
after IN I-PP
covariant JJ B-NP
analysis NN I-NP
taking VBG B-VP
age-related JJ B-NP
changes NNS I-NP
into IN B-PP
account NN B-NP
. . O

Altogether RB B-ADVP
COMMA COMMA O
the DT B-NP
data NNS I-NP
do VBP B-VP
not RB I-VP
provide VB I-VP
any DT B-NP
evidence NN I-NP
to TO B-VP
support VB I-VP
an DT B-NP
assumption NN I-NP
that IN B-SBAR
moderately RB B-NP
increased VBN I-NP
body NN I-NP
burdens NNS I-NP
of IN B-PP
PCDDs\/PCDFs NNS B-NP
in IN B-PP
adults NNS B-NP
induce VBP B-VP
decreases NNS B-NP
in IN B-PP
the DT B-NP
cellular JJ I-NP
components NNS I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
immune JJ I-NP
system NN I-NP
. . O

Adult JJ B-NP
humans NNS I-NP
certainly RB B-ADVP
are VBP B-VP
less RBR B-ADJP
susceptible JJ I-ADJP
to TO B-PP
this DT B-NP
action NN I-NP
of IN B-PP
PCDDs\/PCDFs NNS B-NP
than IN B-PP
adolescent JJ B-NP
Callithrix FW I-NP
jacchus FW I-NP
. . O

The DT B-NP
lymphotoxin NN I-NP
promoter NN I-NP
is VBZ B-VP
stimulated VBN I-VP
by IN B-PP
HTLV-I NN B-NP
tax NN I-NP
activation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
human JJ B-NP
T-cell NN I-NP
lines NNS I-NP
. . O

The DT B-NP
HTLV-I NN I-NP
transcriptional JJ I-NP
activator NN I-NP
tax NN I-NP
was VBD B-VP
used VBN I-VP
to TO B-VP
gain VB I-VP
insight NN B-NP
into IN B-PP
the DT B-NP
mechanism NN I-NP
of IN B-PP
lymphotoxin NN B-NP
( ( O
LT NN B-NP
; : O
TNF-beta NN B-NP
) ) O
gene NN B-NP
induction NN I-NP
. . O

Tax-expressing JJ B-NP
cell NN I-NP
lines NNS I-NP
produce VBP B-VP
LT NN B-NP
biologic JJ I-NP
activity NN I-NP
. . O

An DT O
LT NN B-NP
promoter NN I-NP
( ( O
LT-293 NN B-NP
) ) O
CAT NN B-NP
construct NN I-NP
that WDT B-NP
contained VBD B-VP
an DT B-NP
NF-kappa NN I-NP
B NN I-NP
site NN I-NP
was VBD B-VP
active JJ B-ADJP
in IN B-PP
the DT B-NP
LT-producing JJ I-NP
C81-66-45 NN I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
which WDT B-NP
contains VBZ B-VP
defective JJ B-NP
HTLV-I NN I-NP
but CC O
expresses VBZ B-VP
tax NN B-NP
. . O

The DT B-NP
observation NN I-NP
that IN B-SBAR
a DT B-NP
mutated VBN I-NP
LT-kappa NN I-NP
B NN I-NP
construct NN I-NP
( ( O
M1-CAT NN B-NP
) ) O
was VBD B-VP
inactive JJ B-ADJP
in IN B-PP
C81-66-45 NN B-NP
COMMA COMMA O
confirmed VBD B-VP
the DT B-NP
importance NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
LT NN B-NP
gene NN I-NP
expression NN I-NP
. . O

Tax NN B-NP
was VBD B-VP
transfected VBN I-VP
into IN B-PP
HTLV-I-negative JJ B-NP
human JJ I-NP
T-cell NN I-NP
lines NNS I-NP
. . O

Jurkat NN B-NP
T NN I-NP
cells NNS I-NP
stably RB B-VP
expressing VBG I-VP
tax NN B-NP
contained VBD B-VP
elevated JJ B-NP
levels NNS I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
that WDT B-NP
directly RB B-VP
bound VBD I-VP
to TO B-PP
the DT B-NP
LT-kappa NN I-NP
B NN I-NP
site NN I-NP
. . O

Tax NN B-NP
co-transfected VBN B-VP
with IN B-PP
reporter NN B-NP
constructs NNS I-NP
into IN B-PP
Jurkat NN B-NP
cells NNS I-NP
maximally RB B-VP
activated VBD I-VP
HTLV-I-LTR-CAT NN B-NP
and CC O
kappa NN B-NP
B-fos-CAT NN I-NP
and CC O
also RB O
activated VBD B-VP
LT-293 NN B-NP
to TO B-PP
a DT B-NP
lesser JJR I-NP
extent NN I-NP
. . O

In IN B-PP
JM NN B-NP
T NN I-NP
cells NNS I-NP
COMMA COMMA O
tax NN B-NP
induced JJ B-VP
LT-293 NN B-NP
activity NN I-NP
by IN B-PP
two- CD B-NP
to TO O
four-fold JJ B-NP
COMMA COMMA O
though IN B-SBAR
there EX B-NP
was VBD B-VP
no DT B-NP
induction NN I-NP
of IN B-PP
M1-CAT NN B-NP
. . O

The DT B-NP
increase NN I-NP
in IN B-PP
LT-293 NN B-NP
CAT NN I-NP
activity NN I-NP
mirrored VBD B-VP
the DT B-NP
increase NN I-NP
in IN B-PP
LT NN B-NP
biologic JJ I-NP
activity NN I-NP
seen VBN B-VP
under IN B-PP
these DT B-NP
conditions NNS I-NP
. . O

These DT B-NP
studies NNS I-NP
COMMA COMMA O
the DT B-NP
first JJ I-NP
to TO B-VP
demonstrate VB I-VP
induction NN B-NP
of IN B-PP
LT NN B-NP
promoter NN I-NP
activity NN I-NP
over IN B-PP
basal JJ B-NP
levels NNS I-NP
COMMA COMMA O
indicate VBP B-VP
that IN B-SBAR
HTLV-I NN B-NP
tax NN I-NP
causes VBZ B-VP
low-level JJ B-NP
activation NN I-NP
of IN B-PP
both CC O
endogenous JJ B-NP
LT NN I-NP
and CC O
the DT B-NP
LT NN I-NP
promoter NN I-NP
COMMA COMMA O
at IN B-ADVP
least JJS I-ADVP
in IN B-PP
part NN B-NP
through IN B-PP
activation NN B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
. . O

Transient JJ B-NP
pseudohypoaldosteronism NN I-NP
in IN B-PP
obstructive JJ B-NP
renal JJ I-NP
disease NN I-NP
with IN B-PP
transient JJ B-NP
reduction NN I-NP
of IN B-PP
lymphocytic JJ B-NP
aldosterone NN I-NP
receptors NNS I-NP
. . O

Results NNS B-NP
in IN B-PP
two CD B-NP
affected JJ I-NP
infants NNS I-NP
. . O

We PRP B-NP
report VBP B-VP
two CD B-NP
patients NNS I-NP
with IN B-PP
transient JJ B-NP
pseudohypoaldosteronism NN I-NP
due JJ B-PP
to TO I-PP
obstructive JJ B-NP
renal JJ I-NP
disease NN I-NP
. . O

Both DT B-NP
patients NNS I-NP
presented VBD B-VP
with IN B-PP
a DT B-NP
salt-losing JJ I-NP
episode NN I-NP
simulating VBG I-NP
adrenal JJ I-NP
insufficiency NN I-NP
. . O

In IN B-PP
one CD B-NP
patient NN I-NP
COMMA COMMA O
transient JJ B-NP
reduction NN I-NP
of IN B-PP
aldosterone NN B-NP
receptors NNS I-NP
could MD B-VP
be VB I-VP
documented VBN I-VP
COMMA COMMA O
while IN B-SBAR
in IN B-PP
the DT B-NP
second JJ I-NP
patient NN I-NP
the DT B-NP
clinical JJ I-NP
and CC I-NP
biochemical JJ I-NP
parameters NNS I-NP
were VBD B-VP
consistent JJ B-ADJP
with IN B-PP
transient JJ B-NP
pseudohypoaldosteronism NN I-NP
. . O

The DT B-NP
macrophage NN I-NP
transcription NN I-NP
factor NN I-NP
PU.1 NN I-NP
directs VBZ B-VP
tissue-specific JJ B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
macrophage NN I-NP
colony-stimulating JJ I-NP
factor NN I-NP
receptor NN I-NP
. . O

The DT O
macrophage NN B-NP
colony-stimulating JJ I-NP
factor NN I-NP
( ( O
M-CSF NN B-NP
) ) O
receptor NN B-NP
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
a DT B-NP
tissue-specific JJ I-NP
fashion NN I-NP
from IN B-PP
two CD B-NP
distinct JJ I-NP
promoters NNS I-NP
in IN B-PP
monocytes\/macrophages NNS B-NP
and CC O
the DT B-NP
placenta NN I-NP
. . O

In IN B-SBAR
order NN O
to TO O
further RB B-ADVP
understand VB B-VP
the DT B-NP
transcription NN I-NP
factors NNS I-NP
which WDT B-NP
play VBP B-VP
a DT B-NP
role NN I-NP
in IN B-PP
the DT B-NP
commitment NN I-NP
of IN B-PP
multipotential JJ B-NP
progenitors NNS I-NP
to TO B-PP
the DT B-NP
monocyte\/macrophage NN I-NP
lineage NN I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
initiated VBN I-VP
an DT B-NP
investigation NN I-NP
of IN B-PP
the DT B-NP
factors NNS I-NP
which WDT B-NP
activate VBP B-VP
the DT B-NP
M-CSF NN I-NP
receptor NN I-NP
very RB B-ADVP
early RB I-ADVP
during IN B-PP
the DT B-NP
monocyte NN I-NP
differentiation NN I-NP
process NN I-NP
. . O

Here RB B-ADVP
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
the DT B-NP
human JJ I-NP
monocytic JJ I-NP
M-CSF NN I-NP
receptor NN I-NP
promoter NN I-NP
directs VBZ B-VP
reporter NN B-NP
gene NN I-NP
activity NN I-NP
in IN B-PP
a DT B-NP
tissue-specific JJ I-NP
fashion NN I-NP
. . O

Since IN B-SBAR
one CD B-NP
of IN B-PP
the DT B-NP
few JJ I-NP
transcription NN I-NP
factors NNS I-NP
which WDT B-NP
have VBP B-VP
been VBN I-VP
implicated VBN I-VP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
monocyte NN B-NP
genes NNS I-NP
is VBZ B-VP
the DT O
macrophage- NN B-NP
and CC O
B-cell-specific JJ B-ADJP
PU.1 NN B-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
we PRP B-NP
investigated VBD B-VP
whether IN B-SBAR
PU.1 NN B-NP
binds VBZ B-VP
and CC O
activates VBZ B-VP
the DT B-NP
M-CSF NN I-NP
receptor NN I-NP
promoter NN I-NP
. . O

Here RB B-ADVP
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
both CC O
in FW B-NP
vitro-translated VBN I-NP
PU.1 NN I-NP
and CC O
PU.1 NN B-NP
from IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
bind VBP B-VP
to TO B-PP
a DT B-NP
specific JJ I-NP
site NN I-NP
in IN B-PP
the DT B-NP
M-CSF NN I-NP
receptor NN I-NP
promoter NN I-NP
just RB B-ADVP
upstream JJ I-ADVP
from IN B-PP
the DT B-NP
major JJ I-NP
transcription NN I-NP
initiation NN I-NP
site NN I-NP
. . O

Mutations NNS B-NP
in IN B-PP
this DT B-NP
site NN I-NP
which WDT B-NP
eliminate VB B-VP
PU.1 NN B-NP
binding NN I-NP
decrease VBP B-VP
M-CSF NN B-NP
receptor NN I-NP
promoter NN I-NP
activity NN I-NP
significantly RB B-ADVP
in IN B-PP
macrophage JJ B-NP
cell NN I-NP
lines NNS I-NP
only RB B-ADVP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
PU.1 NN B-NP
transactivates VBZ B-VP
the DT B-NP
M-CSF NN I-NP
receptor NN I-NP
promoter NN I-NP
in IN B-PP
nonmacrophage JJ B-NP
cells NNS I-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
PU.1 NN B-NP
plays VBZ B-VP
a DT B-NP
major JJ I-NP
role NN I-NP
in IN B-PP
macrophage NN B-NP
gene NN I-NP
regulation NN B-NP
and CC O
development NN B-NP
by IN B-PP
directing VBG B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
a DT B-NP
receptor NN I-NP
for IN B-PP
a DT B-NP
key JJ I-NP
macrophage NN I-NP
growth NN I-NP
factor NN I-NP
. . O

Increased VBN B-NP
natural JJ I-NP
killer NN I-NP
cell NN I-NP
activity NN I-NP
correlates VBZ B-VP
with IN B-PP
low JJ B-NP
or CC I-NP
negative JJ I-NP
expression NN I-NP
of IN B-PP
the DT B-NP
HER-2\/neu NN I-NP
oncogene NN I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
breast NN B-NP
cancer NN I-NP
. . O

BACKGROUND NN B-NP
. . O

Increased VBN B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
HER-2\/neu NN I-NP
oncogene NN I-NP
in IN B-PP
breast NN B-NP
cancer NN I-NP
correlates VBZ B-VP
with IN B-PP
decreased VBN B-NP
estrogen NN I-NP
receptor NN I-NP
concentration NN I-NP
and CC O
seems VBZ B-VP
to TO I-VP
be VB I-VP
an DT B-NP
important JJ I-NP
prognostic JJ I-NP
factor NN I-NP
. . O

The DT B-NP
authors NNS I-NP
investigated VBD B-VP
whether IN B-SBAR
there EX B-NP
is VBZ B-VP
a DT B-NP
correlation NN I-NP
between IN B-PP
HER-2\/neu NN B-NP
expression NN I-NP
and CC O
immunologic JJ B-NP
parameters NNS I-NP
representing VBG B-VP
tumor NN B-NP
defense NN I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
breast NN B-NP
cancer NN I-NP
. . O

METHOD NN B-NP
. . O

A DT B-NP
Western JJ I-NP
blot NN I-NP
analysis NN I-NP
was VBD B-VP
used VBN I-VP
to TO B-VP
investigate VB I-VP
HER-2\/neu NN B-NP
expression NN I-NP
COMMA COMMA O
whereas IN O
a DT B-NP
chromium-release NN I-NP
assay NN I-NP
using VBG B-VP
the DT B-NP
K562 NN I-NP
cell NN I-NP
line NN I-NP
as IN B-PP
target NN B-NP
was VBD B-VP
used VBN I-VP
to TO B-VP
measure VB I-VP
natural JJ B-NP
killer NN I-NP
( ( O
NK NN B-NP
) ) O
cell NN B-NP
activity NN I-NP
. . O

RESULTS NNS B-NP
. . O

In IN B-PP
patients NNS B-NP
with IN B-PP
breast NN B-NP
cancer NN I-NP
COMMA COMMA O
NK NN B-NP
cell NN I-NP
activity NN I-NP
was VBD B-VP
significantly RB B-ADJP
higher JJR I-ADJP
compared VBN B-PP
with IN B-PP
patients NNS B-NP
with IN B-PP
benign JJ B-NP
tumors NNS I-NP
( ( O
P NN B-NP
= JJ B-VP
0.006 CD B-NP
) ) O
or CC O
healthy JJ B-NP
control NN I-NP
subjects NNS I-NP
( ( O
P NN B-NP
= JJ B-VP
0.002 CD B-NP
) ) O
. . O

Moreover RB B-ADVP
COMMA COMMA O
23.3 CD B-NP
% NN I-NP
of IN B-PP
patients NNS B-NP
with IN B-PP
breast NN B-NP
cancer NN I-NP
showed VBD B-VP
an DT B-NP
overexpression NN I-NP
of IN B-PP
HER-2\/neu NN B-NP
protein NN I-NP
. . O

Within IN B-PP
this DT B-NP
group NN I-NP
of IN B-PP
patients NNS B-NP
COMMA COMMA O
NK NN B-NP
cell NN I-NP
activity NN I-NP
was VBD B-VP
significantly RB B-ADJP
lower JJR I-ADJP
( ( O
45.6 CD B-NP
+\/- CC I-NP
16.1 CD I-NP
% NN I-NP
) ) O
compared VBN B-PP
with IN B-PP
the DT B-NP
group NN I-NP
with IN B-PP
no DT B-NP
HER-2\/neu NN I-NP
overexpression NN I-NP
( ( O
57.3 CD B-NP
+\/- CC I-NP
11.0 CD I-NP
% NN I-NP
) ) O
. . O

NK NN B-NP
cell NN I-NP
activity NN I-NP
did VBD B-VP
not RB I-VP
increase VB I-VP
in IN B-PP
patients NNS B-NP
with IN B-PP
HER-2\/neu NN B-NP
overexpression NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
there EX B-NP
was VBD B-VP
a DT B-NP
statistically RB I-NP
significant JJ I-NP
correlation NN I-NP
of IN B-PP
cytolytic JJ B-NP
effector NN I-NP
cell NN I-NP
function NN I-NP
with IN B-PP
HER-2\/neu NN B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
tumor NN I-NP
( ( O
P NN B-NP
= JJ B-VP
0.003 CD B-NP
) ) O
COMMA COMMA O
and CC O
HER-2\/neu NN B-NP
overexpression NN I-NP
correlated VBD B-VP
with IN B-PP
a DT B-NP
negative JJ I-NP
estrogen NN I-NP
receptor NN I-NP
status NN I-NP
( ( O
P NN B-NP
= JJ B-VP
0.005 CD B-NP
) ) O
. . O

CONCLUSION NN B-NP
. . O

These DT B-NP
data NNS I-NP
add VBP B-VP
further JJ B-NP
evidence NN I-NP
to TO B-PP
previous JJ B-NP
observations NNS I-NP
from IN B-PP
the DT B-NP
authors NNS I-NP
' POS B-NP
laboratory NN O
that IN B-NP
certain JJ I-NP
tumor NN I-NP
characteristics NNS B-VP
may MD I-VP
be VB I-VP
associated VBN B-PP
with IN B-NP
reactions NNS O
of IN B-NP
the DT I-NP
host NN O
with IN B-NP
breast NN I-NP
cancer NN O

Induction NN B-NP
of IN B-PP
tyrosine NN B-NP
phosphorylation NN I-NP
and CC O
T-cell NN B-NP
activation NN I-NP
by IN B-PP
vanadate NN B-NP
peroxide NN I-NP
COMMA COMMA O
an DT B-NP
inhibitor NN I-NP
of IN B-PP
protein NN B-NP
tyrosine NN I-NP
phosphatases NNS I-NP
. . O

Rapid JJ B-NP
tyrosine NN I-NP
phosphorylation NN I-NP
of IN B-PP
key JJ B-NP
cellular JJ I-NP
proteins NNS I-NP
is VBZ B-VP
a DT B-NP
crucial JJ I-NP
event NN I-NP
in IN B-PP
the DT B-NP
transduction NN I-NP
of IN B-PP
activation NN B-NP
signals NNS I-NP
to TO B-PP
T-lymphocytes NNS B-NP
. . O

The DT B-NP
regulatory JJ I-NP
role NN I-NP
of IN B-PP
protein NN B-NP
tyrosine NN I-NP
phosphatases NNS I-NP
( ( O
PTPases NNS B-NP
) ) O
in IN B-PP
this DT B-NP
process NN I-NP
was VBD B-VP
explored VBN I-VP
by IN B-PP
studying VBG B-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
a DT B-NP
powerful JJ I-NP
PTPase NN I-NP
inhibitor NN I-NP
COMMA COMMA O
vanadate NN B-NP
peroxide NN I-NP
( ( O
pervanadate NN B-NP
) ) O
COMMA COMMA O
on IN B-PP
the DT B-NP
activation NN I-NP
cascade NN I-NP
of IN B-PP
Jurkat NN B-NP
human JJ I-NP
leukaemic JJ I-NP
T-cells NNS I-NP
. . O

Pervanadate NN B-NP
induced VBD B-VP
activation NN B-NP
of IN B-PP
the DT B-NP
tyrosine NN I-NP
kinases NNS I-NP
lck NN B-NP
and CC O
fyn NN B-NP
( ( O
4- CD B-NP
and CC I-NP
3-fold JJ I-NP
respectively RB B-ADVP
) ) O
and CC O
a DT B-NP
dramatic JJ I-NP
increase NN I-NP
in IN B-PP
tyrosine NN B-NP
phosphorylation NN I-NP
of IN B-PP
cellular JJ B-NP
proteins NNS I-NP
COMMA COMMA O
notably RB B-NP
phospholipase NN I-NP
C NN I-NP
gamma NN I-NP
1 CD I-NP
. . O

After IN B-PP
this DT B-NP
event NN I-NP
COMMA COMMA O
we PRP B-NP
observed VBD B-VP
a DT B-NP
rise NN I-NP
in IN B-PP
intracellular JJ B-NP
Ca2+ NN I-NP
concentration NN I-NP
COMMA COMMA O
corresponding VBG B-VP
to TO B-PP
an DT B-NP
influx NN I-NP
. . O

This DT B-NP
effect NN I-NP
required VBD B-VP
surface NN B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
CD45 NN I-NP
PTPase NN I-NP
and CC O
was VBD B-VP
not RB I-VP
observed VBN I-VP
in IN B-PP
CD45-deficient JJ B-NP
variants NNS I-NP
of IN B-PP
Jurkat NN B-NP
cells NNS I-NP
. . O

In IN B-PP
the DT B-NP
CD45-negative JJ I-NP
variant NN I-NP
COMMA COMMA O
the DT B-NP
effect NN I-NP
of IN B-PP
pervanadate NN B-NP
on IN B-PP
tyrosine NN B-NP
phosphorylation NN I-NP
was VBD B-VP
globally RB I-VP
decreased VBN I-VP
and CC O
some DT B-NP
phosphorylated VBN I-NP
substrates NNS I-NP
were VBD B-VP
specifically RB B-ADVP
missing JJ B-ADJP
. . O

Pervanadate NN B-NP
also RB B-ADVP
stimulated VBD B-VP
transcription NN B-NP
of IN B-PP
the DT B-NP
c-fos NN I-NP
gene NN I-NP
and CC O
accumulation NN B-NP
of IN B-PP
its PRP$ B-NP
mRNA NN I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
several JJ B-NP
other JJ I-NP
hallmarks NNS I-NP
of IN B-PP
T-lymphocyte NN B-NP
activation NN I-NP
such JJ B-PP
as IN I-PP
surface NN B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
CD69 NN I-NP
antigen NN I-NP
and CC O
the DT B-NP
interleukin NN I-NP
2 CD I-NP
receptor NN I-NP
alpha-chain NN I-NP
( ( O
CD25 NN B-NP
) ) O
. . O

Pervanadate NN B-NP
synergized VBD B-VP
with IN B-PP
signals NNS B-NP
delivered VBN B-VP
by IN B-PP
T-cell NN B-NP
antigen NN I-NP
receptor NN I-NP
engagement NN I-NP
or CC B-PP
by IN B-PP
a DT B-NP
phorbol NN I-NP
ester NN I-NP
to TO B-VP
induce VB I-VP
interleukin NN B-NP
2 CD I-NP
production NN I-NP
. . O

Pervanadate NN B-NP
activated VBD B-VP
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
as IN B-SBAR
shown VBN B-VP
by IN B-PP
an DT B-NP
increase NN I-NP
in IN B-PP
DNA-binding JJ B-NP
activity NN I-NP
of IN B-PP
this DT B-NP
transcription NN I-NP
factor NN I-NP
. . O

We PRP B-NP
thus RB B-ADVP
conclude VBP B-VP
that IN B-SBAR
PTPases NNS B-NP
play VBP B-VP
a DT B-NP
crucial JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
negative JJ I-NP
regulation NN I-NP
of IN B-PP
signal NN B-NP
transduction NN I-NP
culminating VBG B-VP
in IN B-PP
T-lymphocyte NN B-NP
activation NN I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
induction NN B-NP
of IN B-PP
tyrosine NN B-NP
phosphorylation NN I-NP
appears VBZ B-VP
sufficient JJ B-ADJP
per FW I-ADJP
se FW I-ADJP
to TO B-VP
initiate VB I-VP
a DT B-NP
complete JJ I-NP
activation NN I-NP
programme NN I-NP
. . O

Steroid-resistant JJ B-NP
asthma NN I-NP
. . O

Cellular JJ B-NP
mechanisms NNS I-NP
contributing VBG B-VP
to TO B-PP
inadequate JJ B-NP
response NN I-NP
to TO B-PP
glucocorticoid NN B-NP
therapy NN I-NP
. . O

The DT B-NP
current JJ I-NP
study NN I-NP
examined VBD B-VP
whether IN B-SBAR
alterations NNS B-NP
in IN B-PP
glucocorticoid NN B-NP
receptor NN I-NP
( ( O
GR NN B-NP
) ) O
binding NN B-NP
contribute VBP B-VP
to TO B-PP
poor JJ B-NP
response NN I-NP
to TO B-PP
glucocorticoid NN B-NP
therapy NN I-NP
in IN B-PP
asthma NN B-NP
. . O

29 CD B-NP
asthma NN I-NP
patients NNS I-NP
with IN B-PP
forced VBN B-NP
expiratory JJ I-NP
volume NN I-NP
in IN B-PP
1 CD B-NP
s NN I-NP
( ( O
FEV1 NN B-NP
) ) O
&lt; JJR B-NP
70 CD I-NP
% NN I-NP
predicted VBN B-VP
were VBD B-VP
studied VBN I-VP
. . O

Patients NNS B-NP
were VBD B-VP
classified VBN I-VP
as IN B-PP
steroid NN B-ADJP
sensitive JJ I-ADJP
( ( O
SS JJ B-ADJP
) ) O
if IN B-SBAR
their PRP$ B-NP
morning NN I-NP
FEV1 NN I-NP
increased VBD B-VP
&gt; RBR B-NP
30 CD I-NP
% NN I-NP
after IN B-PP
a DT B-NP
1-wk JJ I-NP
course NN I-NP
of IN B-PP
oral JJ B-NP
prednisone NN I-NP
20 CD B-NP
mg NN I-NP
twice RB B-ADVP
daily RB I-ADVP
and CC O
steroid NN B-ADJP
resistant JJ I-ADJP
( ( O
SR JJ B-ADJP
) ) O
if IN B-SBAR
they PRP B-NP
failed VBD B-VP
to TO I-VP
increase VB I-VP
&gt; RBR B-NP
15 CD I-NP
% NN I-NP
. . O

PBMC NN B-NP
obtained VBN B-VP
from IN B-PP
these DT B-NP
two CD I-NP
groups NNS I-NP
COMMA COMMA O
17 CD B-NP
SR JJ I-NP
and CC O
12 CD B-NP
SS JJ I-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
12 CD B-NP
normal JJ I-NP
controls NNS I-NP
were VBD B-VP
analyzed VBN I-VP
. . O

SR JJ B-NP
patients NNS I-NP
had VBD B-VP
two CD B-NP
distinguishable JJ I-NP
GR NN I-NP
binding NN I-NP
abnormalities NNS I-NP
: : O
15 CD B-NP
of IN B-PP
the DT B-NP
17 CD I-NP
SR JJ I-NP
patients NNS I-NP
demonstrated VBD B-VP
a DT B-NP
significantly RB I-NP
reduced VBN I-NP
GR NN I-NP
binding NN I-NP
affinity NN I-NP
COMMA COMMA O
as IN B-SBAR
compared VBN B-VP
with IN B-PP
SS JJ B-NP
patients NNS I-NP
( ( O
P NN B-NP
= JJ B-VP
0.0001 CD B-NP
) ) O
and CC O
normal JJ B-NP
controls NNS I-NP
( ( O
P NN B-NP
= JJ B-VP
0.0001 CD B-NP
) ) O
. . O

This DT B-NP
defect NN I-NP
was VBD B-VP
localized JJ I-VP
to TO B-PP
T NN B-NP
cells NNS I-NP
and CC O
reverted VBD B-VP
to TO B-PP
normal JJ B-NP
after IN B-PP
48 CD B-NP
h NN I-NP
in IN B-PP
culture NN B-NP
media NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
incubation NN B-NP
with IN B-PP
a DT B-NP
combination NN I-NP
of IN B-PP
IL-2 NN B-NP
and CC O
IL-4 NN B-NP
sustained VBD B-VP
this DT B-NP
abnormality NN I-NP
. . O

The DT B-NP
other JJ I-NP
two CD I-NP
SR JJ I-NP
patients NNS I-NP
had VBD B-VP
an DT B-NP
abnormally RB I-NP
low JJ I-NP
GR NN I-NP
number NN I-NP
with IN B-PP
normal JJ B-NP
binding NN I-NP
affinity NN I-NP
that WDT B-NP
was VBD B-VP
not RB O
limited VBN B-ADJP
to TO B-PP
T NN B-NP
cells NNS I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
GR NN B-NP
number NN I-NP
failed VBD B-VP
to TO I-VP
normalize VB I-VP
after IN B-PP
incubation NN B-NP
in IN B-PP
media NNS B-NP
alone RB B-ADVP
or CC O
IL-2 NN B-NP
and CC O
IL-4 NN B-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
SR JJ B-NP
asthma NN I-NP
may MD B-VP
be VB I-VP
due JJ B-PP
to TO I-PP
more JJR B-NP
than IN I-NP
one CD I-NP
abnormality NN I-NP
COMMA COMMA O
the DT B-NP
majority NN I-NP
related JJ B-ADJP
to TO B-PP
a DT B-NP
reversible JJ I-NP
cytokine-induced JJ I-NP
reduction NN I-NP
in IN B-PP
GR NN B-NP
binding NN I-NP
affinity NN I-NP
and CC O
the DT B-NP
second JJ I-NP
related JJ B-ADJP
to TO B-PP
an DT B-NP
irreversible JJ I-NP
reduction NN I-NP
in IN B-PP
GR NN B-NP
number NN I-NP
. . O

These DT B-NP
findings NNS I-NP
may MD B-VP
have VB I-VP
important JJ B-NP
implications NNS I-NP
for IN B-PP
the DT B-NP
design NN I-NP
of IN B-PP
alternative JJ B-NP
treatment NN I-NP
approaches NNS I-NP
for IN B-PP
recalcitrant JJ B-NP
asthma NN I-NP
. . O

Rhabdomyosarcomas NNS B-NP
do VBP B-VP
not RB I-VP
contain VB I-VP
mutations NNS B-NP
in IN B-PP
the DT B-NP
DNA NN I-NP
binding NN I-NP
domains NNS I-NP
of IN B-PP
myogenic JJ B-NP
transcription NN I-NP
factors NNS I-NP
. . O

Skeletal JJ B-NP
myogenesis NN I-NP
is VBZ B-VP
regulated VBN I-VP
by IN B-PP
a DT B-NP
group NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
( ( O
MyoD NN B-NP
COMMA COMMA O
myogenin NN B-NP
COMMA COMMA O
myf5 NN B-NP
COMMA COMMA O
and CC O
myf6 NN B-NP
) ) O
that WDT B-NP
are VBP B-VP
" `` B-NP
basic JJ I-NP
helix-loop-helix JJ I-NP
" '' I-NP
proteins NNS I-NP
that WDT B-NP
bind VBP B-VP
to TO B-PP
the DT B-NP
promoters NNS I-NP
of IN B-PP
muscle-specific JJ B-NP
genes NNS I-NP
and CC O
promote VBP B-VP
their PRP$ B-NP
expression NN I-NP
. . O

We PRP B-NP
have VBP B-VP
previously RB I-VP
shown VBN I-VP
that IN B-SBAR
after IN B-PP
a DT B-NP
mutation NN I-NP
of IN B-PP
Leu122 NN B-NP
to TO B-PP
Arg NN B-NP
the DT B-NP
DNA NN I-NP
binding NN I-NP
basic JJ I-NP
domain NN I-NP
of IN B-PP
MyoD NN B-NP
confers VBZ B-VP
c-myc-like JJ B-NP
functional JJ I-NP
characteristics NNS I-NP
to TO B-PP
the DT B-NP
protein NN I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
we PRP B-NP
used VBD B-VP
single-strand JJ B-NP
conformation NN I-NP
polymorphism NN I-NP
analysis NN I-NP
to TO B-VP
determine VB I-VP
whether IN B-SBAR
such JJ B-NP
mutations NNS I-NP
occur VBP B-VP
naturally RB B-ADVP
in IN B-PP
rhabdomyosarcomas NNS B-NP
. . O

We PRP B-NP
have VBP B-VP
found VBN I-VP
that IN B-SBAR
the DT B-NP
basic JJ I-NP
domains NNS I-NP
of IN B-PP
all PDT B-NP
the DT I-NP
myogenic JJ I-NP
factors NNS I-NP
remain VBP B-VP
unaltered JJ B-ADJP
in IN B-PP
rhabdomyosarcomas NNS B-NP
. . O

Selection NN B-NP
against IN B-PP
such JJ B-NP
mutations NNS I-NP
may MD B-VP
be VB I-VP
the DT B-NP
result NN I-NP
of IN B-PP
functional JJ B-NP
redundancy NN I-NP
of IN B-PP
these DT B-NP
myogenic JJ I-NP
transcription NN I-NP
factors NNS I-NP
. . O

Increased VBN B-NP
proliferation NN B-NP
COMMA COMMA O
cytotoxicity NN B-NP
COMMA COMMA O
and CC O
gene NN B-NP
expression NN I-NP
after IN B-PP
stimulation NN B-NP
of IN B-PP
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
T NN I-NP
lymphocytes NNS I-NP
through IN B-PP
a DT B-NP
surface NN I-NP
ganglioside NN I-NP
( ( O
GD3 NN B-NP
) ) O
{ ( O
published VBN B-NP
erratum NN I-NP
appears VBZ B-VP
in IN B-PP
J NNP B-NP
Immunol NNP I-NP
1994 CD B-NP
Jul NNP I-NP
15 CD I-NP
; : O
153 CD B-NP
( ( I-NP
2 CD I-NP
) ) O
: : O
910 CD B-NP
} ) O

Previous JJ B-NP
studies NNS I-NP
have VBP B-VP
suggested VBN I-VP
that IN B-SBAR
gangliosides NNS B-NP
have VBP B-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
cell NN B-NP
signaling NN B-NP
and CC O
recognition NN B-NP
. . O

However RB B-ADVP
COMMA COMMA O
their PRP$ B-NP
specific JJ I-NP
function NN I-NP
in IN B-PP
these DT B-NP
processes NNS I-NP
has VBZ B-VP
not RB I-VP
been VBN I-VP
clearly RB I-VP
defined VBN I-VP
. . O

A DT B-NP
mAb NN I-NP
COMMA COMMA O
R24 NN B-NP
COMMA COMMA O
that WDT B-NP
reacts VBZ B-VP
specifically RB B-ADVP
with IN B-PP
a DT B-NP
cell NN I-NP
surface NN I-NP
ganglioside NN I-NP
( ( O
GD3 NN B-NP
) ) O
has VBZ B-VP
been VBN I-VP
demonstrated VBN I-VP
to TO I-VP
stimulate VB I-VP
proliferation NN B-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
derived VBN B-VP
from IN B-PP
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
investigated VBN I-VP
the DT B-NP
mechanisms NNS I-NP
by IN B-PP
which WDT B-NP
the DT B-NP
R24 NN I-NP
mAb NN I-NP
affects VBZ B-VP
T NN B-NP
cell NN I-NP
functions NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
observed VBN I-VP
that IN B-SBAR
the DT B-NP
R24 NN I-NP
mAb NN I-NP
stimulates VBZ B-VP
GD3+ JJ B-NP
T NN I-NP
cell NN I-NP
proliferation NN B-NP
COMMA COMMA O
cytotoxicity NN B-NP
COMMA COMMA O
and CC O
surface NN B-NP
marker NN I-NP
expression NN I-NP
of IN B-PP
IL-2R NN B-NP
alpha-chain NN I-NP
COMMA COMMA O
IL-2R NN B-NP
beta-chain NN I-NP
COMMA COMMA O
HLA-DR NN B-NP
COMMA COMMA O
CD11a NN B-NP
COMMA COMMA O
and CC O
CD11c NN B-NP
. . O

Additionally RB B-ADVP
COMMA COMMA O
IFN-gamma NN B-NP
activity NN I-NP
but CC B-CONJP
not RB I-CONJP
IL-1 NN B-NP
COMMA COMMA O
IL-2 NN B-NP
COMMA COMMA O
or CC O
IL-4 NN B-NP
activity NN B-NP
was VBD B-VP
present JJ B-ADJP
in IN B-PP
culture NN B-NP
supernatants NNS I-NP
72 CD B-NP
h NN I-NP
after IN B-PP
R24 NN B-NP
stimulation NN I-NP
. . O

In IN B-PP
some DT B-NP
donors NNS I-NP
COMMA COMMA O
increased VBN O
IL-6 NN B-NP
and CC O
TNF-alpha NN B-NP
activity NN B-NP
also RB B-ADVP
was VBD B-VP
detected VBN I-VP
after IN B-PP
R24 NN B-NP
treatment NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
R24 NN B-NP
treatment NN I-NP
resulted VBD B-VP
in IN B-PP
translocation NN B-NP
of IN B-PP
c-rel NN B-NP
COMMA COMMA O
but CC O
little JJ B-NP
or CC I-NP
no DT I-NP
NF NN I-NP
kappa NN I-NP
B NN I-NP
p50 NN B-NP
or CC O
p65 NN B-NP
COMMA COMMA O
from IN B-PP
the DT B-NP
cytoplasm NN I-NP
to TO B-PP
the DT B-NP
nucleus NN I-NP
and CC O
an DT B-NP
increase NN I-NP
of IN B-PP
NF NN B-NP
kappa NN I-NP
B NN I-NP
binding NN I-NP
complexes NNS I-NP
containing VBG B-VP
c-rel NN B-NP
and CC O
p50 NN B-NP
. . O

This DT B-NP
treatment NN I-NP
also RB B-ADVP
caused VBD B-VP
increased VBN B-NP
tyrosine NN I-NP
phosphorylation NN I-NP
of IN B-PP
specific JJ B-NP
protein NN I-NP
substrates NNS I-NP
. . O

R24-stimulated JJ B-NP
increases NNS I-NP
in IN B-PP
proliferation NN B-NP
COMMA COMMA O
cytotoxicity NN B-NP
COMMA COMMA O
and CC O
cell NN B-NP
surface NN I-NP
protein NN I-NP
expression NN I-NP
could MD B-VP
be VB I-VP
blocked VBN I-VP
by IN B-PP
cyclosporin NN B-NP
and CC O
staurosporin NN B-NP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
cyclophilin\/calcineurin NN B-NP
and CC O
protein NN B-NP
kinase NN I-NP
C NN I-NP
may MD B-VP
be VB I-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
R24 NN I-NP
signaling NN I-NP
pathway NN I-NP
. . O

Additionally RB B-ADVP
COMMA COMMA O
herbimycin NN B-NP
A NN I-NP
COMMA COMMA O
a DT B-NP
tyrosine NN I-NP
kinase NN I-NP
inhibitor NN I-NP
COMMA COMMA O
blocked VBD B-VP
the DT B-NP
R24-stimulated JJ I-NP
increase NN I-NP
in IN B-PP
proliferation NN B-NP
but CC B-CONJP
not RB I-CONJP
cytotoxicity NN B-NP
at IN B-PP
concentrations NNS B-NP
consistent JJ B-ADJP
with IN B-PP
specificity NN B-NP
for IN B-PP
tyrosine NN B-NP
kinases NNS I-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
multiple JJ B-NP
biochemical JJ I-NP
pathways NNS I-NP
are VBP B-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
human JJ B-NP
T NN I-NP
cells NNS I-NP
by IN B-PP
R24 NN B-NP
. . O

The DT B-NP
SCL NN I-NP
protein NN I-NP
displays VBZ B-VP
cell-specific JJ B-NP
heterogeneity NN I-NP
in IN B-PP
size NN B-NP
. . O

SCL NN B-NP
protein NN I-NP
production NN I-NP
was VBD B-VP
examined VBN I-VP
in IN B-PP
a DT B-NP
variety NN I-NP
of IN B-PP
hemopoietic JJ B-NP
cell NN I-NP
lines NNS I-NP
by IN B-PP
immunoblotting VBG B-NP
using VBG B-VP
specific JJ B-NP
polyclonal JJ I-NP
antisera NNS I-NP
. . O

SCL NN B-NP
protein NN I-NP
was VBD B-VP
detected VBN I-VP
in IN B-PP
erythroid JJ O
COMMA COMMA O
megakaryocyte NN B-NP
COMMA COMMA O
mast NN B-NP
and CC O
early JJ B-ADJP
myeloid JJ I-ADJP
cell NN B-NP
lines NNS I-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
in IN B-PP
several JJ B-NP
lymphoid JJ I-NP
leukemia NN I-NP
cell NN I-NP
lines NNS I-NP
which WDT B-NP
are VBP B-VP
known VBN I-VP
to TO I-VP
harbor VB I-VP
SCL NN B-NP
gene NN I-NP
rearrangements NNS I-NP
. . O

In IN B-PP
most JJS B-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
proteins NNS B-NP
of IN B-PP
molecular JJ B-NP
weight NN I-NP
49 CD B-NP
and CC I-NP
44 CD I-NP
kDa NN I-NP
were VBD B-VP
found VBN I-VP
COMMA COMMA O
however RB B-ADVP
two CD B-NP
myeloid JJ I-NP
cell NN I-NP
lines NNS I-NP
expressed VBD B-VP
only RB B-NP
lower JJR I-NP
molecular JJ I-NP
weight NN I-NP
species NNS I-NP
of IN B-PP
24 CD B-NP
and CC I-NP
22 CD I-NP
kDa NN I-NP
. . O

This DT B-NP
size NN I-NP
discrepancy NN I-NP
appeared VBD B-VP
to TO I-VP
be VB I-VP
due JJ B-PP
to TO I-PP
cell-specific JJ B-NP
translational JJ I-NP
regulation NN I-NP
COMMA COMMA O
since IN B-SBAR
overexpression NN B-NP
of IN B-PP
a DT B-NP
retrovirally RB I-NP
transfected VBN I-NP
SCL NN I-NP
gene NN I-NP
yielded VBD B-VP
the DT B-NP
higher JJR I-NP
molecular JJ I-NP
weight NN I-NP
forms NNS I-NP
in IN B-PP
most JJS B-NP
cell NN I-NP
lines NNS I-NP
( ( O
GP+E-86 NN B-NP
COMMA COMMA O
AT2.5 NN B-NP
COMMA COMMA O
M1 NN B-NP
) ) O
but CC O
only RB B-NP
the DT I-NP
22 CD I-NP
kDa NN I-NP
form NN I-NP
in IN B-PP
the DT B-NP
myeloid JJ I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
WEHI-3B\/D+ NN B-NP
. . O

Overexpression NN B-NP
of IN B-PP
full-length JJ B-NP
SCL NN I-NP
protein NN I-NP
in IN B-PP
the DT B-NP
lymphoid JJ I-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
SupT1 NN B-NP
and CC O
Raji NN B-NP
COMMA COMMA O
did VBD B-VP
not RB I-VP
alter VB I-VP
cell NN B-NP
phenotype NN I-NP
and CC O
there EX B-NP
was VBD B-VP
no DT B-NP
evidence NN I-NP
for IN B-PP
autoregulation NN B-NP
of IN B-PP
SCL NN B-NP
transcription NN I-NP
. . O

The DT B-NP
restricted JJ I-NP
pattern NN I-NP
of IN B-PP
SCL NN B-NP
protein NN I-NP
synthesis NN I-NP
is VBZ B-VP
consistent JJ B-ADJP
with IN B-PP
the DT B-NP
restricted JJ I-NP
expression NN I-NP
of IN B-PP
SCL NN B-NP
mRNA NN I-NP
documented VBN B-VP
previously RB B-ADVP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
the DT B-NP
present JJ I-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
SCL NN B-NP
protein NN I-NP
size NN I-NP
was VBD B-VP
determined VBN I-VP
by IN B-PP
regulation NN B-NP
of IN B-PP
translation NN B-NP
in IN B-PP
a DT B-NP
cell-specific JJ I-NP
manner NN I-NP
. . O

Activation NN B-NP
of IN B-PP
the DT B-NP
granulocyte-macrophage JJ I-NP
colony-stimulating JJ I-NP
factor NN I-NP
promoter NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
requires VBZ B-VP
cooperative JJ B-NP
binding NN I-NP
of IN B-PP
Elf-1 NN B-NP
and CC O
AP-1 NN B-NP
transcription NN B-NP
factors NNS I-NP
. . O

The DT O
granulocyte-macrophage JJ B-NP
colony-stimulating JJ I-NP
factor NN I-NP
( ( O
GM-CSF NN B-NP
) ) O
gene NN B-NP
has VBZ B-VP
been VBN I-VP
studied VBN I-VP
extensively RB B-ADVP
as IN B-PP
a DT B-NP
model NN I-NP
system NN I-NP
of IN B-PP
transcriptional JJ B-NP
induction NN I-NP
during IN B-PP
T-lymphocyte NN B-NP
activation NN I-NP
. . O

The DT B-NP
GM-CSF NN I-NP
gene NN I-NP
is VBZ B-VP
not RB I-VP
expressed VBN I-VP
in IN B-PP
resting VBG B-NP
peripheral JJ I-NP
blood NN I-NP
T NN I-NP
cells NNS I-NP
but CC O
is VBZ B-VP
rapidly RB I-VP
induced VBN I-VP
at IN B-PP
the DT B-NP
transcriptional JJ I-NP
level NN I-NP
following VBG B-PP
activation NN B-NP
through IN B-PP
the DT B-NP
cell NN I-NP
surface NN I-NP
T-cell NN I-NP
receptor NN I-NP
. . O

A DT B-NP
highly RB I-NP
conserved VBN I-NP
19-bp JJ I-NP
element NN I-NP
located JJ B-ADJP
immediately RB I-ADJP
5' JJ B-NP
of IN B-PP
the DT B-NP
human JJ I-NP
GM-CSF NN I-NP
TATA NN I-NP
box NN I-NP
( ( O
bp NN B-NP
-34 CD B-NP
to TO B-PP
-52 CD B-NP
) ) O
COMMA COMMA O
herein RB B-VP
called VBN I-VP
purine NN B-NP
box NN I-NP
1 CD I-NP
( ( O
PB1 NN B-NP
) ) O
COMMA COMMA O
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
to TO B-VP
bind VB I-VP
a DT B-NP
T-cell NN I-NP
nuclear JJ I-NP
protein NN I-NP
complex NN I-NP
and CC O
to TO B-VP
be VB I-VP
required VBN I-VP
for IN B-PP
transcriptional JJ B-NP
induction NN I-NP
of IN B-PP
the DT B-NP
GM-CSF NN I-NP
gene NN I-NP
following VBG B-PP
T-cell NN B-NP
activation NN I-NP
. . O

The DT B-NP
PB1 NN I-NP
sequence NN I-NP
motif NN I-NP
is VBZ B-VP
highly RB B-ADJP
conserved VBN I-ADJP
in IN B-PP
both CC B-NP
human JJ I-NP
and CC I-NP
murine JJ I-NP
GM-CSF NN I-NP
genes NNS I-NP
. . O

In IN B-PP
this DT B-NP
report NN I-NP
COMMA COMMA O
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
the DT B-NP
PB1 NN I-NP
element NN I-NP
alone RB B-ADVP
confers VBZ B-VP
inducibility NN B-NP
on IN B-PP
a DT B-NP
heterologous JJ I-NP
promoter NN I-NP
following VBG B-PP
transfection NN B-NP
into IN B-PP
human JJ B-NP
Jurkat NN I-NP
T NN I-NP
cells NNS I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
we PRP B-NP
identify VBP B-VP
a DT B-NP
major JJ I-NP
PB1 NN I-NP
nuclear JJ I-NP
protein-binding JJ I-NP
complex NN I-NP
that WDT B-NP
is VBZ B-VP
not RB O
present JJ B-ADJP
in IN B-PP
resting VBG B-NP
peripheral JJ I-NP
blood NN I-NP
T NN I-NP
cells NNS I-NP
but CC O
is VBZ B-VP
rapidly RB I-VP
induced VBN I-VP
following VBG B-PP
T-cell NN B-NP
activation NN I-NP
. . O

Sequence NN B-NP
analysis NN I-NP
revealed VBD B-VP
that IN B-SBAR
PB1 NN B-NP
is VBZ B-VP
composed VBN I-VP
of IN B-PP
adjacent JJ B-NP
binding VBG I-NP
sites NNS I-NP
for IN B-PP
Ets NN B-NP
and CC O
AP-1 NN B-NP
transcription NN I-NP
factors NNS I-NP
. . O

In FW B-NP
vitro FW I-NP
mutagenesis NN I-NP
experiments NNS I-NP
demonstrated VBD B-VP
that IN B-SBAR
both CC B-NP
the DT I-NP
Ets NNS B-NP
and CC O
AP-1 NN B-NP
sites NNS I-NP
are VBP B-VP
required VBN I-VP
for IN B-PP
binding NN B-NP
of IN B-PP
the DT B-NP
inducible JJ I-NP
PB1 NN I-NP
nuclear JJ I-NP
protein NN I-NP
complex NN I-NP
and CC B-PP
for IN B-PP
the DT B-NP
transcriptional JJ I-NP
activity NN I-NP
of IN B-PP
this DT B-NP
element NN I-NP
and CC O
the DT B-NP
GM-CSF NN I-NP
promoter NN I-NP
in IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
. . O

( ( O
ABSTRACT NN B-NP
TRUNCATED VBN B-VP
AT IN B-PP
250 CD B-NP
WORDS NNS I-NP
) ) O

Human JJ B-NP
T-cell NN I-NP
leukemia NN I-NP
virus NN I-NP
type NN I-NP
I CD I-NP
Tax NN I-NP
associates VBZ B-VP
with IN B-PP
and CC O
is VBZ B-VP
negatively RB I-VP
regulated VBN I-VP
by IN B-PP
the DT B-NP
NF-kappa NN I-NP
B2 NN I-NP
p100 NN I-NP
gene NN I-NP
product NN I-NP
: : O
implications NNS B-NP
for IN B-PP
viral JJ B-NP
latency NN I-NP
. . O

Human JJ B-NP
T-cell NN I-NP
leukemia NN I-NP
virus NN I-NP
type NN I-NP
I CD I-NP
( ( O
HTLV-I NN B-NP
) ) O
is VBZ B-VP
the DT B-NP
etiologic JJ I-NP
agent NN I-NP
of IN B-PP
the DT B-NP
adult JJ I-NP
T-cell NN I-NP
leukemia NN I-NP
COMMA COMMA O
an DT O
aggressive JJ O
and CC O
often RB B-ADVP
fatal JJ B-NP
malignancy NN I-NP
of IN B-PP
activated VBN B-NP
human JJ I-NP
CD4 NN I-NP
T NN I-NP
cells NNS I-NP
. . O

HTLV-I NN B-NP
encodes VBZ B-VP
an DT B-NP
essential JJ I-NP
40-kDa JJ I-NP
protein NN I-NP
termed VBN B-VP
Tax NN B-NP
that WDT B-NP
not RB B-CONJP
only RB I-CONJP
transactivates VBZ B-VP
the DT B-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
of IN B-PP
this DT B-NP
retrovirus NN I-NP
but CC B-CONJP
also RB I-CONJP
induces VBZ B-VP
an DT B-NP
array NN I-NP
of IN B-PP
cellular JJ B-NP
genes NNS I-NP
. . O

Tax-mediated JJ B-NP
transformation NN I-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
likely RB B-ADVP
involves VBZ B-VP
the DT B-NP
deregulated VBN I-NP
expression NN I-NP
of IN B-PP
various JJ B-NP
cellular JJ I-NP
genes NNS I-NP
that WDT B-NP
normally RB B-ADVP
regulate VBP B-VP
lymphocyte NN B-NP
growth NN I-NP
produced VBN B-VP
by IN B-PP
altered JJ B-NP
activity NN I-NP
of IN B-PP
various JJ B-NP
endogenous JJ I-NP
host NN I-NP
transcription NN I-NP
factors NNS I-NP
. . O

In IN B-PP
particular JJ B-NP
COMMA COMMA O
Tax NN B-NP
is VBZ B-VP
capable JJ B-ADJP
of IN B-PP
modulating VBG B-VP
the DT B-NP
expression NN B-NP
or CC O
activity NN B-NP
of IN B-PP
various JJ B-NP
host NN I-NP
transcription NN I-NP
factors NNS I-NP
COMMA COMMA O
including VBG B-PP
members NNS B-NP
of IN B-PP
the DT O
NF-kappa NN B-NP
B\/Rel NN I-NP
and CC O
CREB\/ATF NN B-NP
families NNS B-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
the DT B-NP
cellular JJ I-NP
factors NNS I-NP
HEB-1 NN B-NP
and CC O
p67SRF NN B-NP
. . O

An DT B-NP
additional JJ I-NP
distinguishing JJ I-NP
characteristic NN I-NP
of IN B-PP
HTLV-I NN B-NP
infection NN I-NP
is VBZ B-VP
the DT B-NP
profound JJ I-NP
state NN I-NP
of IN B-PP
viral JJ B-NP
latency NN I-NP
that WDT B-NP
is VBZ B-VP
present JJ B-ADJP
in IN B-PP
circulating VBG B-NP
primary JJ I-NP
leukemic JJ I-NP
T NN I-NP
cells NNS I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
HTLV-I NN B-NP
Tax NN I-NP
can MD B-VP
physically RB I-VP
associate VB I-VP
with IN B-PP
p100 NN B-NP
COMMA COMMA O
the DT B-NP
product NN I-NP
of IN B-PP
the DT B-NP
Rel-related JJ I-NP
NF-kappa NN I-NP
B2 NN I-NP
gene NN I-NP
COMMA COMMA O
both CC O
in IN B-PP
transfected VBN B-NP
cells NNS I-NP
and CC B-PP
in IN B-PP
HTLV-I-infected JJ B-NP
leukemic JJ I-NP
T-cell NN I-NP
lines NNS I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
the DT B-NP
physical JJ I-NP
interaction NN I-NP
of IN B-PP
Tax NN B-NP
with IN B-PP
p100 NN B-NP
leads VBZ B-VP
to TO B-PP
the DT B-NP
inhibition NN I-NP
of IN B-PP
Tax-induced JJ B-NP
activation NN I-NP
of IN B-PP
the DT O
HTLV-I NN B-NP
and CC O
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
long JJ B-NP
terminal JJ I-NP
repeats NNS I-NP
COMMA COMMA O
reflecting VBG B-VP
p100-mediated JJ B-NP
cytoplasmic JJ I-NP
sequestration NN I-NP
of IN B-PP
the DT O
normally RB B-ADVP
nuclearly RB B-NP
expressed VBN I-NP
Tax NN I-NP
protein NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
a DT B-NP
mutant NN I-NP
of IN B-PP
Tax NN B-NP
that WDT B-NP
selectively RB B-ADVP
fails VBZ B-VP
to TO I-VP
activate VB I-VP
nuclear JJ B-NP
NF-kappa NN I-NP
B NN I-NP
expression NN I-NP
does VBZ B-VP
not RB I-VP
associate VB I-VP
with IN B-PP
p100 NN B-NP
. . O

( ( O
ABSTRACT NN B-NP
TRUNCATED VBN B-VP
AT IN B-PP
250 CD B-NP
WORDS NNS I-NP
) ) O

Regulation NN B-NP
of IN B-PP
the DT B-NP
BZLF1 NN I-NP
promoter NN I-NP
of IN B-PP
Epstein-Barr JJ B-NP
virus NN I-NP
by IN B-PP
second JJ B-NP
messengers NNS I-NP
in IN B-PP
anti-immunoglobulin-treated JJ B-NP
B NN I-NP
cells NNS I-NP
. . O

Initiation NN B-NP
of IN B-PP
the DT O
Epstein-Barr JJ B-NP
virus NN I-NP
( ( O
EBV NN B-NP
) ) O
lytic JJ B-NP
cycle NN I-NP
is VBZ B-VP
dependent JJ B-ADJP
on IN B-PP
the DT B-NP
transcription NN I-NP
of IN B-PP
the DT B-NP
BZLF1 NN I-NP
gene NN I-NP
. . O

The DT B-NP
BZLF1 NN I-NP
gene NN I-NP
promoter NN I-NP
( ( O
Zp NN B-NP
) ) O
was VBD B-VP
activated VBN I-VP
by IN B-PP
crosslinking NN B-NP
of IN B-PP
cell NN B-NP
surface NN I-NP
immunoglobulin NN B-NP
( ( O
Ig NN B-NP
) ) O
with IN B-PP
anti-Ig JJ B-NP
antibody NN I-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
COMMA COMMA O
even RB B-PP
in IN I-PP
the DT I-PP
absence NN I-PP
of IN I-PP
other JJ B-NP
viral JJ I-NP
genes NNS I-NP
. . O

We PRP B-NP
identified VBD B-VP
several JJ B-NP
anti-Ig JJ I-NP
response NN I-NP
elements NNS I-NP
within IN B-PP
Zp NN B-NP
COMMA COMMA O
which WDT B-NP
were VBD B-VP
originally RB I-VP
defined VBN I-VP
as IN B-PP
12-O-tetradecanoylphorbol-13-acetate NN B-NP
( ( O
TPA NN B-NP
) ) O
response NN B-NP
elements NNS I-NP
( ( O
ZI NN B-NP
repeats NNS I-NP
and CC O
ZII NN B-NP
COMMA COMMA O
an DT B-NP
AP-1-like JJ I-NP
domain NN I-NP
) ) O
. . O

Since IN B-SBAR
anti-Ig JJ B-NP
crosslinking NN I-NP
leads VBZ B-VP
to TO B-PP
activation NN B-NP
of IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( O
PKC NN B-NP
) ) O
and CC O
an DT B-NP
increase NN I-NP
in IN B-PP
intracellular JJ B-NP
calcium NN I-NP
level NN I-NP
COMMA COMMA O
Zp NN B-NP
was VBD B-VP
tested VBN I-VP
for IN B-PP
the DT B-NP
response NN I-NP
to TO B-PP
these DT B-NP
cellular JJ I-NP
factors NNS I-NP
. . O

Treatment NN B-NP
with IN B-PP
calcium NN B-NP
ionophore NN I-NP
A23187 NN I-NP
increased VBD B-VP
Zp NN B-NP
activity NN I-NP
. . O

When WRB B-ADVP
the DT B-NP
calcium NN I-NP
ionophore NN I-NP
was VBD B-VP
used VBN I-VP
in IN B-PP
conjunction NN I-PP
with IN I-PP
TPA NN B-NP
COMMA COMMA O
a DT B-NP
PKC NN I-NP
activator NN I-NP
COMMA COMMA O
the DT B-NP
Zp NN I-NP
induction NN I-NP
was VBD B-VP
synergistically RB I-VP
enhanced VBN I-VP
. . O

Retinoic JJ B-NP
acid NN I-NP
downmodulates VBZ B-VP
erythroid JJ B-NP
differentiation NN I-NP
and CC O
GATA1 NN B-NP
expression NN I-NP
in IN B-PP
purified VBN B-NP
adult-progenitor JJ I-NP
culture NN I-NP
. . O

All-trans JJ B-NP
retinoic JJ B-NP
acid NN I-NP
( ( O
RA NN B-NP
) ) O
is VBZ B-VP
an DT B-NP
important JJ I-NP
morphogen NN I-NP
in IN B-PP
vertebrate NN B-NP
development NN I-NP
COMMA COMMA O
a DT B-NP
normal JJ I-NP
constituent NN I-NP
in IN B-PP
human JJ B-NP
adult JJ I-NP
blood NN I-NP
and CC O
is VBZ B-VP
also RB I-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
cell NN B-NP
growth NN B-NP
and CC O
differentiation NN B-NP
in IN B-PP
acute JJ B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
. . O

We PRP B-NP
have VBP B-VP
examined VBN I-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
RA NN B-NP
on IN B-PP
normal JJ B-NP
hematopoiesis NN I-NP
by IN B-PP
using VBG B-VP
early JJ B-NP
hematopoietic JJ B-NP
progenitor NN I-NP
cells NNS I-NP
( ( O
HPC NN B-NP
) ) O
stringently RB B-VP
purified VBN I-VP
from IN B-PP
adult JJ B-NP
peripheral JJ I-NP
blood NN I-NP
. . O

In IN B-PP
clonogenetic JJ O
fetal JJ O
calf NN O
serum-supplemented JJ O
( ( O
FCS+ JJ B-ADJP
) ) O
or CC O
-nonsupplemented JJ O
( ( O
FCS- JJ B-ADJP
) ) O
culture NN B-NP
treated VBN B-VP
with IN B-PP
saturating JJ B-NP
levels NNS I-NP
of IN B-PP
interleukin-3 NN B-NP
( ( O
IL-3 NN B-NP
) ) O
granulocyte-macrophage JJ B-NP
colony-stimulating JJ I-NP
factor NN I-NP
( ( O
GM-CSF NN B-NP
) ) O
and CC O
erythropoietin NN B-NP
( ( O
Ep NN B-NP
) ) O
( ( O
combined VBN B-PP
with IN B-PP
c-kit NN B-NP
ligand NN I-NP
in IN B-PP
FCS(-)-culture JJ B-NP
conditions NNS I-NP
) ) O
COMMA COMMA O
RA NN B-NP
induces VBZ B-VP
a DT B-NP
dramatic JJ I-NP
dose-dependent JJ I-NP
shift NN I-NP
from IN B-PP
erythroid JJ B-NP
to TO B-PP
granulomonocytic JJ B-NP
colony NN B-NP
formation NN I-NP
COMMA COMMA O
the DT B-NP
latter JJ I-NP
colonies NNS I-NP
being VBG B-VP
essentially RB I-VP
represented VBN I-VP
by IN B-PP
granulocytic JJ B-NP
clones NNS I-NP
. . O

This DT B-NP
shift NN I-NP
is VBZ B-VP
apparently RB I-VP
not RB I-VP
caused VBN I-VP
by IN B-PP
a DT B-NP
recruitment NN I-NP
phenomenon NN I-NP
COMMA COMMA O
because IN B-SBAR
in IN B-PP
FCS+ JJ B-NP
culture NN I-NP
COMMA COMMA O
the DT B-NP
total JJ I-NP
number NN I-NP
of IN B-PP
colonies NNS B-NP
is VBZ B-VP
not RB I-VP
significantly RB I-VP
modified VBN I-VP
by IN B-PP
RA NN B-NP
addition NN I-NP
. . O

In IN B-PP
FCS- JJ B-NP
liquid-suspension NN I-NP
culture NN I-NP
supplemented VBN B-VP
with IN B-PP
saturating JJ B-NP
Ep NN I-NP
level NN I-NP
and CC O
low-dose JJ B-NP
IL-3\/GM-CSF NN I-NP
COMMA COMMA O
adult JJ B-NP
HPC NN I-NP
undergo VBP B-VP
unilineage JJ B-NP
erythropoietic JJ I-NP
differentiation NN I-NP
: : O
Here RB B-ADVP
again RB B-ADVP
COMMA COMMA O
treatment NN B-NP
with IN B-PP
high-dose JJ B-NP
RA NN I-NP
induces VBZ B-VP
a DT B-NP
shift NN I-NP
from IN B-PP
the DT B-NP
erythroid JJ I-NP
to TO I-NP
granulocytic JJ I-NP
differentiation NN I-NP
pathway NN I-NP
. . O

Studies NNS B-NP
on IN B-PP
RA NN O
time-response JJ O
or CC O
pulse NN B-NP
treatment NN B-NP
in IN B-PP
semisolid JJ B-NP
or CC I-NP
liquid JJ I-NP
culture NN I-NP
show VBP B-VP
that IN B-SBAR
early JJ B-NP
RA NN I-NP
addition NN I-NP
is VBZ B-VP
most RBS B-ADJP
effective JJ I-ADJP
COMMA COMMA O
thus RB B-ADVP
indicating VBG B-VP
that IN B-SBAR
early JJ B-NP
but CC I-NP
not RB I-NP
late JJ I-NP
HPC NN I-NP
are VBP B-VP
sensitive JJ B-ADJP
to TO B-PP
its PRP$ B-NP
action NN I-NP
. . O

We PRP B-NP
then RB B-ADVP
analyzed VBD B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
master NN I-NP
GATA1 NN I-NP
gene NN I-NP
COMMA COMMA O
which WDT B-NP
encodes VBZ B-VP
a DT B-NP
finger NN I-NP
transcription NN I-NP
factor NN I-NP
required VBN B-VP
for IN B-PP
normal JJ B-NP
erythroid JJ I-NP
development NN I-NP
; : O
addition NN B-NP
of IN B-PP
RA NN B-NP
to TO B-PP
HPC NN B-NP
stimulated VBN B-VP
into IN B-PP
unilineage JJ B-NP
erythropoietic JJ I-NP
differentiation NN I-NP
in IN B-PP
liquid JJ B-NP
culture NN I-NP
caused VBD B-VP
a DT B-NP
virtually RB I-NP
complete JJ I-NP
inhibition NN I-NP
of IN B-PP
GATA1 NN B-NP
mRNA NN I-NP
induction NN I-NP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
RA NN B-NP
directly RB B-ADVP
inhibits VBZ B-VP
the DT B-NP
erythroid JJ I-NP
differentiation NN I-NP
program NN I-NP
at IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
early JJ B-NP
adult JJ I-NP
HPC NN I-NP
COMMA COMMA O
and CC O
may MD B-VP
lead VB I-VP
to TO B-PP
a DT B-NP
shift NN I-NP
from IN B-PP
the DT B-NP
erythroid JJ I-NP
to TO I-NP
granulocytic JJ I-NP
differentiation NN I-NP
pathway NN I-NP
. . O

This DT B-NP
phenomenon NN I-NP
is VBZ B-VP
correlated VBN I-VP
with IN B-PP
inhibition NN B-NP
of IN B-PP
GATA1 NN B-NP
induction NN I-NP
in IN B-PP
the DT B-NP
early JJ I-NP
stages NNS I-NP
of IN B-PP
erythropoietic JJ B-NP
differentiation NN I-NP
. . O

Effects NNS B-NP
of IN B-PP
CD45 NN B-NP
on IN B-PP
NF-kappa NN B-NP
B NN I-NP
. . O

Implications NNS B-NP
for IN B-PP
replication NN B-NP
of IN B-PP
HIV-1 NN B-NP
. . O

Increased VBN B-NP
levels NNS I-NP
of IN B-PP
replication NN B-NP
of IN B-PP
the DT B-NP
HIV NN I-NP
type NN I-NP
1 CD I-NP
are VBP B-VP
observed VBN I-VP
after IN B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
infected JJ B-NP
T NN I-NP
cells NNS I-NP
through IN B-PP
the DT B-NP
TCR NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
anti-CD45 JJ B-NP
antibodies NNS I-NP
inhibit VBP B-VP
these DT B-NP
effects NNS I-NP
in IN B-PP
cells NNS B-NP
from IN B-PP
infected JJ B-NP
individuals NNS I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
we PRP B-NP
examined VBD B-VP
interrelationships NNS B-NP
between IN B-PP
CD45 NN B-NP
and CC O
HIV-1 NN B-NP
further RB B-ADVP
. . O

We PRP B-NP
measured VBD B-VP
effects NNS B-NP
on IN B-PP
the DT B-NP
HIV-1 NN I-NP
LTR NN I-NP
in IN B-PP
T NN B-NP
cell NN I-NP
lines NNS I-NP
that WDT B-NP
were VBD B-VP
stimulated VBN I-VP
with IN B-PP
antibodies NNS B-NP
against IN B-PP
CD45 NN B-NP
and CC B-PP
in IN B-PP
those DT B-NP
that WDT B-NP
lacked VBD B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
CD45 NN B-NP
on IN B-PP
their PRP$ B-NP
surfaces NNS I-NP
. . O

First RB B-ADVP
COMMA COMMA O
anti-CD45 JJ B-NP
antibodies NNS I-NP
did VBD B-VP
not RB I-VP
affect VB I-VP
basal JJ B-NP
but CC O
decreased VBD B-VP
activated JJ B-NP
levels NNS B-NP
of IN B-PP
expression NN B-NP
from IN B-PP
the DT B-NP
HIV-1 NN I-NP
LTR NN I-NP
. . O

Second RB B-ADVP
COMMA COMMA O
T NN B-NP
cells NNS I-NP
COMMA COMMA O
which WDT B-NP
lack VBP B-VP
CD45 NN B-NP
and CC O
can MD B-VP
not RB I-VP
signal VB I-VP
via IN B-PP
the DT B-NP
TCR NN I-NP
COMMA COMMA O
supported VBD B-VP
higher JJR B-NP
levels NNS I-NP
of IN B-PP
viral JJ B-NP
replication NN I-NP
and CC O
gene NN B-NP
expression NN I-NP
. . O

This DT B-NP
was VBD B-VP
due JJ B-PP
to TO I-PP
the DT B-NP
presence NN I-NP
of IN B-PP
active JJ B-NP
NF-kappa NN I-NP
B NN I-NP
complexes NNS I-NP
in IN B-PP
the DT B-NP
nucleus NN I-NP
of IN B-PP
CD45- JJ B-NP
T NN I-NP
cells NNS I-NP
. . O

Additionally RB B-ADVP
COMMA COMMA O
infected JJ B-NP
T NN I-NP
cells NNS I-NP
displayed VBD B-VP
lower JJR B-NP
levels NNS I-NP
of IN B-PP
CD45 NN B-NP
on IN B-PP
their PRP$ B-NP
surfaces NNS I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
CD45 NN B-NP
plays VBZ B-VP
an DT B-NP
active JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
physiology NN I-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
and CC B-PP
in IN B-PP
the DT B-NP
replication NN I-NP
of IN B-PP
HIV-1 NN B-NP
. . O

Induction NN B-NP
of IN B-PP
phosphatidylinositol NN B-NP
turnover NN I-NP
and CC O
EGR-1 NN B-NP
mRNA NN I-NP
expression NN I-NP
by IN B-PP
crosslinking VBG B-NP
of IN B-PP
surface NN B-NP
IgM NN B-NP
and CC O
IgD NN B-NP
in IN B-PP
the DT B-NP
human JJ I-NP
B NN I-NP
cell NN I-NP
line NN I-NP
B104 NN I-NP
. . O

We PRP B-NP
have VBP B-VP
previously RB I-VP
shown VBN I-VP
that IN B-SBAR
a DT B-NP
human JJ I-NP
B NN I-NP
lymphoma NN I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
B104 NN B-NP
COMMA COMMA O
expressed VBD B-VP
surface NN B-NP
IgM NN I-NP
( ( O
sIgM NN B-NP
) ) O
and CC O
surface NN B-NP
IgD NN I-NP
( ( O
sIgD NN B-NP
) ) O
COMMA COMMA O
and CC O
that IN B-SBAR
crosslinking VBG B-NP
of IN B-PP
sIgM NN B-NP
and CC O
sIgD NN B-NP
by IN B-PP
anti-IgM JJ B-NP
antibody NN B-NP
( ( O
Ab NN B-NP
) ) O
and CC O
anti-IgD JJ B-NP
Ab NN I-NP
COMMA COMMA O
respectively RB B-ADVP
COMMA COMMA O
induced VBD B-VP
Ca2+ NN B-NP
influx NN I-NP
to TO B-PP
almost RB B-NP
the DT I-NP
same JJ I-NP
degree NN I-NP
COMMA COMMA O
whereas IN O
only RB B-NP
sIgM-crosslinking NN I-NP
caused VBD B-VP
B104 NN B-NP
cell NN I-NP
death NN I-NP
. . O

Here RB B-ADVP
COMMA COMMA O
we PRP B-NP
investigated VBD B-VP
the DT B-NP
accumulation NN I-NP
of IN B-PP
cyclic JJ B-NP
AMP NN I-NP
( ( O
cAMP NN B-NP
) ) O
COMMA COMMA O
the DT B-NP
hydrolysis NN I-NP
of IN B-PP
inositol NN B-NP
phosphates NNS I-NP
COMMA COMMA O
protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( O
PKC NN B-NP
) ) O
activity NN B-NP
and CC O
the DT B-NP
induction NN I-NP
of IN B-PP
Egr-1 NN B-NP
and CC O
c-fos NN B-NP
mRNA NN B-NP
expression NN I-NP
by IN B-PP
sIgM- NN B-NP
and CC O
sIgD-crosslinking NN B-NP
to TO B-VP
examine VB I-VP
differences NNS B-NP
in IN B-PP
the DT B-NP
signals NNS I-NP
mediated VBN B-VP
through IN B-PP
sIgM NN B-NP
and CC O
sIgD NN B-NP
in IN B-PP
B104 NN B-NP
cells NNS I-NP
. . O

Both CC O
sIgM- NN B-NP
and CC O
sIgD-crosslinking NN B-NP
with IN B-PP
antibodies NNS B-NP
induced VBD B-VP
elevation NN B-NP
of IN B-PP
cAMP NN B-NP
levels NNS I-NP
COMMA COMMA O
phosphatidylinositol NN B-NP
turnover NN I-NP
COMMA COMMA O
PKC NN B-NP
activation NN I-NP
and CC O
expression NN B-NP
of IN B-PP
Egr-1 NN B-NP
and CC O
c-fos NN B-NP
mRNA NN B-NP
COMMA COMMA O
although IN B-SBAR
sIgM-crosslinking NN B-NP
was VBD B-VP
more RBR B-ADJP
effective JJ I-ADJP
than IN B-PP
sIgD-crosslinking NN B-NP
COMMA COMMA O
presumably RB B-ADVP
due JJ B-PP
to TO I-PP
the DT B-NP
higher JJR I-NP
expression NN I-NP
of IN B-PP
sIgM NN B-NP
than IN B-PP
of IN B-PP
sIgD NN B-NP
. . O

Egr-1 NN B-NP
mRNA NN I-NP
expression NN I-NP
induced VBN B-VP
by IN B-PP
sIgM- NN B-NP
and CC O
sIgD-crosslinking NN B-NP
was VBD B-VP
inhibited VBN I-VP
by IN B-PP
H7 NN B-NP
COMMA COMMA O
erbstatin NN B-NP
and CC O
genistein NN B-NP
COMMA COMMA B-PP
but CC I-PP
not RB B-PP
by IN I-PP
HA1004 NN B-NP
. . O

Erbstatin NN B-NP
and CC O
genistein NN B-NP
inhibited VBD B-VP
the DT B-NP
sIg-crosslinking-induced JJ I-NP
Egr-1 NN I-NP
mRNA NN I-NP
expression NN I-NP
in IN B-PP
a DT B-NP
dose-dependent JJ I-NP
manner NN I-NP
parallel JJ B-ADJP
to TO B-PP
that WDT B-NP
observed VBN B-VP
in IN B-PP
the DT B-NP
inhibition NN I-NP
of IN B-PP
sIg-crosslinking-induced JJ B-NP
protein NN I-NP
tyrosine NN I-NP
phosphorylation NN I-NP
. . O

Phorbol NN B-NP
myristate NN I-NP
acetate NN I-NP
induced VBD B-VP
Egr-1 NN B-NP
mRNA NN I-NP
expression NN I-NP
but CC O
forskolin NN B-NP
and CC O
dibutyryl NN B-NP
cyclic JJ I-NP
AMP NN I-NP
did VBD B-VP
not RB O
. . O

These DT B-NP
findings NNS I-NP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
Egr-1 NN I-NP
mRNA NN I-NP
activating NN I-NP
signals NNS I-NP
through IN B-PP
sIgM NN B-NP
and CC O
sIgD NN B-NP
are VBP B-VP
protein NN B-NP
tyrosine NN I-NP
kinase- NN I-NP
and CC O
PKC-dependent JJ B-ADJP
COMMA COMMA O
but CC O
protein NN B-ADJP
kinase NN I-ADJP
A-independent JJ I-ADJP
. . O

Cyclosporin NN B-NP
A NN I-NP
( ( O
CsA NN B-NP
) ) O
and CC O
FK506 NN B-NP
rescued VBD B-VP
B104 NN B-NP
cells NNS I-NP
from IN B-PP
death NN B-NP
induced VBN B-VP
by IN B-PP
anti-IgM JJ B-NP
Ab NN I-NP
COMMA COMMA O
but CC O
did VBD B-VP
not RB I-VP
affect VB I-VP
the DT B-NP
expression NN I-NP
of IN B-PP
Egr-1 NN B-NP
and CC O
c-fos NN B-NP
mRNA NN B-NP
COMMA COMMA O
showing VBG B-VP
that IN B-SBAR
CsA NN B-NP
and CC O
FK506 NN B-NP
affect VBP B-VP
signal NN B-NP
transducers NNS I-NP
differently RB B-ADVP
from IN B-PP
or CC O
downstream RB B-ADVP
to TO B-PP
these DT B-NP
molecules NNS I-NP
. . O

The DT B-NP
difference NN I-NP
in IN B-PP
signals NNS B-NP
transduced VBN B-VP
through IN B-PP
sIgM NN B-NP
and CC O
sIgD NN B-NP
in IN B-PP
B104 NN B-NP
cells NNS I-NP
is VBZ B-VP
discussed VBN I-VP
. . O

G(Anh)MTetra NN B-NP
COMMA COMMA O
a DT B-NP
natural JJ I-NP
bacterial JJ I-NP
cell NN I-NP
wall NN I-NP
breakdown NN I-NP
product NN I-NP
COMMA COMMA O
induces VBZ B-VP
interleukin-1 NN B-NP
beta NN I-NP
and CC O
interleukin-6 NN B-NP
expression NN B-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
. . O

A DT B-NP
study NN I-NP
of IN B-PP
the DT B-NP
molecular JJ I-NP
mechanisms NNS I-NP
involved VBN B-VP
in IN B-PP
inflammatory JJ B-NP
cytokine NN I-NP
expression NN I-NP
{ ( O
published VBN B-NP
erratum NN I-NP
appears VBZ B-VP
in IN B-PP
J NNP B-NP
Biol NNP I-NP
Chem NNP I-NP
1994 CD B-NP
Jun NNP I-NP
17 CD I-NP
; : O
269 CD B-NP
( ( I-NP
24 CD I-NP
) ) O
: : O
16983 CD B-NP
} ) O

It PRP B-NP
is VBZ B-VP
believed VBN I-VP
that IN B-SBAR
induction NN B-NP
of IN B-PP
cytokine NN B-NP
expression NN I-NP
by IN B-PP
bacterial JJ B-NP
cell NN I-NP
wall NN I-NP
components NNS I-NP
plays VBZ B-VP
a DT B-NP
role NN I-NP
in IN B-PP
the DT B-NP
development NN B-NP
and CC O
course NN B-NP
of IN B-PP
sepsis NN B-NP
. . O

However RB B-ADVP
COMMA COMMA O
most JJS B-NP
attention NN I-NP
has VBZ B-VP
been VBN I-VP
focused VBN I-VP
on IN B-PP
lipopolysaccharide NN B-NP
( ( O
LPS NN B-NP
) ) O
. . O

We PRP B-NP
studied VBD B-VP
the DT B-NP
ability NN I-NP
of IN B-PP
N-acetylglucosaminyl-1COMMA6-anhydro-N-acetylmuramyl-L-alanyl-D-isoglutamyl-m-diaminopimelyl-D-alanine NN B-NP
( ( O
G(Anh)MTetra NN B-NP
) ) O
COMMA COMMA O
a DT B-NP
naturally RB I-NP
occurring VBG I-NP
breakdown NN I-NP
product NN I-NP
of IN B-PP
peptidoglycan NN B-NP
that WDT B-NP
is VBZ B-VP
produced VBN I-VP
by IN B-PP
soluble JJ B-NP
lytic JJ I-NP
transglycosylase NN I-NP
of IN B-PP
Escherichia FW B-NP
coli FW I-NP
COMMA COMMA O
to TO B-VP
induce VB I-VP
cytokine NN B-NP
expression NN I-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
. . O

G(Anh)MTetra NN B-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
strongly RB I-VP
induce VB I-VP
interleukin NN B-NP
( ( I-NP
IL NN I-NP
) ) I-NP
-1 CD I-NP
beta NN I-NP
and CC O
IL-6 NN B-NP
mRNA NN B-NP
expression NN I-NP
after IN B-PP
2 CD B-NP
h NN I-NP
and CC O
IL-1 NN B-NP
beta NN I-NP
and CC O
IL-6 NN B-NP
protein NN B-NP
secretion NN I-NP
after IN B-PP
48 CD B-NP
h NN I-NP
of IN B-PP
activation NN B-NP
. . O

The DT B-NP
increase NN I-NP
in IN B-PP
mRNA NN B-NP
accumulation NN I-NP
was VBD B-VP
at IN B-ADVP
least JJS I-ADVP
partly RB B-ADVP
due JJ B-PP
to TO I-PP
an DT B-NP
increase NN I-NP
in IN B-PP
the DT B-NP
transcription NN I-NP
rates NNS I-NP
of IN B-PP
the DT B-NP
respective JJ I-NP
genes NNS I-NP
and CC O
was VBD B-VP
accompanied VBN I-VP
by IN B-PP
a DT B-NP
strong JJ I-NP
induction NN I-NP
of IN B-PP
nuclear JJ B-NP
factor-kappa NN I-NP
B NN I-NP
and CC O
activator NN B-NP
protein-1 NN I-NP
transcription NN I-NP
factor NN I-NP
expression NN B-NP
. . O

Experiments NNS B-NP
using VBG B-VP
inhibitors NNS B-NP
of IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
COMMA COMMA O
protein NN B-NP
kinase NN I-NP
A NN I-NP
COMMA COMMA O
and CC O
tyrosine NN B-NP
kinase-dependent JJ I-NP
pathways NNS I-NP
revealed VBD B-VP
that IN B-SBAR
G(Anh)MTetra-induced JJ O
IL-1 NN B-NP
beta NN I-NP
and CC O
IL-6 NN B-NP
mRNA NN B-NP
expression NN I-NP
involves VBZ B-VP
activation NN B-NP
of IN B-PP
an DT B-NP
H7-inhibitable JJ I-NP
pathway NN I-NP
. . O

By IN B-PP
using VBG B-VP
the DT B-NP
protein NN I-NP
synthesis NN I-NP
inhibitor NN I-NP
cycloheximide NN I-NP
COMMA COMMA O
it PRP B-NP
was VBD B-VP
shown VBN I-VP
that IN B-SBAR
G(Anh)MTetra-induced JJ B-NP
IL-6 NN I-NP
mRNA NN I-NP
expression NN I-NP
depends VBZ B-VP
on IN B-PP
the DT B-NP
synthesis NN I-NP
of IN B-PP
new JJ B-NP
protein NN I-NP
COMMA COMMA O
whereas IN O
G(Anh)MTetra-induced JJ B-NP
IL-1 NN I-NP
beta NN I-NP
mRNA NN I-NP
accumulation NN I-NP
does VBZ B-VP
not RB O
. . O

When WRB B-ADVP
responses NNS B-NP
to TO B-PP
G(Anh)MTetra NN B-NP
were VBD B-VP
compared VBN I-VP
with IN B-PP
those DT B-NP
to TO B-PP
LPS NN B-NP
and CC O
muramyldipeptide NN B-NP
( ( O
MDP NN B-NP
) ) O
COMMA COMMA O
it PRP B-NP
was VBD B-VP
found VBN I-VP
that IN B-SBAR
the DT B-NP
optimal JJ I-NP
response NN I-NP
to TO B-PP
G(Anh)MTetra NN B-NP
induction NN I-NP
was VBD B-VP
similar JJ B-ADJP
to TO B-PP
that DT B-NP
of IN B-PP
LPS NN B-NP
but CC O
significantly RB B-ADJP
higher JJR I-ADJP
than IN B-PP
the DT B-NP
response NN I-NP
to TO B-PP
MDP NN B-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
maximal JJ O
G(Anh)MTetra-induced JJ O
IL-1 NN B-NP
beta NN I-NP
and CC O
IL-6 NN B-NP
mRNA NN B-NP
expression NN I-NP
could MD B-VP
be VB I-VP
enhanced VBN I-VP
by IN B-PP
co-stimulation NN B-NP
with IN B-PP
LPS NN B-NP
or CC O
MDP NN B-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
different JJ B-NP
receptors NNS B-NP
and\/or CC O
transduction NN B-NP
pathways NNS I-NP
were VBD B-VP
involved VBN I-VP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
G(Anh)MTetra NN B-NP
induces VBZ B-VP
IL-1 NN B-NP
beta NN I-NP
and CC O
IL-6 NN B-NP
expression NN B-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
suggesting VBG B-VP
a DT B-NP
possible JJ I-NP
role NN I-NP
for IN B-PP
G(Anh)MTetra NN B-NP
in IN B-PP
the DT B-NP
release NN I-NP
of IN B-PP
cytokines NNS B-NP
during IN B-PP
sepsis NN B-NP
. . O

Human JJ B-NP
interferon NN I-NP
regulatory JJ I-NP
factor NN I-NP
2 CD I-NP
gene NN I-NP
. . O

Intron-exon JJ B-NP
organization NN I-NP
and CC O
functional JJ B-NP
analysis NN I-NP
of IN B-PP
5'-flanking JJ B-NP
region NN I-NP
. . O

Interferon NN B-NP
regulatory JJ I-NP
factor NN I-NP
2 CD I-NP
( ( O
IRF-2 NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
transcriptional JJ I-NP
regulatory JJ I-NP
protein NN I-NP
that WDT B-NP
terminates VBZ B-VP
interferon NN B-NP
beta NN I-NP
expression NN I-NP
initiated VBN B-VP
by IN B-PP
interferon NN B-NP
regulatory JJ I-NP
factor NN I-NP
1 CD I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
we PRP B-NP
isolated VBD B-VP
the DT B-NP
genomic JJ I-NP
DNA NN I-NP
for IN B-PP
human JJ B-NP
IRF-2 NN I-NP
gene NN I-NP
COMMA COMMA O
determined VBD B-VP
the DT B-NP
intron-exon JJ I-NP
structure NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
IRF-2 NN I-NP
gene NN I-NP
COMMA COMMA O
mapped VBD B-VP
the DT B-NP
major JJ I-NP
transcription NN I-NP
initiation NN I-NP
site NN I-NP
COMMA COMMA O
identified VBD B-VP
a DT B-NP
number NN I-NP
of IN B-PP
potential JJ B-NP
regulatory JJ I-NP
elements NNS I-NP
in IN B-PP
the DT B-NP
5'-flanking JJ I-NP
region NN I-NP
COMMA COMMA O
and CC O
localized VBD B-VP
the DT B-NP
IRF-2 NN I-NP
gene NN I-NP
on IN B-PP
human JJ B-NP
chromosome NN I-NP
4 CD I-NP
. . O

The DT B-NP
IRF-2 NN I-NP
promoter NN I-NP
region NN I-NP
contains VBZ B-VP
a DT B-NP
CpG NN I-NP
island NN I-NP
COMMA COMMA O
with IN B-PP
several JJ B-NP
GC NN I-NP
boxes NNS I-NP
COMMA COMMA O
a DT B-NP
putative JJ I-NP
NF-kappa NN I-NP
B-binding JJ I-NP
site NN I-NP
COMMA COMMA O
and CC O
a DT B-NP
CAAT NN I-NP
box NN I-NP
COMMA COMMA O
but CC O
no DT B-NP
TATA NN I-NP
box NN I-NP
. . O

When WRB B-ADVP
the DT B-NP
promoter NN I-NP
region NN I-NP
was VBD B-VP
linked VBN I-VP
with IN B-PP
a DT B-NP
heterologous JJ I-NP
reporter NN I-NP
gene NN I-NP
COMMA COMMA O
we PRP B-NP
found VBD B-VP
that IN B-SBAR
the DT B-NP
promoter NN I-NP
region NN I-NP
is VBZ B-VP
inducible JJ B-ADJP
by IN B-PP
both CC O
interferons NNS B-NP
( ( O
interferon-alpha NN B-NP
and CC O
-gamma NN B-NP
) ) O
and CC O
interferon NN B-NP
regulatory JJ I-NP
factor NN I-NP
1 CD I-NP
. . O

The DT B-NP
region NN I-NP
which WDT B-NP
induced VBD B-VP
these DT B-NP
inductions NNS I-NP
was VBD B-VP
identified VBN I-VP
as IN B-PP
being VBG B-VP
confined VBN I-VP
to TO B-PP
40 CD B-NP
nucleotides NNS I-NP
5' JJ B-NP
to TO B-PP
the DT B-NP
major JJ I-NP
transcriptional JJ I-NP
initiation NN I-NP
site NN I-NP
by IN B-PP
testing VBG B-VP
a DT B-NP
series NN I-NP
of IN B-PP
clones NNS B-NP
with IN B-PP
truncated VBN B-NP
promoter NN I-NP
of IN B-PP
IRF-2 NN B-NP
. . O

This DT B-NP
region NN I-NP
contains VBZ B-VP
elements NNS B-NP
which WDT B-NP
are VBP B-VP
shared VBN I-VP
with IN B-PP
the DT B-NP
transcriptional JJ I-NP
enhancers NNS I-NP
of IN B-PP
other JJ B-NP
genes NNS I-NP
including VBG B-PP
interferon NN B-NP
regulatory JJ I-NP
factor NN I-NP
1 CD I-NP
COMMA COMMA O
interferon NN B-NP
beta NN I-NP
COMMA COMMA O
and CC O
interferon-inducible JJ B-NP
genes NNS I-NP
. . O

These DT B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
interferon NN B-NP
regulatory JJ I-NP
factor NN I-NP
1 CD I-NP
not RB B-CONJP
only RB I-CONJP
triggers VBZ B-VP
the DT B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
interferon NN I-NP
signal NN I-NP
transduction NN I-NP
pathway NN I-NP
COMMA COMMA O
but CC B-CONJP
also RB I-CONJP
may MD B-VP
play VB I-VP
a DT B-NP
role NN I-NP
in IN B-PP
limiting VBG B-VP
the DT B-NP
duration NN I-NP
of IN B-PP
this DT B-NP
response NN I-NP
by IN B-PP
activating VBG B-VP
the DT B-NP
transcription NN I-NP
of IN B-PP
IRF-2 NN B-NP
. . O

rel NN B-NP
Is VBZ B-VP
rapidly RB I-VP
tyrosine-phosphorylated JJ I-VP
following VBG B-PP
granulocyte-colony JJ B-NP
stimulating NN I-NP
factor NN I-NP
treatment NN I-NP
of IN B-PP
human JJ B-NP
neutrophils NNS I-NP
. . O

Stimulation NN B-NP
of IN B-PP
neutrophils NNS B-NP
with IN B-PP
granulocyte-colony JJ B-NP
stimulating NN I-NP
factor NN I-NP
( ( O
G-CSF NN B-NP
) ) O
results VBZ B-VP
in IN B-PP
an DT B-NP
enhanced VBN I-NP
respiratory JJ I-NP
burst NN I-NP
COMMA COMMA O
prolonged JJ B-NP
survival NN I-NP
COMMA COMMA O
and CC O
increased VBN B-NP
tumor NN I-NP
cell NN I-NP
killing NN I-NP
. . O

The DT B-NP
effects NNS I-NP
of IN B-PP
G-CSF NN B-NP
are VBP B-VP
mediated VBN I-VP
by IN B-PP
binding VBG B-NP
to TO B-PP
specific JJ O
COMMA COMMA O
high JJ B-NP
affinity NN I-NP
receptors NNS B-NP
. . O

G-CSF NN B-NP
receptors NNS I-NP
lack VBP B-VP
intrinsic JJ B-NP
tyrosine NN I-NP
kinase NN I-NP
activity NN I-NP
COMMA COMMA O
but CC O
activation NN B-NP
of IN B-PP
the DT B-NP
receptor NN I-NP
results VBZ B-VP
in IN B-PP
the DT B-NP
rapid JJ I-NP
induction NN I-NP
of IN B-PP
tyrosine NN B-NP
kinase NN I-NP
activity NN I-NP
. . O

Antiphosphotyrosine JJ B-NP
immunoblots NNS I-NP
of IN B-PP
whole JJ B-NP
cell NN I-NP
lysates NNS I-NP
prepared VBN B-VP
from IN B-PP
neutrophils NNS B-NP
show VBP B-VP
that IN B-SBAR
the DT B-NP
G-CSF NN I-NP
rapidly RB B-ADVP
induces VBZ B-VP
prominent JJ B-NP
tyrosine NN I-NP
phosphorylation NN I-NP
of IN B-PP
a DT B-NP
protein NN I-NP
of IN B-PP
a DT B-NP
relative JJ I-NP
molecular JJ I-NP
mass NN I-NP
of IN B-PP
80 CD B-NP
kDa NN I-NP
. . O

Using VBG B-VP
monospecific JJ B-NP
antibodies NNS I-NP
COMMA COMMA O
the DT B-NP
80-kDa JJ I-NP
tyrosine-phosphorylated JJ I-NP
protein NN I-NP
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
p80c-rel NN B-NP
COMMA COMMA O
a DT B-NP
proto-oncogene NN I-NP
belonging VBG B-VP
to TO B-PP
a DT B-NP
family NN I-NP
of IN B-PP
transcriptional JJ B-NP
regulators NNS I-NP
which WDT B-NP
include VBP B-VP
NF-kB NN B-NP
. . O

The DT B-NP
induction NN I-NP
of IN B-PP
tyrosine NN B-NP
phosphorylation NN I-NP
of IN B-PP
p80c-rel NN B-NP
was VBD B-VP
unique JJ B-ADJP
to TO B-PP
G-CSF NN B-NP
in IN B-SBAR
that IN I-SBAR
granulocyte-macrophage JJ B-NP
colony NN I-NP
stimulating NN I-NP
factor NN I-NP
which WDT B-NP
also RB B-ADVP
stimulates VBZ B-VP
neutrophils NNS B-NP
and CC O
induces VBZ B-VP
tyrosine NN B-NP
phosphorylation NN I-NP
does VBZ B-VP
not RB I-VP
result VB I-VP
in IN B-PP
tyrosine NN B-NP
phosphorylation NN I-NP
of IN B-PP
p80c-rel NN B-NP
. . O

The DT B-NP
consequences NNS I-NP
of IN B-PP
p80c-rel NN B-NP
tyrosine NN I-NP
phosphorylation NN I-NP
are VBP B-VP
not RB I-VP
yet RB I-VP
known VBN I-VP
; : O
however RB B-ADVP
COMMA COMMA O
tyrosine-phosphorylated JJ B-NP
p80c-rel NN I-NP
is VBZ B-VP
capable JJ B-ADJP
of IN B-PP
binding VBG B-VP
to TO B-PP
DNA NN B-NP
COMMA COMMA O
and CC O
G-CSF NN B-NP
stimulation NN I-NP
results VBZ B-VP
in IN B-PP
an DT B-NP
increase NN I-NP
in IN B-PP
the DT B-NP
amount NN I-NP
of IN B-PP
p80c-rel NN B-NP
which WDT B-NP
binds VBZ B-VP
to TO B-PP
DNA NN B-NP
. . O

These DT B-NP
results NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
one CD B-NP
of IN B-PP
the DT B-NP
first JJ I-NP
biochemical JJ I-NP
events NNS I-NP
which WDT B-NP
occurs VBZ B-VP
in IN B-PP
neutrophils NNS B-NP
following VBG B-PP
G-CSF NN B-NP
stimulation NN I-NP
COMMA COMMA O
activation NN B-NP
of IN B-PP
a DT B-NP
tyrosine NN I-NP
kinase NN I-NP
COMMA COMMA O
leads VBZ B-VP
directly RB B-ADVP
to TO B-PP
the DT B-NP
tyrosine NN I-NP
phosphorylation NN I-NP
of IN B-PP
p80c-rel NN B-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
the DT B-NP
tyrosine NN I-NP
kinase NN I-NP
activated VBN B-VP
by IN B-PP
G-CSF NN B-NP
appears VBZ B-VP
to TO I-VP
directly RB I-VP
transduce VB I-VP
a DT B-NP
signal NN I-NP
to TO B-PP
a DT B-NP
protein NN I-NP
which WDT B-NP
functions VBZ B-VP
as IN B-PP
a DT B-NP
transcriptional JJ I-NP
regulator NN I-NP
. . O

Autoregulation NN B-NP
of IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
transactivator NN I-NP
RelA NN B-NP
( ( O
p65 NN B-NP
) ) O
by IN B-PP
multiple JJ B-NP
cytoplasmic JJ I-NP
inhibitors NNS I-NP
containing VBG B-VP
ankyrin NN B-NP
motifs NNS I-NP
. . O

RelA NN B-NP
( ( O
p65 NN B-NP
) ) O
functions VBZ B-VP
as IN B-PP
the DT B-NP
critical JJ I-NP
transactivating VBG I-NP
component NN I-NP
of IN B-PP
the DT B-NP
heterodimeric JJ I-NP
p50-p65 NN I-NP
NF-kappa NN I-NP
B NN I-NP
complex NN I-NP
and CC O
contains VBZ B-VP
a DT B-NP
high-affinity JJ I-NP
binding VBG I-NP
site NN I-NP
for IN B-PP
its PRP$ B-NP
cytoplasmic JJ I-NP
inhibitor NN I-NP
COMMA COMMA O
I NN B-NP
kappa NN I-NP
B NN I-NP
alpha NN I-NP
. . O

After IN B-PP
cellular JJ B-NP
activation NN I-NP
COMMA COMMA O
I NN B-NP
kappa NN I-NP
B NN I-NP
alpha NN I-NP
is VBZ B-VP
rapidly RB I-VP
degraded VBN I-VP
in IN B-PP
concert NN I-PP
with IN I-PP
the DT B-NP
induced VBN I-NP
nuclear JJ I-NP
translocation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
. . O

The DT B-NP
present JJ I-NP
study NN I-NP
demonstrates VBZ B-VP
that IN B-SBAR
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha-induced JJ I-NP
degradation NN I-NP
of IN B-PP
I NN B-NP
kappa NN I-NP
B NN I-NP
alpha NN I-NP
in IN B-PP
human JJ B-NP
T NN I-NP
cells NNS I-NP
is VBZ B-VP
preceded VBN I-VP
by IN B-PP
its PRP$ B-NP
rapid JJ I-NP
phosphorylation NN I-NP
in FW B-ADVP
vivo FW I-ADVP
. . O

However RB B-ADVP
COMMA COMMA O
these DT B-NP
effects NNS I-NP
on IN B-PP
I NN B-NP
kappa NN I-NP
B NN I-NP
alpha NN I-NP
result VBP B-VP
in IN B-PP
nuclear JJ B-NP
mobilization NN I-NP
of IN B-PP
only RB B-NP
a DT I-NP
fraction NN I-NP
of IN B-PP
the DT B-NP
entire JJ I-NP
cytoplasmic JJ I-NP
pool NN I-NP
of IN B-PP
RelA NN B-NP
. . O

Subsequent JJ B-NP
studies NNS I-NP
have VBP B-VP
revealed VBN I-VP
that IN B-SBAR
( ( B-LST
i LS I-LST
) ) O
cytoplasmic JJ B-NP
RelA NN I-NP
is VBZ B-VP
stably RB I-VP
associated VBN I-VP
not RB B-CONJP
only RB I-CONJP
with IN B-PP
I NN B-NP
kappa NN I-NP
B NN I-NP
alpha NN I-NP
but CC B-CONJP
also RB I-CONJP
with IN B-PP
other JJ B-NP
ankyrin NN I-NP
motif-rich JJ I-NP
proteins NNS I-NP
including VBG B-PP
the DT B-NP
products NNS I-NP
of IN B-PP
the DT O
NF-kappa NN B-NP
B2 NN I-NP
( ( O
p100 NN B-NP
) ) O
and CC O
NF-kappa NN B-NP
B1 NN I-NP
( ( O
p105 NN B-NP
) ) O
genes NNS B-NP
; : O
( ( B-LST
ii LS I-LST
) ) O
in IN B-PP
contrast NN I-PP
to TO I-PP
RelA-I NN B-NP
kappa NN I-NP
B NN I-NP
alpha NN I-NP
COMMA COMMA O
RelA-p100 NN B-NP
cytoplasmic JJ I-NP
complexes NNS I-NP
are VBP B-VP
not RB I-VP
dissociated VBN I-VP
following VBG B-PP
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
activation NN I-NP
; : O
( ( B-LST
iii LS I-LST
) ) O
p100 NN B-NP
functions VBZ B-VP
as IN B-PP
a DT B-NP
potent JJ I-NP
inhibitor NN I-NP
of IN B-PP
RelA-mediated JJ B-NP
transcription NN I-NP
in FW B-ADVP
vivo FW I-ADVP
; : O
( ( B-LST
iv LS I-LST
) ) O
the DT B-NP
interaction NN I-NP
of IN B-PP
RelA NN B-NP
and CC O
p100 NN B-NP
involves VBZ B-VP
the DT B-NP
conserved VBN I-NP
Rel NN I-NP
homology NN I-NP
domain NN I-NP
of IN B-PP
both DT B-NP
proteins NNS I-NP
but CC B-CONJP
not RB I-CONJP
the DT B-NP
nuclear JJ I-NP
localization NN I-NP
signal NN I-NP
of IN B-PP
RelA NN B-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
I NN B-NP
kappa NN I-NP
B NN I-NP
alpha NN I-NP
binding NN I-NP
; : O
( ( B-LST
v LS I-LST
) ) O
p100 NN B-NP
inhibition NN I-NP
of IN B-PP
RelA NN B-NP
function NN I-NP
requires VBZ B-VP
the DT B-NP
C-terminal JJ I-NP
ankyrin NN I-NP
motif NN I-NP
domain NN I-NP
COMMA COMMA O
which WDT B-NP
mediates VBZ B-VP
cytoplasmic JJ B-NP
retention NN I-NP
of IN B-PP
RelA NN B-NP
; : O
and CC O
( ( B-LST
vi LS I-LST
) ) O
as IN B-SBAR
observed VBN B-VP
with IN B-PP
I PRP B-NP
kappa NN I-NP
B NN I-NP
alpha NN I-NP
COMMA COMMA O
nuclear JJ B-NP
RelA NN I-NP
stimulates VBZ B-VP
p100 NN O
mRNA NN B-NP
and CC O
protein NN B-NP
expression NN B-NP
. . O

These DT B-NP
findings NNS I-NP
thus RB B-ADVP
reveal VBP B-VP
the DT B-NP
presence NN I-NP
of IN B-PP
a DT B-NP
second JJ I-NP
inducible JJ I-NP
autoregulated JJ I-NP
inhibitory JJ I-NP
pathway NN I-NP
that WDT B-NP
helps VBZ B-VP
ensure VB I-VP
the DT B-NP
rapid JJ I-NP
but CC I-NP
transient JJ I-NP
action NN I-NP
of IN B-PP
nuclear JJ B-NP
NF-kappa NN I-NP
B NN I-NP
. . O

Calcineurin NN B-NP
acts VBZ B-VP
in IN B-PP
synergy NN B-NP
with IN B-PP
PMA NN B-NP
to TO B-VP
inactivate VB I-VP
I NN B-NP
kappa NN I-NP
B\/MAD3 NN I-NP
COMMA COMMA O
an DT B-NP
inhibitor NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
. . O

The DT O
interleukin-2 NN B-NP
( ( O
IL-2 NN B-NP
) ) O
promoter NN B-NP
consists VBZ B-VP
of IN B-PP
several JJ O
independent JJ O
T NN B-NP
cell NN I-NP
receptor NN I-NP
( ( O
TcR NN B-NP
) ) O
responsive JJ B-NP
elements NNS I-NP
. . O

The DT B-NP
induction NN I-NP
of IN B-PP
promoters NNS B-NP
dependent JJ B-ADJP
on IN B-PP
these DT B-NP
elements NNS I-NP
is VBZ B-VP
inhibitable JJ B-ADJP
by IN B-PP
the DT B-NP
immunosuppressants NNS I-NP
cyclosporin NN B-NP
A NN I-NP
( ( O
CsA NN B-NP
) ) O
and CC O
tacrolimus NN B-NP
( ( O
FK-506 NN B-NP
) ) O
. . O

Calcineurin NN B-NP
COMMA COMMA O
a DT B-NP
Ca2+\/calmodulin-dependent JJ I-NP
protein NN I-NP
phosphatase NN I-NP
COMMA COMMA O
is VBZ B-VP
the DT B-NP
FK-506- NN I-NP
and CC I-NP
CsA-sensitive JJ I-NP
enzyme NN I-NP
required VBN B-VP
for IN B-PP
TcR NN B-NP
mediated JJ I-NP
activation NN I-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
. . O

We PRP B-NP
report VBP B-VP
that IN B-SBAR
a DT B-NP
constitutively RB I-NP
active JJ I-NP
form NN I-NP
of IN B-PP
calcineurin NN B-NP
partially RB B-VP
substitutes VBZ I-VP
for IN B-PP
the DT B-NP
Ca2+ NN I-NP
co-stimulus NN I-NP
required VBN B-VP
to TO B-VP
activate VB I-VP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
elements NNS I-NP
IL-2A NN B-NP
( ( O
which WDT B-NP
binds VBZ B-VP
the DT B-NP
factors NNS I-NP
OAP NN B-NP
and CC O
Oct-1 NN B-NP
) ) O
and CC O
IL-2E NN B-NP
( ( O
which WDT B-NP
binds VBZ B-VP
NF-AT NN B-NP
) ) O
COMMA COMMA O
and CC O
completely RB B-VP
substitutes VBZ I-VP
for IN B-PP
the DT B-NP
Ca2+ NN I-NP
co-stimulus NN I-NP
required VBN B-VP
to TO B-VP
stimulate VB I-VP
an DT B-NP
NF-kappa NN I-NP
B-dependent JJ I-NP
element NN I-NP
. . O

Calcineurin NN B-NP
stimulates VBZ B-VP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
element NN I-NP
by IN B-PP
enhancing VBG B-VP
inactivation NN B-NP
of IN B-PP
I NN B-NP
kappa NN I-NP
B\/MAD3 NN I-NP
COMMA COMMA O
an DT B-NP
inhibitor NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
thereby RB B-VP
increasing VBG I-VP
the DT B-NP
amount NN I-NP
of IN B-PP
nuclear JJ B-NP
NF-kappa NN I-NP
B NN I-NP
DNA NN I-NP
binding NN I-NP
activity NN I-NP
. . O

These DT B-NP
data NNS I-NP
provide VBP B-VP
the DT B-NP
first JJ I-NP
demonstration NN I-NP
in FW B-ADVP
vivo FW I-ADVP
that IN B-SBAR
activation NN B-NP
of IN B-PP
a DT B-NP
protein NN I-NP
phosphatase NN I-NP
can MD B-VP
inactivate VB I-VP
I NN B-NP
kappa NN I-NP
B NN I-NP
COMMA COMMA O
and CC O
suggest VBP B-VP
one CD B-NP
possible JJ I-NP
explanation NN I-NP
for IN B-PP
mechanism-based JJ B-NP
toxicities NNS I-NP
associated VBN B-VP
with IN B-PP
FK-506 NN B-NP
and CC O
CsA NN B-NP
by IN B-PP
demonstrating VBG B-VP
that IN B-SBAR
these DT B-NP
drugs NNS I-NP
can MD B-VP
inhibit VB I-VP
the DT B-NP
calcineurin-dependent JJ I-NP
activation NN I-NP
of IN B-PP
a DT B-NP
virtually RB I-NP
ubiquitous JJ I-NP
transcription NN I-NP
factor NN I-NP
. . O

Direct JJ B-NP
exposure NN I-NP
to TO B-PP
2COMMA3COMMA7COMMA8-tetrachlorodibenzo-p-dioxin NN B-NP
( ( O
TCDD NN B-NP
) ) O
increases VBZ B-VP
infectivity NN B-NP
of IN B-PP
human JJ B-NP
erythrocytes NNS I-NP
to TO B-PP
a DT B-NP
malarial JJ I-NP
parasite NN I-NP
. . O

Direct JJ B-NP
exposure NN I-NP
to TO B-PP
10 CD B-NP
nM NN I-NP
2COMMA3COMMA7COMMA8-TCDD NN I-NP
caused VBD B-VP
a DT B-NP
75 CD I-NP
% NN I-NP
increase NN I-NP
and CC O
a DT B-NP
2-fold JJ I-NP
increase NN I-NP
in IN B-PP
the DT B-NP
infectivity NN I-NP
of IN B-PP
isolated VBN B-NP
human JJ I-NP
erythrocytes NNS I-NP
to TO B-PP
P. FW B-NP
falciparum FW I-NP
after IN B-PP
48 CD B-NP
hours NNS I-NP
when WRB B-ADVP
the DT B-NP
parasites NNS I-NP
were VBD B-VP
in IN B-PP
an DT B-NP
unsynchronized JJ I-NP
or CC I-NP
synchronized JJ I-NP
state NN I-NP
of IN B-PP
growth NN B-NP
COMMA COMMA O
respectively RB B-ADVP
. . O

Treatment NN B-NP
of IN B-PP
human JJ B-NP
erythrocytes NNS I-NP
with IN B-PP
10 CD B-NP
microM NN I-NP
sodium NN B-NP
orthovanadate NN I-NP
( ( O
NaOV NN B-NP
) ) O
COMMA COMMA O
an DT B-NP
inhibitor NN I-NP
of IN B-PP
plasma NN B-NP
membrane NN I-NP
Ca-ATPase NN I-NP
and CC O
phosphotyrosine NN B-NP
phosphatase NN I-NP
COMMA COMMA O
decreased VBD B-VP
parasitemia NN B-NP
by IN B-PP
30 CD B-NP
% NN I-NP
. . O

Co-treatment NN B-NP
of IN B-PP
RBCs NNS B-NP
with IN B-PP
TCDD NN B-NP
and CC O
NaOV NN B-NP
completely RB B-ADVP
blocked VBD B-VP
the DT B-NP
TCDD-induced JJ I-NP
increase NN I-NP
in IN B-PP
parasitemia NN B-NP
. . O

Because IN B-SBAR
erythrocytes NNS B-NP
are VBP B-VP
anucleated JJ I-VP
COMMA COMMA O
these DT B-NP
results NNS I-NP
are VBP B-VP
discussed VBN I-VP
as IN B-PP
evidence NN B-NP
for IN B-PP
biochemical JJ B-NP
changes NNS I-NP
by IN B-PP
TCDD NN B-NP
without IN B-PP
requiring VBG B-VP
the DT B-NP
activation NN I-NP
of IN B-PP
gene NN B-NP
products NNS I-NP
. . O

Comparative JJ B-NP
mapping NN I-NP
of IN B-PP
SRY NN B-NP
in IN B-PP
the DT B-NP
great JJ I-NP
apes NNS I-NP
. . O

Cytogenetic JJ B-NP
studies NNS I-NP
of IN B-PP
the DT B-NP
primate JJ I-NP
Y NN I-NP
chromosomes NNS I-NP
have VBP B-VP
suggested VBN I-VP
that IN B-SBAR
extensive JJ B-NP
rearrangements NNS I-NP
have VBP B-VP
occurred VBN I-VP
during IN B-PP
evolution NN B-NP
of IN B-PP
the DT B-NP
great JJ I-NP
apes NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
used VBN I-VP
in FW B-NP
situ FW I-NP
hybridization NN I-NP
to TO B-VP
define VB I-VP
these DT B-NP
rearrangements NNS I-NP
at IN B-PP
the DT B-NP
molecular JJ I-NP
level NN I-NP
. . O

pHU-14 NN B-NP
COMMA COMMA O
a DT B-NP
probe NN I-NP
including VBG B-PP
sequences NNS B-NP
from IN B-PP
the DT B-NP
sex NN I-NP
determining JJ I-NP
gene NN I-NP
SRY NN I-NP
COMMA COMMA O
hybridizes VBZ B-VP
close RB B-ADVP
to TO B-PP
the DT B-NP
early JJ I-NP
replicating VBG I-NP
pseudoautosomal JJ I-NP
segment NN I-NP
in IN B-PP
a DT B-NP
telomeric JJ I-NP
or CC I-NP
subtelomeric JJ I-NP
position NN I-NP
of IN B-PP
the DT B-NP
Y NN I-NP
chromosomes NNS I-NP
of IN B-PP
all DT B-NP
great JJ I-NP
apes NNS I-NP
. . O

The DT B-NP
low JJ I-NP
copy NN I-NP
repeat NN I-NP
detected VBN B-VP
by IN B-PP
the DT B-NP
probe NN I-NP
Fr35-II NN I-NP
is VBZ B-VP
obviously RB I-VP
included VBN I-VP
in IN B-PP
Y NN B-NP
chromosomal NN I-NP
rearrangements NNS I-NP
during IN B-PP
hominid NN B-NP
evolution NN I-NP
. . O

These DT B-NP
results NNS I-NP
COMMA COMMA O
combined VBN B-VP
with IN B-PP
previous JJ B-NP
studies NNS I-NP
COMMA COMMA O
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
Y NN I-NP
chromosome NN I-NP
in IN B-PP
great JJ B-NP
apes NNS I-NP
has VBZ B-VP
a DT B-NP
conserved VBN I-NP
region NN I-NP
including VBG B-PP
the DT B-NP
pseudoautosomal JJ I-NP
region NN I-NP
and CC O
the DT B-NP
testis-determining JJ I-NP
region NN I-NP
. . O

The DT B-NP
rest NN I-NP
of IN B-PP
the DT B-NP
Y NN I-NP
chromosome NN I-NP
has VBZ B-VP
undergone VBN I-VP
several JJ B-NP
rearrangements NNS I-NP
in IN B-PP
the DT B-NP
different JJ I-NP
great JJ I-NP
apes NNS I-NP
. . O

Detection NN B-NP
of IN B-PP
minimal JJ B-NP
residual JJ I-NP
disease NN I-NP
in IN B-PP
a DT B-NP
patient NN I-NP
with IN B-PP
acute JJ B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
by IN B-PP
RT-PCR NN B-NP
: : O
necessity NN B-NP
of IN B-PP
chemotherapy NN B-NP
following VBG B-PP
ATRA NN B-NP
therapy NN I-NP
. . O

We PRP B-NP
examined VBD B-VP
bone NN B-NP
marrow NN I-NP
cells NNS I-NP
by IN B-PP
reverse JJ B-NP
transcriptase-polymerase NN I-NP
chain NN I-NP
reaction NN I-NP
( ( O
RT-PCR NN B-NP
) ) O
to TO B-VP
detect VB I-VP
residual JJ B-NP
PML\/RAR NN I-NP
alpha NN I-NP
mRNA-containing JJ I-NP
cells NNS I-NP
following VBG B-PP
treatment NN B-NP
with IN B-PP
all-trans JJ B-NP
retinoic JJ I-NP
acid NN I-NP
( ( O
ATRA NN B-NP
) ) O
and CC O
cytotoxic JJ B-NP
chemotherapy NN I-NP
in IN B-PP
a DT B-NP
patient NN I-NP
with IN B-PP
APL NN B-NP
. . O

This DT B-NP
RT-PCR NN I-NP
assay NN I-NP
can MD B-VP
detect VB I-VP
one CD B-NP
leukemic JJ I-NP
cell NN I-NP
in IN B-PP
10(2) CD B-NP
normal JJ I-NP
cells NNS I-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
PML\/RAR NN B-NP
alpha NN I-NP
mRNA NN I-NP
was VBD B-VP
still RB B-ADVP
detectable JJ B-ADJP
despite IN B-PP
clinical JJ B-NP
remission NN I-NP
following VBG B-PP
ATRA NN B-NP
treatment NN I-NP
COMMA COMMA O
but CC O
undetectable JJ B-ADJP
following VBG B-PP
consolidation NN B-NP
with IN B-PP
chemotherapy NN B-NP
. . O

These DT B-NP
data NNS I-NP
show VBP B-VP
that IN B-SBAR
this DT B-NP
technique NN I-NP
is VBZ B-VP
useful JJ B-ADJP
for IN B-PP
the DT B-NP
identification NN I-NP
of IN B-PP
minimal JJ B-NP
residual JJ I-NP
disease NN I-NP
in NN O
patients NNS B-NP
with IN B-PP
APL NN B-NP
and CC O
that IN B-SBAR
cytotoxic JJ B-NP
chemotherapy NN I-NP
following VBG B-PP
ATRA NN B-NP
therapy NN I-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
the DT B-NP
elimination NN I-NP
of IN B-PP
APL NN B-NP
cells NNS I-NP
. . O

Genes NNS B-NP
encoding VBG B-VP
general JJ B-NP
initiation NN I-NP
factors NNS I-NP
for IN B-PP
RNA NN B-NP
polymerase NN I-NP
II CD I-NP
transcription NN I-NP
are VBP B-VP
dispersed VBN I-VP
in IN B-PP
the DT B-NP
human JJ I-NP
genome NN I-NP
. . O

General JJ B-NP
transcription NN I-NP
factors NNS I-NP
are VBP B-VP
required VBN I-VP
for IN B-PP
accurate JJ B-NP
initiation NN I-NP
of IN B-PP
transcription NN B-NP
by IN B-PP
RNA NN B-NP
polymerase NN I-NP
II CD I-NP
. . O

Human JJ B-NP
cDNAs NNS I-NP
encoding VBG B-VP
subunits NNS B-NP
of IN B-PP
these DT B-NP
factors NNS I-NP
have VBP B-VP
been VBN I-VP
cloned VBN I-VP
and CC O
sequenced VBN B-VP
. . O

Using VBG B-VP
fluorescence NN B-NP
in FW I-NP
situ FW I-NP
hybridization NN I-NP
( ( O
FISH NN B-NP
) ) O
COMMA COMMA O
we PRP B-NP
show VBP B-VP
here RB B-ADVP
that IN B-SBAR
the DT B-NP
genes NNS I-NP
encoding VBG B-VP
the DT B-NP
TATA-box NN I-NP
binding NN I-NP
protein NN I-NP
( ( O
TBP NN B-NP
) ) O
COMMA COMMA O
TFIIB NN B-NP
COMMA COMMA O
TFIIE NN B-NP
alpha NN I-NP
COMMA COMMA O
TFIIE NN B-NP
beta NN I-NP
COMMA COMMA O
RAP30 NN B-NP
COMMA COMMA O
RAP74 NN B-NP
and CC O
the DT B-NP
62 CD I-NP
kDa NN I-NP
subunit NN I-NP
COMMA COMMA O
of IN B-PP
TFIIH NN B-NP
are VBP B-VP
located JJ B-ADJP
at IN B-PP
the DT B-NP
human JJ I-NP
chromosomal JJ I-NP
bands NNS I-NP
6q26-27 NN B-NP
COMMA COMMA O
1p21-22 NN B-NP
COMMA COMMA O
3q21-24 NN B-NP
COMMA COMMA O
8p12 NN B-NP
COMMA COMMA O
13q14 NN B-NP
COMMA COMMA O
19p13.3 NN B-NP
and CC O
11p14-15.1 NN B-NP
COMMA COMMA O
respectively RB B-ADVP
. . O

This DT B-NP
dispersed JJ I-NP
localization NN I-NP
of IN B-PP
a DT B-NP
group NN I-NP
of IN B-PP
functionally RB B-NP
related JJ I-NP
gene NN I-NP
provides VBZ B-VP
insights NNS B-NP
into IN B-PP
the DT B-NP
molecular JJ I-NP
mechanism NN I-NP
of IN B-PP
human JJ B-NP
genome NN I-NP
evolution NN I-NP
and CC O
their PRP$ B-NP
possible JJ I-NP
involvement NN I-NP
in IN B-PP
human JJ B-NP
diseases NNS I-NP
. . O

Patterns NN B-NP
of IN B-PP
Pan NN B-NP
expression NN I-NP
and CC O
role NN B-NP
of IN B-PP
Pan NN B-NP
proteins NNS I-NP
in IN B-PP
endocrine NN B-NP
cell NN I-NP
type-specific JJ I-NP
complex JJ I-NP
formation NN I-NP
. . O

The DT B-NP
Pan NN I-NP
gene NN I-NP
encodes VBZ B-VP
at IN B-NP
least JJS I-NP
two CD I-NP
distinct JJ I-NP
transcripts NNS I-NP
COMMA COMMA O
Pan-1 NN B-NP
and CC O
Pan-2 NN B-NP
( ( O
also RB B-VP
known VBN I-VP
as IN B-PP
E47 NN B-NP
and CC O
E12 NN B-NP
COMMA COMMA O
respectively RB B-ADVP
) ) O
COMMA COMMA O
by IN B-PP
the DT B-NP
mechanism NN I-NP
of IN B-PP
alternative JJ B-NP
RNA NN I-NP
splicing NN I-NP
. . O

Northern JJ B-NP
blot NN I-NP
analyses NNS I-NP
performed VBN B-VP
on IN B-PP
rat NN B-NP
and CC O
mouse NN B-NP
tissues NNS B-NP
have VBP B-VP
detected VBN I-VP
ubiquitously RB B-NP
expressed VBN I-NP
Pan NN I-NP
transcripts NNS I-NP
COMMA COMMA O
but CC O
the DT B-NP
abundance NN B-NP
COMMA COMMA O
distribution NN B-NP
COMMA COMMA O
and CC O
form NN B-NP
of IN B-PP
Pan NN B-NP
proteins NNS I-NP
have VBP B-VP
not RB I-VP
been VBN I-VP
clearly RB I-VP
defined VBN I-VP
. . O

Studies NNS B-NP
of IN B-PP
cell NN B-NP
lines NNS I-NP
representing VBG B-VP
endocrine NN O
COMMA COMMA O
fibroblast NN B-NP
COMMA COMMA O
and CC O
lymphoid JJ B-ADJP
lineages NNS B-NP
using VBG B-VP
polyclonal JJ B-NP
antisera NNS I-NP
to TO B-VP
detect VB I-VP
E2A NN B-NP
proteins NNS I-NP
have VBP B-VP
suggested VBN I-VP
that IN B-SBAR
significant JJ B-NP
E2A NN I-NP
protein NN I-NP
expression NN I-NP
is VBZ B-VP
restricted JJ I-VP
to TO B-PP
B-lymphocytes NNS B-NP
. . O

We PRP B-NP
have VBP B-VP
developed VBN I-VP
a DT B-NP
monoclonal JJ I-NP
antibody NN I-NP
COMMA COMMA O
Yae NN B-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
specific JJ B-ADJP
for IN B-PP
Pan\/E2A NN B-NP
proteins NNS I-NP
COMMA COMMA O
and CC O
have VBP B-VP
used VBN I-VP
the DT B-NP
Yae NN I-NP
antibody NN I-NP
to TO B-VP
examine VB I-VP
a DT B-NP
variety NN I-NP
of IN B-PP
endocrine JJ B-NP
and CC I-NP
nonendocrine JJ I-NP
cell NN I-NP
lineages NNS I-NP
for IN B-PP
differences NNS B-NP
in IN B-PP
Pan\/E2A NN B-NP
protein NN I-NP
expression NN I-NP
COMMA COMMA O
subcellular JJ B-NP
localization NN I-NP
COMMA COMMA O
and CC O
heteromeric JJ B-NP
complex JJ I-NP
formation NN I-NP
. . O

In IN B-PP
contrast NN I-PP
to TO I-PP
previous JJ B-NP
results NNS I-NP
obtained VBN B-VP
using VBG B-VP
polyclonal JJ B-NP
antiseras NN I-NP
to TO B-VP
detect VB I-VP
Pan\/E2A NN B-NP
proteins NNS I-NP
COMMA COMMA O
we PRP B-NP
report VBP B-VP
comparable JJ B-NP
levels NNS I-NP
of IN B-PP
Pan NN B-NP
proteins NNS I-NP
in IN B-PP
GH\/PRL- NN B-NP
and CC O
insulin-producing JJ B-ADJP
COMMA COMMA O
B- NN B-NP
and CC O
T-lymphocyte NN B-NP
cells NNS B-NP
. . O

IEF-1 NN B-NP
COMMA COMMA O
a DT B-NP
pancreatic JJ I-NP
beta-cell NN I-NP
type-specific JJ I-NP
complex NN I-NP
believed VBN B-VP
to TO I-VP
regulate VB I-VP
insulin NN B-NP
expression NN I-NP
COMMA COMMA O
is VBZ B-VP
demonstrated VBN I-VP
to TO I-VP
consist VB I-VP
of IN B-PP
at IN B-NP
least JJS I-NP
two CD I-NP
distinct JJ I-NP
species NNS I-NP
COMMA COMMA O
one CD B-NP
of IN B-PP
which WDT B-NP
does VBZ B-VP
not RB I-VP
contain VB I-VP
Pan NN B-NP
molecules NNS I-NP
. . O

Although IN B-SBAR
it PRP B-NP
has VBZ B-VP
been VBN I-VP
postulated VBN I-VP
that IN B-SBAR
pituitary JJ B-NP
endocrine JJ I-NP
cells NNS I-NP
and CC O
pancreatic JJ B-NP
endocrine NN I-NP
beta-cells NNS I-NP
share VBP B-VP
identical JJ B-NP
Pan\/E2A NN I-NP
complexes NNS I-NP
COMMA COMMA O
native-Western JJ B-NP
analyses NNS I-NP
of IN B-PP
pituitary JJ B-NP
and CC I-NP
endocrine JJ I-NP
beta-cells NNS I-NP
detect VBP B-VP
Pan NN B-NP
proteins NNS I-NP
in IN B-PP
distinct JJ B-NP
cell NN I-NP
type-specific JJ I-NP
complexes NNS I-NP
. . O

Interferon NN B-NP
alpha NN I-NP
selectively RB B-ADVP
affects VBZ B-VP
expression NN B-NP
of IN B-PP
the DT B-NP
human JJ I-NP
myeloid JJ I-NP
cell NN I-NP
nuclear JJ I-NP
differentiation NN I-NP
antigen NN I-NP
in IN B-PP
late JJ B-NP
stage NN I-NP
cells NNS I-NP
in IN B-PP
the DT B-NP
monocytic JJ I-NP
but CC B-CONJP
not RB I-CONJP
the DT B-NP
granulocytic JJ I-NP
lineage NN B-NP
. . O

The DT B-NP
human JJ I-NP
myeloid JJ B-NP
cell NN I-NP
nuclear JJ I-NP
differentiation NN I-NP
antigen NN I-NP
( ( O
MNDA NN B-NP
) ) O
is VBZ B-VP
expressed VBN I-VP
constitutively RB B-ADVP
in IN B-PP
cells NNS B-NP
of IN B-PP
the DT B-NP
myeloid JJ I-NP
lineage NN I-NP
COMMA COMMA O
appearing VBG B-VP
in IN B-PP
myeloblast JJ B-NP
cells NNS I-NP
in IN B-PP
some DT B-NP
cases NNS I-NP
of IN B-PP
acute JJ B-NP
myeloid JJ I-NP
leukemia NN I-NP
and CC O
consistently RB B-VP
being VBG I-VP
detected VBN I-VP
in IN B-PP
promyelocyte JJ B-NP
stage NN I-NP
cells NNS I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
in IN B-PP
all DT B-NP
later JJR I-NP
stage NN I-NP
cells NNS I-NP
including VBG B-PP
peripheral JJ B-NP
blood NN I-NP
monocytes NNS I-NP
and CC O
granulocytes NNS B-NP
. . O

The DT B-NP
human JJ I-NP
myeloid JJ I-NP
leukemia NN I-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
HL-60 NN B-NP
COMMA COMMA O
U937 NN B-NP
COMMA COMMA O
and CC O
THP-1 NN B-NP
COMMA COMMA O
express VBP B-VP
similar JJ B-NP
levels NNS I-NP
of IN B-PP
immunochemically RB B-NP
detectable JJ I-NP
MNDA NN I-NP
. . O

Although IN B-SBAR
COMMA COMMA O
the DT B-NP
level NN I-NP
of IN B-PP
MNDA NN B-NP
mRNA NN I-NP
in IN B-PP
primary JJ B-NP
monocytes NNS I-NP
is VBZ B-VP
very RB B-ADJP
low JJ I-ADJP
it PRP B-NP
was VBD B-VP
up-regulated VBN I-VP
at IN B-PP
6 CD B-NP
h NN I-NP
following VBG B-PP
the DT B-NP
addition NN I-NP
of IN B-PP
interferon NN B-NP
alpha NN I-NP
. . O

The DT B-NP
effect NN I-NP
of IN B-PP
interferon NN B-NP
alpha NN I-NP
on IN B-PP
the DT B-NP
MNDA NN I-NP
mRNA NN I-NP
is VBZ B-VP
also RB I-VP
observed VBN I-VP
in IN B-PP
the DT B-NP
cell NN I-NP
lines NNS I-NP
HL-60 NN B-NP
COMMA COMMA O
U937 NN B-NP
COMMA COMMA O
and CC O
THP-1 NN B-NP
. . O

The DT B-NP
MNDA NN I-NP
mRNA NN I-NP
level NN I-NP
in IN B-PP
primary JJ B-NP
granulocytes NNS I-NP
was VBD B-VP
unaffected JJ I-VP
by IN B-PP
addition NN B-NP
of IN B-PP
interferon NN B-NP
alpha NN I-NP
and CC O
other JJ B-NP
agents NNS I-NP
including VBG B-PP
interferon NN B-NP
gamma NN I-NP
COMMA COMMA O
endotoxin NN B-NP
COMMA COMMA O
poly(I).poly(C) NN B-NP
COMMA COMMA O
and CC O
FMLP NN B-NP
. . O

The DT B-NP
MNDA NN I-NP
mRNA NN I-NP
level NN I-NP
in IN B-PP
the DT B-NP
myeloid JJ I-NP
cell NN I-NP
lines NNS I-NP
was VBD B-VP
also RB I-VP
unaffected JJ I-VP
by IN B-PP
the DT B-NP
latter JJ I-NP
four CD I-NP
agents NNS I-NP
. . O

Induction NN B-NP
of IN B-PP
differentiation NN B-NP
in IN B-PP
the DT B-NP
myeloid JJ I-NP
cell NN I-NP
lines NNS I-NP
with IN B-PP
phorbol NN B-NP
ester NN I-NP
induces VBZ B-VP
monocyte NN B-NP
differentiation NN I-NP
which WDT B-NP
was VBD B-VP
accompanied VBN I-VP
by IN B-PP
a DT B-NP
decrease NN I-NP
in IN B-PP
MNDA NN B-NP
mRNA NN I-NP
level NN I-NP
. . O

This DT B-NP
reduced JJ I-NP
level NN I-NP
of IN B-PP
mRNA NN B-NP
could MD B-VP
then RB I-VP
be VB I-VP
elevated JJ I-VP
with IN B-PP
subsequent JJ B-NP
interferon NN I-NP
alpha NN I-NP
treatment NN I-NP
. . O

The DT B-NP
effects NNS I-NP
of IN B-PP
phorbol NN B-NP
ester NN I-NP
on IN B-PP
MNDA NN B-NP
mRNA NN I-NP
appeared VBD B-VP
to TO I-VP
be VB I-VP
associated VBN I-VP
with IN B-PP
induced VBN B-NP
differentiation NN I-NP
since IN B-SBAR
inhibiting VBG B-VP
cell NN B-NP
proliferation NN I-NP
did VBD B-VP
not RB I-VP
alter VB I-VP
the DT B-NP
level NN I-NP
of IN B-PP
MNDA NN B-NP
mRNA NN I-NP
and CC O
cell NN B-NP
cycle NN I-NP
variation NN I-NP
in IN B-PP
MNDA NN B-NP
mRNA NN I-NP
levels NNS I-NP
were VBD B-VP
not RB I-VP
observed VBN I-VP
. . O

The DT B-NP
ability NN I-NP
of IN B-PP
interferon NN B-NP
alpha NN I-NP
to TO B-VP
up-regulate VB I-VP
MNDA NN B-NP
mRNA NN I-NP
in IN B-PP
phorbol NN B-NP
ester NN I-NP
treated JJ B-NP
myeloid JJ I-NP
cell NN I-NP
lines NNS I-NP
is VBZ B-VP
consistent JJ B-ADJP
with IN B-PP
the DT B-NP
observations NNS I-NP
made VBN B-VP
in IN B-PP
primary JJ B-NP
monocytes NNS I-NP
. . O

( ( O
ABSTRACT NN B-NP
TRUNCATED VBN B-VP
AT IN B-PP
250 CD B-NP
WORDS NNS I-NP
) ) O

Calcineurin NN B-NP
potentiates VBZ B-VP
activation NN B-NP
of IN B-PP
the DT B-NP
granulocyte-macrophage JJ I-NP
colony-stimulating JJ I-NP
factor NN I-NP
gene NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
: : O
involvement NN B-NP
of IN B-PP
the DT B-NP
conserved VBN I-NP
lymphokine NN I-NP
element NN I-NP
0 CD I-NP
. . O

Granulocyte-macrophage JJ B-NP
colony-stimulating JJ I-NP
factor NN I-NP
( ( O
GM-CSF NN B-NP
) ) O
and CC O
interleukin-2 NN B-NP
( ( O
IL-2 NN B-NP
) ) O
are VBP B-VP
produced VBN I-VP
by IN B-PP
stimulation NN B-NP
with IN B-PP
phorbol-12-myristate NN B-NP
acetate NN I-NP
( ( O
PMA NN B-NP
) ) O
and CC O
calcium NN B-NP
ionophore NN I-NP
( ( O
A23187 NN B-NP
) ) O
in IN B-PP
human JJ B-NP
T NN I-NP
cell NN I-NP
leukemia NN I-NP
Jurkat NN I-NP
cells NNS I-NP
. . O

The DT B-NP
expression NN I-NP
of IN B-PP
GM-CSF NN B-NP
and CC O
IL-2 NN B-NP
is VBZ B-VP
inhibited VBN I-VP
by IN B-PP
immunosuppressive JJ B-NP
drugs NNS I-NP
such JJ B-PP
as IN I-PP
cyclosporin NN B-NP
A NN I-NP
( ( O
CsA NN B-NP
) ) O
and CC O
FK506 NN B-NP
. . O

Earlier JJR B-NP
studies NNS I-NP
on IN B-PP
the DT B-NP
IL-2 NN I-NP
gene NN I-NP
expression NN I-NP
showed VBD B-VP
that IN B-SBAR
overexpression NN B-NP
of IN B-PP
calcineurin NN B-NP
( ( O
CN NN B-NP
) ) O
COMMA COMMA O
a DT B-NP
Ca2+\/calmodulin-dependent JJ I-NP
protein NN I-NP
phosphatase NN I-NP
COMMA COMMA O
can MD B-VP
stimulate VB I-VP
transcription NN B-NP
from IN B-PP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
through IN B-PP
the DT B-NP
NF-AT-binding JJ I-NP
site NN I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
we PRP B-NP
obtained VBD B-VP
evidence NN B-NP
that IN B-SBAR
transfection NN B-NP
of IN B-PP
the DT B-NP
cDNAs NNS I-NP
for IN B-PP
CN NN B-NP
A NN I-NP
( ( O
catalytic JJ B-ADJP
) ) O
and CC O
CN NN B-NP
B NN I-NP
( ( O
regulatory JJ B-ADJP
) ) O
subunits NNS B-NP
also RB B-ADVP
augments VBZ B-VP
transcription NN B-NP
from IN B-PP
the DT B-NP
GM-CSF NN I-NP
promoter NN I-NP
and CC O
recovers VBZ B-VP
the DT B-NP
transcription NN I-NP
inhibited VBN B-VP
by IN B-PP
CsA NN B-NP
. . O

The DT B-NP
constitutively RB I-NP
active JJ I-NP
type NN I-NP
of IN B-PP
the DT B-NP
CN NN I-NP
A NN I-NP
subunit NN I-NP
COMMA COMMA O
which WDT B-NP
lacks VBZ B-VP
the DT B-NP
auto-inhibitory JJ I-NP
and CC I-NP
calmodulin-binding JJ I-NP
domains NNS I-NP
COMMA COMMA O
acts VBZ B-VP
in IN B-PP
synergy NN B-NP
with IN B-PP
PMA NN B-NP
to TO B-VP
activate VB I-VP
transcription NN B-NP
from IN B-PP
the DT B-NP
GM-CSF NN I-NP
promoter NN I-NP
. . O

We PRP B-NP
also RB B-ADVP
found VBD B-VP
that IN B-SBAR
the DT B-NP
active JJ I-NP
CN NN I-NP
partially RB B-ADVP
replaces VBZ B-VP
calcium NN B-NP
ionophore NN I-NP
in IN B-PP
synergy NN B-NP
with IN B-PP
PMA NN B-NP
to TO B-VP
induce VB I-VP
expression NN B-NP
of IN B-PP
endogenous JJ B-NP
GM-CSF NN B-NP
and CC O
IL-2 NN B-NP
. . O

By IN B-PP
multimerizing VBG B-VP
the DT B-NP
regulatory JJ I-NP
elements NNS I-NP
of IN B-PP
the DT B-NP
GM-CSF NN I-NP
promoter NN I-NP
COMMA COMMA O
we PRP B-NP
found VBD B-VP
that IN B-SBAR
one CD B-NP
of IN B-PP
the DT B-NP
target NN I-NP
sites NNS I-NP
for IN B-PP
the DT B-NP
CN NN I-NP
action NN I-NP
is VBZ B-VP
the DT B-NP
conserved VBN I-NP
lymphokine NN I-NP
element NN I-NP
0 CD I-NP
( ( O
CLE0 NN B-NP
) ) O
COMMA COMMA O
located JJ B-ADJP
at IN B-PP
positions NNS B-NP
between IN B-PP
-54 CD B-NP
and CC O
-40 CD B-NP
. . O

Mobility NN B-NP
shift NN I-NP
assays NNS I-NP
showed VBD B-VP
that IN B-SBAR
the DT B-NP
CLE0 NN I-NP
sequence NN I-NP
has VBZ B-VP
an DT B-NP
AP1-binding JJ I-NP
site NN I-NP
and CC O
is VBZ B-VP
associated VBN I-VP
with IN B-PP
an DT B-NP
NF-AT-like JJ I-NP
factor NN I-NP
COMMA COMMA O
termed VBN B-VP
NF-CLE0 NN B-NP
gamma NN I-NP
. . O

NF-CLE0 NN B-NP
gamma NN I-NP
binding NN I-NP
is VBZ B-VP
induced VBN I-VP
by IN B-PP
PMA\/A23187 NN B-NP
and CC O
is VBZ B-VP
inhibited VBN I-VP
by IN B-PP
treatment NN B-NP
with IN B-PP
CsA NN B-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
CN NN B-NP
is VBZ B-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
coordinated VBN I-NP
induction NN I-NP
of IN B-PP
the DT O
GM-CSF NN B-NP
and CC O
IL-2 NN B-NP
genes NNS B-NP
and CC O
that IN B-SBAR
the DT B-NP
CLE0 NN I-NP
sequence NN I-NP
of IN B-PP
the DT B-NP
GM-CSF NN I-NP
gene NN I-NP
is VBZ B-VP
a DT B-NP
functional JJ I-NP
analogue NN I-NP
of IN B-PP
the DT B-NP
NF-AT-binding JJ I-NP
site NN I-NP
in IN B-PP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
COMMA COMMA O
which WDT B-NP
mediates VBZ B-VP
signals NNS B-NP
downstream RB B-ADJP
of IN B-PP
T NN B-NP
cell NN I-NP
activation NN I-NP
. . O

Novel JJ B-NP
aldosterone NN I-NP
receptors NNS I-NP
: : O
specificity-conferring JJ B-NP
mechanism NN I-NP
at IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
the DT B-NP
cell NN I-NP
membrane NN I-NP
. . O

Functional JJ B-NP
studies NNS I-NP
in IN B-PP
extra-renal JJ B-NP
COMMA COMMA I-NP
nonepithelial JJ I-NP
cells NNS I-NP
such JJ B-PP
as IN I-PP
smooth JJ B-NP
muscle NN I-NP
cells NNS I-NP
and CC O
more RBR B-ADVP
recently RB I-ADVP
circulating VBG B-NP
human JJ I-NP
lymphocytes NNS I-NP
have VBP B-VP
provided VBN I-VP
increasing VBG B-NP
evidence NN I-NP
that IN B-SBAR
aldosterone NN B-NP
produces VBZ B-VP
not RB B-CONJP
only RB I-CONJP
classical JJ B-NP
genomic JJ I-NP
effects NNS I-NP
COMMA COMMA O
but CC B-CONJP
also RB I-CONJP
rapid JJ B-NP
non-genomic JJ I-NP
effects NNS I-NP
on IN B-PP
transmembrane NN B-NP
electrolyte NN I-NP
movements NNS I-NP
. . O

These DT B-NP
involve VBP B-VP
activation NN B-NP
of IN B-PP
the DT B-NP
sodium\/proton-exchanger NN I-NP
of IN B-PP
the DT B-NP
cell NN I-NP
membrane NN I-NP
at IN B-PP
very RB B-NP
low JJ I-NP
COMMA COMMA I-NP
physiological JJ I-NP
concentrations NNS I-NP
of IN B-PP
aldosterone NN B-NP
with IN B-PP
an DT B-NP
acute JJ I-NP
onset NN I-NP
within IN B-PP
1-2 CD B-NP
minutes NNS I-NP
. . O

A DT B-NP
second JJ I-NP
messenger NN I-NP
cascade NN I-NP
involved VBN B-VP
is VBZ B-VP
the DT B-NP
inositol-1COMMA4COMMA5-trisphosphate\/calcium NN I-NP
pathway NN I-NP
which WDT B-NP
responds VBZ B-VP
over IN B-PP
the DT B-NP
same JJ I-NP
rapid JJ I-NP
time NN I-NP
course NN I-NP
. . O

Such JJ B-NP
changes NNS I-NP
clearly RB B-ADVP
can MD B-VP
not RB I-VP
be VB I-VP
explained VBN I-VP
by IN B-PP
genomic JJ B-NP
mechanisms NNS I-NP
COMMA COMMA O
which WDT B-NP
are VBP B-VP
responsible JJ B-ADJP
for IN B-PP
later JJ B-NP
effects NNS I-NP
than IN B-PP
the DT B-NP
membrane-related JJ I-NP
rapid JJ I-NP
responses NNS I-NP
. . O

In IN B-PP
addition NN I-PP
to TO I-PP
its PRP$ B-NP
rapid JJ I-NP
time NN I-NP
course NN I-NP
the DT B-NP
unique JJ I-NP
characteristics NNS I-NP
of IN B-PP
this DT B-NP
new JJ I-NP
pathway NN I-NP
for IN B-PP
steroid NN B-NP
action NN I-NP
include VBP B-VP
a DT B-NP
10000-fold JJ I-NP
selectivity NN I-NP
for IN B-PP
aldosterone NN B-NP
over IN B-PP
cortisol NN B-NP
and CC O
the DT B-NP
ineffectiveness NN I-NP
of IN B-PP
spironolactones NNS B-NP
COMMA COMMA O
classical JJ B-NP
mineralocorticoid NN I-NP
antagonists NNS I-NP
COMMA COMMA O
as IN B-PP
antagonists NNS B-NP
of IN B-PP
the DT B-NP
response NN I-NP
. . O

Subsequently RB B-NP
binding VBG I-NP
sites NNS I-NP
have VBP B-VP
been VBN I-VP
demonstrated VBN I-VP
in IN B-PP
the DT B-NP
plasma NN I-NP
membrane NN I-NP
of IN B-PP
human JJ B-NP
lymphocytes NNS I-NP
which WDT B-NP
show VBP B-VP
pharmacological JJ B-NP
( ( O
aldosterone NN B-NP
specificity NN I-NP
) ) O
and CC O
kinetic JJ B-NP
( ( O
high JJ B-NP
turnover NN I-NP
) ) O
properties NNS B-NP
identical JJ B-ADJP
with IN B-PP
those DT B-NP
of IN B-PP
the DT B-NP
rapid JJ I-NP
aldosterone NN I-NP
effects NNS I-NP
in IN B-PP
the DT B-NP
same JJ I-NP
cells NNS I-NP
. . O

SDS-PAGE NN B-NP
analysis NN I-NP
of IN B-PP
the DT B-NP
receptor NN I-NP
protein NN I-NP
has VBZ B-VP
shown VBN I-VP
a DT B-NP
molecular JJ I-NP
weight NN I-NP
of IN B-PP
approximately RB B-NP
50 CD I-NP
kD NN I-NP
. . O

The DT B-NP
present JJ I-NP
paper NN I-NP
reviews VBZ B-VP
the DT B-NP
data NNS I-NP
supporting VBG B-VP
a DT B-NP
new JJ I-NP
COMMA COMMA I-NP
two-step JJ I-NP
model NN I-NP
for IN B-PP
non-genomic JJ B-NP
and CC I-NP
genomic JJ I-NP
aldosterone NN I-NP
effects NNS I-NP
. . O

It PRP B-NP
also RB B-ADVP
suggests VBZ B-VP
a DT B-NP
novel JJ I-NP
specificity-conferring JJ I-NP
mechanism NN I-NP
for IN B-PP
mineralocorticoid NN B-NP
action NN I-NP
at IN B-PP
the DT B-NP
membrane NN I-NP
level NN I-NP
. . O

Glucocorticoid-mediated JJ B-NP
inhibition NN I-NP
of IN B-PP
interleukin-2 NN O
receptor NN O
alpha NN B-NP
and CC O
-beta NN B-NP
subunit NN B-NP
expression NN I-NP
by IN B-PP
human JJ B-NP
T NN I-NP
cells NNS I-NP
. . O

To TO B-VP
determine VB I-VP
the DT B-NP
mechanism NN I-NP
of IN B-PP
glucocorticoid NN B-NP
( ( I-NP
GC NN I-NP
) ) I-NP
-mediated JJ I-NP
inhibition NN I-NP
of IN B-PP
T NN B-NP
cell NN I-NP
functions NNS I-NP
COMMA COMMA O
the DT B-NP
effect NN I-NP
of IN B-PP
dexamethasone NN B-NP
( ( O
DM NN B-NP
) ) O
on IN B-PP
T NN B-NP
cell NN I-NP
proliferation NN I-NP
and CC O
interleukin-2 NN B-NP
receptor NN I-NP
( ( O
IL-2R NN B-NP
) ) O
generation NN B-NP
were VBD B-VP
studied VBN I-VP
. . O

Dexamethasone NN B-NP
inhibited VBD B-VP
IL-2-induced JJ B-NP
T NN I-NP
cell NN I-NP
proliferation NN I-NP
by IN B-PP
30 CD B-NP
% NN I-NP
- TO I-NP
88 CD I-NP
% NN I-NP
COMMA COMMA O
relative JJ B-PP
to TO I-PP
its PRP$ B-NP
concentration NN I-NP
within IN B-PP
the DT B-NP
cultures NNS I-NP
. . O

The DT B-NP
effect NN I-NP
of IN B-PP
DM NN B-NP
on IN B-PP
expression NN B-NP
of IN B-PP
IL-2R NN B-NP
alpha NN I-NP
( ( O
Tac NN B-NP
COMMA COMMA O
p55 NN B-NP
COMMA COMMA O
CD25 NN B-NP
) ) O
and CC O
beta NN B-NP
( ( O
p75 NN B-NP
) ) O
genes NNS B-NP
in IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
was VBD B-VP
examined VBN I-VP
next RB B-ADVP
. . O

In IN B-PP
T NN B-NP
cells NNS I-NP
stimulated VBN B-VP
with IN B-PP
purified VBN B-NP
phytohemagglutinin NN I-NP
( ( O
PHA-p NN B-NP
) ) O
and CC O
4 CD B-NP
beta-phorbol NN I-NP
12-myristate NN I-NP
13-acetate NN I-NP
( ( O
PMA NN B-NP
) ) O
addition NN B-NP
of IN B-PP
DM NN B-NP
to TO B-PP
the DT B-NP
cultures NNS I-NP
resulted VBD B-VP
in IN B-PP
a DT B-NP
60 CD I-NP
% NN I-NP
reduction NN I-NP
in IN B-PP
IL-2R NN B-NP
alpha NN I-NP
and CC O
a DT B-NP
30 CD I-NP
% NN I-NP
reduction NN I-NP
in IN B-PP
IL-2R NN B-NP
beta NN I-NP
membrane NN I-NP
expression NN I-NP
compared VBN B-VP
to TO B-PP
T NN B-NP
cells NNS I-NP
cultured VBN B-VP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
DM NN B-NP
( ( O
p NN B-NP
&lt; JJR B-NP
0.01 CD I-NP
) ) O
. . O

Inhibition NN B-NP
of IN B-PP
membrane NN O
IL-2R NN B-NP
alpha NN I-NP
and CC O
IL-2R NN B-NP
beta NN I-NP
expression NN B-NP
by IN B-PP
10(-6) CD B-NP
M NN I-NP
DM NN I-NP
was VBD B-VP
partially RB B-ADJP
reversible JJ I-ADJP
by IN B-PP
recombinant JJ B-NP
human JJ I-NP
IL-2 NN I-NP
( ( O
rhIL-2 NN B-NP
) ) O
. . O

By IN B-PP
Northern JJ B-NP
blot NN I-NP
analysis NN I-NP
COMMA COMMA O
DM NN B-NP
caused VBD B-VP
a DT B-NP
comparable JJ I-NP
decrease NN I-NP
in IN B-PP
IL-2R NN B-NP
alpha NN I-NP
and CC B-PP
in IN B-PP
IL-2R NN B-NP
beta NN I-NP
mRNA NN B-NP
levels NNS I-NP
to TO B-PP
membrane NN B-NP
receptor NN I-NP
expression NN I-NP
in IN B-PP
mitogen-stimulated JJ B-NP
T NN I-NP
cells NNS I-NP
. . O

By IN B-PP
in FW B-NP
vitro FW I-NP
transcription NN I-NP
assays NNS I-NP
COMMA COMMA O
DM NN B-NP
regulated VBD B-VP
IL-2R NN B-NP
alpha NN I-NP
gene NN I-NP
expression NN I-NP
at IN B-PP
a DT B-NP
transcriptional JJ I-NP
level NN I-NP
while IN B-SBAR
transcription NN B-NP
of IN B-PP
IL-2R NN B-NP
beta NN I-NP
gene NN I-NP
was VBD B-VP
unaffected VBN I-VP
by IN B-PP
DM NN B-NP
. . O

The DT B-NP
mechanism NN I-NP
of IN B-PP
action NN B-NP
of IN B-PP
DM NN B-NP
on IN B-PP
IL-2R NN B-NP
alpha NN I-NP
transcription NN I-NP
was VBD B-VP
examined VBN I-VP
by IN B-PP
determining VBG B-VP
the DT B-NP
mRNA NN I-NP
levels NNS I-NP
of IN B-PP
the DT B-NP
p50 NN I-NP
subunit NN I-NP
of IN B-PP
nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
( ( O
NF-kappa NN B-NP
B NN I-NP
) ) O
COMMA COMMA O
a DT B-NP
transcription NN I-NP
factor NN I-NP
that WDT B-NP
stimulates VBZ B-VP
IL-2R NN B-NP
alpha NN I-NP
gene NN I-NP
expression NN I-NP
. . O

The DT B-NP
data NNS I-NP
indicate VBP B-VP
that IN B-SBAR
10(-6) CD B-NP
M NN I-NP
DM NN I-NP
increased VBD B-VP
T NN B-NP
cell NN I-NP
p50 NN I-NP
NF-kappa NN I-NP
B NN I-NP
mRNA NN I-NP
levels NNS I-NP
by IN B-PP
four-fold JJ B-NP
compared VBN B-VP
to TO B-PP
the DT B-NP
levels NNS I-NP
obtained VBN B-VP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
DM NN B-NP
. . O

Further RB B-ADVP
COMMA COMMA O
the DT B-NP
level NN I-NP
of IN B-PP
nuclear JJ B-NP
proteins NNS I-NP
capable JJ B-ADJP
of IN B-PP
binding VBG B-VP
to TO B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
sites NNS I-NP
in IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
increased VBD B-VP
in IN B-PP
response NN I-PP
to TO I-PP
DM NN B-NP
. . O

In IN B-PP
sum NN B-NP
COMMA COMMA O
DM NN B-NP
regulates VBZ B-VP
T NN B-NP
cell NN I-NP
membrane NN I-NP
expression NN I-NP
of IN B-PP
IL-2R NN B-NP
by IN B-PP
more JJR B-NP
than IN I-NP
one CD I-NP
molecular JJ I-NP
mechanism NN I-NP
. . O

Function NN B-NP
and CC O
activation NN B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
. . O

NF-kappa NN B-NP
B NN I-NP
is VBZ B-VP
a DT B-NP
ubiquitous JJ I-NP
transcription NN I-NP
factor NN I-NP
. . O

Nevertheless RB B-ADVP
COMMA COMMA O
its PRP$ B-NP
properties NNS I-NP
seem VBP B-VP
to TO I-VP
be VB I-VP
most RBS I-VP
extensively RB I-VP
exploited VBN I-VP
in IN B-PP
cells NNS B-NP
of IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
. . O

Among IN B-PP
these DT B-NP
properties NNS I-NP
are VBP B-VP
NF-kappa NN B-NP
B NN I-NP
's POS B-NP
rapid JJ I-NP
posttranslational JJ I-NP
activation NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
many JJ B-NP
pathogenic JJ I-NP
signals NNS I-NP
COMMA COMMA O
its PRP$ B-NP
direct JJ I-NP
participation NN I-NP
in IN B-PP
cytoplasmic\/nuclear JJ B-NP
signaling NN I-NP
COMMA COMMA O
and CC O
its PRP$ B-NP
potency NN I-NP
to TO B-VP
activate VB I-VP
transcription NN B-NP
of IN B-PP
a DT B-NP
great JJ I-NP
variety NN I-NP
of IN B-PP
genes NNS B-NP
encoding VBG B-VP
immunologically RB B-NP
relevant JJ I-NP
proteins NNS I-NP
. . O

In IN B-PP
vertebrates NNS B-NP
COMMA COMMA O
five CD B-NP
distinct JJ I-NP
DNA NN I-NP
binding NN I-NP
subunits NNS I-NP
are VBP B-VP
currently RB I-VP
known VBN I-VP
which WDT B-NP
might MD B-VP
extensively RB I-VP
heterodimerize VB I-VP
COMMA COMMA O
thereby RB B-ADVP
forming VBG B-VP
complexes NNS B-NP
with IN B-PP
distinct JJ B-NP
transcriptional JJ I-NP
activity NN I-NP
COMMA COMMA O
DNA NN B-NP
sequence NN I-NP
specificity NN I-NP
COMMA COMMA O
and CC O
cell NN B-NP
type- NN I-NP
and CC O
cell NN B-NP
stage- NN I-NP
specific JJ B-NP
distribution NN I-NP
. . O

The DT B-NP
activity NN I-NP
of IN B-PP
DNA NN B-NP
binding NN I-NP
NF-kappa NN I-NP
B NN I-NP
dimers NNS I-NP
is VBZ B-VP
tightly RB I-VP
controlled VBN I-VP
by IN B-PP
accessory NN B-NP
proteins NNS I-NP
called VBN B-VP
I NN B-NP
kappa NN I-NP
B NN I-NP
subunits NNS I-NP
of IN B-PP
which WDT B-NP
there EX B-NP
are VBP B-VP
also RB B-ADVP
five CD B-NP
different JJ I-NP
species NNS I-NP
currently RB B-VP
known VBN I-VP
in IN B-PP
vertebrates NNS B-NP
. . O

I NN B-NP
kappa NN I-NP
B NN I-NP
proteins NNS I-NP
inhibit VBP B-VP
DNA NN B-NP
binding NN I-NP
and CC O
prevent VBP B-VP
nuclear JJ B-NP
uptake NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
complexes NNS I-NP
. . O

An DT B-NP
exception NN I-NP
is VBZ B-VP
the DT B-NP
Bcl-3 NN I-NP
protein NN I-NP
which WDT B-NP
in IN B-PP
addition NN B-NP
can MD B-VP
function VB I-VP
as IN B-PP
a DT B-NP
transcription NN I-NP
activating NN I-NP
subunit NN I-NP
in IN B-PP
th DT B-NP
nucleus NN I-NP
. . O

Other JJ B-NP
I NN I-NP
kappa NN I-NP
B NN I-NP
proteins NNS I-NP
are VBP B-VP
rather RB I-VP
involved VBN I-VP
in IN B-PP
terminating VBG B-VP
NF-kappa NN B-NP
B NN I-NP
's POS B-NP
activity NN I-NP
in IN B-PP
the DT B-NP
nucleus NN I-NP
. . O

The DT B-NP
intracellular JJ I-NP
events NNS I-NP
that WDT B-NP
lead VBP B-VP
to TO B-PP
the DT B-NP
inactivation NN I-NP
of IN B-PP
I NN B-NP
kappa NN I-NP
B NN I-NP
COMMA COMMA O
i.e. FW B-ADVP
the DT B-NP
activation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
are VBP B-VP
complex JJ B-ADJP
. . O

They PRP B-NP
involve VBP B-VP
phosphorylation NN B-NP
and CC O
proteolytic JJ B-NP
reactions NNS I-NP
and CC O
seem VBP B-VP
to TO I-VP
be VB I-VP
controlled VBN I-VP
by IN B-PP
the DT B-NP
cells NNS I-NP
' POS B-NP
redox NN I-NP
status NN I-NP
. . O

Interference NN B-NP
with IN B-PP
the DT B-NP
activation NN B-NP
or CC O
activity NN B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
may MD B-VP
be VB I-VP
beneficial JJ B-ADJP
in IN B-PP
suppressing VBG B-VP
toxic\/septic JJ B-NP
shock NN I-NP
COMMA COMMA O
graft-vs-host JJ B-NP
reactions NNS I-NP
COMMA COMMA O
acute JJ B-NP
inflammatory JJ I-NP
reactions NNS I-NP
COMMA COMMA O
acute JJ B-NP
phase NN I-NP
response NN I-NP
COMMA COMMA O
and CC O
radiation NN B-NP
damage NN I-NP
. . O

The DT B-NP
inhibition NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
by IN B-PP
antioxidants NNS B-NP
and CC O
specific JJ B-NP
protease NN I-NP
inhibitors NNS I-NP
may MD B-VP
provide VB I-VP
a DT B-NP
pharmacological JJ I-NP
basis NN I-NP
for IN B-PP
interfering VBG B-VP
with IN B-PP
these DT B-NP
acute JJ I-NP
processes NNS I-NP
. . O

Pentoxifylline NN B-NP
for IN B-PP
the DT B-NP
treatment NN I-NP
of IN B-PP
infection NN B-NP
with IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
. . O

Cytokine NN B-NP
dysregulation NN I-NP
in IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HIV-1 NN B-NP
) ) O
infection NN B-NP
has VBZ B-VP
been VBN I-VP
documented VBN I-VP
in IN B-PP
numerous JJ B-NP
studies NNS I-NP
and CC O
has VBZ B-VP
been VBN I-VP
cited VBN I-VP
as IN B-PP
an DT B-NP
important JJ I-NP
component NN I-NP
in IN B-PP
the DT B-NP
pathogenesis NN I-NP
of IN B-PP
this DT B-NP
retroviral JJ I-NP
infection NN I-NP
. . O

Pharmacological JJ B-NP
modification NN I-NP
of IN B-PP
cytokine NN B-NP
dysregulation NN I-NP
COMMA COMMA O
therefore RB B-ADVP
COMMA COMMA O
has VBZ B-VP
been VBN I-VP
suggested VBN I-VP
as IN B-PP
a DT B-NP
therapeutic JJ I-NP
modality NN I-NP
for IN B-PP
HIV-1 NN B-NP
infection NN I-NP
. . O

Dr. NNP B-NP
Dezube NNP I-NP
of IN B-PP
Beth NNP B-NP
Israel NNP I-NP
Hospital NNP I-NP
( ( O
Boston NNP B-NP
) ) O
concisely RB B-ADVP
reviews VBZ B-VP
the DT B-NP
state NN I-NP
of IN B-PP
our PRP$ B-NP
knowledge NN I-NP
regarding VBG B-PP
the DT B-NP
effects NNS I-NP
of IN B-PP
pentoxifylline NN B-NP
on IN B-PP
expression NN B-NP
of IN B-PP
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
COMMA COMMA O
a DT B-NP
cytokine NN I-NP
known VBN B-VP
to TO B-VP
influence VB I-VP
HIV-1 NN B-NP
replication NN I-NP
and CC O
to TO B-VP
play VB I-VP
a DT B-NP
possible JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
clinical JJ I-NP
manifestations NNS I-NP
of IN B-PP
advanced JJ B-NP
infection NN I-NP
with IN B-PP
this DT B-NP
virus NN I-NP
. . O

Pentoxifylline NN B-NP
COMMA COMMA O
a DT B-NP
trisubstituted JJ I-NP
xanthine NN I-NP
derivative NN I-NP
COMMA COMMA O
has VBZ B-VP
been VBN I-VP
used VBN I-VP
to TO B-VP
decrease VB I-VP
blood NN B-NP
viscosity NN I-NP
and CC O
is VBZ B-VP
reasonably RB I-VP
well RB I-VP
tolerated VBN I-VP
by IN B-PP
most JJS B-NP
recipients NNS I-NP
of IN B-PP
the DT B-NP
drug NN I-NP
. . O

Results NNS B-NP
of IN B-PP
preliminary JJ B-NP
studies NNS I-NP
COMMA COMMA O
many JJ B-NP
of IN B-PP
which WDT B-NP
were VBD B-VP
conducted VBN I-VP
by IN B-PP
Dr. NNP B-NP
Dezube NNP B-NP
COMMA COMMA O
suggest VBP O
that IN B-NP
use NN O
of IN B-NP
this DT I-NP
agent NN O
in IN B-NP
combination NN O
with IN B-NP
antiretroviral JJ I-NP
compounds NNS B-VP
may MD I-VP
prove VB B-ADJP
useful JJ B-PP
in IN B-NP
the DT I-NP
treatment NN O
of IN B-NP
patients NNS O
with IN B-NP
HIV-1 NN I-NP
infection NN O

Increased VBN B-NP
interleukin NN I-NP
2 CD I-NP
transcription NN I-NP
in IN B-PP
murine JJ B-NP
lymphocytes NNS I-NP
by IN B-PP
ciprofloxacin NN B-NP
. . O

The DT B-NP
fluoroquinolone JJ I-NP
antibiotic JJ I-NP
COMMA COMMA O
ciprofloxacin NN B-NP
( ( O
cipro NN B-NP
) ) O
COMMA COMMA O
induces VBZ B-VP
hyperproduction NN B-NP
of IN B-PP
interleukin NN B-NP
2 CD I-NP
( ( O
IL-2 NN B-NP
) ) O
and CC O
interferon-gamma NN B-NP
( ( O
IFN-gamma NN B-NP
) ) O
in IN B-PP
stimulated VBN B-NP
human JJ I-NP
peripheral JJ I-NP
blood NN I-NP
lymphocytes NNS I-NP
. . O

In IN B-PP
this DT B-NP
investigation NN I-NP
an DT O
enhanced VBN O
and CC O
prolonged JJ O
IL-2 NN B-NP
and CC O
IL-2 NN B-NP
mRNA NN I-NP
response NN B-NP
was VBD B-VP
also RB I-VP
detected VBN I-VP
in IN B-PP
both CC I-PP
stimulated VBN O
( ( O
T NN B-NP
cell NN I-NP
mitogens NNS B-NP
or CC O
alloantigens NNS B-NP
) ) B-NP
murine JJ I-NP
splenocytes NNS I-NP
and CC B-PP
in IN B-PP
the DT B-NP
stimulated VBN I-NP
murine JJ I-NP
T NN I-NP
cell NN I-NP
line NN I-NP
EL-4 NN I-NP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
ciprofloxacin NN B-NP
( ( O
5-80 CD B-NP
micrograms\/ml NN I-NP
) ) O
as IN B-SBAR
compared VBN B-VP
to TO B-PP
control NN B-NP
cells NNS I-NP
without IN B-PP
antibiotics NNS B-NP
. . O

However RB B-ADVP
COMMA COMMA O
in IN B-PP
contrast NN I-PP
to TO I-PP
human JJ B-NP
lymphocytes NNS I-NP
COMMA COMMA O
IFN-gamma NN B-NP
production NN I-NP
was VBD B-VP
inhibited VBN I-VP
and CC O
IFN-gamma NN B-NP
mRNA NN I-NP
levels NNS I-NP
were VBD B-VP
unaffected JJ I-VP
at IN B-PP
24 CD B-NP
h NN I-NP
and CC O
only RB B-VP
slightly RB I-VP
upregulated VBN I-VP
at IN B-PP
48 CD B-NP
and CC I-NP
72 CD I-NP
h NN I-NP
of IN B-PP
culture NN B-NP
in IN B-PP
murine JJ B-NP
splenocytes NNS I-NP
incubated VBN B-VP
with IN B-PP
cipro NN B-NP
( ( O
20 CD B-NP
micrograms\/ml NNS I-NP
) ) O
. . O

EL-4 NN B-NP
cells NNS I-NP
were VBD B-VP
transfected VBN I-VP
with IN B-PP
a DT B-NP
plasmid NN I-NP
containing VBG B-VP
the DT O
IL-2 NN O
promoter NN B-NP
and CC O
enhancer NN B-NP
region NN B-NP
linked VBN B-VP
to TO B-PP
the DT O
chloramphenicol NN B-NP
acetyltransferase NN I-NP
( ( O
CAT NN B-NP
) ) O
reporter NN B-NP
gene NN I-NP
. . O

Analysis NN B-NP
of IN B-PP
CAT NN B-NP
activity NN I-NP
revealed VBD B-VP
that IN B-SBAR
cipro NN B-NP
enhanced VBD B-VP
IL-2 NN B-NP
gene NN I-NP
induction NN I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
EL-4 NN B-NP
cells NNS I-NP
incubated VBN B-VP
with IN B-PP
ciprofloxacin NN B-NP
showed VBD B-VP
an DT B-NP
early JJ I-NP
peak NN I-NP
and CC O
more RBR B-NP
activated VBN I-NP
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
( ( O
NFAT-1 NN B-NP
) ) O
as IN B-SBAR
compared VBN B-VP
to TO B-PP
control NN B-NP
cells NNS I-NP
without IN B-PP
antibiotics NNS B-NP
. . O

Cipro NN B-NP
did VBD B-VP
not RB I-VP
affect VB I-VP
the DT B-NP
nuclear JJ I-NP
transcription NN I-NP
factors NNS I-NP
AP-1 NN B-NP
or CC O
NFIL-2A NN B-NP
. . O

Taken VBN B-VP
together RB B-ADVP
COMMA COMMA O
cipro NN B-NP
inhibited VBD B-VP
IFN-gamma NN B-NP
synthesis NN I-NP
COMMA COMMA O
but CC O
enhanced VBD B-VP
IL-2 NN B-NP
production NN I-NP
in IN B-PP
murine JJ B-NP
lymphocytes NNS I-NP
by IN B-PP
means NNS I-PP
of IN I-PP
influencing VBG B-VP
NFAT-1 NN B-NP
and CC O
causing VBG B-VP
an DT B-NP
increased VBN I-NP
IL-2 NN I-NP
transcription NN I-NP
. . O

Multiple JJ B-NP
prolactin-responsive JJ I-NP
elements NNS I-NP
mediate VBP B-VP
G1 NN B-NP
and CC O
S NN B-NP
phase NN B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
interferon NN I-NP
regulatory JJ I-NP
factor-1 NN I-NP
gene NN I-NP
. . O

The DT O
interferon NN B-NP
regulatory JJ I-NP
factor-1 NN I-NP
( ( O
IRF-1 NN B-NP
) ) O
gene NN B-NP
is VBZ B-VP
both CC O
an DT B-NP
immediate-early JJ I-NP
G1 NN I-NP
phase NN I-NP
gene NN I-NP
and CC O
an DT B-NP
S NN I-NP
phase NN I-NP
gene NN I-NP
inducible JJ B-ADJP
by IN B-PP
PRL NN B-NP
in IN B-PP
rat NN B-NP
Nb2 NN I-NP
T NN I-NP
lymphocytes NNS I-NP
. . O

To TO B-VP
understand VB I-VP
the DT B-NP
mechanism NN I-NP
by IN B-PP
which WDT B-NP
PRL NN B-NP
regulates VBZ B-VP
the DT B-NP
biphasic JJ I-NP
expression NN I-NP
of IN B-PP
IRF-1 NN B-NP
COMMA COMMA O
we PRP B-NP
cloned VBD B-VP
the DT B-NP
rat NN I-NP
IRF-1 NN I-NP
gene NN I-NP
and CC O
functionally RB B-VP
characterized VBD I-VP
the DT B-NP
IRF-1 NN I-NP
promoter NN I-NP
. . O

Upon IN B-PP
transfection NN B-NP
into IN B-PP
Nb2 NN B-NP
T NN I-NP
cells NNS I-NP
COMMA COMMA O
1.7 CD B-NP
kilobases NNS B-NP
( ( O
kb NN B-NP
) ) O
of IN B-PP
IRF-1 NN B-NP
5'-flanking JJ I-NP
DNA NN I-NP
linked VBN B-VP
to TO B-PP
a DT O
chloramphenicol NN B-NP
acetyl JJ I-NP
transferase NN I-NP
( ( O
CAT NN B-NP
) ) O
reporter NN B-NP
gene NN I-NP
mediated VBD B-VP
a DT B-NP
30-fold JJ I-NP
induction NN I-NP
of IN B-PP
CAT NN B-NP
enzyme NN I-NP
activity NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
24 CD B-NP
h NN I-NP
of IN B-PP
PRL NN B-NP
stimulation NN I-NP
. . O

Deletion NN B-NP
mutants NNS I-NP
containing VBG B-VP
1.3 CD B-NP
COMMA COMMA I-NP
0.6 CD I-NP
COMMA COMMA I-NP
and CC I-NP
0.2 CD I-NP
kb NN I-NP
5'-flanking JJ I-NP
DNA NN I-NP
were VBD B-VP
incrementally RB B-ADJP
less RBR I-ADJP
transcriptionally RB I-ADJP
active JJ I-ADJP
COMMA COMMA O
although IN B-SBAR
0.2 CD B-NP
kb NN I-NP
still RB B-ADVP
mediated VBD B-VP
a DT B-NP
12-fold JJ I-NP
induction NN I-NP
by IN B-PP
PRL NN B-NP
. . O

The DT B-NP
sequence NN I-NP
between IN B-PP
-1.7 CD B-NP
and CC I-NP
-0.2 CD I-NP
kb NN I-NP
linked VBN B-VP
to TO B-PP
a DT B-NP
heterologous JJ I-NP
thymidine NN I-NP
kinase NN I-NP
promoter NN I-NP
failed VBD B-VP
to TO I-VP
respond VB I-VP
to TO B-PP
PRL NN B-NP
stimulation NN I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
the DT B-NP
activity NN I-NP
of IN B-PP
upstream JJ B-NP
PRL NN I-NP
response NN I-NP
elements NNS I-NP
may MD B-VP
require VB I-VP
an DT B-NP
interaction NN I-NP
with IN B-PP
promoter-proximal JJ B-NP
elements NNS I-NP
. . O

By IN B-PP
assaying VBG B-VP
CAT NN B-NP
enzyme NN I-NP
activity NN I-NP
across IN B-PP
a DT B-NP
24-h JJ I-NP
PRL NN I-NP
induction NN I-NP
time NN I-NP
course NN I-NP
COMMA COMMA O
we PRP B-NP
were VBD B-VP
able JJ B-ADJP
to TO B-VP
assign VB I-VP
G1 NN B-NP
vs. CC O
S NN B-NP
phase NN B-NP
PRL NN I-NP
responses NNS I-NP
of IN B-PP
the DT B-NP
IRF-1 NN I-NP
gene NN I-NP
to TO B-PP
different JJ B-NP
regions NNS I-NP
of IN B-PP
the DT O
IRF-1 NN O
5'-flanking JJ O
and CC O
promoter NN B-NP
DNA NN B-NP
. . O

The DT B-NP
0.2-kb JJ I-NP
IRF-CAT NN I-NP
construct NN I-NP
was VBD B-VP
induced VBN I-VP
by IN B-PP
PRL NN B-NP
stimulation NN I-NP
during IN B-PP
the DT B-NP
G1 NN I-NP
phase NN I-NP
of IN B-PP
the DT B-NP
cell NN I-NP
cycle NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
the DT B-NP
1.7-kb JJ I-NP
IRF-CAT NN I-NP
construct NN I-NP
was VBD B-VP
inducible JJ B-ADJP
by IN B-PP
PRL NN B-NP
during IN B-PP
both CC O
G1 NN B-NP
and CC O
S NN B-NP
phase NN B-NP
of IN B-PP
the DT B-NP
cell NN I-NP
cycle NN I-NP
. . O

Hence RB B-ADVP
COMMA COMMA O
the DT B-NP
PRL-induced JJ I-NP
biphasic JJ I-NP
expression NN I-NP
of IN B-PP
the DT B-NP
IRF-1 NN I-NP
gene NN I-NP
appears VBZ B-VP
to TO I-VP
be VB I-VP
controlled VBN I-VP
by IN B-PP
separate JJ B-NP
PRL-responsive JJ I-NP
elements NNS I-NP
: : O
elements NNS B-NP
in IN B-PP
the DT B-NP
first JJ I-NP
0.2 CD I-NP
kb NN I-NP
of IN B-PP
the DT B-NP
IRF-1 NN I-NP
promoter NN I-NP
region NN I-NP
act VBP B-VP
during IN B-PP
early JJ B-NP
activation NN I-NP
COMMA COMMA O
and CC O
elements NNS B-NP
between IN B-PP
0.2 CD B-NP
and CC I-NP
1.7 CD I-NP
kb NN I-NP
act VBP B-VP
in IN B-PP
concert NN I-PP
with IN I-PP
the DT B-NP
proximal JJ I-NP
0.2-kb JJ I-NP
region NN I-NP
during IN B-PP
S NN B-NP
phase NN I-NP
progression NN I-NP
. . O

Description NN B-NP
and CC O
functional JJ B-NP
implications NNS I-NP
of IN B-PP
a DT B-NP
novel JJ I-NP
mutation NN I-NP
in IN B-PP
the DT B-NP
sex-determining JJ I-NP
gene NN I-NP
SRY NN I-NP
. . O

The DT B-NP
sex-determining JJ I-NP
gene NN I-NP
SRY NN I-NP
was VBD B-VP
screened VBN I-VP
for IN B-PP
molecular JJ B-NP
alteration NN I-NP
in IN B-PP
an DT B-NP
XY NN I-NP
sex-reversed JJ I-NP
female NN I-NP
by IN B-PP
single-strand JJ B-NP
conformation NN I-NP
polymorphism NN I-NP
( ( O
SSCP NN B-NP
) ) O
technique NN B-NP
. . O

An DT B-NP
A-to-G JJ I-NP
transition NN I-NP
was VBD B-VP
detected VBN I-VP
which WDT B-NP
leads VBZ B-VP
to TO B-PP
an DT B-NP
exchange NN I-NP
of IN B-PP
a DT B-NP
tyrosine NN I-NP
by IN B-PP
a DT B-NP
cysteine NN I-NP
in IN B-PP
the DT B-NP
SRY NN I-NP
protein NN I-NP
. . O

The DT B-NP
affected VBN I-NP
tyrosine NN I-NP
residue NN I-NP
located JJ B-ADJP
at IN B-PP
the DT B-NP
C NN I-NP
terminus NN I-NP
of IN B-PP
the DT B-NP
DNA NN I-NP
binding NN I-NP
protein NN I-NP
is VBZ B-VP
evolutionarily RB I-VP
strongly RB I-VP
conserved VBN I-VP
among IN B-PP
the DT B-NP
members NNS I-NP
of IN B-PP
the DT B-NP
HMG NN I-NP
box NN I-NP
containing VBG I-NP
proteins NNS I-NP
. . O

Using VBG B-VP
gel NN B-NP
shift NN I-NP
assay NN I-NP
and CC O
peptide NN B-NP
synthesis NN I-NP
such PDT B-NP
a DT I-NP
mutation NN I-NP
is VBZ B-VP
shown VBN I-VP
to TO I-VP
abolish VB I-VP
the DT B-NP
SRY NN I-NP
protein NN I-NP
DNA NN I-NP
binding NN I-NP
ability NN I-NP
. . O

The DT B-NP
involvement NN I-NP
of IN B-PP
this DT B-NP
particular JJ I-NP
amino NN I-NP
acid NN I-NP
in IN B-PP
the DT B-NP
binding NN I-NP
specificity NN I-NP
is VBZ B-VP
also RB I-VP
discussed VBN I-VP
. . O

Evidence NN B-NP
for IN B-PP
a DT B-NP
trans-acting JJ I-NP
activator NN I-NP
function NN I-NP
regulating VBG B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
CD5 NN I-NP
antigen NN I-NP
. . O

Interspecies JJ B-NP
somatic JJ I-NP
cell NN I-NP
hybrids NNS I-NP
were VBD B-VP
generated VBN I-VP
by IN B-PP
fusing VBG B-VP
the DT B-NP
mouse NN I-NP
T-lymphoma NN I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
BW5147 NN B-NP
COMMA COMMA O
with IN B-PP
normal JJ B-NP
human JJ I-NP
T NN I-NP
lymphocytes NNS I-NP
at IN B-PP
different JJ B-NP
stages NNS I-NP
of IN B-PP
differentiation NN B-NP
. . O

Thymocytes NNS B-NP
COMMA COMMA O
activated VBN B-NP
peripheral JJ I-NP
T NN I-NP
lymphocytes NNS I-NP
COMMA COMMA O
or CC O
an DT B-NP
activated VBN I-NP
T-cell NN I-NP
clone NN I-NP
were VBD B-VP
used VBN I-VP
as IN B-PP
human JJ B-NP
partners NNS I-NP
COMMA COMMA O
respectively RB B-ADVP
COMMA COMMA O
in IN B-PP
three CD B-NP
independent JJ I-NP
fusions NNS I-NP
. . O

Irrespective JJ B-PP
of IN I-PP
the DT B-NP
human JJ I-NP
cell NN I-NP
partner NN I-NP
used VBN B-VP
for IN B-PP
fusion NN B-NP
COMMA COMMA O
a DT B-NP
certain JJ I-NP
number NN I-NP
of IN B-PP
hybrids NNS B-NP
lost VBD B-VP
CD5 NN B-NP
surface NN I-NP
expression NN I-NP
over IN B-PP
a DT B-NP
period NN I-NP
of IN B-PP
time NN B-NP
in IN B-PP
culture NN B-NP
. . O

Analysis NN B-NP
at IN B-PP
the DT O
phenotype NN B-NP
and CC O
genetic JJ B-ADJP
level NN B-NP
showed VBD B-VP
that IN B-SBAR
lack NN B-NP
of IN B-PP
CD5 NN B-NP
expression NN I-NP
was VBD B-VP
due JJ B-PP
neither CC O
to TO B-PP
segregation NN B-NP
of IN B-PP
human JJ B-NP
autosome NN I-NP
11 CD I-NP
COMMA COMMA O
on IN B-PP
which WDT B-NP
the DT B-NP
CD5 NN I-NP
gene NN I-NP
has VBZ B-VP
been VBN I-VP
mapped VBN I-VP
COMMA COMMA O
nor CC B-PP
to TO B-PP
deletion NN B-NP
of IN B-PP
the DT B-NP
CD5 NN I-NP
structural JJ I-NP
gene NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
loss NN B-NP
of IN B-PP
CD5 NN B-NP
surface NN I-NP
expression NN I-NP
correlated VBD B-VP
with IN B-PP
the DT B-NP
absence NN I-NP
of IN B-PP
specific JJ B-NP
mRNA NN I-NP
. . O

Since IN B-SBAR
these DT B-NP
hybrids NNS I-NP
preferentially RB B-ADVP
segregate VBP B-VP
human JJ B-NP
chromosomes NNS I-NP
COMMA COMMA O
these DT B-NP
results NNS I-NP
indicate VBP B-VP
the DT B-NP
existence NN I-NP
of IN B-PP
a DT B-NP
non-syntenic JJ I-NP
trans-active JJ I-NP
locus NN B-NP
COMMA COMMA O
or CC O
loci NNS B-NP
COMMA COMMA O
positively RB B-VP
controlling VBG I-VP
the DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
CD5 NN I-NP
gene NN I-NP
. . O

Prevalence NN B-NP
of IN B-PP
aneuploidy NN B-NP
COMMA COMMA O
overexpressed JJ B-NP
ER NN I-NP
COMMA COMMA O
and CC O
overexpressed JJ B-NP
EGFR NN I-NP
in IN B-PP
random JJ B-NP
breast NN I-NP
aspirates NNS I-NP
of IN B-PP
women NNS B-NP
at IN B-PP
high JJ B-NP
and CC I-NP
low JJ I-NP
risk NN I-NP
for IN B-PP
breast NN B-NP
cancer NN I-NP
. . O

Breast NN B-NP
tissue NN I-NP
biomarkers NNS I-NP
which WDT B-NP
accurately RB B-ADVP
predict VBP B-VP
breast NN B-NP
cancer NN I-NP
development NN I-NP
within IN B-PP
a DT B-NP
10 CD I-NP
year NN I-NP
period NN I-NP
in IN B-PP
high JJ B-NP
risk NN I-NP
women NNS I-NP
are VBP B-VP
needed VBN B-VP
but CC O
currently RB B-ADJP
not RB I-ADJP
available JJ I-ADJP
. . O

We PRP B-NP
initiated VBD B-VP
this DT B-NP
study NN I-NP
to TO B-VP
determine VB I-VP
1 LS B-LST
) ) O
the DT B-NP
prevalence NN I-NP
of IN B-PP
one CD B-NP
or CC I-NP
more JJR I-NP
breast NN I-NP
tissue NN I-NP
abnormalities NNS I-NP
in IN B-PP
a DT B-NP
group NN I-NP
of IN B-PP
women NNS B-NP
at IN B-PP
high JJ B-NP
risk NN I-NP
for IN B-PP
breast NN B-NP
cancer NN I-NP
COMMA COMMA O
and CC O
2 LS B-LST
) ) O
if IN B-SBAR
the DT B-NP
prevalence NN I-NP
of IN B-PP
biomarker NN B-NP
abnormalities NNS I-NP
is VBZ B-VP
greater JJR B-ADJP
in IN B-PP
high JJ B-NP
risk NN I-NP
than IN B-PP
in IN B-PP
low JJ B-NP
risk NN I-NP
women NNS I-NP
. . O

Eligible JJ B-NP
high JJ I-NP
risk NN I-NP
women NNS I-NP
were VBD B-VP
those DT B-NP
with IN B-PP
a DT B-NP
first JJ I-NP
degree NN I-NP
relative NN I-NP
with IN B-PP
breast NN B-NP
cancer NN I-NP
COMMA COMMA O
prior JJ B-NP
breast NN I-NP
cancer NN I-NP
COMMA COMMA O
or CC O
precancerous JJ B-NP
mastopathy NN I-NP
. . O

Low JJ B-NP
risk NN I-NP
women NNS I-NP
were VBD B-VP
those DT B-NP
without IN B-PP
these DT B-NP
or CC O
other JJ B-NP
major JJ I-NP
identifiable JJ I-NP
risk NN I-NP
factors NNS I-NP
. . O

Ductal JJ B-NP
cells NNS I-NP
were VBD B-VP
obtained VBN I-VP
via IN B-PP
random JJ B-NP
fine JJ I-NP
needle NN I-NP
aspirations NNS I-NP
and CC O
cytologically RB B-VP
classified VBN I-VP
. . O

Biomarkers NNS B-NP
included VBD B-VP
DNA NN B-NP
ploidy NN I-NP
COMMA COMMA O
estrogen NN B-NP
receptor NN I-NP
( ( O
ER NN B-NP
) ) O
COMMA COMMA O
and CC O
epidermal JJ B-NP
growth NN I-NP
factor NN I-NP
receptor NN I-NP
( ( O
EGFR NN B-NP
) ) O
. . O

The DT B-NP
prevalence NN I-NP
of IN B-PP
DNA NN B-NP
aneuploidy NN I-NP
was VBD B-VP
30 CD B-NP
% NN I-NP
COMMA COMMA O
overexpression NN B-NP
of IN B-PP
ER NN B-NP
10 CD B-NP
% NN I-NP
COMMA COMMA O
and CC O
overexpression NN B-NP
of IN B-PP
EGFR NN B-NP
35 CD B-NP
% NN I-NP
COMMA COMMA O
in IN B-PP
the DT B-NP
206 CD I-NP
high JJ I-NP
risk NN I-NP
women NNS I-NP
whose WP$ B-NP
median JJ I-NP
10 CD I-NP
year NN I-NP
Gail NN I-NP
risk NN B-NP
( ( O
projected VBN B-NP
probability NN I-NP
) ) O
of IN B-PP
developing VBG B-VP
breast NN B-NP
cancer NN I-NP
was VBD B-VP
4.5 CD B-NP
% NN I-NP
. . O

The DT B-NP
prevalence NN I-NP
of IN B-PP
aneuploidy NN B-NP
and CC O
overexpressed JJ B-NP
EGFR NN I-NP
was VBD B-VP
significantly RB B-ADJP
higher JJR I-ADJP
in IN B-PP
the DT B-NP
high JJ I-NP
risk NN I-NP
women NNS I-NP
than IN B-PP
in IN B-PP
the DT B-NP
25 CD I-NP
low JJ I-NP
risk NN I-NP
controls NNS I-NP
( ( O
p NN B-NP
&lt; JJR B-NP
0.002 CD I-NP
) ) O
COMMA COMMA O
whose WP$ O
median JJ O
10 CD B-ADJP
year NN I-ADJP
Gail NN B-NP
risk NN I-NP
was VBD B-VP
0.7 CD B-NP
% NN I-NP
. . O

The DT B-NP
difference NN I-NP
in IN B-PP
the DT B-NP
prevalence NN I-NP
of IN B-PP
ER NN B-NP
overexpression NN I-NP
between IN B-PP
high JJ B-NP
and CC I-NP
low JJ I-NP
risk NN I-NP
groups NNS I-NP
was VBD B-VP
not RB O
statistically RB B-ADVP
significant JJ B-ADJP
( ( O
p NN B-NP
= JJ B-VP
0.095 CD B-NP
) ) O
. . O

This DT B-NP
may MD B-VP
be VB I-VP
due JJ B-PP
to TO I-PP
the DT B-NP
low JJ I-NP
prevalence NN I-NP
of IN B-PP
overexpressed JJ B-NP
ER NN I-NP
and CC O
the DT B-NP
small JJ I-NP
number NN I-NP
of IN B-PP
controls NNS B-NP
. . O

A DT B-NP
significant JJ I-NP
difference NN I-NP
was VBD B-VP
noted VBN I-VP
in IN B-PP
the DT B-NP
prevalence NN I-NP
of IN B-PP
one CD B-NP
or CC I-NP
more JJR I-NP
abnormal JJ I-NP
biomarkers NNS I-NP
between IN B-PP
the DT O
high JJ B-NP
risk NN I-NP
and CC O
low JJ B-NP
risk NN I-NP
women NNS B-NP
( ( O
p NN B-NP
&lt; JJR B-NP
0.001 CD I-NP
) ) O
. . O

A DT B-NP
large JJ I-NP
prospective JJ I-NP
trial NN I-NP
is VBZ B-VP
needed VBN I-VP
to TO B-VP
determine VB I-VP
if IN B-SBAR
one CD B-NP
or CC I-NP
more JJR I-NP
of IN B-PP
these DT B-NP
biomarkers NNS I-NP
COMMA COMMA O
is VBZ B-VP
predictive JJ B-ADJP
of IN B-PP
breast NN B-NP
cancer NN I-NP
development NN I-NP
. . O

{ ( O
The DT B-NP
changes NNS I-NP
in IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
in IN B-PP
peripheral JJ B-NP
leukocytes NNS I-NP
in IN B-PP
asthmatic JJ B-NP
subjects NNS I-NP
} ) O

The DT B-NP
number NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
( ( O
GCR NN B-NP
) ) O
in IN B-PP
peripheral JJ B-NP
leukocytes NNS I-NP
was VBD B-VP
determined VBN I-VP
by IN B-PP
radioligand-binding JJ B-NP
assay NN I-NP
in IN B-PP
extrinsic JJ B-NP
and CC I-NP
intrinsic JJ I-NP
asthmatics NNS I-NP
. . O

Their PRP$ B-NP
corresponding JJ I-NP
plasma NN I-NP
cortisol NN I-NP
levels NNS I-NP
were VBD B-VP
assessed VBN I-VP
. . O

The DT B-NP
results NNS I-NP
showed VBD B-VP
that IN B-SBAR
the DT B-NP
average JJ I-NP
number NN I-NP
of IN B-PP
GCR NN B-NP
in IN B-PP
asthmatics NNS B-NP
was VBD B-VP
significantly RB B-ADJP
lower JJR I-ADJP
than IN B-PP
that DT B-NP
in IN B-PP
healthy JJ B-NP
subjects NNS I-NP
( ( O
P NN B-NP
&lt; JJR B-NP
0.01 CD I-NP
) ) O
COMMA COMMA O
and CC O
there EX B-NP
was VBD B-VP
a DT B-NP
linear JJ I-NP
correlation NN I-NP
between IN B-PP
the DT B-NP
number NN I-NP
of IN B-PP
GCR NN B-NP
and CC O
the DT B-NP
course NN I-NP
of IN B-PP
asthma NN B-NP
. . O

Besides RB B-ADVP
COMMA COMMA O
there EX B-NP
was VBD B-VP
also RB B-ADVP
a DT B-NP
linear JJ I-NP
correlation NN I-NP
between IN B-PP
the DT B-NP
number NN I-NP
of IN B-PP
GCR NN B-NP
and CC O
the DT B-NP
age NN I-NP
of IN B-PP
the DT B-NP
initial JJ I-NP
attack NN I-NP
of IN B-PP
asthma NN B-NP
. . O

No DT B-NP
difference NN I-NP
in IN B-PP
plasma NN B-NP
cortisol NN I-NP
level NN I-NP
was VBD B-VP
found VBN I-VP
between IN B-PP
asthmatics NNS B-NP
and CC O
healthy JJ B-NP
subjects NNS I-NP
. . O

These DT B-NP
findings NNS I-NP
suggest VBP B-VP
that IN B-SBAR
there EX B-NP
is VBZ B-VP
no DT B-NP
primary JJ I-NP
and CC I-NP
general JJ I-NP
impairment NN I-NP
of IN B-PP
glucocorticoid NN B-NP
metabolism NN I-NP
in IN B-PP
the DT B-NP
asthmatics NNS I-NP
COMMA COMMA O
but CC O
the DT B-NP
number NN I-NP
of IN B-PP
GCR NN B-NP
in IN B-PP
the DT B-NP
asthmatics NNS I-NP
is VBZ B-VP
lower JJR B-ADJP
than IN B-PP
that DT B-NP
in IN B-PP
healthy JJ B-NP
controls NNS I-NP
. . O

The DT B-NP
decrease NN I-NP
of IN B-PP
the DT B-NP
number NN I-NP
of IN B-PP
GCR NN B-NP
in IN B-PP
asthmatics NNS B-NP
COMMA COMMA O
we PRP B-NP
think VBP B-VP
COMMA COMMA O
is VBZ B-VP
related JJ B-ADJP
to TO B-PP
heredity NN B-NP
and CC O
repeated VBN B-NP
attacks NNS I-NP
of IN B-PP
asthma NN B-NP
. . O

Alternate JJ B-NP
immune JJ I-NP
system NN I-NP
targets VBZ I-NP
for IN B-PP
TCDD NN B-NP
: : O
lymphocyte NN B-NP
stem NN I-NP
cells NNS I-NP
and CC O
extrathymic JJ B-NP
T-cell NN I-NP
development NN I-NP
. . O

We PRP B-NP
here RB B-ADVP
summarize VBP B-VP
evidence NN B-NP
that IN B-SBAR
thymic JJ B-NP
atrophy NN I-NP
induced VBN B-VP
by IN B-PP
2COMMA3COMMA7COMMA8-tetrachlorodibenzo-p-dioxin NN B-NP
( ( O
TCDD NN B-NP
) ) O
can MD B-VP
be VB I-VP
mediated VBN I-VP
COMMA COMMA O
at IN B-ADVP
least JJS I-ADVP
in IN B-PP
part NN B-NP
COMMA COMMA O
by IN B-PP
damage NN B-NP
to TO B-PP
extrathymic JJ B-NP
T-cell NN I-NP
precursors NNS I-NP
in IN B-PP
bone NN B-NP
marrow NN I-NP
and CC O
fetal JJ B-NP
liver NN I-NP
. . O

This DT B-NP
atrophy NN I-NP
induction NN I-NP
does VBZ B-VP
not RB I-VP
involve VB I-VP
apoptotic JJ B-NP
mechanisms NNS I-NP
in IN B-PP
thymocytes NNS B-NP
affected VBN B-VP
by IN B-PP
the DT B-NP
bcl-2 NN I-NP
proto-oncogene NN I-NP
. . O

TCDD NN B-NP
mediates VBZ B-VP
atrophy NN B-NP
induction NN I-NP
through IN B-PP
its PRP$ B-NP
specific JJ I-NP
receptor NN I-NP
( ( O
the DT B-NP
AhR NN I-NP
) ) O
and CC B-PP
not RB B-PP
through IN I-PP
effects NNS B-NP
on IN B-PP
the DT B-NP
estrogen NN I-NP
receptor NN I-NP
. . O

Both CC O
TCDD NN B-NP
and CC O
estradiol NN B-NP
induce VBP B-VP
extrathymic JJ B-NP
T-cell NN I-NP
differentiation NN I-NP
in IN B-PP
the DT B-NP
liver NN I-NP
. . O

These DT B-NP
extrathymic JJ I-NP
T-cell NN I-NP
populations NNS I-NP
include VBP B-VP
cells NNS B-NP
expressing VBG B-VP
elevated JJ B-NP
levels NNS I-NP
of IN B-PP
V NN B-NP
beta NN I-NP
T-cell NN I-NP
receptors NNS I-NP
that WDT B-NP
are VBP B-VP
normally RB I-VP
deleted VBN I-VP
in IN B-PP
thymic JJ B-NP
development NN I-NP
. . O

Alteration NN B-NP
of IN B-PP
structural JJ B-NP
order NN I-NP
of IN B-PP
human JJ B-NP
erythrocyte NN I-NP
ghost NN I-NP
membrane NN I-NP
by IN B-PP
glucocorticoids NNS B-NP
and CC O
the DT B-NP
influence NN I-NP
of IN B-PP
the DT B-NP
glucocorticoid NN I-NP
receptor NN I-NP
antagonist NN I-NP
RU NN I-NP
486 CD I-NP
. . O

High-dose JJ B-NP
pulse NN I-NP
glucocorticoid NN I-NP
therapy NN I-NP
has VBZ B-VP
been VBN I-VP
used VBN I-VP
successfully RB B-ADVP
in IN B-PP
the DT B-NP
clinic NN I-NP
in IN B-PP
severe JJ B-NP
pathological JJ I-NP
conditions NNS I-NP
for IN B-PP
about RB B-NP
20 CD I-NP
years NNS I-NP
. . O

The DT B-NP
mode NN I-NP
of IN B-PP
glucocorticoid NN B-NP
action NN I-NP
after IN B-PP
administration NN B-NP
of IN B-PP
such JJ B-NP
megadoses NNS I-NP
is VBZ B-VP
inexplicable JJ B-ADJP
up RP B-PP
to TO I-PP
now RB B-NP
. . O

It PRP B-NP
is VBZ B-VP
supposed VBN I-VP
that IN B-SBAR
some DT B-NP
effects NNS I-NP
may MD B-VP
be VB I-VP
due JJ B-PP
to TO I-PP
membrane NN B-NP
alterations NNS I-NP
. . O

In IN B-PP
the DT B-NP
present JJ I-NP
in-vitro FW I-NP
experiments NNS I-NP
the DT B-NP
effect NN I-NP
of IN B-PP
dexamethasone NN B-NP
COMMA COMMA O
of IN B-PP
further JJ B-NP
glucocorticoids NNS I-NP
COMMA COMMA B-PP
and CC I-PP
of IN B-PP
the DT B-NP
glucocorticoid NN I-NP
receptor NN I-NP
antagonist NN I-NP
RU NN I-NP
486 CD I-NP
COMMA COMMA O
on IN B-PP
structural JJ B-NP
order NN I-NP
of IN B-PP
human JJ B-NP
erythrocyte NN I-NP
ghost NN I-NP
membranes NNS I-NP
was VBD B-VP
investigated VBN I-VP
by IN B-PP
determining VBG B-VP
the DT B-NP
steady-state JJ I-NP
fluorescence NN I-NP
anisotropy NN I-NP
of IN B-PP
diphenylhexatriene NN B-NP
( ( O
DPH NN B-NP
) ) O
. . O

Dexamethasone NN B-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
induce VB I-VP
a DT B-NP
significant JJ I-NP
decrease NN I-NP
in IN B-PP
membrane NN B-NP
structural JJ I-NP
order NN I-NP
at IN B-PP
concentrations NNS B-NP
of IN B-PP
about RB B-NP
10(-6) CD I-NP
M NN I-NP
in IN B-PP
a DT B-NP
concentration-dependent JJ I-NP
manner NN I-NP
. . O

We PRP B-NP
found VBD B-VP
a DT B-NP
correlation NN I-NP
between IN B-PP
the DT B-NP
uptake NN I-NP
of IN B-PP
dexamethasone NN B-NP
by IN B-PP
the DT B-NP
ghost NN I-NP
membranes NNS I-NP
and CC O
the DT B-NP
decrease NN I-NP
in IN B-PP
the DT B-NP
structural JJ I-NP
order NN I-NP
. . O

The DT B-NP
other JJ I-NP
glucocorticoids NNS I-NP
tested VBN B-VP
COMMA COMMA O
methylprednisolone NN B-NP
and CC O
corticosterone NN B-NP
COMMA COMMA O
were VBD B-VP
also RB B-ADVP
effective JJ B-ADJP
at IN B-PP
concentrations NNS B-NP
of IN B-PP
10(-5) CD B-NP
M NN I-NP
or CC I-NP
greater JJR I-NP
. . O

We PRP B-NP
observed VBD B-VP
no DT B-NP
change NN I-NP
in IN B-PP
membrane NN B-NP
structural JJ I-NP
order NN I-NP
with IN B-PP
RU NN B-NP
486 CD I-NP
up IN B-PP
to TO I-PP
a DT B-NP
concentration NN I-NP
of IN B-PP
10(-4) CD B-NP
M NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
simultaneous JJ B-NP
incubation NN I-NP
of IN B-PP
RU NN B-NP
486 CD I-NP
with IN B-PP
dexamethasone NN B-NP
caused VBD B-VP
a DT B-NP
distinct JJ I-NP
interference NN I-NP
of IN B-PP
RU NN B-NP
486 CD I-NP
with IN B-PP
dexamethasone NN B-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
the DT B-NP
glucocorticoid-induced JJ I-NP
membrane NN I-NP
perturbation NN I-NP
COMMA COMMA O
the DT B-NP
possibility NN I-NP
to TO B-VP
inhibit VB I-VP
it PRP B-NP
by IN B-PP
RU NN B-NP
486 CD I-NP
COMMA COMMA O
and CC O
the DT B-NP
inactivity NN I-NP
of IN B-PP
the DT B-NP
structurally RB I-NP
related JJ I-NP
progesterone NN I-NP
COMMA COMMA O
refer VBP B-VP
to TO B-PP
relatively RB B-NP
specific JJ I-NP
binding VBG I-NP
sites NNS I-NP
for IN B-PP
the DT B-NP
glucocorticoids NNS I-NP
in IN B-PP
the DT B-NP
membrane NN I-NP
of IN B-PP
erythrocyte NN B-NP
ghosts NNS I-NP
. . O

Cloning NN B-NP
and CC O
characterization NN B-NP
of IN B-PP
NF-ATc NN B-NP
and CC O
NF-ATp NN B-NP
: : O
the DT B-NP
cytoplasmic JJ I-NP
components NNS I-NP
of IN B-PP
NF-AT NN B-NP
. . O

Present JJ B-NP
evidence NN I-NP
indicates VBZ B-VP
a DT B-NP
pathway NN I-NP
of IN B-PP
signal NN B-NP
transmission NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
that WDT B-NP
is VBZ B-VP
outlined VBN I-VP
in IN B-PP
figure NN B-NP
1 CD I-NP
. . O

The DT B-NP
elevation NN I-NP
in IN B-PP
intracellular JJ B-NP
calcium NN I-NP
that WDT B-NP
is VBZ B-VP
induced VBN I-VP
by IN B-PP
interactions NNS B-NP
at IN B-PP
the DT B-NP
antigen NN I-NP
receptor NN I-NP
leads VBZ B-VP
to TO B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
calcium-dependent JJ I-NP
phosphatase NN I-NP
calcineurin NN I-NP
. . O

This DT B-NP
in IN B-PP
turn NN B-NP
leads VBZ B-VP
to TO B-PP
the DT B-NP
nuclear JJ I-NP
association NN I-NP
of IN B-PP
the DT B-NP
cytosolic JJ I-NP
component NN I-NP
of IN B-PP
NF-ATc NN B-NP
. . O

The DT B-NP
activation NN I-NP
of IN B-PP
calcineurin NN B-NP
and CC O
the DT B-NP
nuclear JJ I-NP
import NN I-NP
of IN B-PP
NF-ATc NN B-NP
can MD B-VP
both DT I-VP
be VB I-VP
blocked VBN I-VP
by IN B-PP
cyclosporin NN B-NP
A NN I-NP
or CC O
FK506 NN B-NP
in IN B-PP
complex NN B-NP
with IN B-PP
their PRP$ B-NP
respective JJ I-NP
immunophilins NNS I-NP
. . O

Once RB O
in IN B-PP
the DT B-NP
nucleus NN I-NP
COMMA COMMA O
NF-ATc NN B-NP
interacts VBZ B-VP
with IN B-PP
NF-ATn NN B-NP
to TO B-VP
form VB I-VP
an DT B-NP
active JJ I-NP
transcriptional JJ I-NP
complex NN I-NP
. . O

NF-ATn NN B-NP
is VBZ B-VP
a DT B-NP
ubiquitous JJ I-NP
protein NN I-NP
COMMA COMMA O
can MD B-VP
be VB I-VP
synthesized VBN I-VP
in IN B-PP
response NN I-PP
to TO I-PP
PMA NN B-NP
COMMA COMMA O
and CC O
has VBZ B-VP
many JJ B-NP
similarities NNS I-NP
to TO B-PP
AP-1 NN B-NP
. . O

The DT B-NP
mechanism NN I-NP
by IN B-PP
which WDT B-NP
NF-ATc NN B-NP
enters VBZ B-VP
the DT B-NP
nucleus NN I-NP
is VBZ B-VP
unknown JJ B-ADJP
COMMA COMMA O
and CC O
although IN B-SBAR
it PRP B-NP
appears VBZ B-VP
to TO I-VP
require VB I-VP
calcineurin NN B-NP
COMMA COMMA O
NF-ATc NN B-NP
has VBZ B-VP
not RB I-VP
yet RB I-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
an DT B-NP
in FW I-NP
vivo FW I-NP
substrate NN I-NP
of IN B-PP
calcineurin NN B-NP
. . O

Alternative JJ B-NP
mechanisms NNS I-NP
include VBP B-VP
the DT B-NP
possibility NN I-NP
that IN B-SBAR
NF-ATc NN B-NP
operates VBZ B-VP
on IN B-PP
some DT B-NP
cytoplasmic JJ I-NP
anchor NN I-NP
or CC O
that IN B-SBAR
other JJ B-NP
proteins NNS I-NP
that WDT B-NP
are VBP B-VP
controlled VBN I-VP
by IN B-PP
calcineurin NN B-NP
carry VBP B-VP
out RP B-PRT
the DT B-NP
nuclear JJ I-NP
import NN I-NP
of IN B-PP
NF-ATc NN B-NP
. . O

Although IN B-SBAR
NF-ATp NN B-NP
copurifies VBZ B-VP
with IN B-PP
NF-ATc NN B-NP
COMMA COMMA O
there EX B-NP
is VBZ B-VP
as RB B-ADVP
yet RB I-ADVP
no DT B-NP
understanding NN I-NP
of IN B-PP
how WRB B-ADVP
NF-ATp NN B-NP
is VBZ B-VP
functioning VBG I-VP
in FW B-ADVP
vivo FW I-ADVP
. . O

Now RB B-ADVP
that IN B-SBAR
these DT B-NP
proteins NNS I-NP
are VBP B-VP
purified VBN I-VP
and CC O
cloned VBN B-VP
COMMA COMMA O
the DT B-NP
major JJ I-NP
goals NNS I-NP
will MD B-VP
be VB I-VP
to TO B-VP
understand VB I-VP
their PRP$ B-NP
role NN I-NP
and CC O
the DT B-NP
roles NNS I-NP
of IN B-PP
other JJ B-NP
family NN I-NP
members NNS I-NP
in IN B-PP
thymic JJ B-NP
development NN I-NP
. . O

Changes NNS B-NP
in IN B-PP
triiodothyronine NN B-NP
( ( O
T3 NN B-NP
) ) O
mononuclear JJ B-NP
leukocyte NN I-NP
receptor NN I-NP
kinetics NNS I-NP
after IN B-PP
T3 NN B-NP
administration NN I-NP
and CC O
multiple JJ B-NP
cold-air JJ I-NP
exposures NNS I-NP
. . O

Repeated VBN B-NP
cold-air JJ I-NP
exposures NNS I-NP
increase VBP B-VP
human JJ O
triiodothyronine NN B-NP
( ( O
T3 CD B-NP
) ) O
plasma NN B-NP
clearance NN I-NP
rates NNS I-NP
. . O

To TO B-VP
study VB I-VP
the DT B-NP
response NN I-NP
of IN B-PP
the DT B-NP
nuclear JJ I-NP
T3 NN I-NP
receptor NN I-NP
( ( O
NT3R NN B-NP
) ) O
in IN B-PP
this DT B-NP
condition NN I-NP
COMMA COMMA O
binding VBG B-NP
characteristics NNS I-NP
were VBD B-VP
analyzed VBN I-VP
in IN B-PP
human JJ B-NP
mononuclear JJ B-NP
leukocytes NNS I-NP
( ( O
MNL NN B-NP
) ) O
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
we PRP B-NP
supplemented VBD B-VP
one CD B-NP
group NN I-NP
of IN B-PP
individuals NNS B-NP
with IN B-PP
a DT B-NP
daily RB I-NP
oral JJ I-NP
replacement NN I-NP
dose NN I-NP
of IN B-PP
T3 NN B-NP
to TO B-VP
isolate VB I-VP
the DT B-NP
influence NN I-NP
of IN B-PP
serum NN B-NP
thyroxine NN I-NP
( ( O
T4 NN B-NP
) ) O
and CC O
thyrotropin NN B-NP
( ( O
TSH NN B-NP
) ) O
levels NNS B-NP
on IN B-PP
receptor NN B-NP
kinetics NNS I-NP
. . O

The DT B-NP
subjects NNS I-NP
were VBD B-VP
exposed VBN I-VP
to TO B-PP
cold JJ B-NP
air NN I-NP
( ( O
4 CD B-NP
degrees NNS I-NP
C NN I-NP
) ) O
twice\/d RB B-ADVP
COMMA COMMA O
30 CD B-NP
min\/exposure NN I-NP
COMMA COMMA O
for IN B-PP
a DT B-NP
total NN I-NP
of IN B-PP
80 CD B-NP
exposures NNS I-NP
. . O

The DT B-NP
T3- JJ I-NP
subjects NNS I-NP
received VBD B-VP
placebo NN B-NP
{ ( O
n NN B-NP
= JJ B-VP
8 CD B-NP
} ) O
and CC O
the DT B-NP
T3+ JJ I-NP
subjects NNS I-NP
received VBD B-VP
T3 CD B-NP
( ( O
30 CD B-NP
micrograms\/d NN I-NP
) ) O
{ ( O
n NN B-NP
= JJ B-VP
8 CD B-NP
} ) O
in IN B-PP
a DT B-NP
double-blind JJ I-NP
fashion NN I-NP
. . O

Mononuclear JJ B-NP
leukocytes NNS I-NP
were VBD B-VP
isolated VBN I-VP
from IN B-PP
peripheral JJ B-NP
blood NN I-NP
before IN B-SBAR
the DT B-NP
cold JJ I-NP
exposure NN I-NP
and CC O
drug NN B-NP
regimen NNS I-NP
began VBD B-VP
COMMA COMMA O
and CC O
then RB O
after IN B-PP
every DT B-NP
20 CD I-NP
exposures NNS I-NP
. . O

The DT B-NP
dissociation NN B-NP
constant NN I-NP
( ( O
Kd NN B-NP
) ) O
and CC O
maximum NN B-NP
binding NN I-NP
capacity NN I-NP
( ( O
MBC NN B-NP
) ) O
of IN B-PP
the DT B-NP
NT3R NN I-NP
values NNS I-NP
were VBD B-VP
log NN I-VP
transformed VBN I-VP
to TO B-VP
minimize VB I-VP
between-subject JJ B-NP
variability NN I-NP
. . O

In IN B-PP
the DT B-NP
T3+ JJ I-NP
group NN I-NP
COMMA COMMA O
serum NN B-NP
total VBP I-NP
thyroxine NN I-NP
( ( O
TT4 NN B-NP
) ) O
COMMA COMMA O
free JJ B-NP
T4 NN I-NP
( ( O
FT4 NN B-NP
) ) O
COMMA COMMA O
and CC O
TSH NN B-NP
were VBD B-VP
approx RB B-NP
50 CD I-NP
% NN I-NP
lower JJR B-ADJP
than IN B-PP
both CC O
basal JJ B-NP
and CC O
T3-values NNS B-NP
. . O

The DT B-NP
log10Kd NN I-NP
increased VBD B-VP
0.304 CD B-NP
+\/- CC I-NP
0.139 CD I-NP
( ( O
p NN B-NP
&lt; JJR B-NP
0.04 CD I-NP
) ) O
and CC O
the DT B-NP
log10MBC NN I-NP
increased VBD B-VP
0.49 CD B-NP
+\/- CC I-NP
0.10 CD I-NP
( ( O
p NN B-NP
&lt; JJR B-NP
0.001 CD I-NP
) ) O
in IN B-PP
the DT B-NP
T3+ JJ I-NP
subjects NNS I-NP
compared VBN B-PP
to TO B-PP
baseline NN B-NP
. . O

This DT B-NP
change NN I-NP
in IN B-PP
MBC NN B-NP
represents VBZ B-VP
a DT B-NP
311 CD I-NP
% NN I-NP
increase NN I-NP
in IN B-PP
the DT B-NP
MBC NN I-NP
over IN B-PP
baseline NN B-NP
and CC O
a DT B-NP
fivefold JJ I-NP
increase NN I-NP
over IN B-PP
placebo-treated JJ B-NP
subjects NNS I-NP
. . O

The DT B-NP
T3- JJ I-NP
group NN I-NP
showed VBD B-VP
no DT B-NP
change NN I-NP
in IN B-PP
MBC NN B-NP
over IN B-PP
the DT B-NP
study NN I-NP
. . O

These DT B-NP
results NNS I-NP
describe VBP B-VP
for IN B-PP
the DT B-NP
first JJ I-NP
time NN I-NP
the DT B-NP
rapid JJ I-NP
modulation NN I-NP
of IN B-PP
the DT B-NP
NT3R NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
the DT B-NP
combined JJ I-NP
influence NN I-NP
of IN B-PP
cold JJ B-NP
exposure NN I-NP
and CC O
reduced VBN B-NP
circulating VBG I-NP
T4 NN B-NP
and CC O
TSH NN B-NP
. . O

BCL-6 NN B-NP
and CC O
the DT B-NP
molecular JJ I-NP
pathogenesis NN I-NP
of IN B-PP
B-cell NN B-NP
lymphoma NN I-NP
. . O

The DT B-NP
results NNS I-NP
presented VBN B-VP
identify VBP B-VP
the DT B-NP
first JJ I-NP
genetic JJ I-NP
lesion NN I-NP
associated VBN B-VP
with IN B-PP
DLCL NN B-NP
COMMA COMMA O
the DT B-NP
most RBS I-NP
clinically RB I-NP
relevant JJ I-NP
form NN I-NP
of IN B-PP
NHL NN B-NP
. . O

Although IN B-SBAR
no DT B-NP
proof NN I-NP
yet RB B-ADVP
exists VBZ B-VP
of IN B-PP
a DT B-NP
role NN I-NP
for IN B-PP
these DT B-NP
lesions NNS I-NP
in IN B-PP
DLCL NN B-NP
pathogenesis NN I-NP
COMMA COMMA O
the DT B-NP
feature NN I-NP
of IN B-PP
the DT B-NP
BCL-6 NN I-NP
gene NN I-NP
product NN I-NP
COMMA COMMA O
its PRP$ B-NP
specific JJ I-NP
pattern NN I-NP
of IN B-PP
expression NN B-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
COMMA COMMA O
and CC O
the DT B-NP
clustering NN I-NP
of IN B-PP
lesions NNS B-NP
disrupting VBG B-VP
its PRP$ B-NP
regulatory JJ I-NP
domain NN I-NP
strongly RB B-ADVP
suggest VBP B-VP
that IN B-SBAR
deregulation NN B-NP
of IN B-PP
BCL-6 NN B-NP
expression NN I-NP
may MD B-VP
contribute VB I-VP
to TO B-PP
DLCL NN B-NP
development NN I-NP
. . O

A DT B-NP
more RBR I-NP
precise JJ I-NP
definition NN I-NP
of IN B-PP
the DT B-NP
role NN I-NP
of IN B-PP
BCL-6 NN B-NP
in IN B-PP
normal JJ B-NP
and CC I-NP
neoplastic JJ I-NP
B-cell NN I-NP
development NN I-NP
is VBZ B-VP
the DT B-NP
goal NN I-NP
of IN B-PP
ongoing JJ B-NP
study NN I-NP
of IN B-PP
transgenic JJ B-NP
mice NNS I-NP
engineered VBN B-VP
either CC O
to TO B-VP
express VB I-VP
BCL-6 NN B-NP
under IN B-PP
heterologous JJ B-NP
promoters NNS I-NP
or CC O
lacking VBG B-VP
BCL-6 NN B-NP
function NN I-NP
due JJ B-PP
to TO I-PP
targeted VBN B-NP
deletions NNS I-NP
. . O

In IN B-PP
addition NN I-PP
to TO I-PP
contributing VBG B-VP
to TO B-PP
the DT B-NP
understanding NN I-NP
of IN B-PP
DLCL NN B-NP
pathogenesis NN I-NP
COMMA COMMA O
the DT B-NP
identification NN I-NP
of IN B-PP
BCL-6 NN B-NP
lesions NNS I-NP
may MD B-VP
have VB I-VP
relevant JJ B-NP
clinical JJ I-NP
implications NNS I-NP
. . O

DLCL NN B-NP
represent VBP B-VP
a DT B-NP
heterogeneous JJ I-NP
group NN I-NP
of IN B-PP
neoplasms NNS B-NP
which WDT B-NP
are VBP B-VP
treated VBN I-VP
homogeneously RB B-ADVP
despite IN B-PP
the DT B-NP
fact NN I-NP
that IN B-SBAR
only RB B-NP
50 CD I-NP
% NN I-NP
of IN B-PP
patients NNS B-NP
experience VBP B-VP
long-term JJ B-NP
disease-free JJ I-NP
survival NN I-NP
( ( O
Schneider NNP B-NP
et FW B-ADVP
al. FW I-ADVP
1990 CD B-NP
) ) O
. . O

The DT B-NP
fact NN I-NP
that IN B-SBAR
BCL-6 NN B-NP
rearrangements NNS I-NP
identify VBP B-VP
biologically RB B-ADVP
and CC B-ADVP
clinically RB B-ADVP
distinct JJ B-NP
subsets NNS I-NP
of IN B-PP
DLCL NN B-NP
suggests VBZ B-VP
that IN B-SBAR
these DT B-NP
lesions NNS I-NP
may MD B-VP
be VB I-VP
useful JJ B-ADJP
as IN B-PP
markers NNS B-NP
in IN B-PP
selection NN B-NP
of IN B-PP
differential JJ B-NP
therapeutic JJ I-NP
strategies NNS I-NP
based VBN B-PP
on IN B-PP
different JJ B-NP
risk NN I-NP
groups NNS I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
the DT B-NP
BCL-6 NN I-NP
rearrangements NNS I-NP
can MD B-VP
be VB I-VP
used VBN I-VP
to TO B-VP
identify VB I-VP
and CC O
monitor VB B-VP
the DT B-NP
malignant JJ I-NP
clone NN I-NP
with IN B-PP
sensitive JJ B-NP
PCR-based JJ I-NP
techniques NNS I-NP
. . O

Since IN B-SBAR
clinical JJ B-NP
remission NN I-NP
has VBZ B-VP
been VBN I-VP
observed VBN I-VP
in IN B-PP
a DT B-NP
significant JJ I-NP
fraction NN I-NP
of IN B-PP
DLCL NN B-NP
cases NNS I-NP
COMMA COMMA O
these DT B-NP
markers NNS I-NP
may MD B-VP
serve VB I-VP
as IN B-PP
critical JJ B-NP
tools NNS I-NP
for IN B-PP
sensitive JJ B-NP
monitoring NN I-NP
of IN B-PP
minimal JJ B-NP
residual JJ I-NP
disease NN I-NP
and CC O
early JJ B-NP
diagnosis NN I-NP
of IN B-PP
relapse NN B-NP
( ( O
Gribben NNP B-NP
et FW B-ADVP
al. FW I-ADVP
1993 CD B-NP
) ) O
. . O

Selective JJ B-NP
effects NNS I-NP
of IN B-PP
DNA NN B-NP
damaging NN I-NP
agents NNS I-NP
on IN B-PP
HIV NN B-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
activation NN I-NP
and CC O
virus NN B-NP
replication NN I-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

Much JJ B-NP
attention NN I-NP
has VBZ B-VP
recently RB I-VP
focused VBN I-VP
on IN B-PP
the DT B-NP
observation NN I-NP
that IN B-SBAR
UV NN B-NP
light NN I-NP
can MD B-VP
activate VB I-VP
the DT B-NP
long JJ I-NP
terminal JJ I-NP
repeat NN I-NP
( ( O
LTR NN B-NP
) ) O
of IN B-PP
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
( ( O
HIV NN B-NP
) ) O
. . O

Although IN B-SBAR
the DT B-NP
mechanism NN I-NP
of IN B-PP
LTR NN B-NP
activation NN I-NP
remains VBZ B-VP
obscure JJ B-ADJP
COMMA COMMA O
several JJ B-NP
lines NNS I-NP
of IN B-PP
investigation NN B-NP
have VBP B-VP
suggested VBN I-VP
that IN B-SBAR
it PRP B-NP
is VBZ B-VP
a DT B-NP
result NN I-NP
of IN B-PP
activation NN B-NP
of IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
transcription NN I-NP
factor NN I-NP
( ( I-NP
s NNS I-NP
) ) O
following VBG B-PP
signaling NN B-NP
events NNS I-NP
related JJ B-ADJP
to TO B-PP
generalized VBN B-NP
DNA NN I-NP
damage NN I-NP
. . O

In IN B-PP
this DT B-NP
report NN I-NP
COMMA COMMA O
we PRP B-NP
present VBP B-VP
data NNS B-NP
demonstrating NN B-VP
that IN B-SBAR
HIV NN B-NP
LTR NN I-NP
activation NN I-NP
is VBZ B-VP
not RB B-NP
a DT B-NP
general JJ I-NP
consequence NN I-NP
of IN B-PP
cellular JJ B-NP
DNA NN I-NP
damage NN I-NP
COMMA COMMA O
but CC B-CONJP
rather RB I-CONJP
a DT B-NP
process NN I-NP
unique JJ B-ADJP
to TO B-PP
specific JJ B-NP
genotoxic JJ I-NP
stimuli NNS I-NP
COMMA COMMA O
and CC O
that IN B-SBAR
it PRP B-NP
does VBZ B-VP
not RB I-VP
necessarily RB I-VP
depend VB I-VP
on IN B-PP
activation NN B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
several JJ B-NP
of IN B-PP
these DT B-NP
agents NNS I-NP
can MD B-VP
significantly RB I-VP
increase VB I-VP
HIV NN B-NP
replication NN I-NP
and CC O
accelerate VB B-VP
CD4-positive JJ B-NP
lymphocyte NN I-NP
cytotoxicity NN I-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

These DT B-NP
findings NNS I-NP
COMMA COMMA O
therefore RB B-ADVP
COMMA COMMA O
could MD B-VP
have VB I-VP
clinical JJ B-NP
significance NN I-NP
to TO B-PP
AIDS NN B-NP
patients NNS I-NP
with IN B-PP
malignancies NNS B-NP
who WP B-NP
are VBP B-VP
undergoing VBG I-VP
radiotherapy NN B-NP
and CC O
chemotherapy NN B-NP
. . O

Characterization NN B-NP
and CC O
purification NN B-NP
of IN B-PP
a DT B-NP
protein NN I-NP
kinase NN I-NP
C NN I-NP
substrate NN I-NP
in IN B-PP
human JJ B-NP
B NN I-NP
cells NNS I-NP
. . O

Identification NN B-NP
as IN B-PP
lymphocyte-specific JJ B-NP
protein NN I-NP
1 CD I-NP
( ( O
LSP1 NN B-NP
) ) O
. . O

Incubation NN B-NP
of IN B-PP
B-chronic JJ B-NP
lymphocytic JJ I-NP
leukemia NN I-NP
( ( O
B-CLL NN B-NP
) ) O
cells NNS B-NP
with IN B-PP
phorbol NN B-NP
esters NNS I-NP
resulted VBD B-VP
in IN B-PP
the DT B-NP
phosphorylation NN I-NP
of IN B-PP
two CD B-NP
major JJ I-NP
PKC NN I-NP
substrates NNS I-NP
COMMA COMMA O
MARCKS NN B-NP
( ( O
myristoylated VBN B-NP
COMMA COMMA I-NP
alanine-rich JJ I-NP
C NN I-NP
kinase NN I-NP
substrate NN I-NP
) ) O
and CC O
MRP NN B-NP
( ( O
MARCKS-related JJ B-NP
protein NN I-NP
) ) O
COMMA COMMA O
and CC B-PP
of IN B-PP
a DT B-NP
third JJ I-NP
protein NN I-NP
COMMA COMMA O
with IN B-PP
an DT B-NP
apparent JJ I-NP
m.w. NN I-NP
of IN B-PP
60COMMA000 CD B-NP
that WDT B-NP
was VBD B-VP
the DT B-NP
most RBS I-NP
prominent JJ I-NP
protein NN I-NP
kinase NN I-NP
C NN I-NP
substrate NN I-NP
in IN B-PP
these DT B-NP
cells NNS I-NP
. . O

p60 NN B-NP
phosphorylation NN I-NP
was VBD B-VP
time NN B-NP
and CC O
PMA NN B-NP
dose NN I-NP
dependent JJ B-ADJP
COMMA COMMA O
and CC O
was VBD B-VP
induced VBN I-VP
by IN B-PP
cell-permeable JJ B-NP
diacylglycerol NN I-NP
COMMA COMMA B-PP
but CC I-PP
not RB B-PP
by IN I-PP
inactive JJ B-NP
phorbol NN I-NP
esters NNS I-NP
. . O

Two-dimensional JJ B-NP
electrophoretic JJ I-NP
analysis NN I-NP
of IN B-PP
the DT B-NP
protein NN I-NP
phosphorylation NN I-NP
pattern NN I-NP
from IN B-PP
the DT B-NP
B NN I-NP
cell NN I-NP
line NN I-NP
CESS NN I-NP
demonstrated VBD B-VP
the DT B-NP
identity NN I-NP
between IN B-PP
the DT B-NP
p60 NN I-NP
protein NN I-NP
expressed VBN B-VP
in IN B-PP
this DT B-NP
cell NN I-NP
line NN I-NP
and CC O
that DT B-NP
expressed VBN B-VP
in IN B-PP
B-CLL NN B-NP
cells NNS I-NP
. . O

p60 NN B-NP
was VBD B-VP
purified VBN I-VP
from IN B-PP
CESS NN B-NP
cells NNS I-NP
and CC O
peptide NN B-NP
microsequencing NN I-NP
of IN B-PP
this DT B-NP
protein NN I-NP
revealed VBD B-VP
that IN B-SBAR
it PRP B-NP
was VBD B-VP
lymphocyte-specific JJ B-NP
protein NN I-NP
1 CD I-NP
( ( O
LSP1 NN B-NP
) ) O
COMMA COMMA O
that WDT B-NP
is VBZ B-VP
here RB I-VP
characterized VBN I-VP
as IN B-PP
the DT B-NP
most RBS I-NP
prominent JJ I-NP
protein NN I-NP
kinase NN I-NP
C NN I-NP
substrate JJ I-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
. . O

Differential JJ B-NP
regulation NN I-NP
of IN B-PP
IL-6 NN B-NP
gene NN I-NP
transcription NN B-NP
and CC O
expression NN B-NP
by IN B-PP
IL-4 NN B-NP
and CC O
IL-10 NN B-NP
in IN B-PP
human JJ B-NP
monocytic JJ I-NP
cell NN I-NP
lines NNS I-NP
. . O

IL-4 NN B-NP
and CC O
IL-10 NN B-NP
inhibit VBP B-VP
the DT B-NP
cytokine NN B-NP
production NN I-NP
and CC O
mRNA NN B-NP
expression NN I-NP
by IN B-PP
monocytes\/macrophages NNS B-NP
. . O

To TO B-VP
investigate VB I-VP
the DT B-NP
molecular JJ I-NP
mechanism NN I-NP
of IN B-PP
the DT B-NP
inhibitory JJ I-NP
effect NN I-NP
on IN B-PP
transcriptional JJ B-NP
or CC I-NP
post-transcriptional JJ I-NP
regulation NN I-NP
of IN B-PP
IL-6 NN B-NP
gene NN I-NP
expression NN I-NP
by IN B-PP
IL-4 NN B-NP
and CC O
IL-10 NN B-NP
COMMA COMMA O
we PRP B-NP
studied VBD B-VP
IL-6 NN B-NP
production NN I-NP
COMMA COMMA O
expression NN B-NP
level NN I-NP
of IN B-PP
IL-6 NN B-NP
mRNA NN I-NP
COMMA COMMA O
IL-6 NN B-NP
promoter NN I-NP
activity NN I-NP
COMMA COMMA O
transcriptional JJ B-NP
activity NN I-NP
of IN B-PP
NF-kappaB NN B-NP
and CC O
NF-IL-6 NN B-NP
COMMA COMMA O
and CC O
IL-6 NN B-NP
mRNA NN I-NP
stability NN I-NP
in IN B-PP
human JJ B-NP
monocytic JJ I-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
THP-1 NN B-NP
and CC O
U937 NN B-NP
COMMA COMMA O
stimulated VBN B-VP
by IN B-PP
PMA NN B-NP
and CC O
LPS NN B-NP
in IN B-PP
the DT B-NP
absence NN I-NP
or CC O
the DT B-NP
presence NN I-NP
of IN B-PP
IL-4 NN B-NP
or CC O
IL-10 NN B-NP
. . O

Both CC O
IL-4 NN B-NP
and CC O
IL-10 NN B-NP
were VBD B-VP
seen VBN I-VP
to TO I-VP
inhibit VB I-VP
IL-6 NN B-NP
production NN I-NP
and CC O
the DT B-NP
expression NN I-NP
of IN B-PP
IL-6 NN B-NP
mRNA NN I-NP
in IN B-PP
both DT B-NP
monocytic JJ I-NP
cell NN I-NP
lines NNS I-NP
studied VBN B-VP
. . O

In IN B-PP
chloramphenicol NN B-NP
acetyltransferase NN I-NP
assays NNS I-NP
COMMA COMMA O
utilizing VBG B-VP
the DT B-NP
transient JJ I-NP
transfection NN I-NP
of IN B-PP
a DT B-NP
chloramphenicol NN I-NP
acetyltransferase NN I-NP
reporter NN I-NP
plasmid NN I-NP
containing VBG B-VP
the DT B-NP
IL-6 NN I-NP
gene NN I-NP
promoter NN I-NP
COMMA COMMA O
IL-4 NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
IL-10 NN B-NP
COMMA COMMA O
suppressed VBD B-VP
the DT B-NP
transcriptional JJ I-NP
activity NN I-NP
of IN B-PP
the DT B-NP
IL-6 NN I-NP
gene NN I-NP
promoter NN I-NP
stimulated VBN B-VP
by IN B-PP
PMA NN B-NP
and CC O
LPS NN B-NP
. . O

Electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
showed VBD B-VP
that IN B-SBAR
IL-4 NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
IL-10 NN B-NP
COMMA COMMA O
inhibited VBD B-VP
nuclear JJ B-NP
NF-kappaB NN I-NP
activity NN I-NP
COMMA COMMA O
and CC O
that IN B-SBAR
IL-4 NN B-NP
and CC O
IL-10 NN B-NP
did VBD B-VP
not RB I-VP
affect VB I-VP
NF-IL-6 NN B-NP
activity NN I-NP
. . O

On IN B-PP
the DT B-NP
other JJ I-NP
hand NN I-NP
COMMA COMMA O
IL-10 NN B-NP
enhanced VBD B-VP
the DT B-NP
degradation NN I-NP
of IN B-PP
IL-6 NN B-NP
mRNA NN I-NP
in IN B-PP
a DT B-NP
mRNA NN I-NP
stability NN I-NP
assay NN I-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
IL-4 NN B-NP
may MD B-VP
inhibit VB I-VP
the DT B-NP
transcription NN I-NP
of IN B-PP
the DT B-NP
IL-6 NN I-NP
gene NN I-NP
by IN B-PP
affecting VBG B-VP
NF-kappaB NN B-NP
binding NN I-NP
activity NN I-NP
COMMA COMMA O
while IN B-SBAR
IL-10 NN B-NP
may MD B-VP
inhibit VB I-VP
the DT B-NP
IL-6 NN I-NP
mRNA NN I-NP
levels NNS I-NP
post-transcriptionally RB B-ADVP
COMMA COMMA O
without IN B-PP
suppressing VBG B-VP
promoter NN B-NP
activity NN I-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
we PRP B-NP
conclude VBP B-VP
that IN B-SBAR
IL-4 NN B-NP
and CC O
IL-10 NN B-NP
inhibit VBP B-VP
IL-6 NN B-NP
production NN I-NP
by IN B-PP
different JJ B-NP
mechanisms NNS I-NP
in IN B-PP
human JJ B-NP
monocytic JJ I-NP
cell NN I-NP
lines NNS I-NP
. . O

IL-13 NN B-NP
induces VBZ B-VP
phosphorylation NN B-NP
and CC O
activation NN B-NP
of IN B-PP
JAK2 NN B-NP
Janus NN I-NP
kinase NN I-NP
in IN B-PP
human JJ B-NP
colon NN I-NP
carcinoma NN I-NP
cell NN I-NP
lines NNS I-NP
: : O
similarities NNS B-NP
between IN B-PP
IL-4 NN B-NP
and CC O
IL-13 NN B-NP
signaling NN B-NP
. . O

We PRP B-NP
have VBP B-VP
recently RB I-VP
reported VBN I-VP
that IN B-SBAR
IL-13R NN B-NP
may MD B-VP
share VB I-VP
a DT B-NP
component NN I-NP
with IN B-PP
IL-4R NN B-NP
. . O

Here RB B-ADVP
we PRP B-NP
report VBP B-VP
that IN B-SBAR
both CC O
IL-4 NN B-NP
and CC O
IL-13 NN B-NP
share VBP B-VP
signaling NN B-NP
events NNS I-NP
in IN B-PP
human JJ B-NP
colon NN I-NP
carcinoma NN I-NP
cell NN I-NP
lines NNS I-NP
( ( O
HT-29 NN B-NP
and CC O
WiDr NN B-NP
) ) O
. . O

IL-13 NN B-NP
caused VBD B-VP
rapid JJ B-NP
phosphorylation NN I-NP
of IN B-PP
the DT B-NP
three CD I-NP
out IN I-NP
of IN I-NP
four CD I-NP
members NNS I-NP
of IN B-PP
the DT B-NP
known JJ I-NP
Janus NN B-NP
family NN I-NP
of IN B-PP
kinases NNS B-NP
( ( O
JAKs NNS B-NP
) ) O
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
JAK2 NN B-NP
kinase NN I-NP
is VBZ B-VP
rapidly RB I-VP
phosphorylated VBN I-VP
and CC O
activated VBN B-VP
in IN B-PP
response NN I-PP
to TO I-PP
IL-13 NN B-NP
. . O

Within IN B-PP
1 CD B-NP
min NN I-NP
of IN B-PP
activation NN B-NP
COMMA COMMA O
JAK2 NN B-NP
was VBD B-VP
phosphorylated VBN I-VP
COMMA COMMA O
and CC O
peaked VBD B-VP
in IN B-PP
10 CD B-NP
min NN I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
IL-13 NN B-NP
phosphorylated VBD B-VP
insulin NN B-NP
response NN I-NP
substrate-1 NN I-NP
COMMA COMMA O
IL-4R NN B-NP
p140 NN I-NP
COMMA COMMA O
JAK1 NN B-NP
COMMA COMMA O
and CC O
Tyk2 NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
JAK3 NN B-NP
kinase NN I-NP
. . O

IL-4 NN B-NP
also RB B-ADVP
stimulated VBD B-VP
all DT B-NP
three CD I-NP
kinases NNS B-NP
and CC O
substrates NNS B-NP
COMMA COMMA O
but CC O
unlike IN B-PP
in IN B-PP
immune JJ B-NP
cells NNS I-NP
COMMA COMMA O
IL-4 NN B-NP
did VBD B-VP
not RB I-VP
involve VB I-VP
JAK3 NN B-NP
activation NN I-NP
for IN B-PP
its PRP$ B-NP
signaling NN I-NP
in IN B-PP
colon NN B-NP
cancer NN I-NP
cell NN I-NP
lines NNS I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
JAK2 NN B-NP
associated VBN B-VP
with IN B-PP
the DT B-NP
IL-4R NN I-NP
p140 NN I-NP
before IN B-PP
and CC B-PP
after IN B-PP
stimulation NN B-NP
with IN B-PP
IL-13 NN B-NP
. . O

Both CC O
IL-13 NN B-NP
and CC O
IL-4 NN B-NP
induced VBD B-VP
phosphorylation NN B-NP
of IN B-PP
IL-4 NN B-NP
STAT NN I-NP
( ( O
STAT6 NN B-NP
) ) O
but CC B-CONJP
not RB I-CONJP
STAT1 NN B-NP
COMMA COMMA O
STAT3 NN B-NP
COMMA COMMA O
or CC O
STAT5 NN B-NP
. . O

125I-IL-13 NN B-NP
did VBD B-VP
not RB I-VP
bind VB I-VP
to TO B-PP
colon NN B-NP
cancer NN I-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
but CC O
unlabeled JJ B-NP
IL-13 NN I-NP
competed VBD B-VP
for IN B-PP
the DT B-NP
binding NN I-NP
of IN B-PP
125I-IL-4 NN B-NP
. . O

Our PRP$ B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
IL-13 NN B-NP
utilizes VBZ B-VP
IL-4R NN B-NP
and CC O
its PRP$ B-NP
signaling NN I-NP
pathway NN I-NP
COMMA COMMA O
and CC O
JAK2 NN B-NP
may MD B-VP
play VB I-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
function NN I-NP
of IN B-PP
IL-4R NN B-NP
and CC O
IL-13R NN B-NP
in IN B-PP
colon NN B-NP
cancer NN I-NP
cells NNS I-NP
. . O

Effects NNS B-NP
of IN B-PP
interleukin-10 NN B-NP
on IN B-PP
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
mononuclear JJ I-NP
cell NN I-NP
responses NNS I-NP
to TO B-PP
Cryptococcus NN B-NP
neoformans NNS I-NP
COMMA COMMA O
Candida NN B-NP
albicans NNS I-NP
COMMA COMMA O
and CC O
lipopolysaccharide NN B-NP
. . O

Deactivation NN B-NP
of IN B-PP
mononuclear JJ B-NP
phagocytes NNS I-NP
is VBZ B-VP
critical JJ B-ADJP
to TO B-VP
limit VB I-VP
the DT B-NP
inflammatory JJ I-NP
response NN I-NP
but CC O
can MD B-VP
be VB I-VP
detrimental JJ B-ADJP
in IN B-PP
the DT B-NP
face NN I-NP
of IN B-PP
progressive JJ B-NP
infection NN I-NP
. . O

We PRP B-NP
compared VBD B-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
the DT B-NP
deactivating VBG I-NP
cytokine NN I-NP
interleukin NN B-NP
10 CD I-NP
( ( O
IL-10 NN B-NP
) ) O
on IN B-PP
human JJ O
peripheral JJ B-NP
blood NN I-NP
mononuclear JJ I-NP
cell NN I-NP
( ( O
PBMC NN B-NP
) ) O
responses NNS B-NP
to TO B-PP
lipopolysaccharide NN B-NP
( ( O
LPS NN B-NP
) ) O
COMMA COMMA O
Cryptococcus NN B-NP
neoformans NNS I-NP
COMMA COMMA O
and CC O
Candida NN B-NP
albicans NNS I-NP
. . O

IL-10 NN B-NP
effected VBD B-VP
dose-dependent JJ B-NP
inhibition NN I-NP
of IN B-PP
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
( ( O
TNF-alpha NN B-NP
) ) O
release NN B-NP
in IN B-PP
PBMC NN B-NP
stimulated VBN B-VP
by IN B-PP
LPS NN B-NP
and CC O
C. FW B-NP
neoformans FW I-NP
COMMA COMMA O
with IN B-SBAR
significant JJ B-NP
inhibition NN I-NP
seen VBN B-VP
with IN B-PP
0.1 CD B-NP
U\/ml NN I-NP
and CC O
greater JJR B-NP
than IN I-NP
90 CD I-NP
% NN I-NP
inhibition NN B-NP
noted VBN B-VP
with IN B-PP
10 CD B-NP
U\/ml NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
even RB B-PP
at IN I-PP
doses NNS B-NP
as RB B-NP
high JJ I-NP
as IN I-NP
100 CD I-NP
U\/ml NN I-NP
COMMA COMMA O
IL-10 NN B-NP
inhibited VBD B-VP
TNF-alpha NN B-NP
release NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
C. FW B-NP
albicans FW I-NP
by IN B-NP
only RB B-NP
50 CD I-NP
% NN I-NP
. . O

IL-10 NN B-NP
profoundly RB B-ADVP
inhibited VBD B-VP
release NN B-NP
of IN B-PP
IL-1beta NN B-NP
from IN B-PP
PBMC NN B-NP
stimulated VBN B-VP
by IN B-PP
all DT B-NP
three CD I-NP
stimuli NNS I-NP
. . O

TNF-alpha NN B-NP
mRNA NN I-NP
and CC I-NP
release NN I-NP
was VBD B-VP
inhibited VBN I-VP
even RB B-SBAR
if IN I-SBAR
IL-10 NN B-NP
was VBD B-VP
added VBN I-VP
up RP B-NP
to TO I-NP
8 CD I-NP
h NN I-NP
after IN B-PP
cryptococcal JJ B-NP
stimulation NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
inhibition NN B-NP
of IN B-PP
IL-1 NN B-NP
beta NN I-NP
mRNA NN I-NP
was VBD B-VP
of IN B-PP
lesser JJR B-NP
magnitude NN I-NP
and CC O
occurred VBD B-VP
only RB B-ADVP
when WRB I-ADVP
IL-10 NN B-NP
was VBD B-VP
added VBN I-VP
within IN B-PP
2 CD B-NP
h NN I-NP
of IN B-PP
cryptococcal JJ B-NP
stimulation NN I-NP
. . O

IL-10 NN B-NP
inhibited VBD B-VP
translocation NN B-NP
of IN B-PP
NF-kappaB NN B-NP
in IN B-PP
response NN I-PP
to TO I-PP
LPS NN B-NP
but CC B-CONJP
not RB I-CONJP
the DT B-NP
fungal JJ I-NP
stimuli NNS I-NP
. . O

All DT B-NP
three CD I-NP
stimuli NNS I-NP
induced VBD B-VP
IL-10 NN B-NP
production NN I-NP
in IN B-PP
PBMC NN B-NP
COMMA COMMA O
although IN B-SBAR
over IN B-NP
10-fold RB I-NP
less JJR I-NP
IL-10 NN I-NP
was VBD B-VP
released VBN I-VP
in IN B-PP
response NN I-PP
to TO I-PP
C. FW B-NP
neoformans FW I-NP
compared VBN B-PP
with IN B-PP
LPS NN B-NP
and CC O
C. NN B-NP
albicans NNS I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
while IN B-SBAR
IL-10 NN B-NP
has VBZ B-VP
deactivating VBG B-NP
effects NNS I-NP
on IN B-PP
PBMC NN B-NP
responses NNS I-NP
to TO B-PP
all DT B-NP
three CD I-NP
stimuli NNS I-NP
COMMA COMMA O
disparate JJ O
stimulus- NN B-NP
and CC O
response-specific JJ B-ADJP
patterns NNS B-NP
of IN B-PP
deactivation NN B-NP
are VBP B-VP
seen VBN I-VP
. . O

Inhibition NN B-NP
by IN B-PP
IL-10 NN B-NP
of IN B-PP
proinflammatory JJ B-NP
cytokine NN I-NP
release NN I-NP
appears VBZ B-VP
to TO I-VP
occur VB I-VP
at IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
gene NN B-NP
transcription NN I-NP
for IN B-PP
TNF-alpha NN B-NP
and CC O
both CC O
transcriptionally RB B-ADVP
and CC B-ADVP
posttranscriptionally RB B-ADVP
for IN B-PP
IL-1beta NN B-NP
. . O

Activation NN B-NP
of IN B-PP
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
in IN B-PP
a DT B-NP
cyclosporin NN I-NP
A-resistant JJ I-NP
pathway NN I-NP
. . O

The DT B-NP
mechanism NN I-NP
of IN B-PP
action NN B-NP
of IN B-PP
the DT B-NP
immunosuppressive JJ I-NP
drug NN I-NP
cyclosporin NN B-NP
A NN I-NP
( ( O
CsA NN B-NP
) ) O
is VBZ B-VP
the DT B-NP
inactivation NN I-NP
of IN B-PP
the DT B-NP
Ca2+\/calmodulin-dependent JJ I-NP
serine-threonine NN I-NP
phosphatase NN I-NP
calcineurin NN I-NP
by IN B-PP
the DT B-NP
drug-immunophilin JJ I-NP
complex NN I-NP
. . O

Inactive JJ B-NP
calcineurin NN I-NP
is VBZ B-VP
unable JJ B-ADJP
to TO B-VP
activate VB I-VP
the DT B-NP
nuclear JJ I-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
( ( O
NFAT NN B-NP
) ) O
COMMA COMMA O
a DT B-NP
transcription NN I-NP
factor NN I-NP
required VBN B-VP
for IN B-PP
expression NN B-NP
of IN B-PP
the DT O
interleukin NN B-NP
2 CD I-NP
( ( O
IL-2 NN B-NP
) ) O
gene NN B-NP
. . O

IL-2 NN B-NP
production NN I-NP
by IN B-PP
CsA-treated JJ B-NP
cells NNS I-NP
is VBZ B-VP
therefore RB I-VP
dramatically RB I-VP
reduced VBN I-VP
. . O

We PRP B-NP
demonstrate VBP B-VP
here RB B-ADVP
COMMA COMMA O
however RB B-ADVP
COMMA COMMA O
that IN B-SBAR
NFAT NN B-NP
can MD B-VP
be VB I-VP
activated VBN I-VP
COMMA COMMA O
and CC O
significant JJ B-NP
levels NNS I-NP
of IN B-PP
IL-2 NN B-NP
can MD B-VP
be VB I-VP
produced VBN I-VP
by IN B-PP
the DT B-NP
CsA-resistant JJ I-NP
CD28-signaling JJ I-NP
pathway NN I-NP
. . O

In IN B-PP
transient JJ B-NP
transfection NN I-NP
assays NNS I-NP
COMMA COMMA O
both CC O
multicopy JJ B-NP
NFAT- NN I-NP
and CC O
IL-2 NN B-NP
promoter-beta-galactosidase NN I-NP
reporter NN I-NP
gene NN I-NP
constructs NNS B-NP
could MD B-VP
be VB I-VP
activated VBN I-VP
by IN B-PP
phorbol NN B-NP
12-myristate NN I-NP
13-acetate NN I-NP
( ( I-NP
PMA NN I-NP
) ) I-NP
\/alpha-CD28 NN I-NP
stimulation NN I-NP
COMMA COMMA O
and CC O
this DT B-NP
activation NN I-NP
was VBD B-VP
resistant JJ B-ADJP
to TO B-PP
CsA NN B-NP
. . O

Electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assay NN I-NP
showed VBD B-VP
the DT B-NP
induction NN I-NP
of IN B-PP
a DT B-NP
CsA-resistant JJ I-NP
NFAT NN I-NP
complex NN I-NP
in IN B-PP
the DT B-NP
nuclear JJ I-NP
extracts NNS I-NP
of IN B-PP
peripheral JJ B-NP
blood NN I-NP
T NN I-NP
cells NNS I-NP
stimulated VBN B-VP
with IN B-PP
PMA NN B-NP
plus CC O
alphaCD28 NN B-NP
. . O

Peripheral JJ B-NP
blood NN I-NP
T NN I-NP
cells NNS I-NP
stimulated VBN B-VP
with IN B-PP
PMA\/alphaCD28 NN B-NP
produced VBD B-VP
IL-2 NN B-NP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
CsA NN B-NP
. . O

Collectively RB B-ADVP
COMMA COMMA O
these DT B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
NFAT NN B-NP
can MD B-VP
be VB I-VP
activated VBN I-VP
and CC O
IL-2 NN B-NP
can MD B-VP
be VB I-VP
produced VBN I-VP
in IN B-PP
a DT B-NP
calcineurin NN I-NP
independent JJ I-NP
manner NN I-NP
. . O

Age-related JJ B-NP
decreases NNS I-NP
in IN B-PP
IL-2 NN B-NP
production NN I-NP
by IN B-PP
human JJ B-NP
T NN I-NP
cells NNS I-NP
are VBP B-VP
associated VBN I-VP
with IN B-PP
impaired JJ B-NP
activation NN I-NP
of IN B-PP
nuclear JJ B-NP
transcriptional JJ I-NP
factors NNS I-NP
AP-1 NN B-NP
and CC O
NF-AT NN B-NP
. . O

Although IN B-SBAR
transcriptional JJ B-NP
factors NNS I-NP
AP-1 NN I-NP
and CC O
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
( ( O
NF-AT NN B-NP
) ) O
are VBP B-VP
important JJ B-ADJP
for IN B-PP
the DT B-NP
normal JJ I-NP
induction NN I-NP
of IN B-PP
IL-2 NN B-NP
COMMA COMMA O
it PRP B-NP
is VBZ B-VP
unknown JJ B-ADJP
if IN B-SBAR
the DT B-NP
age-related JJ I-NP
decline NN I-NP
in IN B-PP
IL-2 NN B-NP
production NN I-NP
by IN B-PP
activated VBN B-NP
human JJ I-NP
T NN I-NP
cells NNS I-NP
may MD B-VP
be VB I-VP
associated VBN I-VP
with IN B-PP
aberrancies NNS B-NP
in IN B-PP
transcriptional JJ B-NP
regulatory JJ I-NP
proteins NNS I-NP
. . O

In IN B-PP
the DT B-NP
current JJ I-NP
studies NNS I-NP
COMMA COMMA O
IL-2 NN B-NP
production NN I-NP
by IN B-PP
T NN B-NP
cells NNS I-NP
from IN B-PP
elderly JJ O
( ( O
mean NN B-NP
78 CD B-NP
years NNS I-NP
) ) O
and CC O
young JJ O
( ( O
mean NN B-NP
37 CD B-NP
years NNS I-NP
) ) O
humans NNS B-NP
was VBD B-VP
measured VBN I-VP
in IN B-PP
cultures NNS B-NP
stimulated VBN B-VP
with IN B-PP
PHA NN B-NP
COMMA COMMA O
PHA NN B-NP
plus CC O
PMA NN B-NP
COMMA COMMA O
crosslinked VBN B-NP
anti-CD3 JJ I-NP
mAB NN I-NP
OKT3 NN I-NP
plus CC O
PMA NN B-NP
COMMA COMMA O
or CC O
PMA NN B-NP
plus CC O
ionomycin NN B-NP
. . O

Substantial JJ B-NP
decreases NNS I-NP
of IN B-PP
IL-2 NN B-NP
production NN I-NP
were VBD B-VP
observed VBN I-VP
for IN B-PP
cell NN B-NP
cultures NNS I-NP
from IN B-PP
7 CD B-NP
of IN I-NP
12 CD I-NP
elderly JJ I-NP
individuals NNS I-NP
in IN B-PP
response NN I-PP
to TO I-PP
the DT B-NP
different JJ I-NP
stimuli NNS I-NP
COMMA COMMA O
whereas IN O
the DT B-NP
levels NNS I-NP
of IN B-PP
IL-2 NN B-NP
produced VBN B-VP
by IN B-PP
stimulated VBN B-NP
T NN I-NP
cells NNS I-NP
from IN B-PP
other JJ B-NP
elderly JJ I-NP
individuals NNS I-NP
were VBD B-VP
equivalent JJ B-ADJP
to TO B-PP
those DT B-NP
observed VBN B-VP
for IN B-PP
stimulated VBN B-NP
T NN I-NP
cells NNS I-NP
of IN B-PP
young JJ B-NP
subjects NNS I-NP
. . O

Analyses NNS B-NP
of IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
by IN B-PP
electrophoretic JJ B-NP
DNA NN I-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
showed VBD B-VP
that IN B-SBAR
decreased VBN B-NP
IL-2 NN I-NP
production NN I-NP
by IN B-PP
stimulated VBN B-NP
T NN I-NP
cells NNS I-NP
of IN B-PP
elderly JJ B-NP
individuals NNS I-NP
was VBD B-VP
closely RB I-VP
associated VBN I-VP
with IN B-PP
impairments NNS B-NP
in IN B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
both CC O
AP-1 NN B-NP
and CC O
NF-AT NN B-NP
. . O

By IN B-PP
contrast NN B-NP
COMMA COMMA O
T NN B-NP
cells NNS I-NP
from IN B-PP
elderly JJ B-NP
subjects NNS I-NP
with IN B-PP
normal JJ B-NP
levels NNS I-NP
of IN B-PP
IL-2 NN B-NP
production NN I-NP
exhibited VBD B-VP
normal JJ B-NP
activation NN I-NP
of IN B-PP
AP-1 NN B-NP
and CC O
NF-AT NN B-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
the DT B-NP
results NNS I-NP
of IN B-PP
competition NN B-NP
experiments NNS I-NP
analyzing VBG B-VP
the DT B-NP
normal JJ I-NP
components NNS I-NP
of IN B-PP
NF-AT NN B-NP
showed VBD B-VP
that IN B-SBAR
the DT B-NP
age-related JJ I-NP
reductions NNS I-NP
in IN B-PP
stimulus-dependent JJ B-NP
NF-AT NN I-NP
complexes NNS I-NP
corresponded VBD B-VP
to TO B-PP
the DT B-NP
slow JJ I-NP
migrating VBG I-NP
complexes NNS I-NP
that WDT B-NP
were VBD B-VP
composed VBN I-VP
of IN B-PP
c-Fos\/c-Jun NN B-NP
AP-1 NN I-NP
. . O

The DT B-NP
resting JJ I-NP
and CC I-NP
stimulated JJ I-NP
levels NNS I-NP
of IN B-PP
NF NN B-NP
kappa NN I-NP
B NN I-NP
were VBD B-VP
reduced VBN I-VP
in IN B-PP
T NN B-NP
cells NNS I-NP
from IN B-PP
certain JJ B-NP
elderly JJ I-NP
individuals NNS I-NP
; : O
however RB B-ADVP
COMMA COMMA O
alterations NNS B-NP
of IN B-PP
NF NN B-NP
kappa NN I-NP
B NN I-NP
did VBD B-VP
not RB I-VP
correlate VB I-VP
with IN B-PP
changes NNS B-NP
in IN B-PP
IL-2 NN B-NP
expression NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
these DT B-NP
results NNS I-NP
show VBP B-VP
that IN B-SBAR
age-related JJ B-NP
impairments NNS I-NP
in IN B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
AP-1 NN B-NP
and CC O
NF-AT NN B-NP
are VBP B-VP
closely RB I-VP
associated VBN I-VP
with IN B-PP
decreased VBN B-NP
expression NN I-NP
of IN B-PP
IL-2 NN B-NP
and CC O
further RB B-VP
suggest VBP I-VP
that IN B-SBAR
aberrancies NNS B-NP
in IN B-PP
the DT B-NP
signaling NN I-NP
pathways NNS I-NP
important JJ B-ADJP
for IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
transcriptionally RB B-NP
active JJ I-NP
c-Fos\/c-Jun NN I-NP
AP-1 NN I-NP
may MD B-VP
contribute VB I-VP
to TO B-PP
the DT B-NP
impaired JJ I-NP
activation NN I-NP
of IN B-PP
NF-AT NN B-NP
. . O

Transcription NN B-NP
factors NNS I-NP
of IN B-PP
T NN B-NP
and CC O
B NN B-NP
lymphocytes NNS B-NP
-- : O
basic JJ B-NP
research NN I-NP
and CC O
clinical JJ B-NP
perspectives NNS I-NP
for IN B-PP
gastroenterology NN B-NP
. . O

Tissue NN B-NP
specific JJ I-NP
regulation NN I-NP
of IN B-PP
gene NN B-NP
expression NN I-NP
by IN B-PP
transcription NN B-NP
factors NNS I-NP
is VBZ B-VP
a DT B-NP
fascinating JJ I-NP
new JJ I-NP
field NN I-NP
in IN B-PP
molecular JJ B-NP
immunology NN I-NP
. . O

This DT B-NP
review NN I-NP
summarizes VBZ B-VP
data NNS B-NP
on IN B-PP
specific JJ B-NP
regulation NN I-NP
of IN B-PP
promoters NNS B-NP
and CC O
enhancers NNS B-NP
by IN B-PP
nuclear JJ B-NP
trans-acting JJ I-NP
factors NNS I-NP
in IN B-PP
lymphocytes NNS B-NP
. . O

The DT B-NP
structural JJ I-NP
classes NNS I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
are VBP B-VP
described VBN I-VP
and CC O
basic JJ B-NP
methods NNS I-NP
for IN B-PP
detection NN B-NP
and CC O
analysis NN B-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
are VBP B-VP
detailed VBN I-VP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
the DT B-NP
most RBS I-NP
important JJ I-NP
trans-acting JJ I-NP
factors NNS I-NP
of IN B-PP
T NN B-NP
and CC O
B NN B-NP
lymphocytes NNS B-NP
( ( O
e.g. FW B-ADVP
NF-kB NN B-NP
COMMA COMMA O
NF-AT NN B-NP
and CC O
STAT NN B-NP
families NNS B-NP
) ) O
and CC O
their PRP$ B-NP
functional JJ I-NP
importance NN I-NP
are VBP B-VP
described VBN I-VP
. . O

Several JJ B-NP
methods NNS I-NP
for IN B-PP
specific JJ B-NP
down-regulation NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
are VBP B-VP
shown VBN I-VP
that IN B-NP
may MD B-VP
be VB I-VP
relevant JJ B-ADJP
to TO B-PP
treatment NN B-NP
of IN B-PP
human JJ B-NP
disease NN I-NP
. . O

The DT B-NP
data NNS I-NP
are VBP B-VP
discussed VBN I-VP
with IN B-PP
regard NN I-PP
to TO I-PP
their PRP$ B-NP
potential JJ I-NP
clinical JJ I-NP
relevance NN I-NP
for IN B-PP
gastroenterology NN B-NP
. . O

Modulation NN B-NP
of IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
IFN-gamma NN I-NP
receptor NN I-NP
beta-chain NN I-NP
controls VBZ B-VP
responsiveness NN B-NP
to TO B-PP
IFN-gamma NN B-NP
in IN B-PP
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
T NN I-NP
cells NNS I-NP
. . O

IFN-gamma NN B-NP
has VBZ B-VP
potent JJ B-NP
antiproliferative JJ I-NP
and CC I-NP
apoptotic JJ I-NP
effects NNS I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
that WDT B-NP
are VBP B-VP
important JJ B-ADJP
in IN B-PP
determining VBG B-VP
T NN B-NP
cell NN I-NP
development NN B-NP
and CC O
polarized VBN B-NP
differentiation NN I-NP
. . O

In IN B-PP
this DT B-NP
work NN I-NP
COMMA COMMA O
we PRP B-NP
show VBP B-VP
that IN B-SBAR
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
T NN I-NP
cells NNS I-NP
that WDT B-NP
are VBP B-VP
stimulated VBN I-VP
through IN B-PP
the DT B-NP
TCR NN I-NP
and CC O
expanded VBN B-VP
with IN B-PP
IL-2 NN B-NP
are VBP B-VP
unresponsive JJ B-ADJP
to TO B-PP
IFN-gamma NN B-NP
COMMA COMMA O
as IN B-SBAR
determined VBN B-VP
by IN B-PP
a DT B-NP
lack NN I-NP
of IN B-PP
activation NN B-NP
of IN B-PP
jak NN B-NP
kinases NNS I-NP
and CC O
the DT B-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
STAT1(alpha) NN B-NP
COMMA COMMA O
a DT B-NP
signal NN I-NP
transducer NN I-NP
and CC O
activator NN B-NP
of IN B-PP
transcription NN B-NP
. . O

Expression NN B-NP
of IN B-PP
the DT B-NP
beta-chain NN I-NP
can MD B-VP
be VB I-VP
restored VBN I-VP
by IN B-PP
secondary JJ B-NP
TCR NN I-NP
ligation NN I-NP
or CC O
PMA NN B-NP
treatment NN I-NP
. . O

T NN B-NP
cell NN I-NP
blasts NNS I-NP
treated VBN B-VP
with IN B-PP
PMA NNS B-NP
are VBP B-VP
now RB B-ADVP
responsive JJ B-ADJP
to TO B-PP
IFN-gamma NN B-NP
. . O

When WRB B-ADVP
freshly RB B-ADVP
isolated VBN B-VP
COMMA COMMA O
highly RB O
enriched VBN O
( ( O
&gt; JJR B-NP
98 CD I-NP
% NN I-NP
) ) O
T NN B-NP
cells NNS I-NP
are VBP B-VP
examined VBN I-VP
for IN B-PP
IFN-gamma NN B-NP
responsiveness NN I-NP
; : O
these DT B-NP
cells NNS I-NP
can MD B-VP
respond VB I-VP
to TO B-PP
IFN-gamma NN B-NP
and CC O
express VB B-VP
beta-chain NN B-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
as IN B-SBAR
T NN B-NP
cells NNS I-NP
progress VBP B-VP
from IN B-PP
primary JJ B-NP
TCR NN I-NP
activation NN I-NP
through IN B-PP
IL-2-dependent JJ B-NP
proliferation NN I-NP
COMMA COMMA O
followed VBN B-VP
by IN B-PP
secondary JJ B-NP
TCR NN I-NP
stimulation NN I-NP
COMMA COMMA O
their PRP$ B-NP
responsiveness NN I-NP
to TO B-PP
IFN-gamma NN B-NP
varies VBZ B-VP
COMMA COMMA O
and CC O
this DT B-NP
may MD B-VP
affect VB I-VP
their PRP$ B-NP
ability NN I-NP
to TO B-VP
participate VB I-VP
in IN B-PP
an DT B-NP
ongoing JJ I-NP
immune JJ I-NP
response NN I-NP
. . O

Recombinant JJ B-NP
NFAT1 NN I-NP
( ( O
NFATp NN B-NP
) ) O
is VBZ B-VP
regulated VBN I-VP
by IN B-PP
calcineurin NN B-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
and CC O
mediates VBZ B-VP
transcription NN B-NP
of IN B-PP
several JJ B-NP
cytokine NN I-NP
genes NNS I-NP
. . O

Transcription NN B-NP
factors NNS I-NP
of IN B-PP
the DT B-NP
NFAT NN I-NP
family NN I-NP
play VBP B-VP
a DT B-NP
key JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
transcription NN I-NP
of IN B-PP
cytokine NN B-NP
genes NNS I-NP
and CC O
other JJ B-NP
genes NNS I-NP
during IN B-PP
the DT B-NP
immune JJ I-NP
response NN I-NP
. . O

We PRP B-NP
have VBP B-VP
identified VBN I-VP
two CD B-NP
new JJ I-NP
isoforms NNS I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
NFAT1 NN I-NP
( ( O
previously RB B-VP
termed VBN I-VP
NFATp NN B-NP
) ) O
that WDT B-NP
are VBP B-VP
the DT B-NP
predominant JJ I-NP
isoforms NNS I-NP
expressed VBN B-VP
in IN B-PP
murine JJ B-NP
and CC I-NP
human JJ I-NP
T NN I-NP
cells NNS I-NP
. . O

When WRB B-ADVP
expressed VBN B-VP
in IN B-PP
Jurkat NN B-NP
T NN I-NP
cells NNS I-NP
COMMA COMMA O
recombinant JJ B-NP
NFAT1 NN I-NP
is VBZ B-VP
regulated VBN I-VP
COMMA COMMA O
as IN B-SBAR
expected VBN B-VP
COMMA COMMA O
by IN B-PP
the DT B-NP
calmodulin-dependent JJ I-NP
phosphatase NN I-NP
calcineurin NN I-NP
COMMA COMMA O
and CC O
its PRP$ B-NP
function NN I-NP
is VBZ B-VP
inhibited VBN I-VP
by IN B-PP
the DT B-NP
immunosuppressive JJ I-NP
agent NN I-NP
cyclosporin NN B-NP
A NN I-NP
( ( O
CsA NN B-NP
) ) O
. . O

Transactivation NN B-NP
by IN B-PP
recombinant JJ B-NP
NFAT1 NN I-NP
in IN B-PP
Jurkat NN B-NP
T NN I-NP
cells NNS I-NP
requires VBZ B-VP
dual JJ B-NP
stimulation NN I-NP
with IN B-PP
ionomycin NN B-NP
and CC O
phorbol NN B-NP
12-myristate NN I-NP
13-acetate NN I-NP
; : O
this DT B-NP
activity NN I-NP
is VBZ B-VP
potentiated VBN I-VP
by IN B-PP
coexpression NN B-NP
of IN B-PP
constitutively RB B-NP
active JJ I-NP
calcineurin NN I-NP
and CC O
is VBZ B-VP
inhibited VBN I-VP
by IN B-PP
CsA NN B-NP
. . O

Immunocytochemical JJ B-NP
analysis NN I-NP
indicates VBZ B-VP
that IN B-SBAR
recombinant JJ B-NP
NFAT1 NN I-NP
localizes VBZ B-VP
in IN B-PP
the DT B-NP
cytoplasm NN I-NP
of IN B-PP
transiently RB B-NP
transfected VBN I-NP
T NN I-NP
cells NNS I-NP
and CC O
translocates VBZ B-VP
into IN B-PP
the DT B-NP
nucleus NN I-NP
in IN B-PP
a DT B-NP
CsA-sensitive JJ I-NP
manner NN I-NP
following VBG B-PP
ionomycin NN B-NP
stimulation NN I-NP
. . O

When WRB B-ADVP
expressed VBN B-VP
in IN B-PP
COS NN B-NP
cells NNS I-NP
COMMA COMMA O
however RB B-ADVP
COMMA COMMA O
NFAT1 NN B-NP
is VBZ B-VP
capable JJ B-ADJP
of IN B-PP
transactivation NN B-NP
COMMA COMMA O
but CC O
it PRP B-NP
is VBZ B-VP
not RB I-VP
regulated VBN I-VP
correctly RB B-ADVP
: : O
its PRP$ B-NP
subcellular JJ B-NP
localization NN I-NP
and CC O
transcriptional JJ B-NP
function NN I-NP
are VBP B-VP
not RB I-VP
affected VBN I-VP
by IN B-PP
stimulation NN B-NP
of IN B-PP
the DT B-NP
COS NN I-NP
cells NNS I-NP
with IN B-PP
ionomycin NN B-NP
and CC O
phorbol NN B-NP
12-myristate NN I-NP
13-acetate NN I-NP
. . O

Recombinant JJ B-NP
NFAT1 NN I-NP
can MD B-VP
mediate VB I-VP
transcription NN B-NP
of IN B-PP
the DT O
interleukin-2 NN B-NP
COMMA COMMA O
interleukin-4 NN B-NP
COMMA COMMA O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
COMMA COMMA O
and CC O
granulocyte-macrophage JJ B-NP
colony-stimulating JJ I-NP
factor NN I-NP
promoters NNS B-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
NFAT1 NN B-NP
contributes VBZ B-VP
to TO B-PP
the DT B-NP
CsA-sensitive JJ I-NP
transcription NN I-NP
of IN B-PP
these DT B-NP
genes NNS I-NP
during IN B-PP
the DT B-NP
immune JJ I-NP
response NN I-NP
. . O

Epstein-Barr JJ B-NP
virus NN I-NP
nuclear JJ I-NP
antigen NN I-NP
2 CD I-NP
and CC O
latent JJ B-NP
membrane NN I-NP
protein NN I-NP
independently RB B-ADVP
transactivate VBP B-VP
p53 NN B-NP
through IN B-PP
induction NN B-NP
of IN B-PP
NF-kappaB NN B-NP
activity NN I-NP
. . O

B-cell NN B-NP
immortalization NN I-NP
by IN B-PP
Epstein-Barr JJ B-NP
virus NN I-NP
( ( O
EBV NN B-NP
) ) O
is VBZ B-VP
dependent JJ B-ADJP
on IN B-PP
permanent JJ B-NP
control NN I-NP
of IN B-PP
the DT B-NP
cellular JJ I-NP
processes NNS I-NP
which WDT B-NP
normally RB B-VP
regulate VB I-VP
cell NN B-NP
division NN B-NP
and CC O
apoptosis NN B-NP
COMMA COMMA O
functions NNS B-NP
possessed VBN B-VP
by IN B-PP
p53 NN B-NP
in IN B-PP
a DT B-NP
number NN I-NP
of IN B-PP
normal JJ B-NP
cell NN I-NP
types NNS I-NP
. . O

In IN B-PP
studies NNS B-NP
initiated VBN B-VP
to TO I-VP
evaluate VB I-VP
relationships NNS B-NP
between IN B-PP
EBV NN B-NP
latent JJ I-NP
genes NNS I-NP
and CC O
p53 NN B-NP
COMMA COMMA O
p53 NN B-NP
levels NNS I-NP
were VBD B-VP
found VBN I-VP
to TO I-VP
increase VB I-VP
approximately RB B-ADVP
10-fold RB I-ADVP
4 CD B-NP
to TO I-NP
5 CD I-NP
days NNS I-NP
after IN B-PP
EBV NN B-NP
infection NN I-NP
of IN B-PP
purified VBN B-NP
resting VBG I-NP
human JJ I-NP
B NN I-NP
cells NNS I-NP
; : O
the DT B-NP
induced VBN I-NP
p53 NN I-NP
was VBD B-VP
transcriptionally RB B-ADVP
active JJ B-ADJP
. . O

Latent JJ B-NP
membrane NN I-NP
protein NN I-NP
1 CD I-NP
and CC O
COMMA COMMA O
to TO B-PP
a DT B-NP
lesser JJR I-NP
extent NN I-NP
COMMA COMMA O
EBV NN B-NP
nuclear JJ I-NP
antigen NN I-NP
2 CD I-NP
mediated VBD B-VP
the DT B-NP
increase NN I-NP
in IN B-PP
p53 NN B-NP
levels NNS I-NP
via IN B-PP
activation NN B-NP
of IN B-PP
the DT B-NP
NF-kappaB NN I-NP
transcription NN I-NP
factor NN I-NP
. . O

Differential JJ B-NP
utilization NN I-NP
of IN B-PP
Janus NN B-NP
kinase-signal JJ I-NP
transducer NN I-NP
activator NN I-NP
of IN B-PP
transcription NN B-NP
signaling NN I-NP
pathways NNS I-NP
in IN B-PP
the DT B-NP
stimulation NN I-NP
of IN B-PP
human JJ B-NP
natural JJ I-NP
killer NN I-NP
cells NNS I-NP
by IN B-PP
IL-2 NN B-NP
COMMA COMMA O
IL-12 NN B-NP
COMMA COMMA O
and CC O
IFN-alpha NN B-NP
. . O

IL-2- NN B-NP
COMMA COMMA O
IL-12- NN B-NP
COMMA COMMA O
and CC O
IFN-alpha-mediated JJ B-ADJP
signaling NN B-NP
pathways NNS I-NP
were VBD B-VP
analyzed VBN I-VP
in IN B-PP
primary JJ B-NP
NK NN I-NP
cells NNS I-NP
and CC B-PP
in IN B-PP
the DT B-NP
NK3.3 NN I-NP
cell NN I-NP
line NN I-NP
. . O

Gel NN B-NP
mobility NN I-NP
shift NN I-NP
and CC O
immunoprecipitation NN B-NP
analyses NNS B-NP
revealed VBD B-VP
that IN B-SBAR
in IN B-PP
addition NN I-PP
to TO I-PP
activating VBG B-VP
STAT3 NN B-NP
( ( O
signal NN B-NP
transducer NN I-NP
and CC O
activator NN B-NP
of IN B-PP
transcription-3 NN B-NP
) ) O
and CC O
STAT5 NN B-NP
COMMA COMMA O
IL-2 NN B-NP
induced VBD B-VP
tyrosine NN B-NP
and CC O
serine NN B-NP
phosphorylation NN B-NP
of IN B-PP
STAT1 NN B-NP
alpha NN I-NP
COMMA COMMA O
which WDT B-NP
formed VBD B-VP
IFN-gamma-activated JJ B-NP
sequence-binding NN I-NP
complexes NNS I-NP
by IN B-PP
itself PRP B-NP
and CC B-PP
with IN B-PP
STAT3 NN B-NP
. . O

Although IN B-SBAR
IL-2 NN B-NP
and CC O
IFN-alpha NN B-NP
activated VBD B-VP
STAT1 NN B-NP
alpha NN I-NP
and CC O
STAT5 NN B-NP
COMMA COMMA O
IL-2 NN B-NP
predominantly RB B-ADVP
activated VBN B-VP
STAT5 NN B-NP
COMMA COMMA O
while IN B-SBAR
IFN-alpha NN B-NP
predominantly RB B-ADVP
activated VBD B-VP
STAT1 NN B-NP
alpha NN I-NP
. . O

IL-2 NN B-NP
induced VBD B-VP
less RBR B-NP
STAT1 NN I-NP
alpha NN I-NP
activation NN I-NP
and CC O
IFN-alpha NN B-NP
induced VBD B-VP
greater JJR B-NP
STAT5 NN I-NP
activation NN I-NP
in IN B-PP
NK3.3 NN B-NP
cells NNS I-NP
compared VBN B-PP
with IN B-PP
preactivated JJ B-NP
primary JJ I-NP
NK NN I-NP
cells NNS I-NP
. . O

In IN B-PP
NK3.3 NN B-NP
cells NNS I-NP
COMMA COMMA O
IL-2 NN B-NP
induced VBD B-VP
comparable JJ B-NP
formation NN I-NP
of IN B-PP
c-fos NN B-NP
promoter NN I-NP
sis-inducible JJ I-NP
element NN I-NP
IFN-gamma-activated JJ I-NP
sequence-binding NN I-NP
complexes NNS I-NP
containing VBG B-VP
STAT3 NN B-NP
alone RB B-ADVP
with IN B-PP
complexes NNS B-NP
containing VBG B-VP
STAT3 NN B-NP
and CC O
STAT1 NN B-NP
alpha NN I-NP
COMMA COMMA O
while IN B-SBAR
in IN B-PP
preactivated JJ B-NP
primary JJ I-NP
NK NN I-NP
cells NNS I-NP
COMMA COMMA O
it PRP B-NP
preferentially RB B-ADVP
induced VBD B-VP
complexes NNS B-NP
containing VBG B-VP
STAT3 NN B-NP
and CC O
STAT1 NN B-NP
alpha NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
signaling NN B-NP
in IN B-PP
NK3.3 NN B-NP
cells NNS I-NP
is VBZ B-VP
not RB O
always RB B-ADVP
identical JJ B-ADJP
with IN B-PP
that DT B-NP
in IN B-PP
primary JJ B-NP
NK NN I-NP
cells NNS I-NP
. . O

In IN B-PP
contrast NN I-PP
to TO I-PP
IL-2 NN B-NP
and CC O
IFN-alpha NN B-NP
COMMA COMMA O
IL-12 NN B-NP
induced VBD B-VP
strong JJ B-NP
tyrosine NN I-NP
phosphorylation NN I-NP
of IN B-PP
STAT4 NN B-NP
and CC O
variable JJ B-NP
weak JJ I-NP
phosphorylation NN I-NP
of IN B-PP
STAT3 NN B-NP
. . O

However RB B-ADVP
COMMA COMMA O
supershift NN B-NP
analyses NNS I-NP
using VBG B-VP
the DT B-NP
c-fos NN I-NP
promoter NN I-NP
sis-inducible JJ I-NP
element NN I-NP
probe NN I-NP
showed VBD B-VP
that IN B-SBAR
IL-12 NN B-NP
activated VBD B-VP
STAT4 NN B-NP
COMMA COMMA O
STAT1 NN B-NP
alpha NN I-NP
COMMA COMMA O
and CC O
STAT3 NN B-NP
COMMA COMMA O
and CC O
induced VBD B-VP
complexes NNS B-NP
containing VBG B-VP
STAT4 NN B-NP
only RB B-ADVP
COMMA COMMA O
STAT4 NN B-NP
with IN B-PP
STAT1 NN B-NP
alpha NN I-NP
COMMA COMMA O
STAT3 NN B-NP
with IN B-PP
STAT1 NN B-NP
alpha NN I-NP
COMMA COMMA O
or CC O
STAT1 NN B-NP
alpha NN I-NP
only RB B-ADVP
in IN B-PP
preactivated JJ B-NP
primary JJ I-NP
NK NN I-NP
cells NNS I-NP
. . O

STAT1 NN B-NP
alpha NN I-NP
activation NN I-NP
by IN B-PP
IL-12 NN B-NP
correlated VBD B-VP
with IN B-PP
increased VBN B-NP
phosphorylation NN I-NP
of IN B-PP
serine NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
tyrosine NN B-NP
. . O

Finally RB B-ADVP
COMMA COMMA O
IL-2 NN B-NP
induced VBD B-VP
tyrosine NN B-NP
phosphorylation NN I-NP
of IN B-PP
JAK1 NN B-NP
and CC O
JAK3 NN B-NP
COMMA COMMA O
while IN B-SBAR
IL-12 NN B-NP
induced VBD B-VP
phosphorylation NN B-NP
of IN B-PP
JAK2 NN B-NP
and CC O
TYK2 NN B-NP
in IN B-PP
both CC O
preactivated JJ B-NP
primary JJ I-NP
NK NN I-NP
and CC O
NK3.3 NN B-NP
cells NNS B-NP
. . O

Differential JJ B-NP
phosphorylation NN I-NP
and CC O
consequent JJ B-NP
differential JJ I-NP
activation NN I-NP
of IN B-PP
both CC B-NP
separate JJ I-NP
and CC I-NP
overlapping JJ I-NP
STAT NN I-NP
proteins NNS I-NP
by IN B-PP
IL-2 NN B-NP
COMMA COMMA O
IL-12 NN B-NP
COMMA COMMA O
and CC O
IFN-alpha NN B-NP
may MD B-VP
provide VB I-VP
a DT B-NP
molecular JJ I-NP
basis NN I-NP
for IN B-PP
the DT B-NP
similarities NNS B-NP
and CC O
differences NNS B-NP
in IN B-PP
the DT B-NP
actions NNS I-NP
of IN B-PP
these DT B-NP
cytokines NNS I-NP
on IN B-PP
NK NN B-NP
cells NNS I-NP
. . O

Sublethal JJ B-NP
levels NNS I-NP
of IN B-PP
oxidative JJ B-NP
stress NN I-NP
stimulate VBP B-VP
transcriptional JJ B-NP
activation NN I-NP
of IN B-PP
c-jun NN B-NP
and CC O
suppress VBP B-VP
IL-2 NN B-NP
promoter NN I-NP
activation NN I-NP
in IN B-PP
Jurkat NN B-NP
T NN I-NP
cells NNS I-NP
. . O

Sublethal JJ B-NP
levels NNS I-NP
of IN B-PP
oxidative JJ B-NP
stress NN I-NP
are VBP B-VP
well RB I-VP
known VBN I-VP
to TO I-VP
alter VB I-VP
T NN B-NP
cell NN I-NP
functional JJ I-NP
responses NNS I-NP
COMMA COMMA O
but CC O
the DT B-NP
underlying JJ I-NP
mechanisms NNS I-NP
are VBP B-VP
unknown JJ B-ADJP
. . O

The DT B-NP
current JJ I-NP
study NN I-NP
examined VBD B-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
oxidative JJ B-NP
stress NN I-NP
on IN B-PP
transcriptional JJ B-NP
activities NNS I-NP
mediated VBN B-VP
by IN B-PP
c-Fos\/c-Jun NN B-NP
AP-1 NN I-NP
and CC O
the DT B-NP
nuclear JJ I-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
( ( O
NF-AT NN B-NP
) ) O
. . O

The DT B-NP
present JJ I-NP
results NNS I-NP
show VBP B-VP
that IN B-SBAR
Jurkat NN B-NP
T NN I-NP
cells NNS I-NP
acutely RB B-VP
exposed VBN I-VP
to TO B-PP
micromolar JJ B-NP
concentrations NNS I-NP
of IN B-PP
H2O2 NN B-NP
exhibit VBP B-VP
substantial JJ B-NP
increases NNS I-NP
in IN B-PP
AP-1 NN B-NP
binding NN I-NP
activity NN I-NP
and CC O
the DT B-NP
expression NN I-NP
of IN B-PP
c-jun NN B-NP
but CC B-CONJP
not RB I-CONJP
c-fos NN B-NP
mRNA NN B-NP
. . O

The DT B-NP
preferential JJ I-NP
induction NN I-NP
of IN B-PP
c-jun NN B-NP
by IN B-PP
H2O2 NN B-NP
did VBD B-VP
not RB I-VP
represent VB I-VP
redox NN B-NP
stabilization NN I-NP
of IN B-PP
mRNA NN B-NP
transcripts NNS I-NP
COMMA COMMA O
and CC O
oxidative JJ B-NP
signals NNS I-NP
closely RB B-ADVP
resembled VBD B-VP
PHA\/PMA NN B-NP
stimulation NN I-NP
by IN B-PP
effectively RB B-VP
transactivating VBG I-VP
the DT B-NP
full JJ I-NP
length NN I-NP
c-jun NN I-NP
promoter NN I-NP
via IN B-PP
the DT O
proximal JJ O
jun1 NN O
tumor NN B-NP
promoter-responsive JJ I-NP
element NN I-NP
( ( B-NP
TRE NN I-NP
) ) I-NP
-like JJ I-NP
promoter NN I-NP
element NN I-NP
. . O

Similarly RB B-ADVP
COMMA COMMA O
the DT B-NP
complexes NNS I-NP
binding VBG B-VP
the DT B-NP
consensus NN I-NP
AP-1 NN I-NP
TRE NN I-NP
and CC O
jun NN B-NP
TRE-like JJ I-NP
motifs NNS I-NP
in IN B-PP
cells NNS B-NP
exposed VBN B-VP
to TO B-PP
oxidative JJ B-NP
signals NNS I-NP
or CC O
PHA\/PMA NN B-NP
were VBD B-VP
indistinguishable JJ B-ADJP
COMMA COMMA O
being VBG B-VP
composed VBN I-VP
of IN B-PP
c-Fos NN B-NP
COMMA COMMA O
c-Jun NN B-NP
COMMA COMMA O
and CC O
JunD NN B-NP
. . O

However RB B-ADVP
COMMA COMMA O
PHA\/PMA NN B-NP
but CC O
not RB B-ADJP
oxidative JJ I-ADJP
signals NNS B-NP
induced VBD B-VP
the DT B-NP
coordinate JJ B-NP
activation NN I-NP
of IN B-PP
reporter NN B-NP
constructs NNS I-NP
containing VBG B-VP
the DT O
AP-1-TRE NN B-NP
COMMA COMMA O
NF-AT NN B-NP
COMMA COMMA O
and CC O
IL-2 NN B-NP
promoter NN B-NP
regions NNS I-NP
along IN B-CONJP
with IN I-CONJP
IL-2 NN B-NP
mRNA NN I-NP
expression NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
sublethal JJ B-NP
levels NNS I-NP
of IN B-PP
H2O2 NN B-NP
actively RB B-ADVP
suppressed VBD B-VP
the DT B-NP
transcriptional JJ I-NP
activation NN I-NP
of IN B-PP
NF-AT NN B-NP
and CC O
IL-2 NN B-NP
reporters NNS B-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
the DT B-NP
expression NN I-NP
of IN B-PP
IL-2 NN B-NP
mRNA NN I-NP
in IN B-PP
cells NNS B-NP
stimulated VBN B-VP
with IN B-PP
PHA\/PMA NN B-NP
. . O

Gel NN B-NP
shift NN I-NP
analysis NN I-NP
revealed VBD B-VP
that IN B-SBAR
oxidative JJ B-NP
suppression NN I-NP
of IN B-PP
NF-AT NN B-NP
represented VBD B-VP
inhibition NN B-NP
in IN B-PP
the DT B-NP
early JJ I-NP
generation NN I-NP
of IN B-PP
NFAT NN B-NP
complexes NNS I-NP
rather RB B-CONJP
than IN I-CONJP
the DT B-NP
binding NN I-NP
of IN B-PP
preformed JJ B-NP
NF-AT NN I-NP
complexes NNS I-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
oxidative JJ B-NP
signals NNS I-NP
can MD O
positively RB B-ADVP
and CC O
negatively RB B-ADVP
regulate VB B-VP
T NN B-NP
cell NN I-NP
transcriptional JJ I-NP
events NNS I-NP
and CC O
that IN B-SBAR
changes NNS B-NP
in IN B-PP
cellular JJ B-NP
redox NN I-NP
can MD B-VP
uncouple VB I-VP
AP-1 NN B-NP
regulation NN I-NP
of IN B-PP
c-jun NN B-NP
from IN B-PP
transcriptional JJ B-NP
up-regulation NN I-NP
of IN B-PP
IL-2 NN B-NP
via IN B-PP
NF-AT NN B-NP
. . O

Glucocorticoids NNS B-NP
and CC O
interferon-alpha NN B-NP
in IN B-PP
the DT B-NP
acquired VBN I-NP
immunodeficiency NN I-NP
syndrome NN I-NP
. . O

Some DT B-NP
patients NNS I-NP
with IN B-PP
acquired VBN B-NP
immunodeficiency NN I-NP
syndrome NN I-NP
( ( O
AIDS NN B-NP
) ) O
develop VBP B-VP
glucocorticoid NN B-NP
resistance NN I-NP
characterized VBN B-VP
by IN B-PP
low JJ B-NP
receptor NN B-NP
affinity NN I-NP
( ( O
Kd NN B-NP
) ) O
for IN B-PP
glucocorticoids NNS B-NP
in IN B-PP
mononuclear JJ B-NP
COMMA COMMA I-NP
cells NNS I-NP
and CC O
high JJ B-NP
values NNS I-NP
of IN B-PP
ACTH NN B-NP
and CC O
cortisol NN B-NP
. . O

As IN B-SBAR
glucocorticoids NNS B-NP
regulate VBP B-VP
interferon-alpha NN B-NP
( ( O
IFN NN B-NP
alpha NN I-NP
) ) O
production NN B-NP
COMMA COMMA O
we PRP B-NP
hypothesized VBD B-VP
that IN B-SBAR
IFN NN B-NP
alpha NN I-NP
COMMA COMMA O
a DT B-NP
cytokine NN I-NP
produced VBN B-VP
predominantly RB B-PP
by IN I-PP
monocytes NNS B-NP
in IN B-PP
AIDS NN B-NP
COMMA COMMA O
should MD B-VP
be VB I-VP
increased VBN I-VP
in IN B-PP
cortisol-resistant JJ B-NP
AIDS NN I-NP
COMMA COMMA O
attributing VBG B-VP
the DT B-NP
lack NN I-NP
of IN B-PP
cortisol NN B-NP
inhibition NN I-NP
to TO B-PP
IFN NN B-NP
alpha NN I-NP
production NN I-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
we PRP B-NP
examined VBD B-VP
glucocorticoid NN B-NP
receptor NN I-NP
characteristics NNS I-NP
on IN B-PP
monocytes NNS B-NP
by IN B-PP
{3H}dexamethasone NN B-NP
binding NN I-NP
and CC O
measured VBD B-VP
IFN NN B-NP
alpha NN I-NP
COMMA COMMA O
cortisol NN B-NP
COMMA COMMA O
and CC O
ACTH NN B-NP
in IN B-PP
AIDS NN B-NP
patients NNS I-NP
with IN B-PP
( ( O
AIDS-GR NN B-NP
) ) O
or CC O
without IN B-PP
glucocorticoid NN B-NP
resistance NN I-NP
( ( O
AIDS-C NN B-NP
) ) O
and CC O
controls NNS B-NP
( ( O
C NN B-NP
) ) O
. . O

Monocytes NNS B-NP
of IN B-PP
AIDS-GR NN B-NP
patients NNS I-NP
had VBD B-VP
a DT B-NP
receptor NN I-NP
Kd NN I-NP
of IN B-PP
10.5 CD B-NP
+\/- CC I-NP
4.2 CD I-NP
nmol\/L NN I-NP
that WDT B-NP
was VBD B-VP
higher JJR B-ADJP
than IN B-PP
that DT B-NP
in IN B-PP
the DT B-NP
AIDS-C NN I-NP
group NN I-NP
( ( O
2.9 CD B-NP
+\/- CC I-NP
0.8 CD I-NP
nmol\/L NN I-NP
) ) O
and CC O
normal JJ B-NP
subjects NNS I-NP
( ( O
2.0 CD B-NP
+\/- CC I-NP
0.8 CD I-NP
nmol\/L NN I-NP
; : O
P NN B-NP
&lt; JJR B-ADJP
0.01 CD O
) ) O
. . O

IFN NN B-NP
alpha NN I-NP
levels NNS I-NP
were VBD B-VP
increased VBN I-VP
in IN B-PP
the DT B-NP
AIDS-GR NN I-NP
group NN I-NP
( ( O
17 CD B-NP
+\/- CC I-NP
6 CD I-NP
vs. CC O
4 CD B-NP
+\/- CC I-NP
1 CD I-NP
U\/mL NN I-NP
in IN B-PP
the DT B-NP
AIDS-C NN I-NP
group NN I-NP
and CC O
2 CD B-NP
+\/- CC I-NP
0.5 CD I-NP
U\/mL NN I-NP
in IN B-PP
the DT B-NP
C NN I-NP
group NN I-NP
; : O
P NN B-NP
&lt; JJR B-ADJP
0.01 CD O
) ) O
. . O

Correlations NNS B-NP
were VBD B-VP
found VBN I-VP
between IN B-PP
plasma NN B-NP
IFN NN I-NP
alpha NN I-NP
and CC O
receptor NN B-NP
Kd NN I-NP
on IN B-PP
monocytes NNS B-NP
of IN B-PP
AIDS-GR NN B-NP
( ( O
r NN B-NP
= JJ B-VP
0.77 CD B-NP
) ) O
and CC B-PP
between IN B-PP
IFN NN B-NP
alpha NN I-NP
and CC O
plasma NN B-NP
cortisol NN I-NP
in IN B-PP
the DT B-NP
same JJ I-NP
group NN I-NP
( ( O
r NN B-NP
= JJ B-VP
0.74 CD B-NP
) ) O
. . O

The DT B-NP
poly(I)-poly(C)-induced JJ I-NP
IFN NN I-NP
alpha NN I-NP
production NN I-NP
by IN B-PP
monocytes NNS B-NP
was VBD B-VP
inhibited VBN I-VP
by IN B-PP
glucocorticoids NNS B-NP
in IN B-PP
the DT O
C NN B-NP
and CC O
AIDS-C NN B-NP
groups NNS B-NP
( ( O
approximately RB B-NP
80 CD I-NP
% NN I-NP
inhibition NN B-NP
in IN B-PP
both DT B-NP
groups NNS I-NP
) ) O
; : O
the DT B-NP
effect NN I-NP
was VBD B-VP
reversed VBN I-VP
by IN B-PP
the DT B-NP
receptor NN I-NP
antagonist NN I-NP
RU-38486 NN I-NP
. . O

By IN B-PP
contrast NN B-NP
COMMA COMMA O
glucocorticoids NNS B-NP
failed VBD B-VP
to TO I-VP
inhibit VB I-VP
IFNalpha NN B-NP
production NN I-NP
from IN B-PP
AIDS-GR NN B-NP
monocytes NNS I-NP
( ( O
approximately RB B-NP
20 CD I-NP
% NN I-NP
inhibition NN B-NP
) ) O
. . O

In IN B-PP
conclusion NN B-NP
COMMA COMMA O
elevated JJ B-NP
IFN NN I-NP
alpha NN I-NP
levels NNS I-NP
in IN B-PP
AIDS-GR NN B-NP
may MD B-VP
be VB I-VP
due JJ B-PP
to TO I-PP
the DT B-NP
lack NN I-NP
of IN B-PP
inhibitory JJ B-NP
effect NN I-NP
of IN B-PP
cortisol NN B-NP
on IN B-PP
IFN NN B-NP
alpha NN I-NP
production NN I-NP
due IN B-PP
to TO I-PP
cortisol JJ B-NP
resistance NN I-NP
in IN B-PP
monocytes NNS B-NP
. . O

Cooperation NN B-NP
between IN B-PP
core NN B-NP
binding NN I-NP
factor NN I-NP
and CC O
adjacent JJ B-NP
promoter NN I-NP
elements NNS I-NP
contributes VBZ B-VP
to TO B-PP
the DT B-NP
tissue-specific JJ I-NP
expression NN I-NP
of IN B-PP
interleukin-3 NN B-NP
. . O

Tissue-specific JJ B-NP
expression NN I-NP
of IN B-PP
interleukin-3 NN B-NP
( ( O
IL-3 NN B-NP
) ) O
is VBZ B-VP
mediated VBN I-VP
via IN B-PP
cis-acting JJ B-NP
elements NNS I-NP
located JJ B-ADJP
within IN B-PP
315 CD B-NP
base NN I-NP
pairs NNS I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
start NN I-NP
. . O

This DT B-NP
is VBZ B-VP
achieved VBN I-VP
in IN B-PP
part NN B-NP
through IN B-PP
the DT B-NP
positive JJ I-NP
activities NNS I-NP
of IN B-PP
the DT O
AP-1 NN B-NP
and CC O
Elf-1 NN B-NP
sites NNS B-NP
in IN B-PP
the DT B-NP
IL-3 NN I-NP
promoter NN I-NP
. . O

The DT B-NP
contribution NN I-NP
to TO B-PP
T NN B-NP
cell-specific JJ I-NP
expression NN I-NP
by IN B-PP
other JJ B-NP
promoter NN I-NP
sites NNS I-NP
was VBD B-VP
assessed VBN I-VP
in IN B-PP
a DT B-NP
transient JJ I-NP
expression NN I-NP
assay NN I-NP
with IN B-PP
IL-3 NN B-NP
promoter NN I-NP
constructs NNS I-NP
linked VBN B-VP
to TO B-PP
a DT B-NP
luciferase NN I-NP
gene NN I-NP
COMMA COMMA O
focusing VBG B-VP
initially RB B-ADVP
on IN B-PP
the DT O
core NN B-NP
binding NN I-NP
factor NN I-NP
( ( O
CBF NN B-NP
) ) O
site NN B-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
footprinted JJ I-VP
in FW B-ADVP
vivo FW I-ADVP
upon IN B-PP
T NN B-NP
cell NN I-NP
activation NN I-NP
. . O

Activity NN B-NP
of IN B-PP
the DT B-NP
CBF NN I-NP
site NN I-NP
is VBZ B-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
critically RB B-ADJP
dependent JJ I-ADJP
on IN B-PP
the DT B-NP
adjacent JJ I-NP
activator NN I-NP
site NN I-NP
Act-1 CD I-NP
. . O

Together RB B-ADVP
the DT O
Act-1 NN B-NP
and CC O
CBF NN B-NP
sites NNS B-NP
form VBP B-VP
a DT B-NP
functional JJ I-NP
unit NN I-NP
( ( O
AC NN B-NP
unit NN I-NP
) ) O
with IN B-PP
dual JJ B-NP
activity NN I-NP
. . O

The DT B-NP
AC NN I-NP
unit NN I-NP
is VBZ B-VP
demonstrated VBN I-VP
to TO I-VP
enhance VB B-NP
basal JJ B-NP
activity NN I-NP
of IN B-PP
promoters NNS B-NP
both CC B-ADVP
in IN B-PP
fibroblasts NNS B-NP
and CC O
T NN B-NP
cells NNS I-NP
. . O

This DT B-NP
activity NN I-NP
is VBZ B-VP
further RB B-ADJP
inducible JJ I-ADJP
in IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
COMMA COMMA B-PP
but CC I-PP
not RB B-PP
in IN I-PP
fibroblasts NNS B-NP
. . O

In IN B-PP
addition NN I-PP
to TO I-PP
the DT B-NP
already RB I-NP
identified VBN I-NP
NIP NN I-NP
repressor NN I-NP
site NN I-NP
COMMA COMMA O
evidence NN B-NP
is VBZ B-VP
presented VBN I-VP
for IN B-PP
a DT B-NP
second JJ I-NP
repressor NN I-NP
region NN I-NP
that WDT B-NP
restricts VBZ B-VP
promoter NN B-NP
activity NN I-NP
in IN B-PP
fibroblasts NNS B-NP
. . O

Finally RB B-ADVP
COMMA COMMA O
a DT B-NP
novel JJ I-NP
positive JJ I-NP
regulatory JJ I-NP
element NN I-NP
has VBZ B-VP
been VBN I-VP
mapped VBN I-VP
in IN B-PP
the DT B-NP
IL-3 NN I-NP
promoter NN I-NP
between IN B-PP
nucleotide NN B-NP
-180 CD B-NP
and CC O
-210 CD B-NP
that WDT B-NP
leads VBZ B-VP
to TO B-PP
increased VBN B-NP
expression NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
. . O

Together RB B-ADVP
these DT B-NP
results NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
T NN B-NP
cell NN I-NP
expression NN I-NP
of IN B-PP
IL-3 NN B-NP
is VBZ B-VP
not RB I-VP
specified VBN I-VP
by IN B-PP
the DT B-NP
activity NN I-NP
of IN B-PP
a DT B-NP
single JJ I-NP
tissue-specific JJ I-NP
element NN I-NP
COMMA COMMA O
but CC O
instead RB O
involves VBZ B-VP
multiple JJ B-NP
interacting VBG I-NP
elements NNS I-NP
that WDT B-NP
provide VBP B-VP
both CC O
specific JJ B-NP
positive JJ I-NP
regulation NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
and CC O
specific JJ B-NP
negative JJ I-NP
regulation NN I-NP
in IN B-PP
fibroblasts NNS B-NP
. . O

A DT O
3' JJ B-NP
--&gt; TO O
5' JJ B-NP
XPB NN B-NP
helicase NN I-NP
defect NN I-NP
in IN B-PP
repair\/transcription NN B-NP
factor NN I-NP
TFIIH NN I-NP
of IN B-PP
xeroderma NN B-NP
pigmentosum NN I-NP
group NN I-NP
B NN I-NP
affects VBZ B-VP
both CC B-NP
DNA NN I-NP
repair NN B-NP
and CC O
transcription NN B-NP
. . O

XPB NN B-NP
is VBZ B-VP
a DT B-NP
subunit NN I-NP
of IN B-PP
the DT B-NP
basal JJ I-NP
transcription NN I-NP
factor NN I-NP
TFIIH NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
also RB I-VP
involved VBN I-VP
in IN B-PP
nucleotide NN B-NP
excision NN I-NP
repair NN I-NP
( ( O
NER NN B-NP
) ) O
and CC O
potentially RB B-ADVP
in IN B-PP
cell NN B-NP
cycle NN I-NP
regulation NN I-NP
. . O

A DT B-NP
frameshift NN I-NP
mutation NN I-NP
in IN B-PP
the DT B-NP
3'-end NN I-NP
of IN B-PP
the DT B-NP
XPB NN I-NP
gene NN I-NP
is VBZ B-VP
responsible JJ B-ADJP
for IN B-PP
a DT B-NP
concurrence NN I-NP
of IN B-PP
two CD B-NP
disorders NNS I-NP
: : O
xeroderma NN B-NP
pigmentosum NN I-NP
( ( O
XP NN B-NP
) ) O
and CC O
Cockayne NN B-NP
's POS B-NP
syndrome NN I-NP
( ( O
CS NN B-NP
) ) O
. . O

We PRP B-NP
have VBP B-VP
isolated VBN I-VP
TFIIH NN B-NP
from IN B-PP
cells NNS B-NP
derived VBN B-VP
from IN B-PP
a DT B-NP
patient NN I-NP
( ( O
XP11BE NN B-NP
) ) O
who WP B-NP
carries VBZ B-VP
this DT B-NP
frameshift NN I-NP
mutation NN I-NP
( ( O
TFIIHmut NN B-NP
) ) O
and CC O
from IN B-PP
the DT B-NP
mother NN I-NP
of IN B-PP
this DT B-NP
patient NN I-NP
( ( O
TFIIHwt NN B-NP
) ) O
to TO B-VP
determine VB I-VP
the DT B-NP
biochemical JJ I-NP
consequences NNS I-NP
of IN B-PP
the DT B-NP
mutation NN I-NP
. . O

Although IN B-SBAR
identical JJ B-ADJP
in IN B-PP
composition NN B-NP
and CC O
stoichiometry NN B-NP
to TO B-PP
TFIIHwt NN B-NP
COMMA COMMA O
TFIIHmut NN B-NP
shows VBZ B-VP
a DT O
reduced VBN O
3' JJ B-NP
--&gt; TO O
5' JJ B-NP
XPB NN B-NP
helicase NN I-NP
activity NN I-NP
. . O

A DT B-NP
decrease NN I-NP
in IN B-PP
helicase NN B-NP
and CC O
DNA-dependent JJ B-NP
ATPase NN I-NP
activities NNS B-NP
was VBD B-VP
also RB I-VP
observed VBN I-VP
with IN B-PP
the DT B-NP
mutated VBN I-NP
recombinant JJ I-NP
XPB NN I-NP
protein NN I-NP
. . O

The DT B-NP
XPB NN I-NP
mutation NN I-NP
causes VBZ B-VP
a DT I-VP
severe JJ I-VP
NER NN I-VP
defect NN I-VP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
we PRP B-NP
provide VBP B-VP
evidence NN B-NP
for IN B-PP
a DT B-NP
decrease NN I-NP
in IN B-PP
basal JJ B-NP
transcription NN I-NP
activity NN I-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

The DT B-NP
latter JJ I-NP
defect NN I-NP
may MD B-VP
provide VB I-VP
an DT B-NP
explanation NN I-NP
for IN B-PP
many JJ B-NP
of IN B-PP
the DT O
XP NN B-NP
and CC O
CS NN B-NP
symptoms NNS B-NP
that WDT B-NP
are VBP B-VP
difficult JJ B-ADJP
to TO B-VP
rationalize VB I-VP
based VBN B-PP
solely RB B-PP
on IN I-PP
an DT B-NP
NER NN I-NP
defect NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
this DT B-NP
work NN I-NP
presents VBZ B-VP
the DT B-NP
first JJ I-NP
detailed JJ I-NP
analysis NN I-NP
of IN B-PP
a DT B-NP
naturally RB I-NP
occurring VBG I-NP
mutation NN I-NP
in IN B-PP
a DT B-NP
basal JJ I-NP
transcription NN I-NP
factor NN I-NP
and CC O
supports VBZ B-VP
the DT B-NP
concept NN I-NP
that IN B-SBAR
the DT B-NP
combined JJ I-NP
XP\/CS NN I-NP
clinical JJ I-NP
entity NN I-NP
is VBZ B-VP
actually RB B-ADVP
the DT B-NP
result NN I-NP
of IN B-PP
a DT B-NP
combined JJ I-NP
transcription\/repair NN I-NP
deficiency NN I-NP
. . O

Signals NNS B-NP
leading VBG B-VP
to TO B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
transcription NN I-NP
factor NN I-NP
are VBP B-VP
stronger JJR B-ADJP
in IN B-PP
neonatal JJ B-NP
than IN B-PP
adult JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
. . O

The DT B-NP
molecular JJ I-NP
background NN I-NP
of IN B-PP
the DT B-NP
defects NNS I-NP
in IN B-PP
the DT B-NP
immune JJ I-NP
reactivity NN I-NP
of IN B-PP
human JJ B-NP
neonates NNS I-NP
has VBZ B-VP
not RB I-VP
been VBN I-VP
fully RB I-VP
elucidated VBN I-VP
. . O

As IN B-SBAR
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
transcription NN I-NP
factor NN I-NP
has VBZ B-VP
a DT B-NP
central JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
transcription NN B-NP
of IN B-PP
several JJ B-NP
genes NNS I-NP
involved VBN B-VP
in IN B-PP
immune JJ B-NP
and CC I-NP
inflammatory JJ I-NP
responses NNS I-NP
COMMA COMMA O
the DT B-NP
authors NNS I-NP
have VBP B-VP
analysed VBN I-VP
the DT B-NP
activation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
human JJ B-NP
umbilical JJ I-NP
cord NN I-NP
T NN I-NP
lymphocytes NNS I-NP
. . O

The DT B-NP
activity NN I-NP
was VBD B-VP
tested VBN I-VP
by IN B-PP
quantitating VBG B-VP
the DT B-NP
nuclear JJ I-NP
proteins NNS I-NP
binding VBG B-VP
to TO B-PP
an DT B-NP
oligonucleotide NN I-NP
containing VBG B-VP
the DT B-NP
consensus NN I-NP
kappa NN I-NP
B NN I-NP
binding NN I-NP
sequence NN I-NP
( ( O
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assay NN I-NP
) ) O
. . O

The DT B-NP
data NNS I-NP
obtained VBN B-VP
demonstrate VBP B-VP
that IN B-SBAR
phorbol NN B-NP
dibutyrate\/calcium NN I-NP
ionophore NN I-NP
A23187 NN I-NP
( ( O
PDBu\/iono NN B-NP
) ) O
combination NN B-NP
induced VBD B-VP
a DT B-NP
clearly RB I-NP
higher JJR I-NP
nuclear JJ I-NP
translocation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
neonatal JJ B-NP
than IN B-PP
adult JJ B-NP
T NN I-NP
cells NNS I-NP
. . O

This DT B-NP
higher JJR I-NP
NF-kappa NN I-NP
B NN I-NP
activity NN I-NP
was VBD B-VP
restricted JJ I-VP
to TO B-PP
the DT B-NP
CD4+ JJ I-NP
T-cell NN I-NP
subset NN I-NP
. . O

Analysis NN B-NP
of IN B-PP
the DT B-NP
nuclear JJ I-NP
extracts NNS I-NP
with IN B-PP
antibodies NNS B-NP
directed VBN B-VP
against IN B-PP
the DT B-NP
major JJ I-NP
components NNS I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
the DT O
p50 NN B-NP
and CC O
RelA NN B-NP
( ( O
p65 NN B-NP
) ) O
proteins NNS B-NP
COMMA COMMA O
indicated VBD B-VP
that IN B-SBAR
the DT B-NP
composition NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
was VBD B-VP
similar JJ B-ADJP
in IN B-PP
neonatal JJ B-NP
and CC I-NP
adult JJ I-NP
cells NNS I-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
neonatal JJ B-NP
T NN I-NP
cells NNS I-NP
are VBP B-VP
exposed VBN I-VP
to TO B-PP
oxidative JJ B-NP
stress-inducing JJ I-NP
signals NNS I-NP
during IN B-PP
delivery NN B-NP
and\/or CC O
are VBP B-VP
inherently RB B-ADVP
more RBR B-ADJP
sensitive JJ I-ADJP
to TO B-PP
NF-kappa NN B-NP
B NN I-NP
activating NN I-NP
signals NNS I-NP
than IN B-PP
adult JJ B-NP
T NN I-NP
cells NNS I-NP
. . O

Characterization NN B-NP
of IN B-PP
Grb2-binding JJ B-NP
proteins NNS I-NP
in IN B-PP
human JJ B-NP
platelets NNS I-NP
activated VBN B-VP
by IN B-PP
Fc NN B-NP
gamma NN I-NP
RIIA NN I-NP
cross-linking NN I-NP
. . O

Glutathione-S-transferase NN B-NP
( ( I-NP
GST NN I-NP
) ) I-NP
-Grb2 NN I-NP
fusion NN I-NP
proteins NNS I-NP
have VBP B-VP
been VBN I-VP
used VBN I-VP
to TO B-VP
identify VB I-VP
the DT B-NP
potential JJ I-NP
role NN I-NP
of IN B-PP
Grb2-binding JJ B-NP
proteins NNS I-NP
in IN B-PP
platelet NN B-NP
activation NN I-NP
by IN B-PP
the DT B-NP
platelet NN I-NP
low-affinity NN I-NP
IgG NN I-NP
receptor NN I-NP
COMMA COMMA O
Fc NN B-NP
gamma NN I-NP
RIIA NN I-NP
. . O

Two CD B-NP
tyrosine NN I-NP
phosphoproteins NNS I-NP
of IN B-PP
38 CD B-NP
and CC I-NP
63 CD I-NP
kD NN I-NP
bind VBP B-VP
to TO B-PP
the DT B-NP
SH2 NN I-NP
domain NN I-NP
of IN B-PP
Grb2 NN B-NP
following VBG B-PP
Fc NN B-NP
gamma NN I-NP
RIIA NN I-NP
stimulation NN I-NP
of IN B-PP
platelets NNS B-NP
. . O

Both DT B-NP
are VBP B-VP
located JJ B-ADJP
in IN B-PP
the DT B-NP
particulate JJ I-NP
fraction NN I-NP
following VBG B-PP
platelet NN B-NP
activation NN I-NP
and CC O
are VBP B-VP
also RB B-ADVP
able JJ B-ADJP
to TO B-VP
bind VB I-VP
to TO B-PP
a DT B-NP
GST-construct NN I-NP
containing VBG B-VP
the DT O
SH2 NN B-NP
and CC O
SH3 NN B-NP
domains NNS B-NP
of IN B-PP
phospholipase NN B-NP
C NN I-NP
gamma NN I-NP
1 CD I-NP
. . O

p38 NN B-NP
also RB B-VP
forms VBZ I-VP
a DT B-NP
complex NN I-NP
with IN B-PP
the DT B-NP
tyrosine NN I-NP
kinase NN I-NP
csk NN I-NP
in IN B-PP
stimulated VBN B-NP
cells NNS I-NP
and CC O
is VBZ B-VP
a DT B-NP
substrate NN I-NP
for IN B-PP
the DT B-NP
kinase NN I-NP
. . O

The DT B-NP
SH3 NN I-NP
domains NNS I-NP
of IN B-PP
Grb2 NN B-NP
form VBP B-VP
a DT B-NP
stable JJ I-NP
complex NN I-NP
with IN B-PP
SOS1 NN B-NP
and CC O
two CD B-NP
proteins NNS I-NP
of IN B-PP
75 CD B-NP
kD NN I-NP
and CC O
120 CD B-NP
kD NN I-NP
COMMA COMMA O
which WDT B-NP
undergo VBP B-VP
tyrosine NN B-NP
phosphorylation NN I-NP
in IN B-PP
Fc NN B-NP
gamma NN I-NP
RIIA NN I-NP
stimulated JJ B-NP
cells NNS I-NP
. . O

The DT B-NP
75-kD JJ I-NP
protein NN I-NP
is VBZ B-VP
recognized VBN I-VP
by IN B-PP
antibodies NNS B-NP
to TO B-PP
SLP-76 NN B-NP
COMMA COMMA O
which WDT B-NP
has VBZ B-VP
recently RB I-VP
been VBN I-VP
isolated VBN I-VP
from IN B-PP
T NN B-NP
cells NNS I-NP
and CC O
sequenced VBN B-VP
. . O

Tyrosine NN B-NP
phosphorylation NN I-NP
of IN B-PP
p38 NN B-NP
and CC O
p63 NN B-NP
is VBZ B-VP
also RB I-VP
observed VBN I-VP
in IN B-PP
platelets NNS B-NP
stimulated VBN B-VP
by IN B-PP
the DT B-NP
tyrosine NN I-NP
kinase-linked JJ I-NP
receptor NN I-NP
agonist NN I-NP
collagen NN I-NP
and CC B-PP
by IN B-PP
the DT B-NP
G NN I-NP
protein-coupled JJ I-NP
receptor NN I-NP
agonist NN I-NP
thrombin NN I-NP
COMMA COMMA O
although IN B-SBAR
phosphorylation NN B-NP
of IN B-PP
SLP-76 NN B-NP
is VBZ B-VP
only RB I-VP
observed VBN I-VP
in IN B-PP
collagen-stimulated JJ B-NP
platelets NNS I-NP
. . O

p38 NN B-NP
and CC O
p63 NN B-NP
may MD B-VP
provide VB I-VP
a DT B-NP
docking NN I-NP
site NN I-NP
for IN B-PP
Grb2 NN B-NP
COMMA COMMA O
thereby RB B-ADVP
linking VBG B-VP
Grb2 NN B-NP
SH3-binding JJ I-NP
proteins NNS I-NP
SOS1 NN B-NP
COMMA COMMA O
SLP-76 NN B-NP
COMMA COMMA O
and CC O
p120 NN B-NP
to TO B-PP
downstream JJ B-NP
signalling NN I-NP
events NNS I-NP
. . O

Retinoic JJ B-NP
acid NN I-NP
activates VBZ B-VP
interferon NN B-NP
regulatory JJ I-NP
factor-1 JJ I-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
myeloid JJ B-NP
cells NNS I-NP
. . O

All-trans-retinoic JJ B-NP
acid NN I-NP
( ( O
ATRA NN B-NP
) ) O
is VBZ B-VP
the DT B-NP
drug NN I-NP
of IN B-PP
choice NN B-NP
in IN B-PP
the DT B-NP
treatment NN I-NP
of IN B-PP
acute JJ B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
( ( O
APL NN B-NP
) ) O
. . O

ATRA NN B-NP
induces VBZ B-VP
both CC B-NP
in FW I-NP
vitro FW I-NP
and CC I-NP
in FW I-NP
vivo FW I-NP
differentiation NN I-NP
of IN B-PP
APL NN B-NP
cells NNS I-NP
into IN B-PP
mature JJ B-NP
granulocytes NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
molecular JJ I-NP
mechanisms NNS I-NP
involved VBN B-VP
in IN B-PP
ATRA-dependent JJ B-NP
growth NN B-NP
inhibition NN I-NP
and CC O
cellular JJ B-NP
differentiation NN I-NP
are VBP B-VP
not RB I-VP
presently RB I-VP
understood VBN I-VP
. . O

The DT B-NP
NB4 NN I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
derived VBN I-VP
from IN B-PP
the DT B-NP
bone NN I-NP
marrow NN I-NP
of IN B-PP
a DT B-NP
patient NN I-NP
with IN B-PP
APL NN B-NP
during IN B-PP
relapse NN B-NP
COMMA COMMA O
can MD B-VP
be VB I-VP
used VBN I-VP
as IN B-PP
a DT B-NP
model JJ I-NP
system NN I-NP
to TO B-VP
study VB I-VP
the DT B-NP
growth NN B-NP
and CC O
differentiation NN B-NP
of IN B-PP
APL NN B-NP
cells NNS I-NP
. . O

Because IN B-SBAR
interferon NN B-NP
( ( O
IFN NN B-NP
) ) O
regulatory JJ B-NP
factors NNS I-NP
( ( O
IRF-1 NN B-NP
and CC O
IRF-2 NN B-NP
) ) O
and CC O
other JJ B-NP
IFN-inducible JJ I-NP
gene NN I-NP
products NNS I-NP
regulate VBP B-VP
cell NN B-NP
growth NN I-NP
COMMA COMMA O
we PRP B-NP
analyzed VBD B-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
ATRA NN B-NP
on IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
these DT B-NP
genes NNS I-NP
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
ATRA NN B-NP
directly RB B-ADVP
activates VBZ B-VP
IRF-1 NN B-NP
gene NN I-NP
expression NN I-NP
COMMA COMMA O
followed VBN B-VP
by IN B-PP
activation NN B-NP
of IN B-PP
IRF-2 NN B-NP
and CC O
2'-5' JJ B-NP
oligoadenylate NN B-NP
synthetase NN I-NP
( ( O
OAS NN B-NP
) ) O
gene NN B-NP
expression NN I-NP
with IN B-PP
slower JJR B-NP
kinetics NNS I-NP
. . O

In IN B-PP
addition NN I-PP
to TO I-PP
NB4 NN B-NP
cells NNS I-NP
COMMA COMMA O
ATRA NN B-NP
also RB B-ADVP
activated VBD B-VP
IRF-1 NN B-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
HL-60 NN B-NP
COMMA COMMA O
U937 NN B-NP
COMMA COMMA O
and CC O
THP-1 NN B-NP
cells NNS B-NP
COMMA COMMA O
which WDT B-NP
all DT B-NP
respond VBP B-VP
to TO B-PP
ATRA NN B-NP
by IN B-PP
growth NN B-NP
inhibition NN I-NP
. . O

A DT O
more JJR O
than IN B-PP
additive JJ B-ADJP
increase NN B-NP
in IN B-PP
IRF-1 NN B-NP
gene NN I-NP
expression NN I-NP
was VBD B-VP
seen VBN I-VP
with IN B-PP
ATRA NN B-NP
and CC O
IFN-gamma NN B-NP
in IN B-PP
NB4 NN B-NP
cells NNS I-NP
. . O

ATRA NN B-NP
did VBD B-VP
not RB I-VP
activate VB I-VP
nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
or CC O
signal NN B-NP
transducer NN I-NP
and CC O
activator NN B-NP
of IN B-PP
transcription NN B-NP
( ( O
STAT NN B-NP
) ) O
activation NN B-NP
pathways NNS I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
an DT B-NP
alternate JJ I-NP
mechanism NN I-NP
is VBZ B-VP
involved VBN I-VP
in IN B-PP
IRF-1 NN B-NP
gene NN I-NP
activation NN I-NP
. . O

The DT B-NP
ATRA-induced JJ I-NP
expression NN I-NP
of IN B-PP
IRF-1 NN B-NP
COMMA COMMA O
an DT B-NP
activator NN B-NP
of IN B-PP
transcription NN B-NP
and CC O
repressor NN B-NP
of IN B-PP
transformation NN B-NP
COMMA COMMA O
may MD B-VP
be VB I-VP
one CD B-NP
of IN B-PP
the DT B-NP
molecular JJ I-NP
mechanisms NNS I-NP
of IN B-PP
ATRA-induced JJ B-NP
growth NN I-NP
inhibition NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
basis NN I-NP
for IN B-PP
the DT B-NP
synergistic JJ I-NP
actions NNS I-NP
of IN B-PP
ATRA NN B-NP
and CC O
IFNs NN B-NP
in IN B-PP
myeloid JJ B-NP
leukemia NN I-NP
cells NNS I-NP
. . O

The DT B-NP
c-Jun NN I-NP
delta-domain NN I-NP
inhibits VBZ B-VP
neuroendocrine NN B-NP
promoter NN I-NP
activity NN I-NP
in IN B-PP
a DT O
DNA NN B-NP
sequence- NN I-NP
and CC O
pituitary-specific JJ B-ADJP
manner NN B-NP
. . O

The DT O
transcription NN B-NP
and CC O
transformation NN B-NP
activity NN B-NP
of IN B-PP
c-Jun NN B-NP
is VBZ B-VP
governed VBN I-VP
by IN B-PP
a DT B-NP
27-amino JJ I-NP
acid NN I-NP
regulatory JJ I-NP
motif NN I-NP
COMMA COMMA O
labeled VBN B-VP
the DT B-NP
delta-domain NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
deleted VBN I-VP
in IN B-PP
v-Jun NN B-NP
. . O

We PRP B-NP
have VBP B-VP
previously RB I-VP
shown VBN I-VP
that IN B-SBAR
c-Jun NN B-NP
is VBZ B-VP
a DT B-NP
potent JJ I-NP
inhibitor NN I-NP
of IN B-PP
the DT O
rat NN B-NP
prolactin NN I-NP
( ( O
rPRL NN B-NP
) ) O
promoter NN B-NP
activity NN I-NP
induced VBN B-VP
by IN B-PP
either DT B-NP
oncogenic JJ B-NP
Ras NN I-NP
or CC O
phorbol NN B-NP
esters NNS I-NP
. . O

Here RB B-ADVP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
characterized VBN I-VP
the DT B-NP
structural JJ I-NP
and CC I-NP
cell-specific JJ I-NP
requirements NNS I-NP
for IN B-PP
this DT B-NP
c-Jun NN I-NP
inhibitory JJ I-NP
response NN I-NP
COMMA COMMA O
and CC O
we PRP B-NP
show VBP B-VP
that IN B-SBAR
this DT B-NP
c-Jun NN I-NP
inhibitory JJ I-NP
response NN I-NP
mapped VBD B-VP
to TO B-PP
the DT B-NP
rPRL NN I-NP
footprint NN I-NP
II CD I-NP
repressor NN I-NP
site NN I-NP
COMMA COMMA O
was VBD B-VP
pituitary-specific JJ B-ADJP
and CC O
required VBD B-VP
the DT B-NP
c-Jun NN I-NP
delta-domain NN I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
alteration NN B-NP
of IN B-PP
any DT B-NP
one CD I-NP
of IN B-PP
these DT B-NP
features NNS I-NP
( ( O
e.g. FW B-ADVP
COMMA COMMA O
cis-element NN B-NP
COMMA COMMA O
trans-factor NN B-NP
COMMA COMMA O
or CC O
cell-specific JJ B-NP
background NN I-NP
) ) O
switched VBD B-VP
c-Jun NN B-NP
to TO B-PP
a DT B-NP
transcriptional JJ I-NP
activator NN I-NP
of IN B-PP
the DT B-NP
rPRL NN I-NP
promoter NN I-NP
. . O

In IN B-PP
HeLa NN B-NP
nonpituitary JJ I-NP
cells NNS I-NP
COMMA COMMA O
c-Jun NN B-NP
alone RB B-ADVP
activated VBD B-VP
the DT B-NP
rPRL NN I-NP
promoter NN I-NP
via IN B-PP
the DT B-NP
most RBS I-NP
proximal JJ I-NP
GHF-1\/Pit-1 NN I-NP
binding NN I-NP
site NN I-NP
COMMA COMMA O
footprint NN B-NP
I NN I-NP
COMMA COMMA O
and CC O
synergized VBD B-VP
with IN B-PP
GHF-1 NN B-NP
. . O

Finally RB B-ADVP
COMMA COMMA O
recombinant JJ B-NP
GHF-1 NN I-NP
interacted VBD B-VP
directly RB B-ADVP
with IN B-PP
c-Jun NN B-NP
but CC B-CONJP
not RB I-CONJP
c-Fos NN B-NP
proteins NNS B-NP
. . O

These DT B-NP
data NNS I-NP
provide VBP B-VP
important JJ B-NP
fundamental JJ I-NP
insights NNS I-NP
into IN B-PP
the DT B-NP
molecular NN I-NP
mechanisms NNS I-NP
by IN B-PP
which WDT B-NP
the DT B-NP
c-Jun NN I-NP
delta-domain NN I-NP
functions VBZ B-VP
as IN B-PP
a DT B-NP
modulatory JJ I-NP
switch NN I-NP
and CC O
further RB B-VP
imply VBP I-VP
that IN B-SBAR
the DT B-NP
functional JJ I-NP
role NN I-NP
of IN B-PP
c-Jun NN B-NP
is VBZ B-VP
dictated VBN I-VP
by IN B-PP
cell-specific JJ B-NP
influences NNS I-NP
and CC O
the DT B-NP
delta-domain JJ I-NP
motif NN I-NP
. . O

BCL-6 NN B-NP
COMMA COMMA O
a DT B-NP
POZ\/zinc-finger NN I-NP
protein NN I-NP
COMMA COMMA O
is VBZ B-VP
a DT B-NP
sequence-specific JJ I-NP
transcriptional JJ I-NP
repressor NN I-NP
. . O

Approximately RB B-NP
40 CD I-NP
% NN I-NP
of IN B-PP
diffuse JJ B-NP
large JJ I-NP
cell NN I-NP
lymphoma NN I-NP
are VBP B-VP
associated VBN I-VP
with IN B-PP
chromosomal JJ B-NP
translocations NNS I-NP
that WDT B-NP
deregulate VBP B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
BCL6 NN I-NP
gene NN I-NP
by IN B-PP
juxtaposing VBG B-VP
heterologous JJ B-NP
promoters NNS I-NP
to TO B-PP
the DT B-NP
BCL-6 NN I-NP
coding NN I-NP
domain NN I-NP
. . O

The DT B-NP
BCL6 NN I-NP
gene NN I-NP
encodes VBZ B-VP
a DT B-NP
95-kDa JJ I-NP
protein NN I-NP
containing VBG B-VP
six CD B-NP
C-terminal JJ I-NP
zinc-finger NN I-NP
motifs NNS I-NP
and CC O
an DT B-NP
N-terminal JJ I-NP
POZ NN I-NP
domain NN I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
it PRP B-NP
may MD B-VP
function VB I-VP
as IN B-PP
a DT B-NP
transcription NN I-NP
factor NN I-NP
. . O

By IN B-PP
using VBG B-VP
a DT B-NP
DNA NN I-NP
sequence NN I-NP
selected VBN B-VP
for IN B-PP
its PRP$ B-NP
ability NN I-NP
to TO B-VP
bind VB I-VP
recombinant JJ B-NP
BCL-6 NN I-NP
in FW B-ADVP
vitro FW I-ADVP
COMMA COMMA O
we PRP B-NP
show VBP B-VP
here RB B-ADVP
that IN B-SBAR
BCL-6 NN B-NP
is VBZ B-VP
present JJ B-ADJP
in IN B-PP
DNA-binding JJ B-NP
complexes NNS I-NP
in IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
from IN B-PP
various JJ B-NP
B-cell NN I-NP
lines NNS I-NP
. . O

In IN B-PP
transient JJ B-NP
transfectin NN I-NP
experiments NNS I-NP
COMMA COMMA O
BCL6 NN B-NP
can MD B-VP
repress VB I-VP
transcription NN B-NP
from IN B-PP
promoters NNS B-NP
linked VBN B-VP
to TO B-PP
its PRP$ B-NP
DNA NN I-NP
target NN I-NP
sequence NN I-NP
and CC O
this DT B-NP
activity NN I-NP
is VBZ B-VP
dependent JJ B-ADJP
upon IN B-PP
specific JJ B-NP
DNA-binding NN I-NP
and CC O
the DT B-NP
presence NN I-NP
of IN B-PP
an DT B-NP
intact JJ I-NP
N-terminal JJ I-NP
half NN I-NP
of IN B-PP
the DT B-NP
protein NN I-NP
. . O

We PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
this DT B-NP
part NN I-NP
of IN B-PP
the DT B-NP
BCL6 NN I-NP
molecule NN I-NP
contains VBZ B-VP
an DT B-NP
autonomous JJ I-NP
transrepressor NN I-NP
domain NN I-NP
and CC O
that IN B-SBAR
two CD B-NP
noncontiguous JJ I-NP
regions NNS I-NP
COMMA COMMA O
including VBG B-PP
the DT B-NP
POZ NN I-NP
motif NN I-NP
COMMA COMMA O
mediate VBP B-VP
maximum JJ B-NP
transrepressive JJ I-NP
activity NN I-NP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
the DT B-NP
BCL-6 NN I-NP
protein NN I-NP
can MD B-VP
function VB I-VP
as IN B-PP
a DT B-NP
sequence-specific JJ I-NP
transcriptional JJ I-NP
repressor NN I-NP
and CC O
have VBP B-VP
implications NNS B-NP
for IN B-PP
the DT B-NP
role NN I-NP
of IN B-PP
BCL6 NN B-NP
in IN B-PP
normal JJ B-NP
lymphoid JJ I-NP
development NN I-NP
and CC O
lymphomagenesis NN B-NP
. . O

Constitutive JJ B-NP
expression NN I-NP
of IN B-PP
specific JJ B-NP
interferon NN I-NP
isotypes NNS I-NP
in IN B-PP
peripheral JJ B-NP
blood NN I-NP
leukocytes NNS I-NP
from IN B-PP
normal JJ B-NP
individuals NNS I-NP
and CC B-PP
in IN B-PP
promonocytic JJ B-NP
U937 NN I-NP
cells NNS I-NP
. . O

Constitutive JJ B-NP
expression NN I-NP
of IN B-PP
IFN-alpha5 NN B-NP
and CC O
IFN-beta NN B-NP
was VBD B-VP
detected VBN I-VP
in IN B-PP
different JJ B-NP
lymphoid JJ I-NP
cells NNS I-NP
including VBG B-PP
peripheral JJ B-NP
blood NN I-NP
mononuclear JJ I-NP
cells NNS I-NP
from IN B-PP
normal JJ B-NP
individuals NNS I-NP
following VBG B-PP
amplification NN B-NP
of IN B-PP
IFN NN B-NP
mRNA NN I-NP
by IN B-PP
reverse JJ B-NP
transcriptase-polymerase NN I-NP
chain NN I-NP
reaction NN I-NP
and CC O
direct JJ B-NP
sequencing NN I-NP
of IN B-PP
the DT B-NP
amplified VBN I-NP
product NN I-NP
. . O

The DT B-NP
activated JJ I-NP
form NN I-NP
of IN B-PP
the DT B-NP
interferon-induced JJ I-NP
transcription NN I-NP
factor NN I-NP
complex NN I-NP
ISGF3 NN I-NP
was VBD B-VP
also RB I-VP
detected VBN I-VP
in IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
from IN B-PP
uninduced JJ B-NP
cells NNS I-NP
. . O

Culture NN B-NP
supernatants NNS I-NP
from IN B-PP
uninduced JJ B-NP
U937 NN I-NP
cells NNS I-NP
were VBD B-VP
also RB I-VP
found VBN I-VP
to TO I-VP
activate VB I-VP
an DT B-NP
ISRE NN I-NP
cloned VBN B-VP
upstream RB B-ADVP
of IN B-PP
the DT B-NP
luciferase NN I-NP
reporter NN I-NP
gene NN I-NP
COMMA COMMA O
indicating VBG B-VP
the DT B-NP
presence NN I-NP
of IN B-PP
endogenous JJ B-NP
IFN NN I-NP
activity NN I-NP
equivalent JJ B-ADJP
to TO B-PP
approximately RB B-NP
0.3 CD I-NP
to TO I-NP
0.5 CD I-NP
IU\/mL NN I-NP
. . O

This DT B-NP
endogenous JJ I-NP
IFN NN I-NP
was VBD B-VP
also RB I-VP
shown VBN I-VP
to TO I-VP
play VB I-VP
a DT B-NP
role NN I-NP
in IN B-PP
maintaining VBG B-VP
the DT B-NP
basal JJ I-NP
level NN I-NP
of IN B-PP
expression NN B-NP
of IN B-PP
the DT B-NP
major JJ I-NP
histocompatibility NN I-NP
class NN I-NP
I CD I-NP
genes NNS I-NP
in IN B-PP
lymphoid JJ B-NP
cells NNS I-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
IFN-alpha5 NN B-NP
and CC O
IFN-beta NN B-NP
are VBP B-VP
produced VBN I-VP
at IN B-PP
low JJ B-NP
levels NNS I-NP
in IN B-PP
normal JJ B-NP
tissues NNS I-NP
and CC O
play VBP B-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
cell NN B-NP
function NN I-NP
and CC B-PP
in IN B-PP
the DT B-NP
maintenance NN I-NP
of IN B-PP
homeostasis NN B-NP
. . O

Mechanisms NNS B-NP
of IN B-PP
transactivation NN B-NP
by IN B-PP
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells-1 NNS I-NP
. . O

Nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells-family NN I-NP
proteins NNS B-NP
( ( O
NFAT1\/NFATp NN B-NP
COMMA COMMA O
NFATc NN B-NP
COMMA COMMA O
NFAT3 NN B-NP
COMMA COMMA O
and CC O
NFAT4\/NFATx/NFATc3 NN B-NP
) ) O
play VBP B-VP
a DT B-NP
key JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
transcription NN I-NP
of IN B-PP
cytokine NN B-NP
genes NNS I-NP
and CC O
other JJ B-NP
genes NNS I-NP
during IN B-PP
the DT B-NP
immune JJ I-NP
response NN I-NP
. . O

We PRP B-NP
have VBP B-VP
defined VBN I-VP
the DT B-NP
mechanisms NNS I-NP
of IN B-PP
transactivation NN B-NP
by IN B-PP
NFAT1 NN B-NP
. . O

NFAT1 NNP B-NP
possesses VBZ B-VP
two CD B-NP
transactivation NN I-NP
domains NNS I-NP
whose WP$ B-NP
sequences NNS I-NP
are VBP B-VP
not RB I-VP
conserved VBN I-VP
in IN B-PP
the DT B-NP
other JJ I-NP
NFAT-family NN I-NP
proteins NNS I-NP
COMMA COMMA O
and CC O
a DT B-NP
conserved VBN I-NP
DNA-binding JJ I-NP
domain NN I-NP
that WDT B-NP
mediates VBZ B-VP
the DT B-NP
recruitment NN I-NP
of IN B-PP
cooperating VBG B-NP
nuclear JJ I-NP
transcription NN I-NP
factors NNS I-NP
even RB B-ADVP
when WRB I-ADVP
it PRP B-NP
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
other JJ B-NP
regions NNS I-NP
of IN B-PP
the DT B-NP
protein NN I-NP
. . O

The DT B-NP
activity NN I-NP
of IN B-PP
the DT B-NP
NH2-terminal JJ I-NP
transactivation NN I-NP
domain NN I-NP
is VBZ B-VP
modulated VBN I-VP
by IN B-PP
an DT B-NP
adjacent JJ I-NP
regulatory JJ I-NP
region NN I-NP
that WDT B-NP
contains VBZ B-VP
several JJ B-NP
conserved VBN I-NP
sequence NN I-NP
motifs NNS I-NP
represented VBN B-VP
only RB B-PP
in IN I-PP
the DT B-NP
NFAT NN I-NP
family NN I-NP
. . O

Our PRP$ B-NP
results NNS I-NP
emphasize VBP B-VP
the DT B-NP
multiple JJ I-NP
levels NNS I-NP
at IN B-PP
which WDT B-NP
NFAT-dependent JJ B-NP
transactivation NN I-NP
is VBZ B-VP
regulated VBN I-VP
COMMA COMMA O
and CC O
predict VBP B-VP
significant JJ B-NP
differences NNS I-NP
in IN B-PP
the DT B-NP
architecture NN I-NP
of IN B-PP
cooperative JJ B-NP
transcription NN I-NP
complexes NNS I-NP
containing VBG B-VP
different JJ B-NP
NFAT-family NN I-NP
proteins NNS I-NP
. . O

The DT B-NP
Ets NN I-NP
protein NN I-NP
Spi-B NN I-NP
is VBZ B-VP
expressed VBN I-VP
exclusively RB B-PP
in IN I-PP
B NN B-NP
cells NNS I-NP
and CC O
T NN B-NP
cells NNS I-NP
during IN B-PP
development NN B-NP
. . O

Spi-B NN B-NP
and CC O
PU.1 NN B-NP
are VBP B-VP
hematopoietic-specific JJ B-NP
transcription NN I-NP
factors NNS I-NP
that WDT B-NP
constitute VBP B-VP
a DT B-NP
subfamily NN I-NP
of IN B-PP
the DT B-NP
Ets NN I-NP
family NN I-NP
of IN B-PP
DNA-binding JJ B-NP
proteins NNS I-NP
. . O

Here RB B-ADVP
we PRP B-NP
show VBP B-VP
that IN B-SBAR
contrary JJ B-PP
to TO I-PP
previous JJ B-NP
reports NNS I-NP
COMMA COMMA O
PU.1 NN B-NP
and CC O
Spi-B NN B-NP
have VBP B-VP
very RB B-NP
different JJ I-NP
expression NN I-NP
patterns NNS I-NP
. . O

PU.1 NN B-NP
is VBZ B-VP
expressed VBN I-VP
at IN B-PP
high JJ B-NP
levels NNS I-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
COMMA COMMA O
mast NN B-NP
cells NNS I-NP
COMMA COMMA O
megakaryocytes NNS B-NP
COMMA COMMA O
macrophages NNS B-NP
COMMA COMMA O
neutrophils NNS B-NP
COMMA COMMA O
and CC O
immature JJ B-NP
erythroid JJ I-NP
cells NNS I-NP
and CC O
at IN B-PP
lower JJR B-NP
levels NNS I-NP
in IN B-PP
mature JJ B-NP
erythrocytes NNS I-NP
. . O

PU.1 NN B-NP
is VBZ B-VP
completely RB B-ADJP
absent JJ I-ADJP
from IN B-PP
peripheral JJ B-NP
T NN I-NP
cells NNS I-NP
and CC O
most JJS B-NP
T JJ I-NP
cell NN I-NP
lines NNS I-NP
based VBN B-PP
on IN B-PP
sensitive JJ B-NP
RT-PCR NN I-NP
assays NNS I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
Spi-B NN B-NP
is VBZ B-VP
expressed VBN I-VP
exclusively RB B-ADVP
in IN B-PP
lymphoid JJ B-NP
cells NNS I-NP
and CC O
can MD B-VP
be VB I-VP
detected VBN I-VP
in IN B-PP
early JJ B-NP
fetal JJ I-NP
thymus NN B-NP
and CC O
spleen NN B-NP
. . O

In FW B-NP
situ FW I-NP
hybridizations NNS I-NP
of IN B-PP
adult JJ B-NP
murine JJ I-NP
tissues NNS I-NP
demonstrate VBP B-VP
Spi-B NN B-NP
mRNA NN I-NP
in IN B-PP
the DT B-NP
medulla NN I-NP
of IN B-PP
the DT B-NP
thymus NN I-NP
COMMA COMMA O
the DT B-NP
white JJ I-NP
pulp NN I-NP
of IN B-PP
the DT B-NP
spleen NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
germinal JJ I-NP
centers NNS I-NP
of IN B-PP
lymph NN B-NP
nodes NNS I-NP
. . O

Spi-B JJ B-NP
expression NN I-NP
is VBZ B-VP
very RB B-ADJP
abundant JJ I-ADJP
in IN B-PP
B NN B-NP
cells NNS I-NP
and CC O
both CC B-NP
Spi-B NN I-NP
mRNA NN B-NP
and CC O
protein NN B-NP
are VBP B-VP
detected VBN I-VP
in IN B-PP
some DT B-NP
T NN I-NP
cells NNS I-NP
. . O

In FW B-NP
situ FW I-NP
hybridization NN I-NP
and CC O
Northern NN B-NP
blot NN I-NP
analysis NN I-NP
suggest VBP B-VP
that IN B-SBAR
Spi-B NN B-NP
gene NN I-NP
expression NN I-NP
increases VBZ B-VP
during IN B-PP
B NN B-NP
cell NN I-NP
maturation NN I-NP
and CC O
decreases VBZ B-VP
during IN B-PP
T NN B-NP
cell NN I-NP
maturation NN I-NP
. . O

Gel-retardation JJ B-NP
experiments NNS I-NP
show VBP B-VP
that IN B-SBAR
Spi-B NN B-NP
can MD B-VP
bind VB I-VP
to TO B-PP
all DT B-NP
putative JJ I-NP
PU.1 NN I-NP
binding NN I-NP
sites NNS I-NP
COMMA COMMA O
but CC O
do VBP B-VP
not RB I-VP
reveal VB I-VP
any DT B-NP
preferred JJ I-NP
Spi-B NN I-NP
binding NN I-NP
site NN I-NP
. . O

Finally RB B-ADVP
COMMA COMMA O
both CC O
PU.1 NN B-NP
and CC O
Spi-B NN B-NP
function VBP B-VP
as IN B-PP
transcriptional JJ B-NP
activators NNS I-NP
of IN B-PP
the DT B-NP
immunoglobulin JJ I-NP
light-chain NN I-NP
enhancer NN I-NP
E NN I-NP
lambda NN I-NP
2.4 CD I-NP
when WRB B-ADVP
coexpressed VBN B-VP
with IN B-PP
Pip NN B-NP
( ( O
PU.1-interaction JJ B-NP
partner NN I-NP
) ) O
in IN B-PP
NIH-3T3 NN B-NP
cells NNS I-NP
. . O

Taken VBN B-VP
together RB B-ADVP
COMMA COMMA O
these DT B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
differences NNS B-NP
in IN B-PP
patterns NNS B-NP
of IN B-PP
expression NN B-NP
between IN B-PP
Spi-B NN B-NP
and CC O
PU.1 NN B-NP
distinguish VBP B-VP
the DT B-NP
function NN I-NP
of IN B-PP
each DT B-NP
protein NN I-NP
during IN B-PP
development NN B-NP
of IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
. . O

Precise JJ B-NP
alignment NN I-NP
of IN B-PP
sites NNS B-NP
required VBN B-VP
for IN B-PP
mu NN B-NP
enhancer NN I-NP
activation NN I-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
. . O

The DT B-NP
lymphocyte-specific JJ I-NP
immunoglobulin NN I-NP
mu NN I-NP
heavy-chain JJ I-NP
gene NN I-NP
intronic JJ I-NP
enhancer NN I-NP
is VBZ B-VP
regulated VBN I-VP
by IN B-PP
multiple JJ B-NP
nuclear JJ I-NP
factors NNS I-NP
. . O

The DT B-NP
previously RB I-NP
defined VBN I-NP
minimal JJ I-NP
enhancer NN I-NP
containing VBG B-VP
the DT O
muA NN B-NP
COMMA COMMA O
muE3 NN B-NP
COMMA COMMA O
and CC O
muB NN B-NP
sites NNS B-NP
is VBZ B-VP
transactivated VBN I-VP
by IN B-PP
a DT B-NP
combination NN I-NP
of IN B-PP
the DT B-NP
ETS-domain NN I-NP
proteins NNS I-NP
PU.1 NN B-NP
and CC O
Ets-1 NN B-NP
in IN B-PP
nonlymphoid JJ B-NP
cells NNS I-NP
. . O

The DT B-NP
core NN I-NP
GGAAs NNS I-NP
of IN B-PP
the DT O
muA NN B-NP
and CC O
muB NN B-NP
sites NNS B-NP
are VBP B-VP
separated VBN I-VP
by IN B-PP
30 CD B-NP
nucleotides NNS I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
ETS NNS B-NP
proteins NNS I-NP
bind VBP B-VP
to TO B-PP
these DT B-NP
sites NNS I-NP
from IN B-PP
these DT B-NP
same JJ I-NP
side NN I-NP
of IN B-PP
the DT B-NP
DNA NN I-NP
helix NN I-NP
. . O

We PRP B-NP
tested VBD B-VP
the DT B-NP
necessity NN I-NP
for IN B-PP
appropriate JJ B-NP
spatial JJ I-NP
alignment NN I-NP
of IN B-PP
these DT B-NP
elements NNS I-NP
by IN B-PP
using VBG B-VP
mutated VBN B-NP
enhancers NNS I-NP
with IN B-PP
altered JJ B-NP
spacings NNS I-NP
. . O

A DT O
4- CD B-NP
or CC O
10-bp JJ B-ADJP
insertion NN B-NP
between IN B-PP
muE3 NN B-NP
and CC O
muB NN B-NP
inactivated VBD B-VP
the DT B-NP
mu NN I-NP
enhancer NN I-NP
in IN B-PP
S194 NN B-NP
plasma NN I-NP
cells NNS I-NP
but CC O
did VBD B-VP
not RB I-VP
affect VB I-VP
in FW B-NP
vitro FW I-NP
binding NN I-NP
of IN B-PP
Ets-1 NN B-NP
COMMA COMMA O
PU.1 NN B-NP
COMMA COMMA O
or CC O
the DT B-NP
muE3-binding JJ I-NP
protein NN I-NP
TFE3 NN I-NP
COMMA COMMA O
alone RB B-ADVP
or CC O
in IN B-PP
pairwise JJ B-NP
combinations NNS I-NP
. . O

Circular JJ B-NP
permutation NN I-NP
and CC O
phasing NN B-NP
analyses NNS B-NP
demonstrated VBD B-VP
that IN B-SBAR
PU.1 NN B-NP
binding NN I-NP
but CC B-CONJP
not RB I-CONJP
TFE3 NN B-NP
or CC O
Ets-1 NN B-NP
bends VBZ B-VP
mu NN B-NP
enhancer NN I-NP
DNA NN I-NP
toward IN B-PP
the DT B-NP
major JJ I-NP
groove NN I-NP
. . O

We PRP B-NP
propose VBP B-VP
that IN B-SBAR
the DT B-NP
requirement NN I-NP
for IN B-PP
precise JJ B-NP
spacing NN I-NP
of IN B-PP
the DT O
muA NN B-NP
and CC O
muB NN B-NP
elements NNS B-NP
is VBZ B-VP
due JJ O
in IN B-PP
part NN B-NP
to TO B-PP
a DT B-NP
directed JJ I-NP
DNA NN I-NP
bend NN I-NP
induced VBN B-VP
by IN B-PP
PU.1 NN B-NP
. . O

C\/EBP NN B-NP
activators NNS I-NP
are VBP B-VP
required VBN I-VP
for IN B-PP
HIV-1 NN B-NP
replication NN I-NP
and CC O
proviral JJ B-NP
induction NN I-NP
in IN B-PP
monocytic JJ B-NP
cell NN I-NP
lines NNS I-NP
. . O

Previous JJ B-NP
work NN I-NP
has VBZ B-VP
shown VBN I-VP
that IN B-SBAR
C\/EBP NN B-NP
sites NNS I-NP
and CC O
C\/EBP NN B-NP
transcriptional JJ I-NP
activators NNS I-NP
are VBP B-VP
necessary JJ B-ADJP
for IN B-PP
HIV-1 NN B-NP
LTR NN I-NP
activity NN I-NP
in IN B-PP
monocytes\/macrophages NNS B-NP
. . O

We PRP B-NP
have VBP B-VP
investigated VBN I-VP
the DT B-NP
role NN I-NP
that WDT B-NP
C\/EBP NN B-NP
proteins NNS I-NP
play VBP B-VP
in IN B-PP
induction NN B-NP
and CC O
replication NN B-NP
of IN B-PP
HIV-1 NN B-NP
. . O

Ectopic JJ B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
dominant JJ I-NP
negative JJ I-NP
C\/EBP NN I-NP
protein NN I-NP
LIP NN I-NP
inhibited VBD B-VP
HIV-1 NN B-NP
mRNA NN I-NP
and CC O
virus NN B-NP
production NN I-NP
in IN B-PP
activated VBN B-NP
U1 NN I-NP
cells NNS I-NP
COMMA COMMA O
demonstrating VBG B-VP
that IN B-SBAR
C\/EBP NN B-NP
proteins NNS I-NP
are VBP B-VP
required VBN I-VP
for IN B-PP
provirus NN B-NP
induction NN I-NP
. . O

U1 NN B-NP
lines NNS I-NP
overexpressing VBG B-VP
C\/EBP NN B-NP
activator NN I-NP
NF-IL-6 NN I-NP
produced VBD B-VP
more JJR B-NP
viral JJ B-NP
mRNA NN I-NP
and CC O
virus NN B-NP
particles NNS I-NP
following VBG B-PP
cellular JJ B-NP
activation NN I-NP
than IN B-PP
control NN B-NP
lines NNS I-NP
COMMA COMMA O
demonstrating VBG B-VP
that IN B-SBAR
C\/EBP NN B-NP
proteins NNS I-NP
are VBP B-VP
limiting VBG B-ADJP
for IN B-PP
virus NN B-NP
transcription NN I-NP
. . O

HIV-1 NN B-NP
harboring NN I-NP
mutations NNS I-NP
within IN B-PP
two CD B-NP
C\/EBP NN I-NP
sites NNS I-NP
were VBD B-VP
crippled VBN B-ADJP
in IN B-PP
their PRP$ B-NP
ability NN I-NP
to TO B-VP
replicate VB I-VP
in IN B-PP
U937 NN B-NP
promonocytic JJ I-NP
cells NNS I-NP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
these DT B-NP
sites NNS I-NP
are VBP B-VP
required VBN I-VP
for IN B-PP
replication NN B-NP
. . O

These DT B-NP
data NNS I-NP
identify VBP B-VP
C\/EBP NN B-NP
proteins NNS I-NP
as IN B-PP
regulators NNS B-NP
of IN B-PP
HIV-1 NN B-NP
expression NN I-NP
in IN B-PP
monocytes\/macrophages NNS B-NP
. . O

Reversal NN B-NP
of IN B-PP
apoptosis NN B-NP
by IN B-PP
the DT B-NP
leukaemia-associated JJ I-NP
E2A-HLF NN I-NP
chimaeric JJ I-NP
transcription NN I-NP
factor NN I-NP
. . O

The DT B-NP
E2A-HLF NN I-NP
( ( O
for IN B-PP
hepatic JJ B-NP
leukaemia NN I-NP
factor NN I-NP
) ) O
fusion NN B-NP
gene NN I-NP
COMMA COMMA O
formed VBN B-VP
by IN B-PP
action NN B-NP
of IN B-PP
the DT B-NP
t(17;19) NN I-NP
(q22;p13) NN I-NP
chromosomal JJ I-NP
translocation NN I-NP
COMMA COMMA O
drives VBZ B-VP
the DT B-NP
leukaemic JJ I-NP
transformation NN I-NP
of IN B-PP
early JJ B-NP
B-cell NN I-NP
precursors NNS I-NP
COMMA COMMA O
but CC O
the DT B-NP
mechanism NN I-NP
of IN B-PP
this DT B-NP
activity NN I-NP
remains VBZ B-VP
unknown JJ B-ADJP
. . O

Here RB B-ADVP
we PRP B-NP
report VBP B-VP
that IN B-SBAR
human JJ B-NP
leukaemia NN I-NP
cells NNS I-NP
carrying VBG B-VP
the DT B-NP
translocation NN I-NP
t(17;19) NN I-NP
rapidly RB B-ADVP
died VBD B-VP
by IN B-PP
apoptosis NN B-NP
when WRB B-ADVP
programmed VBN B-VP
to TO I-VP
express VB I-VP
a DT B-NP
dominant-negative JJ I-NP
suppressor NN I-NP
of IN B-PP
the DT B-NP
fusion NN I-NP
protein NN I-NP
E2A-HLF NN I-NP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
the DT B-NP
chimaeric JJ I-NP
oncoprotein NN I-NP
probably RB B-ADVP
affects VBZ B-VP
cell NN B-NP
survival NN I-NP
rather RB B-CONJP
than IN I-CONJP
cell NN B-NP
growth NN I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
when WRB B-ADVP
introduced VBN B-VP
into IN B-PP
murine JJ B-NP
pro-B JJ I-NP
lymphocytes NNS I-NP
COMMA COMMA O
the DT B-NP
oncogenic JJ I-NP
E2A-HLF NN I-NP
fusion NN I-NP
protein NN I-NP
reversed VBD B-VP
both CC B-NP
interleukin-3-dependent JJ I-NP
and CC I-NP
p53-mediated JJ I-NP
apoptosis NN I-NP
. . O

The DT B-NP
close JJ I-NP
homology NN I-NP
of IN B-PP
the DT O
basic JJ B-NP
region\/leucine NN I-NP
zipper NN I-NP
( ( O
bZIP NN B-NP
) ) O
DNA-binding JJ B-ADJP
and CC O
dimerization NN B-NP
domain NN B-NP
of IN B-PP
HLF NN B-NP
to TO B-PP
that DT B-NP
of IN B-PP
the DT B-NP
CES-2 NN I-NP
cell-death NN I-NP
specification NN I-NP
protein NN I-NP
of IN B-PP
Caenorhabditis NN B-NP
elegans NNS I-NP
suggests VBZ B-VP
a DT B-NP
model NN I-NP
of IN B-PP
leukaemogenesis NN B-NP
in IN B-PP
which WDT B-NP
E2A-HLF NN B-NP
blocks VBZ B-VP
an DT B-NP
early JJ I-NP
step NN I-NP
within IN B-PP
an DT B-NP
evolutionarily RB I-NP
conserved VBN I-NP
cell-death NN I-NP
pathway NN I-NP
. . O

Effects NNS B-NP
of IN B-PP
IL-10 NN B-NP
and CC O
IL-4 NN B-NP
on IN B-PP
LPS-induced JJ B-NP
transcription NN I-NP
factors NNS I-NP
( ( O
AP-1 NN B-NP
COMMA COMMA O
NF-IL6 NN B-NP
and CC O
NF-kappa NN B-NP
B NN I-NP
) ) O
which WDT B-NP
are VBP B-VP
involved VBN I-VP
in IN B-PP
IL-6 NN B-NP
regulation NN I-NP
. . O

Interleukin-10 NN B-NP
( ( O
IL-10 NN B-NP
) ) O
COMMA COMMA O
like IN B-PP
IL-4 NN B-NP
COMMA COMMA O
is VBZ B-VP
known VBN I-VP
to TO I-VP
inhibit VB I-VP
cytokine NN B-NP
expression NN I-NP
in IN B-PP
activated VBN B-NP
human JJ I-NP
monocytes NNS I-NP
. . O

We PRP B-NP
showed VBD B-VP
that IN B-SBAR
both CC O
IL-10 NN B-NP
and CC O
IL-4 NN B-NP
inhibit VBP B-VP
LPS-induced JJ O
IL-6 NN O
mRNA NN B-NP
and CC O
protein NN B-NP
expression NN B-NP
by IN B-PP
inhibiting VBG B-VP
the DT B-NP
transcription NN I-NP
rate NN I-NP
of IN B-PP
the DT B-NP
IL-6 NN I-NP
gene NN I-NP
. . O

The DT B-NP
strong JJ I-NP
inhibition NN I-NP
of IN B-PP
the DT B-NP
IL-6 NN I-NP
transcription NN I-NP
rate NN I-NP
prompted VBD B-VP
us PRP B-NP
to TO B-VP
study VB I-VP
the DT B-NP
effect NN I-NP
of IN B-PP
IL-10 NN B-NP
and CC O
IL-4 NN B-NP
on IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
. . O

We PRP B-NP
questioned VBD B-VP
whether IN B-SBAR
or CC O
not RB O
IL-10 NN B-NP
and CC O
IL-4 NN B-NP
affected VBD B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
that WDT B-NP
are VBP B-VP
known VBN I-VP
to TO I-VP
be VB I-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
the DT B-NP
IL-6 NN I-NP
transcription NN I-NP
rate NN I-NP
COMMA COMMA B-NP
namely RB I-NP
activator NN B-NP
protein-1 NN I-NP
( ( O
AP-1 NN B-NP
) ) O
COMMA COMMA O
nuclear JJ B-NP
factor NN I-NP
IL-6 NN I-NP
( ( O
NF-IL6 NN B-NP
) ) O
COMMA COMMA O
and CC O
nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
( ( O
NF-kappaB NN B-NP
) ) O
. . O

In IN B-PP
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
( ( O
EMSAs NNS B-NP
) ) O
we PRP B-NP
showed VBD B-VP
that IN B-SBAR
IL-10 NN B-NP
and CC O
IL-4 NN B-NP
inhibited VBD B-VP
LPS-induced JJ B-NP
AP-1 NN I-NP
binding NN I-NP
activity NN I-NP
. . O

The DT B-NP
inhibiting JJ I-NP
effect NN I-NP
of IN B-PP
IL-4 NN B-NP
was VBD B-VP
slightly RB B-ADJP
more RBR I-ADJP
pronounced JJ I-ADJP
than IN B-PP
that DT B-NP
of IN B-PP
IL-10 NN B-NP
. . O

Downregulation NN B-NP
of IN B-PP
LPS-induced JJ B-NP
AP-1 NN I-NP
was VBD B-VP
accompanied VBN I-VP
COMMA COMMA O
and CC O
thus RB O
possibly RB B-VP
explained VBN I-VP
COMMA COMMA O
by IN B-PP
a DT B-NP
reduced VBN I-NP
expression NN I-NP
at IN B-PP
mRNA NN B-NP
level NN I-NP
of IN B-PP
the DT B-NP
two CD I-NP
major JJ I-NP
components NNS I-NP
of IN B-PP
the DT B-NP
AP-1 NN I-NP
complex NN I-NP
COMMA COMMA B-NP
namely RB I-NP
c-fos NN B-NP
and CC O
c-jun NN B-NP
as IN B-SBAR
determined VBN B-VP
by IN B-PP
Northern NN B-NP
experiments NNS I-NP
. . O

Binding NN B-NP
activity NN I-NP
of IN B-PP
NF-IL6 NN B-NP
was VBD B-VP
also RB I-VP
strongly RB I-VP
inhibited VBN I-VP
by IN B-PP
IL-4 NN B-NP
whereas IN O
IL-10 NN B-NP
showed VBD B-VP
no DT B-NP
effect NN I-NP
. . O

NF-IL6 NN B-NP
mRNA NN I-NP
levels NNS I-NP
were VBD B-VP
not RB I-VP
affected VBN I-VP
by IN B-PP
IL-10 NN B-NP
or CC O
IL-4 NN B-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
IL-4 NN B-NP
affects VBZ B-VP
binding NN B-NP
activity NN I-NP
of IN B-PP
preexisting VBG B-NP
NF-IL6 NN I-NP
. . O

Neither CC O
IL-10 NN B-NP
nor CC O
IL-4 NN B-NP
inhibited VBD B-VP
LPS-induced JJ B-NP
NF-kappa NN I-NP
B NN I-NP
binding NN I-NP
activity NN I-NP
. . O

In IN B-PP
agreement NN I-PP
with IN I-PP
this DT B-NP
finding NN I-NP
COMMA COMMA O
Northern NN B-NP
experiments NNS I-NP
where WRB B-ADVP
p65 NN B-NP
and CC O
p105 NN B-NP
mRNA NN B-NP
levels NNS I-NP
were VBD B-VP
determined VBN I-VP
COMMA COMMA O
demonstrated VBD B-VP
that IN B-SBAR
expression NN B-NP
of IN B-PP
these DT B-NP
components NNS I-NP
of IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
transcription NN I-NP
factor NN I-NP
were VBD B-VP
not RB I-VP
affected VBN I-VP
by IN B-PP
IL-10 NN B-NP
or CC O
IL-4 NN B-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
neither CC O
IL-10 NN B-NP
nor CC O
IL-4 NN B-NP
showed VBD B-VP
any DT B-NP
effect NN I-NP
on IN B-PP
I-kappa NN B-NP
B NN I-NP
mRNA NN I-NP
expression NN I-NP
as IN B-SBAR
determined VBN B-VP
by IN B-PP
Northern NN B-NP
experiments NNS I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
IL-10 NN B-NP
and CC O
IL-4 NN B-NP
similarly RB B-ADVP
affect VBP B-VP
IL-6 NN B-NP
expression NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
for IN B-PP
IL-4 NN B-NP
this DT B-NP
was VBD B-VP
accompanied VBN I-VP
with IN B-PP
a DT B-NP
reduction NN I-NP
of IN B-PP
AP-1 NN B-NP
and CC O
NF-IL6 NN B-NP
binding NN B-NP
activity NN I-NP
whereas IN B-SBAR
IL-10 NN B-NP
only RB B-ADVP
inhibited VBD B-VP
AP-1 NN B-NP
binding NN I-NP
activity NN I-NP
. . O

Inhibition NN B-NP
of IN B-PP
transcription NN B-NP
factor NN I-NP
Stat1 NN I-NP
activity NN I-NP
in IN B-PP
mononuclear JJ B-NP
cell NN I-NP
cultures NNS I-NP
and CC O
T NN B-NP
cells NNS I-NP
by IN B-PP
the DT B-NP
cyclic JJ I-NP
AMP NN I-NP
signaling NN I-NP
pathway NN I-NP
. . O

Activation NN B-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
results VBZ B-VP
in IN B-PP
a DT B-NP
cascade NN I-NP
of IN B-PP
gene NN B-NP
activation NN I-NP
and CC O
subsequent JJ B-NP
proliferation NN B-NP
and CC O
differentiation NN B-NP
into IN B-PP
effector NN B-NP
phenotypes NNS I-NP
. . O

The DT B-NP
regulation NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
belonging VBG B-VP
to TO B-PP
the DT O
signal NN B-NP
transducer NN I-NP
and CC O
activator NN B-NP
of IN B-PP
transcription NN B-NP
( ( O
STAT NN B-NP
) ) O
family NN B-NP
was VBD B-VP
analyzed VBN I-VP
in IN B-PP
PHA-activated JJ B-NP
mononuclear JJ I-NP
cells NNS I-NP
and CC B-PP
in IN B-PP
purified VBN B-NP
T NN I-NP
cells NNS I-NP
activated VBN B-VP
by IN B-PP
cross-linking JJ B-NP
cell NN I-NP
surface NN I-NP
CD3 NN I-NP
. . O

Cell NN B-NP
activation NN I-NP
resulted VBD B-VP
in IN B-PP
a DT B-NP
delayed VBN I-NP
induction NN I-NP
of IN B-PP
STAT NN B-NP
DNA-binding JJ I-NP
activity NN I-NP
COMMA COMMA O
which WDT B-NP
was VBD B-VP
sustained JJ I-VP
for IN B-PP
several JJ B-NP
days NNS I-NP
COMMA COMMA O
was VBD B-VP
composed VBN I-VP
predominantly RB B-ADVP
of IN B-PP
Stat1 NN B-NP
and CC O
Stat3 NN B-NP
COMMA COMMA O
and CC O
was VBD B-VP
blocked VBN I-VP
by IN B-PP
cycloheximide NN B-NP
and CC O
actinomycin NN B-NP
D NN I-NP
. . O

Increased VBN O
Stat1 NN B-NP
and CC O
Stat3 NN B-NP
mRNA NN B-NP
and CC O
protein NN B-NP
levels NNS B-NP
were VBD B-VP
detected VBN I-VP
COMMA COMMA O
respectively RB B-ADVP
4 CD B-NP
and CC I-NP
24 CD I-NP
h NN I-NP
after IN B-PP
activation NN B-NP
. . O

Stimulation NN B-NP
of IN B-PP
the DT B-NP
cAMP NN I-NP
signal NN I-NP
transduction NN I-NP
pathway NN I-NP
COMMA COMMA O
which WDT B-NP
skews VBZ B-VP
cytokine NN B-NP
production NN I-NP
toward IN B-PP
a DT B-NP
Th2 NN I-NP
pattern NN I-NP
COMMA COMMA O
resulted VBD B-VP
in IN B-PP
the DT B-NP
preferential JJ I-NP
suppression NN I-NP
of IN B-PP
Stat1 NN B-NP
activity NN I-NP
. . O

cAMP NN B-NP
inhibited VBD B-VP
the DT B-NP
induction NN I-NP
of IN B-PP
expression NN B-NP
of IN B-PP
IL-2 NN B-NP
receptor NN I-NP
components NNS I-NP
COMMA COMMA O
but CC O
did VBD B-VP
not RB I-VP
inhibit VB I-VP
IL-4 NN B-NP
receptor NN I-NP
alpha-chain NN I-NP
and CC O
CD69 NN B-NP
expression NN B-NP
or CC O
the DT B-NP
induction NN I-NP
of IN B-PP
activator NN B-NP
protein NN I-NP
1 CD I-NP
transcription NN I-NP
factors NNS I-NP
. . O

cAMP NN B-NP
signaling NN I-NP
inhibited VBD B-VP
Stat1 NN B-NP
at IN B-PP
several JJ B-NP
different JJ I-NP
levels NNS I-NP
COMMA COMMA O
including VBG B-PP
suppression NN B-NP
of IN B-PP
DNA NN B-NP
binding NN I-NP
and CC O
down-regulation NN B-NP
of IN B-PP
Stat1 NN B-NP
protein NN B-NP
and CC O
mRNA NN B-NP
levels NNS B-NP
. . O

Our PRP$ B-NP
results NNS I-NP
demonstrate VBP B-VP
the DT B-NP
regulation NN I-NP
of IN B-PP
STAT NN B-NP
activity NN I-NP
by IN B-PP
a DT B-NP
signaling NN I-NP
pathway NN I-NP
that WDT B-NP
regulates VBZ B-VP
the DT B-NP
T NN I-NP
cell NN I-NP
functional JJ I-NP
phenotype NN I-NP
and CC O
is VBZ B-VP
distinct JJ B-ADJP
from IN B-PP
the DT B-NP
cytokine-activated JJ I-NP
Janus NN I-NP
kinase-STAT NN I-NP
signaling NN I-NP
pathway NN I-NP
. . O

oriP NN B-NP
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
EBNA NN B-NP
gene NN I-NP
promoter NN I-NP
activity NN I-NP
in IN B-PP
Epstein-Barr JJ B-NP
virus-immortalized JJ I-NP
lymphoblastoid JJ I-NP
cell NN I-NP
lines NNS I-NP
. . O

During IN B-PP
Epstein-Barr JJ B-NP
virus NN I-NP
latent JJ I-NP
infection NN I-NP
of IN B-PP
B NN B-NP
lymphocytes NNS I-NP
in FW B-ADVP
vitro FW I-ADVP
COMMA COMMA O
six CD B-NP
viral JJ I-NP
nuclear JJ I-NP
antigens NNS I-NP
( ( O
EBNAs NN B-NP
) ) O
are VBP B-VP
expressed VBN I-VP
from IN B-PP
one CD B-NP
of IN B-PP
two CD B-NP
promoters NNS I-NP
COMMA COMMA O
Cp NN B-NP
or CC O
Wp NN B-NP
COMMA COMMA O
whose WP$ B-NP
activities NNS I-NP
are VBP B-VP
mutually RB B-ADJP
exclusive JJ I-ADJP
. . O

Upon IN B-PP
infection NN B-NP
COMMA COMMA O
Wp NN B-NP
is VBZ B-VP
initially RB B-ADVP
active JJ B-ADJP
COMMA COMMA O
followed VBN B-VP
by IN B-PP
a DT B-NP
switch NN I-NP
to TO B-PP
Cp NN B-NP
for IN B-PP
the DT B-NP
duration NN I-NP
of IN B-PP
latency NN B-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
the DT B-NP
region NN I-NP
upstream JJ B-ADVP
of IN B-PP
Cp NN B-NP
was VBD B-VP
analyzed VBN I-VP
for IN B-PP
the DT B-NP
presence NN I-NP
of IN B-PP
cis NN B-NP
elements NNS I-NP
involved VBN B-VP
in IN B-PP
regulating VBG B-VP
the DT B-NP
activities NNS I-NP
of IN B-PP
the DT B-NP
EBNA NN I-NP
gene NN I-NP
promoters NNS I-NP
in IN B-PP
established JJ B-NP
in FW I-NP
vitro FW I-NP
immortalized VBN I-NP
lymphoblastoid JJ B-NP
cell NN I-NP
lines NNS I-NP
( ( O
LCLs NNS B-NP
) ) O
. . O

It PRP B-NP
was VBD B-VP
determined VBN I-VP
that IN B-SBAR
oriP NN B-NP
COMMA COMMA O
the DT B-NP
origin NN I-NP
for IN B-PP
episomal JJ B-NP
maintenance NN I-NP
during IN B-PP
latency NN B-NP
COMMA COMMA O
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
efficient JJ B-NP
transcription NN I-NP
initiation NN I-NP
from IN B-PP
either CC O
Cp NN B-NP
or CC O
Wp NN B-NP
in IN B-PP
LCLs NN B-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
in IN B-PP
some DT O
Burkitt NN B-NP
's POS B-NP
lymphoma NN I-NP
cell NN I-NP
lines NNS I-NP
. . O

Deletion NN B-NP
of IN B-PP
the DT B-NP
EBNA2-dependent JJ I-NP
enhancer NN I-NP
located JJ B-ADJP
upstream RB I-ADJP
of IN B-PP
Cp NN B-NP
resulted VBD B-VP
in IN B-PP
a DT B-NP
ca. FW I-NP
two- CD I-NP
to TO I-NP
fivefold JJ I-NP
reduction NN I-NP
in IN B-PP
Cp NN B-NP
activity NN I-NP
in IN B-PP
the DT B-NP
LCLs NNS I-NP
assayed VBN B-VP
. . O

More RBR B-NP
extensive JJ I-NP
deletion NN I-NP
of IN B-PP
sequences NNS B-NP
upstream JJ B-ADVP
of IN B-PP
Cp NN B-NP
COMMA COMMA O
including VBG B-PP
the DT B-NP
EBNA2-dependent JJ I-NP
enhancer NN I-NP
COMMA COMMA O
resulted VBD B-VP
in IN B-PP
nearly RB B-NP
complete JJ I-NP
loss NN I-NP
of IN B-PP
Cp NN B-NP
activity NN I-NP
. . O

This DT B-NP
loss NN I-NP
of IN B-PP
activity NN B-NP
was VBD B-VP
shown VBN I-VP
to TO I-VP
correlate VB I-VP
with IN B-PP
deletion NN B-NP
of IN B-PP
two CD B-NP
CCAAT NN I-NP
boxes NNS I-NP
COMMA COMMA O
a DT B-NP
proximal JJ I-NP
CCAAT NN I-NP
box NN I-NP
located JJ B-ADJP
at IN B-PP
bp NN B-NP
-61 CD B-NP
to TO O
-65 CD B-NP
and CC O
a DT B-NP
distal JJ I-NP
CCAAT NN I-NP
box NN I-NP
located JJ B-ADJP
at IN B-PP
bp NN B-NP
-253 CD B-NP
to TO O
-257 CD B-NP
COMMA COMMA O
upstream RB B-ADVP
of IN B-PP
Cp NN B-NP
. . O

Site-directed JJ B-NP
mutagenesis NN I-NP
of IN B-PP
these DT B-NP
cis NN I-NP
elements NNS I-NP
demonstrated VBD B-VP
that IN B-SBAR
Cp NN B-NP
activity NN I-NP
is VBZ B-VP
highly RB B-ADJP
dependent JJ I-ADJP
on IN B-PP
the DT B-NP
presence NN I-NP
of IN B-PP
a DT B-NP
properly RB I-NP
positioned VBN I-NP
CCAAT NN I-NP
box NN I-NP
COMMA COMMA O
with IN B-PP
the DT B-NP
dependence NN I-NP
on IN B-PP
the DT B-NP
distal JJ I-NP
CCAAT NN I-NP
box NN I-NP
apparent JJ B-ADJP
only RB B-ADVP
when WRB I-ADVP
the DT B-NP
proximal JJ I-NP
CCAAT NN I-NP
box NN I-NP
was VBD B-VP
deleted VBN I-VP
or CC O
mutated VBN B-VP
. . O

Deletion NN B-NP
of IN B-PP
the DT B-NP
glucocorticoid NN I-NP
response NN I-NP
elements NNS I-NP
located JJ B-ADJP
at IN B-PP
ca. FW B-NP
bp NN I-NP
-850 CD I-NP
upstream RB B-ADVP
of IN B-PP
Cp NN B-NP
did VBD B-VP
not RB I-VP
result VB I-VP
in IN B-PP
a DT B-NP
significant JJ I-NP
loss NN I-NP
in IN B-PP
activity NN B-NP
. . O

In IN B-PP
general JJ B-NP
COMMA COMMA O
deletions NNS B-NP
which WDT B-NP
diminished VBD B-VP
Cp JJ B-NP
activity NN I-NP
resulted VBD B-VP
in IN B-PP
induction NN B-NP
of IN B-PP
Wp JJ B-NP
activity NN I-NP
COMMA COMMA O
consistent JJ B-ADJP
with IN B-PP
suppression NN B-NP
of IN B-PP
Wp JJ B-NP
activity NN I-NP
by IN B-PP
transcriptional JJ B-NP
interference NN I-NP
from IN B-PP
Cp NN B-NP
. . O

The DT B-NP
identification NN I-NP
of IN B-PP
oriP NN B-NP
and CC O
the DT B-NP
EBNA2-dependent JJ I-NP
enhancer NN I-NP
as IN B-PP
the DT B-NP
major JJ I-NP
positive JJ I-NP
cis NN I-NP
elements NNS I-NP
involved VBN B-VP
in IN B-PP
regulating VBG B-VP
Cp JJ B-NP
activity NN I-NP
in IN B-PP
LCL NN B-NP
suggests VBZ B-VP
that IN B-SBAR
EBNA NN B-NP
gene NN I-NP
transcription NN I-NP
is VBZ B-VP
largely RB I-VP
autoregulated VBN I-VP
by IN B-PP
EBNA NN B-NP
1 CD I-NP
and CC O
EBNA NN B-NP
2 CD I-NP
. . O

Various JJ B-NP
modes NNS I-NP
of IN B-PP
basic JJ B-NP
helix-loop-helix JJ I-NP
protein-mediated JJ I-NP
regulation NN I-NP
of IN B-PP
murine JJ B-NP
leukemia NN I-NP
virus NN I-NP
transcription NN I-NP
in IN B-PP
lymphoid JJ B-NP
cell NN I-NP
lines NNS I-NP
. . O

The DT B-NP
transcriptionally RB I-NP
regulatory JJ I-NP
regions NNS I-NP
of IN B-PP
the DT B-NP
lymphomagenic JJ I-NP
Akv NN B-NP
and CC O
SL3-3 NN B-NP
murine JJ B-NP
leukemia NN I-NP
retroviruses NNS I-NP
( ( O
MLVs NNS B-NP
) ) O
contain VBP B-VP
two CD B-NP
types NNS I-NP
of IN B-PP
E-box NN B-NP
consensus NN I-NP
motifs NNS I-NP
COMMA COMMA O
CAGATG NN B-NP
. . O

One CD B-NP
type NN I-NP
COMMA COMMA O
EA\/S NN B-NP
COMMA COMMA O
is VBZ B-VP
located JJ B-ADJP
in IN B-PP
the DT B-NP
upstream JJ I-NP
promoter NN I-NP
region NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
other JJ I-NP
COMMA COMMA O
E(gre) NN B-NP
COMMA COMMA O
is VBZ B-VP
located JJ B-ADJP
in IN B-PP
a DT B-NP
tandem JJ I-NP
repeat NN I-NP
with IN B-PP
enhancer NN B-NP
properties NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
examined VBN I-VP
the DT B-NP
requirements NNS I-NP
of IN B-PP
the DT B-NP
individual JJ I-NP
E-boxes NNS I-NP
in IN B-PP
MLV NN B-NP
transcriptional JJ I-NP
regulation NN I-NP
. . O

In IN B-PP
lymphoid JJ B-NP
cell NN I-NP
lines NNS I-NP
only RB B-ADVP
COMMA COMMA O
the DT B-NP
E(gre)-binding JJ I-NP
protein NN I-NP
complexes NNS I-NP
included VBD B-VP
ALF1 NN B-NP
or CC O
HEB NN B-NP
and CC O
E2A NN B-NP
basic JJ B-NP
helix-loop-helix JJ I-NP
proteins NNS I-NP
. . O

Ectopic JJ O
ALF1 NN B-NP
and CC O
E2A NN B-NP
proteins NNS B-NP
required VBD B-VP
intact JJ B-NP
E(gre) NN I-NP
motifs NNS I-NP
for IN B-PP
mediating VBG B-VP
transcriptional JJ B-NP
activation NN I-NP
. . O

ALF1 NNP B-NP
transactivated VBD B-VP
transcription NN B-NP
of IN B-PP
Akv NN B-NP
MLV NN I-NP
through IN B-PP
the DT B-NP
two CD I-NP
E(gre) NN I-NP
motifs NNS I-NP
equally RB B-ADVP
COMMA COMMA O
whereas IN O
E2A NN B-NP
protein NN I-NP
required VBD B-VP
the DT B-NP
promoter-proximal JJ I-NP
E(gre) NN I-NP
motif NN I-NP
. . O

In IN B-PP
T- NN B-NP
and CC O
B-cell NN B-NP
lines NNS B-NP
COMMA COMMA O
the DT B-NP
E(gre) NN I-NP
motifs NNS I-NP
were VBD B-VP
of IN B-PP
major JJ B-NP
importance NN I-NP
for IN B-PP
Akv NN B-NP
MLV NN I-NP
transcriptional JJ I-NP
activity NN I-NP
COMMA COMMA O
while IN B-SBAR
the DT B-NP
EA\/S NN I-NP
motif NN I-NP
had VBD B-VP
some DT B-NP
effect NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
neither CC O
E(gre) NN B-NP
nor CC O
EA\/S NN B-NP
motifs NNS B-NP
contributed VBD B-VP
pronouncedly RB B-ADVP
to TO B-PP
Akv NN B-NP
MLV NN I-NP
transcription NN I-NP
in IN B-PP
NIH NN B-NP
3T3 NN I-NP
cells NNS I-NP
lacking VBG B-VP
DNA-binding JJ O
ALF1 NN B-NP
or CC O
HEB NN B-NP
and CC O
E2A NN B-NP
proteins NNS B-NP
. . O

The DT B-NP
Id1 NN I-NP
protein NN I-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
repress VB I-VP
ALF1 NN B-NP
activity NN I-NP
in FW B-ADVP
vitro FW I-ADVP
and CC B-ADVP
in FW B-ADVP
vivo FW I-ADVP
. . O

Moreover RB B-ADVP
COMMA COMMA O
ectopic JJ B-NP
Id1 NN I-NP
repressed VBD B-VP
E(gre)-directed JJ O
but CC B-CONJP
not RB I-CONJP
EA\/S-directed JJ B-NP
MLV NN I-NP
transcription NN I-NP
in IN B-PP
lymphoid JJ B-NP
cell NN I-NP
lines NNS I-NP
. . O

In IN B-PP
conclusion NN B-NP
COMMA COMMA O
E(gre) NN B-NP
motifs NNS I-NP
and CC O
interacting VBG B-NP
basic JJ I-NP
helix-loop-helix JJ I-NP
proteins NNS I-NP
are VBP B-VP
important JJ B-NP
determinants NNS I-NP
for IN B-PP
MLV NN B-NP
transcriptional JJ I-NP
activity NN I-NP
in IN B-PP
lymphocytic JJ B-NP
cell NN I-NP
lines NNS I-NP
. . O

The DT B-NP
human JJ I-NP
T-cell NN I-NP
leukemia NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
posttranscriptional JJ I-NP
trans-activator NN I-NP
Rex NN I-NP
contains VBZ B-VP
a DT B-NP
nuclear JJ I-NP
export NN I-NP
signal NN I-NP
. . O

The DT B-NP
Rex NN I-NP
protein NN I-NP
of IN B-PP
human JJ B-NP
T-cell NN I-NP
leukemia NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
the DT B-NP
nuclear JJ I-NP
export NN I-NP
of IN B-PP
unspliced JJ B-NP
viral JJ I-NP
mRNA NN I-NP
and CC B-PP
COMMA COMMA I-PP
therefore RB I-PP
COMMA COMMA O
for IN B-PP
virus NN B-NP
replication NN I-NP
. . O

In IN B-PP
this DT B-NP
manuscript NN I-NP
COMMA COMMA O
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
Rex NN B-NP
shuttles VBZ B-VP
between IN B-PP
the DT B-NP
nucleus NN I-NP
and CC O
the DT B-NP
cytoplasm NN I-NP
and CC O
that IN B-SBAR
its PRP$ B-NP
activation NN I-NP
domain NN I-NP
constitutes VBZ B-VP
a DT B-NP
nuclear JJ I-NP
export NN I-NP
signal NN I-NP
that WDT B-NP
specifies VBZ B-VP
efficient JJ B-NP
transport NN I-NP
to TO B-PP
the DT B-NP
cytoplasm NN I-NP
. . O

These DT B-NP
findings NNS I-NP
are VBP B-VP
consistent JJ B-ADJP
with IN B-PP
a DT B-NP
model NN I-NP
for IN B-PP
Rex-mediated JJ B-NP
trans-activation NN I-NP
in IN B-PP
which WDT B-NP
Rex-viral JJ B-NP
mRNA NN I-NP
complexes NNS I-NP
are VBP B-VP
targeted VBN I-VP
for IN B-PP
nuclear JJ B-NP
export NN I-NP
by IN B-PP
the DT B-NP
direct JJ I-NP
action NN I-NP
of IN B-PP
the DT B-NP
activation NN I-NP
domain NN I-NP
. . O

Multiple JJ B-NP
p21ras NN I-NP
effector NN I-NP
pathways NNS I-NP
regulate VBP B-VP
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
. . O

The DT B-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
Nuclear JJ B-NP
Factor NN I-NP
of IN I-NP
Activated VBN I-NP
T NN I-NP
cells NNS I-NP
( ( O
NFAT NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
major JJ I-NP
target NN I-NP
for IN B-PP
p21ras NN B-NP
and CC O
calcium NN B-NP
signalling NN B-NP
pathways NNS I-NP
in IN B-PP
the DT B-NP
IL-2 NN I-NP
gene NN I-NP
and CC O
is VBZ B-VP
induced VBN I-VP
by IN B-PP
p21ras NN B-NP
signals NNS I-NP
acting VBG B-VP
in IN B-PP
synergy NN B-NP
with IN B-PP
calcium\/calcineurin NN B-NP
signals NNS I-NP
. . O

One CD B-NP
p21ras NN I-NP
effector NN I-NP
pathway NN I-NP
involves VBZ B-VP
the DT B-NP
MAP NN I-NP
kinase NN I-NP
ERK-2 NN I-NP
COMMA COMMA O
and CC O
we PRP B-NP
have VBP B-VP
examined VBN I-VP
its PRP$ B-NP
role NN I-NP
in IN B-PP
NFAT NN B-NP
regulation NN I-NP
. . O

Expression NN B-NP
of IN B-PP
dominant JJ B-NP
negative JJ I-NP
MAPKK-1 NN I-NP
prevents VBZ B-VP
NFAT NN B-NP
induction NN I-NP
. . O

Constitutively RB B-NP
active JJ I-NP
MAPKK-1 NN I-NP
fully RB B-ADVP
activates VBZ B-VP
ERK-2 NN B-NP
and CC O
the DT B-NP
transcription NN I-NP
factor NN I-NP
Elk-1 NN I-NP
COMMA COMMA O
but CC O
does VBZ B-VP
not RB I-VP
substitute VB I-VP
for IN B-PP
activated VBN B-NP
p21ras NN I-NP
and CC O
synergize VBP B-VP
with IN B-PP
calcium\/calcineurin NN B-NP
signals NNS I-NP
to TO B-VP
induce VB I-VP
NFAT NN B-NP
. . O

Expression NN B-NP
of IN B-PP
dominant JJ B-NP
negative JJ I-NP
N17Rac NN I-NP
also RB B-ADVP
prevents VBZ B-VP
TCR NN B-NP
and CC O
p21ras NN B-NP
activation NN B-NP
of IN B-PP
NFAT NN B-NP
COMMA COMMA O
but CC O
without IN B-PP
interfering VBG B-VP
with IN B-PP
the DT B-NP
ERK-2 NN I-NP
pathway NN I-NP
. . O

The DT B-NP
transcriptional JJ I-NP
activity NN I-NP
of IN B-PP
the DT B-NP
NFAT NN I-NP
binding NN I-NP
site NN I-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
a DT B-NP
complex NN I-NP
comprising VBG B-VP
a DT B-NP
member NN I-NP
of IN B-PP
the DT B-NP
NFAT NN I-NP
group NN I-NP
and CC O
AP-1 NN B-NP
family NN I-NP
proteins NNS I-NP
. . O

The DT B-NP
induction NN I-NP
of IN B-PP
AP-1 NN B-NP
by IN B-PP
p21ras NN B-NP
also RB B-ADVP
requires VBZ B-VP
Rac-1 NN B-NP
function NN I-NP
. . O

Activated VBN B-NP
Rac-1 NN I-NP
could MD B-VP
mimic VB I-VP
activated VBN B-NP
p21ras NN I-NP
to TO B-VP
induce VB I-VP
AP-1 NN B-NP
but CC O
not RB B-VP
to TO I-VP
induce VB I-VP
NFAT NN B-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
the DT B-NP
combination NN I-NP
of IN B-PP
activated VBN B-NP
MAPKK-1 NN B-NP
and CC O
Rac-1 NN B-NP
could MD B-VP
not RB I-VP
substitute VB I-VP
for IN B-PP
activated VBN B-NP
p21ras NN I-NP
and CC O
synergize VB B-VP
with IN B-PP
calcium NN B-NP
signals NNS I-NP
to TO B-VP
induce VB I-VP
NFAT NN B-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
p21ras NN B-NP
regulation NN I-NP
of IN B-PP
NFAT NN B-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
requires VBZ B-VP
the DT B-NP
activity NN I-NP
of IN B-PP
multiple JJ B-NP
effector NN I-NP
pathways NNS I-NP
including VBG B-PP
those DT B-NP
regulated VBN B-VP
by IN B-PP
MAPKK-1\/ERK-2 NN B-NP
and CC O
Rac-1 NN B-NP
. . O

Protein-tyrosine JJ B-NP
kinase NN I-NP
activation NN I-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
lipopolysaccharide NN B-NP
induction NN I-NP
of IN B-PP
interleukin NN B-NP
1beta NN I-NP
and CC O
NFkappaB NN B-NP
activation NN I-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
NFkappaB NN B-NP
nuclear JJ I-NP
translocation NN I-NP
. . O

In IN B-PP
human JJ B-NP
monocytes NNS I-NP
COMMA COMMA O
interleukin NN B-NP
1beta NN I-NP
protein NN I-NP
production NN I-NP
and CC O
steady JJ B-NP
state NN I-NP
mRNA NN I-NP
levels NNS I-NP
are VBP B-VP
increased VBN I-VP
in IN B-PP
response NN I-PP
to TO I-PP
lipopolysaccharide NN B-NP
COMMA COMMA O
predominantly RB B-ADVP
as IN B-PP
a DT B-NP
result NN I-NP
of IN B-PP
increased VBN B-NP
transcription NN I-NP
of IN B-PP
the DT B-NP
interleukin NN I-NP
1beta NN I-NP
gene NN I-NP
. . O

Expression NN B-NP
of IN B-PP
interleukin NN B-NP
1beta NN I-NP
and CC O
other JJ B-NP
cytokines NNS I-NP
COMMA COMMA O
such JJ B-PP
as IN I-PP
interleukin NN B-NP
6 CD I-NP
and CC O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
COMMA COMMA O
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
dependent JJ B-ADJP
on IN B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
NFkappaB NN B-NP
. . O

Since IN B-SBAR
recent JJ B-NP
studies NNS I-NP
have VBP B-VP
shown VBN I-VP
that IN B-SBAR
lipopolysaccharide-induced JJ B-NP
tyrosine NN I-NP
kinase NN I-NP
activation NN I-NP
is VBZ B-VP
not RB I-VP
required VBN I-VP
for IN B-PP
NFkappaB NN B-NP
nuclear JJ I-NP
translocation NN I-NP
COMMA COMMA O
we PRP B-NP
sought VBD B-VP
to TO I-VP
determine VB I-VP
whether IN B-SBAR
NFkappaB NN B-NP
translocated VBN B-VP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
tyrosine NN B-NP
kinase NN I-NP
activity NN I-NP
was VBD B-VP
active JJ B-ADJP
in IN B-PP
stimulating VBG B-VP
transcription NN B-NP
. . O

We PRP B-NP
have VBP B-VP
found VBN I-VP
that IN B-SBAR
COMMA COMMA O
in IN B-PP
the DT B-NP
human JJ I-NP
pro-monocytic JJ I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
THP-1 NN B-NP
COMMA COMMA O
the DT B-NP
lipopolysaccharide-induced JJ I-NP
expression NN I-NP
of IN B-PP
interleukin NN B-NP
1beta NN I-NP
is VBZ B-VP
dependent JJ B-ADJP
on IN B-PP
tyrosine NN B-NP
kinase NN I-NP
activation NN I-NP
. . O

Tyrosine NN B-NP
kinases NNS I-NP
are VBP B-VP
not RB I-VP
required VBN I-VP
for IN B-PP
lipopolysaccharide-mediated JJ B-NP
nuclear JJ I-NP
translocation NN I-NP
of IN B-PP
NFkappaB NN B-NP
. . O

However RB B-ADVP
COMMA COMMA O
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
tyrosine NN B-NP
kinase NN I-NP
activity NN I-NP
COMMA COMMA O
the DT B-NP
ability NN I-NP
of IN B-PP
NFkappaB NN B-NP
to TO B-VP
stimulate VB I-VP
transcription NN B-NP
is VBZ B-VP
impaired JJ B-ADJP
. . O

This DT B-NP
inhibition NN I-NP
of IN B-PP
transcription NN B-NP
is VBZ B-VP
specific JJ B-ADJP
for IN B-PP
NFkappaB NN B-NP
; : O
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
tyrosine NN B-NP
kinase NN I-NP
activity NN I-NP
COMMA COMMA O
AP-1-dependent JJ B-NP
transcription NN I-NP
is VBZ B-VP
enhanced VBN I-VP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
COMMA COMMA O
while IN B-NP
lipopolysaccharide-induced JJ I-NP
expression NN O
of IN B-NP
inflammatory JJ I-NP
mediators NNS B-VP
requires VBZ B-NP
tyrosine NN I-NP
kinase NN I-NP
activity NN O
COMMA COMMA B-NP
tyrosine NN I-NP
kinase NN I-NP
activity NN B-VP
is VBZ I-VP
not RB B-ADJP
obligatory JJ B-PP
for IN B-NP
lipopolysaccharide NN I-NP
signal NN I-NP
transduction NN O

Granulocyte-macrophage JJ B-NP
colony-stimulating JJ I-NP
factor NN I-NP
preferentially RB B-ADVP
activates VBZ B-VP
the DT B-NP
94-kD JJ I-NP
STAT5A NN I-NP
and CC O
an DT B-NP
80-kD JJ I-NP
STAT5A NN I-NP
isoform NN I-NP
in IN B-PP
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
monocytes NNS I-NP
. . O

Granulocyte-macrophage JJ B-NP
colony-stimulating JJ I-NP
factor NN I-NP
( ( O
GM-CSF NN B-NP
) ) O
induces VBZ B-VP
immediate JJ B-NP
effects NNS I-NP
in IN B-PP
monocytes NNS B-NP
by IN B-PP
activation NN B-NP
of IN B-PP
the DT O
Janus NN B-NP
kinase NN I-NP
( ( O
JAK2 NN B-NP
) ) O
and CC O
STAT NN B-NP
transcription NN I-NP
factor NN I-NP
( ( O
STAT5 NN B-NP
) ) O
pathway NN B-NP
. . O

Recent JJ B-NP
studies NNS I-NP
have VBP B-VP
identified VBN I-VP
homologues NNS B-NP
of IN B-PP
STAT5 NN B-NP
COMMA COMMA O
STAT5A NN B-NP
COMMA COMMA O
and CC O
STAT5B NN B-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
lower JJR B-NP
molecular JJ I-NP
weight NN I-NP
variants NNS I-NP
of IN B-PP
STAT5 NN B-NP
. . O

To TO B-VP
define VB I-VP
the DT B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
STAT5 NN I-NP
homologues NNS B-NP
and CC O
lower JJR B-NP
molecular JJ I-NP
weight NN I-NP
variant NN I-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
and CC O
monocytes NNS B-NP
differentiated VBN B-VP
into IN B-PP
macrophages NNS B-NP
by IN B-PP
culture NN B-NP
in IN B-PP
macrophage-CSF NN B-NP
( ( O
M-CSF NN B-NP
) ) O
COMMA COMMA O
we PRP B-NP
measured VBD B-VP
the DT B-NP
GM-CSF NN I-NP
induced JJ I-NP
tyrosine NN I-NP
phosphorylation NN I-NP
of IN B-PP
STAT5A NN B-NP
COMMA COMMA O
STAT5B NN B-NP
COMMA COMMA O
and CC O
any DT B-NP
lower JJR I-NP
molecular JJ I-NP
weight NN I-NP
STAT5 NN I-NP
isoforms NNS I-NP
. . O

Freshly RB B-NP
isolated VBN I-NP
monocytes NNS I-NP
expressed VBD B-VP
94-kD JJ B-NP
STAT5A NN I-NP
COMMA COMMA O
92-kD JJ B-NP
STAT5B NN I-NP
COMMA COMMA O
and CC O
an DT B-NP
80-kD JJ I-NP
STAT5A NN I-NP
molecule NN I-NP
. . O

Whereas IN B-SBAR
94-kD JJ B-NP
STAT5A NN I-NP
was VBD B-VP
clearly RB I-VP
tyrosine NN I-VP
phosphorylated JJ I-VP
and CC O
bound VBD B-VP
to TO B-PP
the DT B-NP
enhancer NN I-NP
element NN I-NP
COMMA COMMA O
the DT B-NP
gamma NN I-NP
response NN I-NP
region NN I-NP
( ( O
GRR NN B-NP
) ) O
COMMA COMMA O
of IN B-PP
the DT B-NP
Fc NN I-NP
gamma NN I-NP
RI NN I-NP
gene NN I-NP
COMMA COMMA O
substantially RB B-VP
less JJR I-VP
tyrosine NN I-VP
phosphorylated JJ I-VP
STAT5B NN B-NP
bound VBD B-VP
to TO B-PP
the DT B-NP
immobilized JJ I-NP
GRR NN I-NP
element NN I-NP
. . O

Macrophages NNS B-NP
lost VBD B-VP
their PRP$ B-NP
ability NN I-NP
to TO B-VP
express VB I-VP
the DT B-NP
80-kD JJ I-NP
STAT5A NN I-NP
protein NN I-NP
COMMA COMMA O
but CC O
retained VBD B-VP
their PRP$ B-NP
ability NN I-NP
to TO B-VP
activate VB I-VP
STAT5A NN B-NP
. . O

STAT5A-STAT5A JJ B-NP
homodimers NNS I-NP
and CC O
STAT5A-STAT5B NN B-NP
heterodimers NNS I-NP
formed VBD B-VP
in IN B-PP
response NN I-PP
to TO I-PP
GM-CSF NN B-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
activation NN B-NP
of IN B-PP
STAT5A NN B-NP
predominates VBZ B-VP
compared VBN B-PP
to TO B-PP
STAT5B NN B-NP
when WRB B-ADVP
assayed VBN B-VP
by IN B-PP
direct JJ B-NP
immunoprecipitation NN I-NP
and CC B-PP
by IN B-PP
evaluation NN B-NP
of IN B-PP
bound VBN B-NP
STATs NNS I-NP
to TO B-PP
immobilized JJ B-NP
GRR NN I-NP
. . O

Selective JJ B-NP
activation NN I-NP
of IN B-PP
STAT5 NN B-NP
homologues NNS I-NP
in IN B-CONJP
addition NN O
to TO O
generation NN B-NP
of IN B-PP
lower JJR B-NP
molecular JJ I-NP
isoforms NNS I-NP
may MD B-VP
provide VB I-VP
specificity NN B-NP
and CC O
control NN B-NP
to TO B-PP
genes NNS B-NP
expressed VBN B-VP
in IN B-PP
response NN I-PP
to TO I-PP
cytokines NNS B-NP
such JJ B-PP
as IN I-PP
GM-CSF NN B-NP
. . O

LYSP100-associated JJ B-NP
nuclear JJ I-NP
domains NNS I-NP
( ( O
LANDs NNS B-NP
) ) O
: : O
description NN B-NP
of IN B-PP
a DT B-NP
new JJ I-NP
class NN I-NP
of IN B-PP
subnuclear JJ B-NP
structures NNS I-NP
and CC O
their PRP$ B-NP
relationship NN I-NP
to TO B-PP
PML NN B-NP
nuclear JJ I-NP
bodies NNS I-NP
. . O

The DT B-NP
PML NN I-NP
gene NN I-NP
is VBZ B-VP
fused VBN I-VP
to TO B-PP
the DT O
retinoic JJ B-NP
acid NN I-NP
receptor NN I-NP
alpha NN I-NP
( ( O
RAR NN B-NP
alpha NN I-NP
) ) O
gene NN B-NP
in IN B-PP
t(15;17) NN B-NP
acute JJ B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
( ( O
APL NN B-NP
) ) O
COMMA COMMA O
creating VBG B-VP
a DT B-NP
PML-RAR NN I-NP
alpha NN I-NP
fusion NN I-NP
oncoprotein NN I-NP
. . O

The DT B-NP
PML NN I-NP
gene NN I-NP
product NN I-NP
has VBZ B-VP
been VBN I-VP
localized JJ I-VP
to TO B-PP
subnuclear JJ B-NP
dot-like JJ I-NP
structures NNS I-NP
variously RB B-VP
termed VBN I-VP
PODs NNS B-NP
COMMA COMMA O
ND10s NNS B-NP
COMMA COMMA O
Kr NN B-NP
bodies NNS I-NP
COMMA COMMA O
or CC O
PML NN B-NP
nuclear JJ I-NP
bodies NNS I-NP
( ( O
PML NN B-NP
NBs NNS I-NP
) ) O
. . O

The DT B-NP
present JJ I-NP
study NN I-NP
describes VBZ B-VP
the DT B-NP
cloning NN I-NP
of IN B-PP
a DT B-NP
lymphoid-restricted JJ I-NP
gene NN I-NP
COMMA COMMA O
LYSP100 NN B-NP
COMMA COMMA O
that WDT B-NP
is VBZ B-VP
homologous JJ B-ADJP
to TO B-PP
another DT B-NP
protein NN I-NP
that WDT B-NP
localizes VBZ B-VP
to TO B-PP
PML NN B-NP
NBs NNS I-NP
COMMA COMMA O
SP100 NN B-NP
. . O

In IN B-PP
addition NN I-PP
to TO I-PP
SP100 NN B-NP
homology NN I-NP
regions NNS I-NP
COMMA COMMA O
one CD B-NP
LYSP100 NN I-NP
cDNA NN I-NP
isoform NN I-NP
contains VBZ B-VP
a DT B-NP
bromodomain NN I-NP
and CC O
a DT B-NP
PHD\/TTC NN I-NP
domain NN I-NP
COMMA COMMA O
which WDT B-NP
are VBP B-VP
present JJ B-ADJP
in IN B-PP
a DT B-NP
variety NN I-NP
of IN B-PP
transcriptional JJ B-NP
regulatory JJ I-NP
proteins NNS I-NP
. . O

By IN B-PP
immunofluorescence NN B-NP
COMMA COMMA O
LYSP100 NN B-NP
was VBD B-VP
localized JJ I-VP
to TO B-PP
nuclear JJ B-NP
dots NNS I-NP
that WDT B-NP
were VBD B-VP
surprisingly RB B-ADVP
largely RB B-ADJP
nonoverlapping JJ I-ADJP
with IN B-PP
PML NN B-NP
NBs NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
a DT B-NP
minority NN I-NP
of IN B-PP
LYSP100 NN B-NP
nuclear JJ I-NP
dots NNS I-NP
exactly RB B-ADVP
colocalized VBD B-VP
with IN B-PP
PML NN B-NP
and CC O
SP100 NN B-NP
. . O

We PRP B-NP
term VBP B-VP
the DT B-NP
LYSP100 NN I-NP
structures NNS I-NP
" `` O
LANDs NNS B-NP
COMMA COMMA O
" '' O
for IN B-PP
LYSP100-associated JJ B-NP
nuclear JJ I-NP
domains NNS I-NP
. . O

Although IN B-SBAR
LYSP100 NN B-NP
is VBZ B-VP
expressed VBN I-VP
only RB B-PP
in IN I-PP
lymphoid JJ B-NP
cells NNS I-NP
COMMA COMMA O
LANDs NNS B-NP
could MD B-VP
be VB I-VP
visualized VBN I-VP
in IN B-PP
HeLa NN B-NP
cells NNS I-NP
by IN B-PP
transfection NN B-NP
of IN B-PP
a DT B-NP
LYSP100 NN I-NP
cDNA NN I-NP
. . O

Immunoelectron NN B-NP
microscopy NN I-NP
revealed VBD B-VP
LANDs NNS B-NP
to TO B-VP
be VB I-VP
globular JJ B-NP
COMMA COMMA I-NP
electron-dense JJ I-NP
structures NNS I-NP
morphologically RB B-ADJP
distinct JJ I-ADJP
from IN B-PP
the DT B-NP
annular JJ I-NP
structures NNS I-NP
characteristic JJ B-ADJP
of IN B-PP
PML NN B-NP
NBs NNS I-NP
. . O

LANDs NNS B-NP
were VBD B-VP
most RBS I-VP
often RB I-VP
found VBN I-VP
in IN B-PP
the DT B-NP
nucleoplasm NN I-NP
COMMA COMMA O
but CC O
were VBD B-VP
also RB I-VP
found VBN I-VP
at IN B-PP
the DT B-NP
nuclear JJ I-NP
membrane NN I-NP
and CC B-PP
in IN B-PP
the DT B-NP
cytoplasm NN I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
these DT B-NP
structures NNS I-NP
may MD B-VP
traffic VBP I-VP
between IN B-PP
the DT B-NP
cytoplasm NN I-NP
and CC O
the DT B-NP
nucleus NN I-NP
. . O

By IN B-PP
double-immunogold JJ B-NP
labeling NN I-NP
of IN B-PP
PML NN B-NP
and CC O
LYSP100 NN B-NP
COMMA COMMA O
some DT B-NP
LANDs NNS I-NP
were VBD B-VP
shown VBN I-VP
to TO I-VP
contain VB I-VP
both CC O
PML NN B-NP
and CC O
LYSP100 NN B-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
PML NN B-NP
is VBZ B-VP
localized JJ I-VP
to TO O
a DT B-NP
second JJ I-NP
subnuclear JJ I-NP
domain NN I-NP
that WDT B-NP
is VBZ B-VP
morphologically RB B-ADJP
and CC I-ADJP
biochemically RB I-ADJP
distinct JJ I-ADJP
from IN B-PP
PML NN B-NP
NBs NNS I-NP
. . O

Abnormalities NNS B-NP
of IN B-PP
p16 NN B-NP
COMMA COMMA O
p15 NN B-NP
and CC O
CDK4 NN B-NP
genes NNS B-NP
in IN B-PP
recurrent JJ B-NP
malignant JJ I-NP
astrocytomas NNS I-NP
. . O

Abnormalities NNS B-NP
in IN B-PP
the DT O
p16 NN B-NP
COMMA COMMA O
p15 NN B-NP
and CC O
CDK4 NN B-NP
genes NNS B-NP
that WDT B-NP
regulate VBP B-VP
transition NN B-NP
through IN B-PP
the DT B-NP
G1 NN I-NP
phase NN I-NP
of IN B-PP
the DT B-NP
cell NN I-NP
cycle NN I-NP
have VBP B-VP
been VBN I-VP
implicated VBN I-VP
in IN B-PP
the DT B-NP
malignant JJ I-NP
progression NN I-NP
of IN B-PP
astrocytomas NNS B-NP
. . O

The DT B-NP
results NNS I-NP
of IN B-PP
the DT B-NP
present JJ I-NP
study NN I-NP
demonstrate VBP B-VP
that IN B-SBAR
dysfunction NN B-NP
of IN B-PP
these DT B-NP
genes NNS I-NP
also RB B-ADVP
occurs VBZ B-VP
during IN B-PP
recurrence NN B-NP
of IN B-PP
glial JJ B-NP
tumors NNS I-NP
that WDT B-NP
were VBD B-VP
highly RB B-ADJP
malignant JJ I-ADJP
at IN B-PP
first JJ B-NP
presentation NN I-NP
. . O

Analysis NN B-NP
of IN B-PP
10 CD B-NP
matched VBN I-NP
pairs NNS I-NP
of IN B-PP
high JJ B-NP
grade NN I-NP
malignant JJ I-NP
astrocytomas NNS I-NP
and CC O
their PRP$ B-NP
subsequent JJ I-NP
recurrences NNS I-NP
identified VBD B-VP
three CD B-NP
distinct JJ I-NP
groups NNS I-NP
. . O

The DT B-NP
primary JJ I-NP
and CC I-NP
recurrent JJ I-NP
tumors NNS I-NP
in IN B-PP
Group NN B-NP
A NN I-NP
did VBD B-VP
not RB I-VP
show VB I-VP
structural JJ B-NP
alterations NNS I-NP
in IN B-PP
the DT O
p16 NN B-NP
COMMA COMMA O
p15 NN B-NP
or CC O
CDK4 NN B-NP
genes NNS B-NP
COMMA COMMA O
whereas IN O
homozygous JJ B-NP
codeletion NN I-NP
of IN B-PP
p16 NN B-NP
and CC O
p15 NN B-NP
was VBD B-VP
observed VBN I-VP
in IN B-PP
both CC B-NP
primary JJ I-NP
and CC I-NP
recurrent JJ I-NP
tumors NNS I-NP
in IN B-PP
Group NN B-NP
B NN I-NP
. . O

The DT B-NP
primary JJ I-NP
tumors NNS I-NP
in IN B-PP
Group NN B-NP
C NN I-NP
had VBD B-VP
a DT B-NP
normal JJ I-NP
profile NN I-NP
of IN B-PP
p16 NN B-NP
COMMA COMMA O
p15 NN B-NP
and CC O
CDK4 NN B-NP
at IN B-PP
presentation NN B-NP
. . O

Upon IN B-PP
recurrence NN B-NP
COMMA COMMA O
however RB B-ADVP
COMMA COMMA O
the DT B-NP
tumors NNS I-NP
sustained VBD B-VP
either CC O
deletion NN B-NP
of IN B-PP
p16 NN B-NP
alone RB B-ADVP
or CC O
codeletion NN B-NP
of IN B-PP
both CC O
p16 NN B-NP
and CC O
p15 NN B-NP
or CC O
amplification NN B-NP
of IN B-PP
CDK4 NN B-NP
. . O

Analysis NN B-NP
of IN B-PP
the DT B-NP
molecular JJ I-NP
differences NNS I-NP
between IN B-PP
primary JJ B-NP
anaplastic JJ I-NP
astrocytomas\/glioblastomas NNS I-NP
and CC O
their PRP$ B-NP
subsequent JJ I-NP
recurrences NNS I-NP
COMMA COMMA O
which WDT B-NP
are VBP B-VP
clinically RB B-ADVP
indistinguishable JJ B-ADJP
COMMA COMMA O
may MD B-VP
provide VB I-VP
better JJR B-NP
therapeutic JJ I-NP
options NNS I-NP
for IN B-PP
treatment NN B-NP
. . O

CTL NN B-NP
recognition NN I-NP
of IN B-PP
an DT B-NP
altered JJ I-NP
peptide NN I-NP
associated VBN B-VP
with IN B-PP
asparagine NN B-NP
bond NN I-NP
rearrangement NN I-NP
. . O

Implications NNS B-NP
for IN B-PP
immunity NN B-NP
and CC O
vaccine NN B-NP
design NN I-NP
. . O

The DT B-NP
extent NN I-NP
to TO B-PP
which WDT B-NP
peptides NNS B-NP
containing VBG B-VP
chemically RB B-ADVP
and CC B-ADVP
post-translationally RB B-ADVP
modified VBN B-NP
amino NN I-NP
acid NN I-NP
side JJ I-NP
chains NNS I-NP
are VBP B-VP
recognized VBN I-VP
by IN B-PP
primed JJ B-NP
CTL NN I-NP
has VBZ B-VP
not RB I-VP
been VBN I-VP
clearly RB I-VP
defined VBN I-VP
. . O

We PRP B-NP
report VBP B-VP
on IN B-PP
the DT B-NP
CTL NN I-NP
recognition NN I-NP
of IN B-PP
a DT B-NP
MHC NN I-NP
class NN I-NP
I-restricted JJ I-NP
peptide NN I-NP
containing VBG B-VP
a DT O
cyclized JJ B-NP
asparagine NN I-NP
( ( O
succinimide NN B-NP
) ) O
residue NN B-NP
. . O

This DT B-NP
modification NN I-NP
of IN B-PP
the DT B-NP
asparagine NN I-NP
side JJ I-NP
chain NN I-NP
is VBZ B-VP
a DT B-NP
common JJ I-NP
intermediate JJ I-NP
structure NN I-NP
during IN B-PP
deamidation NN B-NP
COMMA COMMA O
isomerization NN B-NP
COMMA COMMA O
and CC O
bond NN B-NP
rearrangements NNS I-NP
of IN B-PP
amide-containing JJ B-NP
amino NN I-NP
acids NNS I-NP
and CC O
also RB O
occurs VBZ B-VP
as IN B-PP
a DT B-NP
side JJ I-NP
reaction NN I-NP
in IN B-PP
peptide NN B-NP
synthesis NN I-NP
. . O

The DT B-NP
CTL NN I-NP
specifically RB B-ADVP
recognized VBD B-VP
the DT B-NP
succinimide-containing JJ I-NP
peptide NN I-NP
showing VBG B-VP
only RB B-NP
weak JJ I-NP
cross-reactivity NN I-NP
at IN B-PP
high JJ B-NP
concentrations NNS I-NP
of IN B-PP
the DT B-NP
parent NN I-NP
peptide NN I-NP
containing VBG B-VP
unmodified JJ B-NP
asparagine NN I-NP
. . O

Similarly RB B-ADVP
COMMA COMMA O
CTL NN B-NP
raised VBN B-VP
against IN B-PP
the DT B-NP
parent NN I-NP
peptide NN I-NP
did VBD B-VP
not RB I-VP
recognize VB I-VP
the DT B-NP
succinimide JJ I-NP
derivative NN I-NP
of IN B-PP
this DT B-NP
peptide NN I-NP
. . O

Naturally RB B-NP
processed VBN I-NP
forms NNS I-NP
of IN B-PP
these DT B-NP
structures NNS I-NP
are VBP B-VP
likely JJ B-ADJP
to TO B-VP
occur VB I-VP
given VBN B-PP
the DT B-NP
importance NN B-NP
and CC O
frequency NN B-NP
of IN B-PP
deamidation NN B-NP
both CC O
in FW B-ADVP
vitro FW I-ADVP
and CC B-ADVP
in FW B-ADVP
vivo FW I-ADVP
. . O

Moreover RB B-ADVP
COMMA COMMA O
since IN B-SBAR
succinimide NN B-NP
intermediates NNS I-NP
of IN B-PP
deamidated VBN B-NP
peptides NNS I-NP
can MD B-VP
occasionally RB I-VP
be VB I-VP
very RB B-ADJP
stable JJ I-ADJP
COMMA COMMA O
these DT B-NP
peptides NNS I-NP
have VBP B-VP
the DT B-NP
potential NN I-NP
to TO B-VP
act VB I-VP
as IN B-PP
altered JJ B-NP
self-Ags NNS I-NP
with IN B-PP
significant JJ B-NP
implications NNS I-NP
for IN B-PP
autoimmunity NN B-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
unwanted JJ B-NP
and CC I-NP
potentially RB I-NP
hazardous JJ I-NP
specificities NNS I-NP
may MD B-VP
be VB I-VP
elicited VBN I-VP
when WRB B-ADVP
using VBG B-VP
synthetic JJ B-NP
peptides NNS I-NP
in IN B-PP
subunit NN B-NP
vaccines NNS I-NP
in IN B-PP
which WDT B-NP
succinimide NN B-NP
residues NNS I-NP
may MD B-VP
form VB I-VP
spontaneously RB B-ADVP
during IN B-PP
storage NN B-NP
or CC O
chemical JJ B-NP
synthesis NN I-NP
. . O

{ ( O
NGFI-B\/nur77 NN B-NP
family NN I-NP
involved VBN B-VP
in IN B-PP
T-cell NN B-NP
apoptosis NN I-NP
} ) O

NGFI-B\/nur77 NN B-NP
is VBZ B-VP
a DT B-NP
member NN I-NP
of IN B-PP
the DT B-NP
steroid NN I-NP
receptor NN I-NP
superfamily NN I-NP
. . O

NGFI-B\/nur77 NN B-NP
and CC O
its PRP$ B-NP
related JJ I-NP
genes NNS I-NP
constitute VBP B-VP
a DT B-NP
family NN I-NP
and CC O
the DT B-NP
NGFI-B\/nur77 NN I-NP
family NN I-NP
consists VBZ B-VP
of IN B-PP
three CD B-NP
subtypes NNS I-NP
COMMA COMMA O
named VBN B-VP
nur77 NN B-NP
alpha NN I-NP
COMMA COMMA O
nur77 NN B-NP
beta NN I-NP
COMMA COMMA O
nur77 NN B-NP
gamma NN I-NP
. . O

We PRP B-NP
cloned VBD B-VP
human JJ B-NP
nur77 NN I-NP
beta NN I-NP
cDNA NN I-NP
COMMA COMMA O
called VBN B-VP
TINUR NN B-NP
. . O

Although IN B-SBAR
NGFI-B\/nur77 NN B-NP
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
TCR-mediated JJ B-NP
apoptosis NN I-NP
in IN B-PP
T-cell NN B-NP
hybridomas NNS I-NP
COMMA COMMA O
the DT B-NP
reports NNS I-NP
on IN B-PP
nur77 NN B-NP
knock-out JJ I-NP
mice NNS I-NP
and CC O
nur77 NN B-NP
dominant JJ I-NP
negative JJ I-NP
transgenic JJ I-NP
mice NNS I-NP
suggest VBP B-VP
that IN B-SBAR
there EX B-NP
is VBZ B-VP
a DT B-NP
functional JJ I-NP
redundancy NN I-NP
among IN B-PP
NGFI-B\/nur77 NN B-NP
family NN I-NP
. . O

NGFI-B\/nur77 NN B-NP
binds VBZ B-VP
to TO B-PP
the DT B-NP
response NN I-NP
element NN I-NP
by IN B-PP
monomer NN B-NP
or CC O
heterodimer NN B-NP
with IN B-PP
retinoid NN B-NP
X NN I-NP
receptor NN I-NP
( ( O
RXR NN B-NP
) ) O
. . O

Assuming VBG B-PP
that IN B-SBAR
9-cis-retinoic JJ B-NP
acid NN I-NP
( ( O
9-cis-RA NN B-NP
) ) O
inhibits VBZ B-VP
TCR-mediated JJ B-NP
apoptosis NN I-NP
COMMA COMMA O
nur77 NNS B-NP
may MD B-VP
cause VB I-VP
apoptosis NN B-NP
by IN B-PP
monomer NN B-NP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
9-cis-RA NN B-NP
and CC O
may MD B-VP
inhibit VB I-VP
apoptosis NN B-NP
by IN B-PP
heterodimer NN B-NP
with IN B-PP
RXR NN B-NP
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
9-cis-RA NN B-NP
. . O

Interaction NN B-NP
of IN B-PP
the DT B-NP
human JJ I-NP
T-cell NN I-NP
lymphotropic JJ I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
tax NN I-NP
transactivator NN I-NP
with IN B-PP
transcription NN B-NP
factor NN I-NP
IIA NN I-NP
. . O

The DT B-NP
Tax NN I-NP
protein NN I-NP
of IN B-PP
human JJ B-NP
T-cell NN I-NP
lymphotropic NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HTLV-1 NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
40-kDa JJ I-NP
transcriptional JJ I-NP
activator NN I-NP
which WDT B-NP
is VBZ B-VP
critical JJ B-ADJP
for IN B-PP
HTLV-1 NN B-NP
gene NN I-NP
regulation NN I-NP
and CC O
virus-induced JJ B-NP
cellular JJ I-NP
transformation NN I-NP
. . O

Tax NN B-NP
is VBZ B-VP
localized JJ I-VP
to TO B-PP
the DT B-NP
DNA NN I-NP
through IN B-PP
its PRP$ B-NP
interaction NN I-NP
with IN B-PP
the DT B-NP
site-specific JJ I-NP
activators NNS I-NP
cyclic JJ B-NP
AMP-responsive JJ I-NP
element-binding JJ I-NP
protein NN I-NP
COMMA COMMA O
NF-kappaB NN B-NP
COMMA COMMA O
and CC O
serum NN B-NP
response NN I-NP
factor NN I-NP
. . O

It PRP B-NP
has VBZ B-VP
been VBN I-VP
suggested VBN I-VP
that IN B-SBAR
the DT B-NP
recruitment NN I-NP
of IN B-PP
Tax NN B-NP
to TO B-PP
the DT B-NP
DNA NN I-NP
positions VBZ B-VP
Tax NN B-NP
for IN B-PP
interaction NN B-NP
with IN B-PP
the DT B-NP
basal JJ I-NP
transcriptional JJ I-NP
machinery NN I-NP
. . O

On IN B-PP
the DT I-PP
basis NN I-PP
of IN I-PP
several JJ B-NP
independent JJ I-NP
assays NNS I-NP
COMMA COMMA O
we PRP B-NP
now RB B-ADVP
report VBP B-VP
a DT B-NP
physical JJ I-NP
and CC I-NP
functional JJ I-NP
interaction NN I-NP
between IN B-PP
Tax NN B-NP
and CC O
the DT B-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
TFIIA NN B-NP
. . O

First RB B-ADVP
COMMA COMMA O
Tax NN B-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
interact VB I-VP
with IN B-PP
the DT O
35-kDa JJ O
( ( O
alpha NN B-NP
) ) O
subunit NN B-NP
of IN B-PP
TFIIA NN B-NP
in IN B-PP
the DT B-NP
yeast NN I-NP
two-hybrid JJ I-NP
interaction NN I-NP
system NN I-NP
. . O

Importantly RB B-ADVP
COMMA COMMA O
two CD B-NP
previously RB I-NP
characterized VBN I-NP
mutants NNS I-NP
with IN B-PP
point NN B-NP
mutations NNS I-NP
in IN B-PP
Tax NN B-NP
COMMA COMMA O
M32 NN B-NP
( ( O
Y196A NN B-NP
COMMA COMMA O
K197S NN B-NP
) ) O
and CC O
M41 NN B-NP
( ( O
H287A NN B-NP
COMMA COMMA O
P288S NN B-NP
) ) O
COMMA COMMA O
which WDT B-NP
were VBD B-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
defective JJ B-ADJP
in IN B-PP
Tax-activated JJ B-NP
transcription NN I-NP
were VBD B-VP
unable JJ B-ADJP
to TO B-VP
interact VB I-VP
with IN B-PP
TFIIA NN B-NP
in IN B-PP
this DT B-NP
assay NN I-NP
. . O

Second RB B-ADVP
COMMA COMMA O
a DT O
glutathione-S-transferase NN B-NP
( ( O
GST NN B-NP
) ) O
affinity-binding JJ B-NP
assay NN I-NP
showed VBD B-VP
that IN B-SBAR
the DT B-NP
interaction NN I-NP
of IN B-PP
holo-TFIIA NN B-NP
with IN B-PP
GST-Tax NN B-NP
was VBD B-VP
20-fold RB B-ADJP
higher JJR I-ADJP
than IN B-PP
that DT B-NP
observed VBN B-VP
with IN B-PP
either CC O
the DT B-NP
GST-Tax NN I-NP
M32 NN I-NP
activation NN I-NP
mutant NN I-NP
or CC O
the DT B-NP
GST NN I-NP
control NN I-NP
. . O

Third RB B-ADVP
COMMA COMMA O
a DT B-NP
coimmunoprecipitation NN I-NP
assay NN I-NP
showed VBD B-VP
that IN B-SBAR
in IN B-PP
HTLV-1-infected JJ B-NP
human JJ I-NP
T NN I-NP
lymphocytes NNS I-NP
COMMA COMMA O
Tax NN B-NP
and CC O
TFIIA NN B-NP
were VBD B-VP
associated VBN I-VP
. . O

Finally RB B-ADVP
COMMA COMMA O
TFIIA NN B-NP
facilitates NNS B-VP
Tax NN B-NP
transactivation NN I-NP
in FW B-ADVP
vitro FW I-ADVP
and CC B-ADVP
in FW B-ADVP
vivo FW I-ADVP
. . O

In FW B-NP
vitro FW I-NP
transcription NN I-NP
studies NNS I-NP
showed VBD B-VP
reduced VBN B-NP
levels NNS I-NP
of IN B-PP
Tax-activated JJ B-NP
transcription NN I-NP
in IN B-PP
cell NN B-NP
extracts NNS I-NP
depleted VBN B-VP
of IN B-PP
TFIIA NN B-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
transfection NN B-NP
of IN B-PP
human JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
with IN B-PP
TFIIA NN B-NP
expression NN I-NP
vectors NNS I-NP
enhanced VBD B-VP
Tax-activated JJ B-NP
transcription NN I-NP
of IN B-PP
an DT B-NP
HTLV-1 NN I-NP
long JJ I-NP
terminal JJ I-NP
repeat-chloramphenicol NN I-NP
acetyltransferase NN I-NP
reporter NN I-NP
construct NN I-NP
. . O

Our PRP$ B-NP
study NN I-NP
suggests VBZ B-VP
that IN B-SBAR
the DT B-NP
interaction NN I-NP
of IN B-PP
Tax NN B-NP
with IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
TFIIA NN I-NP
may MD B-VP
play VB I-VP
a DT B-NP
role NN I-NP
in IN B-PP
Tax-mediated JJ B-NP
transcriptional JJ I-NP
activation NN I-NP
. . O

Peptide NN B-NP
vaccination NN I-NP
can MD B-VP
lead VB I-VP
to TO B-PP
enhanced VBN B-NP
tumor NN I-NP
growth NN I-NP
through IN B-PP
specific JJ B-NP
T-cell NN I-NP
tolerance NN I-NP
induction NN I-NP
. . O

Vaccination NN B-NP
with IN B-PP
synthetic JJ B-NP
peptides NNS I-NP
representing VBG B-VP
cytotoxic JJ B-NP
T NN I-NP
lymphocyte NN I-NP
( ( O
CTL NN B-NP
) ) O
epitopes NNS B-NP
can MD B-VP
lead VB I-VP
to TO B-PP
a DT B-NP
protective JJ I-NP
CTL-mediated JJ I-NP
immunity NN I-NP
against IN B-PP
tumors NNS B-NP
or CC O
viruses NNS B-NP
. . O

We PRP B-NP
now RB B-ADVP
report VBP B-VP
that IN B-SBAR
vaccination NN B-NP
with IN B-PP
a DT B-NP
CTL NN I-NP
epitope NN I-NP
derived VBN B-VP
from IN B-PP
the DT B-NP
human JJ I-NP
adenovirus NN I-NP
type NN I-NP
5 CD I-NP
E1A-region NN I-NP
( ( O
Ad5E1A234-243 NN B-NP
) ) O
COMMA COMMA O
which WDT B-NP
can MD B-VP
serve VB I-VP
as IN B-PP
a DT B-NP
target NN I-NP
for IN B-PP
tumor-eradicating JJ B-NP
CTL NN I-NP
COMMA COMMA O
enhances VBZ B-VP
rather RB B-CONJP
than IN I-CONJP
inhibits VBZ B-VP
the DT B-NP
growth NN I-NP
of IN B-PP
Ad5E1A-expressing JJ B-NP
tumors NNS I-NP
. . O

This DT B-NP
adverse JJ I-NP
effect NN I-NP
of IN B-PP
peptide NN B-NP
vaccination NN I-NP
was VBD B-VP
rapidly RB I-VP
evoked VBN I-VP
COMMA COMMA O
required VBD B-VP
low JJ B-NP
doses NNS I-NP
of IN B-PP
peptide NN B-NP
( ( O
10 CD B-NP
micrograms NNS I-NP
) ) O
COMMA COMMA O
and CC O
was VBD B-VP
achieved VBN I-VP
by IN B-PP
a DT B-NP
mode NN I-NP
of IN B-PP
peptide NN B-NP
delivery NN I-NP
that WDT B-NP
induces VBZ B-VP
protective JJ B-NP
T-cell-mediated JJ I-NP
immunity NN I-NP
in IN B-PP
other JJ B-NP
models NNS I-NP
. . O

Ad5E1A-specific JJ B-NP
CTL NN I-NP
activity NN I-NP
could MD B-VP
no RB I-VP
longer RB I-VP
be VB I-VP
isolated VBN I-VP
from IN B-PP
mice NNS B-NP
after IN B-PP
injection NN B-NP
of IN B-PP
Ad5E1A-peptide NN B-NP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
tolerization NN B-NP
of IN B-PP
Ad5E1A-specific JJ B-NP
CTL NN I-NP
activity NN I-NP
causes VBZ B-VP
the DT B-NP
enhanced VBN I-NP
tumor NN I-NP
outgrowth NN I-NP
. . O

In IN B-PP
contrast NN I-PP
to TO I-PP
peptide NN B-NP
vaccination NN I-NP
COMMA COMMA O
immunization NN B-NP
with IN B-PP
adenovirus NN B-NP
COMMA COMMA O
expressing VBG B-VP
Ad5E1A NN B-NP
COMMA COMMA O
induced VBD B-VP
Ad5E1A-specific JJ B-NP
immunity NN I-NP
and CC O
prevented VBD B-VP
the DT B-NP
outgrowth NN I-NP
of IN B-PP
Ad5E1A-expressing JJ B-NP
tumors NNS I-NP
. . O

These DT B-NP
results NNS I-NP
show VBP B-VP
that IN B-SBAR
immunization NN B-NP
with IN B-PP
synthetic JJ B-NP
peptides NNS I-NP
can MD B-VP
lead VB I-VP
to TO B-PP
the DT B-NP
elimination NN I-NP
of IN B-PP
anti-tumor JJ B-NP
CTL NN I-NP
responses NNS I-NP
. . O

These DT B-NP
findings NNS I-NP
are VBP B-VP
important JJ B-ADJP
for IN B-PP
the DT B-NP
design NN I-NP
of IN B-PP
safe JJ B-NP
peptide-based JJ I-NP
vaccines NNS I-NP
against IN B-PP
tumors NNS B-NP
COMMA COMMA O
allogeneic JJ B-NP
organ NN I-NP
transplants NNS I-NP
COMMA COMMA O
and CC O
T-cell-mediated JJ B-NP
autoimmune JJ I-NP
diseases NNS I-NP
. . O

Transgenic JJ B-NP
expression NN I-NP
of IN B-PP
PML\/RARalpha NN B-NP
impairs VBZ B-VP
myelopoiesis NN B-NP
. . O

The DT B-NP
translocation NN I-NP
found VBN B-VP
in IN B-PP
acute JJ B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
rearranges VBZ B-VP
the DT B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
gene NN I-NP
( ( O
PML NN B-NP
) ) O
on IN B-PP
chromosome NN B-NP
15 CD I-NP
with IN B-PP
the DT B-NP
retinoic JJ I-NP
acid NN I-NP
receptor NN I-NP
alpha NN I-NP
( ( O
RARalpha NN B-NP
) ) O
on IN B-PP
chromosome NN B-NP
17 CD I-NP
. . O

This DT B-NP
yields VBZ B-VP
a DT B-NP
fusion NN I-NP
transcript NN I-NP
COMMA COMMA O
PML\/RARalpha NN B-NP
COMMA COMMA O
a DT B-NP
transcription NN I-NP
factor NN I-NP
with IN B-PP
reported VBN B-NP
dominant JJ I-NP
negative JJ I-NP
functions NNS I-NP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
hormone NN B-NP
. . O

Clinical JJ B-NP
remissions NNS I-NP
induced VBN B-VP
with IN B-PP
all-trans JJ O
retinoic JJ B-NP
acid NN I-NP
( ( O
RA NN B-NP
) ) O
treatment NN B-NP
in IN B-PP
acute JJ B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
are VBP B-VP
linked VBN I-VP
to TO B-PP
PML\/RARalpha NN B-NP
expression NN I-NP
in IN B-PP
leukemic JJ B-NP
cells NNS I-NP
. . O

To TO B-VP
evaluate VB I-VP
the DT B-NP
PML\/RARalpha NN I-NP
role NN I-NP
in IN B-PP
myelopoiesis NN B-NP
COMMA COMMA O
transgenic JJ B-NP
mice NNS I-NP
expressing VBG B-VP
PML\/RARalpha NN B-NP
were VBD B-VP
engineered VBN I-VP
. . O

A DT B-NP
full-length JJ I-NP
PML\/RARalpha NN I-NP
cDNA NN I-NP
driven VBN B-VP
by IN B-PP
the DT B-NP
CD11b NN I-NP
promoter NN I-NP
was VBD B-VP
expressed VBN I-VP
in IN B-PP
transgenic JJ B-NP
mice NNS I-NP
. . O

Expression NN B-NP
was VBD B-VP
confirmed VBN I-VP
in IN B-PP
the DT B-NP
bone NN I-NP
marrow NN I-NP
with IN B-PP
a DT B-NP
reverse JJ I-NP
transcription NN I-NP
PCR NN I-NP
assay NN I-NP
. . O

Basal JJ O
total JJ O
white JJ B-NP
blood NN I-NP
cell NN I-NP
and CC O
granulocyte NN B-NP
counts NNS B-NP
did VBD B-VP
not RB I-VP
appreciably RB I-VP
differ VB I-VP
between IN B-PP
PML\/RARalpha NN O
transgenic JJ O
and CC O
control NN B-NP
mice NNS B-NP
. . O

Cell NN B-NP
sorter NN I-NP
analysis NN I-NP
of IN B-PP
CD11b+ JJ B-NP
bone NN I-NP
marrow NN I-NP
cells NNS I-NP
revealed VBD B-VP
similar JJ B-NP
CD11b+ JJ I-NP
populations NNS I-NP
in IN B-PP
transgenic JJ O
and CC O
control NN B-NP
mice NNS B-NP
. . O

Granulocyte\/macrophage NN B-NP
colony-stimulating JJ I-NP
factor NN I-NP
and CC O
kit NN B-NP
ligand NN I-NP
cotreatment NN I-NP
did VBD B-VP
not RB I-VP
overcome VB I-VP
this DT B-NP
inhibition NN I-NP
. . O

Impaired JJ B-NP
myelopoiesis NN I-NP
in FW B-ADVP
vivo FW I-ADVP
was VBD B-VP
shown VBN I-VP
by IN B-PP
stressing VBG B-VP
these DT B-NP
mice NNS I-NP
with IN B-PP
sublethal JJ B-NP
irradiation NN I-NP
. . O

Following VBG B-PP
irradiation NN B-NP
COMMA COMMA O
PML\/RARalpha NN B-NP
transgenic JJ I-NP
mice NNS I-NP
COMMA COMMA O
as IN B-SBAR
compared VBN B-VP
with IN B-PP
controls NNS B-NP
COMMA COMMA O
more RBR B-ADVP
rapidly RB I-ADVP
depressed VBD B-VP
peripheral JJ B-NP
white JJ I-NP
blood NN I-NP
cell NN I-NP
and CC O
granulocyte NN B-NP
counts NNS B-NP
. . O

As IN B-SBAR
expected VBN B-VP
COMMA COMMA O
nearly RB B-NP
all DT I-NP
control NN I-NP
mice NNS I-NP
( ( O
94.4 CD B-NP
% NN I-NP
) ) O
survived VBD B-VP
irradiation NN B-NP
COMMA COMMA O
yet CC O
this DT B-NP
irradiation NN I-NP
was VBD B-VP
lethal JJ B-ADJP
to TO B-PP
45.8 CD B-NP
% NN I-NP
of IN B-PP
PML\/RARalpha NN B-NP
transgenic JJ I-NP
mice NNS I-NP
. . O

Lethality NN B-NP
was VBD B-VP
associated VBN I-VP
with IN B-PP
more RBR B-NP
severe JJ I-NP
leukopenia NN I-NP
in IN B-PP
transgenic JJ O
versus CC O
control NN B-NP
mice NNS B-NP
. . O

Retinoic JJ B-NP
acid NN I-NP
treatment NN I-NP
of IN B-PP
irradiated JJ B-NP
PML\/RARalpha NN I-NP
mice NNS I-NP
enhanced VBD B-VP
granulocyte NN B-NP
recovery NN I-NP
. . O

These DT B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
abnormal JJ B-NP
myelopoiesis NN I-NP
due IN B-PP
to TO I-PP
PML\/RARalpha NN B-NP
expression NN I-NP
is VBZ B-VP
an DT B-NP
early JJ I-NP
event NN I-NP
in IN B-PP
oncogenic JJ B-NP
transformation NN I-NP
. . O

Defective JJ B-NP
transcription NN I-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
gene NN I-NP
is VBZ B-VP
associated VBN I-VP
with IN B-PP
impaired JJ B-NP
expression NN I-NP
of IN B-PP
c-Fos NN B-NP
COMMA COMMA O
FosB NN B-NP
COMMA COMMA O
and CC O
JunB NN B-NP
in IN B-PP
anergic JJ B-NP
T NN I-NP
helper NN I-NP
1 CD I-NP
cells NNS I-NP
. . O

Anergic JJ B-NP
CD4+ JJ I-NP
Th NN I-NP
cells NNS I-NP
do VBP B-VP
not RB I-VP
produce VB I-VP
IL-2 NN B-NP
when WRB B-ADVP
challenged VBN B-VP
with IN B-PP
Ag-pulsed JJ B-NP
accessory JJ I-NP
cells NNS I-NP
because IN B-PP
of IN I-PP
a DT B-NP
transcriptional JJ I-NP
defect NN I-NP
. . O

In IN B-PP
this DT B-NP
work NN I-NP
COMMA COMMA O
we PRP B-NP
report VBP B-VP
that IN B-SBAR
these DT B-NP
anergic JJ I-NP
T NN I-NP
cells NNS I-NP
are VBP B-VP
defective JJ B-ADJP
in IN B-PP
their PRP$ B-NP
ability NN I-NP
to TO B-VP
up-regulate VB I-VP
protein NN B-NP
binding NN I-NP
and CC O
transactivation NN B-NP
at IN B-PP
two CD B-NP
critical JJ I-NP
IL-2 NN I-NP
DNA NN I-NP
enhancer NN I-NP
elements NNS I-NP
: : O
NF-AT NN B-NP
( ( O
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
; : O
a DT B-NP
sequence NN I-NP
that WDT B-NP
binds VBZ B-VP
a DT O
heterotrimeric JJ O
NFATp NN B-NP
COMMA COMMA O
Fos NN B-NP
COMMA COMMA O
and CC O
Jun NN B-NP
protein NN B-NP
complex NN I-NP
) ) O
and CC O
Activator NN B-NP
Protein-1 NN I-NP
( ( O
AP-1 NN B-NP
) ) O
( ( O
that WDT B-NP
binds VBZ B-VP
Fos NN B-NP
and CC O
Jun NN B-NP
heterodimers NNS B-NP
) ) O
. . O

Western NN B-NP
blot NN I-NP
analysis NN I-NP
of IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
showed VBD B-VP
that IN B-SBAR
the DT B-NP
impaired JJ I-NP
DNA-protein NN I-NP
interactions NNS I-NP
in IN B-PP
anergic JJ B-NP
T NN I-NP
cells NNS I-NP
were VBD B-VP
associated VBN I-VP
with IN B-PP
poor JJ B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
inducible JJ I-NP
AP-1 NN I-NP
family NN I-NP
members NNS I-NP
c-Fos NN B-NP
COMMA COMMA O
FosB NN B-NP
COMMA COMMA O
and CC O
JunB NN B-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
reduced VBN I-NP
expression NN I-NP
of IN B-PP
these DT B-NP
proteins NNS I-NP
was VBD B-VP
not RB O
the DT B-NP
result NN I-NP
of IN B-PP
a DT B-NP
global JJ I-NP
TCR\/CD3-signaling JJ I-NP
defect NN I-NP
because IN B-SBAR
CD3 NN B-NP
cross-linking NN I-NP
induced VBD B-VP
an DT B-NP
equivalent JJ I-NP
increase NN I-NP
in IN B-PP
intracellular-free JJ B-NP
calcium NN I-NP
ions NNS I-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
NFATp NN B-NP
dephosphorylation NN I-NP
COMMA COMMA O
translocation NN B-NP
to TO B-PP
the DT B-NP
nucleus NN I-NP
COMMA COMMA O
and CC O
DNA NN B-NP
binding NN I-NP
in IN B-PP
both CC B-NP
normal JJ I-NP
and CC I-NP
anergic JJ I-NP
T NN I-NP
cells NNS I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
defective JJ B-NP
IL-2 NN I-NP
gene NN I-NP
transcription NN I-NP
appears VBZ B-VP
to TO I-VP
be VB I-VP
due JJ B-PP
COMMA COMMA B-ADVP
at IN I-ADVP
least JJS B-PP
in IN B-NP
part NN O
COMMA COMMA O
to TO B-NP
a DT I-NP
selective JJ I-NP
block NN O
in IN B-NP
the DT I-NP
expression NN O
of IN O
the DT O
AP-1 NN B-NP
Fos NN B-NP
and CC O
Jun NN B-NP
family NN I-NP
members NNS O
in IN B-NP
anergic JJ I-NP
T NN I-NP
cells NNS O

Elevated JJ B-NP
cyclic JJ I-NP
AMP NN I-NP
inhibits VBZ B-VP
NF-kappaB-mediated JJ B-NP
transcription NN I-NP
in IN B-PP
human JJ B-NP
monocytic JJ B-NP
cells NNS I-NP
and CC O
endothelial JJ B-NP
cells NNS I-NP
. . O

The DT B-NP
NF-kappaB\/Rel NN I-NP
family NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
regulates VBZ B-VP
the DT B-NP
inducible JJ I-NP
expression NN I-NP
of IN B-PP
many JJ B-NP
genes NNS I-NP
in IN B-PP
activated VBN B-NP
human JJ I-NP
monocytes NNS B-NP
and CC O
endothelial JJ B-NP
cells NNS I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
we PRP B-NP
examined VBD B-VP
the DT B-NP
molecular JJ I-NP
mechanism NN I-NP
by IN B-PP
which WDT B-NP
agents NNS B-NP
that WDT B-NP
elevate VBP B-VP
intracellular JJ B-NP
cAMP NN I-NP
inhibit VBP B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
the DT O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
( ( O
TNFalpha NN B-NP
) ) O
COMMA COMMA O
tissue NN B-NP
factor NN I-NP
COMMA COMMA O
endothelial JJ B-NP
leukocyte NN I-NP
adhesion NN I-NP
molecule-1 NN I-NP
COMMA COMMA O
and CC O
vascular JJ B-NP
cell NN I-NP
adhesion NN I-NP
molecule-1 NN I-NP
genes NNS B-NP
. . O

Both CC O
forskolin NN B-NP
and CC O
dibutyryl NN B-NP
cAMP NN I-NP
COMMA COMMA O
which WDT B-NP
elevate VBP B-VP
intracellular JJ B-NP
cAMP NN I-NP
by IN B-PP
independent JJ B-NP
mechanisms NNS I-NP
COMMA COMMA O
inhibited VBD B-VP
TNFalpha NN B-NP
and CC O
tissue NN B-NP
factor NN I-NP
expression NN B-NP
at IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
transcription NN B-NP
. . O

Induction NN B-NP
of IN B-PP
NF-kappaB-dependent JJ B-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
transiently RB B-NP
transfected VBN I-NP
human JJ B-NP
monocytic JJ I-NP
THP-1 NN I-NP
cells NNS I-NP
and CC O
human JJ B-NP
umbilical JJ I-NP
vein NN I-NP
endothelial JJ I-NP
cells NNS I-NP
was VBD B-VP
inhibited VBN I-VP
by IN B-PP
elevated JJ B-NP
cAMP NN I-NP
and CC B-PP
by IN B-PP
overexpression NN B-NP
of IN B-PP
the DT B-NP
catalytic JJ I-NP
subunit NN I-NP
of IN B-PP
protein NN B-NP
kinase NN I-NP
A NN I-NP
( ( O
PKA NN B-NP
) ) O
. . O

Elevated JJ B-NP
cAMP NN I-NP
did VBD B-VP
not RB I-VP
prevent VB I-VP
nuclear JJ B-NP
translocation NN I-NP
of IN B-PP
p50\/p65 NN B-NP
and CC O
c-Rel\/p65 NN B-NP
heterodimers NNS B-NP
COMMA COMMA O
decrease VB B-VP
nuclear JJ B-NP
translocation NN I-NP
of IN B-PP
p65 NN B-NP
COMMA COMMA O
or CC O
significantly RB B-VP
modify VB I-VP
TNFalpha-induced JJ B-NP
phosphorylation NN I-NP
of IN B-PP
p65 NN B-NP
. . O

Functional JJ B-NP
studies NNS I-NP
demonstrated VBD B-VP
that IN B-SBAR
transcriptional JJ B-NP
activation NN I-NP
of IN B-PP
a DT B-NP
plasmid NN I-NP
containing VBG B-VP
multimerized JJ B-NP
kappaB NN I-NP
sites NNS I-NP
by IN B-PP
p65 NN B-NP
was VBD B-VP
inhibited VBN I-VP
by IN B-PP
agents NNS B-NP
that IN B-NP
elevate VBP B-VP
cAMP NN B-NP
and CC B-PP
by IN B-PP
overexpression NN B-NP
of IN B-PP
the DT B-NP
catalytic JJ I-NP
subunit NN I-NP
of IN B-PP
PKA NN B-NP
. . O

This DT B-NP
study NN I-NP
indicates VBZ B-VP
that IN B-SBAR
activation NN B-NP
of IN B-PP
PKA NN B-NP
reduces VBZ B-VP
the DT B-NP
induction NN I-NP
of IN B-PP
a DT B-NP
distinct JJ I-NP
set NN I-NP
of IN B-PP
genes NNS B-NP
in IN B-PP
monocytes NNS B-NP
and CC O
endothelial JJ B-NP
cells NNS I-NP
by IN B-PP
inhibiting VBG B-VP
NF-kappaB-mediated JJ B-NP
transcription NN I-NP
. . O

Characterization NN B-NP
of IN B-PP
a DT B-NP
new JJ I-NP
isoform NN I-NP
of IN B-PP
the DT O
NFAT NN B-NP
( ( O
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
) ) O
gene NN B-NP
family NN I-NP
member NN I-NP
NFATc NN B-NP
{ ( O
published VBN B-NP
erratum NN I-NP
appears VBZ B-VP
in IN B-PP
J NNP B-NP
Biol NNP I-NP
Chem NNP I-NP
1996 CD B-NP
Dec NNP I-NP
27 CD I-NP
; : O
271 CD B-NP
( ( I-NP
52 CD I-NP
) ) O
: : O
33705 CD B-NP
} ) O

The DT B-NP
cyclosporin NN I-NP
A NN I-NP
( ( I-NP
CsA NN I-NP
) ) I-NP
\/FK506-sensitive JJ I-NP
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
( ( O
NFAT NN B-NP
) ) O
plays VBZ B-VP
a DT B-NP
key JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
inducible JJ I-NP
expression NN I-NP
of IN B-PP
cytokine NN B-NP
genes NNS I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
. . O

Although IN B-SBAR
NFAT NN B-NP
has VBZ B-VP
been VBN I-VP
recently RB I-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
inducible JJ B-ADJP
in IN B-PP
several JJ B-NP
non-T JJ I-NP
immune JJ I-NP
cells NNS I-NP
COMMA COMMA O
the DT B-NP
NFAT NN I-NP
gene NN I-NP
family NN I-NP
members NNS I-NP
characterized VBN B-VP
to TO B-PP
date NN B-NP
have VBP B-VP
been VBN I-VP
isolated VBN I-VP
only RB B-PP
from IN I-PP
T NN B-NP
cells NNS I-NP
. . O

To TO B-VP
further RBR I-VP
characterize VB I-VP
NFAT NN B-NP
function NN I-NP
in IN B-PP
human JJ B-NP
B NN I-NP
cells NNS I-NP
and CC O
to TO B-VP
demonstrate VB I-VP
cytokine NN B-NP
gene NN I-NP
specificity NN I-NP
of IN B-PP
NFAT NN B-NP
proteins NNS I-NP
COMMA COMMA O
we PRP B-NP
report VBP B-VP
here RB B-ADVP
the DT B-NP
isolation NN B-NP
and CC O
characterization NN B-NP
of IN B-PP
a DT B-NP
cDNA NN I-NP
clone NN I-NP
from IN B-PP
the DT B-NP
Raji NN I-NP
B NN I-NP
cell NN I-NP
line NN I-NP
. . O

The DT B-NP
cDNA NN I-NP
clone NN I-NP
encodes VBZ B-VP
a DT B-NP
new JJ I-NP
isoform NN I-NP
COMMA COMMA O
NFATc.beta NN B-NP
COMMA COMMA O
of IN B-PP
the DT B-NP
NFAT NN I-NP
gene NN I-NP
family NN I-NP
member NN I-NP
NFATc NN I-NP
( ( O
designated VBN B-VP
here RB B-ADVP
NFATc.alpha NN B-NP
) ) O
. . O

The DT B-NP
amino NN I-NP
acid NN I-NP
sequence NN I-NP
of IN B-PP
NFATc.beta NN B-NP
differs VBZ B-VP
from IN B-PP
that DT B-NP
of IN B-PP
NFATc.alpha NN B-NP
in IN B-PP
the DT B-NP
first JJ I-NP
NH2-terminal JJ I-NP
29 CD I-NP
residues NNS I-NP
and CC O
contains VBZ B-VP
an DT B-NP
additional JJ I-NP
region NN I-NP
of IN B-PP
142 CD B-NP
residues NNS I-NP
at IN B-PP
the DT B-NP
COOH NN I-NP
terminus NN I-NP
. . O

Northern NN B-NP
analysis NN I-NP
using VBG B-VP
a VBG B-NP
probe NN I-NP
encompassing VBG B-VP
a DT B-NP
common JJ I-NP
region NN I-NP
of IN B-PP
both DT B-NP
isoforms NNS I-NP
showed VBD B-VP
two CD B-NP
mRNA NN I-NP
species NNS I-NP
of IN B-PP
2.7 CD B-NP
and CC I-NP
4.5 CD I-NP
kilobase NN I-NP
pairs NNS I-NP
COMMA COMMA O
while IN B-SBAR
an DT B-NP
NFATc.beta-specific JJ I-NP
probe NN I-NP
detected VBD B-VP
only RB B-NP
the DT I-NP
4.5-kilobase NN I-NP
pair NN I-NP
mRNA NN I-NP
which WDT B-NP
was VBD B-VP
preferentially RB I-VP
expressed VBN I-VP
in IN B-PP
the DT B-NP
spleen NN I-NP
. . O

Transient JJ B-NP
expression NN I-NP
of IN B-PP
NFATc.beta NN B-NP
was VBD B-VP
capable JJ B-ADJP
of IN B-PP
activating VBG B-VP
an DT B-NP
interleukin-2 NN I-NP
NFAT-driven JJ I-NP
reporter NN I-NP
gene NN I-NP
in IN B-PP
stimulated VBN B-NP
Jurkat NN I-NP
cells NNS I-NP
in IN B-PP
a DT B-NP
CsA-sensitive JJ I-NP
manner NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
NFATc.beta NN B-NP
neither CC O
bound VBD B-VP
to TO B-PP
the DT B-NP
kappa3 NN I-NP
element NN I-NP
( ( O
an DT B-NP
NFAT-binding JJ I-NP
site NN I-NP
) ) O
in IN B-PP
the DT B-NP
tumor NN I-NP
necrosis NN I-NP
factor-alpha NN I-NP
promoter NN I-NP
nor CC O
activated VBD B-VP
the DT B-NP
tumor NN I-NP
necrosis NN I-NP
factor-alpha NN I-NP
promoter NN I-NP
in IN B-PP
cotransfection NN B-NP
assays NN I-NP
. . O

These DT B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
different JJ B-NP
members NNS B-NP
or CC O
isoforms NNS B-NP
of IN B-PP
NFAT NN B-NP
gene NN I-NP
family NN I-NP
may MD B-VP
regulate VB I-VP
inducible JJ B-NP
expression NN I-NP
of IN B-PP
different JJ B-NP
cytokine NN I-NP
genes NNS I-NP
. . O

Activation NN B-NP
of IN B-PP
human JJ B-NP
monocytic JJ I-NP
cells NNS I-NP
by IN B-PP
Treponema FW B-NP
pallidum FW I-NP
and CC O
Borrelia FW B-NP
burgdorferi FW I-NP
lipoproteins NNS B-NP
and CC O
synthetic JJ B-NP
lipopeptides NNS I-NP
proceeds VBZ B-VP
via IN B-PP
a DT B-NP
pathway NN I-NP
distinct JJ B-ADJP
from IN B-PP
that DT B-NP
of IN B-PP
lipopolysaccharide NN B-NP
but CC O
involves VBZ B-VP
the DT B-NP
transcriptional JJ I-NP
activator NN I-NP
NF-kappa NN I-NP
B NN I-NP
. . O

There EX B-NP
is VBZ B-VP
increasing VBG B-NP
evidence NN I-NP
that IN B-SBAR
lipoproteins NNS B-NP
of IN B-PP
Treponema FW B-NP
pallidum FW I-NP
and CC O
Borrelia FW B-NP
burgdorferi FW I-NP
are VBP B-VP
key JJ B-NP
inflammatory JJ I-NP
mediators NNS I-NP
during IN B-PP
syphilis NN B-NP
and CC O
Lyme NN B-NP
disease NN I-NP
. . O

A DT B-NP
principal JJ I-NP
objective NN I-NP
of IN B-PP
the DT B-NP
present JJ I-NP
study NN I-NP
was VBD B-VP
to TO B-VP
identify VB I-VP
more RBR B-ADVP
precisely RB I-ADVP
similarities NNS B-NP
and CC O
divergences NNS B-NP
among IN B-PP
lipopolysaccharide NN B-NP
( ( O
LPS NN B-NP
) ) O
- : O
and CC O
lipoprotein-lipopeptide-induced JJ B-ADJP
immune JJ B-NP
cell NN I-NP
signaling NN I-NP
events NNS I-NP
. . O

Like IN B-PP
LPS NN B-NP
COMMA COMMA O
purified VBN B-NP
native JJ I-NP
B. FW I-NP
burgdorferi FW I-NP
OspA NN I-NP
and CC O
synthetic JJ B-NP
analogs NNS I-NP
of IN B-PP
OspA NN B-NP
COMMA COMMA O
OspB NN B-NP
COMMA COMMA O
and CC O
two CD B-NP
T. FW I-NP
pallidum FW I-NP
lipoproteins NNS I-NP
( ( O
Tpp47 NN B-NP
and CC O
Tpp17 NN B-NP
) ) O
all DT B-NP
induced VBD B-VP
NF-kappa NN B-NP
B NN I-NP
translocation NN I-NP
in IN B-PP
THP-1 NN B-NP
human JJ I-NP
monocytoid NN I-NP
cells NNS I-NP
. . O

Acylation NN B-NP
of IN B-PP
OspA NN B-NP
and CC O
the DT B-NP
synthetic JJ I-NP
peptides NNS I-NP
was VBD B-VP
requisite JJ B-ADJP
for IN B-PP
cell NN B-NP
activation NN I-NP
. . O

Polymyxin NN B-NP
B NN I-NP
abrogated VBD B-VP
only RB B-NP
the DT I-NP
response NN I-NP
to TO B-PP
LPS NN B-NP
. . O

By IN B-PP
using VBG B-VP
70Z\/3-derived JJ B-NP
pre-B-cell NN I-NP
lines NNS I-NP
either CC O
lacking VBG B-VP
or CC O
expressing VBG B-VP
human JJ B-NP
CD14 NN I-NP
( ( O
the DT B-NP
LPS NN I-NP
receptor NN I-NP
) ) O
COMMA COMMA O
it PRP B-NP
was VBD B-VP
observed VBN I-VP
that IN B-SBAR
expression NN B-NP
of IN B-PP
human JJ B-NP
CD14 NN I-NP
imparted VBD B-VP
responsiveness NN B-NP
to TO B-PP
LPS NN B-NP
but CC B-PP
not RB B-PP
to TO I-PP
OspA NN B-NP
or CC O
spirochetal JJ B-NP
lipopeptides NNS I-NP
( ( O
assessed VBN B-VP
by IN B-PP
induction NN B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
and CC O
expression NN B-NP
of IN B-PP
surface NN B-NP
immunoglobulin NN I-NP
M NN I-NP
) ) O
. . O

Finally RB B-ADVP
COMMA COMMA O
the DT B-NP
biological JJ I-NP
relevance NN I-NP
of IN B-PP
the DT B-NP
observation NN I-NP
that IN B-SBAR
T. FW B-NP
pallidum FW I-NP
lipoproteins-lipopeptides NNS I-NP
induce VBP B-VP
both CC O
NF-kappa NN B-NP
B NN I-NP
and CC O
cytokine NN B-NP
production NN B-NP
in IN B-PP
monocytes NNS B-NP
was VBD B-VP
supported VBN I-VP
by IN B-PP
the DT B-NP
ability NN I-NP
of IN B-PP
the DT B-NP
synthetic JJ I-NP
analogs NNS I-NP
to TO B-VP
promote VB I-VP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
replication NN I-NP
in IN B-PP
chronically RB B-NP
infected JJ I-NP
U1 NN I-NP
monocytoid NN I-NP
cells NNS I-NP
; : O
these DT B-NP
observations NNS I-NP
also RB B-ADVP
suggest VBP B-VP
a DT B-NP
potential JJ I-NP
mechanism NN I-NP
whereby WRB B-ADVP
a DT B-NP
syphilitic JJ I-NP
chancre NN I-NP
can MD B-VP
serve VB I-VP
as IN B-PP
a DT B-NP
cofactor NN I-NP
for IN B-PP
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
transmission NN I-NP
. . O

The DT B-NP
combined JJ I-NP
data NNS I-NP
lend VBP B-VP
additional JJ B-NP
support NN I-NP
to TO B-PP
the DT B-NP
proposal NN I-NP
that IN B-SBAR
spirochetal JJ B-NP
lipoproteins NNS I-NP
and CC O
LPS NN B-NP
initiate VBP B-VP
monocyte NN B-NP
activation NN I-NP
via IN B-PP
different JJ B-NP
cell NN I-NP
surface NN I-NP
events NNS I-NP
but CC O
that IN B-SBAR
the DT B-NP
signaling NN I-NP
pathways NNS I-NP
ultimately RB B-ADVP
converge VBP B-VP
to TO I-VP
produce VB I-VP
qualitatively RB B-NP
similar JJ I-NP
cellular JJ I-NP
responses NNS I-NP
. . O

Chronic JJ B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
infection NN I-NP
of IN B-PP
myeloid JJ B-NP
cells NNS I-NP
disrupts VBZ B-VP
the DT B-NP
autoregulatory JJ I-NP
control NN I-NP
of IN B-PP
the DT B-NP
NF-kappaB\/Rel NN I-NP
pathway NN I-NP
via IN B-PP
enhanced VBN B-NP
IkappaBalpha NN I-NP
degradation NN I-NP
. . O

Productive JJ O
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
( ( O
HIV-1 NN B-NP
) ) O
infection NN B-NP
causes VBZ B-VP
sustained JJ B-NP
NF-kappaB NN I-NP
DNA-binding JJ I-NP
activity NN I-NP
in IN B-PP
chronically RB B-NP
infected VBN I-NP
monocytic JJ I-NP
cells NNS I-NP
. . O

A DT B-NP
direct JJ I-NP
temporal JJ I-NP
correlation NN I-NP
exists VBZ B-VP
between IN B-PP
HIV NN B-NP
infection NN I-NP
and CC O
the DT B-NP
appearance NN I-NP
of IN B-PP
NF-kappaB NN B-NP
DNA-binding JJ I-NP
activity NN I-NP
in IN B-PP
myelomonoblastic JJ B-NP
PLB-985 NN I-NP
cells NNS I-NP
. . O

HIV-1 NN B-NP
infection NN I-NP
resulted VBD B-VP
in IN B-PP
constitutive JJ B-NP
COMMA COMMA I-NP
low-level JJ I-NP
expression NN I-NP
of IN B-PP
type NN B-NP
1 CD I-NP
interferon NN B-NP
( ( O
IFN NN B-NP
) ) O
at IN B-PP
the DT B-NP
mRNA NN I-NP
level NN I-NP
. . O

Constitutive JJ B-NP
PKR NN I-NP
activity NN I-NP
was VBD B-VP
also RB I-VP
detected VBN I-VP
in IN B-PP
HIV-1-infected JJ B-NP
cells NNS I-NP
as IN B-PP
a DT B-NP
result NN I-NP
of IN B-PP
low-level JJ B-NP
IFN NN I-NP
production NN I-NP
COMMA COMMA O
since IN B-SBAR
the DT B-NP
addition NN I-NP
of IN B-PP
anti-IFN-alpha\/beta JJ B-NP
antibody NN I-NP
to TO B-PP
the DT B-NP
cells NNS I-NP
decreased VBD B-VP
PKR NN B-NP
expression NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
the DT B-NP
analysis NN I-NP
of IN B-PP
IkappaBalpha NN B-NP
turnover NN I-NP
demonstrated VBD B-VP
an DT B-NP
increased VBN I-NP
degradation NN I-NP
of IN B-PP
IkappaBalpha NN B-NP
in IN B-PP
HIV-1-infected JJ B-NP
cells NNS I-NP
that WDT B-NP
may MD B-VP
account VB I-VP
for IN B-PP
the DT B-NP
constitutive JJ I-NP
DNA NN I-NP
binding NN I-NP
activity NN I-NP
. . O

A DT B-NP
dramatic JJ I-NP
increase NN I-NP
in IN B-PP
the DT B-NP
intracellular JJ I-NP
levels NNS I-NP
of IN B-PP
NF-kappaB NN B-NP
subunits NNS I-NP
c-Rel NN B-NP
and CC O
NF-kappaB2 NN B-NP
p100 NN I-NP
and CC O
a DT B-NP
moderate JJ I-NP
increase NN I-NP
in IN B-PP
NF-kappaB2 NN B-NP
p52 NN I-NP
and CC O
RelA(p65) NN B-NP
were VBD B-VP
detected VBN I-VP
in IN B-PP
HIV-1-infected JJ B-NP
cells NNS I-NP
COMMA COMMA O
whereas IN O
NF-kappaB1 NN B-NP
p105\/p50 NN I-NP
levels NNS I-NP
were VBD B-VP
not RB I-VP
altered VBN I-VP
relative JJ B-PP
to TO I-PP
the DT B-NP
levels NNS I-NP
in IN B-PP
uninfected JJ B-NP
cells NNS I-NP
. . O

We PRP B-NP
suggest VBP B-VP
that IN B-SBAR
HIV-1 NN B-NP
infection NN I-NP
of IN B-PP
myeloid JJ B-NP
cells NNS I-NP
induces VBZ B-VP
IFN NN B-NP
production NN I-NP
and CC O
PKR NN B-NP
activity NN I-NP
COMMA COMMA O
which WDT B-NP
in IN B-PP
turn NN B-NP
contribute VBP B-VP
to TO B-PP
enhanced VBN B-NP
IkappaBalpha NN I-NP
phosphorylation NN I-NP
and CC O
subsequent JJ B-NP
degradation NN I-NP
. . O

Nuclear JJ B-NP
translocation NN I-NP
of IN B-PP
NF-kappaB NN B-NP
subunits NNS I-NP
may MD B-VP
ultimately RB I-VP
increase VB I-VP
the DT B-NP
intracellular JJ I-NP
pool NN I-NP
of IN B-PP
NF-kappaB\/IkappaBalpha NN B-NP
by IN B-PP
an DT B-NP
autoregulatory JJ I-NP
mechanism NN I-NP
. . O

Enhanced VBN B-NP
turnover NN I-NP
of IN B-PP
IkappaBalpha NN B-NP
and CC O
the DT B-NP
accumulation NN I-NP
of IN B-PP
NF-kappaB\/Rel NN B-NP
proteins NNS I-NP
may MD B-VP
contribute VB I-VP
to TO B-PP
the DT B-NP
chronically RB I-NP
activated JJ I-NP
state NN I-NP
of IN B-PP
HIV-1-infected JJ B-NP
cells NNS I-NP
. . O

Transcriptional JJ B-NP
analysis NN I-NP
of IN B-PP
Epstein-Barr JJ B-NP
virus NN I-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
EBV-positive JJ B-NP
gastric JJ I-NP
carcinoma NN I-NP
: : O
unique JJ B-NP
viral JJ I-NP
latency NN I-NP
in IN B-PP
the DT B-NP
tumour NN I-NP
cells NNS I-NP
. . O

Although IN B-SBAR
case-oriented JJ B-NP
evidence NN I-NP
for IN B-PP
an DT B-NP
association NN I-NP
of IN B-PP
Epstein-Barr JJ B-NP
virus NN I-NP
( ( O
EBV NN B-NP
) ) O
with IN B-PP
gastric JJ B-NP
carcinoma NN I-NP
has VBZ B-VP
been VBN I-VP
accumulating VBG I-VP
recently RB B-ADVP
COMMA COMMA O
the DT B-NP
interaction NN I-NP
( ( I-NP
s NNS I-NP
) ) O
between IN B-PP
EBV NN B-NP
and CC O
gastric JJ B-NP
epithelial NN I-NP
cells NNS I-NP
is\/are VBP B-VP
largely RB B-ADJP
unknown JJ I-ADJP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
we PRP B-NP
examined VBD B-VP
seven CD B-NP
EBV-positive JJ I-NP
gastric JJ I-NP
carcinoma NN I-NP
tissues NNS I-NP
for IN B-PP
viral JJ B-NP
gene NN I-NP
expression NN I-NP
at IN B-PP
the DT B-NP
mRNA NN I-NP
level NN I-NP
COMMA COMMA O
from IN B-PP
which WDT B-NP
studies NNS B-NP
on IN B-PP
the DT B-NP
EBV NN I-NP
oncogenicity NN I-NP
in IN B-PP
human JJ B-NP
epithelial JJ I-NP
cells NNS I-NP
will MD B-VP
benefit VB I-VP
. . O

Reverse JJ B-NP
transcription-PCR NN I-NP
analysis NN I-NP
showed VBD B-VP
that IN B-SBAR
all DT B-NP
seven CD I-NP
EBV-positive JJ I-NP
tumour NN I-NP
tissues NNS I-NP
constitutively RB B-ADVP
expressed VBD B-VP
EBV NN B-NP
nuclear JJ I-NP
antigen NN I-NP
( ( O
EBNA NN B-NP
) ) O
1 CD B-NP
mRNA NN I-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
EBNA2 NN B-NP
mRNA NN I-NP
. . O

The DT B-NP
EBNA NN I-NP
transcription NN I-NP
was VBD B-VP
initiated VBN I-VP
from IN B-PP
one CD B-NP
of IN B-PP
three CD B-NP
EBNA NN I-NP
promoters NNS I-NP
COMMA COMMA O
Qp NN B-NP
: : O
by IN B-PP
contrast NN B-NP
COMMA COMMA O
both CC O
Cp NN B-NP
and CC O
Wp NN B-NP
were VBD B-VP
silent JJ B-ADJP
COMMA COMMA O
thus RB B-ADVP
resulting VBG B-VP
in IN B-PP
the DT B-NP
lack NN I-NP
of IN B-PP
EBNA2 NN B-NP
mRNA NN I-NP
. . O

Latent JJ B-NP
membrane NN I-NP
protein NN I-NP
( ( O
LMP NN B-NP
) ) O
2A NN B-NP
mRNA NN I-NP
was VBD B-VP
detected VBN I-VP
in IN B-PP
three CD B-NP
of IN B-PP
seven CD B-NP
cases NNS I-NP
; : O
however RB B-ADVP
COMMA COMMA O
neither CC O
LMP1 NN B-NP
nor CC O
LMP2B NN B-NP
mRNA NN B-NP
was VBD B-VP
detected VBN I-VP
in IN B-PP
any DT B-NP
of IN B-PP
the DT B-NP
tumours NNS I-NP
tested VBN B-VP
. . O

Transcripts NNS B-NP
from IN B-PP
the DT B-NP
BamHI-A NN I-NP
region NN I-NP
of IN B-PP
the DT B-NP
viral JJ I-NP
genome NN I-NP
were VBD B-VP
detectable JJ B-ADJP
in IN B-PP
all DT B-NP
cases NNS I-NP
. . O

BZLF1 NN B-NP
mRNA NN I-NP
and CC O
the DT B-NP
product NN I-NP
COMMA COMMA O
an DT B-NP
immediate-early JJ I-NP
gene NN I-NP
for IN B-PP
EBV NN B-NP
replication NN I-NP
COMMA COMMA O
was VBD B-VP
not RB I-VP
expressed VBN I-VP
in IN B-PP
any DT B-NP
of IN B-PP
them PRP B-NP
COMMA COMMA O
thereby RB B-ADVP
suggesting VBG B-VP
that IN B-SBAR
the DT B-NP
tumour JJ I-NP
cells NNS I-NP
carried VBD B-VP
EBV NN B-NP
genomes NNS I-NP
in IN B-PP
a DT B-NP
tightly RB I-NP
latent JJ I-NP
form NN I-NP
. . O

These DT B-NP
findings NNS I-NP
further RB B-VP
extended VBD I-VP
our PRP$ B-NP
previous JJ I-NP
data NNS I-NP
regarding VBG B-PP
EBV NN B-NP
latency NN I-NP
in IN B-PP
gastric JJ B-NP
carcinoma NN I-NP
cells NNS I-NP
at IN B-PP
the DT B-NP
protein NN I-NP
level NN I-NP
COMMA COMMA O
and CC O
have VBP B-VP
affirmed VBN I-VP
that IN B-SBAR
the DT B-NP
programme NN I-NP
of IN B-PP
viral JJ B-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
the DT B-NP
tumour NN I-NP
more RBR B-ADVP
closely RB I-ADVP
resembles VBZ B-VP
' `` O
latency NN B-NP
I CD I-NP
' '' O
represented VBN B-VP
by IN B-PP
Burkitt NN B-NP
's POS B-NP
lymphoma NN O
than IN O
' `` B-NP
latency NN I-NP
II CD B-NP
' '' O
represented VBN B-PP
by IN B-NP
the DT I-NP
majority NN O
of IN B-NP
nasopharyngeal JJ I-NP
carcinomas NNS O

Sequence-specific JJ B-NP
DNA NN I-NP
binding NN I-NP
of IN B-PP
the DT B-NP
B-cell-specific JJ I-NP
coactivator NN I-NP
OCA-B NN I-NP
. . O

B-cell-specific JJ B-NP
transcription NN I-NP
of IN B-PP
immunoglobulin NN B-NP
genes NNS I-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
the DT B-NP
interaction NN I-NP
of IN B-PP
a DT B-NP
POU NN I-NP
domain NN I-NP
containing VBG B-VP
transcription NN B-NP
factor NN I-NP
Oct-1 NN B-NP
or CC O
Oct-2 NN B-NP
COMMA COMMA O
with IN B-PP
the DT B-NP
B-cell-specific JJ I-NP
coactivator NN I-NP
OCA-B NN I-NP
( ( O
Bob-1 NN B-NP
COMMA COMMA O
OBF-1 NN B-NP
) ) O
and CC O
a DT B-NP
prototype NN I-NP
octamer NN I-NP
element NN I-NP
. . O

We PRP B-NP
find VBP B-VP
that IN B-SBAR
OCA-B NN B-NP
binds VBZ B-VP
DNA NN B-NP
directly RB B-ADVP
in IN B-PP
the DT B-NP
major JJ I-NP
groove NN I-NP
between IN B-PP
the DT B-NP
two CD I-NP
subdomains NNS I-NP
of IN B-PP
the DT B-NP
POU NN I-NP
domain NN I-NP
COMMA COMMA O
requiring VBG B-VP
both CC O
an DT B-NP
A NN I-NP
at IN B-PP
the DT B-NP
fifth JJ I-NP
position NN I-NP
of IN B-PP
the DT B-NP
octamer NN I-NP
element NN I-NP
and CC O
contact NN B-NP
with IN B-PP
the DT B-NP
POU NN I-NP
domain NN I-NP
. . O

An DT B-NP
amino-terminal JJ I-NP
fragment NN I-NP
of IN B-PP
OCA-B NN B-NP
binds VBZ B-VP
the DT B-NP
octamer NN I-NP
site NN I-NP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
a DT B-NP
POU NN I-NP
domain NN I-NP
with IN B-PP
the DT B-NP
same JJ I-NP
sequence NN I-NP
specificity NN I-NP
. . O

Coactivator NN B-NP
OCA-B NN I-NP
may MD B-VP
undergo VB I-VP
a DT B-NP
POU-dependent JJ I-NP
conformational JJ I-NP
change NN I-NP
that WDT B-NP
exposes VBZ B-VP
its PRP$ B-NP
amino NN I-NP
terminus NN I-NP
COMMA COMMA O
allowing VBG B-VP
it PRP B-NP
to TO B-VP
recognize VB I-VP
specific JJ B-NP
DNA NN I-NP
sequences NNS I-NP
in IN B-PP
the DT B-NP
major JJ I-NP
groove NN I-NP
within IN B-PP
the DT B-NP
binding VBG I-NP
site NN I-NP
for IN B-PP
Oct-1 NN B-NP
or CC O
Oct-2 NN B-NP
. . O

The DT B-NP
recognition NN I-NP
of IN B-PP
both CC O
the DT B-NP
POU NN I-NP
domain NN I-NP
and CC O
the DT B-NP
octamer NN I-NP
sequence NN I-NP
by IN B-PP
OCA-B NN B-NP
provides VBZ B-VP
a DT B-NP
mechanism NN I-NP
for IN B-PP
differential JJ B-NP
regulation NN I-NP
of IN B-PP
octamer NN B-NP
sites NNS I-NP
containing VBG B-VP
genes NNS B-NP
by IN B-PP
the DT B-NP
ubiquitous JJ I-NP
factor NN I-NP
Oct-1 NN I-NP
. . O

The DT B-NP
role NN I-NP
of IN B-PP
early JJ B-NP
growth NN I-NP
response NN I-NP
gene NN I-NP
1 CD I-NP
( ( O
egr-1 NN B-NP
) ) O
in IN B-PP
regulation NN B-NP
of IN B-PP
the DT B-NP
immune JJ I-NP
response NN I-NP
. . O

The DT B-NP
induction NN I-NP
of IN B-PP
immediate JJ B-NP
early JJ I-NP
genes NNS I-NP
in IN B-PP
cells NNS B-NP
of IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
is VBZ B-VP
critical JJ B-ADJP
to TO B-PP
determining VBG B-VP
the DT B-NP
ultimate JJ I-NP
outcome NN I-NP
of IN B-PP
exposure NN B-NP
to TO B-PP
antigen NN B-NP
. . O

The DT B-NP
importance NN I-NP
of IN B-PP
many JJ B-NP
of IN B-PP
these DT B-NP
genes NNS I-NP
relates VBZ B-VP
to TO B-PP
the DT B-NP
role NN I-NP
their PRP$ B-NP
transcription NN I-NP
factor NN I-NP
products NNS I-NP
play VBP B-VP
in IN B-PP
dictating VBG B-VP
patterns NNS B-NP
of IN B-PP
expression NN B-NP
of IN B-PP
downstream JJ B-NP
COMMA COMMA I-NP
function-related JJ I-NP
genes NNS I-NP
. . O

Evidence NN B-NP
from IN B-PP
several JJ B-NP
systems NNS I-NP
indicates VBZ B-VP
that IN B-SBAR
the DT B-NP
immediate JJ I-NP
early JJ I-NP
gene NN I-NP
COMMA COMMA O
egr-1 NN B-NP
may MD B-VP
be VB I-VP
of IN B-PP
particular JJ B-NP
importance NN I-NP
in IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
. . O

Recently RB B-ADVP
COMMA COMMA O
the DT B-NP
egr-1 NN I-NP
promoter NN I-NP
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
highly RB B-ADJP
responsive JJ I-ADJP
to TO B-PP
the DT B-NP
diverse JJ I-NP
biochemical JJ I-NP
signals NNS I-NP
generated VBN B-VP
by IN B-PP
antigen NN B-NP
and CC O
cytokines NNS B-NP
in IN B-PP
cells NNS B-NP
of IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
an DT B-NP
important JJ I-NP
role NN I-NP
for IN B-PP
egr-1 NN B-NP
in IN B-PP
determining VBG B-VP
the DT B-NP
differentiation NN I-NP
pathway NN I-NP
of IN B-PP
myeloid JJ B-NP
cell NN I-NP
precursors NNS I-NP
has VBZ B-VP
been VBN I-VP
recently RB I-VP
elaborated VBN I-VP
. . O

Finally RB B-ADVP
COMMA COMMA O
potential JJ B-NP
targets NNS I-NP
of IN B-PP
regulation NN B-NP
by IN B-PP
the DT B-NP
zinc-finger NN I-NP
transcription NN I-NP
factor NN I-NP
encoded VBN B-VP
by IN B-PP
egr-1 NN B-NP
include VBP B-VP
the DT B-NP
interleukin-2 NN B-NP
COMMA COMMA O
CD44 NN B-NP
COMMA COMMA O
ICAM-1 NN B-NP
COMMA COMMA O
and CC O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
genes NNS I-NP
. . O

The DT B-NP
role NN I-NP
of IN B-PP
egr-1 NN B-NP
in IN B-PP
regulation NN B-NP
of IN B-PP
the DT B-NP
immune JJ I-NP
response NN I-NP
will MD B-VP
be VB I-VP
discussed VBN I-VP
in IN B-PP
the DT B-NP
context NN I-NP
of IN B-PP
these DT B-NP
recent JJ I-NP
studies NNS I-NP
. . O

Translocation NN B-NP
(3;14)(q27;q11) NN I-NP
: : O
a DT B-NP
new JJ I-NP
variant JJ I-NP
translocation NN I-NP
in IN B-PP
a DT B-NP
patient NN I-NP
with IN B-PP
non-Hodgkin JJ B-NP
's POS B-NP
lymphoma NN I-NP
of IN B-PP
B-cell NN B-NP
type NN I-NP
with IN B-PP
BCL6 NN B-NP
rearrangement NN I-NP
. . O

We PRP B-NP
report VBP B-VP
a DT B-NP
65-year-old JJ I-NP
woman NN I-NP
with IN B-PP
non-Hodgkin JJ B-NP
's POS B-NP
lymphoma NN I-NP
( ( O
NHL NN B-NP
) ) O
carrying VBG B-VP
a DT B-NP
t(3;14)(q27;q11) NN I-NP
and CC O
BCL6 NN B-NP
rearrangement NN I-NP
in IN B-PP
the DT B-NP
affected VBN I-NP
cells NNS I-NP
. . O

She PRP B-NP
had VBD B-VP
generalized VBN I-VP
lymphadenopathy NN B-NP
and CC O
the DT B-NP
bone NN I-NP
marrow NN I-NP
was VBD B-VP
infiltrated VBN I-VP
by IN B-PP
lymphoma NN B-NP
cells NNS I-NP
at IN B-PP
presentation NN B-NP
. . O

Histological JJ B-NP
diagnosis NN I-NP
was VBD B-VP
" `` O
malignant JJ B-NP
lymphoma NN I-NP
COMMA COMMA O
diffuse JJ B-NP
COMMA COMMA O
large JJ B-NP
cell NN I-NP
" '' B-NP
type NN I-NP
according VBG B-PP
to TO B-PP
an DT B-NP
International NNP I-NP
Working NNP I-NP
Formulation NNP I-NP
. . O

Chromosome NN B-NP
analysis NN I-NP
revealed VBD B-VP
a DT B-NP
t(3;14)(q27;q11) NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
a DT B-NP
new JJ I-NP
variant JJ I-NP
translocation NN I-NP
of IN B-PP
t(3;14)(q27;q32) NN B-NP
. . O

Southern NN B-NP
blot NN I-NP
analysis NN I-NP
showed VBD B-VP
rearrangement NN B-NP
of IN B-PP
BCL6 NN B-NP
COMMA COMMA O
JH NN B-NP
COMMA COMMA O
and CC O
TCR NN B-NP
beta NN I-NP
but CC B-PP
not RB B-PP
of IN I-PP
TCR NN B-NP
delta NN I-NP
. . O

Cosmid NN B-NP
probe NN I-NP
of IN B-PP
BCL6 NN B-NP
hybridized VBD B-VP
to TO B-PP
14q11 NN B-NP
and CC O
3q27 NN B-NP
by IN B-PP
fluorescence NN B-NP
in FW I-NP
situ FW I-NP
hybridization NN I-NP
( ( O
FISH NN B-NP
) ) O
. . O

Although IN B-SBAR
the DT B-NP
band NN I-NP
14q11 NN I-NP
is VBZ B-VP
a DT B-NP
locus NN I-NP
of IN B-PP
T-cell NN B-NP
receptor NN I-NP
alpha- NN B-NP
and CC O
delta-chains NNS B-NP
( ( O
TCR NN B-NP
alpha\/delta NN I-NP
) ) O
COMMA COMMA O
lymphoma NN B-NP
cells NNS I-NP
expressed VBD B-VP
B-cell NN B-NP
COMMA COMMA O
IgGk NN B-NP
phenotype NN B-NP
. . O

The DT B-NP
findings NNS I-NP
suggest VBP B-VP
that IN B-SBAR
a DT B-NP
novel JJ I-NP
proto-oncogene NN I-NP
in IN B-PP
the DT B-NP
vicinity NN I-NP
of IN B-PP
TCR NN B-NP
alpha\/delta NN I-NP
is VBZ B-VP
involved VBN I-VP
in IN B-PP
this DT B-NP
translocation NN I-NP
. . O

Cross NN B-NP
talk NN I-NP
between IN B-PP
cell NN B-NP
death NN I-NP
and CC O
cell NN B-NP
cycle NN I-NP
progression NN I-NP
: : O
BCL-2 NN B-NP
regulates VBZ B-VP
NFAT-mediated JJ B-NP
activation NN I-NP
. . O

BCL-2-deficient JJ B-NP
T NN I-NP
cells NNS I-NP
demonstrate VBP B-VP
accelerated VBN B-NP
cell NN I-NP
cycle NN I-NP
progression NN I-NP
and CC O
increased VBN B-NP
apoptosis NN I-NP
following VBG B-PP
activation NN B-NP
. . O

Increasing VBG B-VP
the DT B-NP
levels NNS I-NP
of IN B-PP
BCL-2 NN B-NP
retarded VBD B-VP
the DT B-NP
G0 NN I-NP
--&gt; TO I-NP
S NN I-NP
transition NN I-NP
COMMA COMMA O
sustained VBD B-VP
the DT B-NP
levels NNS I-NP
of IN B-PP
cyclin-dependent JJ B-NP
kinase NN I-NP
inhibitor NN I-NP
p27Kip1 NN I-NP
COMMA COMMA O
and CC O
repressed VBD B-VP
postactivation NN B-NP
death NN I-NP
. . O

Proximal JJ B-NP
signal NN I-NP
transduction NN I-NP
events NNS I-NP
and CC O
immediate JJ B-NP
early JJ I-NP
gene NN I-NP
transcription NN I-NP
were VBD B-VP
unaffected JJ B-ADJP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
transcription NN B-NP
and CC O
synthesis NN B-NP
of IN B-PP
interleukin NN B-NP
2 CD I-NP
and CC O
other JJ B-NP
delayed VBN I-NP
early JJ I-NP
cytokines NNS I-NP
were VBD B-VP
markedly RB I-VP
attenuated VBN I-VP
by IN B-PP
BCL-2 NN B-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
a DT B-NP
cysteine NN I-NP
protease NN I-NP
inhibitor NN I-NP
that WDT B-NP
also RB B-VP
blocks VBZ I-VP
apoptosis NN B-NP
had VBD B-VP
no DT B-NP
substantial JJ I-NP
affect NN I-NP
upon IN B-PP
cytokine NN B-NP
production NN I-NP
. . O

InterleUkin NN B-NP
2 CD I-NP
expression NN I-NP
requires VBZ B-VP
several JJ B-NP
transcription NN I-NP
factors NNS I-NP
of IN B-PP
which WDT B-NP
nuclear JJ B-NP
translocation NN I-NP
of IN B-PP
NFAT NN B-NP
( ( O
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
) ) O
and CC O
NFAT-mediated JJ B-NP
transactivation NN I-NP
were VBD B-VP
impaired VBN I-VP
by IN B-PP
BCL-2 NN B-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
select JJ B-NP
genetic JJ I-NP
aberrations NNS I-NP
in IN B-PP
the DT B-NP
apoptotic JJ I-NP
pathway NN I-NP
reveal VBP B-VP
a DT B-NP
cell NN I-NP
autonomous JJ I-NP
coregulation NN I-NP
of IN B-PP
activation NN B-NP
. . O

Activation NN B-NP
of IN B-PP
Stat NN B-NP
5b NN I-NP
in IN B-PP
erythroid JJ B-NP
progenitors NNS I-NP
correlates VBZ B-VP
with IN B-PP
the DT B-NP
ability NN I-NP
of IN B-PP
ErbB NN B-NP
to TO B-VP
induce VB I-VP
sustained JJ B-NP
cell NN I-NP
proliferation NN I-NP
. . O

Self NN B-NP
renewal NN I-NP
of IN B-PP
normal JJ B-NP
erythroid JJ I-NP
progenitors NNS I-NP
is VBZ B-VP
induced VBN I-VP
by IN B-PP
the DT B-NP
receptor NN I-NP
tyrosine NN I-NP
kinase NN I-NP
c-ErbB NN I-NP
COMMA COMMA O
whereas IN O
other JJ B-NP
receptors NNS I-NP
( ( O
c-Kit\/Epo-R NNS B-NP
) ) O
regulate VBP B-VP
erythroid JJ B-NP
differentiation NN I-NP
. . O

To TO B-VP
address VB I-VP
possible JJ B-NP
mechanisms NNS I-NP
that WDT B-NP
could MD B-VP
explain VB I-VP
this DT B-NP
selective JJ I-NP
activity NN I-NP
of IN B-PP
c-ErbB NN B-NP
COMMA COMMA O
we PRP B-NP
analyzed VBD B-VP
the DT B-NP
ability NN I-NP
of IN B-PP
these DT B-NP
receptors NNS I-NP
to TO B-VP
activate VB I-VP
the DT B-NP
different JJ I-NP
members NNS I-NP
of IN B-PP
the DT B-NP
Stat NN I-NP
transcription NN I-NP
factor NN I-NP
family NN I-NP
. . O

Ligand NN B-NP
activation NN I-NP
of IN B-PP
c-ErbB NN B-NP
induced VBD B-VP
the DT B-NP
tyrosine NN B-NP
phosphorylation NN I-NP
COMMA COMMA O
DNA-binding NN B-NP
COMMA COMMA O
and CC O
reporter NN B-NP
gene NN I-NP
transcription NN I-NP
of IN B-PP
Stat NN B-NP
5b NN I-NP
in IN B-PP
erythroblasts NNS B-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
ligand NN B-NP
activation NN I-NP
of IN B-PP
c-Kit NN B-NP
was VBD B-VP
unable JJ B-ADJP
to TO B-VP
induce VB I-VP
any DT B-NP
of IN B-PP
these DT B-NP
effects NNS I-NP
in IN B-PP
the DT B-NP
same JJ I-NP
cells NNS I-NP
. . O

Activation NN B-NP
of IN B-PP
the DT B-NP
erythropoietin NN I-NP
receptor NN I-NP
caused VBD B-VP
specific JJ B-NP
DNA-binding NN I-NP
of IN B-PP
Stat NN B-NP
5b NN I-NP
COMMA COMMA O
but CC O
failed VBD B-VP
to TO I-VP
induce VB I-VP
reporter NN B-NP
gene NN I-NP
transcription NN I-NP
. . O

These DT B-NP
biochemical JJ I-NP
findings NNS I-NP
correlate VBP B-VP
perfectly RB B-ADVP
with IN B-PP
the DT B-NP
selective JJ I-NP
ability NN I-NP
of IN B-PP
c-ErbB NN B-NP
to TO B-VP
cause VB I-VP
sustained JJ B-NP
self NN I-NP
renewal NN I-NP
in IN B-PP
erythroid JJ B-NP
progenitors NNS I-NP
. . O

Calcineurin NN B-NP
mutants NNS I-NP
render VBP B-VP
T NN B-NP
lymphocytes NNS I-NP
resistant JJ B-ADJP
to TO B-PP
cyclosporin NN B-NP
A NN I-NP
. . O

The DT B-NP
immunosuppressants NNS I-NP
cyclosporin NN B-NP
A NN I-NP
( ( O
CsA NN B-NP
) ) O
and CC O
FK506 NN B-NP
have VBP B-VP
been VBN I-VP
widely RB I-VP
used VBN I-VP
to TO B-VP
prevent VB I-VP
and CC O
treat VB B-VP
graft NN B-NP
rejection NN I-NP
after IN B-PP
human JJ O
organ NN B-NP
and CC O
tissue NN B-NP
transplantations NNS B-NP
. . O

CsA NN B-NP
and CC O
FK506 NN B-NP
associate VBP B-VP
with IN B-PP
intracellular JJ B-NP
binding VBG I-NP
proteins NNS I-NP
( ( O
i.e. FW B-ADVP
COMMA COMMA O
CsA NN B-NP
with IN B-PP
cyclophilin NN B-NP
A NN I-NP
and CC O
FK506 NN B-NP
with IN B-PP
FKBP12 NN B-NP
) ) O
to TO B-VP
form VB I-VP
protein\/drug NN B-NP
complexes NNS I-NP
that WDT B-NP
suppress VBP B-VP
the DT B-NP
immune JJ I-NP
system NN I-NP
by IN B-PP
preventing VBG B-VP
activation NN B-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
in IN B-PP
response NN I-PP
to TO I-PP
antigen NN B-NP
presentation NN I-NP
. . O

The DT B-NP
common JJ I-NP
target NN I-NP
of IN B-PP
CsA NN B-NP
and CC O
FK506 NN B-NP
is VBZ B-VP
calcineurin NN B-NP
COMMA COMMA O
a DT B-NP
Ca2+\/calmodulin-regulated JJ I-NP
COMMA COMMA I-NP
serine\/threonine-specific JJ I-NP
protein NN I-NP
phosphatase NN I-NP
that WDT B-NP
regulates VBZ B-VP
the DT B-NP
nuclear JJ I-NP
import NN I-NP
of IN B-PP
a DT B-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
NF-AT NN B-NP
COMMA COMMA O
required VBN B-VP
for IN B-PP
expression NN B-NP
of IN B-PP
T NN B-NP
cell NN I-NP
activation NN I-NP
genes NNS I-NP
. . O

In IN B-PP
previous JJ B-NP
studies NNS I-NP
COMMA COMMA O
we PRP B-NP
identified VBD B-VP
calcineurin NN B-NP
mutations NNS I-NP
that WDT B-NP
block VBP B-VP
binding NN B-NP
by IN B-PP
the DT B-NP
cyclophilin NN I-NP
A\/CsA NN I-NP
or CC I-NP
FKBP12\/FK506 NN I-NP
complexes NNS I-NP
and CC O
thereby RB O
render VBP B-VP
yeast NN B-NP
cells NNS I-NP
resistant JJ B-ADJP
to TO B-PP
the DT B-NP
antifungal JJ I-NP
effects NNS I-NP
of IN B-PP
CsA NN B-NP
or CC O
FK506 NN B-NP
. . O

In IN B-PP
this DT B-NP
report NN I-NP
COMMA COMMA O
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
the DT B-NP
corresponding JJ I-NP
mutations NNS I-NP
in IN B-PP
murine JJ B-NP
calcineurin NN I-NP
render VBP B-VP
the DT B-NP
T NN I-NP
cell NN I-NP
receptor NN I-NP
signal NN I-NP
transduction NN I-NP
cascade NN I-NP
CsA NN I-NP
resistant JJ B-ADJP
in IN B-PP
human JJ B-NP
Jurkat NN I-NP
T NN I-NP
cells NNS I-NP
. . O

Our PRP$ B-NP
findings NNS I-NP
support VBP B-VP
the DT B-NP
recently RB I-NP
determined VBN I-NP
calcineurin NN I-NP
X-ray NN I-NP
crystal NN I-NP
structure NN I-NP
COMMA COMMA O
provide VBP B-VP
evidence NN B-NP
that IN B-SBAR
calcineurin NN B-NP
is VBZ B-VP
the DT B-NP
only RB I-NP
CsA-sensitive JJ I-NP
component NN I-NP
limiting VBG B-VP
signaling NN B-NP
from IN B-PP
the DT B-NP
T NN I-NP
cell NN I-NP
receptor NN I-NP
to TO B-PP
the DT B-NP
nucleus NN I-NP
COMMA COMMA O
and CC O
suggest VBP B-VP
a DT B-NP
means NN I-NP
to TO B-VP
render VB I-VP
cells NNS B-NP
and CC O
tissues NNS B-NP
resistant JJ B-ADJP
to TO B-PP
the DT B-NP
toxic JJ I-NP
side JJ I-NP
effects NNS I-NP
of IN B-PP
CsA NN B-NP
and CC O
FK506 NN B-NP
. . O

Retinoid NN B-NP
differentiation NN I-NP
therapy NN I-NP
in IN B-PP
promyelocytic JJ B-NP
leukemia NN I-NP
. . O

Acute JJ B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
( ( O
APL NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
specific JJ I-NP
type NN I-NP
of IN B-PP
acute JJ B-NP
myeloid JJ I-NP
leukemia NN I-NP
characterized VBN B-VP
by IN B-PP
the DT B-NP
morphology NN I-NP
of IN B-PP
the DT B-NP
blast NN I-NP
cells NNS I-NP
COMMA COMMA O
a DT B-NP
specific JJ I-NP
t(15;17) NN I-NP
translocation NN I-NP
COMMA COMMA O
and CC O
risks NNS B-NP
of IN B-PP
definite JJ B-NP
coagulopathy NN I-NP
. . O

Recently RB B-ADVP
this DT B-NP
leukemia NN I-NP
was VBD B-VP
further RB I-VP
characterized VBN I-VP
by IN B-PP
an DT B-NP
exquisite JJ I-NP
sensitivity NN I-NP
to TO B-PP
all-trans JJ B-NP
retinoic JJ I-NP
acid NN I-NP
's POS B-NP
differentiation NN I-NP
effect NN I-NP
and CC O
the DT B-NP
production NN I-NP
of IN B-PP
a DT B-NP
fusion NN I-NP
gene NN I-NP
altering VBG B-VP
the DT B-NP
gene NN I-NP
of IN B-PP
RARalpha NN B-NP
and CC O
a DT B-NP
novel JJ I-NP
gene NN I-NP
PML NN I-NP
. . O

In FW B-NP
vivo FW I-NP
differentiation NN I-NP
therapy NN I-NP
with IN B-PP
retinoids NNS B-NP
in IN B-PP
APL NN B-NP
patients NNS I-NP
follows VBZ B-VP
strict JJ B-NP
guidelines NNS I-NP
related JJ B-ADJP
both CC B-PP
to TO I-PP
the DT B-NP
APL NN I-NP
cell NN I-NP
and CC O
the DT B-NP
biodisposal NN I-NP
of IN B-PP
all-trans JJ B-NP
retinoic JJ I-NP
acid NN I-NP
. . O

Epstein-Barr JJ B-NP
viral JJ I-NP
latency NN I-NP
is VBZ B-VP
disrupted VBN I-VP
by IN B-PP
the DT B-NP
immediate-early JJ I-NP
BRLF1 NN I-NP
protein NN I-NP
through IN B-PP
a DT B-NP
cell-specific JJ I-NP
mechanism NN I-NP
. . O

Epstein-Barr JJ B-NP
virus NN I-NP
( ( O
EBV NN B-NP
) ) O
COMMA COMMA O
the DT B-NP
causative JJ I-NP
agent NN I-NP
of IN B-PP
infectious JJ B-NP
mononucleosis NN I-NP
COMMA COMMA O
is VBZ B-VP
a DT B-NP
human JJ I-NP
herpesvirus NN I-NP
associated VBN B-VP
with IN B-PP
epithelial JJ B-NP
cell NN I-NP
malignancies NNS I-NP
( ( O
nasopharyngeal JJ B-NP
carcinoma NN I-NP
) ) O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
B-cell NN B-NP
malignancies NNS I-NP
. . O

Understanding VBG B-VP
how WRB B-ADVP
viral JJ B-NP
latency NN I-NP
is VBZ B-VP
disrupted VBN I-VP
is VBZ B-VP
a DT B-NP
central JJ I-NP
issue NN I-NP
in IN B-PP
herpesvirus JJ B-NP
biology NN I-NP
. . O

Epithelial JJ B-NP
cells NNS I-NP
are VBP B-VP
the DT B-NP
major JJ I-NP
site NN I-NP
of IN B-PP
lytic JJ B-NP
EBV NN I-NP
replication NN I-NP
within IN B-PP
the DT B-NP
human JJ I-NP
host NN I-NP
COMMA COMMA O
and CC O
viral JJ B-NP
reactivation NN I-NP
occurs VBZ B-VP
in IN B-PP
EBV-associated JJ B-NP
nasopharyngeal JJ I-NP
carcinomas NNS I-NP
. . O

It PRP B-NP
is VBZ B-VP
known VBN I-VP
that IN B-SBAR
expression NN B-NP
of IN B-PP
a DT B-NP
single JJ I-NP
viral JJ I-NP
immediate-early JJ I-NP
protein NN I-NP
COMMA COMMA O
BZLF1 NN B-NP
COMMA COMMA O
is VBZ B-VP
sufficient JJ B-ADJP
to TO B-VP
initiate VB I-VP
the DT B-NP
switch NN I-NP
from IN B-PP
latent JJ B-NP
to TO B-PP
lytic JJ B-NP
infection NN B-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
. . O

Cellular JJ B-NP
regulation NN I-NP
of IN B-PP
BZLF1 NN B-NP
transcription NN I-NP
is VBZ B-VP
therefore RB I-VP
thought VBN I-VP
to TO I-VP
play VB I-VP
a DT B-NP
key JJ I-NP
role NN I-NP
in IN B-PP
regulating VBG B-VP
the DT B-NP
stringency NN I-NP
of IN B-PP
viral JJ B-NP
latency NN I-NP
. . O

Here RB B-ADVP
we PRP B-NP
show VBP B-VP
that IN B-SBAR
COMMA COMMA O
unexpectedly RB B-ADVP
COMMA COMMA O
expression NN B-NP
of IN B-PP
another DT B-NP
viral JJ I-NP
immediate-early JJ I-NP
protein NN I-NP
COMMA COMMA O
BRLF1 NN B-NP
COMMA COMMA O
can MD B-VP
disrupt VB I-VP
viral JJ B-NP
latency NN I-NP
in IN B-PP
an DT B-NP
epithelial JJ I-NP
cell-specific JJ I-NP
fashion NN I-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
the DT B-NP
mechanisms NNS I-NP
leading VBG B-VP
to TO B-PP
disruption NN B-NP
of IN B-PP
EBV NN B-NP
latency NN I-NP
appear VBP B-VP
to TO I-VP
be VB I-VP
cell-type NN B-ADJP
specific JJ I-ADJP
. . O

IL4 NN B-NP
and CC O
IL13 NN B-NP
receptors NNS B-NP
share VBP B-VP
the DT B-NP
gamma NN I-NP
c NN I-NP
chain NN I-NP
and CC O
activate VBP B-VP
STAT6 NN B-NP
COMMA COMMA O
STAT3 NN B-NP
and CC O
STAT5 NN B-NP
proteins NNS B-NP
in IN B-PP
normal JJ B-NP
human JJ I-NP
B NN I-NP
cells NNS I-NP
. . O

IL13 NN B-NP
induces VBZ B-VP
the DT B-NP
same JJ I-NP
biological JJ I-NP
effects NNS I-NP
as IN B-PP
IL4 NN B-NP
in IN B-PP
normal JJ B-NP
human JJ I-NP
B NN I-NP
cells NNS I-NP
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
as IN B-PP
in IN B-PP
the DT B-NP
IL4R NN I-NP
complex NN I-NP
COMMA COMMA O
both CC O
IL4R NN B-NP
alpha NN I-NP
and CC O
IL2R NN B-NP
gamma NN I-NP
c NN I-NP
are VBP B-VP
components NNS B-NP
of IN B-PP
the DT B-NP
IL13R NN I-NP
and CC O
that IN B-SBAR
both DT B-NP
cytokines NNS I-NP
induced VBD B-VP
STAT6 NN B-NP
COMMA COMMA O
STAT3 NN B-NP
and CC O
STAT5 NN B-NP
activation NN B-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
. . O

In IN B-PP
spite NN I-PP
of IN I-PP
this DT B-NP
similar JJ I-NP
downstream JJ I-NP
signalling NN I-NP
COMMA COMMA O
IL4 NN B-NP
and CC O
IL13 NN B-NP
used VBD B-VP
a DT B-NP
different JJ I-NP
set NN I-NP
of IN B-PP
Janus NN B-NP
kinases NNS I-NP
: : O
IL13 NN B-NP
is VBZ B-VP
unable JJ B-ADJP
to TO B-VP
activate VB I-VP
JAK1 NN B-NP
and CC O
JAK3 NN B-NP
. . O

Attenuated VBN B-NP
function NN I-NP
of IN B-PP
a DT B-NP
variant JJ I-NP
form NN I-NP
of IN B-PP
the DT B-NP
helix-loop-helix JJ I-NP
protein NN I-NP
COMMA COMMA O
Id-3 NN B-NP
COMMA COMMA O
generated VBN B-VP
by IN B-PP
an DT B-NP
alternative JJ I-NP
splicing NN I-NP
mechanism NN I-NP
. . O

The DT B-NP
Id NN I-NP
family NN I-NP
of IN B-PP
helix-loop-helix JJ B-NP
proteins NNS I-NP
function VBP B-VP
as IN B-PP
negative JJ B-NP
regulators NNS I-NP
of IN B-NP
DNA NN B-NP
binding NN I-NP
COMMA COMMA I-NP
basic JJ I-NP
helix-loop-helix JJ I-NP
proteins NNS I-NP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
cell NN B-NP
growth NN B-NP
and CC O
differentiation NN B-NP
. . O

We PRP B-NP
report VBP B-VP
here RB B-ADVP
on IN B-PP
the DT B-NP
identification NN I-NP
of IN B-PP
a DT B-NP
17 CD I-NP
kDa NN I-NP
variant NN I-NP
of IN B-PP
the DT B-NP
14 CD I-NP
kDa NN I-NP
Id-3 NN I-NP
protein NN I-NP
termed VBN B-VP
Id-3L NN B-NP
( ( O
long JJ B-NP
version NN I-NP
) ) O
which WDT B-NP
possesses VBZ B-VP
a DT B-NP
unique JJ I-NP
60 CD I-NP
amino NN I-NP
acid NN I-NP
carboxy-terminus NN I-NP
generated VBN B-VP
by IN B-PP
read VBN B-NP
through IN I-NP
of IN B-PP
a DT B-NP
' `` I-NP
coding VBG I-NP
intron NN I-NP
' '' O
and CC O
alternative JJ B-NP
splicing NN I-NP
. . O

Northern NN B-NP
analysis NN I-NP
revealed VBD B-VP
expression NN B-NP
of IN B-PP
a DT B-NP
minor JJ I-NP
1.1 CD I-NP
kb NN I-NP
Id-3L NN I-NP
transcript NN I-NP
together RB B-CONJP
with IN I-CONJP
the DT B-NP
predominant JJ I-NP
0.95 CD I-NP
kb NN I-NP
Id-3 NN I-NP
transcript NN I-NP
in IN B-PP
the DT B-NP
majority NN I-NP
of IN B-PP
adult JJ B-NP
human JJ I-NP
tissues NNS I-NP
analysed VBN B-VP
. . O

The DT B-NP
variant JJ I-NP
Id-3L NN I-NP
protein NN I-NP
is VBZ B-VP
functionally RB B-ADJP
distinguishable JJ I-ADJP
from IN B-PP
conventional JJ B-NP
Id-3 NN I-NP
since IN B-SBAR
in IN B-PP
in FW B-NP
vitro FW I-NP
DNA NN I-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
COMMA COMMA O
it PRP B-NP
was VBD B-VP
greatly RB B-ADJP
impaired JJ I-ADJP
in IN B-PP
its PRP$ B-NP
ability NN I-NP
to TO B-VP
abrogate VB I-VP
binding NN B-NP
of IN B-PP
the DT B-NP
basic JJ I-NP
helix-loop-helix JJ I-NP
protein NN I-NP
COMMA COMMA O
E47 NN B-NP
COMMA COMMA O
to TO B-PP
an DT B-NP
E NN I-NP
box NN I-NP
recognition NN I-NP
sequence NN I-NP
. . O

Multifactor JJ B-NP
cis-dominant JJ I-NP
negative JJ I-NP
regulation NN I-NP
of IN B-PP
IL-2 NN B-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
anergized VBN B-NP
T NN I-NP
cells NNS I-NP
. . O

The DT B-NP
molecular JJ I-NP
mechanism NN I-NP
underlying VBG B-VP
IL-2 NN B-NP
transcriptional JJ I-NP
blockade NN I-NP
in IN B-PP
anergic JJ B-NP
T NN I-NP
cell NN I-NP
clones NNS I-NP
is VBZ B-VP
not RB I-VP
fully RB I-VP
understood VBN I-VP
. . O

To TO B-VP
examine VB I-VP
whether IN B-SBAR
an DT B-NP
active JJ I-NP
negative JJ I-NP
regulatory JJ I-NP
process NN I-NP
occurs VBZ B-VP
COMMA COMMA O
we PRP B-NP
created VBD B-VP
a DT B-NP
reporter NN I-NP
construct NN I-NP
containing VBG B-VP
as IN B-PP
an DT B-NP
enhancer NN I-NP
four CD B-NP
copies NNS I-NP
of IN B-PP
the DT B-NP
NF-AT NN I-NP
site NN I-NP
and CC O
one CD B-NP
copy NN I-NP
of IN B-PP
the DT B-NP
octamer NN I-NP
site NN I-NP
( ( O
4X NN B-NP
NF-AT-Oct NN I-NP
) ) O
. . O

This DT B-NP
construct NN I-NP
was VBD O
only RB B-ADVP
slightly RB I-ADVP
reduced VBN B-VP
( ( O
1.3-fold RB B-ADVP
) ) O
in IN B-PP
its PRP$ B-NP
expression NN I-NP
when WRB B-ADVP
stimulated VBN B-VP
under IN B-PP
anergic JJ B-NP
conditions NNS I-NP
COMMA COMMA O
while IN B-SBAR
a DT B-NP
whole JJ I-NP
mouse NN I-NP
IL-2 NN I-NP
enhancer NN I-NP
construct NN I-NP
showed VBD B-VP
a DT B-NP
reduction NN I-NP
of IN B-PP
4.3-fold JJ B-NP
. . O

Addition NN B-NP
of IN B-PP
the DT O
-176 CD B-NP
to TO O
-96 CD B-NP
sequence NN B-NP
to TO B-PP
the DT B-NP
4X NN I-NP
NF-AT-Oct NN I-NP
construct NN I-NP
did VBD B-VP
not RB I-VP
impart VB I-VP
the DT B-NP
ability NN I-NP
to TO B-VP
be VB I-VP
affected VBN I-VP
by IN B-PP
anergy NN B-NP
COMMA COMMA O
but CC O
addition NN B-NP
of IN B-PP
the DT O
-236 CD B-NP
to TO O
-96 CD B-NP
sequence NN B-NP
did VBD B-VP
COMMA COMMA O
demonstrating VBG B-VP
that IN B-SBAR
anergy NN B-NP
is VBZ B-VP
an DT B-NP
active JJ I-NP
inhibitory JJ I-NP
process NN I-NP
and CC O
that IN B-SBAR
more JJR B-NP
than IN B-PP
the DT B-NP
presence NN I-NP
of IN B-PP
the DT B-NP
-150 CD I-NP
AP-1 NN I-NP
binding NN I-NP
site NN I-NP
( ( O
-152 CD B-NP
to TO O
-147 CD B-NP
) ) O
is VBZ B-VP
required VBN I-VP
to TO B-VP
mediate VB I-VP
the DT B-NP
effect NN I-NP
. . O

Mutational JJ B-NP
studies NNS I-NP
of IN B-PP
the DT O
-236 CD B-NP
to TO O
-96 CD B-NP
sequence NN B-NP
indicated VBD B-VP
that IN B-SBAR
the DT B-NP
presence NN I-NP
of IN B-PP
both CC O
the DT B-NP
-130 CD B-NP
AP-1-like JJ I-NP
site NN I-NP
( ( O
-187 CD B-NP
to TO O
-181 CD B-NP
) ) O
and CC O
the DT B-NP
-150 CD I-NP
proximal JJ I-NP
AP-1 NN I-NP
site NN I-NP
were VBD B-VP
necessary JJ B-ADJP
to TO B-VP
observe VB I-VP
anergy NN B-NP
. . O

Because IN B-SBAR
the DT B-NP
-180 CD I-NP
site NN I-NP
is VBZ B-VP
not RB I-VP
required VBN I-VP
for IN B-PP
trans-activation NN B-NP
COMMA COMMA O
it PRP B-NP
was VBD B-VP
possible JJ B-ADJP
to TO B-VP
confirm VB I-VP
by IN B-PP
mutation NN B-NP
in IN B-PP
the DT B-NP
normal JJ I-NP
mouse NN I-NP
IL-2 NN I-NP
enhancer NN I-NP
that IN B-SBAR
this DT B-NP
site NN I-NP
is VBZ B-VP
absolutely RB B-ADJP
essential JJ I-ADJP
for IN B-PP
anergy NN B-NP
induction NN I-NP
. . O

The DT B-NP
simplest JJS I-NP
model NN I-NP
to TO B-VP
explain VB I-VP
these DT B-NP
results NNS I-NP
is VBZ B-VP
that IN B-SBAR
anergy NN B-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
a DT B-NP
complex NN I-NP
of IN B-PP
multiple JJ B-NP
transcription NN I-NP
factors NNS I-NP
that WDT B-NP
exert VBP B-VP
a DT B-NP
cis-acting JJ I-NP
dominant JJ I-NP
negative JJ I-NP
regulatory JJ I-NP
effect NN I-NP
on IN B-PP
the DT B-NP
trans-activation NN I-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
gene NN I-NP
. . O

Characterization NN B-NP
of IN B-PP
the DT B-NP
human JJ I-NP
myeloid JJ I-NP
cell NN I-NP
nuclear JJ I-NP
differentiation NN I-NP
antigen NN I-NP
gene NN I-NP
promoter NN I-NP
. . O

MNDA NN B-NP
( ( O
myeloid JJ B-NP
cell NN I-NP
nuclear JJ I-NP
differentiation NN I-NP
antigen NN I-NP
) ) O
is VBZ B-VP
an DT O
interferon NN B-NP
alpha NN I-NP
regulated VBN B-NP
nuclear JJ I-NP
protein NN I-NP
expressed VBN B-VP
only RB B-PP
in IN I-PP
cells NNS B-NP
of IN B-PP
the DT B-NP
human JJ I-NP
myelomonocytic JJ I-NP
lineage NN I-NP
. . O

To TO B-VP
identify VB I-VP
mechanisms NNS B-NP
responsible JJ B-ADJP
for IN B-PP
this DT B-NP
lineage-specific JJ I-NP
and CC I-NP
interferon-regulated JJ I-NP
expression NN I-NP
COMMA COMMA O
the DT B-NP
5' JJ I-NP
flanking JJ I-NP
sequence NN I-NP
of IN B-PP
the DT B-NP
gene NN I-NP
has VBZ B-VP
been VBN I-VP
characterized VBN I-VP
. . O

Two CD B-NP
interferon-stimulated JJ B-NP
response NN I-NP
elements NNS I-NP
( ( O
ISRE NN B-NP
) ) O
flank VBP B-VP
a DT B-NP
multiple JJ I-NP
transcription NN I-NP
start NN I-NP
site NN I-NP
region NN I-NP
identifying VBG B-VP
MNDA NN B-NP
as IN B-PP
a DT B-NP
TATA-less JJ I-NP
interferon-regulated JJ I-NP
gene NN I-NP
. . O

Other JJ B-NP
DNA NN I-NP
elements NNS I-NP
present JJ B-ADJP
include VBP B-VP
a DT B-NP
cluster NN I-NP
of IN B-PP
Myb NN B-NP
sites NNS I-NP
COMMA COMMA O
several JJ B-NP
Ets NNS I-NP
COMMA COMMA O
an DT B-NP
Ets NN I-NP
related JJ I-NP
PU.1 NN I-NP
site NN I-NP
and CC O
an DT B-NP
Sp1 NN I-NP
site NN I-NP
located JJ B-ADJP
within IN B-PP
600 CD B-NP
bp NN I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
start NN I-NP
sites NNS I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
DNA NN B-NP
methylation NN I-NP
was VBD B-VP
revealed VBN I-VP
as IN B-PP
one CD B-NP
of IN B-PP
the DT B-NP
possible JJ I-NP
factors NNS I-NP
in IN B-PP
establishing VBG B-VP
MNDA NN B-NP
expression NN I-NP
. . O

The DT B-NP
5' JJ I-NP
flanking JJ I-NP
sequence NN I-NP
has VBZ B-VP
promoter NN B-NP
activity NN I-NP
which WDT B-NP
is VBZ B-VP
elevated VBN I-VP
by IN B-PP
interferon NN B-NP
alpha NN I-NP
. . O

The DT B-NP
findings NNS I-NP
indicate VBP B-VP
that IN B-SBAR
MNDA NN B-NP
expression NN I-NP
is VBZ B-VP
regulated VBN I-VP
by IN B-PP
mechanisms NNS B-NP
similar JJ B-ADJP
to TO B-PP
other JJ O
myelomonocytic JJ B-NP
cell NN I-NP
specific JJ B-NP
genes NNS I-NP
and CC O
genes NNS B-NP
up-regulated VBN B-VP
by IN B-PP
interferon NN B-NP
alpha NN I-NP
. . O

Regulation NN B-NP
of IN B-PP
GM-CSF NN B-NP
gene NN I-NP
transcription NN I-NP
by IN B-PP
core-binding JJ B-NP
factor NN I-NP
. . O

GM-CSF NN B-NP
gene NN I-NP
activation NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
is VBZ B-VP
known VBN I-VP
to TO I-VP
involve VB I-VP
the DT B-NP
transcription NN I-NP
factors NNS I-NP
nuclear JJ B-NP
factor-kappa NN I-NP
B NN I-NP
COMMA COMMA O
AP-1 NN B-NP
COMMA COMMA O
NFAT NN B-NP
COMMA COMMA O
and CC O
Sp1 NN B-NP
. . O

Here RB B-ADVP
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
the DT B-NP
human JJ I-NP
GM-CSF NN I-NP
promoter NN B-NP
and CC O
enhancer NN B-NP
also RB B-ADVP
encompass VBP B-VP
binding VBG B-NP
sites NNS I-NP
for IN B-PP
core-binding JJ B-NP
factor NN I-NP
( ( O
CBF NN B-NP
) ) O
. . O

Significantly RB B-ADVP
COMMA COMMA O
the DT B-NP
CBF NN I-NP
sites NNS I-NP
are VBP B-VP
in IN B-PP
each DT B-NP
case NN I-NP
contained VBN B-VP
within IN B-PP
the DT B-NP
minimum JJ I-NP
essential JJ I-NP
core NN I-NP
regions NNS I-NP
required VBN B-VP
for IN B-PP
inducible JJ B-NP
activation NN I-NP
of IN B-PP
transcription NN B-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
these DT B-NP
core NN I-NP
regions NNS I-NP
of IN B-PP
the DT B-NP
enhancer NN B-NP
and CC O
promoter NN B-NP
each DT B-NP
encompass VBP B-VP
closely RB B-NP
linked VBN I-NP
binding VBG I-NP
sites NNS I-NP
for IN B-PP
CBF NN B-NP
COMMA COMMA O
AP-1 NN B-NP
COMMA COMMA O
and CC O
NFATp NN B-NP
. . O

The DT B-NP
GM-CSF NN I-NP
promoter NN I-NP
CBF NN I-NP
site NN I-NP
TGTGGTCA NN I-NP
is VBZ B-VP
located JJ O
51 CD B-ADJP
bp NN I-ADJP
upstream RB B-ADJP
of IN B-PP
the DT B-NP
transcription NN I-NP
start NN I-NP
site NN I-NP
and CC O
also RB O
overlaps VBZ B-VP
a DT B-NP
YY-1 NN I-NP
binding NN I-NP
site NN I-NP
. . O

A DT B-NP
2-bp JJ I-NP
mutation NN I-NP
within IN B-PP
the DT B-NP
CBF NN I-NP
site NN I-NP
resulted VBD B-VP
in IN B-PP
a DT B-NP
2-3-fold JJ I-NP
decrease NN I-NP
in IN B-PP
the DT B-NP
activities NNS I-NP
of IN B-PP
both CC O
a DT B-NP
69-bp JJ I-NP
proximal JJ I-NP
promoter NN I-NP
fragment NN I-NP
and CC O
a DT B-NP
627-bp JJ I-NP
full-length NN I-NP
promoter NN I-NP
fragment NN I-NP
. . O

Stepwise JJ B-NP
deletions NNS I-NP
into IN B-PP
the DT B-NP
proximal JJ I-NP
promoter NN I-NP
also RB B-ADVP
revealed VBD B-VP
that IN B-SBAR
the DT B-NP
CBF NN I-NP
site NN I-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
the DT B-NP
YY-1 NN I-NP
site NN I-NP
COMMA COMMA O
was VBD B-VP
required VBN I-VP
for IN B-PP
efficient JJ B-NP
induction NN I-NP
of IN B-PP
transcriptional JJ B-NP
activation NN I-NP
. . O

The DT O
AML1 NN B-NP
and CC O
CBF NN B-NP
beta NN I-NP
genes NNS B-NP
that WDT B-NP
encode VBP B-VP
CBF NN B-NP
each DT B-NP
have VBP B-VP
the DT B-NP
ability NN I-NP
to TO B-VP
influence VB I-VP
cell NN B-NP
growth NN B-NP
and CC O
differentiation NN B-NP
and CC O
have VBP B-VP
been VBN B-NP
implicated VBN B-VP
as IN B-PP
proto-oncogenes NNS B-NP
in IN B-PP
acute JJ B-NP
myeloid JJ I-NP
leukemia NN I-NP
. . O

This DT B-NP
study NN I-NP
adds VBZ B-VP
GM-CSF NN B-NP
to TO B-PP
a DT B-NP
growing VBG I-NP
list NN I-NP
of IN B-PP
cytokines NNS B-NP
and CC O
receptors NNS B-NP
that WDT B-NP
are VBP B-VP
regulated VBN I-VP
by IN B-PP
CBF NN B-NP
and CC O
which WDT B-NP
control VBP B-VP
the DT B-NP
growth NN B-NP
COMMA COMMA O
differentiation NN B-NP
COMMA COMMA O
and CC O
activation NN B-NP
of IN B-PP
hemopoietic JJ B-NP
cells NNS I-NP
. . O

The DT B-NP
GM-CSF NN I-NP
locus NN I-NP
may MD B-VP
represent VB I-VP
one CD B-NP
of IN B-PP
several JJ B-NP
target NN I-NP
genes NNS I-NP
that WDT B-NP
are VBP B-VP
dysregulated VBN I-VP
in IN B-PP
acute JJ B-NP
myeloid JJ I-NP
leukemia NN I-NP
. . O

Tyloxapol NN B-NP
inhibits VBZ B-VP
NF-kappa NN B-NP
B NN I-NP
and CC O
cytokine NN B-NP
release NN B-NP
COMMA COMMA O
scavenges VBZ B-VP
HOCI NN B-NP
COMMA COMMA O
and CC O
reduces VBZ B-VP
viscosity NN B-NP
of IN B-PP
cystic JJ B-NP
fibrosis NN I-NP
sputum NN I-NP
. . O

Cystic JJ B-NP
fibrosis NN I-NP
( ( O
CF NN B-NP
) ) O
patients NNS B-NP
develop VB B-VP
progressive JJ B-NP
cytokine-mediated JJ I-NP
inflammatory JJ I-NP
lung NN I-NP
disease NN I-NP
COMMA COMMA O
with IN B-PP
abundant JJ B-NP
production NN I-NP
of IN B-PP
thick JJ O
COMMA COMMA O
tenacious JJ O
COMMA COMMA O
protease- NN B-NP
and CC O
oxidant-rich JJ B-ADJP
purulent JJ B-NP
airway NN I-NP
secretions NNS I-NP
that WDT B-NP
are VBP B-VP
difficult JJ B-ADJP
to TO B-VP
clear VB I-VP
even RB B-PP
with IN I-PP
physiotherapy NN B-NP
. . O

In IN B-PP
the DT B-NP
search NN I-NP
for IN B-PP
a DT B-NP
potential JJ I-NP
treatment NN I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
tested VBN I-VP
tyloxapol NN B-NP
COMMA COMMA O
an DT B-NP
alkylaryl NN I-NP
polyether JJ I-NP
alcohol NN I-NP
polymer NN I-NP
detergent NN I-NP
previously RB B-VP
used VBN I-VP
as IN B-PP
a DT B-NP
mucolytic JJ I-NP
agent NN I-NP
in IN B-PP
adult JJ B-NP
chronic JJ I-NP
bronchitis NN I-NP
. . O

Tyloxapol NN B-NP
inhibits VBZ B-VP
activation NN B-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
nuclear JJ B-NP
factor-kappa NN I-NP
B NN I-NP
( ( O
NK-kappa NN B-NP
B NN I-NP
) ) O
COMMA COMMA O
reduces VBZ B-VP
resting VBG B-NP
secretion NN I-NP
of IN B-PP
the DT B-NP
cytokine NN I-NP
interleukin-8 NN B-NP
( ( O
IL-8 NN B-NP
) ) O
in IN B-PP
cultured VBN B-NP
human JJ I-NP
monocytes NNS I-NP
COMMA COMMA O
and CC O
inhibits VBZ B-VP
lipopolysaccharide NN B-NP
( ( I-NP
LPS NN I-NP
) ) I-NP
-stimulated JJ I-NP
release NN I-NP
of IN B-PP
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
( ( O
TNF-alpha NN B-NP
) ) O
COMMA COMMA O
IL-1 NN B-NP
beta NN I-NP
COMMA COMMA O
IL-6 NN B-NP
COMMA COMMA O
IL-8 NN B-NP
COMMA COMMA O
granulocyte-macrophage JJ B-NP
colony-stimulating JJ I-NP
factor NN I-NP
( ( O
GM-CSF NN B-NP
) ) O
COMMA COMMA O
and CC O
the DT B-NP
eiconsanoids NNS I-NP
thromboxane NN B-NP
A2 NN I-NP
and CC O
leukotriene NN B-NP
B4 NN I-NP
( ( O
LTB4 NN B-NP
) ) O
. . O

We PRP B-NP
have VBP B-VP
previously RB I-VP
shown VBN I-VP
that IN B-SBAR
tyloxapol NN B-NP
is VBZ B-VP
a DT B-NP
potent JJ I-NP
antioxidant NN I-NP
for IN B-PP
hydroxyl NN B-NP
radicals NNS I-NP
( ( O
OH NN B-NP
) ) O
. . O

Tyloxapol NN B-NP
( ( O
0.05 CD B-NP
to TO I-NP
0.1 CD I-NP
% NN I-NP
wt\/vol NN I-NP
) ) O
effectively RB B-ADVP
scavenges VBZ B-VP
the DT B-NP
oxidant JJ I-NP
hypochlorous JJ I-NP
acid NN I-NP
( ( O
HOCl NN B-NP
; : O
1 CD B-NP
to TO I-NP
7.5 CD I-NP
mM NN I-NP
) ) O
in FW B-ADVP
vitro FW I-ADVP
COMMA COMMA O
and CC O
protects VBZ B-VP
from IN B-PP
HOCl-mediated JJ B-NP
lung NN I-NP
injury NN I-NP
in IN B-PP
rats NNS B-NP
. . O

Tyloxapol NN B-NP
also RB B-ADVP
reduces VBZ B-VP
the DT B-NP
viscosity NN I-NP
of IN B-PP
CF NN B-NP
sputum NN I-NP
( ( O
from IN B-PP
463 CD B-NP
+\/- CC I-NP
133 CD I-NP
to TO B-PP
128 CD B-NP
+\/- CC I-NP
52 CD I-NP
centipoise NN B-NP
) ) O
. . O

We PRP B-NP
conclude VBP B-VP
that IN B-SBAR
tyloxapol NN B-NP
is VBZ B-VP
potentially RB B-ADVP
useful JJ B-ADJP
as IN B-PP
a DT B-NP
new JJ I-NP
antiinflammatory JJ I-NP
therapy NN I-NP
for IN B-PP
CF NN B-NP
lung NN I-NP
disease NN I-NP
COMMA COMMA O
and CC O
could MD B-VP
possibly RB I-VP
promote VB I-VP
clearance NN B-NP
of IN B-PP
secretions NNS B-NP
in IN B-PP
the DT B-NP
CF NN I-NP
airway NN I-NP
. . O

Abnormality NN B-NP
of IN B-PP
Oct-1 NN B-NP
DNA NN I-NP
binding NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
from IN B-PP
Sjogren NN B-NP
's POS B-NP
syndrome NN I-NP
patients NNS I-NP
. . O

Primary JJ B-NP
Sjogren NN B-NP
's POS B-NP
syndrome NN I-NP
( ( O
SS NN B-NP
) ) O
is VBZ B-VP
an DT B-NP
autoimmune JJ I-NP
rheumatic JJ I-NP
disease NN I-NP
characterized VBN B-VP
by IN B-PP
T NN B-NP
cell NN I-NP
hypoactivity NN I-NP
. . O

To TO B-VP
understand VB I-VP
the DT B-NP
diminished VBN I-NP
T NN I-NP
cell NN I-NP
response NN I-NP
to TO B-PP
activation NN B-NP
signals NNS I-NP
COMMA COMMA O
we PRP B-NP
measured VBD B-VP
nucleoprotein NN B-NP
DNA-binding JJ I-NP
activities NNS I-NP
regulating VBG B-VP
gene NN B-NP
expression NN I-NP
during IN B-PP
T NN B-NP
cell NN I-NP
activation NN I-NP
using VBG B-VP
the DT B-NP
electrophoretic JJ I-NP
mobility NN I-NP
shift NN I-NP
assay NN I-NP
. . O

Peripheral JJ B-NP
blood NN I-NP
lymphocytes NNS I-NP
from IN B-PP
9\/19 CD B-NP
SS NN I-NP
patients NNS I-NP
were VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
defective JJ B-ADJP
in IN B-PP
their PRP$ B-NP
ability NN I-NP
to TO B-VP
bind VB I-VP
an DT B-NP
october NN I-NP
sequence NN I-NP
( ( O
Oct-1 NN B-NP
) ) O
. . O

This DT B-NP
Oct-1-binding JJ I-NP
phenotype NN I-NP
remained VBD B-VP
stable JJ B-ADJP
in IN B-PP
culture NN B-NP
for IN B-PP
up IN B-NP
to TO I-NP
3 CD I-NP
days NNS I-NP
prior RB B-PP
to TO I-PP
activation NN B-NP
. . O

This DT B-NP
abnormality NN I-NP
was VBD B-VP
not RB I-VP
seen VBN I-VP
in IN B-PP
resting VBG B-NP
T NN I-NP
cells NNS I-NP
nor CC O
T NN B-NP
cells NNS I-NP
from IN B-PP
patients NNS B-NP
with IN B-PP
systemic JJ B-NP
lupus NN I-NP
erythematosus NN I-NP
COMMA COMMA O
rheumatoid JJ B-NP
arthritis NN I-NP
( ( O
RA NN B-NP
) ) O
COMMA COMMA O
or CC O
SS NN B-NP
accompanied VBN B-VP
by IN B-PP
RA NN B-NP
. . O

The DT B-NP
SS NN I-NP
Oct-1 NN I-NP
DNA-binding JJ I-NP
abnormality NN I-NP
correlated VBD B-VP
significantly RB B-ADVP
with IN B-PP
an DT B-NP
inability NN I-NP
of IN B-PP
cells NNS B-NP
to TO B-VP
exit VB I-VP
the DT B-NP
Gzero\/G1 NN I-NP
cell NN I-NP
cycle NN I-NP
phase NN I-NP
when WRB B-ADVP
stimulated VBN B-VP
in FW B-ADVP
vitro FW I-ADVP
. . O

Importantly RB B-ADVP
COMMA COMMA O
nucleoprotein NN B-NP
extracts NNS I-NP
showing VBG B-VP
decreased VBN B-NP
DNA-binding JJ I-NP
activity NN I-NP
had VBD B-VP
normal JJ B-NP
amounts NNS I-NP
of IN B-PP
Oct-1 NN B-NP
proteins NNS I-NP
as IN B-SBAR
determined VBN B-VP
by IN B-PP
immunoprecipitation NN B-NP
COMMA COMMA O
implying VBG B-VP
a DT B-NP
functional JJ I-NP
defect NN I-NP
in IN B-PP
the DT B-NP
Oct-1 NN I-NP
protein NN I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
defective JJ B-NP
DNA NN I-NP
binding NN I-NP
was VBD B-VP
corrected VBN I-VP
by IN B-PP
treatment NN B-NP
with IN B-PP
acid NN B-NP
phosphatase NN I-NP
. . O

Severe JJ B-NP
combined JJ I-NP
immunodeficiency NN I-NP
due IN B-PP
to TO I-PP
defective JJ B-NP
binding NN I-NP
of IN B-PP
the DT B-NP
nuclear JJ I-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
in IN B-PP
T NN B-NP
lymphocytes NNS I-NP
of IN B-PP
two CD B-NP
male JJ I-NP
siblings NNS I-NP
. . O

Peripheral JJ B-NP
blood NN I-NP
lymphocytes NNS I-NP
( ( O
PBL NN B-NP
) ) O
and CC O
alloreactive JJ B-NP
T NN I-NP
cell NN I-NP
lines NNS I-NP
of IN B-PP
two CD B-NP
male JJ I-NP
infants NNS I-NP
born VBN B-VP
to TO B-PP
consanguinous JJ B-NP
parents NNS I-NP
and CC O
presenting VBG B-VP
with IN B-PP
severe JJ B-NP
combined JJ I-NP
immunodeficiency NN I-NP
( ( O
SCID NN B-NP
) ) O
showed VBD B-VP
a DT B-NP
pronounced JJ I-NP
deficiency NN I-NP
in IN B-PP
T NN B-NP
cell NN I-NP
activation NN I-NP
. . O

Although IN B-SBAR
phenotypically RB B-ADJP
normal JJ I-ADJP
COMMA COMMA O
the DT B-NP
proliferative JJ I-NP
response NN I-NP
of IN B-PP
the DT B-NP
childrens NNS I-NP
' POS B-NP
T NN I-NP
cells NNS I-NP
was VBD B-VP
strongly RB I-VP
reduced VBN I-VP
but CC O
could MD B-VP
be VB I-VP
improved VBN I-VP
by IN B-PP
the DT B-NP
addition NN I-NP
of IN B-PP
interleukin-2 NN B-NP
( ( O
IL-2 NN B-NP
) ) O
. . O

Furthermore RB B-ADVP
both DT B-NP
childrens NNS I-NP
' POS B-NP
T NN I-NP
cells NNS I-NP
were VBD B-VP
unable JJ B-ADJP
to TO B-VP
produce VB I-VP
the DT B-NP
cytokines NNS I-NP
IL-2 NN B-NP
COMMA COMMA O
interferon-gamma NN B-NP
( ( O
IFN-gamma NN B-NP
) ) O
COMMA COMMA O
IL-4 NN B-NP
and CC O
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
( ( O
TNF-alpha NN B-NP
) ) O
. . O

This DT B-NP
multiple JJ I-NP
cytokine NN I-NP
production NN I-NP
deficiency NN I-NP
could MD B-VP
not RB I-VP
be VB I-VP
restored VBN I-VP
by IN B-PP
IL-2 NN B-NP
or CC O
co-stimulatory JJ B-ADJP
signals NNS B-NP
provided VBN B-VP
by IN B-PP
antigen-presenting JJ B-NP
cells NNS I-NP
( ( O
APC NN B-NP
) ) O
. . O

Moreover RB B-ADVP
COMMA COMMA O
mRNA NN B-NP
for IN B-PP
IL-2 NN B-NP
and CC O
IFN-gamma NN B-NP
could MD B-VP
not RB I-VP
be VB I-VP
detected VBN I-VP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
expression NN B-NP
of IN B-PP
the DT B-NP
activation-dependent JJ I-NP
cell NN I-NP
surface NN I-NP
markers NNS I-NP
CD25 NN B-NP
and CC O
CD69 NN B-NP
was VBD B-VP
within IN B-PP
normal JJ B-NP
limits NNS I-NP
. . O

To TO B-VP
determine VB I-VP
whether IN B-SBAR
the DT B-NP
functional JJ I-NP
defect NN I-NP
of IN B-PP
the DT B-NP
patients NNS I-NP
' POS B-NP
T NN I-NP
cells NNS I-NP
was VBD B-VP
due JJ B-PP
to TO I-PP
the DT B-NP
absence NN B-NP
or CC O
abnormal JJ B-NP
binding NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
involved VBN B-VP
in IN B-PP
cytokine NN B-NP
gene NN I-NP
expression NN I-NP
COMMA COMMA O
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
were VBD B-VP
used VBN I-VP
to TO B-VP
examine VB I-VP
the DT B-NP
DNA NN I-NP
binding NN I-NP
of IN B-PP
AP-1 NN B-NP
COMMA COMMA O
Oct NN B-NP
COMMA COMMA O
CREB NN B-NP
COMMA COMMA O
SP1 NN B-NP
COMMA COMMA O
NF-kappa NN B-NP
B NN I-NP
and CC O
the DT B-NP
nuclear JJ I-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
( ( O
NF-AT NN B-NP
) ) O
to TO B-PP
their PRP$ B-NP
respective JJ I-NP
response NN I-NP
elements NNS I-NP
in IN B-PP
the DT B-NP
promoter NN I-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
gene NN I-NP
. . O

Whereas IN B-SBAR
AP-1 NN B-NP
COMMA COMMA O
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
Oct NN B-NP
COMMA COMMA O
CREB NN B-NP
and CC O
SP1 NN B-NP
displayed VBD B-VP
normal JJ B-NP
binding NN I-NP
activities NNS I-NP
in IN B-PP
nuclear JJ B-NP
extracts NNS I-NP
COMMA COMMA O
the DT B-NP
binding NN I-NP
of IN B-PP
NF-AT NN B-NP
to TO B-PP
its PRP$ B-NP
IL-2 NN I-NP
promoter NN I-NP
response NN I-NP
element NN I-NP
was VBD B-VP
barely RB B-ADJP
detectable JJ I-ADJP
both CC O
before IN B-PP
and CC B-PP
after IN B-PP
T NN B-NP
cell NN I-NP
stimulation NN I-NP
. . O

Our PRP$ B-NP
results NNS I-NP
strongly RB B-ADVP
suggest VBP B-VP
that IN B-SBAR
this DT B-NP
NF-AT\/DNA NN I-NP
binding NN I-NP
defect NN I-NP
is VBZ B-VP
responsible JJ B-ADJP
for IN B-PP
the DT B-NP
multiple JJ I-NP
cytokine NN I-NP
deficiency NN I-NP
and CC O
the DT B-NP
SCID NN I-NP
phenotype NN I-NP
observed VBN B-VP
in IN B-PP
the DT B-NP
two CD I-NP
infant JJ I-NP
brothers NNS I-NP
. . O

Requirements NNS B-NP
for IN B-PP
induction NN B-NP
of IN B-PP
vitamin NN B-NP
D-mediated JJ I-NP
gene NN I-NP
regulation NN I-NP
in IN B-PP
normal JJ B-NP
human JJ I-NP
B NN I-NP
lymphocytes NNS I-NP
. . O

Mature JJ B-NP
human JJ I-NP
lymphocytes NNS I-NP
are VBP B-VP
unique JJ B-NP
targets NNS I-NP
of IN B-PP
1 CD B-NP
alphaCOMMA25-dihydroxyvitamin NN I-NP
D3 NN I-NP
( ( O
1 CD B-NP
alphaCOMMA25(OH)2D3 NN I-NP
) ) O
in IN B-PP
that IN B-SBAR
vitamin NN B-NP
D NN I-NP
receptors NNS I-NP
( ( O
VDR NN B-NP
) ) O
are VBP B-VP
not RB I-VP
constitutively RB I-VP
expressed VBN I-VP
COMMA COMMA O
and CC O
specific JJ B-NP
cellular JJ I-NP
activation NN I-NP
signals NNS I-NP
are VBP B-VP
required VBN I-VP
for IN B-PP
both DT B-NP
the DT I-NP
up-regulation NN B-NP
of IN B-PP
VDR NN B-NP
and CC O
establishment NN B-NP
of IN B-PP
reactivity NN B-NP
to TO B-PP
the DT B-NP
lipophilic JJ I-NP
ligand NN I-NP
. . O

Treatment NN B-NP
of IN B-PP
B NN B-NP
lymphocytes NNS I-NP
with IN B-PP
the DT B-NP
cytokine NN I-NP
IL-4 NN I-NP
( ( O
IL-4 NN B-NP
) ) O
COMMA COMMA O
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
prior JJ B-NP
activation NN I-NP
COMMA COMMA O
induces VBZ B-VP
a DT B-NP
weak JJ I-NP
up-regulation NN I-NP
of IN B-PP
VDR NN B-NP
expression NN I-NP
but CC O
fails VBZ B-VP
to TO B-VP
generate VB I-VP
vitamin NN B-NP
D-responsive JJ I-NP
element NN I-NP
( ( B-NP
VDRE NN I-NP
) ) I-NP
-reactive JJ I-NP
nuclear JJ I-NP
protein NN I-NP
complexes NNS I-NP
or CC O
to TO B-VP
initiate VB I-VP
the DT B-NP
genomic JJ I-NP
transcription NN I-NP
of IN B-PP
25-hydroxyvitamin NN B-NP
D3 NN I-NP
24-hydroxylase NN I-NP
. . O

Stimulation NN B-NP
of IN B-PP
B NN B-NP
lymphocytes NNS I-NP
by IN B-PP
either CC O
ligation NN B-NP
of IN B-PP
CD40 NN B-NP
Ag NN I-NP
or CC O
cross-linking VBG B-VP
the DT B-NP
Ig NN I-NP
receptor NN I-NP
is VBZ B-VP
also RB B-ADVP
insufficient JJ B-ADJP
to TO B-VP
render VB I-VP
B NN B-NP
lymphocytes NNS I-NP
responsive JJ B-ADJP
to TO B-PP
1 CD B-NP
alphaCOMMA25(OH)2D3 NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
this DT B-NP
apparent JJ I-NP
lack NN I-NP
of IN B-PP
response NN B-NP
to TO B-PP
the DT B-NP
secosterol NN I-NP
can MD B-VP
be VB I-VP
overcome VBN I-VP
by IN B-PP
stimulation NN B-NP
of IN B-PP
B NN B-NP
lymphocytes NNS I-NP
with IN B-PP
a DT B-NP
combination NN I-NP
of IN B-PP
these DT B-NP
cellular JJ I-NP
activation NN I-NP
signals NNS I-NP
COMMA COMMA O
which WDT B-NP
are VBP B-VP
sufficient JJ B-ADJP
to TO B-VP
lead VB I-VP
to TO B-PP
G1 NN B-NP
cell NN I-NP
cycle NN I-NP
progression NN I-NP
. . O

In IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
1 CD B-NP
alphaCOMMA25(OH)2D3 NN I-NP
COMMA COMMA O
cellular JJ B-NP
activation NN I-NP
associated VBN B-VP
with IN B-PP
stimulation NN B-NP
of IN B-PP
such PDT B-NP
a DT I-NP
progression NN I-NP
appears VBZ B-VP
to TO I-VP
be VB I-VP
sufficient JJ B-ADJP
for IN B-PP
the DT B-NP
up-regulation NN I-NP
of IN B-PP
VDR NN B-NP
message NN I-NP
and CC O
protein NN B-NP
and CC O
necessary JJ B-ADJP
for IN B-PP
the DT B-NP
establishment NN I-NP
of IN B-PP
VDRE NN B-NP
binding NN I-NP
complexes NNS I-NP
and CC O
the DT B-NP
induction NN I-NP
of IN B-PP
24-hydroxylase NN B-NP
message NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
biologic JJ B-NP
functions NNS I-NP
are VBP B-VP
modulated VBN I-VP
COMMA COMMA O
in IN B-PP
that IN B-NP
the DT B-NP
hormone NN I-NP
inhibits VBZ B-VP
proliferation NN B-NP
in IN B-PP
a DT B-NP
subset NN I-NP
of IN B-PP
the DT B-NP
activated VBN I-NP
B NN I-NP
cells NNS I-NP
. . O

These DT B-NP
observations NNS I-NP
suggest VBP B-VP
that IN B-SBAR
reactivity NN B-NP
to TO B-PP
1 CD B-NP
alphaCOMMA25(OH)2D3 NN I-NP
is VBZ B-VP
tightly RB I-VP
regulated VBN I-VP
in IN B-PP
B NN B-NP
lymphocytes NNS I-NP
COMMA COMMA O
requiring VBG B-VP
specific JJ B-NP
signals NNS I-NP
for IN B-PP
its PRP$ B-NP
initiation NN I-NP
. . O

Cell-type-specific JJ B-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
tumor NN I-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
gene NN I-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
and CC O
T NN B-NP
cells NNS I-NP
by IN B-PP
NFATp NN B-NP
and CC O
ATF-2\/JUN NN B-NP
. . O

The DT O
human JJ O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
( ( O
TNF-alpha NN B-NP
) ) O
gene NN B-NP
is VBZ B-VP
one CD B-NP
of IN B-PP
the DT B-NP
earliest JJS I-NP
genes NNS I-NP
transcribed VBN B-VP
after IN B-PP
the DT B-NP
stimulation NN I-NP
of IN B-PP
a DT B-NP
B NN I-NP
cell NN I-NP
through IN B-PP
its PRP$ B-NP
antigen NN I-NP
receptor NN I-NP
or CC B-PP
via IN B-PP
the DT B-NP
CD-40 NN I-NP
pathway NN I-NP
. . O

In IN B-PP
both DT B-NP
cases NNS I-NP
COMMA COMMA O
induction NN B-NP
of IN B-PP
TNF-alpha NN B-NP
gene NN I-NP
transcription NN I-NP
can MD B-VP
be VB I-VP
blocked VBN I-VP
by IN B-PP
the DT B-NP
immunosuppressants NNS I-NP
cyclosporin NN B-NP
A NN I-NP
and CC O
FK506 NN B-NP
COMMA COMMA O
which WDT B-NP
suggested VBD B-VP
a DT B-NP
role NN I-NP
for IN B-PP
the DT B-NP
NFAT NN I-NP
family NN I-NP
of IN B-PP
proteins NNS B-NP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
gene NN I-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
in IN B-PP
T NN B-NP
cells NNS I-NP
COMMA COMMA O
two CD B-NP
molecules NNS I-NP
of IN B-PP
NFATp NN B-NP
bind VBP B-VP
to TO B-PP
the DT B-NP
TNF-alpha NN I-NP
promoter NN I-NP
element NN I-NP
kappa NN I-NP
3 CD I-NP
in NN O
association NN B-NP
with IN B-PP
ATF-2 NN B-NP
and CC O
Jun NN B-NP
proteins NNS B-NP
bound VBN B-VP
to TO B-PP
an DT O
immediately RB O
adjacent JJ O
cyclic JJ B-NP
AMP NN I-NP
response NN I-NP
element NN I-NP
( ( O
CRE NN B-NP
) ) O
site NN B-NP
. . O

Here RB B-ADVP
COMMA COMMA O
using VBG B-VP
the DT B-NP
murine JJ I-NP
B-cell NN I-NP
lymphoma NN I-NP
cell NN I-NP
line NN I-NP
A20 NN I-NP
COMMA COMMA O
we PRP B-NP
show VBP B-VP
that IN B-SBAR
the DT B-NP
TNF-alpha NN I-NP
gene NN I-NP
is VBZ B-VP
regulated VBN I-VP
in IN B-PP
a DT B-NP
cell-type-specific JJ I-NP
manner NN I-NP
. . O

In IN B-PP
A20 NN B-NP
B NN I-NP
cells NNS I-NP
COMMA COMMA O
the DT B-NP
TNF-alpha NN I-NP
gene NN I-NP
is VBZ B-VP
not RB I-VP
regulated VBN I-VP
by IN B-PP
NFATp NN B-NP
bound VBN B-VP
to TO B-PP
the DT B-NP
kappa NN I-NP
3 CD I-NP
element NN I-NP
. . O

Instead RB B-ADVP
COMMA COMMA O
ATF-2 NN B-NP
and CC O
Jun NN B-NP
proteins NNS B-NP
bind VBP B-VP
to TO B-PP
the DT B-NP
composite JJ I-NP
kappa NN I-NP
3\/CRE NN I-NP
site NN I-NP
and CC O
NFATp NN B-NP
binds VBZ B-VP
to TO B-PP
a DT B-NP
newly RB I-NP
identified VBN I-NP
second JJ I-NP
NFAT NN I-NP
site NN I-NP
centered JJ B-VP
at IN B-PP
-76 CD B-NP
nucleotides NNS I-NP
relative JJ B-PP
to TO I-PP
the DT B-NP
TNF-alpha NN I-NP
transcription NN I-NP
start NN I-NP
site NN I-NP
. . O

This DT B-NP
new JJ I-NP
site NN I-NP
plays VBZ B-VP
a DT B-NP
critical JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
calcium-mediated JJ I-NP
COMMA COMMA I-NP
cyclosporin NN I-NP
A-sensitive JJ I-NP
induction NN I-NP
of IN B-PP
TNF-alpha NN B-NP
in IN B-PP
both CC O
A20 NN B-NP
B NN I-NP
cells NNS I-NP
and CC O
Ar-5 NN B-NP
cells NNS I-NP
. . O

Consistent JJ B-ADJP
with IN B-PP
these DT B-NP
results NNS I-NP
COMMA COMMA O
quantitative JJ B-NP
DNase NN I-NP
footprinting NN I-NP
of IN B-PP
the DT B-NP
TNF-alpha NN I-NP
promoter NN I-NP
using VBG B-VP
increasing VBG B-NP
amounts NNS I-NP
of IN B-PP
recombinant JJ B-NP
NFATp NN I-NP
demonstrated VBD B-VP
that IN B-SBAR
the DT B-NP
-76 CD I-NP
site NN I-NP
binds VBZ B-VP
to TO B-PP
NFATp NN B-NP
with IN B-PP
a DT B-NP
higher JJR I-NP
affinity NN I-NP
than IN B-PP
the DT B-NP
kappa NN I-NP
3 CD I-NP
site NN I-NP
. . O

Two CD B-NP
other JJ I-NP
previously RB I-NP
unrecognized JJ I-NP
NFATp-binding JJ I-NP
sites NNS I-NP
in IN B-PP
the DT B-NP
proximal JJ I-NP
TNF-alpha NN I-NP
promoter NN I-NP
were VBD B-VP
also RB I-VP
identified VBN I-VP
by IN B-PP
this DT B-NP
analysis NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
through IN B-PP
the DT B-NP
differential JJ I-NP
use NN I-NP
of IN B-PP
the DT B-NP
same JJ I-NP
promoter NN I-NP
element NN I-NP
COMMA COMMA O
the DT B-NP
composite JJ I-NP
kappa NN I-NP
3\/CRE NN I-NP
site NN I-NP
COMMA COMMA O
the DT B-NP
TNF-alpha NN I-NP
gene NN I-NP
is VBZ B-VP
regulated VBN I-VP
in IN B-PP
a DT B-NP
cell-type-specific JJ I-NP
manner NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
the DT B-NP
same JJ I-NP
extracellular JJ I-NP
signal NN I-NP
. . O

Analysis NN B-NP
of IN B-PP
the DT B-NP
ligand-binding JJ I-NP
domain NN I-NP
of IN B-PP
human JJ B-NP
retinoic JJ I-NP
acid NN I-NP
receptor NN I-NP
alpha NN I-NP
by IN B-PP
site-directed JJ B-NP
mutagenesis NN I-NP
. . O

Three CD B-NP
subtypes NNS I-NP
of IN B-PP
retinoic JJ B-NP
acid NN I-NP
receptors NNS I-NP
( ( O
RAR NN B-NP
) ) O
COMMA COMMA O
termed VBN B-VP
RAR NN B-NP
alpha NN I-NP
COMMA COMMA O
RAR NN B-NP
beta NN I-NP
COMMA COMMA O
and CC O
RAR NN B-NP
gamma NN I-NP
COMMA COMMA O
have VBP B-VP
been VBN I-VP
described VBN I-VP
. . O

They PRP B-NP
are VBP B-VP
composed VBN I-VP
of IN B-PP
different JJ B-NP
structural JJ I-NP
domains NNS I-NP
COMMA COMMA O
including VBG B-PP
distinct JJ B-NP
domains NNS I-NP
for IN B-PP
DNA NN B-NP
and CC O
ligand NN B-NP
binding NN B-NP
. . O

RARs NNS B-NP
specifically RB B-ADVP
bind VBP B-VP
all-trans-retinoic JJ B-NP
acid NN I-NP
( ( O
RA NN B-NP
) ) O
COMMA COMMA O
9-cis-RA NN B-NP
COMMA COMMA O
and CC O
retinoid JJ B-NP
analogs NNS I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
we PRP B-NP
examined VBD B-VP
the DT B-NP
functional JJ I-NP
role NN I-NP
of IN B-PP
cysteine NN B-NP
and CC O
arginine NN B-NP
residues NNS B-NP
in IN B-PP
the DT B-NP
ligand-binding JJ I-NP
domain NN I-NP
of IN B-PP
hRAR NN B-NP
alpha NN I-NP
( ( O
hRAR NN B-NP
alpha-LBD NN I-NP
COMMA COMMA O
amino NN B-NP
acids NNS I-NP
154 CD B-NP
to TO O
462 CD B-NP
) ) O
. . O

All DT O
conserved VBN O
cysteine NN B-NP
and CC O
arginine NN B-NP
residues NNS B-NP
in IN B-PP
this DT B-NP
domain NN I-NP
were VBD B-VP
mutated VBN I-VP
by IN B-PP
site-directed JJ B-NP
mutagenesis NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
mutant JJ I-NP
proteins NNS I-NP
were VBD B-VP
characterized VBN I-VP
by IN B-PP
blocking VBG B-NP
reactions NNS I-NP
COMMA COMMA O
ligand-binding JJ B-NP
experiments NNS I-NP
COMMA COMMA O
transactivation NN B-NP
assays NNS I-NP
COMMA COMMA O
and CC O
protease NN B-NP
mapping NN I-NP
. . O

Changes NNS B-NP
of IN B-PP
any DT B-NP
cysteine JJ I-NP
residue NN I-NP
of IN B-PP
the DT B-NP
hRAR NN I-NP
alpha-LBD NN I-NP
had VBD B-VP
no DT B-NP
significant JJ I-NP
influence NN I-NP
on IN B-PP
the DT B-NP
binding NN I-NP
of IN B-PP
all-trans JJ B-NP
RA NN I-NP
or CC O
9-cis JJ B-NP
RA NN I-NP
. . O

Interestingly RB B-NP
COMMA COMMA O
residue JJ B-NP
C-235 NN I-NP
is VBZ B-VP
specifically RB B-ADVP
important JJ B-ADJP
in IN B-PP
antagonist NN B-NP
binding NN I-NP
. . O

With IN B-PP
respect NN I-PP
to TO I-PP
arginine NN B-NP
residues NNS I-NP
COMMA COMMA O
only RB B-NP
the DT I-NP
two CD I-NP
single JJ I-NP
mutations NNS I-NP
of IN B-PP
R-276 NN B-NP
and CC O
R-394 NN B-NP
to TO B-PP
alanine NN B-NP
showed VBD B-VP
a DT B-NP
dramatic JJ I-NP
decrease NN I-NP
of IN B-PP
agonist NN B-NP
and CC O
antagonist NN B-NP
binding NN B-NP
whereas IN B-SBAR
the DT B-NP
R272A NN I-NP
mutation NN I-NP
showed VBD B-VP
only RB B-NP
a DT I-NP
slight JJ I-NP
effect NN I-NP
. . O

For IN B-PP
all DT B-NP
other JJ I-NP
arginine NN I-NP
mutations NNS I-NP
COMMA COMMA O
no DT B-NP
differences NNS I-NP
in IN B-PP
affinity NN B-NP
were VBD B-VP
detectable JJ B-ADJP
. . O

The DT B-NP
two CD I-NP
mutations NNS I-NP
R217A NN B-NP
and CC O
R294A NN B-NP
caused VBD B-VP
an DT B-NP
increased VBN I-NP
binding NN I-NP
efficiency NN I-NP
for IN B-PP
antagonists NNS B-NP
but CC O
no DT B-NP
change NN I-NP
in IN B-PP
agonist NN B-NP
binding NN I-NP
. . O

From IN B-PP
these DT B-NP
results NNS I-NP
COMMA COMMA O
we PRP B-NP
can MD B-VP
conclude VB I-VP
that IN B-SBAR
electrostatic JJ B-NP
interactions NNS I-NP
of IN B-PP
retinoids NNS B-NP
with IN B-PP
the DT B-NP
RAR NN I-NP
alpha-LBD NN I-NP
play VBP B-VP
a DT B-NP
significant JJ I-NP
role NN I-NP
in IN B-PP
ligand NN B-NP
binding NN I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
antagonists NNS B-NP
show VBP B-VP
distinctly RB B-NP
different JJ I-NP
requirements NNS I-NP
for IN B-PP
efficient JJ B-NP
binding NN I-NP
COMMA COMMA O
which WDT B-NP
may MD B-VP
contribute VB I-VP
to TO B-PP
their PRP$ B-NP
interference NN I-NP
in IN B-PP
the DT B-NP
ligand-inducible JJ I-NP
transactivation NN I-NP
function NN I-NP
of IN B-PP
RAR NN B-NP
alpha NN I-NP
. . O

Cloning NN B-NP
and CC O
characterization NN B-NP
of IN B-PP
the DT B-NP
beta NN I-NP
subunit NN I-NP
of IN B-PP
human JJ B-NP
proximal JJ I-NP
sequence NN I-NP
element-binding JJ I-NP
transcription NN I-NP
factor NN I-NP
and CC O
its PRP$ B-NP
involvement NN I-NP
in IN B-PP
transcription NN B-NP
of IN B-PP
small JJ B-NP
nuclear JJ I-NP
RNA NN I-NP
genes NNS I-NP
by IN B-PP
RNA NN B-NP
polymerases NNS I-NP
II CD B-NP
and CC O
III CD B-NP
. . O

The DT O
proximal JJ B-NP
sequence NN I-NP
element NN I-NP
( ( B-NP
PSE NN I-NP
) ) I-NP
-binding JJ I-NP
transcription NN I-NP
factor NN I-NP
( ( O
PTF NN B-NP
) ) O
COMMA COMMA O
which WDT B-NP
binds VBZ B-VP
the DT B-NP
PSE NN I-NP
of IN B-PP
both CC O
RNA NN B-NP
polymerase NN I-NP
II- NN I-NP
and CC O
RNA NN B-ADJP
polymerase NN I-ADJP
III-transcribed JJ I-ADJP
mammalian JJ O
small JJ B-NP
nuclear JJ I-NP
RNA NN I-NP
( ( O
snRNA NN B-NP
) ) O
genes NNS B-NP
COMMA COMMA O
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
their PRP$ B-NP
transcription NN I-NP
. . O

We PRP B-NP
previously RB B-ADVP
reported VBD B-VP
the DT B-NP
purification NN I-NP
of IN B-PP
human JJ B-NP
PTF NN I-NP
COMMA COMMA O
a DT B-NP
complex NN I-NP
of IN B-PP
four CD B-NP
subunits NNS I-NP
COMMA COMMA O
and CC O
the DT B-NP
molecular JJ B-NP
cloning NN I-NP
and CC O
characterization NN B-NP
of IN B-PP
PTF NN O
gamma NN B-NP
and CC O
delta NN B-NP
subunits NNS B-NP
. . O

Here RB B-ADVP
we PRP B-NP
describe VBP B-VP
the DT B-NP
isolation NN B-NP
and CC O
expression NN B-NP
of IN B-PP
a DT B-NP
cDNA NN I-NP
encoding VBG B-VP
PTF NN B-NP
beta NN I-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
functional JJ B-NP
studies NNS I-NP
using VBG B-VP
anti-PTF JJ B-NP
beta NN I-NP
antibodies NNS I-NP
. . O

Native JJ B-NP
PTF NN I-NP
beta NN I-NP
COMMA COMMA O
in IN B-PP
either CC O
protein NN B-NP
fractions NNS I-NP
or CC O
a DT B-NP
PTF-Oct-1-DNA NN I-NP
complex NN I-NP
COMMA COMMA O
can MD B-VP
be VB I-VP
recognized VBN I-VP
by IN B-PP
polyclonal JJ B-NP
antibodies NNS I-NP
raised VBN B-VP
against IN B-PP
recombinant JJ B-NP
PTF NN I-NP
beta NN I-NP
. . O

Immunodepletion NN B-NP
studies NNS I-NP
show VBP B-VP
that IN B-SBAR
PTF NN B-NP
beta NN I-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
transcription NN B-NP
of IN B-PP
both DT B-NP
classes NNS I-NP
of IN B-PP
snRNA NN B-NP
genes NNS I-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
immunoprecipitation NN B-NP
analyses NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
substantial JJ B-NP
and CC I-NP
similar JJ I-NP
molar JJ I-NP
amounts NNS I-NP
of IN B-PP
TATA-binding JJ B-NP
protein NN I-NP
( ( O
TBP NN B-NP
) ) O
and CC O
TFIIIB90 NN B-NP
can MD B-VP
weakly RB I-VP
associate VBP I-VP
with IN B-PP
PTF NN B-NP
at IN B-PP
low JJ B-NP
salt NN I-NP
conditions NNS I-NP
COMMA COMMA O
but CC O
this DT B-NP
association NN I-NP
is VBZ B-VP
dramatically RB I-VP
reduced VBN I-VP
at IN B-PP
high JJ B-NP
salt NN I-NP
concentrations NNS I-NP
. . O

Along IN B-PP
with IN I-PP
our PRP$ B-NP
previous JJ I-NP
demonstration NN I-NP
of IN B-PP
both DT B-NP
physical JJ I-NP
interactions NNS I-NP
between IN B-PP
PTF NN B-NP
gamma NN I-NP
\/ : O
PTF NN B-NP
delta NN I-NP
and CC O
TBP NN B-NP
and CC O
the DT B-NP
involvement NN I-NP
of IN B-PP
TFIIIB90 NN B-NP
in IN B-PP
the DT B-NP
transcription NN I-NP
of IN B-PP
class NN B-NP
III CD I-NP
snRNA NN I-NP
genes NNS I-NP
COMMA COMMA O
these DT B-NP
results NNS I-NP
are VBP B-VP
consistent JJ B-ADJP
with IN B-PP
the DT B-NP
notion NN I-NP
that IN B-SBAR
a DT B-NP
TBP-containing JJ I-NP
complex NN I-NP
related JJ B-ADJP
to TO B-PP
TFIIIB NN B-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
the DT B-NP
transcription NN I-NP
of IN B-PP
class NN B-NP
III CD I-NP
snRNA NN I-NP
genes NNS I-NP
COMMA COMMA O
and CC O
acts VBZ B-VP
through IN B-PP
weak JJ B-NP
interaction NN I-NP
with IN B-PP
the DT B-NP
four-subunit JJ I-NP
PTF NN I-NP
. . O

Induction NN B-NP
of IN B-PP
bcl-2 NN B-NP
expression NN I-NP
by IN B-PP
phosphorylated VBN B-NP
CREB NN I-NP
proteins NNS I-NP
during IN B-PP
B-cell NN B-NP
activation NN I-NP
and CC O
rescue NN B-NP
from IN B-PP
apoptosis NN B-NP
. . O

Engagement NN B-NP
of IN B-PP
surface NN B-NP
immunoglobulin NN I-NP
on IN B-PP
mature JJ B-NP
B NN I-NP
cells NNS I-NP
leads VBZ B-VP
to TO B-PP
rescue NN B-NP
from IN B-PP
apoptosis NN B-NP
and CC B-PP
to TO B-PP
proliferation NN B-NP
. . O

Levels NNS B-NP
of IN B-PP
bcl-2 NN B-NP
mRNA NN B-NP
and CC O
protein NN B-NP
increase VBP B-VP
with IN B-PP
cross-linking NN B-NP
of IN B-PP
surface NN B-NP
immunoglobulin NN I-NP
. . O

We PRP B-NP
have VBP B-VP
located JJ I-VP
the DT B-NP
major JJ I-NP
positive JJ I-NP
regulatory JJ I-NP
region NN I-NP
for IN B-PP
control NN B-NP
of IN B-PP
bcl-2 NN B-NP
expression NN I-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
in IN B-PP
the DT B-NP
5'-flanking JJ I-NP
region NN I-NP
. . O

The DT B-NP
positive JJ I-NP
region NN I-NP
can MD B-VP
be VB I-VP
divided VBN I-VP
into IN B-PP
an DT B-NP
upstream JJ I-NP
and CC O
a DT B-NP
downstream JJ I-NP
regulatory JJ B-NP
region NN I-NP
. . O

The DT B-NP
downstream JJ I-NP
regulatory JJ I-NP
region NN I-NP
contains VBZ B-VP
a DT B-NP
cyclic JJ I-NP
AMP-responsive JJ I-NP
element NN I-NP
( ( O
CRE NN B-NP
) ) O
. . O

We PRP B-NP
show VBP B-VP
by IN B-PP
antibody NN B-NP
supershift NN I-NP
experiments NNS I-NP
and CC O
UV NN B-NP
cross-linking NN I-NP
followed VBN B-VP
by IN B-PP
denaturing VBG B-NP
polyacrylamide NN I-NP
gel NN I-NP
electrophoresis NN I-NP
that IN B-SBAR
both CC O
CREB NN B-NP
and CC O
ATF NN B-NP
family NN B-NP
members NNS I-NP
bind VBP B-VP
to TO B-PP
this DT B-NP
region NN I-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

Mutations NNS B-NP
of IN B-PP
the DT B-NP
CRE NN I-NP
site NN I-NP
that WDT B-NP
result VBP B-VP
in IN B-PP
loss NN B-NP
of IN B-PP
CREB NN B-NP
binding NN I-NP
also RB B-ADVP
lead VBP B-VP
to TO B-PP
loss NN B-NP
of IN B-PP
functional JJ B-NP
activity NN I-NP
of IN B-PP
the DT B-NP
bcl-2 NN I-NP
promoter NN I-NP
in IN B-PP
transient-transfection NN B-NP
assays NNS I-NP
. . O

The DT B-NP
presence NN I-NP
of IN B-PP
an DT B-NP
active JJ I-NP
CRE NN I-NP
site NN I-NP
in IN B-PP
the DT B-NP
bcl-2 NN I-NP
promoter NN I-NP
implies VBZ B-VP
that IN B-SBAR
the DT B-NP
regulation NN I-NP
of IN B-PP
bcl-2 NN B-NP
expression NN I-NP
is VBZ B-VP
linked VBN I-VP
to TO B-PP
a DT B-NP
signal NN I-NP
transduction NN I-NP
pathway NN I-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
. . O

Treatment NN B-NP
of IN B-PP
the DT B-NP
mature JJ I-NP
B-cell NN I-NP
line NN I-NP
BAL-17 NN I-NP
with IN B-PP
either CC O
anti-immunoglobulin JJ B-NP
M NN I-NP
or CC O
phorbol NN B-NP
12-myristate NN I-NP
13-acetate NN I-NP
leads VBZ B-VP
to TO B-PP
an DT B-NP
increase NN I-NP
in IN B-PP
bcl-2 NN B-NP
expression NN I-NP
that WDT B-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
the DT B-NP
CRE NN I-NP
site NN I-NP
. . O

Treatment NN B-NP
of IN B-PP
the DT B-NP
more RBR I-NP
immature JJ I-NP
B-cell NN I-NP
line NN I-NP
COMMA COMMA O
Ramos NN B-NP
COMMA COMMA O
with IN B-PP
phorbol NN B-NP
esters NNS I-NP
rescues VBZ B-VP
the DT B-NP
cells NNS I-NP
from IN B-PP
calcium-dependent JJ B-NP
apoptosis NN I-NP
. . O

bcl-2 NN B-NP
expression NN I-NP
is VBZ B-VP
increased VBN I-VP
following VBG B-PP
phorbol NN B-NP
ester NN I-NP
treatment NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
increased VBN I-NP
expression NN I-NP
is VBZ B-VP
dependent JJ B-ADJP
on IN B-PP
the DT B-NP
CRE NN I-NP
site NN I-NP
. . O

These DT B-NP
stimuli NNS I-NP
result VBP B-VP
in IN B-PP
phosphorylation NN B-NP
of IN B-PP
CREB NN B-NP
at IN B-PP
serine NN B-NP
133 CD I-NP
. . O

The DT B-NP
phosphorylation NN I-NP
of IN B-PP
CREB NN B-NP
that WDT B-NP
results VBZ B-VP
in IN B-PP
activation NN B-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
rather RB B-CONJP
than IN I-CONJP
by IN B-PP
protein NN B-NP
kinase NN I-NP
A NN I-NP
. . O

Although IN B-SBAR
the DT B-NP
CRE NN I-NP
site NN I-NP
is VBZ B-VP
necessary JJ B-ADJP
COMMA COMMA O
optimal JJ B-NP
induction NN I-NP
of IN B-PP
bcl-2 NN B-NP
expression NN I-NP
requires VBZ B-VP
participation NN B-NP
of IN B-PP
the DT B-NP
upstream JJ I-NP
regulatory JJ I-NP
element NN I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
phosphorylation NN B-NP
of IN B-PP
CREB NN B-NP
alters VBZ B-VP
its PRP$ B-NP
interaction NN I-NP
with IN B-PP
the DT B-NP
upstream JJ I-NP
regulatory JJ I-NP
element NN I-NP
. . O

The DT B-NP
CRE NN I-NP
site NN I-NP
in IN B-PP
the DT B-NP
bcl-2 NN I-NP
promoter NN I-NP
appears VBZ B-VP
to TO I-VP
play VB I-VP
a DT B-NP
major JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
bcl-2 NN B-NP
expression NN I-NP
during IN B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
mature JJ B-NP
B NN I-NP
cells NNS I-NP
and CC B-PP
during IN B-PP
the DT B-NP
rescue NN I-NP
of IN B-PP
immature JJ B-NP
B NN I-NP
cells NNS I-NP
from IN B-PP
apoptosis NN B-NP
. . O

It PRP B-NP
is VBZ B-VP
possible JJ B-ADJP
that IN B-SBAR
the DT B-NP
CRE NN I-NP
site NN I-NP
is VBZ B-VP
responsible JJ B-ADJP
for IN B-PP
induction NN B-NP
of IN B-PP
bcl-2 NN B-NP
expression NN I-NP
in IN B-PP
other JJ B-NP
cell NN I-NP
types NNS I-NP
COMMA COMMA O
particularly RB B-NP
those DT I-NP
in IN B-PP
which WDT B-NP
protein NN B-NP
kinase NN I-NP
C NN I-NP
is VBZ B-VP
involved VBN I-VP
. . O

Interleukin-6 NN B-NP
promotes VBZ B-VP
multiple JJ B-NP
myeloma NN I-NP
cell NN I-NP
growth NN I-NP
via IN B-PP
phosphorylation NN B-NP
of IN B-PP
retinoblastoma NN B-NP
protein NN I-NP
. . O

Interleukin-6 NN B-NP
( ( O
IL-6 NN B-NP
) ) O
mediates VBZ B-VP
autocrine NN B-NP
and CC I-NP
paracrine NN I-NP
growth NN I-NP
of IN B-PP
multiple JJ B-NP
myeloma NN I-NP
( ( O
MM NN B-NP
) ) O
cells NNS B-NP
and CC O
inhibits VBZ B-VP
tumor NN B-NP
cell NN I-NP
apoptosis NN I-NP
. . O

Abnormalities NNS B-NP
of IN B-PP
retinoblastoma NN B-NP
protein NN I-NP
( ( O
pRB NN B-NP
) ) O
and CC O
mutations NNS B-NP
of IN B-PP
RB NN B-NP
gene NN I-NP
have VBP B-VP
been VBN I-VP
reported VBN I-VP
in IN B-PP
up IN B-NP
to TO I-NP
70 CD I-NP
% NN I-NP
of IN B-PP
MM NN B-NP
patients NNS I-NP
and CC O
80 CD B-NP
% NN I-NP
of IN B-PP
MM-derived JJ B-NP
cell NN I-NP
lines NNS I-NP
. . O

Because IN B-SBAR
dephosphorylated VBN O
( ( O
activated VBN B-ADJP
) ) O
pRB NN B-NP
blocks VBZ B-VP
transition NN B-NP
from IN B-PP
G1 NN B-NP
to TO B-PP
S NN B-NP
phase NN B-NP
of IN B-PP
the DT B-NP
cell NN I-NP
cycle NN I-NP
whereas IN O
phosphorylated VBN O
( ( O
inactivated VBN B-ADJP
) ) O
pRB NN B-NP
releases VBZ B-VP
this DT B-NP
growth NN I-NP
arrest NN I-NP
COMMA COMMA O
we PRP B-NP
characterized VBD B-VP
the DT B-NP
role NN I-NP
of IN B-PP
pRB NN B-NP
in IN B-PP
IL-6-mediated JJ B-NP
MM NN I-NP
cell NN I-NP
growth NN I-NP
. . O

Both CC B-NP
phosphorylated VBN I-NP
and CC I-NP
dephosphorylated VBN I-NP
pRB NN I-NP
were VBD B-VP
expressed VBN I-VP
in IN B-PP
all DT B-NP
serum-starved JJ B-NP
MM NN I-NP
patient NN I-NP
cells NNS I-NP
and CC O
MM-derived JJ B-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
but CC O
pRB NN B-NP
was VBD B-VP
predominantly RB B-ADVP
in IN B-PP
its PRP$ B-NP
phosphorylated JJ I-NP
form NN I-NP
. . O

In IN B-PP
MM NN B-NP
cells NNS I-NP
that WDT B-NP
proliferated VBD B-VP
in IN B-PP
response NN I-PP
to TO I-PP
IL-6 NN B-NP
COMMA COMMA O
exogenous JJ B-NP
IL-6 NN I-NP
downregulated VBD B-VP
dephosphorylated VBN B-NP
pRB NN I-NP
and CC O
decreased VBD B-VP
dephosphorylated VBN B-NP
pRB-E2F NN I-NP
complexes NNS I-NP
. . O

Importantly RB B-ADVP
COMMA COMMA O
culture NN B-NP
of IN B-PP
MM NN B-NP
cells NNS I-NP
with IN B-PP
RB NN B-NP
antisense JJ I-NP
COMMA COMMA I-NP
but CC I-NP
not RB I-NP
RB NN I-NP
sense NN I-NP
COMMA COMMA O
oligonucleotide NN B-NP
( ( O
ODN NN B-NP
) ) O
triggered VBD B-VP
IL-6 NN B-NP
secretion NN B-NP
and CC O
proliferation NN B-NP
in IN B-PP
MM NN B-NP
cells NNS I-NP
; : O
however RB B-ADVP
COMMA COMMA O
proliferation NN B-NP
was VBD B-VP
only RB I-VP
partially RB I-VP
inhibited VBN I-VP
by IN B-PP
neutralizing VBG B-VP
anti-IL-6 JJ B-NP
monoclonal JJ B-NP
antibody NN I-NP
( ( O
MoAb NN B-NP
) ) O
. . O

In IN B-PP
contrast NN I-PP
to TO I-PP
MM NN B-NP
cells NNS I-NP
COMMA COMMA O
normal JJ B-NP
splenic JJ I-NP
B NN I-NP
cells NNS I-NP
express VBP B-VP
dephosphorylated VBN B-NP
pRB NN I-NP
. . O

Although IN B-SBAR
CD40 NN B-NP
ligand NN I-NP
( ( O
CD40L NN B-NP
) ) O
triggers VBZ B-VP
a DT B-NP
shift NN I-NP
from IN B-PP
dephosphorylated VBN B-NP
to TO B-PP
phosphorylated VBN B-NP
pRB NN B-NP
and CC O
proliferation NN B-NP
of IN B-PP
B NN B-NP
cells NNS I-NP
COMMA COMMA O
the DT B-NP
addition NN I-NP
of IN B-PP
exogenous JJ B-NP
IL-6 NN I-NP
to TO B-PP
CD40L-treated JJ B-NP
B NN I-NP
cells NNS I-NP
does VBZ B-VP
not RB I-VP
alter VB I-VP
either CC O
pRB NN B-NP
or CC O
proliferation NN B-NP
COMMA COMMA O
as IN B-SBAR
observed VBN B-VP
in IN B-PP
MM NN B-NP
cells NNS I-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
phosphorylated VBN B-NP
pRB NN I-NP
is VBZ B-VP
constitutively RB I-VP
expressed VBN I-VP
in IN B-PP
MM JJ B-NP
cells NNS I-NP
and CC O
that IN B-SBAR
IL-6 NN B-NP
further RB B-ADVP
shifts VBZ B-VP
pRB NN B-NP
from IN B-PP
its PRP$ B-NP
dephosphorylated JJ I-NP
to TO B-PP
its PRP$ B-NP
phosphorylated JJ I-NP
form NN B-NP
COMMA COMMA O
thereby RB B-ADVP
promoting VBG B-VP
MM NN B-NP
cell NN I-NP
growth NN I-NP
via IN B-PP
two CD B-NP
mechanisms NNS I-NP
; : O
by IN B-PP
decreasing VBG B-VP
the DT B-NP
amount NN I-NP
of IN B-PP
E2F NN B-NP
bound VBN B-VP
by IN B-PP
dephosphorylated VBN B-NP
pRB NN I-NP
due IN B-PP
to TO I-PP
reduced VBN B-NP
dephosphorylated VBN I-NP
pRB NN I-NP
COMMA COMMA O
thereby RB B-ADVP
releasing VBG B-VP
growth NN B-NP
arrest NN I-NP
; : B-PP
and CC I-PP
by IN B-PP
upregulating VBG B-VP
IL-6 NN B-NP
secretion NN I-NP
by IN B-PP
MM NN B-NP
cells NNS I-NP
and CC O
related JJ B-NP
IL-6-mediated JJ I-NP
autocrine JJ I-NP
tumor NN I-NP
cell NN I-NP
growth NN I-NP
. . O

JNK NN B-NP
( ( O
c-Jun NN B-NP
NH2-terminal JJ I-NP
kinase NN I-NP
) ) O
is VBZ B-VP
a DT B-NP
target NN I-NP
for IN B-PP
antioxidants NNS B-NP
in IN B-PP
T NN B-NP
lymphocytes NNS I-NP
. . O

AP-1 NN B-NP
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
behave VB I-VP
as IN B-PP
a DT B-NP
redox-sensitive JJ I-NP
transcription NN I-NP
factor NN I-NP
that WDT B-NP
can MD B-VP
be VB I-VP
activated VBN I-VP
by IN B-PP
both CC B-NP
oxidant JJ I-NP
and CC I-NP
antioxidant JJ I-NP
stimuli NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
mechanisms NNS I-NP
involved VBN B-VP
in IN B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
AP-1 NN B-NP
by IN B-PP
antioxidants NNS B-NP
are VBP B-VP
largely RB B-ADJP
unknown JJ I-ADJP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
we PRP B-NP
show VBP B-VP
that IN B-SBAR
the DT B-NP
structurally RB I-NP
unrelated JJ I-NP
antioxidant JJ I-NP
agents NNS I-NP
pyrrolidine NN B-NP
dithiocarbamate NN I-NP
( ( O
PDTC NN B-NP
) ) O
COMMA COMMA O
butylated VBN B-NP
hydroxyanisole NN I-NP
COMMA COMMA O
and CC O
Nacetylcysteine NN B-NP
activated VBD B-VP
JNK NN B-NP
( ( O
c-Jun NN B-NP
NH2-terminal JJ I-NP
kinase NN I-NP
) ) O
in IN B-PP
Jurkat NN B-NP
T NN I-NP
cells NNS I-NP
. . O

This DT B-NP
activation NN I-NP
differed VBD B-VP
substantially RB B-ADVP
from IN B-PP
that DT B-NP
mediated VBN B-VP
by IN B-PP
phorbol NN B-NP
12-myristate NN I-NP
13-acetate NN I-NP
( ( O
PMA NN B-NP
) ) O
and CC O
Ca2+ NN B-NP
ionophore NN I-NP
or CC O
produced VBN B-VP
by IN B-PP
costimulation NN B-NP
with IN B-PP
antibodies NNS B-NP
against IN B-PP
the DT B-NP
T NN B-NP
cell NN I-NP
receptor-CD3 NN I-NP
complex NN I-NP
and CC O
to TO O
CD28 NN B-NP
. . O

The DT B-NP
activation NN I-NP
of IN B-PP
JNK NN B-NP
by IN B-PP
classical JJ B-NP
T NN I-NP
cell NN I-NP
stimuli NNS I-NP
was VBD B-VP
transient JJ B-ADJP
COMMA COMMA O
whereas IN O
that DT B-NP
mediated VBN B-VP
by IN B-PP
PDTC NN B-NP
and CC O
butylated VBN B-NP
hydroxyanisole NN I-NP
( ( O
but CC B-CONJP
not RB I-CONJP
N-acetylcysteine NN B-NP
) ) O
was VBD B-VP
sustained JJ B-ADJP
. . O

The DT B-NP
kinetics NNS I-NP
of IN B-PP
JNK NN B-NP
activation NN I-NP
correlated VBD B-VP
with IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
c-jun NN B-NP
which WDT B-NP
was VBD B-VP
transient JJ B-ADJP
after IN B-PP
stimulation NN B-NP
with IN B-PP
PMA NN B-NP
plus CC O
ionophore NN B-NP
and CC O
prolonged VBD B-VP
in IN B-PP
response NN I-PP
to TO I-PP
PDTC NN B-NP
COMMA COMMA O
which WDT B-NP
also RB B-ADVP
transiently RB B-VP
induced VBD I-VP
c-fos NN B-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
JNK NN B-NP
activation NN I-NP
by IN B-PP
PMA NN B-NP
plus CC O
ionophore NN B-NP
was VBD B-VP
sensitive JJ B-ADJP
to TO B-PP
inhibitors NNS B-NP
of IN B-PP
signaling NN B-NP
pathways NNS I-NP
involving VBG B-VP
Ca2+ NN B-NP
COMMA COMMA O
protein NN B-NP
kinase NN I-NP
C NN I-NP
COMMA COMMA O
and CC O
tyrosine NN B-NP
phosphorylation NN B-NP
COMMA COMMA O
which WDT B-NP
failed VBD B-VP
to TO I-VP
inhibit VB I-VP
the DT B-NP
activation NN I-NP
mediated VBN B-VP
by IN B-PP
PDTC NN B-NP
. . O

Transfection NN B-NP
of IN B-PP
trans-dominant JJ B-NP
negative JJ I-NP
expression NN I-NP
vectors NNS I-NP
of IN B-PP
ras NN B-NP
and CC O
raf NN B-NP
COMMA COMMA O
together RB B-CONJP
with IN I-CONJP
AP-1-dependent JJ B-NP
reporter NN I-NP
constructs NNS I-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
Western NN B-NP
blot NN I-NP
analysis NN I-NP
using VBG B-VP
anti-ERK JJ O
( ( O
extracellular JJ B-NP
signal-regulated JJ I-NP
kinase NN I-NP
) ) O
antibodies NNS B-NP
COMMA COMMA O
indicated VBD B-VP
that IN B-SBAR
the DT B-NP
Ras\/Raf/ERK NN I-NP
pathway NN I-NP
did VBD B-VP
not RB I-VP
appear VB I-VP
to TO I-VP
mediate VB I-VP
the DT B-NP
effect NN I-NP
of IN B-PP
the DT B-NP
antioxidant NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
combined JJ I-NP
treatment NN I-NP
with IN B-PP
PDTC NN B-NP
and CC O
PMA NN B-NP
COMMA COMMA O
two CD B-NP
agents NNS I-NP
that WDT B-NP
synergize VBP B-VP
on IN B-PP
AP-1 NN B-NP
activation NN I-NP
COMMA COMMA O
resulted VBD B-VP
in IN B-PP
the DT B-NP
persistent JJ I-NP
phosphorylation NN I-NP
of IN B-PP
ERK-2 NN B-NP
. . O

In IN B-PP
conclusion NN B-NP
COMMA COMMA O
our PRP$ B-NP
results NNS I-NP
identify VBP B-VP
JNK NN B-NP
as IN B-PP
a DT B-NP
target NN I-NP
of IN B-PP
antioxidant JJ B-NP
agents NNS I-NP
which WDT B-NP
can MD B-VP
be VB I-VP
regulated VBN I-VP
differentially RB B-ADVP
under IN B-PP
oxidant JJ B-NP
and CC I-NP
antioxidant JJ I-NP
conditions NNS I-NP
. . O

Cytomegalovirus NN B-NP
modulates VBZ B-VP
interleukin-6 NN B-NP
gene NN I-NP
expression NN I-NP
. . O

Complications NNS B-NP
after IN B-PP
lung NN B-NP
transplantation NN I-NP
include VBP B-VP
the DT B-NP
development NN I-NP
of IN B-PP
rejection NN B-NP
and CC O
an DT B-NP
increased VBN I-NP
incidence NN I-NP
of IN B-PP
infection NN B-NP
COMMA COMMA O
particularly RB B-PP
with IN I-PP
cytomegalovirus NN B-NP
( ( O
CMV NN B-NP
) ) O
. . O

Several JJ B-NP
recent JJ I-NP
studies NNS I-NP
have VBP B-VP
suggested VBN I-VP
that IN B-SBAR
interleukin NN B-NP
( ( I-NP
IL NN I-NP
) ) I-NP
-6 CD I-NP
may MD B-VP
be VB I-VP
used VBN I-VP
to TO B-VP
detect VB I-VP
both CC O
infection NN B-NP
and CC O
rejection NN B-NP
after IN B-PP
lung NN B-NP
transplantation NN I-NP
. . O

In IN O
addition NN B-NP
COMMA COMMA O
IL-6 NN B-NP
may MD B-VP
play VB I-VP
a DT B-NP
role NN I-NP
in IN B-PP
the DT B-NP
development NN I-NP
of IN B-PP
bronchiolitis NN B-NP
obliterans NNS I-NP
after IN B-PP
transplantation NN B-NP
. . O

Because IN B-SBAR
CMV NN B-NP
is VBZ B-VP
also RB I-VP
associated VBN I-VP
with IN B-PP
the DT B-NP
development NN I-NP
of IN B-PP
bronchiolitis NN B-NP
obliterans NNS I-NP
after IN B-PP
transplantation NN B-NP
COMMA COMMA O
we PRP B-NP
determined VBD B-VP
whether IN B-SBAR
CMV NN B-NP
induces VBZ B-VP
IL-6 NN B-NP
gene NN I-NP
expression NN I-NP
. . O

We PRP B-NP
demonstrated VBD B-VP
that IN B-SBAR
CMV NN B-NP
infection NN I-NP
increased VBD B-VP
both CC O
IL-6 NN B-NP
protein NN I-NP
and CC O
mRNA NN B-NP
in IN B-PP
peripheral JJ B-NP
blood NN I-NP
mononuclear JJ I-NP
cells NNS I-NP
. . O

We PRP B-NP
also RB B-ADVP
demonstrated VBD B-VP
that IN B-SBAR
the DT B-NP
CMV NN I-NP
immediate JJ I-NP
early JJ I-NP
1 CD I-NP
gene NN I-NP
product NN I-NP
increased VBD B-VP
expression NN B-NP
of IN B-PP
the DT B-NP
IL-6 NN I-NP
promoter NN I-NP
. . O

This DT B-NP
effect NN I-NP
of IN B-PP
the DT B-NP
CMV NN I-NP
immediate JJ I-NP
early JJ I-NP
1 CD I-NP
gene NN I-NP
product NN I-NP
was VBD B-VP
dependent JJ B-ADJP
upon IN B-PP
the DT B-NP
presence NN I-NP
of IN B-PP
specific JJ B-NP
transcription NN I-NP
factor NN I-NP
binding NN I-NP
sites NNS I-NP
in IN B-PP
the DT B-NP
IL-6 NN I-NP
promoter NN I-NP
. . O

These DT B-NP
studies NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
CMV NN B-NP
may MD B-VP
be VB I-VP
an DT B-NP
important JJ I-NP
cofactor NN I-NP
in IN B-PP
the DT B-NP
development NN I-NP
of IN B-PP
rejection NN B-NP
and CC O
infection NN B-NP
after IN B-PP
transplantation NN B-NP
through IN B-PP
its PRP$ B-NP
effects NNS I-NP
on IN B-PP
IL-6 NN B-NP
. . O

E3 NN B-NP
COMMA COMMA O
a DT B-NP
hematopoietic-specific JJ I-NP
transcript NN I-NP
directly RB B-VP
regulated VBN I-VP
by IN B-PP
the DT B-NP
retinoic JJ I-NP
acid NN I-NP
receptor NN I-NP
alpha NN I-NP
. . O

Retinoic JJ B-NP
acid NN I-NP
( ( I-NP
RA NN I-NP
) ) I-NP
-induced JJ I-NP
maturation NN I-NP
mediated VBN B-VP
by IN B-PP
the DT B-NP
retinoic JJ I-NP
acid NN I-NP
receptor NN I-NP
alpha NN I-NP
( ( O
RAR NN B-NP
alpha NN I-NP
) ) O
has VBZ B-VP
been VBN I-VP
implicated VBN I-VP
in IN B-PP
myeloid JJ B-NP
development NN I-NP
. . O

We PRP B-NP
have VBP B-VP
used VBN I-VP
differential JJ B-NP
hybridization NN I-NP
analysis NN I-NP
of IN B-PP
a DT B-NP
cDNA NN I-NP
library NN I-NP
constructed VBN B-VP
from IN B-PP
the DT B-NP
murine JJ I-NP
RA-inducible JJ I-NP
MPRO NN I-NP
promyelocyte NN I-NP
cell NN I-NP
line NN I-NP
to TO B-VP
identify VB I-VP
immediate-early JJ B-NP
genes NNS I-NP
induced VBN B-VP
by IN B-PP
RA NN B-NP
during IN B-PP
granulocytic JJ B-NP
differentiation NN I-NP
. . O

E3 NN B-NP
COMMA COMMA O
one CD B-NP
of IN B-PP
nine CD B-NP
sequences NNS I-NP
identified VBN B-VP
COMMA COMMA O
was VBD B-VP
upregulated VBN I-VP
in IN B-PP
an DT B-NP
immediate-early JJ I-NP
manner NN I-NP
COMMA COMMA O
with IN B-PP
transcript NN B-NP
levels NNS I-NP
peaking VBG B-VP
after IN B-PP
60 CD B-NP
minutes NNS I-NP
exposure NN B-NP
to TO B-PP
RA NN B-NP
. . O

E3 NN B-NP
transcripts NNS I-NP
were VBD B-VP
RA-inducible JJ B-ADJP
in IN B-PP
HL60 NN B-NP
cells NNS I-NP
COMMA COMMA O
but CC O
not RB B-PP
in IN I-PP
an DT B-NP
RA-resistant JJ I-NP
subclone NN I-NP
COMMA COMMA O
HL60R NN B-NP
COMMA COMMA O
that WDT B-NP
harbors VBZ B-VP
a DT B-NP
mutated VBN I-NP
RAR NN I-NP
alpha NN I-NP
gene NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
when WRB B-ADVP
HL60R NN B-NP
cells NNS I-NP
were VBD B-VP
transduced VBN I-VP
with IN B-PP
a DT B-NP
functional JJ I-NP
copy NN I-NP
of IN B-PP
the DT B-NP
RAR NN I-NP
alpha NN I-NP
gene NN I-NP
COMMA COMMA O
RA NN B-NP
induced VBD B-VP
a DT B-NP
10-fold JJ I-NP
increase NN I-NP
in IN B-PP
E3 NN B-NP
mRNA NN I-NP
levels NNS I-NP
. . O

E3 NN B-NP
transcripts NNS I-NP
are VBP B-VP
present JJ B-ADJP
in IN B-PP
the DT B-NP
myeloid JJ I-NP
COMMA COMMA I-NP
B-lymphoid JJ I-NP
COMMA COMMA I-NP
and CC I-NP
erythroid JJ I-NP
lineages NNS I-NP
COMMA COMMA O
absent JJ B-ADJP
in IN B-PP
nonhematopoietic JJ B-NP
cells NNS I-NP
COMMA COMMA O
and CC O
encode VBP B-VP
a DT B-NP
highly RB I-NP
hydrophobic JJ I-NP
COMMA COMMA I-NP
potentially RB I-NP
phosphorylated VBN I-NP
polypeptide NN I-NP
of IN B-PP
unknown JJ B-NP
function NN I-NP
with IN B-PP
significant JJ B-NP
homology NN I-NP
to TO B-PP
a DT B-NP
putative JJ I-NP
protein NN I-NP
expressed VBN B-VP
in IN B-PP
myeloid JJ B-NP
cells NNS I-NP
. . O

The DT B-NP
murine JJ I-NP
E3 NN I-NP
promoter NN I-NP
harbors VBZ B-VP
a DT B-NP
single JJ I-NP
bipartite JJ I-NP
retinoic JJ I-NP
acid NN I-NP
response NN I-NP
element NN I-NP
which WDT B-NP
in IN B-PP
transient NN B-NP
transfection NN I-NP
assays NNS I-NP
conferred VBD B-VP
RA NN B-NP
sensitivity NN I-NP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
E3 NN B-NP
is VBZ B-VP
a DT B-NP
hematopoietic-specific JJ I-NP
gene NN I-NP
that WDT B-NP
is VBZ B-VP
an DT B-NP
immediate JJ I-NP
target NN I-NP
for IN B-PP
the DT B-NP
activated VBN I-NP
RAR NN I-NP
alpha NN I-NP
during IN B-PP
myelopoiesis NN B-NP
. . O

Interstitial JJ B-NP
deletion NN I-NP
constitutes VBZ B-VP
the DT B-NP
major JJ I-NP
mechanism NN I-NP
for IN B-PP
loss NN B-NP
of IN B-PP
heterozygosity NN B-NP
on IN B-PP
chromosome NN B-NP
20q NN I-NP
in IN B-PP
polycythemia NN B-NP
vera NN I-NP
. . O

An DT B-NP
acquired VBN I-NP
deletion NN I-NP
of IN B-PP
the DT B-NP
long JJ I-NP
arm NN I-NP
of IN B-PP
chromosome NN B-NP
20 CD I-NP
is VBZ B-VP
a DT B-NP
recurrent JJ I-NP
abnormality NN I-NP
in IN B-PP
myeloproliferative JJ B-NP
disorders NNS I-NP
COMMA COMMA O
particularly RB B-NP
polycythemia NN B-NP
vera NN I-NP
and CC O
myelodysplastic JJ B-ADJP
syndromes NNS B-NP
. . O

The DT B-NP
association NN I-NP
of IN B-PP
20q NN B-NP
deletions NNS I-NP
with IN B-PP
myeloid JJ B-NP
" `` I-NP
stem NN I-NP
cell NN I-NP
" '' I-NP
disorders NNS I-NP
suggests VBZ B-VP
that IN B-SBAR
the DT B-NP
deletions NNS I-NP
mark VBP B-VP
the DT B-NP
site NN I-NP
of IN B-PP
one CD B-NP
or CC I-NP
more JJR I-NP
genes NNS I-NP
COMMA COMMA O
loss NN B-NP
or CC O
inactivation NN B-NP
of IN B-PP
which WDT B-NP
plays VBZ B-VP
a DT B-NP
role NN I-NP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
normal JJ B-NP
hematopoietic JJ I-NP
progenitors NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
recently RB I-VP
performed VBN I-VP
a DT B-NP
detailed JJ I-NP
molecular JJ I-NP
analysis NN I-NP
of IN B-PP
20q JJ B-NP
deletions NNS I-NP
in IN B-PP
peripheral JJ B-NP
blood NN I-NP
( ( O
PB NN B-NP
) ) O
granulocytes NNS B-NP
and CC O
defined VBN B-VP
a DT B-NP
commonly RB I-NP
deleted VBN I-NP
region NN I-NP
of IN B-PP
16 CD B-NP
to TO I-NP
21 CD I-NP
centimorgan NN B-NP
( ( O
cM NN B-NP
) ) O
. . O

To TO B-VP
further RBR I-VP
reduce VB I-VP
the DT B-NP
size NN I-NP
of IN B-PP
the DT B-NP
common JJ I-NP
deleted VBN I-NP
region NN I-NP
we PRP B-NP
have VBP B-VP
searched VBN I-VP
for IN B-PP
small JJ B-NP
deletions NNS I-NP
or CC O
mitotic JJ B-NP
recombination NN I-NP
events NNS I-NP
COMMA COMMA O
neither DT B-NP
of IN B-PP
which WDT B-NP
would MD B-VP
be VB I-VP
detected VBN I-VP
by IN B-PP
conventional JJ B-NP
cytogenetics NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
studied VBN I-VP
48 CD B-NP
patients NNS I-NP
with IN B-PP
polycythemia NN B-NP
vera NN I-NP
and CC O
four CD B-NP
patients NNS I-NP
with IN B-PP
idiopathic JJ B-NP
myelofibrosis NN I-NP
. . O

In IN B-PP
each DT B-NP
case NN I-NP
COMMA COMMA O
cytogenetic JJ B-NP
analysis NN I-NP
had VBD B-VP
either RB I-VP
failed VBN I-VP
or CC O
had VBD B-VP
shown VBN I-VP
no DT B-NP
abnormalities NNS I-NP
of IN B-PP
chromosome NN B-NP
20 CD I-NP
. . O

Seventeen CD B-NP
microsatellite NN I-NP
markers NNS I-NP
that WDT B-NP
span VBP B-VP
the DT B-NP
common JJ I-NP
deleted VBN I-NP
region NN I-NP
were VBD B-VP
used VBN I-VP
to TO B-VP
search VB I-VP
for IN B-PP
loss NN B-NP
of IN B-PP
heterozygosity NN B-NP
in IN B-PP
granulocyte NN B-NP
DNA NN I-NP
. . O

No DT B-NP
instance NN I-NP
of IN B-PP
microsatellite NN B-NP
instability NN I-NP
was VBD B-VP
observed VBN I-VP
in IN B-PP
a DT B-NP
total NN I-NP
of IN B-PP
880 CD B-NP
comparisons NNS I-NP
of IN B-PP
granulocyte NN B-NP
and CC O
T-cell NN B-NP
DNA NN B-NP
. . O

Granulocyte NN B-NP
DNA NN I-NP
from IN B-PP
four CD B-NP
patients NNS I-NP
exhibited VBD B-VP
allele NN B-NP
loss NN I-NP
on IN B-PP
20q NN B-NP
. . O

In IN B-PP
each DT B-NP
case NN I-NP
the DT B-NP
allele NN I-NP
loss NN I-NP
was VBD B-VP
caused VBN I-VP
by IN B-PP
an DT B-NP
interstitial JJ I-NP
deletion NN I-NP
because IN B-SBAR
heterozygosity NN B-NP
at IN B-PP
distal JJ B-NP
markers NNS I-NP
was VBD B-VP
retained VBN I-VP
and CC O
because IN B-SBAR
quantitative JJ B-NP
Southern NN I-NP
blotting NN I-NP
demonstrated VBD B-VP
hemizygosity NN B-NP
. . O

Loss NN B-NP
of IN B-PP
heterozygosity NN B-NP
in IN B-PP
PB NN B-NP
granulocytes NNS I-NP
would MD B-VP
be VB I-VP
masked VBN I-VP
by IN B-PP
the DT B-NP
presence NN I-NP
of IN B-PP
significant JJ B-NP
numbers NNS I-NP
of IN B-PP
normal JJ B-NP
granulocytes NNS I-NP
not RB B-VP
derived VBN I-VP
from IN B-PP
the DT B-NP
malignant JJ I-NP
clone NN I-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
the DT B-NP
human JJ I-NP
androgen NN I-NP
receptor NN I-NP
assay NN I-NP
( ( O
HUMARA NN B-NP
) ) O
was VBD B-VP
used VBN I-VP
to TO B-VP
determine VB I-VP
granulocyte NN B-NP
clonality NN I-NP
. . O

In IN B-PP
21 CD B-NP
of IN I-NP
27 CD I-NP
informative JJ I-NP
female NN I-NP
patients NNS I-NP
the DT B-NP
majority NN I-NP
of IN B-PP
the DT B-NP
granulocytes NNS I-NP
were VBD B-VP
clonally RB B-ADJP
derived VBN I-ADJP
. . O

In IN B-PP
5 CD B-NP
patients NNS I-NP
the DT B-NP
granulocytes NNS I-NP
appeared VBD B-VP
polyclonal JJ B-ADJP
and CC O
in IN B-PP
1 CD B-NP
patient NN I-NP
unilateral JJ B-NP
X NN I-NP
inactivation NN I-NP
was VBD B-VP
observed VBN I-VP
in IN B-PP
both CC O
granulocytes NNS B-NP
and CC O
T JJ B-NP
cells NNS I-NP
. . O

These DT B-NP
results NNS I-NP
show VBP B-VP
that IN B-SBAR
COMMA COMMA O
in IN B-PP
the DT B-NP
vast JJ I-NP
majority NN I-NP
of IN B-PP
patients NNS B-NP
presented VBN B-VP
here RB B-ADVP
COMMA COMMA O
the DT B-NP
failure NN I-NP
to TO B-VP
detect VB I-VP
loss NN B-NP
of IN B-PP
heterozygosity NN B-NP
can MD B-VP
not RB I-VP
be VB I-VP
attributed VBN I-VP
to TO B-PP
the DT B-NP
presence NN I-NP
of IN B-PP
normal JJ B-NP
polyclonal JJ I-NP
granulocytes NNS I-NP
. . O

Our PRP$ B-NP
results NNS I-NP
therefore RB B-ADVP
show VBP B-VP
that IN B-SBAR
allele NN B-NP
loss NN I-NP
on IN B-PP
chromosome NN B-NP
20q NN I-NP
in IN B-PP
polycythemia NN B-NP
vera NN I-NP
does VBZ B-VP
not RB I-VP
commonly RB I-VP
involve VB I-VP
mitotic JJ B-NP
recombination NN I-NP
or CC O
chromosome NN B-NP
loss NN I-NP
and CC O
that IN B-SBAR
microsatellite NN B-NP
instability NN I-NP
is VBZ B-VP
a DT B-NP
rare JJ I-NP
event NN I-NP
in IN B-PP
this DT B-NP
disorder NN I-NP
. . O

Transcriptional JJ B-NP
control NN I-NP
of IN B-PP
steroid-regulated JJ B-NP
apoptosis NN I-NP
in IN B-PP
murine JJ B-NP
thymoma NN I-NP
cells NNS I-NP
. . O

Early JJ B-NP
studies NNS I-NP
in IN B-PP
murine JJ B-NP
T NN I-NP
cell NN I-NP
lines NNS I-NP
indicated VBD B-VP
that IN B-SBAR
transcriptional JJ B-NP
transactivation NN I-NP
functions NNS I-NP
encoded VBN B-VP
in IN B-PP
the DT O
glucocorticoid NN B-NP
receptor NN I-NP
( ( O
GR NN B-NP
) ) O
N-terminal JJ B-NP
domain NN I-NP
are VBP B-VP
required VBN I-VP
for IN B-PP
glucocorticoid-mediated JJ B-NP
apoptosis NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
more RBR B-NP
recent JJ I-NP
studies NNS I-NP
in IN B-PP
human JJ B-NP
T NN I-NP
cell NN I-NP
lines NNS I-NP
have VBP B-VP
suggested VBN I-VP
that IN B-SBAR
the DT B-NP
N-terminal JJ I-NP
domain NN I-NP
is VBZ B-VP
not RB O
necessary JJ B-ADJP
for IN B-PP
steroid-regulated JJ B-NP
apoptosis NN I-NP
and CC O
that IN B-SBAR
GR-mediated JJ B-NP
transrepression NN I-NP
may MD B-VP
be VB I-VP
the DT B-NP
more RBR I-NP
critical JJ I-NP
mechanism NN I-NP
. . O

To TO B-VP
better RBR I-VP
understand VB I-VP
the DT B-NP
contribution NN I-NP
of IN B-PP
the DT B-NP
GR NN I-NP
N-terminal JJ I-NP
transactivation NN I-NP
domain NN I-NP
in IN B-PP
mediating VBG B-VP
murine JJ B-NP
thymocyte NN I-NP
apoptosis NN I-NP
COMMA COMMA O
we PRP B-NP
stably RB B-ADVP
transfected VBD B-VP
GR NN B-NP
COMMA COMMA O
GR NN B-NP
variants NNS I-NP
COMMA COMMA O
and CC O
the DT B-NP
androgen NN I-NP
receptor NN I-NP
( ( O
AR NN B-NP
) ) O
into IN B-PP
receptor-negative JJ B-NP
S49 NN I-NP
murine JJ I-NP
thymoma NN I-NP
cells NNS I-NP
. . O

GR NN B-NP
expression NN I-NP
levels NNS I-NP
were VBD B-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
rate-limiting JJ B-ADJP
for IN B-PP
initiating VBG B-VP
the DT B-NP
apoptotic JJ I-NP
pathway NN I-NP
COMMA COMMA O
and CC O
a DT B-NP
positive JJ I-NP
correlation NN I-NP
between IN B-PP
steroid NN B-NP
sensitivity NN I-NP
and CC O
GR-mediated JJ B-NP
induction NN I-NP
of IN B-PP
an DT O
integrated VBN O
mouse NN B-NP
mammary JJ I-NP
tumor NN I-NP
virus NN I-NP
( ( O
MMTV NN B-NP
) ) O
LTR NN B-NP
reporter NN I-NP
gene NN I-NP
was VBD B-VP
observed VBN I-VP
. . O

Analysis NN B-NP
of IN B-PP
GR NN B-NP
chimeric JJ I-NP
receptors NNS I-NP
containing VBG B-VP
the DT O
potent JJ O
VP16 NN B-NP
and CC O
E1A NN B-NP
viral JJ B-NP
transactivation NN I-NP
domains NNS I-NP
in IN B-PP
place NN I-PP
of IN I-PP
the DT B-NP
GR NN I-NP
N NN I-NP
terminus NN I-NP
revealed VBD B-VP
that IN B-SBAR
even RB B-NP
low JJ I-NP
level NN I-NP
expression NN I-NP
of IN B-PP
these DT B-NP
receptors NNS I-NP
resulted VBD B-VP
in IN B-PP
both CC O
enhanced VBN B-NP
steroid NN I-NP
sensitivity NN I-NP
and CC O
MMTV NN B-NP
induction NN I-NP
COMMA COMMA O
thus RB B-VP
supporting VBG I-VP
a DT B-NP
role NN I-NP
for IN B-PP
transactivation NN B-NP
in IN B-PP
apoptosis NN B-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
we PRP B-NP
found VBD B-VP
that IN B-SBAR
AR NN B-NP
can MD B-VP
initiate VB I-VP
apoptosis NN B-NP
in IN B-PP
S49 NN B-NP
cells NNS I-NP
after IN B-PP
treatment NN B-NP
with IN B-PP
5 CD B-NP
alpha-dihydrotestosterone NN I-NP
COMMA COMMA O
despite IN B-PP
its PRP$ B-NP
relative JJ I-NP
inability NN I-NP
to TO B-VP
induce VB I-VP
high JJ B-NP
level NN I-NP
expression NN I-NP
of IN B-PP
MMTV NN B-NP
. . O

To TO B-VP
investigate VB I-VP
this DT B-NP
further RBR B-ADVP
COMMA COMMA O
we PRP B-NP
examined VBD B-VP
the DT B-NP
steroid-regulated JJ I-NP
expression NN I-NP
of IN B-PP
an DT B-NP
endogenous JJ I-NP
thymocyte-specific JJ I-NP
gene NN I-NP
called VBN B-VP
GIG18 NN B-NP
. . O

We PRP B-NP
found VBD B-VP
that IN B-SBAR
GIG18 NN B-NP
was VBD B-VP
rapidly RB I-VP
induced VBN I-VP
to TO B-PP
comparable JJ B-NP
levels NNS I-NP
by IN B-PP
both CC O
AR NN B-NP
and CC O
GR NN B-NP
COMMA COMMA O
demonstrating VBG B-VP
that IN B-SBAR
AR NN B-NP
can MD B-VP
indeed RB I-VP
function VB I-VP
as IN B-PP
a DT B-NP
transcriptional JJ I-NP
activator NN I-NP
in IN B-PP
S49 NN B-NP
cells NNS I-NP
and CC O
COMMA COMMA O
moreover RB O
COMMA COMMA O
that IN B-SBAR
GIG18 NN B-NP
induction NN I-NP
may MD B-VP
be VB I-VP
a DT B-NP
marker NN I-NP
of IN B-PP
early JJ B-NP
apoptotic JJ I-NP
events NNS I-NP
in IN B-PP
steroid-treated JJ B-NP
cells NNS I-NP
. . O

Taken VBN B-VP
together RB B-ADVP
COMMA COMMA O
these DT B-NP
results NNS I-NP
support VBP B-VP
our PRP$ B-NP
conclusion NN I-NP
that IN B-SBAR
transcriptional JJ B-NP
transactivation NN I-NP
is VBZ B-VP
a DT B-NP
necessary JJ I-NP
signaling NN I-NP
component NN I-NP
of IN B-PP
S49 NN B-NP
cell NN I-NP
apoptosis NN I-NP
COMMA COMMA O
although IN B-SBAR
an DT B-NP
additional JJ I-NP
role NN I-NP
for IN B-PP
GR-mediated JJ B-NP
transrepression NN I-NP
can MD B-VP
not RB I-VP
be VB I-VP
excluded VBN O

Suppression NN B-NP
of IN B-PP
c-jun NN B-NP
by IN B-PP
antisense JJ B-NP
oligonucleotides NNS I-NP
inhibits VBZ B-VP
cell NN B-NP
adhesion NN I-NP
but CC B-CONJP
not RB I-CONJP
respiratory JJ B-NP
burst NN I-NP
during IN B-PP
phorbol NN B-NP
ester-induced JJ I-NP
differentiation NN I-NP
of IN B-PP
U937 NN B-NP
human JJ I-NP
monoblastic JJ I-NP
cells NNS I-NP
. . O

We PRP B-NP
studied VBD B-VP
the DT B-NP
role NN I-NP
of IN B-PP
the DT B-NP
immediate JJ I-NP
early JJ I-NP
gene NN I-NP
c-jun NN I-NP
in IN B-PP
cell NN B-NP
proliferation NN I-NP
and CC O
phorbol NN B-NP
12-myristate NN I-NP
13-acetate NN I-NP
( ( I-NP
PMA NN I-NP
) ) I-NP
-induced JJ I-NP
differentiation NN I-NP
in IN B-PP
U937 NN B-NP
human JJ I-NP
monoblastic JJ I-NP
cells NNS I-NP
COMMA COMMA O
using VBG B-VP
c-jun-specific JJ O
antisense JJ O
( ( O
AS JJ B-ADJP
) ) O
phosphorothioate NN B-NP
oligonucleotides NNS I-NP
. . O

In IN B-PP
selecting VBG B-VP
the DT B-NP
most RBS I-NP
specific JJ I-NP
and CC I-NP
potent JJ I-NP
oligonucleotide JJ I-NP
sequence NN I-NP
COMMA COMMA O
we PRP B-NP
performed VBD B-VP
extensive JJ B-NP
analyses NNS I-NP
for IN B-PP
the DT B-NP
binding NN I-NP
specificity NN I-NP
between IN B-PP
all DT B-NP
candidates NNS I-NP
of IN B-PP
c-jun NN B-NP
AS JJ I-NP
oligonucleotides NNS I-NP
and CC O
the DT B-NP
whole JJ I-NP
sequences NNS I-NP
in IN B-PP
GenBank NN B-NP
database NN I-NP
COMMA COMMA O
using VBG B-VP
a DT B-NP
computer NN I-NP
program NN I-NP
. . O

Among IN B-PP
the DT B-NP
20 CD I-NP
selected VBN I-NP
oligonucleotides NNS I-NP
COMMA COMMA O
two CD B-NP
potent JJ I-NP
15-mer JJ I-NP
AS JJ I-NP
oligonucleotides NNS I-NP
( ( O
C-JUN NN B-NP
AS JJ I-NP
oligonucleotides NNS I-NP
) ) O
exhibited VBD B-VP
significant JJ B-NP
inhibition NN I-NP
of IN B-PP
cell NN B-NP
growth NN I-NP
in IN B-PP
a DT B-NP
dose-dependent JJ I-NP
manner NN I-NP
between IN B-NP
2 CD I-NP
and CC I-NP
10 CD I-NP
microM NN I-NP
. . O

Reverse JJ B-NP
transcription-PCR NN I-NP
and CC O
Western NN B-NP
blot NN I-NP
analysis NN I-NP
demonstrated VBD B-VP
that IN B-SBAR
10 CD B-NP
microM NN I-NP
of IN B-PP
C-JUN NN B-NP
AS JJ I-NP
oligonucleotides NNS I-NP
reduced VBD B-VP
c-jun NN B-NP
expression NN I-NP
at IN B-PP
both CC O
the DT O
mRNA NN B-NP
and CC O
protein NN B-NP
levels NNS B-NP
. . O

More RBR B-ADVP
importantly RB I-ADVP
COMMA COMMA O
C-JUN NN B-NP
AS JJ I-NP
oligonucleotides NNS I-NP
showed VBD B-VP
distinct JJ B-NP
effects NNS I-NP
on IN B-PP
two CD B-NP
markers NNS I-NP
of IN B-PP
PMA-induced JJ B-NP
differentiation NN I-NP
; : O
the DT B-NP
C-JUN NN I-NP
AS JJ I-NP
oligonucleotides NNS I-NP
inhibited VBD B-VP
cell NN B-NP
adhesion NN I-NP
COMMA COMMA O
whereas IN O
they PRP B-NP
did VBD B-VP
not RB I-VP
affect VB I-VP
another DT B-NP
marker NN I-NP
of IN B-PP
differentiation NN B-NP
COMMA COMMA O
respiratory JJ B-NP
burst NN I-NP
( ( O
measured VBN B-VP
by IN B-PP
nitro NN B-NP
blue JJ I-NP
tetrazolium NN I-NP
reduction NN I-NP
assay NN I-NP
) ) O
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
a DT B-NP
critical JJ I-NP
role NN I-NP
of IN B-PP
c-jun NN B-NP
in IN B-PP
both CC O
cell NN B-NP
proliferation NN I-NP
and CC O
PMA-induced JJ B-NP
cell NN I-NP
adhesion NN I-NP
but CC B-PP
not RB B-PP
in IN I-PP
PMA-induced JJ B-NP
respiratory JJ I-NP
burst NN I-NP
in IN B-PP
U937 NN B-NP
cells NNS I-NP
. . O

Human JJ B-NP
TAFII NN I-NP
105 CD I-NP
is VBZ B-VP
a DT B-NP
cell NN I-NP
type-specific JJ I-NP
TFIID NN I-NP
subunit NN I-NP
related JJ B-ADJP
to TO B-PP
hTAFII130 NN B-NP
. . O

We PRP B-NP
previously RB B-ADVP
characterized VBD B-VP
Drosophila NN B-NP
and CC O
human JJ B-NP
TAF NN I-NP
subunits NNS B-NP
that WDT B-NP
make VBP B-VP
up RP B-PRT
the DT B-NP
core NN I-NP
TFIID NN I-NP
complex NN I-NP
found VBN B-VP
in IN B-PP
all DT B-NP
cells NNS I-NP
. . O

Here RB B-ADVP
COMMA COMMA O
we PRP B-NP
report VBP B-VP
that IN B-SBAR
differentiated VBN B-NP
B NN I-NP
cells NNS I-NP
contain VBP B-VP
a DT B-NP
novel JJ I-NP
substoichiometric JJ I-NP
TAF NN I-NP
of IN B-PP
105 CD B-NP
kDa NN I-NP
not RB B-VP
found VBN I-VP
associated VBN I-VP
with IN B-PP
TFIID NN B-NP
isolated VBN B-VP
from IN B-PP
other JJ B-NP
cell NN I-NP
types NNS I-NP
. . O

The DT B-NP
cDNA NN I-NP
encoding NN I-NP
hTAFII105 NN I-NP
reveals VBZ B-VP
a DT B-NP
highly RB I-NP
conserved VBN I-NP
C-terminal JJ I-NP
domain NN I-NP
shared VBN B-VP
by IN B-PP
hTAFII130 NN B-NP
and CC O
oTAFII110 NN B-NP
COMMA COMMA O
while IN B-SBAR
the DT B-NP
N-terminal JJ I-NP
coactivator NN I-NP
domain NN I-NP
has VBZ B-VP
diverged VBN I-VP
significantly RB B-ADVP
. . O

All DT B-NP
cells NNS I-NP
tested VBN B-VP
express VBP B-VP
TAFII105 NN B-NP
mRNA NN I-NP
COMMA COMMA O
but CC O
only RB B-NP
B NN I-NP
cells NNS I-NP
contain VBP B-VP
significant JJ B-NP
levels NNS I-NP
of IN B-PP
protein NN B-NP
associated VBN B-VP
with IN B-PP
TFIID NN B-NP
. . O

Transient JJ B-NP
overexpression NN I-NP
of IN B-PP
hTAFII105 NN B-NP
selectively RB B-ADVP
squelches VBZ B-VP
the DT B-NP
transcription NN I-NP
of IN B-PP
some DT B-NP
genes NNS I-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
. . O

These DT B-NP
properties NNS I-NP
suggest VBP B-VP
that IN B-SBAR
TAFII105 NN B-NP
is VBZ B-VP
a DT B-NP
cell NN I-NP
type-specific JJ I-NP
subunit NN I-NP
of IN B-PP
TFIID NN B-NP
that WDT B-NP
may MD B-VP
be VB I-VP
responsible JJ B-ADJP
for IN B-PP
mediating VBG B-VP
transcription NN B-NP
by IN B-PP
a DT B-NP
subset NN I-NP
of IN B-PP
activators NNS B-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
. . O

Uneven JJ B-NP
X NN I-NP
inactivation NN I-NP
in IN B-PP
a DT B-NP
female JJ I-NP
monozygotic JJ I-NP
twin JJ I-NP
pair NN I-NP
with IN B-PP
Fabry NN B-NP
disease NN I-NP
and CC O
discordant JJ B-NP
expression NN I-NP
of IN B-PP
a DT B-NP
novel JJ I-NP
mutation NN I-NP
in IN B-PP
the DT B-NP
alpha-galactosidase NN I-NP
A NN I-NP
gene NN I-NP
. . O

We PRP B-NP
describe VBP B-VP
two CD O
female JJ O
monozygotic JJ O
( ( O
MZ JJ B-ADJP
) ) O
twins NNS B-NP
heterozygous JJ B-ADJP
for IN B-PP
Fabry NN B-NP
disease NN I-NP
COMMA COMMA O
an DT B-NP
X NN I-NP
linked VBN I-NP
disorder NN I-NP
resulting VBG B-VP
from IN B-PP
the DT B-NP
deficient JJ I-NP
activity NN I-NP
of IN B-PP
alpha-galactosidase NN B-NP
A NN I-NP
. . O

While IN B-SBAR
one CD B-NP
of IN B-PP
the DT B-NP
twins NNS I-NP
was VBD B-VP
clinically RB B-ADVP
affected VBN B-ADJP
COMMA COMMA O
the DT B-NP
other JJ I-NP
was VBD B-VP
asymptomatic JJ B-ADJP
. . O

Enzymatic JJ B-NP
assay NN I-NP
of IN B-PP
alpha-galactosidase NN B-NP
in IN B-PP
blood NN B-NP
leucocytes NNS I-NP
COMMA COMMA O
skin NN B-NP
fibroblasts NNS I-NP
COMMA COMMA O
Epstein-Barr JJ B-NP
virus NN I-NP
transformed VBD B-NP
lymphoid JJ I-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
and CC O
hair NN B-NP
follicles NNS I-NP
of IN B-PP
the DT B-NP
twins NNS I-NP
and CC O
their PRP$ B-NP
parents NNS I-NP
confirmed VBD B-VP
the DT B-NP
heterozygous JJ I-NP
status NN I-NP
of IN B-PP
the DT B-NP
twins NNS I-NP
and CC O
indicated VBD B-VP
that IN B-SBAR
Fabry NN B-NP
disease NN I-NP
had VBD B-VP
occurred VBN I-VP
as IN B-PP
a DT B-NP
result NN I-NP
of IN B-PP
a DT B-NP
de FW I-NP
novo FW I-NP
mutation NN I-NP
. . O

The DT B-NP
son NN I-NP
of IN B-PP
the DT B-NP
unaffected JJ I-NP
twin NN I-NP
sister NN I-NP
was VBD B-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
hemizygous JJ B-ADJP
. . O

Molecular JJ B-NP
analysis NN I-NP
of IN B-PP
the DT B-NP
alpha-galactosidase NN I-NP
A NN I-NP
gene NN I-NP
permitted VBD B-VP
the DT B-NP
identification NN I-NP
of IN B-PP
an DT O
as RB B-ADVP
yet RB I-ADVP
undescribed JJ B-NP
point NN I-NP
mutation NN I-NP
at IN B-PP
position NN B-NP
10182 CD I-NP
of IN B-PP
exon NN B-NP
5 CD I-NP
which WDT B-NP
causes VBZ B-VP
an DT O
Asp NN B-NP
to TO O
Asn NN B-NP
substitution NN B-NP
at IN B-PP
codon NN B-NP
231 CD I-NP
. . O

Single JJ B-NP
strand NN I-NP
conformation NN I-NP
polymorphism NN I-NP
( ( O
SSCP NN B-NP
) ) O
analysis NN B-NP
again RB B-ADVP
showed VBD B-VP
the DT B-NP
heterozygous JJ I-NP
status NN I-NP
of IN B-PP
the DT B-NP
twins NNS I-NP
and CC O
a DT B-NP
normal JJ I-NP
pattern NN I-NP
in IN B-PP
their PRP$ B-NP
parents NNS I-NP
. . O

The DT B-NP
basis NN I-NP
for IN B-PP
the DT B-NP
discordant JJ I-NP
expression NN I-NP
of IN B-PP
this DT B-NP
d FW I-NP
novo FW I-NP
mutation NN I-NP
in IN B-PP
the DT B-NP
twins NNS I-NP
was VBD B-VP
investigated VBN I-VP
by IN B-PP
studying VBG B-VP
their PRP$ B-NP
X NN I-NP
inactivation NN I-NP
status NN I-NP
. . O

Analysis NN B-NP
of IN B-PP
the DT O
inactive JJ B-NP
X NN I-NP
specific JJ B-NP
methylation NN I-NP
at IN B-PP
the DT B-NP
androgen NN I-NP
receptor NN I-NP
gene NN I-NP
showed VBD B-VP
unbalanced JJ B-NP
inactivation NN I-NP
in IN B-PP
the DT B-NP
twins NNS I-NP
' POS B-NP
fibroblasts NNS I-NP
and CC B-PP
in IN B-PP
opposite JJ B-NP
directions NNS I-NP
. . O

While IN B-SBAR
the DT B-NP
maternally RB I-NP
derived VBN I-NP
X NN I-NP
chromosome NN I-NP
was VBD B-VP
preferentially RB B-ADJP
active JJ I-ADJP
in IN B-PP
the DT B-NP
asymptomatic JJ I-NP
twin NN I-NP
COMMA COMMA O
the DT B-NP
paternal JJ I-NP
X NN I-NP
chromosome NN I-NP
was VBD B-VP
active JJ B-ADJP
in IN B-PP
the DT B-NP
other JJ I-NP
COMMA COMMA I-NP
affected VBN I-NP
twin NN I-NP
and CC O
was VBD B-VP
found VBN I-VP
in IN B-PP
her PRP$ B-NP
hemizygotic JJ I-NP
nephew NN I-NP
. . O

These DT B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
paternal JJ I-NP
X NN I-NP
chromosome NN I-NP
carries VBZ B-VP
the DT B-NP
de FW I-NP
novo FW I-NP
alpha-galactosidase NN I-NP
A NN I-NP
mutation NN I-NP
and CC O
that IN B-SBAR
uneven JJ B-NP
X NN I-NP
inactivation NN I-NP
is VBZ B-VP
the DT B-NP
underlying VBG I-NP
mechanism NN I-NP
for IN B-PP
disease NN B-NP
expression NN I-NP
in IN B-PP
this DT B-NP
novel JJ I-NP
female NN I-NP
MZ JJ I-NP
twin NN I-NP
pair NN I-NP
. . O

This DT B-NP
is VBZ B-VP
the DT B-NP
first JJ I-NP
documented VBN I-NP
case NN I-NP
of IN B-PP
female JJ B-NP
twins NNS I-NP
discordant JJ B-ADJP
for IN B-PP
Fabry NN B-NP
disease NN I-NP
. . O

Signaling NN B-NP
by IN B-PP
IL-2 NN B-NP
and CC O
related JJ B-NP
cytokines NNS I-NP
: : O
JAKs NNS B-NP
COMMA COMMA O
STATs NNS B-NP
COMMA COMMA O
and CC O
relationship NN B-NP
to TO B-PP
immunodeficiency NN B-NP
. . O

Cytokines NNS B-NP
that WDT B-NP
bind VBP B-VP
to TO B-PP
the DT O
interleukin-2 NN B-NP
( ( O
IL-2 NN B-NP
) ) O
receptor NN B-NP
common JJ I-NP
gamma NN B-NP
chain NN I-NP
( ( O
gamma NN B-NP
c NN I-NP
) ) O
COMMA COMMA O
including VBG B-PP
IL-2 NN B-NP
COMMA COMMA O
IL-4 NN B-NP
COMMA COMMA O
IL-7 NN B-NP
COMMA COMMA O
IL-9 NN B-NP
COMMA COMMA O
and CC O
IL-15 NN B-NP
COMMA COMMA O
are VBP B-VP
important JJ B-ADJP
for IN B-PP
the DT B-NP
growth NN B-NP
and CC O
differentiation NN B-NP
of IN B-PP
T NN B-NP
and CC O
B NN B-NP
lymphocytes NNS B-NP
COMMA COMMA O
natural JJ B-NP
killer NN I-NP
cells NNS I-NP
COMMA COMMA O
macrophages NNS B-NP
COMMA COMMA O
and CC O
monoctyes NNS B-NP
. . O

These DT B-NP
cytokines NNS I-NP
have VBP B-VP
overlapping VBG B-NP
biological JJ I-NP
effects NNS I-NP
that WDT B-NP
in IN B-PP
part NN B-NP
result VBP B-VP
from IN B-PP
the DT B-NP
use NN I-NP
of IN B-PP
the DT B-NP
shared VBN I-NP
receptor NN I-NP
subunit NN I-NP
gamma NN I-NP
c NN I-NP
. . O

Recently RB B-ADVP
it PRP B-NP
has VBZ B-VP
become VBN I-VP
clear JJ B-ADJP
that IN B-SBAR
these DT B-NP
cytokines NNS I-NP
activate VBP B-VP
a DT B-NP
number NN I-NP
of IN B-PP
important JJ B-NP
intracellular JJ I-NP
signaling VBG I-NP
molecules NNS I-NP
COMMA COMMA O
including VBG B-PP
the DT B-NP
Janus NN I-NP
kinases NNS I-NP
JAK1 NN B-NP
and CC O
JAK3 NN B-NP
and CC O
members NNS B-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
family NN I-NP
of IN B-PP
signal NN B-NP
transducers NNS B-NP
and CC O
activators NNS B-NP
of IN B-PP
transcription NN B-NP
( ( O
STATs NNS B-NP
) ) O
. . O

The DT B-NP
discovery NN I-NP
of IN B-PP
these DT B-NP
signaling NN I-NP
pathways NNS I-NP
has VBZ B-VP
led VBN I-VP
to TO B-PP
important JJ B-NP
new JJ I-NP
insights NNS I-NP
into IN B-PP
their PRP$ B-NP
role NN I-NP
in IN B-PP
lymphocyte NN B-NP
maturation NN I-NP
COMMA COMMA O
as IN B-SBAR
it PRP B-NP
has VBZ B-VP
emerged VBN I-VP
that IN B-SBAR
mutations NNS B-NP
in IN B-PP
the DT B-NP
genes NNS I-NP
encoding VBG B-VP
both CC O
gamma NN B-NP
c NN I-NP
and CC O
JAK3 NN B-NP
result VBP B-VP
in IN B-PP
similar JJ B-NP
forms NNS I-NP
of IN B-PP
severe JJ B-NP
combined JJ I-NP
immunodeficiency NN I-NP
( ( O
SCID NN B-NP
) ) O
. . O

In IN B-PP
this DT B-NP
review NN I-NP
we PRP B-NP
examine VBP B-VP
the DT B-NP
structure NN B-NP
and CC O
function NN B-NP
of IN B-PP
cytokine NN B-NP
receptors NNS I-NP
and CC O
the DT B-NP
signaling NN I-NP
pathways NNS I-NP
involved VBN B-VP
in IN B-PP
their PRP$ B-NP
regulation NN I-NP
of IN B-PP
gene NN B-NP
expression NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
we PRP B-NP
discuss VBP B-VP
recent JJ B-NP
advances NNS I-NP
that WDT B-NP
have VBP B-VP
led VBN I-VP
to TO B-PP
a DT B-NP
better JJR I-NP
understanding NN I-NP
of IN B-PP
how WRB B-ADVP
cytokines NNS B-NP
elicit VBP B-VP
intracellular JJ B-NP
responses NNS I-NP
COMMA COMMA O
as RB B-PP
well RB I-PP
as IN I-PP
their PRP$ B-NP
role NN I-NP
in IN B-PP
normal JJ B-NP
lymphoid JJ I-NP
development NN I-NP
. . O

Eosinophil NN B-NP
priming NN I-NP
by IN B-PP
cytokines NNS B-NP
: : O
from IN B-PP
cellular JJ B-NP
signal NN I-NP
to TO B-PP
in FW B-NP
vivo FW I-NP
modulation NN I-NP
. . O

Eosinophils NNS B-NP
play VBP B-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
effector NN I-NP
phase NN I-NP
of IN B-PP
allergic JJ B-NP
inflammation NN I-NP
. . O

This DT B-NP
review NN I-NP
will MD B-VP
focus VB I-VP
on IN B-PP
the DT B-NP
conversion NN I-NP
of IN B-PP
the DT B-NP
unprimed JJ I-NP
eosinophil NN I-NP
phenotype NN I-NP
in IN B-PP
the DT B-NP
peripheral JJ I-NP
blood NN I-NP
of IN B-PP
normal JJ B-NP
individuals NNS I-NP
to TO B-PP
the DT B-NP
primed JJ I-NP
phenotype NN I-NP
found VBN B-VP
in IN B-PP
the DT B-NP
peripheral JJ I-NP
blood NN B-NP
and CC O
tissues NNS B-NP
of IN B-PP
allergic JJ B-NP
patients NNS I-NP
COMMA COMMA O
a DT B-NP
phenomenon NN I-NP
called VBN B-VP
priming NN B-NP
. . O

Recent JJ B-NP
data NNS I-NP
on IN B-PP
the DT B-NP
signals NNS I-NP
initiated VBN B-VP
after IN B-PP
cytokine NN B-NP
receptor NN I-NP
activation NN I-NP
on IN B-PP
eosinophils NNS B-NP
will MD B-VP
be VB I-VP
reviewed VBN I-VP
. . O

Molecular JJ B-NP
mechanisms NNS I-NP
of IN B-PP
steroid NN B-NP
action NN I-NP
: : O
a DT B-NP
novel JJ I-NP
type NN I-NP
of IN B-PP
cross-talk NN B-NP
between IN B-PP
glucocorticoids NNS B-NP
and CC O
NF-kappa NN B-NP
B NN I-NP
transcription NN I-NP
factors NNS I-NP
. . O

Despite IN B-PP
the DT B-NP
widespread JJ I-NP
use NN I-NP
of IN B-PP
glucocorticoids NNS B-NP
in IN B-PP
the DT B-NP
treatment NN I-NP
of IN B-PP
diseases NNS B-NP
characterized VBN B-VP
by IN B-PP
inflammation NN B-NP
COMMA COMMA O
the DT B-NP
molecular JJ I-NP
mechanism NN I-NP
( ( I-NP
s NNS I-NP
) ) O
by IN B-PP
which WDT B-NP
these DT B-NP
hormones NNS I-NP
exert VBP B-VP
this DT B-NP
beneficial JJ I-NP
effect NN I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
asthma NN B-NP
remains VBZ B-VP
to TO I-VP
be VB I-VP
elucidated VBN I-VP
. . O

Therefore RB B-ADVP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
studied VBN I-VP
the DT B-NP
transcriptional JJ I-NP
regulation NN I-NP
of IN B-PP
intercellular JJ B-NP
adhesion NN I-NP
molecule-1 NN I-NP
( ( O
ICAM-1 NN B-NP
) ) O
as IN B-SBAR
adhesion NN B-NP
molecules NNS I-NP
are VBP B-VP
likely JJ B-ADJP
to TO B-VP
play VB I-VP
a DT B-NP
causal JJ I-NP
role NN I-NP
in IN B-PP
inflammation NN B-NP
in IN B-PP
promoting VBG B-VP
cell-cell JJ B-NP
and CC I-NP
cell-matrix JJ I-NP
interactions NNS I-NP
. . O

We PRP B-NP
observed VBD B-VP
that IN B-SBAR
in IN B-PP
a DT B-NP
monocytic JJ I-NP
( ( O
U937 NN B-NP
) ) O
and CC O
a DT B-NP
bronchial JJ I-NP
epithelial NN I-NP
( ( O
H292 NN B-NP
) ) O
cell-line JJ B-NP
dexamethasone NN B-NP
strongly RB B-ADVP
suppressed VBD B-VP
basal JJ B-NP
and CC I-NP
induced VBN I-NP
ICAM-1 NN I-NP
expression NN I-NP
. . O

Subsequent JJ B-NP
analysis NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
ICAM-1 NN I-NP
promoter NN I-NP
has VBZ B-VP
revealed VBN I-VP
that IN B-SBAR
both CC O
12-O-tetradecanoylphorbol NN B-NP
13-acetate NN I-NP
( ( O
TPA NN B-NP
) ) O
and CC O
tumour NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
( ( O
TNF-alpha NN B-NP
) ) O
upregulate VBP B-VP
ICAM-1 NN B-NP
expression NN I-NP
through IN B-PP
the DT B-NP
presence NN I-NP
of IN B-PP
a DT O
nuclear JJ B-NP
factor NN I-NP
( ( O
NF-kappa NN B-NP
B NN I-NP
) ) O
target NN B-NP
sequence NN I-NP
( ( O
TGGAAATTCC NN B-NP
) ) O
. . O

No DT B-NP
glucocorticoid NN I-NP
recognition NN I-NP
sequences NNS I-NP
are VBP B-VP
present JJ B-ADJP
in IN B-PP
this DT B-NP
promoter NN I-NP
region NN I-NP
and CC O
dexamethasone NN B-NP
is VBZ B-VP
still RB B-ADVP
able JJ B-ADJP
to TO B-VP
repress VB I-VP
transcription NN B-NP
when WRB B-ADVP
the DT B-NP
multimerized JJ I-NP
NF-kappa NN I-NP
B NN I-NP
sequence NN I-NP
is VBZ B-VP
transactivated VBN I-VP
by IN B-PP
TNF-alpha NN B-NP
upon IN B-PP
transfection NN B-NP
in IN B-PP
293 CD B-NP
cells NNS I-NP
. . O

We PRP B-NP
propose VBP B-VP
that IN B-SBAR
direct JJ B-NP
interaction NN I-NP
between IN B-PP
the DT B-NP
glucocorticoid NN I-NP
receptor NN I-NP
and CC O
nuclear JJ B-NP
factor-kappa NN I-NP
B NN I-NP
factors NNS I-NP
is VBZ B-VP
at IN B-ADVP
least JJS I-ADVP
a DT B-NP
partial JJ I-NP
explanation NN I-NP
for IN B-PP
the DT B-NP
effects NNS I-NP
of IN B-PP
this DT B-NP
hormone NN I-NP
in IN B-PP
inflammatory JJ B-NP
diseases NNS I-NP
. . O

The DT B-NP
suppression NN I-NP
of IN B-PP
T NN B-NP
cell NN I-NP
function NN I-NP
and CC O
NF(kappa)B NN B-NP
expression NN I-NP
by IN B-PP
serine NN B-NP
protease NN I-NP
inhibitors NNS I-NP
is VBZ B-VP
blocked VBN I-VP
by IN B-PP
N-acetylcysteine NN B-NP
. . O

Direct JJ B-NP
evidence NN I-NP
that IN B-SBAR
N-acetylcysteine NN B-NP
( ( O
NAC NN B-NP
) ) O
enhances VBZ B-VP
the DT B-NP
immune JJ I-NP
response NN I-NP
of IN B-PP
peripheral JJ B-NP
blood NN I-NP
T NN I-NP
cells NNS I-NP
at IN B-PP
the DT B-NP
level NN I-NP
of IN B-PP
NF(kappa)B NN B-NP
is VBZ B-VP
presented VBN I-VP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
NAC NN B-NP
blocks VBZ B-VP
the DT B-NP
suppression NN I-NP
of IN B-PP
T NN B-NP
cell NN I-NP
mitogenesis NN I-NP
and CC O
cytokine NN B-NP
production NN I-NP
by IN B-PP
protease NN B-NP
inhibitors NNS I-NP
such JJ B-PP
as IN I-PP
N-tosylphenylalanine NN B-NP
chloromethyl NN I-NP
ketone NN I-NP
( ( O
TPCK NN B-NP
) ) O
. . O

The DT B-NP
proliferative JJ I-NP
responses NNS I-NP
of IN B-PP
purified VBN B-NP
CD4+ JJ I-NP
or CC I-NP
CD8+ JJ I-NP
T NN I-NP
cells NNS I-NP
are VBP B-VP
suppressed VBN I-VP
more RBR B-ADVP
strongly RB I-ADVP
by IN B-PP
TPCK NN B-NP
when WRB B-ADVP
anti-CD28 NN B-NP
rather RB B-CONJP
than IN I-CONJP
the DT B-NP
phorbol NN I-NP
ester NN I-NP
PMA NN I-NP
is VBZ B-VP
used VBN I-VP
as IN B-PP
the DT B-NP
mitogenic JJ I-NP
coactivator NN I-NP
. . O

Cytokine NN B-NP
( ( O
IL-2 NN B-NP
COMMA COMMA O
IL-6 NN B-NP
COMMA COMMA O
INF-gamma NN B-NP
) ) O
production NN B-NP
is VBZ B-VP
inhibited VBN I-VP
95-100 CD B-NP
% NN I-NP
by IN B-PP
concentrations NNS B-NP
of IN B-PP
TPCK NN B-NP
that WDT B-NP
totally RB B-VP
suppress VB I-VP
the DT B-NP
mitogenesis NN I-NP
of IN B-PP
CD4+ JJ B-NP
or CC I-NP
CD8+ JJ I-NP
cells NNS I-NP
. . O

Using VBG B-VP
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
COMMA COMMA O
we PRP B-NP
find VBP B-VP
that IN B-SBAR
TPCK NN B-NP
virtually RB B-ADVP
abolishes VBZ B-VP
( ( O
to TO B-PP
less JJR B-NP
than IN I-NP
1 CD I-NP
% NN I-NP
) ) O
the DT B-NP
levels NNS I-NP
of IN B-PP
NF(kappa)B NN B-NP
( ( O
but CC B-CONJP
not RB I-CONJP
Oct-1 NN B-NP
) ) O
found VBN B-VP
in IN B-PP
nuclear JJ O
and CC O
whole JJ B-NP
cell NN I-NP
extracts NNS B-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
. . O

Strikingly RB B-ADVP
COMMA COMMA O
the DT B-NP
immunosuppressive JJ I-NP
effects NNS I-NP
of IN B-PP
TPCK NN B-NP
are VBP B-VP
blocked VBN I-VP
when WRB B-ADVP
T NN B-NP
cells NNS I-NP
are VBP B-VP
pretreated VBN I-VP
for IN B-PP
15 CD B-NP
min NN I-NP
with IN B-PP
5 CD B-NP
mM NN I-NP
NAC NN I-NP
. . O

NAC NN B-NP
not RB B-CONJP
only RB I-CONJP
blocks VBZ B-VP
the DT B-NP
effect NN I-NP
of IN B-PP
TPCK NN B-NP
but CC O
enhances VBZ B-VP
mitogenesis NN B-NP
and CC O
cytokine NN B-NP
production NN I-NP
( ( O
&gt; JJR B-ADVP
2.5-fold RB I-ADVP
in IN B-PP
some DT B-NP
cases NNS I-NP
) ) O
upon IN B-PP
activation NN B-NP
of IN B-PP
unsuppressed JJ B-NP
T NN I-NP
cells NNS I-NP
. . O

Our PRP$ B-NP
data NNS I-NP
support VBP B-VP
the DT B-NP
notion NN I-NP
that IN B-SBAR
NF NN B-NP
( ( O
kappa NN B-NP
) ) O
B NN B-VP
and CC B-NP
I NN I-NP
( ( O
kappa NN B-NP
) ) I-NP
B NN I-NP
proteases NNS B-NP
play VBP B-NP
obligate JJ B-VP
roles NNS B-NP
in IN B-NP
T NN B-VP
cell NN I-VP
activation NN B-ADVP
and CC B-PP
mitogenesis NN B-NP
COMMA COMMA O

IL-12-induced JJ B-NP
activation NN I-NP
of IN B-PP
NK NN B-NP
and CC O
T NN B-NP
cells NNS B-NP
occurs VBZ B-VP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
immediate-early JJ B-NP
activation NN I-NP
gene NN I-NP
expression NN I-NP
. . O

The DT B-NP
responses NNS I-NP
of IN B-PP
lymphocytes NNS B-NP
to TO B-PP
IL-2 NN B-NP
and CC O
IL-12 NN B-NP
COMMA COMMA O
involving VBG B-VP
proliferation NN B-NP
COMMA COMMA O
differentiation NN B-NP
COMMA COMMA O
and CC O
cytokine NN B-NP
production NN I-NP
COMMA COMMA O
are VBP B-VP
only RB I-VP
partially RB I-VP
overlapping VBG I-VP
COMMA COMMA O
and CC O
may MD B-VP
depend VB I-VP
on IN B-PP
induced VBN B-NP
differential JJ I-NP
expression NN I-NP
of IN B-PP
specific JJ B-NP
sets NNS I-NP
of IN B-PP
genes NNS B-NP
. . O

Using VBG B-VP
reverse-transcription JJ B-NP
PCR NN I-NP
differential JJ I-NP
display NN I-NP
COMMA COMMA O
we PRP B-NP
isolated VBD B-VP
an DT B-NP
mRNA NN I-NP
species NNS I-NP
expressed VBN B-VP
in IN B-PP
IL-2- NN B-NP
but CC O
not RB B-ADJP
IL-12-stimulated JJ I-ADJP
NK NN B-NP
cells NNS I-NP
. . O

This DT B-NP
was VBD B-VP
identified VBN I-VP
as IN B-PP
the DT B-NP
mRNA NN I-NP
encoding VBG B-VP
the DT B-NP
transcription NN I-NP
factor NN I-NP
egr-1 NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
expressed VBN I-VP
with IN B-PP
fast JJ B-NP
kinetics NNS I-NP
in IN B-PP
T NN B-NP
and CC O
NK NN B-NP
cells NNS B-NP
upon IN B-PP
IL-2 NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
IL-12 NN B-NP
COMMA COMMA O
stimulation NN B-NP
. . O

Analysis NN B-NP
of IN B-PP
the DT B-NP
accumulation NN I-NP
of IN B-PP
mRNA-encoding JJ B-NP
members NNS I-NP
of IN B-PP
the DT B-NP
AP-1 NN I-NP
transcription NN I-NP
factor NN I-NP
family NN I-NP
demonstrated VBD B-VP
that IN B-SBAR
c-fos NN B-NP
and CC O
junB NN B-NP
are VBP B-VP
also RB I-VP
expressed VBN I-VP
upon IN B-PP
stimulation NN B-NP
of IN B-PP
NK NN B-NP
and CC O
T NN B-NP
cells NNS B-NP
with IN B-PP
IL-2 NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
IL-12 NN B-NP
COMMA COMMA O
whereas IN O
expression NN B-NP
of IN B-PP
c-jun NN B-NP
and CC O
junD NN B-NP
is VBZ B-VP
not RB I-VP
modified VBN I-VP
by IN B-PP
either DT B-NP
cytokine NN I-NP
. . O

Accordingly RB B-ADVP
COMMA COMMA O
increased VBN B-NP
AP-1 NN I-NP
DNA-binding JJ I-NP
activity NN I-NP
and CC O
AP-1-dependent JJ B-NP
transcriptional JJ I-NP
activity NN I-NP
were VBD B-VP
detected VBN I-VP
exclusively RB B-ADVP
in IN B-PP
IL-2-stimulated JJ B-NP
cells NNS I-NP
. . O

Analysis NN B-NP
of IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
genes NNS B-NP
reported VBN B-VP
to TO I-VP
regulate VB I-VP
cytokine-induced JJ B-NP
proliferation NN I-NP
demonstrated VBD B-VP
that IN B-SBAR
both CC O
IL-2 NN B-NP
and CC O
IL-12 NN B-NP
induce VBP B-VP
c-myc NN B-NP
mRNA NN I-NP
accumulation NN I-NP
in IN B-PP
NK NN B-NP
and CC O
T NN B-NP
cells NNS B-NP
COMMA COMMA O
whereas IN O
only RB B-NP
IL-2 NN I-NP
induces VBZ B-VP
bcl-2 NN B-NP
expression NN I-NP
. . O

Our PRP$ B-NP
data NNS I-NP
provide VBP B-VP
the DT B-NP
first JJ I-NP
demonstration NN I-NP
that IN B-SBAR
IL-12-mediated JJ B-NP
activation NN I-NP
of IN B-PP
T NN B-NP
and CC O
NK NN B-NP
cells NNS B-NP
does VBZ B-VP
not RB I-VP
involve VB I-VP
expression NN B-NP
of IN B-PP
members NNS B-NP
of IN B-PP
the DT B-NP
immediate-early JJ I-NP
activation NN I-NP
genes NNS I-NP
family NN I-NP
( ( O
egr-1 NN B-NP
COMMA COMMA O
c-fos NN B-NP
COMMA COMMA O
and CC O
junB NN B-NP
) ) O
COMMA COMMA O
AP-1 NN B-NP
transcriptional JJ I-NP
activity NN I-NP
COMMA COMMA O
or CC O
bcl-2 NN B-NP
expression NN I-NP
. . O

This DT B-NP
indicates VBZ B-VP
that IN B-SBAR
functional JJ B-NP
differences NNS I-NP
observed VBN B-VP
in IN B-PP
IL-2- NN B-NP
and CC O
IL-12-stimulated JJ B-ADJP
cells NNS B-NP
may MD O
depend VB O
COMMA COMMA B-ADVP
at IN I-ADVP
least JJS B-PP
in IN B-NP
part NN B-VP
COMMA COMMA O
on IN B-NP
differential JJ I-NP
gene NN I-NP
regulation NN O

A DT B-NP
critical JJ I-NP
role NN I-NP
of IN B-PP
Sp1- NN B-NP
and CC O
Ets-related JJ B-ADJP
transcription NN B-NP
factors NNS I-NP
in IN B-PP
maintaining VBG B-VP
CTL-specific JJ B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
mouse NN I-NP
perforin NN I-NP
gene NN I-NP
. . O

This DT B-NP
study NN I-NP
was VBD B-VP
designed VBN I-VP
to TO B-VP
determine VB I-VP
the DT B-NP
potential JJ I-NP
cis-elements NNS I-NP
involved VBN B-VP
in IN B-PP
transcriptional JJ B-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
mouse NN I-NP
perforin NN I-NP
gene NN I-NP
. . O

DNase NN B-NP
I CD I-NP
hypersensitive JJ I-NP
site NN I-NP
( ( O
DHS NN B-NP
) ) O
mapping NN B-NP
revealed VBD B-VP
that IN B-SBAR
the DT B-NP
perforin NN I-NP
locus NN I-NP
contained VBD B-VP
six CD B-NP
DHS NN I-NP
within IN B-PP
7.0 CD B-NP
kb NN I-NP
of IN B-PP
the DT B-NP
5' JJ I-NP
upstream JJ I-NP
sequence NN I-NP
( ( O
-7.0 CD B-NP
kb NN I-NP
) ) O
and CC O
two CD B-NP
DHS NN I-NP
in IN B-PP
intron NN B-NP
2 CD I-NP
. . O

The DT B-NP
six CD B-NP
5' JJ I-NP
upstream JJ I-NP
and CC O
one CD B-NP
intronic JJ I-NP
DHS NN B-NP
were VBD B-VP
detected VBN I-VP
in IN B-PP
only RB B-NP
perforin-expressing JJ I-NP
lymphocytes NNS I-NP
. . O

Chloramphenicol NN B-NP
acetyltransferase NN I-NP
( ( O
CAT NN B-NP
) ) O
activities NNS B-NP
directed VBN B-VP
by IN B-PP
5' JJ B-NP
upstream JJ I-NP
promoter NN I-NP
were VBD B-VP
detected VBN I-VP
preferentially RB B-ADVP
in IN B-PP
perforin-expressing JJ B-NP
cell NN I-NP
lines NNS I-NP
. . O

A DT B-NP
construct NN I-NP
termed VBN B-VP
PFP5a NN B-NP
containing VBG B-VP
-795 CD B-NP
bp NN I-NP
exhibited VBD B-VP
the DT B-NP
highest JJS I-NP
CAT NN I-NP
activity NN I-NP
COMMA COMMA O
and CC O
PFP9a20 NN B-NP
containing VBG B-VP
only RB B-NP
-73 CD I-NP
bp NN I-NP
also RB B-ADVP
produced VBD B-VP
significantly RB B-NP
high JJ I-NP
CAT NN I-NP
activity NN I-NP
in IN B-PP
CTLL-R8 NN B-NP
cells NNS I-NP
. . O

The DT B-NP
proximal JJ I-NP
region NN I-NP
in IN B-PP
PFP9a20 NN B-NP
contained VBD B-VP
two CD B-NP
potential JJ I-NP
Sp1 NN I-NP
binding NN I-NP
sites NNS I-NP
( ( O
GC NN B-NP
box NN I-NP
and CC O
GT NN B-NP
box NN I-NP
) ) O
and CC O
one CD B-NP
Ets NN I-NP
binding NN I-NP
site NN I-NP
( ( O
EBS NN B-NP
) ) O
. . O

Electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assay NN I-NP
showed VBD B-VP
that IN B-SBAR
each DT B-NP
of IN B-PP
the DT B-NP
cis-elements NNS I-NP
bound VBD B-VP
specific JJ B-NP
protein NN I-NP
factors NNS I-NP
. . O

When WRB B-ADVP
single-point JJ B-NP
mutation NN I-NP
was VBD B-VP
introduced VBN I-VP
to TO B-PP
each DT B-NP
GC NN B-NP
box NN I-NP
COMMA COMMA O
EBS NN B-NP
COMMA COMMA O
and CC O
GT NN B-NP
box NN I-NP
in IN B-PP
PFP9a20 NN B-NP
COMMA COMMA O
at IN B-NP
least JJS I-NP
3-fold RB I-NP
less JJR I-NP
CAT NN I-NP
activity NN I-NP
was VBD B-VP
observed VBN I-VP
in IN B-PP
CTLL-R8 NN B-NP
cells NNS I-NP
. . O

To TO B-VP
confirm VB I-VP
the DT B-NP
importance NN I-NP
of IN B-PP
the DT B-NP
three CD I-NP
cis-acting JJ I-NP
elements NNS I-NP
in IN B-PP
the DT B-NP
perforin NN I-NP
gene NN I-NP
expression NN I-NP
COMMA COMMA O
point NN B-NP
mutation NN I-NP
was VBD B-VP
introduced VBN I-VP
again RB B-ADVP
to TO B-PP
each DT B-NP
proximal JJ I-NP
GC NN B-NP
box NN I-NP
COMMA COMMA O
EBS NN B-NP
COMMA COMMA O
and CC O
GT NN B-NP
box NN I-NP
of IN B-PP
PFP5a NN B-NP
. . O

The DT B-NP
point NN I-NP
mutations NNS I-NP
resulted VBD B-VP
in IN B-PP
a DT B-NP
2.5- CD I-NP
to TO I-NP
3-fold JJ I-NP
reduction NN I-NP
of IN B-PP
CAT NN B-NP
activity NN I-NP
. . O

The DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
a DT B-NP
combination NN I-NP
of IN B-PP
the DT B-NP
three CD I-NP
proximal JJ I-NP
cis-acting JJ I-NP
elements NNS I-NP
may MD B-VP
constitute VB I-VP
a DT B-NP
minimal JJ I-NP
region NN I-NP
responsible JJ B-ADJP
for IN B-PP
CTL-specific JJ B-NP
expression NN I-NP
of IN B-PP
perforin NN B-NP
. . O

Soluble JJ B-NP
factors NNS I-NP
secreted VBN B-VP
by IN B-PP
activated VBN B-NP
T-lymphocytes NNS I-NP
modulate VBP B-VP
the DT B-NP
transcription NN I-NP
of IN B-PP
the DT B-NP
immunosuppressive JJ I-NP
cytokine NN I-NP
TGF-beta NN I-NP
2 CD I-NP
in IN B-PP
glial JJ B-NP
cells NNS I-NP
. . O

Coordination NN B-NP
of IN B-PP
the DT B-NP
immune JJ I-NP
response NN I-NP
to TO B-PP
injury NN B-NP
or CC O
disease NN B-NP
in IN B-PP
the DT B-NP
brain NN I-NP
is VBZ B-VP
postulated VBN I-VP
to TO I-VP
involve VB I-VP
bi-directional JJ B-NP
discourse NN I-NP
between IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
and CC O
the DT B-NP
central JJ I-NP
nervous JJ I-NP
system NN I-NP
. . O

This DT B-NP
cross JJ I-NP
communication NN I-NP
involves VBZ B-VP
soluble JJ B-NP
mediators NNS I-NP
COMMA COMMA O
including VBG B-PP
various JJ B-NP
growth NN I-NP
factors NNS I-NP
COMMA COMMA O
cytokines NNS B-NP
COMMA COMMA O
and CC O
neuropeptides NNS B-NP
. . O

In IN B-PP
this DT B-NP
report NN I-NP
COMMA COMMA O
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
the DT B-NP
supernatant NN I-NP
from IN B-PP
activated VBN B-NP
T-lymphocytes NNS I-NP
is VBZ B-VP
able JJ B-ADJP
to TO B-VP
induce VB I-VP
the DT B-NP
transcription NN I-NP
of IN B-PP
a DT B-NP
potent JJ I-NP
cytokine NN I-NP
COMMA COMMA O
TGF-beta NN B-NP
2 CD I-NP
in IN B-PP
glial JJ B-NP
cells NNS I-NP
. . O

The DT B-NP
activating VBG I-NP
stimulus NN I-NP
invokes VBZ B-VP
signaling NN B-NP
mechanisms NNS I-NP
distinct JJ B-ADJP
from IN B-PP
known JJ O
kinase NN B-NP
or CC O
protease NN B-NP
pathways NNS B-NP
. . O

Activation NN B-NP
of IN B-PP
TGF-beta NN B-NP
2 CD I-NP
transcription NN I-NP
correlates VBZ B-VP
with IN B-PP
the DT B-NP
loss NN I-NP
of IN B-PP
binding NN B-NP
activity NN I-NP
for IN B-PP
an DT B-NP
80 CD I-NP
kDA NN I-NP
glial JJ I-NP
labile NN I-NP
repressor NN I-NP
protein NN I-NP
COMMA COMMA O
GLRP NN B-NP
COMMA COMMA O
to TO B-PP
a DT B-NP
responsive JJ I-NP
region NN I-NP
within IN B-PP
the DT B-NP
TFG-beta NN I-NP
2 CD I-NP
promoter NN I-NP
. . O

Although IN B-SBAR
GLRP NN B-NP
shares VBZ B-VP
some DT B-NP
characteristics NNS I-NP
with IN B-PP
the DT B-NP
inducible JJ I-NP
transcription NN I-NP
factor NN I-NP
AP-1 NN I-NP
COMMA COMMA O
it PRP B-NP
appears VBZ B-VP
to TO I-VP
be VB I-VP
distinct JJ B-ADJP
from IN B-PP
known JJ B-NP
AP-1 NN I-NP
family NN I-NP
members NNS I-NP
. . O

These DT B-NP
data NNS I-NP
along IN B-PP
with IN I-PP
previous JJ B-NP
observations NNS I-NP
demonstrating VBG B-VP
the DT B-NP
potent JJ I-NP
immunosuppressive JJ I-NP
activity NN I-NP
of IN B-PP
TGF-beta NN B-NP
2 CD I-NP
COMMA COMMA O
support VBP B-VP
a DT B-NP
model NN I-NP
for IN B-PP
a DT B-NP
feedback NN I-NP
mechanism NN I-NP
between IN B-PP
the DT B-NP
activated VBN I-NP
T-lymphocytes NNS B-NP
and CC O
astrocytes NNS B-NP
via IN B-PP
TGF-beta NN B-NP
2 CD I-NP
to TO B-VP
regulate VB I-VP
the DT B-NP
immune JJ I-NP
response NN I-NP
. . O

Dual JJ B-NP
action NN I-NP
of IN B-PP
retinoic JJ B-NP
acid NN I-NP
on IN B-PP
human JJ B-NP
embryonic\/fetal JJ I-NP
hematopoiesis NN I-NP
: : O
blockade NN B-NP
of IN B-PP
primitive JJ B-NP
progenitor NN I-NP
proliferation NN I-NP
and CC O
shift NN B-NP
from IN B-PP
multipotent\/erythroid/monocytic JJ B-NP
to TO B-PP
granulocytic JJ B-NP
differentiation NN B-NP
program NN I-NP
. . O

In IN B-PP
preliminary JJ B-NP
studies NNS I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
analyzed VBN I-VP
the DT O
hematopoietic JJ B-NP
growth NN I-NP
factor NN I-NP
( ( O
HGF NN B-NP
) ) O
requirement NN B-NP
of IN B-PP
hematopoietic JJ B-NP
progenitor NN I-NP
cells NNS I-NP
( ( O
HPCs NNS B-NP
) ) O
purified VBN B-VP
from IN B-PP
embryonic-fetal JJ B-NP
liver NN I-NP
( ( O
FL NN B-NP
) ) O
and CC O
grown VBN B-VP
in IN B-PP
fetal JJ O
calf NN O
serum-supplemented JJ O
( ( O
FCS+ NN B-ADJP
) ) O
clonogenic JJ B-NP
culture NN I-NP
. . O

The DT B-NP
key JJ I-NP
role NN I-NP
of IN B-PP
erythropoietin NN B-NP
( ( O
Epo NN B-NP
) ) O
for IN B-PP
colony NN B-NP
formation NN I-NP
by IN B-PP
early JJ B-NP
erythroid JJ I-NP
progenitors NNS I-NP
( ( O
burst-forming JJ B-NP
units-erythroid JJ I-NP
{ ( O
BFU-E NN B-NP
} ) O
) ) O
has VBZ B-VP
been VBN I-VP
confirmed VBN I-VP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
exogenous JJ B-NP
HGFs NNS I-NP
COMMA COMMA O
FL NN B-NP
monocytic JJ I-NP
progenitors NNS I-NP
( ( O
colony-forming JJ B-NP
unit NN I-NP
monocyte NN I-NP
{ ( O
CFU-M NN B-NP
} ) O
) ) O
generate VBP B-VP
large JJ B-NP
colonies NNS I-NP
exclusively RB B-VP
composed VBN I-VP
of IN B-PP
monocytes-macrophages NNS B-NP
; : O
these DT B-NP
colonies NNS I-NP
are VBP B-VP
absent JJ B-ADJP
in IN B-PP
FCS- NN B-NP
clonogenic JJ I-NP
culture NN I-NP
. . O

On IN B-PP
this DT B-NP
basis NN I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
investigated VBN I-VP
the DT B-NP
role NN I-NP
of IN B-PP
all-trans JJ B-NP
retinoic JJ I-NP
acid NN I-NP
( ( O
ATRA NN B-NP
) ) O
and CC O
its PRP$ B-NP
isomer NN I-NP
9-cis JJ I-NP
RA NN I-NP
in IN B-PP
FL NN B-NP
hematopoiesis NN I-NP
. . O

Vitamin NN B-NP
D3- NN I-NP
and CC O
retinoic JJ B-ADJP
acid-induced JJ I-ADJP
monocytic JJ B-NP
differentiation NN I-NP
: : O
interactions NNS B-NP
between IN B-PP
the DT B-NP
endogenous JJ B-NP
vitamin NN I-NP
D3 NN I-NP
receptor NN I-NP
COMMA COMMA O
retinoic JJ B-NP
acid NN I-NP
receptors NNS I-NP
COMMA COMMA O
and CC O
retinoid NN B-NP
X NN I-NP
receptors NNS I-NP
in IN B-PP
U-937 NN B-NP
cells NNS I-NP
. . O

Retinoic JJ B-NP
acid NN I-NP
( ( O
RA NN B-NP
) ) O
and CC O
1COMMA25 CD B-NP
alpha-dihydroxycholecalciferol NN I-NP
( ( O
VitD3 NN B-NP
) ) O
are VBP B-VP
potent JJ B-NP
regulators NNS I-NP
of IN B-PP
hematopoletic JJ B-NP
differentiation NN I-NP
. . O

Yet RB O
COMMA COMMA O
little JJ B-NP
is VBZ B-VP
known VBN I-VP
as IN B-PP
to TO I-PP
how WRB B-ADVP
the DT O
RA NN B-NP
and CC O
VitD3 NN B-NP
receptor NN B-NP
network NN I-NP
operates VBZ B-VP
in IN B-PP
hematopoietic JJ B-NP
cells NNS I-NP
COMMA COMMA O
and CC O
whether IN B-SBAR
receptor NN B-NP
interactions NNS I-NP
can MD B-VP
explain VB I-VP
the DT B-NP
interplay NN I-NP
between IN B-PP
the DT O
RA- NN B-NP
and CC O
VitD3-signaling JJ B-ADJP
pathways NNS B-NP
during IN B-PP
differentiation NN B-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
we PRP B-NP
analyzed VBD B-VP
the DT B-NP
expression NN B-NP
COMMA COMMA O
DNA NN B-NP
binding NN I-NP
COMMA COMMA O
and CC O
transcriptional JJ B-NP
activity NN I-NP
of IN B-PP
the DT O
endogenous JJ O
RA NN B-NP
and CC O
VitD3 NN B-NP
receptors NNS B-NP
{ ( O
retinoic JJ B-NP
acid NN I-NP
receptors NNS I-NP
( ( O
RARs NNS B-NP
) ) O
COMMA COMMA O
retinoid NN B-NP
X NN I-NP
receptors NNS I-NP
( ( O
RXRs NNS B-NP
) ) O
COMMA COMMA O
and CC O
VitD3 NN B-NP
receptor NN I-NP
( ( O
VDR NN B-NP
) ) O
} ) O
in IN B-PP
the DT B-NP
U-937 NN I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
in IN B-PP
which WDT B-NP
RA NN B-NP
and CC O
VitD3 NN B-NP
induce VBP B-VP
distinct JJ B-NP
monocytic JJ I-NP
differentiation NN I-NP
pathways NNS I-NP
. . O

VitD3 NN B-NP
induction NN I-NP
resulted VBD B-VP
in IN B-PP
the DT B-NP
formation NN I-NP
of IN B-PP
VDR\/RXR NN B-NP
DNA-binding JJ I-NP
complexes NNS I-NP
on IN B-PP
both CC O
VitD3 NN B-NP
response NN I-NP
elements NNS I-NP
and CC O
RA NN B-NP
response NN I-NP
elements NNS I-NP
( ( O
RAREs NNS B-NP
) ) O
. . O

However RB B-ADVP
COMMA COMMA O
transcriptional JJ B-NP
activation NN I-NP
was VBD B-VP
only RB I-VP
observed VBN I-VP
from IN B-PP
a DT B-NP
VitD3 NN I-NP
response NN I-NP
element-driven JJ I-NP
reporter NN I-NP
construct NN I-NP
. . O

Several JJ B-NP
DNA-binding JJ I-NP
complexes NNS I-NP
were VBD B-VP
detected VBN I-VP
on IN B-PP
RAREs NNS B-NP
in IN B-PP
undifferentiated JJ B-NP
cells NNS I-NP
. . O

Stimulation NN B-NP
by IN B-PP
RA NN B-NP
resulted VBD B-VP
in IN B-PP
increased VBN B-NP
RAR NN I-NP
beta\/RXR NN I-NP
DNA NN I-NP
binding NN I-NP
COMMA COMMA O
activated VBN B-NP
RARE-dependent JJ I-NP
transcription NN I-NP
COMMA COMMA O
and CC O
increased VBN B-NP
expression NN I-NP
of IN B-PP
RAR-beta NN B-NP
. . O

Concomitant JJ B-NP
stimulation NN I-NP
by IN B-PP
VitD3 NN B-NP
inhibited VBD B-VP
the DT B-NP
RA-stimulated JJ I-NP
formation NN I-NP
of IN B-PP
RAR NN B-NP
beta\/RXR NN I-NP
heterodimers NNS I-NP
COMMA COMMA O
favoring VBG B-VP
VDR\/RXR NN B-NP
binding NN I-NP
to TO B-PP
the DT B-NP
RARE NN I-NP
. . O

Also RB B-ADVP
COMMA COMMA O
VitD3 NN B-NP
inhibited VBD B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
CD23 NN B-NP
and CC O
CD49f NN B-NP
COMMA COMMA O
characteristic JJ B-NP
markers NNS I-NP
of IN B-PP
retinoid-induced JJ B-NP
U-937 NN I-NP
cell NN I-NP
differentiation NN I-NP
. . O

In IN O
contrast NN B-NP
COMMA COMMA O
neither CC O
the DT B-NP
RA-stimulated JJ I-NP
COMMA COMMA I-NP
RARE-mediated JJ I-NP
transcription NN I-NP
nor CC O
the DT B-NP
induced VBN I-NP
RAR-beta NN I-NP
expression NN I-NP
was VBD B-VP
suppressed VBN I-VP
by IN B-PP
VitD3 NN B-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
VitD3 NN B-NP
selectively RB B-ADVP
inhibited VBD B-VP
the DT B-NP
retinoid-induced JJ I-NP
differentiation NN I-NP
program NN I-NP
but CC B-CONJP
not RB I-CONJP
the DT B-NP
RARE-mediated JJ I-NP
signal NN I-NP
. . O

These DT B-NP
results NNS I-NP
demonstrate VBP B-VP
a DT B-NP
complex JJ I-NP
role NN I-NP
for IN B-PP
VitD3 NN B-NP
in IN B-PP
modifying VBG B-VP
the DT B-NP
retinoid NN I-NP
differentiation NN I-NP
pathway NN I-NP
and CC O
may MD B-VP
have VB I-VP
implications NNS B-NP
for IN B-PP
differentiation-inducing JJ B-NP
therapy NN I-NP
of IN B-PP
hematopoietic JJ B-NP
tumors NNS I-NP
. . O

Regulation NN B-NP
of IN B-PP
interferon-gamma NN B-NP
gene NN I-NP
expression NN I-NP
. . O

Interferon-gamma NN B-NP
( ( O
IFN-gamma NN B-NP
) ) O
COMMA COMMA O
also RB B-VP
known VBN I-VP
as IN B-PP
type NN B-NP
II CD I-NP
interferon NN I-NP
COMMA COMMA O
is VBZ B-VP
an DT B-NP
important JJ I-NP
immunoregulatory JJ I-NP
gene NN I-NP
that WDT B-NP
has VBZ B-VP
multiple JJ B-NP
effects NNS I-NP
on IN B-PP
the DT B-NP
development NN B-NP
COMMA COMMA O
maturation NN B-NP
COMMA COMMA O
and CC O
function NN B-NP
of IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
. . O

In IN B-PP
this DT B-NP
review NN I-NP
COMMA COMMA O
I PRP B-NP
describe VBP B-VP
how WRB B-ADVP
DNA NN B-NP
methylation NN I-NP
and CC O
specific JJ B-NP
DNA NN I-NP
binding NN I-NP
proteins NNS I-NP
may MD B-VP
regulate VB I-VP
transcription NN B-NP
of IN B-PP
the DT B-NP
IFN-gamma NN I-NP
gene NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
extracellular JJ B-NP
signals NNS I-NP
. . O

Inorganic JJ B-NP
lead NN I-NP
activates VBZ B-VP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
primary JJ B-NP
human JJ I-NP
CD4+ JJ I-NP
T NN I-NP
lymphocytes NNS I-NP
. . O

Inorganic JJ B-NP
lead NN I-NP
( ( O
Pb NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
ubiquitous JJ I-NP
environmental JJ I-NP
contaminant NN I-NP
that WDT B-NP
produces VBZ B-VP
a DT B-NP
variety NN I-NP
of IN B-PP
effects NNS B-NP
on IN B-PP
humoral JJ B-NP
and CC I-NP
cell NN I-NP
mediated JJ I-NP
immune JJ I-NP
responses NNS I-NP
. . O

The DT B-NP
underlying VBG I-NP
molecular JJ I-NP
mechanism NN I-NP
for IN B-PP
Pb NN B-NP
's POS B-NP
complex JJ I-NP
effects NNS I-NP
on IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
remain VBP B-VP
obscure JJ B-ADJP
. . O

Many JJ B-NP
of IN B-PP
Pb NN B-NP
's POS B-NP
effects NNS I-NP
on IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
could MD B-VP
be VB I-VP
explained VBN I-VP
through IN B-PP
activation NN B-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
COMMA COMMA O
NF-kappa NN B-NP
B NN I-NP
. . O

NF-kappa NN B-NP
B NN I-NP
is VBZ B-VP
critical JJ B-ADJP
for IN B-PP
T NN B-NP
lymphocyte NN I-NP
function NN I-NP
and CC O
is VBZ B-VP
a DT B-NP
strong JJ I-NP
inducer NN I-NP
of IN B-PP
HIV-LTR NN B-NP
activation NN I-NP
. . O

We PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
Pb NN B-NP
at IN B-PP
physiologically RB B-NP
relevant JJ I-NP
concentrations NNS I-NP
activates VBZ B-VP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
primary JJ B-NP
human JJ I-NP
CD4+ JJ I-NP
T NN I-NP
lymphocytes NNS I-NP
. . O

Pb-induced JJ B-NP
activation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
is VBZ B-VP
blocked VBN I-VP
by IN B-PP
antibodies NNS B-NP
for IN B-PP
p65 NN B-NP
and CC O
p50 NN B-NP
subunits NNS B-NP
but CC B-CONJP
not RB I-CONJP
cRel NN B-NP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
the DT B-NP
p65:p50 NN I-NP
heterodimer NN I-NP
( ( O
NF-kappa NN B-NP
B NN I-NP
) ) O
is VBZ B-VP
involved VBN I-VP
. . O

Functional JJ B-NP
activation NN I-NP
of IN B-PP
gene NN B-NP
expression NN I-NP
by IN B-PP
Pb NN B-NP
was VBD B-VP
confirmed VBN I-VP
using VBG B-VP
primary JJ B-NP
CD4+ JJ I-NP
T NN I-NP
cells NNS I-NP
transfected VBN B-VP
with IN B-PP
an DT O
NF-kappa NN B-NP
B NN I-NP
dependent JJ B-NP
reporter NN I-NP
gene NN I-NP
construct NN I-NP
. . O

Pb NN B-NP
did VBD B-VP
not RB I-VP
activate VB I-VP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
4 CD B-NP
different JJ I-NP
T NN I-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
lymphoid JJ B-NP
cell NN I-NP
lines NNS I-NP
may MD B-VP
not RB I-VP
be VB I-VP
reliable JJ B-NP
surrogates NNS I-NP
for IN B-PP
the DT B-NP
study NN I-NP
of IN B-PP
transcriptional JJ B-NP
activation NN I-NP
in IN B-PP
human JJ B-NP
T NN I-NP
cells NNS I-NP
. . O

These DT B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
NF-kappa NN B-NP
B NN I-NP
may MD B-VP
be VB I-VP
an DT B-NP
important JJ I-NP
molecular JJ I-NP
mediator NN I-NP
of IN B-PP
Pb-induced JJ B-NP
immunotoxicity NN I-NP
. . O

Calcium-dependent JJ B-NP
immediate-early JJ I-NP
gene NN I-NP
induction NN I-NP
in IN B-PP
lymphocytes NNS B-NP
is VBZ B-VP
negatively RB I-VP
regulated VBN I-VP
by IN B-PP
p21Ha-ras NN B-NP
. . O

The DT B-NP
induction NN I-NP
of IN B-PP
immediate-early JJ O
( ( O
IE JJ B-ADJP
) ) O
response NN B-NP
genes NNS I-NP
COMMA COMMA O
such JJ B-PP
as IN I-PP
egr-1 NN B-NP
COMMA COMMA O
c-fos NN B-NP
COMMA COMMA O
and CC O
c-jun NN B-NP
COMMA COMMA O
occurs VBZ B-VP
rapidly RB B-ADVP
after IN B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
T NN B-NP
lymphocytes NNS I-NP
. . O

The DT B-NP
process NN I-NP
of IN B-PP
activation NN B-NP
involves VBZ B-VP
calcium NN B-NP
mobilization NN I-NP
COMMA COMMA O
activation NN B-NP
of IN B-PP
protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( O
PKC NN B-NP
) ) O
COMMA COMMA O
and CC O
phosphorylation NN B-NP
of IN B-PP
tyrosine NN B-NP
kinases NNS I-NP
. . O

p21(ras) NN B-NP
COMMA COMMA O
a DT B-NP
guanine NN I-NP
nucleotide NN I-NP
binding NN I-NP
factor NN I-NP
COMMA COMMA O
mediates VBZ B-VP
T-cell NN B-NP
signal NN I-NP
transduction NN I-NP
through IN B-PP
PKC-dependent JJ B-NP
and CC I-NP
PKC-independent JJ I-NP
pathways NNS I-NP
. . O

The DT B-NP
involvement NN I-NP
of IN B-PP
p21(ras) NN B-NP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
calcium-dependent JJ B-NP
signals NNS I-NP
has VBZ B-VP
been VBN I-VP
suggested VBN I-VP
through IN B-PP
analysis NN B-NP
of IN B-PP
its PRP$ B-NP
role NN I-NP
in IN B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
NF-AT NN B-NP
. . O

We PRP B-NP
have VBP B-VP
investigated VBN I-VP
the DT B-NP
inductions NNS I-NP
of IN B-PP
the DT B-NP
IE JJ I-NP
genes NNS I-NP
in IN B-PP
response NN I-PP
to TO I-PP
calcium NN B-NP
signals NNS I-NP
in IN B-PP
Jurkat NN B-NP
cells NNS I-NP
( ( O
in IN B-PP
the DT I-PP
presence NN I-PP
of IN I-PP
activated VBN B-NP
p21(ras) NN I-NP
) ) O
and CC O
their PRP$ B-NP
correlated VBN I-NP
consequences NNS I-NP
. . O

The DT B-NP
expression NN I-NP
of IN B-PP
activated VBN B-NP
p21(ras) NN I-NP
negatively RB B-ADVP
regulated VBD B-VP
the DT B-NP
induction NN I-NP
of IN B-PP
IE JJ B-NP
genes NNS I-NP
by IN B-PP
calcium NN B-NP
ionophore NN I-NP
. . O

This DT B-NP
inhibition NN I-NP
of IN B-PP
calcium-activated JJ B-NP
IE JJ I-NP
gene NN I-NP
induction NN I-NP
was VBD B-VP
reversed VBN I-VP
by IN B-PP
treatment NN B-NP
with IN B-PP
cyclosporin NN B-NP
A NN I-NP
COMMA COMMA O
suggesting VBG B-VP
the DT B-NP
involvement NN I-NP
of IN B-PP
calcineurin NN B-NP
in IN B-PP
this DT B-NP
regulation NN I-NP
. . O

A DT B-NP
later JJ I-NP
result NN I-NP
of IN B-PP
inhibition NN B-NP
of IN B-PP
this DT B-NP
activation NN I-NP
pathway NN I-NP
by IN B-PP
p21(ras) NN B-NP
was VBD B-VP
down-regulation NN B-NP
of IN B-PP
the DT B-NP
activity NN I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
AP-1 NN I-NP
and CC O
subsequent JJ B-NP
coordinate JJ I-NP
reductions NNS I-NP
in IN B-PP
IL-2 NN B-NP
gene NN I-NP
expression NN I-NP
and CC O
protein NN B-NP
production NN I-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
p2l(ras) NN B-NP
is VBZ B-VP
an DT B-NP
essential JJ I-NP
mediator NN I-NP
in IN B-PP
generating VBG B-VP
not RB B-CONJP
only RB I-CONJP
positive JJ O
but CC B-CONJP
also RB I-CONJP
negative JJ B-NP
modulatory JJ I-NP
mechanisms NNS I-NP
controlling VBG B-VP
the DT B-NP
competence NN I-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
in IN B-PP
response NN I-PP
to TO I-PP
inductive JJ B-NP
stimulations NNS I-NP
. . O

CD14-mediated JJ B-NP
signal NN I-NP
pathway NN I-NP
of IN B-PP
Porphyromonas NN B-NP
gingivalis NN I-NP
lipopolysaccharide NN I-NP
in IN B-PP
human JJ B-NP
gingival JJ I-NP
fibroblasts NNS I-NP
. . O

Lipopolysaccharide NN B-NP
( ( O
LPS NN B-NP
) ) O
induces VBZ B-VP
expression NN B-NP
of IN B-PP
inflammatory JJ B-NP
cytokines NNS I-NP
in IN B-PP
monocytes\/macrophages NNS B-NP
via IN B-PP
CD14 NN B-NP
COMMA COMMA O
one CD B-NP
of IN B-PP
the DT B-NP
LPS NN I-NP
receptors NNS I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
expressed VBN I-VP
predominantly RB B-ADVP
in IN B-PP
these DT B-NP
cells NNS I-NP
. . O

It PRP B-NP
has VBZ B-VP
been VBN I-VP
demonstrated VBN I-VP
that IN B-SBAR
Porphyromonas NN B-NP
gingivalis NN I-NP
LPS NN I-NP
( ( O
P-LPS NN B-NP
) ) O
also RB B-ADVP
is VBZ B-VP
able JJ B-ADJP
to TO B-VP
induce VB I-VP
inflammatory JJ B-NP
cytokines NNS I-NP
in IN B-PP
human JJ B-NP
gingival JJ I-NP
fibroblasts NNS I-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
it PRP B-NP
is VBZ B-VP
important JJ B-ADJP
to TO B-VP
determine VB I-VP
whether IN B-SBAR
CD14 NN B-NP
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
gingival JJ B-NP
fibroblasts NNS I-NP
and CC O
to TO B-VP
define VB I-VP
the DT B-NP
P-LPS-mediated JJ I-NP
signal-transducing JJ I-NP
mechanism NN I-NP
in IN B-PP
the DT B-NP
cells NNS I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
we PRP B-NP
observed VBD B-VP
unexpectedly RB B-ADVP
by IN B-PP
immunohistochemical JJ O
COMMA COMMA O
Western JJ B-NP
blotting NN I-NP
( ( O
immunoblotting NN B-NP
) ) O
COMMA COMMA O
and CC O
Northern NN B-NP
( ( I-NP
RNA NN I-NP
) ) I-NP
blotting NN I-NP
assays NNS B-NP
that IN B-SBAR
CD14 NN B-NP
is VBZ B-VP
expressed VBN I-VP
at IN B-PP
high JJ B-NP
density NN I-NP
in IN B-PP
human JJ B-NP
gingival JJ I-NP
fibroblasts NNS I-NP
. . O

P-LPS-induced JJ B-NP
expression NN I-NP
of IN B-PP
the DT O
monocyte NN B-NP
chemoattractant NN I-NP
protein NN I-NP
1 CD I-NP
( ( O
MCP-1 NN B-NP
) ) O
gene NN B-NP
in IN B-PP
the DT B-NP
cells NNS I-NP
was VBD B-VP
inhibited VBN I-VP
markedly RB B-ADVP
by IN B-PP
treatment NN B-NP
with IN B-PP
anti-human JJ B-NP
CD14 NN I-NP
antibody NN I-NP
and CC O
was VBD B-VP
completely RB I-VP
inhibited VBN I-VP
by IN B-PP
herbimycin NN B-NP
A NN I-NP
COMMA COMMA O
a DT B-NP
potent JJ I-NP
inhibitor NN I-NP
of IN B-PP
tyrosine NN B-NP
kinase NN I-NP
. . O

The DT B-NP
inhibitor NN I-NP
also RB B-ADVP
dramatically RB B-VP
inhibited VBD I-VP
monocyte NN B-NP
chemotactic JJ I-NP
activity NN I-NP
of IN B-PP
and CC O
MCP-1 NN B-NP
production NN I-NP
by IN B-PP
the DT B-NP
cells NNS I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
P-LPS-induced JJ B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
MCP-1 JJ I-NP
gene NN I-NP
in IN B-PP
the DT B-NP
cells NNS I-NP
also RB B-ADVP
was VBD B-VP
blocked VBN I-VP
by IN B-PP
inhibitors NNS B-NP
of IN B-PP
two CD B-NP
transcription NN I-NP
factors NNS I-NP
COMMA COMMA O
i.e. FW B-ADVP
COMMA COMMA O
curcumin NN B-NP
COMMA COMMA O
an DT B-NP
inhibitor NN I-NP
of IN B-PP
AP-1 NN B-NP
COMMA COMMA O
and CC O
pyrolidine NN B-NP
dithiocarbamate NN I-NP
COMMA COMMA O
an DT B-NP
inhibitor NN I-NP
of IN B-PP
NF-kappaB NN B-NP
. . O

Both DT B-NP
inhibitors NNS I-NP
inhibited VBD B-VP
monocyte NN B-NP
chemotactic JJ I-NP
activity NN I-NP
in IN B-PP
the DT B-NP
culture NN I-NP
supernatant JJ I-NP
of IN B-PP
P-LPS-treated JJ B-NP
cells NNS I-NP
. . O

Gel NN B-NP
shift NN I-NP
mobility NN I-NP
assay NN I-NP
showed VBD B-VP
stimulation NN B-NP
of IN B-PP
the DT O
AP-1 NN B-NP
and CC O
NF-kappaB NN B-NP
contents NNS B-NP
in IN B-PP
P-LPS-treated JJ B-NP
cells NNS I-NP
. . O

This DT B-NP
study NN I-NP
is VBZ B-VP
the DT B-NP
first JJ I-NP
to TO B-VP
demonstrate VB I-VP
the DT B-NP
expression NN I-NP
of IN B-PP
CD14 NN B-NP
in IN B-PP
human JJ B-NP
gingival JJ I-NP
fibroblasts NNS I-NP
and CC O
to TO B-VP
show VB I-VP
that IN B-SBAR
the DT B-NP
signal-transducing JJ I-NP
pathway NN I-NP
of IN B-PP
P-LPS NN B-NP
in IN B-PP
the DT B-NP
cells NNS I-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
CD14 NN B-NP
. . O

Tyrosines NNS B-NP
113 CD B-NP
COMMA COMMA O
128 CD B-NP
COMMA COMMA O
and CC O
145 CD B-NP
of IN B-PP
SLP-76 NN B-NP
are VBP B-VP
required VBN I-VP
for IN B-PP
optimal JJ B-NP
augmentation NN I-NP
of IN B-PP
NFAT NN B-NP
promoter NN I-NP
activity NN I-NP
. . O

SLP-76 NN B-NP
( ( O
SH2 NN B-NP
domain NN I-NP
leukocyte NN I-NP
protein NN I-NP
of IN B-PP
76 CD B-NP
kDa NN I-NP
) ) O
is VBZ B-VP
a DT B-NP
recently RB I-NP
identified VBN I-NP
substrate NN I-NP
of IN B-PP
the DT B-NP
TCR-stimulated JJ I-NP
protein NN I-NP
tyrosine NN I-NP
kinases NNS I-NP
that WDT B-NP
functions VBZ B-VP
in IN B-PP
the DT B-NP
signal NN I-NP
transduction NN I-NP
cascade NN I-NP
linking VBG B-VP
the DT B-NP
TCR NN I-NP
with IN B-PP
IL-2 NN B-NP
gene NN I-NP
expression NN I-NP
. . O

In IN B-PP
this DT B-NP
report NN I-NP
COMMA COMMA O
we PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
engagement NN B-NP
of IN B-PP
the DT B-NP
TCR NN I-NP
results VBZ B-VP
in IN B-PP
tyrosine NN B-NP
phosphorylation NN I-NP
of IN B-PP
SLP-76 NN B-NP
in IN B-PP
its PRP$ B-NP
amino-terminal JJ I-NP
acidic JJ I-NP
region NN I-NP
. . O

Two CD B-NP
tyrosines NNS I-NP
( ( O
Y113 NN B-NP
and CC O
Y128 NN B-NP
) ) O
fall VBP B-VP
within IN B-PP
an DT B-NP
identical JJ I-NP
five CD I-NP
amino-acid JJ I-NP
motif NN I-NP
and CC O
are VBP B-VP
shown VBN I-VP
to TO B-VP
be VB I-VP
phosphorylated VBN I-VP
upon IN B-PP
TCR NN B-NP
ligation NN I-NP
. . O

Although IN B-SBAR
mutation NN B-NP
of IN B-PP
either CC O
Y113 NN B-NP
and CC O
Y128 NN B-NP
has VBZ B-VP
a DT B-NP
minimal JJ I-NP
effect NN I-NP
on IN B-PP
SLP-76 NN B-NP
function NN I-NP
COMMA COMMA O
mutation NN B-NP
of IN B-PP
both DT B-NP
residues NNS I-NP
decreases VBZ B-VP
significantly RB B-ADVP
the DT B-NP
ability NN I-NP
of IN B-PP
SLP-76 NN B-NP
to TO B-VP
promote VB I-VP
T NN B-NP
cell NN I-NP
activation NN I-NP
. . O

A DT B-NP
third JJ I-NP
tyrosine NN I-NP
within IN B-PP
the DT B-NP
amino-terminal JJ I-NP
region NN I-NP
( ( O
Y145 NN B-NP
) ) O
appears VBZ B-VP
to TO I-VP
be VB I-VP
the DT B-NP
most RBS I-NP
important JJ I-NP
for IN B-PP
optimal JJ B-NP
SLP-76 NN I-NP
function NN I-NP
COMMA COMMA O
as IN B-SBAR
altering VBG B-VP
it PRP B-NP
alone RB B-ADVP
to TO B-PP
phenylalanine NN B-NP
has VBZ B-VP
a DT B-NP
potent JJ I-NP
impact NN I-NP
on IN B-PP
SLP-76 NN B-NP
augmentation NN I-NP
of IN B-PP
NFAT NN B-NP
promoter NN I-NP
activity NN I-NP
. . O

The DT B-NP
catalytic JJ I-NP
domain NN I-NP
of IN B-PP
pp56(lck) NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
its PRP$ B-NP
regulatory JJ I-NP
domain NN I-NP
COMMA COMMA O
is VBZ B-VP
sufficient JJ B-ADJP
for IN B-PP
inducing VBG B-VP
IL-2 NN B-NP
production NN I-NP
. . O

The DT B-NP
lymphoid JJ I-NP
src NN I-NP
kinase NN I-NP
pp56(lck) NN I-NP
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
essential JJ B-ADJP
for IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
different JJ B-NP
T NN I-NP
lymphocyte NN I-NP
responses NNS I-NP
COMMA COMMA O
including VBG B-PP
CD4-mediated JJ B-NP
enhancement NN I-NP
of IN B-PP
Ag-induced JJ B-NP
T NN I-NP
cell NN I-NP
activation NN I-NP
COMMA COMMA O
early JJ B-NP
T NN I-NP
cell NN I-NP
differentiation NN I-NP
COMMA COMMA O
induction NN B-NP
of IN B-PP
IL-2 NN B-NP
production NN I-NP
COMMA COMMA O
and CC O
cytotoxicity NN B-NP
. . O

It PRP B-NP
is VBZ B-VP
assumed VBN I-VP
that IN B-SBAR
pp56(lck) NN B-NP
acts VBZ B-VP
on IN B-PP
these DT B-NP
processes NNS I-NP
by IN B-PP
phosphorylating VBG B-VP
substrates NNS B-NP
. . O

However RB B-ADVP
COMMA COMMA O
it PRP B-NP
has VBZ B-VP
been VBN I-VP
recently RB I-VP
reported VBN I-VP
that IN B-SBAR
the DT B-NP
NH2 NN I-NP
regulatory JJ I-NP
domain NN I-NP
is VBZ B-VP
sufficient JJ B-ADJP
to TO B-VP
mediate VB I-VP
CD4 NN B-NP
accessory JJ I-NP
function NN I-NP
. . O

In IN B-PP
this DT B-NP
report NN I-NP
we PRP B-NP
address VBP B-VP
the DT B-NP
contribution NN I-NP
of IN B-PP
the DT B-NP
regulatory JJ I-NP
and CC I-NP
catalytic JJ I-NP
domains NNS I-NP
of IN B-PP
pp56(lck) NN B-NP
to TO B-PP
another DT B-NP
function NN I-NP
of IN B-PP
this DT B-NP
enzyme NN I-NP
independent JJ B-ADJP
of IN B-PP
CD4 NN B-NP
: : O
TCR-induced JJ B-NP
IL-2 NN I-NP
production NN I-NP
. . O

Two CD B-NP
pp56(lck) NN I-NP
mutants NNS I-NP
lacking VBG B-VP
either CC O
the DT B-NP
entire JJ I-NP
catalytic JJ I-NP
domain NN I-NP
or CC O
the DT B-NP
entire JJ I-NP
NH2 NN I-NP
regulatory JJ I-NP
domain NN I-NP
were VBD B-VP
generated VBN I-VP
COMMA COMMA O
and CC O
their PRP$ B-NP
abilities NNS I-NP
to TO B-VP
trigger VB I-VP
transactivation NN B-NP
of IN B-PP
the DT O
TCR-regulated JJ O
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
( ( O
NF-AT NN B-NP
) ) O
region NN B-NP
of IN B-PP
the DT B-NP
IL-2 NN I-NP
promoter NN I-NP
were VBD B-VP
compared VBN I-VP
. . O

Only RB B-NP
the DT B-NP
catalytic JJ I-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
the DT B-NP
NH2 NN I-NP
regulatory JJ I-NP
COMMA COMMA O
domain NN B-NP
of IN B-PP
pp56(lck) NN B-NP
was VBD B-VP
able JJ B-ADJP
to TO B-VP
induce VB I-VP
NF-AT NN B-NP
region NN I-NP
transactivation NN I-NP
on IN B-PP
its PRP$ B-NP
own JJ I-NP
and CC O
to TO B-VP
cooperate VB I-VP
with IN B-PP
other JJ B-NP
intracellular JJ I-NP
signals NNS I-NP
to TO B-VP
trigger VB I-VP
this DT B-NP
response NN I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
the DT B-NP
catalytic JJ I-NP
domain NN I-NP
of IN B-PP
pp56(lck) NN B-NP
was VBD B-VP
able JJ B-ADJP
to TO B-VP
induce VB I-VP
IL-2 NN B-NP
cytokine NN I-NP
production NN I-NP
to TO B-PP
an DT B-NP
extent NN I-NP
similar JJ B-ADJP
to TO B-PP
that DT B-NP
of IN B-PP
wild-type JJ B-NP
pp56(lck) NN I-NP
. . O

We PRP B-NP
conclude VBP B-VP
that IN B-SBAR
different JJ B-NP
domains NNS I-NP
of IN B-PP
the DT B-NP
pp56(lck) NN I-NP
molecule NN I-NP
contribute VBP B-VP
to TO I-VP
regulate VB I-VP
distinct JJ B-NP
biologic JJ I-NP
functions NNS I-NP
. . O

In IN B-PP
fact NN B-NP
COMMA COMMA O
while IN B-SBAR
the DT B-NP
NH2 NN I-NP
regulatory JJ I-NP
domain NN I-NP
is VBZ B-VP
sufficient JJ B-ADJP
to TO B-VP
mediate VB I-VP
CD4 NN B-NP
accessory JJ I-NP
function NN I-NP
COMMA COMMA O
we PRP B-NP
show VBP B-VP
here RB B-ADVP
that IN B-SBAR
the DT B-NP
catalytic JJ I-NP
domain NN I-NP
of IN B-PP
pp56(lck) NN B-NP
is VBZ B-VP
sufficient JJ B-ADJP
for IN B-PP
induction NN B-NP
of IN B-PP
IL-2 NN B-NP
production NN I-NP
COMMA COMMA O
mimicking VBG B-VP
TCR NN B-NP
ligation NN I-NP
. . O

Isolation NN B-NP
and CC O
characterization NN B-NP
of IN B-PP
murine JJ B-NP
fra-1 NN I-NP
: : O
induction NN B-NP
mediated VBN B-VP
by IN B-PP
CD40 NN B-NP
and CC O
surface NN B-NP
Ig NN I-NP
is VBZ B-VP
protein NN B-NP
kinase NN I-NP
C NN I-NP
dependent JJ B-ADJP
. . O

The DT B-NP
murine JJ I-NP
fra-1 NN I-NP
gene NN I-NP
COMMA COMMA O
encoding VBG B-VP
Fos-related JJ B-NP
Ag NN I-NP
1 CD I-NP
COMMA COMMA O
was VBD B-VP
isolated VBN I-VP
from IN B-PP
a DT B-NP
splenic JJ I-NP
cDNA NN I-NP
library NN I-NP
and CC O
sequenced VBN B-VP
. . O

Murine JJ B-NP
fra-1 NN I-NP
was VBD B-VP
highly RB B-ADJP
homologous JJ I-ADJP
to TO B-PP
rat NN B-NP
and CC O
human JJ B-ADJP
fra-1 NN B-NP
. . O

Oligonucleotide NN B-NP
primers NNS I-NP
based VBN B-PP
on IN B-PP
the DT B-NP
murine JJ I-NP
sequence NN I-NP
were VBD B-VP
used VBN I-VP
to TO B-VP
construct VB I-VP
a DT B-NP
quantitative JJ I-NP
reverse NN I-NP
transcription-PCR NN I-NP
assay NN I-NP
for IN B-PP
gene NN B-NP
expression NN I-NP
. . O

B NN B-NP
lymphocyte NN I-NP
stimulation NN I-NP
via IN B-PP
both CC O
CD40 NN B-NP
and CC O
surface NN B-NP
Ig NN I-NP
( ( O
sIg NN B-NP
) ) O
receptors NNS B-NP
substantially RB B-ADVP
induced VBD B-VP
fra-1 NN B-NP
expression NN I-NP
COMMA COMMA O
and CC O
for IN B-PP
both DT B-NP
receptors NNS I-NP
COMMA COMMA O
induction NN B-NP
was VBD B-VP
protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( O
PKC NN B-NP
) ) O
dependent JJ B-ADJP
. . O

This DT B-NP
contrasts VBZ B-VP
with IN B-PP
induction NN B-NP
of IN B-PP
c-fos NN B-NP
by IN B-PP
both CC O
CD40 NN B-NP
and CC O
sIg NN B-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
PKC NN B-ADJP
independent JJ I-ADJP
and CC O
indicates VBZ B-VP
that IN B-SBAR
CD40 NN B-NP
is VBZ B-VP
capable JJ B-ADJP
of IN B-PP
signaling VBG B-VP
through IN B-PP
PKC NN B-NP
or CC O
a DT B-NP
closely RB I-NP
related JJ I-NP
kinase NN I-NP
. . O

Induction NN B-NP
of IN B-PP
fra-1 NN B-NP
following VBG B-PP
engagement NN B-NP
of IN B-PP
CD40 NN B-NP
did VBD B-VP
not RB I-VP
require VB I-VP
protein NN B-NP
synthesis NN I-NP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
the DT B-NP
PKC-dependent JJ I-NP
linkage NN I-NP
between IN B-PP
CD40 NN B-NP
and CC O
fra-1 NN B-NP
is VBZ B-VP
direct JJ B-ADJP
. . O

CD40-mediated JJ B-NP
fra-1 NN I-NP
induction NN I-NP
did VBD B-VP
require VB I-VP
tyrosine NN B-NP
kinase NN I-NP
activity NN I-NP
. . O

These DT B-NP
results NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
CD40 NN B-NP
COMMA COMMA O
like IN B-PP
sIg NN B-NP
COMMA COMMA O
may MD B-VP
employ VB I-VP
PKC NN B-NP
in IN B-PP
producing VBG B-VP
select JJ B-NP
outcomes NNS I-NP
COMMA COMMA O
that IN B-SBAR
individual JJ B-NP
B NN I-NP
cell NN I-NP
receptors NNS I-NP
may MD B-VP
signal VB I-VP
downstream JJ B-NP
events NNS I-NP
via IN B-PP
both CC B-NP
PKC-dependent JJ I-NP
and CC I-NP
PKC-independent JJ I-NP
pathways NNS I-NP
COMMA COMMA O
and CC O
that IN B-SBAR
multiple JJ B-NP
signal NN I-NP
transduction NN I-NP
pathways NNS I-NP
may MD B-VP
be VB I-VP
used VBN I-VP
to TO B-VP
activate VB I-VP
the DT B-NP
expression NN I-NP
of IN B-PP
closely RB B-NP
related JJ I-NP
genes NNS I-NP
. . O

Apoptosis NN B-NP
signaling NN I-NP
pathways NNS I-NP
in IN B-PP
normal JJ B-NP
T NN I-NP
cells NNS I-NP
: : O
differential JJ B-NP
activity NN I-NP
of IN B-PP
Bcl-2 NN B-NP
and CC O
IL-1beta-converting JJ B-NP
enzyme NN I-NP
family NN I-NP
protease NN I-NP
inhibitors NNS I-NP
on IN B-PP
glucocorticoid- NN B-NP
and CC O
Fas-mediated JJ B-ADJP
cytotoxicity NN B-NP
. . O

Fas-mediated JJ B-NP
apoptosis NN I-NP
plays VBZ B-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
regulating VBG B-VP
the DT B-NP
immune JJ I-NP
response NN I-NP
in IN B-PP
peripheral JJ B-NP
T NN I-NP
cells NNS I-NP
. . O

Restimulation NN B-NP
of IN B-PP
T NN B-NP
cell NN I-NP
blasts NNS I-NP
up-regulates VBZ B-VP
Fas NN B-NP
and CC O
Fas NN B-NP
ligand NN I-NP
expression NN I-NP
COMMA COMMA O
with IN B-PP
subsequent JJ B-NP
interaction NN I-NP
leading VBG B-VP
to TO B-PP
cell NN B-NP
death NN I-NP
. . O

Overexpression NN B-NP
of IN B-PP
Bcl-2 NN B-NP
in IN B-PP
tumor NN B-NP
cells NNS I-NP
blocks VBZ B-VP
apoptosis NN B-NP
induced VBN B-VP
by IN B-PP
many JJ B-NP
stimuli NNS I-NP
COMMA COMMA O
but CC O
inhibition NN B-NP
of IN B-PP
Fas-mediated JJ B-NP
killing NN I-NP
has VBZ B-VP
not RB I-VP
been VBN I-VP
consistently RB I-VP
observed VBN I-VP
. . O

To TO B-VP
examine VB I-VP
the DT B-NP
behavior NN I-NP
of IN B-PP
Bcl-2 NN B-NP
in IN B-PP
normal JJ B-NP
cells NNS I-NP
COMMA COMMA O
T NN B-NP
cell NN I-NP
blasts NNS I-NP
were VBD B-VP
transiently RB I-VP
transfected VBN I-VP
with IN B-PP
Bcl-2 NN B-NP
and CC O
related JJ B-NP
gene NN I-NP
products NNS I-NP
to TO B-VP
determine VB I-VP
the DT B-NP
effect NN I-NP
on IN B-PP
apoptotic JJ B-NP
signaling NN I-NP
. . O

Transient JJ B-NP
overexpression NN I-NP
of IN B-PP
Bcl-2 NN B-NP
in IN B-PP
mouse NN B-NP
and CC O
human JJ B-ADJP
T NN B-NP
cell NN I-NP
blasts NNS I-NP
did VBD B-VP
not RB I-VP
block VB I-VP
Fas-mediated JJ B-NP
apoptosis NN I-NP
COMMA COMMA O
whereas IN O
etoposide- NN B-NP
and CC O
glucocorticoid-induced JJ B-ADJP
cytotoxicity NN B-NP
was VBD B-VP
potently RB I-VP
inhibited VBN I-VP
. . O

Expression NN B-NP
of IN B-PP
Bcl-xL NN B-NP
and CC O
adenovirus NN B-NP
E1B NN I-NP
19K NN I-NP
did VBD B-VP
not RB I-VP
interfere VB I-VP
with IN B-PP
anti-Fas JJ B-NP
killing NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
interleukin-1beta-converting JJ B-NP
enzyme NN I-NP
family NN I-NP
protease NN I-NP
inhibitors NNS I-NP
Ac-DEVD-CHO NN B-NP
and CC O
CrmA NN B-NP
blocked VBD B-VP
Fas-mediated JJ B-NP
apoptosis NN I-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
peripheral JJ B-NP
T NN I-NP
cells NNS I-NP
use VBP B-VP
distinct JJ B-NP
apoptosis NN I-NP
signaling NN I-NP
pathways NNS I-NP
with IN B-PP
differential JJ B-NP
sensitivity NN I-NP
to TO B-PP
Bcl-2 NN B-NP
and CC O
interleukin-1beta-converting JJ B-NP
enzyme NN I-NP
family NN I-NP
protease NN I-NP
inhibitors NNS I-NP
. . O

Since IN B-SBAR
T NN B-NP
cells NNS I-NP
normally RB B-ADVP
express VBP B-VP
Bcl-2 NN B-NP
and CC O
Bcl-xL NN B-NP
following VBG B-PP
activation NN B-NP
COMMA COMMA O
their PRP$ B-NP
inability NN I-NP
to TO B-VP
block VB I-VP
Fas-mediated JJ B-NP
apoptosis NN I-NP
may MD B-VP
allow VB I-VP
for IN B-PP
the DT B-NP
elimination NN I-NP
of IN B-PP
self-reactive JJ B-NP
cells NNS I-NP
and CC O
the DT B-NP
appropriate JJ I-NP
regulation NN I-NP
of IN B-PP
immune JJ B-NP
responses NNS I-NP
. . O

Comparative JJ B-NP
analysis NN I-NP
identifies VBZ B-VP
conserved VBN B-NP
tumor NN I-NP
necrosis NN I-NP
factor NN I-NP
receptor-associated JJ I-NP
factor NN I-NP
3 CD I-NP
binding NN I-NP
sites NNS I-NP
in IN B-PP
the DT B-NP
human JJ I-NP
and CC I-NP
simian JJ I-NP
Epstein-Barr JJ I-NP
virus NN I-NP
oncogene NN I-NP
LMP1 NN I-NP
. . O

Nonhuman JJ B-NP
primates NNS I-NP
are VBP B-VP
naturally RB I-VP
infected VBN I-VP
with IN B-PP
a DT B-NP
B-lymphotropic JJ I-NP
herpesvirus NN I-NP
closely RB B-ADJP
related JJ I-ADJP
to TO B-PP
Epstein-Barr JJ B-NP
virus NN I-NP
( ( O
EBV NN B-NP
) ) O
. . O

These DT B-NP
simian JJ I-NP
EBV NNS I-NP
share VBP B-VP
considerable JJ B-NP
genetic JJ I-NP
COMMA COMMA I-NP
biologic JJ I-NP
COMMA COMMA I-NP
and CC I-NP
epidemiologic JJ I-NP
features NNS I-NP
with IN B-PP
human JJ B-NP
EBV NN I-NP
COMMA COMMA O
including VBG B-PP
virus-induced JJ B-NP
tumorigenesis NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
latent JJ B-NP
COMMA COMMA I-NP
transformation-associated JJ I-NP
viral JJ I-NP
genes NNS I-NP
demonstrate VBP B-VP
marked JJ B-NP
sequence NN I-NP
divergence NN I-NP
among IN B-PP
species NNS B-NP
despite IN B-PP
the DT B-NP
conserved VBN I-NP
functions NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
cloned VBN I-VP
the DT O
latent JJ B-NP
membrane NN I-NP
protein NN I-NP
1 CD I-NP
( ( O
LMP1 NN B-NP
) ) O
homologs NNS B-NP
from IN B-PP
the DT B-NP
simian JJ I-NP
EBV NN I-NP
naturally RB B-VP
infecting VBG I-VP
baboons NNS B-NP
( ( O
cercopithicine NN B-NP
herpesvirus NN I-NP
12 CD I-NP
COMMA COMMA O
herpesvirus NN B-NP
papio NN I-NP
) ) O
and CC O
rhesus NN B-NP
monkeys NNS I-NP
( ( O
cercopithicine NN B-NP
herpesvirus NN I-NP
15 CD I-NP
) ) O
for IN B-PP
a DT B-NP
comparative JJ I-NP
study NN I-NP
with IN B-PP
the DT B-NP
human JJ I-NP
EBV NN I-NP
oncogene NN I-NP
. . O

The DT B-NP
transmembrane NN I-NP
domains NNS I-NP
are VBP B-VP
well RB I-VP
conserved VBN I-VP
COMMA COMMA O
but CC O
there EX B-NP
is VBZ B-VP
striking JJ B-NP
sequence NN I-NP
divergence NN I-NP
of IN B-PP
the DT B-NP
carboxy-terminal JJ I-NP
cytoplasmic JJ I-NP
domain NN I-NP
essential JJ B-ADJP
for IN B-PP
B-cell NN B-NP
immortalization NN I-NP
and CC O
interaction NN B-NP
with IN B-PP
the DT B-NP
tumor NN I-NP
necrosis NN I-NP
factor NN I-NP
receptor NN I-NP
signaling NN I-NP
pathway NN I-NP
. . O

Nevertheless RB B-ADVP
COMMA COMMA O
the DT B-NP
simian JJ I-NP
EBV NN I-NP
LMP1s NNS I-NP
retain VBP B-VP
most JJS B-NP
functions NNS I-NP
in IN B-PP
common NN I-PP
with IN I-PP
EBV NN B-NP
LMP1 NN I-NP
COMMA COMMA O
including VBG B-PP
the DT B-NP
ability NN I-NP
to TO B-VP
induce VB I-VP
NF-(kappa)B NN B-NP
activity NN I-NP
in IN B-PP
human JJ B-NP
cells NNS I-NP
COMMA COMMA O
to TO B-VP
bind VB I-VP
the DT B-NP
tumor NN I-NP
necrosis NN I-NP
factor-associated JJ I-NP
factor NN I-NP
3 CD I-NP
( ( O
TRAF3 NN B-NP
) ) O
in FW B-ADVP
vitro FW I-ADVP
COMMA COMMA O
and CC O
to TO B-VP
induce VB I-VP
expression NN B-NP
of IN B-PP
tumor NN B-NP
necrosis NN I-NP
factor-responsive JJ I-NP
genes NNS I-NP
COMMA COMMA O
such JJ B-PP
as IN I-PP
ICAM1 NN B-NP
COMMA COMMA O
in IN B-PP
human JJ B-NP
B NN I-NP
lymphocytes NNS I-NP
. . O

Multiple JJ B-NP
TRAF3 NN I-NP
binding NN I-NP
sites NNS I-NP
containing VBG B-VP
a DT B-NP
PXQXT\/S NN I-NP
core NN I-NP
sequence NN I-NP
can MD B-VP
be VB I-VP
identified VBN I-VP
in IN B-PP
the DT B-NP
simian JJ I-NP
EBV NN I-NP
LMP1s NNS I-NP
by IN B-PP
an DT B-NP
in FW I-NP
vitro FW I-NP
binding NN I-NP
assay NN I-NP
. . O

A DT B-NP
PXQXT\/S-containing JJ I-NP
sequence NN I-NP
is VBZ B-VP
also RB B-ADVP
present JJ B-ADJP
in IN B-PP
the DT B-NP
cytoplasmic JJ I-NP
domain NN I-NP
of IN B-PP
the DT O
Hodgkin NN B-NP
's POS B-NP
disease NN I-NP
marker NN I-NP
COMMA COMMA O
CD30 NN B-NP
COMMA COMMA O
and CC O
binds VBZ B-VP
TRAF3 NN B-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

The DT B-NP
last JJ I-NP
13 CD I-NP
amino NN I-NP
acids NNS I-NP
containing VBG B-VP
a DT B-NP
PXQXT\/S NN I-NP
sequence NN I-NP
are VBP B-VP
highly RB I-VP
conserved VBN I-VP
in IN B-PP
human JJ B-NP
and CC I-NP
simian JJ I-NP
EBV NN I-NP
LMP1 NN I-NP
but CC O
do VBP B-VP
not RB I-VP
bind VB I-VP
TRAF3 NN B-NP
COMMA COMMA O
suggesting VBG B-VP
a DT B-NP
distinct JJ I-NP
role NN I-NP
for IN B-PP
this DT B-NP
conserved VBN I-NP
region NN I-NP
of IN B-PP
LMP1 NN B-NP
. . O

The DT B-NP
conserved VBN I-NP
TRAF3 NN I-NP
binding NN I-NP
sites NNS I-NP
in IN B-PP
LMP1 NN B-NP
and CC O
the DT O
CD30 NN O
Hodgkin NN B-NP
's POS B-NP
disease NN I-NP
marker NN I-NP
provides VBZ B-VP
further JJ B-NP
evidence NN I-NP
that IN B-SBAR
a DT B-NP
TRAF3-mediated JJ I-NP
signal NN I-NP
transduction NN I-NP
pathway NN I-NP
may MD B-VP
be VB I-VP
important JJ B-ADJP
in IN B-PP
malignant JJ B-NP
transformation NN I-NP
. . O

Rapid JJ B-NP
shuttling NN I-NP
of IN B-PP
NF-AT NN B-NP
in IN B-PP
discrimination NN B-NP
of IN B-PP
Ca2+ NN B-NP
signals NNS I-NP
and CC O
immunosuppression NN B-NP
. . O

Cells NNS B-NP
need VBP B-VP
to TO I-VP
distinguish VB I-VP
between IN B-PP
transient JJ B-NP
Ca2+ NN I-NP
signals NNS I-NP
that WDT B-NP
induce VBP B-VP
events NNS B-NP
such JJ B-PP
as IN I-PP
muscle NN B-NP
contraction NN I-NP
COMMA COMMA O
secretion NN B-NP
COMMA COMMA O
adhesion NN B-NP
and CC O
synaptic JJ B-NP
transmission NN I-NP
COMMA COMMA O
and CC O
sustained JJ B-NP
Ca2+ NN I-NP
signals NNS I-NP
that WDT B-NP
are VBP B-VP
involved VBN I-VP
in IN B-PP
cell NN B-NP
proliferation NN B-NP
and CC O
differentiation NN B-NP
. . O

The DT B-NP
latter JJ I-NP
class NN I-NP
of IN B-PP
events NNS B-NP
is VBZ B-VP
blocked VBN I-VP
in IN B-PP
lymphocytes NNS B-NP
by IN B-PP
the DT B-NP
immunosuppressive JJ I-NP
drugs NNS I-NP
cyclosporin NN B-NP
A NN I-NP
and CC O
FK506 NN B-NP
COMMA COMMA O
which WDT B-NP
inhibit VBP B-VP
calcineurin NN B-NP
COMMA COMMA O
a DT B-NP
Ca2+-activated JJ I-NP
serine\/threonine NN I-NP
phosphatase NN I-NP
necessary JJ B-ADJP
for IN B-PP
the DT B-NP
nuclear JJ I-NP
import NN I-NP
of IN B-PP
NF-AT NN B-NP
transcription NN I-NP
factors NNS I-NP
. . O

Here RB B-ADVP
we PRP B-NP
report VBP B-VP
that IN B-SBAR
sustained JJ B-NP
high JJ I-NP
concentrations NNS I-NP
of IN B-PP
Ca2+ NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
transient JJ B-NP
pulses NNS I-NP
COMMA COMMA O
are VBP B-VP
required VBN I-VP
to TO B-VP
maintain VB I-VP
NF-AT NN B-NP
transcription NN I-NP
factors NNS I-NP
in IN B-PP
the DT B-NP
nucleus NN I-NP
COMMA COMMA O
where WRB B-ADVP
they PRP B-NP
participate VBP B-VP
in IN B-PP
Ca2+-dependent JJ B-NP
induction NN I-NP
of IN B-PP
genes NNS B-NP
required VBN B-VP
for IN B-PP
lymphocyte NN B-NP
activation NN B-NP
and CC O
proliferation NN B-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
overexpression NN B-NP
and CC O
constitutive JJ B-NP
nuclear JJ I-NP
localization NN I-NP
of IN B-PP
NF-AT NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
Jun NN B-NP
COMMA COMMA O
Fos NN B-NP
COMMA COMMA O
NF-kappaB NN B-NP
COMMA COMMA O
Oct NN B-NP
or CC O
Ets NN B-NP
family NN B-NP
members NNS I-NP
COMMA COMMA O
renders VBZ B-VP
the DT B-NP
interleukin-2 NN I-NP
enhancer NN I-NP
in IN B-PP
Jurkat NN B-NP
T NN I-NP
lymphocytes NNS I-NP
resistant JJ B-ADJP
to TO B-PP
FK506 NN B-NP
and CC O
cyclosporin NN B-NP
A NN I-NP
. . O

Thus RB B-ADVP
a DT B-NP
primary JJ I-NP
effect NN I-NP
of IN B-PP
these DT B-NP
immunosuppressive JJ I-NP
reagents NNS I-NP
is VBZ B-VP
to TO B-VP
control VB I-VP
the DT B-NP
subcellular JJ I-NP
localization NN I-NP
of IN B-PP
the DT B-NP
NF-AT NN I-NP
family NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
. . O

Interferons NNS B-NP
induce VBP B-VP
normal JJ B-NP
and CC I-NP
aberrant JJ I-NP
retinoic-acid NN I-NP
receptors NNS I-NP
type NN I-NP
alpha NN I-NP
in IN B-PP
acute JJ B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
cells NNS I-NP
: : O
potentiation NN B-NP
of IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
retinoid-dependent JJ B-NP
differentiation NN I-NP
markers NNS I-NP
. . O

Treatment NN B-NP
of IN B-PP
the DT O
acute JJ O
promyelocytic JJ O
( ( O
APL NN B-ADJP
) ) O
cell NN B-NP
line NN I-NP
NB4 NN I-NP
with IN B-PP
interferon NN B-NP
alpha NN I-NP
( ( O
IFN(alpha) NN B-NP
) ) O
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
IFN(beta) NN B-NP
and CC O
gamma NN B-NP
COMMA COMMA O
results VBZ B-VP
in IN B-PP
an DT B-NP
increased VBN I-NP
expression NN I-NP
of IN B-PP
the DT B-NP
transcripts NNS I-NP
coding VBG B-VP
for IN B-PP
retinoic-acid JJ B-NP
receptor NN I-NP
type NN I-NP
alpha NN I-NP
( ( O
RAR(alpha) NN B-NP
) ) O
and CC O
the DT B-NP
leukemia-specific JJ I-NP
retinoic JJ I-NP
acid NN I-NP
receptor NN I-NP
PML-RAR NN I-NP
. . O

Transcriptional JJ B-NP
induction NN I-NP
of IN B-PP
the DT O
RAR(alpha) NN B-NP
and CC O
PML-RAR NN B-NP
mRNAs NNS B-NP
is VBZ B-VP
rapid JJ B-ADJP
and CC O
it PRP B-NP
is VBZ B-VP
parallelled VBN I-VP
by IN B-PP
an DT B-NP
increase NN I-NP
in IN B-PP
the DT B-NP
corresponding JJ I-NP
proteins NNS I-NP
. . O

Up-regulation NN B-NP
of IN B-PP
RAR(alpha) NN B-NP
and CC O
PML-RAR NN B-NP
gene NN B-NP
expression NN I-NP
by IN B-PP
IFN(alpha) NN B-NP
is VBZ B-VP
accompanied VBN I-VP
by IN B-PP
a DT B-NP
strong JJ I-NP
potentiation NN I-NP
in IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
2 CD B-NP
retinoid-dependent JJ I-NP
granulocytic JJ I-NP
markers NNS I-NP
COMMA COMMA B-NP
i.e. FW I-NP
COMMA COMMA O
granulocyte-colony-stimulating JJ B-NP
factor NN I-NP
receptor NN I-NP
mRNA NN I-NP
and CC O
leukocyte NN B-NP
alkaline NN I-NP
phosphatase NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
IFN(alpha) NN B-NP
does VBZ B-VP
not RB I-VP
have VB I-VP
any DT B-NP
effects NNS I-NP
on IN B-PP
the DT B-NP
retinoid-dependent JJ I-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
myeloid JJ I-NP
surface NN I-NP
markers NNS I-NP
CD11b NN B-NP
and CC O
CD33 NN B-NP
. . O

The DT B-NP
IFN-dependent JJ I-NP
increase NN I-NP
in IN B-PP
RAR(alpha) NN B-NP
levels NNS I-NP
and CC O
the DT B-NP
enhancing JJ I-NP
effect NN I-NP
of IN B-PP
the DT B-NP
cytokine NN I-NP
on IN B-PP
retinoid-dependent JJ B-NP
granulocytic JJ I-NP
markers NNS I-NP
expression NN I-NP
may MD B-VP
be VB I-VP
a DT B-NP
characteristic NN I-NP
of IN B-PP
PML-RAR NN B-NP
positive JJ I-NP
cells NNS I-NP
COMMA COMMA O
since IN B-SBAR
the DT B-NP
phenomena NNS I-NP
are VBP B-VP
not RB I-VP
observed VBN I-VP
in IN B-PP
HL-60 NN B-NP
promyelocytes NNS I-NP
. . O

Interferons NNS B-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
retinoids NNS B-NP
inhibit VBP B-VP
the DT B-NP
growth NN I-NP
of IN B-PP
NB4 NN B-NP
cells NNS I-NP
COMMA COMMA O
although IN B-SBAR
the DT B-NP
2 CD I-NP
classes NNS I-NP
of IN B-PP
compounds NNS B-NP
do VBP B-VP
not RB I-VP
significantly RB I-VP
interact VBP I-VP
in IN B-PP
terms NNS I-PP
of IN I-PP
anti-proliferative JJ B-NP
activity NN I-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
the DT B-NP
possible JJ I-NP
use NN I-NP
of IN B-PP
combinations NNS B-NP
between IN B-PP
IFNs NNS B-NP
and CC O
retinoic JJ B-NP
acid NN I-NP
in IN B-PP
the DT B-NP
cyto-differentiating JJ I-NP
treatment NN I-NP
of IN B-PP
APL NN B-NP
patients NNS I-NP
. . O

Susceptibility NN B-NP
to TO B-PP
natural JJ B-NP
killer NN I-NP
cells NNS I-NP
and CC O
down JJ B-NP
regulation NN I-NP
of IN B-PP
MHC NN B-NP
class NN I-NP
I CD I-NP
expression NN I-NP
in IN B-PP
adenovirus NN B-NP
12 CD I-NP
transformed VBN I-NP
cells NNS I-NP
are VBP B-VP
regulated VBN I-VP
by IN B-PP
different JJ B-NP
E1A NN I-NP
domains NNS I-NP
. . O

All DT B-NP
human JJ I-NP
adenoviruses NNS I-NP
transform VBP B-VP
rodent JJ B-NP
cells NNS I-NP
in FW B-ADVP
vitro FW I-ADVP
COMMA COMMA O
but CC O
only RB B-NP
cells NNS I-NP
transformed VBN B-VP
by IN B-PP
serotypes NNS B-NP
belonging VBG B-VP
to TO B-PP
subgroups NNS B-NP
A NN B-NP
( ( O
Ad12 NN B-NP
) ) O
and CC O
B NN B-NP
( ( O
Ad3 NN B-NP
) ) O
are VBP B-VP
tumorigenic JJ B-ADJP
for IN B-PP
immunocompetent JJ B-NP
animals NNS I-NP
. . O

In IN B-PP
these DT B-NP
cells NNS I-NP
COMMA COMMA O
the DT B-NP
expression NN I-NP
of IN B-PP
MHC-class NN B-NP
I CD I-NP
antigens NNS I-NP
is VBZ B-VP
repressed VBN I-VP
and CC O
might MD B-VP
allow VB I-VP
them PRP B-NP
to TO B-VP
escape VB I-VP
from IN B-PP
recognition NN B-NP
by IN B-PP
cytotoxic JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
( ( O
CTL NN B-NP
) ) O
and CC O
to TO B-VP
develop VB I-VP
in IN B-PP
tumor NN B-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
these DT B-NP
cell NN I-NP
lines NNS I-NP
appear VBP B-VP
resistant JJ B-ADJP
to TO B-PP
lysis NN B-NP
by IN B-PP
natural JJ B-NP
killer NN I-NP
( ( O
NK NN B-NP
) ) O
cells NNS B-NP
. . O

To TO B-VP
determine VB I-VP
the DT B-NP
E1A NN I-NP
domain NN I-NP
( ( I-NP
s NNS I-NP
) ) O
responsible JJ B-ADJP
for IN B-PP
these DT B-NP
properties NNS I-NP
several JJ B-NP
cell NN I-NP
lines NNS I-NP
were VBD B-VP
created VBN I-VP
by IN B-PP
transforming VBG B-NP
baby NN B-NP
rat NN I-NP
kidney NN I-NP
( ( O
BRK NN B-NP
) ) O
cells NNS B-NP
with IN B-PP
a DT B-NP
set NN I-NP
of IN B-PP
plasmids NNS B-NP
expressing VBG B-VP
different JJ B-NP
Ad2\/Ad12 NN I-NP
hybrid NN I-NP
E1A NN I-NP
gene NN I-NP
products NNS I-NP
. . O

The DT B-NP
MHC NN I-NP
class NN I-NP
1 CD I-NP
gene NN I-NP
expression NN I-NP
was VBD B-VP
inhibited VBN I-VP
in IN B-PP
cells NNS B-NP
expressing VBG B-VP
the DT B-NP
Ad12 NN I-NP
13S NN I-NP
mRNA NN I-NP
product NN I-NP
and CC B-PP
in IN B-PP
cells NNS B-NP
transformed VBN B-VP
with IN B-PP
Ad2\/Ad12 NN B-NP
hybrid NN I-NP
E1A NN I-NP
gene NN I-NP
product NN I-NP
harboring VBG B-VP
the DT B-NP
C-terminal JJ I-NP
part NN I-NP
of IN B-PP
the DT O
conserved VBN B-NP
region NN I-NP
( ( O
CR NN B-NP
) ) O
3 CD B-NP
of IN B-PP
Ad12 NN B-NP
. . O

Susceptibility NN B-NP
of IN B-PP
these DT B-NP
transformed VBN I-NP
cell NN I-NP
lines NNS I-NP
to TO B-PP
NK NN B-NP
cells NNS I-NP
was VBD B-VP
determined VBN I-VP
by IN B-PP
cytolytic JJ B-NP
assays NNS I-NP
. . O

The DT B-NP
results NNS I-NP
obtained VBD B-VP
suggest VBP B-VP
that IN B-SBAR
two CD B-NP
Ad12 NN I-NP
E1A NN I-NP
domains NNS I-NP
are VBP B-VP
required VBN I-VP
to TO B-VP
induce VB I-VP
resistance NN B-NP
of IN B-PP
the DT B-NP
cell NN I-NP
lines NNS I-NP
to TO B-PP
NK NN B-NP
cells NNS I-NP
. . O

An DT B-NP
IL-2 NN I-NP
response NN I-NP
element NN I-NP
in IN B-PP
the DT B-NP
human JJ I-NP
IL-2 NN I-NP
receptor NN I-NP
alpha NN I-NP
chain NN I-NP
promoter NN I-NP
is VBZ B-VP
a DT B-NP
composite JJ I-NP
element NN I-NP
that WDT B-NP
binds VBZ B-VP
Stat5 NN B-NP
COMMA COMMA O
Elf-1 NN B-NP
COMMA COMMA O
HMG-I(Y) NN B-NP
and CC O
a DT B-NP
GATA NN I-NP
family NN I-NP
protein NN I-NP
. . O

Expression NN B-NP
of IN B-PP
the DT O
human JJ O
interleukin-2 NN B-NP
( ( O
IL-2 NN B-NP
) ) O
receptor NN B-NP
alpha NN I-NP
chain NN I-NP
gene NN I-NP
is VBZ B-VP
potently RB I-VP
upregulated VBN I-VP
by IN B-PP
its PRP$ B-NP
own JJ I-NP
ligand NN I-NP
COMMA COMMA O
IL-2 NN B-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
we PRP B-NP
characterize VBP B-VP
an DT B-NP
essential JJ I-NP
upstream JJ I-NP
IL-2 NN I-NP
response NN I-NP
element NN I-NP
that WDT B-NP
contains VBZ B-VP
both CC O
consensus NN B-NP
and CC O
non-consensus JJ B-ADJP
GAS NN B-NP
motifs NNS I-NP
COMMA COMMA O
two CD B-NP
putative JJ I-NP
Ets NN B-NP
binding NN I-NP
sites NNS I-NP
( ( O
EBS NN B-NP
) ) O
COMMA COMMA O
one CD B-NP
of IN B-PP
which WDT B-NP
overlaps VBZ B-VP
the DT B-NP
consensus NN I-NP
GAS NN I-NP
motif NN I-NP
COMMA COMMA O
and CC O
a DT B-NP
GATA NN I-NP
motif NN I-NP
COMMA COMMA O
which WDT B-NP
overlaps VBZ B-VP
the DT B-NP
non-consensus JJ I-NP
GAS NN I-NP
motif NN I-NP
. . O

We PRP B-NP
demonstrate VBP B-VP
that IN B-SBAR
although IN B-SBAR
the DT B-NP
individual JJ I-NP
components NNS I-NP
of IN B-PP
this DT B-NP
element NN I-NP
do VBP B-VP
not RB I-VP
respond VB I-VP
to TO B-PP
IL-2 NN B-NP
COMMA COMMA O
together RB B-ADVP
they PRP B-NP
form VBP B-VP
a DT B-NP
composite JJ I-NP
element NN I-NP
capable JJ B-ADJP
of IN B-PP
conferring VBG B-VP
IL-2 NN B-NP
responsiveness NN I-NP
to TO B-PP
a DT B-NP
heterologous JJ I-NP
promoter NN I-NP
. . O

Multiple JJ B-NP
factors NNS I-NP
including VBG B-PP
Stat5 NN B-NP
COMMA COMMA O
Elf-1 NN B-NP
COMMA COMMA O
HMG-I(Y) NN B-NP
and CC O
GATA NN B-NP
family NN I-NP
proteins NNS I-NP
bind VBP B-VP
to TO B-PP
the DT B-NP
IL-2 NN I-NP
response NN I-NP
element NN I-NP
and CC O
mutation NN B-NP
of IN B-PP
any DT B-NP
one CD I-NP
of IN B-PP
these DT B-NP
binding VBG I-NP
sites NNS I-NP
diminishes VBZ B-VP
the DT B-NP
activity NN I-NP
of IN B-PP
this DT B-NP
element NN I-NP
. . O

An DT B-NP
unidentified JJ I-NP
Ets NN I-NP
family NN I-NP
protein NN I-NP
binds VBZ B-VP
to TO B-PP
the DT B-NP
EBS NN I-NP
overlapping VBG B-VP
the DT B-NP
consensus NN I-NP
GAS NN I-NP
motif NN I-NP
and CC O
appears VBZ B-VP
to TO I-VP
negatively RB I-VP
regulate VB I-VP
the DT B-NP
human JJ I-NP
IL-2R NN I-NP
alpha NN I-NP
promoter NN I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
IL-2-induced JJ B-NP
IL-2R NN I-NP
alpha NN I-NP
promoter NN I-NP
activity NN I-NP
requires VBZ B-VP
a DT B-NP
complex JJ I-NP
upstream JJ I-NP
element NN I-NP
COMMA COMMA O
which WDT B-NP
appears VBZ B-VP
to TO I-VP
contain VB I-VP
binding VBG B-NP
sites NNS I-NP
for IN B-PP
both CC B-NP
positive JJ I-NP
and CC I-NP
negative JJ I-NP
regulatory JJ I-NP
factors NNS I-NP
. . O

Tyrosine NN B-NP
kinase NN I-NP
and CC O
cAMP-dependent JJ B-NP
protein NN I-NP
kinase NN I-NP
activities NNS B-NP
in IN B-PP
CD40-activated JJ B-NP
human JJ I-NP
B NN I-NP
lymphocytes NNS I-NP
. . O

In FW B-ADVP
vitro FW I-ADVP
COMMA COMMA O
human JJ B-NP
B NN I-NP
lymphocytes NNS I-NP
undergo VBP B-VP
long-term JJ B-NP
proliferation NN I-NP
when WRB B-ADVP
activated VBN B-VP
through IN B-PP
CD40 NN B-NP
COMMA COMMA O
a DT B-NP
protein NN I-NP
expressed VBN B-VP
on IN B-PP
their PRP$ B-NP
cell NN I-NP
surface NN I-NP
. . O

The DT B-NP
nature NN I-NP
of IN B-PP
CD40-dependent JJ B-NP
signals NNS I-NP
in IN B-PP
proliferating VBG B-NP
fresh JJ I-NP
human JJ I-NP
Epstein-Barr JJ I-NP
virus-negative JJ I-NP
B NN I-NP
lymphocytes NNS I-NP
is VBZ B-VP
currently RB B-ADVP
unknown JJ B-ADJP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
a DT B-NP
CD40-dependent JJ I-NP
B NN I-NP
cell NN I-NP
culture NN I-NP
system NN I-NP
was VBD B-VP
used VBN I-VP
to TO B-VP
examine VB I-VP
the DT B-NP
role NN I-NP
of IN B-PP
different JJ B-NP
signal NN I-NP
transduction NN I-NP
elements NNS I-NP
. . O

Protein NN B-NP
kinase NN I-NP
C NN I-NP
( ( O
PKC NN B-NP
) ) O
depletion NN B-NP
generated VBN B-VP
by IN B-PP
a DT B-NP
long-term JJ I-NP
phorbol NN I-NP
12 CD I-NP
myristate NN I-NP
13-acetate NN I-NP
treatment NN I-NP
had VBD B-VP
weak JJ B-NP
effects NNS I-NP
on IN B-PP
proliferation NN B-NP
. . O

Rather RB B-ADVP
COMMA COMMA O
tyrosine NN B-NP
phosphorylation NN I-NP
was VBD B-VP
shown VBN I-VP
to TO I-VP
be VB I-VP
directly RB I-VP
involved VBN I-VP
in IN B-PP
mediating VBG B-VP
CD40-dependent JJ B-NP
signals NNS I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
the DT O
cAMP-dependent JJ B-NP
protein NN I-NP
kinase NN I-NP
specific JJ B-NP
inhibitor NN I-NP
H-89 NN I-NP
totally RB B-ADVP
inhibited VBD B-VP
HIV-1 NN B-NP
LTR NN I-NP
activity NN I-NP
at IN B-PP
a DT B-NP
concentration NN I-NP
as RB B-NP
low JJ I-NP
as IN I-NP
100 CD I-NP
nM NN I-NP
without IN B-PP
affecting VBG B-VP
cellular JJ B-NP
proliferation NN I-NP
. . O

Electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assay NN I-NP
( ( O
EMSA NN B-NP
) ) O
and CC O
supershift NN B-NP
assay NN I-NP
using VBG B-VP
an DT B-NP
NF-kappa NN I-NP
B NN I-NP
binding NN I-NP
sequence NN I-NP
from IN B-PP
the DT B-NP
kappa NN I-NP
light JJ I-NP
chain NN I-NP
as IN B-PP
a DT B-NP
probe NN I-NP
COMMA COMMA O
revealed VBD B-VP
that IN B-SBAR
both CC O
p65 NNS B-NP
( ( O
RelA NN B-NP
) ) O
and CC O
c-Rel NN B-NP
were VBD B-VP
present JJ B-ADJP
in IN B-PP
CD40-stimulated JJ B-NP
B NN I-NP
cells NNS I-NP
. . O

While IN B-SBAR
PKC NN B-NP
depletion NN I-NP
did VBD B-VP
not RB I-VP
alter VB I-VP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
level NN I-NP
COMMA COMMA O
treatment NN B-NP
of IN B-PP
B NN B-NP
lymphocytes NNS I-NP
with IN B-PP
H-89 NN B-NP
or CC O
herbimycin NN B-NP
A NN I-NP
provoked VBD B-VP
a DT B-NP
decrease NN I-NP
in IN B-PP
the DT B-NP
NF-kappa NN I-NP
B NN I-NP
level NN I-NP
. . O

These DT B-NP
observations NNS I-NP
establish VBP B-VP
the DT B-NP
importance NN I-NP
of IN B-PP
different JJ B-NP
signal NN I-NP
transducing NN I-NP
pathways NNS I-NP
leading VBG B-VP
to TO B-PP
CD40 NN B-NP
activation NN I-NP
of IN B-PP
B NN B-NP
lymphocytes NNS I-NP
. . O

Active JJ B-NP
suppression NN I-NP
of IN B-PP
the DT B-NP
class NN I-NP
II CD I-NP
transactivator-encoding JJ I-NP
AIR-1 NN I-NP
locus NN I-NP
is VBZ B-VP
responsible JJ B-ADJP
for IN B-PP
the DT B-NP
lack NN I-NP
of IN B-PP
major JJ B-NP
histocompatibility NN I-NP
complex NN I-NP
class NN I-NP
II CD I-NP
gene NN I-NP
expression NN I-NP
observed VBN B-VP
during IN B-PP
differentiation NN B-NP
from IN B-PP
B NN B-NP
cells NNS I-NP
to TO B-PP
plasma NN B-NP
cells NNS I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
the DT B-NP
genetic JJ I-NP
control NN I-NP
of IN B-PP
major JJ B-NP
histocompatibility NN I-NP
complex NN I-NP
( ( O
MHC NN B-NP
) ) O
class NN B-NP
II CD I-NP
gene NN I-NP
expression NN I-NP
during IN B-PP
the DT B-NP
transition NN I-NP
from IN B-PP
B NN B-NP
cell NN I-NP
to TO B-PP
plasma NN B-NP
cell NN I-NP
has VBZ B-VP
been VBN I-VP
analyzed VBN I-VP
. . O

Class NN B-NP
II CD I-NP
molecules NNS I-NP
are VBP B-VP
not RB I-VP
expressed VBN I-VP
in IN B-PP
plasma NN B-NP
cells NNS I-NP
because IN B-PP
of IN I-PP
an DT B-NP
active JJ I-NP
suppression NN I-NP
resulting VBG B-VP
in IN B-PP
the DT B-NP
abrogation NN I-NP
of IN B-PP
class NN B-NP
II CD I-NP
gene NN I-NP
transcription NN I-NP
. . O

We PRP B-NP
show VBP B-VP
here RB B-ADVP
that IN B-SBAR
the DT B-NP
plasma NN I-NP
cell-specific JJ I-NP
repressor NN I-NP
function NN I-NP
COMMA COMMA O
designated VBN B-VP
SIR NN B-NP
( ( O
suppressor NN B-NP
of IN B-PP
immune JJ B-NP
response NN I-NP
genes NNS I-NP
) ) O
COMMA COMMA O
does VBZ B-VP
not RB I-VP
act VB I-VP
directly RB B-ADVP
on IN B-PP
the DT B-NP
transcription NN I-NP
of IN B-PP
class NN B-NP
II CD I-NP
genes NNS I-NP
COMMA COMMA B-PP
but CC I-PP
instead RB I-PP
on IN B-PP
the DT B-NP
transcription NN I-NP
of IN B-PP
the DT B-NP
AIR-1 NN I-NP
gene NN I-NP
COMMA COMMA O
whose WP$ B-NP
product NN I-NP
COMMA COMMA O
the DT B-NP
class NN I-NP
II CD I-NP
transactivator NN I-NP
( ( O
CIITA NN B-NP
) ) O
COMMA COMMA O
is VBZ B-VP
fundamental JJ B-ADJP
for IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
constitutive JJ I-NP
and CC I-NP
inducible JJ I-NP
expression NN I-NP
of IN B-PP
MHC NN B-NP
class NN I-NP
II CD I-NP
genes NNS I-NP
. . O

This DT B-NP
was VBD B-VP
unambiguously RB I-VP
demonstrated VBN I-VP
by IN B-PP
the DT B-NP
fact NN I-NP
that IN B-SBAR
plasmacytoma NN B-NP
x NN B-NP
B NN B-NP
cell NN I-NP
hybrids NNS B-NP
carrying VBG B-VP
an DT B-NP
AIR-1 NN I-NP
locus NN I-NP
derived VBN B-VP
from IN B-PP
CIITA-expressing JJ B-NP
cells NNS I-NP
do VBP B-VP
not RB I-VP
express VB I-VP
CIITA-specific JJ B-NP
transcripts NNS I-NP
. . O

Transfection NN B-NP
of IN B-PP
a DT B-NP
cDNA NN I-NP
containing VBG B-VP
the DT B-NP
human JJ I-NP
CIITA NN I-NP
coding NN I-NP
sequence NN I-NP
under IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
an DT B-NP
heterologous JJ I-NP
promoter NN I-NP
restores VBZ B-VP
expression NN B-NP
of IN B-PP
human JJ B-NP
MHC NN I-NP
class NN I-NP
II CD I-NP
genes NNS I-NP
in IN B-PP
the DT B-NP
hybrids NNS I-NP
and CC O
is VBZ B-VP
responsible JJ B-ADJP
for IN B-PP
de FW B-NP
novo FW I-NP
expression NN I-NP
of IN B-PP
mouse NN B-NP
MHC NN I-NP
class NN I-NP
II CD I-NP
genes NNS I-NP
in IN B-PP
both CC O
the DT B-NP
mouse NN I-NP
plasmacytoma NN I-NP
cell NN I-NP
line NN I-NP
and CC O
the DT B-NP
hybrids NNS I-NP
. . O

These DT B-NP
results NNS I-NP
confirm VBP B-VP
and CC O
extend VBP B-VP
the DT B-NP
notion NN I-NP
of IN B-PP
the DT B-NP
functional JJ I-NP
conservation NN I-NP
of IN B-PP
the DT B-NP
AIR-1 JJ I-NP
gene NN I-NP
product NN I-NP
across IN B-PP
species NNS B-NP
barriers NNS I-NP
. . O

Interestingly RB B-ADVP
COMMA COMMA O
in IN B-PP
CIITA-transfected JJ B-NP
cell NN I-NP
hybrids NNS I-NP
COMMA COMMA O
cell NN B-NP
surface NN I-NP
expression NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
HLA-DQ NN I-NP
heterodimer NN I-NP
was VBD B-VP
not RB I-VP
observed VBN I-VP
. . O

This DT B-NP
result NN I-NP
was VBD B-VP
not RB O
attributable JJ B-ADJP
to TO B-PP
lack NN B-NP
of IN B-PP
HLA-DQ NN B-NP
alpha NN I-NP
or CC O
-DQ NN B-NP
beta NN B-NP
transcription NN B-NP
COMMA COMMA O
because IN B-SBAR
both DT B-NP
transcripts NNS I-NP
were VBD B-VP
present JJ B-ADJP
in IN B-PP
the DT B-NP
CIITA-transfected JJ I-NP
hybrids NNS I-NP
COMMA COMMA O
although IN B-SBAR
at IN B-PP
reduced VBN B-NP
levels NNS I-NP
. . O

These DT B-NP
findings NNS I-NP
further RB B-ADVP
support VBP B-VP
our PRP$ B-NP
previous JJ I-NP
observations NNS I-NP
on IN B-PP
the DT B-NP
distinct JJ I-NP
regulation NN I-NP
of IN B-PP
expression NN B-NP
of IN B-PP
the DT B-NP
human JJ I-NP
HLA-DQ NN I-NP
class NN I-NP
II CD I-NP
subset NN I-NP
COMMA COMMA O
which WDT B-NP
may MD B-VP
be VB I-VP
thus RB I-VP
controlled VBN I-VP
at IN B-PP
the DT B-NP
posttranscriptional JJ I-NP
level NN I-NP
by IN B-PP
a DT B-NP
CIITA-independent JJ I-NP
mechanism NN I-NP
. . O

Chromosome NN B-NP
1 CD I-NP
aneusomy NN I-NP
with IN B-PP
1p36 NN B-NP
under-representation NN I-NP
is VBZ B-VP
related JJ B-ADJP
to TO B-PP
histologic JJ B-NP
grade NN I-NP
COMMA COMMA O
DNA NN B-NP
aneuploidy NN I-NP
COMMA COMMA O
high JJ B-NP
c-erb NN I-NP
B-2 NN I-NP
and CC O
loss NN B-NP
of IN B-PP
bcl-2 NN B-NP
expression NN I-NP
in IN B-PP
ductal JJ B-NP
breast NN I-NP
carcinoma NN I-NP
. . O

Chromosome NN B-NP
1 CD I-NP
abnormalities NNS I-NP
with IN B-PP
loss NN B-NP
of IN B-PP
1p36 NN B-NP
have VBP B-VP
been VBN I-VP
investigated VBN I-VP
in IN B-PP
95 CD B-NP
breast-cancer NN I-NP
samples NNS I-NP
by IN B-PP
means NNS I-PP
of IN I-PP
a DT O
dual-target JJ O
fluorescence NN B-NP
in-situ FW I-NP
hybridization NN I-NP
( ( O
FISH NN B-NP
) ) O
technique NN B-NP
using VBG B-VP
the DT O
pUC NN B-NP
1.77 CD I-NP
and CC O
p1-79 NN B-NP
probes NNS B-NP
COMMA COMMA O
specific JJ O
for IN B-PP
the DT O
1q12 NN B-NP
and CC O
1p36 NN B-NP
regions NNS B-NP
COMMA COMMA B-ADJP
respectively RB I-ADJP
. . O

Abnormalities NNS B-NP
for IN B-PP
one CD B-NP
or CC O
both DT B-NP
probes NNS I-NP
were VBD B-VP
detected VBN I-VP
in IN B-PP
83\/95 CD B-NP
samples NNS I-NP
. . O

Relative JJ B-NP
1p36 NN I-NP
under-representation NN I-NP
was VBD B-VP
found VBN I-VP
in IN B-PP
79\/95 CD B-NP
. . O

The DT B-NP
clinical JJ I-NP
relevance NN I-NP
of IN B-PP
these DT B-NP
alterations NNS I-NP
was VBD B-VP
studied VBN I-VP
by IN B-PP
comparing VBG B-VP
the DT B-NP
FISH NN I-NP
results NNS I-NP
with IN B-PP
several JJ B-NP
parameters NNS I-NP
currently RB B-VP
used VBN I-VP
in IN B-PP
breast-cancer JJ B-NP
pathology NN I-NP
. . O

Distinct JJ B-NP
patterns NNS I-NP
of IN B-PP
chromosome NN B-NP
1 CD I-NP
abnormalities NNS I-NP
were VBD B-VP
found VBN I-VP
among IN B-PP
the DT B-NP
histologic JJ I-NP
types NNS I-NP
of IN B-PP
breast NN B-NP
carcinoma NN I-NP
. . O

Lobular JJ B-NP
or CC I-NP
mucinous JJ I-NP
samples NNS I-NP
showed VBD B-VP
few JJ B-NP
or CC I-NP
no DT I-NP
alterations NNS I-NP
COMMA COMMA O
whereas IN O
most JJS B-NP
ductal JJ I-NP
samples NNS I-NP
had VBD B-VP
high JJ B-NP
chromosome NN I-NP
1 CD I-NP
polysomy NN I-NP
with IN B-PP
under-representation NN B-NP
of IN B-PP
1p36 NN B-NP
. . O

In IN B-PP
ductal JJ B-NP
carcinomas NNS I-NP
COMMA COMMA O
chromosome NN B-NP
1 CD I-NP
alterations NNS I-NP
increased VBD B-VP
with IN B-PP
histologic JJ B-NP
grade NN I-NP
COMMA COMMA O
DNA NN B-NP
aneuploidy NN I-NP
COMMA COMMA O
loss NN B-NP
of IN B-PP
bcl-2 NN B-NP
and CC O
high JJ B-NP
c-erb NN I-NP
B-2 NN I-NP
expression NN I-NP
. . O

These DT B-NP
associations NNS I-NP
were VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
statistically RB B-ADVP
significant JJ B-ADJP
. . O

No DT B-NP
correlation NN I-NP
between IN B-PP
chromosome NN B-NP
1 CD I-NP
alterations NNS I-NP
and CC O
nuclear JJ B-NP
grade NN B-NP
COMMA COMMA O
age NN B-NP
COMMA COMMA O
size NN B-NP
COMMA COMMA O
lymph-node JJ B-NP
involvement NN I-NP
COMMA COMMA O
hormonal JJ B-NP
receptor NN I-NP
presence NN I-NP
COMMA COMMA O
proliferation NN B-NP
activity NN I-NP
or CC O
p53 NN B-NP
protein NN I-NP
expression NN I-NP
was VBD B-VP
detected VBN I-VP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
the DT B-NP
utility NN I-NP
of IN B-PP
this DT B-NP
FISH NN I-NP
technique NN I-NP
for IN B-PP
a DT B-NP
better JJR I-NP
definition NN I-NP
of IN B-PP
the DT B-NP
biological JJ I-NP
characteristics NNS I-NP
of IN B-PP
ductal JJ B-NP
carcinomas NNS I-NP
. . O

Silencing NN B-NP
of IN B-PP
human JJ B-NP
fetal JJ I-NP
globin NN I-NP
expression NN I-NP
is VBZ B-VP
impaired JJ I-VP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
the DT B-NP
adult JJ I-NP
beta-globin IN I-NP
gene NN I-NP
activator NN I-NP
protein NN I-NP
EKLF NN I-NP
. . O

Globin NN B-NP
genes NNS I-NP
are VBP B-VP
subject JJ B-ADJP
to TO B-PP
tissue-specific JJ B-NP
and CC I-NP
developmental JJ I-NP
stage-specific JJ I-NP
regulation NN I-NP
. . O

A DT B-NP
switch NN I-NP
from IN B-PP
human JJ B-NP
fetal JJ I-NP
( ( O
gamma NN B-NP
) ) O
-to TO B-PP
adult JJ B-NP
( ( O
beta NN B-NP
) ) O
-globin NN B-NP
expression NN I-NP
occurs VBZ B-VP
within IN B-PP
erythroid JJ B-NP
precursor JJ I-NP
cells NNS I-NP
of IN B-PP
the DT B-NP
adult JJ I-NP
lineage NN I-NP
. . O

Previously RB B-ADVP
we PRP B-NP
and CC O
others NNS B-NP
showed VBD B-VP
by IN B-PP
targeted VBN B-NP
gene NN I-NP
disruption NN I-NP
that IN B-SBAR
the DT B-NP
zinc NN I-NP
finger NN I-NP
gene NN I-NP
COMMA COMMA O
erythroid JJ B-NP
Kruppel-like JJ I-NP
factor NN I-NP
( ( O
EKLF NN B-NP
) ) O
COMMA COMMA O
is VBZ B-VP
required VBN I-VP
for IN B-PP
expression NN B-NP
of IN B-PP
the DT B-NP
beta-globin NN I-NP
gene NN I-NP
in IN B-PP
mice NNS B-NP
COMMA COMMA O
presumably RB B-PP
through IN I-PP
interaction NN B-NP
with IN B-PP
a DT B-NP
high-affinity JJ I-NP
binding VBG I-NP
site NN I-NP
in IN B-PP
the DT B-NP
proximal JJ I-NP
promoter NN I-NP
. . O

To TO B-VP
examine VB I-VP
the DT B-NP
role NN I-NP
of IN B-PP
EKLF NN B-NP
in IN B-PP
the DT B-NP
developmental JJ I-NP
regulation NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
gamma-globin NN I-NP
gene NN I-NP
we PRP B-NP
interbred VBD B-VP
EKLF NN B-NP
heterozygotes NNS I-NP
( ( O
+\/- CC O
) ) O
with IN B-PP
mice NNS B-NP
harboring VBG B-VP
a DT B-NP
human JJ I-NP
beta-globin NN I-NP
yeast NN I-NP
artificial JJ I-NP
chromosome NN I-NP
transgene NN I-NP
. . O

We PRP B-NP
find VBP B-VP
that IN B-SBAR
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
EKLF NN B-NP
COMMA COMMA O
while IN B-SBAR
human JJ B-NP
beta-globin NN I-NP
expression NN I-NP
is VBZ B-VP
dramatically RB I-VP
reduced VBN I-VP
COMMA COMMA O
gamma-globin NN B-NP
transcripts NNS I-NP
are VBP B-VP
elevated JJ I-VP
approximately RB B-ADVP
5-fold RB I-ADVP
. . O

Impaired JJ B-NP
silencing NN I-NP
of IN B-PP
gamma-globin NN B-NP
expression NN I-NP
identifies VBZ B-VP
EKLF NN B-NP
as IN B-PP
the DT B-NP
first JJ I-NP
transcription NN I-NP
factor NN I-NP
participating VBG B-VP
quantitatively RB B-ADVP
in IN B-PP
the DT O
gamma-globin NN B-NP
to TO O
beta-globin NN B-NP
switch NN B-NP
. . O

Our PRP$ B-NP
findings NNS I-NP
are VBP B-VP
compatible JJ B-ADJP
with IN B-PP
a DT B-NP
competitive JJ I-NP
model NN I-NP
of IN B-PP
switching NN B-NP
in IN B-PP
which WDT B-NP
EKLF NN B-NP
mediates VBZ B-VP
an DT B-NP
adult JJ I-NP
stage-specific JJ I-NP
interaction NN I-NP
between IN B-PP
the DT B-NP
beta-globin NN I-NP
gene NN I-NP
promoter NN I-NP
and CC O
the DT B-NP
locus NN I-NP
control NN I-NP
region NN I-NP
that WDT B-NP
excludes VBZ B-VP
the DT B-NP
gamma-globin NN I-NP
gene NN I-NP
. . O

Modulatory JJ B-NP
effects NNS I-NP
of IN B-PP
glucocorticoids NNS B-NP
and CC O
catecholamines NNS B-NP
on IN B-PP
human JJ O
interleukin-12 NN B-NP
and CC O
interleukin-10 NN B-NP
production NN B-NP
: : O
clinical JJ B-NP
implications NNS I-NP
. . O

Interleukin-12 NN B-NP
( ( O
IL-12 NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
key JJ I-NP
inducer NN I-NP
of IN B-PP
differentiation NN B-NP
of IN B-PP
uncommitted JJ O
T NN B-NP
helper NN I-NP
( ( O
TH NN B-NP
) ) O
cells NNS B-NP
toward IN B-PP
the DT B-NP
TH1 NN I-NP
phenotype NN I-NP
COMMA COMMA O
which WDT B-NP
regulates VBZ B-VP
cellular JJ B-NP
immunity NN I-NP
COMMA COMMA O
whereas IN O
IL-10 NN B-NP
inhibits VBZ B-VP
TH1 NN B-NP
functions NNS I-NP
and CC O
potentiates VBZ B-VP
TH2-regulated JJ B-NP
responses NNS I-NP
( ( O
i.e. FW B-NP
COMMA COMMA I-NP
humoral JJ I-NP
immunity NN I-NP
) ) O
. . O

To TO B-VP
examine VB I-VP
the DT B-NP
potential JJ I-NP
effects NNS I-NP
of IN B-PP
stress NN B-NP
on IN B-PP
TH1\/TH2 NN B-NP
balance NN I-NP
COMMA COMMA O
we PRP B-NP
studied VBD B-VP
the DT B-NP
ability NN I-NP
of IN B-PP
three CD B-NP
prototype NN I-NP
stress NN I-NP
hormones NNS I-NP
- : O
dexamethasone NN B-NP
( ( O
a DT B-NP
synthetic JJ I-NP
glucocorticoid NN I-NP
) ) O
and CC O
the DT B-NP
catecholamines NNS I-NP
norepinephrine NN B-NP
and CC O
epinephrine NN B-NP
- : O
to TO B-VP
alter VB I-VP
the DT B-NP
production NN I-NP
of IN B-PP
IL-12 NN B-NP
( ( O
p70 NN B-NP
) ) O
and CC O
IL-10 NN B-NP
induced VBN B-VP
by IN B-PP
bacterial JJ B-NP
lipopolysaccharide NN B-NP
( ( O
LPS NN B-NP
) ) O
in IN B-PP
human JJ B-NP
whole JJ I-NP
blood NN I-NP
. . O

Dexamethasone NN B-NP
inhibited VBD B-VP
LPS-induced JJ B-NP
bioactive JJ I-NP
IL-12 NN I-NP
production NN I-NP
in IN B-PP
a DT B-NP
dose-dependent JJ I-NP
fashion NN I-NP
and CC B-PP
at IN B-PP
physiologically RB B-NP
relevant JJ I-NP
concentrations NNS I-NP
; : O

Nasal JJ O
NK- NN B-NP
and CC O
T-cell NN B-NP
lymphomas NNS B-NP
share VBP B-VP
the DT B-NP
same JJ I-NP
type NN I-NP
of IN B-PP
Epstein-Barr JJ B-NP
virus NN I-NP
latency NN I-NP
as IN B-PP
nasopharyngeal JJ B-NP
carcinoma NN I-NP
and CC O
Hodgkin NN B-NP
's POS B-NP
disease NN I-NP
. . O

Nasal JJ B-NP
T\/NK-cell JJ I-NP
lymphomas NNS I-NP
can MD B-VP
be VB I-VP
further RBR I-VP
separated VBN I-VP
into IN B-PP
those DT B-NP
of IN B-PP
natural JJ B-NP
killer NN I-NP
( ( O
NK NN B-NP
) ) O
cell NN B-NP
lineage NN I-NP
or CC B-PP
of IN B-PP
T-cell NN B-NP
lineage NN I-NP
COMMA COMMA O
with IN B-PP
differences NNS B-NP
in IN B-PP
cellular JJ B-NP
phenotype NN I-NP
COMMA COMMA O
T-cell NN B-NP
receptor NN I-NP
( ( O
TcR NN B-NP
) ) O
gene NN B-NP
rearrangement NN I-NP
and CC O
TcR NN B-NP
transcript NN I-NP
expression NN I-NP
. . O

Both CC O
NK- NN B-NP
and CC O
T-cell NN B-NP
subtypes NNS B-NP
are VBP B-VP
closely RB I-VP
associated VBN I-VP
with IN B-PP
Epstein-Barr JJ B-NP
virus NN I-NP
( ( O
EBV NN B-NP
) ) O
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
EBV NN B-NP
gene NN I-NP
expression NN I-NP
was VBD B-VP
determined VBN I-VP
in IN B-PP
23 CD B-NP
cases NNS I-NP
of IN B-PP
nasal JJ B-NP
lymphoma NN I-NP
( ( O
NL NN B-NP
) ) O
by IN B-PP
in FW B-NP
situ FW I-NP
hybridisation NN I-NP
( ( O
ISH NN B-NP
) ) O
COMMA COMMA O
reverse JJ B-NP
transcriptase-polymerase NN I-NP
chain NN I-NP
reaction NN I-NP
( ( O
RT-PCR NN B-NP
) ) O
and CC O
immunohistochemistry NN B-NP
( ( O
IH NN B-NP
) ) O
. . O

Of IN B-PP
the DT B-NP
23 CD I-NP
cases NNS I-NP
COMMA COMMA O
19 CD B-NP
were VBD B-VP
classified VBN I-VP
as IN B-PP
NK-cell NN O
and CC O
4 CD B-NP
as IN B-PP
T-cell NN B-NP
tumours NNS I-NP
. . O

ISH NN B-NP
for IN B-PP
EBV-encoded JJ B-NP
small JJ I-NP
non-polyadenylated JJ I-NP
RNAs NNS I-NP
showed VBD B-VP
that IN B-SBAR
all DT B-NP
cases NNS I-NP
COMMA COMMA O
whether IN B-SBAR
NK NN B-NP
or CC O
T NN B-NP
COMMA COMMA O
harboured VBD B-VP
EBV NN B-NP
in IN B-PP
virtually RB B-NP
all DT I-NP
tumour NN I-NP
cells NNS I-NP
. . O

RT-PCR NN B-NP
demonstrated VBD B-VP
that IN B-SBAR
NL NN B-NP
of IN B-PP
both DT B-NP
subtypes NNS I-NP
expressed VBD B-VP
EBNAI NN B-NP
of IN B-PP
the DT B-NP
QUK NN I-NP
splice NN I-NP
pattern NN I-NP
COMMA COMMA O
the DT B-NP
latent JJ I-NP
membrane NN I-NP
proteins NNS I-NP
COMMA COMMA O
LMP1 NN B-NP
and CC O
2 CD B-NP
and CC O
the DT B-NP
BamHI NN I-NP
A NN I-NP
rightward JJ I-NP
transcripts NNS I-NP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
EBNA2 NN B-NP
mRNAs NNS I-NP
COMMA COMMA O
compatible JJ B-ADJP
with IN B-PP
the DT B-NP
latency NN I-NP
type NN I-NP
II CD I-NP
pattern NN I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
analysis NN B-NP
of IN B-PP
EBV NN B-NP
protein NN I-NP
expression NN I-NP
by IN B-PP
IH NN B-NP
revealed VBD B-VP
a DT B-NP
heterogeneous JJ I-NP
pattern NN I-NP
of IN B-PP
EBV NN B-NP
gene NN I-NP
expression NN I-NP
at IN B-PP
the DT B-NP
single-cell NN I-NP
level NN I-NP
consisting VBG B-VP
of IN B-PP
both CC B-NP
LMP1+ JJ I-NP
and CC I-NP
LMP1- JJ I-NP
tumour NN I-NP
cells NNS I-NP
COMMA COMMA O
suggesting VBG B-VP
a DT B-NP
mixture NN I-NP
of IN B-PP
latency NN B-NP
I CD B-NP
and CC O
II CD B-NP
. . O

Although IN B-SBAR
2 CD B-NP
early JJ I-NP
lytic JJ I-NP
transcripts NNS I-NP
COMMA COMMA O
BZLF1 NN B-NP
and CC O
BHRF1 NN B-NP
COMMA COMMA O
were VBD B-VP
also RB I-VP
detected VBN I-VP
in IN B-PP
13 CD B-NP
and CC I-NP
10 CD I-NP
cases NNS I-NP
COMMA COMMA O
respectively RB B-ADVP
COMMA COMMA O
the DT B-NP
lack NN I-NP
of IN B-PP
ZEBRA NN B-NP
staining NN I-NP
in IN B-PP
any DT B-NP
case NN I-NP
indicates VBZ B-VP
that IN B-SBAR
these DT B-NP
lytic JJ I-NP
transcripts NNS I-NP
are VBP B-VP
most RBS I-VP
likely RB I-VP
expressed VBN I-VP
by IN B-PP
rare JJ B-NP
cells NNS I-NP
in IN B-PP
the DT B-NP
biopsies NNS I-NP
entering VBG B-VP
lytic JJ B-NP
cycle NN I-NP
. . O

The DT B-NP
viral JJ I-NP
transcriptional JJ I-NP
pattern NN I-NP
similar JJ B-ADJP
to TO B-PP
that DT B-NP
of IN B-PP
nasopharyngeal JJ B-NP
carcinoma NN I-NP
and CC O
Hodgkin NN B-NP
's POS B-NP
disease NN I-NP
suggests VBZ B-VP
that IN B-SBAR
EBV NN B-NP
can MD B-VP
exploit VB I-VP
common JJ B-NP
regulatory JJ I-NP
mechanisms NNS I-NP
for IN B-PP
gene NN B-NP
transcription NN I-NP
in IN B-PP
diverse JJ B-NP
host NN I-NP
cell NN I-NP
types NNS I-NP
. . O

Down-regulation NN B-NP
of IN B-PP
immunogenic JJ B-NP
proteins NNS I-NP
( ( O
EBNA2-EBNA6 NN B-NP
) ) O
in IN B-PP
nasal JJ B-NP
lymphoma NN I-NP
may MD B-VP
enable VB I-VP
tumour NN B-NP
cells NNS I-NP
to TO B-VP
evade VB I-VP
host NN B-NP
cytotoxic JJ I-NP
T-cell NN I-NP
surveillance NN I-NP
. . O

Lack NN B-NP
of IN B-PP
IL-12 NN B-NP
signaling NN I-NP
in IN B-PP
human JJ B-NP
allergen-specific JJ I-NP
Th2 NN I-NP
cells NNS I-NP
. . O

IL-12 NN B-NP
is VBZ B-VP
a DT B-NP
powerful JJ I-NP
skewer NN I-NP
of IN B-PP
CD4+ JJ B-NP
T NN I-NP
cell NN I-NP
responses NNS I-NP
toward IN B-PP
the DT B-NP
Th1 NN I-NP
phenotype NN I-NP
by IN B-PP
inducing VBG B-VP
IFN-gamma NN B-NP
production NN I-NP
in IN B-PP
naive JJ B-NP
Th NN I-NP
cells NNS I-NP
. . O

In IN B-PP
the DT B-NP
present JJ I-NP
study NN I-NP
we PRP B-NP
addressed VBD B-VP
the DT B-NP
question NN I-NP
of IN B-PP
whether IN B-SBAR
IL-12 NN B-NP
can MD B-VP
reverse VB I-VP
established JJ B-NP
Th2 NN I-NP
responses NNS I-NP
into IN B-PP
Th1\/Th0 NN B-NP
responses NNS I-NP
by IN B-PP
inducing VBG B-VP
IFN-gamma NN B-NP
production NN I-NP
in IN B-PP
memory NN B-NP
Th2 NN I-NP
cells NNS I-NP
. . O

To TO B-PP
this DT B-NP
aim NN I-NP
COMMA COMMA O
allergen-specific JJ B-NP
CD4+ JJ I-NP
T NN B-NP
cell NN I-NP
clones NNS I-NP
( ( O
TCC NN B-NP
) ) O
were VBD B-VP
generated VBN I-VP
from IN B-PP
the DT B-NP
peripheral JJ I-NP
blood NN I-NP
of IN B-PP
three CD B-NP
atopic JJ I-NP
patients NNS I-NP
COMMA COMMA O
and CC O
their PRP$ B-NP
cytokine NN I-NP
profiles NNS I-NP
were VBD B-VP
analyzed VBN I-VP
. . O

The DT B-NP
majority NN I-NP
of IN B-PP
these DT B-NP
TCC NN I-NP
exhibited VBD B-VP
a DT B-NP
strongly RB I-NP
polarized VBN I-NP
Th2 NN I-NP
cytokine NN I-NP
profile NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
production NN I-NP
of IN B-PP
IFN-gamma NN B-NP
could MD B-VP
not RB I-VP
be VB I-VP
induced VBN I-VP
by IN B-PP
exogenous JJ B-NP
IL-12 NN I-NP
. . O

Only RB B-NP
those DT I-NP
TCC NN I-NP
with IN B-PP
low JJ B-NP
IFN-gamma NN I-NP
levels NNS I-NP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
IL-12 NN B-NP
responded VBD B-VP
to TO B-PP
IL-12 NN B-NP
by IN B-PP
additional JJ B-NP
enhancement NN I-NP
of IN B-PP
IFN-gamma NN B-NP
production NN I-NP
. . O

The DT B-NP
IL-12 NN I-NP
nonresponsiveness NN I-NP
of IN B-PP
the DT B-NP
Th2 NN I-NP
clones NNS I-NP
was VBD B-VP
further RBR B-ADJP
evident JJ I-ADJP
by IN B-PP
the DT B-NP
total JJ I-NP
lack NN I-NP
of IN B-PP
IL-12-induced JJ B-NP
phosphorylation NN I-NP
of IN B-PP
STAT4 NN B-NP
( ( O
signal NN B-NP
transducer NN I-NP
and CC O
activator NN B-NP
of IN B-PP
transcription-4 NN B-NP
) ) O
COMMA COMMA O
a DT B-NP
transcription NN I-NP
factor NN I-NP
that WDT B-NP
is VBZ B-VP
typically RB I-VP
involved VBN I-VP
in IN B-PP
IL-12 NN B-NP
signaling NN I-NP
. . O

Consequently RB B-ADVP
COMMA COMMA O
IL-12 NN B-NP
also RB B-ADVP
failed VBD B-VP
to TO I-VP
induce VB I-VP
the DT B-NP
DNA-binding JJ I-NP
activity NN I-NP
of IN B-PP
STAT4-containing JJ B-NP
complexes NNS I-NP
in IN B-PP
the DT B-NP
nuclei NNS I-NP
of IN B-PP
these DT B-NP
Th2 NN I-NP
clones NNS I-NP
. . O

All DT B-NP
TCC NN I-NP
expressed VBD B-VP
equal JJ B-NP
levels NNS I-NP
of IN B-PP
the DT B-NP
low-affinity JJ I-NP
IL-12R NN I-NP
beta1 NN I-NP
subunit NN I-NP
. . O

Our PRP$ B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
human JJ B-NP
allergen-specific JJ I-NP
Th NN I-NP
cells NNS I-NP
with IN B-PP
strongly RB B-NP
polarized VBN I-NP
Th2 NN I-NP
cytokine NN I-NP
profiles NNS I-NP
do VBP B-VP
not RB I-VP
respond VB I-VP
to TO B-PP
IL-12 NN B-NP
and CC O
COMMA COMMA O
therefore RB O
COMMA COMMA O
can MD B-VP
not RB I-VP
be VB I-VP
induced VBN I-VP
to TO I-VP
produce VB I-VP
IFN-gamma NN B-NP
. . O

The DT B-NP
apparent JJ I-NP
high JJ I-NP
frequency NN I-NP
of IN B-PP
IL-12-nonresponsive JJ B-NP
Th NN I-NP
cells NNS I-NP
within IN B-PP
the DT B-NP
allergen-specific JJ I-NP
populations NNS I-NP
in IN B-PP
atopic JJ B-NP
patients NNS I-NP
predicts VBZ B-VP
a DT B-NP
limited JJ I-NP
skewing JJ I-NP
potential NN I-NP
of IN B-PP
IL-12 NN B-NP
in IN B-PP
the DT B-NP
case NN I-NP
of IN B-PP
established JJ B-NP
Th2 NN I-NP
responses NNS I-NP
COMMA COMMA O
but CC O
only RB B-VP
affecting VBG I-VP
newly RB B-NP
recruited VBN I-NP
naive JJ I-NP
Th NN I-NP
cells NNS I-NP
. . O

Characterization NN B-NP
of IN B-PP
a DT B-NP
CD43\/leukosialin-mediated JJ I-NP
pathway NN I-NP
for IN B-PP
inducing VBG B-VP
apoptosis NN B-NP
in IN B-PP
human JJ B-NP
T-lymphoblastoid JJ I-NP
cells NNS I-NP
. . O

The DT O
monoclonal JJ B-NP
antibody NN I-NP
( ( O
mAb NN B-NP
) ) O
J393 NN B-NP
induces VBZ B-VP
apoptosis NN B-NP
in IN B-PP
Jurkat NN B-NP
T-cells NNS I-NP
. . O

NH2-terminal JJ B-NP
amino NN I-NP
acid NN I-NP
sequence NN I-NP
analysis NN I-NP
identified VBD B-VP
the DT B-NP
140-kDa JJ I-NP
surface NN I-NP
antigen NN I-NP
for IN B-PP
mAb NN B-NP
J393 NN I-NP
as IN B-PP
CD43\/leukosialin NN B-NP
COMMA COMMA O
the DT B-NP
major JJ I-NP
sialoglycoprotein NN I-NP
of IN B-PP
leukocytes NNS B-NP
. . O

While IN B-SBAR
Jurkat NN B-NP
cells NNS I-NP
co-expressed VBD B-VP
two CD B-NP
discrete JJ I-NP
cell-surface JJ I-NP
isoforms NNS I-NP
of IN B-PP
CD43 NN B-NP
COMMA COMMA O
recognized VBN B-VP
by IN B-PP
mAb NN B-NP
J393 NN I-NP
and CC O
mAb NN B-NP
G10-2 NN I-NP
COMMA COMMA O
respectively RB B-ADVP
COMMA COMMA O
only RB B-NP
J393\/CD43 NN I-NP
signaled VBD B-VP
apoptosis NN B-NP
. . O

J393\/CD43 NN B-NP
was VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
hyposialylated VBN I-VP
COMMA COMMA O
bearing VBG B-VP
predominantly RB B-NP
O-linked JJ I-NP
monosaccharide NN I-NP
glycans NNS I-NP
COMMA COMMA O
whereas IN O
G10-2\/CD43 NN B-NP
bore VBD B-VP
complex JJ O
sialylated VBN O
tetra- JJ B-NP
and CC O
hexasaccharide NN B-NP
chains NNS B-NP
. . O

Treatment NN B-NP
with IN B-PP
soluble JJ B-NP
COMMA COMMA I-NP
bivalent JJ I-NP
mAb NN I-NP
J393 NN I-NP
killed VBD B-VP
25-50 CD B-NP
% NN I-NP
of IN B-PP
the DT B-NP
cell NN I-NP
population NN I-NP
COMMA COMMA O
while IN B-SBAR
concomitant JJ B-NP
engagement NN I-NP
of IN B-PP
either CC O
the DT B-NP
CD3.TcR NN I-NP
complex NN I-NP
or CC O
the DT B-NP
integrins NNS I-NP
CD18 NN B-NP
and CC O
CD29 NN B-NP
significantly RB B-ADVP
potentiated VBD B-VP
this DT B-NP
effect NN I-NP
. . O

Treatment NN B-NP
of IN B-PP
Jurkat NN B-NP
cells NNS I-NP
with IN B-PP
mAb NN B-NP
J393 NN I-NP
induced VBD B-VP
tyrosine NN B-NP
phosphorylation NN I-NP
of IN B-PP
specific JJ B-NP
protein NN I-NP
substrates NNS I-NP
that WDT B-NP
underwent VBD B-VP
hyperphosphorylation NN B-NP
upon IN B-PP
antigen NN B-NP
receptor NN I-NP
costimulation NN I-NP
. . O

Tyrosine NN B-NP
kinase NN I-NP
inhibition NN I-NP
by IN B-PP
herbimycin NN B-NP
A NN I-NP
diminished VBD B-VP
J393\/CD43-mediated JJ B-NP
apoptosis NN I-NP
COMMA COMMA O
whereas IN O
inhibition NN B-NP
of IN B-PP
phosphotyrosine NN B-NP
phosphatase NN I-NP
activity NN I-NP
by IN B-PP
bis(maltolato)oxovanadium-IV NN B-NP
enhanced VBD B-VP
cell NN B-NP
death NN I-NP
. . O

Signal NN B-NP
transduction NN I-NP
through IN B-PP
tyrosine NN B-NP
kinase NN I-NP
activation NN I-NP
may MD B-VP
lead VB I-VP
to TO B-PP
altered JJ B-NP
gene NN I-NP
expression NN I-NP
COMMA COMMA O
as IN B-SBAR
J393\/CD43 NN B-NP
ligation NN I-NP
prompted VBD B-VP
decreases NNS B-NP
in IN B-PP
the DT B-NP
nuclear JJ I-NP
localization NN I-NP
of IN B-PP
the DT B-NP
transcriptional JJ I-NP
regulatory JJ I-NP
protein NN I-NP
NF-kappaB NN I-NP
and CC O
proteins NNS B-NP
binding VBG B-VP
the DT B-NP
interferon-inducible JJ I-NP
regulatory JJ I-NP
element NN I-NP
. . O

Since IN B-SBAR
peripheral JJ B-NP
blood NN I-NP
T-lymphocytes NNS I-NP
express VBP B-VP
cryptic JJ B-NP
epitopes NNS I-NP
for IN B-PP
mAb NN B-NP
J393 NN I-NP
COMMA COMMA O
these DT B-NP
findings NNS I-NP
demonstrate VBP B-VP
the DT B-NP
existence NN I-NP
of IN B-PP
a DT B-NP
tightly RB I-NP
regulated VBN I-NP
CD43-mediated JJ I-NP
pathway NN I-NP
for IN B-PP
inducing VBG B-VP
apoptosis NN B-NP
in IN B-PP
human JJ B-NP
T-cell NN I-NP
lineages NNS I-NP
. . O

Stat3 NN B-NP
recruitment NN I-NP
by IN B-PP
two CD B-NP
distinct JJ I-NP
ligand-induced JJ I-NP
COMMA COMMA I-NP
tyrosine-phosphorylated JJ I-NP
docking NN I-NP
sites NNS I-NP
in IN B-PP
the DT B-NP
interleukin-10 NN I-NP
receptor NN I-NP
intracellular JJ I-NP
domain NN I-NP
. . O

Recent JJ B-NP
work NN I-NP
has VBZ B-VP
shown VBN I-VP
that IN B-SBAR
IL-10 NN B-NP
induces VBZ B-VP
activation NN B-NP
of IN B-PP
the DT B-NP
JAK-STAT NN I-NP
signaling NN I-NP
pathway NN I-NP
. . O

To TO B-VP
define VB I-VP
the DT B-NP
mechanism NN I-NP
underlying VBG B-VP
signal NN B-NP
transducer NN I-NP
and CC O
activator NN B-NP
of IN B-PP
transcription NN B-NP
( ( O
STAT NN B-NP
) ) O
protein NN B-NP
recruitment NN I-NP
to TO B-PP
the DT O
interleukin NN B-NP
10 CD I-NP
( ( O
IL-10 NN B-NP
) ) O
receptor NN B-NP
COMMA COMMA O
the DT B-NP
STAT NN I-NP
proteins NNS I-NP
activated VBN B-VP
by IN B-PP
IL-10 NN B-NP
in IN B-PP
different JJ B-NP
cell NN I-NP
populations NNS I-NP
were VBD B-VP
first RB I-VP
defined VBN I-VP
using VBG B-VP
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
. . O

In IN B-PP
all DT B-NP
cells NNS I-NP
tested VBN B-VP
COMMA COMMA O
IL-10 NN B-NP
activated VBD B-VP
Stat1 NN B-NP
and CC O
Stat3 NN B-NP
and CC O
induced VBD B-VP
the DT B-NP
formation NN I-NP
of IN B-PP
three CD B-NP
distinct JJ I-NP
DNA NN I-NP
binding NN I-NP
complexes NNS I-NP
that WDT B-NP
contained VBD B-VP
different JJ B-NP
combinations NNS I-NP
of IN B-PP
these DT B-NP
two CD I-NP
transcription NN I-NP
factors NNS I-NP
. . O

IL-10 NN B-NP
also RB B-ADVP
activated VBD B-VP
Stat5 NN B-NP
in IN B-PP
Ba\/F3 NN B-NP
cells NNS I-NP
that IN B-NP
stably RB B-ADVP
expressed VBD B-VP
the DT B-NP
murine JJ I-NP
IL-10 NN I-NP
receptor NN I-NP
. . O

Using VBG B-VP
a DT B-NP
structure-function JJ I-NP
mutagenesis NN I-NP
approach NN I-NP
COMMA COMMA O
two CD B-NP
tyrosine NN I-NP
residues NNS I-NP
( ( O
Tyr427 NN B-NP
and CC O
Tyr477 NN B-NP
) ) O
in IN B-PP
the DT B-NP
intracellular JJ I-NP
domain NN I-NP
of IN B-PP
the DT B-NP
murine JJ I-NP
IL-10 NN I-NP
receptor NN I-NP
were VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
redundantly RB I-VP
required VBN I-VP
for IN B-PP
receptor NN B-NP
function NN I-NP
and CC B-PP
for IN B-PP
activation NN B-NP
of IN B-PP
Stat3 NN B-NP
but CC B-PP
not RB B-PP
for IN I-PP
Stat1 NN B-NP
or CC O
Stat5 NN B-NP
. . O

Twelve CD B-NP
amino NN I-NP
acid NN I-NP
peptides NNS I-NP
encompassing VBG B-VP
either DT B-NP
of IN B-PP
these DT B-NP
two CD I-NP
tyrosine NN I-NP
residues NNS I-NP
in IN B-PP
phosphorylated JJ B-NP
form NN I-NP
coprecipitated VBD B-VP
Stat3 NN B-NP
but CC B-CONJP
not RB I-CONJP
Stat1 NN B-NP
and CC O
blocked VBD B-VP
IL-10-induced JJ B-NP
Stat3 NN I-NP
phosphorylation NN I-NP
in IN B-PP
a DT B-NP
cell-free JJ I-NP
system NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
tyrosine-phosphorylated JJ B-NP
peptides NNS I-NP
containing VBG B-VP
Tyr374 NN B-NP
or CC O
Tyr396 NN B-NP
did VBD B-VP
not RB I-VP
interact VB I-VP
with IN B-PP
Stat3 NN B-NP
or CC O
block VB B-VP
Stat3 NN B-NP
activation NN I-NP
. . O

These DT B-NP
data NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
Stat3 NN B-NP
but CC B-NP
not RB I-NP
Stat1 NN B-NP
or CC O
Stat5 NN B-NP
is VBZ B-VP
directly RB I-VP
recruited VBN I-VP
to TO B-PP
the DT B-NP
ligand-activated JJ I-NP
IL-10 NN I-NP
receptor NN I-NP
by IN B-PP
binding VBG B-VP
to TO B-PP
specific JJ B-NP
but CC I-NP
redundant JJ I-NP
receptor NN I-NP
intracellular JJ I-NP
domain NN I-NP
sequences NNS I-NP
containing VBG B-VP
phosphotyrosine NN B-NP
. . O

This DT B-NP
study NN I-NP
thus RB B-ADVP
supports VBZ B-VP
the DT B-NP
concept NN I-NP
that IN B-SBAR
utilization NN B-NP
of IN B-PP
distinct JJ B-NP
STAT NN I-NP
proteins NNS I-NP
by IN B-PP
different JJ B-NP
cytokine NN I-NP
receptors NNS I-NP
is VBZ B-VP
dependent JJ B-ADJP
on IN B-PP
the DT B-NP
expression NN I-NP
of IN B-PP
particular JJ B-NP
ligand-activatable JJ I-NP
COMMA COMMA I-NP
tyrosine-containing JJ I-NP
STAT NN I-NP
docking NN I-NP
sites NNS I-NP
in IN B-PP
receptor NN B-NP
intracellular JJ I-NP
domains NNS I-NP
. . O

Identification NN B-NP
and CC O
characterization NN B-NP
of IN B-PP
a DT B-NP
leukocyte-specific JJ I-NP
component NN I-NP
of IN B-PP
the DT B-NP
nuclear JJ I-NP
body NN I-NP
. . O

The DT B-NP
nuclear JJ I-NP
body NN I-NP
( ( O
NB NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
cellular JJ I-NP
organelle NN I-NP
that WDT B-NP
is VBZ B-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
pathogenesis NN I-NP
of IN B-PP
acute JJ B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
and CC O
viral JJ B-NP
infection NN I-NP
. . O

The DT B-NP
NB NN I-NP
is VBZ B-VP
also RB B-ADVP
a DT B-NP
target NN I-NP
of IN B-PP
antibodies NNS B-NP
in IN B-PP
the DT B-NP
serum NN I-NP
of IN B-PP
patients NNS B-NP
with IN B-PP
the DT B-NP
autoimmune JJ I-NP
disease NN I-NP
primary JJ I-NP
biliary JJ I-NP
cirrhosis NN I-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
COMMA COMMA O
serum NN B-NP
from IN B-PP
a DT B-NP
patient NN I-NP
with IN B-PP
primary JJ B-NP
biliary JJ I-NP
cirrhosis NN I-NP
was VBD B-VP
used VBN I-VP
to TO B-VP
identify VB I-VP
a DT B-NP
cDNA NN I-NP
encoding VBG B-VP
a DT B-NP
novel JJ I-NP
component NN I-NP
of IN B-PP
the DT B-NP
NB NN I-NP
COMMA COMMA O
a DT B-NP
140-kDa JJ I-NP
protein NN I-NP
designated VBN B-VP
Sp140 NN B-NP
. . O

The DT B-NP
predicted VBN I-NP
amino NN I-NP
acid NN I-NP
sequence NN I-NP
of IN B-PP
the DT B-NP
amino-terminal JJ I-NP
portion NN I-NP
of IN B-PP
Sp140 NN B-NP
was VBD B-VP
similar JJ B-ADJP
to TO B-PP
Sp100 NN B-NP
COMMA COMMA O
a DT B-NP
previously RB I-NP
identified VBN I-NP
NB NN I-NP
protein NN I-NP
. . O

The DT B-NP
carboxyl JJ I-NP
portion NN I-NP
of IN B-PP
Sp140 NN B-NP
contained VBD B-VP
a DT B-NP
zinc-finger JJ I-NP
domain NN I-NP
and CC O
a DT B-NP
bromodomain NN I-NP
COMMA COMMA O
motifs NNS B-NP
that WDT B-NP
are VBP B-VP
present JJ B-ADJP
in IN B-PP
proteins NNS B-NP
regulating VBG B-VP
gene NN B-NP
transcription NN I-NP
. . O

High JJ B-NP
levels NNS I-NP
of IN B-PP
Sp140 NN B-NP
mRNA NN I-NP
were VBD B-VP
detected VBN I-VP
in IN B-PP
human JJ O
spleen NN B-NP
and CC O
peripheral JJ B-NP
blood NN I-NP
leukocytes NNS B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
other JJ B-NP
human JJ I-NP
tissues NNS I-NP
. . O

The DT B-NP
level NN I-NP
of IN B-PP
SP140 NN B-NP
mRNA NN I-NP
in IN B-PP
myeloid JJ B-NP
precursor NN I-NP
cell NN I-NP
lines NNS I-NP
HL60 NN B-NP
and CC O
NB4 NN B-NP
markedly RB B-ADVP
increased VBD B-VP
in IN B-PP
response NN I-PP
to TO I-PP
chemically RB B-NP
induced VBN I-NP
cellular JJ I-NP
differentiation NN I-NP
. . O

Immunohistochemical JJ B-NP
techniques NNS I-NP
were VBD B-VP
used VBN I-VP
to TO B-VP
demonstrate VB I-VP
that IN B-SBAR
SP140 NN B-NP
localized VBD B-VP
to TO B-PP
the DT B-NP
NB NN I-NP
in IN B-PP
differentiated VBN O
HL60 NN B-NP
and CC O
NB4 NN B-NP
cells NNS B-NP
. . O

The DT B-NP
location NN I-NP
of IN B-PP
Sp140 NN B-NP
in IN B-PP
the DT B-NP
NB NN I-NP
COMMA COMMA O
and CC O
expression NN B-NP
of IN B-PP
this DT B-NP
gene NN I-NP
in IN B-PP
cells NNS B-NP
involved VBN B-VP
in IN B-PP
host NN B-NP
defense NN I-NP
COMMA COMMA O
suggest VBP B-VP
that IN B-SBAR
Sp140 NN B-NP
may MD B-VP
be VB I-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
pathogenesis NN I-NP
of IN B-PP
acute JJ B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
and CC O
viral JJ B-NP
infection NN I-NP
. . O

T-cell-directed JJ B-NP
TAL-1 NN I-NP
expression NN I-NP
induces VBZ B-VP
T-cell NN B-NP
malignancies NNS I-NP
in IN B-PP
transgenic JJ B-NP
mice NNS I-NP
. . O

The DT B-NP
TAL-1 NN I-NP
gene NN I-NP
specifies VBZ B-VP
for IN B-PP
a DT B-NP
basic JJ I-NP
domain-helix-loop-helix JJ I-NP
protein NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
normal JJ B-NP
hematopoiesis NN I-NP
. . O

In IN B-PP
human JJ B-NP
pathology NN I-NP
COMMA COMMA O
the DT B-NP
TAL-1 NN I-NP
gene NN I-NP
product NN I-NP
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
a DT B-NP
high JJ I-NP
percentage NN I-NP
of IN B-PP
T-cell NN B-NP
acute JJ I-NP
lymphoblastic JJ I-NP
leukemias NNS I-NP
in IN B-PP
the DT B-NP
pediatric JJ I-NP
age NN I-NP
range NN I-NP
; : O
however RB B-ADVP
COMMA COMMA O
it PRP B-NP
has VBZ B-VP
not RB I-VP
been VBN I-VP
established VBN I-VP
whether IN B-SBAR
the DT B-NP
expression NN I-NP
has VBZ B-VP
a DT B-NP
causal JJ I-NP
role NN I-NP
in IN B-PP
oncogenesis NN B-NP
. . O

In IN B-PP
this DT B-NP
report NN I-NP
COMMA COMMA O
we PRP B-NP
describe VBP B-VP
the DT B-NP
phenotype NN I-NP
of IN B-PP
mouse NN B-NP
transgenic JJ I-NP
lines NNS I-NP
obtained VBN B-VP
by IN B-PP
inducing VBG B-VP
tal-1 NN B-NP
protein NN I-NP
expression NN I-NP
in IN B-PP
lymphoid JJ B-NP
tissues NNS I-NP
using VBG B-VP
the DT B-NP
LCK NN I-NP
promoter NN I-NP
. . O

The DT B-NP
survival NN I-NP
rate NN I-NP
of IN B-PP
tal-1 NN B-NP
transgenic JJ I-NP
animals NNS I-NP
was VBD B-VP
much RB B-ADJP
lower JJR I-ADJP
as IN B-SBAR
compared VBN B-VP
with IN B-PP
control NN B-NP
mice NNS I-NP
. . O

Histopathological JJ B-NP
analysis NN I-NP
revealed VBD B-VP
lymphomas NNS B-NP
of IN B-PP
T-cell NN B-NP
type NN I-NP
COMMA COMMA O
often RB B-VP
comprising VBG I-VP
a DT B-NP
minor JJ I-NP
B-cell NN I-NP
component NN I-NP
. . O

Some DT B-NP
mice NNS I-NP
showed VBD B-VP
marked JJ B-NP
splenic JJ I-NP
lymphocyte NN I-NP
depletion NN I-NP
. . O

Primary JJ B-NP
lymphocyte NN I-NP
cultures NNS I-NP
showed VBD B-VP
partial JJ B-NP
independence NN I-NP
from IN B-PP
exogenous JJ B-NP
growth NN I-NP
stimuli NNS I-NP
and CC O
increased VBD B-VP
resistance NN B-NP
to TO B-PP
low-serum JJ B-NP
apoptosis NN I-NP
. . O

To TO B-VP
further RB I-VP
unravel VB I-VP
the DT B-NP
tal-1 NN I-NP
oncogenic JJ I-NP
potential NN I-NP
COMMA COMMA O
a DT B-NP
strain NN I-NP
of IN B-PP
tal-1 NN B-NP
transgenic JJ I-NP
mice NNS I-NP
was VBD B-VP
crossbred VBN I-VP
with IN B-PP
p53-\/- JJ B-NP
mice NNS I-NP
; : O
the DT B-NP
survival NN I-NP
rate NN I-NP
in IN B-PP
these DT B-NP
animals NNS I-NP
was VBD B-VP
reduced VBN I-VP
by IN B-PP
more JJR B-NP
than IN I-NP
one-half NN I-NP
when WRB B-ADVP
compared VBN B-VP
with IN B-PP
that DT B-NP
of IN B-PP
tal-1 NN B-NP
mice NNS I-NP
COMMA COMMA O
and CC O
histopathological JJ B-NP
analysis NN I-NP
revealed VBD B-VP
exclusively RB B-ADVP
T-cell NN B-NP
lymphomas NNS I-NP
. . O

These DT B-NP
data NNS I-NP
indicate VBP B-VP
that IN B-SBAR
TAL-1 NN B-NP
COMMA COMMA O
expressed VBN B-VP
in IN B-PP
T NN B-NP
cells NNS I-NP
COMMA COMMA O
is VBZ B-VP
per FW B-ADVP
se FW I-ADVP
a DT B-NP
potent JJ I-NP
oncogene NN I-NP
COMMA COMMA O
which WDT B-NP
may MD B-VP
exert VB I-VP
a DT B-NP
key JJ I-NP
leukemogenetic JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
majority NN I-NP
of IN B-PP
T-cell NN B-NP
acute JJ I-NP
lymphoblastic JJ I-NP
leukemias NNS I-NP
. . O

Naive JJ B-NP
( ( I-NP
CD45RA+ JJ I-NP
) ) I-NP
T NN I-NP
lymphocytes NNS I-NP
are VBP B-VP
more RBR B-ADJP
sensitive JJ I-ADJP
to TO B-PP
oxidative JJ B-NP
stress-induced JJ I-NP
signals NNS I-NP
than IN B-PP
memory NN B-NP
( ( I-NP
CD45RO+ JJ I-NP
) ) I-NP
cells NNS I-NP
. . O

Formation NN B-NP
of IN B-PP
reactive JJ B-NP
oxygen NN I-NP
intermediates NNS I-NP
( ( O
ROI NN B-NP
) ) O
after IN B-PP
oxidative JJ B-NP
stress NN I-NP
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
to TO B-VP
be VB I-VP
an DT B-NP
activation NN I-NP
signal NN I-NP
for IN B-PP
T NN B-NP
lymphocytes NNS I-NP
COMMA COMMA O
e.g. FW B-ADVP
COMMA COMMA O
expression NN B-NP
of IN B-PP
IL-2 NN B-NP
and CC O
its PRP$ B-NP
receptor NN I-NP
are VBP B-VP
induced VBN I-VP
. . O

These DT B-NP
ROI-induced JJ I-NP
effects NNS I-NP
can MD B-VP
COMMA COMMA O
to TO B-PP
a DT B-NP
large JJ I-NP
extent NN I-NP
COMMA COMMA O
be VB B-VP
attributed VBN I-VP
to TO B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factor NN I-NP
NF-kappaB NN I-NP
. . O

Now RB B-ADVP
we PRP B-NP
have VBP B-VP
examined VBN I-VP
whether IN B-SBAR
naive JJ O
and CC O
memory NN B-NP
T NN B-NP
lymphocytes NNS I-NP
differ VBP B-VP
in IN B-PP
their PRP$ B-NP
sensitivity NN I-NP
to TO B-PP
ROI-mediated JJ B-NP
signals NNS I-NP
. . O

When WRB B-ADVP
CD45RA+ JJ O
( ( O
naive JJ B-ADJP
) ) O
and CC O
CD45RO+ JJ O
( ( O
memory NN B-NP
) ) O
T NN B-NP
lymphocytes NNS I-NP
were VBD B-VP
directly RB I-VP
stimulated VBN I-VP
with IN B-PP
H2O2 NN B-NP
COMMA COMMA O
NF-kappaB NN B-NP
nuclear JJ I-NP
translocation NN I-NP
was VBD B-VP
stronger JJR B-ADJP
in IN B-PP
naive JJ B-NP
cells NNS I-NP
than IN B-PP
in IN B-PP
memory NN B-NP
cells NNS I-NP
and CC O
it PRP B-NP
could MD B-VP
be VB I-VP
induced VBN I-VP
with IN B-PP
lower JJR B-NP
doses NNS I-NP
. . O

The DT B-NP
composition NN I-NP
of IN B-PP
the DT B-NP
induced VBN I-NP
nuclear JJ I-NP
NF-kappaB NN I-NP
( ( O
levels NNS B-NP
of IN B-PP
p50 NN B-NP
and CC O
RelA NN B-NP
proteins NNS B-NP
) ) O
was VBD B-VP
similar JJ B-ADJP
in IN B-PP
these DT B-NP
cell NN I-NP
types NNS I-NP
. . O

The DT B-NP
magnitude NN B-NP
and CC O
kinetics NNS B-NP
of IN B-PP
intracellular JJ B-NP
ROI NN I-NP
were VBD B-VP
similar JJ B-ADJP
COMMA COMMA O
suggesting VBG B-VP
that IN B-SBAR
there EX B-NP
were VBD B-VP
no DT B-NP
differences NNS I-NP
in IN B-PP
ROI-forming JJ B-NP
mechanisms NNS I-NP
or CC O
antioxidative JJ B-NP
capacities NNS I-NP
. . O

The DT B-NP
probable JJ I-NP
regulatory JJ I-NP
point NN I-NP
was VBD B-VP
the DT B-NP
cytoplasmic JJ I-NP
IkappaB NN I-NP
inhibitor NN I-NP
: : O
in IN B-PP
CD45RA+ JJ B-NP
cells NNS I-NP
COMMA COMMA O
H2O2 NN B-NP
caused VBD B-VP
a DT B-NP
more RBR I-NP
profound JJ I-NP
depression NN I-NP
in IN B-PP
the DT B-NP
levels NNS I-NP
of IN B-PP
IkappaB NN B-NP
alpha NN I-NP
. . O

These DT B-NP
findings NNS I-NP
indicate VBP B-VP
that IN B-SBAR
T NN B-NP
cells NNS I-NP
representing VBG B-VP
different JJ O
activation NN B-NP
and\/or CC O
differentiation NN B-NP
stages NNS B-NP
can MD B-VP
be VB I-VP
differentially RB B-ADJP
responsive JJ I-ADJP
to TO B-PP
ROI-mediated JJ B-NP
signals NNS I-NP
. . O

Potent JJ B-NP
gene NN I-NP
regulatory JJ I-NP
and CC I-NP
antiproliferative JJ I-NP
activities NNS I-NP
of IN B-PP
20-methyl JJ B-NP
analogues NNS I-NP
of IN B-PP
1COMMA25 CD B-NP
dihydroxyvitamin NN I-NP
D3 NN I-NP
. . O

The DT B-NP
biological JJ I-NP
active JJ I-NP
form NN I-NP
of IN B-PP
vitamin NN B-NP
D3 NN I-NP
COMMA COMMA O
1COMMA25-dihydroxyvitamin NN B-NP
D3 NN I-NP
( ( O
VD NN B-NP
) ) O
COMMA COMMA O
regulates VBZ B-VP
cellular JJ B-NP
growth NN B-NP
and CC O
differentiation NN B-NP
. . O

This DT B-NP
provides VBZ B-VP
the DT B-NP
hormone NN I-NP
with IN B-PP
an DT B-NP
interesting JJ I-NP
therapeutic JJ I-NP
potential NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
hypercalcemia NN B-NP
is VBZ B-VP
a DT B-NP
side JJ I-NP
effect NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
caused VBN I-VP
by IN B-PP
VD NN B-NP
's POS B-NP
classical JJ I-NP
action NN I-NP
COMMA COMMA O
the DT B-NP
regulation NN I-NP
of IN B-PP
calcium NN B-NP
homeostasis NN I-NP
. . O

This DT B-NP
made VBD B-VP
the DT B-NP
need NN I-NP
for IN B-PP
VD NN B-NP
analogues NNS I-NP
with IN B-PP
selectively RB B-NP
increased VBN I-NP
cell NN I-NP
regulatory JJ I-NP
properties NNS I-NP
. . O

Studies NNS B-NP
with IN B-PP
20-epi JJ B-NP
analogues NNS I-NP
pointed VBD B-VP
out RP B-PRT
the DT B-NP
importance NN I-NP
of IN B-PP
the DT B-NP
carbon-20 NN I-NP
position NN I-NP
and CC O
led VBD B-VP
to TO B-PP
the DT B-NP
development NN I-NP
of IN B-PP
20-methyl NN B-NP
derivatives NNS I-NP
of IN B-PP
VD NN B-NP
. . O

In IN B-PP
this DT B-NP
report NN I-NP
the DT B-NP
biological JJ I-NP
properties NNS I-NP
of IN B-PP
the DT B-NP
compounds NNS I-NP
ZK161422 NN B-NP
and CC O
ZK157202 NN B-NP
COMMA COMMA O
which WDT B-NP
are VBP B-VP
20-methyl- NN B-NP
and CC O
20-methyl-23-eneanalogues NN B-NP
COMMA COMMA O
respectively RB B-ADVP
COMMA COMMA O
have VBP B-VP
been VBN I-VP
analyzed VBN I-VP
in IN B-PP
comparison NN I-PP
with IN I-PP
VD NN B-NP
. . O

Both DT B-NP
compounds NNS I-NP
show VBP B-VP
about IN B-ADVP
2-fold RB I-ADVP
lower JJR B-NP
affinity NN I-NP
to TO B-PP
the DT B-NP
VD NN I-NP
receptor NN I-NP
( ( O
VDR NN B-NP
) ) O
than IN B-PP
VD NN B-NP
. . O

However RB B-ADVP
COMMA COMMA O
compared VBN B-VP
to TO B-PP
VD NN B-NP
COMMA COMMA O
their PRP$ B-NP
antiproliferative JJ I-NP
effect NN I-NP
is VBZ B-VP
up RB B-ADJP
to TO I-ADJP
30-fold RB I-ADJP
higher JJR I-ADJP
on IN B-PP
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
mononuclear JJ I-NP
cells NNS I-NP
and CC O
even RB B-ADJP
up RB I-ADJP
to TO I-ADJP
300-fold RB I-ADJP
higher JJR I-ADJP
on IN B-PP
human JJ B-NP
breast NN I-NP
cancer NN I-NP
MCF-7 NN I-NP
cells NNS I-NP
. . O

Whereas IN B-SBAR
the DT B-NP
hypercalcemic JJ I-NP
effect NN I-NP
for IN B-PP
ZK157202 NN B-NP
is VBZ B-VP
also RB I-VP
increased VBN I-VP
10-fold RB B-ADVP
COMMA COMMA O
ZK161422 NN B-NP
has VBZ B-VP
the DT B-NP
same JJ I-NP
calcium-mobilizing JJ I-NP
potency NN I-NP
as IN B-PP
VD NN B-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
ZK161422 NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
ZK157202 NN B-NP
COMMA COMMA O
showed VBD B-VP
preference NN B-NP
for IN B-PP
gene NN B-NP
activation NN I-NP
from IN B-PP
a DT B-NP
promoter NN I-NP
carrying VBG B-VP
a DT B-NP
VD NN I-NP
response NN I-NP
element NN I-NP
with IN B-PP
a DT B-NP
palindromic JJ I-NP
arrangement NN I-NP
of IN B-PP
two CD B-NP
hexameric JJ I-NP
receptor NN I-NP
binding NN I-NP
sites NNS I-NP
spaced VBN B-VP
by IN B-PP
9 CD B-NP
nucleotides NNS I-NP
( ( O
IP9 NN B-NP
) ) O
rather RB B-CONJP
than IN I-CONJP
for IN B-PP
activation NN B-NP
from IN B-PP
a DT B-NP
response NN I-NP
element NN I-NP
formed VBN B-VP
by IN B-PP
a DT B-NP
direct JJ I-NP
repeat NN I-NP
spaced VBN B-VP
by IN B-PP
3 CD B-NP
nucleotides NNS I-NP
( ( O
DR3 NN B-NP
) ) O
. . O

This DT B-NP
observation NN I-NP
supports VBZ B-VP
a DT B-NP
model NN I-NP
COMMA COMMA O
in IN B-PP
which WDT B-NP
promoter NN B-NP
selectivity NN I-NP
reflects VBZ B-VP
the DT B-NP
selectively RB I-NP
increased VBN I-NP
antiproliferative JJ I-NP
effect NN I-NP
of IN B-PP
VD NN B-NP
analogues NNS I-NP
. . O

Interferon NN B-NP
augments VBZ B-VP
PML NN B-NP
and CC O
PML\/RAR NN B-NP
alpha NN I-NP
expression NN B-NP
in IN B-PP
normal JJ B-NP
myeloid JJ I-NP
and CC I-NP
acute JJ I-NP
promyelocytic JJ I-NP
cells NNS I-NP
and CC O
cooperates VBZ B-VP
with IN B-PP
all-trans JJ B-NP
retinoic JJ I-NP
acid NN I-NP
to TO B-VP
induce VB I-VP
maturation NN B-NP
of IN B-PP
a DT B-NP
retinoid-resistant JJ I-NP
promyelocytic JJ I-NP
cell NN I-NP
line NN I-NP
. . O

The DT B-NP
PML NN I-NP
gene NN I-NP
is VBZ B-VP
fused VBN I-VP
to TO B-PP
the DT B-NP
retinoic JJ I-NP
acid NN I-NP
receptor NN I-NP
alpha NN I-NP
gene NN I-NP
( ( O
RAR NN B-NP
alpha NN I-NP
) ) O
in IN B-PP
the DT O
acute JJ B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
( ( O
APL NN B-NP
) ) O
15 CD B-NP
; : I-NP
17 CD I-NP
translocation NN I-NP
. . O

PML NN B-NP
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
diverse JJ B-NP
tissues NNS B-NP
and CC O
cell NN B-NP
lines NNS I-NP
and CC O
localized JJ B-VP
in IN B-PP
the DT B-NP
nucleus NN I-NP
with IN B-PP
a DT B-NP
typical JJ I-NP
speckled JJ I-NP
pattern NN I-NP
. . O

In IN B-PP
the DT B-NP
bone NN I-NP
marrow NN I-NP
COMMA COMMA O
it PRP B-NP
is VBZ B-VP
preferentially RB I-VP
expressed VBN I-VP
in IN B-PP
myeloid JJ B-NP
cells NNS I-NP
. . O

PML NN B-NP
appears VBZ B-VP
to TO I-VP
be VB I-VP
transcriptionally RB I-VP
regulated VBN I-VP
by IN B-PP
class NN O
I CD B-NP
and CC O
II CD B-NP
interferons NNS B-NP
COMMA COMMA O
which WDT B-NP
raises VBZ B-VP
the DT B-NP
possibility NN I-NP
that IN B-SBAR
interferons NNS B-NP
modulate VBP B-VP
the DT O
function NN B-NP
and CC O
growth NN B-NP
and CC O
differentiation NN B-NP
potential NN B-NP
of IN B-PP
normal JJ B-NP
myeloid JJ I-NP
cells NNS B-NP
and CC O
precursors NNS B-NP
by IN B-PP
activating VBG B-VP
PML-dependent JJ B-NP
pathways NNS I-NP
. . O

Generation NN B-NP
of IN B-PP
CD1+RelB+ JJ B-NP
dendritic JJ I-NP
cells NNS I-NP
and CC O
tartrate-resistant JJ B-NP
acid NN I-NP
phosphatase-positive JJ I-NP
osteoclast-like JJ I-NP
multinucleated JJ I-NP
giant JJ I-NP
cells NNS I-NP
from IN B-PP
human JJ B-NP
monocytes NNS I-NP
. . O

We PRP B-NP
previously RB B-ADVP
showed VBD B-VP
that IN B-SBAR
granulocyte-macrophage JJ B-NP
colony-stimulating JJ I-NP
factor NN I-NP
( ( O
GM-CSF NN B-NP
) ) O
and CC O
macrophage NN B-NP
colony-stimulating JJ I-NP
factor NN I-NP
( ( O
M-CSF NN B-NP
) ) O
stimulate VBP B-VP
the DT B-NP
differentiation NN I-NP
of IN B-PP
human JJ B-NP
monocytes NNS I-NP
into IN B-PP
two CD B-NP
phenotypically RB I-NP
distinct JJ I-NP
types NNS I-NP
of IN B-PP
macrophages NNS B-NP
. . O

However RB B-ADVP
COMMA COMMA O
in FW B-ADVP
vivo FW I-ADVP
COMMA COMMA O
not RB B-CONJP
only RB I-CONJP
CSF NN B-NP
but CC B-CONJP
also RB I-CONJP
many JJ B-NP
other JJ I-NP
cytokines NNS I-NP
are VBP B-VP
produced VBN I-VP
under IN B-PP
various JJ B-NP
conditions NNS I-NP
. . O

Those DT B-NP
cytokines NNS I-NP
may MD B-VP
modulate VB I-VP
the DT B-NP
differentiation NN I-NP
of IN B-PP
monocytes NNS B-NP
by IN B-PP
CSFs NNS B-NP
. . O

In IN B-PP
the DT B-NP
present JJ I-NP
study NN I-NP
COMMA COMMA O
we PRP B-NP
showed VBD B-VP
that IN B-SBAR
CD14+ JJ B-NP
adherent JJ I-NP
human JJ I-NP
monocytes NNS I-NP
can MD B-VP
differentiate VB I-VP
into IN B-PP
CD1+relB+ JJ B-NP
dendritic JJ B-NP
cells NNS I-NP
( ( O
DC NN B-NP
) ) O
by IN B-PP
the DT B-NP
combination NN I-NP
of IN B-PP
GM-CSF NN B-NP
plus CC O
interleukin-4 NN B-NP
( ( O
IL-4 NN B-NP
) ) O
and CC O
that IN B-SBAR
they PRP B-NP
differentiate VBP B-VP
into IN B-PP
tartrate-resistant JJ B-NP
acid NN I-NP
phosphatase NN I-NP
( ( I-NP
TRAP NN I-NP
) ) I-NP
-positive JJ I-NP
osteoclast-like JJ I-NP
multinucleated JJ B-NP
giant JJ I-NP
cells NNS I-NP
( ( O
MGC NN B-NP
) ) O
by IN B-PP
the DT B-NP
combination NN I-NP
of IN B-PP
M-CSF NN B-NP
plus CC O
IL-4 NN B-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
monocyte-derived JJ I-NP
DC NN I-NP
were VBD B-VP
not RB O
terminally RB B-NP
differentiated VBN I-NP
cells NNS I-NP
; : O
they PRP B-NP
could MD B-VP
still RB I-VP
convert VB I-VP
to TO B-PP
macrophages NNS B-NP
in IN B-PP
response NN I-PP
to TO I-PP
M-CSF NN B-NP
. . O

Tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
( ( O
TNF-alpha NN B-NP
) ) O
stimulated VBD B-VP
the DT B-NP
terminal JJ I-NP
differentiation NN I-NP
of IN B-PP
the DT B-NP
DC NN I-NP
by IN B-PP
downregulating VBG B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
M-CSF NN I-NP
receptor NN I-NP
COMMA COMMA O
cfms NN B-NP
mRNA NN I-NP
COMMA COMMA O
and CC O
aborting VBG B-VP
the DT B-NP
potential NN I-NP
to TO B-VP
convert VB I-VP
to TO B-PP
macrophages NNS B-NP
. . O

In IN B-PP
contrast NN I-PP
to TO I-PP
IL-4 NN B-NP
COMMA COMMA O
interferon-gamma NN B-NP
( ( O
IFN-gamma NN B-NP
) ) O
had VBD B-VP
no DT B-NP
demonstrable JJ I-NP
effect NN I-NP
on IN B-PP
the DT B-NP
differentiation NN I-NP
of IN B-PP
monocytes NNS B-NP
. . O

Rather RB B-ADVP
COMMA COMMA O
IFN-gamma NN B-NP
antagonized VBD B-VP
the DT B-NP
effect NN I-NP
of IN B-PP
IL-4 NN B-NP
and CC O
suppressed VBD B-VP
the DT O
DC NN B-NP
and CC O
MGC NN B-NP
formation NN B-NP
induced VBN B-VP
by IN B-PP
GM-CSF NN B-NP
+ CC O
IL-4 NN B-NP
and CC O
M-CSF NN B-NP
+ CC O
IL-4 NN B-NP
COMMA COMMA O
respectively RB B-ADVP
. . O

Taken VBN B-VP
together RB B-ADVP
COMMA COMMA O
these DT B-NP
results NNS I-NP
provide VBP B-VP
a DT B-NP
new JJ I-NP
aspect NN I-NP
to TO B-PP
our PRP$ B-NP
knowledge NN I-NP
of IN B-PP
monocyte NN B-NP
differentiation NN I-NP
and CC O
provide VBP B-VP
evidence NN B-NP
that IN B-SBAR
human JJ B-NP
monocytes NNS I-NP
are VBP B-VP
flexible JJ B-ADJP
in IN B-PP
their PRP$ B-NP
differentiation NN I-NP
potential NN I-NP
and CC O
are VBP B-VP
precursors NNS B-NP
not RB B-CONJP
only RB I-CONJP
of IN B-PP
macrophages NNS B-NP
but CC B-CONJP
also RB I-CONJP
of IN B-PP
CD1+relB+DC NN B-NP
and CC O
TRAP-positive JJ B-NP
MGC NN I-NP
. . O

Such PDT B-NP
a DT I-NP
diverse JJ I-NP
pathway NN I-NP
of IN B-PP
monocyte NN B-NP
differentiation NN I-NP
may MD B-VP
constitute VB I-VP
one CD B-NP
of IN B-PP
the DT B-NP
basic JJ I-NP
mechanisms NNS I-NP
of IN B-PP
immune JJ B-NP
regulation NN I-NP
. . O

T NN B-NP
cell NN I-NP
response NN I-NP
to TO B-PP
Epstein-Barr JJ B-NP
virus NN I-NP
transactivators NNS I-NP
in IN B-PP
chronic JJ B-NP
rheumatoid JJ I-NP
arthritis NN I-NP
. . O

Rheumatoid JJ B-NP
arthritis NN I-NP
is VBZ B-VP
a DT B-NP
multistep JJ I-NP
disorder NN I-NP
associated VBN B-VP
with IN B-PP
autoimmune JJ B-NP
features NNS I-NP
of IN B-PP
yet RB B-NP
unknown JJ I-NP
etiology NN I-NP
. . O

Implication NN B-NP
of IN B-PP
viruses NNS B-NP
such JJ B-PP
as IN I-PP
Epstein-Barr JJ B-NP
virus NN I-NP
( ( O
EBV NN B-NP
) ) O
in IN B-PP
rheumatoid JJ B-NP
arthritis NN I-NP
pathogenesis NN I-NP
has VBZ B-VP
been VBN I-VP
suspected VBN I-VP
on IN B-PP
the DT I-PP
basis NN I-PP
of IN I-PP
several JJ B-NP
indirect JJ I-NP
observations NNS I-NP
COMMA COMMA O
but CC O
thus RB B-ADVP
far RB I-ADVP
COMMA COMMA O
a DT B-NP
direct JJ I-NP
link NN I-NP
between IN B-PP
EBV NN B-NP
and CC O
rheumatoid JJ B-NP
arthritis NN I-NP
has VBZ B-VP
not RB I-VP
been VBN I-VP
provided VBN I-VP
. . O

Here RB B-ADVP
we PRP B-NP
show VBP B-VP
that IN B-SBAR
a DT B-NP
large JJ I-NP
fraction NN I-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
infiltrating VBG B-VP
affected VBN B-NP
joints NNS I-NP
from IN B-PP
a DT B-NP
patient NN I-NP
with IN B-PP
chronic JJ B-NP
rheumatoid JJ I-NP
arthritis NN I-NP
recognizes VBZ B-VP
two CD B-NP
EBV NN I-NP
transactivators NNS I-NP
( ( O
BZLF1 NN B-NP
and CC O
BMLF1 NN B-NP
) ) O
in IN B-PP
a DT B-NP
major JJ I-NP
histocompatibility NN I-NP
complex-restricted JJ I-NP
fashion NN I-NP
. . O

Responses NNS B-NP
to TO B-PP
these DT B-NP
EBV NN I-NP
antigens NNS I-NP
by IN B-PP
synovial JJ B-NP
lymphocytes NNS I-NP
from IN B-PP
several JJ B-NP
other JJ I-NP
chronic JJ I-NP
rheumatoid JJ I-NP
arthritis NN I-NP
patients NNS I-NP
were VBD B-VP
readily RB B-ADJP
detectable JJ I-ADJP
. . O

Thus RB B-ADVP
these DT B-NP
results NNS I-NP
suggest VBP B-VP
a DT B-NP
direct JJ I-NP
contribution NN I-NP
of IN B-PP
EBV NN B-NP
to TO B-PP
chronic JJ B-NP
rheumatoid JJ I-NP
arthritis NN I-NP
pathogenesis NN I-NP
. . O

They PRP B-NP
also RB B-ADVP
demonstrate VBP B-VP
for IN B-PP
the DT B-NP
first JJ I-NP
time NN I-NP
the DT B-NP
occurrence NN I-NP
of IN B-PP
T NN B-NP
cell NN I-NP
responses NNS I-NP
against IN B-PP
EBV NN B-NP
transactivating VBG I-NP
factors NNS I-NP
COMMA COMMA O
which WDT B-NP
might MD B-VP
be VB I-VP
central JJ B-ADJP
in IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
virus NN B-NP
reactivation NN I-NP
. . O

Differential JJ B-NP
nuclear JJ I-NP
localization NN I-NP
of IN B-PP
p50 NN B-NP
COMMA COMMA O
p52 NN B-NP
COMMA COMMA O
and CC O
RelB NN B-NP
proteins NNS B-NP
in IN B-PP
human JJ B-NP
accessory JJ I-NP
cells NNS I-NP
of IN B-PP
the DT B-NP
immune JJ I-NP
response NN I-NP
in FW B-ADVP
situ FW I-ADVP
. . O

The DT B-NP
Rel\/NF-kappa NN I-NP
B NN I-NP
proteins NNS I-NP
COMMA COMMA O
p50 NN B-NP
COMMA COMMA O
p52 NN B-NP
COMMA COMMA O
p65 NN B-NP
COMMA COMMA O
c-Rel NN B-NP
COMMA COMMA O
and CC O
RelB NN B-NP
COMMA COMMA O
constitute VBP B-VP
a DT B-NP
family NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
involved VBN B-VP
in IN B-PP
the DT B-NP
positive JJ I-NP
regulation NN I-NP
of IN B-PP
a DT B-NP
variety NN I-NP
of IN B-PP
genes NNS B-NP
during IN B-PP
the DT B-NP
immune JJ I-NP
response NN I-NP
. . O

Recently RB B-ADVP
COMMA COMMA O
it PRP B-NP
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
that IN B-SBAR
RelB NN B-NP
knockout JJ I-NP
mice NNS I-NP
have VBP B-VP
no DT B-NP
dendritic JJ B-NP
cells NNS I-NP
( ( O
DC NN B-NP
) ) O
. . O

An DT B-NP
overexpression NN I-NP
of IN B-PP
p50 NN B-NP
has VBZ B-VP
been VBN I-VP
described VBN I-VP
in IN B-PP
follicular JJ B-NP
dendritic JJ I-NP
cells NNS I-NP
( ( O
FDC NN B-NP
) ) O
. . O

A DT B-NP
constitutive JJ I-NP
NF-kappa NN I-NP
B NN I-NP
activity NN I-NP
has VBZ B-VP
been VBN I-VP
reported VBN I-VP
in IN B-PP
mature JJ B-NP
macrophages NNS I-NP
. . O

This DT B-NP
led VBD B-VP
to TO B-PP
the DT B-NP
hypothesis NN I-NP
that IN B-SBAR
some DT B-NP
of IN B-PP
the DT B-NP
Rel\/NF-kappa NN I-NP
B NN I-NP
proteins NNS I-NP
were VBD B-VP
key JJ B-NP
nuclear JJ I-NP
factors NNS I-NP
in IN B-PP
functions NNS B-NP
of IN B-PP
accessory JJ B-NP
cells NNS I-NP
of IN B-PP
the DT B-NP
immune JJ I-NP
response NN I-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
we PRP B-NP
investigated VBD B-VP
in FW B-ADVP
situ FW I-ADVP
the DT B-NP
nuclear JJ I-NP
localization NN I-NP
of IN B-PP
Rel\/NF-kappa NN B-NP
B NN I-NP
proteins NNS I-NP
in IN B-PP
accessory JJ B-NP
cells NNS I-NP
of IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
by IN B-PP
immunohistochemistry NN B-NP
and CC O
double JJ B-NP
labeling NN I-NP
by IN B-PP
immunofluorescence NN B-NP
from IN B-PP
five CD B-NP
normal JJ I-NP
human JJ I-NP
tonsils NNS I-NP
and CC O
five CD B-NP
lymph NN I-NP
nodes NNS I-NP
with IN B-PP
follicular JJ B-NP
hyperplasia NN I-NP
. . O

Nuclear JJ O
p65 NN B-NP
and CC O
c-Rel NN B-NP
proteins NNS B-NP
were VBD B-VP
found VBN I-VP
in IN B-PP
all DT B-NP
cell NN I-NP
types NNS I-NP
including VBG B-PP
lymphocytes NNS B-NP
. . O

In IN B-PP
germinal JJ B-NP
centers NNS I-NP
GC NN I-NP
COMMA COMMA O
p50 NN B-NP
COMMA COMMA O
p52 NN B-NP
COMMA COMMA O
and CC O
RelB NN B-NP
were VBD B-VP
found VBN I-VP
in IN B-PP
the DT B-NP
nuclei NNS I-NP
of IN B-PP
FDC NN B-NP
only RB B-ADVP
and CC O
were VBD B-VP
not RB I-VP
detected VBN I-VP
in IN B-PP
the DT B-NP
nuclei NNS I-NP
of IN B-PP
CD68+ JJ B-NP
cells NNS I-NP
. . O

In IN B-PP
T NN B-NP
cell NN I-NP
areas NNS I-NP
COMMA COMMA O
p50 NN B-NP
COMMA COMMA O
p52 NN B-NP
COMMA COMMA O
and CC O
RelB NN B-NP
were VBD B-VP
found VBN I-VP
in IN B-PP
the DT B-NP
nuclei NNS I-NP
of IN B-PP
HLA-DR+ JJ B-NP
cells NNS I-NP
with IN B-PP
an DT O
antigen-presenting JJ B-NP
cell NN I-NP
( ( O
APC NN B-NP
) ) O
morphology NN B-NP
. . O

p52 NN B-NP
and CC O
RelB NN B-NP
were VBD B-VP
detected VBN I-VP
in IN B-PP
the DT B-NP
nuclei NNS I-NP
in IN B-PP
both CC B-NP
CD1a+ JJ I-NP
and CC I-NP
CD68+ JJ I-NP
cells NNS I-NP
from IN B-PP
the DT B-NP
T NN I-NP
cell NN I-NP
area NN I-NP
COMMA COMMA O
whereas IN O
p50 NN B-NP
was VBD B-VP
found VBN I-VP
only RB B-PP
in IN I-PP
CD68- JJ B-NP
and CC I-NP
CD1a- JJ I-NP
cells NNS I-NP
. . O

Cells NNS B-NP
with IN B-PP
nuclear JJ B-NP
p50 NN I-NP
were VBD B-VP
negative JJ B-ADJP
for IN B-PP
the DT O
CD38 NN B-NP
COMMA COMMA O
CD20 NN B-NP
and CC O
CD2 NN B-NP
markers NNS B-NP
. . O

These DT B-NP
results NNS I-NP
show VBP B-VP
that IN B-SBAR
COMMA COMMA O
physiologically RB B-ADVP
COMMA COMMA O
high JJ B-NP
levels NNS I-NP
of IN B-PP
nuclear JJ B-NP
of IN B-PP
p50 NN B-NP
COMMA COMMA O
p52 NN B-NP
and CC O
RelB NN B-NP
are VBP B-VP
restricted JJ I-VP
to TO B-PP
accessory JJ B-NP
cells NNS I-NP
of IN B-PP
the DT B-NP
immune JJ I-NP
system NN I-NP
COMMA COMMA O
which WDT B-NP
include VBP B-VP
FDC NN B-NP
in IN B-PP
GC NN B-NP
COMMA COMMA O
and CC O
DC NN B-NP
and CC O
macrophages NNS B-NP
in IN B-PP
the DT B-NP
T NN I-NP
cell NN I-NP
zone NN I-NP
COMMA COMMA O
that IN B-SBAR
specialized VBN B-NP
scavenger NN I-NP
macrophages NNS I-NP
from IN B-PP
GC NN B-NP
do VBP B-VP
not RB I-VP
have VB I-VP
detectable JJ B-NP
levels NNS I-NP
of IN B-PP
p52 NN B-NP
and CC O
RelB NN B-NP
COMMA COMMA O
whereas IN O
macrophages NNS B-NP
from IN B-PP
the DT B-NP
T NN I-NP
cell NN I-NP
area NN I-NP
COMMA COMMA O
known VBN B-VP
to TO I-VP
present VB I-VP
the DT B-NP
antigen NN I-NP
to TO B-PP
T NN B-NP
cells NNS I-NP
COMMA COMMA O
do VBP B-VP
have VB I-VP
both CC B-NP
nuclear JJ I-NP
p52 NN B-NP
and CC O
RelB NN B-NP
COMMA COMMA O
and CC O
that IN B-SBAR
in IN B-PP
the DT B-NP
T NN I-NP
cell NN I-NP
zone NN I-NP
COMMA COMMA O
p52 NN B-NP
and CC O
RelB NN B-NP
are VBP B-VP
located JJ B-ADJP
in IN B-PP
nuclei NNS B-NP
of IN B-PP
both DT B-NP
CD1a+ JJ I-NP
COMMA COMMA I-NP
CD68+ JJ I-NP
or CC I-NP
both DT I-NP
COMMA COMMA I-NP
cells NNS I-NP
APC NN I-NP
COMMA COMMA O
whereas IN O
p50 NN B-NP
is VBZ B-VP
restricted JJ I-VP
to TO B-PP
CD1a- NN B-NP
and CC I-NP
CD68- JJ I-NP
APC NN I-NP
. . O

The DT B-NP
different JJ I-NP
patterns NNS I-NP
of IN B-PP
p50 NN B-NP
COMMA COMMA O
p52 NN B-NP
and CC O
RelB NN B-NP
protein NN B-NP
nuclear JJ I-NP
localization NN I-NP
may MD B-VP
provide VB I-VP
insight NN B-NP
into IN B-PP
their PRP$ B-NP
different JJ I-NP
roles NNS I-NP
during IN B-PP
the DT B-NP
immune JJ I-NP
response NN I-NP
in FW B-ADVP
vivo FW I-ADVP
. . O

Signal NN B-NP
transduction NN I-NP
by IN B-PP
DR3 NN B-NP
COMMA COMMA O
a DT B-NP
death NN I-NP
domain-containing JJ I-NP
receptor NN I-NP
related JJ B-ADJP
to TO B-PP
TNFR-1 NN B-NP
and CC O
CD95 NN B-NP
. . O

Tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
receptor-1 NN I-NP
( ( O
TNFR-1 NN B-NP
) ) O
and CC O
CD95 NN B-NP
( ( O
also RB B-VP
called VBN I-VP
Fas NN B-NP
or CC O
APO-1 NN B-NP
) ) O
are VBP B-VP
cytokine NN B-NP
receptors NNS I-NP
that WDT B-NP
engage VBP B-VP
the DT B-NP
apoptosis NN I-NP
pathway NN I-NP
through IN B-PP
a DT B-NP
region NN I-NP
of IN B-PP
intracellular JJ B-NP
homology NN I-NP
COMMA COMMA O
designated VBD B-VP
the DT B-NP
" `` I-NP
death NN I-NP
domain NN I-NP
. . O
" '' O

Another DT B-NP
death NN I-NP
domain-containing NN I-NP
member NN I-NP
of IN B-PP
the DT B-NP
TNFR NN I-NP
family NN I-NP
COMMA COMMA O
death NN B-NP
receptor NN I-NP
3 CD I-NP
( ( O
DR3 NN B-NP
) ) O
COMMA COMMA O
was VBD B-VP
identified VBN I-VP
and CC O
was VBD B-VP
shown VBN I-VP
to TO I-VP
induce VB I-VP
both CC O
apoptosis NNS B-NP
and CC O
activation NN B-NP
of IN B-PP
nuclear JJ B-NP
factor NN I-NP
kappaB NN I-NP
. . O

Expression NN B-NP
of IN B-PP
DR3 NN B-NP
appears VBZ B-VP
to TO I-VP
be VB I-VP
restricted JJ I-VP
to TO B-PP
tissues NNS B-NP
enriched VBN B-VP
in IN B-PP
lymphocytes NNS B-NP
. . O

DR3 NN B-NP
signal NN I-NP
transduction NN I-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
a DT B-NP
complex NN I-NP
of IN B-PP
intracellular JJ B-NP
signaling VBG I-NP
molecules NNS I-NP
including VBG B-PP
TRADD NN B-NP
COMMA COMMA O
TRAF2 NN B-NP
COMMA COMMA O
FADD NN B-NP
COMMA COMMA O
and CC O
FLICE NN B-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
DR3 NN B-NP
likely RB B-ADVP
plays VBZ B-VP
a DT B-NP
role NN I-NP
in IN B-PP
regulating VBG B-VP
lymphocyte NN B-NP
homeostasis NN I-NP
. . O

Cloning NN B-NP
and CC O
expression NN B-NP
of IN B-PP
the DT B-NP
Epstein-Barr JJ I-NP
virus-encoded JJ I-NP
dUTPase NN I-NP
: : O
patients NNS B-NP
with IN B-PP
acute JJ B-NP
COMMA COMMA I-NP
reactivated VBN I-NP
or CC I-NP
chronic JJ I-NP
virus NN I-NP
infection NN I-NP
develop VBP B-VP
antibodies NNS B-NP
against IN B-PP
the DT B-NP
enzyme NN I-NP
. . O

The DT B-NP
gene NN I-NP
encoding VBG B-VP
the DT O
Epstein-Barr JJ B-NP
virus NN I-NP
( ( B-NP
EBV NN I-NP
) ) I-NP
-specific JJ I-NP
dUTPase NN I-NP
was VBD B-VP
amplified VBN I-VP
from IN B-PP
virus NN B-NP
DNA NN I-NP
by IN B-PP
PCR NN B-NP
. . O

The DT B-NP
active JJ I-NP
enzyme NN I-NP
was VBD B-VP
expressed VBN I-VP
in IN B-PP
Escherichia FW B-NP
coli FW I-NP
and CC B-PP
in IN B-PP
insect NN B-NP
cells NNS I-NP
as IN B-PP
a DT B-NP
non-fusion JJ I-NP
protein NN I-NP
. . O

The DT B-NP
protein NN I-NP
from IN B-PP
E. FW B-NP
coli FW I-NP
specifically RB B-ADVP
converted VBD B-VP
dUTP NN B-NP
to TO B-PP
dUMP NN B-NP
and CC O
did VBD B-VP
not RB I-VP
react VB I-VP
with IN B-PP
other JJ B-NP
dNTPs NNS B-NP
or CC O
NTPs NNS B-NP
. . O

Preliminary JJ B-NP
experiments NNS I-NP
yielded VBD B-VP
a DT B-NP
Km NN I-NP
value NN I-NP
of IN B-PP
about RB B-NP
0.8 CD I-NP
microM NN I-NP
for IN B-PP
dUTP NN B-NP
. . O

MAbs NNS B-NP
against IN B-PP
the DT B-NP
dUTPase NN I-NP
reacted VBD B-VP
with IN B-PP
a DT B-NP
protein NN I-NP
of IN B-PP
approximately RB B-NP
31 CD I-NP
kDa NN I-NP
in IN B-PP
12-O-tetradecanoyl-phorbol-13-acetate NN B-NP
( ( B-NP
TPA NN I-NP
) ) I-NP
-stimulated JJ I-NP
B NN I-NP
cells NNS I-NP
harbouring VBG B-VP
either CC O
type NN B-NP
1 CD I-NP
or CC O
type NN B-NP
2 CD I-NP
EBV NN B-NP
. . O

The DT B-NP
protein NN I-NP
was VBD B-VP
found VBN I-VP
in IN B-PP
untreated JJ B-NP
cells NNS I-NP
at IN B-PP
low JJ B-NP
levels NNS I-NP
COMMA COMMA O
whereas IN O
induction NN B-NP
of IN B-PP
the DT B-NP
lytic JJ I-NP
replication NN I-NP
cycle NN I-NP
by IN B-PP
TPA NN B-NP
treatment NN I-NP
or CC B-PP
by IN B-PP
providing VBG B-VP
the DT B-NP
immediate JJ I-NP
early JJ I-NP
transactivator NN I-NP
BZLF1 NN I-NP
in IN B-PP
trans NN B-NP
resulted VBD B-VP
in IN B-PP
increased VBN B-NP
expression NN I-NP
. . O

We PRP B-NP
demonstrated VBD B-VP
that IN B-SBAR
the DT B-NP
virus NN I-NP
dUTPase NN I-NP
isolated VBN B-VP
from IN B-PP
EBV-infected JJ B-NP
cells NNS I-NP
is VBZ B-VP
a DT B-NP
phosphoprotein NN I-NP
. . O

The DT B-NP
protein NN I-NP
expressed VBN B-VP
in IN B-PP
insect NN B-NP
cells NNS I-NP
was VBD B-VP
used VBN I-VP
to TO B-VP
test VB I-VP
for IN B-PP
the DT B-NP
presence NN I-NP
of IN B-PP
specific JJ B-NP
antibodies NNS I-NP
in IN B-PP
sera NN B-NP
from IN B-PP
normal JJ B-NP
COMMA COMMA I-NP
healthy JJ I-NP
carriers NNS I-NP
and CC B-PP
from IN B-PP
patients NNS B-NP
with IN B-PP
various JJ B-NP
diseases NNS I-NP
. . O

While IN B-SBAR
the DT B-NP
sera NN I-NP
of IN B-PP
EBV-negative JJ B-NP
individuals NNS I-NP
( ( O
0\/3 CD B-NP
) ) O
or CC O
healthy JJ B-NP
carriers NNS I-NP
( ( O
0\/33 CD B-NP
) ) O
did VBD B-VP
not RB I-VP
contain VB I-VP
detectable JJ B-NP
levels NNS I-NP
of IN B-PP
antibodies NNS B-NP
COMMA COMMA O
patients NNS B-NP
with IN B-PP
mononucleosis NN B-NP
( ( O
5\/18 CD B-NP
) ) O
COMMA COMMA O
chronic JJ B-NP
EBV NN I-NP
infection NN I-NP
( ( O
2\/7 CD B-NP
) ) O
COMMA COMMA O
EBV NN B-NP
reactivation NN I-NP
( ( O
7\/20 CD B-NP
) ) O
and CC O
human JJ B-NP
immunodeficiency NN I-NP
virus NN I-NP
infection NN I-NP
( ( O
5\/24 CD B-NP
) ) O
showed VBD B-VP
elevated JJ B-NP
antibody NN I-NP
titres NNS I-NP
against IN B-PP
the DT B-NP
enzyme NN I-NP
. . O

This DT B-NP
indicated VBD B-VP
that IN B-SBAR
the DT B-NP
dUTPase NN I-NP
is VBZ B-VP
expressed VBN I-VP
during IN B-PP
EBV NN B-NP
replication NN B-NP
and CC O
reactivation NN B-NP
. . O

The DT B-NP
enzyme NN I-NP
might MD B-VP
therefore RB I-VP
be VB I-VP
a DT B-NP
potential JJ I-NP
target NN I-NP
for IN B-PP
drug NN B-NP
therapy NN I-NP
under IN B-PP
conditions NNS B-NP
of IN B-PP
active JJ B-NP
DNA NN I-NP
replication NN I-NP
. . O

Prostaglandin NN B-NP
E2 NN I-NP
induction NN I-NP
of IN B-PP
binding NN B-NP
activity NN I-NP
to TO B-PP
CRE NN B-NP
and CC O
AP-2 NN B-NP
elements NNS B-NP
in IN B-PP
human JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
. . O

Prostaglandins NNP B-NP
of IN B-PP
the DT B-NP
E NN I-NP
series NNS I-NP
are VBP B-VP
immunomodulatory JJ B-NP
agents NNS I-NP
which WDT B-NP
exert VBP B-VP
inhibitory JJ O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
stimulatory JJ B-NP
effects NNS I-NP
on IN B-PP
a DT B-NP
variety NN I-NP
of IN B-PP
immune JJ B-NP
responses NNS I-NP
. . O

Since IN B-SBAR
it PRP B-NP
is VBZ B-VP
known VBN I-VP
that IN B-SBAR
PGE2 NN B-NP
is VBZ B-VP
able JJ B-ADJP
to TO B-VP
increase VB I-VP
cAMP NN B-NP
levels NNS I-NP
COMMA COMMA O
we PRP B-NP
investigated VBD B-VP
whether IN B-SBAR
it PRP B-NP
can MD B-VP
affect VB I-VP
gene NN B-NP
expression NN I-NP
through IN B-PP
the DT B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
transcription NN I-NP
factors NNS I-NP
which WDT B-NP
bind VBP B-VP
enhancer NN B-NP
elements NNS I-NP
in IN B-PP
the DT B-NP
promoter NN I-NP
regions NNS I-NP
of IN B-PP
cAMP-regulated JJ B-NP
genes NNS I-NP
. . O

Using VBG B-VP
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assay NN I-NP
COMMA COMMA O
we PRP B-NP
demonstrated VBD B-VP
that IN B-SBAR
a DT B-NP
short JJ I-NP
treatment NN I-NP
of IN B-PP
human JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
with IN B-PP
PGE2 NN B-NP
induces VBZ B-VP
specific JJ B-NP
binding NN I-NP
activity NN I-NP
to TO B-PP
CRE NN B-NP
and CC O
AP-2 NN B-NP
COMMA COMMA O
but CC B-NP
not RB I-NP
AP-1 NN B-NP
COMMA COMMA O
DNA NN B-NP
elements NNS I-NP
. . O

Since IN B-SBAR
the DT B-NP
okadaic JJ I-NP
acid NN I-NP
COMMA COMMA O
a DT B-NP
potent JJ I-NP
protein NN I-NP
phosphatase NN I-NP
inhibitor NN I-NP
COMMA COMMA O
prolongs VBZ B-VP
the DT B-NP
induction NN I-NP
of IN B-PP
the DT B-NP
binding NN I-NP
activity NN I-NP
COMMA COMMA O
phosphorylation NN B-NP
events NNS I-NP
are VBP B-VP
likely JJ B-ADJP
to TO B-VP
occur VB I-VP
. . O

This DT B-NP
activity NN I-NP
seems VBZ B-VP
to TO I-VP
be VB I-VP
due JJ B-PP
to TO I-PP
increased VBN B-NP
cAMP NN I-NP
levels NNS I-NP
because IN B-SBAR
forskolin NN B-NP
and CC O
IBMX NN B-NP
mimic VBP B-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
PGE2 NN B-NP
. . O

More RBR B-ADVP
interestingly RB I-ADVP
COMMA COMMA O
transfection NN B-NP
experiments NNS I-NP
with IN B-PP
CRE-CAT NN B-NP
plasmide NN I-NP
show VBP B-VP
that IN B-SBAR
PGE2 NN B-NP
activates VBZ B-VP
the DT B-NP
transcription NN I-NP
of IN B-PP
a DT B-NP
CRE-containing NN I-NP
promoter NN I-NP
. . O

These DT B-NP
data NNS I-NP
support VBP B-VP
the DT B-NP
positive JJ I-NP
role NN I-NP
for IN B-PP
PGE2 NN B-NP
on IN B-PP
some DT B-NP
immune JJ I-NP
functions NNS I-NP
. . O

Regulation NN B-NP
of IN B-PP
cytokine NN B-NP
and CC O
cytokine NN B-NP
receptor NN I-NP
expression NN B-NP
by IN B-PP
glucocorticoids NNS B-NP
. . O

Glucocorticoids NNS B-NP
( ( O
GCS NNS B-NP
) ) O
profoundly RB B-ADVP
inhibit VBP B-VP
several JJ B-NP
aspects NNS I-NP
of IN B-PP
T NN B-NP
cell NN I-NP
immunity NN I-NP
largely RB B-PP
through IN I-PP
inhibition NN B-NP
of IN B-PP
cytokine NN B-NP
expression NN I-NP
at IN B-PP
the DT B-NP
transcriptional JJ I-NP
and CC I-NP
posttranscriptional JJ I-NP
levels NNS I-NP
. . O

GCS NNS B-NP
were VBD B-VP
also RB I-VP
reported VBN I-VP
to TO I-VP
act VB I-VP
indirectly RB B-ADVP
by IN B-PP
inducing VBG B-VP
transforming VBG B-NP
growth NN I-NP
factor-beta NN I-NP
expression NN I-NP
COMMA COMMA O
which WDT B-NP
in IN B-PP
turn NN B-NP
blocks VBZ B-VP
T NN B-NP
cell NN I-NP
immunity NN I-NP
. . O

In IN B-PP
exerting VBG B-VP
their PRP$ B-NP
antiproliferative JJ I-NP
effects NNS I-NP
COMMA COMMA O
GCS NNS B-NP
diffuse VBP B-VP
into IN B-PP
target NN B-NP
cells NNS I-NP
where WRB B-ADVP
they PRP B-NP
bind VBP B-VP
their PRP$ B-NP
cytoplasmic JJ I-NP
receptor NN I-NP
COMMA COMMA O
which WDT B-NP
in IN B-PP
turn NN B-NP
translocates VBZ B-VP
to TO B-PP
the DT B-NP
nucleus NN I-NP
where WRB B-ADVP
it PRP B-NP
inhibits VBZ B-VP
transcription NN B-NP
of IN B-PP
cytokine NN B-NP
genes NNS I-NP
through IN B-PP
direct JJ B-NP
binding NN I-NP
to TO B-PP
the DT B-NP
glucocorticoid NN I-NP
response NN I-NP
elements NNS I-NP
( ( O
GRE NN B-NP
) ) O
COMMA COMMA O
which WDT B-NP
are VBP B-VP
located JJ B-ADJP
in IN B-PP
the DT B-NP
promoter NN I-NP
region NN I-NP
of IN B-PP
cytokine NN B-NP
genes NNS I-NP
or CC B-PP
COMMA COMMA O
alternatively RB B-ADVP
COMMA COMMA B-PP
through IN I-PP
antagonism NN B-NP
of IN B-PP
the DT B-NP
action NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
required VBN B-VP
for IN B-PP
optimal JJ B-NP
transcriptional JJ I-NP
activation NN I-NP
. . O

In IN B-PP
contrast NN I-PP
to TO I-PP
their PRP$ B-NP
inhibitory JJ I-NP
effects NNS I-NP
on IN B-PP
cytokine NN B-NP
expression NN I-NP
COMMA COMMA O
GCS NNS B-NP
up-regulate VBP B-VP
cytokine NN B-NP
receptor NN I-NP
expression NN I-NP
that WDT B-NP
correlates VBZ B-VP
with IN B-PP
enhanced VBN B-NP
cytokine NN I-NP
effects NNS I-NP
on IN B-PP
target NN B-NP
cells NNS I-NP
. . O

In IN B-PP
this DT B-NP
review NN I-NP
COMMA COMMA O
we PRP B-NP
summarize VBP B-VP
the DT B-NP
current JJ I-NP
state NN I-NP
of IN B-PP
knowledge NN B-NP
of IN B-PP
the DT B-NP
mechanism NN I-NP
of IN B-PP
action NN B-NP
of IN B-PP
GCS NNS B-NP
COMMA COMMA O
including VBG B-PP
the DT B-NP
phenomenon NN I-NP
of IN B-PP
steroid-induced JJ B-NP
rebound NN I-NP
COMMA COMMA O
which WDT B-NP
ensues VBZ B-VP
upon IN B-PP
GCS NNS B-NP
withdrawal NN I-NP
. . O

The DT B-NP
Oct-2 NN I-NP
transcription NN I-NP
factor NN I-NP
. . O

The DT B-NP
Oct-2 NN I-NP
transcription NN I-NP
factor NN I-NP
is VBZ B-VP
a DT B-NP
member NN I-NP
of IN B-PP
the DT O
POU NN B-NP
( ( O
Pit-Oct-Unc NN B-NP
) ) O
family NN B-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
and CC O
is VBZ B-VP
expressed VBN I-VP
only RB B-ADVP
in IN B-PP
B NN B-NP
lymphocytes NNS I-NP
and CC B-PP
in IN B-PP
neuronal JJ B-NP
cells NNS I-NP
but CC B-PP
not RB B-PP
in IN I-PP
other JJ B-NP
cell NN I-NP
types NNS I-NP
. . O

The DT B-NP
primary JJ I-NP
RNA NN I-NP
transcript NN I-NP
of IN B-PP
the DT B-NP
gene NN I-NP
is VBZ B-VP
subject JJ B-ADJP
to TO B-PP
alternative JJ B-NP
splicing NN I-NP
to TO B-VP
yield VB I-VP
different JJ B-NP
variants NNS I-NP
which WDT B-NP
can MD B-VP
either CC O
activate VBP B-VP
or CC O
repress VBP B-VP
gene NN B-NP
expression NN I-NP
. . O

The DT B-NP
forms NNS I-NP
produced VBN B-VP
in IN B-PP
B NN B-NP
lymphocytes NNS I-NP
have VBP B-VP
a DT B-NP
predominantly RB I-NP
activating JJ I-NP
effect NN I-NP
on IN B-PP
gene NN B-NP
expression NN I-NP
whereas IN O
those DT B-NP
produced VBN B-VP
in IN B-PP
neuronal JJ B-NP
cells NNS I-NP
have VBP B-VP
a DT B-NP
predominantly RB I-NP
inhibitory JJ I-NP
effect NN I-NP
and CC O
can MD B-VP
repress VB I-VP
the DT B-NP
expression NN I-NP
of IN B-PP
both CC O
the DT B-NP
herpes NN I-NP
simplex NN I-NP
virus NN I-NP
immediate-early JJ I-NP
genes NNS I-NP
and CC O
the DT B-NP
cellular JJ I-NP
tyrosine NN I-NP
hydroxylase NN I-NP
gene NN I-NP
. . O

Thus RB B-ADVP
Oct-2 NN B-NP
plays VBZ B-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
cellular JJ B-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
both CC O
B NN B-NP
cells NNS I-NP
and CC O
neuronal JJ B-NP
cells NNS I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
in IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
viral JJ B-NP
latency NN I-NP
. . O

Tissue NN B-NP
and CC O
cell-type JJ B-NP
specific JJ B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
tuberous JJ I-NP
sclerosis NN I-NP
gene NN I-NP
COMMA COMMA O
TSC2 NN B-NP
COMMA COMMA O
in IN B-PP
human JJ B-NP
tissues NNS I-NP
. . O

TSC2 NN B-NP
is VBZ B-VP
a DT B-NP
gene NN I-NP
on IN B-PP
chromosome NN B-NP
16p13.3 NN I-NP
associated VBN B-VP
with IN B-PP
the DT B-NP
autosomal JJ I-NP
dominant JJ I-NP
neurocutaneous JJ I-NP
disorder NN I-NP
COMMA COMMA O
tuberous JJ B-NP
sclerosis NN I-NP
complex NN I-NP
( ( O
TSC NN B-NP
) ) O
. . O

By IN B-PP
using VBG B-VP
a DT B-NP
partial JJ I-NP
nucleotide JJ I-NP
sequence NN I-NP
from IN B-PP
the DT B-NP
cloned VBN I-NP
TSC2 NN I-NP
and CC O
polymerase NN B-NP
chain NN I-NP
reaction NN I-NP
methodology NN I-NP
COMMA COMMA O
we PRP B-NP
constructed VBD B-VP
a DT B-NP
digoxigenin-labeled JJ I-NP
complementary JJ I-NP
DNA NN I-NP
probe NN I-NP
to TO B-VP
examine VB I-VP
TSC2 NN B-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
autopsy- NN B-NP
or CC O
biopsy-derived JJ B-ADJP
human JJ B-NP
tissues NNS I-NP
by IN B-PP
in FW B-NP
situ FW I-NP
hybridization NN I-NP
. . O

TSC2 NN B-NP
messenger NN I-NP
RNA NN I-NP
was VBD B-VP
widely RB I-VP
expressed VBN I-VP
in IN B-PP
various JJ B-NP
cell NN I-NP
types NNS I-NP
throughout IN B-PP
the DT B-NP
body NN I-NP
COMMA COMMA O
including VBG B-PP
epithelia NN B-NP
COMMA COMMA O
lymphocytes NNS B-NP
COMMA COMMA O
and CC O
cells NNS B-NP
with IN B-PP
endocrine JJ B-NP
functions NNS I-NP
COMMA COMMA O
e.g. FW B-ADVP
COMMA COMMA O
adrenal JJ B-NP
cortex NN I-NP
and CC O
anterior JJ B-NP
pituitary NN I-NP
. . O

It PRP B-NP
was VBD O
prominently RB B-ADVP
and CC O
selectively RB B-ADVP
( ( O
within IN B-PP
the DT B-NP
central JJ I-NP
nervous JJ I-NP
system NN I-NP
) ) B-VP
expressed VBN I-VP
in IN B-PP
pyramidal JJ B-NP
cells NNS I-NP
of IN B-PP
the DT B-NP
cerebral JJ I-NP
cortex NN I-NP
and CC O
other JJ B-NP
motor NN I-NP
neurons NNS I-NP
COMMA COMMA O
e.g. FW B-ADVP
COMMA COMMA B-PP
in IN I-PP
spinal JJ B-NP
cord NN I-NP
and CC O
brainstem NN B-NP
nuclei NNS I-NP
. . O

Visceral JJ B-NP
TSC2 NN I-NP
expression NN I-NP
was VBD B-VP
comparable JJ B-ADJP
in IN B-PP
autopsy NN B-NP
tissues NNS I-NP
from IN B-PP
patients NNS B-NP
with IN B-PP
and CC B-PP
without IN B-PP
TSC NN B-NP
; : O
TSC2 NN B-NP
messenger NN I-NP
RNA NN I-NP
expression NN I-NP
was VBD B-VP
most RBS B-ADJP
prominent JJ I-ADJP
in IN B-PP
cells NNS B-NP
with IN B-PP
a DT B-NP
rapid JJ I-NP
mitotic JJ I-NP
rate NN B-NP
and CC O
turnover NN B-NP
COMMA COMMA O
e.g. FW B-ADVP
COMMA COMMA O
epithelia NN B-NP
and CC O
lymphocytes NNS B-NP
COMMA COMMA O
with IN B-PP
central JJ B-NP
nervous JJ I-NP
system NN I-NP
pyramidal JJ B-NP
cells NNS I-NP
and CC O
other JJ B-NP
neurons NNS I-NP
being VBG B-VP
an DT B-NP
obvious JJ I-NP
exception NN I-NP
COMMA COMMA B-PP
and\/or CC I-PP
in IN B-PP
cells NNS B-NP
with IN B-PP
important JJ B-NP
secretory\/transport NN I-NP
functions NNS I-NP
. . O

This DT B-NP
widespread JJ I-NP
expression NN I-NP
of IN B-PP
the DT B-NP
TSC2 NN I-NP
gene NN I-NP
supports VBZ B-VP
the DT B-NP
view NN I-NP
that IN B-SBAR
it PRP B-NP
encodes VBZ B-VP
a DT B-NP
protein NN I-NP
vital JJ B-ADJP
to TO B-PP
cell NN B-NP
growth NN B-NP
and CC O
metabolism NN B-NP
or CC O
one CD B-NP
that WDT B-NP
functions VBZ B-VP
as IN B-PP
a DT B-NP
tumor\/growth NN I-NP
suppressor NN I-NP
. . O

Cell NN B-NP
specific JJ I-NP
expression NN I-NP
of IN B-PP
human JJ B-NP
Bruton NN B-NP
's POS B-NP
agammaglobulinemia NN I-NP
tyrosine NN I-NP
kinase NN I-NP
gene NN I-NP
( ( O
Btk NN B-NP
) ) O
is VBZ B-VP
regulated VBN I-VP
by IN B-PP
Sp1- NN B-NP
and CC O
Spi-1\/PU.1-family NN B-NP
members NNS I-NP
. . O

Bruton NN B-NP
's POS B-NP
agammaglobulinemia NN I-NP
tyrosine NN I-NP
kinase NN I-NP
( ( O
Btk NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
cytoplasmic JJ I-NP
tyrosine NN I-NP
kinase NN I-NP
involved VBN B-VP
in IN B-PP
the DT B-NP
human JJ I-NP
disease NN I-NP
X-linked JJ B-NP
agammaglobulinemia NN I-NP
( ( O
XLA NN B-NP
) ) O
. . O

The DT B-NP
gene NN I-NP
is VBZ B-VP
expressed VBN I-VP
in IN B-PP
all DT B-NP
hematopoietic JJ I-NP
cells NNS I-NP
with IN B-PP
the DT B-NP
exception NN I-NP
of IN B-PP
T-cells NNS B-NP
and CC O
plasma NN B-NP
cells NNS I-NP
. . O

For IN B-PP
this DT B-NP
expression NN I-NP
pattern NN I-NP
the DT B-NP
first JJ I-NP
280 CD I-NP
bp NN I-NP
upstream JJ B-ADJP
of IN B-PP
the DT B-NP
major JJ I-NP
transcriptional JJ I-NP
start NN I-NP
site NN I-NP
seems VBZ B-VP
to TO I-VP
be VB I-VP
sufficient JJ B-ADJP
. . O

In FW B-NP
vitro FW I-NP
footprinting NN I-NP
analysis NN I-NP
within IN B-PP
this DT B-NP
part NN I-NP
of IN B-PP
the DT B-NP
promoter NN I-NP
revealed VBD B-VP
two CD B-NP
Sp1 NN I-NP
binding NN I-NP
sites NNS I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
a DT B-NP
PU-box NN I-NP
. . O

The DT B-NP
transcription NN I-NP
factor NN I-NP
Spi-1\/PU.1 NN I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
the DT B-NP
closely RB I-NP
related JJ I-NP
factor NN I-NP
Spi-B NN I-NP
bound VBD B-VP
to TO B-PP
the DT B-NP
PU-box NN I-NP
in IN B-PP
B-cells NNS B-NP
. . O

In IN B-PP
the DT B-NP
erythroleukemia NN I-NP
cell NN I-NP
line NN I-NP
K562 NN I-NP
COMMA COMMA O
due IN B-PP
to TO I-PP
the DT B-NP
absence NN I-NP
of IN B-PP
Spi-B NN B-NP
COMMA COMMA O
only RB B-NP
PU.1 NN I-NP
bound VBD B-VP
to TO B-PP
the DT B-NP
Btk NN I-NP
promoter NN I-NP
. . O

Mutation NN B-NP
of IN B-PP
either DT B-NP
site NN I-NP
reduced VBD B-VP
the DT B-NP
expression NN I-NP
in IN B-PP
transient JJ B-NP
transfection NN I-NP
experiments NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
mutation NN B-NP
of IN B-PP
the DT B-NP
PU NN I-NP
box NN I-NP
had VBD B-VP
no DT B-NP
effect NN I-NP
in IN B-PP
the DT B-NP
T-cell NN I-NP
line NN I-NP
Jurkat NN I-NP
COMMA COMMA O
where WRB B-ADVP
none NN B-NP
of IN B-PP
the DT B-NP
Spi-1 NN I-NP
family NN I-NP
members NNS I-NP
is VBZ B-VP
expressed VBN I-VP
. . O

In IN B-PP
addition NN B-NP
Spi-B NN B-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
PU.1 NN B-NP
were VBD B-VP
able JJ B-ADJP
to TO B-VP
transactivate VB I-VP
Btk NN B-NP
expression NN I-NP
. . O

In IN B-PP
fetal JJ B-NP
liver NN I-NP
of IN B-PP
PU.1-\/- JJ B-NP
mice NNS I-NP
COMMA COMMA O
which WDT B-NP
lack VBP B-VP
lymphoid JJ B-NP
and CC I-NP
myeloid JJ I-NP
cells NNS I-NP
COMMA COMMA O
expression NN B-NP
of IN B-PP
Btk NN B-NP
was VBD B-VP
reduced VBN I-VP
two- CD B-ADVP
to TO B-ADVP
threefold RB B-ADVP
but CC O
not RB B-VP
abolished VBN I-VP
. . O

Collectively RB B-ADVP
this DT B-NP
study NN I-NP
shows VBZ B-VP
that IN B-SBAR
expression NN B-NP
of IN B-PP
the DT B-NP
Btk NN I-NP
gene NN I-NP
is VBZ B-VP
regulated VBN I-VP
by IN B-PP
the DT B-NP
combined JJ I-NP
action NN I-NP
of IN B-PP
Sp1- NN B-NP
and CC O
PU.1-family NN B-NP
members NNS I-NP
. . O

Elf-1 NN B-NP
and CC O
Stat5 NN B-NP
bind VBP B-VP
to TO B-PP
a DT B-NP
critical JJ I-NP
element NN I-NP
in IN B-PP
a DT B-NP
new JJ I-NP
enhancer NN I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
interleukin-2 NN I-NP
receptor NN I-NP
alpha NN I-NP
gene NN I-NP
{ ( O
published VBN B-NP
erratum NN I-NP
appears VBZ B-VP
in IN B-PP
Mol NNP B-NP
Cell NNP I-NP
Biol NNP I-NP
1997 CD B-NP
Apr NNP I-NP
; : O
17 CD B-NP
( ( I-NP
4 CD I-NP
) ) O
: : O
2351 CD B-NP
} ) O

The DT O
interleukin NN B-NP
2 CD I-NP
receptor NN I-NP
alpha-chain NN I-NP
( ( O
IL-2R NN B-NP
alpha NN I-NP
) ) O
gene NN B-NP
is VBZ B-VP
a DT B-NP
key JJ I-NP
regulator NN I-NP
of IN B-PP
lymphocyte NN B-NP
proliferation NN I-NP
. . O

IL-2R NN B-NP
alpha NN I-NP
is VBZ O
rapidly RB B-ADVP
and CC O
potently RB B-ADVP
induced VBN B-VP
in IN B-PP
T NN B-NP
cells NNS I-NP
in IN B-PP
response NN I-PP
to TO I-PP
mitogenic JJ B-NP
stimuli NNS I-NP
. . O

Interleukin NN B-NP
2 CD I-NP
( ( O
IL-2 NN B-NP
) ) O
stimulates VBZ B-VP
IL-2R NN B-NP
alpha. NN I-NP
transcription NN I-NP
COMMA COMMA O
thereby RB B-ADVP
amplifying VBG B-VP
expression NN B-NP
of IN B-PP
its PRP$ B-NP
own JJ I-NP
high-affinity NN I-NP
receptor NN I-NP
. . O

IL-2R NN B-NP
alpha NN I-NP
transcription NN I-NP
is VBZ B-VP
at IN B-ADVP
least JJS I-ADVP
in IN B-PP
part NN B-NP
controlled VBN B-VP
by IN B-PP
two CD B-NP
positive JJ I-NP
regulatory JJ I-NP
regions NNS I-NP
COMMA COMMA O
PRRI NN B-NP
and CC O
PRRII NN B-NP
. . O

PRRI NN B-NP
is VBZ B-VP
an DT B-NP
inducible JJ I-NP
proximal JJ I-NP
enhancer NN I-NP
COMMA COMMA O
located JJ B-ADJP
between IN B-PP
nucleotides NNS B-NP
-276 CD B-NP
and CC O
-244 CD B-NP
COMMA COMMA O
which WDT B-NP
contains VBZ B-VP
NF-kappaB NN B-NP
and CC O
SRE\/CArG NN B-NP
motifs NNS B-NP
. . O

PRRII NN B-NP
is VBZ B-VP
a DT B-NP
T-cell-specific JJ I-NP
enhancer NN I-NP
COMMA COMMA O
located JJ B-ADJP
between IN B-PP
nucleotides NNS B-NP
-137 CD B-NP
and CC O
-64 CD B-NP
COMMA COMMA O
which WDT B-NP
binds VBZ B-VP
the DT B-NP
T-cell-specific JJ I-NP
Ets NN I-NP
protein NN I-NP
Elf-1 NN I-NP
and CC O
HMG-I(Y) NN B-NP
proteins NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
none NN B-NP
of IN B-PP
these DT B-NP
proximal JJ I-NP
regions NNS I-NP
account VBP B-VP
for IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
IL-2R NN B-NP
alpha NN I-NP
transcription NN I-NP
by IN B-PP
IL-2 NN B-NP
. . O

To TO B-VP
find VB I-VP
new JJ B-NP
regulatory JJ I-NP
regions NNS I-NP
of IN B-PP
the DT B-NP
IL-2R NN I-NP
alpha NN I-NP
gene NN I-NP
COMMA COMMA O
8.5 CD B-NP
kb NN I-NP
of IN B-PP
the DT B-NP
5' JJ I-NP
end NN I-NP
noncoding JJ I-NP
sequence NN I-NP
of IN B-PP
the DT B-NP
IL-2R NN I-NP
alpha NN I-NP
gene NN I-NP
have VBP B-VP
been VBN I-VP
sequenced VBN I-VP
. . O

We PRP B-NP
identified VBD B-VP
an DT B-NP
86-nucleotide JJ I-NP
fragment NN I-NP
that WDT B-NP
is VBZ B-VP
90 CD B-NP
% NN I-NP
identical JJ B-ADJP
to TO B-PP
the DT B-NP
recently RB I-NP
characterized VBN I-NP
murine JJ B-NP
IL-2-responsive JJ I-NP
element NN I-NP
( ( O
mIL-2rE NN B-NP
) ) O
. . O

This DT B-NP
putative JJ I-NP
human JJ I-NP
IL-2rE NN I-NP
COMMA COMMA O
designated VBN B-VP
PRRIII NN B-NP
COMMA COMMA O
confers VBZ B-VP
IL-2 NN B-NP
responsiveness NN I-NP
on IN B-PP
a DT B-NP
heterologous JJ I-NP
promoter NN I-NP
. . O

PRRIII NN B-NP
contains VBZ B-VP
a DT B-NP
Stat NN I-NP
protein NN I-NP
binding NN I-NP
site NN I-NP
that WDT B-NP
overlaps VBZ B-VP
with IN B-PP
an DT B-NP
EBS NN I-NP
motif NN I-NP
( ( O
GASd\/EBSd NN B-NP
) ) O
. . O

These DT B-NP
are VBP B-VP
essential JJ B-ADJP
for IN B-PP
IL-2 NN B-NP
inducibility NN I-NP
of IN B-PP
PRRIII\/CAT NN B-NP
reporter NN I-NP
constructs NNS I-NP
. . O

IL-2 NN B-NP
induced VBD B-VP
the DT B-NP
binding NN I-NP
of IN B-PP
Stat5a NN B-NP
and CC O
b NN B-NP
proteins NNS B-NP
to TO B-PP
the DT B-NP
human JJ I-NP
GASd NN I-NP
element NN I-NP
. . O

To TO B-VP
confirm VB I-VP
the DT B-NP
physiological JJ I-NP
relevance NN I-NP
of IN B-PP
these DT B-NP
findings NNS I-NP
COMMA COMMA O
we PRP B-NP
carried VBD B-VP
out RP B-PRT
in FW B-NP
vivo FW I-NP
footprinting NN I-NP
experiments NNS I-NP
which WDT B-NP
showed VBD B-VP
that IN B-SBAR
stimulation NN B-NP
of IN B-PP
IL-2R NN B-NP
alpha NN I-NP
expression NN I-NP
correlated VBD B-VP
with IN B-PP
occupancy NN B-NP
of IN B-PP
the DT B-NP
GASd NN I-NP
element NN I-NP
. . O

Our PRP$ B-NP
data NNS I-NP
demonstrate VBP B-VP
a DT B-NP
major JJ I-NP
role NN I-NP
of IN B-PP
the DT B-NP
GASd\/EBSd NN I-NP
element NN I-NP
in IN B-PP
IL-2R NN B-NP
alpha NN I-NP
regulation NN I-NP
and CC O
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
T-cell-specific JJ I-NP
Elf-1 NN I-NP
factor NN I-NP
can MD B-VP
serve VB I-VP
as IN B-PP
a DT B-NP
transcriptional JJ I-NP
repressor NN I-NP
. . O

Association NN B-NP
of IN B-PP
TRAF1 NN B-NP
COMMA COMMA O
TRAF2 NN B-NP
COMMA COMMA O
and CC O
TRAF3 NN B-NP
with IN B-PP
an DT B-NP
Epstein-Barr JJ I-NP
virus NN I-NP
LMP1 NN I-NP
domain NN I-NP
important JJ B-ADJP
for IN B-PP
B-lymphocyte NN B-NP
transformation NN I-NP
: : O
role NN B-NP
in IN B-PP
NF-kappaB NN B-NP
activation NN I-NP
. . O

The DT B-NP
Epstein-Barr JJ I-NP
virus NN I-NP
( ( O
EBV NN B-NP
) ) O
transforming VBG B-NP
protein NN I-NP
LMP1 NN I-NP
appears VBZ B-VP
to TO I-VP
be VB I-VP
a DT B-NP
constitutively RB I-NP
activated VBN I-NP
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
receptor NN I-NP
( ( O
TNFR NN B-NP
) ) O
on IN B-PP
the DT I-PP
basis NN I-PP
of IN I-PP
an DT B-NP
intrinsic JJ I-NP
ability NN I-NP
to TO B-VP
aggregate VB I-VP
in IN B-PP
the DT B-NP
plasma NN I-NP
membrane NN I-NP
and CC O
an DT B-NP
association NN I-NP
of IN B-PP
its PRP$ B-NP
cytoplasmic JJ I-NP
carboxyl NN B-NP
terminus NN I-NP
( ( O
CT NN B-NP
) ) O
with IN B-PP
TNFR-associated JJ B-NP
factors NNS I-NP
( ( O
TRAFs NNS B-NP
) ) O
. . O

We PRP B-NP
now RB B-ADVP
show VBP B-VP
that IN B-SBAR
in IN B-PP
EBV-transformed JJ B-NP
B NN I-NP
lymphocytes NNS I-NP
most JJS B-NP
of IN B-PP
TRAF1 NN B-NP
or CC O
TRAF3 NN B-NP
and CC O
5 CD B-NP
% NN I-NP
of IN B-PP
TRAF2 NN B-NP
are VBP B-VP
associated VBN I-VP
with IN B-PP
LMP1 NN B-NP
and CC O
that IN B-SBAR
most JJS B-NP
of IN B-PP
LMP1 NN B-NP
is VBZ B-VP
associated VBN I-VP
with IN B-PP
TRAF1 NN B-NP
or CC O
TRAF3 NN B-NP
. . O

TRAF1 NN B-NP
COMMA COMMA O
TRAF2 NN B-NP
COMMA COMMA O
and CC O
TRAF3 NN B-NP
bind VBP B-VP
to TO B-PP
a DT B-NP
single JJ I-NP
site NN I-NP
in IN B-PP
the DT B-NP
LMP1 NN I-NP
CT NN I-NP
corresponding VBG B-VP
to TO B-PP
amino NN B-NP
acids NNS I-NP
( ( O
aa NNS B-NP
) ) O
199 CD B-NP
to TO O
214 CD B-NP
COMMA COMMA O
within IN B-PP
a DT B-NP
domain NN I-NP
which WDT B-NP
is VBZ B-VP
important JJ B-ADJP
for IN B-PP
B-lymphocyte NN B-NP
growth NN I-NP
transformation NN I-NP
( ( O
aa NNS B-NP
187 CD B-NP
to TO O
231 CD B-NP
) ) O
. . O

Further JJ O
deletional JJ O
and CC O
alanine NN B-NP
mutagenesis NN I-NP
analyses NNS B-NP
and CC O
comparison NN B-NP
with IN B-PP
TRAF NN B-NP
binding NN I-NP
sequences NNS I-NP
in IN B-PP
CD40 NN B-NP
COMMA COMMA O
in IN B-PP
CD30 NN B-NP
COMMA COMMA B-PP
and CC I-PP
in IN B-PP
the DT B-NP
LMP1 NN I-NP
of IN B-PP
other JJ B-NP
lymphycryptoviruses NNS I-NP
provide VBP B-VP
the DT B-NP
first JJ I-NP
evidence NN I-NP
that IN B-SBAR
PXQXT\/S NN B-NP
is VBZ B-VP
a DT B-NP
core NN I-NP
TRAF NN I-NP
binding NN I-NP
motif NN I-NP
. . O

The DT B-NP
negative JJ I-NP
effects NNS I-NP
of IN B-PP
point NN B-NP
mutations NNS I-NP
in IN B-PP
the DT B-NP
LMP1(1-231) NN I-NP
core NN I-NP
TRAF NN I-NP
binding NN I-NP
motif NN I-NP
on IN B-PP
TRAF NN B-NP
binding NN I-NP
and CC O
NF-kappaB NN B-NP
activation NN I-NP
genetically RB B-ADVP
link VBP B-VP
the DT B-NP
TRAFs NNS I-NP
to TO B-PP
LMP1(1-231)-mediated JJ B-NP
NF-kappaB NN I-NP
activation NN I-NP
. . O

NF-kappaB NN B-NP
activation NN I-NP
by IN B-PP
LMP1(1-231) NN B-NP
is VBZ B-VP
likely JJ B-ADJP
to TO B-VP
be VB I-VP
mediated VBN I-VP
by IN B-PP
TRAF1\/TRAF2 NN B-NP
heteroaggregates NNS I-NP
since IN B-SBAR
TRAF1 NN B-NP
is VBZ B-VP
unique JJ B-ADJP
among IN B-PP
the DT B-NP
TRAFs NNS I-NP
in IN B-PP
coactivating VBG B-VP
NF-kappaB NN B-NP
with IN B-PP
LMP1(1-231) NN B-NP
COMMA COMMA O
a DT B-NP
TRAF2 NN I-NP
dominant-negative JJ I-NP
mutant NN I-NP
can MD B-VP
block VB I-VP
LMP1(1-231)-mediated JJ B-NP
NF-kappaB NN I-NP
activation NN I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
TRAF1 NN B-NP
coactivation NN I-NP
COMMA COMMA O
and CC O
30 CD B-NP
% NN I-NP
of IN B-PP
TRAF2 NN B-NP
is VBZ B-VP
associated VBN I-VP
with IN B-PP
TRAF1 NN B-NP
in IN B-PP
EBV-transformed JJ B-NP
B NN I-NP
cells NNS I-NP
. . O

TRAF3 NN B-NP
is VBZ B-VP
a DT B-NP
negative JJ I-NP
modulator NN I-NP
of IN B-PP
LMP1(1-231)-mediated JJ B-NP
NF-kappaB NN I-NP
activation NN I-NP
. . O

Surprisingly RB B-ADVP
COMMA COMMA O
TRAF1 NN B-NP
COMMA COMMA O
-2 CD B-NP
COMMA COMMA O
or CC O
-3 CD B-NP
does VBZ B-VP
not RB I-VP
interact VB I-VP
with IN B-PP
the DT B-NP
terminal JJ I-NP
LMP1 NN I-NP
CT NN I-NP
aa NNS I-NP
333 CD B-NP
to TO O
386 CD B-NP
which WDT B-NP
can MD B-VP
independently RB I-VP
mediate VBP I-VP
NF-kappaB NN B-NP
activation NN I-NP
. . O

The DT B-NP
constitutive JJ I-NP
association NN I-NP
of IN B-PP
TRAFs NNS B-NP
with IN B-PP
LMP1 NN B-NP
through IN B-PP
the DT O
aa NNS O
187 CD B-NP
to TO O
231 CD B-NP
domain NN B-NP
which WDT B-NP
is VBZ B-VP
important JJ B-ADJP
in IN B-PP
NF-kappaB NN B-NP
activation NN I-NP
and CC O
primary JJ B-NP
B-lymphocyte NN I-NP
growth NN I-NP
transformation NN I-NP
implicates VBZ B-VP
TRAF NN B-NP
aggregation NN I-NP
in IN B-PP
LMP1 NN B-NP
signaling NN I-NP
. . O

CD40 NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
lipopolysaccharide NN B-NP
and CC O
anti-IgM JJ B-ADJP
stimulation NN B-NP
of IN B-PP
primary JJ B-NP
B NN I-NP
lymphocytes NNS I-NP
COMMA COMMA O
leads VBZ B-VP
to TO B-PP
a DT B-NP
persistent JJ I-NP
nuclear JJ I-NP
accumulation NN I-NP
of IN B-PP
RelB NN B-NP
. . O

In IN B-PP
this DT B-NP
study NN I-NP
we PRP B-NP
analyzed VBD B-VP
the DT B-NP
effect NN I-NP
of IN B-PP
CD40 NN B-NP
stimulation NN I-NP
on IN B-PP
the DT B-NP
activity NN B-NP
and CC O
nuclear JJ B-NP
appearance NN I-NP
of IN B-PP
Rel\/nuclear NN B-NP
factor NN I-NP
kappaB NN I-NP
( ( O
NF-kappaB NN B-NP
) ) O
factors NNS B-NP
in IN B-PP
primary JJ B-NP
murine JJ I-NP
B NN I-NP
lymphocytes NNS I-NP
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
triggering NN B-NP
of IN B-PP
CD40 NN B-NP
signaling NN I-NP
pathway NN I-NP
( ( I-NP
s NNS I-NP
) ) O
by IN B-PP
CD40 NN B-NP
ligands NNS I-NP
expressed VBN B-VP
on IN B-PP
L NN B-NP
cells NNS I-NP
led VBD B-VP
to TO B-PP
strong JJ B-NP
activation NN I-NP
of IN B-PP
an DT B-NP
NF-kappaB-controlled JJ I-NP
beta-globin NN I-NP
reporter NN I-NP
gene NN I-NP
in IN B-PP
primary JJ B-NP
B NN I-NP
lymphocytes NNS I-NP
from IN B-PP
transgenic JJ B-NP
mice NNS I-NP
. . O

Analyses NNS B-NP
of IN B-PP
nuclear JJ B-NP
translocation NN I-NP
of IN B-PP
individual JJ B-NP
members NNS I-NP
of IN B-PP
Rel NN B-NP
proteins NNS I-NP
after IN B-PP
CD40 NN B-NP
induction NN I-NP
of IN B-PP
primary JJ B-NP
B NN I-NP
cells NNS I-NP
showed VBD B-VP
a DT B-NP
strong JJ I-NP
and CC I-NP
long-lasting JJ I-NP
accumulation NN I-NP
of IN B-PP
RelB NN B-NP
and CC O
COMMA COMMA B-NP
less RBR I-NP
pronounced JJ I-NP
COMMA COMMA O
of IN B-PP
c-Rel NN B-NP
. . O

LPS NN B-NP
stimulation NN I-NP
did VBD B-VP
not RB I-VP
give VB I-VP
rise NN B-NP
to TO B-PP
a DT B-NP
persistent JJ I-NP
nuclear JJ I-NP
accumulation NN I-NP
of IN B-PP
RelB NN B-NP
and CC O
c-Rel NN B-NP
COMMA COMMA O
whereas IN O
nuclear JJ B-NP
c-Rel NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
RelB NN B-NP
COMMA COMMA O
accumulated VBD B-VP
after IN B-PP
B NN B-NP
cell NN I-NP
receptor NN I-NP
stimulation NN I-NP
. . O

CD40 NN B-NP
induced VBD B-VP
not RB B-CONJP
only RB I-CONJP
nuclear JJ B-NP
translocation NN I-NP
but CC B-CONJP
also RB I-CONJP
de FW B-NP
novo FW I-NP
synthesis NN I-NP
of IN B-PP
RelB NN B-NP
RNA NN B-NP
and CC O
protein NN B-NP
. . O

S107 NN B-NP
plasmacytoma NN I-NP
cells NNS I-NP
COMMA COMMA O
which WDT B-NP
express VBP B-VP
CD40 NN B-NP
but CC O
are VBP B-VP
defective JJ B-ADJP
for IN B-PP
the DT B-NP
nuclear JJ I-NP
appearance NN I-NP
of IN B-PP
p50\/p65-NF-kappaB NN B-NP
COMMA COMMA O
do VBP B-VP
not RB I-VP
express VB I-VP
RelB NN B-NP
after IN B-PP
CD40 NN B-NP
stimulation NN I-NP
. . O

In IN B-PP
S107 NN B-NP
cells NNS I-NP
stably RB B-VP
transfected VBN I-VP
with IN B-PP
relB NN B-NP
genes NNS I-NP
COMMA COMMA O
stimulation NN B-NP
of IN B-PP
nuclear JJ B-NP
RelB NN I-NP
translocation NN I-NP
by IN B-PP
CD40 NN B-NP
was VBD B-VP
observed VBN I-VP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
stimulation NN B-NP
of IN B-PP
CD40 NN B-NP
signaling NN I-NP
pathways NNS I-NP
exerts VBZ B-VP
a DT B-NP
long-lasting JJ I-NP
stimulatory JJ I-NP
effect NN I-NP
on IN B-PP
both CC B-NP
the DT I-NP
transcription NN B-NP
and CC O
nuclear JJ B-NP
translocation NN I-NP
of IN B-PP
RelB NN B-NP
. . O

Since IN B-SBAR
LPS NN B-NP
and CC O
anti-IgM NN B-NP
were VBD B-VP
unable JJ B-ADJP
to TO B-VP
activate VB I-VP
RelB NN B-NP
COMMA COMMA O
CD40 NN B-NP
appears VBZ B-VP
to TO I-VP
trigger VB I-VP
a DT B-NP
special JJ I-NP
program NN I-NP
of IN B-PP
gene NN B-NP
expression NN I-NP
involved VBN B-VP
in IN B-PP
the DT B-NP
proliferation NN B-NP
and\/or CC O
differentiation NN B-NP
of IN B-PP
B NN B-NP
lymphocytes NNS I-NP
. . O

Sterol NN B-NP
dependent JJ I-NP
LDL-receptor NN I-NP
gene NN I-NP
transcription NN I-NP
in IN B-PP
lymphocytes NNS B-NP
from IN B-PP
normal JJ O
and CC O
CML NN B-NP
patients NNS B-NP
. . O

Sterol NN B-NP
regulatory JJ I-NP
element NN I-NP
( ( O
SRE NN B-NP
) ) O
has VBZ B-VP
been VBN I-VP
recognized VBN I-VP
to TO I-VP
regulate VB I-VP
various JJ B-NP
key JJ I-NP
genes NNS I-NP
coding VBG B-VP
for IN B-PP
especially RB B-NP
low JJ I-NP
density NN I-NP
lipoprotein NN I-NP
( ( I-NP
LDL NN I-NP
) ) I-NP
-receptor NN I-NP
COMMA COMMA O
3-hydroxy-3-methylglutaryl NN B-NP
coenzyme NN I-NP
A NN I-NP
( ( O
HMG-CoA NN B-NP
) ) O
reductase NN B-NP
and CC O
HMG-CoA NN B-NP
synthase NN I-NP
known VBN B-VP
to TO I-VP
play VB I-VP
a DT B-NP
crucial JJ I-NP
role NN I-NP
in IN B-PP
the DT B-NP
cholesterol NN I-NP
feedback NN I-NP
mechanism NN I-NP
. . O

The DT B-NP
deranged JJ I-NP
cholesterol NN I-NP
feedback NN I-NP
mechanism NN I-NP
has VBZ B-VP
been VBN I-VP
widely RB I-VP
recognised VBN I-VP
in IN B-PP
initiation NN B-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
progression NN B-NP
of IN B-PP
various JJ B-NP
types NNS I-NP
of IN B-PP
cancers NNS B-NP
including VBG B-PP
chronic JJ B-NP
myeloid JJ I-NP
leukaemia NN I-NP
( ( O
CML NN B-NP
) ) O
. . O

Consequently RB B-ADVP
COMMA COMMA O
the DT B-NP
present JJ I-NP
study NN I-NP
was VBD B-VP
addressed VBN I-VP
to TO B-VP
understand VB I-VP
this DT B-NP
phenomenon NN I-NP
and CC O
revealed VBD B-VP
the DT B-NP
existence NN I-NP
of IN B-PP
a DT B-NP
unique JJ I-NP
47 CD I-NP
kDa NN I-NP
protein NN I-NP
factor NN I-NP
having VBG B-VP
affinity NN B-NP
for IN B-PP
this DT B-NP
SRE NN I-NP
sequence NN I-NP
in IN B-PP
lymphocytes NNS B-NP
from IN B-PP
normal JJ B-NP
subjects NNS I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
its PRP$ B-NP
absence NN I-NP
in IN B-PP
lymphocytes NNS B-NP
from IN B-PP
untreated JJ B-NP
CML NN I-NP
patients NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
this DT B-NP
factor NN I-NP
appeared VBD B-VP
when WRB B-ADVP
the DT B-NP
CML NN I-NP
patients NNS I-NP
achieved VBD B-VP
complete JJ B-NP
haematological JJ I-NP
remission NN I-NP
( ( O
CHR NN B-NP
) ) O
through IN B-PP
alpha-interferon NN B-NP
therapy NN I-NP
. . O

Further RB B-ADVP
COMMA COMMA O
an DT B-NP
inverse NN I-NP
relationship NN I-NP
was VBD B-VP
also RB I-VP
observed VBN I-VP
between IN B-PP
sterol NN B-NP
modulated JJ I-NP
LDL-receptor NN I-NP
gene NN I-NP
transcription NN I-NP
and CC O
the DT B-NP
binding NN I-NP
affinity NN I-NP
of IN B-PP
this DT B-NP
47 CD I-NP
kDa NN I-NP
factor NN I-NP
to TO B-PP
the DT B-NP
SRE NN I-NP
sequence NN I-NP
. . O

Based VBN B-PP
upon IN B-PP
these DT B-NP
results NNS I-NP
we PRP B-NP
propose VBP B-VP
that IN B-SBAR
alpha-interferon NN B-NP
through IN B-PP
its PRP$ B-NP
receptor NN I-NP
initiates VBZ B-VP
phosphatidic JJ B-NP
acid NN I-NP
dependent JJ B-NP
signalling NN I-NP
which WDT B-NP
in IN B-PP
turn NN B-NP
regulates VBZ B-VP
the DT B-NP
affinity NN I-NP
of IN B-PP
47 CD B-NP
kDa NN I-NP
sterol NN I-NP
regulatory JJ I-NP
element NN I-NP
binding NN I-NP
factor NN I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
LDL-receptor NN B-NP
gene NN I-NP
transcription NN I-NP
in IN B-PP
lymphocytes NNS B-NP
from IN B-PP
CML NN B-NP
patients NNS I-NP
. . O

Effects NNS B-NP
of IN B-PP
Ara-C NN B-NP
on IN B-PP
neutral JJ B-NP
sphingomyelinase NN I-NP
and CC O
mitogen- NN B-NP
and CC I-NP
stress-activated JJ I-NP
protein NN I-NP
kinases NNS I-NP
in IN B-PP
T-lymphocyte NN B-NP
cell NN I-NP
lines NNS I-NP
. . O

Neutral JJ B-NP
sphingomyelinase NN B-NP
( ( O
SMase NN B-NP
) ) O
can MD B-VP
be VB I-VP
activated VBN I-VP
by IN B-PP
extracellular JJ B-NP
signals NNS I-NP
to TO B-VP
produce VB I-VP
ceramide NN B-NP
COMMA COMMA O
which WDT B-NP
may MD B-VP
affect VB I-VP
mitogen-activated JJ B-NP
protein NN I-NP
kinase NN I-NP
( ( O
MAPK NN B-NP
) ) O
activities NNS B-NP
. . O

Neutral JJ B-NP
SMase NN I-NP
activity NN I-NP
was VBD B-VP
assessed VBN I-VP
in IN B-PP
membranes NNS B-NP
from IN B-PP
Jurkat NN B-NP
COMMA COMMA O
a DT B-NP
human JJ I-NP
T-cell NN I-NP
line NN I-NP
COMMA COMMA O
and CC O
EL4 NN B-NP
COMMA COMMA O
a DT B-NP
murine JJ I-NP
T-cell NN I-NP
line NN I-NP
. . O

Ara-C NN B-NP
activated VBD B-VP
SMase NN B-NP
with IN B-PP
10 CD B-NP
minutes NNS I-NP
in IN B-PP
both CC O
Jurkat NN B-NP
and CC O
EL4 NN B-NP
cells NNS B-NP
COMMA COMMA O
while IN B-SBAR
phorbol NN B-NP
ester NN I-NP
( ( O
PMA NN B-NP
) ) O
had VBD B-VP
no DT B-NP
effect NN I-NP
. . O

PMA NN B-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
Ara-C NN B-NP
or CC O
ceramides NNS B-NP
COMMA COMMA O
activated VBD B-VP
ERK NN B-NP
MAPKS NNS I-NP
COMMA COMMA O
in IN B-PP
Jurkat NN B-NP
and CC O
EL4 NN B-NP
. . O

PMA NN B-NP
acted VBD B-VP
synergistically RB B-ADVP
with IN B-PP
ionomycin NN B-NP
to TO B-VP
activate VB I-VP
JNK NN B-NP
MAPKs NNS I-NP
in IN B-PP
Jurkat NN B-NP
and CC O
EL4 NN B-NP
within IN B-PP
10 CD B-NP
minutes NNS I-NP
. . O

Ara-C NN B-NP
activated VBD B-VP
JNKs NNS B-NP
only RB B-PP
after IN I-PP
prolonged JJ B-NP
incubation NN I-NP
( ( O
90-120 CD B-NP
minutes NNS I-NP
) ) O
. . O

Thus RB B-ADVP
COMMA COMMA O
ceramide NN B-NP
is VBZ B-VP
not RB O
a DT B-NP
positive JJ I-NP
signal NN I-NP
for IN B-PP
ERK NN B-NP
activation NN I-NP
in IN B-PP
T-cell NN B-NP
lines NNS I-NP
. . O

The DT B-NP
effects NNS I-NP
of IN B-PP
Ara-C NN B-NP
on IN B-PP
JNK NN B-NP
activity NN I-NP
may MD B-VP
be VB I-VP
mediated VBN I-VP
through IN B-PP
secondary JJ B-NP
response NN I-NP
pathways NNS I-NP
. . O

{ ( B-NP
Cortisone-resistant JJ I-NP
bronchial JJ I-NP
asthma NN I-NP
} ) O

There EX B-NP
is VBZ B-VP
general JJ B-NP
agreement NN I-NP
on IN B-PP
the DT B-NP
inflammatory JJ I-NP
pathogenesis NN I-NP
of IN B-PP
bronchial JJ B-NP
asthma NN I-NP
: : O
an DT B-NP
accumulation NN I-NP
of IN B-PP
activated VBN B-NP
eosinophils NNS I-NP
COMMA COMMA O
degranulated VBN B-NP
mast NN I-NP
cells NNS I-NP
COMMA COMMA O
T NN B-NP
lymphocytes NNS I-NP
and CC O
in IN B-PP
very RB B-NP
severe JJ I-NP
forms NNS I-NP
COMMA COMMA O
granulocytes NNS B-NP
has VBZ B-VP
constantly RB I-VP
been VBN I-VP
found VBN I-VP
in IN B-PP
the DT B-NP
bronchial JJ I-NP
mucosa NN I-NP
. . O

In IN B-PP
allergic JJ B-NP
bronchial JJ I-NP
asthma NN I-NP
COMMA COMMA O
inflammation NN B-NP
seems VBZ B-VP
to TO I-VP
be VB I-VP
orchestrated VBN I-VP
predominantly RB B-ADVP
by IN B-PP
a DT B-NP
subset NN I-NP
of IN B-PP
T NN B-NP
lymphocytes NNS I-NP
COMMA COMMA O
with IN B-PP
a DT B-NP
phenotype NN I-NP
similar JJ B-ADJP
to TO B-PP
the DT B-NP
Th2 NN I-NP
subset NN I-NP
able JJ B-ADJP
to TO B-VP
produce VB I-VP
IL-4 NN B-NP
and CC O
IL-5 NN B-NP
. . O

Although IN B-SBAR
corticosteroids NNS B-NP
are VBP B-VP
the DT B-NP
most RBS I-NP
potent JJ I-NP
therapeutic JJ I-NP
agents NNS I-NP
used VBN B-VP
for IN B-PP
this DT B-NP
disease NN I-NP
COMMA COMMA O
their PRP$ B-NP
anti-inflammatory JJ I-NP
effect NN I-NP
differs VBZ B-VP
from IN B-PP
patient NN B-NP
to TO B-PP
patient NN B-NP
. . O

Some DT B-NP
criteria NNS I-NP
which WDT B-NP
can MD B-VP
be VB I-VP
used VBN I-VP
to TO B-VP
define VB I-VP
steroid-resistant JJ B-NP
bronchial JJ I-NP
asthma NN I-NP
are VBP B-VP
listed VBN I-VP
here RB B-ADVP
. . O

This DT B-NP
review NN I-NP
analyzes VBZ B-VP
various JJ B-NP
molecular JJ I-NP
alterations NNS I-NP
responsible JJ B-ADJP
for IN B-PP
the DT B-NP
deficient JJ I-NP
response NN I-NP
to TO B-PP
corticosteroid NN B-NP
treatment NN I-NP
observed VBN B-VP
in IN B-PP
steroid-resistant JJ B-NP
bronchial JJ I-NP
asthmatic JJ I-NP
subjects NNS I-NP
. . O

New JJ B-NP
knowledge NN I-NP
on IN B-PP
the DT B-NP
mechanism NN I-NP
of IN B-PP
steroid NN B-NP
resistance NN I-NP
may MD B-VP
have VB I-VP
important JJ B-NP
implications NNS I-NP
for IN B-PP
the DT B-NP
treatment NN I-NP
of IN B-PP
chronic JJ B-NP
asthma NN I-NP
and CC O
other JJ B-NP
diseases NNS I-NP
. . O

Expression NN B-NP
of IN B-PP
Egr-1 NN B-NP
correlates VBZ B-VP
with IN B-PP
the DT B-NP
transformed VBN I-NP
phenotype NN I-NP
and CC O
the DT B-NP
type NN I-NP
of IN B-PP
viral JJ B-NP
latency NN I-NP
in IN B-PP
EBV NN B-NP
genome NN I-NP
positive JJ B-NP
lymphoid JJ I-NP
cell NN I-NP
lines NNS I-NP
. . O

In IN B-PP
this DT B-NP
paper NN I-NP
we PRP B-NP
have VBP B-VP
investigated VBN I-VP
the DT B-NP
role NN I-NP
of IN B-PP
Egr-1 NN B-NP
in IN B-PP
B NN B-NP
cell NN I-NP
growth NN I-NP
regulation NN I-NP
by IN B-PP
examining VBG B-VP
the DT B-NP
gene NN I-NP
expression NN I-NP
in IN B-PP
a DT B-NP
panel NN I-NP
of IN B-PP
B NN B-NP
cell NN I-NP
lines NNS I-NP
COMMA COMMA O
including VBG B-PP
both CC O
EBV NN B-NP
genome NN I-NP
negative JJ O
and CC O
EBV NN B-ADJP
carrying VBG I-ADJP
cell NN B-NP
lines NNS I-NP
. . O

Egr-1 NN B-NP
expression NN I-NP
correlates VBZ B-VP
with IN B-PP
the DT B-NP
cellular JJ I-NP
phenotype NN I-NP
and CC O
the DT B-NP
specific JJ I-NP
pattern NN I-NP
of IN B-PP
viral JJ B-NP
latency NN I-NP
established VBN B-VP
within IN B-PP
the DT B-NP
individual JJ I-NP
cell NN I-NP
lines NNS I-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
constitutive JJ B-NP
activation NN I-NP
of IN B-PP
Egr-1 NN B-NP
gene NN I-NP
is VBZ B-VP
invariably RB I-VP
associated VBN I-VP
with IN B-PP
unrestricted JJ B-NP
expression NN I-NP
of IN B-PP
viral JJ B-NP
latent JJ I-NP
genes NNS I-NP
in IN B-PP
all DT O
group NN O
III CD O
EBV NN B-NP
genome NN I-NP
carrying VBG B-NP
cell NN I-NP
lines NNS I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
Egr-1 NN B-NP
expression NN I-NP
is VBZ B-VP
abrogated VBN I-VP
in IN B-PP
group NN B-NP
I NN I-NP
Burkitt NN I-NP
tumor NN I-NP
cells NNS I-NP
COMMA COMMA O
irrespective JJ B-ADVP
of IN B-PP
the DT B-NP
EBV NN I-NP
genome NN I-NP
carrying NN I-NP
status NN I-NP
. . O

Activated VBN B-NP
viral JJ I-NP
gene NN I-NP
expression NN I-NP
associated VBN B-VP
with IN B-PP
phenotypic JJ B-NP
conversion NN I-NP
of IN B-PP
group NN B-NP
I NN I-NP
cell NN I-NP
lines NNS I-NP
in IN B-PP
to TO I-PP
group NN B-NP
II CD B-NP
or CC O
III CD B-NP
restores VBZ B-VP
the DT B-NP
Egr-1 NN I-NP
gene NN I-NP
expression NN I-NP
. . O

Several JJ B-NP
forms NNS I-NP
of IN B-PP
EGR-1 JJ B-NP
protein NN I-NP
are VBP B-VP
found VBN I-VP
within IN B-PP
the DT B-NP
different JJ I-NP
groups NNS I-NP
of IN B-PP
cell NN B-NP
lines NNS I-NP
COMMA COMMA O
and CC O
the DT B-NP
binding NN I-NP
activity NN I-NP
to TO B-PP
DNA NN B-NP
consensus NN I-NP
sequences NNS I-NP
was VBD B-VP
investigated VBN I-VP
. . O

Finally RB B-ADVP
COMMA COMMA O
time NN B-NP
course NN I-NP
analysis NN I-NP
of IN B-PP
Egr-1 NN B-NP
expression NN I-NP
during IN B-PP
the DT B-NP
early JJ I-NP
steps NNS I-NP
of IN B-PP
EBV NN B-NP
infection NN I-NP
in FW B-ADVP
vitro FW I-ADVP
demonstrated VBD B-VP
that IN B-SBAR
Egr-1 NN B-NP
is VBZ B-VP
upregulated VBN I-VP
within IN B-PP
minutes NNS B-NP
from IN B-PP
the DT B-NP
initial JJ I-NP
interaction NN I-NP
with IN B-PP
the DT B-NP
B NN I-NP
lymphocyte NN I-NP
. . O

The DT B-NP
proximal JJ I-NP
regulatory JJ I-NP
element NN I-NP
of IN B-PP
the DT B-NP
interferon-gamma NN I-NP
promoter NN I-NP
mediates VBZ B-VP
selective JJ B-NP
expression NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
. . O

Interferon-gamma NN B-NP
( ( O
IFN-gamma NN B-NP
) ) O
is VBZ B-VP
produced VBN I-VP
by IN B-PP
natural JJ B-NP
killer NN I-NP
cells NNS I-NP
and CC O
certain JJ B-NP
subsets NNS I-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
COMMA COMMA O
but CC O
the DT B-NP
basis NN I-NP
for IN B-PP
its PRP$ B-NP
selective JJ I-NP
expression NN I-NP
is VBZ B-VP
unknown JJ B-ADJP
. . O

Within IN B-PP
the DT B-NP
region NN I-NP
between IN B-PP
-108 CD B-NP
and CC O
-40 CD B-NP
base NN B-NP
pairs NNS I-NP
of IN B-PP
the DT B-NP
IFN-gamma NN I-NP
promoter NN I-NP
are VBP B-VP
two CD B-NP
conserved VBN I-NP
and CC I-NP
essential JJ I-NP
regulatory JJ I-NP
elements NNS I-NP
COMMA COMMA O
which WDT B-NP
confer VBP B-VP
activation-specific JJ B-NP
expression NN I-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
. . O

This DT B-NP
report NN I-NP
describes VBZ B-VP
studies NNS B-NP
indicating VBG B-VP
that IN B-SBAR
the DT B-NP
most RBS I-NP
proximal JJ I-NP
of IN B-PP
these DT B-NP
two CD I-NP
regulatory JJ I-NP
elements NNS I-NP
is VBZ B-VP
an DT B-NP
important JJ I-NP
determinant NN I-NP
of IN B-PP
its PRP$ B-NP
restricted JJ I-NP
expression NN I-NP
. . O

The DT B-NP
proximal JJ I-NP
element NN I-NP
is VBZ B-VP
a DT B-NP
composite JJ I-NP
site NN I-NP
that WDT B-NP
binds VBZ B-VP
members NNS B-NP
of IN B-PP
the DT O
CREB\/ATF NN B-NP
COMMA COMMA O
AP-1 NN B-NP
COMMA COMMA O
and CC O
octamer NN B-NP
families NNS B-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
. . O

Jun NN B-NP
is VBZ B-VP
essential JJ B-ADJP
for IN B-PP
activation-induced JJ B-NP
transcription NN I-NP
and CC O
binds VBZ B-VP
preferably RB B-ADVP
as IN B-PP
a DT B-NP
heterodimer NN I-NP
with IN B-PP
ATF-2 NN B-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
CREB NN B-NP
appears VBZ B-VP
to TO I-VP
dampen VB I-VP
transcription NN B-NP
from IN B-PP
this DT B-NP
element NN I-NP
. . O

The DT B-NP
CpG NN I-NP
dinucleotide NN I-NP
in IN B-PP
this DT B-NP
element NN I-NP
is VBZ B-VP
selectively RB I-VP
methylated VBN I-VP
in IN B-PP
Th2 NN B-NP
T NN I-NP
cells NNS I-NP
and CC O
other JJ B-NP
cells NNS I-NP
that WDT B-NP
do VBP B-VP
not RB I-VP
express VB I-VP
IFN-gamma NN B-NP
COMMA COMMA O
and CC O
methylation NN B-NP
markedly RB B-ADVP
reduces VBZ B-VP
transcription NN B-NP
factor NN I-NP
binding NN I-NP
. . O

As IN B-PP
a DT B-NP
target NN I-NP
for IN B-PP
DNA NN B-NP
methylation NN I-NP
and CC B-PP
for IN B-PP
binding NN B-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
that WDT B-NP
mediate VBP B-VP
or CC O
impede VBP B-VP
transcription NN B-NP
COMMA COMMA O
this DT B-NP
element NN I-NP
appears VBZ B-VP
to TO I-VP
play VB I-VP
a DT B-NP
central JJ I-NP
role NN I-NP
in IN B-PP
controlling VBG B-VP
IFN-gamma NN B-NP
expression NN I-NP
. . O

Activation NN B-NP
of IN B-PP
nuclear JJ B-NP
factor-kappaB NN I-NP
via IN B-PP
T NN B-NP
cell NN I-NP
receptor NN I-NP
requires VBZ B-VP
a DT O
Raf NN B-NP
kinase NN I-NP
and CC O
Ca2+ NN B-NP
influx NN B-NP
. . O

Functional JJ B-NP
synergy NN I-NP
between IN B-PP
Raf NN B-NP
and CC O
calcineurin NN B-NP
. . O

Signals NNS B-NP
transduced VBN B-VP
via IN B-PP
the DT B-NP
TCR NN I-NP
activate VBP B-VP
the DT B-NP
transcription NN I-NP
factor NN I-NP
nuclear JJ B-NP
factor-kappaB NN I-NP
( ( O
NF-kappaB NN B-NP
) ) O
COMMA COMMA O
which WDT B-NP
COMMA COMMA O
in IN B-PP
turn NN B-NP
COMMA COMMA O
is VBZ B-VP
critical JJ B-ADJP
to TO B-PP
the DT B-NP
transcriptional JJ I-NP
induction NN I-NP
of IN B-PP
many JJ B-NP
genes NNS I-NP
important JJ B-ADJP
for IN B-PP
the DT B-NP
proliferation NN B-NP
and CC O
expression NN B-NP
of IN B-PP
a DT B-NP
differentiated VBN I-NP
phenotype NN I-NP
. . O

Treatment NN B-NP
of IN B-PP
T NN B-NP
cells NNS I-NP
with IN B-PP
the DT B-NP
protein NN I-NP
kinase NN I-NP
C NN I-NP
activator NN I-NP
PMA NN I-NP
in IN B-PP
combination NN B-NP
with IN B-PP
Ca2+ NN B-NP
ionophores NNS I-NP
mimics VBZ B-VP
this DT B-NP
process NN I-NP
COMMA COMMA O
and CC O
the DT B-NP
two CD I-NP
agents NNS I-NP
are VBP B-VP
often RB I-VP
substituted VBN I-VP
for IN B-PP
TCR NN B-NP
stimulation NN I-NP
COMMA COMMA O
bypassing VBG B-VP
the DT B-NP
TCR NN I-NP
. . O

Here RB B-ADVP
we PRP B-NP
identify VBP B-VP
intracellular JJ B-NP
signaling VBG I-NP
components NNS I-NP
involved VBN B-VP
in IN B-PP
activation NN B-NP
of IN B-PP
NF-kappaB NN B-NP
following VBG B-PP
TCR NN B-NP
stimulation NN I-NP
. . O

TCR NN B-NP
signaling NN I-NP
was VBD B-VP
triggered VBN I-VP
by IN B-PP
treating VBG B-VP
Jurkat NN B-NP
T NN I-NP
cells NNS I-NP
with IN B-PP
PHA NN B-NP
or CC O
anti-CD3 JJ B-ADJP
Abs NNS B-NP
COMMA COMMA O
and CC O
NF-kappaB NN B-NP
activation NN I-NP
was VBD B-VP
monitored VBN I-VP
by IN B-PP
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
and\/or CC B-PP
by IN B-PP
kappaB-dependent JJ B-NP
reporter NN I-NP
assays NNS I-NP
. . O

Contrary JJ B-PP
to TO I-PP
the DT B-NP
idea NN I-NP
that IN B-SBAR
protein NN B-NP
kinase NN I-NP
C NN I-NP
is VBZ B-VP
involved VBN I-VP
in IN B-PP
TCR-mediated JJ B-NP
activation NN I-NP
of IN B-PP
NF-kappaB NN B-NP
COMMA COMMA O
high JJ B-NP
doses NNS I-NP
of IN B-PP
staurosporine NN B-NP
did VBD B-VP
not RB I-VP
interfere VB I-VP
with IN B-PP
activation NN B-NP
of IN B-PP
NF-kappaB NN B-NP
by IN B-PP
PHA NN B-NP
COMMA COMMA O
while IN B-SBAR
the DT B-NP
same JJ I-NP
dose NN I-NP
of IN B-PP
staurosporine NN B-NP
completely RB B-ADVP
blocked VBD B-VP
activation NN B-NP
by IN B-PP
PMA NN B-NP
. . O

PHA-induced JJ B-NP
kappaB-dependent JJ I-NP
reporter NN I-NP
activity NN I-NP
was VBD B-VP
COMMA COMMA O
however RB B-ADVP
COMMA COMMA O
effectively RB B-VP
blocked VBN I-VP
by IN B-PP
a DT B-NP
dominant JJ I-NP
negative JJ I-NP
form NN I-NP
of IN B-PP
Raf-1 NN B-NP
COMMA COMMA O
suggesting VBG B-VP
a DT B-NP
critical JJ I-NP
role NN I-NP
for IN B-PP
a DT B-NP
Raf NN I-NP
kinase NN I-NP
. . O

The DT B-NP
TCR-mediated JJ I-NP
activation NN I-NP
of IN B-PP
NF-kappaB NN B-NP
was VBD B-VP
also RB B-ADVP
dependent JJ B-ADJP
on IN B-PP
a DT B-NP
Ca2+ NN I-NP
influx NN I-NP
COMMA COMMA O
because IN B-SBAR
the DT B-NP
Ca2+ NN I-NP
channel NN I-NP
blocker NN I-NP
COMMA COMMA O
SK&amp;F NN B-NP
96365 CD I-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
other JJ B-NP
agents NNS I-NP
that WDT B-NP
prevented VBD B-VP
the DT B-NP
Ca2+ NN I-NP
influx NN I-NP
COMMA COMMA O
inhibited VBD B-VP
NF-kappaB NN B-NP
activation NN I-NP
. . O

Cotransfection NN B-NP
of IN B-PP
a DT B-NP
constitutively RB I-NP
active JJ I-NP
form NN I-NP
of IN B-PP
calcineurin NN B-NP
largely RB B-VP
substituted VBD I-VP
for IN B-PP
the DT B-NP
Ca2+ NN I-NP
requirement NN I-NP
and CC O
reversed VBD B-VP
the DT B-NP
blockade NN I-NP
by IN B-PP
SK&amp;F NN B-NP
96365 CD I-NP
. . O

Consistent JJ B-ADJP
with IN B-PP
these DT B-NP
observations NNS I-NP
COMMA COMMA O
coexpression NN B-NP
of IN B-PP
constitutively RB B-NP
active JJ I-NP
forms NNS I-NP
of IN B-PP
Raf-1 NN B-NP
and CC O
calcineurin NN B-NP
synergistically RB B-ADVP
induced VBD B-VP
kappaB-dependent JJ B-NP
reporter NN I-NP
activity NN I-NP
COMMA COMMA O
suggesting VBG B-VP
a DT B-NP
physiologically RB I-NP
relevant JJ I-NP
functional JJ I-NP
interaction NN I-NP
between IN B-PP
the DT B-NP
kinase NN I-NP
and CC O
the DT B-NP
phosphatase NN I-NP
. . O

Induction NN B-NP
of IN B-PP
the DT B-NP
CD11b NN I-NP
gene NN I-NP
during IN B-PP
activation NN B-NP
of IN B-PP
the DT B-NP
monocytic JJ I-NP
cell NN I-NP
line NN I-NP
U937 NN I-NP
requires VBZ B-VP
a DT B-NP
novel JJ I-NP
nuclear JJ I-NP
factor NN I-NP
MS-2 NN I-NP
{ ( O
published VBN B-NP
erratum NN I-NP
appears VBZ B-VP
in IN B-PP
J NNP B-NP
Immunol NNP I-NP
1999 CD B-NP
Jul NNP I-NP
15 CD I-NP
; : O
163 CD B-NP
( ( I-NP
2 CD I-NP
) ) O
: : O
1091 CD B-NP
} ) O

The DT B-NP
differentiation NN I-NP
of IN B-PP
myeloid JJ B-NP
precursors NNS I-NP
into IN B-PP
mature JJ B-NP
myelomonocytic JJ I-NP
cells NNS I-NP
is VBZ B-VP
characterized VBN I-VP
by IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
the DT B-NP
gene NN I-NP
encoding VBG B-VP
the DT B-NP
beta2 NN I-NP
integrin NN I-NP
CD11b NN I-NP
. . O

The DT B-NP
transcription NN I-NP
factors NNS I-NP
Sp1 NN B-NP
and CC O
PU.1 NN B-NP
prime VBP B-VP
the DT B-NP
CD11b NN I-NP
promoter NN I-NP
COMMA COMMA O
but CC O
the DT B-NP
nature NN I-NP
of IN B-PP
the DT B-NP
factors NNS I-NP
responsible JJ B-ADJP
for IN B-PP
its PRP$ B-NP
inducible JJ I-NP
expression NN I-NP
are VBP B-VP
unknown JJ B-ADJP
. . O

In IN B-PP
addition NN I-PP
to TO I-PP
the DT B-NP
CD11b NN I-NP
gene NN I-NP
COMMA COMMA O
the DT B-NP
homologous JJ I-NP
genes NNS I-NP
encoding VBG B-VP
CD11a NN B-NP
and CC O
CD11c NN B-NP
also RB B-ADVP
exhibit VBP B-VP
inducible JJ B-NP
expression NN I-NP
during IN B-PP
myeloid JJ B-NP
differentiation NN I-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
we PRP B-NP
compared VBD B-VP
the DT B-NP
nucleotide JJ I-NP
sequences NNS I-NP
of IN B-PP
the DT O
CD11a NN B-NP
COMMA COMMA O
CD11b NN B-NP
COMMA COMMA O
and CC O
CD11c NN B-NP
gene NN B-NP
promoters NNS I-NP
to TO B-VP
identify VB I-VP
common JJ B-NP
elements NNS I-NP
that WDT B-NP
might MD B-VP
contribute VB I-VP
to TO B-PP
inducible JJ B-NP
expression NN I-NP
. . O

This DT B-NP
analysis NN I-NP
identified VBD B-VP
one CD B-NP
such JJ I-NP
element NN I-NP
repeated VBN B-VP
four CD B-NP
times NNS I-NP
within IN B-PP
the DT B-NP
CD11b NN I-NP
promoter NN I-NP
. . O

Mutation NN B-NP
of IN B-PP
these DT B-NP
elements NNS I-NP
indicated VBD B-VP
that IN B-SBAR
two CD B-NP
COMMA COMMA O
MS-2beta NN B-NP
and CC O
MS-2gamma NN B-NP
COMMA COMMA O
are VBP B-VP
critical JJ B-ADJP
to TO B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
the DT B-NP
CD11b NN I-NP
gene NN I-NP
during IN B-PP
differentiation NN B-NP
of IN B-PP
the DT B-NP
pro-monocytic JJ I-NP
cell NN I-NP
line NN I-NP
U937 NN I-NP
. . O

Electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
indicate VBP B-VP
that IN B-SBAR
MS-2beta NN B-NP
and CC O
MS-2gamma NN B-NP
interact VBP B-VP
with IN B-PP
nuclear JJ B-NP
factors NNS I-NP
that WDT B-NP
are VBP B-VP
induced VBN I-VP
during IN B-PP
U937 NN B-NP
differentiation NN I-NP
. . O

These DT B-NP
factors NNS I-NP
are VBP B-VP
detected VBN I-VP
at IN B-PP
the DT B-NP
time NN I-NP
the DT B-NP
CD11b NN I-NP
promoter NN I-NP
is VBZ B-VP
activated VBN I-VP
. . O

The DT B-NP
molecular JJ I-NP
mass NN I-NP
of IN B-PP
these DT B-NP
factors NNS I-NP
is VBZ B-VP
approximately RB B-NP
28 CD I-NP
kDa NN I-NP
COMMA COMMA O
and CC O
their PRP$ B-NP
DNA NN I-NP
binding NN I-NP
characteristics NNS I-NP
are VBP B-VP
indistinguishable JJ B-ADJP
from IN B-PP
those DT B-NP
of IN B-PP
the DT B-NP
novel JJ I-NP
nuclear JJ I-NP
factor NN I-NP
MS-2 NN I-NP
. . O

Taken VBN B-VP
together RB B-ADVP
COMMA COMMA O
our PRP$ B-NP
data NNS I-NP
indicate VBP B-VP
that IN B-SBAR
MS-2 NN B-NP
mediates VBZ B-VP
induction NN B-NP
of IN B-PP
the DT B-NP
CD11b NN I-NP
gene NN I-NP
as IN B-SBAR
cells NNS B-NP
of IN B-PP
the DT B-NP
monocytic JJ I-NP
lineage NN I-NP
mature VBP B-VP
. . O

The DT B-NP
presence NN I-NP
of IN B-PP
multiple JJ B-NP
potential JJ I-NP
binding VBG I-NP
sites NNS I-NP
for IN B-PP
MS-2 NN B-NP
in IN B-PP
the DT B-NP
promoter NN I-NP
regions NNS I-NP
of IN B-PP
a DT B-NP
wide JJ I-NP
range NN I-NP
of IN B-PP
genes NNS B-NP
expressed VBN B-VP
in IN B-PP
mature JJ B-NP
myeloid JJ I-NP
cells NNS I-NP
suggests VBZ B-VP
this DT B-NP
factor NN I-NP
plays VBZ B-VP
a DT B-NP
general JJ I-NP
role NN I-NP
in IN B-PP
myeloid JJ B-NP
differentiation NN I-NP
. . O

HIV-1 NN B-NP
LTR NN I-NP
activity NN I-NP
in IN B-PP
human JJ B-NP
CD40-activated JJ I-NP
B NN I-NP
lymphocytes NNS I-NP
is VBZ B-VP
dependent JJ B-ADJP
on IN B-PP
NF-kappaB NN B-NP
. . O

CD40-stimulated JJ B-NP
human JJ I-NP
B NN I-NP
lymphocytes NNS I-NP
are VBP B-VP
highly RB B-ADJP
permissive JJ I-ADJP
to TO B-PP
a DT B-NP
productive JJ I-NP
infection NN I-NP
by IN B-PP
the DT B-NP
human JJ I-NP
immunodeficiency NN I-NP
virus NN I-NP
type NN I-NP
1 CD I-NP
. . O

In IN B-PP
these DT B-NP
cells NNS I-NP
COMMA COMMA O
nuclear JJ B-NP
factors NNS I-NP
involved VBN B-VP
in IN B-PP
activation NN B-NP
of IN B-PP
the DT B-NP
HIV-1 NN I-NP
LTR NN I-NP
COMMA COMMA O
which WDT B-NP
contains VBZ B-VP
the DT B-NP
transcriptional JJ I-NP
control NN I-NP
elements NNS I-NP
of IN B-PP
the DT B-NP
virus NN I-NP
COMMA COMMA O
are VBP B-VP
unknown JJ B-ADJP
. . O

Transient JJ B-NP
expression NN I-NP
assays NNS I-NP
with IN B-PP
plasmids NNS B-NP
containing VBG B-VP
deleted VBN B-NP
parts NNS I-NP
of IN B-PP
the DT B-NP
LTR NN I-NP
region NN I-NP
linked VBN B-VP
to TO B-PP
a DT B-NP
reporter NN I-NP
gene NN I-NP
showed VBD B-VP
that IN B-SBAR
the DT B-NP
NF-kappaB NN I-NP
binding NN I-NP
site NN I-NP
was VBD B-VP
essential JJ B-ADJP
for IN B-PP
HIV-1 NN B-NP
LTR NN I-NP
activity NN I-NP
in IN B-PP
CD40-stimulated JJ B-NP
B NN I-NP
lymphocytes NNS I-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
and CC O
supershift NN B-NP
assays NNS B-NP
revealed VBD B-VP
that IN B-SBAR
important JJ B-NP
NF-kappaB NN I-NP
binding NN I-NP
activity NN I-NP
composed VBN B-VP
of IN B-PP
at IN B-ADVP
least JJS I-ADVP
p50 NN B-NP
COMMA COMMA O
p65 NN B-NP
COMMA COMMA O
and CC O
c-Rel NN B-NP
NF-kappaB NN I-NP
subunits NNS B-NP
was VBD B-VP
present JJ B-ADJP
in IN B-PP
nuclei NNS B-NP
of IN B-PP
CD40-stimulated JJ B-NP
B NN I-NP
cells NNS I-NP
. . O

These DT B-NP
results NNS I-NP
confirm VBP B-VP
at IN B-PP
a DT B-NP
molecular JJ I-NP
level NN I-NP
the DT B-NP
ability NN I-NP
of IN B-PP
HIV-1 NN B-NP
to TO B-VP
replicate VB I-VP
in IN B-PP
B NN B-NP
cells NNS I-NP
and CC O
that IN B-SBAR
this DT B-NP
activity NN I-NP
is VBZ B-VP
strongly RB I-VP
associated VBN I-VP
with IN B-PP
NF-kappaB NN B-NP
. . O

Mutation NN B-NP
of IN B-PP
tyrosines NNS B-NP
492\/493 CD I-NP
in IN B-PP
the DT B-NP
kinase NN I-NP
domain NN I-NP
of IN B-PP
ZAP-70 NN B-NP
affects VBZ B-VP
multiple JJ B-NP
T-cell NN I-NP
receptor NN I-NP
signaling NN I-NP
pathways NNS I-NP
. . O

The DT B-NP
protein-tyrosine JJ I-NP
kinase NN I-NP
ZAP-70 NN I-NP
is VBZ B-VP
implicated VBN I-VP
COMMA COMMA O
together RB B-PP
with IN I-PP
the DT B-NP
Src NN I-NP
kinase NN I-NP
p56(lck) NN I-NP
COMMA COMMA O
in IN B-PP
controlling VBG B-VP
the DT B-NP
early JJ I-NP
steps NNS I-NP
of IN B-PP
the DT O
T-cell NN B-NP
antigen NN I-NP
receptor NN I-NP
( ( O
TCR NN B-NP
) ) O
signaling NN B-NP
cascade NN I-NP
. . O

To TO B-VP
help VB I-VP
elucidate VB I-VP
further RBR B-ADVP
the DT B-NP
mechanism NN I-NP
by IN B-PP
which WDT B-NP
ZAP-70 NN B-NP
regulates VBZ B-VP
these DT B-NP
initial JJ I-NP
events NNS I-NP
COMMA COMMA O
we PRP B-NP
used VBD B-VP
a DT B-NP
dominant-negative JJ I-NP
mutant NN I-NP
approach NN I-NP
. . O

We PRP B-NP
overexpressed VBD B-VP
in IN B-PP
the DT B-NP
Jurkat NN I-NP
T-cell NN I-NP
line NN I-NP
ZAP-70 NN B-NP
mutated VBN B-VP
on IN B-PP
Tyr-492 NN B-NP
and CC O
Tyr-493 NN B-NP
in IN B-PP
the DT B-NP
putative JJ I-NP
regulatory JJ I-NP
loop NN I-NP
of IN B-PP
its PRP$ B-NP
kinase NN I-NP
domain NN I-NP
. . O

This DT B-NP
mutant NN I-NP
inhibited VBD B-VP
TCR-induced JJ B-NP
activation NN I-NP
of IN B-PP
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
by IN B-PP
interfering VBG B-VP
with IN B-PP
both CC O
intracellular JJ B-NP
calcium NN I-NP
increase NN I-NP
and CC O
Ras-regulated JJ B-NP
activation NN I-NP
of IN B-PP
extracellular JJ B-NP
signal-regulated JJ I-NP
kinases NNS I-NP
. . O

Moreover RB B-ADVP
COMMA COMMA O
TCR-induced JJ B-NP
phosphorylation NN I-NP
of IN B-PP
pp36-38 NN B-NP
COMMA COMMA O
thought VBN B-VP
to TO I-VP
play VB I-VP
a DT B-NP
role NN I-NP
upstream RB B-ADVP
of IN B-PP
these DT B-NP
pathways NNS I-NP
COMMA COMMA O
was VBD B-VP
found VBN I-VP
to TO I-VP
be VB I-VP
reduced VBN I-VP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
overexpression NN B-NP
of IN B-PP
wild-type JJ B-NP
ZAP-70 NN I-NP
induced VBD B-VP
constitutive JJ B-NP
activation NN I-NP
of IN B-PP
nuclear JJ B-NP
factor NN I-NP
of IN B-PP
activated VBN B-NP
T NN I-NP
cells NNS I-NP
. . O

The DT B-NP
ZAP-70 NN I-NP
mutant NN I-NP
studied VBN B-VP
here RB B-ADVP
could MD B-VP
be VB I-VP
phosphorylated VBN I-VP
on IN B-PP
tyrosine NN B-NP
when WRB B-ADVP
associated VBN B-VP
to TO B-PP
the DT B-NP
TCR NN I-NP
zeta NN I-NP
chain NN I-NP
and CC O
was VBD B-VP
able JJ B-ADJP
to TO B-VP
bind VB I-VP
p56(lck) NN B-NP
. . O

This DT B-NP
result NN I-NP
demonstrates VBZ B-VP
that IN B-SBAR
Tyr-492 NN B-NP
and CC O
Tyr-493 NN B-NP
are VBP B-VP
not RB O
responsible JJ B-ADJP
for IN B-PP
the DT B-NP
Src NN I-NP
homology NN I-NP
domain NN I-NP
2-mediated JJ I-NP
association NN I-NP
of IN B-PP
p56(lck) NN B-NP
with IN B-PP
ZAP-70 NN B-NP
. . O

Our PRP$ B-NP
data NNS I-NP
are VBP B-VP
most RBS B-ADJP
consistent JJ I-ADJP
with IN B-PP
a DT B-NP
model NN I-NP
in IN B-PP
which WDT B-NP
recruitment NN B-NP
to TO B-PP
the DT B-NP
TCR NN I-NP
allows VBZ B-VP
ZAP-70 NN B-NP
autophosphorylation NN B-NP
and CC O
binding NN B-NP
to TO B-PP
p56(lck) NN B-NP
COMMA COMMA O
which WDT B-NP
in IN B-PP
turn NN B-NP
phosphorylates VBZ B-VP
Tyr-492 NN B-NP
and\/or CC O
Tyr-493 NN B-NP
with IN B-PP
consequent JJ B-NP
up-regulation NN I-NP
of IN B-PP
the DT B-NP
ZAP-70 NN I-NP
kinase NN I-NP
activity NN I-NP
. . O

ZAP-70 NN B-NP
will MD B-VP
then RB I-VP
be VB I-VP
able JJ B-ADJP
to TO B-VP
effectively RB I-VP
control VB I-VP
phosphorylation NN B-NP
of IN B-PP
its PRP$ B-NP
substrates NNS I-NP
and CC O
lead VB B-VP
to TO B-PP
gene NN B-NP
activation NN I-NP
. . O

Dexamethasone NN B-NP
suppression NN I-NP
test NN I-NP
: : O
corticosteroid NN B-NP
receptors NNS I-NP
regulation NN I-NP
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
of IN B-PP
young JJ B-NP
and CC I-NP
aged JJ I-NP
subjects NNS I-NP
. . O

The DT B-NP
dexamethasone NN I-NP
suppression NN I-NP
test NN I-NP
( ( O
DST NN B-NP
) ) O
is VBZ B-VP
considered VBN I-VP
an DT B-NP
indicator NN I-NP
of IN B-PP
the DT B-NP
function NN I-NP
of IN B-PP
the DT B-NP
adrenal JJ I-NP
pituitary JJ I-NP
axis NN I-NP
. . O

The DT B-NP
effect NN I-NP
of IN B-PP
the DT B-NP
steroid NN I-NP
is VBZ B-VP
mediated VBN I-VP
by IN B-PP
its PRP$ B-NP
binding NN I-NP
to TO B-PP
corticosteroid NN B-NP
receptors NNS I-NP
. . O

We PRP B-NP
previously RB B-ADVP
suggested VBD B-VP
that IN B-SBAR
the DT B-NP
measurement NN I-NP
of IN B-PP
corticosteroid NN B-NP
receptors NNS I-NP
in IN B-PP
lymphocytes NNS B-NP
is VBZ B-VP
an DT B-NP
index NN I-NP
of IN B-PP
an DT B-NP
analogous JJ I-NP
pattern NN I-NP
in IN B-PP
brain NN B-NP
. . O

In IN B-PP
the DT B-NP
present JJ I-NP
study NN I-NP
COMMA COMMA O
corticosteroid NN O
Type NN B-NP
I CD I-NP
and CC O
Type NN B-NP
II CD I-NP
receptors NNS B-NP
in IN B-PP
mononuclear JJ B-NP
leukocytes NNS I-NP
were VBD B-VP
measured VBN I-VP
in IN B-PP
10 CD B-NP
elderly JJ I-NP
subjects NNS I-NP
and CC B-PP
in IN B-PP
9 CD B-NP
young JJ I-NP
adults NNS I-NP
COMMA COMMA O
before IN B-PP
and CC B-PP
after IN B-PP
overnight JJ B-NP
DST NN I-NP
( ( O
1 CD B-NP
mg NN I-NP
) ) O
. . O

Receptors NNS B-NP
were VBD B-VP
measured VBN I-VP
by IN B-PP
radioreceptor NN B-NP
assay NN I-NP
. . O

In IN B-PP
all PDT B-NP
the DT I-NP
subjects NNS I-NP
COMMA COMMA O
dexamethasone NN B-NP
was VBD B-VP
able JJ B-ADJP
to TO B-VP
suppress VB I-VP
plasma NN B-NP
cortisol NN I-NP
. . O

The DT B-NP
number NN I-NP
of IN B-PP
Type NN B-NP
I CD I-NP
and CC O
Type NN B-NP
II CD I-NP
receptors NNS B-NP
before IN B-PP
the DT B-NP
test NN I-NP
was VBD B-VP
lower JJR B-ADJP
in IN B-PP
elderly JJ B-NP
subjects NNS I-NP
than IN B-PP
in IN B-PP
adults NNS B-NP
. . O

In IN B-PP
the DT B-NP
control NN I-NP
group NN I-NP
COMMA COMMA O
dexamethasone NN B-NP
produced VBD B-VP
a DT B-NP
significant JJ I-NP
depression NN I-NP
of IN B-PP
Type NN B-NP
I CD I-NP
receptors NNS I-NP
( ( O
from IN B-PP
267 CD B-NP
+\/- CC I-NP
72 CD I-NP
to TO B-PP
169 CD B-NP
+\/- CC I-NP
71 CD I-NP
receptors NNS B-NP
per IN B-PP
cell NN B-NP
) ) O
COMMA COMMA O
which WDT B-NP
can MD B-VP
be VB I-VP
interpreted VBN I-VP
as IN B-PP
a DT B-NP
primary JJ I-NP
involvement NN I-NP
of IN B-PP
Type NN B-NP
I CD I-NP
receptors NNS I-NP
in IN B-PP
the DT B-NP
response NN I-NP
to TO B-PP
dexamethasone NN B-NP
; : O
Type NN B-NP
II CD I-NP
receptors NNS I-NP
decreased VBD B-VP
in IN B-PP
half PDT B-NP
the DT I-NP
subjects NNS I-NP
( ( O
from IN B-PP
2849 CD B-NP
+\/- CC I-NP
703 CD I-NP
to TO B-PP
2345 CD B-NP
+\/- CC I-NP
569 CD I-NP
receptors NNS B-NP
per IN B-PP
cell NN B-NP
) ) O
. . O

In IN B-PP
elderly JJ B-NP
healthy JJ I-NP
subjects NNS I-NP
COMMA COMMA O
Type NN B-NP
II CD I-NP
receptors NNS I-NP
were VBD B-VP
also RB I-VP
significantly RB I-VP
decreased VBN I-VP
( ( O
from IN B-PP
1796 CD B-NP
+\/- CC I-NP
671 CD I-NP
to TO B-PP
720 CD B-NP
+\/- CC I-NP
345 CD I-NP
) ) O
. . O

We PRP B-NP
suggest VBP B-VP
that IN B-SBAR
in IN B-PP
young JJ B-NP
subjects NNS I-NP
Type NN B-NP
II CD I-NP
receptors NNS I-NP
are VBP B-VP
initially RB I-VP
up-regulated VBN I-VP
by IN B-PP
dexamethasone NN B-NP
COMMA COMMA O
and CC O
then RB B-VP
down-regulated VBN I-VP
COMMA COMMA O
while IN B-SBAR
in RB B-PP
aged JJ B-NP
subjects NNS I-NP
an DT B-NP
up-regulation NN I-NP
can MD B-VP
not RB I-VP
be VB I-VP
achieved VBN I-VP
COMMA COMMA O
as IN O
suggested VBN B-PP
by IN B-NP
the DT I-NP
higher JJR I-NP
values NNS O
of IN B-NP
plasma NN I-NP
cortisol NN B-ADVP
usually RB O
found VBN B-PP
in IN B-NP
aging VBG I-NP
subjects NNS O

Lymphocytes NNS B-NP
from IN B-PP
CML NN B-NP
patients NNS I-NP
lack VBP B-VP
a DT B-NP
47 CD I-NP
kDa NN I-NP
factor NN I-NP
having VBG B-VP
affinity NN B-NP
for IN B-PP
a DT B-NP
genomic JJ I-NP
sterol NN I-NP
regulatory JJ I-NP
sequence NN I-NP
. . O

Deranged VBN B-NP
cellular JJ I-NP
cholesterol NN I-NP
homeostasis NN I-NP
has VBZ B-VP
been VBN I-VP
widely RB I-VP
recognized VBN I-VP
in IN B-PP
the DT B-NP
initiation NN B-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
progression NN B-NP
of IN B-PP
various JJ B-NP
types NNS I-NP
of IN B-PP
cancers NNS B-NP
including VBG B-PP
chronic JJ B-NP
myeloid JJ I-NP
leukaemia NN I-NP
( ( O
CML NN B-NP
) ) O
. . O

Since IN B-SBAR
the DT B-NP
human JJ I-NP
genomic JJ I-NP
sterol NN B-NP
regulatory JJ I-NP
element NN I-NP
( ( O
SRE NN B-NP
) ) O
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
regulate VB I-VP
various JJ B-NP
key JJ I-NP
genes NNS I-NP
involved VBN B-VP
in IN B-PP
this DT B-NP
phenomenon NN I-NP
COMMA COMMA O
the DT B-NP
present JJ I-NP
study NN I-NP
revealed VBD B-VP
the DT B-NP
existence NN I-NP
of IN B-PP
a DT B-NP
unique JJ I-NP
47 CD I-NP
kDa NN I-NP
protein NN I-NP
factor NN I-NP
having VBG B-VP
affinity NN B-NP
for IN B-PP
this DT B-NP
SRE JJ I-NP
sequence NN I-NP
in IN B-PP
lymphocytes NNS B-NP
from IN B-PP
normal JJ B-NP
subjects NNS I-NP
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
its PRP$ B-NP
absence NN I-NP
in IN B-PP
lymphocytes NNS B-NP
from IN B-PP
untreated JJ B-NP
CML NN I-NP
patients NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
this DT B-NP
factor NN I-NP
appeared VBD B-VP
when WRB B-ADVP
these DT B-NP
CML NN I-NP
patients NNS I-NP
achieved VBD B-VP
complete JJ B-NP
haematological JJ I-NP
remission NN I-NP
( ( O
CHR NN B-NP
) ) O
through IN B-PP
alpha-interferon NN B-NP
therapy NN I-NP
. . O

Furthermore RB B-ADVP
COMMA COMMA O
an DT B-NP
inverse JJ I-NP
relationship NN I-NP
was VBD B-VP
also RB I-VP
observed VBN I-VP
between IN B-PP
the DT B-NP
LDL NN I-NP
receptor NN I-NP
gene NN I-NP
expression NN I-NP
at IN B-PP
the DT B-NP
transcriptional JJ I-NP
level NN I-NP
and CC O
the DT B-NP
binding NN I-NP
affinity NN I-NP
of IN B-PP
this DT B-NP
47 CD I-NP
kDa NN I-NP
protein NN I-NP
factor NN I-NP
to TO B-PP
the DT B-NP
SRE NN I-NP
sequence NN I-NP
. . O

Based VBN B-PP
upon IN B-PP
these DT B-NP
results NNS I-NP
we PRP B-NP
propose VBP B-VP
that IN B-SBAR
this DT B-NP
factor NN I-NP
may MD B-VP
have VB I-VP
a DT B-NP
role NN I-NP
in IN B-PP
pathophysiology NN B-NP
of IN B-PP
chronic JJ B-NP
myeloid JJ I-NP
leukaemia NN I-NP
. . O

Synergistic JJ B-NP
interactions NNS I-NP
between IN B-PP
overlapping VBG B-NP
binding VBG I-NP
sites NNS I-NP
for IN B-PP
the DT B-NP
serum NN I-NP
response NN I-NP
factor NN I-NP
and CC O
ELK-1 NN B-NP
proteins NNS I-NP
mediate VBP B-VP
both CC O
basal JJ B-NP
enhancement NN I-NP
and CC O
phorbol NN B-NP
ester NN I-NP
responsiveness NN I-NP
of IN B-PP
primate JJ B-NP
cytomegalovirus NN I-NP
major JJ I-NP
immediate-early JJ I-NP
promoters NNS I-NP
in IN B-PP
monocyte NN B-NP
and CC O
T-lymphocyte NN B-NP
cell NN B-NP
types NNS I-NP
. . O

Cytomegalovirus NN B-NP
( ( O
CMV NN B-NP
) ) O
infection NN B-NP
is VBZ B-VP
nonpermissive JJ B-ADJP
or CC O
persistent JJ B-ADJP
in IN B-PP
many JJ B-NP
lymphoid JJ I-NP
and CC I-NP
myeloid JJ I-NP
cell NN I-NP
types NNS I-NP
but CC O
can MD B-VP
be VB I-VP
activated VBN I-VP
in IN B-PP
differentiated VBN B-NP
macrophages NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
shown VBN I-VP
elsewhere RB B-ADVP
that IN B-SBAR
both CC O
the DT O
major JJ B-NP
immediate-early JJ I-NP
gene NN I-NP
( ( O
MIE NN B-NP
) ) O
and CC O
lytic JJ B-NP
cycle NN I-NP
infectious JJ I-NP
progeny NN I-NP
virus NN I-NP
expression NN B-NP
can MD B-VP
be VB I-VP
induced VBN I-VP
in IN B-PP
otherwise JJ B-ADVP
nonpermissive JJ B-NP
monocyte-like JJ I-NP
U-937 NN I-NP
cell NN I-NP
cultures NNS I-NP
infected VBN B-VP
with IN B-PP
either CC O
human JJ B-NP
CMV NN I-NP
( ( O
HCMV NN B-NP
) ) O
or CC O
simian JJ B-NP
CMV NN I-NP
( ( O
SCMV NN B-NP
) ) O
by IN B-PP
treatment NN B-NP
with IN B-PP
the DT B-NP
phorbol NN I-NP
ester NN I-NP
12-O-tetradecanoylphorbol-13-acetate NN I-NP
( ( O
TPA NN B-NP
) ) O
. . O

Two CD B-NP
multicopy JJ I-NP
basal JJ I-NP
enhancer NN I-NP
motifs NNS I-NP
within IN B-PP
the DT B-NP
SCMV NN I-NP
MIE NN I-NP
enhancer NN I-NP
COMMA COMMA B-NP
namely RB I-NP
COMMA COMMA O
11 CD B-NP
copies NNS I-NP
of IN B-PP
the DT B-NP
16-bp JJ I-NP
cyclic JJ B-NP
AMP NN I-NP
response NN I-NP
element NN I-NP
( ( O
CRE NN B-NP
) ) O
and CC O
3 CD B-NP
copies NNS I-NP
of IN B-PP
novel JJ O
17-bp JJ O
serum NN B-NP
response NN I-NP
factor NN I-NP
( ( O
SRF NN B-NP
) ) O
binding NN B-NP
sites NNS I-NP
referred VBN B-VP
to TO B-PP
as IN B-PP
the DT B-NP
SNE NN I-NP
( ( O
SRF\/NFkappaB-like JJ B-NP
element NN I-NP
) ) O
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
four CD B-NP
classical JJ I-NP
NFkappaB NN I-NP
sites NNS I-NP
within IN B-PP
the DT B-NP
HCMV NN I-NP
version NN I-NP
COMMA COMMA O
contribute VBP B-VP
to TO B-PP
TPA NN B-NP
responsiveness NN I-NP
in IN B-PP
transient JJ B-NP
assays NNS I-NP
in IN B-PP
monocyte NN B-NP
and CC O
T-cell NN B-NP
types NNS B-NP
. . O

The DT B-NP
SCMV NN I-NP
SNE NN I-NP
sites NNS I-NP
contain VBP B-VP
potential JJ B-NP
overlapping VBG I-NP
core NN I-NP
recognition NN I-NP
binding NN I-NP
motifs NNS I-NP
for IN B-PP
SRF NN B-NP
COMMA COMMA O
Rel\/NFkappaB NN B-NP
COMMA COMMA O
ETS NN B-NP
COMMA COMMA O
and CC O
YY1 NN B-NP
class NN B-NP
transcription NN I-NP
factors NNS I-NP
but CC O
fail VBP B-VP
to TO I-VP
respond VB I-VP
to TO B-PP
either CC O
serum NN B-NP
or CC O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
to TO B-VP
evaluate VB I-VP
the DT B-NP
mechanism NN I-NP
of IN B-PP
TPA NN B-NP
responsiveness NN I-NP
of IN B-PP
the DT B-NP
SNE NN I-NP
motifs NNS I-NP
and CC B-PP
of IN B-PP
a DT O
related JJ O
16-bp JJ O
SEE NN B-NP
( ( O
SRF\/ETS NN B-NP
element NN I-NP
) ) O
motif NN B-NP
found VBN B-VP
in IN B-PP
the DT O
HCMV NN B-NP
and CC O
chimpanzee NN B-NP
CMV NN I-NP
MIE NN B-NP
enhancers NNS I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
examined VBN I-VP
the DT B-NP
functional JJ B-NP
responses NNS I-NP
and CC O
protein NN B-NP
binding NN I-NP
properties NNS I-NP
of IN B-PP
multimerized JJ B-NP
wild-type JJ I-NP
and CC I-NP
mutant JJ I-NP
elements NNS I-NP
added VBN B-VP
upstream RB B-ADVP
to TO B-PP
the DT O
SCMV NN B-NP
MIE NN I-NP
or CC O
simian JJ B-NP
virus NN I-NP
40 CD B-NP
minimal JJ I-NP
promoter NN I-NP
regions NNS I-NP
in IN B-PP
the DT O
U-937 NN B-NP
COMMA COMMA O
K-562 NN B-NP
COMMA COMMA O
HL-60 NN B-NP
COMMA COMMA O
THP-1 NN B-NP
COMMA COMMA O
and CC O
Jurkat NN B-NP
cell NN B-NP
lines NNS I-NP
. . O

Unlike IN B-PP
classical JJ B-NP
NFkappaB NN I-NP
sites NNS I-NP
COMMA COMMA O
neither CC O
the DT B-NP
SNE NN I-NP
nor CC O
the DT B-NP
SEE NN I-NP
motif NN B-NP
responded VBD B-VP
to TO B-PP
phosphatase NN B-NP
inhibition NN I-NP
by IN B-PP
okadaic JJ B-NP
acid NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
TPA NN I-NP
responsiveness NN I-NP
of IN B-PP
both DT B-NP
CMV NN I-NP
elements NNS I-NP
proved VBD B-VP
to TO I-VP
involve VB I-VP
synergistic JJ B-NP
interactions NNS I-NP
between IN B-PP
the DT B-NP
core NN I-NP
SRF NN I-NP
binding NN I-NP
site NN I-NP
( ( O
CCATATATGG NN B-NP
) ) O
and CC O
the DT B-NP
adjacent JJ I-NP
inverted VBN I-NP
ETS NN I-NP
binding NN I-NP
motifs NNS I-NP
( ( O
TTCC NN B-NP
) ) O
COMMA COMMA O
which WDT B-NP
correlated VBD B-VP
directly RB B-ADVP
with IN B-PP
formation NN B-NP
of IN B-PP
a DT B-NP
bound VBN I-NP
tripartite JJ I-NP
complex NN I-NP
containing VBG B-VP
both CC O
the DT B-NP
cellular JJ I-NP
SRF NN I-NP
and CC O
ELK-1 NN B-NP
proteins NNS I-NP
. . O

This DT B-NP
protein NN I-NP
complex NN I-NP
was VBD B-VP
more RBR B-ADJP
abundant JJ I-ADJP
in IN B-PP
U-937 NN B-NP
COMMA COMMA O
K-562 NN B-NP
COMMA COMMA O
and CC O
HeLa NN B-NP
cell NN B-NP
extracts NNS I-NP
than IN B-PP
in IN B-PP
Raji NN B-NP
COMMA COMMA O
HF NN B-NP
COMMA COMMA O
BALB\/c NN B-NP
3T3 NN I-NP
COMMA COMMA O
or CC O
HL-60 NN B-NP
cells NNS B-NP
COMMA COMMA O
but CC O
the DT B-NP
binding NN I-NP
activity NN I-NP
was VBD B-VP
altered VBN I-VP
only RB B-ADVP
twofold RB I-ADVP
after IN B-PP
TPA NN B-NP
treatment NN I-NP
. . O

A DT B-NP
40-fold JJ I-NP
stimulation NN I-NP
of IN B-PP
chloramphenicol JJ B-NP
acetyltransferase NN I-NP
activity NN I-NP
mediated VBN B-VP
by IN B-PP
four CD B-NP
tandem JJ I-NP
repeats NNS I-NP
of IN B-PP
the DT B-NP
SNE NN I-NP
could MD B-VP
be VB I-VP
induced VBN I-VP
within IN B-PP
2 CD B-NP
h NN I-NP
( ( O
and CC O
up RB B-ADVP
to TO I-ADVP
250-fold JJ I-ADVP
within IN B-PP
6 CD B-NP
h NN I-NP
) ) O
after IN B-PP
addition NN B-NP
of IN B-PP
TPA NN B-NP
in IN B-PP
DNA-transfected JJ B-NP
U-937 NN I-NP
cells NNS I-NP
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
the DT B-NP
stimulation NN I-NP
appeared VBD B-VP
likely JJ B-ADJP
to TO B-VP
be VB I-VP
a DT B-NP
true JJ I-NP
protein NN I-NP
kinase NN I-NP
C-mediated JJ I-NP
signal NN I-NP
transduction NN I-NP
event NN I-NP
rather RB B-CONJP
than IN I-CONJP
a DT B-NP
differentiation NN I-NP
response NN I-NP
. . O

Slight JJ B-NP
differences NNS I-NP
in IN B-PP
the DT B-NP
sequence NN I-NP
of IN B-PP
the DT B-NP
core NN I-NP
SRF NN I-NP
binding NN I-NP
site NN I-NP
compared VBN B-PP
with IN B-PP
that DT B-NP
of IN B-PP
the DT B-NP
classical JJ I-NP
c-Fos NN I-NP
promoter NN I-NP
serum NN I-NP
response NN I-NP
element NN I-NP
COMMA COMMA O
together RB B-PP
with IN I-PP
differences NNS B-NP
in IN B-PP
the DT B-NP
spacing NN I-NP
between IN B-PP
the DT O
SRF NN B-NP
and CC O
ETS NN B-NP
motifs NNS B-NP
COMMA COMMA O
appear VBP B-VP
to TO I-VP
account VB I-VP
for IN B-PP
the DT B-NP
inability NN I-NP
of IN B-PP
the DT B-NP
SCMV NN I-NP
SNEs NNS I-NP
to TO B-VP
respond VB I-VP
to TO B-PP
serum NN B-NP
induction NN I-NP
. . O

Acetylsalicylic JJ B-NP
acid NN I-NP
and CC O
sodium NN B-NP
salicylate NN I-NP
inhibit VBP B-VP
LPS-induced JJ B-NP
NF-kappa NN I-NP
B\/c-Rel NN I-NP
nuclear JJ I-NP
translocation NN I-NP
COMMA COMMA O
and CC O
synthesis NN B-NP
of IN B-PP
tissue NN B-NP
factor NN I-NP
( ( O
TF NN B-NP
) ) O
and CC O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alfa NN I-NP
( ( O
TNF-alpha NN B-NP
) ) O
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
. . O

We PRP B-NP
have VBP B-VP
investigated VBN I-VP
the DT B-NP
effects NNS I-NP
of IN B-PP
acetylsalicylic JJ B-NP
acid NN I-NP
and CC O
sodium NN B-NP
salicylate NN I-NP
on IN B-PP
the DT B-NP
LPS-induced JJ I-NP
synthesis NN I-NP
of IN B-PP
the DT B-NP
pro-coagulant JJ I-NP
protein NN I-NP
tissue NN B-NP
factor NN I-NP
( ( O
TF NN B-NP
) ) O
and CC O
the DT B-NP
pro-inflammatory JJ I-NP
protein NN I-NP
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
( ( O
TNF-alpha NN B-NP
) ) O
COMMA COMMA O
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
the DT B-NP
prostaglandin NN I-NP
PGE2 NN I-NP
in IN B-PP
human JJ B-NP
monocytes NNS I-NP
. . O

Both DT B-NP
drugs NNS I-NP
dose-dependently RB B-ADVP
inhibited VBD B-VP
LPS-induced JJ O
TF NN B-NP
and CC O
TNF-alpha NN B-NP
synthesis NN B-NP
at IN B-PP
the DT B-NP
mRNA NN I-NP
and CC O
the DT B-NP
protein NN I-NP
level NN B-NP
COMMA COMMA O
and CC O
reduced VBD B-VP
PGE2 NN B-NP
production NN I-NP
. . O

As IN B-SBAR
evidenced VBN B-VP
by IN B-PP
electro NN B-NP
mobility NN I-NP
shift NN I-NP
assay NN I-NP
( ( O
EMSA NN B-NP
) ) O
and CC O
the DT B-NP
use NN I-NP
of IN B-PP
a DT B-NP
NF-kappa NN I-NP
B NN I-NP
prototypic JJ I-NP
probe NN I-NP
COMMA COMMA O
these DT B-NP
drugs NNS I-NP
probably RB B-ADVP
exert VBP B-VP
their PRP$ B-NP
inhibitory JJ I-NP
effects NNS I-NP
by IN B-PP
interference NN B-NP
with IN B-PP
the DT B-NP
nuclear JJ I-NP
translocation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B\/c-Rel NN I-NP
proteins NNS I-NP
. . O

These DT B-NP
data NNS I-NP
may MD B-VP
expand VB I-VP
the DT B-NP
understanding NN I-NP
of IN B-PP
the DT B-NP
anti-thrombotic JJ I-NP
and CC I-NP
anti-inflammatory JJ I-NP
effects NNS I-NP
of IN B-PP
these DT B-NP
drugs NNS I-NP
when WRB B-ADVP
activation NN B-NP
of IN B-PP
monocytes NNS B-NP
occurs VBZ B-VP
. . O

Octamer NN B-NP
independent JJ I-NP
activation NN I-NP
of IN B-PP
transcription NN B-NP
from IN B-PP
the DT B-NP
kappa NN I-NP
immunoglobulin NN I-NP
germline NN I-NP
promoter NN I-NP
. . O

Previous JJ B-NP
analyses NNS I-NP
of IN B-PP
immunoglobulin NN B-NP
V JJ I-NP
region NN I-NP
promoters NNS I-NP
has VBZ B-VP
led VBN I-VP
to TO B-PP
the DT B-NP
discovery NN I-NP
of IN B-PP
a DT B-NP
common JJ I-NP
octamer NN I-NP
motif NN I-NP
which WDT B-NP
is VBZ B-VP
functionally RB B-ADVP
important JJ B-ADJP
in IN B-PP
the DT B-NP
tissue-specific JJ I-NP
and CC I-NP
developmentally RB I-NP
regulated VBN I-NP
transcriptional JJ I-NP
activation NN I-NP
of IN B-PP
immunoglobulin NN B-NP
genes NNS I-NP
. . O

The DT B-NP
germline NN I-NP
promoters NNS I-NP
( ( O
Ko NN B-NP
) ) O
located JJ B-ADJP
upstream RB I-ADJP
of IN B-PP
the DT B-NP
J JJ I-NP
region NN I-NP
gene NN I-NP
segments NNS I-NP
of IN B-PP
the DT B-NP
kappa NN I-NP
locus NN I-NP
also RB B-ADVP
contain VBP B-VP
an DT B-NP
octamer NN I-NP
motif NN I-NP
( ( O
containing VBG B-VP
a DT B-NP
single JJ I-NP
base NN I-NP
pair NN I-NP
mutation NN I-NP
and CC O
referred VBN B-VP
to TO B-PP
as IN B-PP
the DT B-NP
variant JJ I-NP
octamer NN I-NP
) ) O
which WDT B-NP
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
previously RB I-VP
to TO I-VP
bind VB I-VP
Oct-1 NN B-NP
and CC O
Oct-2 NN B-NP
transcription NN B-NP
factors NNS I-NP
in FW B-ADVP
vitro FW I-ADVP
. . O

To TO B-VP
further RB I-VP
elucidate VB I-VP
the DT B-NP
role NN I-NP
of IN B-PP
this DT B-NP
variant JJ I-NP
octamer NN I-NP
motif NN I-NP
in IN B-PP
the DT B-NP
regulation NN I-NP
of IN B-PP
germline NN B-NP
transcription NN I-NP
from IN B-PP
the DT B-NP
unrearranged JJ I-NP
kappa NN I-NP
locus NN I-NP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
quantitated VBN I-VP
the DT B-NP
relative JJ I-NP
binding NN I-NP
affinity NN I-NP
of IN B-PP
Oct-1 NN B-NP
and CC O
Oct-2 NN B-NP
for IN B-PP
the DT B-NP
variant JJ I-NP
octamer NN I-NP
motif NN I-NP
and CC O
determined VBD B-VP
the DT B-NP
functional JJ I-NP
role NN I-NP
of IN B-PP
this DT B-NP
octamer NN I-NP
motif NN I-NP
in IN B-PP
transcriptional JJ B-NP
activation NN I-NP
. . O

We PRP B-NP
find VBP B-VP
that IN B-SBAR
COMMA COMMA O
although IN B-SBAR
the DT B-NP
variant JJ I-NP
octamer NN I-NP
motif NN I-NP
binds VBZ B-VP
Oct-1 NN B-NP
and CC O
Oct-2 NN B-NP
in FW B-ADVP
vitro FW I-ADVP
with IN B-PP
5-fold JJ B-NP
lower JJR I-NP
affinity NN I-NP
than IN B-PP
the DT B-NP
consensus NN I-NP
octamer NN I-NP
motif NN I-NP
COMMA COMMA O
mutation NN B-NP
of IN B-PP
the DT B-NP
variant JJ I-NP
octamer NN I-NP
motif NN I-NP
to TO B-PP
either CC O
a DT O
consensus NN B-NP
octamer NN I-NP
or CC O
non-octamer JJ B-ADJP
motif NN B-NP
has VBZ B-VP
no DT B-NP
effect NN I-NP
on IN B-PP
transcriptional JJ B-NP
activation NN I-NP
from IN B-PP
the DT B-NP
germline NN I-NP
promoter NN I-NP
. . O

We PRP B-NP
also RB B-ADVP
find VBP B-VP
significant JJ B-NP
differences NNS I-NP
in IN B-PP
activation NN B-NP
of IN B-PP
germline NN B-NP
and CC O
V JJ B-NP
region NN I-NP
promoters NNS B-NP
by IN B-PP
kappa NN B-NP
enhancers NNS I-NP
. . O

Our PRP$ B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
germline NN B-NP
promoters NNS I-NP
and CC O
V JJ B-NP
region NN I-NP
promoters NNS I-NP
differ VBP B-VP
in IN B-PP
their PRP$ B-NP
dependence NN I-NP
on IN B-PP
octamer NN B-NP
for IN B-PP
activation NN B-NP
and CC O
respond VBP B-VP
differently RB B-ADVP
to TO B-PP
enhancer NN B-NP
activation NN I-NP
. . O

These DT B-NP
findings NNS I-NP
have VBP B-VP
important JJ B-NP
implications NNS I-NP
in IN B-PP
regulation NN B-NP
of IN B-PP
germline NN B-NP
transcription NN I-NP
as RB B-CONJP
well RB I-CONJP
as IN I-CONJP
concomitant JJ B-NP
activation NN I-NP
of IN B-PP
the DT B-NP
V-J JJ I-NP
recombination NN I-NP
of IN B-PP
the DT B-NP
kappa NN I-NP
light JJ I-NP
chain NN I-NP
locus NN I-NP
. . O

Characterization NN B-NP
of IN B-PP
the DT B-NP
murine JJ I-NP
cyclin-dependent JJ I-NP
kinase NN I-NP
inhibitor NN I-NP
gene NN I-NP
p27Kip1 NN I-NP
. . O

The DT B-NP
cyclin-dependent JJ I-NP
kinase NN I-NP
inhibitor NN I-NP
p27Kip1 NN I-NP
plays VBZ B-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
regulating VBG B-VP
cell-cycle JJ B-NP
progression NN I-NP
. . O

p27Kip1 NN B-NP
directly RB B-ADVP
inhibits VBZ B-VP
the DT B-NP
catalytic JJ I-NP
activity NN I-NP
of IN B-PP
cyclin\/cdks NNS O
( ( O
cyclin-dependent JJ B-NP
kinase NN I-NP
) ) O
complexes NNS B-NP
and\/or CC O
interferes VBZ B-VP
physically RB B-ADVP
with IN B-PP
cyclin\/cdks NN B-NP
activation NN I-NP
by IN B-PP
CAK NN B-NP
. . O

Interestingly RB B-ADVP
COMMA COMMA O
the DT B-NP
expression NN I-NP
level NN I-NP
of IN B-PP
p27Kip1 NN B-NP
mRNA NN I-NP
was VBD B-VP
maximal JJ B-ADJP
in IN B-PP
resting VBG B-NP
Go NN I-NP
T-cells NNS I-NP
and CC O
rapidly RB B-VP
declined VBD I-VP
following VBG B-PP
anti-CD3 JJ B-NP
activation NN I-NP
. . O

We PRP B-NP
report VBP B-VP
here RB B-ADVP
the DT B-NP
cloning NN I-NP
of IN B-PP
p27Kip1 NN B-NP
gene NN I-NP
from IN B-PP
murine JJ B-NP
genomic JJ I-NP
DNA NN I-NP
and CC O
the DT B-NP
functional JJ I-NP
analysis NN I-NP
of IN B-PP
the DT B-NP
promoter NN I-NP
of IN B-PP
the DT B-NP
p27Kip1 NN I-NP
gene NN I-NP
. . O

The DT B-NP
gene NN I-NP
consists VBZ B-VP
of IN B-PP
at IN B-NP
least JJS I-NP
three CD I-NP
exons NNS I-NP
and CC O
spans NNS B-VP
more RBR B-NP
than IN I-NP
5.6 CD I-NP
kb NN I-NP
of IN B-PP
DNA NN B-NP
. . O

Primer NN B-NP
extension NN I-NP
and CC O
nuclease NN B-NP
S1 NN I-NP
protection NN I-NP
analysis NN B-NP
revealed VBD B-VP
two CD B-NP
major JJ I-NP
transcription NN I-NP
initiation NN I-NP
sites NNS I-NP
. . O

The DT B-NP
promoter NN I-NP
region NN I-NP
lacked VBD B-VP
a DT B-NP
TATA NN I-NP
box NN I-NP
but CC O
contained VBD B-VP
potential JJ B-NP
binding VBG I-NP
sites NNS I-NP
for IN B-PP
the DT B-NP
transcriptional JJ I-NP
factors NNS I-NP
including VBG B-PP
two CD B-NP
Sp1 NN I-NP
COMMA COMMA O
CRE NN B-NP
COMMA COMMA O
Myb NN B-NP
and CC O
NFkB NN B-NP
located JJ B-ADJP
at IN B-PP
positions NNS B-NP
-153 CD B-NP
COMMA COMMA O
-178 CD B-NP
COMMA COMMA O
-286 CD B-NP
COMMA COMMA O
-875 CD B-NP
COMMA COMMA O
and CC O
-1011 CD B-NP
COMMA COMMA O
respectively RB B-ADVP
. . O

To TO B-VP
analyze VB I-VP
the DT B-NP
regulatory JJ I-NP
mechanisms NNS I-NP
controlling VBG B-VP
p27Kip1 NN B-NP
gene NN I-NP
expression NN I-NP
COMMA COMMA O
we PRP B-NP
characterized VBD B-VP
the DT B-NP
5'-flanking JJ I-NP
region NN I-NP
from IN B-PP
nt NN B-NP
-1609 CD I-NP
to TO B-PP
+178 CD B-NP
. . O

The DT B-NP
-326 CD I-NP
to TO I-NP
-615 CD I-NP
region NN I-NP
contained VBD B-VP
positive JJ B-NP
regulatory JJ I-NP
elements NNS I-NP
. . O

Glucocorticoid-mediated JJ B-NP
inhibition NN I-NP
of IN B-PP
RANTES NN B-NP
expression NN I-NP
in IN B-PP
human JJ B-NP
T NN I-NP
lymphocytes NNS I-NP
. . O

The DT B-NP
chemokine NN I-NP
RANTES NN I-NP
has VBZ B-VP
been VBN I-VP
implicated VBN I-VP
in IN B-PP
the DT B-NP
pathogenesis NN I-NP
of IN B-PP
allergic JJ B-NP
inflammatory JJ I-NP
diseases NNS I-NP
including VBG B-PP
asthma NN B-NP
and CC O
rhinitis NN B-NP
which WDT B-NP
are VBP B-VP
frequently RB I-VP
treated VBN I-VP
with IN B-PP
glucocorticoids NNS B-NP
. . O

We PRP B-NP
observed VBD B-VP
that IN B-SBAR
dexamethasone NN B-NP
dramatically RB B-ADVP
inhibited VBD B-VP
RANTES NN B-NP
mRNA NN I-NP
expression NN I-NP
dose NN B-ADVP
dependently RB I-ADVP
in IN B-PP
anti-CD3 NN B-NP
activated JJ I-NP
Hut-78 NN I-NP
T NN I-NP
cells NNS I-NP
and CC O
human JJ B-NP
PBMCs NNS I-NP
. . O

Inhibition NN B-NP
of IN B-PP
RANTES NNS B-NP
expression NN I-NP
did VBD B-VP
not RB I-VP
appear VB I-VP
to TO I-VP
be VB I-VP
secondary JJ B-ADJP
to TO B-PP
IL-2 NN B-NP
inhibition NN I-NP
and CC O
required VBD B-VP
binding VBG B-NP
to TO B-PP
the DT B-NP
intracellular JJ I-NP
glucocorticoid NN I-NP
receptor NN I-NP
. . O

The DT B-NP
down-regulation NN I-NP
of IN B-PP
RANTES NN B-NP
expression NN I-NP
by IN B-PP
glucocorticoids NNS B-NP
in IN B-PP
T NN B-NP
cells NNS I-NP
may MD B-VP
directly RB I-VP
contribute VB I-VP
to TO B-PP
the DT B-NP
efficacy NN I-NP
of IN B-PP
these DT B-NP
agents NNS I-NP
in IN B-PP
suppressing VBG B-VP
cellular JJ B-NP
infiltration NN I-NP
and CC B-PP
to TO B-PP
their PRP$ B-NP
anti-inflammatory JJ I-NP
properties NNS I-NP
. . O

A DT B-NP
novel JJ I-NP
SP-1 NN I-NP
site NN I-NP
in IN B-PP
the DT B-NP
human JJ I-NP
interleukin-1 NN I-NP
beta NN I-NP
promoter NN I-NP
confers VBZ B-VP
preferential JJ B-NP
transcriptional JJ I-NP
activity NN I-NP
in IN B-PP
keratinocytes NNS B-NP
. . O

To TO B-VP
investigate VB I-VP
the DT B-NP
mechanisms NNS I-NP
of IN B-PP
transcriptional JJ B-NP
activation NN I-NP
of IN B-PP
interleukin-1beta NN B-NP
( ( O
IL-1beta NN B-NP
) ) O
in IN B-PP
non-monocytic JJ B-NP
cells NNS I-NP
COMMA COMMA O
we PRP B-NP
constructed VBD B-VP
a DT B-NP
series NN I-NP
of IN B-PP
reporter NN B-NP
plasmids NNS I-NP
with IN B-PP
the DT B-NP
bacterial JJ I-NP
chloramphenicol NN I-NP
acetyltransferase NN I-NP
gene NN I-NP
linked VBN B-VP
to TO B-PP
various JJ B-NP
parts NNS I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
IL-1beta NN I-NP
promoter NN I-NP
and CC O
performed VBD B-VP
transient JJ B-NP
transfection NN I-NP
experiments NNS I-NP
. . O

We PRP B-NP
identified VBD B-VP
a DT B-NP
promoter NN I-NP
segment NN I-NP
that WDT B-NP
activates VBZ B-VP
transcription NN B-NP
most RBS B-ADVP
efficiently RB I-ADVP
in IN B-PP
keratinocytes NNS B-NP
. . O

Electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
( ( O
EMSA NN B-NP
) ) O
with IN B-PP
a DT B-NP
43-mer NN I-NP
oligonucleotide NN I-NP
derived VBN B-VP
from IN B-PP
the DT B-NP
functionally RB I-NP
identified VBN I-NP
cis-acting JJ I-NP
element NN I-NP
revealed VBD B-VP
specific JJ B-NP
complexes NNS I-NP
. . O

By IN B-PP
competition NN B-NP
analysis NN I-NP
with IN B-PP
transcription NN B-NP
factor NN I-NP
consensus NN I-NP
sequence NN I-NP
oligonucleotides NNS I-NP
and CC B-PP
by IN B-PP
immunosupershift NN B-NP
COMMA COMMA O
transcription NN B-NP
factor NN I-NP
SP-1 NN I-NP
or CC O
a DT B-NP
closely RB I-NP
related JJ I-NP
protein NN I-NP
was VBD B-VP
shown VBN I-VP
to TO I-VP
bind VBP I-VP
to TO B-PP
this DT B-NP
regulatory JJ I-NP
element NN I-NP
. . O

The DT B-NP
closest JJS I-NP
match NN I-NP
to TO B-PP
the DT B-NP
known VBN I-NP
SP-1 NN I-NP
consensus NN I-NP
sequence NN I-NP
within IN B-PP
the DT B-NP
respective JJ I-NP
region NN I-NP
is VBZ B-VP
a DT B-NP
TCCCCTCCCCT NN I-NP
motif NN I-NP
. . O

Mutation NN B-NP
of IN B-PP
this DT B-NP
motif NN I-NP
almost RB B-ADVP
completely RB I-ADVP
COMMA COMMA O
and CC O
specifically RB B-ADVP
COMMA COMMA B-VP
abolished VBD I-VP
the DT B-NP
binding NN I-NP
of IN B-PP
two CD B-NP
low-mobility JJ I-NP
complexes NNS I-NP
and CC O
led VBD B-VP
to TO B-PP
a DT B-NP
95 CD I-NP
% NN I-NP
decrease NN I-NP
of IN B-PP
constitutive JJ B-NP
transcriptional JJ I-NP
activation NN I-NP
of IN B-PP
a DT B-NP
reporter NN I-NP
construct NN I-NP
IL-1beta NN I-NP
( ( O
-170\/+108 CD B-NP
) ) O
. . O

Likewise RB B-ADVP
COMMA COMMA O
activation NN B-NP
of IN B-PP
this DT B-NP
reporter NN I-NP
construct NN I-NP
by IN B-PP
tumor NN B-NP
necrosis NN I-NP
factor-alpha NN I-NP
depended VBD B-VP
on IN B-PP
the DT B-NP
SP-1 NN I-NP
site NN I-NP
. . O

These DT B-NP
observations NNS I-NP
suggest VBP B-VP
that IN B-SBAR
a DT B-NP
so-far-unrecognized JJ I-NP
SP-1 NN I-NP
site NN I-NP
in IN B-PP
the DT B-NP
human JJ I-NP
IL-1beta NN I-NP
promoter NN I-NP
may MD B-VP
participate VB I-VP
in IN B-PP
the DT B-NP
transcriptional JJ I-NP
regulation NN I-NP
of IN B-PP
this DT B-NP
gene NN I-NP
in IN B-PP
keratinocytes NNS B-NP
. . O

Effects NNS B-NP
of IN B-PP
glucocorticoids NNS B-NP
on IN B-PP
lymphocyte NN B-NP
activation NN I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
steroid-sensitive JJ B-NP
and CC I-NP
steroid-resistant JJ I-NP
asthma NN I-NP
. . O

BACKGROUND NN B-NP
: : O
Glucocorticoids NNS B-NP
are VBP B-VP
important JJ B-NP
medications NNS I-NP
used VBN B-VP
to TO B-VP
control VB I-VP
the DT B-NP
airway NN I-NP
inflammation NN I-NP
associated VBN B-VP
with IN B-PP
asthma NN B-NP
. . O

Synthetic JJ B-NP
glucocorticoids NNS I-NP
vary VBP B-VP
in IN B-PP
their PRP$ B-NP
binding NN I-NP
affinity NN I-NP
for IN B-PP
the DT B-NP
glucocorticoid NN I-NP
receptor NN I-NP
( ( O
GCR NN B-NP
) ) O
. . O

METHODS NNS B-NP
: : O
We PRP B-NP
compared VBD B-VP
hydrocortisone NN B-NP
COMMA COMMA O
beclomethasone NN B-NP
dipropionate NN I-NP
COMMA COMMA O
triamcinolone NN B-NP
acetonide NN I-NP
COMMA COMMA O
flunisolide NN B-NP
COMMA COMMA O
and CC O
budesonide NN B-NP
with IN B-PP
regard NN B-NP
to TO B-PP
their PRP$ B-NP
capacity NN I-NP
to TO B-VP
inhibit VB I-VP
phytohemagglutinin-induced JJ B-NP
peripheral JJ I-NP
blood NN I-NP
mononuclear JJ I-NP
cell NN I-NP
proliferation NN I-NP
from IN B-PP
six CD B-NP
patients NNS I-NP
with IN B-PP
steroid-sensitive JJ B-NP
asthma NN I-NP
and CC O
seven CD B-NP
patients NNS I-NP
with IN B-PP
steroid-resistant JJ B-NP
asthma NN I-NP
. . O

Peripheral JJ B-NP
blood NN I-NP
mononuclear JJ I-NP
cell NN I-NP
GCR NN I-NP
binding NN I-NP
affinities NNS I-NP
for IN B-PP
dexamethasone NN B-NP
and CC O
budesonide NN B-NP
were VBD B-VP
also RB I-VP
determined VBN I-VP
for IN B-PP
both DT B-NP
patient NN I-NP
groups NNS I-NP
by IN B-PP
using VBG B-VP
a DT B-NP
radioligand NN I-NP
binding NN I-NP
assay NN I-NP
and CC O
Scatchard NN B-NP
analysis NN I-NP
. . O

RESULTS NNS B-NP
: : O
Dose-dependent JJ B-NP
inhibition NN I-NP
was VBD B-VP
demonstrated VBN I-VP
for IN B-PP
all DT B-NP
glucocorticoids NNS I-NP
in IN B-PP
both DT B-NP
patient NN I-NP
groups NNS I-NP
COMMA COMMA O
with IN B-PP
the DT B-NP
steroid-resistant JJ I-NP
group NN I-NP
requiring VBG B-VP
approximately RB B-NP
2 CD I-NP
log-fold JJ I-NP
more JJR I-NP
glucocorticoids NNS I-NP
for IN B-PP
an DT B-NP
equivalent JJ I-NP
degree NN I-NP
of IN B-PP
inhibition NN B-NP
. . O

The DT B-NP
mean NN I-NP
concentrations NNS I-NP
necessary JJ B-ADJP
to TO B-VP
cause VB I-VP
50 CD B-NP
% NN I-NP
inhibition NN I-NP
of IN B-PP
lymphocyte NN B-NP
proliferation NN I-NP
( ( O
IC50s NNS B-NP
) ) O
for IN B-PP
the DT B-NP
steroid-sensitive JJ I-NP
group NN I-NP
ranged VBD B-VP
from IN B-PP
2 CD B-NP
x CC I-NP
10(-10) CD I-NP
mol\/L NN I-NP
for IN B-PP
budesonide NN B-NP
to TO B-PP
7 CD B-NP
x CC I-NP
10(-8) CD I-NP
mol\/L NN I-NP
for IN B-PP
hydrocortisone NN B-NP
COMMA COMMA O
whereas IN O
the DT B-NP
mean NN I-NP
IC50s NNS I-NP
for IN B-PP
the DT B-NP
steroid-resistant JJ I-NP
group NN I-NP
ranged VBD B-VP
from IN B-PP
approximately RB B-NP
2 CD I-NP
x CC I-NP
10(-8) CD I-NP
mol\/L NN I-NP
for IN B-PP
budesonide NN B-NP
to TO B-PP
greater JJR B-NP
than IN I-NP
10(-6) CD I-NP
mol\/L NN I-NP
for IN B-PP
hydrocortisone NN B-NP
. . O

In IN B-PP
addition NN B-NP
COMMA COMMA O
a DT B-NP
significant JJ I-NP
correlation NN I-NP
was VBD B-VP
noted VBN I-VP
between IN B-PP
the DT B-NP
degree NN I-NP
of IN B-PP
inhibition NN B-NP
of IN B-PP
lymphocyte NN B-NP
proliferation NN I-NP
( ( O
IC50 NN B-NP
) ) O
and CC O
the DT B-NP
binding NN I-NP
affinity NN I-NP
of IN B-PP
dexamethasone NN B-NP
to TO B-PP
the DT B-NP
GCR NN I-NP
. . O

Patients NNS B-NP
with IN B-PP
steroid-resistant JJ B-NP
asthma NN I-NP
have VBP B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
have VB I-VP
a DT B-NP
reduced VBN I-NP
GCR NN I-NP
binding NN I-NP
affinity NN I-NP
. . O

The DT B-NP
GCR NN I-NP
binding NN I-NP
affinity NN I-NP
for IN B-PP
budesonide NN B-NP
was VBD B-VP
significantly RB B-ADJP
higher JJR I-ADJP
in IN B-PP
both DT B-NP
groups NNS I-NP
( ( O
i.e. FW B-ADVP
COMMA COMMA O
lower JJR B-NP
dissociation NN I-NP
constant NN I-NP
) ) O
than IN B-PP
that DT B-NP
obtained VBN B-VP
for IN B-PP
dexamethasone NN B-NP
. . O

CONCLUSION NN B-NP
: : O
These DT B-NP
data NNS I-NP
suggest VBP B-VP
that IN B-SBAR
glucocorticoids NNS B-NP
such JJ B-PP
as IN I-PP
budesonide NN B-NP
COMMA COMMA O
by IN B-PP
virtue NN I-PP
of IN I-PP
their PRP$ B-NP
high JJ B-NP
GCR NN I-NP
binding NN I-NP
affinities NNS I-NP
and CC O
greater JJR B-NP
ability NN I-NP
to TO B-VP
suppress VB I-VP
lymphocyte NN B-NP
proliferation NN I-NP
COMMA COMMA O
may MD B-VP
therefore RB I-VP
be VB I-VP
beneficial JJ B-ADJP
in IN B-PP
the DT B-NP
management NN I-NP
of IN B-PP
difficult-to-control JJ B-NP
asthma NN I-NP
. . O

Involvement NN B-NP
of IN B-PP
nuclear JJ B-NP
factor-kappa NN I-NP
B NN I-NP
activation NN I-NP
in IN B-PP
IgE NN B-NP
synthesis NN I-NP
in IN B-PP
human JJ B-NP
B NN I-NP
cells NNS I-NP
. . O

Nuclear JJ B-NP
factor-kappa NN I-NP
B NN I-NP
( ( O
NF-kappa NN B-NP
B NN I-NP
) ) O
is VBZ B-VP
a DT B-NP
transcription NN I-NP
factor NN I-NP
that WDT B-NP
binds VBZ B-VP
to TO B-PP
the DT B-NP
consensus NN I-NP
DNA NN I-NP
sequence NN I-NP
in IN B-PP
the DT B-NP
cis-acting JJ I-NP
elements NNS I-NP
of IN B-PP
various JJ B-NP
genes NNS I-NP
. . O

Although IN B-SBAR
NF-kappa NN B-NP
B NN I-NP
activates VBZ B-VP
the DT B-NP
expression NN I-NP
of IN B-PP
many JJ B-NP
genes NNS I-NP
involved VBN B-VP
in IN B-PP
immune JJ B-NP
and CC I-NP
inflammatory JJ I-NP
responses NNS I-NP
COMMA COMMA O
little JJ B-NP
is VBZ B-VP
known VBN I-VP
about IN B-PP
the DT B-NP
role NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
in IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
IgE NN B-NP
synthesis NN I-NP
in IN B-PP
human JJ B-NP
B NN I-NP
cells NNS I-NP
. . O

Therefore RB B-ADVP
we PRP B-NP
first RB B-ADVP
examined VBD B-VP
the DT B-NP
participation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
in IN B-PP
germline NN B-NP
C NN I-NP
epsilon NN I-NP
transcription NN I-NP
in IN B-PP
a DT B-NP
human JJ I-NP
Burkitt NN I-NP
lymphoma NN I-NP
B NN I-NP
cell NN I-NP
line NN I-NP
COMMA COMMA O
DND39 NN B-NP
. . O

Stimulation NN B-NP
of IN B-PP
DND39 NN B-NP
cells NNS I-NP
with IN B-PP
IL-4 NN B-NP
or CC O
anti-CD40 JJ B-NP
monoclonal JJ B-NP
antibody NN I-NP
( ( O
mAb NN B-NP
) ) O
activated VBD B-VP
phosphatidylinositol NN B-NP
3-kinase NN I-NP
and CC O
subsequently RB B-VP
induced VBD I-VP
nuclear JJ B-NP
expression NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
which WDT B-NP
was VBD B-VP
identified VBN I-VP
by IN B-PP
electrophoretic JJ B-NP
mobility NN I-NP
shift NN I-NP
assays NNS I-NP
. . O

n-Acetyl-L-cysteine NN B-NP
( ( O
NAC NN B-NP
) ) O
COMMA COMMA O
a DT B-NP
potent JJ I-NP
antioxidant NN I-NP
COMMA COMMA O
blocked VBD B-VP
NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
caused VBN B-VP
by IN B-PP
IL-4 NN B-NP
and CC B-PP
by IN B-PP
anti-CD40 JJ B-NP
mAb NN I-NP
. . O

Although IN B-SBAR
inhibition NN B-NP
of IN B-PP
IL-4-driven JJ B-NP
germline NN I-NP
C NN I-NP
epsilon NN I-NP
transcription NN I-NP
by IN B-PP
NAC NN B-NP
was VBD B-VP
not RB O
sufficient JJ B-ADJP
COMMA COMMA O
the DT B-NP
agent NN I-NP
remarkably RB B-ADVP
diminished VBD B-VP
anti-CD40 JJ B-NP
mAb-mediated JJ I-NP
up-regulation NN I-NP
of IN B-PP
germline NN B-NP
C NN I-NP
epsilon NN I-NP
transcription NN I-NP
. . O

Second RB B-ADVP
COMMA COMMA O
we PRP B-NP
studied VBD B-VP
the DT B-NP
effect NN I-NP
of IN B-PP
NAC NN B-NP
on IN B-PP
IgE NN B-NP
synthesis NN I-NP
in IN B-PP
human JJ B-NP
normal JJ I-NP
B NN I-NP
cells NNS I-NP
costimulated VBN B-VP
with IN B-PP
IL-4 NN B-NP
and CC O
anti-CD40 JJ B-NP
mAb NN I-NP
. . O

NAC NN B-NP
was VBD B-VP
effective JJ B-ADJP
in IN B-PP
inhibiting VBG B-VP
mature JJ B-NP
C NN I-NP
epsilon NN I-NP
transcription NN I-NP
and CC O
IgE NN B-NP
synthesis NN I-NP
in IN B-PP
the DT B-NP
T NN I-NP
cell-independent JJ I-NP
culture NN I-NP
system NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
NAC NN B-NP
did VBD B-VP
not RB I-VP
significantly RB I-VP
affect VB I-VP
the DT B-NP
spontaneous JJ I-NP
production NN I-NP
of IN B-PP
IgE NN B-NP
by IN B-PP
atopic JJ B-NP
B NN I-NP
cells NNS I-NP
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
NF-kappa NN B-NP
B NN I-NP
activity NN I-NP
is VBZ B-VP
commonly RB B-ADVP
inducible JJ B-ADJP
in IN B-PP
DND39 NN B-NP
cells NNS I-NP
by IN B-PP
IL-4 NN B-NP
and CC O
anti-CD40 JJ B-NP
mAb NN I-NP
and CC O
suggest VBP B-VP
that IN B-SBAR
NF-kappa NN B-NP
B NN I-NP
sensitive JJ B-ADJP
to TO B-PP
NAC NN B-NP
may MD B-VP
play VB I-VP
a DT B-NP
role NN I-NP
in IN B-PP
regulating VBG B-VP
IgE NN B-NP
synthesis NN I-NP
in IN B-PP
B NN B-NP
cells NNS I-NP
. . O

{ ( O
Molecular JJ B-NP
mechanisms NNS I-NP
of IN B-PP
age-related JJ B-NP
lymphocyte NN I-NP
dysfunction NN I-NP
} ) O

Aging NN B-NP
is VBZ B-VP
classically RB I-VP
accompanied VBN I-VP
by IN B-PP
a DT B-NP
dysregulation NN I-NP
of IN B-PP
the DT B-NP
immunologic JJ I-NP
machinery NN I-NP
. . O

As IN B-PP
a DT B-NP
consequence NN I-NP
COMMA COMMA O
the DT B-NP
immune JJ I-NP
response NN I-NP
developed VBN B-VP
in IN B-PP
senescent JJ B-NP
organisms NNS I-NP
is VBZ B-VP
usually RB B-ADVP
inappropriate JJ B-ADJP
COMMA COMMA O
often RB B-ADVP
inefficient JJ B-ADJP
COMMA COMMA O
sometimes RB B-ADVP
aberrant JJ B-ADJP
COMMA COMMA O
and CC O
potentially RB B-ADVP
detrimental JJ B-ADJP
. . O

The DT B-NP
age-associated JJ I-NP
immune JJ I-NP
dysfunction NN I-NP
may MD B-VP
be VB I-VP
implicated VBN I-VP
to TO B-PP
some DT B-NP
degree NN I-NP
in IN B-PP
the DT B-NP
extreme JJ I-NP
susceptibility NN I-NP
of IN B-PP
the DT B-NP
elderly JJ I-NP
to TO B-PP
infection NN B-NP
and CC O
neoplasia NN B-NP
and CC O
may MD B-VP
even RB I-VP
participate VB I-VP
in IN B-PP
various JJ B-NP
aspects NNS I-NP
of IN B-PP
senescence NN B-NP
. . O

The DT B-NP
current JJ I-NP
understanding NN I-NP
of IN B-PP
the DT B-NP
molecular JJ I-NP
mechanisms NNS I-NP
underlying VBG B-VP
immunosenescence NN B-NP
is VBZ B-VP
still RB B-ADVP
fragmentary JJ B-ADJP
. . O

The DT O
most RBS B-ADVP
extensively RB I-ADVP
studied VBN B-NP
phenomenon NN I-NP
is VBZ B-VP
the DT B-NP
progressive JJ I-NP
decline NN I-NP
in IN B-PP
the DT B-NP
proliferative JJ I-NP
capacities NNS I-NP
of IN B-PP
T NN B-NP
lymphocytes NNS I-NP
with IN B-PP
aging NN B-NP
. . O

The DT B-NP
loss NN I-NP
of IN B-PP
proliferative JJ B-NP
potential NN I-NP
in IN B-PP
response NN I-PP
to TO I-PP
antigenic JJ B-NP
challenge NN I-NP
is VBZ B-VP
a DT B-NP
characteristic JJ I-NP
feature NN I-NP
of IN B-PP
immune JJ B-NP
senescence NN I-NP
. . O

It PRP B-NP
is VBZ B-VP
directly RB I-VP
implicated VBN I-VP
in IN B-PP
the DT B-NP
emergence NN I-NP
of IN B-PP
the DT B-NP
age-related JJ I-NP
immune JJ I-NP
deficiency NN I-NP
. . O

The DT B-NP
purpose NN I-NP
of IN B-PP
this DT B-NP
review NN I-NP
is VBZ B-VP
to TO B-VP
show VB I-VP
how WRB B-ADVP
the DT B-NP
accumulation NN I-NP
of IN B-PP
various JJ B-NP
biochemical JJ I-NP
lesions NNS I-NP
with IN B-PP
advancing VBG B-NP
age NN I-NP
leads VBZ B-VP
to TO B-PP
the DT B-NP
failure NN I-NP
of IN B-PP
a DT B-NP
critical JJ I-NP
cell NN I-NP
function NN I-NP
COMMA COMMA B-NP
namely RB I-NP
the DT B-NP
activation-induced JJ I-NP
lymphocyte NN I-NP
proliferation NN I-NP
. . O

The DT B-NP
biochemical JJ I-NP
modifications NNS I-NP
responsible JJ B-ADJP
for IN B-PP
the DT B-NP
defect NN I-NP
in IN B-PP
transduction NN B-NP
and CC O
execution NN B-NP
of IN B-PP
the DT B-NP
proliferative JJ I-NP
signal NN I-NP
are VBP B-VP
analyzed VBN I-VP
as IN B-PP
a DT B-NP
function NN I-NP
of IN B-PP
age NN B-NP
. . O

The DT B-NP
multiple JJ I-NP
alterations NNS I-NP
observed VBN B-VP
on IN B-PP
the DT B-NP
various JJ I-NP
biochemical JJ I-NP
pathways NNS I-NP
may MD B-VP
appear VB I-VP
as IN B-PP
a DT B-NP
consequence NN I-NP
of IN B-PP
a DT B-NP
unique JJ I-NP
deleterious JJ I-NP
mechanism NN I-NP
more RBR B-ADJP
fundamentally RB I-ADJP
related JJ I-ADJP
to TO B-PP
the DT B-NP
process NN I-NP
of IN B-PP
senescence NN B-NP
such JJ B-PP
as IN I-PP
the DT B-NP
inability NN I-NP
to TO B-VP
cope VB I-VP
with IN B-PP
oxidative JJ B-NP
stress NN I-NP
. . O

Stimulation NN B-NP
of IN B-PP
human JJ B-NP
peripheral JJ I-NP
blood NN I-NP
mononuclear JJ I-NP
cells NNS I-NP
by IN B-PP
zinc NN B-NP
and CC O
related JJ B-NP
cations NNS I-NP
. . O

Zinc NN B-NP
is VBZ B-VP
an DT B-NP
important JJ I-NP
trace NN I-NP
element NN I-NP
for IN B-PP
immune JJ B-NP
function NN I-NP
. . O

Here RB B-ADVP
COMMA COMMA O
we PRP B-NP
show VBP B-VP
that IN B-SBAR
zinc NN B-NP
addition NN I-NP
in IN B-PP
a DT O
serum- NN B-NP
and CC O
lipopolysaccharide-free JJ B-ADJP
cell NN B-NP
culture NN I-NP
system NN I-NP
leads VBZ B-VP
to TO B-PP
significantly RB B-NP
enhanced JJ I-NP
levels NNS I-NP
of IN B-PP
interleukin NN B-NP
1 CD I-NP
beta NN I-NP
( ( O
IL-1 NN B-NP
beta NN I-NP
) ) O
and CC O
tumour NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
( ( O
TNF-alpha NN B-NP
) ) O
and CC B-PP
to TO B-PP
expression NN B-NP
of IN B-PP
the DT B-NP
corresponding JJ I-NP
mRNA NN I-NP
in IN B-PP
human JJ B-NP
peripheral JJ B-NP
blood NN I-NP
mononuclear JJ I-NP
cells NNS I-NP
( ( O
PBMC NN B-NP
) ) O
. . O

Structurally RB B-NP
related JJ I-NP
divalent JJ I-NP
cations NNS I-NP
like IN B-PP
cobalt NN B-NP
COMMA COMMA O
nickel NN B-NP
COMMA COMMA O
and CC O
mercury NN B-NP
also RB B-ADVP
partially RB B-VP
increase VBP I-VP
monokine NN B-NP
secretion NN I-NP
but CC O
to TO B-PP
a DT B-NP
much RB I-NP
lower JJR I-NP
and CC I-NP
thus RB I-NP
insignificant JJ I-NP
extent NN I-NP
. . O

They PRP B-NP
fail VBP B-VP
to TO I-VP
induce VB I-VP
mRNA NN B-NP
of IN B-PP
TNF-alpha NN B-NP
after IN B-PP
3 CD B-NP
h NN I-NP
of IN B-PP
culture NN B-NP
. . O

Therefore RB B-ADVP
COMMA COMMA O
monokine NN B-NP
induction NN I-NP
is VBZ B-VP
a DT B-NP
zinc-specific JJ I-NP
effect NN I-NP
influenced VBN B-VP
by IN B-PP
the DT B-NP
physicochemical JJ I-NP
properties NNS I-NP
of IN B-PP
the DT B-NP
ion NN I-NP
. . O

Confirmation NN B-NP
of IN B-PP
the DT B-NP
unique JJ I-NP
significance NN I-NP
of IN B-PP
zinc NN B-NP
for IN B-PP
immune JJ B-NP
function NN I-NP
provides VBZ B-VP
a DT B-NP
better JJR I-NP
understanding NN I-NP
of IN B-PP
the DT B-NP
mechanisms NNS I-NP
of IN B-PP
specific JJ B-NP
zinc-mediated JJ I-NP
immune JJ I-NP
modulation NN I-NP
. . O

Sequence NN B-NP
analysis NN I-NP
and CC O
expression NN B-NP
in IN B-PP
cultured VBN B-NP
lymphocytes NNS I-NP
of IN B-PP
the DT B-NP
human JJ I-NP
FOSB NN I-NP
gene NN I-NP
( ( O
G0S3 NN B-NP
) ) O
. . O

G0S3 NN B-NP
is VBZ B-VP
a DT B-NP
member NN I-NP
of IN B-PP
a DT B-NP
set NN I-NP
of IN B-PP
putative JJ B-NP
G0\/G1 NN I-NP
switch NN I-NP
regulatory JJ I-NP
genes NNS I-NP
( ( O
G0S NN B-NP
genes NNS I-NP
) ) O
selected VBN B-VP
by IN B-PP
screening VBG B-VP
cDNA NN B-NP
libraries NNS I-NP
prepared VBN B-VP
from IN B-PP
human JJ B-NP
blood NN I-NP
mononuclear JJ I-NP
cells NNS I-NP
cultured VBN B-VP
for IN B-PP
2 CD B-NP
hr NN I-NP
with IN B-PP
lectin NN B-NP
and CC O
cycloheximide NN B-NP
. . O

The DT B-NP
sequence NN I-NP
shows VBZ B-VP
high JJ B-NP
homology NN I-NP
with IN B-PP
the DT B-NP
murine JJ I-NP
FOSB NN I-NP
gene NN I-NP
COMMA COMMA O
which WDT B-NP
encodes VBZ B-VP
a DT B-NP
component NN I-NP
of IN B-PP
the DT B-NP
AP1 NN I-NP
transcriptional JJ I-NP
regulator NN I-NP
. . O

Comparison NN B-NP
of IN B-PP
cDNA NN B-NP
and CC O
genomic JJ B-NP
sequences NNS I-NP
reveals VBZ B-VP
a DT B-NP
4-exon JJ I-NP
structure NN I-NP
characteristic JJ I-NP
of IN B-PP
the DT B-NP
FOS NN I-NP
family NN I-NP
of IN B-PP
genes NNS B-NP
. . O

Freshly RB B-NP
isolated VBN I-NP
cells NNS I-NP
show VBP B-VP
high JJ B-NP
levels NNS I-NP
of IN B-PP
FOSB\/G0S3 NN B-NP
and CC O
FOS\/G0S7 NN B-NP
mRNAs NNS B-NP
COMMA COMMA O
which WDT B-NP
decline VBP B-VP
rapidly RB B-ADVP
during IN B-PP
incubation NN B-NP
in IN B-PP
culture NN B-NP
medium NN I-NP
. . O

The DT B-NP
kinetics NNS I-NP
of IN B-PP
expression NN B-NP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
high JJ I-NP
initial JJ I-NP
levels NNS I-NP
are VBP B-VP
caused VBN I-VP
by IN B-PP
the DT B-NP
isolation NN I-NP
procedure NN I-NP
COMMA COMMA O
and CC O
do VBP B-VP
not RB I-VP
reflect VB I-VP
constitutive JJ B-NP
expression NN I-NP
. . O

In IN B-PP
cells NNS B-NP
preincubated VBN B-VP
for IN B-PP
a DT B-NP
day NN I-NP
COMMA COMMA O
levels NNS B-NP
of IN B-PP
FOS NN B-NP
mRNA NN I-NP
reach VBP B-VP
a DT B-NP
maximum NN I-NP
20 CD B-NP
min NN I-NP
after IN B-PP
the DT B-NP
addition NN I-NP
of IN B-PP
lectin NN B-NP
and CC O
decline VBP B-VP
to TO B-PP
control NN B-NP
levels NNS I-NP
over IN B-PP
the DT B-NP
next JJ I-NP
3 CD I-NP
hr NN I-NP
. . O

Levels NNS B-NP
of IN B-PP
FOSB NN B-NP
mRNA NN I-NP
reach VBP B-VP
a DT B-NP
maximum JJ I-NP
40 CD B-NP
min NN I-NP
after IN B-PP
the DT B-NP
addition NN I-NP
of IN B-PP
lectin NN B-NP
and CC O
decline VBP B-VP
to TO B-PP
control NN B-NP
levels NNS I-NP
over IN B-PP
the DT B-NP
next JJ I-NP
6 CD I-NP
hr NN I-NP
. . O

In IN B-PP
freshly RB B-NP
isolated VBN I-NP
cells NNS I-NP
COMMA COMMA O
both CC O
FOS NNS B-NP
and CC O
FOSB NN B-NP
mRNAs NNS B-NP
increase VBP B-VP
dramatically RB B-ADVP
in IN B-PP
response NN I-PP
to TO I-PP
the DT B-NP
protein NN I-NP
synthesis NN I-NP
inhibitor NN I-NP
cycloheximide NN I-NP
. . O

In IN B-PP
preincubated JJ B-NP
cells NNS I-NP
COMMA COMMA O
the DT B-NP
cycloheximide NN I-NP
response NN I-NP
is VBZ B-VP
decreased VBN I-VP
COMMA COMMA O
especially RB B-PP
in IN I-PP
the DT B-NP
case NN I-NP
of IN B-PP
FOSB NN B-NP
. . O

These DT B-NP
differences NNS I-NP
in IN B-PP
expression NN B-NP
of IN B-PP
FOS NN B-NP
and CC O
FOSB NN B-NP
suggest VBP B-VP
different JJ B-NP
roles NNS B-NP
and CC O
regulation NN B-NP
. . O

Regions NNS B-NP
of IN B-PP
low JJ B-NP
base NN I-NP
order-dependent JJ I-NP
stem-loop JJ I-NP
potential NN I-NP
in IN B-PP
the DT B-NP
region NN I-NP
of IN B-PP
the DT B-NP
gene NN I-NP
are VBP B-VP
defined VBN I-VP
. . O

These DT B-NP
indicate VBP B-VP
where WRB B-ADVP
base NN B-NP
order NN I-NP
has VBZ B-VP
been VBN I-VP
adapted VBN I-VP
for IN B-PP
purposes NNS B-NP
other JJ B-PP
than IN I-PP
stem-loop JJ B-NP
stability NN I-NP
( ( O
e.g. FW B-ADVP
COMMA COMMA O
encoding VBG B-VP
proteins NNS B-NP
or CC O
gene NN B-NP
regulation NN I-NP
) ) O
. . O

Regions NNS B-NP
of IN B-PP
low JJ B-NP
potential NN I-NP
in IN B-PP
a DT B-NP
68.5-kb JJ I-NP
genomic JJ I-NP
segment NN I-NP
containing VBG B-VP
the DT B-NP
FOSB NN I-NP
gene NN I-NP
suggest VBP B-VP
that IN B-SBAR
the DT B-NP
potential NN I-NP
may MD B-VP
help VB I-VP
locate VB I-VP
genes NNS B-NP
in IN B-PP
uncharted JJ B-NP
DNA NN I-NP
sequences NNS I-NP
. . O

Signaling NN B-NP
via IN B-PP
IL-2 NN B-NP
and CC O
IL-4 NN B-NP
in IN B-PP
JAK3-deficient JJ B-NP
severe JJ I-NP
combined JJ I-NP
immunodeficiency NN I-NP
lymphocytes NNS I-NP
: : O
JAK3-dependent JJ B-NP
and CC I-NP
independent JJ I-NP
pathways NNS I-NP
. . O

Both CC O
IL-2 NN B-NP
and CC O
IL-4 NN B-NP
bind VBP B-VP
to TO B-PP
receptors NNS B-NP
containing VBG B-VP
the DT B-NP
common JJ I-NP
gamma NN I-NP
chain NN I-NP
and CC O
JAK3 NN B-NP
. . O

Although IN B-SBAR
JAK3 NN B-NP
is VBZ B-VP
required VBN I-VP
for IN B-PP
proper JJ B-NP
lymphoid JJ I-NP
development NN I-NP
COMMA COMMA O
the DT B-NP
precise JJ I-NP
roles NNS I-NP
of IN B-PP
this DT B-NP
kinase NN I-NP
in IN B-PP
IL-2 NN B-NP
and CC O
IL-4 NN B-NP
signaling NN B-NP
in IN B-PP
lymphocytes NNS B-NP
have VBP B-VP
not RB I-VP
been VBN I-VP
defined VBN I-VP
. . O

Here RB B-ADVP
COMMA COMMA O
we PRP B-NP
have VBP B-VP
studied VBN I-VP
IL-2 NN B-NP
and CC O
IL-4 NN B-NP
signaling NN B-NP
in IN B-PP
B NN B-NP
cell NN I-NP
lines NNS I-NP
lacking VBG B-VP
JAK3 NN B-NP
. . O

Although IN B-SBAR
IL-2-induced JJ B-NP
phosphorylation NN I-NP
of IN B-PP
IL-2R NN B-NP
beta NN I-NP
COMMA COMMA O
JAK1 NN B-NP
COMMA COMMA O
and CC O
STAT5 NN B-NP
all DT B-ADVP
required VBN B-VP
the DT B-NP
presence NN I-NP
of IN B-PP
JAK3 NN B-NP
COMMA COMMA O
IL-4-mediated JJ B-NP
phosphorylation NN I-NP
of IN B-PP
JAK1 NN B-NP
COMMA COMMA O
STAT6 NN B-NP
COMMA COMMA O
and CC O
insulin NN B-NP
receptor NN I-NP
substrates NNS I-NP
1 CD B-NP
and CC O
2 CD B-NP
did VBD B-VP
not RB O
. . O

However RB B-ADVP
COMMA COMMA O
IL-4-induced JJ B-NP
effects NNS I-NP
were VBD B-VP
clearly RB I-VP
improved VBN I-VP
following VBG B-PP
JAK3 NN B-NP
expression NN I-NP
. . O

These DT B-NP
data NNS I-NP
indicate VBP B-VP
that IN B-SBAR
IL-4 NN B-NP
signaling NN I-NP
occurs VBZ B-VP
in IN B-PP
the DT I-PP
absence NN I-PP
of IN I-PP
of IN I-PP
JAK3 NN B-NP
COMMA COMMA O
but CC O
is VBZ B-VP
comparatively RB B-ADJP
inefficient JJ I-ADJP
. . O

These DT B-NP
findings NNS I-NP
may MD B-VP
help VB I-VP
in RP B-PP
understanding VBG B-VP
the DT B-NP
pathogenesis NN I-NP
of IN B-PP
the DT B-NP
immunodeficiency NN I-NP
that WDT B-NP
occurs VBZ B-VP
with IN B-PP
mutations NNS B-NP
of IN B-PP
JAK3 NN B-NP
and CC O
may MD B-VP
suggest VB I-VP
a DT B-NP
mechanism NN I-NP
for IN B-PP
the DT B-NP
pleiotropic JJ I-NP
effects NNS I-NP
of IN B-PP
IL-4 NN B-NP
. . O

Identification NN B-NP
of IN B-PP
Bcd NN B-NP
COMMA COMMA O
a DT B-NP
novel JJ I-NP
proto-oncogene NN I-NP
expressed VBN B-VP
in IN B-PP
B-cells NNS B-NP
. . O

A DT O
novel JJ O
B-cell NN O
derived JJ O
( ( O
Bcd NN B-ADJP
) ) O
oncogene NN B-NP
has VBZ B-VP
been VBN I-VP
isolated VBN I-VP
from IN B-PP
the DT B-NP
peripheral JJ I-NP
blood NN I-NP
lymphocytes NNS I-NP
of IN B-PP
one CD O
B-cell NN B-NP
chronic JJ I-NP
lymphocytic JJ I-NP
leukemia NN I-NP
( ( O
B-CLL NN B-NP
) ) O
patient NN B-NP
using VBG B-VP
DNA NN B-NP
transfer NN I-NP
and CC O
a DT B-NP
mouse NN I-NP
tumorigenicity NN I-NP
assay NN I-NP
. . O

The DT B-NP
Bcd NN I-NP
proto-oncogene NN I-NP
was VBD B-VP
activated VBN I-VP
by IN B-PP
a DT B-NP
truncation NN I-NP
in IN B-PP
the DT B-NP
5' JJ I-NP
UTR NN I-NP
. . O

It PRP B-NP
predicts VBZ B-VP
for IN B-PP
two CD B-NP
open JJ B-NP
reading NN I-NP
frames NNS I-NP
( ( O
ORFs NNS B-NP
) ) O
. . O

ORF1 NN B-NP
consists VBZ B-VP
of IN B-PP
240 CD B-NP
bp NN I-NP
that WDT B-NP
would MD B-VP
encode VB I-VP
80 CD B-NP
amino NN I-NP
acids NNS I-NP
COMMA COMMA O
while IN B-SBAR
the DT B-NP
major JJ I-NP
ORF2 NN I-NP
consists VBZ B-VP
of IN B-PP
648 CD B-NP
bp NN I-NP
capable JJ B-ADJP
of IN B-PP
coding VBG B-VP
for IN B-PP
216 CD B-NP
amino NN I-NP
acids NNS I-NP
. . O

Predicted VBN B-NP
peptide NN I-NP
sequence NN I-NP
of IN B-PP
ORF2 NN B-NP
contained VBD B-VP
a DT B-NP
zinc NN I-NP
finger NN I-NP
domain NN I-NP
which WDT B-NP
showed VBD B-VP
significant JJ B-NP
homology NN I-NP
to TO B-PP
GC NN B-NP
box NN I-NP
binding NN I-NP
proteins NNS I-NP
BTEB2 NN B-NP
and CC O
SP1 NN B-NP
. . O

Transfection NN B-NP
of IN B-PP
an DT B-NP
expression NN I-NP
vector NN I-NP
containing VBG B-VP
ORF2 NN B-NP
but CC B-CONJP
not RB I-CONJP
full JJ B-NP
length NN I-NP
cDNA NN I-NP
was VBD B-VP
able JJ B-ADJP
to TO B-VP
transform VB I-VP
NIH3T3 NN B-NP
cells NNS I-NP
and CC O
induce VB B-VP
tumors NNS B-NP
in IN B-PP
nude JJ B-NP
mice NNS I-NP
. . O

Bcd NN B-NP
mRNA NN I-NP
transcripts NNS I-NP
of IN B-PP
&lt; JJR B-NP
or CC I-NP
= JJ I-NP
2.6 CD I-NP
kb NN I-NP
were VBD B-VP
selectively RB I-VP
expressed VBN I-VP
in IN B-PP
PBL NN B-NP
and CC O
testis NN B-NP
of IN B-PP
healthy JJ B-NP
individuals NNS I-NP
. . O

Within IN B-PP
the DT B-NP
PBL NN I-NP
COMMA COMMA O
Bcd NN B-NP
gene NN I-NP
expression NN I-NP
was VBD B-VP
restricted JJ B-ADJP
to TO B-PP
CD19+ JJ B-NP
B-cells NNS I-NP
and CC O
absent JJ B-ADJP
from IN B-PP
CD14+ JJ B-NP
monocytes NNS I-NP
and CC O
T-cells NNS B-NP
. . O

Bcd NN B-NP
transcripts NNS I-NP
were VBD B-VP
detected VBN I-VP
in IN B-PP
all DT B-NP
normal JJ I-NP
PBL NN I-NP
samples NNS I-NP
tested VBN B-VP
but CC O
not RB B-PP
in IN I-PP
several JJ B-NP
malignant JJ I-NP
human JJ I-NP
B-cell NN I-NP
lines NNS I-NP
and CC B-PP
not RB B-PP
in IN I-PP
50 CD B-NP
% NN I-NP
of IN B-PP
B-cells NNS B-NP
from IN B-PP
B-CLL NN B-NP
patients NNS I-NP
. . O

However RB B-ADVP
COMMA COMMA O
stimulation NN B-NP
of IN B-PP
B-cells NNS B-NP
from IN B-PP
B-CLL NN B-NP
patients NNS I-NP
under IN B-PP
conditions NNS B-NP
which WDT B-NP
induced VBD B-VP
differentiation NN B-NP
into IN B-PP
plasma NN B-NP
cells NNS I-NP
was VBD B-VP
associated VBN I-VP
with IN B-PP
induction NN B-NP
of IN B-PP
Bcd NN B-NP
gene NN I-NP
expression NN I-NP
. . O

The DT B-NP
Bcd NN I-NP
gene NN I-NP
may MD B-VP
therefore RB I-VP
play VB I-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
B-cell NN B-NP
growth NN B-NP
and CC O
development NN B-NP
. . O

Pancreatic JJ B-NP
development NN B-NP
and CC O
maturation NN B-NP
of IN B-PP
the DT B-NP
islet NN I-NP
B NN I-NP
cell NN I-NP
. . O

Studies NNS B-NP
of IN B-PP
pluripotent JJ B-NP
islet NN I-NP
cultures NNS I-NP
. . O

Pancreas NN B-NP
organogenesis NN I-NP
is VBZ B-VP
a DT B-NP
highly RB I-NP
regulated VBN I-NP
process NN I-NP
COMMA COMMA O
in IN B-PP
which WDT B-NP
two CD B-NP
anlage NNS I-NP
evaginate VBP B-VP
from IN B-PP
the DT B-NP
primitive JJ I-NP
gut NN I-NP
. . O

They PRP B-NP
later RB B-ADVP
fuse VBP B-VP
COMMA COMMA O
and CC O
COMMA COMMA O
under IN B-PP
the DT B-NP
influence NN I-NP
of IN B-PP
the DT B-NP
surrounding VBG I-NP
mesenchyme NN I-NP
COMMA COMMA O
the DT B-NP
mature JJ I-NP
organ NN I-NP
develops VBZ B-VP
COMMA COMMA O
being VBG B-VP
mainly RB I-VP
composed VBN I-VP
of IN B-PP
ductal JJ B-NP
COMMA COMMA I-NP
exocrine JJ I-NP
and CC I-NP
endocrine JJ I-NP
compartments NNS I-NP
. . O

Early JJ B-NP
buds NNS I-NP
are VBP B-VP
characterized VBN I-VP
by IN B-PP
a DT B-NP
branching VBG I-NP
morphogenesis NN I-NP
of IN B-PP
the DT B-NP
ductal JJ I-NP
epithelium NN I-NP
from IN B-PP
which WDT B-NP
endocrine JJ B-NP
and CC I-NP
exocrine JJ I-NP
precursor NN I-NP
cells NNS I-NP
bud VBP B-VP
to TO B-VP
eventually RB I-VP
form VB I-VP
the DT B-NP
two CD I-NP
other JJ I-NP
compartments NNS I-NP
. . O

The DT B-NP
three CD I-NP
compartments NNS I-NP
are VBP B-VP
thought VBN I-VP
to TO I-VP
be VB I-VP
of IN B-PP
common JJ B-NP
endodermal JJ I-NP
origin NN I-NP
; : O
in IN B-PP
contrast NN I-PP
to TO I-PP
earlier JJR B-NP
hypotheses NNS I-NP
COMMA COMMA O
which WDT B-NP
suggested VBD B-VP
that IN B-SBAR
the DT B-NP
endocrine JJ I-NP
compartment NN I-NP
was VBD B-VP
of IN B-PP
neuroectodermal JJ B-NP
origin NN I-NP
. . O

It PRP B-NP
is VBZ B-VP
thus RB I-VP
generally RB I-VP
believed VBN I-VP
that IN B-SBAR
the DT B-NP
pancreatic JJ I-NP
endocrine-lineage NN I-NP
possesses VBZ B-VP
the DT B-NP
ability NN I-NP
to TO B-VP
mature VB I-VP
along IN B-PP
a DT B-NP
differentiation NN I-NP
pathway NN I-NP
that WDT B-NP
shares VBZ B-VP
many JJ B-NP
characteristics NNS I-NP
with IN B-PP
those DT B-NP
of IN B-PP
neuronal JJ B-NP
differentiation NN I-NP
. . O

During IN B-PP
recent JJ B-NP
years NNS I-NP
COMMA COMMA O
studies NNS B-NP
of IN B-PP
insulin-gene JJ B-NP
regulation NN I-NP
and CC O
COMMA COMMA O
in IN B-PP
particular JJ B-NP
COMMA COMMA O
the DT B-NP
tissue-specific JJ I-NP
transcriptional JJ I-NP
control NN I-NP
of IN B-PP
insulin-gene JJ B-NP
activity NN I-NP
have VBP B-VP
provided VBN I-VP
information NN B-NP
on IN B-PP
pancreas NN B-NP
development NN I-NP
in IN B-PP
general JJ B-NP
. . O

The DT B-NP
present JJ I-NP
review NN I-NP
summarizes VBZ B-VP
these DT B-NP
findings NNS I-NP
COMMA COMMA O
with IN B-PP
a DT B-NP
special JJ I-NP
focus NN I-NP
on IN B-PP
our PRP$ B-NP
own JJ I-NP
studies NNS I-NP
on IN B-PP
pluripotent JJ B-NP
endocrine JJ I-NP
cultures NNS I-NP
of IN B-PP
rat NN B-NP
pancreas NN I-NP
. . O

Induction NN B-NP
of IN B-PP
vascular JJ B-NP
cell NN I-NP
adhesion NN I-NP
molecule-1 NN I-NP
by IN B-PP
low-density JJ B-NP
lipoprotein NN I-NP
. . O

Low-density JJ B-NP
lipoprotein NN I-NP
( ( O
LDL NN B-NP
) ) O
is VBZ B-VP
a DT B-NP
well-established JJ I-NP
risk NN I-NP
factor NN I-NP
for IN B-PP
atherosclerosis NN B-NP
. . O

When WRB B-ADVP
endothelial JJ B-NP
cells NNS I-NP
are VBP B-VP
incubated VBN I-VP
with IN B-PP
this DT B-NP
lipoprotein NN I-NP
in IN B-PP
pathophysiologic JJ B-NP
amounts NNS I-NP
COMMA COMMA O
the DT B-NP
cells NNS I-NP
are VBP B-VP
activated VBN I-VP
. . O

Among IN B-PP
the DT B-NP
documented VBN I-NP
cellular JJ I-NP
responses NNS I-NP
to TO B-PP
LDL NN B-NP
is VBZ B-VP
increased VBN B-NP
recruitment NN I-NP
of IN B-PP
monocytes NNS B-NP
COMMA COMMA O
which WDT B-NP
are VBP B-VP
believed VBN I-VP
to TO I-VP
play VB I-VP
a DT B-NP
major JJ I-NP
role NN I-NP
in IN B-PP
promoting VBG B-VP
intimal JJ B-NP
plaque NN I-NP
formation NN I-NP
. . O

The DT B-NP
findings NNS I-NP
presented VBN B-VP
here RB B-ADVP
link VB B-VP
an DT B-NP
atheogenic JJ I-NP
lipoprotein NN I-NP
COMMA COMMA O
LDL NN B-NP
COMMA COMMA O
with IN B-PP
the DT B-NP
induction NN I-NP
of IN B-PP
an DT B-NP
adhesion NN I-NP
molecule NN I-NP
important JJ B-ADJP
in IN B-PP
atherogenesis NN B-NP

Human JJ B-NP
LDL NN I-NP
induces VBZ B-VP
the DT B-NP
vascular JJ I-NP
cell NN I-NP
adhesion NN I-NP
molecule-1 NN I-NP
( ( O
VCAM-1 NN B-NP
) ) O
transcriptionally RB B-ADVP
with IN B-PP
an DT B-NP
increase NN I-NP
in IN B-PP
mRNA NN B-NP
levels NNS I-NP
through IN B-PP
activation NN B-NP
of IN B-PP
the DT B-NP
VCAM NN I-NP
promoter NN I-NP
. . O

This DT B-NP
effect NN I-NP
is VBZ B-VP
blocked VBN I-VP
by IN B-PP
anti-VCAM JJ B-NP
antibodies NNS I-NP
. . O

After IN B-PP
a DT B-NP
2-day JJ I-NP
incubation NN I-NP
in IN B-PP
LDL NN B-NP
COMMA COMMA O
the DT B-NP
binding NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
which WDT B-NP
is VBZ B-VP
believed VBN I-VP
to TO I-VP
be VB I-VP
a DT B-NP
key JJ I-NP
oxidative-stress JJ I-NP
sensor NN I-NP
for IN B-PP
VCAM NN B-NP
regulation NN I-NP
COMMA COMMA O
remains VBZ B-VP
at IN B-PP
basal JJ B-NP
level NN I-NP
. . O

In IN B-PP
contrast NN B-NP
COMMA COMMA O
the DT B-NP
binding NN I-NP
activities NNS I-NP
of IN B-PP
AP-1 NN B-NP
and CC O
GATA NN B-NP
COMMA COMMA O
on IN B-PP
the DT B-NP
other JJ I-NP
hand NN I-NP
COMMA COMMA O
are VBP B-VP
increased VBN I-VP
by IN B-PP
LDL NN B-NP
. . O

Thus RB B-ADVP
COMMA COMMA O
a DT B-NP
component NN I-NP
of IN B-PP
LDL-enhanced JJ B-NP
endothelial JJ I-NP
recruitment NN I-NP
of IN B-PP
monocytes NNS B-NP
is VBZ B-VP
attributed VBN I-VP
to TO B-PP
VCAM-1 JJ B-NP
expression NN I-NP
COMMA COMMA O
which WDT B-NP
appears VBZ B-VP
to TO I-VP
be VB I-VP
mediated VBN I-VP
through IN B-PP
AP-1 NN B-NP
and CC O
GATA NN B-NP
. . O

These DT B-NP
data NNS I-NP
identify VBP B-VP
LDL NN B-NP
as IN B-PP
a DT B-NP
VCAM-inducer NN I-NP
possibly RB B-ADJP
distinct JJ I-ADJP
from IN B-PP
cytokines NNS B-NP
and CC O
endotoxin NN B-NP
. . O

The DT B-NP
NF-kappa NN I-NP
B NN I-NP
inhibitor NN I-NP
COMMA COMMA O
tepoxalin NN B-NP
COMMA COMMA O
suppresses VBZ B-VP
surface NN B-NP
expression NN I-NP
of IN B-PP
the DT B-NP
cell NN I-NP
adhesion NN I-NP
molecules NNS I-NP
CD62E NN B-NP
COMMA COMMA O
CD11b\/CD18 NN B-NP
and CC O
CD106 NN B-NP
. . O

Tepoxalin NN B-NP
COMMA COMMA O
a DT B-NP
dual JJ I-NP
enzyme NN I-NP
inhibitor NN I-NP
of IN B-PP
cyclooxygenase NN B-NP
and CC O
5-lipoxygenase NN B-NP
has VBZ B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
inhibit VB I-VP
T-cell NN B-NP
activation NN I-NP
. . O

Its PRP$ B-NP
immunosuppressive JJ I-NP
property NN I-NP
is VBZ B-VP
distinct JJ B-ADJP
from IN B-PP
cyclosporin NN B-NP
because IN B-SBAR
only RB B-NP
tepoxalin NN I-NP
COMMA COMMA O
but CC B-CONJP
not RB I-CONJP
cyclosporin NN B-NP
COMMA COMMA O
suppresses VBZ B-VP
NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
. . O

Here RB B-ADVP
we PRP B-NP
report VBP B-VP
that IN B-SBAR
tepoxalin NN B-NP
selectively RB B-ADVP
inhibits VBZ B-VP
intercellular JJ B-NP
adhesion NN I-NP
molecule-1 NN I-NP
( ( I-NP
ICAM-1 NN I-NP
COMMA COMMA I-NP
CD54 NN I-NP
) ) I-NP
\/MAC-1 NN I-NP
( ( I-NP
CD11b\/CD18 NN I-NP
) ) O
dependent JJ B-NP
adhesion NN I-NP
of IN B-PP
polymorphonuclear JJ B-NP
cells NNS I-NP
to TO B-PP
IL-1 NN B-NP
activated JJ I-NP
human JJ I-NP
umbilical JJ I-NP
vein NN I-NP
endothelial JJ I-NP
cells NNS I-NP
. . O

The DT B-NP
mechanism NN I-NP
of IN B-PP
inhibition NN B-NP
is VBZ B-VP
related JJ B-ADJP
to TO B-PP
the DT B-NP
surface NN I-NP
expression NN I-NP
of IN B-PP
several JJ B-NP
cell NN I-NP
adhesion NN I-NP
molecules NNS I-NP
. . O

Flow NN B-NP
cytometry NN I-NP
analyses NNS I-NP
on IN B-PP
cultured VBN B-NP
cells NNS I-NP
that WDT B-NP
were VBD B-VP
treated VBN I-VP
with IN B-PP
tepoxalin NN B-NP
or CC O
antisense JJ B-NP
oligonucleotides NNS I-NP
to TO B-PP
the DT B-NP
P65\/p50 NN I-NP
subunit NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
COMMA COMMA O
and CC O
then RB O
stimulated VBN B-VP
with IN B-PP
PMA NN B-NP
COMMA COMMA O
revealed VBD B-VP
a DT B-NP
reduced VBN I-NP
expression NN I-NP
of IN B-PP
CD11b\/CD18 NN B-NP
on IN B-PP
monocytic JJ B-NP
HL60 NN I-NP
cells NNS I-NP
COMMA COMMA O
and CC O
endothelial JJ B-NP
adhesion NN I-NP
molecule-1 NN I-NP
( ( O
CD62E NN B-NP
) ) O
and CC O
vascular JJ B-NP
adhesion NN I-NP
molecule-1 NN I-NP
( ( O
CD106 NN B-NP
) ) O
on IN B-PP
human JJ B-NP
umbilical JJ I-NP
vein NN I-NP
endothelial JJ I-NP
cells NNS I-NP
. . O

Expression NN B-NP
of IN B-PP
other JJ B-NP
adhesion NN I-NP
molecules NNS I-NP
such JJ B-PP
as IN I-PP
lymphocyte NN B-NP
function NN I-NP
associated-antigen-1 NN I-NP
( ( O
CD11a\/CD18 NN B-NP
) ) O
and CC O
CD54 NN B-NP
were VBD B-VP
unaffected JJ B-ADJP
. . O

Tepoxalin NN B-NP
also RB B-ADVP
inhibited VBD B-VP
the DT B-NP
secretion NN I-NP
of IN B-PP
a DT O
NF-kappa NN B-NP
B NN I-NP
regulated JJ B-NP
chemokine NN I-NP
COMMA COMMA O
IL-8 NN B-NP
COMMA COMMA O
a DT B-NP
known JJ I-NP
inducer NN I-NP
of IN B-PP
CD11b\/CD18 NN B-NP
expression NN I-NP
. . O

Thus RB B-ADVP
the DT B-NP
suppression NN I-NP
of IN B-PP
CD11b\/CD18 NN B-NP
expression NN I-NP
by IN B-PP
tepoxalin NN B-NP
may MD B-VP
involve VB I-VP
IL-8 NN B-NP
. . O

Our PRP$ B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
by IN B-PP
inhibiting VBG B-VP
NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
COMMA COMMA O
surface NN B-NP
expression NN I-NP
of IN B-PP
several JJ B-NP
adhesion NN I-NP
molecules NNS I-NP
can MD B-VP
be VB I-VP
modulated VBN I-VP
and CC O
that IN B-SBAR
tepoxalin NN B-NP
may MD B-VP
be VB I-VP
useful JJ B-ADJP
in IN B-PP
treating VBG B-VP
selected VBN B-NP
adhesion NN I-NP
mediated JJ I-NP
events NNS I-NP
such JJ B-PP
as IN I-PP
leukocyte NN B-NP
migration NN I-NP
or CC O
atherosclerotic JJ B-NP
plaque NN I-NP
formation NN I-NP
. . O

Expression NN B-NP
of IN B-PP
erythroid-specific JJ B-NP
genes NNS I-NP
in IN B-PP
megakaryoblastic JJ B-NP
disorders NNS I-NP
. . O

Currently RB B-NP
available JJ I-NP
data NNS I-NP
indicate VBP B-VP
that IN B-SBAR
erythroid JJ B-NP
and CC I-NP
megakaryocytic JJ I-NP
differentiation NN I-NP
pathways NNS I-NP
are VBP B-VP
closely RB B-ADJP
related JJ I-ADJP
to TO B-PP
each DT B-NP
other JJ I-NP
COMMA COMMA O
and CC O
there EX B-NP
may MD B-VP
exist VB I-VP
progenitor NN B-NP
cells NNS I-NP
common JJ B-ADJP
to TO B-PP
those DT B-NP
two CD I-NP
lineages NNS I-NP
may MD O
exist VB O
. . O

Acute JJ B-NP
megakaryoblastic JJ I-NP
leukemia NN I-NP
( ( O
AML-M7 NN B-NP
) ) O
and CC O
transient JJ B-NP
myeloproliferative JJ I-NP
disorder NN I-NP
in IN B-PP
Down NN B-NP
's POS B-NP
syndrome NN I-NP
( ( O
TMD NN B-NP
) ) O
are VBP B-VP
characterized VBN I-VP
by IN B-PP
rapid JJ B-NP
growth NN I-NP
of IN B-PP
abnormal JJ B-NP
blast NN I-NP
cells NNS I-NP
which WDT B-NP
express VBP B-VP
megakaryocytic JJ B-NP
markers NNS I-NP
. . O

These DT B-NP
blast NN I-NP
cells NNS I-NP
express VBP B-VP
lineage-specific JJ B-NP
transcription NN I-NP
factors NNS I-NP
such JJ B-PP
as IN I-PP
GATA-1 NN B-NP
common JJ B-ADJP
to TO B-PP
these DT B-NP
lineages NNS I-NP
and CC O
frequently RB B-VP
express VBP I-VP
erythroid-specific JJ B-NP
mRNAs NNS I-NP
such JJ B-PP
as IN I-PP
gamma-globin NN B-NP
and CC O
erythroid JJ B-NP
delta-aminolevulinate NN I-NP
synthase NN I-NP
( ( O
ALAS-E NN B-NP
) ) O
COMMA COMMA O
indicating VBG B-VP
that IN B-SBAR
most JJS B-NP
of IN B-PP
the DT B-NP
blasts NNS I-NP
in IN B-PP
M7 NN B-NP
and CC O
TMD NN B-NP
cases NNS B-NP
have VBP B-VP
erythroid JJ B-NP
and CC I-NP
megakaryocytic JJ I-NP
phenotypes NNS I-NP
. . O

These DT B-NP
results NNS I-NP
suggest VBP B-VP
that IN B-SBAR
blasts NNS B-NP
in IN B-PP
M7 NN B-NP
and CC O
TMD NN B-NP
may MD B-VP
correspond VB I-VP
to TO B-PP
progenitors NNS B-NP
of IN B-PP
both CC B-NP
erythroid JJ I-NP
and CC I-NP
megakaryocytic JJ I-NP
lineages NNS I-NP
. . O

Nuclear JJ B-NP
NF-ATp NN I-NP
is VBZ B-VP
a DT B-NP
hallmark NN I-NP
of IN B-PP
unstimulated JJ B-NP
B NN I-NP
cells NNS I-NP
from IN B-PP
B-CLL NN B-NP
patients NNS I-NP
. . O

B NN B-NP
lymphocytes NNS I-NP
from IN B-PP
the DT B-NP
peripheral JJ I-NP
blood NN I-NP
of IN B-PP
patients NNS B-NP
with IN B-PP
chronic JJ B-NP
lymphocytic JJ I-NP
leukaemia NN I-NP
( ( O
CLL NN B-NP
) ) O
were VBD B-VP
analysed VBN I-VP
for IN B-PP
the DT B-NP
nuclear JJ B-NP
presence NN I-NP
and CC O
DNA NN B-NP
binding NN I-NP
of IN B-PP
a DT B-NP
panel NN I-NP
of IN B-PP
transcription NN B-NP
factors NNS I-NP
which WDT B-NP
are VBP B-VP
involved VBN I-VP
in IN B-PP
the DT B-NP
gene NN I-NP
control NN I-NP
of IN B-PP
lymphoid JJ B-NP
cells NNS I-NP
. . O

The DT B-NP
following JJ I-NP
transcription NN I-NP
factors NNS I-NP
were VBD B-VP
studied VBN I-VP
: : O
the DT B-NP
Octamer NN I-NP
factors NNS I-NP
Oct-1 NN B-NP
and CC O
Oct-2 NN B-NP
COMMA COMMA O
members NNS B-NP
of IN B-PP
the DT B-NP
AP-1 NN I-NP
factor NN I-NP
family NN I-NP
COMMA COMMA O
NF-AT NN B-NP
factors NNS I-NP
COMMA COMMA O
in IN B-PP
particular JJ B-NP
NF-ATp NN B-NP
COMMA COMMA O
and CC O
members NNS B-NP
of IN B-PP
the DT B-NP
Rel\/NF-kB NN I-NP
family NN I-NP
. . O

We PRP B-NP
show VBP B-VP
that IN B-SBAR
the DT B-NP
constitutive JJ I-NP
nuclear JJ I-NP
translocation NN I-NP
of IN B-PP
NF-ATp NN B-NP
COMMA COMMA O
a DT B-NP
member NN I-NP
of IN B-PP
the DT B-NP
growing VBG I-NP
family NN I-NP
of IN B-PP
NF-AT NN B-NP
factors NNS I-NP
COMMA COMMA O
is VBZ B-VP
a DT B-NP
hallmark NN I-NP
of IN B-PP
nonstimulated JJ B-NP
B NN I-NP
cells NNS I-NP
from IN B-PP
CLL NN B-NP
patients NNS I-NP
that WDT B-NP
distinguishes VBZ B-VP
B-CLL NN B-NP
cells NNS I-NP
from IN B-PP
' `` B-NP
normal JJ I-NP
' '' I-NP
B NN I-NP
lymphocytes NNS I-NP
. . O

Constitutive JJ B-NP
nuclear JJ I-NP
appearance NN I-NP
was VBD B-VP
also RB I-VP
observed VBN I-VP
for IN B-PP
NF-kB2\/p52 NN B-NP
. . O

Constitutive JJ B-NP
binding NN I-NP
of IN B-PP
further JJ B-NP
factor NN I-NP
proteins NNS I-NP
to TO B-PP
DNA NN B-NP
COMMA COMMA O
such JJ B-PP
as IN I-PP
JunD NN B-NP
COMMA COMMA O
c-Fos NN B-NP
and CC O
FosB NN B-NP
COMMA COMMA O
was VBD B-VP
detected VBN I-VP
in IN B-PP
several JJ B-NP
patients NNS I-NP
whereas IN B-SBAR
the DT B-NP
localisation NN B-NP
and CC O
DNA NN B-NP
binding NN I-NP
of IN B-PP
other JJ B-NP
factors NNS I-NP
such JJ B-PP
as IN I-PP
c-Jun NN B-NP
COMMA COMMA O
RelA\/p65 NN B-NP
and CC O
c-Rel NN B-NP
was VBD B-VP
unaltered JJ B-ADJP
. . O

It PRP B-NP
is VBZ B-VP
remarkable JJ B-ADJP
that IN B-SBAR
in IN B-PP
B-CLL JJ B-NP
cells NNS I-NP
the DT B-NP
nuclear JJ B-NP
appearance NN I-NP
and CC O
DNA NN B-NP
binding NN I-NP
of IN B-PP
specific JJ B-NP
transcription NN I-NP
factors NNS I-NP
is VBZ B-VP
dramatically RB I-VP
affected JJ I-VP
whereas IN B-SBAR
other JJ B-NP
members NNS I-NP
of IN B-PP
the DT B-NP
same JJ I-NP
factor NN I-NP
family NN I-NP
remained VBD B-VP
unaltered JJ B-ADJP
in IN B-PP
these DT B-NP
leukemic JJ I-NP
cells NNS I-NP
. . O

It PRP B-NP
remains VBZ B-VP
to TO I-VP
be VB I-VP
shown VBN I-VP
which WDT B-NP
molecular JJ I-NP
events NNS I-NP
lead VBP B-VP
to TO B-PP
the DT B-NP
specific JJ I-NP
' `` I-NP
pre-activation NN I-NP
' '' O
COMMA COMMA O
i.e. FW B-ADVP
constitutive JJ B-NP
nuclear JJ I-NP
translocation NN I-NP
and CC O
DNA NN B-NP
binding NN I-NP
COMMA COMMA O
of IN B-PP
these DT B-NP
members NNS I-NP
of IN B-PP
NF-AT NN B-NP
COMMA COMMA O
NF-kB NN B-NP
and CC O
AP-1 NN B-NP
factor NN B-NP
families NNS I-NP
. . O

{ ( O
The DT B-NP
value NN I-NP
of IN B-PP
the DT B-NP
clinical JJ I-NP
test NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
of IN B-PP
peripheral JJ B-NP
blood NN I-NP
leukocytes NNS I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
chronic JJ B-NP
pulmonary JJ I-NP
heart NN I-NP
disease NN I-NP
} ) O

In IN B-SBAR
order NN O
to TO O
inquire VB B-VP
into IN B-PP
the DT B-NP
functional JJ I-NP
state NN I-NP
of IN B-PP
adrenal JJ B-NP
cortex NN I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
pulmonary JJ B-NP
heart NN I-NP
disease NN I-NP
COMMA COMMA O
the DT B-NP
number NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
( ( O
GCR NN B-NP
) ) O
of IN B-PP
peripheral JJ B-NP
blood NN I-NP
leukocytes NNS I-NP
in IN B-PP
patients NNS B-NP
with IN B-PP
chronic JJ B-NP
pulmonary JJ I-NP
heart NN I-NP
disease NN I-NP
was VBD B-VP
determined VBN I-VP
with IN B-PP
radioligand-binding JJ B-NP
assay NN I-NP
and CC O
the DT B-NP
corresponding JJ I-NP
plasma NN I-NP
cortisol NN I-NP
levels NNS I-NP
were VBD B-VP
assessed VBN I-VP
with IN B-PP
radioimmune JJ B-NP
assays NNS I-NP
. . O

The DT B-NP
results NNS I-NP
showed VBD B-VP
that IN B-SBAR
the DT B-NP
number NN I-NP
of IN B-PP
GCR NN B-NP
in IN B-PP
the DT B-NP
patients NNS I-NP
was VBD B-VP
significantly RB I-VP
reduced VBN I-VP
( ( O
P NN B-NP
&lt; JJR B-NP
0.01 CD I-NP
) ) O
and CC O
it PRP B-NP
was VBD B-VP
increased VBN I-VP
when WRB B-ADVP
their PRP$ B-NP
health NN I-NP
state NN I-NP
was VBD B-VP
improved VBN I-VP
. . O

However RB B-ADVP
COMMA COMMA O
it PRP B-NP
was VBD B-VP
still RB B-ADVP
lower JJR B-ADJP
than IN B-PP
that DT B-NP
in IN B-PP
healthy JJ B-NP
subjects NNS I-NP
( ( O
P NN B-NP
&lt; JJR B-NP
0.01 CD I-NP
) ) O
. . O

The DT B-NP
number NN I-NP
of IN B-PP
GCR NN B-NP
in IN B-PP
the DT B-NP
patients NNS I-NP
was VBD B-VP
greatly RB I-VP
increased VBN I-VP
when WRB B-ADVP
these DT B-NP
patients NNS I-NP
were VBD B-VP
treated VBN I-VP
with IN B-PP
oxygen NN B-NP
( ( O
P NN B-NP
&lt; JJR B-NP
0.01 CD I-NP
) ) O
. . O

No DT B-NP
difference NN I-NP
in IN B-PP
plasma NN B-NP
cortisol NN I-NP
was VBD B-VP
found VBN I-VP
between IN B-PP
the DT B-NP
patients NNS I-NP
and CC O
the DT B-NP
healthy JJ I-NP
subjects NNS I-NP
( ( O
P NN B-NP
&gt; JJR B-NP
0.05 CD I-NP
) ) O
. . O

These DT B-NP
results NNS I-NP
indicate VBP B-VP
that IN B-SBAR
the DT B-NP
function NN I-NP
of IN B-PP
adrenal JJ B-NP
cortex NN I-NP
may MD B-VP
be VB I-VP
improved VBN I-VP
by IN B-PP
the DT B-NP
compensation NN I-NP
mechanism NN I-NP
of IN B-PP
the DT B-NP
patients NNS I-NP
COMMA COMMA O
but CC O
the DT B-NP
lower JJR I-NP
GCR NN I-NP
number NN I-NP
was VBD B-VP
the DT B-NP
result NN I-NP
of IN B-PP
lacking NN B-NP
of IN B-PP
oxygen NN B-NP
in IN B-PP
the DT B-NP
patients NNS I-NP
. . O

The DT B-NP
number NN I-NP
of IN B-PP
GCR NN B-NP
may MD B-VP
be VB I-VP
improved VBN I-VP
by IN B-PP
inhalation NN B-NP
of IN B-PP
oxygen NN B-NP
. . O

Therefore RB B-ADVP
oxygen NN B-NP
therapy NN I-NP
is VBZ B-VP
helpful JJ B-ADJP
in IN B-PP
raising VBG B-VP
the DT B-NP
activity NN I-NP
of IN B-PP
glucocorticoid NN B-NP
receptors NNS I-NP
and CC O
controlling VBG B-VP
the DT B-NP
development NN I-NP
of IN B-PP
the DT B-NP
disease NN I-NP
. . O

Inhibition NN B-NP
of IN B-PP
nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
subunit NN I-NP
p65 NN I-NP
mRNA NN I-NP
accumulation NN I-NP
in IN B-PP
lipopolysaccharide-stimulated JJ B-NP
human JJ I-NP
monocytic JJ I-NP
cells NNS I-NP
treated VBN B-VP
with IN B-PP
sodium NN B-NP
salicylate NN I-NP
. . O

Lipopolysaccharide NN B-NP
is VBZ B-VP
one CD B-NP
of IN B-PP
the DT B-NP
most RBS I-NP
potent JJ I-NP
trigger NN I-NP
substances NNS I-NP
for IN B-PP
monocytes NNS B-NP
and CC O
macrophages NNS B-NP
causing VBG B-VP
secretion NN B-NP
of IN B-PP
inflammatory JJ B-NP
mediators NNS I-NP
such JJ B-PP
as IN I-PP
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
and CC O
interleukin-1 NN B-NP
. . O

The DT B-NP
nature NN I-NP
of IN B-PP
the DT B-NP
nuclear JJ I-NP
factors NNS I-NP
involved VBN B-VP
in IN B-PP
regulation NN B-NP
of IN B-PP
these DT B-NP
cytokine NN I-NP
genes NNS I-NP
is VBZ B-VP
still RB B-ADVP
unknown JJ B-ADJP
. . O

Nuclear JJ B-NP
factor NN I-NP
kappa NN I-NP
B NN I-NP
( ( O
NF-kappa NN B-NP
B NN I-NP
; : O
heterodimer NN B-NP
of IN B-PP
p50 NN B-NP
and CC O
p65 NN B-NP
) ) O
proteins NNS B-NP
have VBP B-VP
been VBN I-VP
suggested VBN I-VP
to TO I-VP
play VB I-VP
an DT B-NP
important JJ I-NP
role NN I-NP
in IN B-PP
gene NN B-NP
transcription NN I-NP
of IN B-PP
inflammatory JJ B-NP
mediators NNS I-NP
when WRB B-ADVP
monocytes NNS B-NP
are VBP B-VP
stimulated VBN I-VP
with IN B-PP
lipopolysaccharide NN B-NP
. . O

Nonsteroidal JJ B-NP
anti-inflammatory JJ I-NP
drugs NNS I-NP
such JJ B-PP
as IN I-PP
salicylates NNS B-NP
have VBP B-VP
been VBN I-VP
used VBN I-VP
to TO B-VP
treat VB I-VP
symptoms NNS B-NP
of IN B-PP
inflammation NN B-NP
COMMA COMMA O
and CC O
a DT B-NP
new JJ I-NP
mechanism NN I-NP
of IN B-PP
drug NN B-NP
action NN I-NP
was VBD B-VP
suggested VBN I-VP
recently RB B-ADVP
. . O

Salicylates NNS B-NP
have VBP B-VP
been VBN I-VP
shown VBN I-VP
to TO I-VP
inhibit VB I-VP
lipopolysaccharide-induced JJ B-NP
gene NN I-NP
transcription NN I-NP
via IN B-PP
inhibition NN B-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
activation NN I-NP
by IN B-PP
preventing VBG B-VP
the DT B-NP
degradation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
inhibitor NN I-NP
" `` I-NP
I NN I-NP
kappa NN I-NP
B NN I-NP
" '' O
COMMA COMMA O
blocking VBG B-VP
the DT B-NP
translocation NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
into IN B-PP
the DT B-NP
nuclear JJ I-NP
compartment NN I-NP
. . O

However RB B-ADVP
COMMA COMMA O
the DT B-NP
nature NN I-NP
of IN B-PP
the DT B-NP
subunit NN I-NP
involved VBN B-VP
in IN B-PP
this DT B-NP
mechanism NN I-NP
has VBZ B-VP
not RB I-VP
been VBN I-VP
defined VBN I-VP
. . O

To TO B-VP
examine VB I-VP
the DT B-NP
mechanisms NNS I-NP
by IN B-PP
which WDT B-NP
salicylates NNS B-NP
affect VBP B-VP
cytokine NN B-NP
gene NN I-NP
transcription NN I-NP
COMMA COMMA O
the DT B-NP
amount NN I-NP
of IN B-PP
active JJ B-NP
and CC I-NP
inactive JJ I-NP
NF-kappa NN I-NP
B NN I-NP
and CC O
NF-kappa NN B-NP
B NN I-NP
mRNA NN I-NP
COMMA COMMA O
in IN B-PP
Porphyromonas NN B-NP
gingivalis NN I-NP
lipopolysaccharide-stimulated JJ I-NP
human JJ I-NP
monocytic JJ I-NP
cells NNS I-NP
was VBD B-VP
assessed VBN I-VP
. . O

High JJ B-NP
doses NNS I-NP
of IN B-PP
sodium NN B-NP
salicylate NN I-NP
suppressed VBD B-VP
NF-kappa NN B-NP
B NN I-NP
p65 NN I-NP
mRNA NN I-NP
accumulation NN I-NP
COMMA COMMA O
resulting VBG B-VP
in IN B-PP
suppression NN B-NP
of IN B-PP
total JJ B-NP
NF-kappa NN I-NP
B NN I-NP
COMMA COMMA O
p50 NN B-NP
on IN B-PP
tissue NN B-NP
oligonucleotide NN I-NP
had VBD B-VP
no DT B-NP
effects NNS I-NP
on IN B-PP
lipopolysaccharide-induced JJ B-NP
NF-kappa NN I-NP
B NN I-NP
activation NN I-NP
. . O

The DT B-NP
data NNS I-NP
demonstrate VBP B-VP
that IN B-SBAR
the DT B-NP
p65 NN I-NP
subunit NN I-NP
of IN B-PP
NF-kappa NN B-NP
B NN I-NP
is VBZ B-VP
inhibited VBN I-VP
by IN B-PP
salicylate NN B-NP
treatment NN I-NP
and CC O
highlight VBP B-VP
the DT B-NP
role NN I-NP
of IN B-PP
salicylate NN B-NP
in IN B-PP
the DT B-NP
control NN I-NP
of IN B-PP
gene NN B-NP
expression NN I-NP
of IN B-PP
inflammatory JJ B-NP
mediators NNS I-NP
. . O

Lack NN B-NP
of IN B-PP
T-cell-mediated JJ B-NP
recognition NN I-NP
of IN B-PP
the DT B-NP
fusion NN I-NP
region NN I-NP
of IN B-PP
the DT B-NP
pml\/RAR-alpha NN I-NP
hybrid NN I-NP
protein NN I-NP
by IN B-PP
lymphocytes NNS B-NP
of IN B-PP
acute JJ B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
patients NNS I-NP
. . O

In IN B-PP
previous JJ B-NP
studies NNS I-NP
COMMA COMMA O
it PRP B-NP
was VBD B-VP
shown VBN I-VP
that IN B-SBAR
the DT B-NP
fusion NN I-NP
region NN I-NP
of IN B-PP
the DT B-NP
pml\/RAR-alpha NN I-NP
protein NN I-NP
COMMA COMMA O
expressed VBN B-VP
by IN B-PP
acute JJ B-NP
promyelocytic JJ I-NP
leukemia NN I-NP
( ( O
APL NN B-NP
) ) O
cells NNS B-NP
COMMA COMMA O
can MD B-VP
be VB I-VP
specifically RB I-VP
recognized VBN I-VP
in FW B-ADVP
vitro FW I-ADVP
by IN B-PP
donor NN B-NP
( ( O
D. NNP B-NP
E. NNP I-NP
) ) O
CD4 NN B-NP
T NN I-NP
cells NNS I-NP
in IN B-PP
a DT B-NP
HLA NN I-NP
class NN I-NP
II CD I-NP
DR11-restricted JJ I-NP
fashion NN I-NP
. . O

We PRP B-NP
present VBP B-VP
here RB B-ADVP
the DT B-NP
results NNS I-NP
on IN B-PP
the DT B-NP
recognition NN I-NP
of IN B-PP
several JJ B-NP
pml\/RAR-alpha NN I-NP
peptides NNS I-NP
by IN B-PP
APL NN B-NP
patients NNS I-NP
expressing VBG B-VP
HLA NN B-NP
DR11 NN I-NP
. . O

The DT B-NP
in FW I-NP
vitro FW I-NP
immunization NN I-NP
of IN B-PP
peripheral JJ B-NP
blood NN I-NP
lymphocytes NNS I-NP
from IN B-PP
four CD B-NP
patients NNS I-NP
in IN B-PP
remission NN B-NP
( ( O
S.R. NNP B-NP
COMMA COMMA O
F.R. NNP B-NP
COMMA COMMA O
M.M. NNP B-NP
COMMA COMMA O
P. NNP B-NP
G. NNP I-NP
) ) O
with IN B-PP
BCR1\/25 NN B-NP
COMMA COMMA O
a DT B-NP
25-mer NN I-NP
pml\/RAR-alpha NN I-NP
COMMA COMMA O
did VBD B-VP
not RB I-VP
elicit VB I-VP
either CC O
a DT B-NP
polyclonal JJ I-NP
or CC O
a DT B-NP
clonal JJ I-NP
immune JJ B-NP
response NN I-NP
specific JJ B-ADJP
to TO B-PP
the DT B-NP
peptide NN I-NP
. . O

We PRP B-NP
then RB B-ADVP
generated VBD B-VP
new JJ B-NP
donor NN I-NP
anti-pml\/RAR-alpha JJ I-NP
CD4(+) JJ I-NP
T-cell NN I-NP
clones NNS I-NP
. . O

These DT B-NP
clones NNS I-NP
were VBD B-VP
tested VBN I-VP
for IN B-PP
their PRP$ B-NP
recognition NN I-NP
of IN B-PP
BCR1\/25 NN B-NP
. . O

One CD B-NP
clone NN I-NP
( ( O
C3\/5 NN B-NP
COMMA COMMA O
CD3(+) JJ B-ADJP
COMMA COMMA O
CD4(+) JJ B-ADJP
COMMA COMMA O
CD8(-) JJ B-ADJP
) ) O
was VBD B-VP
selected VBN I-VP
for IN B-PP
further JJ B-NP
analysis NN I-NP
. . O

Clone NN B-NP
C3\/5 NN I-NP
showed VBD B-VP
specific JJ B-NP
proliferation NN B-NP
COMMA COMMA O
cytotoxicity NN B-NP
COMMA COMMA O
and CC O
cytokine NN B-NP
( ( O
tumor NN B-NP
necrosis NN I-NP
factor NN I-NP
alpha NN I-NP
COMMA COMMA O
granulocyte-macrophage JJ B-ADJP
colony-stimulating JJ I-ADJP
factor NN B-NP
) ) O
production NN B-NP
when WRB B-ADVP
challenged VBN B-VP
with IN B-PP
autologous JJ B-NP
lymphoblastic JJ I-NP
cell NN I-NP
lines NNS I-NP
pulsed VBN B-VP
with IN B-PP
peptide NN B-NP
BCR1\/25 NN I-NP
. . O

C3\/5 NN B-NP
cells NNS I-NP
developed VBD B-VP
specific JJ B-NP
proliferation NN B-NP
and CC O
cytotoxicity NN B-NP
when WRB B-ADVP
challenged VBN B-VP
with IN B-PP
peptide-pulsed JJ B-NP
lymphoblastic JJ B-NP
cell NN I-NP
lines NNS I-NP
and CC O
peripheral JJ B-NP
blood NN I-NP
lymphocytes NNS I-NP
from IN B-PP
the DT B-NP
four CD I-NP
DR11(+) JJ I-NP
APL NN I-NP
patients NNS I-NP
. . O

APL NN B-NP
blasts NNS I-NP
COMMA COMMA O
available JJ B-ADJP
only RB B-PP
from IN I-PP
patients NNS B-NP
F.R. NNP B-NP
and CC O
P.G. NNP B-NP
COMMA COMMA O
were VBD B-VP
not RB I-VP
lysed VBN I-VP
by IN B-PP
C3\/5 NN B-NP
and CC O
were VBD B-VP
unable JJ B-ADJP
to TO B-VP
present VB I-VP
peptide NN B-NP
BCR1\/25 NN I-NP
. . O

Incubation NN B-NP
of IN B-PP
APL NN B-NP
cells NNS I-NP
with IN B-PP
IFN-gamma NN B-NP
failed VBD B-VP
to TO I-VP
induce VB I-VP
HLA NN B-NP
class NN I-NP
II CD I-NP
molecules NNS I-NP
and CC O
recognition NN B-NP
by IN B-PP
the DT B-NP
C3\/5 NN I-NP
clone NN I-NP
. . O

Since IN B-SBAR
APL NN B-NP
cells NNS I-NP
do VBP B-VP
not RB I-VP
express VB I-VP
HLA NN B-NP
class NN I-NP
II CD I-NP
molecules NNS I-NP
COMMA COMMA O
we PRP B-NP
tested VBD B-VP
in IN B-PP
two CD B-NP
donors NNS I-NP
( ( O
D.E. NNP B-NP
and CC O
C.H.R. NNP B-NP
) ) O
and CC B-PP
in IN B-PP
patients NNS B-NP
S.R. NN B-NP
and CC O
P.G. NN B-NP
whether CC O
the DT B-NP
use NN I-NP
of IN B-PP
9-mer NN B-NP
peptides NNS I-NP
( ( O
BCR1\/9 NN B-NP
) ) O
would MD B-VP
generate VB I-VP
a DT B-NP
CD8\/HLA NN I-NP
class NN I-NP
I-restricted JJ I-NP
response NN I-NP
. . O

No DT B-NP
peptide-specific JJ I-NP
T-cell NN I-NP
line NN B-NP
or CC O
clone NN B-NP
could MD B-VP
be VB I-VP
generated VBN I-VP
from IN B-PP
both CC O
donors NNS B-NP
and CC O
patients NNS B-NP
. . O

These DT B-NP
findings NNS I-NP
are VBP B-VP
discussed VBN I-VP
in IN B-PP
relation NN I-PP
to TO I-PP
possible JJ B-NP
therapeutic JJ I-NP
approaches NNS I-NP
to TO B-PP
the DT B-NP
immunotherapy NN I-NP
of IN B-PP
APL NN B-NP
. . O

